<SEC-DOCUMENT>0000920148-23-000017.txt : 20230228
<SEC-HEADER>0000920148-23-000017.hdr.sgml : 20230228
<ACCEPTANCE-DATETIME>20230228140604
ACCESSION NUMBER:		0000920148-23-000017
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		122
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230228
DATE AS OF CHANGE:		20230228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LABORATORY CORP OF AMERICA HOLDINGS
		CENTRAL INDEX KEY:			0000920148
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133757370
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11353
		FILM NUMBER:		23683591

	BUSINESS ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215
		BUSINESS PHONE:		3362291127

	MAIL ADDRESS:	
		STREET 1:		358 S MAIN ST
		CITY:			BURLINGTON
		STATE:			NC
		ZIP:			27215

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NATIONAL HEALTH LABORATORIES HOLDINGS INC
		DATE OF NAME CHANGE:	19940314
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>lh-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5,d:9affef4b263d4c7097546e2ee7326a4a--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:lh="http://www.labcorp.com/20221231" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lh-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF80LTEtMS0xLTExNzAyOQ_2335c0ab-db80-4c17-84ee-adab86ba7fbe">0000920148</ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF81LTEtMS0xLTExNzAyOQ_39f344a7-1320-4254-bfab-b8260503d5dc">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF84LTEtMS0xLTExNzAyOQ_1b45a3e2-6804-4b10-a08d-3427f4ffcd9f">December 31, 2022</ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF85LTEtMS0xLTExNzAyOQ_cb343bf5-4c9b-4032-81ff-b3c6b743e232">2021</ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF8xMC0xLTEtMS0xMTcwMjk_df499d52-374d-4220-b88d-ab5873410e73">FY</ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF8xMS0xLTEtMS0xMTcwMjk_a2b79077-2b41-4425-8f4f-2c0703472a7b">FALSE</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzItMS0xLTEtMTE3MDI5_5bee593b-47f3-4b57-b723-174cb931b6ea">43.5</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzItMy0xLTEtMTE3MDI5_2248baec-71c6-42ea-96de-e2ef71539061">21.5</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzUtMS0xLTEtMTE3MDI5_022934dc-6776-44c0-8aa3-1daff8d6f7e5">88.2</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzUtMy0xLTEtMTE3MDI5_5b97fdfe-a8ee-42ba-abd7-a48f646c59d2">93.1</ix:nonFraction><ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</ix:nonNumeric><ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lh-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04baeb7b9b0c4b62bc8ac723f9759148_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3df4ce9e79c24b838b1688ef5f97af09_I20230227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic711bbfcced34e89878863bb09676b90_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieabfe2258e1446b192ef394f16489167_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b91351337c44079b374875b323d3e4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a7f666344b43219373509023b86a61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00703317297439a899a69e868562330_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7efbc2922164408c936797e755136d6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i174342f325564eb4800f5d7bafca1841_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91139fb3405c40e89005a42835b1528e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6714ab30154ab7adf7919442029308_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41204750b78b41e99bbfcab862d31763_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22ae928d35a54533906182c59b812aa3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba36eacc3c943cca03f3598759b2674_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0855e4e7139742529986707c444dfb8e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6cb383b4834da09d62346a62279532_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a5e69b64f4d470b8506561651160652_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4525567f3af4381925d303df86c2fd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>lh:Employee</xbrli:measure></xbrli:unit><xbrli:context id="ib253ed0180004b288aff33fe175b56f2_I20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77657f2f79234f079d9a8cd7d6c65a76_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a4f1d89351477a9562246200d846a1_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bfd8f9f712d4be1a34741259880f138_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59610a560d54411f901c49edcd62d761_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8132459128c444ab29724e750a1d08f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29cec420761b431ca0cff711e7a085bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5185fa2e825b418aaad59fc411dd8793_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82508c48b8e24f59b776527555dac0a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i716799a1a7a34a15b3e9adffdce6996d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icff6b868a72748489c76618831c34913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56cc8aeb3db74b298d1f3c1cc41c86b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9537d406d674d4bbf0f98e30498723b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d55b4cb03d64378863d2e96d420a6d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f313e3a123c4e398f0c391421791a68_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id782ff201d364db6a73b7f362d0a9678_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061db6fec9f94dce9fe88b9a6f4fc138_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab6bb1719c3747d69b101c25f39073a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b6a6d5c6ce048f5affe8b3f830295da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94949d3130ed4a5799cf762de995588d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a92509bdd1c40ecb4512f86503921ae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5ba3c1e35eb464c897bb213112248c3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a192c3cef59471da28f4a1f91336aa3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8df4fdf2ac64fa69822e22b9afd91f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c8d59fa396741e39a1c2b4ec07bf248_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4750c2997b414c319516d7f0f3c2d043_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="y"><xbrli:measure>utr:Y</xbrli:measure></xbrli:unit><xbrli:context id="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib808cf79e1a9467cb239ce57e26f5d7a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08dd77efa97448c782606eca830b8ac9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8553f543bdb4c5ea631132f326bb1fb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05bf67d55164f34a2b82099cdad4337_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d2be985d134f92a0588488c2ad06b2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bb990f93a5446cc99f3cafcfb16a8c7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70260250d8b54b01818e471ec885d017_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a5f472de164e8dbe46d04714a66b05_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c371a44ae834a938c2eab8e3804c578_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c412272fff644b58159484e9b5ae929_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia869d1147bc1446495aafb25f926c462_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i965638d43bce41e3b02735b64f560508_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia91cd079354742c0867df4a66528389e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19585208fde04b1c81981c0ca9f09061_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3128ec1b43564e2d96eb81597c02d663_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacdf9de7116494789ce8f50dcb91a04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5219a3f22dd9428d97614fe3e7a1a766_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19f57dcee3c4712a2023169a0f785c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcd8265eb4614ca3a1c91f1a4b31e2c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia997b5615fe74d49820b0e37481079c8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d6b5e93fe48483fa4d489a84eb90fcb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if90cdd4fb44c490e8db96e23d840e242_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604cb92437094b8da834d312ee51fefc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2cf3a400b1f476ea5787c60f96898cd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71debf6a8f0d4523940cba33bbfde672_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:PGDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:AscensionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bcda50b59314d499c99aefc300d073a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:MeasurementPeriodAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd6fa1609f454ee999006a2ca5c7fbf4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:PGDxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab204c91683402d8304f351f2d9d8b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:AscensionAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib16467344b1b432cbe4bb34ac4e88ed2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:MeasurementPeriodAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2021AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i252781e154ce4ee68f3712bac1795dba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:ExcludingEnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3c9245830049a8a009561519bdef0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib748907fa89944549ecc3829559ec590_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i346bf5e89d8c47e791d9565de78267f2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2020AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2020AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:ExcludingEnvigoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id29c59dc621c4fc5a3ef2e75514684f8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f418d9de6144d5faff8fb13ade9ed0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2019AcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f046cd09934cefaa22ced67e90f4fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife7be025871a46fd9996d5ad9debe4f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ab45a11aea4219a7df41bd1d97f0ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb2ae9f163ab4ccfb154f4e3d2b57376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ba475ac08fc422a97df2c8e89234910_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9115627d081a4e7f8da9645e6c6e0dbd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15ec77218cf94460acd857ca3fc42292_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id32383bcdde34b8fbc97617bf62c3dd2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7758f5f025ff42db97476f45552e5168_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea6006a8e5f2488bbb8e13dc157b4650_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1624bc86da8f4e7c97d88cbeedab552c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i761a366fe39c434287e8300df93759d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34a480df3781456c930f1c1d2bf6e6d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i811cf99c6ab84718b8ec51529c8c38e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b1af064155a4d36999ebf514f2fb89f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950679da32524bd98789e95cea30a39a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if213a3c74f2f48209419ad339b5b7d96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia778a92aafcf4f3b86b6acf7a5f3bd00_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6f1b47c1da4a07a4d90f7f6d9d6873_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4c96b0a864423fb6941c990f0bd412_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06896b17e3534bd886142dad93e0126c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7047efd7d9e048fc9d889f0909b29db0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2d22758b6b4c40aba801d1dee0b10e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c4ccb6a1234b26931a664345261420_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i467dc562a91848b1b0ce1f13ff671106_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id565f2f485384d39b6ede80e66028f65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ab483bf28244679437409e834f6f56_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7460360be9421682235ca8d2d1749e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec9e46526e14376968e12d3425dfbdc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i394a9bbf406443b3a0435107240e0db4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4cde614e4cb446986b4fbfecce3dcce_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d54c5d3e8640c59106fdafc1864dc7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40cd958885374ef0bb6f568bdbc00731_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ced70fc3e4428cb308d3a5643870c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3297036cb7294fb5ad2fc2995880b522_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6584c6c572e74242b54ad664f78e8847_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34801d131d6f4e44960ce44490a04267_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2265572a137642caacddaf6582838a7e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i653a67810f964ce0b55ec76d45884668_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea8da233e774824b5531b77c20884c5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:MediaContentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MediaContentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e23aae794934b8d8478e5f0a45bacac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic421e408749148f891c6d7f1c116e693_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe4125fff374c76adf4d24857926f50_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3735b80739147d5a271f0e1938aabc1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89543227f0574d3080d3504a668d3480_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ab31968f0e34f71a97366c123d49ff0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:SeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ba87d3d0c7416484b4fcb375524965_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermDebtIssueCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i065eee6e47b54c3090870de60295f740_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermDebtIssueCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd89f07e99954cd38ca792abfb00c002_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:NotePayableCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75e40fe043084cb7ba090e2fc3810877_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:NotePayableCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d9f832f2302410f92ba15e850ffaa63_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b64d538c794125b25d372f3e739448_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ebdf7872d5a46479565341763836748_I20190603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied82a46b37fa415f996b1384457e6076_I20141219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i241890ceccc848f18d43631185197134_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22a0f88f6f224901b84e2ba995acd60f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">lh:A2022ASRSettlementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a95541978174baabe4f6bf28dc42c4e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lh:A2022ShareRepurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2257a78dc611411cbe54235fc9161d50_I20230207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i612c1ffa3dbf48b1ba151c5142988893_D20230112-20230112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-12</xbrli:startDate><xbrli:endDate>2023-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb5d5fbbddd149d0a71aea12be2f36ad_I20230112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9deaf97408a241ccbbd50fa1238da6cd_D20230313-20230313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-13</xbrli:startDate><xbrli:endDate>2023-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i042ee9fdbf47424cb316cf8e47c149ca_D20230223-20230223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-23</xbrli:startDate><xbrli:endDate>2023-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536124e79a094520854fc8863d11ccad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7178226fd2c74faf83c80dbbaa06de64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbadcad8fa62418ba708fec2acad3e8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">lh:Post2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa411a036c347a7814b3b8f3d7473d6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lh:FederalLossCarryoverDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc08ff0a0d474d61afc14770005abe03_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973ac99fa8bc44b7b6e05a3777b91219_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90bbd94ee3fd44f1a0f4ecc350cc8574_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514823945de04d5ca0f42a63418890ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8b4d8b13a24d3298f7077d489fb327_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e10f76783344eadb4cecdca2d63df8b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i804964d2063644ac808d8d6365286160_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i390fbbf533d04684b80801b69914f782_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1bc0781f34c41a480538dd92da69d4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49569d8604944a6835acbc1ac8e6491_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60896f9da0414bb28b3e4a6cb0503006_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i121f72a018ec4c9f8b54ddf0db87bf57_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:CashBalanceRetirementPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883357ce9ee9480da21af5fa83f5e410_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:CashBalanceRetirementPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2273640650a44965b54c030f812dcedd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804f88e2691b4702a7deef00d5e7453d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:UKPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f604723897e4eb18b2d274c0a3e642e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b51bec3994e47d28d92a02668477358_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb1ac24816154f94bf39eb4750cfb55d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f42b96cf07842bf9fa62fba969481aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0963421655a043af8a2b5bbb8989a17c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05fb58427b7c4800985757cce94eaf0d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i891ad191af8840378b461971806bc9ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie883fffe23064af6952bf1c7966447d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75b0f3b14f749a2a2501b3580890929_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44818990a4aa4815b47c3efcb5d6ae2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af7b58ae38646cf89971672cf01e93e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i446afb2f73d045dda711f7c831299b78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9e08d02460648ceb4f5d1073cf29452_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30b8718e15b74da59c3573b8d71f7af5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f729a2b5424259b6e99e69e9d72ff9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24dd8a27e334839bd22287ccd572072_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192893a861a0482dad94f453f9c613a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:InternationalDevelopedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7439af4f1d3a4692b0653838638d8af8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:UsFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84b6a0f91f946deb9c23815d77889ba_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df3c43a8db540988490dbc3e564ddea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e1165a52a6489db2d1942fb682beb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia678cf83b6f6441dad461ad8e5dd1bd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02645e959c074c3f93e3d43221951719_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:MutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3662d054eed4f3eb5eafc0e90748600_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a1ab53d5f946889e265c64121dfdef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4323784b9ba6471abb2b94652c3bbd60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i911d298b24e044ba8bf3996c13022e04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:InternationalDevelopedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia533eccefe7c42269410fcbf42b37fbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0179f13a6a7141e6a26b122221a62bff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:UsFixedIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90d8ce237094025b4a5a63bbeb2766e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd158ee242794532a7ea7bd54577418d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f7b3a1a2f964982926273037d0b54b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:MutualFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i099c0ee08c294db19c4ae5023b72d7bc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8343104e0af14f108a0fbe74beca5c54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ec771cc41634795906fe138e1c81da2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7cf312ecfe346bc8025109327803b22_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0255c909ecf4062be8e1ef4d572ecce_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460a5c47a3364d9fb3e031edfbfbabf3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfdcdc0c2f94425c91be11297fbb8ce7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia240fb91ddb54361a789dbb9530b8f1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8760f818f2b14f7fbcf0a940eec93d45_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f143c0038649379b2fa66b119f8d69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i692e176a76174874b466ab85db6c1c50_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52b7c1c428d4e3eb3aaf9e375478112_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib97b7437ac9d4146bc2f4ed185519c80_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6813336b6e7e427a800450b3823e6bec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0fe63c273ca4dc4a880fceff9e1b046_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9b971586ec34065819f0eebea18797c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic020e345f5144121aead1d17fd7809f2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea4ad6f940d54031b324772fcccbf937_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d404caf16a542c58ecb2494a483b6d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd89c14ab1bc418b95827960d8faf263_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6911f4e40cef4e0daf420e676d7ec31a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f3586c7f5d42f880ddfd468ec2f11f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cd1a0cfffa24ae3b00be3abc0a69934_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74347e5ffa2b413b99cd4565f3bf9e5e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8535bd9bae349cda74905f20fef9702_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae84d9b5d624724bd2b3879c40582be_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95215116016547b1b171fa14b5466684_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5709179a954534b3ce4e1599336837_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c42916431b444feabb231e74e766011_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8799065c4f474b92bc1ecf19ea0d73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b1e06d6958940bf87696cd12422aa1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2e111bc212c4b4b8fa775e86b3df66c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1897fa2127453ea83329424c5d5a7c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e936d64daeb461b84ea45f5f4b467e5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfb61b234a44fe89faf7bfc24db3774_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d1e82ad70f4603a498897f322acee1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe23aa99b6847ed961d4fb0f516aeb5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide46a6b378da475296703e0ec9e436bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i471286d90c4d438bb8e6af11b7d82b62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d960808d8d4f428d66f07f05dab5ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eeb4246efc64a0cb377026f549a6398_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i499f72b196a94fd5ad14338aeaee2727_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6761ac2c526642dd8202c09476f40e82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6496b6e7dad462cbf7891c975366ed1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8742ac35d38745ad93ae0f53d955fd73_I20130331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62637e2f6fb743b9ae7a0465221d295a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72fecf8a9a614c76a5f20c1427477921_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402e968b57904d3c829927474cb21229_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2022SwapAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34dcbd66606a4b4bbdf2c53cc57f54e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3e361c43a754d01b7cfa82e6747efc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d4a564210ff40f48048c331cff9cf8b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d9c8469896f45ecba498b0ede39dbb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50138a8641f3407a9f5402ee74004755_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3097c8bb523449408d110548f79bebbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i109abf7ae534497d9389f80792db885b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b210f3dae2a47ea886765221136d822_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93446d1780df4a17825fb9e3f5392c19_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c02350e7d7648358cd4fcc8dac9614c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i009fbbaa1fa344c2b260736d3d45ab4b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264e173e323a4a219f6dc0e8e01fa43f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc8674bb0c33459fbc4f9f5bbe2b7c1e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2ec3658b894ce2949ed8539bf599fb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fbdfe4753ce4100b31ceb13d3703285_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia768e38536fd419f880dba505b33374f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536e737a10ed408381b0090740cf262a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e70f9eae14480099b40da70d85557b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8003dc869194e32943cb16d8eb14897_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a321f32243f4029afccd94fb3812764_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida3e59b3cfa94c3a8576e7a963f623b4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieacd7dfc507846ec8b5ce92f17564027_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e71eb1cfbd34d7fb34466d92877d3c6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcbab8d63eb841018519ada24b99d545_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c5cb78f4904c6aacf992f36ac8a90c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64aa8e649bdb4c108b75103b2eb4a2fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56daedd82c3646baa58c1523980c51f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide1d0653044641ba893251b0fd4296c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i502b3fc0ff254fd1bf2c37a2fa0d8698_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15d2c61db1f64f1b9741884acf529ebf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17669eb64069457a845cbd59f00480e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ae52be303bc4ee4954f1fb18ca47961_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a7562319b848598560ae7b3eb035ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de2a6c8c4714f6c8bfd3e3f4c4ff1f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id75f25869b5146e58f626502da7c7971_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ce077a3e4744e96a9f84ad3d59a2424_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic98ae2d3393544a89fec8d3f7e79ceb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia62a4bb28ea746489ab2bda95c3e5be5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib64989aa30ef4d9295e8155f32cda7f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000920148</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9affef4b263d4c7097546e2ee7326a4a_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgz_d437eedd-a60e-49b6-8abf-57f6aa3caa7f">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">[</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg0_fce0c7fa-2017-4af9-bab2-db582913ccbf">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended&#160;December 31, 2022 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">[</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc4_c9d6ed54-d7f7-42a7-afe2-f2ccfaef6011">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ______ to&#160;&#160;______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission file number - <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg1_221c68b1-b99e-4b2d-9c7d-5dd6943b7a94">1-11353</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg2_eea1b153-30ab-4b4c-9905-8c2f860aafb7">LABORATORY CORPORATION OF AMERICA HOLDINGS</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6ZjhhMTAyMGMwYmRiNGE1ZTk3MWQ5OGY5NmE1M2YyNTUvdGFibGVyYW5nZTpmOGExMDIwYzBiZGI0YTVlOTcxZDk4Zjk2YTUzZjI1NV8wLTAtMS0xLTExNzAyOQ_29521173-5b92-4f48-924e-d42520eabb44">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6ZjhhMTAyMGMwYmRiNGE1ZTk3MWQ5OGY5NmE1M2YyNTUvdGFibGVyYW5nZTpmOGExMDIwYzBiZGI0YTVlOTcxZDk4Zjk2YTUzZjI1NV8wLTItMS0xLTExNzAyOQ_e724134b-68c4-46c4-bea0-c8acb607c9fb">13-3757370</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:23.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8wLTAtMS0xLTExNzAyOQ_975e90bf-3866-4fd2-bf2e-24c7cc645e56">358 South Main Street</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTAtMS0xLTExNzAyOQ_ebe590a6-55ec-4c37-8ab2-36fb4b3cca3d">Burlington,</ix:nonNumeric> </span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTEtMS0xLTExNzAyOQ_a7b92f49-735e-41f6-a1b7-d22aced14a01">North Carolina</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTMtMS0xLTExNzAyOQ_a1d9720d-805f-4c27-9ba9-3c738579d648">27215</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc0_e64a3f9f-2298-4425-865c-7a022b31ec51">336</ix:nonNumeric>-<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc1_b52ce19e-46f2-469d-891c-5cab0e431fc7">229-1127</ix:nonNumeric> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTAtMS0xLTExNzAyOQ_03edfa8c-be6a-4137-814a-e27699ab4277">Common Stock, $0.10 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTEtMS0xLTExNzAyOQ_800146d3-0af7-476c-9736-ab5e6e5cc615">LH</ix:nonNumeric></span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTItMS0xLTExNzAyOQ_1996f8a0-38b2-423f-bfc5-026c6a377338">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc5_192e40cd-831e-4a16-8322-f6c662459b82">Yes</ix:nonNumeric> [X] No [&#160;&#160;]. &#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes [&#160;&#160;] <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg3_3be64ec0-f174-43bc-b4b5-cbdc003d283d">No</ix:nonNumeric> [X]. &#160;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc3_3fd67593-0c5a-4553-856a-a442c1e9cee9">Yes</ix:nonNumeric> [X] No [&#160;&#160;].</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgw_ac6442da-33f5-4021-bce0-bb57fc4eadb7">Yes</ix:nonNumeric> [X] No [&#160;&#160;].</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8wLTAtMS0xLTExNzAyOQ_688bed30-0ff3-4696-8b2c-945fe8a2121e">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8xLTMtMS0xLTExNzAyOQ_ed36906f-fd59-4fb8-a540-f729f7689fd3">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8yLTMtMS0xLTExNzAyOQ_4c6ebbc6-eae2-4251-9b5c-8e2c5d114b67">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:2pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   Yes <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgy_c369acb4-69d4-42f8-ac53-5ee5864dee10">&#9746;</ix:nonNumeric> No [&#160;&#160;].&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;Yes [</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc2_55f3d903-7082-46d8-b13f-38daf09cf9e4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">] No [X].</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i04baeb7b9b0c4b62bc8ac723f9759148_I20220630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8yODY3_a0826877-09a8-4801-b086-96684029aeac">20.2</ix:nonFraction> billion, based on the closing price on such date of the registrant&#8217;s common stock on the New York Stock Exchange.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date: <ix:nonFraction unitRef="shares" contextRef="i3df4ce9e79c24b838b1688ef5f97af09_I20230227" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zMTA3_11e47222-d3dd-4d5d-afe1-4179797ffdfe">88.5</ix:nonFraction> million shares as of February&#160;27, 2023.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg5_d12b5485-a9cf-409b-9fa9-8b48fad45363" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">List hereunder the following documents if incorporated by reference and the Part of the Form&#160;10-K into which the document is incorporated:</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the Registrant&#8217;s Notice of Annual Meeting and Proxy Statement to be filed no later than 120&#160;days following December&#160;31, 2022, are incorporated by reference into Part III.</span></div></ix:nonNumeric><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Index</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_10">Summary of Material Risks</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_10">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_16">Part I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_19">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_19">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_73">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_73">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_76">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_76">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_79">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_79">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_82">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_82">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_85">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_85">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_88">Part II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_91">Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_91">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_94">Selected Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_94">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_97">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_97">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_109">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_112">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_112">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_115">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_115">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_118">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_121">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_121">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_124">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_124">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_127">Part III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_130">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_130">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_133">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_133">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_136">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_136">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_139">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_139">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_142">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_142">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_145">Part IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_148">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_148">68</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_151">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_151">71</a></span></div></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_10"></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:center;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Material Risks</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Holdings together with its subsidiaries (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> or the Company) is subject to a variety of risks and uncertainties, including risks that could have a material adverse effect on its business, consolidated financial condition, revenues, results of operations, profitability, reputation, and cash flows. This summary should be read together with the more detailed description of the risks that the Company deems material described under &#8220;Risk Factors&#8221; in Item 1A of this Annual Report on Form 10-K (Annual Report) and should not be relied upon as an exhaustive summary of the material risks facing the Company&#8217;s business. In addition to the following summary, investors should carefully consider all of the information set forth in this Annual Report before deciding to invest in any of the Company&#8217;s securities. The risks below are not the only ones that the Company faces. Additional risks not presently known to the Company, or that it presently deems immaterial, may also negatively impact the Company. This Annual Report also includes forward-looking statements, immediately following this risk summary, that involve risks or uncertainties. The Company&#8217;s results could differ materially from those anticipated in these forward-looking statements as&#160;a result of certain factors, including the risks described below and elsewhere. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Company&#8217;s Business Including Global Economic and Geopolitical Factors</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">General or macro-economic factors in the United States (U.S.) and globally may have a material adverse effect upon the Company, and significant fluctuations in the economy, inflation and an increase in the costs of goods and services could negatively impact testing volumes, drug development services, cash collections, profitability, and the availability and cost of credit.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Operations may be disrupted and adversely impacted by the effects of adverse weather, natural disasters, geopolitical events, public health crises, hostilities or acts of terrorism, acts of vandalism, disruption to supply chains, access to natural resources, and other catastrophic events outside of the Company's control.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">An inability to attract and retain experienced and qualified personnel, including key management personnel, and increased personnel costs, could adversely affect the Company&#8217;s business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Continued changes in healthcare reimbursement models and products, changes in government payment and reimbursement systems, or changes in payer mix, including an increase in third-party benefits management programs and value-based payment models, could have a material adverse effect on the Company's revenues, profitability, and cash flow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Changes in government regulation or in practices relating to the pharmaceutical, biotechnology or medical device industries could decrease the need for certain services that the Company provides.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt">Increased competition, including price competition, could have an adverse effect on the Company&#8217;s revenues and profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Failure to obtain and retain new customers, the loss of existing customers or material contracts, or a reduction in services or tests ordered or specimens submitted by existing customers, or the inability to retain existing and/or create new relationships with health systems could impact the Company&#8217;s ability to successfully grow its business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Discontinuation or recalls of existing testing products, failure to develop or acquire licenses for new or improved testing technologies, or the Company's customers using new technologies to perform their own tests, could adversely affect the Company&#8217;s business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt">Changes or disruption in services, supplies, or transportation provided by third parties could adversely affect the Company&#8217;s business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt">A failure to identify and successfully close and integrate strategic acquisition targets could have a material adverse effect on the Company's business objectives and its revenues and profitability.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Unfavorable labor environments, union strikes, work stoppages, union or works council negotiations, or failure to comply with labor or employment laws could adversely affect the Company's operations and have a material adverse effect upon the Company's business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt">Continued and increased consolidation of pharmaceutical, biotechnology and medical device companies, health systems, physicians, and other customers could adversely affect the Company's business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.23pt">Damage or disruption to the Company's facilities could adversely affect the Company's business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Financial Matters </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company bears financial risk for contracts that, including for reasons beyond the Company's control, may be underpriced, subject to cost overruns, delayed, terminated or reduced in scope.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">A significant increase in the Company&#8217;s days sales outstanding could have an adverse effect on the Company&#8217;s business, including its cash flow, by increasing its bad debt or decreasing its cash flow.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company's Drug Development segment revenues depend on the pharmaceutical, biotechnology and medical device industries, including those industries' R&amp;D spending, ability to raise capital, reimbursement from governmental programs or commercial payers, and  trends and other economic conditions affecting those industries.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Foreign currency exchange fluctuations could have a material adverse effect on the Company&#8217;s business.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company&#8217;s uses of financial instruments to limit its exposure to interest rate and currency fluctuations could expose it to risks and financial losses that may adversely affect the Company&#8217;s financial condition, liquidity, and results of operations.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt">The Company&#8217;s level of indebtedness could adversely affect the Company&#8217;s liquidity, results of operations and business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Planned Spin-off of the Company's Clinical Development and Commercialization Services Business</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;The planned spin-off of the Company&#8217;s Clinical Development and Commercialization Services business may not be completed on the terms or timeline currently contemplated, if at all, and may not achieve the intended results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Compliance Matters </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Changes in payer regulations or policies, insurance regulations or approvals, or changes in or interpretations of, other laws, regulations or policies in the U.S. or globally may have a material adverse effect upon the Company.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The Company could face significant monetary damages and penalties and/or exclusion from government programs if it violates anti-fraud and abuse laws.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company&#8217;s business could be harmed from the loss or suspension of a license or imposition of fines or penalties under, or future changes in, or interpretations of, the law or regulations of the Clinical Laboratory Improvement Act of 1967, and the Clinical Laboratory Improvement Amendments of 1988 (CLIA), or those of Medicare, Medicaid or other national, state, or local agencies in the U.S. and other countries where the Company operates laboratories.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Failure of the Company or its third-party service providers to comply with privacy and security laws and regulations could result in fines, penalties, and damage to the Company&#8217;s reputation with customers and have a material adverse effect upon the Company&#8217;s business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company&#8217;s international operations could subject it to additional risks and expenses that could have a material adverse impact on the business or results of operations, including exposure to liabilities under tax, trade, anti-corruption, and data privacy laws. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.67pt">Failure to comply with the regulations of drug regulatory agencies could result in fines, penalties, and sanctions and have a material adverse effect upon the Company.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Increased regulations and restrictions on the import and supply of research animals, actions of animal rights activists, diseases in research animal populations, and the failure to conduct animal research in compliance with applicable  laws and regulations could have a material adverse effect upon the Company. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">U.S. Food and Drug Administration (FDA), European Union and other regulation of diagnostic products and medical devices, including laboratory-developed tests, could result in increased costs, fines, and penalties.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.23pt">Failure to comply with national, state, local or international environmental, health and safety laws and regulations, including the U.S. Occupational Safety and Health Administration Act, and the U.S. Needlestick Safety and Prevention Act, could result in fines and penalties.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Technology and Cybersecurity</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Failure to maintain the security of information relating to the Company, or its customers, patients, or vendors, whether as a result of cybersecurity attacks on the Company&#8217;s information systems or otherwise, could damage the Company&#8217;s reputation, cause it to incur substantial additional costs, result in litigation and enforcement actions, and materially adversely affect the Company&#8217;s business and operating results. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Failure or delays in the Company&#8217;s information technology systems, including the failure to develop and implement updates and enhancements to those systems, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could disrupt the Company&#8217;s operations or customer relationships.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The Company depends on third parties to provide services critical to the Company's business, and depends on them to comply with applicable laws and regulations. Breaches of the information technology systems of third parties could have a material adverse effect on the Company's operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Legal Matters</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Adverse results in material litigation matters could have a material adverse effect upon the Company&#8217;s business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The failure to successfully obtain, maintain and enforce intellectual property rights and defend against challenges to the Company&#8217;s intellectual property rights could adversely affect the Company.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Changes in tax laws and regulations or the interpretation of such may have a significant impact on the financial position, results of operations and cash flows of the Company.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">If the Company fails to perform contract research services in accordance with contractual requirements and regulatory standards, the Company could be subject to significant costs or liability.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the COVID-19 Pandemic </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">The ongoing COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption that could have an adverse effect on the Company&#8217;s business and financial position, human capital resources, and reputation if the Company&#8217;s continued response is not appropriate or is perceived by customers to be inadequate.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this Annual Report, the Company makes, and from time to time may otherwise make in its public filings, press releases and discussions by Company management, forward-looking statements concerning the Company&#8217;s operations, performance and financial condition, as well as its strategic objectives. Some of these forward-looking statements relate to future events and expectations and can be identified by the use of forward-looking words such as &#8220;believes&#8221;, &#8220;expects&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;seeks&#8221;, &#8220;approximately&#8221;, &#8220;intends&#8221;, &#8220;plans&#8221;, &#8220;estimates&#8221;, or &#8220;anticipates&#8221; or the negative of those words or other comparable terminology. Such forward-looking statements speak only as of the time they are made and are subject to various risks and uncertainties and the Company claims the protection afforded by the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those currently anticipated due to a number of factors in addition to those discussed elsewhere herein, including in the &#8220;Summary of Material Risks&#8221; above and in the &#8220;Risk Factors&#8221; section of this Annual Report, and in the Company&#8217;s other public filings, press releases, and discussions with Company management, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in government and third-party payer regulations, reimbursement, or coverage policies or other future reforms in the U.S. healthcare system (or in the interpretation of current regulations), new insurance or payment systems, including state, regional or private insurance cooperatives (e.g., health insurance exchanges) affecting governmental and third-party coverage or reimbursement for commercial laboratory testing, including the impact of the U.S. Protecting Access to Medicare Act of 2014 (PAMA);</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">significant monetary damages, fines, penalties, assessments, refunds, repayments, damage to the Company's reputation, unanticipated compliance expenditures, and/or exclusion or debarment from or ineligibility to participate in government programs, among other adverse consequences, arising from enforcement of anti-fraud and abuse laws and other laws applicable to the Company in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">significant fines, penalties, costs, unanticipated compliance expenditures, and/or damage to the Company&#8217;s reputation arising from the failure to comply with applicable privacy and security laws and regulations, including the U.S. Health Insurance Portability and Accountability Act of 1996, the U.S. Health Information Technology for Economic and Clinical Health Act, the European Union's General Data Protection Regulation and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">loss or suspension of a license or imposition of fines or penalties under, or future changes in, or interpretations of applicable licensing laws or regulations regarding the operation of clinical laboratories and the delivery of clinical laboratory test results, including, but not limited to, the U.S. Clinical Laboratory Improvement Act of 1967 and the U.S. Clinical Laboratory Improvement Amendments of 1988 and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">penalties or loss of license arising from the failure to comply with applicable occupational and workplace safety laws and regulations, including the U.S. Occupational Safety and Health Administration requirements, the U.S. Needlestick Safety and Prevention Act, and similar laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">fines, unanticipated compliance expenditures, suspension of manufacturing, enforcement actions, damage to the Company's reputation, injunctions, or criminal prosecution arising from failure to maintain compliance with current good manufacturing practice regulations and similar requirements of various regulatory agencies in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">sanctions or other remedies, including fines, unanticipated compliance expenditures, enforcement actions, injunctions or criminal prosecution arising from failure to comply with the Animal Welfare Act or applicable national, state and local laws and regulations in jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in testing guidelines or recommendations by government agencies, medical specialty societies, and other authoritative bodies affecting the utilization of laboratory tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">changes in applicable government regulations or policies affecting the approval, availability of, and the selling and marketing of diagnostic tests, drug development, or the conduct of drug development and medical device and diagnostic studies and trials, including regulations and policies of the U.S. Food and Drug Administration, the U.S. Department of Agriculture, the Medicine and Healthcare products Regulatory Agency in the United Kingdom, the National Medical Products Administration in China, the Pharmaceutical and Medical Devices Agency in Japan, the European Medicines Agency, the European Union and similar regulations and policies of agencies in other jurisdictions in which the Company conducts business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in government regulations or reimbursement pertaining to the pharmaceutical, biotechnology and medical device and diagnostic industries, changes in reimbursement of pharmaceutical products, or reduced spending on research and development by pharmaceutical, biotechnology and medical device and diagnostic customers;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">liabilities that result from the failure to comply with corporate governance requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increased competition, including price competition, potential reduction in rates in response to price transparency initiatives and consumerism, competitive bidding and/or changes or reductions to fee schedules, and competition from companies that do not comply with existing laws or regulations or otherwise disregard compliance standards in the industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in payer mix or payment structure or process, including insurance carrier participation in health insurance exchanges, an increase in capitated reimbursement mechanisms, the impact of clearinghouses on the claims reimbursement process, the impact of a shift to consumer-driven health plans or plans carrying an increased level of member cost-sharing, and adverse changes in payer reimbursement or payer coverage policies (implemented directly or through a third-party utilization management organization) related to specific diagnostic tests, categories of testing or testing methodologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to retain or attract MCO business as a result of changes in business models, including risk based or network approaches, out-sourced laboratory network management or utilization management companies, or other changes in strategy or business models by MCOs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to obtain and retain new customers, an unfavorable change in the mix of testing services ordered, or a reduction in tests ordered, specimens submitted, or services requested by existing customers, and delays in payments from customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">consolidation and convergence of customers, competitors, and suppliers, potentially causing material shifts in insourcing, utilization, pricing, reimbursement and supply chain access;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to effectively develop and deploy new systems, system modifications or enhancements required in response to evolving market and business needs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">customers choosing to insource services that are or could be purchased from the Company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to identify, successfully close and effectively integrate and/or manage acquisitions of new businesses or failure to maintain key customers and/or employees as a result of uncertainty surrounding the integration of acquisitions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to achieve the expected benefits and synergies of newly-acquired businesses, including due to items not discovered in the due diligence process, and the impact on the Company's cash position, levels of indebtedness and stock price;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">termination, loss, delay, reduction in scope or increased costs of contracts, including large contracts and multiple contracts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">liability arising from errors or omissions in the performance of testing services, contract research services or other contractual arrangements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes or disruption in the provision or transportation of services or supplies provided by third parties; or their termination for failure to follow the Company's performance standards and requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">damage or disruption to the Company's facilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">damage to the Company's reputation, loss of business, or other harm from acts of animal rights activists or potential harm and/or liability arising from animal research activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">adverse results in litigation matters;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to attract and retain experienced and qualified personnel or the loss of significant personnel as a result of illness, increased competition for talent, wage growth, or other market factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to develop or acquire licenses for new or improved technologies, such as point-of-care testing, mobile health technologies, and digital pathology, or potential use of new technologies by customers and/or consumers to perform their own tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">substantial costs arising from the inability to commercialize newly licensed tests or technologies or to obtain appropriate coverage or reimbursement for such tests;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to obtain, maintain, and enforce intellectual property rights for protection of the Company's products and services and defend against challenges to those rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">scope, validity, and enforceability of patents and other proprietary rights held by third parties that may impact the Company's ability to develop, perform, or market the Company's products or services or operate its business;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruption, receivables impairment, delays in cash collection impacting days sales outstanding, supply chain disruptions or inventory obsolescence, increases in material cost or other operating costs, or other impacts on the business due to natural disasters, including adverse weather, fires and earthquakes; political crises, including terrorism and war; public health crises and disease epidemics and pandemics; changes in the global economy; and other events outside of the Company's control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">discontinuation or recalls of existing testing products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a failure in the Company's information technology systems, including with respect to testing turnaround time and billing processes, or the failure of the Company or its third-party suppliers and vendors to maintain the security of business information or systems or to protect against cybersecurity attacks such as denial of service attacks, malware, ransomware, and computer viruses, or delays or failures in the development and implementation of the Company&#8217;s automation platforms, any of which could result in a negative effect on the Company&#8217;s performance of services, a loss of business or increased costs, damages to the Company&#8217;s reputation, significant litigation exposure, an inability to meet required financial reporting deadlines, or the failure to meet future regulatory or customer information technology, data security and connectivity requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruption, increased costs, and other adverse effects on the Company's operations due to the unionization of employees, union strikes, work stoppages, general labor unrest or failure to comply with labor or employment laws;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to maintain the Company's days sales outstanding levels, cash collections (in light of increasing levels of patient responsibility), profitability and/or reimbursement arising from unfavorable changes in third-party payer policies, payment delays introduced by third-party utilization management organizations, and increasing levels of patient payment responsibility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">impact on the Company's revenues, cash collections, and the availability of credit for general liquidity or other financing needs arising from a significant deterioration in the economy or financial markets or in the Company's credit ratings by Standard &amp; Poor's and/or Moody's;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to maintain the expected capital structure for the Company, including failure to maintain the Company's investment grade rating, or leverage ratio covenants under its revolving credit facility;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in reimbursement by foreign governments and foreign currency fluctuations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inability to obtain certain billing information from physicians, resulting in increased costs and complexity, a temporary disruption in receipts, and ongoing reductions in reimbursements and revenues;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expenses and risks associated with international operations, including, but not limited to, compliance with the U.S. Foreign Corrupt Practices Act (FPCA), the U.K. Bribery Act, other applicable anti-corruption laws and regulations, trade sanction laws and regulations, and economic, political, legal and other operational risks associated with foreign jurisdictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failure to achieve expected efficiencies and savings in connection with the Company's business process improvement initiatives;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in tax laws and regulations or changes in their interpretation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global economic conditions and government and regulatory changes; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">risks associated with the impact, timing, expected benefits and costs, or terms of the planned spin-off of the Company&#8217;s Clinical Development and Commercialization Services (CDCS) business, which includes the parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations, including but not limited to (i) uncertainties as to the completion and timing of the transaction; (ii) the failure to obtain appropriate assurances regarding the tax-free nature of the spin-off; (iii) the failure to obtain receipt of required regulatory approvals; (iv) the effect of the announcement or pendency of the transaction on the Company&#8217;s business relationships, operating results, and business generally; (v) unexpected issues that arise in the continued planning for the transaction; (vi) the failure to have the Form 10 registration statement that will be filed with the SEC declared effective on a timely basis, or at all; (vii) risks that the proposed transaction disrupts current plans and operations of Labcorp or CDCS; (viii) potential difficulties attracting or retaining Company or CDCS employees as a result of the spin-off announcement, pendency or completion of the spin-off; (ix) risks related to diverting management&#8217;s attention from the Company and CDCS&#8217; ongoing business operations; (x) the ability of the Company to successfully separate CDCS operations from the Company&#8217;s ongoing operations; (xi) market receptiveness to effect transactions in the capital markets; and (xii) market reaction to the announcement and planning for the transaction; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the effects, duration, and severity of the ongoing COVID-19 pandemic, including the impact on operations, personnel, supplies, liquidity, and collections, as well as the impact of past or future actions or omissions by the Company or governments in response to the COVID-19 pandemic and damage to the Company's reputation or loss of business resulting from the perception of the Company's response to the COVID-19 pandemic.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as may be required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Given these uncertainties, one should not put undue reliance on any forward-looking statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_19"></div><div style="margin-bottom:7pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;BUSINESS</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than 80,000 employees, the Company serves clients in more than 100 countries. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through its Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD) segments, the Company provides diagnostic, drug development, and technology-enabled solutions for more than 160 million patient encounters per year, or more than 3 million per week. In addition, the Company supports clinical trial activity through its world-class central laboratory, preclinical, and clinical development businesses. The Company's capabilities enable it to play a leading role in advancing healthcare across the globe.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant reach, breadth, and advancement of the Company's offerings have resulted in Base Business revenue growth of 2.8% from 2021 through 2022 and 5.9% versus 2019 CAGR. Base Business includes the Company's business operations except for COVID-19 Testing. The Company believes that its diversified offerings help to balance the impact of changes in the global economic and healthcare systems and due to global geopolitical events. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the period ended December&#160;31, 2022, the Company generated revenues of $14,876.8 million, diluted earnings per share of $13.97, and had a total operating cash flow of $1,955.9 million.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that science, technology, and innovation drive its continued success, differentiate the Company, and are foundational to its future. They are critical to the Company's ability to carry out its mission to improve health and improve lives. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic Review of Company Structure and Capital Allocation Strategy</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company announced the undertaking of a comprehensive review by its board of directors (the Board) and management team of the Company's structure and capital allocation strategy. In December 2021, the Company announced the Board's conclusion, as well as actions that the management team and the Board would take to enhance shareholder returns. These actions have included: </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiating a dividend in the second quarter of 2022, as well as subsequent dividends paid in the third and fourth quarters of 2022, with total dividend payments for 2022 in the amount of $195.2 million;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing a $2.50 billion share repurchase program. As part of this program, $1.0 billion was repurchased under an accelerated share repurchase plan in 2021, and a total of $1.1 billion of stock was repurchased in 2022, representing approximately 4.7 million shares;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implementing a new LaunchPad business process improvement initiative, targeting savings of $350.0 million through 2025;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing a longer-term outlook in connection with the announcement of the Company's 2021 year-end results in addition to the Company's annual guidance;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing additional business insights through enhanced disclosures beginning with the Company's results for the first quarter of 2022; and</span></div><div style="margin-bottom:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing a commitment to profitable growth through investments in science, innovation, and new technologies; and</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 28, 2022, the Company announced that it would pursue a planned spin-off of its Clinical Development and Commercialization Services (CDCS) business, as further discussed below.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management and the Board are committed to continuing to evaluate all avenues for enhancing shareholder value.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The updated capital allocation plan is designed to enable the Company to continue investment in key growth areas. This plan is expected to fuel growth through innovation by using the Company's unique data and insights to bring scientific advancements&#8212;both those developed internally and those developed by outside companies and scientists&#8212;to market at scale. It reflects the Board's confidence in the Company's strong balance sheet and cash flow generation profile, as well as the Board's commitment to deploying capital to enhance value for shareholders, patients, providers, and pharmaceutical customers worldwide.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_22"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spin-Off of the Company's CDCS Business</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that the Board authorized the Company to pursue a spin-off of the Company&#8217;s wholly owned CDCS business to its shareholders through a tax-free transaction. The planned spin-off will result in two independent companies, each poised for strong, sustainable growth. On January 9, 2023, Thomas (Tom) Pike joined the Company as president and chief executive officer of its DD Clinical Development business unit, and when the planned spin-off is complete, Mr. Pike will become the chief executive officer and chairman of the board of directors of the independent, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">publicly listed company. On February 9, 2023, the Company announced that the name of the CDCS business will become Fortrea in connection with the planned spin-off.     </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is targeting completion of the planned spin-off in mid-2023. The planned spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's Board, the receipt of appropriate assurances regarding the tax-free nature of the separation and effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). There can be no assurances regarding the ultimate timing of the transaction or that the spin-off will be completed.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the transaction is complete, the resulting companies will be Labcorp, comprising the Company&#8217;s routine and esoteric labs, central labs and early development research labs, and Fortrea, a global contract research organization (CRO) providing Phase I-IV clinical trial management, market access and technology solutions to pharmaceutical and biotechnology organizations.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned spin-off is expected to provide each company with:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthened strategic flexibility and operational focus to pursue specific market opportunities and better meet customer needs;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">focused capital structures and capital allocation strategies to drive innovation and growth; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a more targeted investment opportunity for different investor bases; and </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">the ability to align its particular incentive compensation with its financial performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the planned spin-off, the Company believes that Labcorp will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in R&amp;D and innovation to develop and launch diagnostic advancements globally in key clinical areas including oncology, Alzheimer's, and autoimmune and liver disease through organic and inorganic opportunities; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bring together its global health and patient data and provide insights to enable customers to innovate; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilize its worldwide laboratory network to serve a broad, growing and global customer base including pharmaceutical and biotechnology companies, physicians, health systems, consumers, and other start-ups and laboratories that require lab services or diagnostic testing; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launch innovative tests globally, providing patients, physicians, health systems and pharmaceutical companies with access to its advanced science, technology and diagnostic capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the planned spin-off, the Company believes that Fortrea will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capitalize on growth opportunities across Phases I-IV clinical trials and extend its leadership in oncology, cell and gene therapy, rare disease, and other emerging therapeutic areas;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase agility with large pharmaceutical and biotechnology clients to better serve customers and advance life-saving therapies;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">access to unique data sets and insights through an arrangement with the Company for a defined period of time which will enable Fortrea to provide enhanced trial execution and a differentiated value proposition; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in capabilities, technologies, diverse talent and innovation to enhance trial execution and better serve all of its customers; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement a capital structure that is tailored to support its growth strategy and enhance stakeholder value.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned spin-off is intended to qualify as a tax-free transaction for U.S. federal income tax purposes. See &#8220;Risk Factors - Risks Related to the Planned Spin-off of the Company&#8217;s Clinical Development and Commercialization Services Business.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enterprise Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides vital information to help its customers make clear and confident health decisions. Through its science, data, and global laboratory network, the Company accelerates and advances innovations in testing and treatments to improve patient care.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is expanding its role in the rapidly evolving healthcare market by strengthening its positions across its portfolio of capabilities, growing strategic opportunities that drive new business, and differentiating its unique offerings, capabilities, and financial performance. To do so, the Company is focusing on executing the following strategic priorities, which have evolved to reflect its operations and strategic vision:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6pt">Build on the Company's Leadership in Oncology</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The field of oncology receives significant investment in research, development, and treatment, yet it remains an area of great unmet medical need. The Company believes the diagnosis and treatment of cancer will be the fastest-growing therapeutic area in the near future.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the increased adoption of precision medicine, health and cancer care providers are relying on advanced testing to identify patients who will benefit from new, targeted treatments and therapies that are more effective and often have fewer side effects than chemotherapy and other traditional treatments. Since forming an oncology business unit and launching an enterprise oncology platform in 2021, the Company has become an oncology leader. By focusing its diagnostic and drug development services on the fight against cancer, the Company is delivering targeted solutions that power better decision and improved patient outcomes. The Company believes it maintains the broadest portfolio and capabilities in oncology diagnostics today. The Company intends to accelerate its leadership and enhance its offerings, particularly in genomic testing, personalized medicine and liquid biopsy. The Company is also leveraging its oncological capabilities and platforms to progress its work in other areas, including neurodegenerative disease, autoimmune and liver diseases, and cell and gene therapy. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company completed its acquisition of Personal Genome Diagnostics (PGDx), a provider of comprehensive liquid biopsy and tissue-based genomic products and services. The acquisition of PGDx enhances the Company's precision diagnostic portfolio and its ability to increase access to oncology care globally. In addition, the Company continues to realize benefits from its portfolio of OmniSeq products such as OmniSeq INSIGHT, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.  Differentiate Through Digital and Data </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare and life sciences industries remain among the most significantly impacted by technological advancements. By maximizing the use of advances in artificial intelligence (AI), data, digitalization, and analytics in compliance with applicable regulations, the Company strives to improve operating efficiency and business performance, and to create new, differentiated products and services that the Company believes will help its customers and deliver better care to patients.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is using AI to better identify and predict trends such as the timing and location of demand shifts for certain tests. In doing so, the Company is supporting an efficient use of supplies, staffing, and the Company&#8217;s advanced logistics used to route testing to the most appropriate laboratories and quickly deliver results. AI capabilities and advanced logistics have played, and are expected to continuing playing, an important role in the Company&#8217;s response to periods of heightened demand for COVID-19 polymerase chain reaction (PCR) testing. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company creates, and has access to, significant volumes of data. By applying advanced analytics to its data in compliance with data privacy regulations, the Company can help its customers improve their processes and reach better outcomes. The Company&#8217;s repository of test results help study sponsors assess patients' eligibility for clinical trials more quickly and accurately, enroll those patients faster, shorten the time needed for regulatory submission, and accelerate the availability of new medicines. Data is also being used by the Company to advance science and the public's understanding of certain treatments and illnesses.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digitalization continues to be an area of focus for the Company as it responds to the use of technology-enabled tools and services by healthcare providers, patients and pharmaceutical companies for absorbing, handling, and disseminating information. These services include decentralized clinical trials, which offer the potential to remove barriers that may have slowed or prevented studies from being conducted in the past. Decentralized clinical trials can also make trial participation an option for more people, including individuals from underrepresented populations.   </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Company continues to improve its patients' experience in patient service centers (PSCs) by creating a seamless digital journey from appointment scheduling to results delivery. With an average of 3 million patients served in a given week, the Company strives to enhance their experience using its digital channels. </span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.  Drive Customer Centricity</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves a broad range of customers, including managed care organizations (MCOs), pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, CROs, and independent clinical laboratories. The Company continues to focus on its customers, anticipate their needs, and deliver valuable solutions that help them achieve their goals. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prioritizes a consistent, coordinated focus across all aspects of its operations, placing the customer at the center of its services, with the objective of becoming the customer's primary partner for solutions to their needs. In an effort to provide a leading customer experience, the Company seeks customer feedback, communicates best practices and lessons learned, and provides robust employee training with respect to the needs of its customers.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company routinely introduces new products, services, and initiatives that benefit its customers. For example, the Company launched a new test in mid-2022 to assist in the identification and confirmation of neurodegenerative disease and neuronal injury. The Company also expanded access to its services in the Midwestern U.S. with the opening of a new laboratory, and it announced plans to expand its laboratory footprint in Japan. In addition, the Company continues to experience </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">growing demand for its consumer-initiated wellness testing available through Labcorp OnDemand, and it believes its pipeline of innovative, consumer-focused offerings is strong. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.  Expand Globally</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a long history of disciplined use of capital to invest in the growth of the business and intends to grow its business globally by leveraging its advanced laboratory network, scientific capabilities, health data and insights, and its results-oriented culture to achieve better health for all people. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made significant investments in the deployment of new technologies through both licensing and internal research and development, as well as strategic and tuck-in acquisitions. The Company has also invested in establishing collaborative partnerships with other leading companies and organizations that share the Company&#8217;s goals and expectations. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its business and the broader healthcare and life sciences markets to proactively identify and assess:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential growth opportunities; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business areas that might not support continued growth and should be revamped or divested; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisition targets that meet its criteria for quality, value, and return on investment; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new products that would successfully integrate with or extend the Company&#8217;s offerings; and</span></div><div style="margin-bottom:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a balanced formula for capital allocation. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through a continued focus on these strategic priorities, reinforced through the Company's capital allocation plan, the Company expects to be in an optimal position to make disciplined choices that maximize shareholder value, better protect the Company from market fluctuations and outside impacts, and fuel significant and profitable short- and long-term revenue growth. </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_25"></div><div style="margin-bottom:6pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Pandemic Response</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has supported the fight against COVID-19 since the earliest stages of the pandemic, and it continues to play an important role in ongoing response efforts. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company further expanded access to COVID-19 testing and continued to support the development of COVID-19 vaccines and therapies.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received FDA Emergency Use Authorization (EUA) for multiple innovations during the year. In June, the Company was granted FDA EUA for its next-generation sequencing test used to identify specific SARS-CoV-2 lineages. This was the first test authorized for the identification and differentiation of SARS-CoV-2 Phylogenetic Assignment of Named Global Outbreak (PANGO) lineages, which are genetic variations in circulating virus strains. The Company also received FDA EUA for the first non-prescription, at-home collection kit for combined COVID-19, flu and respiratory syncytial virus (RSV) detection. These achievements built on the Company's first COVID-19-related FDA EUA, which was received on March 16, 2020, for COVID-19 PCR testing, the FDA EUA in April 2020 for the Pixel by Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> COVID-19 test home collection kit, and in December 2020 for over-the-counter purchase of these home collection kits. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's additional contributions to the pandemic response in 2022 included assisting in the identification and monitoring of COVID-19 variants and spikes in confirmed cases, as well as expanding no-cost access to at-home test collections for individuals who met clinical guidelines. The Company maintained its ability to quickly scale up COVID-19 PCR testing capacity throughout the year, even during periods of reduced demand. In doing so, the Company was able to immediately and effectively respond to surges in positive cases and testing needs. The Company performed approximately 13 million COVID-19 PCR tests and 1 million antibody tests in 2022, and since the start of the pandemic has performed approximately 74 million COVID-19 PCR tests and 9 million antibody tests.</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Outlook</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has had, and continues to have, a substantial impact on the global health and economic environments. The Company continues to closely monitor the impact of the COVID-19 pandemic on all aspects of its business, given continued unpredictability, corresponding state, local and federal government restrictions and policies, the continued emergence of new variants that may cause increases in cases that may impact the Company, and the potential for shifts in customer behavior.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company anticipates that COVID-19 will continue impacting its business in 2023 and potentially beyond, the Company expects a continued decline in demand for COVID-19 Testing, with the potential for increases in demand at different times and across different geographies. As a result, COVID-19 Testing demand in 2023 is not predicted to match 2022 levels.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Capital Allocation</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes it has a strong track record of deploying capital to investments that enhance the Company's business and return capital to shareholders. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company invested $1,164.0 million in strategic business acquisitions. The acquisitions have expanded the Company&#8217;s service offerings, expanded its customer and revenue mix, and strengthened and broadened the scope of its geographic presence. The Company continues to evaluate acquisition opportunities that leverage the Company&#8217;s core competencies, complement existing scientific and technological capabilities, increase the Company&#8217;s presence in key geographic, therapeutic and strategic areas, and meet or exceed the Company&#8217;s financial criteria. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company repurchased 5.6 million shares of its common stock at an average price of $233.48 for a total cost of $1,100.0 million. This included 0.9 million shares which were repurchased in 2022 but were part of the $1,000.0 million Accelerated Share Repurchase (ASR) Program paid for in 2021. At the end of 2022, the Company had outstanding authorization from the Board to purchase $531.5 of Company common stock. On February 7, 2023, the board of directors adopted a new share repurchase plan authorizing up to $1,000.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. The repurchase authorization has no expiration. The repurchase authorization has no expiration date.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, capital expenditures were $481.9 million. The Company expects capital expenditures in 2023 to be approximately 3.5% of revenues, primarily in connection with projects to support growth in the Company's core businesses, facility expansion and updates, projects related to its LaunchPad initiative, and further acquisition integration initiatives. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will continue to evaluate opportunities for strategic deployment of capital in light of market conditions.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_31"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality and External Factors</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company experiences seasonality across its business. For example, testing volume generally declines during the year-end holiday period and other major holidays and can also decline due to inclement weather or natural disasters. Declines in testing volume reduce revenues, operating margins and cash flows. Operations are also impacted by changes in the global economy, exchange rate fluctuations, political and regulatory changes, the progress of ongoing studies and the startup of new studies, as well as the level of expenditures made by the pharmaceutical, biotechnology and medical device industries in R&amp;D. As discussed in more detail elsewhere in Item 1, COVID-19 impacted the Company in 2022. This impact included the effect of the Company&#8217;s response to the virus through its testing and drug development services, as well as the effect of COVID-19 on the global economy and demand for the Company&#8217;s non-COVID-19 services.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, approximately 14.7% of the Company's revenues were billed in currencies other than the U.S. dollar, with the Swiss franc, British pound, Canadian dollar, and the euro representing the largest components of its currency exposure. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the seasonality and changing economic factors impacting the business, comparison of the results for successive quarters may not accurately reflect trends or results for the full year.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_34"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Company Reporting </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports are made available free of charge through the Investor Relations section of the Company&#8217;s website at www.labcorp.com as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. Additionally, the SEC maintains a website at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers, including the Company, that file electronically with the SEC. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The matters discussed in this &#8220;Business&#8221; section should be read in conjunction with the Consolidated Financial Statements found in Item 8 of Part II of this Annual Report, which include additional financial information about the Company. This Annual Report includes forward-looking statements that involve risks or uncertainties. The Company&#8217;s results could differ materially from those anticipated in these forward-looking statements as&#160;a result of certain factors, including the risk factors described in Item 1A of Part I of this Annual Report and elsewhere. For more information about forward-looking statements, see &#8220;Forward-Looking Statements&#8221; included prior to Part I in this Annual Report.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company's Business</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due primarily to a decrease in COVID-19 testing, the Company experienced a reduction in revenues and other key financial metrics in 2022. However, by the end of the year, the Company saw accelerated revenue growth in Dx, continued strong underlying fundamentals in DD and margin expansion.</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:74.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In Millions, Except Per Share Data</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMi0xLTEtMS0xMTcwMjk_f02d3f7e-93e6-4a21-8bcc-953fb6556130">14,876.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMi0zLTEtMS0xMTcwMjk_b1b6fb31-f9f6-4069-b3b2-4d9d9c3d850e">16,120.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMy0xLTEtMS0xMTcwMjk_414b2651-844a-40d1-9e2a-9cc3fc012519">4,385.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMy0zLTEtMS0xMTcwMjk_8d6eb6e6-13fb-454e-8c95-d06eecf9b483">5,624.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNC0xLTEtMS0xMTcwMjk_77e12ae7-49ce-4bab-8e8b-de5fcc7b7d81">1,773.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNC0zLTEtMS0xMTcwMjk_118fad5f-102e-4974-8764-5010abdfaf5f">3,259.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNS0xLTEtMS0xMTcwMjk_a648e5fa-167d-48bd-9b66-6a6ff1f04bcd">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNS0zLTEtMS0xMTcwMjk_a7c0966d-8759-47fc-83f1-391bc08f1ef0">2,377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNi0xLTEtMS0xMTcwMjk_9173d25d-6494-423a-8f66-2f2d307ad7c8">1,955.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNi0zLTEtMS0xMTcwMjk_d1f4f905-3646-4b99-969a-b636bd9c2d56">3,109.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNy0xLTEtMS0xMTcwMjk_3d467232-2984-4d36-be98-65e82f53d2d7">14.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNy0zLTEtMS0xMTcwMjk_dbaf8495-e4a7-4752-8d1f-e320357f2df3">24.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfOC0xLTEtMS0xMTcwMjk_124eaada-abe6-4543-86ad-651f961eafca">13.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfOC0zLTEtMS0xMTcwMjk_a364f97f-1356-46af-af58-894d5264fb1c">24.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Dx and DD. In 2022, Dx and DD contributed <ix:nonFraction unitRef="number" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RleHRyZWdpb246NjU1YmZjOTljMGU3NDI4ODg1MjYxMTRlOTQzMmYzYmNfMTY0OTI2NzQ0MjczOA_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9">61</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RleHRyZWdpb246NjU1YmZjOTljMGU3NDI4ODg1MjYxMTRlOTQzMmYzYmNfMTY0OTI2NzQ0Mjc0Mg_afc9324a-33dc-46c5-9679-e8205e4a8f3f">39</ix:nonFraction>%, respectively, of revenues to the Company, and in 2021 contributed 64% and 36%, respectively. Nearly all of Dx&#8217;s revenues are generated in the U.S., with a smaller portion in Canada and a relatively small amount in the rest of the world. DD&#8217;s revenues are nearly evenly split between the U.S. and the rest of the world, with approximately 48% derived from the U.S. and approximately 52% from other countries. Although this allocation of revenues provides some protection from economic shifts in any one country, it is still heavily tilted towards the U.S. As a result, the Company continues to actively explore new and expanded business opportunities outside the U.S. to further diversify its sources of revenues. The Company's revenues by segment payers/customer groups and by geography for the years ended December&#160;31, 2022, 2021 and 2020 are as follows:</span></div><div style="margin-bottom:2pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2022</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xLTEtMS0xMTcwMjk_ffc564ba-8c08-4e02-9e36-4cfcf25da42c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieabfe2258e1446b192ef394f16489167_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC01LTEtMS0xMTcwMjk_b63d29fd-58e7-41a0-90db-8742148ecf6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xMS0xLTEtMTE3MDI5_13409024-b8e3-476d-9198-58552d60e9ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xMy0xLTEtMTE3MDI5_6b38d010-9e52-4de0-883f-c880cc44e098">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNS0xLTEtMTE3MDI5_07b9660a-b5f8-43fc-929c-9e7cd9237695"><ix:nonFraction unitRef="number" contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNS0xLTEtMTE3MDI5_626eb1b8-cde0-433c-9a5c-0582f25db4b6">17</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNy0xLTEtMTE3MDI5_6073ba1f-ad2e-4cb9-827d-dd2892784277"><ix:nonFraction unitRef="number" contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNy0xLTEtMTE3MDI5_d12b806a-8dcf-42a4-b103-6bc2c46af939">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xOS0xLTEtMTE3MDI5_08fee676-7298-42f2-8979-ba5ac9530b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yMS0xLTEtMTE3MDI5_12c3a73d-ffc2-460c-b492-f6f0e84e52ed">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yNi0xLTEtMTE3MDI5_d0a4dde7-6ce1-4ae4-941c-81c6984a18c5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yOC0xLTEtMTE3MDI5_0033e698-efea-453a-b32b-565fd7769b1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0zMC0xLTEtMTE3MDI5_4574c43c-fd5c-46bb-8068-2f89e424d107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49a7f666344b43219373509023b86a61_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0zMi0xLTEtMTE3MDI5_6ca3ffa6-06ac-4718-931c-d4190a6121cb">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia00703317297439a899a69e868562330_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xLTEtMS0xMTcwMjk_ef97beb1-888f-42d9-ae8d-9979489a819a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS01LTEtMS0xMTcwMjk_60bfad80-1852-4063-bb23-ba78d8484bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xMS0xLTEtMTE3MDI5_b3615c40-cf3a-4401-9f2e-e2fbc73ea475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xMy0xLTEtMTE3MDI5_bd2e2dc1-cdb1-4e5a-be2c-5a9f0045617a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNS0xLTEtMTE3MDI5_b4618336-8de7-4c99-8f44-1afe835df481"><ix:nonFraction unitRef="number" contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNS0xLTEtMTE3MDI5_df747fb9-cdb5-4c5c-a6a9-d416d133c9ab">6</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNy0xLTEtMTE3MDI5_0eb6022d-a832-402d-91ee-5d68f01b747d"><ix:nonFraction unitRef="number" contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNy0xLTEtMTE3MDI5_2ed3078a-cda5-435b-885e-cc7fe72d3caf">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xOS0xLTEtMTE3MDI5_40c782aa-8fce-4bbd-b307-78d4654e0c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yMS0xLTEtMTE3MDI5_9efee418-80ce-409f-8629-af8e491f90c5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yNi0xLTEtMTE3MDI5_90f2575d-3455-4c87-9f85-6aa3fe6fff5d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i174342f325564eb4800f5d7bafca1841_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yOC0xLTEtMTE3MDI5_267a854d-e4f7-4d0e-8790-e5ad4a2aadea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0zMC0xLTEtMTE3MDI5_4ff9c6a3-e335-4262-a979-9a92fb978ed9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0zMi0xLTEtMTE3MDI5_12644480-1493-43b0-bcf8-84c48a043fe7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xLTEtMS0xMTcwMjk_67e351da-d65a-4295-a8cc-ece7f1f99a38">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi01LTEtMS0xMTcwMjk_f646bbc9-b8b6-48b0-a1c5-b50997ce3c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xMS0xLTEtMTE3MDI5_34b02f11-9cd6-45f7-baea-f0b0491afd9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xMy0xLTEtMTE3MDI5_8ed16f25-da28-41c6-afef-6869fbf47139">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xNS0xLTEtMTE3MDI5_f973d042-f777-48a0-a891-e29bfda029b6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xNy0xLTEtMTE3MDI5_91e8b979-b035-46c7-9e52-c2b260bb8fbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xOS0xLTEtMTE3MDI5_871a9ce1-825c-4f28-9a5c-728bc0ec2050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91139fb3405c40e89005a42835b1528e_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yMS0xLTEtMTE3MDI5_2960cd61-5005-442c-9d7f-be8ed330f94c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yNi0xLTEtMTE3MDI5_64b01766-aabe-4261-a609-4d55644aaf75">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yOC0xLTEtMTE3MDI5_4a75ef98-1a52-423f-8a2c-0b73b3bf9c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a6714ab30154ab7adf7919442029308_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0zMC0xLTEtMTE3MDI5_4cdec5cc-324d-46d8-8413-a8c5cead4ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0zMi0xLTEtMTE3MDI5_e9e15cb8-fdb5-438c-9198-1f99fe6320cb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41204750b78b41e99bbfcab862d31763_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xLTEtMS0xMTcwMjk_63813dc7-22b0-4a7d-9a8b-fd9090a0b7be">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy01LTEtMS0xMTcwMjk_70d61c3a-3e16-4a0a-95d5-37cd6c9d135d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xMS0xLTEtMTE3MDI5_13ca5584-843c-4ae3-a6b9-2e745ede783e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xMy0xLTEtMTE3MDI5_0a4ba1e5-b42b-4f23-a67d-cbcd8e3e94ed">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNS0xLTEtMTE3MDI5_70729d38-b348-4dd0-afa1-1a00f039691e"><ix:nonFraction unitRef="number" contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNS0xLTEtMTE3MDI5_ff99a912-0abb-48d1-8d0f-5ec2ab08ea63">34</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNy0xLTEtMTE3MDI5_85f65e7c-332f-432a-b53a-7cb88cac73ac"><ix:nonFraction unitRef="number" contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNy0xLTEtMTE3MDI5_97d013f3-a788-472d-a26d-2c1998700fe6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xOS0xLTEtMTE3MDI5_4b70d3fb-a907-4b5a-adfa-4b6c5a823426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yMS0xLTEtMTE3MDI5_39c638c6-bee2-4791-928b-d85fd3398a89">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icba36eacc3c943cca03f3598759b2674_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yNi0xLTEtMTE3MDI5_e5d5ad7e-2525-47de-8f31-7efb3615015f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0855e4e7139742529986707c444dfb8e_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yOC0xLTEtMTE3MDI5_52547e93-e813-481b-9d65-fee6d2958cb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0zMC0xLTEtMTE3MDI5_3954c7ba-fe0e-4984-a8d1-ae0cbbd82172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0zMi0xLTEtMTE3MDI5_c0762774-d1f9-4e55-ac60-5a875c84e108">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xLTEtMS0xMTcwMjk_1df03a3a-3473-4142-8290-de28e08c71b8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC01LTEtMS0xMTcwMjk_8d8e043e-5e46-48b2-a6bb-b62b8f05e94d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xMS0xLTEtMTE3MDI5_40b117a3-3b9c-4f4c-ae9b-db27e72b7930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xMy0xLTEtMTE3MDI5_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNS0xLTEtMTE3MDI5_459fb7af-ea71-46b1-9421-9014ef0e075c"><ix:nonFraction unitRef="number" contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNS0xLTEtMTE3MDI5_9b353615-beba-4a6c-b30d-8ca80952dd95">64</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNy0xLTEtMTE3MDI5_0d3b4240-9e6b-4e1a-8123-ae947e718326"><ix:nonFraction unitRef="number" contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNy0xLTEtMTE3MDI5_af6cef02-8ffc-4923-963b-ca0aeb989cc6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xOS0xLTEtMTE3MDI5_8b829856-5fdb-442b-8a81-b5ad38c20ee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yMS0xLTEtMTE3MDI5_fd1d06cd-0880-47e1-8150-f015cfcf2156">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yNi0xLTEtMTE3MDI5_6fa054ce-c676-4930-8d75-2cccdeaf3d65">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yOC0xLTEtMTE3MDI5_d96f4e69-3b29-4eb7-a9b3-953b42eee06c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0zMC0xLTEtMTE3MDI5_dd5313ff-22fa-4bbb-80d5-ceb07e723aa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0zMi0xLTEtMTE3MDI5_e67c0e10-1410-47f0-a90f-0ea6c273b1b5">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d6cb383b4834da09d62346a62279532_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMS0xLTEtMTE3MDI5_e131afc4-2553-49a8-8c2f-dc4bd0f75154">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtNS0xLTEtMTE3MDI5_9a407ba3-fa15-43c6-b033-6b8312a87745">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTEtMS0xLTExNzAyOQ_036beacc-c9dd-4559-9188-54df60e51a22">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTMtMS0xLTExNzAyOQ_afc9324a-33dc-46c5-9679-e8205e4a8f3f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTUtMS0xLTExNzAyOQ_20acbe51-b459-4b87-b617-11ab6216626c"><ix:nonFraction unitRef="number" contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTUtMS0xLTExNzAyOQ_879f0a87-5a50-41fc-8f1d-dbf58b56e8a5">17</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTctMS0xLTExNzAyOQ_d79968d6-ce59-43f0-9dc5-cd16d6cffb73">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTktMS0xLTExNzAyOQ_1e78b6da-23c4-4f45-9d78-d44e3e8ccdf0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjEtMS0xLTExNzAyOQ_52fe24e0-75d3-4fe4-a6d8-89237790a347">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjYtMS0xLTExNzAyOQ_b6a25641-78f7-4516-ab75-e80b637a8582">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjgtMS0xLTExNzAyOQ_f1a23581-874c-4fcd-ab66-2d26297114f2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMzAtMS0xLTExNzAyOQ_56277e88-def6-4dc2-a1dd-76cd7ca6adef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMzItMS0xLTExNzAyOQ_33a05168-7621-4556-83b6-de53c125691d">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMS0xLTEtMTE3MDI5_612a8796-4e7e-4e04-b1ca-0198692185a3">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtNS0xLTEtMTE3MDI5_c469b4e7-a1e4-49b5-9420-f8dcbbf09f01">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTEtMS0xLTExNzAyOQ_f68c79a3-a685-40ca-8dc5-98fcc0ea280c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTMtMS0xLTExNzAyOQ_bfa7e972-0219-45bc-a914-44231b26c937">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTUtMS0xLTExNzAyOQ_46045b06-3430-4017-9a0a-5c0d447afab8"><ix:nonFraction unitRef="number" contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTUtMS0xLTExNzAyOQ_ad0d209e-2de6-407e-b7e2-0db9f088d21e">81</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTctMS0xLTExNzAyOQ_003c51be-60ae-468a-a7b5-f3f331d06e35"><ix:nonFraction unitRef="number" contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTctMS0xLTExNzAyOQ_e88f5c8e-7c19-4729-94a5-4ee6e181e3b4">13</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTktMS0xLTExNzAyOQ_cbfd13a0-9667-47cb-a51d-2614a6e840cf">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjEtMS0xLTExNzAyOQ_f1776bcb-6186-42f3-8e06-a6acd66b5946">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjYtMS0xLTExNzAyOQ_370a4c43-c13d-443c-8cfd-7d01f5614536">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjgtMS0xLTExNzAyOQ_fa6e2047-c3a0-4938-bcd9-fdcb3f93f6ad">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMzAtMS0xLTExNzAyOQ_d9f50ece-a52d-4a8f-9fe9-8c3eab0c8c38">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMzItMS0xLTExNzAyOQ_de74e993-a7fa-4325-8015-5903478ed42a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19 costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability.</span></div><div style="margin-bottom:7pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_40"></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dx Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Dx segment generated $<ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RleHRyZWdpb246MzUxYmNlNmEzNDc2NDQyODlkNDUwNDIwYjNiNmJiYWVfNTM_30f32314-7ae3-4f09-b0d9-3c2e086e63af">9,203.5</ix:nonFraction> million in total revenues and $<ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RleHRyZWdpb246MzUxYmNlNmEzNDc2NDQyODlkNDUwNDIwYjNiNmJiYWVfODY_458408f8-72f6-480d-998a-f67b133babd9">2,025.5</ix:nonFraction> million in segment operating income, resulting in an operating margin of 22.0%. </span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:74.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In Millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMi0xLTEtMS0xMTcwMjk_30f32314-7ae3-4f09-b0d9-3c2e086e63af">9,203.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMi0zLTEtMS0xMTcwMjk_4fec45df-805b-48fd-8373-f5f46650fedd">10,363.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMy0xLTEtMS0xMTcwMjk_458408f8-72f6-480d-998a-f67b133babd9">2,025.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMy0zLTEtMS0xMTcwMjk_779620f1-60ea-43df-b065-615153a31746">3,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx is an independent clinical laboratory business. It offers a comprehensive menu of frequently requested core testing and specialty testing through an integrated network of primary and specialty laboratories across the U.S. and Canada. This network is supported by a sophisticated information technology system, with more than 80,000 electronic interfaces to deliver test </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results, nimble and efficient logistics, and local labs offering rapid response testing. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx also provides patient access points that are strategically and conveniently located throughout the U.S., including more than 2,000 PSCs and more than 6,000 in-office phlebotomists located in customer offices and facilities. Although testing for healthcare purposes and customers who provide healthcare services represents the most significant portion of the clinical laboratory industry, clinical laboratories also perform testing for other purposes and customers, including employment and occupational testing, DNA testing to determine parentage and to assist in immigration eligibility determinations, environmental testing, wellness testing, toxicology testing, pain management testing, and medical drug monitoring. Dx offers an expansive test menu that includes a wide range of clinical, anatomic pathology, genetic and genomic tests, and regularly adds new tests and improves the methodology of existing tests to enhance patient care. Dx also offers consumer-initiated wellness testing available online through its Labcorp OnDemand&#8482; platform. The Pixel by Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> COVID-19 PCR and combined COVID-19 + flu at-home collection kits are also available through Labcorp OnDemand. Dx typically processes tests for more than 3 million patient encounters each week. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of an ongoing commitment to be an efficient and high-value provider of laboratory services, Dx implemented a comprehensive business process improvement initiative known as LaunchPad. The initiative was designed to reengineer the Company's systems and processes to create a sustainable and more efficient business model, and to improve the experience of all stakeholders. Dx&#8217;s LaunchPad initiative delivered approximately $200 million in net savings for the period of late 2018 through the end of 2021.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dx business can be categorized into the following components:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:17.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.299%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service</span></td><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Features</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Testing Operations and Productivity</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Network of PSCs offering specimen collection services</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Comprehensive, nimble supply chain for transferring specimens across the entire life cycle of a patient sample</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">1-2 day turnaround time for most test results, with the vast majority of results delivered electronically to healthcare providers and to patients who have a Labcorp Patient&#8482; account</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Rigorous standard of quality - 24 regional/specialty labs hold ISO 15189 certification, 3 labs hold ISO 13485 certification, and one lab holds both</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Testing and Related Services</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Standard Testing Services - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">frequently-ordered tests used in regular patient care include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, prostate-specific antigen (PSA), tests for sexually transmitted diseases (e.g. chlamydia, gonorrhea, trichomoniasis and human immunodeficiency (HIV), and hepatitis C (HCV)), vitamin D, microbiology cultures and procedures, and alcohol and other substance abuse tests</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Specialty Testing Services -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> industry leader in gene-based and esoteric testing; advanced tests target specific diseases and use new technologies; services include anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Dx offers a range of health and wellness services to employers and MCOs, including health fairs, on-site and at-home testing, vaccinations and health screenings </span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development of New Tests</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">More than 130 new tests launched in 2022</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Active diagnostics and therapeutics research division: approximately 650 studies, articles, and presentations produced in 2022</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Continuous investing, internally and externally, in new testing technologies and advanced testing capabilities</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Technology-Enabled Services and Support</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A range of services and support using proprietary technologies to improve the customer and patient experience and provide convenient access to data and analytics, including:</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Nearly 6.5 million enhanced clinical decision support (CDS) reports delivered to physicians and health systems</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Online and mobile applications improving the patient experience by allowing patients to schedule PSC visits, check-in upon arrival, complete documentation, access test results, and manage their accounts</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Online applications for MCOs and accountable care organizations (ACOs) to obtain test results and population and health management data</span></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of U.S. Market Changes on the Clinical Laboratory Business</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he delivery of, and reimbursement for, healthcare continues to change in the U.S., impacting all stakeholders, including the clinical laboratory business. Medicare (which principally serves patients who are 65 and older), Medicaid (which principally serves low-income patients) and insurers have increased their efforts to control the cost, utilization and delivery of healthcare services. Measures to regulate healthcare delivery in general and clinical laboratories in particular have resulted in reduced prices, added costs, increased coverage denials and claims edits, and decreased test utilization for the clinical laboratory industry by imposing new, increasingly complex regulatory and administrative requirements. The government also has continued to adjust the Medicare and Medicaid fee schedules at the national and local level, and the Company believes that pressure to reduce government reimbursement will continue.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees for most laboratory services reimbursed by Medicare are established in the Clinical Laboratory Fee Schedule (CLFS) and fees for other testing reimbursed by Medicare, primarily related to pathology, are covered by the Physician Fee Schedule (PFS). During 2022, approximately 8.9% of Dx&#8217;s revenue was reimbursed under the CLFS (8.5% in 2021), and approximately 0.4% was reimbursed under the PFS (0.4% in 2021). Dx has experienced governmental reimbursement reductions as a direct result of several Congressional acts and regulatory initiatives. These laws include provisions designed to control healthcare expenses reimbursed by government programs through a combination of reductions to fee schedules, incentives to physicians to participate in alternative payment models such as risk-sharing, and new methods to establish and adjust fees.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant of these developments was the Protecting Access to Medicare Act (PAMA), which became law on April 1, 2014, and which went into effect on January 1, 2018. Beginning in 2018, under PAMA, the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) set the CLFS using the weighted median of reported private payer prices paid to certain laboratories that receive a majority of their Medicare revenue from the CLFS and PFS and that bill Medicare under their own National Provider Identifier (NPI). Applicable labs, including Dx, were required to begin reporting their test-specific private payer payment amounts to CMS during the first quarter of 2017. CMS used that private market data to calculate weighted median prices for each test (based on applicable current procedural technology (CPT) codes) to represent the new CLFS rates beginning in 2018, subject to certain phase-in limits. For 2018 through 2020, a test price could not be reduced by more than 10.0% per year. PAMA resulted in a net reduction in reimbursement revenue of approximately $245.0 million between 2018-2020 from all payers affected by the CLFS.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to enactment of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) passed by Congress on March 27, 2020, the Medicare reimbursement cuts that would have occurred under PAMA in 2021 were delayed by one year. In 2021, Dx realized an increase of approximately $0.3 million in PFS revenue as a result of the provisions included in the Omnibus Appropriations and Coronavirus Relief Package. In 2021, Dx realized an additional increase of approximately $5.8 million in aggregate Medicare reimbursement associated with the suspension of sequestration through December of 2021, as a result of provisions included in the Omnibus Appropriations and Coronavirus Relief Package that were extended as a result of an Act to Prevent Across-the-Board Direct Spending Cuts.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 10, 2021, President Biden signed into law the Protecting Medicare and American Farmers from Sequester Cuts Act, which delayed by one additional year the data reporting requirements and Medicare reimbursement cuts that would have occurred under PAMA in 2022, resulting in a 0% update to the CLFS in 2022. In 2022, Dx realized a decrease of approximately $0.4 million in PFS revenue driven by reductions in reimbursement for flow cytometry procedures and a decrease of approximately $10.0 million in aggregate Medicare reimbursement associated with the phased in reinstitution of sequestration as a result of provisions included in the Protecting Medicare and American Farmers from Sequester Cuts Act.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Protecting Medicare and American Farmers from Sequester Cuts Act also included mitigations to several other non-PAMA Medicare cuts in addition to delaying Medicare reimbursement cuts under PAMA. It delayed the 4% Medicare cuts that would otherwise have occurred in 2022 under statutory &#8220;pay-as-you-go,&#8221; or PAYGO, rules to offset the cost of the American Rescue Plan Act by one year. In addition, it delayed the resumption of the 2% Medicare sequestration until April 1, 2022, and reduced to 0.75% the previous 3.75% reduction to PFS reimbursement that was scheduled for 2022. To offset the cost, the Medicare sequestration was increased to 2.25% for January through June of 2030, and to 3.0% for July through December 2030.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 29, 2022, President Biden signed into law H.R. 2617, the Consolidated Appropriations Act, 2023, which delayed by one additional year the data reporting requirements and Medicare reimbursement cuts that would have occurred under PAMA in 2023, resulting in a 0% update to the CLFS for 2023. The Consolidated Appropriations Act, 2023 also included mitigations to several other non-PAMA Medicare cuts in addition to delaying Medicare reimbursement cuts under PAMA. It delayed until October 1, 2024 the 4% Medicare cuts that would otherwise have been effective January 1, 2023 under PAYGO rules. In addition, it mitigated PFS cuts in 2023 and 2024 to by 2.5% and 1.25%, respectively, that would otherwise have been (4.47%) in 2023 based on the conversation factor put forward in the 2023 Medicare PFS Final Rule. To offset the </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cost, it extended the 2% Medicare sequestration through the first six months of 2032 and set the sequestration percentage at 2% in fiscal years 2030 and 2031.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, Dx anticipates a net PFS revenue increase of 0.8% ($0.3 million) from the 2023 PFS Final Rule, driven by a (2.0%) change to the PFS conversion factor that is offset by net positive changes in relative value units (RVUs) for flow cytometry and changes to RVUs for other PFS procedures. The 2023 PFS Final Rule also included an increase in the CLFS fee for specimen collection by venipuncture from $3.00 to $8.57, which is estimated to increase Dx CLFS revenue for specimen collection by $38.6 million in 2023.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to PAMA as amended, for 2024 through 2026, a CLFS test price cannot be reduced by more than 15.0% per year (excluding non-PAMA reimbursement changes). CLFS rates for 2027 and subsequent periods will not be subject to phase-in limits. The phase-in of rates for Clinical Diagnostic Laboratory Tests (CDLTs) established in 2018 will resume in 2024. New CLFS rates will be established in 2025 based on data from 2019 to be reported in 2024. New CLFS rates will be established in 2028 based on data from 2026 to be reported in 2027. CLFS rates for Advanced Diagnostic Laboratory Tests will be updated annually.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Clinical Laboratory Association (ACLA) filed a federal civil action in 2017 challenging the legal basis for the data collection methodology CMS used to derive the data from which the median prices were calculated. On July 15, 2022, the U.S. Court of Appeals for the D.C. Circuit ruled in favor of ACLA on the merits, finding that CMS harmed laboratories by collecting data in an arbitrary and capricious manner, but refused to grant relief due to PAMA&#8217;s statutory bar on judicial review of establishment of the rates.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the initial data collection, CMS has revised its PAMA regulations to increase the number of hospital outreach labs that will be required to report private market data in future collections. Reports by the U.S. Government Accountability Office (GAO), the HHS Office of Inspector General (OIG), and the Medicare Payment Advisory Commission (MedPAC) on PAMA implementation have identified certain instances of actual or potential increased Medicare expenditures under PAMA, as well as potential alternative methodologies for data collection under PAMA, which could result in further efforts to amend PAMA by Congress.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACLA has continued to work with Congress on potential legislative reform of PAMA, which if adopted could reduce the negative impact of PAMA as currently implemented by CMS. Under the Laboratory Access for Beneficiaries (LAB) Act, MedPAC was required to conduct a study and make recommendations to Congress on ways to improve data collection, reporting, and rate setting under PAMA to achieve, in a less burdensome manner, CLFS rates that accurately and fairly reflect private market rates. MedPAC's June 2021 report to Congress included an analysis of potential statistical sampling methodologies that could accomplish that objective, and ACLA incorporated the concept in PAMA reform proposals to Congress. On June 22, 2022, the Saving Access to Laboratory Services Act (S. 4449 H.R. 8188) was introduced in both the U.S. Senate and the U.S. House of Representatives to provide for permanent reform of PAMA incorporating many of ACLA&#8217;s proposals. The Company supports the ongoing efforts to prevent or lessen the negative impact of the changes to the CLFS pursuant to PAMA, and the full impact of those efforts, but what the long-term effect will be on the CLFS rates is not yet known.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further healthcare reform could occur in 2023, including changes to the Patient Protection and Affordable Care Act (ACA) and Medicare reform, as well as administrative requirements that may continue to affect coverage, reimbursement, and utilization of laboratory services in ways that are currently unpredictable.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, market-based changes have affected and will continue to affect the clinical laboratory business. Reimbursement from commercial payers for diagnostic testing may shift away from traditional, fee-for-service models to alternatives, including value-based, bundled pay-for-performance, and other risk-sharing payment models. The growth of the managed care sector and consolidation of MCOs present various challenges and opportunities to Dx and other clinical laboratories. Dx's ability to attract and retain MCO customers has become even more important as the impact of various healthcare reform initiatives continues, including expanded health insurance exchanges and ACOs.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves many MCOs. These organizations have different contracting philosophies, which are influenced by the design of their products. Some MCOs contract with a limited number of clinical laboratories and engage in direct negotiation of rates. Other MCOs adopt broader networks with generally uniform fee structures for participating clinical laboratories. In some cases, those fee structures are specific to independent clinical laboratories, while the fees paid to hospital-based and physician-office laboratories may be different, and are typically higher. MCOs may also offer Managed Medicare or Managed Medicaid plans. In addition, some MCOs use capitation rates to fix the cost of laboratory testing services for their enrollees. Under a capitated reimbursement arrangement, the clinical laboratory receives a per-member, per-month payment for an agreed upon menu of laboratory tests, or based upon the proportionate share earned by the clinical laboratory from a capitation pool. When the agreed upon reimbursement is based solely on an established rate per member, revenue is not impacted by the volume of </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">testing performed. Under a capitation pool arrangement, the aggregate value of an established rate per member is distributed based on the volume and complexity of the procedures performed by laboratories participating in the agreement. For the year ended December 31, 2022, capitated contracts with MCOs accounted for approximately $332.3 million, or 3.2%, of Dx's revenues.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to reductions in test reimbursement, the Company also anticipates potential declines in test volumes as a result of increased controls over the utilization of laboratory services by Medicare, Medicaid, and other third-party payers, particularly MCOs. MCOs are implementing, directly or through third parties, various types of laboratory benefit management programs, which may include laboratory networks, utilization management tools (such as prior authorization and/or prior notification), and claims edits, which impact coverage and reimbursement of clinical laboratory tests. Some of these programs address clinical laboratory testing broadly, while others are focused on certain types of testing, including molecular, genetic and toxicology testing. In addition, continued movement by patients into consumer-driven health plans may have an impact on the utilization of laboratory testing. Test volumes in 2023 could also change compared to 2022 and 2021 if demand for SARS-CoV-2 testing changes.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helping to balance the overall negative market changes regarding reimbursement discussed above, the Company believes that the volume of clinical laboratory testing is positively influenced by several factors, including an increase in the number and types of tests that are readily available (due to advances in technology and increased cost efficiencies) for the diagnosis of disease, and the general aging of the U.S. population. Periodic infectious disease outbreaks such as the SARS-CoV-2 virus also have the potential to generate additional testing volume in the future, and enhance stakeholders&#8217; appreciation for the value of laboratory testing in combating future potential outbreaks. Dx believes that its enhanced and growing esoteric menu of tests, leading position with companion diagnostics, broad geographic footprint, and operating efficiency make it well positioned for growth due to a number of market factors, primarily related to a continued drive to improve outcomes and reduce costs across the healthcare system, including but not limited to greater price transparency required under &#8220;surprise billing&#8221; laws and regulations requiring disclosure of hospital charges. </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_43"></div><div style="margin-bottom:7pt;margin-top:9pt;text-align:center;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD Segment</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the DD segment generated $<ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RleHRyZWdpb246NjU2ZmVmM2ZmN2RjNDM5NDk4M2QxZWU2MmM1ODc2NzRfNTQ_88d88882-f1b2-4c91-81b6-71096c0d9524">5,710.2</ix:nonFraction> million in total revenue and $<ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RleHRyZWdpb246NjU2ZmVmM2ZmN2RjNDM5NDk4M2QxZWU2MmM1ODc2NzRfODY_6f9ffa4b-d948-4818-b060-bec59c92a0e9">801.1</ix:nonFraction> million in segment operating income, resulting in an operating margin of 14.0%.</span></div><div style="margin-bottom:2pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:74.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">In Millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMi0xLTEtMS0xMTcwMjk_88d88882-f1b2-4c91-81b6-71096c0d9524">5,710.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMi0zLTEtMS0xMTcwMjk_e903ff10-b2cf-48ad-a344-3fd8bc1637d7">5,845.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMy0xLTEtMS0xMTcwMjk_6f9ffa4b-d948-4818-b060-bec59c92a0e9">801.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMy0zLTEtMS0xMTcwMjk_7c9dc5f1-7242-49a3-a711-d9905ce8b60f">887.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD provides end-to-end drug development, medical device and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. Its customers are comprised of pharmaceutical, biotechnology, medical device, and diagnostic companies across the world. With a global network of operations, DD offers deep expertise in early development and clinical trials in each therapeutic area. DD had provided support for 90% of the new drugs and therapeutic products approved in 2022 by the U.S. FDA, including 100% of those specific to oncology  and 87% of those submitted by biotechnology companies. Through its industry-leading central laboratory business, it supports clinical trial activity in approximately 100 countries.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:18.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.988%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service</span></td><td colspan="3" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Key Features</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preclinical Services</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Lead optimization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: connects early discovery activities to regulated pre-clinical studies</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Analytical services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: bioanalytical testing services offering appropriate dose and frequency of drug administration</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Safety assessment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: general, genetic, and immunotoxicology services; nonclinical pathology; safety pharmacology services; preclinical medical device services; respiratory services; and developmental and reproductive toxicology (DART) studies</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Chemistry manufacturing services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: robust, cost-effective solutions in the areas of safety, identity, strength, quality, and purity assessments for biologics</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Early phase development solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: focused, multidisciplinary teams of experts that craft integrated solutions to identify and develop lead drug candidates and reduce development challenges</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Crop protection and chemical testing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Consulting services for chemical manufacturers and other firms engaged in the development of modern crop protection technology</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Central Laboratory Services</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Clinical laboratory services for individuals participating in clinical studies</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Provided to biopharmaceutical customers through its global network of central laboratories in the U.S., Europe, and Asia</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Operates world's largest automated clinical trial sample collection kit production line that enables kits to be produced with 5.5 sigma precision</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Six ISO 15189-certified laboratories</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Development and Commercialization Services</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Comprehensive range of services including the full-service delivery of Phase I through IV clinical studies, along with a wide offering of functional service provider solutions</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Dedicated group experienced in conduct of trials for medical devices and diagnostics to provide services for expanding market in medical devices</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Leader in clinical pharmacology</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Wide range of commercialization solutions including life cycle management and post-approval studies</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Market access solutions</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Technology Solutions</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary digital tools and services providing customers with greater access to key insights and results, as well as improved trial management, enhanced transparency, quality, and speed of clinical trials, resulting in reduced costs and increased market potential for customers:</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Patient-facing software applications supporting virtual, hybrid, and traditional trials</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Metrics and benchmarking applications for trial performance monitoring and optimization</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Award-winning informatics software suite for risk-based quality management across clinical trials</span></div><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Patient randomization and Clinical Supply Management</span></div></td></tr></table></div><div id="i9affef4b263d4c7097546e2ee7326a4a_46"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Human Capital </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mission and Culture</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp believes in the power of science to change lives. The Company&#8217;s culture centers around its mission to improve health and improve lives. The Company's more than <ix:nonFraction unitRef="employee" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80Ni9mcmFnOjZhMDUyMTQxMjAxZjQ3ODc4OTFjMGE1YjBlYTBhZTcyL3RleHRyZWdpb246NmEwNTIxNDEyMDFmNDc4Nzg5MWMwYTViMGVhMGFlNzJfMTY0OTI2NzQ5ODk2Mw_81e39c35-370e-4198-aa43-087366bb81b2">80,000</ix:nonFraction> employees serve clients in over 100 countries. They are essential to the Company&#8217;s ability to innovate and advance science and technology to empower patients, providers, and pharmaceutical companies to make clear and confident decisions. Engaging the collective expertise and passion of its employees is vital to achieving the Company&#8217;s mission, which permeates its performance-driven, collaborative, inclusive, customer-centered, and inquisitive culture.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workforce Demographics</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s success depends on its sustained ability to attract, develop, and retain a highly specialized and skilled global workforce. Employees are globally dispersed, with 77% in the U.S. and Canada, 11% in Asia, 11% in Europe, the Middle East, and Africa, and 1% in Latin America. Of the Company&#8217;s global workforce, 88% of employees are full time, and 12% are part time. 3.3% of Labcorp&#8217;s global workforce is employed under a collective bargaining agreement. Depending on business demand and the talent-hiring environment, Labcorp supplements up to 8% of its workforce with contingent workers.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The challenges of 2022, felt globally, also presented the Company with significant challenges in acquiring and retaining talent. Despite these obstacles, Labcorp&#8217;s global workforce increased by more than 10% from a combination of organic growth and adding employees through acquisitions. The majority of Labcorp's hires are sourced through an internal talent acquisition </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">team. The Company made significant investments to retain talent and enable the organization to meet the business needs for growth, which are discussed further in the section below on &#8220;Compensation and Benefits.&#8221;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, the majority of employees who do not work with patients, animals, in labs, or in logistics, worked remotely. This includes call center employees, customer service teams, sales teams, and corporate and functional teams. While some employees returned to on-site work in 2022, the Company expects that a significant number of employees will continue working remotely, or through hybrid, in-office and remote work arrangements. The Company believes that flexibility in work location and arrangements expands the pool from which it can source experienced and valuable talent. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity and Inclusion</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp's diverse, global talent is core to its ability to innovate and meet patient and customer needs. The Company believes that the diversity of its employees and its inclusive programs contribute to a healthy, productive, and respectful work environment.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Workforce Diversity Profile: </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Gender, Ethnicity, and Race</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global Workforce by </span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENDER</span></div><div style="text-align:justify"><img src="lh-20221231_g1.jpg" alt="lh-20221231_g1.jpg" style="height:131px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Workforce by </span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENDER</span></div><div style="text-align:justify"><img src="lh-20221231_g2.jpg" alt="lh-20221231_g2.jpg" style="height:125px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Workforce by </span><span style="color:#00ffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RACE &amp; ETHNICITY</span></div><div style="text-align:justify"><img src="lh-20221231_g3.jpg" alt="lh-20221231_g3.jpg" style="height:125px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Diversity and Inclusion (D&amp;I) strategic framework, with three overarching pillars of focus: empowering inclusive leadership; developing and sustaining a diverse talent pipeline; and creating an environment for engagement across the Company and in its communities. Labcorp&#8217;s D&amp;I strategy is designed as a continuing journey to maintain and further evolve its inclusive workforce consistent with the changing dynamics of the global workforce. Highlights of actions supporting the Company&#8217;s D&amp;I framework that it believes will foster a more inclusive environment and strengthen its culture include:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the continuation of an unconscious bias training program designed to improve self-awareness of personal biases. The program was rolled out globally in 2021 to all of the Company's people leaders, and more than 6,000 have completed the training through 2022. Labcorp also deployed Global Harassment training to over 70,000 employees;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversity metrics shared quarterly with senior leaders, and establishment of D&amp;I plans at the segment level;</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">monthly meeting of the Company's D&amp;I advisory council, consisting of a cross section of leaders to learn about, and be advocates for, our initiatives;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a formal mentoring initiative that includes a Reverse Diverse Mentoring program that received the Gold Award in the category of Best Advance in Mentoring to Develop Diverse Leaders from the Brandon Hall Group in 2021;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued offerings of leadership development programs for women in senior management through the vice president level, and the second annual virtual women's summit for executive women leaders;</span></div><div style="margin-bottom:1pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued global expansion of Employee Resource Groups (ERGs). ERGs are led by employee volunteers and are important resources to foster cross-company connections, encourage belonging, support career development, and champion employee voices. The Company now has eight unique ERGs with 106 chapters in 15 countries, growing by more than 30 local chapters from 2021. Each ERG has executive sponsorship from senior leadership; and</span></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">celebration of different cultures, constituencies, and observances throughout the year, including a &#8220;Days of Understanding&#8221; series in partnership with ERGs and in alignment with CEO Action, a business-led initiative to advance diversity, equity and inclusion in the workplace.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was named to FORTUNE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> magazine's 2022 List of World's Most Admired Companies, making the annual list for the fourth time. Labcorp also made the Forbes 2022 list of World's Best Employers for the third consecutive year, as well as the Forbes 2022 List of Best Employers for New Graduates. In 2022, the Company was recognized for the fifth consecutive year as a Best Place to Work for LGBTQ+ Equality, with a score of 100% on the Human Rights Campaign Foundation's Corporate Equality Index. The Index is the nation's foremost benchmarking survey and report on corporate policies and practices related to LGBTQ+ workplace equality.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was also named as a Best Place to Work for Disability Inclusion by the Disability Equality Index and one of Newsweek's 2022 America's Most Responsible Companies. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also implemented opportunities for greater engagement between employees and management. These include quarterly global town halls that are held virtually and are open to all employees, interactions with front-line employees on visits to the Company's facilities, and in-person town halls with employees in select business units. In early 2022, the Company initiated a Voice of the Employee Survey. Responses were received from nearly 50% of Company employees across 64 countries. The insights provided by employees are being used to make improvements in the virtual onboarding experience for new employees, introduction of a modern global human resources portal, and a reimagined U.S. benefits portal to help employees to better evaluate their benefits options.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a complex, global, and dynamic life sciences industry and believes that its compensation and benefits programs must continue to be competitive and flexible to attract and retain the caliber of talent needed to sustainably grow the business. In 2022, the Company&#8217;s workforce grew by over 10%. The Company believes that its ability to expand the workforce in 2022 provides support that the Company's compensation and benefit strategies are competitive and support the Company's ability to attract and retain talent.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually monitors market activity and employee movement within and outside of the core life sciences industry to maintain competitiveness, given the dynamic business and economic environment and labor market challenges it faces. In 2022, the Company invested more than $39 million in pay adjustments in addition to annual pay increases, to increase pay competitiveness in the markets in which we compete for talent.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Wellness</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also continued investing in the health and wellness of its global workforce, with particular emphasis on improving its U.S. health benefits program for employees. The Company&#8217;s efforts on this front included:</span></div><div style="margin-top:7pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no annual cost increase for the payroll contributions in its U.S. Healthy medical, dental and vision insurance plans, impacting approximately 35,000 covered employees and more than 30,000 dependents. For approximately 19,000 employees in the U.S. earning less than $50,000 per year, the Company further reduced the cost of monthly medical insurance contributions by $240 per year; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing up to $4,560 in annual medical plan contribution discounts for over 35,000 employees and their spouses and domestic partners for committing to and maintaining a healthy and tobacco-free lifestyle; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">encouraging health and wellness education and activities by providing up to $1,000 in Health Reimbursement Account contributions to approximately 35,000 employees and their spouses or partners; and</span></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reimbursing up to $300 in fitness-related costs for approximately 13,000 employees.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company routinely continually educates its workforce on health issues of importance and has prioritized continuous education on the importance of mental well-being by providing communications and resources to all employees. The Company </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">believes that its investments in compensation and wellness are crucial to maintaining competitive positioning and a productive and engaged workforce.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development and Training</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To meet the needs of patients and clients in the evolving and competitive diagnostics and drug development markets, the Company is committed to creating a work environment that supports a focus on the continuous development and training of its employees. With this focus, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Company believes it is well-positioned in the long term to meet the demands of the regulatory environment and accelerate its ability to innovate and develop talent in a highly skilled and competitive talent market.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp's curriculum has three primary focus areas: regulatory training; technical training; and professional development. Regulatory training is required by laws and regulations for the Company to operate in certain areas within the life sciences industry and in certain jurisdictions. Technical training and professional development enable the Company to compete more effectively in the life sciences industry.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an extensive library of over 48,000 courses that are available virtually within its global learning management system. In 2022, Labcorp employees completed over 2.7 million hours of training, primarily consisting of regulatory and technical training. In addition, due to the Company&#8217;s access to sensitive and personally identifiable information, employees completed over 720,000 IT security training courses, representing more than 150,000 total hours, with the goal of maintaining IT system safety and security for clients and patients.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp also invests in the professional development of its talent, and in retaining its best employees for future internal opportunities. In 2022, employees completed more than 50,000 hours of professional development. In addition, 343 employees completed the Labcorp UK Apprenticeship program that the Company plans to expand in 2023 to include US employees.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Challenges in the talent labor market have reinforced the need to offer new and engaging learning resources. In 2021, the Company expanded its approach to tuition assistance. Through 2022, the Labcorp Education Advantage program has fully  sponsored 742 employees in their pursuit of higher education in the sciences, with 13 employees completing their bachelor&#8217;s degree with this benefit. Employees enrolled in the Labcorp Education Advantage program have an 11 point lower attrition rate than the global population, evidencing a strong social and human capital impact. In addition, Labcorp added new relationships with leading academic institutions and learning partners that provide open, online courses. These partners provide video courses, job aides, and short, self-paced learning taught by industry experts.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health and Safety</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of the Company's business requires employees to work directly with patients and animals. This includes the handling, processing, and testing of human or animal specimens on a daily basis. As the health and safety of employees is a primary concern, the Company has established numerous employee health and safety protocols, including engineering and administrative controls, policies, procedures, processes, and training to minimize the potential for, and the severity of, work-related injuries and illnesses.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company was able to reduce its work-related injury rate per 100 employees to 1.5%, a reduction of 6.3% over 2021. The Company maintained its work-related lost work injury rate per 100 employees at 0.3%. The Company completed a Corporate EHS Audit on 15 significant laboratory facilities, allowing it to assess locations against common expectations and performance criteria. In response to COVID-19, the Company modified the audit format so that it could be effectively performed virtually, with the added benefit of reducing audit travel-related greenhouse gas emissions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company faced extraordinary challenges in assisting the nearly 400 employees, and in many cases their families, who were adversely affected by the Ukraine/Russia crisis. In response, the Company supported employees with emergency, short- and long-term housing, transportation and relocation assistance, and provided help with communications, food, and other necessary supplies and services.   </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Community Engagement</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Labcorp Charitable Foundation, a private, charitable 501(c)(3) organization established by the Company, invested in more than 120 programs in 2022 that align with the Company&#8217;s strategic mission to improve health and improve lives in the areas of health, education, and community across the globe. The Foundation supports efforts to increase access to health services and create equitable opportunities for underserved populations across the globe. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Colleagues around the globe are invited to participate in the company&#8217;s annual Employee Giving Campaign. Through the campaign, colleagues had the opportunity to donate to one or more of seven selected charities: the American Cancer Society, American Heart Association, American Diabetes Association, American Red Cross (Disaster Relief), United Way, the National Urban League and new for 2022, Project HOPE. Employee contributions support these charities to provide needed services in </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their local communities and around the globe. The Labcorp Charitable Foundation offers a match opportunity for contributions made through the campaign. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company's employees took advantage of opportunities to support charitable causes and make a positive impact in their communities.  For example, in honor of the life and legacy of Dr. Martin Luther King Jr., colleagues participated in the &#8220;Cards of Encouragement&#8221; campaign, a global initiative to lift the spirits of hospitalized children and their families. With the help of Cards for Hospitalized Kids, close to 8,000 cards were distributed to children and their families staying at Ronald McDonald Houses or receiving treatment at nonprofit children&#8217;s hospitals. The Labcorp Charitable Foundation made a financial donation to the 39 supported charities.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's global colleagues also support the local communities where they live and work. In observation of Childhood Cancer Awareness Month, Company colleagues in Geneva, Switzerland supported ARFEC (Association Romande des Familles d&#8217;Enfants atteints d&#8217;un Cancer) to benefit hospitalized children and their families through toy drives, the creation and sale of a calendar and participation in the Geneva 20 kilometer race.   </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dynacare, a Labcorp company based in Canada, teamed up with Diabetes Canada to organize the #Dyncare4Diabetes campaign for the second consecutive year. The campaign raises awareness of diabetes and provides accessible and free testing for at risk individuals. In addition to offering free hemoglobin A1C testing at all Dynacare laboratory locations across the Greater Toronto Area and at mobile community clinics, Dynacare donated 50 cents to Diabetes Canada for every individual that participated in the campaign, up to a total of $25,000. </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_49"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customers </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides its services to a broad range of customers across Dx and DD. The primary customer groups serviced by the Company include:</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:105%;padding-left:8.03pt">Health Plans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The Company serves many health plans, including MCOs and other health insurance providers, each of which operate on a national, regional, or local basis. In certain locations, health plans may delegate to independent physician associations (IPAs) or other alternative delivery systems (e.g., ACOs) the ability to negotiate for services on behalf of certain members. </span></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:10pt">Pharmaceutical, Biotechnology, Medical Device, and Diagnostics Companies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides development services to hundreds of pharmaceutical, biotechnology, medical device, and diagnostics companies, ranging from the world's largest multi-nationals to emerging, small and mid-market companies. </span></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:10pt">Physicians and Other Healthcare Providers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians who require clinical laboratory testing for their patients are a primary source of requests for Dx's testing services. </span></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:10pt">Hospitals and Health Systems. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides hospitals and health systems with services ranging from core and specialty testing to supply chain and technical support services, and the opportunity to be a research partner for participation in studies and clinical trials with DD. In some cases, a hospital&#8217;s on-site laboratory may be operated or managed by an outside contractor or independent laboratory, including the Company. </span></div><div style="margin-top:7pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:10pt">Other Customers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves a broad range of other customers, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">incl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uding, but not limited to, governmental agencies, employers, patients and consumers, CROs, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_52"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sales, Marketing, and Customer Service</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers its services through a sales force focused on serving the specific needs of customers in different market segments. The Company's sales force is responsible for both new sales and for customer retention and relationship building.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Dx, these market segments generally include primary care, women's health, specialty medicine (e.g., infectious diseases, endocrinology, gastroenterology, and rheumatology), oncology, ACOs, and hospitals and health systems, with different representatives focused on each segment to better understand and respond to the unique needs of each clinical area. The DD global sales organization provides customer coverage across the pharmaceutical, biotechnology, and medical device industries for services including lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access and technology solutions. As part of the Company's ongoing strategic priority to maximize the value of its unique leadership in both diagnostics and drug development, sales representatives from each business segment work together on outreach to potential customers of each business, including hospitals and health systems that may purchase testing and participate in clinical trials, or pharmaceutical, biotechnology or medical device companies whose studies may benefit from use of Dx&#8217;s specialty testing or network of PSCs.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Market Opportunity</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dx</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that in 2022, the U.S. clinical laboratory testing industry generated revenues of more than $80 billion. The clinical laboratory industry consists primarily of three types of providers: hospital-based laboratories, physician-office laboratories, and independent clinical and anatomical pathology laboratories, such as those operated by Dx.</span></div><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical laboratory business is intensely competitive, and the Company believes that both competition and consolidation in the clinical laboratory business will continue. CMS has estimated that, as of February 2023, there were 9,165 hospital-based laboratories, 123,511 physician-office laboratories, and 9,411 independent clinical and anatomic pathology laboratories in the U.S. Dx competes with all of those laboratories. In addition, an increasing number of health system laboratories have been expanding their operations and business, resulting in greater competition for testing from physicians within those systems and from unaffiliated physicians in the health system laboratories&#8217; service areas. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx believes that the selection of a laboratory is primarily based on the following factors, all of which the Company believes it competes favorably in:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality, timeliness, and consistency in reporting test results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reputation of the laboratory in the medical community or field of specialty;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual relationships with MCOs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">service capability and convenience;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">number and type of tests performed;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">connectivity solutions offered; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing of the laboratory&#8217;s services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the factors listed above, the Company believes that the operational and economic efficiencies provided by its integrated service and logistics network, large-scale automated testing, and regular introduction of new technologies will allow the Company to compete effectively with other providers of laboratory services.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Drug development services companies like DD are also referred to as CROs and typically derive substantially all of their revenue from research and development (R&amp;D), as well as marketing expenditures, of the pharmaceutical, biotechnology and medical device industries. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outsourcing of R&amp;D services to CROs has increased in the past, and is expected to continue increasing in the future. Increasing pressures to improve return on investment, to increase R&amp;D productivity, to stay abreast of scientific advances and to comply with stringent government regulations and attempts to reduce and control the price of prescription drugs have all contributed to this outsourcing to CROs. A CRO provides clients with flexibility in aligning resources to demand. In the face of mounting complexity, the investment and amount of time required to develop new products are significant and have been increasing. These trends create opportunities for DD and other CROs that can help make the development process more efficient.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The drug development industry has many participants ranging from hundreds of small providers to a limited number of large CROs with global capabilities. DD competes against these small and large CROs, as well as in-house departments of pharmaceutical, biotechnology, medical device and diagnostic companies, and to a lesser extent, selected academic research centers, universities and teaching hospitals.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD believes that customers selecting a CRO often consider the following factors, all of which the Company believes it competes favorably in: </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reputation for quality and regulatory compliance; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">efficient, timely performance;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expertise and experience in operations;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">application of technology and innovation;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">specific therapeutic and scientific expertise;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">data and analytical capabilities;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">post-approval and market access services; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">ability to recruit patients;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">scope of service offerings; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">strengths in various geographic markets; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">price; </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quality of facilities; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">quality of relationships, including investigator and patient; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">ability to manage large-scale clinical trials both domestically and internationally, including the recruitment of appropriate and sufficient clinical trial subjects; </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">size and scale;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">decentralized clinical trial capabilities;</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">ability to develop companion diagnostics; and</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">access to talent.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_55"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quality</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx and DD have comprehensive quality systems and processes appropriate for their respective businesses. The Company's quality programs are overseen by Dx's National Office of Quality, DD&#8217;s Global Regulatory Compliance and Quality Assurance Unit, DD's clinical trial services global vendor management department, DD's central laboratory services expanded laboratory management services department, and the Company's global supply chain management department and project management staff. The Company has procedures for monitoring its internal performance, as well as that of its vendors, suppliers, and other key stakeholders. In addition, various groups and departments within the Company provide oversight to monitor and control vendor products and performance, and play an essential role in the Company&#8217;s approach to quality through improvements in processes and automation. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all facets of the Company&#8217;s services are subject to quality programs and procedures, including accuracy and reproducibility of tests, turnaround time, customer service, data integrity, patient satisfaction, and billing. The Company&#8217;s quality programs include measures that compare current performance against desired performance goals to monitor critical aspects of service to its customers and patients. This includes licensing, credentialing, training and competency of professional and technical staff, and internal auditing. In addition to the Company's own quality programs, the Company&#8217;s laboratories, facilities and processes are subject to on-site regulatory agency inspections and accreditation evaluations, in addition to surveys and proficiency testing, by local or national government agencies; independent external accrediting programs; and inspections and audits by customers. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thirty-three of the Company's laboratories have received ISO 15189 and/or ISO 13485 accreditation, demonstrating that they meet international standards for quality and technical competence.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_58"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Systems </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is committed to developing and commercializing technology-enabled solutions to support its operations and provide better care. The Company operates standard platforms for its core business services and its financial and reporting systems. These standard systems provide consistency within workflows and information as well as a high level of system availability, security, and stability. The primary laboratory systems include standardized support for molecular diagnostics, digital pathology and enhanced specialty laboratory solutions. The Company's centralized information systems are responsible for operational efficiencies, enabling the Company to achieve consistent, structured, and standardized operating results and effective patient care.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information systems used by Dx and DD are discussed in more detail in the sections dedicated to each of those segments.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_61"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property Rights</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on a combination of patents, trademarks, copyrights, trade secrets, and nondisclosure and non-competition agreements to establish and protect its proprietary technology. The Company has filed and obtained numerous patents in the U.S. and abroad, and regularly files patent applications, when appropriate, to establish and protect its proprietary technology. Occasionally, the Company also licenses U.S. and non-U.S. patents, patent applications, technology, trade secrets, know-how, copyrights or trademarks owned by others. The Company believes, however, that no single patent, technology, trademark, intellectual property asset or license is material to its business as a whole.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents covering the Company's technologies are subject to challenges. Issued patents may be successfully challenged, invalidated, circumvented, or declared unenforceable so that patent rights would not create an effective competitive barrier. In addition, the laws of some countries may not protect proprietary rights to the same extent as do the laws of the U.S.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parties may file claims asserting that the Company's technologies infringe on their intellectual property. The Company cannot predict whether parties will assert such claims against it, or whether those claims will harm its business. If the Company is forced to defend against such claims, the Company could face costly litigation and diversion of management&#8217;s attention and resources. As result of such disputes, the Company may have to develop costly non-infringing technology or enter into licensing agreements. These agreements, if necessary, may require financial or other terms that could have an adverse effect on </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company's business and financial condition.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_64"></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation and Reimbursement</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Company operates in a number of distinct environments and in a variety of locations worldwide, it is subject to numerous, and sometimes overlapping, regulatory requirements. Both the clinical laboratory industry and the drug development business are subject to significant governmental regulation at the national, state and local levels. As described below, these regulations concern licensure and operation of clinical laboratories, claim submission and reimbursement for laboratory services, healthcare fraud and abuse, drug development services, security and confidentiality of health information, quality, and environmental and occupational safety.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulation of Clinical Laboratories</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Virtually all clinical laboratories operating in the U.S. must be certified by the federal government or by a federally approved accreditation agency. In most cases, that certification is regulated by CMS through CLIA, which requires that applicable clinical laboratories meet quality assurance, quality control, and personnel standards. Laboratories also must undergo proficiency testing and are subject to inspections. Clinical laboratories in locations other than the U.S. are generally subject to comparable regulation in their respective jurisdictions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standards for testing under CLIA are based on the complexity of the tests performed by the laboratory, with tests classified as &#8220;high complexity,&#8221; &#8220;moderate complexity,&#8221; or &#8220;waived.&#8221; Laboratories performing high-complexity testing are required to meet more stringent requirements than moderate-complexity laboratories. Laboratories performing only waived tests, which are tests determined by the FDA to have a low potential for error and requiring little oversight, may apply for a certificate of waiver exempting them from most CLIA requirements. All major and many smaller Company facilities hold CLIA certificates to perform high-complexity testing. The Company's remaining smaller testing sites hold CLIA certificates to perform moderate-complexity testing or a certificate of waiver. The sanctions for failure to comply with CLIA requirements include suspension, revocation, or limitation of a laboratory's CLIA certificate, which is necessary to conduct business; cancellation&#160;or suspension of the laboratory's approval to receive Medicare and/or Medicaid reimbursement; as well as significant fines and/or criminal penalties. The loss or suspension of a CLIA certification, imposition of a fine or other penalties, or future changes in the CLIA law or regulations (or interpretation of the law or regulations) could have a material adverse effect on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to state and local laboratory regulation. CLIA provides that a state may adopt laboratory regulations different from or more stringent than those under federal law, and a number of states have implemented their own laboratory regulatory requirements. State laws may require that laboratory personnel meet certain qualifications, specify certain quality controls, or require maintenance of certain records.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all laboratory requirements applicable to its laboratories operating both within the U.S. and in other countries. The Company's laboratories have continuing programs to maintain operations in compliance with all such regulatory requirements, but no assurances can be given that the Company's laboratories will pass all future licensure or certification inspections.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA and Other Regulatory Agency Laws and Regulations</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various regulatory agencies, including CMS and the FDA in the U.S., regulate the development, testing, manufacturing, labeling, advertising, marketing, distribution, storage, import, export, performance, and surveillance of diagnostic and therapeutic products and services, including certain products and services offered by the Company and the development of therapeutic products that comprise the majority of DD&#8217;s business. The FDA and other regulatory agencies periodically inspect and review the manufacturing processes and product performance of diagnostic and therapeutic products, while CMS, certain state programs, and accreditation entities inspect and review the facilities, personnel, and procedures of clinical laboratories and their laboratory operations. The FDA and other regulatory agencies also periodically inspect clinical study sites and CROs that conduct clinical trials, including test facilities that perform tests on samples from human subjects enrolled in such clinical studies of drugs, biologics, and medical devices. These agencies have the authority to take various administrative and legal actions for noncompliance, such as fines, withdrawal of product approval, warning or untitled letters, seizures, recalls, injunctions, and other civil and criminal sanctions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2014, there have been ongoing discussions and advocacy between stakeholders, including the clinical laboratory industry, the FDA, and Congress, about potential FDA regulation of laboratory-developed tests (LDTs), which are assays developed and performed in-house by clinical laboratories and can be made available to the public without pre-market review by the FDA (although COVID-19 diagnostic PCR LDTs have been subject to FDA pre-market requirements as a consequence of the national health emergency). Various regulatory and legislative proposals are under consideration, including some that </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">could increase general FDA oversight of clinical laboratories and LDTs. The outcome and ultimate impact of such proposals on the Company is difficult to predict at this time.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar national and regional regulatory agencies, and regulations, in the jurisdictions outside of the U.S. in which the Company operates. For example, the European Union In Vitro Diagnostics Regulation (Regulation (EU) 2017/746 (EU IVDR)), which became applicable May 26, 2022, established a new legislative framework for in vitro diagnostic devices including a rule-based classification and quality and safety standards. In addition, both Switzerland and the United Kingdom are implementing new legislative frameworks similar to the EU IVDR.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD&#8217;s laboratory facilities and Dx's clinical laboratory facilities that perform testing in support of clinical trials, must conform to a range of standards and regulations, including good laboratory practice (GLP) and good clinical practice (GCP), good manufacturing practice (cGMP), human subject protection and investigational product exemption regulations, and quality system regulation (QSR) requirements, as applicable. The preclinical and clinical studies that the Company conducts are subject to periodic inspections by the FDA as well as other regulatory agencies in the jurisdictions outside the U.S. in which the Company operates, which may include, without limitation, the Medicines and Healthcare products Regulatory Agency (MHRA) in the U.K., the European Medicines Agency, the National Medical Products Administration in China, and the Pharmaceuticals and Medical Devices Agency in Japan, to determine compliance with GLP and GCP as well as other applicable standards and regulations. If a regulatory agency determines during an inspection that the Company&#8217;s equipment, facilities, laboratories, operations, or processes do not comply with applicable regulations and GLP and/or GCP standards, the regulatory agency may issue a formal notice (FDA Form 483), which may be followed by a warning letter if observations are not addressed satisfactorily. Noncompliance may result in, among other things, unanticipated compliance expenditures, or the regulatory agency seeking civil, criminal or administrative sanctions and/or remedies against the Company, including suspension of its operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA Modernization Act 2.0 was enacted in December 2022 as Section 3209 of the Consolidated Appropriations Act, 2023. This Act amended Section 505 of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 355) to clarify the methods manufacturers and sponsors can use to investigate the safety and efficacy of a drug or the toxicity of a bioisimilar biologic product to include tests on animals as well as certain tests that are not performed on animals. Specifically, the Act replaces a statutory reference to &#8220;tests on animals&#8221; as a viable option for pre-clinical testing with a reference to &#8220;nonclinical tests&#8221;, which includes animal testing, cell-based assays, microphysiological systems, or bioprinted or computer models. The Act does not eliminate animal testing or require the use of non-animal models. FDA previously had the authority to allow non-animal data to be considered during safety and efficacy reviews of new drugs and had previously issued related guidance. However, many procedures intended to reduce animal tests are still in various stages of development. Since such alternative methodologies must first be validated before FDA will approve of their use instead of validated animal models, the practical impact of the Act is likely to be limited for some time.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain DD services and activities, such as chemistry, manufacturing, and controls (CMC) services and manufacturing of investigational medicinal products for use in certain Phase I studies managed by DD, must conform to cGMP. DD is subject to periodic inspections by the FDA and the MHRA, as well as other regulatory agencies in the jurisdictions outside the U.S. in which the Company operates, in order to assess, among other things, cGMP compliance. If a regulatory agency identifies deficiencies during an inspection, it may issue a formal notice, which may be followed by a warning letter if observations are not addressed satisfactorily. Failure to maintain compliance with cGMP regulations and other applicable requirements of various regulatory agencies could result in, among other things, fines, warnings or untitled letters, unanticipated compliance expenditures, suspension of manufacturing, enforcement actions, product seizures or recalls, injunctions, or criminal prosecution.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some Dx products are regulated by the FDA and other similar national regulatory agencies as medical devices. The FDA defines a medical device in part as an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article which is intended for the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease in man. FDA regulates the development, testing, manufacturing, marketing, post&#8209;market surveillance, distribution, advertising and labeling of products classified as medical devices separate from clinical diagnostic testing services offered under CLIA requirements. FDA regulatory requirements include: all of the relevant elements of the Quality System Regulation (which requires manufacturers to follow stringent design, testing, control, documentation and other quality assurance procedures), labeling regulations, restrictions on promotion and advertising, Medical Device Reporting regulations (which requires the manufacturer to report to the FDA if its device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur), the Reports of Corrections and Removals regulations (which requires manufacturers to report certain recalls and field actions to the FDA), and other post-market requirements.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To ensure compliance with regulatory requirements, medical device manufacturers are subject to market surveillance and periodic, pre-scheduled and unannounced inspections by the FDA. Failure to comply with applicable regulatory requirements </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">can result in enforcement action by the FDA, which may include sanctions, operating restrictions, partial suspension or total shutdown of production; refusal to grant clearance or approvals of new devices; withdrawal of clearance or approval; and civil or criminal prosecution.</span></div><div style="margin-bottom:7pt;margin-top:2pt;padding-left:4.5pt;padding-right:6.75pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Animal Welfare Laws and Regulations</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conduct of animal research at DD&#8217;s facilities in the U.S. must be in compliance with the Animal Welfare Act (AWA), which</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governs the care and use of warm-blooded animals for research in the U.S. other than laboratory rats, mice, and chickens, and is enforced through periodic inspections by the U.S. Department of Agriculture (USDA). The AWA establishes facility standards regarding several aspects of animal welfare, including housing, ventilation, lighting, feeding and watering, handling, veterinary care, and recordkeeping.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD complies with licensing and registration requirement standards set by the USDA and similar agencies in foreign jurisdictions such as the European Union, the U.K., and China for the care and use of regulated species. If the USDA determines that DD&#8217;s equipment, facilities, laboratories or processes do not comply with applicable AWA standards, it may issue an inspection report documenting the deficiencies and setting deadlines for any required corrective actions. The USDA may impose fines, suspend and/or revoke licenses and registrations, or confiscate research animals. Other countries where the Company conducts business have similar laws and regulations with which the Company must also comply. In addition, certain of DD&#8217;s animal-related activities may be subject to regulation by the U.S. Centers for Disease Control and Prevention (CDC), the Office of Laboratory Animal Welfare of the National Institutes of Health, the U.S. Fish and Wildlife Service, and similar organizations in other jurisdictions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;padding-right:6.75pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payment for Clinical Laboratory Services</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, Dx derived approximately 10.8% of its revenue directly from traditional Medicare and Medicaid programs. In addition, Dx's other commercial laboratory testing business that is not directly related to Medicare or Medicaid nevertheless depends significantly on continued participation in these programs and in other government healthcare programs, in part because customers often want a single laboratory to perform all of their testing services. In recent years, both governmental and private-sector payers have made efforts to contain or reduce healthcare costs, including reducing reimbursement for clinical laboratory services.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement under the Medicare PFS is capped at different rates in each Medicare Administrative Contractor's jurisdiction. Pursuant to PAMA, unless modified by Congress, reimbursement under the CLFS is set at a national rate that is updated every three years for most tests. State Medicaid programs are prohibited from paying more than the Medicare fee schedule limit for clinical laboratory services furnished to Medicaid recipients. Laboratories primarily bill and are reimbursed by Medicare and Medicaid directly for covered tests performed on behalf of Medicare and Medicaid beneficiaries. For beneficiaries that participate in Managed Medicare and Managed Medicaid plans, laboratory bills are submitted to and paid by MCOs that manage those plans. Approximately 8.9% of Dx's revenue is reimbursed directly by Medicare under the CLFS.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many pathology services performed by Dx are reimbursed by Medicare under the PFS. The PFS assigns relative value units to each procedure or service, and a conversion factor is applied to calculate the reimbursement. The PFS is also subject to adjustment on an annual basis. Such adjustments can impact both the conversion factor and relative value units. The Sustainable Growth Rate (SGR), the formula previously used to calculate the fee schedule conversion factor, would have resulted in significant decreases in payment for most physician services for each year since 2003. However, Congress intervened repeatedly to prevent these payment reductions, and the conversion factor was increased or frozen for the subsequent year. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) permanently replaced the SGR formula and transitioned PFS reimbursement to a value-based payment system. MACRA retroactively avoided a 21.2% reduction in PFS reimbursement that had been scheduled for April 1, 2015, and provided for PFS conversion factor increases of 0.5% from July 1, 2015 to December 31, 2015, and 0.5% in each of years 2016-2019, followed by no updates for 2020 through 2025, and updates that vary based on participation in alternative payment models in subsequent years. These changes to the conversion factor may be offset by reductions to the relative value units, as was the case with the 2016 PFS reductions. For 2022, Congress increased the conversion factor by 3.0% over the amount announced in the final rule, instead of allowing a 3.75% reduction to take effect. In the Consolidated Appropriations Act of 2023, Congress mitigated PFS cuts in 2023 and 2024 by 2.5% and 1.25%, respectively, that would otherwise have been (4.47%) in 2023 based on the conversation factor put forward in the 2023 Medicare Physician Fee Schedule final rule. Approximately 0.4% of Dx's revenue is reimbursed under the PFS.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to changes in reimbursement rates, Dx is also impacted by changes in coverage policies for laboratory tests and annual CPT coding revisions. Medicare, Medicaid and private payer diagnosis code requirements and payment policies negatively impact Dx's ability to be paid for some of the tests it performs. Further, some payers require additional information to process claims, employ third-party utilization management tools, or have implemented prior authorization policies which delay or prohibit payment. In 2022, there were limited coding and billing changes. While limited changes are expected to be implemented in 2023, the Company typically expects some delays in pricing and reimbursement as new codes are introduced.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes in national, state and local laws and regulations (or in the interpretation of current regulations) affecting government payment for clinical laboratory testing could have a material adverse effect on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further healthcare reform could occur in 2023, including changes to the ACA and Medicare reform, as well as administrative requirements that may continue to affect coverage, reimbursement, and utilization of laboratory services in ways that are currently unpredictable.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Privacy, Security and Confidentiality of Health Information and Other Personal Information</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Health Insurance Portability and Accountability Act of 1996 (HIPAA) was designed to address issues related to the security and confidentiality of health information and to improve the efficiency and effectiveness of the healthcare system by facilitating the electronic exchange of information in certain financial and administrative transactions. These regulations apply to health plans and healthcare providers that conduct standard transactions electronically and healthcare clearinghouses (covered entities). Six such regulations include: (i) the Transactions and Code Sets Rule; (ii) the Privacy Rule; (iii) the Security Rule; (iv) the Standard Unique Employer Identifier Rule; (v) the National Provider Identifier Rule; and (vi) the Health Plan Identifier Rule. The Company, which may act as a HIPAA covered entity in certain circumstances, believes that it is in compliance in all material respects with each of the HIPAA Rules identified above.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Privacy Rule regulates the use and disclosure of protected health information (PHI) by covered entities. It also sets forth certain rights that an individual has with respect to his or her PHI maintained by a covered entity, such as the right to access or amend certain records containing PHI or to request restrictions on the use or disclosure of PHI. The Privacy Rule requires covered entities to contractually bind third parties, known as business associates, in the event that they perform an activity or service for or on behalf of the covered entity that involves the creation, receipt, maintenance, or transmission of PHI. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2014, CMS and HHS published final regulations that amended the HIPAA Privacy Rule to provide individuals (or their personal representatives) with the right to receive copies of their test reports from laboratories subject to HIPAA, or to request that copies of their test reports be transmitted to designated third parties. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 12, 2018, HHS issued a request for information (RFI) seeking input from the public on how the HIPAA regulations and the Privacy Rule, in particular, could be modified to amend existing, or impose additional, obligations relating to the processing of PHI. Subsequent to the RFI, on January 21, 2021, HHS published a notice of proposed rulemaking (NPRM) containing potential modifications to the Privacy Rule addressing standards that may impede the transition to value-based healthcare and strengthen individuals' rights to access their health information. The public comment period for the NPRM was closed on May 6, 2021. The Company is monitoring the NPRM process. If modifications to the Privacy Rule are adopted, they may impact the Company's compliance obligations under HIPAA. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Health Information Technology for Economic and Clinical Health Act (HITECH), which was enacted in February 2009, with regulations effective on September 23, 2013, strengthened and expanded the HIPAA Privacy and Security Rules and their restrictions on use and disclosure of PHI. HITECH includes, but is not limited to, prohibitions on exchanging PHI for remuneration and additional restrictions on the use of PHI for marketing. HITECH also fundamentally changes a business associate&#8217;s obligations by imposing a number of Privacy Rule requirements and a majority of Security Rule provisions directly on business associates that were previously only directly applicable to covered entities. Moreover, HITECH requires covered entities to provide notice to individuals, HHS, and, as applicable, the media when unsecured PHI is breached, as that term is defined by HITECH. Business associates are similarly required to notify covered entities of a breach. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The administrative simplification provisions of HIPAA mandate the adoption of standard unique identifiers for healthcare providers. The intent of these provisions is to improve the efficiency and effectiveness of the electronic transmission of health information. The National Provider Identifier Rule requires that all HIPAA-covered healthcare providers, whether they are individuals or organizations, must obtain an NPI to identify themselves in standard HIPAA transactions. NPI replaces the unique provider identification number and other provider numbers previously assigned by payers and other entities for the purpose of identifying healthcare providers in standard electronic transactions. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA provisions could result in civil and/or criminal penalties, including significant fines and up to 10 years in prison. HITECH also significantly strengthened HIPAA enforcement by increasing the civil penalty amounts that may be imposed, requiring HHS to conduct periodic audits to confirm compliance and authorizing state attorneys general to bring civil actions seeking either injunctions or damages in response to violations of the HIPAA privacy and security regulations that affect the privacy of state residents. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total cost associated with meeting the ongoing requirements of HIPAA and HITECH is not expected to be material to the Company&#8217;s operations or cash flows. However, future regulations and interpretations of HIPAA and HITECH could impose significant costs on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information blocking provisions (Information Blocking Rules) of the 21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Century Cures Act became effective on April </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5, 2021. The Information Blocking Rules prohibit covered actors, including healthcare providers, from engaging in activity that is likely to interfere with the access, exchanges, or use of electronic health information (EHI) unless such activity falls into one of eight exceptions. The Information Blocking Rules provide for civil monetary penalties for noncompliance by healthcare IT vendors and, separately, &#8220;appropriate disincentives&#8221; for noncompliance by healthcare providers. The Company believes that it is in compliance in all material respects with the requirements of the Information Blocking Rules. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to the regulations described above, numerous other data protection, privacy and similar laws govern the confidentiality, security, use, and disclosure of personal information, as well as breach notification responsibilities. These laws vary by jurisdiction, but they most commonly regulate or restrict the collection, use, and disclosure of medical and financial information and other personal information. In the U.S., the Federal Trade Commission (FTC) has authority to regulate unfair or deceptive acts or practices, including with respect to data privacy and security. If the Company&#8217;s public statements about collection, use or disclosure of personal information are perceived to be inconsistent with the Company&#8217;s actual practices, the Company may face accusations of unfairness or deception under the FTC Act or state law equivalents. In addition, some state laws are more restrictive and, therefore, are not preempted by HIPAA. Penalties for violation of these laws may include sanctions against a laboratory's licensure, as well as civil and/or criminal penalties. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress and state legislatures also have been implementing new legislation relating to privacy and data protection. For example, on June 28, 2018, the California legislature passed the California Consumer Privacy Act (CCPA), which became effective January 1, 2020. The CCPA created transparency requirements and granted California residents several new rights with regard to their personal information. In addition, in November 2020, California voters approved the California Privacy Rights Act (CPRA) ballot initiative, which introduced significant amendments to the CCPA and established and funded a dedicated California privacy regulator, the California Privacy Protection Agency (CPPA). The amendments introduced by the CPRA went into effect on January 1, 2023, and new implementing regulations are expected to be introduced by the CPPA. Failure to comply with the CCPA may result in, among other things, significant civil penalties and injunctive relief, or potential statutory or actual damages. In addition, California residents have the right to bring a private right of action in connection with certain types of incidents. These claims may result in significant liability and potential damages. Other states have passed legislation similar to the CCPA, including the Virginia Consumer Data Protection Act (VCDPA), which became effective January 1, 2023, the Colorado Privacy Act (CPA) and the Connecticut Data Privacy Act (CTDPA), both effective July 1, 2023, and the Utah Consumer Privacy Act (UCPA), effective December 31, 2023. The VCDPA, CPA, CTDPA, and UCPA heavily mirror the principles and requirements of the CCPA; however, these laws do not provide for a private right of action. The Company continues to assess the impact of these laws on the Company&#8217;s business, and the Company is implementing and will prepare to implement appropriate processes to manage compliance with these laws as they become effective and more guidance is provided. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective August 14, 2020, the Substance Abuse and Mental Health Services Administration of HHS (SAMHSA) announced the finalization of proposed changes to the Confidentiality of Substance Use Disorder Patient Records regulation, 42 Code of Federal Regulations Part 2. This regulation protects the confidentiality of patient records relating to the identity, diagnosis, prognosis, or treatment that are maintained in connection with the performance of any federally assisted program or activity relating to substance use disorder education, prevention, training, treatment, rehabilitation, or research. Under the regulation, patient identifying information may only be released with the individual&#8217;s written consent, subject to certain limited exceptions. The latest changes to this regulation seek to better facilitate care coordination, while maintaining more stringent confidentiality of substance use disorder information. The Company adopted changes to its policies and procedures necessary for compliance.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Union General Data Protection Regulation (GDPR) Regulation (EU) 2016/679, became effective May 25, 2018, replacing Directive 95/46/EC. The GDPR established requirements applicable to the use and transfer of personal data and imposes penalties for noncompliance of up to the greater of &#8364;20 million or 4% of worldwide revenue. The GDPR,  as well as the U.K.'s implementation - the U.K. General Data Protection Regulation - requires transparency with regard to the means and purposes of processing of personal data; collection of consent to process personal data in certain circumstances; the ability to provide records of processing upon request by a supervisory authority or data controller; implementation of appropriate technical and organizational measures to maintain security of personal data; notification of personal data breaches to supervisory authorities, data controllers, and individuals within expedient time frames; and performance of data protection impact assessments for certain processing activities. The GDPR also provides individual data subjects with certain rights, where applicable, including the right of access, the right to rectification, the right to be forgotten, the right to restrict or object to processing, and the right to data portability. The GDPR requires that personal data may only be transferred outside of the European Union to a country that offers an adequate level of data protection under standards set by the European Union, or where such transfer is otherwise pursuant to a legal framework approved by the European Union. On July 16, 2020, the Court of Justice of the European Union (CJEU) released its decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Protection Commission v. Facebook Ireland Limited, Maximillian Schrems (Schrems II)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which invalidated the EU-U.S. Privacy Shield as a legal framework for the transfer of personal data outside of the European Union, and suggesting additional safeguards for the use of Standard Contractual Clauses </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(SCCs) as a legal framework for the transfer of personal data outside of the European Union. On June 4, 2021, the European Commission release updated SCCs, which, in part, adopted many of the additional safeguards highlighted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Schrems II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision. Companies using SCCs for the transfer of personal data outside of the European Union are required to use the new SCCs for new transfers of personal data as of September 27, 2021, and for all transfers of personal data as of December 27, 2022. The Company has established processes and frameworks to manage compliance with the GDPR and other global privacy and data protection requirements, and to manage preparation for future enacted regulations. Compliance could impose significant costs on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the GDPR, numerous other countries have laws governing the collection, use, disclosure, and transmission (including cross-border transfer) of personal information, including medical information. The legislative and regulatory landscape for privacy and data protection is complex and continually evolving. Data protection regulations have been enacted or updated in regions where the Company does business including in Asia, Latin America, and Europe, and in countries such as Canada, India, and the UK. Failure to comply with these regulations may result in, among other things, civil, criminal and contractual liability, fines, regulatory sanctions and damage to the Company&#8217;s reputation.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fraud and Abuse Laws and Regulations</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing U.S. laws governing federal healthcare programs, including Medicare and Medicaid, as well as similar state laws, impose a variety of broadly described fraud and abuse prohibitions on healthcare providers, including clinical laboratories. These laws are interpreted liberally and enforced aggressively by multiple government agencies, including the U.S. Department of Justice, OIG and various state agencies. Historically, the clinical laboratory industry has been the focus of major governmental enforcement initiatives. The U.S. government's enforcement efforts have been conducted under statutory authorities such as those contained in HIPAA, which includes several provisions related to fraud and abuse enforcement, including the establishment of a program to coordinate and fund U.S., state and local law enforcement efforts, and in the Deficit Reduction Act of 2005, which included requirements directed at Medicaid fraud, including increased spending on enforcement and financial incentives for states to adopt false claims act provisions similar to the U.S. False Claims Act. Amendments to the False Claims Act, and other enhancements to the U.S. fraud and abuse laws enacted as part of the ACA, have further increased fraud and abuse enforcement efforts and compliance risks. For example, the ACA established an obligation to report and refund&#160;overpayments from Medicare or Medicaid within 60 days of identification (whether or not paid through any fault of the recipient); failure to comply with this requirement can give rise to additional&#160;liability under the False Claims Act and Civil Monetary Penalties statute.&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Anti-Kickback Statute prohibits knowingly providing anything of value in return for, or to induce the referral of, Medicare, Medicaid or other U.S. federal healthcare program business. Violations can result in imprisonment, fines, penalties, and/or exclusion from participation in U.S. federal healthcare programs. The OIG has published &#8220;safe harbor&#8221; regulations that specify certain arrangements that are protected from prosecution under the Anti-Kickback Statute if all conditions of the relevant safe harbor are met. Failure to fit within a safe harbor does not necessarily constitute a violation of the Anti-Kickback Statute; rather, the arrangement would be subject to scrutiny by regulators and prosecutors and would be evaluated on a case-by-case basis. Many states have their own Medicaid anti-kickback laws, and several states also have anti-kickback laws that apply to all payers (i.e., not just government healthcare programs).</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the OIG issues alerts and other guidance on certain practices in the healthcare industry that implicate the Anti-Kickback Statute or other fraud and abuse laws. OIG Special Fraud Alerts and Advisory Opinions relevant to the Company set forth a number of practices allegedly engaged in by some clinical laboratories and healthcare providers that raise issues under the U.S. fraud and abuse laws, including the Anti-Kickback Statute. These practices include: (i) providing employees to furnish valuable services for physicians (other than collecting patient specimens for testing) that are typically the responsibility of the physicians&#8217; staff; (ii) offering or providing discounted laboratory services billed to referral sources in return for referrals of other tests that are billed to U.S. federal healthcare programs; (iii) providing free testing to physicians&#8217; managed care patients in situations where the referring physicians benefit from such reduced laboratory utilization; (iv) providing free pickup and disposal of biohazardous waste for physicians for items unrelated to a laboratory&#8217;s testing services; (v) providing general-use facsimile machines or computers to physicians that are not exclusively used in connection with the laboratory services; (vi) providing free testing for healthcare providers, their families and their employees (i.e., so-called &#8220;professional courtesy&#8221; testing); (vii) rental of space in physician offices by equipment suppliers or other healthcare entities to which the physicians make referrals; (viii) compensation paid by laboratories to physicians and hospitals for blood specimen processing and for submitting patient data to registries; and (ix) remuneration provided to physicians and other health care professionals by pharmaceutical and medical device companies in connection with company-sponsored speaker programs.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Anti-Kickback Statute, in October 2018, the U.S. enacted the Eliminating Kickbacks in Recovery Act of 2018 (EKRA), as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act). EKRA is an all-payer anti-kickback law that makes it a criminal offense to pay any remuneration to induce referrals to, or in exchange for, patients using the services of a recovery home, a substance use clinical </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment facility, or laboratory. Although it appears that EKRA was intended to reach patient brokering and similar arrangements to induce patronage of substance use recovery and treatment, the language in EKRA is broadly written. As drafted, an EKRA prohibition on incentive compensation to sales employees is inconsistent with the federal anti-kickback statute and regulations, which permit payment of employee incentive compensation, a practice that is common in the industry. Significantly, EKRA permits the U.S. Department of Justice to issue regulations clarifying EKRA&#8217;s exceptions or adding additional exceptions, but such regulations have not yet been issued, and there is no additional DOJ or other government guidance to indicate how and to what extent it will be applied and enforced in the industry. The Company is working through its trade association to address the scope of EKRA.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under another U.S. statute, known as the Stark Law or &#8220;physician self-referral&#8221; prohibition, physicians who have a financial or a compensation relationship with a clinical laboratory may not, unless an exception applies, refer Medicare or Medicaid patients for testing to the laboratory, regardless of the intent of the parties. Similarly, laboratories may not bill Medicare or Medicaid for services furnished pursuant to a prohibited self-referral. There are several Stark Law exceptions that are relevant to arrangements involving clinical laboratories, including: (i) fair market value compensation for the provision of items or services; (ii) payments by physicians to a laboratory for clinical laboratory services;&#160;(iii) ancillary services (including laboratory services) provided within the referring physician's own office, if certain criteria are satisfied; (iv) physician investment in a company whose stock is traded on a public exchange and has stockholder equity exceeding $75.0 million; and (v) certain space and equipment rental arrangements that are set at a fair market value rate and satisfy other requirements. Many states have their own self-referral laws as well, which in some cases apply to all patient referrals, not just government reimbursement programs.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the OIG and CMS published final rules to amend certain regulations implementing the Anti-Kickback Statute and the Stark Law, respectively. The amendments were primarily intended to alleviate perceived impediments to coordinated care and value-based compensation arrangements through new safe harbors to the Anti-Kickback Statute and new exceptions to the Stark Law, and have varying degrees of applicability to laboratories. The CMS final rule incorporates laboratories and permits support for value-based arrangements, under certain conditions for purposes of the Stark Law. However, the OIG final rule generally excludes laboratories from protection under the Anti-Kickback Statute safe harbors for value-based arrangements. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a variety of other types of U.S. and state fraud and abuse laws, including laws prohibiting submission of false or fraudulent claims and that require certain companies to disclose payments and other transfers of value to certain healthcare professionals and providers. The Company seeks to conduct its business in compliance with all U.S. and state fraud and abuse laws. The Company is unable to predict how these laws will be applied in the future, and no assurances can be given that its arrangements will not be subject to scrutiny under such laws. Sanctions for violations of these laws may include exclusion from participation in Medicare, Medicaid, and other U.S. or state healthcare programs, significant criminal and civil fines and penalties, and loss of licensure. Any exclusion from participation in a U.S. healthcare program, or material loss of licensure, arising from any action by any federal or state regulatory or enforcement authority, would likely have a material adverse effect on the Company's business. In addition, any significant criminal or civil penalty resulting from such proceedings could have a material adverse effect on the Company's business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enrollment and re-enrollment in U.S. healthcare programs, including Medicare and Medicaid, are subject to certain program integrity requirements intended to protect the programs from fraud, waste, and abuse. In September 2019, CMS published a final rule implementing program integrity enhancements to provider enrollment requiring Medicare, Medicaid, and Children&#8217;s Health Insurance Program (CHIP) providers and suppliers to disclose on an enrollment application or a revalidation application any current or previous direct or indirect affiliation with a provider or supplier that (i) has uncollected debt; (ii) has been or is subject to a payment suspension under a federal health care program; (iii) has been or is excluded by the OIG from Medicare, Medicaid, or CHIP, or (iv) has had its Medicare, Medicaid, or CHIP billing privileges denied or revoked. This rule permits CMS to deny enrollment based on such an affiliation when CMS determines that the affiliation poses an undue risk of fraud, waste, or abuse. CMS is phasing in this new affiliation disclosure requirement.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, CMS published a final rule for the 2022 Medicare Physician Fee Schedule, which included further program integrity requirements. CMS finalized its proposal to expand the categories of parties within the purview of the denial and revocation provisions to include excluded administrative or management services personnel who furnish services payable by a federal healthcare program, such as a billing specialist, accountant, or human resources specialist. CMS also codified the billing privilege deactivation rebuttal process, under which a provider or supplier would have 15 calendar days from receipt of written notice of a deactivation to submit a rebuttal, and CMS could, in its discretion, extend the 15-day period to account for certain special situations. In addition, CMS defined factors it would use to determine whether revocation or suspension of billing privileges is appropriate due to a pattern or practice of non-compliant billing, which would be: (i) the percentage of submitted claims that were denied during the period under consideration; (ii) whether the provider or supplier has any history of final adverse actions and the nature of any such actions; (iii) the type of billing non-compliance and the specific facts surrounding said non-compliance (to the extent this can be determined); and (iv) any other information regarding the provider's </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or supplier's specific circumstances that CMS deems relevant to the determination. This is a reduction in the number of factors that were previously considered and a revision of some previous factors. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environment, Health, and Safety</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to licensing and requirements under laws and regulations relating to the protection of the environment, and employee health and safety. These laws and regulations include the safe handling, use, transportation and disposal of potentially infectious and hazardous materials; the assessment of potential work-related risks and establishment of work practice and engineering controls, and providing protective clothing and equipment, training, and medical surveillance; designed to minimize risk to employee health and safety and the environment. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is committed to reducing its carbon footprint. The Company participates in the Carbon Disclosure Project (CDP) and the EcoVadis sustainable procurement rating processes. In December 2022, the Company submitted science-based targets to the Science Based Target Institute. Energy-saving measures at Company facilities include for example, installation of more efficient boilers, chillers, ventilation systems and LED lighting, engaging in waste-to-energy disposition, and reducing waste going to landfills. Funding for these and similar projects continued through 2022 and is expected to continue through 2023.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to comply with all relevant environment, employee health and safety laws and regulations. Failure to comply could subject the Company to various administrative and/or other enforcement actions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Testing</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drug testing for public sector employees is regulated by the SAMHSA, which has established detailed performance and quality standards that laboratories must meet to be approved to perform drug testing on employees of U.S. government contractors and certain other entities. To the extent that the Company&#8217;s laboratories perform such testing, each must be certified as meeting SAMHSA standards. The Company&#8217;s laboratories in Research Triangle Park, North Carolina; Raritan, New Jersey; Houston, Texas; Southaven, Mississippi; and St. Paul, Minnesota are all SAMHSA certified. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controlled Substances</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD handles controlled substances as part of the services it provides in preclinical testing and clinical trials. The use of controlled substances in testing for drugs of abuse is regulated by the U.S. Drug Enforcement Administration under the Controlled Substances Act (CSA) and its implementing regulations. The CSA establishes, among other things, certain registration, security, recordkeeping, reporting, import, export and other requirements for controlled substances. The Company seeks to conduct its business in compliance with these requirements as applicable. Violations of these rules may result in criminal and civil fines and penalties.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_67"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance Program</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a global compliance program that includes ongoing evaluation and monitoring of its compliance with the laws and regulations of the U.S. and the other countries in which it has operations. The objective of the Company&#8217;s compliance program is to develop, implement, monitor, and update compliance safeguards, as appropriate. Although the Company is subject to a broad range of regulations, its compliance program has a particular focus on regulations related to healthcare fraud and abuse, anti-kickback, physician self-referral, government reimbursement programs, anti-bribery/anti-corruption, anti-human trafficking, and trade sanctions, among others. Emphasis is placed on developing and implementing compliance policies and guidelines, personnel training programs, monitoring and auditing activities, and providing systems for reporting and investigation of potential or actual compliance concerns. The compliance program demonstrates the Company's commitment to conducting business at the highest standards of ethical conduct and integrity.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to conduct its business in compliance with all statutes, regulations, and other requirements applicable to its clinical laboratory operations and drug development business. The clinical laboratory industry and drug development industries are, however, subject to extensive regulation, and many of these statutes and regulations have not been interpreted by the courts. In addition, the applicability or interpretation of statutes and regulations may not be clear in light of emerging changes in clinical testing science, healthcare technology, and healthcare organizations. Applicable statutes and regulations may be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would materially adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, exclusion from participation in governmental healthcare programs, and the loss of various licenses, certificates, and authorizations necessary to operate, as well as potential liabilities from third-party claims, all of which could have a material adverse effect on the Company&#8217;s business.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:7pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Security</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information security is one of the Company's top priorities. Securing personal and health information is critical to the Company&#8217;s business operations and to future growth, as the Company is committed to using technology to improve the delivery of care. A security breach could have a material adverse operational, financial, regulatory, and reputational impact to the Company. The Company employs a secure technology framework that enables continuous operations of laboratory devices, computers, and communications systems. The Company has experienced and expects to continue to confront attempts by cybercriminals who seek access to its systems and data. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses state-of-the art tools and advanced analytics to proactively identify and protect against potential information system disruptions and breaches; to monitor, test and secure key networks and services, and to facilitate prompt resumption of operations if a system disruption or interruption should occur. The Company has implemented policies and procedures designed to comply with global laws and regulations related to the privacy and security of personal and health information. Additionally, the Company maintains a comprehensive behavior management and communications program, which addresses the human element of cybersecurity by providing staff with extensive awareness, education, and training to help prevent cybercrime from succeeding through human error. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to risks related to information security arising from the information technology systems and operations of third parties, including the Company's vendors and partners. Therefore, the Company follows a process to evaluate the cybersecurity status of vendors or third parties that will have access to the Company's data or information technology systems. The Company also carries cybersecurity and business interruption insurance. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the past several years, the Company has significantly increased its investment in cybersecurity technology and training to help protect its information technology systems and operations in response to the ever-evolving cyber threat landscape. Additional resources will be dedicated as needed to expand the Company&#8217;s ability to investigate and remediate any cybersecurity vulnerabilities, and to manage any impact of a cybersecurity event on its business and operations.&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, the Company experienced a ransomware incident which affected certain Dx information technology systems.   The incident temporarily affected certain other information technology systems involved in conducting Company-wide operations. An investigation determined that the ransomware did not and could not transfer patient or client data outside of Company systems and that there was no theft or misuse of patient or client data. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Credit Bureau, Inc. d/b/a/ American Medical Collections Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company's patients (the AMCA Incident). The Company is involved in pending and threatened litigation  related to  the AMCA Incident, as well as various government and regulatory inquiries and processes. For additional information about the AMCA Incident, see Note 14 Commitments and Contingencies to the Consolidated Financial Statements and &#8220;Risk Factors - Risks Related to Technology and Cybersecurity&#8221;.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_73"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. &#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors should carefully consider all of the information set forth in this Annual Report, including the following risk factors, before deciding to invest in any of the Company&#8217;s securities. The risks below are not the only ones that the Company faces. Additional risks not presently known to the Company, or that it presently deems immaterial, may also negatively impact the Company. The Company&#8217;s business, consolidated financial condition, revenues, results of operations, profitability, reputation or cash flows could be materially impacted by any of these factors.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Company's Business Including Global Economic and Sociopolitical Factors</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General or macro-economic factors in the U.S. and globally may have a material adverse effect upon the Company, and significant fluctuations in the economy, recession, inflation and an increase in the costs of goods and services could negatively impact testing volumes, drug development services, cash collections, profitability and the availability and cost of credit. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are dependent upon ongoing demand for diagnostic testing and drug development services by patients, physicians, hospitals, MCOs, pharmaceutical, biotechnology and medical device companies and others. Fluctuations in the global economy, including inflation and the risk of short- or long-term recession, inflation and an increase in the costs of goods and services have impacted and in the future could have continued or greater negative impact on the demand for diagnostic testing and drug development services, the ability of customers to pay for services rendered, and the Company&#8217;s profitability. In addition, uncertainty in the credit markets and fluctuations in interest rates could reduce the availability and increase the cost of credit and impact the Company&#8217;s ability to meet its financing needs in the future.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operations may be disrupted and adversely impacted by the effects of adverse weather, natural disasters, geopolitical events, public health crises, hostilities or acts of terrorism, acts of vandalism, disruption to supply chains, access to natural resources, and other events outside of the Company's control.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters, such as adverse weather, fires, earthquakes, power shortages and outages, geopolitical events, such as terrorism, war, political instability, or other conflict, public health crises and disease epidemics and pandemics,  criminal activities, disruptions to supply chains, access to natural resources, and other disruptions or events outside of the Company&#8217;s control could negatively affect the Company&#8217;s operations. Any of these events may result in a temporary decline of volumes in both segments. In addition, such events may temporarily interrupt the Company&#8217;s ability to transport specimens, efficiently commence studies, utilize information technology systems, utilize certain laboratories, and/or ability to receive material from its suppliers. Such events can also affect customer operations and thereby impact testing volume. Long-term disruptions in the infrastructure and operations caused by such events (particularly involving locations in which the Company has operations), could harm the Company's operating results. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">An inability to attract and retain experienced and qualified personnel, including key management personnel, and increased personnel costs, could adversely affect the Company&#8217;s business. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of key management personnel or the inability to attract and retain experienced and qualified employees, at the Company&#8217;s clinical laboratories, drug development, and diagnostic facilities, and increased costs related to such personnel and employees, could adversely affect the business. The success of the Company is dependent in part on the efforts of key members of its management team. Success in maintaining the Company&#8217;s leadership position in genomic and other advanced testing and diagnostic technologies will depend in part on the Company&#8217;s ability to attract and retain skilled research professionals. In addition, the success of the Company&#8217;s early discovery, clinical, and commercial laboratories also depend on employing and retaining qualified and experienced professionals, including specialists, who perform laboratory research activities and testing services. The same is true for patient-facing staff with specialized training required to perform activities related to specimen collection or clinical research activities. In the future, if competition for the services of these professionals increases, the Company may not be able to continue to attract and retain individuals in its markets. Changes in key management, or the ability to attract and retain qualified personnel, as a result of increased competition for talent, wage growth, or other market factors, could lead to strategic and operational challenges and uncertainties, distractions of management from other key initiatives, and inefficiencies and increased costs, any of which could adversely affect the Company&#8217;s business, financial condition, results of operations, and cash flows.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued changes in healthcare reimbursement models and products (e.g., health insurance exchanges), changes in government payment and reimbursement systems, or changes in payer mix, including an increase in third-party benefits management and value-based payment models, could have a material adverse effect on the Company's revenues, profitability and cash flow.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx's testing services are billed to MCOs, Medicare, Medicaid, physicians and physician groups, hospitals, patients and employer groups. Most testing services are billed to a party other than the physician or other authorized person who ordered the test. Increases in the percentage of services billed to government and MCOs could have an adverse effect on the Company&#8217;s revenues. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company serves many MCOs. These organizations have different contracting philosophies, which are influenced by the design of their products. Some MCOs contract with a limited number of clinical laboratories and engage in direct negotiation of rates. Other MCOs adopt broader networks with generally uniform fee structures for participating clinical laboratories. In some cases, those fee structures are specific to independent clinical laboratories, while the fees paid to hospital-based and physician-office laboratories may be different, and are typically higher. MCOs may also offer Managed Medicare or Managed Medicaid plans. In addition, an increasing number of MCOs are implementing, directly or through third parties, various types of laboratory benefit management programs that may include laboratory networks, utilization management tools (such as prior authorization and/or prior notification), and claims edits, which may impact coverage or reimbursement for commercial laboratory tests. Some of these programs address commercial laboratory testing broadly, while others are focused on certain types of testing such as molecular, genetic and toxicology testing. An increase in the use of such programs could lead to increased denial of claims, extended appeals, and reduced revenue.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some MCOs use capitation rates to fix the cost of laboratory testing services for their enrollees. Under a capitated reimbursement arrangement, the clinical laboratory receives a per-member, per-month payment for an agreed upon menu of laboratory tests provided to MCO members during the month, regardless of the number of tests performed. Capitation shifts the risk of increased test utilization (and the underlying mix of testing services) to the commercial laboratory provider. The </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company makes significant efforts to obtain adequate compensation for its services in its capitated arrangements. For the year ended December 31, 2022, such capitated contracts accounted for approximately $332.3 million, or 3.2%, of Dx's revenues.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's ability to attract and retain MCOs is critical given the impact of healthcare reform, related products and expanded coverage (e.g. health insurance exchanges and Medicaid expansion) and evolving value-based care and risk-based reimbursement delivery models (e.g., accountable care organizations (ACOs) and Independent Physician Associations (IPAs)).</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the managed care fee-for-service revenues is collectible from patients in the form of deductibles, coinsurance and copayments. As patient cost-sharing has been increasing, the Company's collections may be adversely impacted.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In addition, Medicare and Medicaid and private insurers have increased their efforts to control the cost, utilization and delivery of healthcare services, including commercial laboratory services. Measures to regulate healthcare delivery in general, and clinical laboratories in particular, have resulted in reduced prices, added costs and decreased test utilization for the commercial laboratory industry by increasing complexity and adding new regulatory and administrative requirements. Pursuant to legislation passed in late 2003, the percentage of Medicare beneficiaries enrolled in Managed Medicare plans has increased. The percentage of Medicaid beneficiaries enrolled in Managed Medicaid plans has also increased; however, changes to, or repeal of, the Patient Protection and Affordable Care Act (ACA) may continue to affect coverage, reimbursement, and utilization of laboratory services, as well as administrative requirements, in ways that are currently unpredictable. Further healthcare reform could adversely affect laboratory reimbursement from Medicare, Medicaid or commercial carriers.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has periodically experienced delays in the pricing and implementation of coding and billing changes among various payers, including Medicaid, Medicare and commercial carriers. While some delays were expected, payer policy changes in coverage have had a negative impact on revenue, revenue per requisition, and margins and cash flows. In 2022, limited coding and billing changes were implemented. While limited changes are expected to be implemented in 2023, the Company typically expects some delays in pricing and reimbursement as new codes are introduced. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects the efforts to impose reduced reimbursement, more stringent payment policies, and utilization and cost controls by government and other payers to continue. If Dx cannot offset additional reductions in the payments it receives for its services by reducing costs, increasing test volume, and/or introducing new services and procedures, it could have a material adverse effect on the Company&#8217;s revenues, profitability and cash flows. In 2014, Congress passed PAMA, requiring Medicare to change the way payment rates are calculated for tests paid under the CLFS, and to base the payment on the weighted median of rates paid by private payers. On June 23, 2016, CMS issued a final rule to implement PAMA that required applicable laboratories, including Dx, to begin reporting their test-specific private payer payment amounts to CMS during the first quarter of 2017. CMS exercised enforcement discretion to permit reporting for an additional 60 days, through May 30, 2017. CMS used that private market data to calculate weighted median prices for each test (based on applicable current procedural technology (CPT) codes) to represent the new CLFS rates beginning in 2018, subject to certain phase-in limits. For 2018-2020, a test price could not be reduced by more than 10% per year. As a result of provisions included within the CARES Act, PAMA rate reductions for 2021 were suspended, and therefore the Company did not experience any incremental reimbursement rate impact due to PAMA in 2021. As a result of the Protecting Medicare and American Farmers from Sequester Cuts Act that became law in December 2021, the data reporting requirements and Medicare reimbursement cuts that would have occurred under PAMA in 2022 were delayed by one additional year, and the Company did not experience incremental reimbursement rate impact due to PAMA in 2022. As a result of the Consolidated Appropriations Act, 2023, which became law in December 2022, the data reporting requirements and Medicare reimbursement cuts that would have occurred under PAMA in 2023 were delayed by one additional year, and the Company will not experience an incremental reimbursement rate impact due to PAMA in 2023.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024-2026, a test price cannot be reduced by more than 15.0% per year. The process of data reporting and repricing will be repeated every three years for Clinical Diagnostic Laboratory Tests (CDLTs) beginning in 2024. CFLS rates for 2027 and subsequent periods will not be subject to phase-in limits. The phase-in of rates for CDLTs established in 2018 will resume in 2024.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New CLFS rates will be established in 2025 based on data from 2019 to be reported in 2024. New CLFS rates will be established in 2028 based on data from 2026 to be reported in 2027 CLFS rates for Advanced Diagnostic Laboratory Tests (ADLTs) will be updated annually.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS published its initial proposed CLFS rates under PAMA for 2018-2020 on September 22, 2017. Following a public comment period, CMS made adjustments and published final CLFS rates for 2018-2020 on November 17, 2017, with additional adjustments published on December 1, 2017. For 2020, the Company realized a net reduction in reimbursement of approximately $72.01 million from all payers affected by the CLFS (approximately $107.0 million in 2019). 2021, 2022 and 2023 PAMA rates were frozen as described above. Unless implementation of PAMA is further delayed or changed, an additional reduction of approximately $100.0 million is expected for 2024, from all payers affected by the CLFS. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform legislation also contains numerous regulations that will require the Company, as an employer, to implement significant process and record-keeping changes to be in compliance. These changes increase the cost of providing healthcare coverage to employees and their families. Given the limited release of regulations to guide compliance, as well as potential changes to the ACA, the exact impact to employers, including the Company, is uncertain.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in government regulation or in practices relating to the pharmaceutical, biotechnology, or medical device industries could decrease the need for certain services that DD provides.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD assists pharmaceutical, biotechnology and medical device companies in navigating the regulatory approval process. Changes in regulations such as a relaxation in regulatory requirements or the introduction of simplified approval procedures, or an increase in regulatory requirements that DD has difficulty satisfying or that make its services less competitive, could eliminate or substantially reduce the demand for its services. Also, if government efforts to contain drug and medical product and device costs impact profits from such items, or if health insurers were to change their practices with respect to reimbursement for those items, some of DD&#8217;s customers may spend less, or reduce their growth in spending on R&amp;D.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, implementation of healthcare reform legislation that adds costs could limit the profits that can be made from the development of new drugs and medical products and devices. This could adversely affect R&amp;D expenditures by such companies, which could in turn decrease the business opportunities available to DD both in the U.S. and other countries. New laws or regulations may create a risk of liability, increase DD costs or limit service offerings through DD.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Increased competition, including price competition, could have an adverse effect on the Company&#8217;s revenues and profitability.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Item 1 of Part I of this Annual Report, both Dx and DD operate in highly competitive industries. The commercial laboratory business is intensely competitive both in terms of price and service. Pricing of laboratory testing services is often one of the most significant factors used by physicians, third-party payers and consumers in selecting a laboratory. As a result of significant consolidation in the commercial laboratory industry, larger commercial laboratory providers are able to increase cost efficiencies afforded by large-scale automated testing. This consolidation results in greater price competition. Dx may be unable to increase cost efficiencies sufficiently, if at all, and as a result, its net earnings and cash flows could be negatively impacted by such price competition. The Company may face increased competition from health system laboratories, due to physicians within those systems directing their testing to the health system laboratory and away from the Company, and as those laboratories seek to expand their testing volume from unaffiliated physicians in their service areas. The Company may also face  competition from companies that do not comply with existing laws or regulations or otherwise disregard compliance standards in the industry. Additionally, the Company may also face changes in fee schedules, competitive bidding for laboratory services, or other actions or pressures reducing payment schedules as a result of increased or additional competition.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors in the CRO industry range from hundreds of smaller CROs to a limited number of large CROs with global capabilities. DD&#8217;s main competition consists of these small and large CROs, as well as in-house departments of pharmaceutical, biotechnology and medical device companies and, to a lesser extent, select universities and teaching hospitals. DD&#8217;s services have from time to time experienced periods of increased price competition that had an adverse effect on a segment's profitability and consolidated revenues and net income. There is competition among CROs for both customers and potential acquisition candidates. Additionally, few barriers to entering the CRO industry further increases possible new competition. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These competitive pressures may affect the attractiveness or profitability of Dx&#8217;s and DD&#8217;s services, and could adversely affect the financial results of the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to obtain and retain new customers, the loss of existing customers or material contracts, or a reduction in services or tests ordered or specimens submitted by existing customers, or the inability to retain existing and/or create new relationships with health systems could impact the Company&#8217;s ability to successfully grow its business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maintain and grow its business, the Company needs to obtain and retain new customers and business partners. In addition, a reduction in tests ordered or specimens submitted by existing customers, a decrease in demand for the Company's services from existing customers, or the loss of existing contracts, without offsetting growth in its customer base, could impact the Company's ability to successfully grow its business and could have a material adverse effect on the Company&#8217;s revenues and profitability. The Company competes primarily on the basis of the quality of services, reporting and information systems, reputation in the medical community and the drug development industry, the pricing of&#160;services and ability to employ qualified personnel. The Company's failure to successfully compete on any of these factors could result in the loss of existing customers, an inability to gain new customers and a reduction in the Company's business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Discontinuation or recalls of existing testing products; failure to develop or acquire licenses for new or improved testing technologies; or the Company&#8217;s customers using new technologies to perform their own tests could adversely affect the Company&#8217;s business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, manufacturers discontinue or recall reagents, test kits or instruments used by the Company to perform laboratory testing. Such discontinuations or recalls could adversely affect the Company&#8217;s costs, testing volume and revenue.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial laboratory industry is subject to changing technology and new product introductions. The Company&#8217;s success in maintaining a leadership position in genomic and other advanced testing technologies will depend, in part, on its ability to develop, acquire or license new and improved technologies on favorable terms and to obtain appropriate coverage and reimbursement for these technologies. The Company may not be able to negotiate acceptable licensing arrangements, and it cannot be certain that such arrangements will yield commercially successful diagnostic tests. If the Company is unable to license these testing methods at competitive rates, its research and development (R&amp;D) costs may increase as a result. In addition, if the Company is unable to license new or improved technologies to expand its esoteric testing operations, its testing methods may become outdated when compared with the Company&#8217;s competition, and testing volume and revenue may be materially and adversely affected.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In addition, advances in technology may lead to the development of more cost-effective technologies such as point-of-care testing equipment that can be operated by physicians or other healthcare providers (including physician assistants, nurse practitioners and certified nurse midwives, generally referred to herein as physicians) in their offices or by patients themselves without requiring the services of freestanding clinical laboratories. Development of such technology and its use by the Company&#8217;s customers could reduce the demand for its laboratory testing services and the utilization of certain tests offered by the Company and negatively impact its revenues.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Currently, most commercial laboratory testing is categorized as high or moderate complexity, and thereby is subject to extensive and costly regulation under CLIA. The cost of compliance with CLIA makes it impractical for most physicians to operate clinical laboratories in their offices, and other laws limit the ability of physicians to have ownership in a laboratory and to refer tests to such a laboratory. Manufacturers of laboratory equipment and test kits could seek to increase their sales by marketing point-of-care laboratory equipment to physicians and by selling test kits approved for home or physician office use to both physicians and patients. Diagnostic tests approved for home use are automatically deemed to be &#8220;waived&#8221; tests under CLIA and may be performed in physician office laboratories as well as by patients in their homes with minimal regulatory oversight. Other tests meeting certain FDA criteria also may be classified as &#8220;waived&#8221; for CLIA purposes. The FDA has regulatory responsibility over instruments, test kits, reagents and other devices used by clinical laboratories, and it has taken responsibility from the U.S. Centers for Disease Control and Prevention for classifying the complexity of tests for CLIA purposes. Increased approval of &#8220;waived&#8221; test kits could lead to increased testing by physicians in their offices or by patients at home, which could affect the Company&#8217;s market for laboratory testing services and negatively impact its revenues.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes or disruption in services supplies, or transportation provided by third parties have impacted and could continue to impact or adversely affect the Company&#8217;s business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company depends on third parties to provide supplies and services critical to the Company&#8217;s business. Although the Company has a significant proprietary network of ground and air transport capabilities, certain of the Company's businesses are heavily reliant on third-party ground and air travel for transport of clinical trial and diagnostic testing supplies and specimens, research products, and people. A significant disruption to these travel systems, or the Company's access to them, could have a material adverse effect on the Company's business. The Company is also reliant on an extensive network of third-party suppliers and vendors of certain services and products, including for certain animal populations. Disruptions to the continued supply, or increases in costs, of these services, products, or animal populations may arise from export/import restrictions or embargoes, political or economic instability, pressure from animal rights activists, adverse weather, natural disasters, public health crises, transportation disruptions, cyber attacks, or other causes, as well as from termination of relationships with suppliers or vendors for their failure to follow the Company&#8217;s performance standards and requirements. Disruption of supply and services has impacted and could continue to impact or have a material adverse effect on the Company&#8217;s business. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A failure to identify and successfully close and integrate strategic acquisition targets could have a material adverse effect on the Company's business objectives and its revenues and profitability. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part of the Company's strategy involves deploying capital in investments that enhance the Company's business, which includes pursuing strategic acquisitions to strengthen the Company's scientific capabilities and enhance therapeutic expertise, enhance esoteric testing and global drug development capabilities, and increase presence in key geographic areas. Since 2018, the Company has invested net cash of approximately $2.9 billion in strategic business acquisitions. However, the Company cannot assure that it will be able to identify acquisition targets that are attractive to the Company or that are of a large enough size to have a meaningful impact on the Company's operating results. Furthermore, the successful closing and integration of a strategic acquisition entails numerous risks, including, among others: </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">failure to obtain regulatory clearance, including due to antitrust concerns;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">loss of key customers or employees;</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">difficulty in consolidating redundant facilities and infrastructure and in standardizing information and other systems;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">unidentified regulatory problems;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">failure to maintain the quality of services that such companies have historically provided;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">unanticipated costs and other liabilities;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">potential liabilities related to litigation including the acquired companies; </span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">potential periodic impairment of goodwill and intangible assets acquired;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">coordination of geographically separated facilities and workforces; and</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the potential disruption of the ongoing business and diversion of management's resources.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot assure that current or future acquisitions, if any, or any related integration efforts will be successful, or that the Company's business will not be adversely affected by any future acquisitions, including with respect to revenues and profitability. Even if the Company is able to successfully integrate the operations of businesses that it may acquire in the future, the Company may not be able to realize the benefits that it expects from such acquisitions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfavorable labor environments, union strikes, work stoppages, union or works council negotiations, or failure to comply with labor or employment laws could adversely affect the Company's operations and have a material adverse effect upon the Company's business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to a limited number of collective bargaining agreements with various labor unions and is subject to employment and labor laws and unionization activity in the U.S. Similar employment and labor obligations exist across other countries in which it conducts business, including appropriate engagement with works councils in Europe. Disputes with regard to the terms of labor agreements or obligations for consultation, potential inability to negotiate acceptable contracts with these unions, unionization activity, or a failure to comply with labor or employment laws could result in, among other things, labor unrest, strikes, work stoppages, slowdowns by the affected workers, fines and penalties. If any of these events were to occur, or other employees were to become unionized, the Company could experience a significant disruption of its operations or higher ongoing labor costs, either of which could have a material adverse effect upon the Company's business. Additionally, future labor agreements, or renegotiation of labor agreements or provisions of labor agreements, or changes in labor or employment laws, could compromise its service reliability and significantly increase its costs, which could have a material adverse effect upon the Company's business. Also, the Company may incur substantial additional costs and become subject to litigation and enforcement actions if the Company fails to comply with legal requirements affecting its workforce and labor practices, including laws and regulations related to wage and hour practices, Office of Federal Contract Compliance Programs (OFCCP) compliance, and unlawful workplace harassment and discrimination.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued and increased consolidation of pharmaceutical, biotechnology and medical device companies, health systems, physicians and other customers could adversely affect the Company's business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many healthcare companies and providers, including pharmaceutical, biotechnology and medical device  companies, health systems and physician practices are consolidating through mergers, acquisitions, joint ventures and other types of transactions and collaborations. In addition to these more traditional horizontal mergers that involve entities that previously competed against each other, the healthcare industry is experiencing an increase in vertical mergers, which involve entities that previously did not offer competing goods or services. As the healthcare industry consolidates, competition to provide goods and services may become more intense, and vertical mergers may give those combined companies greater control over more aspects of healthcare, including increased bargaining power. This competition and increased customer bargaining power may adversely affect the price and volume of the Company&#8217;s services.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as the broader healthcare industry trend of consolidation continues, including the acquisition of physician practices by health systems, relationships with hospital-based health systems and integrated delivery networks are becoming more important. Dx has a well-established base of relationships with those systems and networks, including collaborative agreements. Dx's inability to retain its existing relationships with those physicians as they become part of healthcare systems and networks and/or to create new relationships could impact its ability to successfully grow its business.</span></div><div style="margin-bottom:7pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Damage or disruption to the Company&#8217;s facilities could adversely affect the Company&#8217;s business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s facilities could be difficult to replace in a short period of time. Any event that causes a disruption of the operation of these facilities might impact the Company's ability to provide services to customers and, therefore, could have a material adverse effect on the Company's financial condition, results of operations, and cash flows.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Financial Matters</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company bears financial risk for contracts that, including for reasons beyond the Company's control, may be underpriced, subject to cost overruns, delayed, or terminated or reduced in scope.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has many contracts that are structured as fixed-price for fixed-contracted services or fee-for-service with a </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cap. The Company bears the financial risk if these contracts are underpriced or if contract costs exceed estimates. Such underpricing or significant cost overruns could have an adverse effect on the Company's business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of DD&#8217;s contracts, in particular, provide for services on a fixed-price or fee-for-service with a cap basis and they may be terminated or reduced in scope either immediately or upon notice. Cancellations may occur for a variety of reasons, including:</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">failure of products to satisfy safety requirements;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">unexpected or undesired results of the products;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">insufficient clinical trial subject enrollment;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">insufficient investigator recruitment;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a customer's decision to terminate the development of a product or to end a particular study; and</span></div><div style="margin-bottom:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">DD&#8217;s failure to perform its duties properly under the contract.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although its contracts often entitle it to receive the costs of winding down the terminated projects, as well as all fees earned up to the time of termination, the loss, reduction in scope or delay of a large contract or the loss, delay or conclusion of multiple contracts could materially adversely affect DD.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A significant increase in the Company's days sales outstanding could have an adverse effect on the Company&#8217;s business, including its cash flow, by increasing its bad debt or decreasing its cash flow.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billing for laboratory services is a complex process. Laboratories bill many different payers, including doctors, patients, hundreds of insurance companies, Medicare, Medicaid and employer groups, all of which have different billing requirements. In addition to billing complexities, Dx has experienced an increase in patient responsibility as a result of managed care fee-for-service plans that continue to increase patient deductibles, coinsurance and copayments, or implement restrictive coverage or administrative policies that can further increase patient costs. Dx expects this trend to continue. A material increase in Dx&#8217;s days sales outstanding level could have an adverse effect on the Company's business, including potentially increasing its bad debt rate and decreasing its cash flows. Although DD does not face the same level of complexity in its billing processes, it could also experience delays in billing or collection, and a material increase in DD&#8217;s days sales outstanding could have an adverse effect on the Company&#8217;s business, including potentially decreasing its cash flows.</span></div><div style="margin-bottom:7pt;margin-top:2pt;padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DD&#8217;s revenues depend on the pharmaceutical, biotechnology and medical device industries.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD&#8217;s revenues depend greatly on the expenditures made by the pharmaceutical, biotechnology and medical device industries in R&amp;D. In some instances, these  companies are reliant on their ability to raise capital in order to fund their R&amp;D projects. These companies are also reliant on reimbursement for their products from government programs and commercial payers. Accordingly, economic factors and industry trends affecting DD&#8217;s customers in these industries may also affect DD. If these companies were to reduce the number of R&amp;D projects they conduct or outsource, whether through the inability to raise capital, reductions in reimbursement from governmental programs or commercial payers, industry trends, economic conditions or otherwise, DD could be materially adversely affected.</span></div><div style="margin-bottom:7pt;margin-top:2pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency exchange fluctuations could have an adverse effect on the Company&#8217;s business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has business and operations outside the U.S., and DD derives a significant portion of its revenues from international operations. Since the Company's consolidated financial statements are denominated in U.S. dollars, fluctuations in exchange rates from period to period will have an impact on reported results. In addition, DD may incur costs in one currency related to its services or products for which it is paid in a different currency. As a result, factors associated with international operations, including changes in foreign currency exchange rates, could significantly affect DD's results of operations, financial condition and cash flows. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s uses of financial instruments to limit its exposure to interest rate and currency exchange fluctuations could expose it to risks and financial losses that may adversely affect the Company&#8217;s financial condition, liquidity and results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To limit the Company&#8217;s exposure to interest rate fluctuations and currency exchange fluctuations, it has entered into, and in the future may enter into for these or other purposes, financial swaps, or hedging arrangements, with various financial counterparties. In addition to any risks related to the counterparties, there can be no assurances that the Company&#8217;s hedging activity will be effective in insulating it from the risks associated with the underlying transactions, that the Company would not have been better off without entering into these hedges, or that the Company will not have to pay additional amounts</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upon settlement.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s level of indebtedness and debt service requirements could adversely affect the Company&#8217;s liquidity, results of operations and business. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, indebtedness on the Company's outstanding Senior Notes totaled approximately&#160;$5,450.0 million in aggregate principal. The Company is also a party to credit agreements relating to a $<ix:nonFraction unitRef="usd" contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV83My9mcmFnOmU3NWRlZjNhMzcwZjQ4ODM5MGExNjJhYzZmYTVlOWY0L3RleHRyZWdpb246ZTc1ZGVmM2EzNzBmNDg4MzkwYTE2MmFjNmZhNWU5ZjRfNjA0NzMxNDMyMzg2Mg_7718d4b5-2602-4814-bf17-844c9ef16a28">1.0</ix:nonFraction> billion revolving credit facility. Under the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment-grade-rated borrowers, and the Company is required to maintain a leverage ratio within certain limits.&#160; </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s level of indebtedness and debt service requirements could adversely affect its business. In particular, it could increase the Company&#8217;s vulnerability to sustained, adverse macroeconomic weakness, limit its ability to obtain further financing or refinance existing debt at maturity, and limit its ability to pursue certain operational and strategic opportunities, including large acquisitions. Additionally, the Company's cost of funds could increase due to the impact of increases in prevailing interest rates on its variable rate debt and should the Company refinance existing debt at maturity or obtain further financing.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also enter into additional transactions or credit facilities, including other long-term debt, which may increase its indebtedness and result in additional restrictions upon the business. In addition, major debt rating agencies regularly evaluate the Company's debt based on a number of factors. There can be no assurance that the Company will be able to maintain its existing debt ratings, and failure to do so could adversely affect the Company's cost of funds, liquidity and access to capital markets.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company's quarterly operating results may vary.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operating results may vary significantly from quarter to quarter and are influenced by factors over which the Company has little control, such as:</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">changes in the general global economy;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">exchange rate fluctuations;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the commencement, completion, delay or cancellation of large projects or contracts or groups of projects;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the progress of ongoing projects;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">weather;</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the timing of and charges associated with completed acquisitions or other events; and</span></div><div style="margin-bottom:7pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">changes in the utilization mix of the Company's services.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that operating results for any particular quarter are not necessarily a meaningful indication of future results. While fluctuations in the Company's quarterly operating results could negatively or positively affect the market price of the Company's common stock, these fluctuations may not be related to the Company's future overall operating performance.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Planned Spin-off of the Company&#8217;s Clinical Development and Commercialization Services Business</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The planned spin-off of the Company&#8217;s Clinical Development and Commercialization Services business may not be completed on the terms or timeline currently contemplated, if at all, and may not achieve the intended results.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is pursuing a spin-off of its wholly owned Clinical Development and Commercialization Services (CDCS) business, which includes the parts of its DD segment focused on providing Phase I-IV clinical trial management, market access, and technology solutions to pharmaceutical and biotechnology organizations, which would result in two independent, publicly traded companies. Unanticipated issues including, but not limited to, the failure to obtain regulatory approval, obtain appropriate assurances regarding the tax-free nature of the spin-off, or have the Form 10 registration statement that will be filed with the SEC declared effective on a timely basis or at all, could delay, prevent, or otherwise adversely affect the planned spin-off. There can be no assurance that the conditions of the spin-off will be satisfied or that Company will be able to complete the spin-off on the terms or on the anticipated timeline, or at all.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects that pursuing and implementing the spin-off will continue to require significant expenses and management time and effort, may divert management&#8217;s attention from the Company and CDCS' ongoing business operations and may adversely impact relationships with customers, suppliers, employees, and other business counterparties. The Company may experience delays, business disruption, increased costs, including from lost synergies or from restructuring transactions, negative market reaction to the announcement and planning for the transaction, change in market receptiveness to effect transactions in the capital markets, and other challenges during or following the spin-off, which could adversely affect the Company&#8217;s business, financial condition, and results of operations. The Company may also experience increased challenges in attracting, retaining, and motivating key personnel during the pendency of the spin-off and following its completion, which could harm the Company&#8217;s business. The Company anticipates that, consistent with any applicable legal and tax requirements, there will be ongoing transitional and commercial arrangements to provide for a seamless delivery of services to the customers </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other stakeholders of the independent companies following the spin-off, but those arrangements may not meet the intended objectives, which could negatively impact the Company&#8217;s and CDCS&#8217; business, including relationships with customers and other business counterparties.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if the planned spin-off is completed, the anticipated benefits of the transaction may not be realized within the expected time periods or at all. Failure to implement the planned spin-off effectively or the negative reaction of customers, the Company&#8217;s employees, and other stakeholders could also result in a decline in value of one or both of the companies.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Compliance Matters</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes, including changes in interpretation, in payer regulations, policies or approvals, or changes in laws, regulations or policies in the U.S. or globally, may adversely affect the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S. and state government payers, such as Medicare and Medicaid, as well as insurers, including MCOs, have increased their efforts to control the cost, utilization and delivery of healthcare services. From time to time, Congress has considered and implemented changes in Medicare fee schedules in conjunction with budgetary legislation. The first phase of reductions pursuant to PAMA came into effect on January 1, 2018, and will continue annually subject to certain delays in implementation and phase-in limits through 2026, and without limitations for subsequent periods. Further reductions due to changes in policy regarding coverage of tests or other requirements for payment, such as prior authorization, diagnosis code and other claims edits, may be implemented from time to time. Reimbursement for pathology services performed by Dx is also subject to statutory and regulatory reduction. Reductions in the reimbursement rates and changes in payment policies of other third-party payers may occur as well. Such changes in the past have resulted in reduced payments as well as added costs and have decreased test utilization for the commercial laboratory industry by adding more complex new regulatory and administrative requirements. Further changes in third-party payer regulations, policies, or laboratory benefit or utilization management programs may have a material adverse effect on Dx's business. Actions by federal and state agencies regulating insurance, including healthcare exchanges, or changes in other laws, regulations, or policies may also have a material adverse effect upon Dx's business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company could face significant monetary damages and penalties and/or exclusion from government programs if it violates anti-fraud and abuse laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to extensive government regulation at the federal, state, and local levels in the U.S. and other countries where it operates. The Company&#8217;s failure to meet governmental requirements under these regulations, including those relating to billing practices and financial relationships with physicians, hospitals, and health systems could lead to civil and criminal penalties, exclusion from participation in Medicare and Medicaid and possible prohibitions or restrictions on the use of its laboratories. While the Company believes that it is in material compliance with all statutory and regulatory requirements, there is a risk that government authorities might take a contrary position. This risk includes, but is not limited to, the potential that government enforcement authorities may take a contrary position with respect to the Eliminating Kickbacks in Recovery Act, given the lack of associated regulations to clarify or add exceptions. Such occurrences, regardless of their outcome, could damage the Company&#8217;s reputation and adversely affect important business relationships.&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company&#8217;s business could be harmed from the loss or suspension of a license or imposition of a fine or penalties under, or future changes in, or interpretations of, the law or regulations of CLIA, Medicare, Medicaid or other national, state or local agencies in the U.S. and other countries where the Company operates laboratories.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial laboratory testing industry is subject to extensive U.S. regulation, and many of these statutes and regulations have not been interpreted by the courts. CLIA extends federal oversight to virtually all clinical laboratories operating in the U.S. by requiring that they be certified by the federal government or by a federally approved accreditation agency. The sanction for failure to comply with CLIA requirements may be suspension, revocation or limitation of a laboratory&#8217;s CLIA certificate, which is necessary to conduct business, as well as significant fines and/or criminal penalties. In addition, the Company is subject to regulation under state law. State laws may require that laboratories and/or laboratory personnel meet certain qualifications, specify certain quality controls or require maintenance of certain records. The Company also operates laboratories outside of the U.S. and is subject to laws governing its laboratory operations in the other countries where it operates. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory or judicial authority in a manner that would adversely affect the Company's business. Potential sanctions for violation of these statutes and regulations include significant fines and the suspension or loss of various licenses, certificates and authorizations, which could have a material adverse effect on the Company&#8217;s business. In addition, compliance with future legislation could impose additional requirements on the Company, which may be costly.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure of the Company or its third-party service providers to comply with privacy and security laws and regulations could result in fines, penalties and damage to the Company&#8217;s reputation with customers and have a material adverse effect upon the Company&#8217;s business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company and its third-party service providers do not comply with existing or new laws and regulations related to protecting the privacy and security of personal or health information, it could be subject to monetary fines, civil penalties or criminal sanctions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy and security regulations, including the expanded requirements under U.S. Health Information Technology for Economic and Clinical Health Act (HITECH), establish comprehensive standards with respect to the use and disclosure of protected health information (PHI), by covered entities, in addition to setting standards to protect the confidentiality, integrity and security of PHI. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA restricts the Company&#8217;s ability to use or disclose PHI, without patient authorization, for purposes other than payment, treatment or healthcare operations (as defined by HIPAA), except for disclosures for various public policy purposes and other permitted purposes outlined in the privacy regulations. HIPAA and HITECH provide for significant fines and other penalties for wrongful use or disclosure of PHI in violation of the privacy and security regulations, including potential civil and criminal fines and penalties. The regulations establish a complex regulatory framework on a variety of subjects, including:</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the circumstances under which the use and disclosure of PHI are permitted or required without a specific authorization by the patient, including, but not limited to, treatment purposes, activities to obtain payments for the Company&#8217;s services, and its healthcare operations activities;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a patient&#8217;s rights to access, amend and receive an accounting of certain disclosures of PHI;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the content of notices of privacy practices for PHI;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">administrative, technical and physical safeguards required of entities that use or receive PHI; and</span></div><div style="margin-bottom:7pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the protection of computing systems maintaining electronic PHI.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has implemented policies and procedures designed to comply with the HIPAA privacy and security requirements as applicable. The privacy and security regulations establish a &#8220;floor&#8221; and do not supersede state laws that are more stringent. Therefore, the Company is required to comply with both additional federal privacy and security regulations and varying state privacy and security laws. In addition, federal and state laws that protect the privacy and security of patient information may be subject to enforcement and interpretations by various governmental authorities and courts, resulting in complex compliance issues. For example, the Company could incur damages under state laws, including pursuant to an action brought by a private party for the wrongful use or disclosure of health information or other personal information.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also be required to comply with the data privacy and security laws of other countries in which it operates or with which it transfers and receives data. For example, the EU's General Data Protection Regulation (GDPR), which took effect May 25, 2018, created a range of compliance obligations for subject companies and imposes penalties for noncompliance of up to the greater of &#8364;20 million or 4% of worldwide revenue.&#160;The Company has established processes and frameworks to manage compliance with the GDPR. Potential fines and penalties in the event of a violation of the GDPR could have a material adverse effect on the Company&#8217;s business and operations.&#160;In addition, similar data protection regulations addressing access, use, disclosure and transfer of personal data have been enacted or updated in regions where the Company does business, including in Asia, Latin America, and Europe.&#160;The Company expects to make changes to its business practices and to incur additional costs associated with compliance with these evolving and complex regulations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company's international operations could subject it to additional risks and expenses that could adversely impact the business or results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's international operations expose it to risks from potential failure to comply with foreign laws and regulations that differ from those under which the Company operates in the U.S. In addition, the Company may be adversely affected by other risks of expanded operations in foreign countries, including, but not limited to, changes in reimbursement by foreign governments for services provided by the Company; compliance with export controls and trade regulations; changes in tax policies or other foreign laws; compliance with foreign labor and employee relations laws and regulations; restrictions on currency repatriation; judicial systems that less strictly enforce contractual rights; countries that do not have clear or well-established laws and regulations concerning issues relating to commercial laboratory testing or drug development services; countries that provide less protection for intellectual property rights; and procedures and actions affecting approval, production, pricing, reimbursement and marketing of products and services. Further, international operations could subject the Company to additional expenses that the Company may not fully anticipate, including those related to enhanced time and resources necessary to comply with foreign laws and regulations, difficulty in collecting accounts receivable and longer collection periods, and difficulties and costs of staffing and managing foreign operations. In some countries, the Company's success will depend in part on its ability to form relationships with local partners. The Company's inability to identify appropriate partners or </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reach mutually satisfactory arrangements could adversely affect the business and operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expanded international operations may increase the Company&#8217;s exposure to liabilities under the anti-corruption laws.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anti-corruption laws in the countries where the Company conducts business, including the U.S. Foreign Corrupt Practices Act (FCPA), U.K. Bribery Act, and similar laws in other jurisdictions, prohibit companies and their intermediaries from engaging in bribery including improperly offering, promising, paying or authorizing the giving of anything of value to individuals or entities for the purpose of corruptly obtaining or retaining business. The Company operates in some parts of the world where corruption may be common and where anti-corruption laws may conflict to some degree with local customs and practices. The Company maintains an anti-corruption program including policies, procedures, training and safeguards in the engagement and management of third parties acting on the Company&#8217;s behalf. Despite these safeguards, the Company cannot guarantee protection from corrupt acts committed by employees or third parties associated with the Company. Violations or allegations of violations of anti-corruption laws could have a significant adverse effect on the business or results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to comply with the regulations of pharmaceutical and medical device regulatory agencies, such as the FDA, the Medicines and Healthcare Products Regulatory Agency in the United Kingdom (U.K.), the European Medicines Agency, the National Medical Products Administration in China (NMPA), and the Pharmaceuticals and Medical Devices Agency in Japan, could result in fines, penalties, and sanctions against DD and have a material adverse effect upon the Company. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operation of DD's preclinical laboratory facilities and clinical trial operations must conform to good laboratory practice (GLP) and good clinical practice (GCP), as applicable, as well as all other applicable standards and regulations, as further described in Item 1 of Part I of this Annual Report. The business operations of DD&#8217;s clinical and preclinical laboratories also require the import, export and use of medical devices, in vitro diagnostic devices, reagents, and human and animal biological products. Such activities are subject to numerous applicable local and international regulations with which DD must comply. If DD does not comply, DD could potentially be subject to civil, criminal or administrative sanctions and/or remedies, including suspension of its ability to conduct preclinical and clinical studies, and to import or export to or from certain countries, which could have a material adverse effect upon the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain DD services and activities must conform to current good manufacturing practice (cGMP), as further described in Item 1 of Part I of this Annual Report. Failure to maintain compliance with GLP, GCP, or cGMP regulations and other applicable requirements of various regulatory agencies could result in warning or untitled letters, fines, unanticipated compliance expenditures, suspension of manufacturing, and civil, criminal or administrative sanctions and/or remedies against DD, including suspension of its laboratory operations, which could have a material adverse effect upon the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Increased regulations and restrictions on the import of research animals, limitations of supply of research animals, and actions of animal rights activists may have an adverse effect on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD's preclinical services utilize animals in preclinical testing of the safety and efficacy of drugs and devices. Such activities are required for the development of new medicines and medical devices under regulatory regimes in the U.S., Europe, Japan, and other countries. Increased regulations and restrictions on the import of research animals into various countries, as well as limitations of supply, such as those the Company and others experienced in 2022 due to market factors in certain global regions, could impact DD&#8217;s ability to conduct preclinical research and could have an adverse effect on DD&#8217;s financial condition, results of operations, and cash flows. In addition, acts of vandalism and other acts by animal rights activists who object to the use of animals in drug development could have an adverse effect on the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Animal populations may suffer diseases that can damage DD's inventory, harm its reputation, or result in other liability.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that research products be free of diseases, including infectious diseases. The presence of diseases can distort or compromise the quality of research results, cause loss of animals in DD&#8217;s inventory, result in harm to humans or outside animal populations if the disease is not contained to animals in inventory, or result in other losses. Such results could harm DD&#8217;s reputation or have an adverse effect on DD's financial condition, results of operations, and cash flows.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to conduct animal research in compliance with animal welfare laws and regulations could result in sanctions and/or remedies against DD and have a material adverse effect upon the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conduct of animal research at DD&#8217;s facilities must be in compliance with applicable laws and regulations in the jurisdictions in which those activities are conducted. These laws and regulations include the U.S. Animal Welfare Act (AWA), which governs the care and use of warm-blooded animals for research in the U.S. other than laboratory rats, mice and chickens, and is enforced through periodic inspections by the U.S. Department of Agriculture (USDA). The AWA establishes facility standards regarding several aspects of animal welfare, including housing, ventilation, lighting, feeding and watering, handling, veterinary care, and recordkeeping. Similar laws and regulations apply in other jurisdictions in which DD conducts animal research, including the UK, EU, and China. DD complies with licensing and registration requirement standards set by these </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">laws and regulations in the jurisdictions in which it conducts animal research. If an enforcement agency determines that DD&#8217;s equipment, facilities, laboratories or processes do not comply with applicable standards, it may issue an inspection report documenting the deficiencies and setting deadlines for any required corrective actions. For noncompliance, the agency may take action against DD that may include fines, suspension and/or revocation of animal research licenses, or confiscation of research animals. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Food and Drug Administration (FDA) regulation of diagnostic products, increased FDA regulation of laboratory-developed tests (LDTs), and regulation by other countries of diagnostic products could result in increased costs and the imposition of fines or penalties, and could have a material adverse effect upon the Company&#8217;s business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has regulatory responsibility for instruments, test kits, reagents and other devices used by clinical laboratories.&#160;The FDA enforces laws and regulations that govern the development, testing, manufacturing, performance, labeling, advertising, marketing, distribution, and surveillance of diagnostic products, and it regularly inspects and reviews the manufacturing processes and product performance of diagnostic products.&#160;Dx&#8217;s point-of-care testing devices are subject to regulation by the FDA.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the 1990s, the FDA has asserted that it has authority to regulate LDTs as medical devices, but has exercised enforcement discretion to refrain from systematic regulation of LDTs. In 2014, the FDA issued draft guidance describing how it intended to discontinue its enforcement discretion policy and begin regulating LDTs as medical devices; however, that draft guidance has not been finalized, and the FDA has instead continued its enforcement discretion policy and has indicated that it intends to work with Congress to enact comprehensive legislative reform of diagnostics oversight. As such, LDTs developed by high complexity clinical laboratories are currently generally offered as services to health care providers under the CLIA regulatory framework administered by CMS, without the requirement for FDA clearance or approval. There are other regulatory and legislative proposals that would increase general FDA oversight of clinical laboratories and LDTs. The outcome and ultimate impact of such proposals on the business is difficult to predict at this time. On February 20, 2020, the FDA issued a statement with a table of pharmacogenetic associations setting forth certain gene-drug interactions that the agency has determined are supported by the scientific literature to help ensure that claims being made for pharmacogenetic tests are grounded in sound science, thereby reducing the risk of enforcement actions with respect to LDTs offering claims consistent with the table. The FDA noted that while it is committed to work with Congress on new comprehensive diagnostic oversight reform legislation, it could still take enforcement actions under the current medical device framework regarding diagnostic claims the agency determines not to be sufficiently supported. Even without issuance of a finalized LDT oversight framework, in light of the April 4, 2019, FDA warning letter issued to Inova Genomics Laboratory related to certain LDTs that Inova offered, as well as the February 2020 pharmacogenetics statement and the failure to pass diagnostic reform legislation in 2022, there may be an increased risk of FDA enforcement actions for laboratory tests offered by companies without FDA clearance or approval.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current FDA regulation of the Company&#8217;s diagnostic products and the potential for</span><span style="color:#1f497d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future increased regulation of the Company&#8217;s LDTs in the future could result in increased costs and administrative and legal actions for noncompliance, including warning letters, fines, penalties, product suspensions, product recalls, injunctions, and other civil and criminal sanctions, which could have a material adverse effect upon the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulation of diagnostics products in jurisdictions outside the U.S. in which the Company operates may impact laboratory testing offered by the Company in both Dx and DD. For example, the European Union In Vitro Diagnostics Regulation (Regulation (EU) 2017/746 (EU IVDR)), which became applicable on May 26, 2022, establishes a new legislative framework for in vitro diagnostic devices that are used in certain circumstances, and includes a rule-based classification and quality and safety standards. The EU IVDR, where applicable to DD's services, could impact DD's ability to support trials, result in increased costs and administrative and legal actions, and have an adverse effect.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to comply with U.S., state, local or international environmental, health and safety laws and regulations, including the U.S. Occupational Safety and Health Administration Act and the U.S. Needlestick Safety and Prevention Act, could result in fines, penalties and loss of licensure, and have a material adverse effect upon the Company.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed in Item 1 of Part I of this Annual Report, the Company is subject to licensing and regulation under laws and regulations relating to the protection of the environment and human health and safety, including laws and regulations relating to the handling, transportation and disposal of medical specimens, infectious and hazardous waste and radioactive materials, as well as regulations relating to the safety and health of laboratory employees. Failure to comply with these laws and regulations could subject the Company to denial of the right to conduct business, fines, criminal penalties and/or other enforcement actions that would have a material adverse effect on its business. In addition, compliance with future legislation could impose additional requirements on the Company that may be costly.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Technology and Cybersecurity</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to maintain the security of customer-related information or compliance with security requirements could damage the Company&#8217;s reputation with customers, cause it to incur substantial additional costs and become subject to litigation and enforcement actions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives and stores certain personal and financial information about its customers. In addition, the Company depends upon the secure transmission of confidential information over public networks, including information permitting cashless payments. The Company also works with third-party service providers and vendors that provide technology systems and services that are used in connection with the receipt, storage, and transmission of customer personal and financial information. A compromise in the Company&#8217;s security systems, or those of the Company's third-party service providers and vendors, that results in customer personal information being obtained by unauthorized persons, or the Company&#8217;s or a third party's failure to comply with security requirements for financial transactions, including security standards for payment cards (e.g., the Payment Card Industry Data Security Standard), could adversely affect the Company&#8217;s reputation with its customers and others, as well as the Company&#8217;s results of operations, financial condition and liquidity. It could also result in litigation against the Company and the imposition of fines and penalties. For example, in connection with the AMCA Incident the Company has incurred, and expects to continue to incur, costs, and the Company is involved in pending and threatened litigation, as well as various government and regulatory inquiries and processes. For additional information about the AMCA Incident, see Note 14 Commitments and Contingencies to the Consolidated Financial Statements of Part III of the Annual Report.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure in the Company&#8217;s information technology systems or delays or failures in the development and implementation of new systems or updates or enhancements to existing systems could disrupt the Company&#8217;s operations or customer relationships.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations and customer relationships depend, in part, on the continued performance of its information technology systems. A failure of the network or data-gathering procedures could impede the processing of data, delivery of databases and services, customer orders and day-to-day management of the business and could result in the corruption or loss of data. Despite network security measures and other precautions the Company has taken, including the development of disaster recovery plans, its information technology systems are potentially vulnerable to physical or electronic break-ins, computer viruses, fire, natural disaster, power loss, telecommunications failures, cybersecurity breaches and similar disruptions, and there may not be adequate protections, mitigation plans or redundant facilities available in the event of such system failures. In addition, the Company may experience system failures or interruptions as it integrates the information technology systems of newly acquired businesses. Failures or interruption of the Company&#8217;s systems in one or more of its operations could result in interruptions of service, disrupt the Company&#8217;s ability to process laboratory requisitions, perform testing, provide test results or drug development data in a timely manner and/or conduct timely billing operations. Such system failures could require the Company to transfer operations to an alternative provider of services, which could result in a delays in the delivery of products and services to customers. Additionally, significant delays in the planned delivery of system enhancements or improvements, or inadequate performance of the systems once they are complete could damage the Company's reputation and harm the business. Furthermore, failure of the Company&#8217;s information technology systems could adversely affect the Company&#8217;s business, profitability, financial condition, and reputation.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security breaches and unauthorized access to the Company's or its customers&#8217; data could harm the Company&#8217;s reputation and adversely affect its business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced and expects to continue to experience attempts by computer programmers and hackers to attack and penetrate the Company&#8217;s layered security controls, like the 2018 ransomware attack. The Company has also experienced and expects to continue to experience similar attempts to attack and penetrate the systems of third-party suppliers and vendors to whom the Company has provided data, like the 2019 AMCA data breach. These attempts, if successful, could result in the misappropriation or compromise of personal information or proprietary or confidential information stored within the Company's systems or within the systems of third parties, create system disruptions or cause shutdowns. External actors are developing and deploying viruses, worms and other malicious software programs that attack the Company&#8217;s systems, the systems of third-parties, or otherwise exploit any security vulnerabilities. Outside parties may also attempt to fraudulently induce employees to take actions, including the release of confidential or sensitive information or to make fraudulent payments through illegal electronic spamming, phishing, spear phishing, or other tactics. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has robust information security procedures and other safeguards in place, including evaluating the cybersecurity status of third-party suppliers and vendors that will have access to the Company&#8217;s data or information technology systems, which are monitored and routinely tested internally and by external parties. However, because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and often are not recognized until launched against a target, the Company may be unable to anticipate all of these techniques or to implement adequate preventive </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measures. In addition, as cyber threats continue to evolve, the Company may be required to expend additional resources to continue to enhance the Company&#8217;s information security measures or to investigate and remediate any information security vulnerabilities. The Company&#8217;s remediation efforts may not be successful and could result in interruptions, delays or cessation of service. This could also impact the cost and availability of cyber insurance to the Company. Breaches of the Company&#8217;s or third parties' security measures and the unauthorized dissemination of personal, proprietary or confidential information about the Company or its customers or other third parties could expose customers&#8217; private information. Such breaches could expose customers to the risk of financial or medical identity theft or expose the Company or other third parties to a risk of loss or misuse of this information, result in litigation and potential liability for the Company, damage the Company&#8217;s brand and reputation or otherwise harm the Company&#8217;s business. Any of these disruptions or breaches of security could have a material adverse effect on the Company&#8217;s business, regulatory compliance, financial condition and results of operations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company faces increased cybersecurity risks due to the number of employees that continue to work remotely, which increased significantly as a result of the COVID-19 pandemic, and which remains at levels higher than prior to the pandemic as a result of changes in the workplace and to management and employee expectations. Increased levels of remote access create additional opportunities for cybercriminals to exploit vulnerabilities, and employees may be more susceptible to phishing and social engineering attempts. In addition, technological resources may become strained due to the number of remote users. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Company depends on third parties to provide services critical to the Company's business, and depends on them to comply with applicable laws and regulations. Additionally, any breaches of the information technology systems of third parties could have a material adverse effect on the Company's operations. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company depends on third parties to provide services critical to the Company's business, including supplies, ground and air transport of clinical and diagnostic testing supplies and specimens, research products, and people, among other services. Third parties that provide services to the Company are subject to similar risks related to security of customer-related information and compliance with U.S., state, local, or international environmental, health and safety, and privacy and security laws and regulations as the Company. Any failure by third parties to comply with applicable laws, or any failure of third parties to provide services more generally, could have a material impact on the Company, whether because of the loss of the ability to receive services from the third parties, legal liability of the Company for the actions or inactions of third parties, or otherwise.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, third parties to whom the Company outsources certain services or functions may process personal data, or other confidential information of the Company. A breach or cyber attack affecting these third parties, like the AMCA Incident, could also harm the Company's business, results of operations and reputation. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Legal Matters</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse results in material litigation matters could have a material adverse effect upon the Company&#8217;s business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently and may continue to be subject in the ordinary course of business to legal actions related to, among other things, intellectual property disputes, contract disputes, data and privacy issues, professional liability and employee-related matters, which may be or may become material. The Company also has received and may in the future receive inquiries and requests for information from governmental agencies and bodies, including Medicare or Medicaid payers, requesting comment and/or information on various matters, including allegations of billing irregularities, billing and pricing arrangements, or privacy practices that are brought to its attention through audits or third parties. Legal actions can result in substantial monetary damages as well as damage to the Company&#8217;s reputation with customers, which could have a material adverse effect upon its business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The failure to successfully obtain, maintain and enforce intellectual property rights and defend against challenges to the Company&#8217;s intellectual property rights could adversely affect the Company. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s services, products and processes rely on intellectual property, including patents, copyrights, trademarks and trade secrets. In some cases, that intellectual property is owned by another party and licensed to the Company, sometimes exclusively. The value of the Company&#8217;s intellectual property relies in part on the Company&#8217;s ability to maintain its proprietary rights to such intellectual property. The Company has been in the past and may be unable in the future to obtain or maintain the proprietary rights to its intellectual property, to prevent attempted infringement against its intellectual property, or to defend against claims that it is infringing on another party&#8217;s intellectual property, and the Company could be adversely affected. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, in October 2020, Ravgen Inc. filed a patent infringement lawsuit against the Company alleging infringement of two Ravgen-owned U.S. patents, and in September 2022, a jury rendered a verdict in favor of Ravgen on the remaining patent at issue, finding that the Company willfully infringed Ravgen's patent, and awarded damages of $272 million. Ravgen has filed post-trial motions seeking enhanced damages of up to $817 million based on the finding of willfulness, as well as </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attorney's fees and costs. The Company strongly disagrees with the verdict, based on a number of legal factors, and will vigorously defend the lawsuit through the appeal process. On June 4, 2021, the Company also instituted proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challenging the validity of the Ravgen patent at issue in the trial. In November 2022, the Patent Trial and Appeal Board issued a decision upholding the validity of the Ravgen patent, and the Company has filed an appeal of this decision.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse effects resulting from the failure to successfully obtain, maintain, and enforce intellectual property rights and defend against challenges to the Company's intellectual property rights could include the Company having to abandon, alter and/or delay the deployment of products, services or processes that rely on such intellectual property; having to procure and pay for licenses from the holders of intellectual property rights that the Company seeks to use; and having to pay damages, fines, court costs and attorney's fees in connection with intellectual property litigation.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in tax laws and regulations or the interpretation of such may have a significant impact on the financial position, results of operations and cash flows of the Company.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. and foreign governments continue to review, reform and modify tax laws, including with respect to the Organisation for Economic Co-operation and Development&#8217;s base erosion and profit shifting initiative. Changes in tax laws and regulations could result in material changes to the domestic and foreign taxes that the Company is required to provide for and pay.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company is subject to regular audits with respect to its various tax returns and processes in the jurisdictions in which it operates. Errors or omissions in tax returns, process failures or differences in interpretation of tax laws by tax authorities and the Company may lead to litigation, payments of additional taxes, penalties and interest.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract research services in the drug development industry create liability risks.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contracting to work on drug development trials and studies, DD faces a range of potential liabilities, including:</span></div><div style="padding-left:13.5pt;padding-right:4.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Errors or omissions that create harm to clinical trial subjects during a trial or to consumers of a drug after the trial is completed and regulatory approval of the drug has been granted;</span></div><div style="padding-left:13.5pt;padding-right:4.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">General risks associated with clinical pharmacology facilities, including negative consequences from the administration of drugs to clinical trial participants or the professional malpractice of clinical pharmacology physicians;</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Risks that animals in DD&#8217;s facilities may be infected with diseases that may be harmful and even lethal to themselves and humans despite preventive measures contained in DD's business policies, including those for the quarantine and handling of imported animals; and</span></div><div style="padding-left:13.5pt;padding-right:4.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Errors and omissions during a trial or study that may undermine the usefulness of a trial or study, or data from the trial or study or that may delay the entry of a drug to the market.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD contracts with physicians, also referred to as investigators, to conduct the clinical trials to test new drugs on clinical trial subjects. These tests can create a risk of liability for personal injury or death to clinical trial subjects resulting from negative reactions to the drugs administered or from professional malpractice by third party investigators.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While DD endeavors to include in its contracts provisions entitling it to be indemnified and entitling it to a limitation of liability, these provisions are not always successfully obtained and, even if obtained, do not uniformly protect DD against liability arising from certain of its own actions. DD could be materially and adversely affected if it were required to pay damages or bear the costs of defending any claim that is not covered by a contractual indemnification provision, or in the event that a party which must indemnify it does not fulfill its indemnification obligations, or in the event that DD is not successful in limiting its liability or in the event that the damages and costs exceed DD's insurance coverage. DD may also be required to agree to contract provisions with clinical trial sites or its customers related to the conduct of clinical trials, and DD could be materially and adversely affected if it were required to indemnify a site or customer against claims pursuant to such contract terms. There can be no assurance that DD will be able to maintain sufficient insurance coverage on acceptable terms.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the COVID-19 Pandemic</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The effects of the outbreak of the COVID-19 pandemic could have material adverse impacts on the Company&#8217;s business, results of operations, cash flows, and financial position.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is closely monitoring the impact of the COVID-19 pandemic on all aspects of its business. Fluctuations in the number of COVID-19 cases typically result in corresponding fluctuations in the Company's COVID-19 PCR and antibody testing (COVID-19 Testing) volumes and its Base Business (operations except for COVID-19 Testing), and may have a negative effect on the Company's business and financial performance. Given the continued unpredictability pertaining to the COVID-19 pandemic, the impact on the Company's business continues to be uncertain and depends on a number of evolving factors that the Company may not be able to predict or effectively respond to.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A resurgence of COVID-19, including the rise of variants, and the Company&#8217;s initiatives to help limit the spread of the illness, could impact the Company&#8217;s ability to carry out its business as usual, which could materially adversely impact its business and financial condition. The Company has incurred additional costs in order to provide for the safety of its employees and patients and the continuity of its operations. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes in government and third-party payer regulations, reimbursement, or coverage policies (or in the interpretation of current regulations) relating to COVID-19 testing could materially impact the Company's results of operations, cash flows and financial position.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred additional costs to implement operational changes in response to this pandemic. The COVID-19 pandemic disrupted, and along with other economic factors, a resurgence in COVID-19 could continue to disrupt, the Company&#8217;s supply chain, including its ability to secure test collection and testing supplies and equipment and personal protective equipment for its employees. For similar reasons, the COVID-19 pandemic has also adversely impacted, and may continue to adversely impact, third parties that are critical to the Company&#8217;s business, including vendors, suppliers, and business partners. These developments, and others that are difficult or impossible to predict, could materially impact the Company&#8217;s business, financial results, cash flows, and financial position. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If there is a resurgence of the pandemic, the Company may be forced to prioritize its application of resources to the continued mitigation of COVID-19, at the expense of other potentially profitable opportunities or initiatives, such as the development of new products or selected business acquisitions.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If the Company does not respond appropriately to the ongoing COVID-19 pandemic, or if the Company&#8217;s customers do not perceive its response to be adequate, the Company could suffer damage to its reputation, which could adversely affect its business.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the Company&#8217;s efforts to respond to and mitigate the impact of COVID-19 on its business and operations since the global pandemic was declared on March 11, 2020, the failure of the Company to appropriately and adequately respond as the effects of the pandemic continue may cause  the Company&#8217;s customers and other stakeholders to perceive the Company&#8217;s responses to the pandemic as insufficient, inadequate, or not equivalent to or better than competitors, including with respect to the availability of testing, collection  kits, and the amount of time it takes for delivery of test results or fulfillment of kit orders. Factors that may be out of the Company&#8217;s control, such as the availability of equipment, supplies, and key personnel and geographical changes in demand, may impact the Company&#8217;s ability to meet customer demand and may have an adverse effect on the Company&#8217;s operations. Any such disruptions could result in negative publicity, and the Company could suffer damage to its reputation, which could adversely affect its business, results of operations, cash flows, and financial position.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_76"></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. &#160;&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;PROPERTIES </span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's corporate headquarters are located in Burlington, North Carolina, and include facilities that are both owned and leased.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp Diagnostics (Dx) operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The table below summarizes certain information as to Dx's principal operating and administrative facilities as of December&#160;31, 2022.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Location</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature of Occupancy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary Facilities:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Birmingham, Alabama</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, Arizona</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Los Angeles, California</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monrovia, California</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, California</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco, California</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shelton, Connecticut</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tampa, Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Bend, Indiana</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wichita, Kansas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Westborough, Massachusetts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Troy, Michigan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St. Paul, Minnesota</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raritan, New Jersey</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Burlington, North Carolina (5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned/Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research Triangle Park, North Carolina (3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dublin, Ohio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tulsa, Oklahoma</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brentwood, Tennessee</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Houston, Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Herndon, Virginia</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seattle, Washington</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spokane, Washington (2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oak Creek, Wisconsin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labcorp Drug Development (DD) operates on a global scale. The table below summarizes certain information as to DD's principal operating and administrative facilities as of December&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Location</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature of Occupancy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primary Facilities:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mechelen, Belgium</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beijing, China </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shanghai, China (2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned/Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Muenster, Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pune, India</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bangalore, India</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Geneva, Switzerland</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eye, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Harrogate, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Huntingdon, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leeds, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maidenhead, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shardlow, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">York, United Kingdom</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Francisco, California</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daytona Beach, Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greenfield, Indiana</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indianapolis, Indiana</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bedford, Massachusetts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ann Arbor, Michigan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minneapolis, Minnesota</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Princeton, New Jersey</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somerset, New Jersey</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dallas, Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chantilly, Virginia</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased</span></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison, Wisconsin</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Owned</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s primary laboratory and drug development facilities have been built or improved for the purpose of providing commercial laboratory testing or drug development services. The Company believes that these existing facilities and plans for expansion are suitable and adequate and will provide sufficient production capacity for the Company's currently foreseeable level of operations.&#160;The Company believes that if it were unable to renew a lease or if a lease were to be terminated on any of the facilities it presently leases, it could find alternate space at competitive market rates and readily relocate its operations to such new locations without material disruption to its operations.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_82"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 14 Commitments and Contingencies to the Consolidated Financial Statements.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_85"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_88"></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_91"></div><div style="padding-left:76.5pt;text-align:justify;text-indent:-76.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's common stock, par value $0.10 per share, or Common Stock, trades on the New York Stock Exchange or NYSE under the symbol &#8220;LH.&#8221;&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;27, 2023, there were approximately 1,249 holders of record of the Common Stock.</span></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent for the Company's Common Stock is American Stock Transfer &amp; Trust Company, Shareholder Services, 6201 Fifteenth Avenue, Brooklyn, NY 11219, telephone: 800-937-5449, website: www.amstock.com.</span></div><div style="margin-bottom:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:4pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company initiated a quarterly dividend beginning in the second quarter of 2022. The Company&#8217;s ability to pay dividends is primarily dependent on earnings from operations, the adequacy of capital and the availability of liquid assets for distribution.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, the Company paid $195.2 in common stock dividends. The Company expects common dividend declarations, if made, to occur in January, April, July, and October with payment dates in March, June, September and December, and are subject to Board approval. There can be no assurance that the Company will continue to pay quarterly cash dividends at the current rate or at all.</span></div><div style="margin-bottom:4pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock Performance</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the cumulative total return assuming an investment of $100 on December 31, 2017, in each of the Company&#8217;s Common Stock, the Standard &amp; Poor&#8217;s, or S&amp;P Composite-500 Stock Index and the S&amp;P 500 Health Care Index, or Peer Group, and assuming that all dividends were reinvested.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of Cumulative Total Return</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.22&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.06&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.61&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.98&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.91&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><img src="lh-20221231_g4.jpg" alt="lh-20221231_g4.jpg" style="height:372px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer Purchases of Equity Securities (all amounts in millions, except per share amounts)</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to purchases of shares of the Company&#8217;s common stock made during the quarter ended December&#160;31, 2022, by or on behalf of the Company:</span></div><div style="margin-top:3pt;text-align:center;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.513%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Number of Shares Repurchased as Part of Publicly Announced Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maximum Dollar Value of Shares that May Yet Be Repurchased Under the Program</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1 - October 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211.91&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1 - November 30</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1 - December 31</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.48&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.5&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Board adopted a new share repurchase plan authorizing repurchase of up to $2,500.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. On December 13, 2021, the Company entered into ASR Agreements with Goldman Sachs &amp; Co. LLC and Barclays Bank PLC to repurchase the Company&#8217;s common stock (Common Stock), as part of the Company&#8217;s common stock repurchase program. Under the ASR Agreements, $1,000.0 was paid to the banks in December 2021 and the Company received 80% of the shares calculated at the price at the inception of the Agreements, approximately 2.7 shares. </span><span style="color:#00000e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the forward contract was settled during 2022, the Company received 0.9 shares, which were retired in 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the end of 2021, the Company had outstanding authorization from the Board to purchase $1,631.5 of Company common stock. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the year ended December&#160;31, 2022, the Company purchased 4.7 shares of its common stock at an average price of $233.48 for a total cost of&#160;$1,100.0. When the Company repurchases shares, the amount paid to repurchase the shares in excess of the par or stated value is allocated to additional paid-in-capital unless subject to limitation or the balance in additional paid-in-capital is exhausted. Remaining amounts are recognized as a reduction in retained earnings. At the end of 2022, the Company had outstanding authorization from the Board to purchase up to $531.5 of the Company's common stock. The repurchase authorization has no expiration date. </span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, the board of directors adopted a new share repurchase plan authorizing up to $1,000.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. The repurchase authorization has no expiration.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_94"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;SELECTED FINANCIAL DATA</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.  </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_97"></div><div style="margin-bottom:7pt;padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (in millions)</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company's revenues were $14.9 billion, a decrease of 7.7% from $16.1 billion in 2021. The decrease was due to lower organic revenue of 7.5% and foreign currency translation of 1.0%, partially offset by acquisitions net of divestitures of 0.8%. The 7.5% decrease in organic revenue was due to a 10.0% decrease in COVID-19 Testing, partially offset by a 2.5% increase in the Company's organic Base Business.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company defines organic growth as the increase in revenue excluding the year over year impact of acquisitions, divestitures, and currency. Acquisition and divestiture impact is considered for a twelve-month period following the close of each transaction. Base Business includes the Company's business operations except for COVID-19 Testing.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic Review of Company Structure and Capital Allocation Strategy</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, the Company announced the undertaking of a comprehensive review by its board of directors (the Board) and management team of the Company's structure and capital allocation strategy. In December 2021, the Company announced the Board's conclusion, as well as actions that the management team and the Board would take to enhance shareholder returns. These actions have included: </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiating a dividend in the second quarter of 2022, as well as subsequent dividends paid in the third and fourth quarters of 2022, with total dividend payments for 2022 in the amount of $195.2 million;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing a $2.50 billion share repurchase program. As part of this program, $1.0 billion was repurchased under an accelerated share repurchase plan in 2021, and a total of $1.1 billion of stock was repurchased in 2022, representing approximately 4.7 million shares;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implementing a new LaunchPad business process improvement initiative, targeting savings of $350.0 million through 2025;</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing a longer-term outlook in connection with the announcement of the Company's 2021 year-end results in addition to the Company's annual guidance;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing additional business insights through enhanced disclosures beginning with the Company's results for the first quarter of 2022; and</span></div><div style="margin-bottom:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing a commitment to profitable growth through investments in science, innovation, and new technologies; and</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 28, 2022, the Company announced that it would pursue a planned spin-off of its Clinical Development and Commercialization Services (CDCS) business, as further discussed below.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management and the Board are committed to continuing to evaluate all avenues for enhancing shareholder value.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The updated capital allocation plan is designed to enable the Company to continue investment in key growth areas. This plan is expected to fuel growth through innovation by using the Company's unique data and insights to bring scientific advancements&#8212;both those developed internally and those developed by outside companies and scientists&#8212;to market at scale. It reflects the Board's confidence in the Company's strong balance sheet and cash flow generation profile, as well as the Board's commitment to deploying capital to enhance value for shareholders, patients, providers, and pharmaceutical customers worldwide.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Spin-Off of the Company's CDCS Business</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Company announced that the Board authorized the Company to pursue a spin-off of the Company&#8217;s wholly owned CDCS business to its shareholders through a tax-free transaction. The planned spin-off will result in two independent companies, each poised for strong, sustainable growth. On January 9, 2023, Thomas (Tom) Pike joined the Company as president and chief executive officer of its DD Clinical Development business unit, and when the planned spin-off is complete, Mr. Pike will become the chief executive officer and chairman of the board of directors of the independent, publicly listed company. On February 9, 2023, the Company announced that the name of the CDCS business will become Fortrea in connection with the planned spin-off.     </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is targeting completion of the planned spin-off in mid-2023. The planned spin-off will be subject to the satisfaction of certain customary conditions, including, among others, the receipt of final approval by the Company's Board, the receipt of appropriate assurances regarding the tax-free nature of the separation and effectiveness of any required filings with the U.S. Securities and Exchange Commission (SEC). There can be no assurances regarding the ultimate timing of the transaction or that the spin-off will be completed.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the transaction is complete, the resulting companies will be Labcorp, comprising the Company&#8217;s routine and esoteric labs, central labs and early development research labs, and Fortrea, a global contract research organization (CRO) providing Phase I-IV clinical trial management, market access and technology solutions to pharmaceutical and biotechnology organizations.</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned spin-off is expected to provide each company with:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strengthened strategic flexibility and operational focus to pursue specific market opportunities and better meet customer needs;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">focused capital structures and capital allocation strategies to drive innovation and growth; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a more targeted investment opportunity for different investor bases; and </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt">the ability to align its particular incentive compensation with its financial performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the planned spin-off, the Company believes that Labcorp will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in R&amp;D and innovation to develop and launch diagnostic advancements globally in key clinical areas including oncology, Alzheimer's, and autoimmune and liver disease through organic and inorganic opportunities; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">bring together its global health and patient data and provide insights to enable customers to innovate; </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilize its worldwide laboratory network to serve a broad, growing and global customer base including pharmaceutical and biotechnology companies, physicians, health systems, consumers, and other start-ups and laboratories that require lab services or diagnostic testing; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launch innovative tests globally, providing patients, physicians, health systems and pharmaceutical companies with access to its advanced science, technology and diagnostic capabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the planned spin-off, the Company believes that Fortrea will be positioned to:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capitalize on growth opportunities across Phases I-IV clinical trials and extend its leadership in oncology, cell and gene therapy, rare disease, and other emerging therapeutic areas;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase agility with large pharmaceutical and biotechnology clients to better serve customers and advance life-saving therapies;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">access to unique data sets and insights through an arrangement with the Company for a defined period of time which will enable Fortrea to provide enhanced trial execution and a differentiated value proposition; </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">invest in capabilities, technologies, diverse talent and innovation to enhance trial execution and better serve all of its customers; and</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement a capital structure that is tailored to support its growth strategy and enhance stakeholder value.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The planned spin-off is intended to qualify as a tax-free transaction for U.S. federal income tax purposes. See &#8220;Risk Factors - Risks Related to the Planned Spin-off of the Company&#8217;s Clinical Development and Commercialization Services Business.&#8221;</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, the disclosure in this Annual Report assumes that Clinical Development and Commercialization Services business will be with the Company for the full year.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Outlook</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Company anticipates that COVID-19 will continue impacting its business in 2023 and potentially beyond, the Company expects a continued decline in demand for COVID-19 Testing, with the potential for increases in demand at different times and across different geographies. As a result, COVID-19 Testing demand in 2023 is not predicted to match 2022 levels.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_100"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the financial measures that management considers to be the most significant indicators of the Company's performance. For discussion of 2021 results and comparison with 2020 results refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Conditions and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Company's Annual Report on Form 10-K for the fiscal year ended&#160;December&#160;31, 2021.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Years ended December 31, 2022 and 2021</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenues </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,363.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.2)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,845.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,876.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,120.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 7.7% decrease in revenues for the year ended December&#160;31, 2022, as compared to the corresponding period in 2021 was due to lower organic revenue of 7.5% and unfavorable foreign currency translation of 1.0%, partially offset by acquisitions net of divestitures of 0.8%. The 7.5% decrease in organic revenue was due to a 10.0% decrease in COVID-19 Testing, partially offset by a 2.5% increase in the Company's organic Base Business.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx revenues for the year ended December&#160;31, 2022, were $9,203.5, a decrease of 11.2% compared to revenues of $10,363.6 in the corresponding period in 2021. The decrease was primarily due to lower organic revenue of 12.1% and unfavorable foreign currency translation of 0.1%, partially offset by acquisitions of 1.1%. The 12.1% decrease in organic revenue was due to a 15.6% decrease in COVID-19 Testing, partially offset by a 3.4% contribution from organic Base Business.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total volume, measured by requisitions, decreased by 7.5% as organic volume decreased by 8.4% and acquisition volume contributed growth of 0.8%. Organic volume was impacted by a 10.4% decrease in COVID-19 Testing, partially offset by a 2.0% increase in Base Business. Price/mix decreased by 3.7% due to lower COVID-19 Testing of 5.2% and unfavorable foreign currency translation of 0.1%, partially offset by higher Base Business of 1.4% and acquisitions of 0.2%.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD revenues for the year ended December&#160;31, 2022, were $5,710.2, a decrease of 2.3% over revenues of $5,845.5 in the corresponding period in 2021. The decrease in revenues was primarily due to unfavorable foreign currency translation of 2.6% and lower COVID-19 Testing of 0.6%, partially offset by organic base business growth of 0.5%, and acquisitions net of divestitures of 0.3%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cost of Revenues</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,491.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,496.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues as a % of revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenues were flat in 2022 as compared with 2021 and increased as a percentage of revenues to 70.5% in 2022 as compared to 65.1% in 2021. This increase in cost of revenues as a percentage of revenues was primarily due to a reduction in </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">higher margin COVID-19 Testing, higher personnel expenses, and other inflationary costs, partially offset by organic Base Business growth and LaunchPad savings.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,996.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,952.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A as a % of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Selling, general and administrative expenses as a percentage of revenues increased to 13.4% in 2022 compared to 12.1% in 2021. The increase in selling, general and administrative expenses as a percentage of revenues is primarily due to a decrease in higher margin COVID-19 Testing and higher personnel costs, partially offset by LaunchPad savings.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Goodwill and Other Asset Impairments</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 impairment charges were primarily comprised of $260.0 of goodwill impairment for the early development reporting unit, which is part of the DD segment, and the impairment of a technology intangible asset. There were no goodwill and other asset impairments for the year ended December&#160;31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Amortization of Intangibles and Other Assets</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in amortization of intangibles and other assets for the year ended December&#160;31, 2022 is primarily due to $88.4 in amortization acceleration of certain intangible assets related to trade names as a result of the Company's rebranding initiative recognized during 2021, partially offset by the impact of acquisitions.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Restructuring and Other Charges</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;During 2022, the Company recorded net restructuring charges of $83.8. The charges were comprised of $39.3 in severance and other personnel costs, $45.7 in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $0.3 in unused severance and $0.9 in unused facility-related costs.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company recorded net restructuring charges of $43.1. The charges were comprised of $16.3 in severance and other personnel costs and $28.0 in facility closures, lease terminations, and general integration activities. The charges were offset by the reversal of previously established liability of $0.4 and $0.8 in unused severance costs and facility-related costs, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Expense</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.0)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in interest expense for 2022 as compared with the corresponding period in 2021 is primarily due to the costs of redeeming the outstanding 3.20% senior notes due February 1, 2022 and the 3.75% notes due August 23, 2022 and issuing the new senior notes in 2021 and lower outstanding debt partially offset by a higher average cost of debt in 2022.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Equity Method Income, Net</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.7)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method income, net represents the Company's ownership share in joint venture partnerships along with equity investments in other companies in the health care industry. The decrease in income for 2022 as compared with the corresponding period in 2021 was primarily due to the decreased profitability of the Company's joint ventures in 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other, Net</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in Other, net for the year ended December&#160;31, 2022, as compared to the year ended December&#160;31, 2021, was primarily due to investment losses of $19.6 compared to $61.8 of investment gains in the corresponding period of 2021. In addition, foreign currency transaction losses of $5.0 and $4.4 were recognized for the years ended December 31, 2022 and 2021, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Tax Expense</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense as a % of income before tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current year effective tax rate was favorably impacted by the Company's research and development tax credits, changes in effective state income tax rates, and deferred tax adjustments.  During the third quarter, the Company completed a detailed domestic research and development tax credit analysis for the 2019, 2020, and 2021 tax years that resulted in an incremental income tax benefit.  The prior year effective tax rate was favorably impacted by stock-based compensation arrangements that was offset by the deferred revaluation related to the U.K. rate change.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Operating Results by Segment</span></div><div style="margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19 costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability.</span></div><div style="margin-bottom:1pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:55.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,205.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.8)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx operating income was $2,025.5 for the year ended December&#160;31, 2022, a decrease of 36.8% over operating income of $3,205.6 in the corresponding period of 2021, and Dx operating margin decreased 890 basis points in operating margin year-over-year. The decrease in operating income and margin were primarily due to a reduction in COVID-19 Testing, higher personnel expense, the mix impact from Ascension, partially offset by organic Base Business growth.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD operating income was $801.1 for the year ended December&#160;31, 2022, a decrease of 9.7% from operating income of $887.1 in the corresponding period of 2021. The decrease was primarily due to a reduction in COVID-19 Testing, a reduction in COVID-19 related work, the interruption of some clinical trial activity due to the Ukraine/Russia crisis, and other inflationary costs. These impacts were partially offset by Base Business growth and LaunchPad savings.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General corporate expenses are comprised primarily of administrative services such as executive management, human resources, legal, finance, corporate affairs, and information technology. Corporate expenses were $438.1 for the year ended December&#160;31, 2022, an increase of 4.2% over corporate expenses of $420.5 in the corresponding period of 2021, primarily due to higher personnel costs, bonus allocation, research and development costs, and other costs.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_103"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity, Capital Resources and Financial Position</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's strong cash-generating capability and financial condition typically have provided ready access to capital markets. The Company's principal source of liquidity is operating cash flow, supplemented by proceeds from debt offerings. The Company's senior unsecured revolving credit facility is further discussed in Note 10 Debt to the Company's Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary the Company's cash flows were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:69.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.999%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Year Ended December 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,955.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,109.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,652.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(884.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,322.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,065.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate on changes in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,042.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at December&#160;31, 2022 and 2021 totaled $430.0 and $1,472.7, respectively. Cash and cash equivalents consist of highly liquid instruments, such as time deposits and other money market investments, which have original maturities of three months or less.  </span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company's operations provided $1,955.9 of cash as compared to $3,109.6 in 2021. The $1,153.7 decrease in cash provided from operations in 2022 as compared with the corresponding 2021 period was primarily due to lower cash earnings as COVID-19 revenues decreased significantly.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used by investing activities for the year ended December&#160;31, 2022 was $1,652.2 as compared to net cash used by investing activities of $884.6 for the year ended December&#160;31, 2021. The $767.6 increase in net cash used by investing activities for the year ended December&#160;31, 2022, was primarily due to a year over year increase of $667.1 in cash paid for acquisitions. The Company had proceeds of $87.3 from the sale of assets and disposition of businesses during 2021 in comparison to $1.4 during 2022. Capital expenditures were $481.9 and $460.4 for the years ended December&#160;31, 2022 and 2021, respectively. Capital expenditures in 2022 were 3.2% of revenues, primarily in connection with projects to support growth in the Company's core businesses. The Company intends to continue to pursue acquisitions to drive growth, to make important investments in its business, including in information technology, and to improve efficiency and enable the execution of the Company's mission. Such expenditures are expected to be funded by cash flow from operations or, as needed, through borrowings under debt facilities, including the Company's revolving credit facility or any successor facility. The Company expects capital expenditures in 2023 to be approximately 3.5% of revenues, primarily in connection with projects to support growth in the Company's core businesses, facility updates, projects related to LaunchPad, and further acquisition integration initiatives.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities for the year ended December&#160;31, 2022 was $1,322.2 compared to cash used in financing activities of $2,065.8 for the year ended December&#160;31, 2021. This movement in cash within financing activities for 2022, as compared to 2021, was primarily a result of $1,100.0 in share repurchases in 2022 compared to $1,668.5 in 2021 and the commencement of quarterly dividend payments in the second quarter of 2022.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2021, the Company issued new senior notes representing $1,000.0 in debt securities and consisting of $500.0 aggregate principal amount of 1.55% senior notes due 2026 and $500.0 aggregate principal amount of 2.70% senior notes due 2031. Interest on these notes is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 1, 2021. Net proceeds from the offering of these notes were $989.4 after deducting underwriting discounts and other expenses of the offering. The net proceeds were used to redeem, prior to maturity, the Company's outstanding 3.20% senior notes due February 1, 2022 and 3.75% senior notes due August 23, 2022.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%. These instruments are designated as hedges against changes in the fair value of a portion of the Company's long-term debt. The aggregate fair value of $79.7 at December&#160;31, 2022, was included as a component of other long-term liabilities and deducted from the reported value of the senior notes. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021, the Company amended and restated its revolving credit facility. It consists of a five-year revolving facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $500.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from 0.100% to 0.225%, depending on the Company&#8217;s debt ratings. Borrowings under the revolving credit facility will accrue interest at a per annum rate equal to, at the Company&#8217;s election, either (x) a LIBOR rate plus a margin ranging from 0.775% to 1.275% or (y) a base rate plus a margin ranging from 0% to 0.275%, in each case, depending on the Company&#8217;s debt ratings.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to evaluate its outstanding debt portfolio to take advantage of market conditions that would allow the Company to reduce its interest rate or financing risk and provide a lower long-term borrowing cost.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants under the revolving credit facility at December&#160;31, 2022, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company repurchased 5.6 shares of its common stock at an average price of $233.48 for a total cost of $1,100.0. This included 0.9 shares which were repurchased in 2022 but were part of the $1,000.0 ASR Program paid for in 2021. At the end of 2022, the Company had outstanding authorization from the Board to purchase $531.5 of Company common stock. The repurchase authorization has no expiration date. On February 7, 2023, the board of directors adopted a new share repurchase plan authorizing up to $1,000.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. The repurchase authorization has no expiration date.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2022, the Company paid $195.2 in common stock dividends. On January 12, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the first quarter, or approximately $64.8 in the aggregate. The dividend will be payable on March 13, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on February 23, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's board of directors.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Ratings</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment grade debt ratings from Moody&#8217;s and Standard &amp; Poor's (S&amp;P) contribute to its ability to access capital markets.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have transactions or relationships with &#8220;special purpose&#8221; entities, and the Company does not have any off-balance sheet financing other than normal operating leases and letters of credit.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commercial Commitments</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the Company provided letters of credit aggregating approximately $84.5, primarily in connection with certain insurance programs which are renewed annually.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual value of the noncontrolling interest put in the Company's Ontario subsidiary totaled $15.0 and $16.3 at December&#160;31, 2022, and 2021, respectively, and has been classified as mezzanine equity in the Company's consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current and projected levels of cash flows from operations, coupled with availability under its revolving credit facility, the Company believes it has sufficient liquidity to meet both its anticipated short-term and long-term cash needs for the next 12 months and the reasonably foreseeable future; however, the Company continually reassesses its liquidity position in light of market conditions and other relevant factors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. While the Company believes these estimates are reasonable and consistent, they are by their very nature estimates of amounts that will depend on future events. Accordingly, actual results could differ from these estimates. The Company&#8217;s Audit Committee periodically reviews the Company&#8217;s significant accounting policies. The Company&#8217;s critical accounting policies arise in conjunction with the following:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue recognition; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Business combinations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income taxes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill and indefinite-lived assets; and</span></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal contingencies.</span></div><div style="margin-bottom:3.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dx</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Dx segment, a revenue transaction is initiated when Dx receives a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. Dx recognizes revenue and satisfies its performance obligation for services rendered when the testing process is complete and the associated results are reported. Revenues are distributed among four payer portfolios - clients, patients, Medicare and Medicaid and third party. Dx considers negotiated discounts and anticipated adjustments, including historical collection experience for the payer portfolio, when revenues are recorded. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of the Dx payer portfolios:</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clients</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Client payers represent the portion of Dx&#8217;s revenue related to physicians, hospitals, health systems, accountable care organizations (ACOs), employers and other entities where payment is received exclusively from the entity ordering the testing service. Generally, client revenues are recorded on a fee-for-service basis at Dx&#8217;s client list price, less any negotiated discount. A portion of client billing is for laboratory management services, collection kits and other non-testing services or products. In these cases, revenue is recognized when services are rendered or delivered. </span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio includes revenue from uninsured patients and member cost-share for insured patients (e.g., coinsurance, deductibles and non-covered services). Uninsured patients are billed based upon Dx&#8217;s patient fee schedules, net of any discounts negotiated with physicians on behalf of their patients. Dx bills insured patients as directed by their health plan and after consideration of the fees and terms associated with an established health plan contract.  </span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare and Medicaid</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio relates to fee-for-service revenue from traditional Medicare and Medicaid programs. Net revenue from these programs is based on the fee schedule established by the related government authority. In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining net revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#8217;s results of operations in any period presented</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Party</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third party includes revenue related to MCOs. The majority of Dx's third-party revenue is reimbursed on a fee-for-service basis. These payers are billed at Dx's established list price and revenue is recorded net of contractual discounts. The majority of Dx&#8217;s MCO revenues are recorded based upon contractually negotiated fee schedules with revenues for non-contracted MCOs recorded based on historical reimbursement experience. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party reimbursement is also received through capitation agreements with MCOs and independent physician associations (IPAs). Under capitated agreements, revenue is recognized based on a negotiated per-member, per-month payment for an agreed upon menu of tests, or based upon the proportionate share earned by Dx from a capitation pool. When the agreed upon reimbursement is based solely on an established rate per member, revenue is not impacted by the volume of testing performed. Under a capitation pool arrangement, the aggregate value of an established rate per member is distributed based on </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the volume and complexity of the procedures performed by laboratories participating in the agreement. Dx recognizes revenue monthly, based upon the established capitation rate or anticipated distribution from a capitated pool.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx has a formal process to estimate implicit price concessions for uncollectable accounts. The majority of Dx's collection risk is related to accounts receivable from both insured and uninsured patients who are unwilling or unable to pay. Anticipated write-offs are recorded as adjustments to revenue at an amount considered necessary to record the segment's revenue at its net realizable value. In addition to contractual discounts, other adjustments including anticipated payer denials and other external factors that could affect the collectability of its receivables are considered when determining revenue and the net receivable amount. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx's results of operations in any period presented.</span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DD</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of DD&#8217;s revenues are earned under contracts that are long term in nature, ranging in duration from a few months to many years. The majority of DD's contracts contain a single performance obligation, as DD provides a significant service of integrating all promises in the contract and the promises are highly interdependent and interrelated with one another. For contracts that include multiple performance obligations, DD allocates the contract value to the goods and services based on a customer price list, if available. If a price list is not available, DD will estimate the transaction price using either market prices or an &#8220;expected cost plus margin&#8221; approach. The total contract value is estimated at the beginning of the contract, and is equal to the amount expected to be billed to the customer. Other payments and billing adjustments may also factor into the calculation of total contract value, such as the reimbursement of out-of-pocket costs and volume-based rebates. These contracts generally take the form of fixed-price or fee-for-service arrangements subject to pricing adjustments based on changes in scope.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed-price contracts are typically recognized as revenue over time based on a proportional-performance basis, using either input or output methods that are specific to the service provided. In an output method, revenue is determined by dividing the actual units of output achieved by the total units of output required under the contract and multiplying that percentage by the total contract value. When using an input method, revenue is recognized by dividing the actual costs incurred by the total estimated cost expected to complete the contract, and multiplying that percentage by the total contract value. Contract costs principally include direct labor and reimbursable out-of-pocket costs. The estimate of total costs expected to complete the contract requires significant judgment and estimates are based on various assumptions of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</span></div><div style="margin-bottom:7pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fee-for-service contracts are typically priced based on transaction volume or time and materials. For volume based contracts the contract value is entirely variable and revenue is recognized as the specific product or service is completed. For services billed based on time and materials, revenue is recognized using the right to invoice practical expedient.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts are often modified to account for changes in contract specifications and requirements. Generally, when contract modifications create new performance obligations, the modification is considered to be a separate contract and revenue is recognized prospectively. When contract modifications change existing performance obligations, the impact on the existing transaction price and measure of progress for the performance obligation to which it relates is generally recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most contracts are terminable with or without cause by the customer, either immediately or upon notice. These contracts often require payment to DD of expenses to wind-down the study or project, fees earned to date and, in some cases, a termination fee or a payment to DD of some portion of the fees or profits that could have been earned by DD under the contract if it had not been terminated early. Termination fees are included in revenues when services are performed and realization is assured.</span></div><div style="margin-bottom:3.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combination transactions under the acquisition method of accounting and reported the results of operations of the acquired entities from its respective date of acquisition. Assets acquired were recorded at their estimated fair values as of the acquisition date. Estimated fair values were based on various valuation methodologies, including an income approach using primarily discounted cash flow techniques for the customer relationships intangible assets. The aforementioned income methods utilize management's estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. The excess of the fair value of the consideration conveyed over the fair value of the assets acquired was recorded as goodwill. The goodwill reflects management's expectations of the ability to gain access to and penetrate the acquired entities' historical patient base and the benefits of being able to leverage operational efficiencies with favorable growth opportunities based on positive demographic trends in the market.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:3.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes utilizing the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit, unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position. If the recognition threshold is met, the Company recognizes a tax benefit measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized.&#160;The Company records interest and penalties in income tax expense.</span></div><div style="margin-bottom:3.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite-Lived Assets</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#8217;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income-based fair value methodology requires management's assumptions and judgments regarding economic conditions in the markets in which the Company operates and conditions in the capital markets, many of which are outside of management's control. At the reporting unit level, fair value estimation requires management's assumptions and judgments regarding the effects of overall economic conditions on the specific reporting unit, along with assessment of the reporting unit's strategies and forecasts of future cash flows. Forecasts of individual reporting unit cash flows involve management's estimates and assumptions regarding:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Annual cash flows, on a debt-free basis, arising from future revenues and profitability, changes in working capital, capital spending and income taxes for at least a five-year forecast period.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A terminal growth rate for years beyond the forecast period. The terminal growth rate is selected based on consideration of growth rates used in the forecast period, historical performance of the reporting unit and economic conditions.</span></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A discount rate that reflects the risks inherent in realizing the forecasted cash flows. A discount rate considers the risk-free rate of return on long-term treasury securities, the risk premium associated with investing in equity securities of comparable companies, the beta obtained from the comparable companies and the cost of debt for investment grade issuers. In addition, the discount rate may consider any company-specific risk in achieving the prospective financial information.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the market-based fair value methodology, judgment is required in evaluating market multiples and recent transactions. Management believes that the assumptions used for its impairment tests are representative of those that would be used by market participants performing similar valuations of the reporting units.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units and a quantitative assessment for all of the DD reporting units and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.</span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, a significant supplier of our early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated its impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2022 or future years vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA. </span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. These matters include, but are not limited to, intellectual property disputes, commercial and contract disputes, professional liability claims, employee-related matters, transaction related disputes, securities and corporate law matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss is reasonably possible but not known or probable, and may be reasonably estimated, the estimated loss or range of loss is disclosed. For more information about legal contingencies, see Note 14 Commitments and Contingencies to the Consolidated Financial Statements.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_109"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK (in millions)</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as foreign currency exchange rates, interest rates and other relevant market rate or price changes. In the ordinary course of business, the Company is exposed to various market risks, including changes in foreign currency exchange and interest rates, and the Company regularly evaluates the exposure to such changes. The Company addresses its exposure to market risks, principally the market risks associated with changes in foreign currency exchange rates and interest rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments such as foreign currency forward contracts, cross currency swaps and interest rate swap agreements. The Company does not hold or issue derivative financial instruments for trading purposes. </span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rates</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 14.7% and 15.3% of the Company's revenues for the year ended December&#160;31, 2022 and 2021, respectively,  were denominated in currencies other than the U.S. dollar (USD). The Company's financial statements are reported in USD and, accordingly, fluctuations in exchange rates will affect the translation of revenues and expenses denominated in foreign currencies into USD for purposes of reporting the Company's consolidated financial results. In both 2022 and 2021, the most significant currency exchange rate exposures were to the Canadian dollar, Swiss franc, euro and British pound. Excluding the impacts from any outstanding or future hedging transactions, a hypothetical change of 10% in average exchange rates used to translate all foreign currencies to USD would have impacted income before income taxes for 2022 by approximately $26.9. Gross accumulated currency translation adjustments recorded as a separate component of shareholders&#8217; equity were $(336.4) and $(104.6) at December&#160;31, 2022, and 2021, respectively. The Company does not have significant operations in countries in which the economy is considered to be highly inflationary.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company earns revenue from service contracts over a period of several months and, in some cases, over a period of several years. Accordingly, exchange rate fluctuations during this period may affect the Company's profitability with respect to such contracts. The Company is also subject to foreign currency transaction risk for fluctuations in exchange rates during the period of time between the consummation and cash settlement of transactions. The Company limits its foreign currency transaction risk through exchange rate fluctuation provisions stated in some of its contracts with customers, or it may hedge transaction risk with foreign currency forward contracts. At December&#160;31, 2022, the Company had 27 open foreign exchange forward contracts with various amounts maturing monthly through January 2023 with a notional value totaling approximately $629.5. At December&#160;31, 2021, the Company had 28 open foreign exchange forward contracts with various amounts maturing monthly through January 2022 with a notional value totaling approximately $600.7.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to USD to Swiss Franc cross-currency swap agreements with a notional amount of $600.0, maturing in 2024 and 2025, as a hedge against the impact of foreign exchange movements on its net investment in its Swiss Franc functional currency subsidiary.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rates</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's debt is subject to interest at variable rates. As a result, fluctuations in interest rates affect the Company's financial results. The Company attempts to manage interest rate risk and overall borrowing costs through an appropriate mix of fixed and variable rate debt including the utilization of derivative financial instruments, primarily interest rate swaps.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Company's term loan credit facilities and revolving credit facility are subject to variable interest rates, unless fixed through interest rate swaps or other agreements.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May, 2021, to hedge against changes in the fair value portion of the Company's long-term debt, the Company entered into fixed-to-variable interest rate swap agreements for the 2.70% senior notes due 2031 with an aggregate notional value of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%.   </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_112"></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of the Company required in this item are set forth beginning on page F-1 of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_118"></div><div style="margin-bottom:7pt;margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this Annual Report, the Company carried out under the supervision and with the participation of the Company&#8217;s management, including the Company&#8217;s principal executive officer and principal financial officer, an evaluation of the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended).&#160;Based upon this evaluation, the Company&#8217;s principal executive officer and principal financial officer concluded that the Company&#8217;s disclosure controls and procedures were effective as of the end of the period covered by this Annual Report.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in the Company&#8217;s internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the quarter ended&#160;December&#160;31, 2022,&#160;that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Management on Internal Control over Financial Reporting</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934).</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The internal control over financial reporting at the Company was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the U.S. Internal control over financial reporting includes those policies and procedures that:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the U.S.;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022. Management based this assessment on criteria for effective internal control over financial reporting described in &#8220;Internal Control - Integrated Framework 2013&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, the Company's management determined that, as of December&#160;31, 2022, the Company maintained effective internal control over financial reporting. Management reviewed the results of its assessment with the Audit Committee of the Company&#8217;s Board.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deloitte and Touche LLP, an independent registered public accounting firm, who audited and reported on the consolidated financial statements of the Company included in this Annual Report, also audited the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022, as stated in its report, which is included herein immediately preceding the Company&#8217;s audited financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_121"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_124"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.&#160;&#160;&#160;&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_127"></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_130"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.&#160;&#160;&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by the item regarding directors is incorporated by reference to the Company&#8217;s Definitive Proxy Statement to be filed with the Securities and Exchange Commission in connection with the Annual Meeting of Stockholders to be held in 2023 (the 2023 Proxy Statement) under the caption Election of Directors. Information regarding executive officers is incorporated by reference to the Company&#8217;s 2023 Proxy Statement under the caption Executive Officers. Information concerning the Company&#8217;s Audit Committee, including the designation of audit committee financial experts is incorporated by reference to the Company&#8217;s 2023 Proxy Statement under the captions Corporate Governance and Delinquent Section 16(a) Reports, respectively. Information concerning the Company's code of ethics is incorporated by reference to the Company's 2023 Proxy Statement under the caption Corporate Governance Policies and Procedures.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_133"></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.&#160;&#160;&#160;&#160;EXECUTIVE COMPENSATION</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to information in the 2023 Proxy Statement under the captions &#8220;Executive Compensation&#8221; and &#8220;Director Compensation.&#8221;</span></div><div style="text-align:justify;text-indent:15.75pt"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_136"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.&#160;&#160;&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 Stock Compensation Plans to the Consolidated Financial Statements for a discussion of the Company&#8217;s Stock Compensation Plans. Except for the above referenced footnote, the information called for by this item is incorporated by reference to information in the 2023 Proxy Statement under the captions &#8220;Security Ownership of Certain Beneficial Holders and Management,&#8221;&#160;&#8220;Compensation Discussion &amp; Analysis&#8221; and &#8220;Executive Compensation.&#8221;</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_139"></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to information in the 2023 Proxy Statement under the captions &#8220;Board Independence&#8221; and &#8220;Related Party Transactions.&#8221;</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_142"></div><div style="margin-top:7pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to information in the 2023 Proxy Statement under the caption &#8220;Fees to Independent Registered Public Accounting Firm.&#8221;</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_148"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)   List of documents filed as part of this Annual Report:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.719%"><tr><td style="width:1.0%"></td><td style="width:4.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm included herein:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">See Index on page F-1</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statement Schedules:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All schedules are omitted as they are inapplicable or the required information is furnished in the Consolidated Financial Statements or notes thereto.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to and List of Exhibits</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000095010301501450/oct1901_x0301.txt">Amended and Restated Certificate of Incorporation of the Company dated May 24, 2001 (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Registration Statement on Form S-3, filed with the Commission on October 19, 2001, File No. 333-71896).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014820000043/amendedandrestatedbyla.htm">Amended and Restated By-Laws of the Company, adopted and effective July 7, 2020 (incorporated by reference herein to Exhibit 3.1 to the Company&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014802000015/stockcert.txt">Specimen of the Company&#8217;s Common Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2001).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014810000110/ex_4-1.htm">Indenture, dated as of November 19, 2010, between the Company and U.S. Bank National Association, as trustee (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on November 19, 2010).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312513422088/d619416dex43.htm">Sixth Supplemental Indenture, dated as of November 1, 2013, between the Company and U.S. Bank National Association, as trustee, including the form of the 2023 Notes (incorporated herein by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on November 1, 2013).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312515026832/d860928dex44.htm">Ninth Supplemental Indenture, dated as of January 30, 2015, between the Company and U.S. Bank National Association, as trustee, including the form of the 2025 Notes (incorporated herein by reference to Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on January 30, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312515026832/d860928dex45.htm">Tenth Supplemental Indenture, dated as of January 30, 2015, between the Company and U.S. Bank National Association, as trustee, including the form of the 2045 Notes (incorporated herein by reference to Exhibit 4.5 to the Company&#8217;s Current Report on Form 8-K filed on January 30, 2015).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312517264395/d427802dex42.htm">Eleventh Supplemental Indenture, dated as of August 22, 2017, between the Company and U.S. Bank National Association, as trustee, including the form of the 2024 Notes (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on August 22, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312517264395/d427802dex43.htm">Twelfth Supplemental Indenture, dated as of August 22, 2017, between the Company and U.S. Bank National Association, as trustee, including the form of the 2027 Notes (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on August 22, 2017).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312519300013/d839349dex42.htm">Thirteenth Supplemental Indenture, dated as of November 25, 2019, between the Company and U.S. Bank National Association, as trustee, including the form of the 2024 Notes (incorporated herein by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on November 25, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312519300013/d839349dex43.htm">Fourteenth Supplemental Indenture, dated as of November 25, 2019, between the Company and U.S. Bank National Association, as trustee, including the form of the 2029 Notes (incorporated herein by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on November 25, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000920148/000119312521173705/d149828dex42.htm">Fifteenth Supplemental Indenture, dated as of May 26, 2021, between the Company and U.S. Bank National Association, as trustee, including the form of the 2026 Notes</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312519300013/d839349dex42.htm"> (incorporated herein by reference to Exhibit 4.2 to the Company's Current Report on Form 8-K filed on May 26, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000920148/000119312521173705/d149828dex43.htm">Sixteenth Supplemental Indenture, dated as of May 26, 2021, between the Company and U.S. Bank National Association, as trustee, including the form of the 2031 Notes</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312519300013/d839349dex42.htm"> (incorporated herein by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K filed on May 26, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014821000018/exhibit416descriptionofreg.htm">Description of the Registrant's securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to Exhibit 4.18 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">National Health Laboratories Incorporated Pension Equalization Plan (incorporated herein by reference to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 1992).</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014804000191/ex10-1_pepplan.htm">Laboratory Corporation of America Holdings Amended and Restated New Pension Equalization Plan (incorporated herein by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2004).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014804000191/ex10-2_pepamend.htm">First Amendment to the Laboratory Corporation of America Holdings Amended and Restated New Pension Equalization Plan (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 2004).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014805000049/pepamend2_10-4.htm">Second Amendment to the Laboratory Corporation of America Holdings Amended and Restated New Pension Equalization Plan (incorporated herein by reference to Exhibit 10.4 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014805000161/exhibit10-6.htm">Third Amendment to the Laboratory Corporation of America Amended and Restated New Pension Equalization Plan (incorporated herein by reference Exhibit 10.6 to the Company&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2005).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014805000049/defcomp_ex10-22.htm">Laboratory Corporation of America Holdings Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.22 the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014805000049/defcompamend_ex10-23.htm">First Amendment to the Laboratory Corporation of America Holdings Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.23 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2004).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014805000161/ex10-8_defcomp.htm">Second Amendment to the Laboratory Corporation of America Holdings Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.8 to the Company&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2005).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000116923207001103/ex10-28_defcomp.htm">Third Amendment to the Laboratory Corporation of America Holdings Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.28 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2006).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000092014808000071/ex10-34_defcomp.htm">Fourth Amendment to the Laboratory Corporation of America Holdings Deferred Compensation Plan (incorporated herein by reference to Exhibit 10.34 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2007).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014821000041/labcorp-thirdarcreditagree.htm">Third Amended and Restated Credit Agreement, dated as of April 30, 2021, among the Company, Bank of America N.A., as administrative agent, and the lenders party thereto (incorporated herein by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on May 4, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">*</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1012thirdarcreditag.htm">Amendment No. 1, dated as of January 13, 2023, to the Third Amended and Restated Credit Agreement (originally dated as of April 30, 2021), among the Company, Bank of America, N.A., as administrative agent, and lenders party thereto. </a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312516591935/d169343dex101.htm">Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (incorporated by reference herein to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 16, 2016).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312516591935/d169343dex102.htm">Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan (incorporated by reference herein to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on May 16, 2016).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000119312519164256/d755218dex101.htm">Term Loan Credit Agreement, dated June 3, 2019, by and among Laboratory Corporation of America Holdings, Bank of America, N.A., as administrative agent, and the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 3, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014820000029/exhibit101amendment.htm">Amendment No. 1, dated as of May 7, 2020, to the Term Loan Credit Agreement, dated June 3, 2019, among the Company, Bank of America, N.A. as administrative agent, and the lenders party thereto. (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 8, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/920148/000119312519165518/d758193dex101.htm">Executive Employment Agreement, dated June 4, 2019, by and between Laboratory Corporation of America Holdings and Adam H. Schechter (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on June 5, 2019).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="exhibit1018thomaspikeemplo.htm">Executive Employment Agreement, dated January 4, 2023, by and between Laboratory Corporation of America and Thomas Pike.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000092014821000018/exhibit1021amendedandresta.htm">Amended and Restated Master Senior Executive Severance Plan (incorporated by reference to 10.22 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/920148/000119312520287013/d141788dex161.htm">Letter of PricewaterhouseCoopers LLP, dated November 5, 2020 (incorporated by reference to Exhibit 16.1 to the Company&#8217;s Current Report on Form 8-K filed on November 5, 2020).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0000920148/000092014821000021/lh-20201102.htm">Letter of PricewaterhouseCoopers LLP, dated March 3, 2021 (incorporated by reference to Exhibit 16.1 to the Company's Current Report on Form 8-K/A filed on March 3, 2021).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit212022.htm">List of Subsidiaries of the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2312022.htm">Consent of Deloitte &amp; Touche LLP, an independent registered public accounting firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2322022.htm">Consent of PricewaterhouseCoopers LLP, an independent register public accounting firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2412022.htm">Power of Attorney of Kerrii B. Anderson</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2422022.htm">Power of Attorney of Jean-Luc B&#233;lingard</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2432022.htm">Power of Attorney of Jeffrey A. Davis</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2442022.htm">Power of Attorney of D. Gary Gilliland, M.D., Ph.D.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2452022.htm">Power of Attorney of Kirsten M. Kliphouse</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2462022.htm">Power of Attorney of Garheng Kong, M.D., Ph.D.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2472022.htm">Power of Attorney of Peter M. Neupert</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8* </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2482022.htm">Power of Attorney of Richelle P. Parham</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit2492022.htm">Power of Attorney of Kathryn E. Wengel</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.10*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit24102022.htm">Power of Attorney of R. Sanders Williams, M.D.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lh10-kex3112022.htm">Certification by the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lh10-kex3122022.htm">Certification by the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lh10-kex322022.htm">Written Statement of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed or furnished herewith, as required</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contracts or compensatory plans or arrangements</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;FORM 10-K SUMMARY</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_154"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LABORATORY CORPORATION OF AMERICA HOLDINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ADAM H. SCHECHTER</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the registrant on&#160;February&#160;28, 2023 in the capacities indicated.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ADAM H. SCHECHTER</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GLENN A. EISENBERG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PETER J. WILKINSON</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Accounting Officer </span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Wilkinson</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kerrii B. Anderson</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Luc B&#233;lingard</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Davis</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D. Gary Gilliland, M.D., Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kirsten M. Kliphouse</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garheng Kong, M.D., Ph.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Neupert</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richelle Parham</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kathryn E. Wengel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Sanders Williams, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;Sandra van der Vaart, by her signing her name hereto, does hereby sign this Annual Report on behalf of the directors of the Registrant after whose typed names asterisks appear, pursuant to powers of attorney duly executed by such directors and filed with the Securities and Exchange Commission.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.967%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.968%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sandra van der Vaart</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra van der Vaart</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attorney-in-fact</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.356%"><tr><td style="width:1.0%"></td><td style="width:59.211%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.364%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_160">Report of Independent Registered Public Accounting Firm Deloitte &amp; Touche LLP</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCAOB ID No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNTcvZnJhZzozYmFjMzE5YWY0YjM0NGNhOWVlYTBmMTE0NTllZTY2Ny90YWJsZTozNzMyOTNjNWU0MTE0ZTIxOTA4NDYyZGU4N2FlZDIzYS90YWJsZXJhbmdlOjM3MzI5M2M1ZTQxMTRlMjE5MDg0NjJkZTg3YWVkMjNhXzItMi0xLTEtMTE3MDI5_ba3eee71-7ff8-44b0-b6c9-1e1e30d21864">34</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_160">2</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_163">Report of Independent Registered Public Accounting Firm PricewaterhouseCoopers LLP</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCAOB ID No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNTcvZnJhZzozYmFjMzE5YWY0YjM0NGNhOWVlYTBmMTE0NTllZTY2Ny90YWJsZTozNzMyOTNjNWU0MTE0ZTIxOTA4NDYyZGU4N2FlZDIzYS90YWJsZXJhbmdlOjM3MzI5M2M1ZTQxMTRlMjE5MDg0NjJkZTg3YWVkMjNhXzQtMi0xLTEtMTE3MDI5_b56b8030-2fef-4e51-845e-badd83ec692b">238</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_166">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_166">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_172">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_172">8</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_175">Consolidated Statements of Comprehensive Earnings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_175">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_178">Consolidated Statements of Changes in Shareholders' Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_178">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_181">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_181">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_184">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_184">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the shareholders and Board of Directors of Laboratory Corporation of America Holdings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheet of Laboratory Corporation of America Holdings and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive earnings, changes in shareholders&#8217; equity, and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 28, 2023, expressed an unqualified opinion on the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition for Full-Service Clinical Trial Contracts&#8212; Refer to Note 2 to the financial statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Drug Development (DD) segment, the Company provides Phase I through Phase IV clinical development services to pharmaceutical, biotechnology, and medical device companies worldwide. A majority of the Company&#8217;s revenues are earned under contracts that are long term in nature, ranging in duration from a few months to many years. The majority of the Company's contracts contain a single performance obligation, as the Company provides a significant service of integrating all promises in the contract and the promises are highly interdependent and interrelated with one another. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed-price contracts are typically recognized as revenue over time based on a proportional-performance basis, using either input or output methods that are specific to the service provided. When using an input method, revenue is recognized by dividing the actual costs incurred by the total estimated contract costs expected to complete the contract and multiplying that percentage by the total contract value. Contract costs principally include direct labor and reimbursable out-of-pocket costs. The estimate of total costs expected to complete the contract requires significant judgment and estimates are based on various </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assumptions of events that often span several years. These estimates are reviewed periodically, and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the judgments necessary to recognize revenue for fixed-price contracts that use an input method based on estimated total costs, auditing such estimates required extensive audit effort due to the complexity of these contracts and a high degree of auditor judgment when performing audit procedures and evaluating the results of those procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to management&#8217;s estimates of costs for purposes of revenue recognition for full-service contracts which use an input method based on estimated total contract costs and included the following, among others:</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over fixed-price contract revenue, including those over the estimates of total contract costs related to the performance obligation. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We selected a sample of long-term contracts and performed the following:</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Evaluated whether the contracts were properly accounted for by management based on the terms and conditions of each contract, including whether over time revenue recognition was appropriate. </span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Compared the transaction prices to the consideration expected to be received based on current rights and obligations under the contracts and any contract modifications that were agreed upon with the customers.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Evaluated management&#8217;s identification of distinct performance obligations by assessing whether the underlying services were highly interdependent or highly interrelated.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Tested the accuracy and completeness of the total contract costs incurred to date for the performance obligation.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Evaluated the estimates of total contract cost for the performance obligation by: </span></div><div style="margin-top:3pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Comparing costs incurred to date to the costs management estimated to be incurred to date.</span></div><div style="margin-top:3pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Assessing management&#8217;s ability to achieve the estimates of total contract cost by performing corroborating inquiries with the Company&#8217;s project managers and project financial analysts and comparing the estimates to management&#8217;s work plans and cost estimates.</span></div><div style="margin-top:3pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Comparing management&#8217;s estimates for the selected contracts to historical experience and original budgets, when applicable. </span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Tested the mathematical accuracy of management&#8217;s calculation of revenue for the performance obligation. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s ability to accurately estimate total contract costs and revenue by comparing actual costs to management&#8217;s historical estimates for performance obligations that have been fulfilled.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Labcorp Diagnostics Segment (Dx) Net Accounts Receivable&#8212; Refer to Note 2  to the financial statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes Dx revenue and accounts receivable net of negotiated discounts and anticipated adjustments, including historical collection experience for each of its four payer portfolios (clients, patients, Medicare &amp; Medicaid, and third party). Management has a formal process to estimate implicit price concessions for uncollectable accounts.  Anticipated write-offs are recorded as adjustments to revenue at an amount considered necessary to record revenue at its net realizable value. In addition to negotiated contractual discounts, other adjustments including anticipated payer denials and other external factors that could affect the collectability of its receivables are considered when determining revenue and the net receivable amount.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the significant judgment and estimates necessary to determine the net realizable value of accounts receivable related to the Dx segment, auditing such estimates required extensive audit effort and a high degree of auditor judgment when performing audit procedures and evaluating the results of those procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to Dx Net Accounts Receivable included the following, among others: </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over the valuation of net accounts receivable.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated management&#8217;s methodology for recording Dx net accounts receivable by performing a retrospective comparison of actual cash collected to the prior year estimate of net accounts receivable.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We developed an independent estimate of net accounts receivable by taking into consideration historical collections, write-offs, and other relevant internal and external factors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the completeness and accuracy of underlying historical data used as an input to management&#8217;s methodology and our independent estimate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill- Reporting Unit within the DD Segment &#8211; Refer to Notes 1 and 7 to the consolidated financial statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The Company recognizes an impairment charge for the amount by which a reporting unit's carrying amount exceeds its fair value. Fair value of a reporting unit is estimated using both market-based valuation and income-based valuation approaches. Management&#8217;s impairment assessments utilize significant judgments and assumptions related to the market multiples selected for the market-based valuation approach and the related estimates of cash flows arising from future revenues and profitability, terminal growth rates, and the discount rate used in the income-based valuation approach.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed an interim impairment assessment as of December 31, 2022, based on the loss in December 2022 of a supplier of critical testing supplies for the early development reporting unit in the Company&#8217;s DD segment. Based on the results of the interim impairment assessment, the Company concluded that fair value was less than carrying value for this reporting unit and recorded a goodwill impairment charge of $260 million for the DD segment.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified goodwill for the early development reporting unit as a critical audit matter due to the significant estimates and assumptions by management to estimate the fair value of the reporting unit. Performing audit procedures to evaluate management's estimate of fair value of the reporting unit required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the market multiples selected by management for the market-based valuation approach and management&#8217;s estimates related to the cash flows arising from future revenues and profitability, terminal growth rates, and the discount rate used in the income-based valuation approach included the following, among others:</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over management's goodwill impairment evaluation, including those over the determination of the fair value of the reporting unit, such as controls related to management's selection of market multiples, cash flows arising from future revenues and profitability, the terminal growth rate, and the discount rate.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We evaluated the reasonableness of management&#8217;s forecasts by comparing the forecasts to (1) historical forecasts and the associated actual results, (2) internal communications to management, and (3) forecasted information included in analyst and industry reports for the Company and certain of its peer companies.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the (1) valuation methodology, (2) the discount rate, and (3) market activity by:</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Testing the source information underlying the determination of the discount rate and market multiples, including the mathematical accuracy of the calculations.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Developing a range of independent estimates and comparing those to the discount rate and market multiples selected by management.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzkyNjQ_e0d24a53-7ee3-4fd5-938b-85693f39e709">Deloitte &amp; Touche LLP</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzkyNjg_8d7b3a51-b7ed-4111-8d0c-c47d48da78bb">Raleigh, North Carolina</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023</span></div><div><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2021.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">To the shareholders and the Board of Directors of Laboratory Corporation of America Holdings</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of Laboratory Corporation of America Holdings and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by COSO. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2022, of the Company and our report dated February 28, 2023, expressed an unqualified opinion on those financial statements. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzEwOTk1MTE2NTY2NTg_e0d24a53-7ee3-4fd5-938b-85693f39e709">Deloitte &amp; Touche LLP</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Raleigh, North Carolina</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">February&#160;28, 2023</span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Shareholders of Laboratory Corporation of America Holdings</span></div><div style="margin-bottom:7pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the consolidated statements of operations, comprehensive earnings, changes in shareholders' equity and cash flows of Laboratory Corporation of America Holdings and its subsidiaries (the &#8220;Company&#8221;) for the year ended December 31, 2020, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the results of operations and cash flows of the Company for the year ended December 31, 2020 in conformity with accounting principles generally accepted in the United States of America.</span></div><div><span><br/></span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ PricewaterhouseCoopers LLP </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raleigh, North Carolina</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">February&#160;25, 2021, </span><span style="color:#000000;font-family:'Georgia',serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">except for the effects of the revision discussed in Note 1 (not presented herein) to the consolidated financial statements appearing under Item 8 of the Company&#8217;s 2021 annual report on Form 10-K, as to which the date is February 25, 2022, and except for the effects of the change in the segment performance measure discussed in Note 19, as to which the date is February 28, 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We served as the Company's auditor from 1997 to 2021.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 1.&#160;&#160;Financial Information</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Millions)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMtMS0xLTEtMTE3MDI5_d3a0058d-93d3-4a3d-a26b-16d898c1ab91">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMtMy0xLTEtMTE3MDI5_f26128bf-d652-4425-80bb-aa947f3b2e70">1,472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQtMS0xLTEtMTE3MDI5_39848748-d178-4782-9c9a-2d4f746edb2b">2,222.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQtMy0xLTEtMTE3MDI5_5fb65c46-0213-49dc-b39c-42f8acdbe7c5">2,261.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzUtMS0xLTEtMTE3MDI5_1d689de6-82b6-43f2-8c5a-9cc633d520c0">795.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzUtMy0xLTEtMTE3MDI5_909112b3-c216-4619-89d3-524f951b214a">716.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzYtMS0xLTEtMTE3MDI5_9ec6a82b-7203-4299-a455-5a550ba47ffe">470.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzYtMy0xLTEtMTE3MDI5_23c225fb-4c01-4791-b41d-b3124ec86283">401.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzctMS0xLTEtMTE3MDI5_ec4bc904-2f1e-4e0e-b10a-7875917312f9">707.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzctMy0xLTEtMTE3MDI5_e11567fb-7c37-4627-82f8-d7bd0f85b31b">478.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzktMS0xLTEtMTE3MDI5_138b546e-d3e3-4822-89de-082efc5b8650">4,625.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzktMy0xLTEtMTE3MDI5_cfc76232-45f2-42c8-81ff-ea46cddb96cb">5,330.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEwLTEtMS0xLTExNzAyOQ_bea5130b-fcfa-4ea7-91bf-2e52c8753550">2,956.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEwLTMtMS0xLTExNzAyOQ_d185207e-e465-41ea-aa73-033a77a39f13">2,815.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzExLTEtMS0xLTExNzAyOQ_280832d2-73c6-4c45-b8d8-922f1c9d3afa">8,121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzExLTMtMS0xLTExNzAyOQ_fc1f8afb-ab16-49ba-8d23-8c3763334bf7">7,958.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEyLTEtMS0xLTExNzAyOQ_84feb2ae-3606-416d-a049-1e727dac0404">3,946.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEyLTMtMS0xLTExNzAyOQ_0abc04ee-2ea3-4fde-8727-d3b2fe3f6977">3,735.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joint venture partnerships and equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEzLTEtMS0xLTExNzAyOQ_55c7f46a-5de0-4bea-806b-259cbe1855b7">65.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEzLTMtMS0xLTExNzAyOQ_7277a8ed-9bdd-43da-8f66-a45fbc98941b">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE0LTEtMS0xLTExNzAyOQ_376c9b6b-0733-4ad1-b672-e7c5833b810f">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE0LTMtMS0xLTExNzAyOQ_273622b8-21bf-49e1-a123-9aa7b1feaa99">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE1LTEtMS0xLTExNzAyOQ_1d40f257-1001-4748-9eab-b1bf16104f85">432.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE1LTMtMS0xLTExNzAyOQ_aa04c84a-231d-482b-9e04-12b46df92081">462.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE3LTEtMS0xLTExNzAyOQ_0021c342-72c8-4582-9272-4972fef81d21">20,155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE3LTMtMS0xLTExNzAyOQ_a48ad7af-66df-48db-ad40-6be85cfdc32b">20,385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIwLTEtMS0xLTExNzAyOQ_1d35ab0f-2d1b-4475-973d-14f9bbafca5a">934.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIwLTMtMS0xLTExNzAyOQ_8e29c96a-0f50-452c-9a4a-ecec13fd5a38">621.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIxLTEtMS0xLTExNzAyOQ_1c9529d2-81b4-4a56-aeee-d9af7305e5c6">1,068.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIxLTMtMS0xLTExNzAyOQ_63a8274b-2a3d-4445-8f52-3b7b6c233d46">1,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIyLTEtMS0xLTExNzAyOQ_103c76d1-cb53-45b2-bd5a-63142fd11ccc">582.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIyLTMtMS0xLTExNzAyOQ_cc080f9e-2a0c-42df-86d9-fb17d86449a9">558.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIzLTEtMS0xLTExNzAyOQ_64bf13b7-299d-4fbf-9082-c11925180667">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIzLTMtMS0xLTExNzAyOQ_14197753-fb95-4f4a-9186-a1c1634ced1d">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI0LTEtMS0xLTExNzAyOQ_102be517-3a54-40db-b1fa-2a51a56ae1c1">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI0LTMtMS0xLTExNzAyOQ_a5123ddb-dc78-433a-a6e7-835dc14ed789">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:ShortTermDebtAndLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI2LTEtMS0xLTExNzAyOQ_1da9799f-5fb1-40a6-a114-bed8986111c1">301.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:ShortTermDebtAndLongTermDebtCurrentMaturities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI2LTMtMS0xLTExNzAyOQ_6431adb3-8991-40b4-9dfb-4f23dcc7c499">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI4LTEtMS0xLTExNzAyOQ_66fdf978-323b-4dc4-b86e-581427602d4c">3,078.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI4LTMtMS0xLTExNzAyOQ_18e2c13d-6226-43e0-92c5-226df42cb188">2,782.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI5LTEtMS0xLTExNzAyOQ_8b813eff-b9a2-4fbd-b0be-cdf0fa25f6ad">5,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI5LTMtMS0xLTExNzAyOQ_9847adc3-b295-4ec6-bddf-506f9317e003">5,416.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMwLTEtMS0xLTExNzAyOQ_2a33db96-17e5-404d-8408-5247ef0d9532">679.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMwLTMtMS0xLTExNzAyOQ_d24e74c4-edd5-41ca-a993-5f37b5ef94ac">642.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMxLTEtMS0xLTExNzAyOQ_fbc6605d-5777-485b-b063-6328b7065382">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMxLTMtMS0xLTExNzAyOQ_dd08b24a-8a21-49f3-9cf6-c7f803204745">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMyLTEtMS0xLTExNzAyOQ_4c3fd5f9-ff19-4696-b159-c36ff6167c82">736.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:DeferredIncomeTaxesAndOtherTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMyLTMtMS0xLTExNzAyOQ_244abb11-9ae0-44ce-8c2a-9e1e2edcdfda">762.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMzLTEtMS0xLTExNzAyOQ_a7f59e79-f43a-47d0-8808-674d4492689a">422.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMzLTMtMS0xLTExNzAyOQ_52403ebb-7597-4e36-a27b-d121aa2d75fa">402.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM1LTEtMS0xLTExNzAyOQ_5edff649-9726-426c-98ba-44740ae22503">10,039.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM1LTMtMS0xLTExNzAyOQ_4051a9f1-b821-417c-83f0-7deaeea4beba">10,091.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingent liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM2LTEtMS0xLTExNzAyOQ_c0e29716-bdc8-44f8-929f-8fc8667c2e7b"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM2LTMtMS0xLTExNzAyOQ_2bfa567a-d787-4dc8-9f7f-77b000332e26"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM3LTEtMS0xLTExNzAyOQ_bda369f1-a701-4b90-adb2-79e033b9a6af">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:NoncontrollingInterestMezzanineEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM3LTMtMS0xLTExNzAyOQ_f5b16f17-acb8-450e-a654-a4f76b9eb114">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, 88.2 and 93.1 shares outstanding at December 31, 2022 and 2021, respectively</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM5LTEtMS0xLTExNzAyOQ_b50f073d-2eb1-432f-a9e1-cd8181115836">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM5LTMtMS0xLTExNzAyOQ_47b7c8e5-af5c-41a8-a5c2-80591d4ef3b9">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQxLTEtMS0xLTExNzAyOQ_28a2b739-5924-4df0-993f-e4a46f8ab5da">10,581.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQxLTMtMS0xLTExNzAyOQ_3cad82bd-0293-4a2c-8a18-f106aa4ba5e2">10,456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQzLTEtMS0xLTExNzAyOQ_cfa43b07-d936-42b6-9c80-f128135e8cf8">493.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQzLTMtMS0xLTExNzAyOQ_f5e997fe-20c4-4cd1-a1f2-f3a214f23e4d">191.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ0LTEtMS0xLTExNzAyOQ_4c4af3c3-12b5-4c0b-9084-423f84703ab2">10,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ0LTMtMS0xLTExNzAyOQ_1507328e-a3c8-49ba-9428-893deb6c0b41">10,273.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ1LTEtMS0xLTExNzAyOQ_d9acf7aa-91e4-4ddb-908c-ce3df6382d32">20,155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ1LTMtMS0xLTExNzAyOQ_0840c502-2419-49e0-be5e-d267bc732561">20,385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Millions, Except Per Share Data)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItMS0xLTEtMTE3MDI5_f02d3f7e-93e6-4a21-8bcc-953fb6556130">14,876.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItMy0xLTEtMTE3MDI5_b1b6fb31-f9f6-4069-b3b2-4d9d9c3d850e">16,120.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItNS0xLTEtMTE3MDI5_25c5ed2c-1570-4d01-b849-f3bdf263947e">13,978.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtMS0xLTEtMTE3MDI5_75a0a920-e896-405e-b336-8169d1f6af57">10,491.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtMy0xLTEtMTE3MDI5_0a1e3f3b-c347-4fd1-8c85-1ef7a27e1b60">10,496.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtNS0xLTEtMTE3MDI5_1a3d1d78-ca34-4096-b9e0-7d8baf7821c9">9,025.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtMS0xLTEtMTE3MDI5_414b2651-844a-40d1-9e2a-9cc3fc012519">4,385.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtMy0xLTEtMTE3MDI5_8d6eb6e6-13fb-454e-8c95-d06eecf9b483">5,624.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtNS0xLTEtMTE3MDI5_433778b4-ab99-407f-b2ef-8630bef103f1">4,952.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtMS0xLTEtMTE3MDI5_8cb81d45-2ea0-48eb-9631-bd8ee1c7063b">1,996.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtMy0xLTEtMTE3MDI5_8e823644-145c-4327-bf97-31fb427dfcd4">1,952.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtNS0xLTEtMTE3MDI5_08645b8b-0bec-4749-896c-15f42b3f72cf">1,729.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtMS0xLTEtMTE3MDI5_aa615816-7afb-4fb6-a562-cf6a67fce7c6">259.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtMy0xLTEtMTE3MDI5_958e26b1-2e8a-4378-9901-3fb4ba28d903">369.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtNS0xLTEtMTE3MDI5_72ea0087-e8e9-4a76-b519-1f5c8add9b9e">275.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctMS0xLTEtMTE3MDI5_4729479a-d0ab-4b46-bf34-fbc30bbc0c58">271.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctMy0xLTEtMTE3MDI5_2ae93eff-4f35-475a-9ae2-19031f49afd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctNS0xLTEtMTE3MDI5_6e049b46-452e-4955-aa7d-fc39818f0486">462.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtMS0xLTEtMTE3MDI5_d6c4c36b-0737-4602-8cec-3910db4b981f">83.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtMy0xLTEtMTE3MDI5_b43138b8-beb4-4a2c-b575-9e81563b2dac">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:NetRestructuringAndOtherSpecialCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtNS0xLTEtMTE3MDI5_a5e35ea9-31a0-4534-8e68-1f8fb56c9735">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktMS0xLTEtMTE3MDI5_77e12ae7-49ce-4bab-8e8b-de5fcc7b7d81">1,773.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktMy0xLTEtMTE3MDI5_118fad5f-102e-4974-8764-5010abdfaf5f">3,259.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktNS0xLTEtMTE3MDI5_755e095c-9779-47ae-9f66-4959e2733b2d">2,445.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTEtMS0xLTExNzAyOQ_52365995-fba8-480b-903a-62a66555a456">180.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTMtMS0xLTExNzAyOQ_04781d49-441f-4a3d-acb6-8bb89a0d6bcb">212.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTUtMS0xLTExNzAyOQ_72d21cf6-04fe-4def-a1d8-25b8a147ba9f">207.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTEtMS0xLTExNzAyOQ_a62e319e-a23b-4e72-86ef-4d52a1ce0757">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTMtMS0xLTExNzAyOQ_6966f306-5d97-405d-b9f9-9220804138a9">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTUtMS0xLTExNzAyOQ_7014ca8a-4f2f-48dd-8c03-f089d4e8c940">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTEtMS0xLTExNzAyOQ_1e1118a3-9db8-491b-b626-8365670e99d4">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTMtMS0xLTExNzAyOQ_051ac375-267d-42ef-84de-cf6c78cdfd4e">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTUtMS0xLTExNzAyOQ_f8463c3c-77f9-4a1e-8a4e-607045ea3d31">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTEtMS0xLTExNzAyOQ_f090d029-f859-4f78-946b-ff3d552f0746">25.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTMtMS0xLTExNzAyOQ_b800425c-29f5-4cb8-a43a-3bab2539a89c">42.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTUtMS0xLTExNzAyOQ_72aa637b-2427-418f-8102-bc80350bb471">32.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTEtMS0xLTExNzAyOQ_955ac377-a460-4426-b970-6c6f873439f8">1,582.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTMtMS0xLTExNzAyOQ_d5f7ba27-c403-4f24-b416-a8a42c4479dc">3,126.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTUtMS0xLTExNzAyOQ_5e7942ca-c587-4a72-8f65-ead2d988ce74">2,219.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTEtMS0xLTExNzAyOQ_20ca11ef-a71e-481d-9d06-fa816cbc06b6">302.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTMtMS0xLTExNzAyOQ_a916b30a-b037-4572-8862-95b0200bc003">747.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTUtMS0xLTExNzAyOQ_6f67fd3b-7166-4221-b038-2a8887699fb4">662.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTEtMS0xLTExNzAyOQ_1840ea73-e5c1-480b-ad35-34196084a195">1,280.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTMtMS0xLTExNzAyOQ_b5d362c9-8e1d-47df-9e38-f302c4874dd4">2,379.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTUtMS0xLTExNzAyOQ_d392bde8-bfe6-4568-8081-76c718de3ad4">1,557.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTEtMS0xLTExNzAyOQ_4d656c67-03c9-4b72-9b82-b85e59487df1">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTMtMS0xLTExNzAyOQ_da56c9fe-8ced-4486-b813-08269b0e1727">2.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTUtMS0xLTExNzAyOQ_59e55cb6-bf38-43c5-82fc-8544a091b589">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTEtMS0xLTExNzAyOQ_a648e5fa-167d-48bd-9b66-6a6ff1f04bcd">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTMtMS0xLTExNzAyOQ_a7c0966d-8759-47fc-83f1-391bc08f1ef0">2,377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTUtMS0xLTExNzAyOQ_6fd29664-31fc-4bfc-bc03-9bd056632b10">1,556.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTEtMS0xLTExNzAyOQ_3d467232-2984-4d36-be98-65e82f53d2d7">14.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTMtMS0xLTExNzAyOQ_dbaf8495-e4a7-4752-8d1f-e320357f2df3">24.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTUtMS0xLTExNzAyOQ_677563fe-67ac-4fed-9828-6d847d642f12">15.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTEtMS0xLTExNzAyOQ_124eaada-abe6-4543-86ad-651f961eafca">13.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTMtMS0xLTExNzAyOQ_a364f97f-1356-46af-af58-894d5264fb1c">24.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTUtMS0xLTExNzAyOQ_f0b1ac48-903e-47d5-a901-f46b07c7de55">15.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Millions, Except Per Share Data)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItMS0xLTEtMTE3MDI5_58990259-d62c-4024-ba7e-1b9a10899421">1,280.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItMy0xLTEtMTE3MDI5_ca825183-0347-4877-9c49-009c78e50438">2,379.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItNS0xLTEtMTE3MDI5_47a7ae89-5b75-472a-b83e-f68d5f17184b">1,557.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtMS0xLTEtMTE3MDI5_bc837c12-4210-4e70-9112-216ba4882627">336.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtMy0xLTEtMTE3MDI5_c116365d-0e1f-44e8-bfda-a59f3b303604">104.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtNS0xLTEtMTE3MDI5_a1a01119-d678-4e53-b24a-139886501d8f">264.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit plan adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtMS0xLTEtMTE3MDI5_933a25c0-6e80-4657-b7b8-68bda24d9571">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtMy0xLTEtMTE3MDI5_d97430e6-b1b7-4bf6-afe8-d96b565ded55">91.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtNS0xLTEtMTE3MDI5_4c5b7b7a-9dc4-4cf8-84dd-c84415f19797">65.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 10pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss) before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtMS0xLTEtMTE3MDI5_891e245d-999a-48b1-87b4-7e52167bddf9">291.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtMy0xLTEtMTE3MDI5_a296612a-2297-4ede-98ff-c56a902bde78">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtNS0xLTEtMTE3MDI5_d4639ad7-d234-4622-889b-1696d10e3ff6">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Provision) benefit for income tax related to items of comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtMS0xLTEtMTE3MDI5_af242c5e-71b9-4c27-a741-ca19e45fbdc9">9.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtMy0xLTEtMTE3MDI5_6f8036de-611b-4349-a2f9-fa99f55ab63a">17.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtNS0xLTEtMTE3MDI5_43bb0bde-ef78-4ee9-bd20-a41c90b5ebe0">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctMS0xLTEtMTE3MDI5_05922529-2ba8-4713-843f-0a8c6dac88e1">301.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctMy0xLTEtMTE3MDI5_82d10e96-1097-46a8-8a8f-af0298cf422d">30.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctNS0xLTEtMTE3MDI5_f5bfb15a-32f7-440e-afeb-9bdf9cc9f2b1">210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtMS0xLTEtMTE3MDI5_2de92550-e814-4e7d-aa95-7a8fcffa5831">979.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtMy0xLTEtMTE3MDI5_15f3a6c5-98a4-45f2-9227-ca67aa05a311">2,349.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtNS0xLTEtMTE3MDI5_90837cba-5091-4b1a-be13-04e05b6c3482">1,767.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net earnings attributable to the noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktMS0xLTEtMTE3MDI5_68f992ea-4ea3-45b2-8bbf-6eb767efe987">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktMy0xLTEtMTE3MDI5_fc4ef3fc-0db2-4a0e-afe4-f99d613955ce">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktNS0xLTEtMTE3MDI5_c8bdd3d2-7092-405f-aac6-de2d18804896">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTEtMS0xLTExNzAyOQ_907dda24-81d5-4e6d-980a-d1a83892475f">977.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTMtMS0xLTExNzAyOQ_2adc2915-5288-4a7a-bb24-e9687b5e3127">2,347.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTUtMS0xLTExNzAyOQ_6ee66995-3bec-4841-80ff-1b71b794c293">1,766.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Millions)</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER 31, 2019</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMS0xLTEtMTE3MDI5_5310de7f-4ee1-4733-b2cf-79bc97ded7d4">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMy0xLTEtMTE3MDI5_5fd317c2-6634-4934-9089-bc1ecd1332ff">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtNS0xLTEtMTE3MDI5_349d3ac6-d619-425b-8d95-fa01392c006f">7,980.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtOS0xLTEtMTE3MDI5_ca92a65a-11c4-4ec8-af8d-c27db02e157a">372.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMTEtMS0xLTExNzAyOQ_1a1dae31-86bf-4e52-b271-bc3bded9f4e7">7,643.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of credit loss accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77657f2f79234f079d9a8cd7d6c65a76_I20200101" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMS0xLTEtMTE3MDI5_608da403-c356-457b-ba0a-5e9aa8ec9e3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7a4f1d89351477a9562246200d846a1_I20200101" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMy0xLTEtMTE3MDI5_2682fef1-f196-4cc0-9e1f-acbca38b0e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bfd8f9f712d4be1a34741259880f138_I20200101" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItNS0xLTEtMTE3MDI5_ca1b211b-fdff-428e-a42b-ac26e7bcc699">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59610a560d54411f901c49edcd62d761_I20200101" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItOS0xLTEtMTE3MDI5_fb7d0365-39b6-4ac7-8f71-a69eb466e351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bfd8f9f712d4be1a34741259880f138_I20200101" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMTEtMS0xLTExNzAyOQ_9682ff79-43ae-470a-a608-695bf8a8211c">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMS0xLTEtMTE3MDI5_6e6bbefa-9305-473e-a7f4-59a421fcdff1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMy0xLTEtMTE3MDI5_1808dc14-f614-4069-8923-c3194e6ed748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtNS0xLTEtMTE3MDI5_aa37f0b0-8db5-499e-bc12-028a8fab3c9c">1,556.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtOS0xLTEtMTE3MDI5_038cacb9-5ba9-41ab-9e75-8443117009c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMTEtMS0xLTExNzAyOQ_4d011b29-fee5-466d-a4ff-ec086fafcb82">1,556.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMS0xLTEtMTE3MDI5_792b3095-fc5c-41af-ba63-4be3469866cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMy0xLTEtMTE3MDI5_8778efcc-8ee2-449a-af80-85e3d3e88c5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtNS0xLTEtMTE3MDI5_7b41155d-abd6-42b7-93a4-67619da9d841">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtOS0xLTEtMTE3MDI5_32c46738-0e8c-4d8b-b21d-ca9f95b73474">210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMTEtMS0xLTExNzAyOQ_d6386370-b0f3-4bc3-9200-86900fe3f59c">210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMS0xLTEtMTE3MDI5_8b0596ab-808e-434a-9285-322fc03d5543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMy0xLTEtMTE3MDI5_2b80e813-872c-487f-94cf-ab3bc6e2299e">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtNS0xLTEtMTE3MDI5_fa0ab15f-7a24-4601-9c6b-a3b88c29bf86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtOS0xLTEtMTE3MDI5_3ba0aaec-d743-45f3-9e0b-bd992961b97a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMTEtMS0xLTExNzAyOQ_51e2442a-6a1a-45b9-ac1d-f5a76be3dc79">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMS0xLTEtMTE3MDI5_d44df1a4-0121-4655-bacb-6e3b6bceec1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMy0xLTEtMTE3MDI5_e1e55758-0c22-4bbb-a92b-e3efead53740">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctNS0xLTEtMTE3MDI5_7fc96432-3246-4dcd-a37e-04ccfe412b7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctOS0xLTEtMTE3MDI5_121a04f7-a4f7-4b4f-8580-cbe857a5d64b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMTEtMS0xLTExNzAyOQ_efeafce5-07dd-4df4-abcc-7ca74e2b8f74">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMS0xLTEtMTE3MDI5_305cbe42-ae5f-482b-b9a3-805b2c56741c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMy0xLTEtMTE3MDI5_1f1d50db-e517-494b-bed6-e828375e6057">111.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtNS0xLTEtMTE3MDI5_b0f8843d-8a8d-48d6-b076-315fd1f88708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtOS0xLTEtMTE3MDI5_13a8e4e3-4abd-47d1-8fc0-54b47e4d2421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMTEtMS0xLTExNzAyOQ_eae3f6c5-7711-4cbb-92b8-ccc9cbc46df8">111.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTEtMS0xLTExNzAyOQ_4c52993d-97aa-4b0b-a632-4ed4e32907f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTMtMS0xLTExNzAyOQ_d426df7e-ff2d-47d8-b5a5-b0cf4af2a89e">49.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTUtMS0xLTExNzAyOQ_625049a7-d63d-4016-934d-c328f7e1317b">50.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTktMS0xLTExNzAyOQ_e9932188-ac03-44c9-b762-e11f81f61f00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTExLTEtMS0xMTcwMjk_8bed66bf-1d8e-4371-a12f-76a4fb3b0037">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER&#160;&#160;31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29cec420761b431ca0cff711e7a085bb_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTEtMS0xLTExNzAyOQ_0d7b5a34-73a2-431d-8b8a-cbd2fc1de909">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5185fa2e825b418aaad59fc411dd8793_I20201231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTMtMS0xLTExNzAyOQ_33ea29d2-84d4-40f3-a1f4-ecbd6df068b5">110.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82508c48b8e24f59b776527555dac0a5_I20201231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTUtMS0xLTExNzAyOQ_41bccf7d-196e-4bc7-936a-d27973dfc989">9,479.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i716799a1a7a34a15b3e9adffdce6996d_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTktMS0xLTExNzAyOQ_787f6597-b8d2-400e-a291-248b75b9a032">161.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTExLTEtMS0xMTcwMjk_3c98b4c4-da18-411b-955d-a7c6bfb2be77">9,436.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTEtMS0xLTExNzAyOQ_f64c3f4f-fa3d-4696-8f76-d9d8423126e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTMtMS0xLTExNzAyOQ_c4a7b085-4e25-448a-a27e-3bb99f701fef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTUtMS0xLTExNzAyOQ_37b1a024-08ab-4bd3-90fc-e7c9efe509d4">2,377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTktMS0xLTExNzAyOQ_d268c18c-03f0-4c72-8f6f-5fab62155376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTExLTEtMS0xMTcwMjk_d0b5f40d-9d20-4415-b1e9-c146c5503a0f">2,377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTEtMS0xLTExNzAyOQ_3f269b90-d2a0-438d-b3e8-b59b6788bb80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTMtMS0xLTExNzAyOQ_3ce92735-17b7-4c54-8936-c8afa0a64cc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTUtMS0xLTExNzAyOQ_118954ba-b6bf-4b89-90af-69490c6f9468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTktMS0xLTExNzAyOQ_10af1339-99ab-4092-9f12-bb19a4f19203">30.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTExLTEtMS0xMTcwMjk_0859c590-5a4c-4bc2-b77c-8270c848ee0b">30.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTEtMS0xLTExNzAyOQ_9a434179-f6cd-4096-8d26-34dd0c607e48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTMtMS0xLTExNzAyOQ_b8d234d9-e988-478e-b45d-778e7d1c5636">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTUtMS0xLTExNzAyOQ_1cee322d-40e5-49f1-ac9c-57de70ad0cce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTktMS0xLTExNzAyOQ_82ddc685-5166-43e2-80a6-1fe390bedf00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTExLTEtMS0xMTcwMjk_e4c3e660-22e7-4a64-84fb-c608e90e575d">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTEtMS0xLTExNzAyOQ_02c24251-2fbf-4c81-ab29-c1474018b898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTMtMS0xLTExNzAyOQ_82d154da-f55b-49bd-a886-c7a830faf8fd">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTUtMS0xLTExNzAyOQ_b332108e-4c0a-4d07-8bbb-029226bdca00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTktMS0xLTExNzAyOQ_da13bc67-ee8a-48f9-ac02-66db28cf8c95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTExLTEtMS0xMTcwMjk_7774efc9-fe7b-4ea8-928e-a9e08484ec90">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTEtMS0xLTExNzAyOQ_32dc0f8b-2c80-4b69-9c52-7173d0ccbf25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTMtMS0xLTExNzAyOQ_3ac5d52f-b2d6-41f6-9b35-36f6e0456e42">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTUtMS0xLTExNzAyOQ_2266555e-facf-466a-91ed-1ce845dbfaad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTktMS0xLTExNzAyOQ_e601000b-b44c-4cab-a401-8c41f7183e02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTExLTEtMS0xMTcwMjk_5f79d850-b830-4fdb-bdec-c484c7238e68">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTEtMS0xLTExNzAyOQ_3fc80e94-1bac-46ce-b68d-586f46d01a68">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTMtMS0xLTExNzAyOQ_d455fb39-6722-412f-91f3-11fa8bdcbbf0">268.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTUtMS0xLTExNzAyOQ_5d1786c9-5816-4575-b288-e9ab987c0aaa">1,399.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTktMS0xLTExNzAyOQ_c28d8519-f0d0-41d2-8b05-556a47762665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTExLTEtMS0xMTcwMjk_1597c6ca-6847-41b9-9456-a39a04006b84">1,668.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER&#160;&#160;31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cc8aeb3db74b298d1f3c1cc41c86b7_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTEtMS0xLTExNzAyOQ_4cae7e78-08ee-4b9b-a483-5194bb8e74b5">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9537d406d674d4bbf0f98e30498723b_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTMtMS0xLTExNzAyOQ_ec3d5628-fda7-42f5-a33b-cbabc95c20a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d55b4cb03d64378863d2e96d420a6d0_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTUtMS0xLTExNzAyOQ_5e5f2990-0d40-40b9-9fbc-709480ca08c9">10,456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTktMS0xLTExNzAyOQ_58abfeda-6bad-4bb7-93b6-c52d0ed5c3e7">191.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTExLTEtMS0xMTcwMjk_cafc1d92-b60f-4daa-933d-b855d970f751">10,273.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTEtMS0xLTExNzAyOQ_decda89c-aedd-4eef-8b6d-bad5c2735f78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTMtMS0xLTExNzAyOQ_ebea39cf-f4e1-4f6c-b55d-5a69e7e7f4a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTUtMS0xLTExNzAyOQ_bbd5361a-94ca-4b38-b178-d0e039d5a4e7">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTktMS0xLTExNzAyOQ_9f796bee-96ba-4857-8782-7c341eddae12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTExLTEtMS0xMTcwMjk_e21a2c5a-4431-4df9-817e-e7d8c8e640b1">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTEtMS0xLTExNzAyOQ_70f5dbeb-58b8-4a38-97fc-04cd045cf899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTMtMS0xLTExNzAyOQ_124d135d-0063-422b-9d64-4d4abe7ab1b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTUtMS0xLTExNzAyOQ_a40d0b9d-c23f-40e1-950d-0bdfca67196b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTktMS0xLTExNzAyOQ_fa957c36-3fd2-4b72-80db-77d585cbd7cb">301.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTExLTEtMS0xMTcwMjk_b8520daa-8721-4428-bd13-b2d66b5b788d">301.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTEtMS0xLTE3MTM1Mg_90a3c869-6867-48c9-8b07-a5db5e236f07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTMtMS0xLTE3MTM1Mg_4787bbb8-37b8-4429-bdae-2b1ae7b3d296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTUtMS0xLTE3MTM1Mg_6d2ae627-76f5-4d16-a8c3-db105895f8cd">198.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="us-gaap:Dividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTktMS0xLTE3MTM1Mg_efb65d4e-2cd2-4c75-9559-b31f97fbd896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTExLTEtMS0xNzEzNTI_e6e0aba3-00ed-4276-ab18-c9bac541c762">198.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTEtMS0xLTExNzAyOQ_ec08c097-629f-4ae8-b78a-3c0422240eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTMtMS0xLTExNzAyOQ_f88716bc-42bc-4fa9-866f-567357aaa871">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTUtMS0xLTExNzAyOQ_5332fcac-3d78-4fbd-8070-30354f323a92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTktMS0xLTExNzAyOQ_eb02fb47-96bf-4e9f-831f-af25e29d47d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:IssuanceOfCommonStockUnderEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTExLTEtMS0xMTcwMjk_0450bbf2-14c6-40c3-b56f-11ec5f9d3080">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTEtMS0xLTExNzAyOQ_a04c707b-a6c5-4da5-af75-7f21fb7433a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTMtMS0xLTExNzAyOQ_2093b03f-d414-4c4f-835b-26353135d3ca">50.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTUtMS0xLTExNzAyOQ_31877fe3-6d0e-4705-b188-d5969002a695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTktMS0xLTExNzAyOQ_ecf482d1-f37d-4020-ab77-28d9d6435168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTExLTEtMS0xMTcwMjk_8a91d059-e9f5-4675-86f4-38327e4e8f0a">50.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTEtMS0xLTExNzAyOQ_d3aca269-86e8-4bd0-8f91-6d486c9179cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTMtMS0xLTExNzAyOQ_7840f0b4-0b1a-4a83-9155-a04a0fc40f00">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTUtMS0xLTExNzAyOQ_9e05a210-be6b-48ae-ad48-4ed5db9404a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTktMS0xLTExNzAyOQ_10caf214-56d3-45a9-a7da-ef26694ccd2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTExLTEtMS0xMTcwMjk_f7789a92-0409-4912-a5dd-3d9f5f6c8092">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTEtMS0xLTExNzAyOQ_d99280d6-f483-4c8b-9ff8-8fd4ab8f8aec">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTMtMS0xLTExNzAyOQ_e3cab06f-031e-4ce2-b0f7-215051522498">144.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTUtMS0xLTExNzAyOQ_f010735d-cae6-4047-bb42-93dc29729542">955.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTktMS0xLTExNzAyOQ_a041c095-be2d-4bb8-a16f-2a8ca17d9640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTExLTEtMS0xMTcwMjk_dae67fc2-6e7b-4d19-ba26-88eee2eed52c">1,100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE AT DECEMBER&#160;&#160;31, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f313e3a123c4e398f0c391421791a68_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTEtMS0xLTExNzAyOQ_5d8d916e-d600-4845-a449-a7c1fa78cf28"><ix:nonFraction unitRef="usd" contextRef="i9f313e3a123c4e398f0c391421791a68_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTEtMS0xLTExNzAyOQ_6659ea2d-a720-4374-9f18-a8c8cc6233df">8.1</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id782ff201d364db6a73b7f362d0a9678_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTMtMS0xLTExNzAyOQ_dff287bf-d017-4e62-a81b-d6c0a5e66a8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i061db6fec9f94dce9fe88b9a6f4fc138_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTUtMS0xLTExNzAyOQ_c7498f39-28de-4a76-b1ef-c477dc307ddd">10,581.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6bb1719c3747d69b101c25f39073a8_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTktMS0xLTExNzAyOQ_d1a06825-c71d-465e-8590-272f845fffb5">493.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTExLTEtMS0xMTcwMjk_a230c102-5d24-4b06-a5fe-1bc27bbb8560">10,096.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Millions)</span></div><div style="margin-bottom:4pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:72.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtMS0xLTEtMTE3MDI5_6c9ff166-f483-4bc4-8a83-78f131b0105e">1,280.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtMy0xLTEtMTE3MDI5_3c501244-91af-4fa7-8b82-b1826c728151">2,379.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtNS0xLTEtMTE3MDI5_95c58bc0-58fe-4e4e-84e5-6879a022447a">1,557.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 7.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtMS0xLTEtMTE3MDI5_895fe350-7a27-45d0-9f8c-e998b5644f59">633.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtMy0xLTEtMTE3MDI5_9c69ce36-f767-413b-b5a9-72dc7cf8822b">745.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtNS0xLTEtMTE3MDI5_b0decfd6-7b2f-4b1f-babc-246174593793">624.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtMS0xLTEtMTE3MDI5_5949ccb8-37cd-4992-8821-62122949cb87">144.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtMy0xLTEtMTE3MDI5_e9ffadd1-db62-4be1-a1db-01e9f46c6945">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtNS0xLTEtMTE3MDI5_6ac7ca3c-192f-4ce8-968d-87ab681d8581">111.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtMS0xLTEtMTE3MDI5_6089e5e0-8eab-44af-906a-3c8c79cf1652">194.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtMy0xLTEtMTE3MDI5_a4e7dd25-baab-4176-87f5-d051b24d509b">194.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:DepreciationAndAmortizationOfLeasedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtNS0xLTEtMTE3MDI5_8782cb7a-ccb2-4497-a382-8d4df5bbbe51">200.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktMS0xLTEtMTE3MDI5_95560979-6991-4816-a152-8e3868e9b905">271.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktMy0xLTEtMTE3MDI5_97334796-ff3b-49c9-94dc-0041f0a33090">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktNS0xLTEtMTE3MDI5_0c7d0038-68b9-4861-8069-0eb2cd0cca5e">462.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTEtMS0xLTExNzAyOQ_4b9ad95d-5588-42e4-902a-29d9318cfdf3">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTMtMS0xLTExNzAyOQ_f56c2e71-25b5-475e-a0bf-ec6900044111">75.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTUtMS0xLTExNzAyOQ_577fdbdd-e31b-4b06-b7ab-5d94e1784b78">47.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTEtMS0xLTExNzAyOQ_48b7df12-4ff8-4515-8f70-c4ba57321211">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTMtMS0xLTExNzAyOQ_a7c6b214-87ca-493f-a05f-2bed2ed47e6c">24.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTUtMS0xLTExNzAyOQ_397c5bc1-a9ce-4a6c-ba34-d4c4444106cb">83.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in assets and liabilities (net of effects of acquisitions and divestitures):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease in accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTEtMS0xLTExNzAyOQ_60559a10-f8f7-4936-9201-ce419cf30f22">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTMtMS0xLTExNzAyOQ_5edd853b-938f-447a-8a9e-6b99f5d2f1b7">222.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTUtMS0xLTExNzAyOQ_82d85aa3-ed00-4e0b-84e1-61f474dd2f4d">913.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTEtMS0xLTExNzAyOQ_dc049ad0-35dc-42f7-8918-0d604ff5f82c">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTMtMS0xLTExNzAyOQ_3855ff46-3257-4554-84a2-9b2c235deaf6">179.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTUtMS0xLTExNzAyOQ_ddbf2470-6259-4edf-9226-86b41f371534">42.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease in inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTEtMS0xLTExNzAyOQ_84644a8e-e9c5-4fea-91e7-f38e35b2630a">45.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTMtMS0xLTExNzAyOQ_214c4c3e-6acb-477f-adb4-aaa000cfa315">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTUtMS0xLTExNzAyOQ_e544447e-1d2d-4eba-929a-9b7fcdd2d2cd">196.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTEtMS0xLTExNzAyOQ_ab32311a-ddd6-485a-9a25-25b1055a14da">256.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTMtMS0xLTExNzAyOQ_d105b3b7-4311-495e-a694-2bdb9ef394bc">68.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTUtMS0xLTExNzAyOQ_30ba40c6-b055-422f-89cb-812bcc7a3fa5">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTEtMS0xLTExNzAyOQ_2120af7a-c945-452f-b9d8-d794b95c46ad">307.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTMtMS0xLTExNzAyOQ_7b0918b8-a14e-470e-9f47-967caac9a273">10.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTUtMS0xLTExNzAyOQ_93bbe5e9-5259-4167-9673-7dc57b5a7639">5.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTEtMS0xLTExNzAyOQ_ca9c60a8-f660-4457-8280-d9b595a7f473">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTMtMS0xLTExNzAyOQ_51694ea2-5db8-4c62-945b-f53b531ae0d6">45.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTUtMS0xLTExNzAyOQ_5a31e26d-4b7b-46a7-b15c-4e49ca782fa2">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTEtMS0xLTExNzAyOQ_d3b72b52-5e4e-4367-96b4-f76239b7479e">559.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTMtMS0xLTExNzAyOQ_61bdae03-83b2-4428-b773-170b6647b6bd">275.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTUtMS0xLTExNzAyOQ_4c80f29c-b38b-45a6-8c1b-e78e0575c490">257.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTEtMS0xLTExNzAyOQ_9173d25d-6494-423a-8f66-2f2d307ad7c8">1,955.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTMtMS0xLTExNzAyOQ_d1f4f905-3646-4b99-969a-b636bd9c2d56">3,109.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTUtMS0xLTExNzAyOQ_b4738aa9-25d1-4f07-8aa9-04555b6de67b">2,135.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTEtMS0xLTExNzAyOQ_80fc3efa-4bde-4941-9645-1e2dbf7ca873">481.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTMtMS0xLTExNzAyOQ_30621b0c-34b7-4037-8d2c-35d69b25b88f">460.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTUtMS0xLTExNzAyOQ_13831d73-a3c5-4ec0-bc64-7a55cd07fd0f">381.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTEtMS0xLTExNzAyOQ_d6506857-e5dd-4f53-98cc-4257756d409b">17.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTMtMS0xLTExNzAyOQ_3ee90854-1753-4a41-a323-afe6bfc55b7c">27.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTUtMS0xLTExNzAyOQ_375101bd-dce8-4593-9613-b2d588ba089e">40.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTEtMS0xLTExNzAyOQ_28c4a76b-75eb-40a4-8d74-cf2ff6748ec0">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTMtMS0xLTExNzAyOQ_ea3c5875-0add-475a-bcb1-2642680ee583">87.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTUtMS0xLTExNzAyOQ_c7f7f2eb-fa30-43bd-9884-448e68cdf32f">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale or distribution of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTEtMS0xLTExNzAyOQ_46337047-47b8-4906-a7b0-9d7e608a12c5">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTMtMS0xLTExNzAyOQ_52d2b0a0-5332-48bd-90f3-3f2af505e003">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleOfOtherInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTUtMS0xLTExNzAyOQ_96aa5ea0-698a-435e-93e3-fe37c11ae3ca">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exit from swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTEtMS0xLTExNzAyOQ_16a3accc-abf7-4b72-95cc-036c46e150a4">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTMtMS0xLTExNzAyOQ_6c4daae6-d706-4925-967a-f5ff666b09bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTUtMS0xLTExNzAyOQ_678877f4-8247-474c-b691-846501ab6211">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTEtMS0xLTExNzAyOQ_0c6b898c-ab45-46af-8ce2-4c2bbec07007">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTMtMS0xLTExNzAyOQ_54469adf-cdac-45fe-b764-d16eb8eb5daa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTUtMS0xLTExNzAyOQ_1c0eb515-712c-4ccd-83c7-197a2b03e8f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTEtMS0xLTExNzAyOQ_76694034-4c4f-4f1c-b82d-8f4ca6537906">1,164.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTMtMS0xLTExNzAyOQ_acbf2d04-9f3b-4e1f-8aa4-315f3bce49de">496.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTUtMS0xLTExNzAyOQ_a353cb41-b15d-4045-b89f-e7fa421ab0b0">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTEtMS0xLTExNzAyOQ_a28b531a-84f3-4a7f-8623-4c3c1a595101">1,652.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTMtMS0xLTExNzAyOQ_63450bfb-5f0d-429a-816f-d5c81684e73b">884.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTUtMS0xLTExNzAyOQ_88a0a69e-a518-4f16-8652-f5a26c128235">643.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from senior note offerings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTEtMS0xLTExNzAyOQ_390a44c1-40ca-471b-9c5d-a4df7a5a4945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTMtMS0xLTExNzAyOQ_a2730fc3-a0ee-489e-b5f7-7902cc39fea4">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTUtMS0xLTExNzAyOQ_036a36ba-5b75-439d-983e-400d7095991a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTEtMS0xLTExNzAyOQ_78d45773-078d-461f-bdd9-e8ae336c1fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTMtMS0xLTExNzAyOQ_41900365-6bef-4fc8-8baa-4dd1bd3ea386">1,000.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTUtMS0xLTExNzAyOQ_3044f449-f7ed-4f0a-8bc5-e931c2bd3971">412.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTEtMS0xLTExNzAyOQ_9aa581ab-679e-4a16-b014-56eb8dfcbfd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTMtMS0xLTExNzAyOQ_bc7dfa99-ec76-44e3-ba67-664c258a3bfc">375.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTUtMS0xLTExNzAyOQ_958917e9-1082-4e7f-806c-8c0b406cb5a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTEtMS0xLTExNzAyOQ_03b142fb-1930-45e0-8c86-d7e4b4092b6c">787.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTMtMS0xLTExNzAyOQ_ac1321aa-7a7f-466a-8063-3629c492156f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTUtMS0xLTExNzAyOQ_a4a81604-6e7f-453f-8de0-1c801d821320">151.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTEtMS0xLTExNzAyOQ_0365a918-5377-4cc7-9d53-68929ed206f6">787.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTMtMS0xLTExNzAyOQ_9d3785cc-8316-4961-9e51-f982ba4b81f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTUtMS0xLTExNzAyOQ_c9457b20-851d-4519-8b72-23e3fd9ebb9b">151.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net share settlement tax payments from issuance of stock to employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTEtMS0xLTExNzAyOQ_2c23b128-8c5d-4e5a-b481-bdfd6ba1b685">50.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTMtMS0xLTExNzAyOQ_06c3482e-9c9d-4e30-98c3-6613293f1fd8">47.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTUtMS0xLTExNzAyOQ_a448752b-790a-41a9-b4c0-edb6d5683426">34.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from issuance of stock to employees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTEtMS0xLTExNzAyOQ_2508a813-476a-46f9-8b9d-871170680cf7">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTMtMS0xLTExNzAyOQ_017c904e-424d-49f0-825a-74e63ca61d18">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:NetProceedsFromIssuanceOfStockToEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTUtMS0xLTExNzAyOQ_529358cb-13c1-4a0f-ba91-aaaf41ec110c">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTEtMS0xLTE3MTM2MA_b7d25101-fd19-4fbc-812d-f19e650920a1">195.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTMtMS0xLTE3MTM2MA_6b07c7ee-7047-40a8-83fe-f8a639a9308b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTUtMS0xLTE3MTM2MA_79acf21c-96a8-4c23-a59c-41d3fb2256f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTEtMS0xLTExNzAyOQ_997fb769-c154-489d-8059-424ce1541b5c">1,100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTMtMS0xLTExNzAyOQ_2f23f481-6963-4153-807b-eac74a51f22e">1,668.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTUtMS0xLTExNzAyOQ_0601d04b-4f3c-4176-be2a-aacdda9b5740">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTEtMS0xLTExNzAyOQ_bcadcc88-f12a-4163-b2b2-41ab1aa63494">27.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTMtMS0xLTExNzAyOQ_df55c7e3-56ef-40b3-b7bb-9e16e00369c6">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTUtMS0xLTExNzAyOQ_2191ec67-c3d9-45b3-a941-94ffca82bda1">26.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTEtMS0xLTExNzAyOQ_785e153c-9444-4e39-9d09-f4c149dcb9bc">1,322.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTMtMS0xLTExNzAyOQ_22b7a90b-5d3c-4f30-b569-ca29a88e069a">2,065.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTUtMS0xLTExNzAyOQ_1d043645-e53d-439d-8367-03938db12e0c">517.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTEtMS0xLTExNzAyOQ_6389bf17-cc17-40c6-b2ea-7020f0134ba6">24.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTMtMS0xLTExNzAyOQ_c8afdffb-2d15-4cf9-9d3f-0cb17d3dde70">7.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTUtMS0xLTExNzAyOQ_7b64cc71-fb2b-4b8a-b4a8-206ffc625c0c">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTEtMS0xLTExNzAyOQ_54fae651-3e5d-4d27-94db-479fee9e4214">1,042.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTMtMS0xLTExNzAyOQ_1e69941f-20bb-4448-8d23-1857864a5567">151.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTUtMS0xLTExNzAyOQ_54101907-83f3-485d-b61f-1a0a5a9d5494">983.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTEtMS0xLTExNzAyOQ_f96b8d96-f74c-4845-9b90-8091b2552a20">1,472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTMtMS0xLTExNzAyOQ_7b9784fd-12dc-4cda-a072-04c1b58c454b">1,320.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTUtMS0xLTExNzAyOQ_f934f54d-3cea-45df-ab5a-ecb780889b82">337.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTEtMS0xLTExNzAyOQ_d3a0058d-93d3-4a3d-a26b-16d898c1ab91">430.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTMtMS0xLTExNzAyOQ_be8e1167-05fd-44cb-ab72-a153de7e00c4">1,472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTUtMS0xLTExNzAyOQ_1deb2f08-72e3-44ae-81c7-9062c22dcf9f">1,320.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_184"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDIw_b219f4d3-5a21-4fc8-8a02-210e30006174" continuedAt="ie50d56e9ecaa4adc87472e4e913538d9" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ie50d56e9ecaa4adc87472e4e913538d9" continuedAt="icada09efb96e43c49fb08df399c7b9cf"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDE0_be0ed146-d3f3-404d-8cd1-a4c4621bfcf9" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than <ix:nonFraction unitRef="employee" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="0" name="dei:EntityNumberOfEmployees" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzUzMg_81e39c35-370e-4198-aa43-087366bb81b2">80,000</ix:nonFraction> employees, the Company serves clients in more than 100 countries. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, including information for each of the last three fiscal years regarding revenue, operating income, and other important information, see Note 19 Business Segment Information. In 2022, Dx and DD contributed <ix:nonFraction unitRef="number" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0Nzk0NjI_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9">61</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0Nzk0NjY_afc9324a-33dc-46c5-9679-e8205e4a8f3f">39</ix:nonFraction>%, respectively, of revenues to the Company, and in 2021 contributed <ix:nonFraction unitRef="number" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyOTY_45cfe58f-f40f-45d7-a53f-7b2947417913">64</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEzMDM_fd465a4f-9db9-42d8-a50d-5049df0e0196">36</ix:nonFraction>%, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than <ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="lh:CostMethodInvestmentsMaximumOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE3NzE_560bf21c-2b47-4ebb-8772-c9a5139fd622">20</ix:nonFraction>% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU1_d6d7b173-b1a1-4fa7-be86-b184f62589a9" continuedAt="i8ab96639bd154af48244fba3652f8e9e" escape="true">Reimbursable Out-of-Pocket Expenses</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8ab96639bd154af48244fba3652f8e9e">DD pays on behalf of its customers certain out-of-pocket costs for which the Company is reimbursed at cost, without mark-up or profit. Out-of-pocket costs paid by DD are reflected in cost of revenues, while the reimbursements received are reflected in revenues in the consolidated statements of operations.</ix:continuation> </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzY2_5716d0a6-e885-4db0-b4af-75281cd99537" escape="true"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes direct labor and related benefit charges, reimbursable expenses, other direct costs, shipping and handling fees, and an allocation of facility charges and information technology costs. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, advertising and promotional expenses, administrative travel and an allocation of facility charges and information technology costs. Cost of advertising is expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzQ2_d67d767a-59d5-41ac-bcf7-8d9bfac4d3b1" continuedAt="i5889c9a0b21f4f3785d6d30cae71005a" escape="true"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Significant estimates include implicit price concessions, revenue estimates, the allowances for doubtful accounts, deferred tax assets, fair values of acquired assets and assumed liabilities in business combinations, fair value of goodwill and indefinite-lived intangible assets, amortization lives for acquired intangible assets, and accruals for self-insurance reserves, litigation reserves and pensions. Actual results could differ from those estimates.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will continue to impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2022, and through the date of this Annual Report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price </span></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="icada09efb96e43c49fb08df399c7b9cf" continuedAt="i0da4fb31431c47548aaebd40169a3055"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5889c9a0b21f4f3785d6d30cae71005a">concessions and credit losses, equity investments, and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could impact the Company&#8217;s consolidated financial statements in future reporting periods.</ix:continuation></span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ConcentrationOfCreditRiskPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU4_be7d1347-5f10-4537-a460-c58ad47afe22" continuedAt="ia7b4d9a6fd594edea4a11ca5fbdee3a5" escape="true">Concentration of Credit Risk</ix:nonNumeric></span></div><ix:continuation id="ia7b4d9a6fd594edea4a11ca5fbdee3a5" continuedAt="ie27053d98df34c009c7fd5311201684c"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. The total cash and cash equivalent balances that exceeded the balances insured by the Federal Deposit Insurance Commission, were approximately $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CashUninsuredAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzYwNjM_50cac80e-1eb4-4651-90d0-17f26a6676a1">428.1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzYwNzA_f0599e31-9d50-49a6-a640-c794e8ed0efd">1,471.0</ix:nonFraction> at December&#160;31, 2022, and 2021, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s accounts receivable are with companies in the healthcare or pharmaceutical industry and individuals. However, concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many different geographic regions. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Dx has receivables due from U.S. and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by U.S. and state governments, and payment is primarily dependent upon submitting appropriate documentation. Accounts receivable balances (gross) from Medicare and Medicaid were $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzY3ODU_5e87ade5-aa9a-4df6-9a0e-5c15b752ed24">85.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzY3OTI_563b8f6d-eaeb-4237-9dd6-f0df646fb302">94.5</ix:nonFraction> at December&#160;31, 2022, and 2021, respectively.  </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company's operations in Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (Ministry) determines who can establish a licensed community medical laboratory and caps the amount that each of these licensed laboratories can bill the government sponsored healthcare plan. The Ontario government-sponsored healthcare plan covers the cost of commercial laboratory testing performed by the licensed laboratories. The provincial government discounts the annual testing volumes based on certain utilization discounts and establishes an annual maximum it will pay for all community laboratory tests. The agreed-upon reimbursement rates are subject to Ministry review at the end of year and can be adjusted (at the government's discretion) based upon the actual volume and mix of test work performed by the licensed healthcare providers in the province during the year. There were no capitated accounts receivable balances from the Ontario government sponsored healthcare plan at December&#160;31, 2022. The balance was CAD <ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0NzkyNDQ_3c20a754-6f70-4a4d-af01-e997064a1094">7.2</ix:nonFraction> at December&#160;31, 2021.</span></div></ix:continuation><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie27053d98df34c009c7fd5311201684c">The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.&#160;At December&#160;31, 2022, and 2021, receivables due from patients represented approximately <ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="3" name="lh:Percentofgrossaccountsreceivableduefrompatients" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzgwNDI_aa0c0588-7384-4b7c-b8f7-ae405862fb25">15.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="3" name="lh:Percentofgrossaccountsreceivableduefrompatients" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzgwNDk_9c139232-4e7c-4016-b6aa-2a963525803c">16.7</ix:nonFraction>% of the Company's consolidated gross accounts receivable, respectively.&#160;The Company applies assumptions and judgments including historical collection experience and reasonable and supportable forecasts for assessing collectability and determining allowances for doubtful accounts for accounts receivable from patients.</ix:continuation>&#160; </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDMz_96108e79-2a9a-4f42-9294-7817ba411ee8" continuedAt="ib6987cd9a62643dab497d216e9b44444" escape="true"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzUx_3f4fcfa4-2ef0-400e-a3bc-2bde64241f73" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.930%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMS0xLTEtMTE3MDI5_6c9c432c-2f80-4387-b977-fe870e83c900">1,279.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMy0xLTEtMTE3MDI5_7ea63d9c-b69f-4e9b-9b79-3edb5c132fca">91.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItNS0xLTEtMTE3MDI5_f7152bd0-027d-4c40-84a0-b4c298eb7ea5">14.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItNy0xLTEtMTE3MDI5_5f7cb0ed-49f8-4444-ab62-60c63f84b6e4">2,377.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItOS0xLTEtMTE3MDI5_3838bc8c-611e-401a-b667-8433a71c1497">96.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTEtMS0xLTExNzAyOQ_d8b67f9a-a70b-40e7-ab41-1f14100f603b">24.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTMtMS0xLTExNzAyOQ_73c47453-2556-4ba8-8d95-017fda5027d7">1,556.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTUtMS0xLTExNzAyOQ_7b869233-48ea-49d1-b7b5-6127b4a4f4c9">97.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTctMS0xLTExNzAyOQ_0d11ea3d-a409-4d22-ad96-4c070379f440">15.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:IncrementalCommonSharesAttributableToStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtMy0xLTEtMTE3MDI5_6596c32c-ff74-4961-b5af-8b53b57f0838">0.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:IncrementalCommonSharesAttributableToStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtOS0xLTEtMTE3MDI5_9c6d4745-c03c-4461-a391-e4aa75c7056f">0.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:IncrementalCommonSharesAttributableToStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtMTUtMS0xLTExNzAyOQ_e90a18ee-af77-47b0-80b7-553fcba98370">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMS0xLTEtMTE3MDI5_e05371cf-58b4-4ffe-b4b1-6722a73dc14a">1,279.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMy0xLTEtMTE3MDI5_63b78522-290a-4fff-911f-7399c90aa1dd">91.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtNS0xLTEtMTE3MDI5_831c88e8-3795-4a2f-b3c0-ec658dbbb428">13.97</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtNy0xLTEtMTE3MDI5_ea11cc6c-f56b-4c82-9e67-1d9c5f2dc97c">2,377.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtOS0xLTEtMTE3MDI5_107103f8-6daa-4c00-98ab-a172500cd26f">97.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTEtMS0xLTExNzAyOQ_eb1d2596-80bb-43f1-976f-e86cf9921c66">24.39</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTMtMS0xLTExNzAyOQ_399edced-e8c1-42a1-a6d0-0e671dccac6b">1,556.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTUtMS0xLTExNzAyOQ_08bdf5af-ee19-4d46-9236-98955f0a5a0e">98.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTctMS0xLTExNzAyOQ_40d82b1c-7c85-4009-93fa-f6b67373dd46">15.88</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i0da4fb31431c47548aaebd40169a3055" continuedAt="ib62ccdfc3c7c4ae4a1dbd268ce9e2b7d"><ix:continuation id="ib6987cd9a62643dab497d216e9b44444"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:4pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDQ4_e32eb58e-0962-4b86-b296-26ad2b95ecb1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:EarningsPerSharePotentiallyDilutiveSecurities" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItMS0xLTEtMTE3MDI5_97f89b55-c69c-4378-a8c9-af110c95f8bb">0.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" name="us-gaap:EarningsPerSharePotentiallyDilutiveSecurities" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItMy0xLTEtMTE3MDI5_4debc57e-3388-41d1-b219-c48b2bc70996">0.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" name="us-gaap:EarningsPerSharePotentiallyDilutiveSecurities" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItNS0xLTEtMTE3MDI5_a6da5e5d-1ffc-4dea-a7dd-be8e0239ca4d">0.2</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div></ix:continuation><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzYy_80bbd136-2a24-48e1-a8d6-e01b73f7774e" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Compensation Plans</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units is determined based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and the Company's determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and the Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 Stock Compensation Plans for assumptions used in calculating compensation expense for the Company&#8217;s stock compensation plans.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzYz_cd8a96ca-85ce-4598-8064-8bea164c9e29" continuedAt="i7e77cbafef4a495782d14eca45a6b974" escape="true">Cash Equivalents</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7e77cbafef4a495782d14eca45a6b974">Cash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits, and other money market instruments, which have maturities when purchased of three months or less.</ix:continuation> </span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzIx_03ced079-31f0-4717-bb02-fce26be6c01e" continuedAt="ia9363419739440caa143824329ae3024" escape="true">Supplies Inventory</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ia9363419739440caa143824329ae3024">Inventories, consisting primarily of purchased laboratory and customer supplies and finished goods, are stated at the lower of cost (first-in, first-out) or net realizable value. Supplies accounted for $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OtherInventorySupplies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMTYx_c3bdb2f7-215b-4939-a587-d76f30a95ec1">412.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OtherInventorySupplies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMTY5_12b9300b-4ca1-464c-ab80-81c46df27771">371.5</ix:nonFraction> and finished goods accounted for $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMjA2_0cd51d69-c21b-470d-b33f-6d28e4533b49">57.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMjE0_4bcb9a88-d267-41ca-8d8a-8ad65b9817ed">29.9</ix:nonFraction> of total inventory at December&#160;31, 2022, and 2021, respectively. The Company's inventory reserve balance was $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMzEw_fd896f84-20c1-4599-8246-4a9a29d7273f">23.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="8" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMzE4_9aa231af-8832-4574-b289-7d95620c66c0">40.1</ix:nonFraction>, as of December&#160;31, 2022 and 2021, respectively.</ix:continuation> </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzI5_73a8867b-68ce-4806-b865-aa0386626bef" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using the straight-line method.</span></div><div style="margin-bottom:3pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDI1_0cb112b0-8a9d-4608-8359-576c1768eeed" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b6a6d5c6ce048f5affe8b3f830295da_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzEtMS0xLTEtMTE3MDI5_ed7126a9-96e2-4f72-aa93-1dabf133a152">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i94949d3130ed4a5799cf762de995588d_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzEtMy0xLTEtMTE3MDI5_73c5b060-f157-4d88-ba38-4fd216445ffc">35</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5a92509bdd1c40ecb4512f86503921ae_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzItMS0xLTEtMTE3MDI5_0dade6d1-5acf-4c1e-b37b-f2e4544164bd">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia5ba3c1e35eb464c897bb213112248c3_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzItMy0xLTEtMTE3MDI5_8e1547c4-0252-4944-a8c1-56abf5e8e665">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a192c3cef59471da28f4a1f91336aa3_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzMtMS0xLTEtMTE3MDI5_424721a6-c494-40b5-bfc7-a8c2bb9054ad">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8df4fdf2ac64fa69822e22b9afd91f3_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzMtMy0xLTEtMTE3MDI5_85649d8c-72c0-4859-9113-00a430e8a96e">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1c8d59fa396741e39a1c2b4ec07bf248_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzQtMS0xLTEtMTE3MDI5_a59022fb-86d9-4753-8da2-1adfeb5c0cbe">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4750c2997b414c319516d7f0f3c2d043_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzQtMy0xLTEtMTE3MDI5_f996c0dd-fa1b-4972-be55-8649eaf139bd">10</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:InternalUseSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDE3_00b028be-0617-4953-984d-090af0219b65" continuedAt="if1f51fcde923411584755140c5fa94a3" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capitalized Software Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes purchased software that is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and the Company commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development (R&amp;D) costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system ranging from <ix:nonFraction unitRef="y" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="lh:Propertyplantandequipmentusefullifesoftwareminimum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyNzky_f745a0d3-4fbb-4e3b-a612-33a176f52086">three</ix:nonFraction> to </span></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ib62ccdfc3c7c4ae4a1dbd268ce9e2b7d" continuedAt="id06382ee94a44dceac8840fefac060fa"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1f51fcde923411584755140c5fa94a3"><ix:nonFraction unitRef="y" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="lh:Propertyplantandequipmentusefullifesoftwaremaximum" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyNzk4_10b6658e-0792-41d8-af1b-b8843bfbd3c3">fifteen</ix:nonFraction> years, generally <ix:nonFraction unitRef="y" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="lh:PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyODE4_34d6d32a-4f8d-4bbb-a094-f2b38556eb39">five</ix:nonFraction> years. Amortization begins once the underlying system is substantially complete and ready for its intended use.</ix:continuation></span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Indefinite-lived Intangibles</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjky_827f874d-2d6f-491c-87a6-52fad186593e" continuedAt="i4c53c2e1a5e44b90b9843fceea5fabe5" escape="true"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjky_bb14ca00-b852-40b6-a2f6-51c709eb980a" continuedAt="i29594fd39c0d4681a8a740ced0ba9fe1" escape="true"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#8217;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. </span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.</span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEwOTk1MTE2NzcwNjA_e829c17a-e2ec-407d-a615-0d4f9008c522">260.0</ix:nonFraction> in the DD segment.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years </span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="id06382ee94a44dceac8840fefac060fa" continuedAt="i5c9c5cffa4c947908ff81fe7844b69cf"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4c53c2e1a5e44b90b9843fceea5fabe5"><ix:continuation id="i29594fd39c0d4681a8a740ced0ba9fe1">vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:IntangibleAssetsFiniteLivedPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU2_519df5de-a92b-4ab1-ae4b-2f2b053bdeea" escape="true"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzE0_d986a1c9-5edb-4438-a7eb-65faaf07868e" escape="true"><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:468.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:15.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib808cf79e1a9467cb239ce57e26f5d7a_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzEtMS0xLTEtMTE3MDI5_5cdeaddb-30c9-4bab-9751-85dd3ca73e56">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08dd77efa97448c782606eca830b8ac9_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzEtMy0xLTEtMTE3MDI5_f40cbd7e-2a68-43ce-9a4e-121e8c1b2f71">36</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if8553f543bdb4c5ea631132f326bb1fb_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzItMS0xLTEtMTE3MDI5_2f1505c7-ebc3-47a5-8294-c7820e7994c3">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib05bf67d55164f34a2b82099cdad4337_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzItMy0xLTEtMTE3MDI5_22e67571-a944-4e24-a01b-cbd08dca6cd2">15</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01d2be985d134f92a0588488c2ad06b2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzMtMS0xLTEtMTE3MDI5_36a86842-d6a5-4122-ad90-318fb9b7d3fd">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bb990f93a5446cc99f3cafcfb16a8c7_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzMtMy0xLTEtMTE3MDI5_e0a06336-60e4-449d-a4b7-e91741f80c26">5</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70260250d8b54b01818e471ec885d017_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzQtMS0xLTEtMTE3MDI5_4f8c26d0-9496-4bbd-a9ec-8834a3b43a37">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id0a5f472de164e8dbe46d04714a66b05_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzQtMy0xLTEtMTE3MDI5_37f118f5-44f7-4c49-8af6-3d017d11f14c">15</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzE1_c41ec9a1-579b-4a62-af3d-3e892c0cf2e0" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Issuance Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs related to the issuance of debt are capitalized, netted against the related debt for presentation purposes and amortized to interest expense over the terms of the related debt.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ProfessionalLiabilityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mzk2_ada2303b-6b3a-48ad-8c07-fe384b3c35e7" continuedAt="ib3cc1916742646b2b8dfea05fab5f06b" escape="true">Professional Liability</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib3cc1916742646b2b8dfea05fab5f06b">The Company is self-insured (up to certain limits) for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is based on assumptions and factors for known and incurred but not reported claims, including the frequency and payment trends of historical claims.</ix:continuation> </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzMx_15733664-0d1d-42c9-93eb-fbf70bea4129" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All leases with a lease term greater than 12 months, regardless of lease type classification, are recorded as an obligation on the balance sheet with a corresponding right-of-use asset. Both finance and operating leases are reflected as liabilities on the commencement date of the lease based on the present value of the lease payments to be made over the lease term. Right-of-use assets are valued at the initial measurement of the lease liability, plus any initial direct costs or rent prepayments, minus lease incentives and any deferred lease payments. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A certain number of these leases contain rent escalation clauses either fixed or adjusted periodically for inflation or market rates that are factored into the Company's determination of lease payments. The Company also has variable lease payments that do not depend on a rate or index, for items such as volume purchase commitments, which are recorded as variable cost when incurred. As most of the Company's leases do not provide an implicit rate, the Company estimates an incremental borrowing rate based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company uses this rate to discount payments to present value. Some operating leases contain renewal options, some of which also include options to early terminate the leases. The exercise of these options is at the Company's discretion and the Company evaluates each renewal option to determine if it is reasonably possible to be exercised and should be included in the accounting lease term. See Note 5 Leases to the Consolidated Financial Statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjg0_9bcbf98c-8edb-4cf6-813f-fd420eb7089b" continuedAt="ifefdc7769825440395f41eb66b64a071" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Income Taxes</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.&#160;If the recognition threshold is met, the Company recognizes a tax benefit </span></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i5c9c5cffa4c947908ff81fe7844b69cf"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifefdc7769825440395f41eb66b64a071">measured at the largest amount of the tax benefit that the Company believes is greater than <ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="2" name="lh:IncomeTaxBenefitMinimumCertaintyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzIwNjYy_eb9c9945-f1aa-45df-9cb2-1265364e255c">50</ix:nonFraction>% likely to be realized. The Company records interest and penalties in income tax expense.</ix:continuation></span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDM2_b67726fd-4e39-42f3-80a1-a12b5bd693dd" continuedAt="i9f08805909dc4c35948146fe38fb4e13" escape="true"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments. The Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements, which have been used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative financial instruments are accounted for as fair value hedges that increase or decrease the value of the Senior Notes with the offset being recorded as a component of other long-term assets or liabilities, as applicable. As the specific terms and notional amounts of the derivative financial instruments match those of the fixed-rate debt being hedged, the derivative instruments are assumed to be perfectly effective hedges and accordingly, there is no impact to the Company's consolidated statements of operations. Cash flows from the interest rate swaps are including in operating activities.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross currency swap agreements, which have been used by the Company to hedge the foreign currency exposure of its net investment in a foreign subsidiary denominated in non-U.S. currency, are accounted for at fair value. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statements of Comprehensive Earnings.</span></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9f08805909dc4c35948146fe38fb4e13">Foreign currency forward contracts, which have been used by the Company to hedge foreign currency receivables, are recognized as assets or liabilities at their fair value. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The fair value of these contracts is not significant as of December&#160;31, 2022 and 2021.</ix:continuation> </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzUw_4c3f77f6-4a50-4b1f-800f-3b517fcc6c7f" escape="true"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements for financial assets and liabilities are determined based on the assumptions that a market participant would use in pricing an asset or liability. A three-tiered fair value hierarchy draws distinctions between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2), and (iii) unobservable inputs that require the Company to use present value and other valuation techniques in the determination of fair value (Level 3).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MjM2_ea828661-77e7-4f54-9b5b-6142f4e01114" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses R&amp;D costs as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzA2_e33bc3da-ea64-4618-b787-da5fad45365c" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries outside of the U.S. that operate in a local currency environment, income and expense items are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders&#8217; equity in the consolidated balance sheets and are included in the determination of comprehensive income in the consolidated statements of comprehensive earnings and consolidated statements of changes in shareholders&#8217; equity. Transaction gains and losses are included in the determination of net income in the consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_190"></div><div style="margin-bottom:3pt;margin-top:7pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDI3_de7c7bf7-f7f7-43aa-b3ae-fafe83415e4f" continuedAt="ib4bec4dd04d44b318971342e3ee73d3f" escape="true">REVENUES</ix:nonNumeric></span></div><ix:continuation id="ib4bec4dd04d44b318971342e3ee73d3f" continuedAt="ic6053e980d6c45d2946a23dc20430187"><div style="margin-bottom:3pt;margin-top:4pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Revenues</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dx attributes revenues to a geographical region based upon where the diagnostic test is performed, while DD attributes revenues to a geographical region based upon where the services are performed. <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDMz_ef5adad3-e55b-43c5-b723-e52094a673d9" continuedAt="i6d8763afe9d44fda832a8541940eaf37" escape="true">The Company's revenue by segment payers/customer groups for the years ended December&#160;31, 2022, 2021 and 2020 is as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ic6053e980d6c45d2946a23dc20430187" continuedAt="ia7547fe972fc4efea1c3b459d3c58baf"><div style="margin-top:5pt;text-align:center"><ix:continuation id="i6d8763afe9d44fda832a8541940eaf37"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:94.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:28.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2022</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMS0xLTEtMTE3MDI5_ffc564ba-8c08-4e02-9e36-4cfcf25da42c">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieabfe2258e1446b192ef394f16489167_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtNS0xLTEtMTE3MDI5_b63d29fd-58e7-41a0-90db-8742148ecf6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTEtMS0xLTExNzAyOQ_13409024-b8e3-476d-9198-58552d60e9ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTMtMS0xLTExNzAyOQ_6b38d010-9e52-4de0-883f-c880cc44e098">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTUtMS0xLTExNzAyOQ_07b9660a-b5f8-43fc-929c-9e7cd9237695"><ix:nonFraction unitRef="number" contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTUtMS0xLTExNzAyOQ_626eb1b8-cde0-433c-9a5c-0582f25db4b6">17</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTctMS0xLTExNzAyOQ_6073ba1f-ad2e-4cb9-827d-dd2892784277"><ix:nonFraction unitRef="number" contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTctMS0xLTExNzAyOQ_d12b806a-8dcf-42a4-b103-6bc2c46af939">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTktMS0xLTExNzAyOQ_08fee676-7298-42f2-8979-ba5ac9530b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjEtMS0xLTExNzAyOQ_12c3a73d-ffc2-460c-b492-f6f0e84e52ed">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjYtMS0xLTExNzAyOQ_d0a4dde7-6ce1-4ae4-941c-81c6984a18c5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjgtMS0xLTExNzAyOQ_0033e698-efea-453a-b32b-565fd7769b1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMzAtMS0xLTExNzAyOQ_4574c43c-fd5c-46bb-8068-2f89e424d107">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49a7f666344b43219373509023b86a61_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMzItMS0xLTExNzAyOQ_6ca3ffa6-06ac-4718-931c-d4190a6121cb">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia00703317297439a899a69e868562330_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMS0xLTEtMTE3MDI5_ef97beb1-888f-42d9-ae8d-9979489a819a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtNS0xLTEtMTE3MDI5_60bfad80-1852-4063-bb23-ba78d8484bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTEtMS0xLTExNzAyOQ_b3615c40-cf3a-4401-9f2e-e2fbc73ea475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTMtMS0xLTExNzAyOQ_bd2e2dc1-cdb1-4e5a-be2c-5a9f0045617a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTUtMS0xLTExNzAyOQ_b4618336-8de7-4c99-8f44-1afe835df481"><ix:nonFraction unitRef="number" contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTUtMS0xLTExNzAyOQ_df747fb9-cdb5-4c5c-a6a9-d416d133c9ab">6</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTctMS0xLTExNzAyOQ_0eb6022d-a832-402d-91ee-5d68f01b747d"><ix:nonFraction unitRef="number" contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTctMS0xLTExNzAyOQ_2ed3078a-cda5-435b-885e-cc7fe72d3caf">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTktMS0xLTExNzAyOQ_40c782aa-8fce-4bbd-b307-78d4654e0c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjEtMS0xLTExNzAyOQ_9efee418-80ce-409f-8629-af8e491f90c5">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjYtMS0xLTExNzAyOQ_90f2575d-3455-4c87-9f85-6aa3fe6fff5d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i174342f325564eb4800f5d7bafca1841_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjgtMS0xLTExNzAyOQ_267a854d-e4f7-4d0e-8790-e5ad4a2aadea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMzAtMS0xLTExNzAyOQ_4ff9c6a3-e335-4262-a979-9a92fb978ed9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMzItMS0xLTExNzAyOQ_12644480-1493-43b0-bcf8-84c48a043fe7">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMS0xLTEtMTE3MDI5_67e351da-d65a-4295-a8cc-ece7f1f99a38">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtNS0xLTEtMTE3MDI5_f646bbc9-b8b6-48b0-a1c5-b50997ce3c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTEtMS0xLTExNzAyOQ_34b02f11-9cd6-45f7-baea-f0b0491afd9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTMtMS0xLTExNzAyOQ_8ed16f25-da28-41c6-afef-6869fbf47139">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTUtMS0xLTExNzAyOQ_f973d042-f777-48a0-a891-e29bfda029b6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTctMS0xLTExNzAyOQ_91e8b979-b035-46c7-9e52-c2b260bb8fbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTktMS0xLTExNzAyOQ_871a9ce1-825c-4f28-9a5c-728bc0ec2050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91139fb3405c40e89005a42835b1528e_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjEtMS0xLTExNzAyOQ_2960cd61-5005-442c-9d7f-be8ed330f94c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjYtMS0xLTExNzAyOQ_64b01766-aabe-4261-a609-4d55644aaf75">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjgtMS0xLTExNzAyOQ_4a75ef98-1a52-423f-8a2c-0b73b3bf9c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a6714ab30154ab7adf7919442029308_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMzAtMS0xLTExNzAyOQ_4cdec5cc-324d-46d8-8413-a8c5cead4ef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMzItMS0xLTExNzAyOQ_e9e15cb8-fdb5-438c-9198-1f99fe6320cb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41204750b78b41e99bbfcab862d31763_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMS0xLTEtMTE3MDI5_63813dc7-22b0-4a7d-9a8b-fd9090a0b7be">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctNS0xLTEtMTE3MDI5_70d61c3a-3e16-4a0a-95d5-37cd6c9d135d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTEtMS0xLTExNzAyOQ_13ca5584-843c-4ae3-a6b9-2e745ede783e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTMtMS0xLTExNzAyOQ_0a4ba1e5-b42b-4f23-a67d-cbcd8e3e94ed">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTUtMS0xLTExNzAyOQ_70729d38-b348-4dd0-afa1-1a00f039691e"><ix:nonFraction unitRef="number" contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTUtMS0xLTExNzAyOQ_ff99a912-0abb-48d1-8d0f-5ec2ab08ea63">34</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTctMS0xLTExNzAyOQ_85f65e7c-332f-432a-b53a-7cb88cac73ac"><ix:nonFraction unitRef="number" contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTctMS0xLTExNzAyOQ_97d013f3-a788-472d-a26d-2c1998700fe6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTktMS0xLTExNzAyOQ_4b70d3fb-a907-4b5a-adfa-4b6c5a823426">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjEtMS0xLTExNzAyOQ_39c638c6-bee2-4791-928b-d85fd3398a89">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icba36eacc3c943cca03f3598759b2674_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjYtMS0xLTExNzAyOQ_e5d5ad7e-2525-47de-8f31-7efb3615015f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0855e4e7139742529986707c444dfb8e_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjgtMS0xLTExNzAyOQ_52547e93-e813-481b-9d65-fee6d2958cb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMzAtMS0xLTExNzAyOQ_3954c7ba-fe0e-4984-a8d1-ae0cbbd82172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMzItMS0xLTExNzAyOQ_c0762774-d1f9-4e55-ac60-5a875c84e108">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMS0xLTEtMTE3MDI5_1df03a3a-3473-4142-8290-de28e08c71b8">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtNS0xLTEtMTE3MDI5_8d8e043e-5e46-48b2-a6bb-b62b8f05e94d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTEtMS0xLTExNzAyOQ_40b117a3-3b9c-4f4c-ae9b-db27e72b7930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTMtMS0xLTExNzAyOQ_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTUtMS0xLTExNzAyOQ_459fb7af-ea71-46b1-9421-9014ef0e075c"><ix:nonFraction unitRef="number" contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTUtMS0xLTExNzAyOQ_9b353615-beba-4a6c-b30d-8ca80952dd95">64</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTctMS0xLTExNzAyOQ_0d3b4240-9e6b-4e1a-8123-ae947e718326"><ix:nonFraction unitRef="number" contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTctMS0xLTExNzAyOQ_af6cef02-8ffc-4923-963b-ca0aeb989cc6">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTktMS0xLTExNzAyOQ_8b829856-5fdb-442b-8a81-b5ad38c20ee0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjEtMS0xLTExNzAyOQ_fd1d06cd-0880-47e1-8150-f015cfcf2156">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjYtMS0xLTExNzAyOQ_6fa054ce-c676-4930-8d75-2cccdeaf3d65">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjgtMS0xLTExNzAyOQ_d96f4e69-3b29-4eb7-a9b3-953b42eee06c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMzAtMS0xLTExNzAyOQ_dd5313ff-22fa-4bbb-80d5-ceb07e723aa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMzItMS0xLTExNzAyOQ_e67c0e10-1410-47f0-a90f-0ea6c273b1b5">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d6cb383b4834da09d62346a62279532_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTEtMS0xLTExNzAyOQ_e131afc4-2553-49a8-8c2f-dc4bd0f75154">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTUtMS0xLTExNzAyOQ_9a407ba3-fa15-43c6-b033-6b8312a87745">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTExLTEtMS0xMTcwMjk_036beacc-c9dd-4559-9188-54df60e51a22">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTEzLTEtMS0xMTcwMjk_afc9324a-33dc-46c5-9679-e8205e4a8f3f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE1LTEtMS0xMTcwMjk_20acbe51-b459-4b87-b617-11ab6216626c"><ix:nonFraction unitRef="number" contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE1LTEtMS0xMTcwMjk_879f0a87-5a50-41fc-8f1d-dbf58b56e8a5">17</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231" decimals="2" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE3LTEtMS0xMTcwMjk_d79968d6-ce59-43f0-9dc5-cd16d6cffb73">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE5LTEtMS0xMTcwMjk_1e78b6da-23c4-4f45-9d78-d44e3e8ccdf0">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTIxLTEtMS0xMTcwMjk_52fe24e0-75d3-4fe4-a6d8-89237790a347">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTI2LTEtMS0xMTcwMjk_b6a25641-78f7-4516-ab75-e80b637a8582">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTI4LTEtMS0xMTcwMjk_f1a23581-874c-4fcd-ab66-2d26297114f2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTMwLTEtMS0xMTcwMjk_56277e88-def6-4dc2-a1dd-76cd7ca6adef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTMyLTEtMS0xMTcwMjk_33a05168-7621-4556-83b6-de53c125691d">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTEtMS0xLTExNzAyOQ_612a8796-4e7e-4e04-b1ca-0198692185a3">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTUtMS0xLTExNzAyOQ_c469b4e7-a1e4-49b5-9420-f8dcbbf09f01">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTExLTEtMS0xMTcwMjk_f68c79a3-a685-40ca-8dc5-98fcc0ea280c">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTEzLTEtMS0xMTcwMjk_bfa7e972-0219-45bc-a914-44231b26c937">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE1LTEtMS0xMTcwMjk_46045b06-3430-4017-9a0a-5c0d447afab8"><ix:nonFraction unitRef="number" contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE1LTEtMS0xMTcwMjk_ad0d209e-2de6-407e-b7e2-0db9f088d21e">81</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE3LTEtMS0xMTcwMjk_003c51be-60ae-468a-a7b5-f3f331d06e35"><ix:nonFraction unitRef="number" contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE3LTEtMS0xMTcwMjk_e88f5c8e-7c19-4729-94a5-4ee6e181e3b4">13</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE5LTEtMS0xMTcwMjk_cbfd13a0-9667-47cb-a51d-2614a6e840cf">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTIxLTEtMS0xMTcwMjk_f1776bcb-6186-42f3-8e06-a6acd66b5946">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTI2LTEtMS0xMTcwMjk_370a4c43-c13d-443c-8cfd-7d01f5614536">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTI4LTEtMS0xMTcwMjk_fa6e2047-c3a0-4938-bcd9-fdcb3f93f6ad">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTMwLTEtMS0xMTcwMjk_d9f50ece-a52d-4a8f-9fe9-8c3eab0c8c38">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="lh:PercentofRevenueContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTMyLTEtMS0xMTcwMjk_de74e993-a7fa-4325-8015-5903478ed42a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues in the U.S. were $<ix:nonFraction unitRef="usd" contextRef="i4c371a44ae834a938c2eab8e3804c578_D20220101-20221231" decimals="7" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM3NA_8f70a3d5-4651-4d16-99df-882fad749393">11,530.5</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="lh:PercentOfDomesticRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM3OA_f6857fb8-225c-409b-9601-1f3475d41149">77.5</ix:nonFraction>%), $<ix:nonFraction unitRef="usd" contextRef="i0c412272fff644b58159484e9b5ae929_D20210101-20211231" decimals="7" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM4Mw_26dab332-2eb0-478c-897d-b86e67e06d24">12,566.2</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="lh:PercentOfDomesticRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM4Nw_e9ce859f-7573-4dd3-a56b-b6b6af71a97d">77.9</ix:nonFraction>%) and $<ix:nonFraction unitRef="usd" contextRef="ia869d1147bc1446495aafb25f926c462_D20200101-20201231" decimals="7" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM5NQ_0b7b7ff9-271c-4e6f-beae-e4ddb6add241">11,192.3</ix:nonFraction> (<ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="lh:PercentOfDomesticRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM5OQ_cc436f64-53a8-4b3f-b9e9-343c39d46fad">80.1</ix:nonFraction>%) for the years ended December&#160;31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the current revenue recognition policies of the Company:</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dx Revenues</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx is an independent clinical laboratory business. It offers a comprehensive menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the U.S. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx also offered a range of other testing services.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Dx segment, a revenue transaction is initiated when Dx receives a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. Dx recognizes revenue and satisfies its performance obligation for services rendered when the testing process is complete and the associated results are reported. Revenues are distributed among four payer portfolios - clients, patients, Medicare and Medicaid and third party. Dx considers negotiated discounts and anticipated adjustments, including historical collection experience for the payer portfolio, when revenues are recorded.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of the Dx payer portfolios:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clients</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Client payers represent the portion of Dx&#8217;s revenue related to physicians, hospitals, health systems, accountable care organizations (ACOs), employers and other entities where payment is received exclusively from the entity ordering the testing service. Generally, client sales are recorded on a fee-for-service basis at Dx&#8217;s client list price, less any negotiated discount. A portion of client billing is for laboratory management services, collection kits and other non-testing services or products. In these cases, revenue is recognized when services are rendered or delivered. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio includes revenue from uninsured patients and member cost-share for insured patients (e.g., coinsurance, deductibles and non-covered services). Uninsured patients are billed based upon Dx&#8217;s patient list fee schedules, net of any discounts negotiated with physicians on behalf of their patients. Dx bills insured patients as directed by their health plan and after consideration of the fees and terms associated with an established health plan contract.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare and Medicaid</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio relates to fee-for-service revenue from traditional Medicare and Medicaid programs. Revenue from these programs is based on the fee schedule established by the related government authority. In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#8217;s results of operations in any period presented</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ia7547fe972fc4efea1c3b459d3c58baf" continuedAt="if5c285cc39e840d1ab637622f9cc84da"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Party</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third party includes revenue related to managed care organizations (MCOs). The majority of Dx's third-party revenue is reimbursed on a fee-for-service basis. These payers are billed at Dx's established list price and revenue is recorded net of contractual discounts. The majority of Dx&#8217;s MCO sales are recorded based upon contractually negotiated fee schedules with sales for non-contracted MCOs recorded based on historical reimbursement experience. </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#8217;s results of operations in any period presented.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party reimbursement is also received through capitation agreements with MCOs and independent physician associations (IPAs). Under capitated agreements, revenue is recognized based on a negotiated per-member, per-month payment for an agreed upon menu of tests, or based upon the proportionate share earned by Dx from a capitation pool. When the agreed upon reimbursement is based solely on an established rate per member, revenue is not impacted by the volume of testing performed. Under a capitation pool arrangement, the aggregate value of an established rate per member is distributed based on the volume and complexity of the procedures performed by laboratories participating in the agreement. Dx recognizes revenue monthly, based upon the established capitation rate or anticipated distribution from a capitated pool.  </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD Revenues</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD is a global contract research organization (CRO) business that provides end-to-end drug development services. DD provides these services predominantly to pharmaceutical, biotechnology, and medical device companies worldwide. A majority of DD&#8217;s revenues are earned under contracts that are long term in nature, ranging in duration from a few months to many years.  The majority of DD's contracts contain a single performance obligation, as DD provides a significant service of integrating all promises in the contract and the promises are highly interdependent and interrelated with one another. For contracts that include multiple performance obligations, DD allocates the contract value to the goods and services based on a customer price list, if available. If a price list is not available, DD will estimate the transaction price using either market prices or an &#8220;expected cost plus margin&#8221; approach. The total contract value is estimated at the beginning of the contract, and is equal to the amount expected to be billed to the customer. Other payments and billing adjustments may also factor into the calculation of total contract value, such as the reimbursement of out-of-pocket costs and volume-based rebates. These contracts generally take the form of fixed-price or fee-for-service arrangements subject to pricing adjustments based on changes in scope.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fixed-price contracts are typically recognized as revenue over time based on a proportional-performance basis, using either input or output methods that are specific to the service provided.  In an output method, revenue is determined by dividing the actual units of output achieved by the total units of output required under the contract and multiplying that percentage by the total contract value. When using an input method, revenue is recognized by dividing the actual costs incurred by the total estimated cost expected to complete the contract, and multiplying that percentage by the total contract value. Contract costs principally include direct labor and reimbursable out-of-pocket costs.  The estimate of total costs expected to complete the contract requires significant judgment and estimates are based on various assumptions of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee-for-service contracts are typically priced based on transaction volume or time and materials. For volume based contracts the contract value is entirely variable and revenue is recognized as the specific product or service is completed. For services billed based on time and materials, revenue is recognized using the right to invoice practical expedient.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts are often modified to account for changes in contract specifications and requirements. Generally, when contract modifications create new performance obligations, the modification is considered to be a separate contract and revenue is recognized prospectively. When contract modifications change existing performance obligations, the impact on the existing transaction price and measure of progress for the performance obligation to which it relates is generally recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most contracts are terminable with or without cause by the customer, either immediately or upon notice. These contracts often require payment to DD of expenses to wind-down the study or project, fees earned to date and, in some cases, a termination fee or a payment to DD of some portion of the fees or profits that could have been earned by DD under the contract if it had not been terminated early. Termination fees are included in revenues when services are performed and realization is assured. </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="if5c285cc39e840d1ab637622f9cc84da" continuedAt="i2add1151caad40a5b288a29351f13ad3"><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">DD Contract costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:SalesCommissionAmortizationPeriodMinimum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzkxNDM_ec39e073-b492-4a76-a544-623f62cc0b59">1</ix:nonNumeric> to <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:SalesCommissionAmortizationPeriodMaximum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzkxNDY_bc981511-ab5e-4d38-a72e-5b2fdaa54d96">5</ix:nonNumeric> years, depending on the business. For businesses that enter primarily short-term contracts, DD applies the practical expedient which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain services. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from <ix:nonNumeric contextRef="i965638d43bce41e3b02735b64f560508_I20221231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMDMx_28d8d117-e591-4282-b069-f6bb44722c7f">2</ix:nonNumeric> to <ix:nonNumeric contextRef="ia91cd079354742c0867df4a66528389e_I20221231" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMDM0_c68bea15-6b77-4f19-b483-05ea39aae010">5</ix:nonNumeric> years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.</span></div><div style="margin-bottom:1pt;margin-top:5pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:CapitalizedContractCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDMx_847a32e8-bc00-4751-bf95-ffb73f7c8425" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:331.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzEtMS0xLTEtMTE3MDI5_c1686821-5345-4d14-a8d0-6cbab33551ae">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="7" name="us-gaap:AccruedSalesCommissionCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzEtMy0xLTEtMTE3MDI5_c39adcb4-fa7f-46bc-8036-cd4198be518c">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzItMS0xLTEtMTE3MDI5_907c5b9a-4beb-4adb-8a58-6683876ad83c">15.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="7" name="us-gaap:CapitalizedContractCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzItMy0xLTEtMTE3MDI5_729d40a6-4ee7-482c-9996-2d8b18b684eb">14.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzMtMS0xLTEtMTE3MDI5_8a29b9be-27cd-40f5-acf1-d5a5ef3dd9fe">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="7" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzMtMy0xLTEtMTE3MDI5_f79b7ccd-6fb0-43a1-a487-e8982f2be861">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the years ended December&#160;31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjQ5_614d4958-f2a5-43b9-b7af-e3fa8318a500">33.9</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjUz_4fee2a6f-d959-475d-8927-242d18ecb839">27.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfDeferredSalesCommissions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjYw_5987a3f7-863b-406f-8206-8760aa7afe68">23.2</ix:nonFraction>, respectively. Amortization related to deferred contract fulfillment costs for the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzc2_17d7f3b8-c83c-41d0-a2e6-f661aac6d360">12.4</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzgw_954b47f3-f69f-415a-bd55-35afdac8a8ee">14.2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzg3_124b93eb-0f35-482f-8558-b1eb60a465f1">10.1</ix:nonFraction>, respectively. Impairment expense related to contract costs was insignificant to the Company&#8217;s consolidated statements of operations. DD applies the practical expedient to not recognize the effect of financing in its contracts with customers, when the difference in timing of payment and performance is one year or less. </span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Accounts Receivable, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Differences in the timing of revenue recognition and associated billing and cash collections result in recording accounts receivable, unbilled services and unearned revenue in the consolidated balance sheet. Payments received in advance of services being provided are contract liabilities recognized as unearned revenue. Revenue recognized in advance of billing are recognized as unbilled services and the majority of DD's unbilled services represent unbilled receivables. Once a customer is invoiced, the contract asset is reduced for the amount billed, and a corresponding accounts receivable is recognized. All contract assets are billable to customers within one year from the respective balance sheet date. The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDE5_36b6ce3e-78b9-414d-adba-d01c5d463e99" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:325.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:88.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19585208fde04b1c81981c0ca9f09061_I20221231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEtMS0xLTEtMTE3MDI5_a0614f07-3ce4-4961-8573-cbe67e471b5c">1,046.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEtMy0xLTEtMTE3MDI5_89804ae8-5ddb-43a9-a14f-008f0794d222">1,193.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3128ec1b43564e2d96eb81597c02d663_I20221231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzItMS0xLTEtMTE3MDI5_5c23372a-c2f0-4950-8393-9afe48fc1538">1,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzItMy0xLTEtMTE3MDI5_65cf276b-2e84-423d-936d-463555151c88">1,089.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzMtMS0xLTEtMTE3MDI5_68142d5e-b315-485d-a8af-3cccb5256d50">43.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzMtMy0xLTEtMTE3MDI5_48e6fed0-1bcc-471d-bb51-642a815d6bd1">21.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzQtMS0xLTEtMTE3MDI5_5a7f1bfa-1154-4bac-b03b-bfee231bb586">2,222.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzQtMy0xLTEtMTE3MDI5_6e1b2ea1-2fbd-47a9-a607-64ed4012b6ff">2,261.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzYtMS0xLTEtMTE3MDI5_a5f16c5d-219a-489c-93db-235830bd7d0a">805.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzYtMy0xLTEtMTE3MDI5_fa2e554c-d6f0-435f-bd48-437c530bad96">730.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzctMS0xLTEtMTE3MDI5_a2f27860-5bdd-4f98-a524-01a8b4d410f9">10.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzctMy0xLTEtMTE3MDI5_43e37523-a43c-4a0e-849e-489ff310c01c">14.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzgtMS0xLTEtMTE3MDI5_3c14bb0a-6b82-46b8-9295-b8573932f06d">795.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzgtMy0xLTEtMTE3MDI5_e99e2891-02e6-4abc-aa34-ee7abc3a45f8">716.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEwLTEtMS0xLTExNzAyOQ_b9c95c47-66ee-4ae0-8baf-140d5b5aba31">582.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEwLTMtMS0xLTExNzAyOQ_1d4e4e26-d36e-4f4e-90ed-cbaa5b734fad">558.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the period, that was included in the unearned revenue balance at the beginning of the period, for the years ended December&#160;31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExNzkx_7d41f583-e493-40d9-b79b-abebfed407a1">330.5</ix:nonFraction>,  $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExNzk2_6e1b659c-ae97-4df7-84c1-b87c34dd0a32">319.4</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:DeferredRevenueRevenueRecognized1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExODA0_79b9232c-479b-42bb-9f6b-6dbea5388762">262.6</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Credit Loss Rollforward</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the year ended December&#160;31, 2022, is as follows:</span></div></ix:continuation><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDIw_88856f5e-d367-49e6-a434-862142490fc5" continuedAt="ib580525c0d79486e906d785b05dfa9c9" escape="true"></ix:nonNumeric><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i2add1151caad40a5b288a29351f13ad3"><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><ix:continuation id="ib580525c0d79486e906d785b05dfa9c9"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtMS0xLTEtMTE3MDI5_86d69123-810d-4257-b619-4f8f14cac4b2">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtMy0xLTEtMTE3MDI5_87f6ab28-44eb-4b3b-b279-0f8abd1b4b42">11.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtNS0xLTEtMTE3MDI5_900956e4-5a3f-4777-84d0-0f2652c60a24">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtNy0xLTEtMTE3MDI5_f9ae7e7c-11d8-4ad4-bf83-6622073924dd">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtMS0xLTEtMTE3MDI5_7822ee94-c545-4011-87d1-7df9457d4b57">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:UnbilledServicesCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtMy0xLTEtMTE3MDI5_d0c62bd4-b793-43f8-8233-b55573c1e4d5">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:NoteReceivableCreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtNS0xLTEtMTE3MDI5_bcfc94a5-a346-40bc-806c-2a61862ca692">5.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:CreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtNy0xLTEtMTE3MDI5_6596f4a1-91b3-4365-889b-290cb9b689bf">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5219a3f22dd9428d97614fe3e7a1a766_D20210101-20211231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtMS0xLTEtMTE3MDI5_82520baf-7f31-4db3-9403-7aca6442741c">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id19f57dcee3c4712a2023169a0f785c2_D20210101-20211231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtMy0xLTEtMTE3MDI5_a4f19c03-e7a0-4a09-97bd-2319120adb5c">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd8265eb4614ca3a1c91f1a4b31e2c1_D20210101-20211231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtNS0xLTEtMTE3MDI5_d5670a82-5bf5-485d-985d-c2a8bd38fedc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtNy0xLTEtMTE3MDI5_013f48c6-3982-41c0-82bf-ee47d98d8fb5">4.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtMS0xLTEtMTE3MDI5_2248baec-71c6-42ea-96de-e2ef71539061">21.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtMy0xLTEtMTE3MDI5_e538ab34-1997-44a1-8ad7-7db4dda52a6b">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtNS0xLTEtMTE3MDI5_783280ab-07c3-4fd1-b016-e4bc5ab477d1">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtNy0xLTEtMTE3MDI5_68e2d976-6374-4404-9fc8-007d3dd27e25">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctMS0xLTEtMTE3MDI5_2880703c-be6b-432a-ac05-2aa652bedfef">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:UnbilledServicesCreditLossExpenseReversal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctMy0xLTEtMTE3MDI5_d2acfece-7d0b-4781-9ef8-4e8b89d0e145">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:NoteReceivableCreditLossExpenseReversal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctNS0xLTEtMTE3MDI5_2a715fd0-f3d8-4f4b-bd56-8324a0ffa238">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:CreditLossExpenseReversal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctNy0xLTEtMTE3MDI5_3b5ab47a-c01d-4cf4-bcd7-6f98540d1277">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia997b5615fe74d49820b0e37481079c8_D20220101-20221231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtMS0xLTEtMTE3MDI5_e7c00914-2e8c-4af5-b0ce-44b799ee38c6">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d6b5e93fe48483fa4d489a84eb90fcb_D20220101-20221231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtMy0xLTEtMTE3MDI5_b83003ff-ca05-4be1-b917-733ff7d91dca">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90cdd4fb44c490e8db96e23d840e242_D20220101-20221231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtNS0xLTEtMTE3MDI5_4ee7ab3e-10ac-4605-8772-34e113f1a201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:AllowanceforCreditLossWriteOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtNy0xLTEtMTE3MDI5_977079eb-b71f-4b2e-bc7d-814d6b4a3d2e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktMS0xLTEtMTE3MDI5_5bee593b-47f3-4b57-b723-174cb931b6ea">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:UnbilledServicesAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktMy0xLTEtMTE3MDI5_cea05ab3-cd08-44e9-b2b8-766168f18f08">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:NoteReceivableAllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktNS0xLTEtMTE3MDI5_a6b3e541-e1c3-47dc-ba2a-3751d79b7412">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:AllowanceforCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktNy0xLTEtMTE3MDI5_0a23e3fd-2f38-4445-981c-a744f452b11f">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at DD consist primarily of fully managed clinical studies within the DD segment. The amount of existing performance obligations under such long-term contracts unsatisfied as of December&#160;31, 2022, was $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNDUx_9d02b59d-33f1-46cc-b848-be771876f82e">5,122.1</ix:nonFraction>. DD expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="INF" name="lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNTIz_1fa4c62a-44d8-40c4-bfcc-511a8a78cfb2">30.0</ix:nonFraction>% of the remaining performance obligations as of December&#160;31, 2022, as revenue over the next 12 months, and the balance thereafter. DD's long-term contracts generally range from <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:LongTermContractsDurationMinimum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNjk2_34f24c46-98ce-495c-92ea-d8f963cbfa26">1</ix:nonNumeric> to <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:LongTermContractsDurationMaximum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNzAy_3c72c314-6d3f-4c5f-a6d9-ffb6188903fb">8</ix:nonNumeric> years.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD applied the practical expedient and does not disclose information about remaining performance obligations that have original expected durations of one year or less. DD also did not disclose information about remaining performance obligations when the variable consideration was related to a wholly unsatisfied performance obligation within a series of obligations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within DD, revenue of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzMTIw_0062cd85-dbd8-40bc-9a75-1f7501003d41">73.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzMTI3_0a2e3211-6b3b-457a-b524-414fb9dfc70c">69.8</ix:nonFraction> was recognized during the year ended December&#160;31, 2022, and December&#160;31, 2021, respectively, from performance obligations that were partially satisfied in previous periods. This revenue comes primarily from adjustments related to changes in scope.</span></div></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_193"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU5ODc_d91a7c01-b678-4c70-acd3-aada4685cbcb" continuedAt="i7c58f6f8e3634f308fbd7c1d329d80a1" escape="true">BUSINESS ACQUISITIONS AND DISPOSITIONS</ix:nonNumeric></span></div><ix:continuation id="i7c58f6f8e3634f308fbd7c1d329d80a1" continuedAt="iebcef85b2fb2463ca48d508e89e44f66"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2022</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company acquired various businesses and related assets for approximately $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE1Nw_76694034-4c4f-4f1c-b82d-8f4ca6537906">1,164.0</ix:nonFraction> in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="i604cb92437094b8da834d312ee51fefc_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzM1OQ_c8f06515-92c9-4cbb-bb4c-b5761c7c7fdb">542.3</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzQ2Ng_43ebcfe1-34cc-4c4a-b7f3-66b91744f586">598.5</ix:nonFraction>. The amortization periods for intangible assets acquired from these transactions range from <ix:nonNumeric contextRef="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU2MQ_f18662a4-7156-440c-b36e-9b3d9c262faf">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU2Nw_f23e02fb-c1f6-48d9-9e6d-1ece2dd0ea83">19</ix:nonNumeric> years for customer relationships, <ix:nonNumeric contextRef="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzYxMA_ddf5eede-3833-4588-9b0d-099b3fbd86e0">15</ix:nonNumeric> years for patents and technology, <ix:nonNumeric contextRef="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzY0Nw_ce47dae1-b97c-4c62-8f65-3bf8de3c8415">5</ix:nonNumeric> years for non-compete agreements, and <ix:nonNumeric contextRef="ia2cf3a400b1f476ea5787c60f96898cd_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwNzk_16c86e34-4efa-457a-8572-dbb4da03df67">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzY4OA_faac15a3-4d6d-41c4-8f6f-a1d2eef4364f">10</ix:nonNumeric> years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill reflects the Company's expectations to utilize the acquired businesses&#8217; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2022 for these businesses is included below:</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="iebcef85b2fb2463ca48d508e89e44f66" continuedAt="ia8d2f5aa5a8f42b3bb3f86a649b5af52"><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:24.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.057%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preliminary Personal Genome Diagnostics Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preliminary Ascension Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Acquired During Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMS0xLTEtMTg4ODM3_16cbbf9b-dcf0-4539-aae9-0957bc4de9f2">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMi0xLTEtMTg4ODM3_44c25c33-4245-4c60-b90d-02f89f12e983">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMy0xLTEtMTg4ODM3_b0d17d0e-e446-4987-89ca-0fb628ce5616">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItNC0xLTEtMTg4ODM3_3b21e688-c206-4bd0-9294-0e5effd7542e">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMS0xLTEtMTE3MDI5_bca8649c-8902-4b15-9984-41e9899fd951">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMS0xLTEtMTg4ODM3_494e345c-1c8e-4dd2-b3e3-310105953f69">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMi0xLTEtMTg4ODM3_d21616fd-c904-4157-939e-9b5f2068ecec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMy0xLTEtMTg4ODM3_0b2e265e-e864-4232-b899-b11dcac767da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtNC0xLTEtMTg4ODM3_d127e61e-a4ad-47a1-bf89-01acd73117b1">3.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMS0xLTEtMTE3MDI5_8b0e06a6-520f-4a53-807e-7311e5ebf804">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMS0xLTEtMTg4ODM3_7861712a-35de-4d22-a1b9-917d1523294a">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMi0xLTEtMTg4ODM3_18243ac5-883a-4570-a098-3e7e854ab7f2">24.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMy0xLTEtMTg4ODM3_e9621b57-9491-4c1d-bf24-f00120db4c5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtNC0xLTEtMTg4ODM3_02ba09ae-f7ce-4462-b663-29f0bf727035">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMS0xLTEtMTE3MDI5_0054c193-e070-4047-bb02-ce91ccd4e6f5">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMS0xLTEtMTg4ODM3_ccdcb66e-98a5-4a5e-bd02-a3f1468e9ef1">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMi0xLTEtMTg4ODM3_c606397a-ee84-440c-925b-98204c5fc514">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMy0xLTEtMTg4ODM3_66b41253-ba54-44ed-af17-ee4a59c11c61">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtNC0xLTEtMTg4ODM3_4e61811b-cfa1-41dc-b97a-f9e0927ab5e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMS0xLTEtMTE3MDI5_aebec458-65f8-4aff-8bf5-f71fcc8f7d9b">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMS0xLTEtMTg4ODM3_bbf973ec-366d-402d-961c-13cb365e7a08">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMi0xLTEtMTg4ODM3_eb2d5de9-81c3-48bc-8be5-03e59ae75023">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMy0xLTEtMTg4ODM3_8870da93-2d7e-4412-86bd-32af880d3e13">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtNC0xLTEtMTg4ODM3_7f282e8c-560b-4f9e-95f3-5abe85568f15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMS0xLTEtMTE3MDI5_230409ea-1736-4c6b-8130-35043cf1fd12">53.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMS0xLTEtMTg4ODM3_305a2875-2dfc-4b86-87ab-2fc35975fd8b">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMi0xLTEtMTg4ODM3_c6a01f22-3d6e-443c-847a-43adfde34765">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMy0xLTEtMTg4ODM3_584ab316-bdce-4c3e-bdab-1ae048da566e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctNC0xLTEtMTg4ODM3_7561ccd2-4222-4d7f-b269-6b9c02fa384c">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMS0xLTEtMTE3MDI5_74e500f7-b441-4997-9a4a-bf5eaa53ccef">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6fa1609f454ee999006a2ca5c7fbf4_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMS0xLTEtMTg4ODM3_9ee10d23-23aa-4ae2-96ff-23c173e05551">346.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab204c91683402d8304f351f2d9d8b7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMi0xLTEtMTg4ODM3_836c0743-71a4-44ba-8eff-dc7279f72673">125.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604cb92437094b8da834d312ee51fefc_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMy0xLTEtMTg4ODM3_31b86239-ba52-44da-8403-f6727f694565">126.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16467344b1b432cbe4bb34ac4e88ed2_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtNC0xLTEtMTg4ODM3_b6a7ab4c-e001-4153-986a-2b0427a65f5b">40.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMS0xLTEtMTE3MDI5_93dd1af6-9960-469a-ac05-1aabd0d77ce1">558.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMS0xLTEtMTg4ODM3_522fccb8-6560-448d-8607-74d32aa2c369">136.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMi0xLTEtMTg4ODM3_f50c4608-3e15-4d1b-ae4f-f1754ea45659">233.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMy0xLTEtMTg4ODM3_6d84ea61-fd3e-4b53-96d9-b4cda2ba39f1">172.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktNC0xLTEtMTg4ODM3_2bf54951-694e-47ad-9c32-fe0829e7d45a">30.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMS0xLTEtMTE3MDI5_30e5e7c8-e061-45e8-914c-b319554d47d8">572.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTEtMS0xLTE4ODgzNw_37b4ed37-ce2c-467f-9a53-638f695dd550">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTItMS0xLTE4ODgzNw_59f5b97c-f551-424c-a7c0-ebe977d3416a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTMtMS0xLTE4ODgzNw_8ecdbf80-c641-43c0-9a0d-663e8a117270">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTQtMS0xLTE4ODgzNw_ccdc3fe8-fccd-4135-ba73-329becba2873">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTEtMS0xLTExNzAyOQ_647209dd-b913-45e3-b705-66154d43d2a8">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTEtMS0xLTE4ODgzNw_ea676147-2f57-425c-a05d-f033a6c91200">534.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTItMS0xLTE4ODgzNw_0880a990-69b6-4f05-9851-e21cd6bd1790">426.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTMtMS0xLTE4ODgzNw_a1a635a5-e10a-4a38-86da-072edad38fa7">300.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTQtMS0xLTE4ODgzNw_82cc7a19-f3e0-4675-ba6d-9e0d69abc92a">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTEtMS0xLTExNzAyOQ_f3986993-c748-4c8c-bbeb-da620ba25907">1,258.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTEtMS0xLTE4ODgzNw_2c5c1a33-5851-4527-acbd-5e645cb8624f">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTItMS0xLTE4ODgzNw_b4dc9a24-ab2d-41a4-a3b6-1dba30ead3d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTMtMS0xLTE4ODgzNw_e9f4f45f-73d9-4ccf-9885-12aab906e4ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTQtMS0xLTE4ODgzNw_9a1e7088-1e06-43f1-915b-c5ff5a9d0f74">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTEtMS0xLTExNzAyOQ_d542af5b-d555-4118-b849-9a52ef834f6e">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTEtMS0xLTE4ODgzNw_50fd9eb9-8d50-4232-9232-612cd623c826">57.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTItMS0xLTE4ODgzNw_2045ecc4-10d4-4a79-97de-44d084186aab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTMtMS0xLTE4ODgzNw_c510b90f-734e-4401-8311-d789a213082c">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTQtMS0xLTE4ODgzNw_ac740ff0-79c3-41c6-9862-c1a15106e5a4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTEtMS0xLTExNzAyOQ_05a1c9d5-b378-4179-a653-81409edac8e4">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTEtMS0xLTE4ODgzNw_76fb0cdf-2a3b-4b47-b0a3-99c648f5baa6">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTItMS0xLTE4ODgzNw_bd4825eb-55b8-4c7d-abb7-0aeb2c6074f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTMtMS0xLTE4ODgzNw_be9101fc-9a86-4574-81f6-757cc05d6089">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTQtMS0xLTE4ODgzNw_1db90927-6088-4849-846a-bdd5c114b7e8">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTEtMS0xLTExNzAyOQ_a0d461be-a43a-4887-badd-8d6f43d02cfa">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTEtMS0xLTE4ODgzNw_6f11305f-a4f9-4954-8f3a-546749493235">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTItMS0xLTE4ODgzNw_ce6b2cc0-6ec0-45aa-8b20-d0e85a1ddf2a">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTMtMS0xLTE4ODgzNw_bc32a254-e3c7-49f8-a788-69ce0c589bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTQtMS0xLTE4ODgzNw_badd4da3-0ec1-4b46-952f-ef03564b4d8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTUtMS0xLTE4ODgzMQ_b0b19a77-9ed6-4915-949e-bbef4a9b9675">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTEtMS0xLTE4ODgzNw_3cd81d3f-d3d3-48d2-b394-dc2a719835a7">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTItMS0xLTE4ODgzNw_2d2ee00e-fd32-4bcc-8113-e0a552032769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTMtMS0xLTE4ODgzNw_b7ff5fd1-d6ec-4122-9287-0ab85b4a9682">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTQtMS0xLTE4ODgzNw_0ed07567-f113-4269-9874-6d957f3e8cd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTEtMS0xLTExNzAyOQ_c03f6470-c655-45c9-848a-6c4346bead3c">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTEtMS0xLTE4ODgzNw_752c6496-e871-4a36-9c19-f84c35ee8825">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTItMS0xLTE4ODgzNw_b1e6fc5b-6152-408f-8c17-9dfae9083669">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTMtMS0xLTE4ODgzNw_aa6a3b75-1e21-4057-8228-3410a1663979">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" sign="-" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTQtMS0xLTE4ODgzNw_900ca518-4e6f-4ffc-90ad-50265a5ca223">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTEtMS0xLTExNzAyOQ_75dd6719-daf3-4c8f-84c8-aa4118e83443">94.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTEtMS0xLTE4ODgzNw_1bd1c2ef-c75a-464a-8d21-d347b1c81b07">455.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTItMS0xLTE4ODgzNw_53271c5d-cb67-4d82-b466-feb8058ade12">423.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTMtMS0xLTE4ODgzNw_ecb90259-6b6e-491e-aeec-7fb96217f660">285.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTQtMS0xLTE4ODgzNw_c7583945-c9d1-4829-9779-f0559af08bb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTEtMS0xLTExNzAyOQ_584606b2-620d-4f5e-8c7b-c1fc9a8b4d42">1,164.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation for several transactions are still preliminary and subject to change. The areas of the purchase price allocation that are not yet finalized relate primarily to property, plant and equipment, intangible assets, goodwill, and the impact of finalizing deferred taxes. Accordingly, adjustments may be made as additional information is obtained about the facts and circumstances that existed as of the valuation date. Any adjustments will be recorded in the period in which they are identified.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2022 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2022 acquisitions been completed as of January 1, 2021, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:70.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.273%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzItMS0xLTEtMTE3MDI5_661fc683-16f9-4495-9e8d-524bc8012399">14,997.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzItMi0xLTEtMTE3MDI5_5f2bb436-b2e5-41b7-82d5-8b8d6c261988">16,310.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzMtMS0xLTEtMTE3MDI5_1fdbf802-4469-4b53-82ba-7d667d104355">1,282.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzMtMi0xLTEtMTE3MDI5_c028b8cc-3dc8-470b-a58d-e30d120dfc22">2,362.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2021</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company acquired various businesses and related assets for approximately $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzIxNTE_acbf2d04-9f3b-4e1f-8aa4-315f3bce49de">496.9</ix:nonFraction> in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzIzNTM_ecfee67c-6139-4cb5-969c-a9562c284607">198.5</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="i252781e154ce4ee68f3712bac1795dba_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzI0NjA_55cdfef7-980c-497a-995d-481d9f0af79c">298.4</ix:nonFraction>. The amortization periods for intangible assets acquired from these businesses range from <ix:nonNumeric contextRef="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE4Nzc_f18662a4-7156-440c-b36e-9b3d9c262faf">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzI1NTk_f23e02fb-c1f6-48d9-9e6d-1ece2dd0ea83">19</ix:nonNumeric> years for customer relationships, <ix:nonNumeric contextRef="iad3c9245830049a8a009561519bdef0b_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE5OTY_6453979d-a140-442d-813e-fd212c0f096d">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDA_ddf5eede-3833-4588-9b0d-099b3fbd86e0">15</ix:nonNumeric> years for patents and technology, <ix:nonNumeric contextRef="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDQ_ce47dae1-b97c-4c62-8f65-3bf8de3c8415">5</ix:nonNumeric> years for non-compete agreements, and <ix:nonNumeric contextRef="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDg_faac15a3-4d6d-41c4-8f6f-a1d2eef4364f">10</ix:nonNumeric> years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill reflects the Company's expectations to utilize the acquired businesses&#8217; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2021 for these businesses is included below:</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ia8d2f5aa5a8f42b3bb3f86a649b5af52"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:66.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Acquired During Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzItMS0xLTEtMTE3MDI5_8ca79e16-026e-4ace-8ffd-784e114a0356">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzMtMS0xLTEtMTE3MDI5_6edb12d8-bb82-4e60-a2f8-9c20d0e7d465">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzQtMS0xLTEtMTE3MDI5_9e35fe8a-56df-42f2-9fe8-823edd797ad5">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzUtMS0xLTEtMTczNDUy_3c5b5b11-bee8-4ecc-ba7c-64cb2c76eb14">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzYtMS0xLTEtMTE3MDI5_33e903ee-3669-47c1-a17b-728936969c27">56.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346bf5e89d8c47e791d9565de78267f2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzgtMS0xLTEtMTE3MDI5_daf3cfdf-897f-48ae-b974-b167fac2d1f8">298.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzktMS0xLTEtMTE3MDI5_329aeeb2-5795-4b8d-a801-b87035e4da97">198.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzExLTEtMS0xLTExNzAyOQ_9e8de72d-42c7-4f7b-bed6-60adfd2aed42">572.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzEyLTEtMS0xLTExNzAyOQ_d2c10a79-e5e9-4734-886e-9b80cb99dc1b">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzEzLTEtMS0xLTExNzAyOQ_51f6ac0f-e382-4527-a204-f9966da964a7">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE0LTEtMS0xLTExNzAyOQ_5db16932-c9e8-4a55-b330-095a77501ce4">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE2LTEtMS0xLTExNzAyOQ_4c8241d8-5cb4-4e7c-939e-0966b545e5bd">62.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE3LTEtMS0xLTExNzAyOQ_2ea24a9a-15fa-497b-8e05-6570df1aa688">75.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib748907fa89944549ecc3829559ec590_I20211231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE4LTEtMS0xLTExNzAyOQ_6a7973c3-2d2a-4e90-a7ba-b15bd2affef1">496.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU5NzQ_312e5dc2-e7f6-418a-9c63-df26cb460966" escape="true"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2021 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2021 acquisitions been completed as of January 1, 2020, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:70.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.273%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzItMS0xLTEtMTE3MDI5_86a0bfd8-095d-4c2c-8d6a-9df867b52a19">16,216.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzItMi0xLTEtMTE3MDI5_3000ed40-b244-4326-804e-d2f0a46ed0fe">14,112.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231" decimals="-4" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzMtMS0xLTEtMTE3MDI5_0d791158-a260-41f9-942e-ca003be2f104">2,378.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231" decimals="-4" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzMtMi0xLTEtMTE3MDI5_70d377fd-f030-48e0-96b7-5dc15c3e4ed8">1,554.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2020</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company acquired various businesses and related assets for approximately $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MTA_a353cb41-b15d-4045-b89f-e7fa421ab0b0">267.6</ix:nonFraction> in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $<ix:nonFraction unitRef="usd" contextRef="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MTY_0bddee86-87b5-45b0-b86c-08480f2a2963">121.3</ix:nonFraction> in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $<ix:nonFraction unitRef="usd" contextRef="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MjE_6b1f68e8-c5f7-4f4e-99ae-c2af65fe4e07">166.2</ix:nonFraction>. The amortization periods for intangible assets acquired from these businesses range from <ix:nonNumeric contextRef="id29c59dc621c4fc5a3ef2e75514684f8_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTA3MDM_ecaae15e-272a-40cf-891f-41dd30c18832">12</ix:nonNumeric> to <ix:nonNumeric contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwODM_89c00102-f1b5-4641-8b75-748daf8a422b">15</ix:nonNumeric> years for customer relationships. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill reflects the Company's expectations to utilize the acquired businesses&#8217; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2020 for these businesses is included below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:66.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Acquired During Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzItMS0xLTEtMjI1MjY1_c9fa00ff-7da0-44ac-96fa-625596558707">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzMtMS0xLTEtMjI1MjY1_600350f3-e916-44b6-ad7e-43b16ad09543">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzYtMS0xLTEtMjI1MjY1_e3e495d3-e9da-4275-8a62-a5d04b3376a3">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f418d9de6144d5faff8fb13ade9ed0c_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzgtMS0xLTEtMjI1MjY1_62a1695e-1d37-4b3c-b244-a2fbbbfddd38">166.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzktMS0xLTEtMjI1MjY1_c1cbaf1a-e968-4243-89a3-c6339cf982b3">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzExLTEtMS0xLTIyNTI2NQ_f5d47062-1f43-414e-842f-3db28a412df0">296.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzEyLTEtMS0xLTIyNTI2NQ_93cfc063-4739-45fe-9d2a-7ddd01bd15dd">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzEzLTEtMS0xLTIyNTI2NQ_613d90bd-5fc9-48e7-9f4f-817c88e37c55">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE0LTEtMS0xLTIyNTI2NQ_5799ecce-3069-4406-ae43-43845e38a11a">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE2LTEtMS0xLTIyNTI2NQ_203d71b3-fad5-479d-ad04-344be3b75ddc">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE3LTEtMS0xLTIyNTI2NQ_55bc30e4-5b08-4266-8b72-51a2999b2e71">28.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE4LTEtMS0xLTIyNTI2NQ_f3bdea71-7539-4155-8a0c-47884a756dbb">267.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2020 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2020 acquisitions been completed as of January 1, 2019, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:68.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.774%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZToyY2IzNzM5ZDI2NmM0NzRmYjJjZmQ3MzA1NDdkYzAyZC90YWJsZXJhbmdlOjJjYjM3MzlkMjY2YzQ3NGZiMmNmZDczMDU0N2RjMDJkXzItMS0xLTEtMTcxNjI0_abd7d159-a877-4f22-860f-8b89effcca93">14,032.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231" decimals="-5" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZToyY2IzNzM5ZDI2NmM0NzRmYjJjZmQ3MzA1NDdkYzAyZC90YWJsZXJhbmdlOjJjYjM3MzlkMjY2YzQ3NGZiMmNmZDczMDU0N2RjMDJkXzMtMS0xLTEtMTcxNjI0_e276e040-af1f-4902-af1c-6112e33a8841">1,564.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i9affef4b263d4c7097546e2ee7326a4a_196"></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2MTQ_c7c69e08-b6ab-4ac1-b08a-06834232595e" escape="true"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. RESTRUCTURING AND OTHER CHARGES </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company recorded net restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwMg_b2080884-7fb5-400a-bf1f-bb0ac884e8e8">83.8</ix:nonFraction>. The charges were comprised of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDQyMzQ_6e49f270-1109-4e3b-8f9c-26861d55006b">39.3</ix:nonFraction> in severance and other personnel costs, $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzIxMw_0d5950f3-d47d-4548-b708-85bb4fcc7655">45.7</ix:nonFraction> in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDQyMzA_ebad3dbe-0ef3-4b22-8573-ac6f50c4f986">0.3</ix:nonFraction> in unused severance and $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:FacilityRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzQwNg_41c38d9e-7ac5-4241-8d0b-4e7e2eefaeaa">0.9</ix:nonFraction> in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company recorded net restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzUwNA_0e64d288-52d1-4edb-82e4-96e7d764d70b">43.1</ix:nonFraction>. The charges were comprised of $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzU2OQ_8358b8c1-ddb8-46ba-9206-1f0fb3c2b51e">16.3</ix:nonFraction> in severance and other personnel costs and $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzY4OA_5dfbeca6-5fd5-4e00-9ac5-07d5dcf3cacf">28.0</ix:nonFraction> in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzgyNw_c038108f-6e93-4a3d-83b9-d2c1d643d14d">0.4</ix:nonFraction> in unused severance and $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:FacilityRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzgzNA_dee88a83-9103-4aa8-8102-565c6a4ccc0e">0.8</ix:nonFraction> in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company recorded net restructuring charges of $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3Xzk2Ng_404ecba5-d63e-4c5d-93ea-13cf5958c213">40.6</ix:nonFraction>. The charges were comprised of $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwMzE_df9ca682-5650-4770-acad-8774b988e4d6">14.1</ix:nonFraction> in severance and other personnel costs, $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDM3MzI_601cf834-c69c-4b7d-9795-59d6270c4b07">17.4</ix:nonFraction> for facility, operating lease right-of-use and equipment impairments, and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwNzc_a7125b87-90b8-4b37-ad2f-9bbfcb7a5d77">18.9</ix:nonFraction> in facility closures and general integration activities. The charges were offset by the reversal of previously established liability of $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEyNDM_ca966b08-6bb5-4695-ac73-51d985cdc5ab">0.6</ix:nonFraction> in unused severance and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:FacilityRelatedRestructuringReserveAccrualAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEyNzA_debd3042-3c4e-42af-ac77-4ca208881b4b">9.2</ix:nonFraction> in unused facility-related costs.</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2MTY_dd546d1b-ebcc-4959-bf9e-d4ec36d07248" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring activities for the period indicated:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:38.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.719%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other<br/>Employee Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and Other<br/>Facility Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93f046cd09934cefaa22ced67e90f4fa_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItMS0xLTEtMTE3MDI5_9e6b347a-dcac-4735-a8e5-64be6ed6e740">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife7be025871a46fd9996d5ad9debe4f6_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItMy0xLTEtMTE3MDI5_a44559d2-f020-4a11-ba79-0952fb9beb9a">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItOS0xLTEtMTE3MDI5_1b2d16ab-61af-4bab-a4bb-7e79b5e3968f">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtMS0xLTEtMTE3MDI5_9d80ec8a-50a5-4187-82d2-a0b51daca3d9">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtMy0xLTEtMTE3MDI5_f0020de6-866c-4803-847d-f963489f4b84">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtOS0xLTEtMTE3MDI5_c7b7e5fa-f026-4f28-949b-66a54bf027cc">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMS0xLTEtMTE3MDI5_131f7fd3-f740-4b14-85d9-2322a3f73cf3">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMy0xLTEtMTE3MDI5_dbbb8031-6cf9-4d55-a374-f573811c7127"><ix:nonFraction unitRef="usd" contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMy0xLTEtMTE3MDI5_faae35ac-1e40-42c3-8d4d-b476bc9b8efc">0.8</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtOS0xLTEtMTE3MDI5_8a86edaa-c724-4edb-b073-9c500aa511de">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtMS0xLTEtMTE3MDI5_b418b2e5-6e50-4380-9a68-2aae218a4d4b">14.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtMy0xLTEtMTE3MDI5_4cfe10d0-dc64-44b1-a940-5be109d6b027">28.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtOS0xLTEtMTE3MDI5_7e239049-1eb5-4f3e-851c-8e9101cf7914">42.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7ab45a11aea4219a7df41bd1d97f0ec_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctMS0xLTEtMTE3MDI5_4610b26e-64f3-4f16-8b0f-bd971005153c">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2ae9f163ab4ccfb154f4e3d2b57376_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctMy0xLTEtMTE3MDI5_b5e092c5-208d-42f2-ab5e-5f6f8808f9fb">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctOS0xLTEtMTE3MDI5_6b36e5ec-4553-4579-90f3-c6c98a0c0979">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtMS0xLTEtMTE3MDI5_ab204a6c-c26f-4e6a-b605-356833de35b0">39.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtMy0xLTEtMTE3MDI5_38747a0b-aef2-4fad-9257-e7efff481eb6">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtOS0xLTEtMTE3MDI5_7d5020dd-2112-4094-878a-9f1825a30086">85.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTEtMS0xLTExNzAyOQ_f877ce15-9889-4442-bb27-82304b876781">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTMtMS0xLTExNzAyOQ_6a5a0923-5f17-45f6-9597-e8e9b92de3a5">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTktMS0xLTExNzAyOQ_6c3c947d-02d4-4441-a47f-7a0c7eb2c79e">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTEtMS0xLTExNzAyOQ_2500a624-d88a-4440-9c26-c7542c4aebbd">39.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTMtMS0xLTExNzAyOQ_c8afc9a9-67f5-4611-bc69-696e2a5eb936">34.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTktMS0xLTExNzAyOQ_720d8014-31be-474b-b28b-b9fc48171d19">73.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ba475ac08fc422a97df2c8e89234910_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTEtMS0xLTExNzAyOQ_b7a89c61-12f8-4b12-83cc-ca25d7784791">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9115627d081a4e7f8da9645e6c6e0dbd_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTMtMS0xLTExNzAyOQ_7d58ae55-98cb-496e-b4da-54ecf1d44f04">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTktMS0xLTExNzAyOQ_0369c108-ccdc-4764-a4b1-b2e2ddbb7243">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RestructuringReserveCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEzLTktMS0xLTExNzAyOQ_301cfc0c-a058-4b85-be72-266ed04fb1ef">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RestructuringReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzE0LTktMS0xLTExNzAyOQ_4a7d35a5-f361-4d23-bc4e-562204d77899">10.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzE1LTktMS0xLTExNzAyOQ_2c30e6b0-350e-4573-a6d3-be10ebff7b55">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The non-current portion of the restructuring liabilities is expected to be paid out over <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE0OTc_f3e96a99-36b0-4727-8861-55f3e2f90378">10.7</ix:nonNumeric> years. Cash payments and other adjustments include the reclassification of profit sharing, pension, and holiday accrual.</span></div></ix:nonNumeric><div id="i9affef4b263d4c7097546e2ee7326a4a_199"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMzI_f3345263-6722-4c3f-a807-6e8cbf93f328" continuedAt="i7907f4e0b1db4ef590ffe27258d318b5" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i7907f4e0b1db4ef590ffe27258d318b5" continuedAt="i46107d903dec468f87d78186741f23f3"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for patient service centers, laboratories and testing facilities, clinical facilities, general office spaces, vehicles, and office and laboratory equipment. Leases have remaining lease terms of less than a year to <ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzI3NA_a2a7d3d9-4211-40c2-a671-ee35bb0af8ab">16</ix:nonNumeric> years, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzM0NQ_8f775fb4-4e50-4cb0-9dbf-38d576923807">15</ix:nonNumeric> years.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="text-align:center"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:LeaseDisclosureTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMzM_cdff8d6e-a4c3-4362-858a-9479899dddf4" continuedAt="if445bb7e0ac748dab3ab56cede0ce2f1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.006%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzItMS0xLTEtMTE3MDI5_cc263f8b-3f86-45d7-8aa7-895b91656142">220.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzItMi0xLTEtMTE3MDI5_6fb7e76c-30a5-4461-8aaf-3c930ba36f2e">220.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzUtMS0xLTEtMTE3MDI5_014cec33-8037-4a23-9e61-d1fc85cdf7e3">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzUtMi0xLTEtMTE3MDI5_84509427-7dfd-42a8-8c2d-8a2dcb90f8ba">9.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzYtMS0xLTEtMTE3MDI5_476c1d30-92ac-47fd-b358-5d688759b4a0">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzYtMi0xLTEtMTE3MDI5_d777c242-ce2b-4a4b-8350-ea9502b660ef">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzctMS0xLTEtMTE3MDI5_1d84c149-6cc5-4c96-99ad-cfc4c3f041cc">13.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzctMi0xLTEtMTE3MDI5_b29e141e-0f51-4a6b-a4e9-a55f1ba3031a">14.8</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i46107d903dec468f87d78186741f23f3" continuedAt="i1bc1fcc0fb874a4f878da716d885efdf"><ix:continuation id="if445bb7e0ac748dab3ab56cede0ce2f1"><div style="margin-top:2pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzMtMS0xLTEtMTE3MDI5_717f614c-a6a7-4733-8308-9b3f0a1fa4a6">225.9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzMtMi0xLTEtMTE3MDI5_bf770e84-c300-4cee-8352-e940e9a246e4">219.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzQtMS0xLTEtMTE3MDI5_e3ae1763-12ff-4716-a6a6-2912c5285163">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzQtMi0xLTEtMTE3MDI5_53f4ea87-5538-4bc5-9bff-275ea8b479c8">5.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzUtMS0xLTEtMTE3MDI5_5c428bc6-4848-42a9-af3e-e5e2adb47361">12.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzUtMi0xLTEtMTE3MDI5_a937a474-9339-4d2c-9efb-f989da787b3b">13.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzgtMS0xLTEtMTE3MDI5_4c5692b7-6b80-40f8-b03c-53bf40f87f53">178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzgtMi0xLTEtMTE3MDI5_4f20342e-2c51-4bcd-b79b-99b9c42a2d58">164.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzktMS0xLTEtMTE3MDI5_0c6d4ac0-1a42-47ab-bb69-d23614e80efa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzktMi0xLTEtMTE3MDI5_85476ac7-e665-43e1-b1fa-efa880eb7ab4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMjI_d7551ce7-9ad6-48e6-b47d-e5a99e7ed421" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:63.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.133%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f">Operating lease ROU assets (included in Property, plant and equipment, net)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMS0xLTEtMTE3MDI5_d7e51360-ae56-4352-9491-70c8ca8bd6eb">773.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMi0xLTEtMTE3MDI5_1ebb2b95-6512-421b-aa4e-121f98310047">746.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzQtMS0xLTEtMTE3MDI5_9d60b77b-6b54-4329-83f5-f91e7ea8d5ce">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzQtMi0xLTEtMTE3MDI5_72ab5a33-c9dc-4afe-9c4b-b421f7a79ec7">187.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzUtMS0xLTEtMTE3MDI5_a82eb22b-13c1-4361-b287-f7c262e2ff2d">679.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzUtMi0xLTEtMTE3MDI5_dd17dc81-c386-49db-bf55-cabbc678f38f">642.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzYtMS0xLTEtMTE3MDI5_6158a173-df85-4089-9d0d-e99785338d32">865.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzYtMi0xLTEtMTE3MDI5_57329298-6af5-4ae1-b9d4-e4f20af46992">829.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a">Finance lease ROU assets (included in Other assets)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTEtMS0xLTExNzAyOQ_c5ec9f06-ed0a-4b2e-9559-6b69d68d5e65">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTItMS0xLTExNzAyOQ_46f65082-1511-4a79-ba57-02ce33753c9f">81.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEyLTEtMS0xLTExNzAyOQ_102be517-3a54-40db-b1fa-2a51a56ae1c1">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEyLTItMS0xLTExNzAyOQ_a5123ddb-dc78-433a-a6e7-835dc14ed789">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEzLTEtMS0xLTExNzAyOQ_fbc6605d-5777-485b-b063-6328b7065382">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEzLTItMS0xLTExNzAyOQ_dd08b24a-8a21-49f3-9cf6-c7f803204745">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE0LTEtMS0xLTExNzAyOQ_0cd5a64f-3e40-4ba8-a959-6b5279047c30">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE0LTItMS0xLTExNzAyOQ_7f43c8c8-afd9-425f-80e4-0312e67c2f6d">95.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE3LTEtMS0xLTExNzAyOQ_21cb837e-b87f-41fe-a1df-e9a41e5e6b4a">8.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE3LTItMS0xLTExNzAyOQ_50d57322-72aa-4a4c-8dee-e5bbd43a6d24">8.4</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE4LTEtMS0xLTExNzAyOQ_27931e86-9c56-434b-8ac6-d26cdaa4773c">15.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE4LTItMS0xLTExNzAyOQ_4e86507e-e611-4082-8073-17092a635468">15.5</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIxLTEtMS0xLTExNzAyOQ_7ca38074-1e05-44ef-8ff4-d0cc84c6cbb6">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIxLTItMS0xLTExNzAyOQ_7a086fda-be71-4d8f-b4f9-7aad14b34879">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIyLTEtMS0xLTExNzAyOQ_ce5fe88b-9857-48b8-98bb-b29aad480788">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIyLTItMS0xLTExNzAyOQ_e01c81e3-cfb7-4009-bcd5-c8098ffe3958">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMTY_57959557-7c09-41a8-9f75-2321f1fceec9" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEtMS0xLTEtMTE3MDI5_22affe25-b795-4ae7-9a8f-f9c58ee17a61">213.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEtMy0xLTEtMTE3MDI5_84eb7c0a-f298-4c31-bcf0-64cdb01a4282">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzItMS0xLTEtMTE3MDI5_e9ddf924-0f0b-4936-8959-906f165f577c">160.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzItMy0xLTEtMTE3MDI5_559f8542-74b1-43e0-906a-702054459385">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzMtMS0xLTEtMTE3MDI5_ba188ece-b344-4035-ab72-d141ac70d9ab">119.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzMtMy0xLTEtMTE3MDI5_08a214a5-93f3-495c-980a-873e0be6d56f">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzQtMS0xLTEtMTE3MDI5_0f4f2335-3dff-44c6-9c47-824898252a52">89.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzQtMy0xLTEtMTE3MDI5_b024b2b5-0a5b-452d-9b06-be472eb49fef">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzUtMS0xLTEtMTE3MDI5_cd64ad19-ac1a-4623-9f13-b61de17bf635">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzUtMy0xLTEtMTE3MDI5_0b66e83a-ad47-4c19-a63b-4e0557dfcb6f">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzYtMS0xLTEtMTE3MDI5_cdebade1-39d3-44b0-8727-ba4059b3ae02">369.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzYtMy0xLTEtMTE3MDI5_89aab050-aee8-4e95-8c2e-1383777b1757">85.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzctMS0xLTEtMTE3MDI5_dc5fa7b8-a8f9-4faf-b4af-a35ffa93e059">1,024.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzctMy0xLTEtMTE3MDI5_f855499f-264d-4c69-b0bf-63a6a273aea0">129.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzgtMS0xLTEtMTE3MDI5_8130036f-8d65-42b6-9cb3-b137351ebdbb">159.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzgtMy0xLTEtMTE3MDI5_63365e7d-344a-4d17-8ecd-705d29720224">39.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzktMS0xLTEtMTE3MDI5_c0404fe4-f4f4-40f5-bdab-835dff479672">185.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzktMy0xLTEtMTE3MDI5_6026e8c4-d519-460d-871d-e03f4108bc69">6.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities, due beyond one year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEwLTEtMS0xLTExNzAyOQ_6b8d26c1-9aa7-40d6-8ecc-18f08e492099">679.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEwLTMtMS0xLTExNzAyOQ_9df5a52e-1a26-4c8a-aa81-de6ad0a9ba7c">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:15.75pt"><ix:continuation id="i1bc1fcc0fb874a4f878da716d885efdf" continuedAt="i5d5d160c8892476193f34c0624093c93"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for short term leases with a term less than one year for the years ended December&#160;31, 2022, 2021, and 2020  amounted to $<ix:nonFraction unitRef="usd" contextRef="i15ec77218cf94460acd857ca3fc42292_D20220101-20221231" decimals="7" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzcyNg_f4bf513a-018c-41d5-b31f-50016a8e5ff1">22.2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="id32383bcdde34b8fbc97617bf62c3dd2_D20210101-20211231" decimals="7" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzczMA_88826e5d-d4de-4179-905f-de4bec966fb3">19.5</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7758f5f025ff42db97476f45552e5168_D20200101-20201231" decimals="7" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzczNA_340984ce-0ace-4f7b-a840-79488aa6d0cf">6.8</ix:nonFraction>, respectively. The Company has variable lease payments that do not depend on a rate index, primarily for purchase volume commitments, which are recorded as variable cost when incurred. Total variable payments for the year ended December&#160;31, 2022, 2021 and 2020 were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="7" name="us-gaap:VariableLeasePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk4NA_c6c54462-1158-40e9-a6bd-79ddf9c180ad">27.9</ix:nonFraction></span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5d5d160c8892476193f34c0624093c93">,  $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="7" name="us-gaap:VariableLeasePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk4OQ_fb6c4071-3d3e-4f1c-9ea8-1200787c4082">28.4</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="7" name="us-gaap:VariableLeasePayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk5Nw_678b35cc-b229-4f44-a133-ae6f9839cf83">26.7</ix:nonFraction>, respectively.</ix:continuation> </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="i9affef4b263d4c7097546e2ee7326a4a_202"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzI2MQ_a9972a0d-a9a8-447b-a42e-5e89a4ba5de5" continuedAt="i8826c0d04beb426884b3bb0bc7c07a98" escape="true">PROPERTY, PLANT AND EQUIPMENT, NET</ix:nonNumeric></span></div><ix:continuation id="i8826c0d04beb426884b3bb0bc7c07a98"><div style="margin-bottom:3pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzI1OA_b2bf8ff7-fab6-4181-9664-c7dce613a0f2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea6006a8e5f2488bbb8e13dc157b4650_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEtMS0xLTEtMTE3MDI5_327b80cf-8c0a-4023-b74c-07c0af870a43">99.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1624bc86da8f4e7c97d88cbeedab552c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEtMy0xLTEtMTE3MDI5_85020de3-09f0-490e-805d-eb7f54d2d7a4">101.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i761a366fe39c434287e8300df93759d6_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzItMS0xLTEtMTE3MDI5_56df6489-af7c-490b-918a-d3267d71d5e6">1,023.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34a480df3781456c930f1c1d2bf6e6d9_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzItMy0xLTEtMTE3MDI5_c3b2c0b4-3d87-48ca-b83c-296fc75d28e1">954.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811cf99c6ab84718b8ec51529c8c38e9_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzMtMS0xLTEtMTE3MDI5_bde50e1d-3f6a-4f81-95f9-326065cd0fc2">1,893.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b1af064155a4d36999ebf514f2fb89f_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzMtMy0xLTEtMTE3MDI5_97b1b120-255f-4909-a5a7-5b5e1011a34c">1,670.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950679da32524bd98789e95cea30a39a_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzQtMS0xLTEtMTE3MDI5_b343de98-e9b9-4af1-96d5-6650a03ce36c">906.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if213a3c74f2f48209419ad339b5b7d96_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzQtMy0xLTEtMTE3MDI5_00973a93-3798-4105-aa95-2c80aa4330eb">840.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia778a92aafcf4f3b86b6acf7a5f3bd00_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzUtMS0xLTEtMTE3MDI5_c9c7f1d8-3f51-402c-96b2-e986bdb19f26">514.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a6f1b47c1da4a07a4d90f7f6d9d6873_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzUtMy0xLTEtMTE3MDI5_dfc02efe-8f0a-4ef7-b78e-a266b05b556b">459.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida4c96b0a864423fb6941c990f0bd412_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzYtMS0xLTEtMTE3MDI5_3e1c578e-6e4d-4503-ac20-311eb171f138">118.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06896b17e3534bd886142dad93e0126c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzYtMy0xLTEtMTE3MDI5_df3d9f86-6247-4770-9b1c-7c1f6d4132a8">111.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7047efd7d9e048fc9d889f0909b29db0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzctMS0xLTEtMTE3MDI5_91a00293-2cb3-44fd-b36a-6fc6f303d9ca">350.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2d22758b6b4c40aba801d1dee0b10e_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzctMy0xLTEtMTE3MDI5_1c70789b-dd1d-494a-821f-2496e3baee25">344.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07c4ccb6a1234b26931a664345261420_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzgtMS0xLTEtMTE3MDI5_98e11763-7403-4815-b908-6455880374da">773.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467dc562a91848b1b0ce1f13ff671106_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzgtMy0xLTEtMTE3MDI5_171839a9-af76-4f9d-b99d-2195c3e95325">746.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzktMS0xLTEtMTE3MDI5_102ecf12-1b51-4508-9122-08532eeb7ac9">5,679.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzktMy0xLTEtMTE3MDI5_fe3ae800-277a-47f0-b7ca-a1d96583c46d">5,228.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEwLTEtMS0xLTExNzAyOQ_09f5d711-8fe5-402d-95b3-e1b3b5247271">2,722.8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEwLTMtMS0xLTExNzAyOQ_3fde1cbd-01df-4c22-9ad5-a5d53233ee02">2,413.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzExLTEtMS0xLTExNzAyOQ_40555849-385a-4acd-994e-9cea76720344">2,956.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzExLTMtMS0xLTExNzAyOQ_bd723bf7-c118-4bbb-a160-2633165499b9">2,815.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense and amortization of property, plant and equipment was $<ix:nonFraction unitRef="usd" contextRef="id565f2f485384d39b6ede80e66028f65_D20220101-20221231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEyMg_62fbaa1d-0a1e-4924-8e4c-65c8fe76291d">374.6</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if2ab483bf28244679437409e834f6f56_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEyNg_9ae0b9b0-540e-4344-9ac6-ee9784198f67">375.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="iab7460360be9421682235ca8d2d1749e_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEzMw_1f6d7079-9574-4c40-a0a6-9657b4a8d7e7">349.3</ix:nonFraction> for 2022, 2021 and 2020, respectively, including software amortization of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="lh:SoftwareDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIwNA_46d03327-53bd-4ed4-8cc3-c35377c57982">84.2</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:SoftwareDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIwOA_1affc43a-f304-4822-bad1-4a6656c2a210">82.4</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:SoftwareDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIxNg_27522f05-3768-45dc-a276-0a892cbf4e93">84.7</ix:nonFraction> for 2022, 2021 and 2020, respectively.</span></div></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_205"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NDM_5a9096fc-cca6-4dc2-9655-38dc31b2c41a" continuedAt="i7c6bc7231fc142ce8743b5c376cbbbd8" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i7c6bc7231fc142ce8743b5c376cbbbd8" continuedAt="i08806dfd8b7e4f589026c69f932b2abb"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NTU_bf333c28-bbbd-45e8-976c-0e0c59e95518" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill (net of impairment) for the years ended December&#160;31, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMS0xLTEtMTE3MDI5_0cc21ff3-1486-4933-b068-3a3588af479c">4,046.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec9e46526e14376968e12d3425dfbdc_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMy0xLTEtMTE3MDI5_16cf0f76-ec9c-4aa9-8cc5-dd314fd1535d">3,800.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItNS0xLTEtMTE3MDI5_913ea126-d11c-4ec7-bfec-384d451b7a3b">3,912.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i394a9bbf406443b3a0435107240e0db4_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItNy0xLTEtMTE3MDI5_61f7c7e7-3dab-4c64-ac4f-e37a0655a974">3,951.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItOS0xLTEtMTE3MDI5_3e555066-c247-4680-85e9-7d13d9e65b3a">7,958.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMTEtMS0xLTExNzAyOQ_da1872a5-8c9d-4942-8b76-2c82be145a18">7,751.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMS0xLTEtMTE3MDI5_12f229b9-b1f5-46de-a6b1-435ec0a8ea10">557.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMy0xLTEtMTE3MDI5_d45c0255-c563-4f8e-b22b-457691d691cc">245.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtNS0xLTEtMTE3MDI5_571f770c-4bf0-4c6e-acd6-ae7a7375e411">40.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtNy0xLTEtMTE3MDI5_c57c740a-04f1-4fa7-88a2-fcf5c7edc36b">53.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtOS0xLTEtMTE3MDI5_339d369f-d6a4-4d7f-97cd-db10cf7aadd5">598.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMTEtMS0xLTExNzAyOQ_c8f68747-925f-4c78-9754-ad7559a7fa28">298.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="7" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMS0xLTEtMTE3MDI5_0f5e6703-2192-4d90-aba8-a0ef3e023c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMy0xLTEtMTE3MDI5_db66d8d5-1cae-4b1a-9666-dc34468d8d50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtNS0xLTEtMTE3MDI5_e829c17a-e2ec-407d-a615-0d4f9008c522">260.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtNy0xLTEtMTE3MDI5_966e5e33-ea15-4dfd-9d9e-622e297a52e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtOS0xLTEtMTE3MDI5_1f38e743-6d90-48fa-8684-0cdf035bb549">260.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMTEtMS0xLTExNzAyOQ_2e85423e-26fe-4d93-9bf5-4b1ab2c57096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMS0xLTEtMTE3MDI5_3e9c5fbe-0e46-4ea7-beb0-b36054a43b62">70.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMy0xLTEtMTE3MDI5_0c3d46de-7569-4fbf-91f5-adf94a5e1ee8">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctNS0xLTEtMTE3MDI5_9b39cbf0-51a5-48b4-ad4f-6bd86fc91f3c">105.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctNy0xLTEtMTE3MDI5_f6ab61f7-43e0-49aa-899a-9605ed141932">91.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctOS0xLTEtMTE3MDI5_82394ee1-869a-4e58-be78-3ebbf00c886c">176.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMTEtMS0xLTExNzAyOQ_0a41943b-1ce4-4bb6-b0df-7d2b62336440">91.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19585208fde04b1c81981c0ca9f09061_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMS0xLTEtMTE3MDI5_8aa67590-bb8b-454c-8d55-27dd9887e3c0">4,533.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMy0xLTEtMTE3MDI5_ccc818c1-d94c-45b2-b305-fc2eba4497c3">4,046.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3128ec1b43564e2d96eb81597c02d663_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtNS0xLTEtMTE3MDI5_0fa619c7-04c1-4abb-86e1-786e7da188c0">3,587.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtNy0xLTEtMTE3MDI5_54223fd2-e475-404b-a3c4-94a9de32811f">3,912.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtOS0xLTEtMTE3MDI5_69653839-116b-49c5-a0ad-5cb74ce636ae">8,121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMTEtMS0xLTExNzAyOQ_db4fb3ae-5ccf-4741-8de3-f8fb0f6afa51">7,958.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NzI_7837e292-22c9-4273-90ad-10cb3d6c5a8e" escape="true"><div style="margin-top:2pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMS0xLTEtMTE3MDI5_4d7d89e3-56ba-4083-9f63-31ccd123de46">4,681.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMy0xLTEtMTE3MDI5_1fa51a71-2e83-4fcd-bffc-dbc8c04c7ae1">1,546.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItNS0xLTEtMTE3MDI5_9a6b484e-7502-49b2-b685-ec2d801e7a06">3,134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItNy0xLTEtMTE3MDI5_bb2b1e33-5232-477b-9de6-22c9fdf1bf0c">4,336.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItOS0xLTEtMTE3MDI5_a97425eb-14bb-4bb3-ade9-505f7c0e1ae2">1,362.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMTEtMS0xLTExNzAyOQ_17c9b007-786d-41b3-a126-ce12bbbc5d31">2,973.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMS0xLTEtMTE3MDI5_a57eaa17-5fb2-49bf-b07b-789d68d1695a">574.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMy0xLTEtMTE3MDI5_7c32d9bf-0c42-4d22-9bd1-abae2bbc2062">291.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtNS0xLTEtMTE3MDI5_95c11c5c-25ec-47fa-9f83-44dd98803c14">283.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtNy0xLTEtMTE3MDI5_abb8ea95-186e-4dda-b594-31f96871d4e4">484.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtOS0xLTEtMTE3MDI5_34007617-9f56-4f65-bc52-ce3ba7c4f305">267.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMTEtMS0xLTExNzAyOQ_f1004df0-cd9f-4efd-aba2-99525dfa8ff4">217.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMS0xLTEtMTE3MDI5_01698fd2-6391-4e2f-aead-933579ac1ebb">86.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMy0xLTEtMTE3MDI5_afb4c8d4-5fba-4859-92e5-cd9ccfa9be0b">50.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtNS0xLTEtMTE3MDI5_a37b8d74-8b81-47d7-a025-245dfc3345f7">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtNy0xLTEtMTE3MDI5_9508bbad-3a2b-4320-8b5d-42b108c668d3">70.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtOS0xLTEtMTE3MDI5_61e686c8-7e1b-4ef0-87a4-733602ec637d">35.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMTEtMS0xLTExNzAyOQ_4e95549b-97a1-4a18-949f-21d4d55fcacc">34.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMS0xLTEtMTE3MDI5_91a788d5-1caa-482a-b2dd-73a046e17480">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMy0xLTEtMTE3MDI5_c159e4a6-5731-4703-8dff-3346dd62cffc">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtNS0xLTEtMTE3MDI5_da5654f9-26c4-484f-9234-c7151eaa1cab">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34801d131d6f4e44960ce44490a04267_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtNy0xLTEtMTE3MDI5_80760edc-391b-4060-a912-73a252e4d70f">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34801d131d6f4e44960ce44490a04267_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtOS0xLTEtMTE3MDI5_134059ff-9fef-42ce-8ad7-d4462bbac29e">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34801d131d6f4e44960ce44490a04267_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMTEtMS0xLTExNzAyOQ_eece2ecf-13c7-4e9e-b527-273df7c1510f">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2265572a137642caacddaf6582838a7e_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMS0xLTEtMTE3MDI5_6f9cb998-b58e-4eec-bdb8-9a727a868814">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2265572a137642caacddaf6582838a7e_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMy0xLTEtMTE3MDI5_c131de58-5614-4522-a59a-8b6797b82c94">8.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2265572a137642caacddaf6582838a7e_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtNS0xLTEtMTE3MDI5_46d52f3e-f840-4fd0-9ac7-228e4e555ac0">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i653a67810f964ce0b55ec76d45884668_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtNy0xLTEtMTE3MDI5_cca95d84-66e5-46fc-99a9-3e4c6f6bea3f">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i653a67810f964ce0b55ec76d45884668_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtOS0xLTEtMTE3MDI5_07136d5d-f7c9-427f-9aab-fc2813584cc7">7.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i653a67810f964ce0b55ec76d45884668_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMTEtMS0xLTExNzAyOQ_ef37dc4f-9d93-4b8f-b424-beca48615c22">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMS0xLTEtMTE3MDI5_43db4405-5f4e-4e9b-a55a-2d0d7a078258">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMy0xLTEtMTE3MDI5_87988098-9c39-48c8-a8f6-178a9b1a7775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctNS0xLTEtMTE3MDI5_fcd96248-0d18-4210-b80c-5c2c0be3cae8">468.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctNy0xLTEtMTE3MDI5_181ef7f1-6e4f-40dd-8e86-b5ac29eaaf11">493.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctOS0xLTEtMTE3MDI5_d2f8478a-fb9f-40db-b818-48a5d1e494fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMTEtMS0xLTExNzAyOQ_c95a7da5-81c1-4dd0-a09d-3515f97ed445">493.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea8da233e774824b5531b77c20884c5_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMS0xLTEtMjA3MzQ5_0a254e5f-86ce-4447-9d35-0da5e2299b5e">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibea8da233e774824b5531b77c20884c5_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMy0xLTEtMjA3MzU2_4f8eb92b-cafa-4d32-954a-78a00bd360b0">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea8da233e774824b5531b77c20884c5_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNS0xLTEtMjA3NDAz_3ec1e885-7a68-4a27-8b88-b889c1c43bcd">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNy0xLTEtMjA3NDA4_a98d2c40-c3d5-4a67-9de5-badf9a693631">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtOS0xLTEtMjA3Mzk2_115dfcb7-71fb-4fbc-b27f-83d4b145b0cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMTEtMS0xLTIwNzQxNQ_d6c90b14-e829-4a4c-bf10-db86d78a031a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMS0xLTEtMTE3MDI5_459fe194-9026-450f-be63-9cd38e80b0a9">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMy0xLTEtMTE3MDI5_4cd0c194-6680-47b6-8000-850bf9aeda63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNS0xLTEtMTE3MDI5_7eb7ff34-5d0e-4bd4-b0ee-f70814cce05f">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic421e408749148f891c6d7f1c116e693_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNy0xLTEtMTE3MDI5_7d4281fd-8d77-490f-8d1a-f73b5e4f23fb">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic421e408749148f891c6d7f1c116e693_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtOS0xLTEtMTE3MDI5_c92d774c-ce65-4131-94a0-f07616812d9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic421e408749148f891c6d7f1c116e693_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMTEtMS0xLTExNzAyOQ_b27f4061-639c-468d-936c-587df164b988">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMS0xLTEtMTE3MDI5_b5becc6d-95e9-4c51-ba17-7f388d0ac433">5,851.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMy0xLTEtMTE3MDI5_0fe40f7f-ca27-4246-a097-3810d02c072f">1,904.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktNS0xLTEtMTE3MDI5_56fa19d3-bbab-42dc-9ec9-e995520fcff6">3,946.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktNy0xLTEtMTE3MDI5_b8a34c13-ca5f-4a3e-badf-0b9e631c4be5">5,423.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktOS0xLTEtMTE3MDI5_2b9650b7-0fba-415d-bf48-84bd2192f559">1,688.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMTEtMS0xLTExNzAyOQ_7acc4aad-3267-459c-a359-4e0609894e3a">3,735.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company recorded goodwill and other asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzIxOTkwMjMyNTczODY_4729479a-d0ab-4b46-bf34-fbc30bbc0c58">271.5</ix:nonFraction> which was primarily comprised of goodwill impairment and the impairment of a technology intangible asset.</span></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company recorded goodwill and other asset impairment charges of $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1MzA_6811fcf9-ab4a-4b27-870e-207c95b67677">462.1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1MzU_1b0eb31d-6e47-4a00-8fc4-432d8f5764c8">450.5</ix:nonFraction> within DD and $<ix:nonFraction unitRef="usd" contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1NTM_6c836512-c9fc-4dac-8b1f-ababbad4cc7e">11.6</ix:nonFraction> within Dx. The Company concluded that the fair value was less than the carrying value for two of its reporting units and recorded goodwill impairment of $<ix:nonFraction unitRef="usd" contextRef="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNDU_5faa72d4-66eb-4340-8518-096847ace3db">418.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNDk_a607219e-66d4-4e61-a5ff-b1f4b7d85645">3.7</ix:nonFraction> for DD and Dx, respectively. Additional impairment of identifiable intangible and tangible assets of $<ix:nonFraction unitRef="usd" contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNTM_0c39c72c-fe2d-4507-b92b-6e442f2639ea">31.8</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNTc_a6d7e45e-54c6-4e9f-a8c2-7c336c781de8">7.9</ix:nonFraction> was recorded for DD and Dx, respectively, in 2020, for impairment of a tradename, software, customer relationships, and technology assets.</span></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative goodwill impairment for the Company through December&#160;31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:GoodwillImpairmentCumulative" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNjY_2b83178c-b072-4094-9bd3-a6692d8a773d">733.6</ix:nonFraction>.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i08806dfd8b7e4f589026c69f932b2abb"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company undertook a rebranding initiative and reduced the estimated useful life of its trade name assets to reflect their anticipated use through December 2021. This change in estimated useful life resulted in accelerated amortization of $<ix:nonFraction unitRef="usd" contextRef="icfe4125fff374c76adf4d24857926f50_D20220101-20221231" decimals="7" name="us-gaap:AdjustmentForAmortization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwNjk_52bc2b04-8c8e-41de-bde7-94d037a57123">88.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie3735b80739147d5a271f0e1938aabc1_D20210101-20211231" decimals="7" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwNzc_8413b60d-dc7d-48d8-95da-c6a43d843408">27.5</ix:nonFraction> in 2021 and 2020.</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3ODI_b2275981-2e39-4f65-8317-d7fec26240b8" escape="true"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of amortizable intangible assets acquired during 2022, and their respective weighted average amortization periods are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.254%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average<br/>Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzEtMS0xLTEtMTE3MDI5_3be5a043-73de-4059-9109-6f660c4d3b16">408.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzEtMy0xLTEtMTE3MDI5_33841120-7d27-4c9c-8bf8-fe3ebc977357">18.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89543227f0574d3080d3504a668d3480_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzItMS0xLTEtMTE3MDI5_da012684-22ec-49f0-b276-e7069d55be62">106.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i89543227f0574d3080d3504a668d3480_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzItMy0xLTEtMTE3MDI5_1badd8eb-f175-4163-acae-af38af96a786">13.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzMtMS0xLTEtMTE3MDI5_1412343c-b59d-4044-b2c3-0cf9e9b16925">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzMtMy0xLTEtMTE3MDI5_325d6124-dd56-43db-a67b-3df5d8b28301">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzQtMS0xLTEtMTE3MDI5_5a592b8d-113d-487d-9832-3b21457deb27">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzQtMy0xLTEtMTE3MDI5_ffe72ee2-9052-49ae-8b55-d012d46ffdbe">6.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzYtMS0xLTEtMTE3MDI5_337bdcff-6970-4501-b8c3-eae37d392425">542.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzYtMy0xLTEtMTE3MDI5_deffea06-9461-4497-aaaa-c6a74d057add">16.7</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MTQ_b20fe0ce-5ef6-41f6-8d6c-491dc5072fb8">259.3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MTg_51d50dda-b8c2-47b5-b307-e11cee34c6f1">369.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MjU_1e102f54-5024-497f-8dbb-ad0f1adf0432">275.4</ix:nonFraction> in 2022, 2021 and 2020, respectively.&#160;Amortization expense of intangible assets is estimated to be $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2Mzg_2a8d3633-d871-45ce-98e8-3dc9a67200a3">273.5</ix:nonFraction> in fiscal 2023, $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NTU_fc2de64f-65ff-4ee3-964c-01b3d43f9b2b">268.9</ix:nonFraction> in fiscal 2024, $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NzI_1a090f0b-e2e2-4e68-b068-9817a929a5b7">256.7</ix:nonFraction> in fiscal 2025, $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2ODk_529b7597-b18c-4411-b5b4-77261a931ee4">246.9</ix:nonFraction> in fiscal 2026, $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3MDY_48c83eeb-cb29-484c-b590-fa098a03dbed">232.5</ix:nonFraction> in fiscal 2027, and $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3Mjc_657d2b2f-f085-4a60-8ee6-cdc0766d4484">2,055.6</ix:nonFraction> thereafter.</span></div></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_208"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90ZXh0cmVnaW9uOmNlOGY3MTNkODJjMjRjNDBiMTY1YjQ0ZTdiNDdhYjUzXzQw_5a806a5a-2962-4aa8-aaea-0b54f7ca03dd" continuedAt="i3ace24df6a5c489fa27ebc40049b2ccf" escape="true">ACCRUED EXPENSES AND OTHER</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i3ace24df6a5c489fa27ebc40049b2ccf"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90ZXh0cmVnaW9uOmNlOGY3MTNkODJjMjRjNDBiMTY1YjQ0ZTdiNDdhYjUzXzM3_6d8f9fcb-b811-4e62-9091-cdaf902cdeaa" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEtMS0xLTEtMTE3MDI5_7c02f2a4-3dd6-4da4-b4c3-90a70139a550">527.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEtMy0xLTEtMTE3MDI5_cbe7d45d-904d-46a7-8cc9-a8af964d2825">735.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzMtMS0xLTEtMTE3MDI5_253386dd-a4db-4bc2-b4ee-6468da3e938b">146.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzMtMy0xLTEtMTE3MDI5_d9c596e3-1e17-42b2-ab6d-eb777c5959f4">239.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pass through expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:AccruedPassThroughExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzktMS0xLTEtMTE3MDI5_33992932-d20a-4b2d-a9bd-693c6feef46e">136.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:AccruedPassThroughExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzktMy0xLTEtMTE3MDI5_eccb3bb7-3404-4d98-8cf0-40d335024945">149.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEwLTEtMS0xLTExNzAyOQ_c92dfa70-2757-4b57-935e-d362455e9fef">259.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEwLTMtMS0xLTExNzAyOQ_b50634cd-4c2a-45b5-b6d8-bdb124f7b953">279.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzExLTEtMS0xLTExNzAyOQ_d30e353e-901d-473c-a378-fa514616315d">1,068.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzExLTMtMS0xLTExNzAyOQ_e6dccb7e-03fc-428c-895a-4dca3c2b3c06">1,404.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i9affef4b263d4c7097546e2ee7326a4a_211"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90ZXh0cmVnaW9uOjRjYmNjYmZmYTZlMzRiZGRiOTNmMGQyMDBiYzI4NjhmXzI5_4ba5a126-7b54-45fb-8cda-54446092208c" continuedAt="i3b7d89be2d4c4563a598b104efe8fd0a" escape="true">OTHER LIABILITIES</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i3b7d89be2d4c4563a598b104efe8fd0a"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90ZXh0cmVnaW9uOjRjYmNjYmZmYTZlMzRiZGRiOTNmMGQyMDBiYzI4NjhmXzQ0_89e99317-b266-49ae-888b-68b93ec8b968" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan obligation</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEtMS0xLTEtMjAxNzk3_cf1ca794-c2bc-4c49-bfa6-c302176980ee">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEtMy0xLTEtMjAxNzk3_5b5998ab-3d72-461d-9a9e-e63b71277b9a">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzItMS0xLTEtMTE3MDI5_b7a983a7-b4fa-476a-9828-33dd8d7c42e0">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzItMy0xLTEtMTE3MDI5_5c461cfc-862b-4d59-af12-4c8ec60344ff">136.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worker's compensation and auto</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzctMS0xLTEtMjAxNzY3_bab8bf62-e44f-4f90-b515-156d8c05a532">46.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzctMy0xLTEtMjAxNzY3_6d04e266-bc24-4311-b2ef-c1880ed26dcb">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzgtMS0xLTEtMjAxNzY3_57ed3e61-9417-434b-9614-273c5af2dced">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzgtMy0xLTEtMjAxNzY3_33c0890b-e698-4d12-9c9b-abad1b2c309a">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:OtherLiabilitiesNoncurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEwLTEtMS0xLTExNzAyOQ_a915d034-4205-4559-9e10-920517fbfc67">178.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:OtherLiabilitiesNoncurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEwLTMtMS0xLTExNzAyOQ_04e5038e-1987-491e-983c-8510cd18a499">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzExLTEtMS0xLTExNzAyOQ_119d8712-cdba-4bb4-84b8-a7eece76c731">422.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzExLTMtMS0xLTExNzAyOQ_94aa0d0d-a208-4d04-8631-15a7bfd7bf09">402.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i9affef4b263d4c7097546e2ee7326a4a_214"></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5NjQ_561a99a7-5bb9-4549-afb9-f9a946156128" continuedAt="i02f0cc06a9ce4b0f98b80341918a7ae2" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i02f0cc06a9ce4b0f98b80341918a7ae2" continuedAt="i06f914245853422eaa7380dc7c89dce0"><ix:nonNumeric contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Nzc_97b8639e-ac98-4c21-b650-7de8e1eb4b02" escape="true"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and current portion of long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab31968f0e34f71a97366c123d49ff0_I20221231" decimals="-5" name="lh:A4.00Seniornotesdue2023" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzUtMS0xLTEtMTE3MDI5_9497a8be-b9be-4998-a2d4-67dcee8f4cc3">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ba87d3d0c7416484b4fcb375524965_I20211231" decimals="-5" name="lh:A4.00Seniornotesdue2023" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzUtMy0xLTEtMTE3MDI5_38cf9543-a190-4595-b09c-fcc27f9683cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i065eee6e47b54c3090870de60295f740_I20221231" decimals="-5" name="lh:Shorttermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzYtMS0xLTEtMTE3MDI5_954b154e-b400-424a-972d-a5bf00eb058d">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ba87d3d0c7416484b4fcb375524965_I20211231" decimals="-5" name="lh:Shorttermdebtissuancecosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzYtMy0xLTEtMTE3MDI5_9cb9ba24-001b-4e5b-b035-099dea84195a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd89f07e99954cd38ca792abfb00c002_I20221231" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzctMS0xLTEtMTE3MDI5_02b6e4da-b620-4009-bf4d-a7a56c6ff0e9">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e40fe043084cb7ba090e2fc3810877_I20211231" decimals="-5" name="us-gaap:NotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzctMy0xLTEtMTE3MDI5_e5de0d30-cca1-49ec-9e05-4edddd31685b">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzgtMS0xLTEtMTE3MDI5_bfdcf190-827a-4768-aa50-bb216a9e8cfd">301.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzgtMy0xLTEtMTE3MDI5_27fc4c97-f81b-4aa0-a53a-c484bfc57ddb">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i06f914245853422eaa7380dc7c89dce0" continuedAt="ia5c9eb99d34748519afe784f7a1b5655"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5NjI_fe358623-4d30-470e-a503-106fb53bfd23" escape="true"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Njc_21777285-6290-4952-a1cd-40e947c99900" escape="true"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9f832f2302410f92ba15e850ffaa63_I20221231" decimals="-5" name="lh:A4.00Seniornotesdue2023" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzctMS0xLTEtMTE3MDI5_c6de49f6-bc25-4a06-92ae-912227dad940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A4.00Seniornotesdue2023" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzctMy0xLTEtMTE3MDI5_dab37d08-39fe-44ab-9111-830514368261">300.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMS0xLTEtMjAxMzY3_1fced0ec-4baa-4beb-bb11-0874d22f3b1c">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A2.30seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMy0xLTEtMjAxMzY3_9af1613f-e4b7-43c0-a914-1f9f134f0086">400.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:Seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMS0xLTEtMTE3MDI5_6ea34bd5-1549-49c4-9b73-1cd2b6254676">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:Seniornotesdue2024" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMy0xLTEtMTE3MDI5_aa9164fd-247e-461c-ab05-91d2d8e408ed">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:A3.60Seniornotesdue2025" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzktMS0xLTEtMTE3MDI5_884ab129-48c7-450f-844a-3c8f903d9c00">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A3.60Seniornotesdue2025" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzktMy0xLTEtMTE3MDI5_3b6ed9e7-9b42-4d00-970d-900348ea2952">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55% senior notes due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:A155SeniorNotesDue2026" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEwLTEtMS0xLTExNzAyOQ_b11c6423-b7f9-4cb3-8467-b0c8e0e4c9a4">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A155SeniorNotesDue2026" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEwLTMtMS0xLTExNzAyOQ_ea7d8cf0-2247-43f5-a1ce-c565cd4d2d81">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:Seniornotesdue2027" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzExLTEtMS0xLTExNzAyOQ_2b712a5e-c8c0-4745-a65d-90468e134ef1">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:Seniornotesdue2027" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzExLTMtMS0xLTExNzAyOQ_487edddf-e2c1-4f43-98f2-32ecd141fc67">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTEtMS0xLTIwMTM5MQ_0ffcf4af-8ea0-4443-987b-63918d852d71">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A2.95seniornotesdue2029" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTMtMS0xLTIwMTM5MQ_41bcc55d-2760-4bc0-9b74-f7c2154ffbe7">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% senior notes due 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b64d538c794125b25d372f3e739448_I20221231" decimals="-5" name="lh:A270SeniorNotesDue2031" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEyLTEtMS0xLTExNzAyOQ_7ccc8a5c-73c8-4ec9-bed8-0a9a469eab5f">420.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A270SeniorNotesDue2031" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEyLTMtMS0xLTExNzAyOQ_073cf810-aab0-45c0-a8dd-21438e452957">502.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:A4.70Seniornotesdue2045" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTEtMS0xLTExNzAyOQ_12d2bc22-bb35-4402-8878-0d5b3ee97639">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:A4.70Seniornotesdue2045" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTMtMS0xLTExNzAyOQ_7977be02-fd4d-43e4-af3a-b60a4357d8dc">900.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzE5LTEtMS0xLTExNzAyOQ_1a1e0434-1755-4257-b8bc-78ca7d11414a">33.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:Longtermdebtissuancecosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzE5LTMtMS0xLTExNzAyOQ_8f21baab-40fc-493f-a09f-9adb147a8e69">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIwLTEtMS0xLTExNzAyOQ_cdeda4bd-3fc2-41e2-837e-6166639f6072">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:LongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIwLTMtMS0xLTExNzAyOQ_a30d1a47-79f3-4b6b-a04c-83a029941c72">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIxLTEtMS0xLTExNzAyOQ_75d8a958-b4f9-492d-a987-e7954d8f6226">5,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIxLTMtMS0xLTExNzAyOQ_6b14b8a1-f98e-48a2-93a1-e36bcfa3fc4a">5,416.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2019, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i7ebdf7872d5a46479565341763836748_I20190603" decimals="-5" name="lh:A2019TermLoan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzI0MA_f03e0483-dda5-4739-9348-9bde4e70461f">850.0</ix:nonFraction> term loan (the 2019 Term Loan). The Company fully repaid the remaining 2019 Term Loan balance during the first quarter of 2021. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a senior revolving credit facility, which was amended and restated on April 30, 2021. It consists of a five-year revolving facility in the principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzU2NA_7718d4b5-2602-4814-bf17-844c9ef16a28">1,000.0</ix:nonFraction>, with the option of increasing the facility by up to an additional $<ix:nonFraction unitRef="usd" contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219" decimals="-5" name="lh:CreditFacilityOptiontoIncrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzYzNA_0e6b0112-62a3-44e3-8d6f-5fd9a90a180e">500.0</ix:nonFraction>, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219" decimals="-5" name="lh:CreditFacilityMaximumSwingLineBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzg0OA_420397b4-3430-44fc-a373-126214384db1">100.0</ix:nonFraction> for swing line borrowings and a subfacility of up to $<ix:nonFraction unitRef="usd" contextRef="ied82a46b37fa415f996b1384457e6076_I20141219" decimals="-5" name="lh:CreditFacilityMaximumLettersofCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzkwNA_77dd0000-4380-4f5d-bcc4-bd3c11b92a75">150.0</ix:nonFraction> for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:LineOfCreditFacilityCommitmentFeeDescription" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzEwODg_850fac32-c59a-497d-88e8-615bfe2694be">0.10% to 0.225%</ix:nonNumeric>, depending on the Company's debt ratings. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions, and other investments. There were no balances outstanding on the Company's current revolving credit facility at December&#160;31, 2022, or December&#160;31, 2021. As of December&#160;31, 2022, the effective interest rate on the revolving credit facility was <ix:nonFraction unitRef="rate" contextRef="i241890ceccc848f18d43631185197134_I20221231" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzE1Mzc_7ed491d0-2407-46be-aa44-afcefd2b5581">5.39</ix:nonFraction>%. The credit facility expires on April 30, 2026. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants in its term loans and the revolving credit facility at December&#160;31, 2022, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revolving credit facility is not encumbered by any of the Company's outstanding letters of credit. There were $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzIyNTg_2a19ae85-36eb-483c-99fd-e3b8dcf077c3">84.5</ix:nonFraction> in outstanding letters of credit as of December&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2021, the Company issued new senior notes representing $1,000.0 in debt securities consisting of $500.0 aggregate principal amount of 1.55% senior notes due 2026 and $500.0 aggregate principal amount of 2.70% senior notes due 2031. Interest on these notes is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2021. Net proceeds from the offering of these notes were $989.4 after deducting underwriting discounts and other expenses of the offering. The net proceeds were used, along with cash on hand, to redeem, prior to maturity, the Company's outstanding 3.20% senior notes due February 1, 2022 and 3.75% senior notes due August 23, 2022.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706% to hedge against changes in the fair value of a portion of the Company's long-term debt. These interest rate swaps are included in other long-term liabilities and deducted from the value of the senior notes with an aggregate fair value of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM0NjA_eddde4b6-b479-4d1f-be29-ab70e0d59553">79.7</ix:nonFraction> at December&#160;31, 2022.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ia5c9eb99d34748519afe784f7a1b5655"><ix:nonNumeric contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Njk_ff8f33df-3bbf-49a9-9bcb-8a4195856064" escape="true"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled payments of long-term debt at the end of 2022 are summarized as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:82.331%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzEtMy0xLTEtMTE3MDI5_652b1411-574e-474e-b8aa-6b6bda21b9f7">301.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzItMy0xLTEtMTE3MDI5_5c5ad481-01b2-4bad-96cd-1bf87bf0307e">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzMtMy0xLTEtMTE3MDI5_9edd84a2-f5f6-4760-94a1-23bf57307508">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzQtMy0xLTEtMTE3MDI5_450a19d8-a854-425e-bf58-dff5480d9aaf">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzUtMy0xLTEtMTE3MDI5_fd7883ce-e6e9-49db-ba7f-08dd548edb4c">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzYtMy0xLTEtMTE3MDI5_1828a106-6cc6-49e5-942c-fe2484559b9e">1,972.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total scheduled payments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:Longtermdebtfutureminimumpaymentsinterestincludedinpayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzctMy0xLTEtMTE3MDI5_0b019dc9-d3ea-4994-b98c-18b02a548faf">5,373.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term debt issuance costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:TotalShortandLongTermDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzgtMy0xLTEtMTE3MDI5_96923794-6ba1-4278-b453-595228888e05">33.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:LongTermDebtExcludingDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzktMy0xLTEtMTE3MDI5_224dded1-25ba-44e9-8c18-24b96aec61ee">5,340.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzEwLTMtMS0xLTExNzAyOQ_04a4950c-7200-4d32-8a9b-c5b1f437c7cb">301.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, due beyond one year</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzExLTMtMS0xLTExNzAyOQ_528853a9-fc6f-4545-a867-0a9cb71e852d">5,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_220"></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NjA_d57cd00c-1691-4bcd-ad9e-a12ad61aa74b" continuedAt="i9c18d82bb96c434ca691ff904b65e3ec" escape="true">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9c18d82bb96c434ca691ff904b65e3ec" continuedAt="ia1d96d62026f48cbbeb8f01360065435"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NTc_cbf47c01-13f9-45d1-b6dc-33169b28dfb1" escape="true">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5Xzk5_2ffe9feb-5ba5-474d-8514-87bc6199e5f2">265.0</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzEzNg_12242400-33bb-4b58-aca5-36f5fe1594f2">0.10</ix:nonFraction> per share. The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE5MQ_d72151af-1311-4730-a7b5-15ac684ee2ed">30.0</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzIzMQ_2baeff62-d14c-4fe4-87f7-7d9dc24de148">0.10</ix:nonFraction> per share. There were no preferred shares outstanding as of December&#160;31, 2022 and 2021.</ix:nonNumeric>&#160;</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NDI_ee06e93a-1ced-40ef-b6aa-d63aa91fa19c" escape="true"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued and held in treasury are summarized below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItMS0xLTEtMTE3MDI5_5b97fdfe-a8ee-42ba-abd7-a48f646c59d2">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItMy0xLTEtMTE3MDI5_a2ed4230-0a51-427e-a74e-2558687d5c73">97.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItNS0xLTEtMTE3MDI5_7aef5c4a-5487-4f31-b1a6-7dbd0db494c1">97.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtMS0xLTEtMTE3MDI5_7cf12849-702f-4397-b559-918c93f2edf5">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtMy0xLTEtMTE3MDI5_952477ba-1e17-4459-806a-45e61f90d5f3">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtNS0xLTEtMTE3MDI5_752c747c-5d39-4596-a205-046e93cb0046">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtMS0xLTEtMTE3MDI5_703c238c-869d-4f9d-9e14-5ee01504e077">5.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtMy0xLTEtMTE3MDI5_606fcf08-d20e-43e1-a012-2a0366b4f24d">5.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtNS0xLTEtMTE3MDI5_73713695-02c4-4db6-b7f3-17621a07c115">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctMS0xLTEtMTE3MDI5_022934dc-6776-44c0-8aa3-1daff8d6f7e5">88.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctMy0xLTEtMTE3MDI5_c61614d4-c86b-44e9-b6b5-63435dff1309">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctNS0xLTEtMTE3MDI5_70a66768-816e-4156-a82c-5fdae7e862af">97.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s treasury shares are recorded at aggregate cost. </span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of  2021, the board of directors (the Board) adopted a new share repurchase plan authorizing up to $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5Xzc2Ng_53bfcfd0-59f8-4d97-b4b5-fc35cb376d79">2,500.0</ix:nonFraction> of the Company's shares in addition to the remaining amount outstanding under the previous plan. Under this plan, the Company commenced an Accelerated Share Repurchase (ASR) program. At inception, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDU4Njg_180d0c57-f9ec-4ac9-a531-c2f0c9bee1cc">1,000.0</ix:nonFraction> and received <ix:nonFraction unitRef="shares" contextRef="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDU4ODU_2fa3d1df-f7ea-4cef-a238-448497620ce1">2.7</ix:nonFraction> shares based on a calculation using 80% of the shares calculated at the price at the inception of the ASR agreements with two different banks, Goldman Sachs &amp; Co. LLC and Barclays Bank PLC. The initial shares received under the ASR program were removed from the outstanding share count in 2021. During the twelve months ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i22a0f88f6f224901b84e2ba995acd60f_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5NTM_1fcffe0a-0588-4754-a158-0b003e115a97">0.9</ix:nonFraction> shares were retired as part of this ASR program.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the twelve months ended December&#160;31, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i9a95541978174baabe4f6bf28dc42c4e_D20220101-20221231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5MjE_a2ed51f7-b1d0-408a-a9e8-87f7625f4b23">4.7</ix:nonFraction> shares of its common stock at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzEzOTM_05208c4f-ea1a-494f-8709-811d81477cf2">233.48</ix:nonFraction> for a total cost of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE0MTY_70f52ebf-b5f3-4971-9079-acd100649e15">1,100.0</ix:nonFraction>. At the end of 2022, the Company had outstanding authorization from the board of directors to purchase up to $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:CommonStockRepurchaseAuthorizationOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzMxODM_23c05ce4-cb43-443b-b1d5-15aa5d8bd352">531.5</ix:nonFraction> of the Company's common stock.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, the Board approved an additional $<ix:nonFraction unitRef="usd" contextRef="i2257a78dc611411cbe54235fc9161d50_I20230207" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTE0NzI_6e06a93d-0920-4607-b61f-3db1fac30daf">1,000.0</ix:nonFraction> for share repurchases, bringing the total available authorization to $<ix:nonFraction unitRef="usd" contextRef="i2257a78dc611411cbe54235fc9161d50_I20230207" decimals="-5" name="lh:CommonStockRepurchaseAuthorizationOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTE0NzY_181be92a-be39-4e79-87d7-c9bcd2c098e1">1,531.5</ix:nonFraction>. The repurchase authorization has no expiration.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended  December&#160;31, 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5MjU_b7d25101-fd19-4fbc-812d-f19e650920a1">195.2</ix:nonFraction> in common stock dividends. On <ix:nonNumeric contextRef="i612c1ffa3dbf48b1ba151c5142988893_D20230112-20230112" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTAyOTU_dbd9574f-84f7-4a09-99d8-d40a227d78fc">January 12, 2023</ix:nonNumeric>, the Company announced a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="icb5d5fbbddd149d0a71aea12be2f36ad_I20230112" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTAzNDE_a643288a-aa26-4fb2-9ffe-eb2dc9116843">0.72</ix:nonFraction> per share of common stock for the first quarter, or approximately $64.8 in the aggregate. The dividend will be payable on <ix:nonNumeric contextRef="i9deaf97408a241ccbbd50fa1238da6cd_D20230313-20230313" name="us-gaap:DividendPayableDateToBePaidDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTA0NjM_02751667-ea4a-46c9-bacc-e8bf7392e17b">March 13, 2023</ix:nonNumeric>, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on <ix:nonNumeric contextRef="i042ee9fdbf47424cb316cf8e47c149ca_D20230223-20230223" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTA1Nzg_c7eb2e45-0ff7-4829-8d96-8d5ac033ab43">February 23, 2023</ix:nonNumeric>. The declaration and payment of any future dividends will be at the discretion of the Company's Board.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ia1d96d62026f48cbbeb8f01360065435" continuedAt="ifafe4684fb6a4631bd1f21a9364c99c1"><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NTY_1d6727f9-d9bd-4b05-a48c-885ce3c99c70" escape="true"><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:59.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.559%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Benefit<br/>Plan<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktMS0xLTEtMTE3MDI5_72da5528-d556-44d4-8d3e-a3993c04c38d">21.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktMy0xLTEtMTE3MDI5_ab9eaba4-1302-4719-a9d4-b7c42a0ecfe0">140.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i716799a1a7a34a15b3e9adffdce6996d_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktNS0xLTEtMTE3MDI5_fc071602-5052-41f8-bd27-143e17b4d852">161.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTEtMS0xLTExNzAyOQ_1a678c04-1d9a-4ba9-8f54-589e8328ed3f">104.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTMtMS0xLTExNzAyOQ_3522aebd-33a2-44dc-9865-ddcc0b599860">101.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTUtMS0xLTExNzAyOQ_f57ed13d-1ee1-4beb-9d91-885388e16be2">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536124e79a094520854fc8863d11ccad_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTEtMS0xLTExNzAyOQ_f42ccc22-08a5-41ec-ba4a-441e13404dfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTMtMS0xLTExNzAyOQ_2e437316-9908-4239-a443-78314aa35507">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTUtMS0xLTExNzAyOQ_d977ec70-631b-4fce-aaa9-f458fa43ba88">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTEtMS0xLTExNzAyOQ_526bb9bf-6bbd-4bd2-b31c-f0d42dc306e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTMtMS0xLTExNzAyOQ_eea47f39-1397-493e-b9b3-2de7a3771a96">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTUtMS0xLTExNzAyOQ_91a1afc3-c2f7-4fb2-b82e-3ffd1e5a3efe">6.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTEtMS0xLTExNzAyOQ_c2e91d8e-6f05-443a-a6c0-a8fecf8dc3ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTMtMS0xLTExNzAyOQ_d3175acf-7ac4-447e-8e7c-3f814cd2d1eb">17.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTUtMS0xLTExNzAyOQ_a54c32c5-293f-4d90-b3ce-ffe1cf623217">17.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTEtMS0xLTExNzAyOQ_cb18c1d4-3d5b-40b1-9e2a-1288f42ea84a">125.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTMtMS0xLTExNzAyOQ_e23d91ea-4bb7-4d73-8f22-e50ad1c6ea77">66.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTUtMS0xLTExNzAyOQ_6e7d3cea-76e2-4ca7-93d0-8357775287b6">191.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTEtMS0xLTE3NDEzNQ_8602f195-d89b-48c7-a274-32dadce1c1ba">335.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTMtMS0xLTE3NDE3NA_56e0aab7-9477-4afa-aa46-fee320bc006c">52.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTUtMS0xLTE3NDIxMQ_e7b8c0df-a4ec-4ef1-81d7-7dd22c9975f7">283.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7178226fd2c74faf83c80dbbaa06de64_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTEtMS0xLTE3NDEzNQ_4ebf4bfd-9b06-4753-bfe4-4c1830961a0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTMtMS0xLTE3NDE3NA_edd71ab9-c63f-46dc-954e-a67aa6ce4186">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTUtMS0xLTE3NDIxMQ_33194d3a-d9ea-4970-9e45-ea479739ca37">3.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTEtMS0xLTE3NDEzNQ_abb27a68-f0a8-4034-b178-cc18dfac337e">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTMtMS0xLTE3NDE3NA_2a9d02a7-3d21-4d3e-9ae5-c6635a233781">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTUtMS0xLTE3NDIxMQ_ce0c2123-27c9-464c-854a-e4a0bd978230">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTEtMS0xLTE3NDEzNQ_a46d1c8d-8046-46a9-9bea-9a75b9bef859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTMtMS0xLTE3NDE3NA_de7c855c-04ff-4249-b14b-77e6c7437597">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTUtMS0xLTE3NDIxMQ_fee33208-1da6-4b3a-971c-f66162c3521d">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTEtMS0xLTE3NDEzNQ_1ffa1b32-73a2-4e1c-8afa-a71e01e22d59">462.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTMtMS0xLTE3NDE3NA_63478a9c-8ecf-4125-b41e-be9a02df512e">30.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTUtMS0xLTE3NDIxMQ_102bd21e-c2f5-48a9-aea4-562f7f4d16c3">493.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ifafe4684fb6a4631bd1f21a9364c99c1" continuedAt="i54001d1173ab4c70b79e1471d6a93468">(a) </ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i54001d1173ab4c70b79e1471d6a93468">The amortization of prior service cost is included in the computation of net periodic benefit cost. Refer to Note&#160;15 Pension and Postretirement Plans for additional information regarding the Company's net periodic benefit cost.</ix:continuation>  </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_223"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMjI_0d949481-6107-41d0-8f7f-189d83d9424e" continuedAt="i741437bc12e34c40bc274e32b0c623b6" escape="true">INCOME TAXES </ix:nonNumeric></span></div><ix:continuation id="i741437bc12e34c40bc274e32b0c623b6" continuedAt="idd93840d596d43ffaf94c2b27d440a6a"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ5OTc_9b40de3c-37c7-4e82-bcdc-5df975d8c5fc" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of income before taxes, classified between domestic and foreign entities, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtMS0xLTEtMTE3MDI5_0bdae5df-6540-4e89-b0e3-831cce40f9fc">1,321.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtMy0xLTEtMTE3MDI5_604c99de-1633-4bc0-87f7-25949097599b">2,580.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtNS0xLTEtMTE3MDI5_56abdd1f-551e-41ac-a62a-4888023878d6">1,846.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItMS0xLTEtMTE3MDI5_557f4c06-d5e2-40ba-8c21-f6508b656bf3">261.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItMy0xLTEtMTE3MDI5_97490ed9-0f8a-4221-978b-878330077037">546.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItNS0xLTEtMTE3MDI5_4de9a89b-5d65-43fd-a651-31b89c2d62b1">372.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtMS0xLTEtMTE3MDI5_6a741d35-b661-4ba4-b846-133731797e7e">1,582.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtMy0xLTEtMTE3MDI5_3cc87c37-b4d2-45ba-a0f1-417bf8248584">3,126.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtNS0xLTEtMTE3MDI5_b4207b1d-b0d9-404a-860d-b75b8d71f034">2,219.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMTk_5345eaff-4502-47ea-b66a-b41df9242b4d" escape="true"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of  income tax expense attributable to continuing operations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtMS0xLTEtMTE3MDI5_a382b409-3a7d-45b0-ac5f-297f4d3deb47">189.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtMy0xLTEtMTE3MDI5_5743b62a-60fd-4f28-b3d6-3e36c45ba661">545.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtNS0xLTEtMTE3MDI5_d51e54fe-597c-4191-bdab-507cb1ece358">455.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtMS0xLTEtMTE3MDI5_c6d86d55-3ce2-4fab-ab3a-abdc658ca481">40.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtMy0xLTEtMTE3MDI5_eb7cc06b-f291-49e0-a83a-fa1a13da9456">171.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtNS0xLTEtMTE3MDI5_4f0d9d12-8f9f-4f89-9ef9-120fd5317ea5">172.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtMS0xLTEtMTE3MDI5_d0ab3d7a-b237-4109-bb88-dc187bf11f74">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtMy0xLTEtMTE3MDI5_5fa68392-3493-4b12-8c02-8021edc67bc4">107.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtNS0xLTEtMTE3MDI5_13d6d984-bbe0-4f84-a7e3-9614bfd118d8">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtMS0xLTEtMTE3MDI5_3433ee4f-84bf-4c08-8bf4-9c347d47e9d4">294.8</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtMy0xLTEtMTE3MDI5_49340618-209a-4250-a9de-7898b5467494">825.1</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtNS0xLTEtMTE3MDI5_eec6c845-052f-4d09-89c7-a0f61bef7984">709.1</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense/(benefit):</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtMS0xLTEtMTE3MDI5_f747f407-dd15-409e-b8ef-2619535fe4bd">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtMy0xLTEtMTE3MDI5_0510436d-a759-467d-b138-42a54d97321a">64.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtNS0xLTEtMTE3MDI5_87f5330b-dde2-4e96-a1a7-caa4c8f8eacf">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktMS0xLTEtMTE3MDI5_4d520205-4e3f-4746-8af5-fbbdc16c415e">5.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktMy0xLTEtMTE3MDI5_e9e07170-4d65-4e19-bb4c-ee81369cb7d1">13.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktNS0xLTEtMTE3MDI5_d3589edf-57d7-4814-a311-0b21bd34d5f6">28.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTEtMS0xLTExNzAyOQ_ce9d0cb9-3599-473f-bfce-6707dfaf1d4b">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTMtMS0xLTExNzAyOQ_1374b2f0-b1e6-437a-ae12-bf4051b5d4b0">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTUtMS0xLTExNzAyOQ_04d9b6e7-6a3c-4e76-b952-6af02d31ca7c">12.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTEtMS0xLTExNzAyOQ_44d21646-f980-4c1b-bd43-7d0f0f1efd50">7.2</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTMtMS0xLTExNzAyOQ_375f1701-3e11-4bcc-a1df-b2dca23828ff">78.0</ix:nonFraction>)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTUtMS0xLTExNzAyOQ_23f86429-f513-4b6e-8e63-aee6b7d90910">47.0</ix:nonFraction>)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTEtMS0xLTExNzAyOQ_a986a9e2-2c98-4c4e-a37f-62e88241599f">302.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTMtMS0xLTExNzAyOQ_a7c434b4-8596-45bf-bd4b-c90ae8a6f932">747.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTUtMS0xLTExNzAyOQ_26baf99e-bc97-43c2-a01e-7aecbc15ddaa">662.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMDA_1f09f11d-b2dc-49cb-a09f-a60c9cf6aadb" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The effective tax rates on earnings before income taxes are reconciled to statutory U.S. income tax rates as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:65.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItMS0xLTEtMTE3MDI5_7ad39fc3-b940-44c7-8781-86cf51ac79c0">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItMy0xLTEtMTE3MDI5_6a38af66-1661-47c1-908b-e5c090578d28">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItNS0xLTEtMTE3MDI5_f2791d90-615b-413f-a272-b5d7551487af">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of U.S. federal income tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtMS0xLTEtMTE3MDI5_c70649c6-14c4-4603-b39e-0d70c25d03b8">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtMy0xLTEtMTE3MDI5_d085e66c-50b7-4d38-93d5-ee774e222bc8">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtNS0xLTEtMTE3MDI5_3663f81b-bcfb-4068-8397-dbdad962c459">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign earnings taxed at lower rates than the statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtMS0xLTEtMTE3MDI5_62286751-0611-4bb9-b722-6cd80164b984">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtMy0xLTEtMTE3MDI5_8da29877-e99d-4e0a-bfc8-31c222a09b5d">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtNS0xLTEtMTE3MDI5_0d020980-a667-429d-a282-d8258e0d6923">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtMS0xLTEtMTk5Njc5_90b9ea6a-6976-4bc1-87a0-eec98c176049">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtMy0xLTEtMTk5Njc5_73c15e80-6556-43be-ad2f-f72e698f4bd0">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtNS0xLTEtMTk5Njc5_cd89613f-f215-4438-a704-168d867f71b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtMS0xLTEtMTE3MDI5_c1df6d84-e030-4acb-a689-18cdcb192d7a">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtMy0xLTEtMTE3MDI5_fd97a0a2-5982-4119-b868-a7668cdb4400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtNS0xLTEtMTE3MDI5_dd713e83-a4c6-4fc6-a7de-35846942fdea">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTEtMS0xLTE5OTY5MQ_38b3fb22-cbea-46dc-9121-3bc1f5b5ab51">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTMtMS0xLTE5OTY5MQ_84aa62b6-ba9e-43d2-80f3-a72fb3b89f46">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTUtMS0xLTE5OTY5MQ_7642b8c2-ff00-4b6c-8eff-778d58233ced">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTEtMS0xLTExNzAyOQ_68ffb731-f5e6-4703-af78-f13fa96ca988">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTMtMS0xLTExNzAyOQ_1f172666-1c52-48a6-8747-fefecddc723b">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTUtMS0xLTExNzAyOQ_27b7941d-4ef7-490a-a287-37b09fbc9f5f">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTEtMS0xLTExNzAyOQ_c969112b-260a-43ab-9dfe-c644c4f8271b">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTMtMS0xLTExNzAyOQ_410e6cc0-e214-4fbb-82ad-9ae0192bc04e">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTUtMS0xLTExNzAyOQ_f4889e54-208b-49f0-811c-e1cad105ba6a">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="idd93840d596d43ffaf94c2b27d440a6a" continuedAt="i0d22abff25cb47e6914200101a85193f"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ5ODQ_5bb329f5-dadd-4556-a07d-778cad7503b5" escape="true"><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:61.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzItMS0xLTEtMTE3MDI5_5b326caa-3ec1-4e6c-a93b-f82c7b4aa68e">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzItMy0xLTEtMTE3MDI5_c4f55298-8192-4138-853c-2145488a1042">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzMtMS0xLTEtMTE3MDI5_7dc1c79b-9291-41c0-8d08-d98f503a998f">114.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzMtMy0xLTEtMTE3MDI5_ceee200e-aae8-43dd-b2f9-d7916e9d0da1">145.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:DeferredTaxAssetRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzQtMS0xLTEtMTE3MDI5_ae3ea33c-bd71-4d12-8e86-3564d85d7e1a">189.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:DeferredTaxAssetRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzQtMy0xLTEtMTE3MDI5_ad334211-6eac-4b9b-abec-a8a769665183">176.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and restructuring reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzctMS0xLTEtMTE3MDI5_3c3a9bd7-ea8b-4a0e-a0aa-d36453265d3c">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzctMy0xLTEtMTE3MDI5_03ae7d0c-1708-4405-b352-10ced09c2104">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMS0xLTEtMTk5ODE3_8393ce54-56a5-45e6-a491-fb0535eb9cd8">54.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMy0xLTEtMTk5ODE3_27ad4ca9-d971-457c-8e43-3df33c488bd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMS0xLTEtMTE3MDI5_9a9463a4-9a68-4179-a745-8dfb74263224">242.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMy0xLTEtMTE3MDI5_4f9960c2-3cdd-4ea7-8ae3-b7a4736197eb">184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzktMS0xLTEtMTE3MDI5_e6b8033c-1e8b-42ee-a791-2e463654521d">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzktMy0xLTEtMTE3MDI5_e0bfe029-aa47-4ef1-8f64-1253c23bd8f8">92.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;      Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEwLTEtMS0xLTExNzAyOQ_01db3cd7-496f-4768-990c-2b7dd5782b41">749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEwLTMtMS0xLTExNzAyOQ_b13c7a07-8ced-45cb-9609-e0094fa87f6a">640.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzExLTEtMS0xLTExNzAyOQ_f8611cc2-7cf3-4878-883d-d7848f142b57">151.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzExLTMtMS0xLTExNzAyOQ_1905af21-1d82-4248-b0e2-026af6c2c247">149.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net of valuation allowance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEyLTEtMS0xLTExNzAyOQ_3102c83c-d5f6-4fca-94e0-085d7ae8a0aa">598.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEyLTMtMS0xLTExNzAyOQ_f6b8b463-5331-4416-be03-c91dc5c553b0">490.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE2LTEtMS0xLTExNzAyOQ_5d656e27-5ab1-4f0f-b78c-cf080a0d547b">172.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE2LTMtMS0xLTExNzAyOQ_7b7ce968-5100-4df2-968e-ba74df95bbc9">166.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE3LTEtMS0xLTExNzAyOQ_37eac44a-59af-40c4-84f9-a4f0f73455cd">811.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE3LTMtMS0xLTExNzAyOQ_a06ea787-329f-47e9-9713-65fa1885b97b">823.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE4LTEtMS0xLTExNzAyOQ_1e7a2512-4a4b-4f61-9556-44169e1a3e10">188.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE4LTMtMS0xLTExNzAyOQ_f804bab5-b35a-46ff-aaa7-fab0c115f691">143.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIwLTEtMS0xLTExNzAyOQ_45b737f3-81ab-4a8f-b4a0-68ce47bfcd7a">87.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIwLTMtMS0xLTExNzAyOQ_df6d83a9-4504-4270-8431-65a514a80436">47.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIxLTEtMS0xLTExNzAyOQ_90420d8f-6e23-44ee-b6d3-3257942803c7">1,259.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIxLTMtMS0xLTExNzAyOQ_cbcf19df-7714-481a-89c5-bb4c46fd66a1">1,182.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIyLTEtMS0xLTExNzAyOQ_88264de6-8c6b-4dc0-9495-dfd8ac404c50">661.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIyLTMtMS0xLTExNzAyOQ_b4a0502f-ccb7-4085-9d79-90912ce46099">691.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMDY_24082f2f-fc85-41ba-84af-5d0629780e9f" escape="true"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a rollforward of the valuation allowance:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtMS0xLTEtMTE3MDI5_bc1553ac-6896-48b1-9fb2-fca9c24142ef">149.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtMy0xLTEtMTE3MDI5_958e84c2-b5d9-4456-9b4e-e70d3474bdc2">167.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtNS0xLTEtMTE3MDI5_1dfb5b98-5cc9-4cb1-9db1-7b2f80434ae5">145.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItMS0xLTEtMTE3MDI5_b040ac85-ffe9-40d7-b452-bbc6862259fe">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItMy0xLTEtMTE3MDI5_3bddc7c2-a608-400f-a985-0f586aa2e4e7">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItNS0xLTEtMTE3MDI5_9a8147dd-2d80-41d2-a91a-8c6de47f2016">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtMS0xLTEtMTE3MDI5_eac1ecc8-679e-444c-bcb4-3c7b9eaea07c">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtMy0xLTEtMTE3MDI5_ed742617-1a37-4d01-b1bb-4c7c10652ca3">25.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtNS0xLTEtMTE3MDI5_4c6f3a7f-7664-43c0-a6da-f308429542cf">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtMS0xLTEtMTE3MDI5_92f4d02f-577a-442d-a61a-7a484be376bf">151.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtMy0xLTEtMTE3MDI5_2b48544f-64e6-406d-86c2-08a48e806b6f">149.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtNS0xLTEtMTE3MDI5_88f9c646-530c-4b4a-a619-a2a76c1e5b5b">167.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has U.S. federal tax loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:FederalTaxLossCarryovers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzY3OQ_b21a191c-f59c-48a1-9537-3213c4339cfa">161.5</ix:nonFraction>, which expire periodically through 2037, as well as post-2017 carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ifbadcad8fa62418ba708fec2acad3e8b_I20221231" decimals="-5" name="lh:FederalTaxLossCarryovers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwOTk1MTE2MjgyODQ0_b14465f7-8af2-4a62-8741-c9dd066801eb">202.7</ix:nonFraction> that are limited to <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2Xzc4MQ_0f965d71-a4ea-4786-ad37-d28ed62f1b1d">80</ix:nonNumeric>% of taxable income and have an indefinite carryforward period. The utilization of tax loss carryforwards is limited due to change of ownership rules; however, at this time, the Company expects to fully utilize substantially all U.S. federal tax loss carryforwards with the exception of approximately $<ix:nonFraction unitRef="usd" contextRef="iaaa411a036c347a7814b3b8f3d7473d6_D20220101-20221231" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwNzQ_4a6d1be7-e789-4206-aa97-ca1b08578c09">6.5</ix:nonFraction> for which a full valuation allowance has been provided. The Company has U.S. state tax loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzExODY_58eefc33-87ee-4409-8bb4-34475dc0919d">485.5</ix:nonFraction>, a portion of which expire annually, and on which a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEyNzM_1b2ed34f-b111-4918-adcd-0030d3ca9ae0">340.0</ix:nonFraction> has been provided. In addition to federal and state tax loss carryforwards, the Company has other federal and state attribute carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:FederalandStateAttributeCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE0MjA_b36fa8c5-9185-4781-b5ca-529e4ab9dcf3">129.6</ix:nonFraction>. A portion of these attribute carryforwards will expire through 2027 and have a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:FederalandStateAttributeCarryforwardValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE1MDU_6aa25b13-fb4e-43b3-8009-a790761d379b">88.1</ix:nonFraction> while the remainder have indefinite carryforward periods. The Company has foreign tax loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:ForeignTaxLossCarryovers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE1NjA_c94aca79-e506-4a5b-8ef7-9aabd4dee351">115.7</ix:nonFraction>, the majority of which have indefinite carryforward periods, but a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:ForeignTaxLossCarryoverValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE2MzE_34159826-3735-4237-83ac-f73719f9911c">20.3</ix:nonFraction> has been provided for jurisdictions where the future tax benefits of the attributes are not more likely than not to be realized.  Additionally, the Company has foreign tax loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:ForeignTaxLossCarryoversExpirein2034" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE2OTg_501f85c5-28cf-4ee9-b04b-e5bfd823a9ae">444.2</ix:nonFraction> which expire periodically through 2034 that have a full valuation allowance. In addition to the foreign net operating losses, the Company has a foreign capital loss carryforward of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE4ODI_2637a467-4921-4b83-a641-4d4ada1949c2">26.6</ix:nonFraction> with an indefinite carryforward period and a full valuation allowance. </span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance increased from $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIwMjI_bc1553ac-6896-48b1-9fb2-fca9c24142ef">149.2</ix:nonFraction> in 2021 to $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIwMzQ_92f4d02f-577a-442d-a61a-7a484be376bf">151.3</ix:nonFraction> in 2022 primarily due to the establishment of valuation allowances related to acquired attributes and U.K. losses, offset by the partial release of the valuation allowance on U.S. capital losses.  </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized income tax benefits were $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIxNjg_f373cad3-ec6e-4a14-a955-219b0ba291d4">44.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIxNzU_86968fc2-c03b-4543-a083-cc46389ef320">52.4</ix:nonFraction> at December&#160;31, 2022, and 2021, respectively. It is anticipated that the amount of the unrecognized income tax benefits will decrease by $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwOTk1MTE2MjgzODM2_527ee9c8-b538-4f4b-8fb4-e93c94e9f7c9">10.6</ix:nonFraction> within the next 12 months due to statute of limitation lapses and anticipated audit settlements; however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI2NTk_551a7133-d8e9-41b6-a821-d061db189d7c">4.7</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI2NjY_15df0478-cc3c-4469-86c1-9e2fb3f90684">6.5</ix:nonFraction> as of December&#160;31, 2022, and 2021, respectively. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NjI_c41b2d0f-5fe3-48ed-a689-555da349f8f2">1.6</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NjY_f2a9eaa7-5152-4458-8e3c-ca3bb8b80b29">1.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxExaminationPenaltiesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NzM_5a138cad-6066-46b5-8cef-ccaadc384aa5">4.4</ix:nonFraction>, respectively, in </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i0d22abff25cb47e6914200101a85193f"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest and penalties expense, which was offset by a benefit from reversing previous accruals for interest and penalties of $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MTk_19a96867-a4e5-4948-a675-773629ab3cf2">3.3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MjM_941d556b-eb55-4ab4-896f-db50e6feb93b">3.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MzA_f93a8168-1d1d-4500-87d5-3b3f574f2ef3">3.0</ix:nonFraction>, respectively. </span></div><ix:nonNumeric contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" name="us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMjU_4ec5eee0-8b03-4836-8068-074556e69a18" escape="true"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a reconciliation of the unrecognized income tax benefits, excluding interest and penalties, from uncertain tax positions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtMS0xLTEtMTE3MDI5_e74e1e2b-f150-463d-9171-0293348ab950">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtMy0xLTEtMTE3MDI5_3f647b58-3929-4f9c-8adf-57bf1221c0ee">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtNS0xLTEtMTE3MDI5_985efa5c-4deb-4d14-92af-d44b3a1ca7b1">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve for tax positions taken in the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItMS0xLTEtMTE3MDI5_bd1a36e8-ff4b-43de-8c48-6ab92a72b977">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItMy0xLTEtMTE3MDI5_2e3b9393-e108-457b-8ea5-85973eb6f87e">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItNS0xLTEtMTE3MDI5_d79ce25e-6e45-4f13-9f4b-b6c688044208">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve from an acquisition's opening balance sheet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtMS0xLTEtMTE3MDI5_2a764e6e-82ef-48f1-8e68-95ea3039d033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtMy0xLTEtMTE3MDI5_d25179d0-a670-42ee-a905-6dc7bd7bb69b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtNS0xLTEtMTE3MDI5_55b68aac-2281-4e8d-8df5-1a708ab85937">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtMS0xLTEtMTE3MDI5_654378c5-2d5d-451e-a4c8-16b132e04170">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtMy0xLTEtMTE3MDI5_a0192127-0ecd-47be-ae27-dad9f8e70c13">7.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtNS0xLTEtMTE3MDI5_f733c755-e9ad-41ed-875f-adace6073bf7">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of lapses in the statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtMS0xLTEtMTE3MDI5_1a4f3adc-88b6-4f75-8b83-ab0b0d643f0b">7.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtMy0xLTEtMTE3MDI5_2a34b77b-8542-4450-8a98-66113fb97d72">20.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtNS0xLTEtMTE3MDI5_11baa58a-7580-4f94-a820-0501a3b0b43e">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctMS0xLTEtMTE3MDI5_563a0656-5765-40de-9882-25a99aa1b146">44.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctMy0xLTEtMTE3MDI5_2bf548fb-7727-4d2a-a493-7342e75300c9">52.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctNS0xLTEtMTE3MDI5_2ee5327b-5b15-45b9-965a-8d7e8ed6ecb0">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also included in the balance of unrecognized tax benefits as of December&#160;31, 2022, 2021 and 2020, are $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzNzA_4bf01541-d579-4c8f-8180-86faf47e475c">0.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzNzQ_d18fe790-38cb-4c7c-9a03-35fc43ad2650">0.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzODE_1c7900bf-d276-44fb-9696-e48ad513b499">2.1</ix:nonFraction>, respectively, of tax benefits that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes. As of December&#160;31, 2022, 2021 and 2020 there are $<ix:nonFraction unitRef="usd" contextRef="ibc08ff0a0d474d61afc14770005abe03_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NDM_5790d702-21f8-4f19-95d2-ace0495ee482">44.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i973ac99fa8bc44b7b6e05a3777b91219_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NDc_ff04988b-1d4d-458b-93cd-b65e783df415">51.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i90bbd94ee3fd44f1a0f4ecc350cc8574_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NTQ_c75207f7-f9d7-4415-af29-e8883047f9c9">46.7</ix:nonFraction>, respectively, of tax benefits that, if recognized, would favorably impact the effective income tax rate. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has substantially concluded all U.S. federal income tax matters for years through 2018 and is currently under IRS examination for tax years 2019 and 2020.&#160;Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2012, respectively.  The Company has various state and foreign income tax examinations ongoing throughout the year.  The Company believes adequate provisions have been recorded related to all open tax years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a result of the Tax Cuts and Jobs Act (TCJA), the Company was effectively taxed on all of its previously unremitted foreign earnings. The TCJA also enacts a territorial tax system that allows, for the most part, tax-free repatriation of foreign earnings. The Company still considers the earnings of its foreign subsidiaries to be permanently reinvested, but, if repatriation were to occur, the Company would be required to accrue U.S. taxes, if any, and remit applicable withholding taxes as appropriate. The Company has unremitted earnings and profits of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ2MTU_29a529c4-401a-4c88-a33c-922fa7be5f0b">1,726.3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ2MjI_51caa621-83a1-42eb-800b-e305191de3e9">1,291.8</ix:nonFraction> that are permanently reinvested in its foreign subsidiaries as of December&#160;31, 2022, and 2021, respectively. A determination of the amount of the unrecognized deferred tax liability related to these undistributed earnings is not practicable due to the complexity and variety of assumptions necessary based on the manner in which the undistributed earnings would be repatriated.</span></div></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_226"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzMzg_33f82cea-78d0-40c4-9fc7-3e9555b09b1c" continuedAt="i8b379eb6c1bb48a0a21eea860fae1d50" escape="true">STOCK COMPENSATION PLANS</ix:nonNumeric></span></div><ix:continuation id="i8b379eb6c1bb48a0a21eea860fae1d50" continuedAt="ieaf8926de48c46159c1ebf2424174dff"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the shareholders approved the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the Plan). Under the Plan, as of December&#160;31, 2022, there are <ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzIxNQ_c7756bfb-5442-4cbc-8b1b-f63f6a803c91">8.6</ix:nonFraction> shares authorized for issuance and <ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI1Mw_4a0bd172-2bfe-4e0b-b522-9260d5c64dcb">3.6</ix:nonFraction> shares available for grant. </span></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes grants of non-qualified options made by the Company to officers, key employees, and non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Also, for each grant, options vest ratably over a period of three years on the anniversaries of the grant date, and have a contractual exercise period of 10 years subject to their earlier expiration or termination.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNTU_006e1b43-d4d3-475c-8350-a8b87aade71d" continuedAt="i21bb0a6f9e3047c9ac1bc2fa4d03911f" escape="true">hanges in options outstanding under the plans for the period indicated were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="i21bb0a6f9e3047c9ac1bc2fa4d03911f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:41.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.493%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i514823945de04d5ca0f42a63418890ee_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzEtMS0xLTEtMTE3MDI5_15069e5f-ff52-4622-9641-cfd17843d948">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i514823945de04d5ca0f42a63418890ee_I20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzEtMy0xLTEtMTE3MDI5_12c84a62-e106-4b61-bba4-3f43fb3dfd24">169.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzItMS0xLTEtMTE3MDI5_81e8a780-b1b5-4d7b-bb38-88159a8e0f63">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzItMy0xLTEtMTE3MDI5_10b42feb-21d0-4fec-8ef1-3edfd02d94e5">276.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzMtMS0xLTEtMTE3MDI5_83476ae3-b1d7-44fa-a6b8-b58feb9cd932">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzMtMy0xLTEtMTE3MDI5_281ad5ff-636a-4808-8849-af47286d5529">118.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzQtMS0xLTEtMTE3MDI5_c334d018-3b9f-492b-a347-716f8e976d14">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzQtMy0xLTEtMTE3MDI5_2ac5374f-b523-4d0e-aacc-487f20f6da00">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtMS0xLTEtMTE3MDI5_793607e8-f1eb-4ab2-97e2-1edcd8745ea3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtMy0xLTEtMTE3MDI5_428a24d1-b1c3-4fce-a5f4-1df23ae025bb">188.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtNS0xLTEtMTE3MDI5_ce29792d-18b5-4362-8a14-d1854a6bf3f1">6.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtNy0xLTEtMTE3MDI5_08bbd1c7-6aba-4a66-b42b-4c7ec047e51f">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctMS0xLTEtMTE3MDI5_9bba9590-bf10-4d25-bf8a-ba3f4081456f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctMy0xLTEtMTE3MDI5_474ce0fb-8e97-42d7-baf9-244f3b90b53b">168.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctNS0xLTEtMTE3MDI5_74f0584e-0876-401e-ae03-ac0a9d71969b">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctNy0xLTEtMTE3MDI5_879cb812-4a0b-445b-abdd-bb0510b1cfe8">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ieaf8926de48c46159c1ebf2424174dff" continuedAt="i44e2595f112b4eae8e62f55f7834d335"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company&#8217;s closing stock price on the last trading day of 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2022. </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNjE_193bffc3-1670-49df-83c0-9e2718bc50dd" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received by the Company from option exercises, the actual tax benefit realized for the tax deductions and the aggregate intrinsic value of options exercised from option exercises under all share-based payment arrangements during the years ended December&#160;31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received by the Company</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtMS0xLTEtMTE3MDI5_dc0c0453-0591-49df-9463-ab429c196699">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtMy0xLTEtMTE3MDI5_955dfc49-8097-499e-985b-4ca6eba448cc">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtNS0xLTEtMTE3MDI5_e831df02-3329-4a6b-b41d-bf160e2edad0">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItMS0xLTEtMTE3MDI5_b8d5e50a-6c31-44de-8ff7-85ba6a866609">1.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItMy0xLTEtMTE3MDI5_a6fc8b3b-b49a-49a0-b74d-74c93847d80e">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItNS0xLTEtMTE3MDI5_c00dd9fc-5838-4179-b0dc-d0ffd26d7b6b">4.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtMS0xLTEtMTE3MDI5_57d5e86d-e727-47b5-be2e-dae3ba53d37d">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtMy0xLTEtMTE3MDI5_76dc6eea-75a8-4964-a8b2-3bbd14d82107">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtNS0xLTEtMTE3MDI5_d205ee5b-3b4a-4897-bcb0-fe888ac2140a">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNjI_7dd0b20d-fee9-4a41-8fa1-deef31d78754" continuedAt="i76621570f3bb41c7b1d680c3f41d0be4" escape="true"><div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItMS0xLTEtMTE3MDI5_ac3ded86-fffa-4d81-88ee-d22756e93b92">76.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItMy0xLTEtMTE3MDI5_2043d402-b194-4552-a3e5-958bdacecb70">62.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItNS0xLTEtMTE3MDI5_add42ecc-3c35-4c1d-bc62-df31ed693202">40.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtMS0xLTEtMTE3MDI5_dd7a1f5c-6c28-4cdb-8a58-66829624f61a">6.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtMy0xLTEtMTE3MDI5_18e52b83-57cb-477b-9e69-aa86f8da0122">6.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtNS0xLTEtMTE3MDI5_0b6a6744-e0b3-4374-a9a8-133e947b4995">6.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtMS0xLTEtMTE3MDI5_556d7ae4-f04b-4543-a976-9e143aafd1f5">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtMy0xLTEtMTE3MDI5_da9159e7-54ce-4b51-a670-078fd05972f6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtNS0xLTEtMTE3MDI5_79ee5ecf-6f3e-4631-9a19-5210d28bf4fe">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtMS0xLTEtMTE3MDI5_090f0129-ed83-4a29-bc45-ea050ac8f162">28.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtMy0xLTEtMTE3MDI5_bbd815e5-b3d1-4550-bee1-dfafa5070ab9">28.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtNS0xLTEtMTE3MDI5_74775d21-31c4-4642-82da-62259de7329b">20.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzctMS0xLTEtMTE3MDI5_9f7a92a2-9de2-4d86-af87-5378bb668df6">0.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black Scholes model incorporates assumptions to value stock-based awards. The risk-free interest rate for periods within the contractual life of the option is based on a zero-coupon U.S. government instrument over the contractual term of the equity instrument. Expected volatility of the Company&#8217;s stock is based on historical volatility of the Company&#8217;s stock. The Company estimates expected option terms through an analysis of actual, historical post-vesting exercise, cancellation and expiration behavior by employees and projected post-vesting activity of outstanding options. Groups of employees and non-employee directors that have similar exercise behavior with regard to option exercise timing and forfeiture rates are considered separately for valuation purposes. For 2022, 2021 and 2020, expense related to the Company&#8217;s stock option plan totaled $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="us-gaap:StockOptionPlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MDU_073e169d-eae5-4399-adef-27ac9b32923d">4.3</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="0" name="us-gaap:StockOptionPlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MDk_3d28ffb6-2d92-4840-96cd-60388139fc93">3.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="0" name="us-gaap:StockOptionPlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MTY_3d864e33-1ea1-44a3-9265-1c264461084f">3.4</ix:nonFraction>, respectively, and is included in selling, general and administrative expenses. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock, Restricted Stock Units and Performance Shares</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock, restricted stock units, and performance shares (non-vested shares) to officers and key employees and grants restricted stock and restricted stock units to non-employee directors. Restricted stock and units typically vest annually in equal <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzMwNDA_4a635913-c53b-4d6c-88ee-274523d32557">one-third increments beginning on the first anniversary of the grant</ix:nonNumeric>. A performance share grant in 2020 represents a three-year award opportunity for the period 2020-2022, and if earned, vests fully (to the extent earned) in the first quarter of 2023. A performance share grant in 2021 represents a three-year award opportunity for the period of 2021-2023 and, if earned, vests fully (to the extent earned) in the first quarter of 2024. A performance share grant in 2022 represents a three-year award opportunity for the period of 2022-2024 and, if earned, vests fully (to the extent earned) in the first quarter of 2025. <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM1OTA_4b33fe4f-b358-4e55-a05e-4c1d3d4d0610">Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets</ix:nonNumeric>, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned restricted stock and performance share compensation is amortized to expense, when probable, over the applicable vesting periods. For 2022, 2021, and 2020, total restricted stock, restricted stock unit, and performance share compensation expense was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:RestrictedStockPerformanceSharesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5Nzg_52881d3d-1d73-4eb0-b8f9-48987b0adedb">125.0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:RestrictedStockPerformanceSharesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5ODI_0188e2e0-eb15-44d1-9840-3e3fb7ebd691">135.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:RestrictedStockPerformanceSharesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5ODk_6eb4aa87-1ea7-466c-8ced-9092fe219d7f">98.1</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i44e2595f112b4eae8e62f55f7834d335"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNzk_f2f480ce-da46-4e00-b135-a2f884b5af50" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of non-vested shares for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e8b4d8b13a24d3298f7077d489fb327_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzEtMS0xLTEtMTE3MDI5_77a92ff9-5b84-4a76-9729-f3cff315e56c">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e8b4d8b13a24d3298f7077d489fb327_I20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzEtMy0xLTEtMTE3MDI5_7e602876-fe64-49ee-8738-d1dbf5699e78">212.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzItMS0xLTEtMTE3MDI5_7a1a66a6-3a76-44c9-861e-b347a9a9a369">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzItMy0xLTEtMTE3MDI5_d97f821f-b966-4c44-80f9-9aa11fe3c8fc">270.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzMtMS0xLTEtMTE3MDI5_632391b3-8ed6-468b-a6c3-2f4e80e2bcd8">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzMtMy0xLTEtMTE3MDI5_ae074720-5132-4d49-963c-9b66925fde76">177.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzQtMS0xLTEtMTE3MDI5_fbb3f5e1-3a52-4a0f-9735-ef2745efd0e5">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzQtMy0xLTEtMTE3MDI5_7b754081-634b-4161-bec8-e5f08418f2ac">252.54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e10f76783344eadb4cecdca2d63df8b_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzUtMS0xLTEtMTE3MDI5_233fc310-cf12-4299-adcf-f37da2784928">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e10f76783344eadb4cecdca2d63df8b_I20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzUtMy0xLTEtMTE3MDI5_55caff86-9beb-411c-ab78-10052ca87846">254.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQxNDA_7b51b0d7-9f0f-4c7f-9939-49bc81e7ef44">155.3</ix:nonFraction> of total unrecognized compensation cost related to non-vested stock options, restricted stock, restricted stock unit and performance share-based compensation arrangements granted under the Company's stock incentive plans. That cost is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ0Mzg_f26599fd-837f-4d6e-9c4f-8647b88a043a">1.9</ix:nonNumeric> years and will be included in cost of revenues and selling, general and administrative expenses.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2016 Employee Stock Purchase Plan, the Company is authorized to issue <ix:nonFraction unitRef="shares" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:EmployeeStockPurchasePlanNumberOfAuthorizedShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ2NDc_081935c8-bdf8-434b-b471-5e484165c312">1.8</ix:nonFraction> shares of common stock. The plan permits substantially all U.S. and Canada employees to purchase a limited number of shares of Company stock at <ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="lh:EmployeeStockPurchasePlanPercentOfMarketPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ3ODM_bf82fcfb-7c0d-4387-9802-00d5b7e14915">85</ix:nonFraction>% of market value. The Company issues shares to participating employees semi-annually in January and July of each year. Approximately <ix:nonFraction unitRef="shares" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:EmployeeStockPurchasePlanNumberOfSharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5MTg_1b50c39d-70fb-4fa2-a1cf-700031bff964">0.2</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:EmployeeStockPurchasePlanNumberOfSharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5MjI_07c1387e-1952-4caf-8d73-86098a6c13d8">0.2</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:EmployeeStockPurchasePlanNumberOfSharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5Mjk_ccd34b7c-967f-42f3-abe3-062665f6f938">0.3</ix:nonFraction> shares were purchased by eligible employees in 2022, 2021 and 2020, respectively. For 2022, 2021 and 2020, expense related to the Company&#8217;s employee stock purchase plan was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:EmployeeStockPurchasePlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUwOTM_575f83e9-e62c-4b41-8c30-d64ea11c9b55">14.8</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:EmployeeStockPurchasePlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUwOTc_aaf20904-768b-4ff7-a4b7-0bdaca5637e0">14.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:EmployeeStockPurchasePlanExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUxMDQ_88cf4cf7-076b-4c48-b6c1-cf0b649e8f44">10.3</ix:nonFraction>, respectively.</span></div><ix:continuation id="i76621570f3bb41c7b1d680c3f41d0be4"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to calculate the fair value of the employee&#8217;s purchase right. The fair value of the employee&#8217;s purchase right and the assumptions used in its calculation are as follows:</span></div><div style="margin-bottom:2pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of the employee&#8217;s purchase right</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="2" name="lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtMS0xLTEtMTE3MDI5_35cff926-db03-4ba9-951d-23a69436b524">62.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="2" name="lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtMy0xLTEtMTE3MDI5_931b1cf7-20f9-43cb-b620-e9bff1a92049">59.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="2" name="lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtNS0xLTEtMTE3MDI5_4dd0b0a1-d0f9-4c59-ad84-5aef27ce4bd7">35.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtMS0xLTEtMTE3MDI5_874e9f09-3b19-47b8-8c91-07f82894ad8d">1.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtMy0xLTEtMTE3MDI5_da5b3191-93c0-4d7e-9667-3957f5146453">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtNS0xLTEtMTE3MDI5_c11a9f06-255b-43d5-b7d0-6b3c2269f099">0.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtMS0xLTEtMTE3MDI5_ae5c07a3-212d-4b5e-940e-7d8bb541188a">0.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtMy0xLTEtMTE3MDI5_6f66ec98-d020-4bee-9428-98437536cd47">0.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtNS0xLTEtMTE3MDI5_3114a5d7-3835-49e5-9c66-d3965d5ec90a">0.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtMS0xLTEtMTE3MDI5_069b8e7f-01aa-40fd-b8a8-5739f9fe61da">0.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtMy0xLTEtMTE3MDI5_05012eed-4251-452d-a8b2-772dc4751221">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtNS0xLTEtMTE3MDI5_03e47dcd-9920-46d9-8f1f-ab927bf8146b">&#8212;</ix:nonFraction>%</span></td></tr></table></div></ix:continuation></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_232"></div><div style="margin-bottom:7pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzIvZnJhZzo4MGNhZmMyNDVkNGU0MzcyYjQ1NDkyNGVjNDFjZWRlMS90ZXh0cmVnaW9uOjgwY2FmYzI0NWQ0ZTQzNzJiNDU0OTI0ZWM0MWNlZGUxXzMwMzEz_22835765-e6bf-446a-88db-d51ba38aeca7" continuedAt="i5b302ea81dab4d9cb871b4a7ea631aa6" escape="true">COMMITMENTS AND CONTINGENCIES </ix:nonNumeric></span></div><ix:continuation id="i5b302ea81dab4d9cb871b4a7ea631aa6" continuedAt="iee7f7e0c225f4d1b89252c5a40adda09"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes, commercial and contract disputes, professional liability claims, employee-related matters, transaction related disputes, securities and corporate law matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="iee7f7e0c225f4d1b89252c5a40adda09" continuedAt="if39c1dce01bf45ba8972c99d5b60ebd1"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages, (ii) there is uncertainty as to the outcome of pending appeals or motions, (iii) there are significant factual issues to be resolved, and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the adverse outcomes are probable and estimable, and it does not believe they will have a material adverse effect on the Company's financial statements. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the Southern District of New York unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviewed the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. On August 24, 2021, the U.S. government filed a notice indicating that it did not intend to intervene in the matter. On October 27, 2021, the Fourth Amended Complaint was unsealed. The Fourth Amended Complaint is similar to the Third Amended Complaint in that it alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare and Medicaid business, and it further alleges that the Company unlawfully charged Medicare amounts substantially in excess of its alleged usual charges. Similar to the Third Amended Complaint, the Fourth Amended Complaint alleges violations of the federal False Claims Act and the False Claims Act of 14 states and the District of Columbia. On February 3, 2022, the Company filed a Motion to Dismiss all claims. On August 29, 2022, the Court entered an order granting the Motion to Dismiss and declining to exercise supplemental jurisdiction over the state law claims. Plaintiff did not appeal the Court's order.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On January 26, 2021, the Company was notified that a qui tam Petition was pending under seal in the District Court, 250th Judicial District, Travis County, Texas, and that the State of Texas has intervened. On April 14, 2021, the Petition was unsealed. The Petition alleges that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid&#8217;s alleged &#8220;best price&#8221; regulations, and that the Company offered remuneration to Texas health care providers in the form of discounted pricing for certain laboratory testing services in exchange for the providers&#8217; referral of Texas Medicaid business to the Company. The Petition seeks actual and double damages and civil penalties, as well as recovery of costs, attorney's fees, and legal expenses. On August 1, 2022, the District Court entered an order granting the Company's Motion for Partial Summary Judgment with respect to the claim that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid's alleged &#8220;best price&#8221; regulations. Plaintiffs filed a Notice of Non-Suit and Motion for Entry of Final Judgment and, on November 11, 2022, the Court entered a Judgment. Plaintiffs filed a Notice of Appeal with respect to the Court's order granting the Company's Motion for Partial Summary Judgment, referenced above. The Company will vigorously defend the lawsuit.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="if39c1dce01bf45ba8972c99d5b60ebd1" continuedAt="i8d4fb2cebd4d48b28b63379b4ced51cd"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2015, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patty Davis v. Laboratory Corporation of America, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#8217;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#8217;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Florida Second District Court of Appeal reversed the Circuit Court&#8217;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court held oral arguments on December 9, 2020. On May 26, 2022, the Florida Supreme Court issued an opinion approving the result of the Florida Second District Court of Appeal in favor of the Plaintiff. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. On March 12, 2021, the Company filed a Motion for Summary Judgment related to all remaining claims. On June 16, 2021, the Court denied the Company&#8217;s Motion for Summary Judgment. In December 2022, the parties reached a settlement to resolve the lawsuit. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anderson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. On August 26, 2021, Plaintiffs filed a Motion for Class Certification. On February 13, 2023, the Court entered an order denying Plaintiffs' Motion for Class Certification. On December 29, 2021, a related lawsuit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Nathaniel J. Nolan, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient acknowledgement of estimated financial responsibility form is misleading. The lawsuit seeks a declaratory judgment under the consumer protection laws of Nevada and Florida that the form is materially misleading and deceptive, an injunction barring the use of the form, damages on behalf of an alleged class, and attorney's fees and expenses. On February 28, 2022, the Company filed a Motion to Dismiss all claims. On February 13, 2023, the Court entered an order granting the Company's Motion to Dismiss. The Company will vigorously defend the lawsuits.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i8d4fb2cebd4d48b28b63379b4ced51cd" continuedAt="idd227c7d2d334871a4e30e7ccfe2e2f2"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#8217;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#8217;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#8217;s system was at risk during that time period. Information on AMCA&#8217;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#8217;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for some individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge for 24 months.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits were consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleged that the Company did not adequately protect its patients&#8217; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserted various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint sought damages on behalf of a class of all affected Company customers. On December 16, 2021, the Court granted in part and denied in part the Company's Motion to Dismiss. On March 31, 2022, the Plaintiffs filed an Amended Complaint alleging claims for negligence, negligence </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">per se</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, breach of confidence, invasion of privacy, and various state statutory claims, including a claim under the California Confidentiality of Medical Information Act. The Company filed a Motion to Dismiss certain claims of the Amended Complaint. The Company will vigorously defend the remaining claims in the multi-district litigation.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was served with a shareholder derivative lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#8217;s behalf against the Company&#8217;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#8217;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. On April 26, 2021, the Plaintiffs and the Company each filed Motions for Summary Judgment and the Plaintiffs filed a Motion for Class Certification. On May 23, 2022, the Court entered an order granting Plaintiffs&#8217; Motion for Class Certification. On June 6, 2022, the Company </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="idd227c7d2d334871a4e30e7ccfe2e2f2" continuedAt="if36f04c0dfba4978a4d596c72f0e0ae5"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed a Petition for Permission to Appeal the Order Granting Class Certification with the Ninth Circuit Court of Appeals. On September 22, 2022, the Ninth Circuit Court of Appeals granted the Company's Petition for Permission to Appeal the Order Granting Class Certification. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2020, Ravgen Inc. filed a patent infringement lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ravgen Inc. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the U.S. District Court&#8239;for the Western District of&#8239;Texas, alleging infringement of two Ravgen-owned U.S. patents.  The lawsuit seeks monetary damages, enhancement of those damages for willfulness, and recovery of attorney&#8217;s fees and costs. On September 28, 2022, a jury rendered a verdict in favor of the Plaintiff on the remaining patent at issue, finding that the Company willfully infringed Ravgen's patent, and awarded damages of $272 million. Plaintiff has filed post-trial motions seeking enhanced damages of up to $817 million based on the finding of willfulness, as well as attorney's fees and costs. The Company strongly disagrees with the verdict, based on a number of legal factors, and will vigorously defend the lawsuit through the appeal process. On June 4, 2021, the Company also instituted proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challenging the validity of the Ravgen patent at issue in the trial. In November 2022, the Patent Trial and Appeal Board issued a decision upholding the validity of the Ravgen patent, and the Company has filed an appeal of this decision.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo I)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo II), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On October 28, 2020, the court issued an order staying proceedings in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending resolution of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On February 24, 2022, the parties entered into a Memorandum of Understanding of the terms of a settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, subject to court approval. If approved, the settlement will also resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits discussed below.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, a single plaintiff filed a Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Superior Court of California, County of Orange, alleging various violations of the California Labor Code, including that the Plaintiff was not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, and received inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 23, 2021, the Company was served with a single plaintiff Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Kern, alleging various violations of the California Labor Code, including that Plaintiff was not properly paid wages owed, not properly paid meal and rest break premiums, not reimbursed for certain business related expenses, and other allegations including the untimely payment of wages and receipt of inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney's fees and costs. The case was removed to the U.S. District Court for the Eastern District of California. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Williams v. LabCorp Employer Services, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. On November 4, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. On June 24, 2021, the District Court remanded the case to the Superior Court of California, County of Los Angeles on the grounds that potential damages did not meet the Class Action Fairness Act (CAFA), 28 U.S.C. &#167; 1332(d), jurisdictional threshold. The parties entered into a settlement agreement dated September 9, 2022, which is pending court approval.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="if36f04c0dfba4978a4d596c72f0e0ae5"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Camden, New Jersey requiring the production of documents related to non-invasive prenatal screening tests. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Boston, Massachusetts requiring the production of documents related to urine drug testing. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various other pending legal proceedings involving the Company including, but not limited to, additional employment-related lawsuits, professional liability lawsuits, and commercial lawsuits. While it is not feasible to predict the outcome of such proceedings, in the opinion of the Company, the likelihood of loss is remote and any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s financial condition, results of operations, or cash flows, either individually or in the aggregate.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div></ix:continuation><div id="i9affef4b263d4c7097546e2ee7326a4a_238"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4ODQ_129b3599-e935-4f90-9367-6359e25b2027" continuedAt="icb0abfbacdf74df3aabd67fedf5deced" escape="true">PENSION AND POSTRETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="icb0abfbacdf74df3aabd67fedf5deced" continuedAt="i543c8145b18643b1a2785948e98d6d83"><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Retirement Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various U.S. defined contribution retirement plans (401K Plans). Under these 401K Plans, employees can contribute a portion of their salary to the plan and the Company makes minimum non-elective contributions, discretionary contributions, and matching contributions, depending on the terms of the specific plan. On January 1, 2021, all of the 401K Plans were modified to provide for 100% match of employee contributions up to 5% of their salary. Total expense, for the years ended December 31, 2022, 2021, and 2020, was $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYxMQ_8eaeb287-31c5-432c-abc4-11bafd88acde">183.1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYxNQ_e33f2da5-65bc-41da-8b14-e06871139732">168.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:DefinedContributionPlanTotalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYyMg_87bd2d7e-af64-4810-8c75-9dfbca3f4cf1">141.8</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors both funded and unfunded defined benefit pension plans which provide benefits based on various criteria such as years of service and salary. The Company maintained two plans in the United States, three plans in the United Kingdom and one in Germany.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The two plans in the United States (U.S. Plans) were closed to new entrants and the accrual of service credits at the end of 2009. The U.K. pension plans were closed to new entrants and the accrual of service credits for one plan as of December 31, 2002, and the accrual of service credits for the other two plans as of December 31, 2019. The German plan was closed to new entrants on December 31, 2009 but participants continue to accrue service credits. The U.K. and German plans are aggregated for disclosure as the Non-U.S. Plans.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Costs</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic benefit costs for the defined benefit pension plans are as follows:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NjM_2f7dcfe0-7dc1-4597-b4f5-caac3e9ddbc5" continuedAt="ia5cfbfa9bf38484b853e4bac98ae9183" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMS0xLTEtMTE3MDI5_935924cf-7fb5-4667-b23f-d0e146e5afe7">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMy0xLTEtMTE3MDI5_2f4cdb1d-9d8e-43ba-b47d-2e987a574273">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtNS0xLTEtMTE3MDI5_34d6c047-7e96-444c-9b23-77938943a438">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtNy0xLTEtMTE3MDI5_2488ca20-b796-4528-91ac-d46c22af5ccf">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtOS0xLTEtMTE3MDI5_9eae99c2-5980-42f5-9416-23ea9c8e7cb7">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMTEtMS0xLTExNzAyOQ_3a208e3a-7876-4e80-85d6-a7c2d078da95">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMS0xLTEtMTE3MDI5_f1aaa62e-61b4-46e2-aa22-73b06bb07901">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMy0xLTEtMTE3MDI5_ed419c03-1581-4cfc-8572-669ca89f949a">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtNS0xLTEtMTE3MDI5_afb9f740-63dc-4c4b-a568-f51ae4fce3e5">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtNy0xLTEtMTE3MDI5_57525871-3693-443d-90cc-b8332d2989bf">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtOS0xLTEtMTE3MDI5_df342609-91a7-4a62-b9ac-4cf8c7101478">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMTEtMS0xLTExNzAyOQ_ecb086cb-a900-4508-a9ed-1bc381344ae7">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMS0xLTEtMTE3MDI5_b86ea03c-7d6f-485d-bd19-e7e340df0e1d">12.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMy0xLTEtMTE3MDI5_d83dae6b-3fba-45a1-8d3d-b07e85b30d8c">17.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtNS0xLTEtMTE3MDI5_f8bb37bc-df0e-44ce-b409-45735fde9568">14.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtNy0xLTEtMTE3MDI5_03198ddb-cf1c-4cdc-9b60-07d20968f638">18.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtOS0xLTEtMTE3MDI5_35be9ee2-5347-4c78-9046-56581492b496">16.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMTEtMS0xLTExNzAyOQ_e15af7d0-f120-4354-bce5-8ef9f2ec3a8b">16.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMS0xLTEtMTE3MDI5_16ed00cc-2643-4459-916f-76a38d705ea3">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMy0xLTEtMTE3MDI5_3ead24b2-0a2e-4d3d-82dd-5c7bbaa84e74">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtNS0xLTEtMTE3MDI5_302ffdd3-f24f-49ee-bf54-bb8281a14da0">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtNy0xLTEtMTE3MDI5_91164a5f-4f71-49c1-9398-351419307b2f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtOS0xLTEtMTE3MDI5_6fb6d5f7-fc46-472c-bf9a-2c49c6f8e692">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMTEtMS0xLTExNzAyOQ_df719fb0-7cf4-41a4-aaab-564fa4186e54">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMS0xLTEtMTE3MDI5_103ba158-1707-493a-9bc1-119e5002eb23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMy0xLTEtMTE3MDI5_20578442-6502-42b0-b1c9-f6fd26f8ca92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctNS0xLTEtMTE3MDI5_b3eed85f-ee41-4a48-97c2-a4d025a742a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctNy0xLTEtMTE3MDI5_1d6fca94-1a4c-427b-ba58-9379585b6d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctOS0xLTEtMTE3MDI5_2f0f38ce-a021-4ad2-baaf-28496adc9f84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMTEtMS0xLTExNzAyOQ_3adbf8d6-5b89-478a-b297-9ec3420af612">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMS0xLTEtMTE3MDI5_da0a25d0-a67f-458b-90c0-735d8976f4de">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMy0xLTEtMTE3MDI5_2675a2e3-215c-4d71-9869-87d3ccfeec79">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtNS0xLTEtMTE3MDI5_e8254cbd-dfd6-4b93-bc65-020b0d3b2c06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtNy0xLTEtMTE3MDI5_d44c535e-a437-4162-b99f-14e19937ea2e">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtOS0xLTEtMTE3MDI5_2a40f883-99dd-4661-bfc6-cd6ec2afc198">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMTEtMS0xLTExNzAyOQ_55bc84d6-5701-4809-be53-a3ae8c93d276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMS0xLTEtMTE3MDI5_c451b447-ffa6-48ed-b9b1-e01e1683ed74">7.7</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMy0xLTEtMTE3MDI5_bc88f7c1-7cf2-4c5c-8bda-d846db9033ad">8.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktNS0xLTEtMTE3MDI5_6bdffdf6-a6b3-42f7-8b6a-b901d15f4cb0">11.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktNy0xLTEtMTE3MDI5_ea5fd70d-1de0-4b4c-ad97-1628a161ba79">5.5</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktOS0xLTEtMTE3MDI5_ba331b3d-b14a-4b18-8507-f7367f678678">3.7</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMTEtMS0xLTExNzAyOQ_e5a78353-cb99-40d9-9439-f2a1ad1cfa75">3.3</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i543c8145b18643b1a2785948e98d6d83" continuedAt="i0da5632f6394458eab1963d292af417f"><ix:continuation id="ia5cfbfa9bf38484b853e4bac98ae9183" continuedAt="i455a1bc028d6430c922d943754f0824e"><div style="margin-bottom:9pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service costs are the only component of net periodic benefit costs recorded within Operating income. For the year ended December&#160;31, 2022, the Company recognized a partial plan settlement charge of $3.0 as a component of Other, net.   </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss in accumulated other comprehensive earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtMS0xLTEtMTE3MDI5_b38fb298-1008-4b48-9cd2-f48e62fb7101">60.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtMy0xLTEtMTE3MDI5_1e2af235-b1d2-4557-95b5-2d5393d1a403">66.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtNy0xLTEtMTE3MDI5_75d2ed3e-084c-4bf9-b5d9-d6f4fc294d6a">22.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtOS0xLTEtMTE3MDI5_e989040e-be30-4844-9d56-beb2c134b629">58.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Projected Benefit Obligation</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the projected benefit obligation as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><ix:continuation id="i455a1bc028d6430c922d943754f0824e" continuedAt="ibcc7119afbb5421fae47ef90e5fecd81"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:52.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtMS0xLTEtMTE3MDI5_2672a584-7354-401e-ba94-4177e8ff7f3c">333.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtMy0xLTEtMTE3MDI5_c8b3bd02-9eec-4f7f-9d4f-ea4c5f44f09a">369.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtNS0xLTEtMTE3MDI5_11172516-043b-4308-b0f2-6b272d961c6d">633.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60896f9da0414bb28b3e4a6cb0503006_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtNy0xLTEtMTE3MDI5_dc92a096-1b39-46cd-add3-eb1863a6007a">690.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtMS0xLTEtMTE3MDI5_366343f1-f241-4428-829b-e3453094550d">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtMy0xLTEtMTE3MDI5_59718674-7a8c-49a5-8457-5a4a8ba5e713">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtNS0xLTEtMTE3MDI5_3a41e546-eb09-41b4-b7f0-b6f5481945f7">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtNy0xLTEtMTE3MDI5_a3c18393-5ef5-4c4d-8527-011bdd932ceb">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtMS0xLTEtMTE3MDI5_03cc05b3-656d-43f7-a83d-f5ffbf0621ba">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtMy0xLTEtMTE3MDI5_e27a15c5-36ac-40dd-8c4a-3d14269f8bcd">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtNS0xLTEtMTE3MDI5_687b5ee8-afe7-4c88-bd9d-9be1483e5096">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtNy0xLTEtMTE3MDI5_5711bd82-67f3-4ed0-9e86-3ecec55905dd">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctMS0xLTEtMTE3MDI5_452af2ef-5908-484b-ba23-107771d9433d">58.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctMy0xLTEtMTE3MDI5_a9cc0f9b-3e32-4375-8f6b-caf19d08577d">18.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctNS0xLTEtMTE3MDI5_a8abbb15-d7b7-475d-b935-05b264853ad8">212.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctNy0xLTEtMTE3MDI5_6695123b-7434-4867-abb5-0b47476dc367">34.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtMS0xLTEtMTE3MDI5_5f899740-3a58-477f-ab20-380056a92205">27.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtMy0xLTEtMTE3MDI5_d8e99449-6ffe-4800-8a50-29948fcd7f34">30.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtNS0xLTEtMTE3MDI5_26508fae-e9f2-4553-966a-135afc274778">21.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtNy0xLTEtMTE3MDI5_81cae30c-9358-4f4c-99bc-b32045e6136d">22.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTEtMS0xLTExNzAyOQ_a282ed67-0ee7-4d5e-a6af-203df5ceb847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTMtMS0xLTExNzAyOQ_10aee40e-48d7-4499-8628-bde991b53468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="0" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTUtMS0xLTExNzAyOQ_bd89ecaa-d33c-4bfb-8759-de070315252f">60.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTctMS0xLTExNzAyOQ_46ffa169-fafb-4aac-a6c7-2262d8bd51a1">9.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of the year</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTEtMS0xLTExNzAyOQ_264ea259-31aa-455e-9e6d-bdaa0cd67816">259.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTMtMS0xLTExNzAyOQ_35e74905-3b8f-4117-9740-cee08dbad851">333.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTUtMS0xLTExNzAyOQ_f434b62e-f14e-4105-9850-149ce941d572">352.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTctMS0xLTExNzAyOQ_1911bec4-a57b-4fdf-9684-a92bf14a0862">633.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation as of December&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="7" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxMTA_1d822f1a-df65-4649-b624-4c836cec74bd">259.5</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="7" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxMTc_4507760a-c64c-4374-ad3b-bb4a8bb4aafe">333.3</ix:nonFraction>, respectively for the U.S. Plans and $<ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="0" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxNTc_d7bf755a-e715-4e7f-b3c3-60b45cab0fc0">352.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="0" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxNjQ_5630881b-2b01-42a1-94ec-a081fd6432ec">633.8</ix:nonFraction>, respectively for the Non-U.S. Plans. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Fair Value of Plan Assets&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in plan assets as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4ODU_617052af-89a4-487a-8b07-2df570e09b4a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtMS0xLTEtMTE3MDI5_5eee172a-af6a-488c-9027-230135661896">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtMy0xLTEtMTE3MDI5_a65ead8c-e4b3-4f9f-9610-f8f271f1cad1">300.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtNS0xLTEtMTE3MDI5_950a1dc2-2420-4483-8e85-ed098536032b">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60896f9da0414bb28b3e4a6cb0503006_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtNy0xLTEtMTE3MDI5_3d63209f-2452-42ac-b5a5-06a70c91cab5">535.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtMS0xLTEtMTE3MDI5_7270e434-efac-4818-8f5e-467fd9120902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtMy0xLTEtMTE3MDI5_c77e53e1-7bf7-42bc-bdd4-a9f5a2054b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtNS0xLTEtMTE3MDI5_7411ac97-6015-4486-80d1-2bde6e363959">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtNy0xLTEtMTE3MDI5_e1903afd-4827-4878-8ea5-117356d31742">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctMS0xLTEtMTE3MDI5_b8e6671e-45d5-4b74-aeb4-32aef535d61f">48.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctMy0xLTEtMTE3MDI5_4dc30029-5491-4fc6-ae94-5499743a2a64">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctNS0xLTEtMTE3MDI5_8330f6d7-6556-4eee-b67a-ce968906c046">157.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctNy0xLTEtMTE3MDI5_07ac2a05-fed5-425f-a3d9-43563d00bbb0">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i121f72a018ec4c9f8b54ddf0db87bf57_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtMS0xLTEtMTE3MDI5_7491f904-4b74-407e-88ed-9e726edba869">24.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i883357ce9ee9480da21af5fa83f5e410_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtMy0xLTEtMTE3MDI5_5bb283cf-59e6-40c8-a2bd-bf9ffdfad3e4">28.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2273640650a44965b54c030f812dcedd_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtNS0xLTEtMTE3MDI5_9f281933-21c0-4269-8daf-858405bb9869">16.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i804f88e2691b4702a7deef00d5e7453d_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtNy0xLTEtMTE3MDI5_c9536b33-e6a3-450b-9e65-62d32f372131">21.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktMS0xLTEtMTE3MDI5_a20e4dbb-ce1c-4d95-8f0e-3c6e699e8422">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktMy0xLTEtMTE3MDI5_86a19153-c717-4ea7-b388-6944efdeac41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktNS0xLTEtMTE3MDI5_e9914b22-94b9-47b5-b400-01dd8570f48f">54.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktNy0xLTEtMTE3MDI5_adc404dc-785d-4405-8f38-63e4738c6776">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTEtMS0xLTExNzAyOQ_c44ec052-aa97-45f4-bfa9-b02973516eea">226.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTMtMS0xLTExNzAyOQ_61b06a22-584f-42f3-8dda-e0333f9b8890">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTUtMS0xLTExNzAyOQ_33bcbacd-13a6-4e5d-8b4f-73552a27dfb1">331.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTctMS0xLTExNzAyOQ_5f488db0-b193-4349-a81c-947d77d6e479">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Funded Status and Reconciliation of Amounts Recorded in the Balance Sheet</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the funded status of the plan and a reconciliation of such funded status to the amounts reported in the consolidated balance sheet as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div style="text-align:center;text-indent:15.75pt"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfNetFundedStatusTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk5MDc_69e5baad-ffdb-44c0-9f16-7f34fbc84571" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:282.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtMS0xLTEtMTE3MDI5_58149092-047c-42f2-b767-370035355ec0">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtMy0xLTEtMTE3MDI5_86b9e27d-9464-4e20-81f0-4aad26818655">33.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtNS0xLTEtMTE3MDI5_23b7fb84-5fcb-4fb9-90ec-5fb0e1260a9b">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtNy0xLTEtMTE3MDI5_d34bfbb7-d5b1-4dac-9e6c-c4fd277018a5">89.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f604723897e4eb18b2d274c0a3e642e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtMS0xLTEtMTE3MDI5_3dc04564-f9d8-4c50-aafb-8f37cf9c4d3a">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b51bec3994e47d28d92a02668477358_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtMy0xLTEtMTE3MDI5_a81e5d0a-88c6-43d7-bd87-b6d330ac0450">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1ac24816154f94bf39eb4750cfb55d_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtNS0xLTEtMjE2MTAx_3382739e-50da-4dec-86de-d48c53735d86">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f42b96cf07842bf9fa62fba969481aa_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtNy0xLTEtMjE2MTAx_3ef67817-8ffd-4b59-be59-66cbaf472adf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0963421655a043af8a2b5bbb8989a17c_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctMS0xLTEtMTE3MDI5_74f5b045-a244-4115-9492-b4bbef62a226">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fb58427b7c4800985757cce94eaf0d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctMy0xLTEtMTE3MDI5_a093cfde-bbb2-483f-af69-0db7ef650c38">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891ad191af8840378b461971806bc9ed_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctNS0xLTEtMTE3MDI5_6391c3dd-7f50-4e00-83d9-b90a1592a7c1">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie883fffe23064af6952bf1c7966447d4_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctNy0xLTEtMTE3MDI5_590e1677-9045-444f-a41e-bddbcae2e170">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75b0f3b14f749a2a2501b3580890929_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtMS0xLTEtMTE3MDI5_f2195fc9-7ba9-442e-8785-914c7450ebf4">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44818990a4aa4815b47c3efcb5d6ae2d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtMy0xLTEtMTE3MDI5_602a3ed7-1d69-4ba0-9967-dcbb1f1285e4">44.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af7b58ae38646cf89971672cf01e93e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtNS0xLTEtMTE3MDI5_74d3f3e4-6e07-4a5c-b857-49f765644aeb">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i446afb2f73d045dda711f7c831299b78_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtNy0xLTEtMTE3MDI5_12a8821f-2369-4f2c-be25-fd3d716299b1">88.6</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i0da5632f6394458eab1963d292af417f" continuedAt="i9458e8d66ef743838583ff18039129ae"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assumptions</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NzM_3f90d4a7-53aa-4e6b-be96-4c7ab90cdd5f" continuedAt="ied655ed10d504a0da414c0942d26a3b8" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit costs are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="5" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMS0xLTEtMTE3MDI5_26ec3ca7-6f0e-4e2e-8dde-7ab58e13b5f5">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMy0xLTEtMTE3MDI5_43f7a2cf-542e-4298-95a5-b9e2523ac276">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtNS0xLTEtMTE3MDI5_daf51955-e95e-48d1-9bd9-69b8a80db5bc">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtNy0xLTEtMTE3MDI5_651173d7-4049-43c6-a427-7c3d355e36bf">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtOS0xLTEtMTE3MDI5_639e8917-b696-4eb0-a19f-77b89be73163">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMTEtMS0xLTExNzAyOQ_5cddeb16-e49e-4cc6-be6c-887caca8a04d">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtNy0xLTEtMTE3MDI5_cfc46142-4510-41ba-b76f-ca43cb5af465">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtOS0xLTEtMTE3MDI5_623b53de-220a-4a12-b807-ba14c65a5ebe">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtMTEtMS0xLTExNzAyOQ_ca95b47d-83b4-485b-8c44-743694953793">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long term rate of return </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="3" name="lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMS0xLTEtMTE3MDI5_366c6635-3429-42c7-b39f-7874cbb4fc9e">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="3" name="lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMy0xLTEtMTE3MDI5_d6a6b7f4-ac5f-4660-9663-98f4fe3a4944">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231" decimals="3" name="lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtNS0xLTEtMTE3MDI5_3c201edb-e24f-4c34-b33e-dbe1e4812b02">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="3" name="lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtNy0xLTEtMTE3MDI5_9418047e-9cfc-41e8-af84-9c29bf9b160b">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231" decimals="3" name="lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtOS0xLTEtMTE3MDI5_0054c399-e50a-43ca-ba31-689f55f44304">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="rate" contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231" decimals="3" name="lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMTEtMS0xLTExNzAyOQ_5d0b24cf-4717-411c-907e-309900fedd7e">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest credit rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtMS0xLTEtMTE3MDI5_be043455-2f80-4719-b32f-81e8822493a7">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtMy0xLTEtMTE3MDI5_794d8a93-271b-45b0-b32b-fb813bbbc819">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtNS0xLTEtMTE3MDI5_41b677ce-8419-4514-a4be-02f73ead4925">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $<ix:nonFraction unitRef="usd" contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzI4Mjk_93a68b92-102c-4256-bf60-f945ac442d72">0.8</ix:nonFraction> for the U.S. Plans. A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $<ix:nonFraction unitRef="usd" contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzMwMDc_b32e7d31-32ef-413c-b9c0-cd1ff362e617">2.8</ix:nonFraction> for the Non-U.S. Plans.</span></div><ix:continuation id="ied655ed10d504a0da414c0942d26a3b8" continuedAt="i60589b578ef94905bcac462b4f70f169"><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit obligations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:65.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtMS0xLTEtMTE3MDI5_8ae81cd8-9c72-4e71-985b-11c4920c336c">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtMy0xLTEtMTE3MDI5_f03bb004-b54c-4d5a-a93c-6fd84899af1d">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtNS0xLTEtMTE3MDI5_8413f316-93bd-4e0f-85b0-7c524a728fbe">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="4" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtNy0xLTEtMTE3MDI5_4ee95141-d507-4131-8e1d-1db197f91aca">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzQtNS0xLTEtMTE3MDI5_7a15fe9f-b047-41b3-a916-3ebf842aaadd">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzQtNy0xLTEtMTE3MDI5_9928c0f9-d051-408f-bb53-f9997c03eefa">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using the weighted-average yields on high-quality fixed income securities that have maturities consistent with the timing of benefit payments. Lower discount rates increase the size of the benefit obligation and generally increase pension expense in the following year; higher discount rates reduce the size of the benefit obligation and generally reduce subsequent-year pension expense. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected return on plan assets is the estimated long-term rate of return that will be earned on the investments used to fund the pension obligations. To determine this rate, the Company considers the composition of plan investments, historical returns earned, and expectations about the future. Actual asset over/under performance compared to expected returns will respectively decrease/increase unrecognized loss. The change in the unrecognized loss will change amortization cost in upcoming periods. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $<ix:nonFraction unitRef="usd" contextRef="ic9e08d02460648ceb4f5d1073cf29452_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzQyMTI_a8674434-8338-42af-9e5f-c8fa331f8268">3.0</ix:nonFraction> for the U.S. Plans. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $<ix:nonFraction unitRef="usd" contextRef="i30b8718e15b74da59c3573b8d71f7af5_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanOtherCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzQzODg_1925378f-ec1c-4741-bf1f-3ba9aedd1015">5.0</ix:nonFraction> for the Non-U.S. Plans.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The salary increase assumptions are used to estimate the annual rate at which pay of plan participants will grow. If the rate of growth assumed increases, the size of the pension obligations will increase, as will the amount recorded in Accumulated other comprehensive income (loss) in the Company's Consolidated Statement of Financial Position and amortized into earnings in subsequent periods. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates other assumptions periodically, such as retirement age, mortality and turnover, and updates them as necessary to reflect the Company's actual experience and expectations for the future. Differences between actual results and assumptions utilized are recorded in Accumulated other comprehensive income each period. These differences are amortized into earnings over the remaining average future service of active participating employees or the expected life of inactive participants, as applicable.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i9458e8d66ef743838583ff18039129ae" continuedAt="i3318361db66c4343b688a6c30ba175a1"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets</span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk5MzE_5a5dbeae-c951-4d72-b29f-b1b7ff5388d6" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the assets at December&#160;31, 2022, and 2021, by asset category are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzItMi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzItNi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24dd8a27e334839bd22287ccd572072_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzMtNC0xLTEtMTE3MDI5_90e50b6e-68fc-45a3-a0a6-f027d31041ec">39.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24dd8a27e334839bd22287ccd572072_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzMtNi0xLTEtMTE3MDI5_90e50b6e-68fc-45a3-a0a6-f027d31041ec">39.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192893a861a0482dad94f453f9c613a6_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzQtNC0xLTEtMTE3MDI5_8db49468-70e1-48b8-b5ae-63aced93a464">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192893a861a0482dad94f453f9c613a6_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzQtNi0xLTEtMTE3MDI5_8db49468-70e1-48b8-b5ae-63aced93a464">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzUtNC0xLTEtMTE3MDI5_c807657f-047b-429e-9b7c-4cfe84032e3a">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzUtNi0xLTEtMTE3MDI5_c807657f-047b-429e-9b7c-4cfe84032e3a">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7439af4f1d3a4692b0653838638d8af8_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzYtNC0xLTEtMTE3MDI5_b4264e2c-ba76-4250-aa09-56ab0f64209d">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7439af4f1d3a4692b0653838638d8af8_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzYtNi0xLTEtMTE3MDI5_b4264e2c-ba76-4250-aa09-56ab0f64209d">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctMi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if84b6a0f91f946deb9c23815d77889ba_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctNC0xLTEtMTE3MDI5_2d5d13dd-64cb-4df5-89da-706318614d9a">222.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctNi0xLTEtMTE3MDI5_24222cab-00cf-46d1-bdbe-b6e4c8575ebd">226.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df3c43a8db540988490dbc3e564ddea_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEwLTItMS0xLTExNzAyOQ_dae7bb4e-6d66-45c7-b2a0-c3567c485d00">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df3c43a8db540988490dbc3e564ddea_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEwLTYtMS0xLTExNzAyOQ_dae7bb4e-6d66-45c7-b2a0-c3567c485d00">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTItMS0xLTExNzAyOQ_a122ae6f-0ab7-45f2-9671-7f39eaaaf658">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia678cf83b6f6441dad461ad8e5dd1bd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTQtMS0xLTExNzAyOQ_685d2105-3c1a-4d68-a03c-437cb7ee495a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTYtMS0xLTExNzAyOQ_878147fb-5218-45d1-9af8-2f0bb4918572">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02645e959c074c3f93e3d43221951719_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEyLTQtMS0xLTExNzAyOQ_4d047e5c-dd19-4dee-8bed-83071a4c086f">268.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02645e959c074c3f93e3d43221951719_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEyLTYtMS0xLTExNzAyOQ_4d047e5c-dd19-4dee-8bed-83071a4c086f">268.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3662d054eed4f3eb5eafc0e90748600_I20221231" decimals="7" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTItMS0xLTExNzAyOQ_9e68c859-505c-4801-a00a-dca7180302d0">63.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28a1ab53d5f946889e265c64121dfdef_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTQtMS0xLTExNzAyOQ_4f515131-3212-414f-a508-acc9064de328">268.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTYtMS0xLTExNzAyOQ_b32d0bf0-8580-48e7-8f03-df57c68c3732">331.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzItMi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzItNi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzMtNC0xLTEtMTE3MDI5_6f6f72eb-ed5e-4a7b-b11e-412a68db38f2">52.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzMtNi0xLTEtMTE3MDI5_250daf9f-dabe-4d1b-9220-898fd7ded619">52.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911d298b24e044ba8bf3996c13022e04_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzQtNC0xLTEtMTE3MDI5_a6ffda9c-bfb2-4a04-9119-acc3cc9ad77c">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911d298b24e044ba8bf3996c13022e04_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzQtNi0xLTEtMTE3MDI5_293f97a2-77d3-4c9b-910c-20853603a061">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate index fund</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533eccefe7c42269410fcbf42b37fbe_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzUtNC0xLTEtMTE3MDI5_2d468068-6318-4e81-8db5-3e8574490614">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia533eccefe7c42269410fcbf42b37fbe_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzUtNi0xLTEtMTE3MDI5_f268ec16-b2a4-428d-b38d-5039f7aeedf9">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0179f13a6a7141e6a26b122221a62bff_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzYtNC0xLTEtMTE3MDI5_bfab631e-43d8-4f66-ac07-a600a173e580">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0179f13a6a7141e6a26b122221a62bff_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzYtNi0xLTEtMTE3MDI5_84a3ac3c-6c22-4ade-88a8-828f9ec592ed">213.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctMi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90d8ce237094025b4a5a63bbeb2766e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctNC0xLTEtMTE3MDI5_a09aadad-2cdf-4174-bd0a-f98959ad39fb">295.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctNi0xLTEtMTE3MDI5_babf4c8c-277d-417e-a6aa-7b040da9c6ab">299.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEwLTItMS0xLTExNzAyOQ_71a0b719-0693-44b1-a7a4-fec368866cd1">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEwLTYtMS0xLTExNzAyOQ_66ae5f97-b3ee-4c5e-afd3-6ca8b41d95f6">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd158ee242794532a7ea7bd54577418d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTItMS0xLTExNzAyOQ_230d44c7-05ab-4735-8ece-1f915961887e"><ix:nonFraction unitRef="usd" contextRef="icd158ee242794532a7ea7bd54577418d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTItMS0xLTExNzAyOQ_4f13bbf7-0d69-4c64-862d-af446234a242">97.9</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd158ee242794532a7ea7bd54577418d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTYtMS0xLTExNzAyOQ_230d44c7-05ab-4735-8ece-1f915961887e"><ix:nonFraction unitRef="usd" contextRef="icd158ee242794532a7ea7bd54577418d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTYtMS0xLTExNzAyOQ_4f13bbf7-0d69-4c64-862d-af446234a242">97.9</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f7b3a1a2f964982926273037d0b54b5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEyLTQtMS0xLTExNzAyOQ_ec0bb876-9cd6-49eb-9364-eaf8faafc7f1">427.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f7b3a1a2f964982926273037d0b54b5_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEyLTYtMS0xLTExNzAyOQ_ec0bb876-9cd6-49eb-9364-eaf8faafc7f1">427.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099c0ee08c294db19c4ae5023b72d7bc_I20211231" decimals="7" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTItMS0xLTExNzAyOQ_688bc9f0-0580-45a9-b0f0-9a5dcea0c706">117.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8343104e0af14f108a0fbe74beca5c54_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTQtMS0xLTExNzAyOQ_b64d1833-2568-414d-b7ad-067d05e76931">427.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTYtMS0xLTExNzAyOQ_1e0704d2-cc72-44fe-971b-c33c337a6ac9">544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of index funds and pooled investment funds are valued using the net asset value (NAV) unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund. The fair value of annuity investments are based on discounted cash flow techniques using unobservable valuation inputs such as discount rates and actuarial mortality tables.</span></div><div style="margin-bottom:4pt;margin-top:5pt;text-align:center;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.001%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement of Level 3 Pension Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec771cc41634795906fe138e1c81da2_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzEtMi0xLTEtMTE3MDI5_bc4bc1b2-cb72-402b-b976-2fedd7990a59">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cf312ecfe346bc8025109327803b22_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzItMi0xLTEtMTE3MDI5_356e6bcf-8ff2-48d6-b416-04f879d42c30">39.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd158ee242794532a7ea7bd54577418d_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzMtMi0xLTEtMTE3MDI5_cfe08951-b284-42b7-a733-f4f27912a93c">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0255c909ecf4062be8e1ef4d572ecce_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzQtMi0xLTEtMTE3MDI5_547afe52-8c60-44e9-a8c2-7bd20a26ce18">37.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzUtMi0xLTEtMTE3MDI5_a72744a2-ad8b-45ae-9467-c2f58d885e81">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Investment Policies</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan fiduciaries of various plans set investment policies and strategies, based on consultation with professional advisors, and oversee investment allocation, which includes selecting investment managers and setting long-term strategic targets. The primary strategic investment objectives are balancing investment risk and return and monitoring the plan&#8217;s liquidity position in order to meet the near-term benefit payment and other cash needs. Target allocation percentages are established at an asset class level by plan fiduciaries. Target allocation ranges are guidelines, not limitations, and occasionally plan fiduciaries will approve allocations above or below a target range.</span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i3318361db66c4343b688a6c30ba175a1" continuedAt="ide2c2827904f4619b0f727595855fa58"><ix:continuation id="i60589b578ef94905bcac462b4f70f169"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocation of the plan assets as of December&#160;31, 2022, by asset category is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:63.760%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i460a5c47a3364d9fb3e031edfbfbabf3_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzItMi0xLTEtMTE3MDI5_05287014-497e-42d6-9046-e79effdbd869">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibfdcdc0c2f94425c91be11297fbb8ce7_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzItNC0xLTEtMTE3MDI5_d71e1026-f321-4218-9600-72dbbcaf607d">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia240fb91ddb54361a789dbb9530b8f1b_I20221231" decimals="INF" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzMtMi0xLTEtMTE3MDI5_f8844954-bceb-4206-b459-5a262b4d2779">71.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8760f818f2b14f7fbcf0a940eec93d45_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzMtNC0xLTEtMTE3MDI5_e765ce87-c27b-4c90-a61f-8cf513a69799">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0f143c0038649379b2fa66b119f8d69_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzQtMi0xLTEtMTE3MDI5_31b904bc-4af7-4b96-93fd-a00fc43c2aa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i692e176a76174874b466ab85db6c1c50_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzQtNC0xLTEtMTE3MDI5_574c875e-ebd2-4e37-bb68-c9ec5a6946a4">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if52b7c1c428d4e3eb3aaf9e375478112_I20221231" decimals="INF" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzUtMi0xLTEtMTE3MDI5_1c2b3111-dcee-43bc-8287-6d5569bd92f1">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib97b7437ac9d4146bc2f4ed185519c80_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzUtNC0xLTEtMTE3MDI5_802ec7b4-94b7-4ba7-be97-a3d2ec1eb0d2">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6813336b6e7e427a800450b3823e6bec_I20221231" decimals="INF" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzYtMi0xLTEtMTE3MDI5_e185ea93-ae60-4c87-b4e1-06a9cd86db5b">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0fe63c273ca4dc4a880fceff9e1b046_I20221231" decimals="3" name="lh:DefinedBenefitPlanActualAssetAllocation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzYtNC0xLTEtMTE3MDI5_c88392af-b9d9-4562-9d32-82bf364e88f9">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average target asset allocation of the plan assets is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:60.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9b971586ec34065819f0eebea18797c_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtMi0xLTEtMTE3MDI5_ee245a20-5448-496c-a95b-f94c2e22bb49">17.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic020e345f5144121aead1d17fd7809f2_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtNC0xLTEtMTE3MDI5_473bac78-78e5-449a-a480-f958987a1e39">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea4ad6f940d54031b324772fcccbf937_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtNi0xLTEtMTE3MDI5_d0348269-3a6f-42f3-a906-4ef0a32d429c">35.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d404caf16a542c58ecb2494a483b6d6_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtOC0xLTEtMTE3MDI5_e32b79d4-7cae-4de0-8807-f4059256d87e">45.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd89c14ab1bc418b95827960d8faf263_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItMi0xLTEtMTE3MDI5_75add34c-6656-4cbf-9113-e6bc5d644d2b">61.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6911f4e40cef4e0daf420e676d7ec31a_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItNC0xLTEtMTE3MDI5_08fe058c-1456-4b0f-adf4-140ae9b4c09c">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0f3586c7f5d42f880ddfd468ec2f11f_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItNi0xLTEtMTE3MDI5_270c661b-cf41-40ae-b0fa-8a0ab854e03a">30.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3cd1a0cfffa24ae3b00be3abc0a69934_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItOC0xLTEtMTE3MDI5_283174e9-ab43-4574-a8f6-4d97e0035e57">40.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74347e5ffa2b413b99cd4565f3bf9e5e_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtMi0xLTEtMTE3MDI5_9541d0b1-0d8a-4e6f-8ca2-3dbdfc4f079d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8535bd9bae349cda74905f20fef9702_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtNC0xLTEtMTE3MDI5_a0e2a07f-c775-4fc0-86c2-03eb02a6cdf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibae84d9b5d624724bd2b3879c40582be_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtNi0xLTEtMTE3MDI5_cbf73eb9-888f-42cc-83b4-f99a7206fdda">10.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95215116016547b1b171fa14b5466684_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtOC0xLTEtMTE3MDI5_05f4fc11-b421-4745-ad71-154e712e05aa">20.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if52b7c1c428d4e3eb3aaf9e375478112_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtMi0xLTEtMTE3MDI5_21ec10c9-c19d-4ea9-baf6-2625d719d893">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb5709179a954534b3ce4e1599336837_I20221231" decimals="4" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtNC0xLTEtMTE3MDI5_83209283-a2ed-4e57-a285-2a6027520b7c">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c42916431b444feabb231e74e766011_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtNi0xLTEtMTE3MDI5_2956f699-5d78-49b5-a8b2-de6371bb7046">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8e8799065c4f474b92bc1ecf19ea0d73_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtOC0xLTEtMTE3MDI5_19d1ac9a-0710-4a88-bc28-07464ac68f44">10.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b1e06d6958940bf87696cd12422aa1e_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtMi0xLTEtMTE3MDI5_f47106a0-4f4b-4bf2-a3ac-2eee7ee96d11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2e111bc212c4b4b8fa775e86b3df66c_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtNC0xLTEtMTE3MDI5_35bd57c5-a464-4e09-b184-d1099511a046">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idb1897fa2127453ea83329424c5d5a7c_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtNi0xLTEtMTE3MDI5_c97f3a24-bc11-4c99-8574-33cb50144a5a">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e936d64daeb461b84ea45f5f4b467e5_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtOC0xLTEtMTE3MDI5_625a6678-facd-488b-97ae-61e303f5a59b">5.0</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Funding and Cash Flows</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to make approximately $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzY3OTQ_bcebbd0e-cd3e-4de7-b710-1b28d4160586">18.2</ix:nonFraction> in required contributions to its defined benefit pension plans during 2023. The Company targets funding the minimum required contributions but may make additional contributions into the pension plans in 2023, depending upon factors such as how the funded status of those plans change or to reduce the administrative costs of the plan.</span></div><ix:continuation id="ibcc7119afbb5421fae47ef90e5fecd81" continuedAt="icb0c95a913614aa6af0c0b952c8f4b4f"><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated benefit payments, which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U. S. Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzEtMS0xLTEtMTE3MDI5_f5cedf79-532f-41ed-bd3d-c7cae82689eb">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzEtMy0xLTEtMTE3MDI5_3d211c25-22b3-4c6c-bb32-aef88a61fe26">14.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzItMS0xLTEtMTE3MDI5_130b7816-25e9-47de-a00e-2a3ffd3e3605">25.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzItMy0xLTEtMTE3MDI5_7a2d3549-f4a5-4dc4-ad62-71b77b37db06">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzMtMS0xLTEtMTE3MDI5_05ca6264-649f-4849-8739-b33dc5740ae5">25.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzMtMy0xLTEtMTE3MDI5_fee18280-8d4c-4cf5-9142-536145d1879d">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzQtMS0xLTEtMTE3MDI5_46655590-7c82-4d2f-bb3a-78043fa35694">24.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzQtMy0xLTEtMTE3MDI5_ab093c8e-c0f7-4a81-b370-e1b05998cb7c">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzUtMS0xLTEtMTE3MDI5_61623d2f-069a-42fa-b1c1-c1de8cc59a63">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzUtMy0xLTEtMTE3MDI5_094c04bd-9941-4453-bb0e-44aebacbef10">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 to 2037</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzYtMS0xLTEtMTE3MDI5_02b87d13-84ef-4066-ac08-d12a38b507ff">106.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzYtMy0xLTEtMTE3MDI5_020c90e2-a694-4e72-bb6c-2a8f030b5f2f">95.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-employment Retiree Health and Welfare Plan</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a post-employment retiree health and welfare plan for the benefit of eligible employees at certain U.S. subsidiaries who retire after satisfying service and age requirements. This plan is funded on a pay-as-you-go basis and the cost of providing these benefits is shared with the retirees.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-retirement Medical Plan</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed obligations under a subsidiary's post-retirement medical plan. Coverage under this plan is restricted to a limited number of existing employees of the subsidiary. This plan is unfunded and the Company&#8217;s policy is to fund benefits as claims are incurred. <ix:continuation id="icb0c95a913614aa6af0c0b952c8f4b4f" continuedAt="id3e500d0fcb740dba0814c519c214882">The effect on operations of the post-retirement medical plan is shown in the following table:</ix:continuation></span></div><div style="margin-bottom:6pt"><ix:continuation id="id3e500d0fcb740dba0814c519c214882" continuedAt="ib6654271b5d945e1be457cfc714023a5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:65.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtMS0xLTEtMTE3MDI5_16a622e0-0f26-43b4-a936-12d14048e737">0.1</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtMy0xLTEtMTE3MDI5_6ab3a887-cf00-4415-9951-855b8735eaf1">0.1</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtNS0xLTEtMTE3MDI5_a21e0ff0-7f5b-4128-8288-058c4a9adc8a">0.2</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtMS0xLTEtMTE3MDI5_10e0ae4a-56dc-4bf5-b4dc-c0429852f8c2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtMy0xLTEtMTE3MDI5_0a76e837-e085-40c7-aa99-843e0a734569">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:DefinedBenefitPlanAmortizationAndDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtNS0xLTEtMTE3MDI5_2c6f41f3-06c6-4321-b338-7582a81c2657">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-retirement medical plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtMS0xLTEtMTE3MDI5_d2182556-94da-4c23-ba70-acf71264cc5f">0.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtMy0xLTEtMTE3MDI5_a35e94a0-3777-4ce2-9cce-47aec5eb27ab">0.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtNS0xLTEtMTE3MDI5_2f2f5274-92fb-474f-a674-cb6fd1a71594">0.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in accumulated other comprehensive earnings consist of unamortized net (income) loss of $(<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgxMjU_a05d83bc-6a49-4f19-816b-05da3b69a2d4">0.2</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgxMzI_9ab7de6e-93e5-42ca-b2f6-0c5ee3382b22">0.8</ix:nonFraction>. </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ide2c2827904f4619b0f727595855fa58" continuedAt="iab4741d56cc34c8cb7ee116a5007497b"><ix:continuation id="ib6654271b5d945e1be457cfc714023a5"><div style="text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the changes in the accumulated post-retirement benefit obligation follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEtMS0xLTEtMTE3MDI5_a18690c3-c2c7-4273-ae2d-75f90739cba4">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icff6b868a72748489c76618831c34913_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEtMy0xLTEtMTE3MDI5_c54f21d2-41f2-41e9-99d7-e7ef59bed241">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzMtMS0xLTEtMTE3MDI5_e0e242c7-db27-4ad1-b8d4-a248c1a9e98e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzMtMy0xLTEtMTE3MDI5_6df4270e-066f-4650-ad31-553aedf4983a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzQtMS0xLTEtMTE3MDI5_29168319-ace8-4ac3-8151-c15e89f5ee33">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzQtMy0xLTEtMTE3MDI5_9ceee8ed-9982-441f-87bd-ee7695f4f9ad">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzUtMS0xLTEtMTE3MDI5_ff89ca7b-f609-4838-95ed-6b3b3a4764de">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzUtMy0xLTEtMTE3MDI5_b4389654-c528-4013-8b55-464719f175ab">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzctMS0xLTEtMTE3MDI5_f2fa654b-915b-40cc-9123-af1e034ddf41">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzctMy0xLTEtMTE3MDI5_4e918f5e-9fb8-450b-817d-7dfb6ee49974">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfb61b234a44fe89faf7bfc24db3774_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEwLTEtMS0xLTExNzAyOQ_7073132b-17fb-4c5b-bbae-ce0a63f163b9">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d1e82ad70f4603a498897f322acee1_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEwLTMtMS0xLTExNzAyOQ_7c7d993d-de58-487a-9137-74ccb5c7cdd8">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe23aa99b6847ed961d4fb0f516aeb5_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzExLTEtMS0xLTExNzAyOQ_472c1623-4756-4b57-b85f-2ffcbd8660c7">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide46a6b378da475296703e0ec9e436bb_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzExLTMtMS0xLTExNzAyOQ_21a4c8ce-b098-4ed4-bde2-b731de582f5a">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEyLTEtMS0xLTExNzAyOQ_5738b20a-6bba-42d2-8279-f3739ddef97b">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEyLTMtMS0xLTExNzAyOQ_82fa0e8c-d930-4084-b2ba-bdf7ad306b89">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average discount rates used in the calculation of the accumulated post-retirement benefit obligation were <ix:nonFraction unitRef="number" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgzNDc_f765b0db-d730-4ebe-a96e-3bdbfdcf17ed">5.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgzNTQ_1973aedb-3a93-4745-a9de-b8de8699bb58">2.7</ix:nonFraction>% as of December&#160;31, 2022, and 2021, respectively. The healthcare cost trend rate was removed due to the expectation of future funding to be at the same level as the previous year's funding. </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="lh:AssumedBenefitPaymentsByYearTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NTU_e2377a23-9c4f-4f24-aebc-ba56f8c13dcd" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumed benefit payments under the Company's post-retirement benefit plan, which reflect expected future service, as appropriate, and which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzAtMS0xLTEtMTE3MDI5_919bb3fe-b00a-4183-a29c-40e6494d368c">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzEtMS0xLTEtMTE3MDI5_b3e6c863-68b5-46d7-b19a-448c744c5bbc">0.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzItMS0xLTEtMTE3MDI5_02eb99af-c128-4e5c-923e-9b746ecfc1b1">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzMtMS0xLTEtMTE3MDI5_5d0e32c5-5837-4735-b319-e8110f762324">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzQtMS0xLTEtMTE3MDI5_09cae0ce-965e-4149-bb36-0894bd206da6">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzUtMS0xLTEtMTE3MDI5_95bd587d-640a-4b39-b777-e3f15c671908">1.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:7pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div></ix:continuation><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab4741d56cc34c8cb7ee116a5007497b">The Company has Deferred Compensation Plans (DCP) under which certain of its executives may elect to defer up to <ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="lh:Maximumdeferralpercentageofannualcashincentivepay" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzg5Mjk_9776f9ba-4e7d-467c-a10a-d08fab7e2f89">100.0</ix:nonFraction>% of their annual cash incentive pay and/or up to <ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="3" name="lh:Maximumdeferralpercentageofannualbasesalary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzg5ODA_23140175-0c0a-4a31-8353-e83d97e56b90">50.0</ix:nonFraction>% of their annual base salary and/or eligible commissions subject to annual limits established by the U.S. government. The DCP provides executives a tax efficient strategy for retirement savings and capital accumulation without significant cost to the Company. The Company makes no contributions to the DCP. Amounts deferred by a participant are credited to a bookkeeping account maintained on behalf of each participant, which is used for measurement and determination of amounts to be paid to a participant, or his or her designated beneficiary, pursuant to the terms of the DCP. The amounts accrued under these plans were $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk2MDY_78aeb035-8aa0-4f98-800a-94c4c26812ac">96.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk2MTM_e909bbb1-a861-4ad9-a4fa-e0253cbb6761">104.4</ix:nonFraction> at December&#160;31, 2022, and 2021, respectively. Deferred amounts are the Company's general unsecured obligations and are subject to claims by the Company's creditors. The Company's general assets may be used to fund obligations and pay DCP benefits.</ix:continuation>    </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_241"></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3ODM_bbefffe3-20cc-4ccd-ae32-5892b1ffa114" continuedAt="ie97a3d8604094720bae55eb304f578f3" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie97a3d8604094720bae55eb304f578f3" continuedAt="ic5a14a4814c64421ac6e9d6532854269"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3NzU_2bf6869b-07ba-4208-8790-7430782d33fe" continuedAt="i155a44515d60492886ff9bdb1fe7e878" escape="true"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of December&#160;31, 2022, and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.235%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.659%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.688%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtMi0xLTEtMTE3MDI5_225d0985-f546-4b87-afd8-56a86622cd17">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtNC0xLTEtMTE3MDI5_4e249d4f-3c45-4a40-b4e3-69bd73d32613">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtNi0xLTEtMTE3MDI5_7ae21d4f-71ff-449a-92cc-7fe468bd46a5">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtOC0xLTEtMTE3MDI5_4720d7d6-16b4-4827-9aaf-3120767ac934">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtMi0xLTEtMTE3MDI5_82cc10f7-9c57-4890-a338-e06b975a04da">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtNC0xLTEtMTE3MDI5_38569d43-fff9-4b2c-8f09-b0159368c785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtNi0xLTEtMTE3MDI5_c47b505e-1d84-46f0-ac73-2e1b7f2dd342">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtOC0xLTEtMTE3MDI5_47b1e85c-0410-4092-ab8b-615e26aa29e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="7" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtMi0xLTEtMTE3MDI5_eddde4b6-b479-4d1f-be29-ab70e0d59553">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtNC0xLTEtMTE3MDI5_66ca3394-4968-4f14-97c7-78e051be91a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtNi0xLTEtMTE3MDI5_5b48389a-f054-49bc-a9ed-ed6cb5092460">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtOC0xLTEtMTE3MDI5_71b81055-314a-491f-b089-a8635c41d05d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctMi0xLTEtMTE3MDI5_0632689b-e634-4e55-bea7-99fa5e0dad80">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctNC0xLTEtMTE3MDI5_b36f9316-2dfd-477b-b2de-cfb72c6342c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctNi0xLTEtMTE3MDI5_00351135-2b32-4e8b-ac3f-7f2069d91ed2">100.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctOC0xLTEtMTE3MDI5_410dab13-67db-4fc7-b9e7-2f180f4914c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtMi0xLTEtMTE3MDI5_f09ca1e8-a5aa-4355-a52b-fd097ac93878">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtNC0xLTEtMTE3MDI5_74152215-964d-4675-8c2e-b60aba6387af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtNi0xLTEtMTE3MDI5_cd5f120e-e864-4943-8b0d-f2cf20b82a1d">96.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtOC0xLTEtMTE3MDI5_234c7dd7-e1cd-46ec-9db4-5a86149cd225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTItMS0xLTExNzAyOQ_a9c6773b-6701-49cb-9edf-94d36c9a813f">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTQtMS0xLTExNzAyOQ_b5e16af4-f452-4d45-a097-e0667c726eaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTYtMS0xLTExNzAyOQ_0871ccf8-3fc1-48e0-a20a-a56adf977867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTgtMS0xLTExNzAyOQ_5addb5c1-e9e8-4e6f-a266-1832065e1292">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="ic5a14a4814c64421ac6e9d6532854269" continuedAt="ie473b87f1c7845d88d6859e99a510296"><div style="margin-bottom:3pt"><ix:continuation id="i155a44515d60492886ff9bdb1fe7e878"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.762%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtMi0xLTEtMTE3MDI5_896f1528-4a08-4b17-98d2-ca144612f2f5">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtNC0xLTEtMTE3MDI5_51e3234a-ba4a-4e2d-bfb5-4cd8bf1ee327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtNi0xLTEtMTE3MDI5_94cf823e-9b4a-4bc7-a627-5ce9bceaee12">16.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtOC0xLTEtMTE3MDI5_f14c846d-4831-4320-9d7d-a4349cf8bb10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtMi0xLTEtMTE3MDI5_d6e47b3a-db4e-425b-8467-7a18b425eeb9">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtNC0xLTEtMTE3MDI5_0a4cb177-8fd6-4e02-9d64-7e54dcad5044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtNi0xLTEtMTE3MDI5_a8c174c3-b7c5-4b31-ad07-2f80fd7c64d5">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtOC0xLTEtMTE3MDI5_9938ede8-12c3-4e4c-954d-b63ca5bd3ec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="7" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtMi0xLTEtMTgyNDE3_136cfadd-06af-4c65-828b-961bf6a34904">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNC0xLTEtMTgyNDI0_f9640fb5-5efc-40d1-b8fc-72fd0d310cb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNi0xLTEtMTgyNDQw_b8cf6006-48af-4575-a67f-c4c39c3040fe">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtOC0xLTEtMTgyNDQ3_59e550ba-9f41-4b0c-9e39-aa14c43ebd04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtMi0xLTEtMTE3MDI5_9426dfe2-ffc6-4bdc-b869-26cfc5fbe2ae">106.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNC0xLTEtMTE3MDI5_bb3ea0e0-ac58-49ac-b36f-9019249216ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNi0xLTEtMTE3MDI5_6ebc002b-93fa-4bf8-a3ee-4a8831007d02">106.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:CashSurrenderValueFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtOC0xLTEtMTE3MDI5_439220f5-3fc5-4003-b783-97c6e91c77f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctMi0xLTEtMTE3MDI5_c6137b7f-f9a5-4232-837d-db95e579e8f5">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctNC0xLTEtMTE3MDI5_1e019f58-db07-4089-ba8e-5ff9c38d835b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctNi0xLTEtMTE3MDI5_31aec1f3-9b7b-4c67-a6b4-e989fe62a6c1">104.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctOC0xLTEtMTE3MDI5_b44b93be-b659-40fb-8931-ea1161b814f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="7" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktMi0xLTEtMTgyMzM1_1450c7ad-f99f-4cca-b3be-2b94f987fc7d">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktNC0xLTEtMTgyMzQy_66e26fc5-3d6c-4afa-a407-ea15f5fcff91">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktNi0xLTEtMTgyMzU4_1fbda211-cf19-43b6-ab1a-359977fd1fd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktOC0xLTEtMTgyMzY1_ffb31f18-99af-43be-89fe-bb271f32c586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtMi0xLTEtMTE3MDI5_86dce3c2-a33c-42bc-b7fc-1b46eb18b406">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtNC0xLTEtMTE3MDI5_65494d16-8ce0-4f59-82c2-8967b652c897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtNi0xLTEtMTE3MDI5_cff364dd-5312-4b2e-9b06-afedd6f5b03f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtOC0xLTEtMTE3MDI5_55c1587b-14ee-4785-82b3-51f8ed77e956">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3Nzg_b5165398-87bc-40bd-a24b-22a7601cc3aa" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:75.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6761ac2c526642dd8202c09476f40e82_I20201231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzEtMi0xLTEtMTE3MDI5_50fe9a96-58b5-49fa-91ec-94df8dd875cb">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzItMi0xLTEtMTE3MDI5_49725e80-205a-42d2-9c83-3ff416783506">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:Contingentconsiderationadjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzMtMi0xLTEtMTE3MDI5_a7fb675a-6dcc-4111-807f-89989c17c5a3">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzQtMi0xLTEtMTE3MDI5_334816e7-1b8a-4492-abf5-1a22c55da208">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzUtMi0xLTEtMTE3MDI5_98a6ff52-3b48-4a11-a028-1444aac1729b">68.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:Contingentconsiderationadjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzYtMi0xLTEtMTE3MDI5_6fbcdc34-db2f-4bb3-a98c-826eef5ebb43">12.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzctMi0xLTEtMTE3MDI5_23f0738b-e7de-4211-b99c-63668eef7342">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value. During the year ended December&#160;31, 2022, the carrying value of the noncontrolling interest put decreased by $<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:IncreaseDecreaseInNoncontrollingInterestPut" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzU2MA_0d6f63cd-6a1a-4d7a-a856-7e97a029f93b">0.2</ix:nonFraction> for foreign currency translation.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in a DCP. A participant's deferrals are allocated by the participant to one or more of 16 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div></ix:continuation><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie473b87f1c7845d88d6859e99a510296">The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:SeniorNotesFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI1NTk_634da5e1-fd82-47fa-850e-d766539bcf98">4,973.9</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:SeniorNotesFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI1NjY_996039da-c144-4029-a4b1-41650502a7d2">5,841.1</ix:nonFraction> as of December&#160;31, 2022, and 2021, respectively. The Company's note and debt instruments are considered Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</ix:continuation> </span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_244"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNjI_153b3973-9772-4468-ade8-59937eb3b6b8" continuedAt="i9a581cae64964b329dcaa3a8dbc84303" escape="true">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ix:nonNumeric></span></div><ix:continuation id="i9a581cae64964b329dcaa3a8dbc84303" continuedAt="i98b666507f524bdb97c70d344f2c71a6"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%. These agreements were designated as hedges against changes in the fair value of a portion of the Company's long-term debt. </span></div></ix:continuation><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="i98b666507f524bdb97c70d344f2c71a6" continuedAt="i4fb4f8278c0a4b40bd818ed231a89fb7"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2013, the Company entered into two fixed-to-variable interest rate swap agreements for the <ix:nonFraction unitRef="number" contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEyMTI_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5">4.625</ix:nonFraction>% Senior Notes due 2020 with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i8742ac35d38745ad93ae0f53d955fd73_I20130331" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEyNzQ_c8d79798-b75c-4663-b49e-94b7bd41345d">600.0</ix:nonFraction> and variable interest rates based on one-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="5" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEzMzU_a4d14128-6958-4868-896a-93bb23a95467">2.298</ix:nonFraction>% to hedge against changes in the fair value of a portion of the Company's long-term debt.&#160;The Company exited the remaining fixed-to-variable interest rate swap agreement in August 2020, in connection with the redemption of the remaining $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:BalanceOfSeniorNotesMatureDuringQ42020" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3MTQ_7b9a0955-af39-4d20-bf29-332db0ebfc9a">412.2</ix:nonFraction> of its <ix:nonFraction unitRef="number" contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3MjQ_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5">4.625</ix:nonFraction>% Senior Notes due November 15, 2020, and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="lh:GainRecognizedonExitofInterestRateSwapArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3ODY_0c8b4855-1fd1-47ee-9246-852e3937e9f7">1.6</ix:nonFraction> on the extinguishment. The gain was included in Other, net on the Consolidated Statement of Operations.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross Currency Swaps</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into U.S. Dollar (USD) to Swiss Franc cross-currency swap agreements with an aggregate notional value of $<ix:nonFraction unitRef="usd" contextRef="i62637e2f6fb743b9ae7a0465221d295a_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzMxNzM_9ade9715-14d5-47e8-8332-c5643e1867e9">600.0</ix:nonFraction>. During the second quarter of 2022, the Company terminated $<ix:nonFraction unitRef="usd" contextRef="i72fecf8a9a614c76a5f20c1427477921_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE2NDkyNjc0NDc4NzI_ef26f967-63c0-4182-80b3-a32183ec59ba">300.0</ix:nonFraction> of those cross-currency swap agreements and entered into new USD to Swiss Franc cross-currency swap agreements with an aggregate notional value of $<ix:nonFraction unitRef="usd" contextRef="i402e968b57904d3c829927474cb21229_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE2NDkyNjc0NDg2MjU_3607ee1a-ac78-46d0-8835-37166b82e6d0">300.0</ix:nonFraction> that mature in 2024. These instruments are designated as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary.   </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNzQ_db3348cd-d114-4070-bb3b-e5c6ea91926e" escape="true"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:17.255%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.317%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMy0xLTEtMTE3MDI5_56a138a6-a575-48ce-b20b-3f751a3fc205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231" decimals="1" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtNS0xLTEtMTE3MDI5_eb7878a0-8696-45d8-9808-51cf2485a6dc">79.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34dcbd66606a4b4bbdf2c53cc57f54e9_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtNy0xLTEtMTE3MDI5_32c1aee8-b56a-4233-9817-68bd511a3131">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e361c43a754d01b7cfa82e6747efc3_I20211231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtOS0xLTEtMTE3MDI5_f3dcdae6-b19f-4d61-be52-928ea422fbaf">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3e361c43a754d01b7cfa82e6747efc3_I20211231" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMTEtMS0xLTExNzAyOQ_edda860d-4f78-471d-a671-3afa63876c22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d4a564210ff40f48048c331cff9cf8b_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMTMtMS0xLTExNzAyOQ_dd429aad-2463-45ac-88b5-0b48c6367c32">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d9c8469896f45ecba498b0ede39dbb8_I20221231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMy0xLTEtMTE3MDI5_a9f6f848-b240-4f52-8520-3a3cebc3c0aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d9c8469896f45ecba498b0ede39dbb8_I20221231" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtNS0xLTEtMTE3MDI5_20b506e3-cab3-4c4c-9608-4bc40b355abc">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50138a8641f3407a9f5402ee74004755_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtNy0xLTEtMTE3MDI5_dfa1b051-f6db-4d4a-9a56-cb8054839fd4">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3097c8bb523449408d110548f79bebbe_I20211231" decimals="-5" name="us-gaap:FairValueHedgeAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtOS0xLTEtMTE3MDI5_4a56634b-b26a-4ad6-8049-210e4c6a3d52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3097c8bb523449408d110548f79bebbe_I20211231" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMTEtMS0xLTExNzAyOQ_55015f12-660e-42a1-8300-42407ee66f87">32.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62637e2f6fb743b9ae7a0465221d295a_I20211231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMTMtMS0xLTExNzAyOQ_474e29b0-e9b7-4be3-87bf-1984912d5c4d">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><ix:nonNumeric contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNzI_87be176b-fdcc-4655-9cd6-c871d73d95a9" escape="true"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging relationships:</span></div><div style="margin-bottom:7.1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231" decimals="2" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMi0xLTEtMTE3MDI5_c2e590c8-6a8a-4601-8df3-69d82751d7ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109abf7ae534497d9389f80792db885b_D20210101-20211231" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtNC0xLTEtMTE3MDI5_ba86f799-ce01-404b-a0e6-5f8df7d2abc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b210f3dae2a47ea886765221136d822_D20200101-20201231" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtNi0xLTEtMTE3MDI5_a41e2540-c34b-42fe-b158-7fdda4cc0050">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtOC0xLTEtMTE3MDI5_3176631b-6601-42f9-9ea0-40fd75d22f34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i109abf7ae534497d9389f80792db885b_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMTAtMS0xLTExNzAyOQ_63a47d66-7158-48e8-aad7-0ea65d400439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b210f3dae2a47ea886765221136d822_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMTItMS0xLTExNzAyOQ_30a6c9da-16f9-48a3-84c5-dc7fa43425fb">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMi0xLTEtMTE3MDI5_0a4cc961-73f4-4ac7-8ba3-2838e46e3563">12.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231" decimals="-5" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtNC0xLTEtMTE3MDI5_71cd89f7-25c8-4aeb-a6a5-ac5fcdec2c92">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtNi0xLTEtMTE3MDI5_27e5b876-58e5-4cf1-ac50-59d6a01aec36">43.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtOC0xLTEtMTE3MDI5_04a470c2-1cfa-4414-b020-02858aa8ccfb">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMTAtMS0xLTExNzAyOQ_c1e66389-fb21-497a-9e05-355a2433dee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231" decimals="-5" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMTItMS0xLTExNzAyOQ_75c46621-b13e-4589-8c77-69ccba160bc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4fb4f8278c0a4b40bd818ed231a89fb7">The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="lh:GainRecognizedonExitofInterestRateSwapArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzQ3Mzg_09be7d88-a6a6-45f2-a8c2-a75323556ef9">1.6</ix:nonFraction> on the extinguishment of its interest rate swap agreement in the year December 31, 2020 in connection with the redemption of the <ix:nonFraction unitRef="number" contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzQ4ODQ_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5">4.625</ix:nonFraction>% Senior Notes due 2020. No gains or losses from derivative instruments classified as hedging instruments were recognized into income for the year ended December 31, 2021.</ix:continuation> In May 2022, the Company reclassified a gain of $<ix:nonFraction unitRef="usd" contextRef="i93446d1780df4a17825fb9e3f5392c19_D20221001-20221231" decimals="1" name="us-gaap:GainLossOnOilAndGasHedgingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEwOTk1MTE2MzczMjU_e5a9c0cd-9bfe-4006-bef8-25b22514d136">0.9</ix:nonFraction> to the Consolidated Statement of Operations within other, net, due to the exit of $<ix:nonFraction unitRef="usd" contextRef="i72fecf8a9a614c76a5f20c1427477921_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEwOTk1MTE2Mzc0MTE_ef26f967-63c0-4182-80b3-a32183ec59ba">300.0</ix:nonFraction> of the cross-currency swap agreements.</span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_247"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90ZXh0cmVnaW9uOjVkMDNhOTQ2YzM0ZDQ4ZmRiNjYzMjFhNTUyMzNlMjA0XzQ1_fdc7b6e3-db35-483a-a265-b08c44dc7232" continuedAt="i4bbde34d33574713aa2eb3b85eaedaef" escape="true">SUPPLEMENTAL CASH FLOW INFORMATION</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="i4bbde34d33574713aa2eb3b85eaedaef"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90ZXh0cmVnaW9uOjVkMDNhOTQ2YzM0ZDQ4ZmRiNjYzMjFhNTUyMzNlMjA0XzUw_0b7f1323-3f96-4192-9b91-4a3e6faafeae" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:65.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtMS0xLTEtMTE3MDI5_92ae5919-db4d-45c5-a1f6-1536ead5bc4a">197.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtMy0xLTEtMTE3MDI5_afad16c0-cf04-43db-b9db-964963dc798f">194.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:InterestPaidInCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtNS0xLTEtMTE3MDI5_398b8468-943e-427e-b344-4c60d67c0bbd">216.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtMS0xLTEtMTE3MDI5_a1f8ab75-3d15-494d-9ed7-086bf20e0086">504.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtMy0xLTEtMTE3MDI5_939fd5fe-11d3-4438-8f4a-9c9c605921c7">1,000.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtNS0xLTEtMTE3MDI5_41a7c7ef-871d-4b6c-aa2e-8d21121370a7">500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="0" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktMS0xLTEtMTE3MDI5_de91cca6-0ca1-48ba-860d-c88dc7e0c9ef">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktMy0xLTEtMTE3MDI5_b1f434ac-70fc-4f5e-9d07-6da1f4d669c2">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktNS0xLTEtMTE3MDI5_818a6f1f-70f2-45f1-b78a-50b6ac9a9692">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i9affef4b263d4c7097546e2ee7326a4a_250"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19<ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90ZXh0cmVnaW9uOmM3NDUxNjM5MDZkODQ3ZWU4NjQ4YWRjMmM1MGNmZDdkXzEwMzM_71a09b4a-819c-43a1-8edf-95dc850740e8" continuedAt="id2ff15778f9247e383e90b36f80e32d6" escape="true">.&#160;&#160;BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id2ff15778f9247e383e90b36f80e32d6" continuedAt="if60b55549fbd4da7a8e9f64c98943ff0">The following table is a summary of segment information for the years ended December&#160;31, 2022, 2021, and 2020. The &#8220;management approach&#8221; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing </ix:continuation></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9affef4b263d4c7097546e2ee7326a4a_7">Index</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LABORATORY CORPORATION OF AMERICA HOLDINGS AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars and shares in millions, except per share data)</span></div><div style="margin-bottom:7pt;text-align:center;text-indent:15.75pt"><span><br/></span></div></div><ix:continuation id="if60b55549fbd4da7a8e9f64c98943ff0"><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19 costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability. Segment asset information is not presented because it is not used by the CODM at the segment level. </span></div><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90ZXh0cmVnaW9uOmM3NDUxNjM5MDZkODQ3ZWU4NjQ4YWRjMmM1MGNmZDdkXzEwMjQ_59749555-554e-4a90-a257-d9efb46d02e6" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"></td><td style="width:322.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItMi0xLTEtMTE3MDI5_30f32314-7ae3-4f09-b0d9-3c2e086e63af">9,203.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItNC0xLTEtMTE3MDI5_4fec45df-805b-48fd-8373-f5f46650fedd">10,363.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItNi0xLTEtMTE3MDI5_0c109c4c-9dde-4001-a000-0c219878fcb2">9,253.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtMi0xLTEtMTE3MDI5_88d88882-f1b2-4c91-81b6-71096c0d9524">5,710.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtNC0xLTEtMTE3MDI5_e903ff10-b2cf-48ad-a344-3fd8bc1637d7">5,845.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtNi0xLTEtMTE3MDI5_9e0980a2-52ec-40e4-95dc-75f00fac2be2">4,877.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c02350e7d7648358cd4fcc8dac9614c_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtMi0xLTEtMTE3MDI5_30f77263-6161-47ec-a93e-ddb30a8e7604">36.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009fbbaa1fa344c2b260736d3d45ab4b_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtNC0xLTEtMTE3MDI5_bcc90c5a-a932-40e0-b0dc-8e7f881e93ab">88.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i264e173e323a4a219f6dc0e8e01fa43f_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtNi0xLTEtMTE3MDI5_f3f451f4-e53f-4112-94e0-ef9b907c5ac8">152.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtMi0xLTEtMTE3MDI5_e49aa44c-579a-46f6-b3a1-aace21bc634a">14,876.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtNC0xLTEtMTE3MDI5_bada6e0a-c126-4244-b290-4aa0264ef84e">16,120.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtNi0xLTEtMTE3MDI5_93f35549-7265-4fb9-99d5-282147e827a8">13,978.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Earnings:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtMi0xLTEtMTE3MDI5_458408f8-72f6-480d-998a-f67b133babd9">2,025.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtNC0xLTEtMTE3MDI5_779620f1-60ea-43df-b065-615153a31746">3,205.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtNi0xLTEtMTE3MDI5_dd73d2b5-b7e7-4f8a-9b6b-11e955e03f9b">2,801.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktMi0xLTEtMTE3MDI5_6f9ffa4b-d948-4818-b060-bec59c92a0e9">801.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktNC0xLTEtMTE3MDI5_7c9dc5f1-7242-49a3-a711-d9905ce8b60f">887.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktNi0xLTEtMTE3MDI5_13d3916f-6180-4e01-b596-147bc2626f38">721.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc8674bb0c33459fbc4f9f5bbe2b7c1e_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTItMS0xLTE5NTk1NQ_8ee37eb2-d99f-493c-9be1-ad63b13edb5b">2,826.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f2ec3658b894ce2949ed8539bf599fb_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTQtMS0xLTE5NTk1Ng_7e5f691e-7e88-4c7d-a107-ae95d108b326">4,092.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fbdfe4753ce4100b31ceb13d3703285_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTYtMS0xLTE5NTk2NQ_f61c5abc-d25e-4dd7-a404-d2aa4710e5cd">3,522.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia768e38536fd419f880dba505b33374f_D20220101-20221231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTItMS0xLTExNzAyOQ_3260c302-1c19-4871-b408-5b147423b144">438.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i536e737a10ed408381b0090740cf262a_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTQtMS0xLTExNzAyOQ_3724ef48-386d-4a79-875a-0b37546f18c5">420.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTYtMS0xLTExNzAyOQ_f3b59807-028c-47ce-8eef-0c8f59756461">299.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTItMS0xLTE5NTk3Mw_13facb12-4af8-437e-a420-c765584cbf03">259.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTQtMS0xLTE5NTk3Mw_add6e722-8522-43cc-858f-30be9350c875">369.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTYtMS0xLTE5NTk3Mw_d18c0dd9-c8ed-4ce9-9a40-ca84f23fdb14">275.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTItMS0xLTE5Nzg5MQ_5664251c-625d-4621-bf8e-d7428504aa68">83.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTQtMS0xLTE5Nzg5MQ_dd0bf8af-0fb1-4160-85dd-410e58f24aae">43.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="lh:NetRestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTYtMS0xLTE5Nzg5MQ_9640d554-8ebd-4ac1-a67a-145db6e5614c">40.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTItMS0xLTE5NTk3Mw_08a39089-3e83-4263-8378-5b5eac13f4ff">271.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTQtMS0xLTE5NTk3Mw_11d76079-5a35-461c-b817-cfbef6de1d8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTYtMS0xLTE5NTk3Mw_2b88b98d-4578-4085-895a-b44284deca4d">462.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTItMS0xLTExNzAyOQ_e481c7c6-2a27-4162-b8e1-1876401d657e">1,773.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTQtMS0xLTExNzAyOQ_44b485d5-3126-4213-a76e-e6dbccaee533">3,259.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTYtMS0xLTExNzAyOQ_42317b1e-c92f-4b00-a582-c671b5889ea1">2,445.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"></td><td style="width:322.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItMi0xLTEtMTE3MDI5_d59cb94e-2315-4be2-be7d-bbe38feda22b">227.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItNC0xLTEtMTE3MDI5_0bfb21bc-a1a2-439b-8b19-e1898891cafe">238.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItNi0xLTEtMTE3MDI5_130f2295-5f7f-4355-954f-84c16ba808e5">222.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtMi0xLTEtMTE3MDI5_20c1ae37-79e1-4e47-9918-10ecd02073de">143.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtNC0xLTEtMTE3MDI5_41523277-493b-4b29-97d1-af79dc381ec0">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtNi0xLTEtMTE3MDI5_548b2dfd-59c3-4c0f-b13d-561c3b3c92ab">124.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia768e38536fd419f880dba505b33374f_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtMi0xLTEtMTE3MDI5_f9572a06-033a-4226-ba75-5132c9f32007">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536e737a10ed408381b0090740cf262a_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtNC0xLTEtMTE3MDI5_1bf1f1be-c736-436e-91ac-4216a5587dfc">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtNi0xLTEtMTE3MDI5_7f65b074-b63f-4c8c-a6d8-00f9ac57cd04">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtMi0xLTEtMTE3MDI5_50d90c07-9ad7-4e63-9ba1-82895dee1cd9">374.6</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtNC0xLTEtMTE3MDI5_8f7aba42-89d5-4451-af46-1efca9c74a50">375.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtNi0xLTEtMTE3MDI5_baf654a3-3e09-44f9-b118-bde23951fdf1">349.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Geographic Distribution of property, plant and equipment, net:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:503.25pt"><tr><td style="width:1.0pt"></td><td style="width:322.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:3.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:52.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e70f9eae14480099b40da70d85557b_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItMi0xLTEtMTE3MDI5_350c6fa0-f3a6-4699-8305-ce90fc3a7870">1,669.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8003dc869194e32943cb16d8eb14897_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItNC0xLTEtMTE3MDI5_b52c7444-fe16-4bf7-b709-9d33cb453a14">730.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a321f32243f4029afccd94fb3812764_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItNi0xLTEtMTE3MDI5_162bd871-2a91-476a-99dd-ed3de2f57458">2,399.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3e59b3cfa94c3a8576e7a963f623b4_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtMi0xLTEtMTE3MDI5_023be1dd-e150-4dc7-ba1d-354fae914659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieacd7dfc507846ec8b5ce92f17564027_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtNC0xLTEtMTE3MDI5_92c79ddb-e6b3-4475-8eca-d63ca11b0a9e">425.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e71eb1cfbd34d7fb34466d92877d3c6_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtNi0xLTEtMTE3MDI5_fbc6ce26-1d86-440a-8c4a-6127672dd949">425.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcbab8d63eb841018519ada24b99d545_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtMi0xLTEtMTE3MDI5_53b82f16-85ce-4ce5-b5dd-735ae08b07ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c5cb78f4904c6aacf992f36ac8a90c_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtNC0xLTEtMTE3MDI5_897c2e1d-951d-403b-ba45-e14a8877141a">131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64aa8e649bdb4c108b75103b2eb4a2fc_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtNi0xLTEtMTE3MDI5_22b6995f-3d25-4b97-82e1-f110c450f438">131.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56daedd82c3646baa58c1523980c51f9_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtMi0xLTEtMTE3MDI5_238fdd09-d300-429b-a774-5abf4bb3b20b">1,669.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide1d0653044641ba893251b0fd4296c1_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtNC0xLTEtMTE3MDI5_c1240b61-ef21-4e65-8440-ba119b6a3375">1,287.0</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4525567f3af4381925d303df86c2fd0_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtNi0xLTEtMTE3MDI5_33bd3dda-e6a7-4cb3-bca7-e584597b1f17">2,956.2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:63.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.781%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502b3fc0ff254fd1bf2c37a2fa0d8698_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItMi0xLTEtMjI5NTc5_c4bec827-9139-4c8b-802f-a3ea49420924">1,507.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d2c61db1f64f1b9741884acf529ebf_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItNC0xLTEtMjI5NTc5_2d6ed571-a811-4a97-aaf4-339b80a1da72">670.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17669eb64069457a845cbd59f00480e0_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItNi0xLTEtMjI5NTc5_b993f514-9c6e-4ccb-b5ab-f2fccea03853">2,177.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ae52be303bc4ee4954f1fb18ca47961_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtMi0xLTEtMjI5NTc5_9ce84c40-9f4b-45d9-b345-ba400d26015f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a7562319b848598560ae7b3eb035ad_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtNC0xLTEtMjI5NTc5_4fa919c1-8bfb-4c23-9890-8e86d86f3289">449.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de2a6c8c4714f6c8bfd3e3f4c4ff1f6_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtNi0xLTEtMjI5NTc5_2e6d19b4-b6b7-466a-a53d-7db2bc8b9e7d">449.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id75f25869b5146e58f626502da7c7971_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtMi0xLTEtMjI5NTc5_47e340f6-7307-487e-a570-6ef177e228a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ce077a3e4744e96a9f84ad3d59a2424_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtNC0xLTEtMjI5NTc5_e6dd2134-4c6c-49ef-bed8-52816a9abaac">188.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic98ae2d3393544a89fec8d3f7e79ceb2_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtNi0xLTEtMjI5NTc5_4757575d-635b-401d-8fd2-6f34f43efb09">188.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia62a4bb28ea746489ab2bda95c3e5be5_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtMi0xLTEtMjI5NTc5_17bd2630-202a-45e0-baf5-ef313bf0283d">1,507.3</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64989aa30ef4d9295e8155f32cda7f8_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtNC0xLTEtMjI5NTc5_34b0323b-693f-42ce-92ce-5d13a10e33fb">1,308.1</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtNi0xLTEtMjI5NTc5_2d26fccf-b860-4f56-8657-d2d5812ca435">2,815.4</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i9affef4b263d4c7097546e2ee7326a4a_253"></div><div style="margin-top:9pt"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTMvZnJhZzo2MzdjYWI0ODYzN2E0Yzg1YTA4OTdiZGZiYTZmYzc5YS90ZXh0cmVnaW9uOjYzN2NhYjQ4NjM3YTRjODVhMDg5N2JkZmJhNmZjNzlhXzEyNTc_f1d61ba0-283a-4656-a543-5475b46e2dd9" escape="true">20.&#160;&#160;SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.12
<SEQUENCE>2
<FILENAME>exhibit1012thirdarcreditag.htm
<DESCRIPTION>EX-10.12
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id073909f1d284e22814288a8e9ff4e65_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.12</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Execution Version</font></div></div><div style="margin-bottom:4pt;text-align:justify"><font><br></font></div><div style="margin-bottom:4pt;text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">&#91;1&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">AMENDMENT NO. 1 dated as of January 13, 2023 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) to THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of April 30, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), among LABORATORY CORPORATION OF AMERICA HOLDINGS, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), the LENDERS AND L&#47;C ISSUERS party hereto and BANK OF AMERICA, N.A., as Administrative Agent.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">W I T N E S S E T H &#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Borrower has requested that the Credit Agreement be amended as set forth herein&#894; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Administrative Agent, the Lenders and the L&#47;C Issuers executing this Amendment as a Lender are willing to amend the Credit Agreement on the terms set forth herein&#894;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">NOW, THEREFORE, in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">. Defined Terms&#59; References.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Unless otherwise specifically defined herein, each term used herein that is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">. Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  Each of the parties hereto agrees that, effective on the Amendment No. 1 Effective Date (as defined below), the Credit Agreement shall be amended to delete the stricken text (indicated textually in the same manner as the following example&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) and to add the double-underlined text (indicated textually in the same manner as the following example&#58; </font><font style="color:#0070c0;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">double-underlined text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">) as set forth on the pages of the Credit Agreement attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> hereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">.  Representations and Warranties.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Each Loan Party represents and warrants to the other parties hereto that&#58;</font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  the execution, delivery and performance by such Person of this Amendment are within such Person&#8217;s corporate powers and have been duly authorized by all necessary corporate and, if required, stockholder action&#59;</font></div><div style="text-align:justify;text-indent:46.8pt"><font><br></font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  this Amendment has been duly executed and delivered by such Person and constitutes a legal, valid and binding obligation of such Person, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law&#894; </font></div><div style="text-align:justify;text-indent:46.8pt"><font><br></font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The execution, delivery and performance by such Person of this Amendment will not (i) violate (A) any provision of law, statute, rule or regulation, or of the Organization Documents of the Company or any Subsidiary, (B) any order of any Governmental Authority or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(C) any provision of any indenture, agreement or other instrument to which the Company or any Subsidiary is a party or by which any of them or any of their property is or may be bound, the effect of which could reasonably be expected to result in a Material Adverse Effect, (ii) result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, or give rise to any right to accelerate or to require the prepayment, repurchase or redemption of any obligation under any such indenture, agreement or other instrument, the effect of which could reasonably be expected to result in a Material Adverse Effect, or (iii) result in the creation or imposition of any Lien (other than Liens permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Section 7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> of the Credit Agreement) upon or with respect to any property or assets now owned or hereafter acquired by the Company or any Subsidiary.</font></div><div style="text-indent:46.8pt"><font><br></font></div><div style="text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  the representations and warranties contained in the Credit Agreement and any other Loan Document are true and correct in all material respects (other than any such representation and warranty that is already qualified by materiality or &#8220;Material Adverse Effect&#8221; in the text thereof, in which case such representation and warranty shall be true in all respects) on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties are true and correct in all material respects on and as of such earlier date. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">. Effectiveness.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Amendment shall become effective as of the first date on which the following conditions precedent have been satisfied (or waived in accordance with Section 11.01 of the Credit Agreement) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Amendment No. 1 Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;)&#58;</font></div><div style="text-align:justify;text-indent:46.8pt"><font><br></font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  the Administrative Agent (or its counsel) shall have received from each Loan Party, the Lenders (constituting all Lenders under the Credit Agreement) and the Administrative Agent either (i) a counterpart of this Amendment signed on behalf of such party or (ii) written evidence reasonably satisfactory to the Administrative Agent that such party has signed a counterpart of this Amendment&#59; </font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  the Administrative Agent (or its counsel) shall have received a certificate, dated the Amendment No. 1 Effective Date and signed by the President and Chief Executive Officer, a Vice President or a Financial Officer of the Borrower, confirming (i) the accuracy of the representations and warranties set forth in Section 3 of this Amendment and (ii) the absence of any Default or Event of Default&#59; </font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  all fees and out-of-pocket expenses of the Administrative Agent and its applicable Affiliates required to be paid on or before the Amendment No. 1 Effective Date pursuant to Section 11.04 of the Credit Agreement, shall have been paid&#59; and</font></div><div style="text-align:justify;text-indent:46.8pt"><font><br></font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  the Borrower shall have paid all reasonable and documented out-of-pocket fees, charges and disbursements of counsel to the Administrative Agent to the extent invoiced at least three (3) days prior to the Amendment No. 1 Effective Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> such additional amounts of such fees, charges and disbursements as shall constitute its reasonable estimate of such fees, charges and disbursements incurred or to be incurred by it through the Amendment No. 1 Effective Date (provided that such estimate shall not thereafter preclude a final settling of accounts between the Borrower and the Administrative Agent).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%"> Governing Law.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The terms of the Credit Agreement with respect to governing law, submission to jurisdiction, waiver of venue and waiver of jury trial are incorporated herein by reference, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, and the parties hereto agree to such terms.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Amendment may be in the form of an electronic record (in &#8220;.pdf&#8221; form or otherwise) and may be executed using electronic signatures, which shall be considered as originals and shall have the same legal effect, validity and enforceability as a paper record.  This Amendment may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts shall be one and the same Amendment.  For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by the Administrative Agent of a manually signed Amendment which has been converted into electronic form (such as scanned into &#8220;.pdf&#8221; format), or an electronically signed Amendment converted into another format, for transmission, delivery and&#47;or retention.   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Section 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font></div><div style="text-indent:46.8pt"><font><br></font></div><div style="text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Notwithstanding anything to the contrary in the Credit Agreement or this Amendment, any Eurodollar Rate Loans (as defined in the Credit Agreement) outstanding as of the Amendment No. 1 Effective Date shall continue to the end of the current applicable Interest Period for such Eurodollar Rate Loans and the provisions of the Credit Agreement applicable thereto shall continue and remain in effect (notwithstanding the alternate rate of interest to LIBOR established pursuant to this Amendment on the Amendment No. 1 Effective Date) until the end of such Interest Period for such Eurodollar Rate Loans, after which such provisions shall have no further force or effect.</font></div><div style="text-indent:46.8pt"><font><br></font></div><div style="text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Loan Documents, and the obligations of each Loan Party under the Loan Documents, are hereby ratified and confirmed and shall remain in full force and effect according to their terms.  This Amendment is a Loan Document.</font></div><div style="text-indent:46.8pt"><font><br></font></div><div style="text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  Each Loan Party (i) acknowledges and consents to all of the terms and conditions of this Amendment, (ii) affirms all of its obligations under the Loan Documents and (iii) agrees that this Amendment and all documents executed in connection herewith do not operate to reduce or discharge its obligations under the Loan Documents. Each Guarantor hereby reaffirms its obligations under the Guaranty and agrees that its obligation to guarantee the Obligations is in full force and effect as of the date hereof.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Signature Pages Follow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:199.25pt;text-indent:36pt"><font><br></font></div><div style="padding-left:199.25pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:11.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LABORATORY CORPORATION OF AMERICA HOLDINGS,<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a Delaware corporation<br></font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Robert S. Pringle</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Robert S. Pringle</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Senior Vice President and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="padding-right:3.1pt"><font><br></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.314%"><tr><td style="width:1.0%"></td><td style="width:13.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BANK OF AMERICA, N.A., </font></div><div style="margin-bottom:24pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as Administrative Agent</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Aamir Saleem</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:65.75pt;padding-right:2.75pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Aamir Saleem&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.314%"><tr><td style="width:1.0%"></td><td style="width:13.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BANK OF AMERICA, N.A., </font></div><div style="margin-bottom:24pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender, Swing Line Lender and L&#47;C Issuer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph L. Corah</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 66.75pt;text-align:left;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Joseph L. Corah</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 66.75pt;text-align:left;text-indent:-36pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.314%"><tr><td style="width:1.0%"></td><td style="width:13.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION, </font></div><div style="margin-bottom:24pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">as a Lender and L&#47;C Issuer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Darin Mullis</font></td></tr><tr><td colspan="3" style="padding:0 1pt 0 96.75pt;text-indent:-36pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Darin Mullis</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt 0 31pt;text-indent:-36pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.75pt;padding-right:2.75pt;text-indent:-18.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Managing Director</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.314%"><tr><td style="width:1.0%"></td><td style="width:13.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC, </font></div><div style="margin-bottom:24pt;padding-left:20.75pt;padding-right:2.75pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as a Lender</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Warren Veech III</font></td></tr><tr><td colspan="3" style="padding:0 1pt 0 72.75pt;text-indent:-36pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;Warren Veech III</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt 0 66.75pt;text-indent:-36pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;Vice President</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit A</font></div><div style="margin-bottom:4pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-bottom:2pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CUSIP&#58; 50540QAS3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CUSIP&#58; 50540QAT1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated as of April 30, 2021</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">as amended by Amendment No. 1, dated as of January 13, 2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>(Originally dated as of December 21, 2011,<br>amended and restated as of December 19, 2014,<br>further amended as of July 13, 2016,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">further amended and restated as of September 15, 2017,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and further amended as of May 7, 2020 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and further amended and restated as of April 30, 2021)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">among</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LABORATORY CORPORATION OF AMERICA HOLDINGS,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as the Borrower,</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BANK OF AMERICA, N.A.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Administrative Agent, Swing Line Lender and L&#47;C Issuer,</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Syndication Agent and L&#47;C Issuer,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BARCLAYS BANK PLC,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CITIBANK, N.A.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">JPMORGAN CHASE BANK, N.A.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">KEYBANK NATIONAL ASSOCIATION,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MUFG BANK, LTD.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">PNC BANK, NATIONAL ASSOCIATION,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TD BANK, N.A.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. BANK NATIONAL ASSOCIATION,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Documentation Agents</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THE OTHER LENDERS PARTY HERETO</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BofA SECURITIES, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WELLS FARGO SECURITIES, LLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Joint Lead Arrangers and Joint Book Managers</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I  DEFINITIONS AND ACCOUNTING TERMS&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">26</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">24</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">27</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">25</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">28</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">26</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Times of Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">28</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">26</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">28</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">26</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Divisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">29</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">26</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">29</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">26</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II  THE COMMITMENTS AND CREDIT EXTENSIONS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">29</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">27</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">29</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">27</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowings, Conversions and Continuations of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">29</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">27</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">32</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">29</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">42</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">38</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">44</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">41</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination or Reduction of Aggregate Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">46</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">42</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">46</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">43</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">47</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">43</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">47</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">43</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Computation of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">48</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">44</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Evidence of Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">48</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">44</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Generally&#59; Administrative Agent&#8217;s Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">49</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">45</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sharing of Payments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">50</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">46</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">51</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">47</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">52</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">48</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Permitted Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">54</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">50</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III  TAXES, YIELD PROTECTION AND ILLEGALITY&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">56</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">51</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">56</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">51</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">60</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">55</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Inability to Determine Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">60</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">55</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">64</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">57</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation for Losses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">65</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">59</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation Obligations&#59; Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">66</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">59</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">66</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">59</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV  CONDITIONS PRECEDENT TO CREDIT EXTENSIONS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">66</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">60</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">66</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">60</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to all Credit Extensions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">68</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">61</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V  REPRESENTATIONS AND WARRANTIES&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">69</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">62</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organization&#59; Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">69</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">62</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">70</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">70</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">70</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">70</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Reserved&#93;.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation&#59; Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">64</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Misstatements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employee Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Senior Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">65</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI  AFFIRMATIVE COVENANTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existence&#59; Businesses and Properties&#59; Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">74</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations and Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">74</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">66</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements, Reports, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">74</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">67</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Other Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">76</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">68</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maintaining Records&#59; Access to Properties and Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">76</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">69</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">77</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">69</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">77</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">69</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">77</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">69</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII  NEGATIVE COVENANTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">78</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">70</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">78</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">70</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">79</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">72</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mergers, Consolidations and Sales of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">82</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">74</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business of the Loan Parties and their Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">82</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">75</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">75</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">75</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">75</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">75</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII  EVENTS OF DEFAULT AND REMEDIES&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">84</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">76</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">84</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">76</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies Upon Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">86</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">77</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Application of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">86</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">78</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX  ADMINISTRATIVE AGENT&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">79</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appointment and Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">79</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">79</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">79</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance by Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">80</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">81</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation of Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">81</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">90</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">82</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Other Duties&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">91</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">82</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent May File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">91</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">82</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">92</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">83</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X  GUARANTY&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">92</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">83</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">92</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">83</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Setoff or Deductions&#59; Taxes&#59; Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">84</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rights of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">84</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">84</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations Independent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">85</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limitation on Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">85</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">85</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination&#59; Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">85</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subordination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">95</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">86</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stay of Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">95</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">86</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">95</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">86</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Condition of the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">95</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">86</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">96</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">87</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE XI  MISCELLANEOUS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">96</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">87</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.01</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">96</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">87</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.02</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices and Other Communications&#59; Facsimile Copies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">98</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">89</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.03</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Waiver&#59; Cumulative Remedies&#59; Enforcement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">100</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">91</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.04</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses&#59; Indemnity&#59; and Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">101</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">91</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.05</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Set Aside</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">94</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.06</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">94</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.07</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Certain Information&#59; Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">108</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">98</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.08</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">109</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">99</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.09</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rate Limitation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">100</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts&#59; Integration&#59; Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">100</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">100</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">100</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">111</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">101</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">112</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">102</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Right to Trial by Jury</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">113</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">102</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">113</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">103</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">114</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">103</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Advisory or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">114</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">104</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lender ERISA Representation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">114</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">104</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">116</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">105</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Third Amendment and Restatement of Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">116</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">106</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Regarding Any Supported QFCs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">116</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">106</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Holdco Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">117</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">107</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SCHEDULES</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments and Applicable Percentages</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Certain Addresses for Notices</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBITS</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Loan Notice</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Swing Line Loan Notice</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">C&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Revolving Note</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;Form of Swing Line Note</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">E&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Compliance Certificate</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">F&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Assignment and Assumption</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">G&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Lender Joinder Agreement</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">H&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Letter of Credit Report</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form of Joinder Agreement</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIRD AMENDED AND RESTATED CREDIT AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This THIRD AMENDED AND RESTATED CREDIT AGREEMENT is entered into as of April 30, 2021 (originally dated as of December 21, 2011, amended and restated as of December 19, 2014, further amended as of July 13, 2016, further amended and restated as of September 15, 2017 and further amended as of May 7, 2020) among LABORATORY CORPORATION OF AMERICA HOLDINGS, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Guarantors (defined herein) from time to time party hereto, the Lenders (defined herein) and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L&#47;C Issuer.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower has requested that the Lenders provide credit facilities for the purposes set forth herein, and the Lenders are willing to do so on the terms and conditions set forth herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In consideration of the mutual covenants and agreements herein contained, the parties hereto agree to amend and restate the Existing Credit Agreement to read in its entirety as set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE I<br><br>DEFINITIONS AND ACCOUNTING TERMS</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in this Agreement, the following terms shall have the meanings set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accepting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the acquisition by the Company or any Wholly Owned Subsidiary of (i) all or substantially all of the assets of a Person or line of business of such Person where the aggregate consideration (in whatever form) payable by the Company or any Subsidiary is greater than or equal to 10% of the consolidated assets of the Company and its Subsidiaries prior to giving effect to such Acquisition, or (ii) all or substantially all of the Equity Interests of a Person who, after giving effect to such Acquisition, constitutes a Material Subsidiary.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Bank of America in its capacity as administrative agent under any of the Loan Documents, or any successor administrative agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Administrative Agent&#8217;s address and, as appropriate, account as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 11.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or such other address or account as the Administrative Agent may from time to time notify the Loan Parties and the Lenders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.02(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Revolving Commitments of all the Lenders.  The aggregate principal amount of the Aggregate Revolving Commitments in effect on the Third Amendment and Restatement Effective Date is ONE BILLION DOLLARS ($1,000,000,000).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means this Third Amended and Restated Credit Agreement, as amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any Lender at any time, the percentage of the Aggregate Revolving Commitments represented by such Lender&#8217;s Revolving Commitment at such time, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the commitment of each Lender to make Revolving Loans and the obligation of each L&#47;C Issuer to make L&#47;C Credit Extensions have been terminated pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or if the Aggregate Revolving Commitments have expired, then the Applicable Percentage of each Lender shall be determined based on the Applicable Percentage of such Lender most recently in effect, giving effect to any subsequent assignments.  The initial Applicable Percentage of each Lender is set forth opposite the name of such Lender on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in the Assignment and Assumption pursuant to which such Lender becomes a party hereto, as applicable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to Revolving Loans, Swing Line Loans, Letters of Credit and the Facility Fee, the following percentages per annum, based upon the Debt Rating as set forth below&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:22.05pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.510%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Pricing</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Level</font></div></td><td colspan="6" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Debt Rating</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Moody&#8217;s</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Applicable Rate for</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Facility Fee</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Applicable Rate for</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"> Loans, Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"> Loans and Letter of Credit Fee</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Applicable Rate for</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Base Rate Loans</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">I</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#62;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> A-</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A3</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.100%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.775%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">II</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#VALUE!</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baa1</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.110%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.890%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">III</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#NAME&#63;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baa2</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.125%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.000%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IV</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">#VALUE!</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Baa3</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.150%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.100%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.100%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">V</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">&#60;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> BB+</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ba1</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.225%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.275%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.275%</font></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, the rating as determined by either S&#38;P or Moody&#8217;s (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Ratings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of the Borrower&#8217;s Index Debt or, following the Holdco Reorganization Effective Date, if the Debt Ratings of the Borrower&#8217;s Index Debt are not available, the Parent&#8217;s Index Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (a) if each of the respective Debt Ratings issued by the foregoing rating agencies falls within a different pricing level listed above (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pricing Level</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Pricing Level shall be set based on the higher of such Pricing Levels&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if there is a split in Debt Ratings of more than one level, the Pricing Level that is one level lower than the Pricing Level of the higher Debt Rating shall apply&#59; (b) if the Borrower or, if applicable, the Parent has only one Debt Rating, the Pricing Level shall be set based upon such Debt Rating&#59; and (c) if neither the Borrower nor the Parent has  any Debt Rating, Pricing Level V shall apply.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Initially, the Applicable Rate shall be determined based upon the Debt Ratings specified in the certificate delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Thereafter, each change in the Applicable Rate resulting from a publicly announced change in the Debt Rating, shall be effective during the period commencing on the date of the public announcement thereof and ending  on the date immediately preceding the effective date of the next such change.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignee Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means two or more Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an assignment and assumption entered into by a Lender and an Eligible Assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and accepted by the Administrative Agent, in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other form approved by the Administrative Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date, (a) in respect of any Synthetic Lease of any Person, the capitalized amount of the remaining lease payments under the relevant lease that would appear on a balance sheet of such Person prepared as of such date in accordance with GAAP if such lease were accounted for as a Capital Lease Obligation and (b) in respect of any Securitization Transaction of any Person, the outstanding principal amount of such financing, after taking into account reserve accounts and making appropriate adjustments, as reasonably determined by the Company in good faith.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Audited Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the audited consolidated balance sheet of the Borrower and its Subsidiaries for the fiscal year ended December 31, 2020, and the related consolidated statements of income or operations, shareholders&#8217; equity and cash flows for such fiscal year of the Borrower and its Subsidiaries, including the notes thereto, audited by independent public accountants of recognized national standing and prepared in conformity with GAAP.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auto-Extension Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Availability Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Revolving Commitments, the period from and including the Third Amendment and Restatement Effective Date to the earliest of (a) for each Lender, the Maturity Date with respect to such Lender&#8217;s Commitment, (b) the date of termination of the Aggregate Revolving Commitments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (c) the date of termination of the commitment of each Lender to make Loans and of the obligation of each L&#47;C Issuer to make L&#47;C Credit Extensions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, rule, regulation or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bank of America</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Bank of America, N.A. and its successors.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means for any day a fluctuating rate per annum equal to the highest of (a) the Federal Funds Rate plus 0.50%, (b) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its &#8220;prime rate&#8221; and (c) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 1.00%&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Base Rate would otherwise be less than 0.00% the Base Rate shall be deemed to be 0.00%.  The &#8220;prime rate&#8221; is a rate set by Bank of America based upon various factors including Bank of America&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.  Any change in the &#8220;prime rate&#8221; announced by Bank of America shall take effect at the opening of business on the day specified in the public announcement of such change.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> If the Base Rate is being used as an alternate rate of interest pursuant to Section 3.03 hereof, then the Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Base Rate Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest based on the Base Rate.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means 31 C.F. R. &#167;1020.230.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Code or (c) any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">BofA Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means BofA Securities, Inc., in its capacity as joint lead arranger and joint book manager, and its successors and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the introductory paragraph hereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of the following&#58; (a) a borrowing of Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (b) a borrowing consisting of simultaneous Loans of the same Type and, in the case of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, having the same Interest Period made by each of the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Laws</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of, or are in fact closed in, the state where the Administrative Agent&#8217;s Office is located</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> and, if such day relates to any Eurodollar Rate Loan or Daily Floating LIBOR Rate Loan, means any such day that is also a London Banking Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Lease Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person means, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.03(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP, and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateralize</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means to pledge and deposit with or deliver to the Administrative Agent, for the benefit of the Administrative Agent, the relevant L&#47;C Issuer or Swing Line Lender (as applicable) and the Lenders, as collateral for L&#47;C Obligations, Obligations in respect of Swing Line Loans or obligations of Lenders to fund participations in respect of either thereof (as the context may require), cash or deposit account balances or, if each L&#47;C Issuer or Swing Line Lender benefitting from such collateral shall agree in its sole discretion, other credit support, in each case pursuant to documentation in form and substance satisfactory to (a) the Administrative Agent and (b) the relevant L&#47;C Issuer or the Swing Line Lender (as applicable).  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have a meaning correlative to the foregoing and shall include the proceeds of such cash collateral and other credit support.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence, after the date of this Agreement, of any of the following&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States regulatory </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law&#8221;, regardless of the date enacted, adopted or issued.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any of the following events&#58; (a) any person or group (within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the date hereof) shall own, directly or indirectly, beneficially or of record, Equity Interests representing more than 45% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of the Company, (b) a majority of the seats (other than vacant seats) on the board of directors of the Company shall at any time cease to be occupied by persons (i) who were members of the board of directors on the Third Amendment and Restatement Effective Date (in the case of the Borrower) or the Holdco Reorganization Effective Date (in the case of the Parent, if applicable), (ii) who were nominated or elected to the board of directors, or whose nomination or election was approved, by individuals referred to in clause (i) constituting at the time of such election, nomination or approval at least a majority of the members of the board of directors or (iii) who were nominated or elected to the board of directors, or whose nomination or election was approved, by individuals referred to in clauses (i) and (ii) above constituting at the time of such election, nomination or approval at least a majority of the board of directors or (c) following the Holdco Reorganization Effective Date, if any, the Borrower shall cease to be a direct or indirect Wholly Owned Subsidiary of the Parent. For the avoidance of doubt, the Permitted Holdco Reorganization shall not be a Change in Control, so long as the condition set forth in clause (a) of this definition is not satisfied with respect to the ownership of Equity Interests in the Parent on the Holdco Reorganization Effective Date immediately after giving effect to the Permitted Holdco Reorganization.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;CME&#8221; means CME Group Benchmark Administration Limited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to each Lender, the Revolving Commitment of such Lender.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) prior to the Holdco Reorganization Effective Date, the Borrower and (b) from the Holdco Reorganization Effective Date, the Parent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a certificate substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information Memorandum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Confidential Information Memorandum of the Borrower dated April 2021.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Conforming Changes&#8221; means, with respect to the use, administration of or any conventions associated with SOFR or any proposed Successor Rate or Term SOFR, as applicable, any conforming changes to the definitions of &#8220;Base Rate&#8221;, &#8220;SOFR&#8221;, &#8220;Term SOFR&#8221; and &#8220;Interest Period&#8221;, timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definitions of &#8220;Business Day&#8221; and &#8220;U.S. Government Securities Business Day&#8221;, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent, in consultation with the Borrower, to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent determines (in consultation with the Borrower) is reasonably necessary in connection with the administration of this Agreement and any other Loan Document).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period for the Company and its Subsidiaries on a consolidated basis, Consolidated Net Income for such period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (a) without duplication and to the extent deducted in determining such Consolidated Net Income, the sum of (i) consolidated interest expense net of interest income for such period, (ii) consolidated income tax expense for such period, (iii) all amounts attributable to depreciation and amortization for such period, (iv) all non-cash write-offs and write-downs of amortizable and depreciable items for such period and (v) any extraordinary, unusual or non-recurring charges, expenses and losses (including charges, fees and expenses incurred in connection with any issuance of debt or equity, Acquisitions, investments, restructuring activities or Dispositions, whether or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">not successful) for such period, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) without duplication, to the extent included in determining such Consolidated Net Income, (i) all non-cash items of income for such period and (ii) all extraordinary, unusual or non-recurring gains for such period, all as determined in accordance with GAAP.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any period, the net income or loss of the Company and its Subsidiaries for such period determined on a consolidated basis in accordance with GAAP.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Worth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as of any date of determination, consolidated shareholders' equity of the Company and its Subsidiaries as of that date determined in accordance with GAAP.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; have meanings correlative thereto.  Without limiting the generality of the foregoing, a Person shall be deemed to be Controlled by another Person if such other Person possesses, directly or indirectly, power to vote 5% or more of the securities having ordinary voting power for the election of directors, managing general partners or the equivalent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.22(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of the following&#58; (a) a Borrowing and (b) an L&#47;C Credit Extension.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Daily Floating LIBOR Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, for any day and subject to availability, a fluctuating rate of interest per annum which can change on each Business Day, equal to LIBOR, as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11&#58;00 a.m., London time, two Business Days prior to such date for Dollar deposits with a term equivalent to a one month term beginning on that date&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, that if the Daily Floating LIBOR Rate shall be less than zero, the Daily Floating LIBOR Rate shall be deemed to be zero for all purposes of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Daily Simple SOFR&#8221; means the rate per annum equal to SOFR determined for any day pursuant to the definition thereof plus the SOFR Adjustment.  Any change in Daily Simple SOFR shall be effective from and including the date of such change without further notice.  If the rate as so determined would be less than zero, such rate shall be deemed to be zero for purposes of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan that bears interest at a rate based on </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans shall be denominated in Dollars.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debtor Relief Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bankruptcy Code of the United States, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debt Rating</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any event or condition that constitutes an Event of Default or that, with the giving of any notice, the passage of time, or both, would be an Event of Default.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) when used with respect to Obligations other than Letter of Credit Fees, an interest rate equal to (i) the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the Applicable Rate, if any, applicable to Base Rate Loans </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (iii) 2% per annum&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that with respect to a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, the Default Rate shall be an interest rate equal to the interest rate (including any Applicable Rate) otherwise applicable to such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 2% per annum, in each case to the fullest extent permitted by applicable Laws and (b) when used with respect to Letter of Credit Fees, a rate equal to the Applicable Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 2% per annum.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any Lender that (a) has failed to perform any of its funding obligations hereunder, including in respect of its Loans or participations in respect of Letters of Credit or Swing Line Loans, within three (3) Business Days of the date required to be funded by it hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s good faith determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) has notified the Borrower or the Administrative Agent that it does not intend to comply with its funding obligations or has made a public statement to that effect with respect to its funding obligations hereunder (unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s good faith determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in writing or public statement) cannot be satisfied), (c) has failed, within three (3) Business Days after written request by the Administrative Agent, to confirm in a manner satisfactory to the Administrative Agent or the Borrower that it will comply with its funding obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such Lender shall cease to be a Defaulting Lender under this clause (c) upon receipt of such confirmation by the Administrative Agent in a manner reasonably satisfactory to the Administrative Agent or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had a receiver, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or a custodian appointed for it, (iii) taken any action in furtherance of, or indicated its consent to, approval of or acquiescence in any such proceeding or appointment or (iv) become the subject of a Bail-In Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any Equity Interests in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.  Any determination by the Administrative Agent that a Lender is a Defaulting Lender under clauses (a) through (d) above shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) as of the date established therefor by the Administrative Agent in a written notice of such determination, which shall be delivered by the Administrative Agent to the Borrower, the L&#47;C Issuers, the Swing Line Lender and each other Lender promptly following such determination.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any country or territory to the extent that such country or territory itself is the subject of any Sanctions (as of the Third Amendment and Restatement Effective Date, Crimea, Cuba, Iran, North Korea and Syria).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dispose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the sale, transfer, license, lease or other disposition (including any Sale and Leaseback Transaction) of any property by the Company or any Subsidiary (including the Equity Interests of any Material Subsidiary), including any sale, assignment, transfer or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith where either (i) the aggregate consideration (in whatever form) received by the Company or any Subsidiary is greater than or equal to 10% of the consolidated assets of the Company and its Subsidiaries prior to giving effect to such disposition or (ii) such disposition constitutes the sale, assignment, transfer or disposal of all or substantially all of the Equity Interests of a Subsidiary who, prior to giving effect to such disposition, constitutes a Material Subsidiary, but excluding (a) the sale, lease, license, transfer or other disposition of inventory in the ordinary course of business&#59; (b)  the sale, lease, license, transfer or other disposition in the ordinary course of business of surplus, obsolete or worn out property no longer used or useful in the conduct of business of the Company and its Subsidiaries&#59; (c) any sale, lease, license, transfer or other disposition of property to the Company or any Subsidiary&#59; and (d) any Involuntary Disposition. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean lawful money of the United States.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a Subsidiary of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the member states of the European Union, Iceland, Liechtenstein and Norway.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person that meets the requirements to be an assignee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (subject to such consents, if any, as may be required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all Laws, rules, regulations, codes, ordinances, orders, decrees, judgments or injunctions issued, promulgated or entered into by or with any Governmental Authority, relating to the environment, the preservation or reclamation of natural resources, the management or release of Hazardous Materials or to the effect of the environment on human health and safety.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means liabilities, obligations, claims, actions, suits, judgments or orders under or relating to any Environmental Law for any damages, injunctive relief, losses, fines, penalties, fees, expenses (including fees and expenses of attorneys and consultants) or costs, whether contingent or otherwise, including those arising from or relating to (a) any action to address the on- or off-site presence, release of, or exposure to, Hazardous Materials, (b) permitting and licensing, governmental administrative oversight and financial assurance requirements, (c) any personal injury (including death), any property damage (real or personal) or natural resource damage and (d) the violation of any Environmental Law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;  means, with respect to any Person, all of the shares of capital stock of (or other ownership or profit interests in) such Person, all of the warrants, options or other rights for the purchase or acquisition from such Person of shares of capital stock of (or other ownership or profit interests in) such Person, all of the securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in) such Person or warrants, rights or options for the purchase or acquisition from such Person of such shares (or such other interests), and all of the other ownership or profit interests in such Person (including partnership, member or trust interests therein), whether voting or nonvoting, and whether or not such shares, warrants, options, rights or other interests are outstanding on any date of determination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any trade or business (whether or not incorporated) that, together with the Company, is treated as a single employer under Section 414(b) or (c) of the Internal Revenue Code, or solely for purposes of Section 302 of ERISA and Section 412 of the Internal Revenue Code, is treated as a single employer under Section 414 of the Internal Revenue Code.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any &#8220;reportable event&#8221;, as defined in Section 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) prior to the effectiveness of the applicable provisions of the Pension Act, the existence with respect to any Plan of an &#8220;accumulated funding deficiency&#8221; (as defined in Section 412 of the Internal Revenue Code or Section 302 of ERISA) or, on and after the effectiveness of the applicable provisions of the Pension Act, any failure by any Plan to satisfy the minimum funding standard (within the meaning of Section 412 of the Internal Revenue Code or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to, prior to the effectiveness of the applicable provisions of the Pension Act, Section 412(d) of the Internal Revenue Code or Section 303(d) of ERISA or, on and after the effectiveness of the applicable provisions of the Pension Act, Section 412(c) of the Internal Revenue Code or Section 302(c) of ERISA, of an application for a waiver of the minimum funding standard with respect to any Plan, (d) on and after the effectiveness of the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provisions of the Pension Act, a determination that any Plan is, or is expected to be, in &#8220;at- risk&#8221; status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Internal Revenue Code), (e) the incurrence by the Company or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Company or any of its ERISA Affiliates from any Plan or Multiemployer Plan, (f) the receipt by the Company or any of its ERISA Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (g) prior to the effectiveness of the applicable provisions of the Pension Act, the adoption of any amendment to a Plan that would require the provision of security pursuant to Section 401(a)(29) of the Internal Revenue Code or Section 307 of ERISA, (h) the receipt by the Company or any of its ERISA Affiliates of any notice, or the receipt by any Multiemployer Plan from the Company or any of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA or, on and after the effectiveness of the applicable provisions of the Pension Act, in endangered or critical status, within the meaning of Section 305 of ERISA&#59; or (i) the occurrence of a &#8220;prohibited transaction&#8221; with respect to which the Company or any of the Subsidiaries is a &#8220;disqualified person&#8221; (within the meaning of Section 4975 of the Internal Revenue Code) or with respect to which the Company or any such Subsidiary could otherwise be liable. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurodollar Base Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(a) for any Interest Period with respect to a Eurodollar Rate Loan, the rate per annum equal to (i) the ICE Benchmark Association LIBOR Rate (&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;), as published by Bloomberg (or such other commercially available source providing quotations of LIBOR as may be designated by the Administrative Agent from time to time) at approximately 11&#58;00 a.m., London time, two Business Days prior to the commencement of such Interest Period, for Dollar deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period or (ii) if such rate is not available at such time for any reason, the rate per annum determined by the Administrative Agent to be the rate at which deposits in Dollars for delivery on the first day of such Interest Period in same day funds in the approximate amount of the Eurodollar Rate Loan being made, continued or converted and with a term equivalent to such Interest Period would be offered by Bank of America&#8217;s London Branch to major banks in the London interbank eurodollar market at their request at approximately 11&#58;00 a.m. (London time) two Business Days prior to the commencement of such Interest Period&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(b) for any interest rate calculation with respect to a Base Rate Loan on any date, the rate per annum equal to (i) LIBOR, as published by Bloomberg (or such other commercially available source providing quotations of LIBOR as may be designated by the Administrative Agent from time to time), at approximately 11&#58;00 a.m. London time determined two Business Days prior to such date for Dollar deposits being delivered in the London interbank market for a term of one month commencing that day or (ii) if such published rate is not available at such time for any reason, the rate per annum determined by the Administrative Agent to be the rate at which deposits in Dollars for delivery on the date of determination in same day funds in the approximate amount of the Base Rate Loan being made or maintained with a term equal to one month would be offered by Bank of America&#8217;s London Branch to major banks in the London interbank eurodollar market at their request at the date and time of determination.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurodollar Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means (a) for any Interest Period with respect to any Eurodollar Rate Loan, a rate per annum determined by the Administrative Agent to be equal to the quotient obtained by dividing (i) the Eurodollar Base Rate for such Eurodollar Rate Loan for such Interest Period by (ii) one </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">minus</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> the Eurodollar Reserve Percentage for such Eurodollar Rate Loan for such Interest Period and (b) for any day with respect to any Base Rate Loan bearing interest at a rate based on the Eurodollar Rate, a rate per annum determined by the Administrative Agent to be equal to the quotient obtained by dividing (i) the Eurodollar Base Rate for such Base Rate Loan for such day by (ii) one </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">minus</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> the Eurodollar Reserve Percentage for such Base Rate Loan for such day&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:line-through">provided </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">that if the Eurodollar Rate determined in accordance with any of the foregoing shall be less than zero, the Eurodollar Rate shall be deemed to be zero for all purposes of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurodollar Rate Loan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means a Loan that bears interest at a rate based on clause (a) of the definition of &#8220;Eurodollar Rate&#8221;.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Eurodollar Reserve Percentage</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, for any day during any Interest Period, the reserve percentage (expressed as a decimal, carried out to five decimal places) in effect on such day, whether or not applicable to any Lender, under regulations issued from time to time by the FRB for determining the maximum reserve requirement (including any emergency, supplemental or other marginal reserve requirement) with respect to Eurocurrency funding (currently referred to as &#8220;Eurocurrency liabilities&#8221;).  The Eurodollar Rate for each outstanding Eurodollar Rate Loan shall be adjusted automatically as of the effective date of any change in the Eurodollar Reserve Percentage.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Administrative Agent, any Lender, any L&#47;C Issuer or any other recipient of any payment to be made by or on account of any obligation of the Loan Parties hereunder, (a) Taxes imposed on or measured by its overall net income (however denominated), franchise taxes imposed on it (in lieu of net income taxes) and capital Taxes other than capital Taxes resulting from a Change in Law, in each case, (i) by the jurisdiction (or any political subdivision thereof) under the Laws of which such recipient is organized or in which its principal office is located or, in the case of any Lender, in which its applicable Lending Office is located or (ii) that are Other Connection Taxes, (b) any branch profits Taxes imposed by the United States or any similar Tax imposed by any other jurisdiction in which a Loan Party is located that are Other Connection Taxes, (c) any backup withholding Tax that is required by the Internal Revenue Code to be withheld from amounts payable to a Lender that has failed to comply with clause (A) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(e)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (d) in the case of a Foreign Lender (other than an assignee pursuant to a request by the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), any United States withholding tax that (i) is required to be imposed on amounts payable to such Foreign Lender pursuant to the Laws in force at the time such Foreign Lender becomes a party hereto (or designates a new Lending Office) or (ii) is attributable to such Foreign Lender&#8217;s failure or inability (other than as a result of a Change in Law) to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(e)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except to the extent that such Foreign Lender (or its assignor, if any) was entitled, at the time of designation of a new Lending Office (or assignment), to receive additional amounts from the Loan Parties with respect to such withholding Tax pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (e) any U.S. federal withholding Taxes imposed under FATCA.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means that certain Second Amended and Restated Credit Agreement dated as of September 15, 2017 (originally dated as of December 21, 2011, amended and restated as of December 19, 2014, further amended as of July 13, 2016, further amended and restated as of September 15, 2017 and further amended as of May 7, 2020 and as otherwise amended or modified from time to time prior to the Third Amendment and Restatement Effective Date), among the Borrower, the lenders party thereto and Bank of America, N.A., as agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facilities Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the letter agreement, dated as of April 8, 2021 among the Borrower, Bank of America, BofA Securities, Wells Fargo Bank and WFS.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.09(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for any day, the rate per annum equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System, as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding Business Day, and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate (rounded upward, if necessary, to a whole multiple of 1&#47;100 of 1%) charged to Bank of America on such day on such transactions as determined by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Federal Funds Rate would otherwise be less than 0.00%, the Federal Funds Rate shall be deemed to be 0.00%.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Lender that is organized under the Laws of a jurisdiction other than that in which the Borrower is resident for tax purposes (including such a Lender when acting in the capacity of an L&#47;C Issuer).  For purposes of this definition, the United States, each State thereof and the District of Columbia shall be deemed to constitute a single jurisdiction. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FRB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Governors of the Federal Reserve System of the United States.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fronting Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time there is a Defaulting Lender, (a) with respect to an L&#47;C Issuer, such Defaulting Lender&#8217;s Applicable Percentage of the outstanding L&#47;C Obligations other than L&#47;C Obligations as to which such Defaulting Lender&#8217;s participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof and (b) with respect to the Swing Line Lender, such Defaulting Lender&#8217;s Applicable Percentage of the participation in any Swing Line Loans other than Swing Line Loans as to which such Defaulting Lender&#8217;s participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its activities.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board, consistently applied and as in effect from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the government of the United States or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of or by any Person (the &#8220;guarantor&#8221;) means any obligation, contingent or otherwise, of such Person guaranteeing or having the economic effect of guaranteeing any Indebtedness of any other Person (the &#8220;primary obligor&#8221;) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or to purchase (or to advance or supply funds for the purchase of) any security for the payment of such Indebtedness, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness of the payment of such Indebtedness or other obligation, (c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the term &#8220;Guarantee&#8221; shall not include endorsements for collection or deposit in the ordinary course of business.  The amount of any Guarantee shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such Guarantee is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined by the guaranteeing Person in good faith.  The term &#8220;Guarantee&#8221; as a verb has a corresponding meaning.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of (i) if the Holdco Reorganization Effective Date has occurred, the Parent and any Intermediate Holding Company and (ii) any Subsidiary Guarantor, in each case, that has executed and delivered to the Administrative Agent a Joinder Agreement which has not subsequently been released pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Guaranty pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article X</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> made by the Parent, any Intermediate Holding Company or any Subsidiary Guarantor in favor of the Lender Parties evidenced by a Joinder Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) petroleum products and byproducts, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, per- and polyfluoroalkyl substances, radon gas, chlorofluorocarbons and all other ozone-depleting substances and (b) any chemical, material, substance, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">waste, pollutant or contaminant that is prohibited, limited or regulated by or pursuant to any law relating to the environment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Hedging Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Holdco Reorganization Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the date on which the Borrower becomes a direct or indirect Wholly Owned Subsidiary of the Parent pursuant to a Permitted Holdco Reorganization.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Honor Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(l)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Person at a particular time, without duplication, all of the following whether or not included as indebtedness or liabilities in accordance with GAAP&#58; (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property or assets purchased by such Person, (d) all obligations of such Person issued or assumed as the deferred purchase price of property or services (excluding (i) trade accounts payable and accrued obligations incurred in the ordinary course of business, (ii) deferred compensation payable to directors, officers, employees or consultants and (iii) any purchase price adjustment or earnout incurred in connection with an acquisition until such adjustment or earnout becomes due and payable), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (f) all Guarantees by such Person of Indebtedness of others, (g) all Capital Lease Obligations of such Person, (h) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (i) all obligations, contingent or otherwise, of such Person in respect of bankers&#8217; acceptances, (j) all obligations of such Person to make contingent cash payments in respect of any acquisition, to the extent such obligations are or are required to be shown as liabilities on the balance sheet of such Person in accordance with GAAP and (k) Attributable Indebtedness of Securitization Transactions and Synthetic Leases&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the term &#8220;Indebtedness&#8221; shall not include (i) deferred or prepaid revenue</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) purchase price holdbacks in respect of a portion of the purchase price of an asset to satisfy warranty or other unperformed obligations of the seller</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or (iii) any obligations under a Receivables Purchase Transaction (to the extent such obligations are not or are not required to be shown as liabilities on the balance sheet of such Person in accordance with GAAP)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnified Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Taxes other than Excluded Taxes.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Index Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the senior, unsecured, non-credit enhanced, long-term indebtedness for borrowed money of the Borrower or, if applicable, the Parent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Initial L&#47;C Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of Bank of America and Wells Fargo and their successors and assigns, each in its capacity as issuer of Letters of Credit hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) as to any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, the last day of each Interest Period applicable to such Loan and the Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if any Interest Period for a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan exceeds three months, the respective dates that fall every three months after the beginning of such Interest Period shall also be Interest Payment Dates&#59; (b) as to any Base Rate Loan (including any Swing Line Loan that is a Base Rate Loan), the last Business Day </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of each March, June, September and December and the Maturity Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (c) as to any Swing Line Loan that is a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, the last Business Day of each month and the Maturity Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> means</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as to each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, the period commencing on the date such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan is disbursed or converted to or continued as a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan and ending on the date one, three or six months (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">and, if agreed to by all Lenders, twelve months</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">in each case, subject to availability thereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) thereafter, as selected by the Borrower in its Loan Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day unless such Business Day falls in another calendar month, in which case such Interest Period shall end on the next preceding Business Day&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">b</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end of such Interest Period&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">c</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) &#160;&#160;&#160;&#160;no Interest Period </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">with respect to any Revolving Loan that begins before any Maturity Date for any Lender shall end after such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">shall extend beyond the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Maturity Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intermediate Holding Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Subsidiary of the Parent at all times organized under the laws of a jurisdiction of the United States that directly or indirectly owns any Equity Interests of the Borrower.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Internal Revenue Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the United States Internal Revenue Service.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Involuntary Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any loss of, damage to or destruction of, or any condemnation or other taking for public use of, any property of the Company or any of its Subsidiaries where the value of the property subject to such loss, damage, destruction or condemnation is greater than or equal to 10% of the consolidated assets of the Company and its Subsidiaries prior to giving effect to such disposition.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">ISDA Definitions</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:line-through"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ISP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, the &#8220;International Standby Practices 1998&#8221; published by the Institute of International Banking Law &#38; Practice, Inc. (or such later version thereof as may be in effect at the time of issuance).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Issuer Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means with respect to any Letter of Credit, the Letter of Credit Application, and any other document, agreement and instrument entered into by an L&#47;C Issuer and the Borrower (or any Subsidiary) or in favor of such L&#47;C Issuer and relating to any such Letter of Credit.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Joinder Agreement made by the Parent, any Intermediate Holding Company or any Subsidiary Guarantor in substantially the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Joint Lead Arrangers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means BofA Securities and WFS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Advance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to each Lender, such Lender&#8217;s funding of its participation in any L&#47;C Borrowing in accordance with its Applicable Percentage.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Borrowing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an extension of credit resulting from a drawing under any Letter of Credit which has not been reimbursed on the date when made or refinanced as a Borrowing of Revolving Loans.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the increase of the amount thereof.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Fronting Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to the each Initial L&#47;C Issuer, $75,000,000 (or such greater amount as shall be agreed in writing from time to time by such Initial L&#47;C Issuer) and (ii) with respect to any other L&#47;C Issuer, the amount agreed in writing by such L&#47;C Issuer and the Borrower, subject in each case to any increase pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, individually or collectively, as applicable, each Initial L&#47;C Issuer, and any other Lender appointed by the Borrower and approved by the Administrative Agent (as long as such Lender so appointed agrees in its sole discretion in writing to act as such in accordance with this Agreement).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as at any date of determination, the aggregate amount available to be drawn under all outstanding Letters of Credit </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the aggregate of all Unreimbursed Amounts, including all L&#47;C Borrowings.  For purposes of computing the amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For all purposes of this Agreement, if on any date of determination a Letter of Credit has expired by its terms but any amount may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be &#8220;outstanding&#8221; in the amount so remaining available to be drawn. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lender Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, collectively, the Lenders (including the Swing Line Lender), the L&#47;C Issuers and the Administrative Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each of the Persons identified as a &#8220;Lender&#8221; on the signature pages hereto, each Person joining as a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and their successors and assigns and, as the context requires, includes the Swing Line Lender.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to any Lender, the office or offices of such Lender described as such in such Lender&#8217;s Administrative Questionnaire, or such other office or offices as a Lender may from time to time notify the Borrower and the Administrative Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any letter of credit issued hereunder.  A Letter of Credit may be a commercial letter of credit or a standby letter of credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any commercial Letter of Credit issued hereunder shall provide solely for cash payment upon presentation of a sight draft.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an application and agreement for the issuance or amendment of a letter of credit in the form from time to time in use by an L&#47;C Issuer.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the day that is five (5) Business Days prior to the Maturity Date then in effect (or, if such day is not a Business Day, the next preceding Business Day).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a report substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an amount equal to the lesser of (a) the Aggregate Revolving Commitments and (b) $150,000,000, as such amount may be increased pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Letter of Credit Sublimit is part of, and not in addition to, the Aggregate Revolving Commitments.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Holiday</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date, the ratio of Total Debt on such date to Consolidated EBITDA for the period of four consecutive fiscal quarters most recently ended on or prior to such date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that solely for purposes of calculating Total Debt for determining the Leverage Ratio on the last day of the period of four consecutive fiscal quarters of the Company ending as of March 31, 2021, clause (b) of the definition of Total Debt shall be excluded. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning specified in the definition of Eurodollar Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Replacement Date</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning specified in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Screen Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the LIBOR quote on the applicable screen page that the Administrative Agent designates to determine LIBOR (or such other commercially available source providing such quotations as designated by the Administrative Agent from time to time).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Successor Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning specified in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Successor Rate Conforming Changes</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, with respect to any proposed LIBOR Successor Rate, any conforming changes to the definitions of Base Rate, Daily Floating LIBOR Rate and Interest Period, timing and frequency of determining rates and making payments of interest and other technical, administrative or operational matters (including, for the avoidance of doubt, the definition of Business Day, timing of borrowing requests or prepayment, conversion or continuation notices, and length of look-back periods) as may be appropriate, in the Administrative Agent's discretion, to reflect the adoption and implementation of such LIBOR Successor Rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such LIBOR Successor Rate exists, in such other manner of administration as the Administrative Agent determines is reasonably necessary in connection with the administration of this Agreement and any other Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, encumbrance, charge or security interest in or on such asset or (b) the interest of a vendor or a lessor under any conditional sale agreement, capital lease or title retention agreement (or any financing lease having substantially the same economic effect as any of the foregoing) relating to such asset.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an extension of credit by a Lender to the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the form of a Revolving Loan or Swing Line Loan.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means this Agreement, each Note, each Joinder Agreement, each Issuer Document, any agreement creating or perfecting rights in Cash Collateral pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and the Facilities Fee Letter. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Modification Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Loan Modification Agreement in form and substance reasonably satisfactory to the Administrative Agent and the Loan Parties, among the Loan Parties, one or more Accepting Lenders and the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Modification Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a notice of (a) a Borrowing of Loans, (b) a conversion of Loans from one Type to the other, or (c) a continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, in each case pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which shall be substantially in the form of Exhibit A or such other form as may be approved by the Administrative Agent  (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Borrower and each Guarantor.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">London Banking Day</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means any day on which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Margin Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning assigned to such term in Regulation U issued by the FRB.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a materially adverse effect on the financial condition, results of operations or business of the Company and the Subsidiaries, taken as a whole.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Indebtedness (other than the Loans and Letters of Credit), or obligations in respect of any Hedging Agreement, of the Company or any of the Subsidiaries in a principal amount exceeding $200,000,000 (in each case, other than intercompany Indebtedness owing to the Parent or any of its Subsidiaries).  For purposes of determining Material Indebtedness, the &#8220;principal amount&#8221; of the obligations of the Company or any Subsidiary in respect of any Hedging Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that the Company or such Subsidiary would be required to pay if such Hedging Agreement were terminated at such time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means and includes, at any time, any Subsidiary, except Subsidiaries which, if aggregated and considered as a single Subsidiary, would not meet the definition of a &#8220;significant subsidiary&#8221; contained as of the date hereof in Regulation S-X of the Securities and Exchange Commission. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (i) with respect to any Lender that has not extended the Maturity Date of its Commitment pursuant to Section 2.16, the Original Maturity Date and (ii) with respect to any tranche of Loans extended pursuant to a Loan Modification Offer, the final maturity date as specified in the applicable Loan Modification Offer accepted by the respective Accepting Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in each case, that if such day is not a Business Day, the applicable Maturity Date shall be the Business Day immediately preceding such day.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Moody&#8217;s Investors Service, Inc. and any successor thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Accepting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extension Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Revolving Notes and&#47;or the Swing Line Note, individually or collectively, as appropriate.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all advances to, and debts, liabilities, obligations, covenants and duties of, the Loan Parties arising under any Loan Document or otherwise with respect to any Loan or Letter of Credit, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against the Company or any Subsidiary thereof of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Office of Foreign Assets Control of the United States Department of the Treasury.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organization Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any corporation, the certificate or articles of incorporation and the bylaws (or equivalent or comparable constitutive documents with respect to any non-U.S. jurisdiction)&#59; (b) with respect to any limited liability company, the certificate or articles of formation or organization and operating agreement&#59; and (c) with respect to any partnership, joint venture, trust or other form of business entity, the partnership, joint venture or other applicable agreement of formation or organization and any agreement, instrument, filing or notice with respect thereto filed in connection with its formation or organization with the applicable Governmental Authority in the jurisdiction of its formation or organization and, if applicable, any certificate or articles of formation or organization of such entity.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Original Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the date that is the fifth anniversary of the Third Amendment and Restatement Effective Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any recipient of a payment hereunder, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other than connections arising solely from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future stamp or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Outstanding Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to any Loans on any date, the aggregate outstanding principal amount thereof after giving effect to any borrowings and prepayments or repayments of any Loans occurring on such date&#59; and (b) with respect to any L&#47;C Obligations on any date, the amount of such L&#47;C Obligations on such date after giving effect to any L&#47;C Credit Extension occurring on such date and any other changes in the aggregate amount of the L&#47;C Obligations as of such date, including as a result of any reimbursements by the Borrower of Unreimbursed Amounts.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the entity identified as the Parent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which shall be an entity which at all times is organized under the laws of a jurisdiction of the United States and directly or indirectly through one or more Intermediate Holding Companies owns 100% of the Equity Interests of the Borrower.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Pension Benefit Guaranty Corporation or any successor thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pension Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Pension Protection Act of 2006, as amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Holdco Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a transaction pursuant to which the Borrower becomes a Wholly Owned Subsidiary of the Parent as contemplated by, and subject to the conditions set forth in, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Reorganization Merger Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in Section 11.23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of Title IV of ERISA or Section 412 of the Internal Revenue Code or Section 302 of ERISA, and in respect of which the Company or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Pre-Adjustment Successor Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; has the meaning specified in as defined in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pricing Level</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in the definition of &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Basis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, for purposes of calculating the financial covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any Disposition, Involuntary Disposition, Acquisition or Restricted Payment shall be deemed to have occurred as of the first day of the most recent four fiscal quarter period preceding the date of such transaction for which the Company was required to deliver financial statements pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In connection with the foregoing, (i)(a) with respect to any Disposition or Involuntary Disposition, income statement and cash flow statement items (whether positive or negative) attributable to the property disposed of shall be excluded to the extent relating to any period occurring prior to the date of such transaction and (b) with respect to any Acquisition, income statement items attributable to the Person or property acquired shall be included to the extent relating to any period applicable in such calculations to the extent (A) such items are not otherwise included in such income statement items for the Company and its Subsidiaries in accordance with GAAP or in accordance with any defined terms set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (B) such items are supported by financial statements or other information reasonably satisfactory to the Administrative Agent and (ii) any Indebtedness incurred or assumed by the Company or any Subsidiary (including the Person or property acquired) in connection with such transaction (A) shall be deemed to have been incurred as of the first day of the applicable period and (B) if such Indebtedness has a floating or formula rate, shall have an implied rate of interest for the applicable period for purposes of this definition determined by utilizing the rate which is or would be in effect with respect to such Indebtedness as at the relevant date of determination.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any acquisition by the Company or any Subsidiary of (i) all or substantially all of the assets of a Person or line of business of such Person, or (ii) at least a majority of the Equity Interests of a Person, in each case, where the aggregate consideration (in whatever form) payable by the Company and its Subsidiaries is greater than $1,000,000,000.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Receivables Purchase Transaction&#8221; means an arrangement whereby the Borrower or any of its Subsidiaries (including a special purpose subsidiary) sells, on a non-recourse basis, except to the extent customary in a &#8220;true sale&#8221; arrangement, its accounts receivable in connection with the collection of such accounts receivable in the ordinary course of business.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Related Adjustment</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means, in determining any LIBOR Successor Rate, the first relevant available alternative set forth in the order below that can be determined by the Administrative Agent applicable to such LIBOR Successor Rate&#58; (a) the spread adjustment, or method for calculating or determining such spread adjustment, that has been selected or recommended by the Relevant Governmental Body for the relevant Pre-Adjustment Successor Rate (taking into account the interest period, interest payment date or payment period for interest calculated and&#47;or tenor thereto) and which adjustment or method (i) is published on an information service as selected by the Administrative Agent from time to time in its discretion or (ii) solely with respect to Term SOFR, if not currently published, which was previously so recommended for Term SOFR and published on an information service </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">acceptable to the Administrative Agent&#59; or (b) the spread adjustment that would apply (or has previously been applied) to the fallback rate for a derivative transaction referencing the ISDA Definitions (taking into account the interest period, interest payment date or payment period for interest calculated and&#47;or tenor thereto).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, such Person&#8217;s Affiliates and the partners, directors, officers, employees, agents, trustees and advisors of such Person and of such Person&#8217;s Affiliates.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Relevant Governmental Body</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221; means the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Removal Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replaced Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Request for Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) with respect to a Borrowing, conversion or continuation of Loans, a Loan Notice, (b) with respect to an L&#47;C Credit Extension, a Letter of Credit Application and (c) with respect to a Swing Line Loan, a Swing Line Loan Notice.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, Lenders holding in the aggregate more than 50% of (a) the unfunded Commitments, the outstanding Loans, L&#47;C Obligations and participations therein or (b) if the Commitments have been terminated, the outstanding Loans, L&#47;C Obligations and participations therein.  The unfunded Commitments of, and the outstanding Loans held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of the applicable Loan Party and, solely for purposes of the delivery of certificates pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the secretary or any assistant secretary of such Loan Party and, solely for purposes of notices given pursuant to Article II, any other officer or employee of such Loan Party so designated by any of the foregoing officers in a notice to the Administrative Agent or any other officer or employee of such Loan Party designated in or pursuant to an agreement between such Loan Party and the Administrative Agent.  Any document delivered hereunder that is signed by a Responsible Officer of a Loan Party shall be conclusively presumed to have been authorized by all necessary corporate, partnership and&#47;or other action on the part of such Loan Party and such Responsible Officer shall be conclusively presumed to have acted on behalf of such Loan Party.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any dividend or other distribution (whether in cash, securities or other property) with respect to any Equity Interests in the Company or any Subsidiary, or (b) any Share Repurchase.  It is understood that the withholding of shares, and the payment of cash to the Internal Revenue Service in an amount not to exceed the value of the withheld shares, by the Company in connection with any of its stock incentive plans shall not constitute Restricted Payments.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, as to each Lender, its obligation to (a) make Revolving Loans to the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) purchase participations in L&#47;C Obligations and (c) purchase participations in Swing Line Loans, in an aggregate principal amount at any one time outstanding not to exceed the amount set forth opposite such Lender&#8217;s name on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in the Assignment and Assumption pursuant to which such Lender becomes a party hereto, as applicable, as such amount may be adjusted from time to time in accordance with this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means S&#38;P Global Ratings, a subsidiary of S&#38;P Global, Inc., and any successor thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to the Company or any Subsidiary, any arrangement, directly or indirectly, with any Person whereby the Company or such Subsidiary shall sell or transfer any property used or useful in its business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property that it intends to use for substantially the same purpose or purposes as the property being sold or transferred.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the United States Government (including without limitation those administered by OFAC or the U.S. Department of State), or (b) the United Nations Security Council, the European Union, any European Union member state, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Her</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">His</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Majesty&#8217;s Treasury of the United Kingdom or other relevant sanctions authority.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Scheduled Unavailability Date&#8221; has the meaning specified in Section 3.03(b)(ii).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Securitization Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, any financing </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">transaction or series of financing transactions (including factoring arrangements) pursuant to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">arrangement under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> which such Person or any Subsidiary of such Person may sell, convey or otherwise transfer, or grant a security interest in, accounts, payments, receivables, rights to future lease payments or residuals or similar rights to payment to a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">special purpose subsidiary or affiliate of such Person.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">trust, partnership, corporation, limited liability company or other entity (which may be an SPE Subsidiary), which transfer is funded in whole or in part, directly or indirectly, by the incurrence or issuance by the transferee or successor transferee (which may be an SPE Subsidiary) of Indebtedness, other securities or interests that are to receive payments from, or that represent interests in, the cash flow derived from such accounts, payments, receivables, rights to future lease payments or residuals or similar rights to payment&#59; provided, that a Receivables Purchase Transaction shall not constitute a Securitization Transaction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Share Repurchase</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the payment (whether in cash, securities or other property), including any sinking fund or similar deposit, on account of the purchase, redemption, retirement, acquisition, cancelation or termination of any Equity Interests in the Company or any Subsidiary, other than (i) a payment to the extent consisting of Equity Interests of equal or junior ranking and (ii) acquisitions of Equity Interests pursuant to employee and&#47;or director stock plans or employee and&#47;or director compensation plans, including acquisitions (or withholding) of Equity Interests in the Company or any Subsidiary pursuant to any such plan pursuant to the term thereof or in satisfaction of withholding or similar taxes payable by any present or former officer, employee, director or member of management.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Business Day, the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable determination date, the Secured Overnight Financing Rate published on the U.S. Government Securities Business Day preceding such date by the SOFR Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on the Federal Reserve Bank of New </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">York's</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">York&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> website (or any successor source)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> at approximately 8&#58;00 a.m. (New York City time) on the immediately succeeding Business Day and, in each case, that has been selected or recommended by the Relevant Governmental Body.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#59; provided however that if such determination date is not a U.S. Government Securities Business Day, then SOFR means such rate that applied on the first U.S. Government Securities Business Day immediately prior thereto.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;SOFR Adjustment&#8221; means 0.10%.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;SOFR Administrator&#8221; means the Federal Reserve Bank of New York, as the administrator of SOFR, or any successor administrator of SOFR designated by the Federal Reserve Bank of New York or other Person acting as the SOFR Administrator at such time that is satisfactory to the Administrative Agent.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> &#8220;SPE Subsidiary&#8221; means any Subsidiary formed solely for the purpose of, and that engages only in, one or more Securitization Transactions and transactions related or incidental thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subordinated Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Indebtedness of the Borrower that is subordinated to the Obligations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of the shares of Voting Stock is at the time beneficially owned, or the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person.  Unless otherwise specified, all references herein to a &#8220;Subsidiary&#8221; or to &#8220;Subsidiaries&#8221; shall refer to a Subsidiary or Subsidiaries of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Successor Rate&#8221; has the meaning specified in Section 3.03(b).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Bank of America in its capacity as provider of Swing Line Loans, or any successor swing line lender hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a notice of a Borrowing of Swing Line Loans pursuant to Section 2.04(b), which shall be substantially in the form of Exhibit B or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approve by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an amount equal to the lesser of (a) $100,000,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and (b) the Aggregate Revolving Commitments.  The Swing Line Sublimit is part of, and not in addition to, the Aggregate Revolving Commitments.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Synthetic Lease</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any synthetic lease, tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing arrangement whereby the arrangement is considered borrowed money indebtedness for tax purposes but is classified as an operating lease or does not otherwise appear on a balance sheet under GAAP.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR&#8221; means&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">for any Interest Period with respect to a Term SOFR Loan, the rate per annum equal to the Term SOFR Screen Rate two U.S. Government Securities Business Days prior to the commencement of such Interest Period with a term equivalent to such Interest Period&#59; provided that if the rate is not published prior to 11&#58;00 a.m. on such determination date then Term SOFR means the Term SOFR Screen Rate on the first U.S. Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for such Interest Period&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">for any interest calculation with respect to a Base Rate Loan on any date, the rate per annum equal to the Term SOFR Screen Rate with a term of one month commencing that day&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided that if Term SOFR determined in accordance with either of the foregoing provisions (a) or (b) of this definition would otherwise be less than zero, Term SOFR shall be deemed zero for purposes of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Loan&#8221; means a Loan that bears interest at a rate based on clause (a) of the definition of Term SOFR.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Replacement Date&#8221; has the meaning specified in Section 3.03(b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the forward-looking </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">term rate </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">for any period that is approximately (as determined by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administered by CME (or any successor administrator satisfactory to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Administrative Agent) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">as long as any of the Interest Period options set forth in the definition of &#8220;Interest Period&#8221; and that is based on SOFR and that has been selected or recommended by the Relevant Governmental Body, in each case as published on an information service as selected</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">and published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the Administrative Agent from time to time</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> in its discretion. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">).  For the purposes of this definition, &#8220;SOFR&#8221; shall mean the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Third Amendment and Restatement Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means April 30, 2021.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at any time, (a) the consolidated total Indebtedness of the Company and the Subsidiaries at such time (excluding (i) Indebtedness of the type described in clause (h) of the definition of such term, except to the extent of any unreimbursed drawings thereunder, as determined in accordance with GAAP, and (ii) Indebtedness incurred for the purpose of consummating a Qualified Acquisition if (and for so long as) (A) such Qualified Acquisition has not been consummated and (B) (x) the proceeds of such Indebtedness are held by the Company or any of its Subsidiaries in the form of unrestricted cash or cash equivalents or (y) such Indebtedness is subject to mandatory redemption in the event such Qualified Acquisition is not consummated) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) the aggregate amount of unrestricted cash and cash equivalents of the Company and its Subsidiaries in excess of $500,000,000.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Revolving Outstandings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the aggregate Outstanding Amount of all Revolving Loans, all Swing Line Loans and all L&#47;C Obligations.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Loan, its character as a Base Rate Loan, a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan or a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person subject to IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; mean the United States of America.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unreimbursed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (Title III of Pub. L. No. 107-56 (signed into law October 26, 2001)).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;U.S. Government Securities Business Day&#8221; means any Business Day, except any Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any Person, Equity Interests issued by such Person the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of such Person, even though the right so to vote has been suspended by the happening of such a contingency.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Wells Fargo Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Wells Fargo Bank, National Association.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">WFS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Wells Fargo Securities, LLC, in its capacity as joint lead arranger and joint book manager.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Wholly Owned Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person 100% of whose Equity Interests are at the time owned by the Company directly or indirectly through other Persons 100% of whose Equity Interests are at the time owned, directly or indirectly, by the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withdrawal Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means liability to a Multiemployer Plan as a result of a complete or partial withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Interpretive Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">With reference to this Agreement and each other Loan Document, unless otherwise specified herein or in such other Loan Document&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined.  Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.  The words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">include</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">includes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be deemed to be followed by the phrase &#8220;without limitation.&#8221;  The word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">will</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be construed to have the same meaning and effect as the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">shall</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#8221;  Unless the context requires otherwise, (i) any definition of or reference to any agreement, instrument or other document (including any Organization Document) shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein or in any other Loan Document), (ii) any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns, (iii) the words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">hereto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">hereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">hereunder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; and words of similar import when used in any Loan Document, shall be construed to refer to such Loan Document in its entirety and not to any particular provision thereof, (iv) all references in a Loan Document to Articles, Sections, Exhibits and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, the Loan Document in which such references appear, (v) any reference to any law shall include all statutory and regulatory provisions consolidating, amending, replacing or interpreting such law and any reference to any law or regulation shall, unless otherwise specified, refer to such law or regulation as amended, modified or supplemented from time to time, (vi) the words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">asset</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be construed to have the same meaning and effect and to refer to any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and all real and personal property and tangible and intangible assets and properties, including cash, securities, accounts and contract rights and (vii) any reference to &#8220;L&#47;C Issuer&#8221; shall refer to any L&#47;C Issuer, each L&#47;C Issuer, the applicable L&#47;C Issuer or all L&#47;C Issuers as the context may require.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In the computation of periods of time from a specified date to a later specified date, the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">from</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">from and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;&#8221; the words &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">until</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; each mean &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">to but excluding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;&#8221; and the word &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">through</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">to and including</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#8221;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Section headings herein and in the other Loan Documents are included for convenience of reference only and shall not affect the interpretation of this Agreement or any other Loan Document.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accounting Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as otherwise specifically prescribed herein, all accounting terms not specifically or completely defined herein shall be construed in conformity with, and all financial data (including financial ratios and other financial calculations) required to be submitted pursuant to this Agreement shall be prepared in conformity with, GAAP applied on a consistent basis, as in effect from time to time, applied in a manner consistent with that used in preparing the Audited Financial Statements&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that calculations of Attributable Indebtedness under any Synthetic Lease or the implied interest component of any Synthetic Lease shall be made by the Company in accordance with accepted financial practice and consistent with the terms of such Synthetic Lease.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Changes in GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company will provide a written summary of material changes in GAAP and in the consistent application thereof with each annual and quarterly Compliance Certificate delivered in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If at any time any change (or any application thereof following such change) in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either the Borrower or the Required Lenders shall so request, the Administrative Agent, the Lenders and the Loan Parties shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP or the application thereof (subject to the approval of the Required Lenders)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP in effect prior to such change therein (or the application thereof) and (ii) the Company shall provide to the Administrative Agent and the Lenders financial statements and other documents required under this Agreement or as requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP (or the application thereof). Notwithstanding any other provision contained herein, all obligations of any Person that are or would be characterized as an operating lease as determined in accordance with GAAP as in effect on December 31, 2018 (whether or not such operating lease was in effect on such date) shall continue to be accounted for as an operating lease (and not as a Capital Lease Obligation) for purposes of this Agreement regardless of any change in GAAP following December 31, 2018 that would otherwise require such obligation to be recharacterized as a Capital Lease Obligation.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Calculations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding the above, the parties hereto acknowledge and agree that all calculations of the financial covenant in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be made on a Pro Forma Basis.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FASB ASC 825 and FASB ASC 470-20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding the above, for purposes of determining compliance with any covenant (including the computation of any financial covenant) contained herein, Indebtedness of the Company and its Subsidiaries shall be deemed to be carried at 100% of the outstanding principal amount thereof, and the effects of FASB ASC 825 and FASB ASC 470-20 on financial liabilities shall be disregarded.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rounding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any financial ratios required to be maintained by the Borrower pursuant to this Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Times of Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise specified, all references herein to times of day shall be references to Eastern time (daylight or standard, as applicable).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the stated amount of such Letter of Credit in effect at such time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that with respect to any Letter of Credit that, by its terms or the terms of any Issuer Document related thereto, provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Divisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws)&#58; (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent does not warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the rates in the definitions of &#8220;Eurodollar Rate&#8221; or &#8220;Daily Floating LIBOR Rate&#8221;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any reference rate referred to herein</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or with respect to any rate </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(including, for the avoidance of doubt, the selection  of such rate and any related spread or other adjustment) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that is an alternative or replacement for or successor to any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such rate (including, without limitation, any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Successor Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">) (or any component of any of the foregoing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or the effect of any of the foregoing, or of any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR Successor Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Conforming Changes. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or any alternative, successor or replacement rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to the Borrower.  The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Successor Rate) (or any component of any of the foregoing), in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE II<br><br>THE COMMITMENTS AND CREDIT EXTENSIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the terms and conditions set forth herein, each Lender severally agrees to make loans (each such loan, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower in Dollars from time to time on any Business Day during the Availability Period in an aggregate amount not to exceed at any time outstanding the amount of such Lender&#8217;s Revolving Commitment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that after giving effect to any Borrowing of Revolving Loans, (i) the Total Revolving Outstandings shall not exceed the Aggregate Revolving Commitments, and (ii) the aggregate Outstanding Amount of the Revolving Loans of any Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all L&#47;C Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all Swing Line Loans shall not exceed such Lender&#8217;s Revolving Commitment.  Within the limits of each Lender&#8217;s Revolving Commitment, and subject to the other terms and conditions hereof, the Borrower may borrow under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, prepay under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and reborrow under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Revolving Loans may be Base Rate Loans or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, or a combination thereof, as further provided herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowings, Conversions and Continuations of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Each Borrowing, each conversion of Loans from one Type to the other, and each continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans shall be made upon the Borrower&#8217;s irrevocable notice to the Administrative Agent, which may be given by (A) telephone, or (B) a Loan Notice&#59; provided that any telephonic notice must be confirmed promptly by delivery to the Administrative Agent of a Loan Notice.  Each such Loan Notice must be received by the Administrative Agent not later than 11&#58;00 a.m. (i) three Business Days prior to the requested date of any Borrowing of, conversion to or continuation of, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or of any conversion of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans to Base Rate Loans, and (ii) on the requested date of any Borrowing of Base Rate Loans</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">however</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, that if the Borrower wishes to request Eurodollar Rate Loans having an Interest Period other than one, three or six months in duration as provided in the definition of &#8220;Interest Period,&#8221; the applicable notice must be received by the Administrative Agent not later than 11&#58;00 a.m. four Business Days prior to the requested date of such Borrowing, conversion or continuation, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is acceptable to all of them</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Not later than 11&#58;00 a.m., three Business Days before the requested date of such Borrowing, conversion or continuation, the Administrative Agent shall notify the Borrower (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders.  Each Borrowing of, conversion to or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans shall be in a principal amount of $2,000,000 or a whole multiple of $1,000,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in excess thereof.  Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Borrowing of or conversion to Base Rate Loans shall be in a principal amount of $1,000,000 or a whole multiple of $500,000 in excess thereof.  Each Loan Notice shall specify (i) whether the Borrower is requesting a Borrowing, a conversion of Loans from one Type to the other, or a continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, (ii) the requested date of the Borrowing, conversion or continuation, as the case may be (which shall be a Business Day), (iii) the principal amount of Loans to be borrowed, converted or continued, (iv) the Type of Loans to be borrowed or to which existing Loans are to be converted, and (v) if applicable, the duration of the Interest Period with respect thereto.  If the Borrower fails to specify a Type of a Loan in a Loan Notice or if the Borrower fails to give a timely notice requesting a conversion or continuation, then the applicable Loans shall be made as, or converted to, Base Rate Loans. Any such automatic conversion to Base Rate Loans shall be effective as of the last day of the Interest Period then in effect with respect to the applicable </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans.  If the Borrower requests a Borrowing of, conversion to, or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans in any Loan Notice, but fails to specify an Interest Period, it will be deemed to have specified an Interest Period of one month.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Following receipt of a Loan Notice, the Administrative Agent shall promptly notify each Lender of the amount of its Applicable Percentage of the applicable Loans, and if no timely notice of a conversion or continuation is provided by the Borrower, the Administrative Agent shall notify each Lender of the details of any automatic conversion to Base Rate Loans as described in the preceding subsection.  In the case of a Borrowing, each Lender shall make the amount of its Loan available to the Administrative Agent in immediately available funds at the Administrative Agent&#8217;s Office not later than 1&#58;00 p.m. on the Business Day specified in the applicable Loan Notice.  Upon satisfaction of the applicable conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (and, if such Borrowing is the initial Credit Extension, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the Administrative Agent shall make all funds so received available to the Borrower in like funds as received by the Administrative Agent either by (i) crediting the account of the Borrower on the books of Bank of America with the amount of such funds or (ii) wire transfer of such funds, in each case in accordance with instructions provided to (and reasonably acceptable to) the Administrative Agent by the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if, on the date of a Borrowing of Revolving Loans, there are L&#47;C Borrowings outstanding, then the proceeds of such Borrowing, first, shall be applied to the payment in full of any such L&#47;C Borrowings and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall be made available to the Borrower as provided above.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Except as otherwise provided herein, a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan may be continued or converted only on the last day of the Interest Period for such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan.  During the existence of a Default, no Loans may be requested as Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or requested as, converted to or continued as </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans without the consent of the Required Lenders, and the Required Lenders may demand that any or all of the then outstanding Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans and&#47;or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans be converted immediately to Base Rate Loans.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;The Administrative Agent shall promptly notify the Borrower and the Lenders of the interest rate applicable to any Interest Period for </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans upon determination of such interest rate.  At any time that Base Rate Loans are outstanding, the Administrative Agent shall notify the Borrower and the Lenders of any change in Bank of America&#8217;s prime rate used in determining the Base Rate promptly following the public announcement of such change.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;After giving effect to all Borrowings, all conversions of Loans from one Type to the other, and all continuations of Loans as the same Type, there shall not be more than 10 Interest Periods in effect with respect to all Loans. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">With respect to SOFR or Term SOFR, the Administrative Agent will have the right, in consultation with the Borrower, to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document&#59; provided that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;The Borrower may, at any time and from time to time, upon prior written notice by the Borrower to the Administrative Agent increase the Aggregate Revolving Commitments (which increase (x) may provide for the payment of upfront fees in consideration for such increase solely to existing and new Lenders participating in such increase and (y) at the election of the Borrower and subject to the written consent of the L&#47;C Issuers and&#47;or the Swing Line Lender, as applicable, may increase the Letter of Credit Sublimit and&#47;or the Swing Line Sublimit in a ratable amount relative to the increase in the Aggregate Revolving Commitments) by a maximum aggregate amount of up to FIVE HUNDRED MILLION DOLLARS ($500,000,000) with additional Revolving Commitments from any existing Lender with a Revolving Commitment or new Revolving Commitments from any other Person selected by the Borrower and reasonably acceptable to the Administrative Agent and the L&#47;C Issuers&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;any such increase shall be in a minimum principal amount of $10,000,000 and in integral multiples of $1,000,000 in excess thereof&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;no Default or Event of Default shall exist and be continuing at the time of any such increase&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;no existing Lender shall be under any obligation to increase its Commitment and any such decision whether to increase its Commitment shall be in such Lender&#8217;s sole and absolute discretion&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)&#160;&#160;&#160;&#160;(1) any new Lender shall join this Agreement by executing a joinder agreement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto and&#47;or (2) any existing Lender electing to increase its Commitment shall have executed a commitment agreement reasonably satisfactory to the Administrative Agent&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)&#160;&#160;&#160;&#160;the Borrower is in compliance with the financial covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at the time of any such increase&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(F)&#160;&#160;&#160;&#160;as a condition precedent to such increase, (I) the Borrower shall deliver to the Administrative Agent a certificate of the Borrower dated as of the date of such increase signed by a Responsible Officer of the Borrower (1) certifying and attaching the resolutions adopted by the Borrower approving or consenting to such increase, and (2) certifying that, before and after </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">giving effect to such increase, (x) the representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the other Loan Documents are true and correct in all material respects on and as of the date of such increase, except that (i) any such representation and warranty that is qualified by materiality or a reference to Material Adverse Effect is true and correct in all respects on and as of the date of such increase and (ii) to the extent that any such representation and warranty specifically refers to an earlier date, each such representation and warranty is true and correct in all material respects as of such earlier date (except that any such representation and warranty that is qualified by materiality or reference to Material Adverse Effect is true and correct in all respects as of such earlier date), and except that for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and (y) no Default or Event of Default exists and (II) the Guarantors, if any, shall deliver to the Administrative Agent a certificate reaffirming their obligations under this Agreement&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(G)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed revised to reflect the new Commitments made by the applicable Lenders pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">f</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the effectiveness of any such increase, subject to the payment of applicable amounts pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in connection therewith, the Borrower shall be deemed to have made such borrowings and repayments of the Loans, and the Lenders shall make such adjustments of outstanding Loans between and among them, as shall be necessary to effect the reallocation of the Commitments such that, after giving effect thereto, the Loans shall be held by the Lenders (including any new Lenders) ratably in accordance with their respective Commitments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Letter of Credit Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Subject to the terms and conditions set forth herein, (A) each L&#47;C Issuer agrees, in reliance upon the agreements of the Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (1) from time to time on any Business Day during the period from the Third Amendment and Restatement Effective Date until the Letter of Credit Expiration Date, to issue Letters of Credit denominated in Dollars for the account of the Borrower, the Parent (solely after the Holdco Reorganization Effective Date) or any Subsidiary, and to amend or extend Letters of Credit previously issued by it, in accordance with subsection (b) below, and (2) to honor drawings under the Letters of Credit&#59; and (B) the Lenders severally agree to participate in Letters of Credit issued for the account of the Borrower, the Parent or any Subsidiary and any drawings thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that after giving effect to any L&#47;C Credit Extension with respect to any Letter of Credit, (w) the Total Revolving Outstandings shall not exceed the Aggregate Revolving Commitments, (x) the aggregate Outstanding Amount of the Revolving Loans of any Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all L&#47;C Obligations </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all Swing Line Loans shall not exceed such Lender&#8217;s Revolving Commitment, (y) the Outstanding Amount of the L&#47;C Obligations shall not exceed the Letter of Credit Sublimit and (z) the Outstanding Amount of L&#47;C Obligations with respect to any L&#47;C Issuer shall not exceed such L&#47;C Issuer&#8217;s L&#47;C Fronting Sublimit.  Each request by the Borrower for the issuance or amendment of a Letter of Credit shall be deemed to be a representation by the Borrower that the L&#47;C Credit Extension so requested complies with the conditions set forth in the proviso to the preceding sentence.  Within the foregoing limits, and subject to the terms and conditions hereof, the Borrower&#8217;s ability to obtain Letters of Credit shall be fully revolving, and accordingly the Borrower may, during the foregoing period, obtain Letters of Credit to replace Letters of Credit that have expired or that have been drawn upon and reimbursed. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;An L&#47;C Issuer shall not issue any Letter of Credit if&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160; subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the expiry date of such requested Letter of Credit would occur more than twelve months after the date of issuance or last extension, unless the Required Lenders have approved such expiry date&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;the expiry date of such requested Letter of Credit would occur after the date twelve months after the Maturity Date, unless all the Lenders have approved such expiry date. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;An L&#47;C Issuer shall not be under any obligation to issue any Letter of Credit if&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain such L&#47;C Issuer from issuing such Letter of Credit, or any Law applicable to such L&#47;C Issuer or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such L&#47;C Issuer shall prohibit, or request that such L&#47;C Issuer refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon such L&#47;C Issuer with respect to such Letter of Credit any restriction, reserve or capital requirement (for which such L&#47;C Issuer is not otherwise compensated hereunder) not in effect on the Third Amendment and Restatement Effective Date, or shall impose upon such L&#47;C Issuer any unreimbursed loss, cost or expense which was not applicable on the Third Amendment and Restatement Effective Date and which such L&#47;C Issuer in good faith deems material to it&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;the issuance of such Letter of Credit would violate one or more policies of such L&#47;C Issuer applicable to letters of credit generally&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;such Letter of Credit is to be denominated in a currency other than Dollars&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)&#160;&#160;&#160;&#160;any Lender is at that time a Defaulting Lender, unless such L&#47;C Issuer has entered into arrangements, including the delivery of Cash Collateral, satisfactory to such L&#47;C Issuer (in its sole discretion) with the Borrower or such Lender to eliminate such L&#47;C Issuer&#8217;s actual or potential Fronting Exposure (after giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(iv</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)) with respect to the Defaulting Lender arising from either the Letter of Credit then proposed to be issued or that Letter of Credit and all other L&#47;C Obligations as to which such L&#47;C Issuer has actual or potential Fronting Exposure, as it may elect in its sole discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;An L&#47;C Issuer shall not amend any Letter of Credit if such L&#47;C Issuer would not be permitted at such time to issue the Letter of Credit in its amended form under the terms hereof.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;An L&#47;C Issuer shall be under no obligation to amend any Letter of Credit if (A) such L&#47;C Issuer would have no obligation at such time to issue such Letter of Credit in its amended form under the terms hereof, or (B) the beneficiary of such Letter of Credit does not accept the proposed amendment to such Letter of Credit.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)&#160;&#160;&#160;&#160;An L&#47;C Issuer shall act on behalf of the Lenders with respect to any Letters of Credit issued by it and the documents associated therewith, and such L&#47;C Issuer shall have all of the benefits and immunities (A) provided to the Administrative Agent in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to any acts taken or omissions suffered by such L&#47;C Issuer in connection with Letters of Credit issued by it or proposed to be issued by it and Issuer Documents pertaining to such Letters of Credit as fully as if the term &#8220;Administrative Agent&#8221; as used in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IX</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> included such L&#47;C Issuer with respect to such acts or omissions, and (B) as additionally provided herein with respect to such L&#47;C Issuer.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Procedures for Issuance and Amendment of Letters of Credit&#59; Auto-Extension Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Each Letter of Credit shall be issued or amended, as the case may be, upon the request of the Borrower delivered to the relevant L&#47;C Issuer (with a copy to the Administrative Agent) in the form of a Letter of Credit Application, appropriately completed and signed by a Responsible Officer of the Borrower.  Such Letter of Credit Application must be received by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">relevant L&#47;C Issuer and the Administrative Agent not later than 11&#58;00 a.m. at least five (5) Business Days (or such later date and time as the Administrative Agent and the relevant L&#47;C Issuer may agree in a particular instance in their sole discretion) prior to the proposed issuance date or date of amendment, as the case may be.  In the case of a request for an initial issuance of a Letter of Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the relevant L&#47;C Issuer&#58; (A) the proposed issuance date of the requested Letter of Credit (which shall be a Business Day)&#59; (B) the amount thereof&#59; (C) the expiry date thereof&#59; (D) the name and address of the beneficiary thereof&#59; (E) the documents to be presented by such beneficiary in case of any drawing thereunder&#59; (F) the full text of any certificate to be presented by such beneficiary in case of any drawing thereunder&#59; (G) the purpose and nature of the requested Letter of Credit&#59; and (H) such other matters as the relevant L&#47;C Issuer may require.  In the case of a request for an amendment of any outstanding Letter of Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the relevant L&#47;C Issuer (A) the Letter of Credit to be amended&#59; (B) the proposed date of amendment thereof (which shall be a Business Day)&#59; (C) the nature of the proposed amendment&#59; and (D) such other matters as the relevant L&#47;C Issuer may reasonably require.  Additionally, the Borrower shall furnish to the relevant L&#47;C Issuer and the Administrative Agent such other documents and information pertaining to such requested Letter of Credit issuance or amendment, including any Issuer Documents, as the relevant L&#47;C Issuer or the Administrative Agent may reasonably require.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;Promptly after receipt of any Letter of Credit Application, the relevant L&#47;C Issuer will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has received a copy of such Letter of Credit Application from the Borrower and, if not, such L&#47;C Issuer will provide the Administrative Agent with a copy thereof.  Unless the relevant L&#47;C Issuer has received written notice from any Lender, the Administrative Agent or the Borrower, at least one Business Day prior to the requested date of issuance or amendment of the applicable Letter of Credit, that one or more applicable conditions contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not be satisfied, then, subject to the terms and conditions hereof, such L&#47;C Issuer shall, on the requested date, issue a Letter of Credit for the account of the Borrower or the applicable Subsidiary or enter into the applicable amendment, as the case may be, in each case in accordance with such L&#47;C Issuer&#8217;s usual and customary business practices.  Immediately upon the issuance of each Letter of Credit, each Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from such L&#47;C Issuer a risk participation in such Letter of Credit in an amount equal to the product of such Lender&#8217;s Applicable Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the amount of such Letter of Credit.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;If the Borrower so requests in any applicable Letter of Credit Application, the relevant L&#47;C Issuer may, in its sole discretion, agree to issue a Letter of Credit that has automatic extension provisions (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Auto-Extension Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such Auto-Extension Letter of Credit must permit the relevant L&#47;C Issuer to prevent any such extension at least once in each twelve-month period (commencing with the date of issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof not later than a day (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Extension Notice Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in each such twelve-month period to be agreed upon at the time such Letter of Credit is issued.  The Borrower shall not be required to make a specific request to the relevant L&#47;C Issuer for any such extension.  Once an Auto-Extension Letter of Credit has been issued, the Lenders shall be deemed to have authorized (but may not require) the relevant L&#47;C Issuer to permit the extension of such Letter of Credit at any time to an expiry date not later than the date twelve months after the Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the relevant L&#47;C Issuer shall not permit any such extension if (A) such L&#47;C Issuer has determined that it would not be permitted, or would have no obligation, at such time to issue such Letter of Credit in its revised form (as extended) under the terms hereof (by reason of the provisions of clause (ii) or (iii) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or otherwise), or (B) it has received notice (which may be by telephone or in writing) on or before the day that is seven Business Days before the Non-Extension Notice Date from the Administrative Agent, any Lender or the Borrower that one or more of the applicable conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is not then satisfied, and in each case directing such L&#47;C Issuer not to permit such extension.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;Promptly after its delivery of any Letter of Credit or any amendment to a Letter of Credit to an advising bank with respect thereto or to the beneficiary thereof, the relevant L&#47;C </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issuer will also deliver to the Borrower and the Administrative Agent a true and complete copy of such Letter of Credit or amendment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Drawings and Reimbursements&#59; Funding of Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;Upon receipt from the beneficiary of any Letter of Credit of any notice of drawing under such Letter of Credit, the relevant L&#47;C Issuer shall notify the Borrower and the Administrative Agent thereof.  Not later than 11&#58;00 a.m. on the date of any payment by an L&#47;C Issuer under a Letter of Credit (each such date, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Honor Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Borrower shall reimburse such L&#47;C Issuer through the Administrative Agent in an amount equal to the amount of such drawing.  If the Borrower does not reimburse such L&#47;C Issuer by such time, the Administrative Agent shall promptly notify each Lender of the Honor Date, the amount of the unreimbursed drawing (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unreimbursed Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the amount of such Lender&#8217;s Applicable Percentage thereof.  In such event, the Borrower shall be deemed to have requested a Borrowing of Base Rate Loans to be disbursed on the Honor Date in an amount equal to the Unreimbursed Amount, without regard to the minimum and multiples specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for the principal amount of Base Rate Loans, but subject to the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (other than the delivery of a Loan Notice) and provided that, after giving effect to such Borrowing, the Total Revolving Outstandings shall not exceed the Aggregate Revolving Commitments.  Any notice given by an L&#47;C Issuer or the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may be given by telephone if immediately confirmed in writing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the lack of such an immediate confirmation shall not affect the conclusiveness or binding effect of such notice.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;Each Lender shall upon any notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> make funds available (and the Administrative Agent may apply Cash Collateral provided for this purpose) to the Administrative Agent for the account of the relevant L&#47;C Issuer at the Administrative Agent&#8217;s Office in an amount equal to its Applicable Percentage of the Unreimbursed Amount not later than 1&#58;00 p.m. on the Business Day specified in such notice by the Administrative Agent, whereupon, subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Lender that so makes funds available shall be deemed to have made a Base Rate Loan to the Borrower in such amount.  The Administrative Agent shall remit the funds so received to the relevant L&#47;C Issuer.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;With respect to any Unreimbursed Amount that is not (x) fully refinanced by a Borrowing of Base Rate Loans because the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> cannot be satisfied or for any other reason or (y) otherwise reimbursed by the Borrower on the Honor Date, the Borrower shall be deemed to have incurred from the relevant L&#47;C Issuer an L&#47;C Borrowing in the amount of the Unreimbursed Amount that is not so refinanced, which L&#47;C Borrowing shall be due and payable on demand (together with interest) and shall bear interest at the Default Rate.  In such event, each Lender&#8217;s payment to the Administrative Agent for the account of the relevant L&#47;C Issuer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed payment in respect of its participation in such L&#47;C Borrowing and shall constitute an L&#47;C Advance from such Lender in satisfaction of its participation obligation under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;Until each Lender funds its Revolving Loan or L&#47;C Advance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to reimburse the relevant L&#47;C Issuer for any amount drawn under any Letter of Credit, interest in respect of such Lender&#8217;s Applicable Percentage of such amount shall be solely for the account of the relevant L&#47;C Issuer.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;Each Lender&#8217;s obligation to make Revolving Loans or L&#47;C Advances to reimburse an L&#47;C Issuer for amounts drawn under Letters of Credit, as contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Lender may have against the relevant L&#47;C Issuer, the Borrower or any other Person for any reason whatsoever&#59; (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that each Lender&#8217;s obligation to make Revolving Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is subject to the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (other than delivery by the Borrower of a Loan Notice).  No such making of an L&#47;C Advance shall relieve or otherwise impair the obligation of the Borrower </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to reimburse the relevant L&#47;C Issuer for the amount of any payment made by such L&#47;C Issuer under any Letter of Credit, together with interest as provided herein.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(vi)&#160;&#160;&#160;&#160;If any Lender fails to make available to the Administrative Agent for the account of the relevant L&#47;C Issuer any amount required to be paid by such Lender pursuant to the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the time specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then, without limiting the other provisions of this Agreement, such L&#47;C Issuer shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to such L&#47;C Issuer at a rate per annum equal to the greater of the Federal Funds Rate and a rate determined by such L&#47;C Issuer in accordance with banking industry rules on interbank compensation.  A certificate of an L&#47;C Issuer submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (vi) shall be conclusive absent manifest error.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;At any time after an L&#47;C Issuer has made a payment under any Letter of Credit and has received from any Lender such Lender&#8217;s L&#47;C Advance in respect of such payment in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if the Administrative Agent receives for the account of such L&#47;C Issuer any payment in respect of the related Unreimbursed Amount or interest thereon (whether directly from the Borrower or otherwise, including proceeds of Cash Collateral applied thereto by the Administrative Agent), the Administrative Agent will distribute to such Lender its Applicable Percentage thereof (appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender&#8217;s L&#47;C Advance was outstanding) in the same funds as those received by the Administrative Agent.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;If any payment received by the Administrative Agent for the account of an L&#47;C Issuer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is required to be returned under any of the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including pursuant to any settlement entered into by such L&#47;C Issuer in its discretion), each Lender shall pay to the Administrative Agent for the account of such L&#47;C Issuer its Applicable Percentage thereof on demand of the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> interest thereon from the date of such demand to the date such amount is returned by such Lender, at a rate per annum equal to the Federal Funds Rate from time to time in effect.  The obligations of the Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations Absolute</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligation of the Borrower to reimburse the relevant L&#47;C Issuer for each drawing under each Letter of Credit and to repay each L&#47;C Borrowing shall be absolute, unconditional and irrevocable, and shall be paid strictly in accordance with the terms of this Agreement under all circumstances, including the following&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;any lack of validity or enforceability of such Letter of Credit, this Agreement or any other Loan Document&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;the existence of any claim, counterclaim, setoff, defense or other right that the Borrower or any Subsidiary may have at any time against any beneficiary or any transferee of such Letter of Credit (or any Person for whom any such beneficiary or any such transferee may be acting), the relevant L&#47;C Issuer or any other Person, whether in connection with this Agreement, the transactions contemplated hereby or by such Letter of Credit or any agreement or instrument relating thereto, or any unrelated transaction&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;any draft, demand, certificate or other document presented under such Letter of Credit proving to be forged, fraudulent, invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect&#59; or any loss or delay in the transmission or otherwise of any document required in order to make a drawing under such Letter of Credit&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;any payment by the relevant L&#47;C Issuer under such Letter of Credit against presentation of a draft or certificate that does not strictly comply with the terms of such Letter of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Credit&#59; or any payment made by the relevant L&#47;C Issuer under such Letter of Credit to any Person purporting to be a trustee in bankruptcy, debtor-in-possession, assignee for the benefit of creditors, liquidator, receiver or other representative of or successor to any beneficiary or any transferee of such Letter of Credit, including any arising in connection with any proceeding under any Debtor Relief Law&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;any other circumstance or happening whatsoever, whether or not similar to any of the foregoing, including any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Borrower or any Subsidiary.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower shall promptly examine a copy of each Letter of Credit and each amendment thereto that is delivered to it and, in the event of any claim of noncompliance with the Borrower&#8217;s instructions or other irregularity, the Borrower will promptly notify the relevant L&#47;C Issuer.  The Borrower shall be conclusively deemed to have waived any such claim against the relevant L&#47;C Issuer and its correspondents unless such notice is given as aforesaid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Role of L&#47;C Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Lender and the Borrower agree that, in paying any drawing under a Letter of Credit, the relevant L&#47;C Issuer shall not have any responsibility to obtain any document (other than any sight draft, certificates and documents expressly required by such Letter of Credit) or to ascertain or inquire as to the validity or accuracy of any such document or the authority of the Person executing or delivering any such document.  None of the L&#47;C Issuers, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant or assignee of any L&#47;C Issuer shall be liable to any Lender for (i) any action taken or omitted in connection herewith at the request or with the approval of the Lenders or the Required Lenders, as applicable&#59; (ii) any action taken or omitted in the absence of gross negligence or willful misconduct&#59; or (iii) the due execution, effectiveness, validity or enforceability of any document or instrument related to any Letter of Credit or Issuer Document.  The Borrower hereby assumes all risks of the acts or omissions of any beneficiary or transferee with respect to its use of any Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that this assumption is not intended to, and shall not, preclude the Borrower&#8217;s pursuing such rights and remedies as it may have against the beneficiary or transferee at law or under any other agreement.  None of the L&#47;C Issuers, the Administrative Agent, any of their respective Related Parties nor any correspondent, participant or assignee of any L&#47;C Issuer shall be liable or responsible for any of the matters described in clauses (i) through (v) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that anything in such clauses to the contrary notwithstanding, the Borrower may have a claim against an L&#47;C Issuer, and such L&#47;C Issuer may be liable to the Borrower, to the extent, but only to the extent, of any direct, as opposed to consequential or exemplary, damages suffered by the Borrower which the Borrower proves were caused by such L&#47;C Issuer&#8217;s willful misconduct or gross negligence or such L&#47;C Issuer&#8217;s willful failure to pay under any Letter of Credit after the presentation to it by the beneficiary of a sight draft and certificate(s) strictly complying with the terms and conditions of a Letter of Credit unless the L&#47;C Issuer is prevented or prohibited from so paying as a result of any order or directive of any court or other Governmental Authority.  In furtherance and not in limitation of the foregoing, each L&#47;C Issuer may accept documents that appear on their face to be in order, without responsibility for further investigation, regardless of any notice or information to the contrary, and no L&#47;C Issuer shall be responsible for the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign a Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or ineffective for any reason.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicability of ISP and UCP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless otherwise expressly agreed by the relevant L&#47;C Issuer and the Borrower when a Letter of Credit is issued, (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the rules of the ISP shall apply to each standby Letter of Credit, and (ii) the rules of the Uniform Customs and Practice for Documentary Credits, as most recently published by the International Chamber of Commerce at the time of issuance, shall apply to each commercial Letter of Credit.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall pay to the Administrative Agent for the account of each Lender in accordance with its Applicable Percentage a Letter of Credit fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) for each Letter of Credit equal to the Applicable Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the daily maximum amount available to be drawn under such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any Letter of Credit Fees otherwise payable for the account of a Defaulting Lender with respect to any Letter of Credit as to which such Defaulting Lender has not provided Cash Collateral satisfactory to the relevant L&#47;C Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not be paid to such Defaulting Lender but shall be payable, to the maximum extent </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">permitted by applicable Law, to the other Lenders in accordance with the upward adjustments in their respective Applicable Percentages allocable to such Letter of Credit pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, with the balance (unless the Borrower has provided Cash Collateral to the relevant L&#47;C Issuer in an amount sufficient to remove such L&#47;C Issuer&#8217;s Fronting Exposure in respect of such Defaulting Lender remaining after giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in which case no Letter of Credit Fee shall be payable in respect of such amount sufficient to remove such Fronting Exposure) of such fee, if any, payable to the relevant L&#47;C Issuer for its own account.  For purposes of computing the daily amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Letter of Credit Fees shall be (i) computed on a quarterly basis in arrears and (ii) due and payable on the first Business Day after the end of each March, June, September and December, commencing with the first such date to occur after the issuance of such Letter of Credit, on the Maturity Date and thereafter on demand.  If there is any change in the Applicable Rate during any quarter, the daily amount available to be drawn under each Letter of Credit shall be computed and multiplied by the Applicable Rate separately for each period during such quarter that such Applicable Rate was in effect.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fronting Fee and Documentary and Processing Charges Payable to L&#47;C Issuers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower shall pay directly to each L&#47;C Issuer for its own account a fronting fee with respect to each Letter of Credit, at the rate per annum equal to 0.125%), computed on the actual daily maximum amount available to be drawn under such Letter of Credit (whether or not such maximum amount is then in effect under such Letter of Credit) and on a quarterly basis in arrears.  Such fronting fee shall be due and payable on the tenth Business Day after the end of each March, June, September and December in respect of the most recently-ended quarterly period (or portion thereof, in the case of the first payment), commencing with the first such date to occur after the issuance of such Letter of Credit, on the Maturity Date and thereafter on demand.  For purposes of computing the daily amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In addition, the Borrower shall pay directly to each L&#47;C Issuer for its own account the customary issuance, presentation, amendment and other processing fees, and other standard costs and charges, of such L&#47;C Issuer relating to letters of credit as from time to time in effect.  Such customary fees and standard costs and charges are due and payable by the Borrower promptly following receipt of a reasonably detailed invoice therefor and are nonrefundable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conflict with Issuer Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event of any conflict between the terms hereof and the terms of any Issuer Document, the terms hereof shall control.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit Issued for Subsidiaries or the Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Subsidiary or the Parent, the Borrower shall be obligated to reimburse the relevant L&#47;C Issuer hereunder for any and all drawings under such Letter of Credit.  The Borrower hereby acknowledges that the issuance of Letters of Credit for the account of Subsidiaries or the Parent inures to the benefit of the Borrower, and that the Borrower&#8217;s business derives substantial benefits from the businesses of the Parent and such Subsidiaries.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increases in Letter of Credit Sublimit and L&#47;C Fronting Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;From time to time during the term of this Agreement, the Borrower may, upon notice to the Administrative Agent (which shall promptly notify the L&#47;C Issuers and the Lenders) and subject to the terms and conditions of this Section 2.03(l), request that the L&#47;C Issuers agree to (x) increase the Letter of Credit Sublimit by an amount not to exceed $100,000,000 in the aggregate (for all such requests) and (y) increase the L&#47;C Fronting Sublimit of each L&#47;C Issuer as may be agreed between such L&#47;C Issuer and the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such requested increase in the amount of the Letter of Credit Sublimit shall be at least $5,000,000 and (ii) no more than three such requests may be made during the term of this Agreement. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;At the time of sending such notice, the Borrower (in consultation with the Administrative Agent) shall specify the time period within which each L&#47;C Issuer is requested to respond (which shall in no event be less than ten Business Days from the date of delivery of such notice to the L&#47;C Issuers). Each L&#47;C Issuer shall notify the Administrative Agent within such time period whether or not it agrees to increase the Letter of Credit Sublimit and its L&#47;C Fronting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sublimit. Any L&#47;C Issuer not responding within such time period shall be deemed to have declined to increase the Letter of Credit Sublimit and its L&#47;C Fronting Sublimit.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;The Administrative Agent shall notify the Borrower, each L&#47;C Issuer and each other Lender of the responses received to a request hereunder. If any L&#47;C Issuer agrees to increase the Letter of Credit Sublimit, then (x) each such agreeing L&#47;C Issuer and the Borrower shall determine any increase of such L&#47;C Issuer&#8217;s L&#47;C Fronting Sublimit and notify the Administrative Agent thereof and (y) the Borrower, the Administrative Agent and each such agreeing L&#47;C Issuer shall determine the effective date of any increase of the Letter of Credit Sublimit or such L&#47;C Issuer&#8217;s L&#47;C Fronting Sublimit (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Administrative Agent shall promptly notify the Borrower, the L&#47;C Issuers and the other Lenders of such increases and of the Increase Effective Date.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;As a condition precedent to any Letter of Credit Sublimit increase and L&#47;C Fronting Sublimit increase hereunder, (I) the Borrower shall deliver to the Administrative Agent a certificate dated as of the Increase Effective Date signed by a Responsible Officer certifying that, before and after giving effect to such increase, (A) the representations and warranties herein and in the other Loan Documents are true and correct in all material respects as of the Increase Effective Date, except that (i) any such representation and warranty that is qualified by materiality or a reference to Material Adverse Effect is true and correct in all respects on and as of the date of such increase and (ii) to the extent that any such representation and warranty specifically refers to an earlier date, each such representation and warranty is true and correct in all material respects as of such earlier date (except that any such representation and warranty that is qualified by materiality or reference to Material Adverse Effect is true and correct in all respects as of such earlier date), and except that for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (B) no Default exists and (II) the Guarantors, if any, shall deliver to the Administrative Agent a certificate reaffirming their obligations under this Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">L&#47;C Issuer Reports to the Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Unless otherwise agreed by the Administrative Agent, each L&#47;C Issuer shall, in addition to its notification obligations set forth elsewhere in this Section, provide the Administrative Agent a Letter of Credit Report, as set forth below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;reasonably prior to the time that such L&#47;C Issuer issues, amends, renews, increases or extends a Letter of Credit, the date of such issuance, amendment, renewal, increase or extension and the stated amount of the applicable Letters of Credit after giving effect to such issuance, amendment, renewal or extension (and whether the amounts thereof shall have changed)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;on each Business Day on which such L&#47;C Issuer makes a payment pursuant to a Letter of Credit, the date and amount of such payment&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;on any Business Day on which the Borrower fails to reimburse a payment made pursuant to a Letter of Credit required to be reimbursed to such L&#47;C Issuer on such day, the date of such failure and the amount of such payment&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;on any other Business Day, such other information as the Administrative Agent shall reasonably request as to the Letters of Credit issued by such L&#47;C Issuer&#59; and </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;for so long as any Letter of Credit issued by an L&#47;C Issuer is outstanding, such L&#47;C Issuer shall deliver to the Administrative Agent (A) on the last Business Day of each calendar month, (B) at all other times a Letter of Credit Report is required to be delivered pursuant to this Agreement, and (C) on each date that (1) an L&#47;C Credit Extension occurs or (2) there is any expiration, cancellation and&#47;or disbursement, in each case, with respect to any such Letter of Credit, a Letter of Credit Report appropriately completed with the information for every outstanding Letter of Credit issued by such L&#47;C Issuer.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions set forth herein, the Swing Line Lender, in reliance upon the agreements of the other Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, agrees to make loans (each such loan, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower in Dollars from time to time on any Business Day during the Availability Period in an aggregate amount not to exceed at any time outstanding the amount of the Swing Line Sublimit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that after giving effect to any Swing Line Loan, (i) the Total Revolving Outstandings shall not exceed the Aggregate Revolving Commitments, and (ii) the aggregate Outstanding Amount of the Revolving Loans of any Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all L&#47;C Obligations, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Lender&#8217;s Applicable Percentage of the Outstanding Amount of all Swing Line Loans shall not exceed such Lender&#8217;s Revolving Commitment, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Borrower shall not use the proceeds of any Swing Line Loan to refinance any outstanding Swing Line Loan.  Within the foregoing limits, and subject to the other terms and conditions hereof, the Borrower may borrow under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, prepay under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and reborrow under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Swing Line Loan shall be a Base Rate Loan or a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan.  Immediately upon the making of a Swing Line Loan, each Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the Swing Line Lender a risk participation in such Swing Line Loan in an amount equal to the product of such Lender&#8217;s Applicable Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the amount of such Swing Line Loan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Borrowing of Swing Line Loans shall be made upon the Borrower&#8217;s irrevocable notice to the Swing Line Lender and the Administrative Agent, which may be given by (A) telephone or (B) a Swing Line Loan Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any telephonic notice must be confirmed promptly by delivery to the Swing Line Lender and the Administrative Agent of a Swing Line Loan Notice.  Each such Swing Line Loan Notice must be received by the Swing Line Lender and the Administrative Agent not later than </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(i) for Base Rate Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2&#58;00 p.m. on the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">requested borrowing date, or (ii) for Daily Floating LIBOR Rate Loans, 12&#58;00 noon one Business Day prior to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">requested borrowing date, and shall specify (x) the amount to be borrowed, which shall be a minimum principal amount of $500,000 and integral multiples of $100,000 in excess thereof, (y) the requested borrowing date, which shall be a Business Day and (z) the Type of such Swing Line Loan.  Promptly after receipt by the Swing Line Lender of any Swing Line Loan Notice, the Swing Line Lender will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has also received such Swing Line Loan Notice and, if not, the Swing Line Lender will notify the Administrative Agent (by telephone or in writing) of the contents thereof.  Unless the Swing Line Lender has received notice (by telephone or in writing) from the Administrative Agent (including at the request of any Lender) prior to 3&#58;00 p.m. on the date of the proposed Borrowing of Swing Line Loans (A) directing the Swing Line Lender not to make such Swing Line Loan as a result of the limitations set forth in the first proviso to the first sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (B) that one or more of the applicable conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is not then satisfied, then, subject to the terms and conditions hereof, the Swing Line Lender will, not later than 4&#58;00 p.m. on the borrowing date specified in such Swing Line Loan Notice, make the amount of its Swing Line Loan available to the Borrower either by (i) crediting the account of the Borrower on the books of Bank of America with the amount of such funds or (ii) wire transfer of such funds, in each case in accordance with instructions provided to (and reasonably acceptable to) the Swing Line Lender by the Borrower.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing of Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;The Swing Line Lender at any time in its sole discretion may request, on behalf of the Borrower (which hereby irrevocably requests and authorizes the Swing Line Lender to so request on its behalf), that each Lender make a Base Rate Loan or a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, as applicable, in an amount equal to such Lender&#8217;s Applicable Percentage of the amount of Swing Line Loans then outstanding.  Such request shall be made in writing (which written request shall be deemed to be a Loan Notice for purposes hereof) and in accordance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without regard to the minimum and multiples specified therein for the principal amount of any Loans, but subject to the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (other than the delivery of a Loan Notice) and provided that, after giving effect to such Borrowing, the Total Revolving Outstandings shall not exceed the Aggregate Revolving Commitments.  The Swing Line Lender shall furnish the Borrower with a copy of the applicable Loan Notice promptly after delivering such notice to the Administrative Agent.  Each Lender </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall make an amount equal to its Applicable Percentage of the amount specified in such Loan Notice available to the Administrative Agent in immediately available funds (and the Administrative Agent may apply Cash Collateral available with respect to the applicable Swing Line Loan) for the account of the Swing Line Lender at the Administrative Agent&#8217;s Office not later than 1&#58;00 p.m. on the day specified in such Loan Notice, whereupon, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Lender that so makes funds available shall be deemed to have made a Base Rate Loan or a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan, as applicable, to the Borrower in such amount.  The Administrative Agent shall remit the funds so received to the Swing Line Lender.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;If for any reason any Swing Line Loan cannot be refinanced by such a Borrowing of Base Rate Loans or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, as applicable, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the request for Base Rate Loans or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, as applicable, submitted by the Swing Line Lender as set forth herein shall be deemed to be a request by the Swing Line Lender that each of the Lenders fund its risk participation in the relevant Swing Line Loan and each Lender&#8217;s payment to the Administrative Agent for the account of the Swing Line Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed payment in respect of such participation.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;If any Lender fails to make available to the Administrative Agent for the account of the Swing Line Lender any amount required to be paid by such Lender pursuant to the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by the time specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Swing Line Lender shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to the Swing Line Lender at a rate per annum equal to the greater of the Federal Funds Rate and a rate determined by the Swing Line Lender in accordance with banking industry rules on interbank compensation.  A certificate of the Swing Line Lender submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (iii) shall be conclusive absent manifest error.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;Each Lender&#8217;s obligation to make Revolving Loans or to purchase and fund risk participations in Swing Line Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right that such Lender may have against the Swing Line Lender, the Borrower or any other Person for any reason whatsoever, (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that each Lender&#8217;s obligation to make Revolving Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is subject to the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No such purchase or funding of risk participations shall relieve or otherwise impair the obligation of the Borrower to repay Swing Line Loans, together with interest as provided herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;At any time after any Lender has purchased and funded a risk participation in a Swing Line Loan, if the Swing Line Lender receives any payment on account of such Swing Line Loan, the Swing Line Lender will distribute to such Lender its Applicable Percentage of such payment (appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender&#8217;s risk participation was funded) in the same funds as those received by the Swing Line Lender.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;If any payment received by the Swing Line Lender in respect of principal or interest on any Swing Line Loan is required to be returned by the Swing Line Lender under any of the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including pursuant to any settlement entered into by the Swing Line Lender in its discretion), each Lender shall pay to the Swing Line Lender its Applicable Percentage thereof on demand of the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> interest thereon from the date of such demand to the date such amount is returned, at a rate per annum equal to the Federal Funds Rate.  The Administrative Agent will make such demand upon the request of the Swing Line Lender.  The obligations of the Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest for Account of Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Swing Line Lender shall be responsible for invoicing the Borrower for interest on the Swing Line Loans.  Until each Lender funds its Base Rate Loans, Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or risk participation pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to refinance such Lender&#8217;s Applicable Percentage of any Swing Line Loan, interest in respect of such Applicable Percentage shall be solely for the account of the Swing Line Lender.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Directly to Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall make all payments of principal and interest in respect of the Swing Line Loans directly to the Swing Line Lender.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower may, upon notice from the Borrower to the Administrative Agent, at any time or from time to time voluntarily prepay Revolving Loans, in whole or in part without premium or penalty&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) such notice must be in a form reasonably acceptable to the Administrative Agent and be received by the Administrative Agent not later than 11&#58;00 a.m. (1) three Business Days prior to any date of prepayment of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans and (2) on the date of prepayment of Base Rate Loans&#59; (B) any such prepayment of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans shall be in a principal amount of $2,000,000 or a whole multiple of $1,000,000 in excess thereof (or, if less, the entire principal amount thereof then outstanding)&#59; and (C) any prepayment of Base Rate Loans shall be in a principal amount of $1,000,000 or a whole multiple of $500,000 in excess thereof (or, if less, the entire principal amount thereof then outstanding).  Each such notice shall specify the date and amount of such prepayment and the Type(s) of Loans to be prepaid</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> and, if Term SOFR Loans are to be prepaid, the Interest Period(s) of such Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent will promptly notify each Lender of its receipt of each such notice, and of the amount of such Lender&#8217;s Applicable Percentage of such prepayment.  If such notice is given by the Borrower, the Borrower shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein.  Any prepayment of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan shall be accompanied by all accrued interest on the amount prepaid, together with any additional amounts required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each such prepayment shall be applied to the Loans of the Lenders in accordance with their respective Applicable Percentages.  Each notice delivered by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be irrevocable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a notice of prepayment delivered by the Borrower may state that such notice is conditioned on the occurrence of a refinancing of all or any portion of the Loans or the occurrence of any other event which would have provided the cash proceeds for such prepayment, in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified closing date of such refinancing or other such event) if such condition is not satisfied.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower may, upon notice to the Swing Line Lender (with a copy to the Administrative Agent), at any time or from time to time, voluntarily prepay Swing Line Loans in whole or in part without premium or penalty&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such notice must be received by the Swing Line Lender and the Administrative Agent not later than 1&#58;00 p.m. on the date of the prepayment, and (ii) any such prepayment shall be in a minimum principal amount of $500,000 or a whole multiple of $100,000 in excess thereof (or, if less, the entire principal thereof then outstanding).  Each such notice shall specify the date and amount of such prepayment.  If such notice is given by the Borrower, the Borrower shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Prepayments of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If for any reason the Total Revolving Outstandings at any time exceed the Aggregate Revolving Commitments then in effect, the Borrower shall promptly, and in any event within one (1) Business Day, prepay Revolving Loans and&#47;or the Swing Line Loans and&#47;or Cash Collateralize the L&#47;C Obligations in an aggregate amount equal to such excess&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Borrower shall not be required to Cash Collateralize the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">L&#47;C Obligations pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> unless after the prepayment in full of the Revolving Loans and the Swing Line Loans the Total Revolving Outstandings exceed the Aggregate Revolving Commitments then in effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Application of Mandatory Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All amounts required to be paid pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be applied ratably to Revolving Loans and Swing Line Loans and (after all Revolving Loans and Swing Line Loans have been repaid) to Cash Collateralize L&#47;C Obligations.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Within the parameters of the applications set forth above, prepayments shall be applied first to Base Rate Loans, then to Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans and then to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans in direct order of Interest Period maturities.  All prepayments under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.05(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, but otherwise without premium or penalty, and shall be accompanied by interest on the principal amount prepaid through the date of prepayment.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination or Reduction of Aggregate Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Optional Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower may, upon notice to the Administrative Agent, terminate the Aggregate Revolving Commitments, or from time to time permanently reduce the Aggregate Revolving Commitments to an amount not less than the Outstanding Amount of Revolving Loans, Swing Line Loans and L&#47;C Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) any such notice shall be received by the Administrative Agent not later than 12&#58;00 noon three (3) Business Days prior to the date of termination or reduction, (ii) any such partial reduction shall be in an aggregate amount of $2,000,000 or any whole multiple of $1,000,000 in excess thereof and (iii) the Borrower shall not terminate or reduce (A) the Aggregate Revolving Commitments if, after giving effect thereto and to any concurrent prepayments hereunder, the Total Revolving Outstandings would exceed the Aggregate Revolving Commitments, (B) the Letter of Credit Sublimit if, after giving effect thereto, the Outstanding Amount of L&#47;C Obligations not fully Cash Collateralized hereunder would exceed the Letter of Credit Sublimit, or (C) the Swing Line Sublimit if, after giving effect thereto and to any concurrent prepayments hereunder, the Outstanding Amount of Swing Line Loans would exceed the Swing Line Sublimit. Each notice delivered by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be irrevocable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a notice of termination of the Aggregate Revolving Commitments delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities (including, without limitation, credit facilities evidenced by a credit agreement or an indenture), in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to the specified effective date) if such condition is not satisfied.&#160; Any termination or reduction of the Aggregate Revolving Commitments pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be permanent.&#160; Each reduction of the Aggregate Revolving Commitments pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be made to the Revolving Commitments of the Lenders in accordance with their Applicable Percentage.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If after giving effect to any reduction or termination of Revolving Commitments under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Letter of Credit Sublimit or the Swing Line Sublimit exceed the Aggregate Revolving Commitments at such time, the Letter of Credit Sublimit or the Swing Line Sublimit, as the case may be, shall be automatically reduced by the amount of such excess.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent will promptly notify the Lenders of any termination or reduction of the Letter of Credit Sublimit, Swing Line Sublimit or the Aggregate Revolving Commitments under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon any reduction of the Aggregate Revolving Commitments, the Revolving Commitment of each Lender shall be reduced by such Lender&#8217;s Applicable Percentage of such reduction amount.  All fees in respect of the Aggregate Revolving Commitments accrued until the effective date of any termination of the Aggregate Revolving Commitments shall be paid on the effective date of such termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repayment of Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall repay to the Lenders on the Maturity Date the aggregate principal amount of all Revolving Loans outstanding on such date.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall repay each Swing Line Loan on the earliest to occur of (i) the date within one (1) Business Day of demand therefor by the Swing Line Lender, (ii) the date that is ten (10) Business Days after the date such Swing Line Loan is made and (iii) the Maturity Date.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Subject to the provisions of subsection (b) below, (i) each </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan shall bear interest on the outstanding principal amount thereof for each Interest Period at a rate per annum equal to the sum of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for such Interest Period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate, (ii) each Base Rate Loan shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (iii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">) each Daily Simple SOFR Loan shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to Daily Simple SOFR plus the Applicable Rate and (iv</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) each Swing Line Loan shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the Base Rate or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Applicable Rate.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;If any amount hereunder is not paid when due (after giving effect to any applicable grace periods), whether at stated maturity, by acceleration or otherwise, then such amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable Laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii)&#160;&#160;&#160;&#160;Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be due and payable upon demand.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Interest on each Loan shall be due and payable in arrears on each Interest Payment Date applicable thereto and at such other times as may be specified herein.  Interest hereunder shall be due and payable in accordance with the terms hereof before and after judgment, and before and after the commencement of any proceeding under any Debtor Relief Law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In addition to certain fees described in subsections (h) and (i) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall pay to the Administrative Agent, for the account of each Lender in accordance with its Applicable Percentage, a facility fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at a rate per annum equal to the product of (i) the Applicable Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the actual daily amount of the Aggregate Revolving Commitments (or, if the Aggregate Revolving Commitments have terminated, on the Outstanding Amount of all Loans and L&#47;C Obligations), regardless of usage, subject to adjustment as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Facility Fee shall accrue at all times during the Availability Period, including at any time during which one or more of the conditions in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is not met, and shall be due and payable quarterly in arrears on the last Business Day of each March, June, September and December, commencing with the first such date to occur after the Third Amendment and Restatement Effective Date, and on the Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (A) no Facility Fee shall accrue on the Revolving Commitment of a Defaulting Lender so long as such Lender shall be a Defaulting Lender and (B) any Facility Fee accrued with respect to the Revolving Commitment of a Defaulting Lender during the period prior to the time such Lender became a Defaulting Lender and unpaid at such time shall not be payable by the Borrower so long as such Lender shall be a Defaulting Lender.  The Facility Fee shall be calculated quarterly in arrears, and if there is any change in the Applicable Rate during any quarter, the actual daily amount shall be computed and multiplied by the Applicable Rate separately for each period during such quarter that such Applicable Rate was in effect.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall pay to the Joint Lead Arrangers and the Administrative Agent for their own respective accounts fees in the amounts and at the times specified in the Facilities Fee Letter.  Such fees shall be fully earned when paid and shall be non-refundable for any reason whatsoever.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Computation of Interest and Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All computations of interest for Base Rate Loans (including Base Rate Loans determined by reference to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) shall be made on the basis of a year of 365 or 366 days, as the case may be, and actual days elapsed.  All other computations of fees and interest shall be made on the basis of a 360-day year and actual days elapsed (which results in more fees or interest, as applicable, being paid than if computed on the basis of a 365-day year).  Interest shall accrue on each Loan for the day on which the Loan is made, and shall not accrue on a Loan, or any portion thereof, for the day on which the Loan or such portion is paid, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any Loan that is repaid on the same day on which it is made shall, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, bear interest for one day.  Each determination by the Administrative Agent of an interest rate or fee hereunder shall be conclusive and binding for all purposes, absent manifest error.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Evidence of Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Credit Extensions made by each Lender shall be evidenced by one or more accounts or records maintained by such Lender and by the Administrative Agent in the ordinary course of business.  The accounts or records maintained by the Administrative Agent and each Lender shall be conclusive absent manifest error of the amount of the Credit Extensions made by the Lenders to the Borrower and the interest and payments thereon.  Any failure to so record or any error in doing so shall not, however, limit or otherwise affect the obligation of the Borrower hereunder to pay any amount owing with respect to the Obligations.  In the event of any conflict between the accounts and records maintained by any Lender and the accounts and records of the Administrative Agent in respect of such matters, the accounts and records of the Administrative Agent shall control in the absence of manifest error.  Upon the request of any Lender made through the Administrative Agent, the Borrower shall execute and deliver to such Lender (through the Administrative Agent) a promissory note, which shall evidence such Lender&#8217;s Loans in addition to such accounts or records.  Each such promissory note shall (i) in the case of Revolving Loans, be in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) in the case of Swing Line Loans, be in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swing Line Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Each Lender may attach schedules to its Note and endorse thereon the date, Type (if applicable), amount and maturity of its Loans and payments with respect thereto.  Promptly following the written request to a Lender by the Borrower upon the termination of this Agreement, such Lender shall use commercially reasonable efforts to (i) return to the Borrower each Note issued to it, or (ii) in the case of any loss, theft or destruction of any such Note, a customary lost note affidavit in form and substance reasonably satisfactory to the Borrower.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In addition to the accounts and records referred to in subsection (a), each Lender and the Administrative Agent shall maintain in accordance with its usual practice accounts or records evidencing the obligations of such Lender in respect of participations in Letters of Credit and Swing Line Loans.  In the event of any conflict between the accounts and records maintained by the Administrative Agent and the accounts and records of any Lender in respect of such matters, the accounts and records of the Administrative Agent shall control in the absence of manifest error.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Generally&#59; Administrative Agent&#8217;s Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All payments to be made by a Loan Party shall be made without condition or deduction for any counterclaim, defense, recoupment or setoff.  Except as otherwise expressly provided herein, all payments by a Loan Party hereunder shall be made to the Administrative Agent, for the account of the respective Lenders to which such payment is owed, at the Administrative Agent&#8217;s Office in Dollars and in immediately available funds not later than 2&#58;00 p.m. on the date specified herein.  The Administrative Agent will promptly distribute to each Lender its Applicable Percentage (or other applicable share as provided herein) of such payment in like funds as received by wire transfer to such Lender&#8217;s Lending Office.  All payments received by the Administrative Agent after 2&#58;00 p.m. shall be deemed received on the next succeeding Business Day and any applicable interest or fee shall continue to accrue.  Subject to the definition of &#8220;Interest Period&#8221;, if any payment to be made by a Loan Party shall come due on a day other than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;(i)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funding by Lenders&#59; Presumption by Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrowing of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans (or, in the case of any Borrowing of Base Rate Loans, prior to 12&#58;00 noon on the date of such Borrowing) that such Lender will not make available to the Administrative Agent such Lender&#8217;s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or, in the case of any Borrowing of Base Rate Loans, that such Lender has made such share available in accordance with and at the time required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and may, in reliance upon such assumption, make available to the Borrower a corresponding amount.  In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on demand such corresponding amount in immediately available funds with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (A) in the case of a payment to be made by such Lender, the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation and (B) in the case of a payment to be made by the Borrower, the interest rate applicable to Base Rate Loans.  If the Borrower and such Lender shall pay such interest to the Administrative Agent for the same or an overlapping period, the Administrative Agent shall promptly remit to the Borrower the amount of such interest paid by the Borrower for such period.  If such Lender pays its share of the applicable Borrowing to the Administrative Agent, then the amount so paid shall constitute such Lender&#8217;s Loan included in such Borrowing.  Any payment by the Borrower shall be without prejudice to any claim the Borrower may have against a Lender that shall have failed to make such payment to the Administrative Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments by Borrower&#59; Presumptions by Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or the L&#47;C Issuers hereunder that the applicable Loan Party will not make such payment, the Administrative Agent may assume that such Loan Party has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or the L&#47;C Issuers, as the case may be, the amount due.  With respect to any payment that the Administrative Agent makes for the account of the Lenders or the L&#47;C Issuers hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58; (1) a Loan Party has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by such Loan Party (whether or not then owed)&#59; or (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the L&#47;C Issuers, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender or the L&#47;C Issuers, in immediately available funds with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A notice of the Administrative Agent to any Lender or the Borrower with respect to any amount owing under this subsection (b) shall be conclusive, absent manifest error.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Failure to Satisfy Conditions Precedent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Lender makes available to the Administrative Agent funds for any Loan to be made by such Lender as provided in the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and such funds are not made available to the Borrower by the Administrative Agent because the conditions to the applicable Credit Extension set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender, without interest.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations of Lenders Several</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations of the Lenders hereunder to make Loans, to fund participations in Letters of Credit and Swing Line Loans and to make payments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are several and not joint.  The failure of any Lender to make any Loan, to fund any such participation or to make any payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no Lender shall be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">responsible for the failure of any other Lender to so make its Loan, to purchase its participation or to make its payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funding Source</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sharing of Payments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any Lender shall, by exercising any right of setoff or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of the Loans made by it, or the participations in L&#47;C Obligations or in Swing Line Loans held by it (excluding any amounts applied by the Swing Line Lender to outstanding Swing Line Loans) resulting in such Lender&#8217;s receiving payment of a proportion of the aggregate amount of such Loans or participations and accrued interest thereon greater than its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> share thereof as provided herein, then the Lender receiving such greater proportion shall (a) notify the Administrative Agent of such fact, and (b) purchase (for cash at face value) participations in the Loans and subparticipations in L&#47;C Obligations and Swing Line Loans of the other Lenders, or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Loans and other amounts owing them, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;if any such participations or subparticipations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations or subparticipations shall be rescinded and the purchase price restored to the extent of such recovery, without interest&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the provisions of this Section shall not be construed to apply to (x) any payment made by or on behalf of a Loan Party pursuant to and in accordance with the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender), (y) the application of Cash Collateral provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or subparticipations in L&#47;C Obligations or Swing Line Loans to any assignee or participant, other than an assignment to the Company or any Subsidiary thereof (as to which the provisions of this Section shall apply).</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower consents to the foregoing and agrees, to the extent it may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower rights of setoff and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Credit Support Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon the request of the Administrative Agent or the relevant L&#47;C Issuer (i) if such L&#47;C Issuer has honored any full or partial drawing request under any Letter of Credit and such drawing has resulted in an L&#47;C Borrowing or (ii) if, as of the Letter of Credit Expiration Date, any L&#47;C Obligation for any reason remains outstanding, the Borrower shall, in each case, promptly Cash Collateralize the then Outstanding Amount of all L&#47;C Obligations.  At any time that there shall exist a Defaulting Lender, promptly upon the request of the Administrative Agent, the L&#47;C Issuers or the Swing Line Lender, the Borrower shall deliver to the Administrative Agent Cash Collateral in an amount sufficient to cover all Fronting Exposure (after giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and any Cash Collateral provided by the Defaulting Lender).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Security Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All Cash Collateral (other than credit support not constituting funds subject to deposit) shall be maintained in blocked, non-interest bearing deposit accounts at the Administrative Agent.  The Borrower, and to the extent provided by any Lender, such Lender, hereby grants to (and subjects to the control of) the Administrative Agent, for the benefit of the Administrative Agent, the L&#47;C Issuers and the Lenders (including the Swing Line Lender) and agrees to maintain, a first priority security interest in all such cash, deposit accounts and all balances therein, and all other property so provided as collateral pursuant hereto, and in all proceeds of the foregoing, all as security for the obligations to which such Cash Collateral may be applied pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If at any time the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent determines that Cash Collateral is subject to any right or claim of any Person other than the Administrative Agent as herein provided, or that the total amount of such Cash Collateral is less than the applicable Fronting Exposure and other obligations secured thereby, the Borrower will, promptly upon demand by the Administrative Agent, pay or provide to the Administrative Agent additional Cash Collateral in an amount sufficient to eliminate such deficiency.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained in this Agreement, Cash Collateral provided under any of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in respect of Letters of Credit or Swing Line Loans shall be held and applied in satisfaction of the specific L&#47;C Obligations, Swing Line Loans, obligations to fund participations therein (including, as to Cash Collateral provided by a Defaulting Lender, any interest accrued on such obligation) and other obligations for which the Cash Collateral was so provided, prior to any other application of such property as may be provided herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Cash Collateral (or the appropriate portion thereof) provided to reduce Fronting Exposure or other obligations shall be released promptly following (i) the elimination of the applicable Fronting Exposure or other obligations giving rise thereto (including by the termination of Defaulting Lender status of the applicable Lender) or (ii) the good faith determination of the Administrative Agent  and the L&#47;C Issuers (which determination shall not be unreasonably withheld or delayed) that there exists excess Cash Collateral (including following the Borrower&#8217;s request)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (x) that Cash Collateral furnished by or on behalf of the Borrower shall not be released during the continuance of a Default or Event of Default (and following application as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may be otherwise applied in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and (y) the Person providing Cash Collateral and the L&#47;C Issuers or Swing Line Lender, as applicable, may agree that Cash Collateral shall not be released but instead held to support future anticipated Fronting Exposure or other obligations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as that Lender is no longer a Defaulting Lender, to the extent permitted by applicable Law&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Waivers and Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Defaulting Lender&#8217;s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reallocation of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any payment of principal, interest, fees or other amount received by the Administrative Agent for the account of that Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or otherwise, and including any amounts made available to the Administrative Agent by that Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), shall be applied at such time or times as may be determined by the Administrative Agent as follows&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of any amounts owing by that Defaulting Lender to the Administrative Agent hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis of any amounts owing by that Defaulting Lender to any L&#47;C Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if so determined by the Administrative Agent or requested by any L&#47;C Issuer or Swing Line Lender, to be held as Cash Collateral for future funding obligations of that Defaulting Lender of any participation in any Swing Line Loan or Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as the Borrower may request (so long as no Default or Event of Default exists), to the funding of any Loan in respect of which that Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if so determined by the Administrative Agent and the Borrower, to be held in a non-interest bearing deposit account and released in order to satisfy obligations of that Defaulting Lender to fund Loans under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of any amounts owing to the Lenders, the L&#47;C Issuers or Swing Line Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender, L&#47;C Issuer or Swing Line Lender against that Defaulting Lender as a result of that Defaulting Lender&#8217;s breach of its obligations under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, so long as no Default or Event of Default exists, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against that Defaulting Lender as a result of that Defaulting Lender&#8217;s breach of its obligations under this Agreement&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to that Defaulting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if (x) such payment is a payment of the principal amount of any Loans or L&#47;C Borrowings in respect of which that Defaulting Lender has not fully funded its appropriate share and (y) such Loans or L&#47;C Borrowings were made at a time when the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> were satisfied or waived, such payment shall be applied solely to the pay the Loans of, and L&#47;C Borrowings owed to, all non-Defaulting Lenders on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis prior to being applied to the payment of any Loans of, or L&#47;C Borrowings owed to, that Defaulting Lender.  Any payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post Cash Collateral pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed paid to and redirected by that Defaulting Lender, and each Lender irrevocably consents hereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;Each Defaulting Lender shall be entitled to receive Facility Fees for any period during which such Lender is a Defaulting Lender only to the extent allocable to the sum of (1) the outstanding principal amount of the Loans funded by it and (2) its Applicable Percentage of the stated amount of Letters of Credit for which it has provided Cash Collateral pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;Each Defaulting Lender shall be entitled to receive Letter of Credit Fees for any period during which that Lender is a Defaulting Lender only to the extent allocable to its Applicable Percentage of the stated amount of Letters of Credit for which it has provided Cash Collateral pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;With respect to any Facility Fee or any Letter of Credit Fee, in each case, not required to be paid to any Defaulting Lender pursuant to clause (A) or (B) above, the Borrower shall (x) pay to any non-Defaulting Lender that portion of any such fee otherwise payable to such Defaulting Lender with respect to such Defaulting Lender&#8217;s participation in Swing Line Loans or L&#47;C Obligations that has been reallocated to such non-Defaulting Lender pursuant to clause (iv) below, (y) pay to the L&#47;C Issuers and Swing Line Lender, as applicable, the amount of any such fee otherwise payable to such Defaulting Lender to the extent allocable to each L&#47;C Issuer&#8217;s or the Swing Line Lender&#8217;s Fronting Exposure to such Defaulting Lender and (z) not be required to pay the remaining amount of any such fee.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reallocation of Applicable Percentages to Reduce Fronting Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  During any period in which there is a Defaulting Lender, for purposes of computing the amount of the obligation of each non-Defaulting Lender to acquire, refinance or fund participations in Letters of Credit or Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the &#8220;Applicable Percentage&#8221; of each non-Defaulting Lender shall be computed without giving effect to the Commitment of that Defaulting Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (x) each such reallocation shall be given effect only if, at the date the applicable Lender becomes a Defaulting Lender, (I) no Default or Event of Default exists and (II) the condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is satisfied at such time (and, unless the Borrower shall have otherwise notified the Administrative Agent at such time, the Borrower shall be deemed to have represented and warranted that such condition is satisfied at such time)&#59; and (y) the aggregate obligation of each non-Defaulting Lender to acquire, refinance or fund participations in Letters of Credit and Swing Line Loans shall not exceed the positive difference, if any, of (1) the Commitment of that non-Defaulting Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (2) the aggregate Outstanding Amount of the Revolving Loans of that Lender.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender Cure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the Borrower, the Administrative Agent, Swing Line Lender and the L&#47;C Issuers agree in writing in their sole discretion that a Defaulting Lender should no longer be deemed to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any Cash Collateral), that Lender will, to the extent applicable, purchase at par that portion of outstanding Loans of the other Lenders or take such other actions as the Administrative Agent may determine to be necessary to cause the Revolving Loans and funded and unfunded participations in Letters of Credit and Swing Line Loans to be held on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lenders in accordance with their Applicable Percentages (without giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15(a)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), whereupon that Lender will cease to be a Defaulting Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrower while that Lender was a Defaulting Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender having been a Defaulting Lender.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Permitted Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Borrower may, by written notice to the Administrative Agent from time to time beginning on the date that is 18 months after the Third Amendment and Restatement Effective Date, but not more than three times during the term of this Agreement (and with no more than one such offer outstanding at any one time), make one or more offers (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Modification Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to all the Lenders to make one or more Permitted Amendments pursuant to procedures reasonably specified by the Administrative Agent and reasonably acceptable to the Borrower.  Such notice shall set forth (i) the terms and conditions of the requested Permitted Amendment and (ii) the date on which such Permitted Amendment is requested to become effective.  Notwithstanding anything to the contrary in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Permitted Amendment shall only require the consent of the Loan Parties, the Administrative Agent and those Lenders that accept the applicable Loan Modification Offer (such Lenders, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Accepting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and each Permitted Amendment shall become effective only with respect to the Loans and Commitments of the Accepting Lenders.  In connection with any Loan Modification Offer, the Borrower may, at its sole option, with respect to one or more of the Lenders that are not Accepting Lenders (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Accepting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) replace such Non-Accepting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon the effectiveness of any Permitted Amendment and any assignment of any Non-Accepting Lender&#8217;s Commitments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, subject to the payment of applicable amounts pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in connection therewith, the Borrower shall be deemed to have made such borrowings and repayments of the Loans, and the Lenders shall make such adjustments of outstanding Loans between and among them, as shall be necessary to effect the reallocation of the Commitments such that, after giving effect thereto, the Loans shall be held by the Lenders (including the Eligible Assignees as the new Lenders) ratably in accordance with their Commitments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;The Loan Parties and each Accepting Lender shall execute and deliver to the Administrative Agent a Loan Modification Agreement and such other documentation as the Administrative Agent shall reasonably specify to evidence the acceptance of the Permitted Amendments and the terms and conditions thereof.  The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Loan Modification Agreement.  Each of the parties hereto hereby agrees that, upon the effectiveness of any Loan Modification Agreement, this Agreement shall be deemed amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Permitted Amendment evidenced thereby and only with respect to the Loans and Commitments of the Accepting Lenders, including any amendments necessary to treat the applicable Loans and&#47;or Commitments of the Accepting Lenders as a new &#8220;Class&#8221; or &#8220;Tranche&#8221; of loans and&#47;or commitments hereunder.  Notwithstanding the foregoing, no Permitted Amendment shall become effective unless the Administrative Agent, to the extent reasonably requested by the Administrative Agent, shall have received legal opinions, board resolutions, officer&#8217;s and secretary&#8217;s certificates and other documentation consistent with those delivered on the Third Amendment and Restatement Effective Date under this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any or all of the following&#58; (i) an extension of the Maturity Date applicable solely to the Loans and&#47;or Commitments of the Accepting Lenders, (ii) an increase in the interest rate with respect to the Loans and&#47;or Commitments of the Accepting Lenders, (iii) the inclusion of additional fees to be payable to the Accepting Lenders in connection with the Permitted Amendment (including any commitment fees and upfront fees), (iv) such amendments to this Agreement and the other Loan Documents as shall be appropriate, in the reasonable judgment of the Administrative Agent, to provide the rights and benefits of this Agreement and other Loan Documents to each new &#8220;Class&#8221; or &#8220;Tranche&#8221; of loans and&#47;or commitments resulting therefrom, provided that payments of principal and interest on Loans (including Loans of Accepting Lenders) shall continue to be shared pro rata in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, except that notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Loans and Commitments of the Non-Accepting Lenders may be repaid and terminated on their applicable Maturity Date, without any pro rata reduction of the commitments and repayment of Loans of Accepting Lenders </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with a different Maturity Date and (v) such other amendments to this Agreement and the other Loan Documents as shall be appropriate, in the reasonable judgment of the Administrative Agent, to give effect to the foregoing Permitted Amendments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall supersede any provision in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the contrary.  Notwithstanding any reallocation into extending and non-extending &#8220;Classes&#8221; or &#8220;Tranches&#8221; in connection with a Permitted Amendment, all Loans to the Borrower under this Agreement shall rank pari-passu in right of payment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE III<br><br>TAXES, YIELD PROTECTION AND ILLEGALITY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Free of Taxes&#59; Obligation to Withhold&#59; Payments on Account of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (i) Any and all payments by or on account of any obligation of the Loan Parties hereunder or under any other Loan Document shall to the extent permitted by applicable Laws be made free and clear of and without reduction or withholding for any Taxes.  If, however, applicable Laws require a Loan Party or the Administrative Agent to withhold or deduct any Tax, such Tax shall be withheld or deducted in accordance with such Laws as determined by the Borrower or the Administrative Agent, as the case may be, upon the basis of the information and documentation to be delivered pursuant to subsection (e) below. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;If a Loan Party or the Administrative Agent shall be required to withhold or deduct any Taxes, including both United States Federal backup withholding and withholding Taxes, from any payment, then (A) the Administrative Agent shall withhold or make such deductions as are determined by the Administrative Agent to be required based upon the information and documentation it has received pursuant to subsection (e) below, (B) the Administrative Agent shall timely pay the full amount withheld or deducted to the relevant Governmental Authority, and (C) to the extent that the withholding or deduction is made on account of Indemnified Taxes or Other Taxes, the sum payable by a Loan Party shall be increased as necessary so that after any required withholding or the making of all required deductions (including deductions applicable to additional sums payable under this Section) the Administrative Agent, Lender or L&#47;C Issuer, as the case may be, receives an amount equal to the sum it would have received had no such withholding or deduction been made.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Other Taxes by the Borrower.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Without limiting the provisions of subsection (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable Law.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Indemnifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (i) Without limiting the provisions of subsection (a) or (b) above, the Loan Parties shall, and do hereby, indemnify the Administrative Agent, each Lender and each L&#47;C Issuer, and shall make payment in respect thereof within 10 days after demand therefor, for the full amount of any Indemnified Taxes or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this Section) withheld or deducted by a Loan Party or the Administrative Agent paid by the Administrative Agent, such Lender or such L&#47;C Issuer, as the case may be, and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that such indemnity shall not, as to any indemnitee, be available to the extent that the imposition of such Taxes is determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such indemnitee.  The Loan Parties shall also, and do hereby, indemnify the Administrative Agent, and shall make payment in respect thereof within 10 days after demand therefor, for any amount which a Lender or L&#47;C Issuer for any reason fails to pay indefeasibly to the Administrative Agent as required by clause (ii) of this subsection.  A certificate as to the amount of any such payment or liability delivered to a Loan Party by a Lender or L&#47;C Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender or L&#47;C Issuer, shall be conclusive absent manifest error.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Without limiting the provisions of subsection (a) or (b) above, each Lender and L&#47;C Issuer shall, and does hereby, indemnify the Loan Parties and the Administrative Agent, and shall make payment in respect thereof within 10 days after demand therefor, against any and all Taxes and any and all related losses, claims, liabilities, penalties, interest and expenses (including the fees, charges and disbursements of any counsel for the Borrower or the Administrative Agent) incurred by or asserted against the Loan Parties or the Administrative Agent by any Governmental Authority as a result of the failure by such Lender or L&#47;C Issuer, as the case may be, to deliver, or as a result of the inaccuracy, inadequacy or deficiency of, any documentation required to be delivered by such Lender or L&#47;C Issuer, as the case may be, to the Loan Parties or the Administrative Agent pursuant to subsection (e).  Each Lender and L&#47;C Issuer hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender or L&#47;C Issuer, as the case may be, under this Agreement or any other Loan Document against any amount due to the Administrative Agent under this clause (ii).  The agreements in this clause (ii) shall survive the resignation and&#47;or replacement of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender or L&#47;C Issuer, the termination of the Aggregate Revolving Commitments and the repayment, satisfaction or discharge of all other Obligations.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon request by the Borrower or the Administrative Agent, as the case may be, after any payment of Taxes by the Borrower or by the Administrative Agent to a Governmental Authority as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall deliver to the Administrative Agent or the Administrative Agent shall deliver to the Borrower, as the case may be, the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of any return required by Laws to report such payment or other evidence of such payment reasonably satisfactory to the Borrower or the Administrative Agent, as the case may be.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Status of Lenders&#59; Tax Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (i) Each Lender shall deliver to the Borrower and to the Administrative Agent, at the time or times prescribed by applicable Laws or when reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by applicable Laws or by the taxing authorities of any jurisdiction and such other reasonably requested information as will permit the Borrower or the Administrative Agent, as the case may be, to determine (A) whether or not payments made hereunder or under any other Loan Documents are subject to Taxes, (B) if applicable, the required rate of withholding or deduction, and (C) such Lender&#8217;s entitlement to any available exemption from, or reduction of, applicable Taxes in respect of all payments to be made to such Lender by the Borrower pursuant to this Agreement or otherwise to establish such Lender&#8217;s status for withholding tax purposes in the applicable jurisdiction.  Notwithstanding anything to the contrary in the previous sentence, the completion, execution and submission of such documentation (other than such documentation set forth in paragraphs (e)(ii)(A), (ii)(B)(I) through (ii)(B)(IV) and (ii)(C) of this Section) shall not be required if in the Lender&#8217;s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Without limiting the generality of the foregoing, if the Borrower is resident for tax purposes in the United States, </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;any Lender that is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Internal Revenue Code shall deliver to the Borrower and the Administrative Agent executed copies of Internal Revenue Service Form W-9 or such other documentation or information prescribed by applicable Laws or reasonably requested by the Borrower or the Administrative Agent certifying that such Lender is exempt from U.S. federal backup withholding&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;each Foreign Lender that is entitled under the Internal Revenue Code or any applicable treaty to an exemption from or reduction of withholding Tax with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(I)&#160;&#160;&#160;&#160;executed copies of Internal Revenue Service Form W-8BEN or Form W-8BEN-E, as applicable, claiming eligibility for benefits of an income tax treaty to which the United States is a party,</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(II)&#160;&#160;&#160;&#160;executed copies of Internal Revenue Service Form W-8ECI,</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(III)&#160;&#160;&#160;&#160;executed copies of Internal Revenue Service Form W-8IMY and all required supporting documentation, </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IV) &#160;&#160;&#160;&#160;in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under section 881(c) of the Internal Revenue Code, (x) a certificate to the effect that such Foreign Lender is not (A) a &#8220;bank&#8221; within the meaning of section 881(c)(3)(A) of the Internal Revenue Code, (B) a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of section 881(c)(3)(B) of the Internal Revenue Code, or (C) a &#8220;controlled foreign corporation&#8221; described in section 881(c)(3)(C) of the Internal Revenue Code and (y) executed copies of  Internal Revenue Service Form W-8BEN or Form W-8BEN-E, as applicable, or</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(V)&#160;&#160;&#160;&#160;executed copies of any other form prescribed by applicable Laws as a basis for claiming exemption from or a reduction in United States Federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower or the Administrative Agent to determine the withholding or deduction required to be made&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment.  Solely for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(e)(ii)(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;Each Lender shall promptly (A) notify the Borrower and the Administrative Agent of any change in circumstances which would modify or render invalid any claimed Tax exemption or Tax reduction, and (B) take such steps as shall not be materially disadvantageous to it, in the reasonable judgment of such Lender, and as may be reasonably necessary (including the re-designation of its Lending Office) to avoid any requirement of applicable Laws of any jurisdiction that the Borrower or the Administrative Agent make any withholding or deduction for Taxes from amounts payable to such Lender.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)  Each Lender agrees that if any form or certification it previously delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless required by applicable Laws, at no time shall the Administrative Agent have any obligation to file for or otherwise pursue on behalf of a Lender or L&#47;C Issuer, or have any obligation to pay to any Lender or L&#47;C Issuer, any refund of Taxes withheld or deducted from funds paid for the account of such Lender or L&#47;C Issuer, as the case may be. If the Administrative Agent, any Lender or L&#47;C Issuer determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes or Other Taxes as to which it has been indemnified by the Loan Parties or with respect to which a Loan Party has paid additional amounts pursuant to this Section, it shall pay to such Loan Party an amount equal to such refund (but only to the extent of indemnity payments </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">made, or additional amounts paid, by such Loan Party under this Section with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses incurred by the Administrative Agent, such Lender or L&#47;C Issuer, as the case may be, and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that each Loan Party, upon the request of the Administrative Agent, such Lender or L&#47;C Issuer, agrees to repay the amount paid over to such Loan Party (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or L&#47;C Issuer in the event the Administrative Agent, such Lender or L&#47;C Issuer is required to repay such refund to such Governmental Authority.  This subsection shall not be construed to require the Administrative Agent, any Lender or L&#47;C Issuer to make available its Tax returns (or any other information relating to its taxes that it deems confidential) to the Loan Parties or any other Person.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For purposes of determining withholding taxes imposed under FATCA, from and after the Third Amendment and Restatement Effective Date, the Borrower and the Administrative Agent shall treat (and the Lenders hereby authorize the Administrative Agent to treat) the Agreement as not qualifying as a &#8220;grandfathered obligation&#8221; within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Illegality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund Loans whose interest is determined by reference to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate or the Daily Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR, Term SOFR or Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or to determine or charge interest rates based upon </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate or the Daily Floating LIBOR Rate, or any Governmental Authority has imposed material restrictions on the authority of such Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR, Term SOFR or Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">upon</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> notice thereof by such Lender to the Borrower </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">through the Administrative Agent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (i) any obligation of such Lender to make or continue </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or to convert Base Rate Loans to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans shall be suspended</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) if such notice asserts the illegality of such Lender making or maintaining Base Rate Loans the interest rate on which is determined by reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Base Rate, the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Base Rate, in each case until such Lender notifies the Administrative Agent and the Borrower that the circumstances giving rise to such determination no longer exist.  Upon receipt of such notice, (x)&#160;the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), (1) promptly prepay or, if applicable, convert all Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans to Base Rate Loans (the interest rate on which Base Rate Loans shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Base Rate) and (2) prepay or, if applicable, convert all </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans of such Lender to Base Rate Loans (the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Base Rate), either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to such day, or immediately, if such Lender may not lawfully continue to maintain such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (y) if such notice asserts the illegality of such Lender determining or charging interest rates based upon </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall during the period of such suspension compute the Base Rate applicable to such Lender without reference to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon any such prepayment or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, together with any additional amounts required pursuant to Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Inability to Determine Rates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If in connection with any request for a Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">a Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan or a conversion to or </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">continuation thereof, (i) the Administrative Agent determines </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">that (A) Dollar deposits are not being offered to banks in the London interbank </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">eurodollar market for the applicable amount and Interest Period (in the case of a Eurodollar Rate Loan)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(which determination shall be conclusive absent manifest error) that (A) no Successor Rate has been determined in accordance with Section 3.03(b), and the circumstances under clause (i) of Section 3.03(b) or the Scheduled Unavailability Date has occurred</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (B) </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(x) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">adequate and reasonable means do not </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">otherwise </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">exist for determining </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Eurodollar Base Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR for any determination date or Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for any requested Interest Period with respect to a proposed </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR  Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or in connection with an existing or proposed Base Rate Loan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> and (y) the circumstances described in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> do not apply (in each case with respect to this clause (i), &#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Impacted Loans</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or (ii) the Administrative Agent or the Required Lenders determine </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">that </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for any reason </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to a proposed Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate Loan or the Eurodollar Base Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR Loan or that Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for any requested Interest Period with respect to a proposed </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan, as applicable, does not adequately and fairly reflect the cost to such Lenders of funding such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Daily Floating LIBOR Rate Loan or Eurodollar Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">as applicable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Administrative Agent will promptly so notify the Borrower and </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">all Lenders</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">each Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Thereafter, (x)&#160;the obligation of the Lenders to make or maintain Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans, as applicable, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or to convert Base Rate Loans to Daily Simple SOFR Loans or Term SOFR Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be suspended (to the extent of the affected </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or Interest Periods), and (y)&#160;in the event of a determination described in the preceding sentence with respect to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component of the Base Rate, the utilization of the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> component in determining the Base Rate shall be suspended, in each case until the Administrative Agent (or, in the case of a determination by the Required Lenders described in clause (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.03(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, until the Administrative Agent upon instruction of the Required Lenders) revokes such notice.  Upon receipt of such notice, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Borrower may revoke any pending request for a Borrowing of Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans and&#47;or a Borrowing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">conversion to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or continuation of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans (to the extent of the affected </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Committed </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrowing of Base Rate Loans in the amount specified therein</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">and (ii) any outstanding Daily Simple SOFR Loans shall be deemed to have been converted to Base Rate Loans immediately and any outstanding Term SOFR Loans shall be deemed to have been converted to Base Rate Loans immediately at the end of their respective applicable Interest Period.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Notwithstanding the foregoing, if the Administrative Agent has made the determination described in clause (i) of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, the Administrative Agent, in consultation with the Borrower and the Required Lenders, may establish an alternative interest rate for the Impacted Loans, in which case, such alternative rate of interest shall apply with respect to the Impacted Loans until (i) the Administrative Agent revokes the notice delivered with respect to the Impacted Loans under clause (i) of </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(a)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, (ii) the Administrative Agent or the Required Lenders notify the Administrative Agent and the Borrower that such alternative interest rate does not adequately and fairly reflect the cost to such Lenders of funding the Impacted Loans, or (iii) any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for such Lender or its applicable Lending Office to make, maintain or fund Loans whose interest is determined by reference to such alternative rate of interest or to determine or charge interest rates based upon such rate or any Governmental Authority has imposed material restrictions on the authority of such Lender to do any of the foregoing and provides the Administrative Agent and the Borrower written notice thereof.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in this Agreement or any other Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Document</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or Required Lenders (as applicable) have determined, that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#160;&#160;&#160;&#160;adequate and reasonable means do not exist for ascertaining </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR for any Interest Period hereunder or any other tenors of LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">one month, three month and six month interest periods of Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, including</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without limitation</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> because the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) &#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CME or any successor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> administrator of the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent or such administrator </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to its publication of Term SOFR, in each case acting in such capacity, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has made a public statement </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">or publication of information stating that all tenors of LIBOR that are or may</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">identifying a specific date </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">after which one month, three month and six month  interest periods of Term SOFR or the Term SOFR Screen Rate shall or will no longer be made available, or permitted to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> be used for determining the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">length of an Interest Period are or will no longer be representative, or made available, or used for determining the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interest rate of </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar denominated syndicated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">loans, or shall or will otherwise cease,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provided that, at the time of such statement</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or publication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, there is no successor administrator that is satisfactory to the Administrative Agent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that will continue to provide </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">any representative tenors of LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such  interest periods of Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after such specific date (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">such specific date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the latest date on which one month, three month and six month interest periods of Term SOFR or the Term SOFR Screen Rate are no longer available permanently or indefinitely</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the administrator of the LIBOR Screen Rate or a Governmental Authority having jurisdiction over such administrator has made a public statement announcing that all Interest Periods and other tenors of LIBOR are no longer representative&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">syndicated loans currently being executed, or that include language similar to that contained in this </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">in the case of clauses (i) through (iii) above, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">on a date and time determined by the Administrative Agent (any such date, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which date shall be at the end of an Interest Period or on the relevant interest payment date, as applicable, for interest calculated and</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> shall occur within a reasonable period of time after the occurrence of any of the events or circumstances under clauses (i) through (iii) above and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, solely with respect to clause (ii) above, no later than the Scheduled Unavailability Date, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be replaced hereunder and under </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the other Loan Documents with, subject to the proviso below, the first available alternative set forth in the order below</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any Loan Document with Daily Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for any payment period for interest calculated that can be determined by the Administrative Agent, in each case, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">LIBOR Successor Rate</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#8221;&#59; and any such rate before giving effect to the Related Adjustment, &#8220;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Pre-Adjustment </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">&#58;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Term SOFR plus the Related Adjustment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(y) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">SOFR plus</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:line-through"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the Related Adjustment&#59; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">and in the case of clause (iv) above, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing LIBOR under this Agreement and the other Loan Documents in accordance with the definition of &#8220;LIBOR Successor Rate&#8221; and such amendment will become effective at 5&#58;00 p.m. on the fifth Business Day after the Administrative Agent shall have notified the Lenders and the Borrower of the occurrence of the circumstances described in clause (iv) above unless, prior to such time, the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to the implementation of a LIBOR Successor Rate pursuant to such clause&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">that</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> if the Administrative Agent determines that Term SOFR has become available, is administratively feasible for the Administrative Agent and would have been identified as the Pre-Adjustment Successor Rate in accordance with the foregoing if it had been so available at the time that the LIBOR Successor Rate then in effect was so identified, and notifies the Borrower and the Lenders of such availability, then from and after the beginning of the Interest Period, relevant interest payment date or payment period for interest calculated, in each case, commencing no less than thirty (30) days after the date of such notice, the Pre-Adjustment Successor Rate shall be Term SOFR and the LIBOR Successor Rate shall be Term SOFR plus</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:line-through"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the relevant Related Adjustment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">The Administrative Agent will promptly (in one or more notices) notify the Borrower and the Lenders of (x) any occurrence of any of the events, periods or circumstances under clauses (i) through (iii) above, (y) a LIBOR Replacement Date, and (z) the LIBOR Successor Rate.  Any LIBOR Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">that</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> to the extent such market practice is not administratively feasible for the Administrative Agent, such LIBOR Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.  Notwithstanding anything else herein, if at any time any LIBOR Successor Rate as so determined would otherwise be less than zero, the LIBOR Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">In connection with the implementation of a LIBOR Successor Rate, the Administrative Agent will have the right to make LIBOR Successor Rate Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such LIBOR Successor Rate Conforming Changes will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">provided</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">that</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such LIBOR Successor Rate Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">If events or circumstances of the type described in clauses (i) through (iii) above have occurred with respect to the LIBOR Successor Rate then in effect, then the successor rate thereto shall be determined in accordance with the definition of &#8220;LIBOR Successor Rate.&#8221;</font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">If the Successor Rate is Daily Simple SOFR, all interest payments will be payable on a monthly basis.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">a) after any such determination by the Administrative Agent or receipt by the Administrative Agent of any such notice described under </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> through </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">(iii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as applicable,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Administrative Agent determines that </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">none of the LIBOR Successor Rates is</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Daily Simple SOFR is not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> available on or prior to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Replacement Date, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) if </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the events or circumstances described in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)(iv)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> have occurred but none of the LIBOR Successor Rates are available, or (iii) if </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.03(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">b</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">through</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">iii</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ii</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> have occurred with respect to the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Successor Rate then in effect</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> and the Administrative Agent determines that none of the LIBOR Successor Rates is available</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then in each case, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any then current </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Successor Rate in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  at the end of any Interest Period, relevant interest payment date or payment period for interest calculated, as applicable, with </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">another alternate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">an alternative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> benchmark rate giving due consideration to any evolving or then existing convention for similar Dollar denominated </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">syndicated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">credit facilities </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">syndicated and agented in the United States </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for such alternative </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">benchmarks</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">benchmark.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, in each case, including any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Related Adjustments and any other </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar Dollar denominated </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">syndicated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">credit facilities </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">syndicated and agented in the United States </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">benchmarks</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">benchmark</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated.  For the avoidance of doubt, any such proposed rate and adjustments</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall constitute a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">LIBOR </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successor Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any such amendment shall become effective at 5&#58;00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">all</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Lenders and the Borrower unless, prior to such time, </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders comprising </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">If, at the end of any Interest Period, relevant interest payment date or payment period for interest calculated, no LIBOR Successor Rate has been determined in accordance with </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> and the circumstances under </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)(i)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">(iii)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> above exist or the Scheduled Unavailability Date has occurred (as applicable), the Administrative Agent will promptly so notify the Borrower and the Lenders.  Thereafter, (a) the obligation of the Lenders to make or maintain Daily Floating LIBOR Rate Loans or Eurodollar Rate Loans shall be suspended (to the extent of the affected Eurodollar Rate Loans, Interest Periods, interest payment dates or payment periods), and (b) the LIBOR component shall no longer be utilized in determining the Base Rate, until the LIBOR Successor Rate has been determined in accordance with </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.03(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">. Upon receipt of such notice, the Borrower may revoke any pending request for a Borrowing of Daily Floating LIBOR Rate Loans and&#47;or a Borrowing, conversion to or continuation of Eurodollar Rate Loans (to the extent of the affected Loans, Interest Periods, interest payment dates or payment periods) or, failing that, will be deemed to have converted such request into a request for Base Rate Loans (subject to the foregoing clause (b)) in the amount specified therein.</font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of the implementation of any Successor Rate.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Any Successor Rate shall be applied in a manner consistent with market practice&#59; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notwithstanding anything else herein, if at any time any Successor Rate as so determined would otherwise be less than zero, the Successor Rate will be deemed to be zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">In connection with the implementation of a Successor Rate, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement&#59; provided that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Costs Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Change in Law shall&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;impose, modify or deem applicable any reserve, special deposit, compulsory loan, insurance charge or similar requirement against assets of, deposits with or for the account of, or credit extended or participated in by, any Lender </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(except any reserve requirement included in determining the Eurodollar Rate or the Daily Floating LIBOR Rate) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or L&#47;C Issuer&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;subject any Lender or L&#47;C Issuer to any Tax of any kind whatsoever with respect to this Agreement, any Letter of Credit, any participation in a Letter of Credit or any </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan made by it, or change the basis of taxation of payments to such Lender or L&#47;C Issuer in respect thereof (except in each case for Indemnified Taxes or Other Taxes covered by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the imposition of, or any change in the rate of, any Excluded Tax payable by such Lender or L&#47;C Issuer)&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;impose on any Lender or L&#47;C Issuer or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the London</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any applicable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> interbank market any other condition, cost or expense affecting this Agreement or </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans or Daily </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Floating LIBOR Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Simple SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loans made by such Lender or any Letter of Credit or participation therein&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and the result of any of the foregoing shall be to increase the cost to such Lender of making </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">converting to, continuing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or maintaining any Loan </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">the interest on which is determined by reference to the Eurodollar Rate or the Daily Floating LIBOR Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(or of maintaining its obligation to make any such Loan), or to increase the cost to such Lender or L&#47;C Issuer of participating in, issuing or maintaining any Letter of Credit (or of maintaining its obligation to participate in or to issue any Letter of Credit), or to reduce the amount of any sum received or receivable by such Lender or L&#47;C Issuer hereunder (whether of principal, interest or any other amount) then, promptly after receipt of the certificate contemplated by Section 3.04(c) from such Lender or L&#47;C Issuer, the Borrower will pay to such Lender or L&#47;C Issuer, as the case may be, such additional amount or amounts as will compensate such Lender or L&#47;C Issuer, as the case may be, for such additional costs incurred or reduction suffered.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Lender or L&#47;C Issuer determines that any Change in Law affecting such Lender or L&#47;C Issuer or any Lending Office of such Lender or such Lender&#8217;s or L&#47;C Issuer&#8217;s holding company, if any, regarding capital or liquidity requirements has or would have the effect of reducing the rate of return on such Lender&#8217;s or L&#47;C Issuer&#8217;s capital or on the capital of such Lender&#8217;s or L&#47;C Issuer&#8217;s holding company, if any, as a consequence of this Agreement, the Commitments of such Lender or the Loans made by, or participations in Letters of Credit held by, such Lender, or the Letters of Credit issued by an L&#47;C Issuer, to a level below that which such Lender or L&#47;C Issuer or such Lender&#8217;s or L&#47;C Issuer&#8217;s holding company could have achieved but for such Change in Law (taking into consideration such Lender&#8217;s or L&#47;C Issuer&#8217;s policies and the policies of such Lender&#8217;s or L&#47;C Issuer&#8217;s holding company with respect to capital adequacy and liquidity), then, promptly after receipt of the certificate contemplated by Section 3.04(c) from such Lender or L&#47;C Issuer, the Borrower will pay to such Lender or L&#47;C Issuer, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as the case may be, such additional amount or amounts as will compensate such Lender or L&#47;C Issuer or such Lender&#8217;s or L&#47;C Issuer&#8217;s holding company for any such reduction suffered.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certificates for Reimbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A certificate of a Lender or L&#47;C Issuer setting forth in reasonable detail the amount or amounts necessary to compensate such Lender or L&#47;C Issuer or its holding company, as the case may be, as specified in subsection (a) or (b) of this Section and delivered to the Borrower shall be conclusive absent manifest error&#59; provided, however, that notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the case of any Change in Law, it shall be a condition to a Lender&#8217;s exercise of its rights, if any, under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Lender shall generally be exercising similar rights with respect to borrowers under similar agreements where available.  The Borrower shall pay such Lender or L&#47;C Issuer, as the case may be, the amount shown as due on any such certificate within 15 days after receipt thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delay in Requests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Failure or delay on the part of any Lender or L&#47;C Issuer to demand compensation pursuant to the foregoing provisions of this Section shall not constitute a waiver of such Lender&#8217;s or L&#47;C Issuer&#8217;s right to demand such compensation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall not be required to compensate a Lender or L&#47;C Issuer pursuant to the foregoing provisions of this Section for any increased costs incurred or reductions suffered more than six months prior to the date that such Lender or L&#47;C Issuer, as the case may be, notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender&#8217;s or L&#47;C Issuer&#8217;s intention to claim compensation therefor (except that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the six-month period referred to above shall be extended to include the period of retroactive effect thereof).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation for Losses.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon demand (which demand shall set forth the basis for compensation and a reasonable detailed calculation of such compensation) of any Lender (with a copy to the Administrative Agent) from time to time, the Borrower shall promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense incurred by it as a result of&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any continuation, conversion, payment or prepayment of any Loan other than a Base Rate Loan on a day other than the last day of the Interest Period</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, relevant interest payment date or payment period, as applicable,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for such Loan (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;any failure by the Borrower (for a reason other than the failure of such Lender to make a Loan) to prepay, borrow, continue or convert any Loan other than a Base Rate Loan on the date or in the amount notified by the Borrower&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;any assignment of a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Loan on a day other than the last day of the Interest Period therefor as a result of a request by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">excluding any loss of anticipated profits, but including any loss or expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees payable to terminate the deposits from which such funds were obtained.  The Borrower shall also pay any customary administrative fees charged by such Lender in connection with the foregoing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">For purposes of calculating amounts payable by the Borrower to the Lenders under this </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline line-through">Section 3.05</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, each Lender shall be deemed to have funded each Daily Floating LIBOR Rate Loan or Eurodollar Rate Loan, as applicable, made by it at the Daily Floating LIBOR Rate or the Eurodollar Base Rate used in determining the Eurodollar Rate for such Loan, respectively, by a matching deposit or other borrowing in the London interbank eurodollar market for a comparable amount and for a comparable period, whether or not such Daily Floating LIBOR Rate Loan or Eurodollar Rate Loan, as applicable, was in fact so funded. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mitigation Obligations&#59; Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designation of a Different Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or any Loan Party is required to pay any additional amount to any Lender, L&#47;C Issuer or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governmental Authority for the account of any Lender or L&#47;C Issuer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or if any Lender gives a notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then such Lender or L&#47;C Issuer shall, as applicable, use reasonable efforts to designate a different Lending Office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its offices, branches or affiliates, if, in the judgment of such Lender or L&#47;C Issuer, such designation or assignment (i) would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as the case may be, in the future, or eliminate the need for the notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, and (ii) in each case, would not subject such Lender or L&#47;C Issuer, as the case may be, to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender or L&#47;C Issuer, as the case may be.  The Borrower hereby agrees to pay all reasonable costs and expenses incurred by any Lender or L&#47;C Issuer in connection with any such designation or assignment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If (i) any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) any Loan Party is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (iii) any Lender delivers a notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower may replace such Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All of the Loan Parties&#8217; obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive termination of the Aggregate Revolving Commitments, repayment of all other Obligations hereunder and resignation of the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IV<br><br>CONDITIONS PRECEDENT TO CREDIT EXTENSIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This third amendment and restatement to the Existing Credit Agreement shall become effective upon satisfaction of the following conditions precedent&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Receipt by the Administrative Agent of executed counterparts of this Agreement and the other Loan Documents, each properly executed by a Responsible Officer of the Borrower and, in the case of this Agreement, by each Lender.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Opinions of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Receipt by the Administrative Agent of favorable opinions of legal counsel to the Borrower, addressed to the Administrative Agent and each Lender, dated as of the Third Amendment and Restatement Effective Date, and in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organization Documents, Resolutions, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Receipt by the Administrative Agent of the following, each of which shall be originals or facsimiles (followed promptly by originals), in form and substance satisfactory to the Administrative Agent and its legal counsel&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;copies of the Organization Documents of the Borrower certified to be true and complete as of a recent date by the appropriate Governmental Authority of the state or other jurisdiction of its incorporation or organization, where applicable, and certified by a secretary or assistant secretary of the Borrower to be true and correct as of the Third Amendment and Restatement Effective Date&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;such certificates of resolutions or other action, incumbency certificates and&#47;or other certificates of Responsible Officers of the Borrower as the Administrative Agent may require evidencing the identity, authority and capacity of each Responsible </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Officer thereof authorized to act as a Responsible Officer in connection with this Agreement and the other Loan Documents to which the Borrower is a party&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;such documents and certifications as the Administrative Agent may require to evidence that the Borrower is duly organized or formed, and is validly existing, in good standing and qualified to engage in business in its state of organization or formation.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Receipt by the Administrative Agent of a certificate signed by a Responsible Officer of the Borrower certifying (i)(A) that there has not occurred since December 31, 2020 any event or condition that has had or could reasonably be expected, either individually or in the aggregate, to cause a material adverse change in, or a material adverse effect on, the financial condition, results of operations or business of the Borrower and its Subsidiaries, taken as a whole, other than as disclosed in the Borrower&#8217;s current reports on Form 8-K, as filed with the SEC prior to the Third Amendment and Restatement Effective Date and (B) there does not exist any action, suit, investigation or proceeding pending or to the Borrower&#8217;s knowledge, threatened in any court or before an arbitrator or Governmental Authority that could reasonably be expected to have a Material Adverse Effect, (ii) that the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (each as though a Credit Extension were being made on the Third Amendment and Restatement Effective Date) have been satisfied and (iii) the current Debt Ratings.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reserved</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.&#93;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Receipt by the Administrative Agent, the Joint Lead Arrangers and the Lenders of any fees required to be paid on or before the Third Amendment and Restatement Effective Date, including all facility fees, letter of credit fees and fronting fees accrued under the Existing Credit Agreement prior to the Third Amendment and Restatement Effective Date.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">KYC Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Receipt by the Administrative Agent and the Lenders of all documentation and other information requested by the Administrative Agent and the Lenders that is required to satisfy applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act and, to the extent applicable, the Beneficial Ownership Regulation.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Attorney Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Unless waived by the Administrative Agent, the Borrower shall have paid all reasonable and documented out-of-pocket fees, charges and disbursements of counsel to the Administrative Agent to the extent invoiced at least three (3) days prior to the Third Amendment and Restatement Effective Date, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such additional amounts of such fees, charges and disbursements as shall constitute its reasonable estimate of such fees, charges and disbursements incurred or to be incurred by it through the closing proceedings (provided that such estimate shall not thereafter preclude a final settling of accounts between the Borrower and the Administrative Agent).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Receipt by the Administrative Agent and the Lenders of such other documents, instruments, agreements and information as reasonably requested by the Administrative Agent or any Lender, including, but not limited to, information regarding litigation, tax, accounting, labor, insurance, pension liabilities (actual or contingent), real estate leases, material contracts, debt agreements, property ownership, environmental matters, contingent liabilities and management of the Borrower and its Subsidiaries.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the generality of the provisions of the last paragraph of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, for purposes of determining compliance with the conditions specified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Third Amendment and Restatement Effective Date specifying its objection thereto.  The Administrative Agent shall notify the Borrower and the Lenders of the occurrence of the Third Amendment and Restatement Effective Date, and such notice shall be conclusive and binding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conditions to all Credit Extensions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The obligation of each Lender to honor any Request for Credit Extension (but not any continuation or conversion of a Loan) is subject to the following conditions precedent&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The representations and warranties of the Loan Parties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article V</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other Loan Document, or which are contained in any document furnished at any time under or in connection herewith or therewith, shall be true and correct in all material respects on and as of the date of such Credit Extension, except that (x) any such representation and warranty that is qualified by materiality or a reference to Material Adverse Effect shall be true and correct in all respects on and as of the date of such Credit Extension and (y) to the extent that any such representation and warranty specifically refers to an earlier date, each such representation and warranty shall be true and correct in all material respects as of such earlier date (except that any such representation and warranty that is qualified by materiality or reference to Material Adverse Effect shall be true and correct in all respects as of such earlier date), and except that for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the representations and warranties contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to refer to the most recent statements furnished pursuant to clauses (a) and (b), respectively, of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;No Default or Event of Default shall exist, or would result from such proposed Credit Extension or from the application of the proceeds thereof.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Administrative Agent and, if applicable, the L&#47;C Issuers and&#47;or the Swing Line Lender shall have received a Request for Credit Extension in accordance with the requirements hereof.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Each Request for Credit Extension (other than any continuation or conversion of a Loan) submitted by the Borrower shall be deemed to be a representation and warranty that the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 4.02(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> have been satisfied on and as of the date of the applicable Credit Extension.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE V<br><br>REPRESENTATIONS AND WARRANTIES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Loan Parties represents and warrants to the Administrative Agent, the L&#47;C Issuers and each of the Lenders, on the Third Amendment and Restatement Effective Date and each other date required by Section 4.02(a), that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Organization&#59; Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Each of the Loan Parties (i) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (ii) has all requisite power and authority to (x) own its property and assets and to carry on its business as now conducted and (y) execute, deliver and perform its obligations under the Loan Documents to which it is a party and (iii) is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required, except, in the case of each of  clause (i) (other than the Parent and the Borrower), clause (ii) (other than the Parent and the Borrower) and clause (iii), where the failure to do so could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Each of the Subsidiaries (other than each Loan Party) (i) is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (ii) has all requisite power and authority to own its property and assets and to carry on its business as now conducted and (iii) is qualified to do business in, and is in good standing in, every jurisdiction where such qualification is required, except in the case of any of the foregoing clauses (i), (ii) and (iii) where the failure to do so could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The execution, delivery and performance by the Loan Parties of this Agreement and the transactions contemplated hereby (including the Borrowings hereunder) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (a) are within each such Person&#8217;s corporate powers and have been duly authorized by all requisite corporate and, if required, stockholder action and (b) will not (i) violate (A) any provision of law, statute, rule or regulation, or of the Organization Documents of the Company or any Subsidiary, (B) any order of any Governmental Authority or (C) any provision of any indenture, agreement or other instrument to which the Company or any Subsidiary is a party or by which any of them or any of their property is or may be bound, the effect of which could reasonably be expected to result in a Material Adverse Effect, (ii) result in a breach of or constitute (alone or with notice or lapse of time or both) a default under, or give rise to any right to accelerate or to require the prepayment, repurchase or redemption of any obligation under any such indenture, agreement or other instrument, the effect of which could reasonably be expected to result in a Material Adverse Effect, or (iii) result in the creation or imposition of any Lien (other than Liens permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) upon or with respect to any property or assets now owned or hereafter acquired by the Company or any Subsidiary.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement and each other Loan Document has been duly executed and delivered by each Loan Party party thereto and constitutes a legal, valid and binding obligation of each such Person enforceable against such Person in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws affecting the enforceability of creditors&#8217; rights generally and to general principles of equity, regardless of whether considered in a proceeding in equity or at law.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Approvals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No action, consent or approval of, registration or filing with or any other action by any Governmental Authority is or will be required in connection with the Transactions, except for such as have been made or obtained and are in full force and effect or those which the failure to obtain could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower has heretofore furnished to the Lenders its consolidated balance sheets and related statements of income, stockholders&#8217; equity and cash flows as of and for the fiscal year ended December 31, 2020, audited by and accompanied by the opinion of PricewaterhouseCoopers LLP, independent public accountants.  Such financial statements present fairly, in all material respects, the financial condition and results of operations and cash flows of the Borrower and its consolidated Subsidiaries as of such date and for such period referred to therein in accordance with GAAP, subject to normal year-end audit adjustments and the absence of footnotes when the foregoing representation in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is deemed to refer to the most recent statements furnished pursuant to clause (b) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Adverse Change</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;As of the Third Amendment and Restatement Effective Date, since December 31, 2020, there has been no material adverse change in the financial condition, results of operations or business of the Borrower and the Subsidiaries, taken as a whole, other than as disclosed in the Borrower&#8217;s current reports on Form 8-K, as filed with the SEC prior to the Third Amendment and Restatement Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.07&#160;&#160;&#160;&#160;&#91;Reserved&#93;.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation&#59; Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;There are not any actions, suits or proceedings at law or in equity, or by or before any Governmental Authority now pending or, to the knowledge of the Loan Parties, threatened against or affecting the Company or any Subsidiary or any business, property or rights of any such Person (i) that purport to affect the legality, validity or enforceability of this Agreement or the consummation of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Transactions or (ii) that could reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;None of the Company or any of the Subsidiaries is in violation of any law, rule or regulation, or is in default with respect to any judgment, writ, injunction, decree or order of any Governmental Authority, where such violation or default could reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Reserve Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;None of the Loan Parties is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;No part of the proceeds of any Loan or any Letter of Credit will be used, whether directly or indirectly, and whether immediately, incidentally or ultimately, to purchase or carry Margin Stock or to extend credit to others for the purpose of purchasing or carrying Margin Stock or for any purpose that entails a violation of, or that is inconsistent with, the provisions of Regulations T, U or X of the FRB.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investment Company Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">None of the Loan Parties is an &#8220;investment company&#8221; as defined in, or subject to regulation under, the Investment Company Act of 1940.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower will use the proceeds of the Credit Extensions solely for general corporate purposes of the Company and its Subsidiaries, including (a) working capital, (b) capital expenditures, (c) (i) the funding of Share Repurchases and (ii) other Restricted Payments permitted hereunder, (d) acquisitions and other investments and (e) the repayment of all amounts outstanding or due under the Existing Credit Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Returns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Company and the Subsidiaries has filed or caused to be filed all federal, state, local and foreign Tax returns or materials required to have been filed by it and has paid or caused to be paid all Taxes due and payable by it and all assessments received by it, except (a) Taxes that are being contested in good faith by appropriate proceedings and for which the Company or such Subsidiary, as applicable, shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP or (b) to the extent that the failure to do so could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Material Misstatements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">None of (a) the Confidential Information Memorandum or (b) any other information, report, financial statement, exhibit or schedule furnished by or on behalf of the Loan Parties to the Administrative Agent or any Lender in connection with the negotiation of this Agreement (other than any information of a general economic or industry nature) contains, when furnished, any material misstatement of fact or omits to state any material fact necessary to make the statements therein taken as a whole, in the light of the circumstances under which they were made, not materially misleading&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or projection, each of the Loan Parties represents only that it acted in good faith and utilized reasonable assumptions at the time prepared and at the time furnished to the Administrative Agent or any Lender and due care in the preparation of such information, report, financial statement, exhibit or schedule (it being understood that projections as to future events are not to be viewed as facts or guaranties of future performance, that actual results during the period or periods covered by such projections may differ from the projected results and that such differences may be material and that no assurances are being given that such projections will be in fact realized).  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Employee Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;As of the Third Amendment and Restatement Effective Date, the Company is not and will not be (1) an employee benefit plan subject to Title I of ERISA, (2) a plan or account subject to Section 4975 of the Internal Revenue Code, (3) an entity deemed to hold &#8220;plan assets&#8221; of any such plans or accounts for purposes of ERISA or the Internal Revenue Code, or (4) a &#8220;governmental plan&#8221; within the meaning of ERISA.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except with respect to any matters that, individually or in the aggregate, could not reasonably be expected to result in a Material Adverse Effect, neither the Company nor any of the Subsidiaries (a) has failed to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (b) is subject to any Environmental Liability, (c) has received written notice of any claim with respect to any Environmental Liability or (d) knows of any basis for any Environmental Liability of the Company or the Subsidiaries.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Senior Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Loans and other obligations hereunder constitute &#8220;senior indebtedness&#8221; (or such other similar term) under and as defined in the definitive documentation governing any Subordinated Indebtedness.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Default has occurred and is continuing.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neither the Company nor any of its Subsidiaries, nor, to the knowledge of the Company and its Subsidiaries, any director, officer, employee, agent, affiliate or representative thereof, is an individual or entity currently the subject of any Sanctions, nor is the Company or any Subsidiary located, organized or resident in a Designated Jurisdiction.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company and its Subsidiaries have conducted their businesses in compliance in all material respects with applicable anti-corruption laws and Sanctions and have instituted and maintained policies and procedures reasonably designed to promote and achieve compliance with such laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">None of the Loan Parties is an Affected Financial Institution.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VI<br><br>AFFIRMATIVE COVENANTS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;So long as any Lender shall have any Commitment hereunder, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied (other than contingent indemnification obligations for which no claim has been asserted), or any Letter of Credit shall remain outstanding (other than any Letter of Credit for which the Borrower has provided Cash Collateral in accordance with the terms hereof), each Loan Party shall, and the Loan Parties shall cause each Subsidiary to&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existence&#59; Businesses and Properties&#59; Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Do or cause to be done all things necessary to preserve, renew and keep in full force and effect its legal existence, except as otherwise permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Preserve, renew and maintain in full force and effect its good standing under the laws of the jurisdiction of its organization, except to the extent the failure to do so could not reasonably be expected to have a Material Adverse Effect.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Do or cause to be done all things necessary to obtain, preserve, renew, extend and keep in full force and effect its rights, licenses, permits, franchises, authorizations, patents, copyrights, trademarks and trade names, and comply in all material respects with all applicable laws, rules, regulations and decrees and orders of any Governmental Authority, in each case except where the failure to do so could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Maintain with responsible and reputable insurance companies insurance, to such extent and against such risks as is customary with companies in the same or similar businesses operating in the same or similar locations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations and Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pay its Indebtedness and other obligations, including Taxes, before the same shall become delinquent or in default, except where (a) the validity or amount thereof shall be contested in good faith by appropriate proceedings and the Company shall have set aside on its books adequate reserves with respect thereto in accordance with GAAP or (b) to the extent that the failure to do so could not reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements, Reports, etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the case of the Company, furnish to the Administrative Agent&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;within 105 days after the end of each fiscal year, its consolidated balance sheet and related statements of income, stockholders&#8217; equity and cash flows as of the close of and for such fiscal year, together with comparative figures for the immediately preceding fiscal year, all audited by PricewaterhouseCoopers LLP or other independent public accountants of recognized national standing and accompanied by an opinion of such accountants (which shall either (i)  not be qualified in any material respect (excluding for purposes of this clause (i) any &#8220;going concern&#8221; or like qualification or exception solely to the extent of, related solely to or resulting solely from the classification of the Loans hereunder as short-term indebtedness during the twelve-month period ending as of the Maturity Date) or (ii) be reasonably acceptable to the Required Lenders) to the effect that such consolidated financial statements present fairly in all material respects the financial condition and results of operations of the Company and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;within 50 days after the end of each of the first three fiscal quarters of each fiscal year, its consolidated balance sheet and related statements of income, stockholders&#8217; equity and cash flows as of the close of and for such fiscal quarter and the then elapsed portion of the fiscal year, and comparative figures for the same periods in the immediately preceding fiscal year, all certified by one of its Responsible Officers as presenting fairly in all material respects the financial condition and results of operations of the Company and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;concurrently with any delivery of financial statements under paragraph (a) or (b) above, a Compliance Certificate executed by a Responsible Officer of the Company (i) certifying that no Event of Default or Default has occurred or, if such an Event of Default or Default has occurred, specifying the nature and extent thereof and any corrective action taken or proposed to be taken with respect thereto, (ii) setting forth computations in reasonable detail satisfactory to the Administrative Agent demonstrating compliance with the covenant contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iii) stating whether any material change in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GAAP or in the application thereof has occurred since the date of the audited financial statements referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, if any such change has occurred, specifying the effect of such change on the financial statements accompanying such certificate&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;promptly after the same become publicly available, copies of all periodic and other reports, proxy statements and other materials filed by the Company or any Subsidiary with the SEC, or with any national securities exchange, or distributed to its shareholders generally, as the case may be&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;&#91;reserved&#93;&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;promptly, from time to time, such other information regarding the operations, business affairs and financial condition of the Company or any Subsidiary, or compliance with the terms of this Agreement, as the Administrative Agent or any Lender may reasonably request&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;promptly, following a request by any Lender, all documentation and other information that such Lender reasonably requests in order to comply with its ongoing obligations under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act and the Beneficial Ownership Regulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Documents required to be delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i) on which the Borrower or the Parent posts such documents, or provides a link thereto on the Borrower&#8217;s or the Parent&#8217;s website on the Internet at the website address listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 11.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or (ii) on which such documents are posted on the Borrower&#8217;s or the Parent&#8217;s behalf on an Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58; (i) the Company shall deliver paper copies of such documents required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the Administrative Agent or any Lender upon its request to the Borrower to deliver such paper copies until a written request to cease delivering paper copies is given by the Administrative Agent or such Lender and (ii) the Borrower shall notify the Administrative Agent (by telecopier or electronic mail) of the posting of any such documents required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.04(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent shall have no obligation to request the delivery of or to maintain paper copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery by a Lender, and each Lender shall be solely responsible for requesting delivery to it or maintaining its copies of such documents.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower hereby acknowledges that (a)&#160;the Administrative Agent and&#47;or the Joint Lead Arrangers will make available to the Lenders and the L&#47;C Issuers materials and&#47;or information provided by or on behalf of the Loan Parties hereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) by posting the Borrower Materials on DebtDomain, IntraLinks, Syndtrak, ClearPar, or another similar electronic system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (b)&#160;certain of the Lenders (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Public Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) may have personnel who do not wish to receive material non-public information with respect to any of the Company, its Affiliates, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with respect to such Persons&#8217; securities.  The Loan Parties hereby agree that upon the written request of the Administrative Agent (w)&#160;all Borrower Materials that are to be made available to Public Lenders shall be clearly and conspicuously marked &#8220;PUBLIC&#8221; which, at a minimum, shall mean that the word &#8220;PUBLIC&#8221; shall appear prominently on the first page thereof&#59; (x)&#160;by marking Borrower Materials &#8220;PUBLIC,&#8221; the Loan Parties shall be deemed to have authorized the Administrative Agent, the Joint Lead Arrangers, the L&#47;C Issuers and the Lenders to treat such Borrower Materials as not containing any material non-public information with respect to the Borrower or the Parent or its respective securities for purposes of United States Federal and state securities laws (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that to the extent such Borrower Materials constitute Information, they shall be treated as set forth in Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; (y)&#160;all Borrower Materials marked &#8220;PUBLIC&#8221; are permitted to be made available through a portion of the Platform designated &#8220;Public Side Information&#59;&#8221; and (z)&#160;the Administrative Agent and the Joint Lead Arrangers shall be entitled to treat any Borrower Materials that are not marked &#8220;PUBLIC&#8221; as being suitable only for posting on a portion of the Platform not designated &#8220;Public Side Information.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Litigation and Other Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the case of the Company, furnish to the Administrative Agent prompt written notice of the following after actual knowledge thereof by any Responsible Officer of the Company&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any Event of Default or Default, specifying the nature and extent thereof and the corrective action (if any) taken or proposed to be taken with respect thereto&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;the filing or commencement of, or any written threat or notice of intention of any Person to file or commence, any action, suit or proceeding, whether at law or in equity or by or before any Governmental Authority, against the Company or any Subsidiary thereof that could reasonably be expected to result in a Material Adverse Effect&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;any change in the rating by S&#38;P or Moody&#8217;s of the Index Debt&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;the occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maintaining Records&#59; Access to Properties and Inspections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Keep books of record and account in all material respects in conformity with GAAP and all requirements of law in relation to its business and activities.  The Company will, and will cause each of its Subsidiaries to, permit any representatives designated by the Administrative Agent or any Lender, upon reasonable prior notice, to visit and inspect the financial records and the properties of the Company or any Subsidiary at reasonable times  and to make extracts from and copies of such financial records, and permit any representatives designated by the Administrative Agent or any Lender to discuss the affairs, finances and condition of the Company or any Subsidiary with the officers thereof and independent accountants therefor (so long as an officer of the Company or the Borrower is provided a reasonable opportunity to participate in any such meeting with the independent accountants)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, unless a Default or Event of Default has occurred and is continuing, (i) such visitations or inspections shall be limited to one (1) time in any twelve-month period and (ii) the costs and expenses of such a visitation or inspection shall be the responsibility of the inspecting party or parties.  Notwithstanding the foregoing or any other provision of this Agreement, in no event will the Company or its Subsidiaries be required to disclose to the Administrative Agent or any Lender privileged documents or other documents the disclosure of which would violate regulatory or contractual confidentiality obligations binding upon the Company or any of its Subsidiaries.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Use the proceeds of the Credit Extensions only for the purposes set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Maintain policies and procedures reasonably designed to promote and achieve compliance by the Company and its Subsidiaries with applicable anti-corruption laws and Sanctions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On the Holdco Reorganization Effective Date, the Parent shall Guarantee the Obligations hereunder by executing and delivering to the Administrative Agent a Joinder Agreement, together with (i) a customary secretary&#8217;s certificate containing the items set forth in Section 4.01(e) with respect to the Parent, (ii) a favorable opinion of legal counsel to the Parent, addressed to the Administrative Agent and each Lender, dated as of the Holdco Reorganization Effective Date, in form and substance reasonably satisfactory to the Administrative Agent and consistent with the opinions of legal counsel delivered on the Third Amendment and Restatement Effective Date and (iii) such documentation and other information reasonably requested by the Administrative Agent or the Lenders that is required to satisfy applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation the USA PATRIOT Act and the Beneficial Ownership Regulation.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intermediate Holding Company Guaranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  On the Holdco Reorganization Effective Date, or, if later, within thirty (30) days (or such later date as may be agreed to by the Administrative Agent) the date such Intermediate Holding Company is created or formed, the Parent shall cause each Intermediate Holding Company to Guarantee the Obligations hereunder by executing and delivering to the Administrative Agent a Joinder Agreement together with (i) a customary secretary&#8217;s certificate containing the items set forth in Section 4.01(e) with respect to such Intermediate Holding Company, (ii) a favorable opinion of legal counsel to such Intermediate Holding Company, addressed to the Administrative Agent and each Lender, dated as of the effective date of such Joinder Agreement, in form and substance reasonably satisfactory to the Administrative Agent and consistent with the opinions of legal counsel delivered on the Third Amendment and Restatement Effective Date and (iii) such documentation and other information reasonably requested by the Administrative Agent or the Lenders that is required to satisfy applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation the USA PATRIOT Act and the Beneficial Ownership Regulation.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guaranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  At its option, the Borrower may cause any of its Subsidiaries (each such Subsidiary, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to Guarantee the Obligations hereunder, pursuant to a Joinder Agreement executed by such Subsidiary and delivered to the Administrative Agent, together with (i) a customary secretary&#8217;s certificate containing the items set forth in Section 4.01(e) with respect to such Subsidiary, (ii) a favorable opinion of legal counsel to such Subsidiary, addressed to the Administrative Agent and each Lender, dated as of the effective date of such Joinder Agreement, in form and substance reasonably satisfactory to the Administrative Agent and consistent with the opinions of legal counsel delivered on the Third Amendment and Restatement Effective Date and (iii) such documentation and other information reasonably requested by the Administrative Agent or the Lenders that is required to satisfy applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation the USA PATRIOT Act and the Beneficial Ownership Regulation.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release of Subsidiary Guaranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to (i) the absence of any continuing or immediately resulting Event of Default and (ii) the receipt by the Administrative Agent of a certificate signed by a Responsible Officer of the Borrower confirming that such release is permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and that there is no continuing Event of Default after giving effect thereto, the Administrative Agent shall, at the request and expense of the Borrower, and without the need for any consent or approval by the Lenders, execute and deliver an instrument of release to evidence any termination of a Joinder Agreement described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in a form reasonably acceptable to the Borrower and the Administrative Agent with respect to any Subsidiary Guarantor. No Guarantor shall be released from its Guaranty except as contemplated by this clause (d), or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VII<br><br>NEGATIVE COVENANTS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;So long as any Lender shall have any Commitment hereunder, any Loan or other Obligation hereunder shall remain unpaid or unsatisfied (other than any contingent indemnification obligations for which no claim has been asserted), or any Letter of Credit shall remain outstanding (other than any Letter of Credit for which the Borrower has provided Cash Collateral in accordance with the terms hereof), no Loan Party shall, nor shall the Loan Parties permit any Subsidiary to, directly or indirectly&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  With respect to the Subsidiaries (other than any Subsidiary that is a Loan Party), incur, create, issue, assume or permit to exist any Indebtedness or preferred stock, except&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Indebtedness or preferred stock existing on the Third Amendment and Restatement Effective Date and having a principal amount (or, in the case of preferred stock, a liquidation preference), in each case less than $25,000,000 and, in the case of any such Indebtedness, any extensions, renewals or replacements thereof to the extent the principal amount of such Indebtedness is not increased, and such Indebtedness, if subordinated to the Obligations, remains so subordinated on terms no less favorable to the Lenders, and the original obligors in respect of such Indebtedness remain the only obligors thereon&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Indebtedness created or existing hereunder&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;intercompany Indebtedness or preferred stock to the extent owing to or held by the Company or another Subsidiary&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Indebtedness of any Subsidiary (other any Subsidiary that is a Loan Party) incurred to finance the acquisition, construction or improvement of any fixed or capital assets, and extensions, renewals and replacements of any such Indebtedness that do not increase the outstanding principal amount thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness is incurred prior to or within 180 days after such acquisition or the completion of such construction or improvement and (ii) the aggregate principal amount of Indebtedness at any time outstanding permitted by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, when combined with the aggregate principal amount of all Capital Lease Obligations incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding and all Indebtedness incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding, shall not exceed the greater of (x) $1,250,000,000 and (y) 20% of Consolidated Net Worth&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Capital Lease Obligations in an aggregate principal amount at any time outstanding, when combined with the aggregate principal amount of all Indebtedness incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding, not to exceed the greater of (x) $1,250,000,000 and (y) 20% of Consolidated Net Worth&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;Indebtedness of any Person that becomes a Subsidiary after the Third Amendment and Restatement Effective Date (other than any such Subsidiary that is a Loan Party)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Indebtedness exists at the time such Person becomes a Subsidiary and is not created in contemplation of or in connection with such Person becoming a Subsidiary, (ii) immediately before and after such Person becomes a Subsidiary, no Event of Default or Default shall have occurred and be continuing and (iii) the aggregate principal amount of Indebtedness at any time outstanding permitted by this clause (f), when combined with the aggregate principal amount of all Indebtedness incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding and all Capital Lease Obligations incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding, shall not exceed the greater of (x) $1,250,000,000 and (y) 20% of Consolidated Net Worth&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;Indebtedness under performance bonds or with respect to workers&#8217; compensation claims, in each case incurred in the ordinary course of business&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;additional Indebtedness (including attributable Indebtedness in respect of Sale and Leaseback Transactions) or preferred stock of the Subsidiaries (other any Subsidiary that is a Loan Party) to the extent not otherwise permitted by the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in an aggregate principal amount at any time outstanding (or, in the case of preferred stock, with an aggregate liquidation preference), when combined (without duplication) with the amount of obligations of the Company and its Subsidiaries secured by Liens pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.02(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding, not to exceed the greater of (x) $1,250,000,000 and (y) 20% of Consolidated Net Worth&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Indebtedness in respect of netting services, overdraft protections and otherwise arising from treasury, depository and cash management services or in connection with any automated clearing-house transfers of funds, overdraft or any similar services, in each case in the ordinary course of business&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;Indebtedness in the form of purchase price adjustments and earn-outs incurred in connection with any acquisition or joint venture investment not prohibited hereunder&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;Indebtedness owing to any insurance company in connection with the financing of insurance premiums permitted by such insurance company in the ordinary course of business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Create, incur, assume or permit to exist any Lien on any property or assets (including Equity Interests or other securities of any Person, including any Subsidiary) now owned or hereafter acquired by it or on any income or revenues or rights in respect of any thereof, except&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Liens on property or assets of the Borrower and its Subsidiaries existing on the Third Amendment and Restatement Effective Date and encumbering property or assets with a fair market value, and securing obligations having a principal amount, in each case of less than $25,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) such Liens shall secure only those obligations which they secure on the Third Amendment and Restatement Effective Date and extensions, renewals and replacements thereof permitted hereunder and (y) such Liens shall not apply to any other property or assets of the Company or any of the Subsidiaries&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;any Lien existing on any property or asset prior to the acquisition thereof by the Company or any Subsidiary or existing on any property or asset of any Person that becomes a Subsidiary after the Third Amendment and Restatement Effective Date prior to the time such Person becomes a Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, as the case may be, (ii) such Lien does not apply to any other property or assets of the Company or any Subsidiary and (iii) such Lien shall secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be and extensions, renewals and replacements thereof permitted hereunder&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;Liens for Taxes not yet delinquent or which are being contested in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s or other like Liens arising in the ordinary course of business and securing obligations that are not overdue by more than 90 days or which are being contested in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;pledges and deposits made in the ordinary course of business in compliance with workmen&#8217;s compensation, unemployment insurance and other social security laws or regulations&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;deposits to secure the performance of bids, trade contracts (other than for Indebtedness), leases (other than Capital Lease Obligations), statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature, in each case in the ordinary course of business&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;zoning restrictions, easements, rights-of-way, restrictions on use of real property and other similar encumbrances incurred in the ordinary course of business which, in the aggregate, are not substantial in amount and do not materially detract from the marketability of the property subject thereto or interfere with the ordinary conduct of the business of the Company or any of its Subsidiaries&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;purchase money security interests in real property, improvements thereto or equipment hereafter acquired (or, in the case of improvements, constructed) by the Company or any Subsidiary&#59; provided that (i) such security interests secure Indebtedness not prohibited by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) such security interests are incurred, and the Indebtedness secured thereby is created, within 180 days after such acquisition (or construction) and (iii) such security interests do not apply to any other property or assets of the Company or any Subsidiary&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Liens in respect of judgments that do not constitute an Event of Default&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)&#160;&#160;&#160;&#160;Liens, if any, in favor of the Administrative Agent on Cash Collateral delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;Liens on property or assets of the Company and its Subsidiaries securing Indebtedness permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) any such Lien shall attach to the property being acquired, constructed or improved with such Indebtedness and (y) such Liens do not apply to any other property or assets of the Company or any Subsidiary&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)&#160;&#160;&#160;&#160;Liens not otherwise permitted by the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> securing obligations otherwise permitted by this Agreement in an aggregate principal and face amount at any time outstanding, when combined (without duplication) with the amount of Indebtedness or preferred stock of Subsidiaries incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.01(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and then outstanding, not to exceed the greater of (x) $1,250,000,000 and (y) 20% of Consolidated Net Worth&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)&#160;&#160;&#160;&#160;bankers&#8217; liens, rights of setoff or similar rights and remedies as to deposit accounts or other funds maintained with depository institutions and securities accounts and other financial assets maintained with securities intermediaries&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)&#160;&#160;&#160;&#160;Liens arising by virtue of Uniform Commercial Code financing statement filings (or similar filings under applicable law) regarding operating leases entered into by the Company and the Subsidiaries in the ordinary course of business&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)&#160;&#160;&#160;&#160;Liens representing any interest or title of a licensor, lessor or sublicensor or sublessor, or a licensee, lessee or sublicensee or sublessee, in the property subject to any lease (other than Capital Lease Obligations), license or sublicense or concession agreement permitted by this Agreement&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)&#160;&#160;&#160;&#160;Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)&#160;&#160;&#160;&#160;Liens on specific items of inventory or other goods and proceeds thereof of any Person securing such Person&#8217;s obligations in respect of bankers&#8217; acceptances or letters of credit issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods in the ordinary course of business&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)&#160;&#160;&#160;&#160;deposits of cash with the owner or lessor of premises leased and operated by the Company or any Subsidiary to secure the performance of its obligations under the lease for such premises, in each case in the ordinary course of business&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(s)&#160;&#160;&#160;&#160;Liens on cash and cash equivalents deposited with a trustee or a similar Person to defease or to satisfy and discharge any Indebtedness, provided that such defeasance or satisfaction and discharge is permitted hereunder&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(t)&#160;&#160;&#160;&#160;Liens that are contractual rights of setoff&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(u)&#160;&#160;&#160;&#160;Liens arising out of consignment or similar arrangements for the sale of goods entered into by the Company or any Subsidiary in the ordinary course of business&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;in connection with the sale or transfer of any Equity Interests or other assets in a transaction permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;7.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, customary rights and restrictions contained in agreements relating to such sale or transfer pending the completion thereof&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(w)&#160;&#160;&#160;&#160;in the case of (i) any Subsidiary that is not a Wholly Owned Subsidiary or (ii) the Equity Interests in any Person that is not a Subsidiary, any encumbrance or restriction, including any put and call arrangements, related to Equity Interests in such Subsidiary or such other Person set forth in the organizational documents of such Subsidiary or such other Person or any related joint venture, shareholders&#8217; or similar agreement&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)&#160;&#160;&#160;&#160;Liens solely on any cash earnest money deposits, escrow arrangements or similar arrangements made by the Company or any Subsidiary in connection with any letter of intent or purchase agreement for an acquisition or other transaction permitted hereunder&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(y)&#160;&#160;&#160;&#160;(i) deposits made in the ordinary course of business to secure obligations to insurance carriers providing casualty, liability or other insurance to the Company and the Subsidiaries and (ii) Liens on insurance policies and the proceeds thereof securing the financing of the premiums with respect thereto&#59; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(z)&#160;&#160;&#160;&#160;Liens on the net cash proceeds of any Indebtedness described in clause (ii) of the definition of Total Debt held in escrow by a third party escrow agent prior to the release thereof from escrow</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Liens on accounts receivable and the proceeds thereof existing or deemed to exist in connection with any Receivables Purchase Transaction, to the extent arising as a result of a recharacterization of a sale of accounts receivable thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mergers, Consolidations and Sales of Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Merge into or consolidate with any other Person, or permit any other Person to merge into or consolidate with it, or sell, transfer, lease or otherwise dispose of (in one transaction or in a series of transactions (whether pursuant to a merger, consolidation or otherwise)) all or substantially all the assets (whether now owned or hereafter acquired) of the Company and its Subsidiaries, taken as a whole, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liquidate or dissolve, except that, if at the time thereof and immediately after giving effect thereto no Event of Default or Default shall have occurred and be continuing, (a) any Person (may merge into the Borrower in a transaction in which the Borrower is the surviving corporation, (b) subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any Person (other than the Borrower or the Parent) may merge into or consolidate with any Subsidiary in a transaction in which the surviving entity is a Subsidiary, (c) any Subsidiary (other than, if the Holdco Reorganization Effective Date has occurred, the Borrower) may liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and is not materially disadvantageous to the Lenders, (d) if the Holdco Reorganization Effective Date has occurred, any Person (other than the Borrower) may merge into the Parent or any Intermediate Holding Company in a transaction in which the Parent or the Intermediate Holding Company, as applicable, is the surviving corporation and (e) any Subsidiary may sell, transfer, lease or otherwise dispose of its assets, and the Company may sell, transfer, lease or otherwise dispose of any of its Subsidiaries (other than, if the Holdco Reorganization Effective Date has occurred, the Borrower), in each case pursuant to one or more mergers or consolidations of any such Subsidiary with other Persons (other than the Borrower) so long as after giving effect to such merger or consolidation or series of mergers and consolidations, as the case may be, the Company and its Subsidiaries have not sold, transferred, leased or otherwise disposed of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business of the Loan Parties and their Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Engage to any material extent in any business or business activity other than businesses of the type currently conducted by the Company and the Subsidiaries and business activities reasonably related thereto.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Permit the Leverage Ratio (a) on the last day of the period of four consecutive fiscal quarters of the Company ending as of March 31, 2021, taken as one accounting period, to be greater than 4.50&#58;1.00 and (b) on the last day of any period of four consecutive fiscal quarters of the Company in each case taken as one accounting period, commencing with such period ending as of June 31, 2021, to be greater than 4.00&#58;1.00 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maintenance Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the event the Company consummates a Qualified Acquisition, the Borrower may elect by notice to the Administrative Agent (which election may be made (x) at any time on or prior to the date that the next Compliance Certificate is delivered pursuant to Section 6.04(c) following the consummation of such Qualified Acquisition and (y) in such Compliance Certificate) that the Maintenance Leverage Ratio be (and, subject to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Maintenance Leverage Ratio shall be) (i) with respect to the last day of the fiscal quarter in which such Qualified Acquisition is consummated and with respect to the last day of each of the next succeeding three (3) fiscal quarters, 4.50&#58;1.00 (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Holiday</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and (ii) with respect to the last day of the fiscal quarter following the first anniversary of the consummation of such Qualified Acquisition and thereafter, 4.00&#58;1.00, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, following any Leverage Holiday, the Borrower shall not be entitled to make another such election unless and until the Maintenance Leverage Ratio shall have been equal to or less than 4.00&#58;1.00 on the last day of at least two fiscal quarters following the end of the preceding Leverage Holiday. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Directly, or indirectly, use the proceeds of any Credit Extension, or lend, contribute or otherwise make available such proceeds to, if the Holdco Reorganization Effective Date has occurred, the Parent or any Subsidiary, joint venture partner or other individual or entity, to fund any activities of or business with any individual or entity, that, at the time of such funding, is the subject of Sanctions, or in any country or territory that, at the time of such funding, is a Designated Jurisdiction, except to the extent licensed by OFAC or otherwise authorized under U.S. law, or in any other manner that will result in a violation by any individual or entity (including any individual or entity participating in the transaction, whether as Lender, Joint Lead Arranger, Administrative Agent, L&#47;C Issuer, Swing Line Lender, or otherwise) of Sanctions. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Corruption Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Directly, or to the knowledge of the Borrower, indirectly use the proceeds of any Credit Extension for any purpose which would breach the United States Foreign Corrupt Practices Act of 1977, the UK Bribery Act 2010, or other similar legislation in other jurisdictions.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE VIII<br><br>EVENTS OF DEFAULT AND REMEDIES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any of the following shall constitute an Event of Default&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;any representation or warranty made or deemed made in or in connection with this Agreement or the Borrowings or issuances of Letters of Credit hereunder, or any representation, warranty, statement or information contained in any report, certificate, financial statement or other instrument furnished in connection with or pursuant to this Agreement, shall prove to have been false or misleading in any material respect when so made, deemed made or furnished&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;the Borrower fails to pay (i) when and as required to be paid herein, any amount of principal of any Loan or any L&#47;C Obligation, or (ii) within five Business Days after the same becomes due, any interest on any Loan or on any L&#47;C Obligation, or any fee due hereunder, or (iii) within five Business Days after the same becomes due, any other amount payable hereunder or under any other Loan Document&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;default shall be made in the due observance or performance by the Loan Parties of any covenant, condition or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (with respect to the Parent or the Borrower), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.05(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.09(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article VII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;default shall be made in the due observance or performance by the Loan Parties of any covenant, condition or agreement contained in this Agreement (other than those specified in paragraphs (b) or (c) above) and such default shall continue unremedied for a period of 30 days after the earlier of (i) the date such default first becomes known to any Responsible Officer of the Borrower and (ii) written notice thereof from the Administrative Agent to the Borrower (which notice will be given at the request of any Lender)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;(i) the Parent, the Borrower or any Material Subsidiary shall fail to pay any principal or interest, regardless of amount, due in respect of any Material Indebtedness, when and as the same shall become due and payable (after giving effect to any applicable grace period), or (ii) any other event or condition occurs (after giving effect to any applicable grace period) that results in any Material Indebtedness becoming due prior to its scheduled maturity or that enables or permits the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity (other than (i) customary non-default mandatory prepayment requirements, including mandatory prepayment events associated with asset sales, casualty events, debt or equity issuances, extraordinary receipts or borrowing base limitations and (ii) any prepayment, repurchase, redemption or defeasance of any Indebtedness described in clause (ii) of the definition of Total Debt if the related Qualified Acquisition is not consummated)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;an involuntary proceeding shall be commenced or an involuntary petition shall be filed in a court of competent jurisdiction seeking (i) relief in respect of the Parent, the Borrower or any Material Subsidiary, or of a substantial part of the property or assets of the Parent, the Borrower or any Material Subsidiary, under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Parent, the Borrower or any Material Subsidiary or for a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">substantial part of the property or assets of the Parent, the Borrower or any Material Subsidiary or (iii) the winding-up or liquidation of the Parent, the Borrower or any Material Subsidiary&#59; and such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;the Parent, the Borrower or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking relief under Title 11 of the United States Code, as now constituted or hereafter amended, or any other Federal, state or foreign bankruptcy, insolvency, receivership or similar law, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or the filing of any petition described in paragraph (f) above, (iii) apply for or consent to the appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Parent, the Borrower or any Material Subsidiary or for a substantial part of the property or assets of the Parent, the Borrower or any Material Subsidiary, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors, (vi) become unable, admit in writing its inability or fail generally to pay its debts as they become due or (vii) take any action for the purpose of effecting any of the foregoing&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)&#160;&#160;&#160;&#160;a judgment for the payment of money in an amount in excess of $200,000,000 shall be rendered against the Parent, the Borrower or any Material Subsidiary and the same shall remain undischarged for a period of 30 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of the Parent, the Borrower or any Material Subsidiary to enforce any such judgment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any such judgment shall not be an Event of Default under this paragraph (h) if and for so long as (i) the entire amount of such judgment in excess of $200,000,000 is covered by a valid and binding policy of insurance between the defendant and the insurer covering payment thereof and (ii) such insurer, which shall be rated at least &#8220;A&#8221; by A.M. Best Company, has been notified of, and has not disputed the claim made for payment of the amount of such judgment&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;an ERISA Event shall have occurred that results in liability of the Company and its ERISA Affiliates exceeding $200,000,000&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(j)&#160;&#160;&#160;&#160;there shall have occurred a Change in Control&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)&#160;&#160;&#160;&#160;other than as a result of the satisfaction in full of all the Obligations (excluding contingent indemnification obligations for which no claim has been asserted) or a release pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (i) any material provision of the Guaranty at any time and for any reason other than as permitted hereunder, ceases to be in full force and effect, (ii) any Loan Party or any other Subsidiary contests in any manner the validity or enforceability of any provision of the Guaranty or (iii) any Guarantor denies that it has any or further liability or obligation under the Guaranty, or purports to revoke, terminate or rescind any provision of the Guaranty.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies Upon Event of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any Event of Default occurs and is continuing at any time, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders, by written notice to the Borrower, take any or all of the following actions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;declare the commitment of each Lender to make Loans and any obligation of each L&#47;C Issuer to make L&#47;C Credit Extensions to be terminated, whereupon such commitments and obligation shall be terminated&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;declare the unpaid principal amount of all outstanding Loans, all interest accrued and unpaid thereon, and all other amounts owing or payable hereunder or under any other Loan Document to be immediately due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived by the Loan Parties&#59; </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;require that the Borrower Cash Collateralize the L&#47;C Obligations (in an amount equal to the then Outstanding Amount thereof)&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Loan Documents&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that upon the occurrence of an actual or deemed entry of an order for relief with respect to any Loan Party under the Bankruptcy Code of the United States, the obligation of each Lender to make Loans and any obligation of each L&#47;C Issuer to make L&#47;C Credit Extensions shall automatically terminate, the unpaid principal amount of all outstanding Loans and all interest and other amounts as aforesaid shall automatically become due and payable, and the obligation of the Borrower to Cash Collateralize the L&#47;C Obligations as aforesaid shall automatically become effective, in each case without further act of the Administrative Agent or any Lender.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Application of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">After the exercise of remedies provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or after the Loans have automatically become immediately due and payable and the L&#47;C Obligations have automatically been required to be Cash Collateralized as set forth in the proviso to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), any amounts received on account of the Obligations shall, subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, be applied by the Administrative Agent in the following order&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to payment of that portion of the Obligations constituting fees, indemnities, expenses and other amounts (including fees, charges and disbursements of counsel to the Administrative Agent and amounts payable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) payable to the Administrative Agent in its capacity as such&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to payment of that portion of the Obligations constituting fees, indemnities and other amounts (other than principal, interest and Letter of Credit Fees) payable to the Lenders and L&#47;C Issuers (including fees, charges and disbursements of counsel to the respective Lenders and L&#47;C Issuers) arising under the Loan Documents and amounts payable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, ratably among them in proportion to the respective amounts described in this clause </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> payable to them&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to payment of that portion of the Obligations constituting accrued and unpaid Letter of Credit Fees and interest on the Loans and L&#47;C Borrowings, ratably among the Lenders and L&#47;C Issuers in proportion to the respective amounts described in this clause </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> held by them&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to (a) payment of that portion of the Obligations constituting accrued and unpaid principal of the Loans and L&#47;C Borrowings and (b) Cash Collateralize that portion of L&#47;C Obligations comprised of the aggregate undrawn amount of Letters of Credit, ratably among the Lenders and L&#47;C Issuers in proportion to the respective amounts described in this clause </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> held by them&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Last</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the balance, if any, after all of the Obligations have been indefeasibly paid in full, to the Borrower or as otherwise required by Law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, amounts used to Cash Collateralize the aggregate undrawn amount of Letters of Credit pursuant to clause </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above shall be applied to satisfy drawings under such Letters of Credit as they occur.  If any amount remains on deposit as Cash Collateral after all Letters of Credit have either been fully drawn or expired, such remaining amount shall be applied to the other Obligations, if any, in the order set forth above or if the Obligations above have been fully satisfied, released to the Borrower, if applicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE IX<br><br>ADMINISTRATIVE AGENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Appointment and Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Lenders and L&#47;C Issuers hereby irrevocably appoints Bank of America to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are incidental thereto.  The provisions of this Article (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) are solely for the benefit of the Administrative Agent, the Lenders and the L&#47;C Issuers, and the Loan Parties shall not have rights as a third party beneficiary of any of such provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Person serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity.  Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with the Company or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exculpatory Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents, and its duties hereunder shall be administrative in nature.  Without limiting the generality of the foregoing, the Administrative Agent&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Company or any of its Affiliates that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or (ii) in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment.  The Administrative Agent shall be deemed not to have knowledge of any Default unless and until notice describing such Default is given in writing to the Administrative Agent by a Loan Party, a Lender or an L&#47;C Issuer.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance by Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person.  The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon.  In determining compliance with any condition hereunder to the making of a Loan, or the issuance of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or L&#47;C Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or L&#47;C Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or L&#47;C Issuer prior to the making of such Loan or the issuance of such Letter of Credit.  The Administrative Agent may consult with legal counsel (who may be counsel for the Loan Parties), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delegation of Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent.  The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties.  The exculpatory provisions of this Article shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation of Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Administrative Agent may at any time give notice of its resignation to the Lenders, the L&#47;C Issuers and the Borrower.  Upon receipt of any such notice of resignation, the Required Lenders shall have the right to appoint a successor (and so long as an Event of Default has not occurred and is continuing, with the consent of the Borrower (not to be unreasonably withheld or delayed)), which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States.  If no such successor shall have been appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders and so long as an Event of Default has not occurred and is continuing, the Borrower) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the retiring Administrative Agent may (but shall not be obligated to) on behalf of the Lenders and the L&#47;C Issuers, appoint (and so long as an Event of Default has not occurred and is continuing, with the consent of the Borrower (not to be unreasonably withheld or delayed)) a successor Administrative Agent meeting the qualifications set forth above.  Whether or not a successor has been appointed, such resignation shall become effective in accordance with such notice on the Resignation Effective Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;If the Person serving as Administrative Agent is a Defaulting Lender, the Required Lenders may, to the extent permitted by applicable Law by notice in writing to the Borrower and such Person remove such Person as the Administrative Agent and, so long as an Event of Default has not occurred and is continuing, with the consent of the Borrower (not to be unreasonably withheld or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">delayed), appoint a successor.  If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within thirty (30) days (or such earlier day as shall be agreed by the Required Lenders) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Removal Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective Date.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;With effect from the Resignation Effective Date or the Removal Effective Date (as applicable) (1) the retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents, (2) all payments and communications  provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender and L&#47;C Issuer directly and (3) all determinations provided to be made by the Administrative Agent shall instead be made by the Required Lenders, until such time as the Required Lenders appoint a successor Administrative Agent as provided for above in this Section.  Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring or removed Administrative Agent, and the retiring or removed Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section).  The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor.  After the retiring or removed Administrative Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this Article and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall continue in effect for the benefit of such retiring or removed Administrative Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any resignation by or removal of Bank of America as Administrative Agent pursuant to this Section shall also constitute its resignation or removal as L&#47;C Issuer and Swing Line Lender.  Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring L&#47;C Issuer and Swing Line Lender, (b) the retiring L&#47;C Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents, and (c) the successor L&#47;C Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the retiring L&#47;C Issuer to effectively assume the obligations of the retiring L&#47;C Issuer with respect to such Letters of Credit.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Reliance on Administrative Agent and Other Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Lender and each L&#47;C Issuer acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement.  Each Lender and each L&#47;C Issuer also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Other Duties&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anything herein to the contrary notwithstanding, none of the bookrunners, arrangers, syndication agents, documentation agents or co-agents shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, a Lender or an L&#47;C Issuer hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent May File Proofs of Claim</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the a Loan Party, the Administrative Agent (irrespective of whether the principal of any Loan or L&#47;C Obligation shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Administrative Agent shall have made any demand on a Loan Party) shall be entitled and empowered, by intervention in such proceeding or otherwise&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans, L&#47;C Obligations and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders, the L&#47;C Issuers and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders, the L&#47;C Issuers and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders, the L&#47;C Issuers and the Administrative Agent under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.03(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) allowed in such judicial proceeding&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender and each L&#47;C Issuer to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders and the L&#47;C Issuers, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.09</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender or L&#47;C Issuer any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Recovery of Erroneous Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or L&#47;C Issuer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), whether or not in respect of an Obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Credit Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith promptly on demand, but in any event no later than one Business Day thereafter, the Rescindable Amount received by such Credit Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation. Each Credit Party irrevocably waives to the extent permitted by applicable law any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount. The Administrative Agent shall inform each Credit Party promptly upon determining that any payment made to such Credit Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE X<br><br>GUARANTY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor hereby absolutely and unconditionally guarantees, as a guaranty of payment and performance and not merely as a guaranty of collection, prompt payment when due, whether at stated maturity, by required prepayment, upon acceleration, demand or otherwise, and at all times thereafter, of any and all of the Obligations, whether for principal, interest, premiums, fees, indemnities, damages, costs, expenses or otherwise, of the Borrower to the Lender Parties arising hereunder or under any other Loan Document (including all renewals, extensions, amendments, refinancings and other modifications </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">thereof and all costs, attorneys&#8217; fees and expenses incurred by the Lender Parties in connection with the collection or enforcement thereof in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).  Without limiting the generality of the foregoing, the Obligations shall to the maximum extent permitted by applicable law include any such indebtedness, obligations and liabilities, or portion thereof, which may be or hereafter become unenforceable or compromised or shall be an allowed or disallowed claim under any proceeding or case commenced by or against a Loan Party under any Debtor Relief Laws.  The Administrative Agent&#8217;s books and records showing the amount of the Obligations shall be admissible in evidence in any action or proceeding, and shall be binding upon each Guarantor, and conclusive for the purpose of establishing the amount of the Obligations absent manifest error.  This Guaranty shall not be affected by the genuineness, validity, regularity or enforceability of the Obligations or any instrument or agreement evidencing any Obligations, or by the existence, validity, enforceability, perfection, non-perfection or extent of any collateral therefor, or by any fact or circumstance relating to the Obligations which might otherwise constitute a defense to the obligations of any Guarantor under this Guaranty (other than full payment and performance), and each Guarantor hereby irrevocably waives to the maximum extent permitted by applicable law any defenses it may now have or hereafter acquire in any way relating to any or all of the foregoing.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Setoff or Deductions&#59; Taxes&#59; Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor represents and warrants that it is organized in the United States of America.  Each Guarantor shall make all payments hereunder without setoff or counterclaim and subject to, and in accordance with, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, free and clear of and without deduction for any Taxes.  The obligations of each Guarantor under this paragraph shall survive the payment in full of the Obligations and termination of this Guaranty.  All payments under this Guaranty shall be made in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The obligations hereunder shall not be affected by any acts of any legislative body or governmental authority affecting the Borrower, including, but not limited to, any restrictions on the conversion of currency or repatriation or control of funds or any total or partial expropriation of the Borrower&#8217;s property, or by economic, political, regulatory or other events in the countries where the Borrower is located. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rights of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the terms of this Agreement, each Guarantor consents and agrees to the maximum extent permitted by applicable law that the Lender Parties may, at any time and from time to time, without notice or demand, and without affecting the enforceability or continuing effectiveness hereof&#58; (a) amend, extend, renew, compromise, discharge, accelerate or otherwise change the time for payment or the terms of the Obligations or any part thereof&#59; (b) take, hold, exchange, enforce, waive, release, fail to perfect, sell, or otherwise dispose of any security for the payment of this Guaranty or any Obligations&#59; (c) apply such security and direct the order or manner of sale thereof as the Administrative Agent, the L&#47;C Issuers and the Lenders in their sole discretion may determine&#59; and (d) release or substitute one or more of any endorsers or other guarantors of any of the Obligations.  Without limiting the generality of the foregoing, each Guarantor consents to the taking of, or failure to take, any action which might in any manner or to any extent vary such Guarantor&#8217;s risks under this Guaranty or which, but for this provision, might operate as a discharge of such Guarantor.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Waivers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor waives to the maximum extent permitted by applicable law (a) any defense arising by reason of any disability or other defense of the Borrower or any other guarantors, or the cessation from any cause whatsoever (including any act or omission of any Lender Party) of the liability of the Borrower&#59; (b) any defense based on any claim that such Guarantor&#8217;s obligations exceed or are more burdensome than those of the Borrower&#59; (c) the benefit of any statute of limitations affecting such Guarantor&#8217;s liability hereunder&#59; (d) any right to proceed against the Borrower, proceed against or exhaust any security for the Obligations, or pursue any other remedy in the power of any Lender Party whatsoever&#59; (e) any benefit of and any right to participate in any security now or hereafter held by any Lender Party&#59; (f) any defense arising from any law or regulation of any jurisdiction or any other event affecting any term of an obligation of such Guarantor&#59; and (g) to the fullest extent permitted by law, any and all other defenses or benefits that may be derived from or afforded by applicable law limiting the liability of or exonerating guarantors or sureties (other than full payment and performance).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor expressly waives to the maximum extent permitted by applicable law all setoffs and counterclaims and all presentments, demands for payment or performance, notices of nonpayment or nonperformance, protests, notices of protest, notices of dishonor and all other notices or demands of any kind or nature whatsoever with respect to the Obligations, and all notices of acceptance of this Guaranty or of the existence, creation or incurrence of new or additional Obligations. As provided below, this Guaranty shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations Independent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The obligations of each Guarantor hereunder are those of primary obligor, and not merely as surety, and are independent of the Obligations and the obligations of any other guarantor. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limitation on Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provisions of this Agreement, the obligations of each Guarantor under this Guaranty shall be limited under the relevant laws applicable to such Guarantor and the granting of this Guaranty (including laws relating to corporate benefit, capital preservation, financial assistance, fraudulent conveyances and transfers, voidable preferences, or transactions under value) to the maximum amount payable such that this Guaranty shall not constitute a fraudulent conveyance, fraudulent transfer, voidable preference, a transaction under value or unlawful financial assistance or otherwise, or under similar laws affecting the rights of creditors generally, cause such Guarantor to be insolvent under relevant law or this Guaranty to be void, unenforceable or ultra vires or cause the directors and officers of such Guarantor to be held in breach of applicable corporate or commercial law providing for this Guaranty. The obligations of each Guarantor will be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Guarantor (including but not limited to any Guarantee by it of other indebtedness), result in the obligations of such Guarantor under this Guaranty not constituting a fraudulent conveyance or fraudulent transfer under applicable law, or being void or unenforceable under any law relating to insolvency of debtors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subrogation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor shall not exercise any right of subrogation, contribution, indemnity, reimbursement or similar rights with respect to any payments it makes under this Guaranty until all of the Obligations and any other amounts payable under this Guaranty have been indefeasibly paid and performed in full (other than unasserted indemnification, tax gross up, expense reimbursement or yield protection obligations, in each case, for which no claim has been made) and the Commitments are terminated.  If any amounts are paid to any Guarantor in violation of the foregoing limitation, then such amounts shall be held in trust for the benefit of the Lender Parties and shall forthwith be paid to the Lender Parties to reduce the amount of the Obligations, whether matured or unmatured.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination&#59; Reinstatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Guaranty is a continuing and irrevocable guaranty of all Obligations now or hereafter existing and shall remain in full force and effect until all Obligations and any other amounts payable under this Guaranty are indefeasibly paid in full in cash (other than unasserted indemnification, tax gross up, expense reimbursement or yield protection obligations, in each case, for which no claim has been made) and the Commitments are terminated.  Notwithstanding the foregoing, this Guaranty shall continue in full force and effect or be revived, as the case may be, if any payment by or on behalf of the Borrower or any Guarantor is made, or any of the Lender Parties exercises its right of setoff, in respect of the Obligations and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by any of the Lender Parties in their discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Laws or otherwise, all as if such payment had not been made or such setoff had not occurred and whether or not the Lender Parties are in possession of or have released this Guaranty and regardless of any prior revocation, rescission, termination or reduction.  The obligations of each Guarantor under this paragraph shall survive termination of this Guaranty.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subordination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor hereby subordinates the payment of all obligations and indebtedness of the Borrower owing to such Guarantor, whether now existing or hereafter arising, including but not limited to any obligation of the Borrower to such Guarantor as subrogee of the Lender Parties or resulting from such Guarantor&#8217;s performance under this Guaranty, to the indefeasible payment in full in cash of all Obligations. If the Lender Parties so request after the occurrence and during the continuance of an Event of Default, any such obligation or indebtedness of the Borrower to any Guarantor shall be enforced and performance received by such Guarantor as trustee for the Lender Parties and the proceeds thereof shall be paid over to the Lender Parties on account of the Obligations, but without reducing or affecting in any manner the liability of such Guarantor under this Guaranty.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stay of Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If acceleration of the time for payment of any of the Obligations is stayed, in connection with any case commenced by or against any Guarantor or the Borrower under any Debtor Relief Laws, or otherwise, all such amounts shall nonetheless be payable by such Guarantor immediately upon written demand by the Lender Parties. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No failure by the Administrative Agent to exercise, and no delay in exercising, any right, remedy or power hereunder shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, remedy or power hereunder preclude any other or further exercise thereof or the exercise of any other right, power or remedy.  The remedies herein provided are cumulative and not exclusive of any remedies provided by law or in equity.  The unenforceability or invalidity of any provision of this Guaranty shall not affect the enforceability or validity of any other provision herein.  Unless otherwise agreed by the Administrative Agent and the applicable Guarantor in writing, this Guaranty is not intended to supersede or otherwise affect any other guaranty now or hereafter given by such Guarantor for the benefit of the Administrative Agent, any Lender Party or any term or provision thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Condition of the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Guarantor acknowledges and agrees that it has the sole responsibility for, and has adequate means of, obtaining from the Borrower and any other guarantor such information concerning the financial condition, business and operations of the Borrower and any such other guarantor as such Guarantor  requires, and that none of the Lender Parties has any duty, and such Guarantor is not relying on the Lender Parties at any time, to disclose to such Guarantor any information relating to the business, operations or financial condition of the Borrower or any other guarantor (such Guarantor waiving any duty on the part of the Lender Parties to disclose such information and any defense relating to the failure to provide the same).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If and to the extent any payment is not made when due hereunder and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent or any Lender may, at any time following the occurrence and during the continuance of Event of Default, set off and charge from time to time any amount so due against any or all of any Guarantor&#8217;s accounts or deposits with the Administrative Agent or such Lender, respectively.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE XI<br><br>MISCELLANEOUS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.01&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No amendment or waiver of any provision of this Agreement or any other Loan Document, and no consent to any departure by the Loan Parties therefrom, shall be effective unless in writing signed by the Required Lenders and the Loan Parties, as the case may be, and acknowledged by the Administrative </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agent, and each such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;no such amendment, waiver or consent shall&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;extend or increase the Commitment of a Lender (or reinstate any Commitment terminated pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) without the written consent of such Lender whose Commitment is being extended or increased (it being understood and agreed that a waiver of any condition precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or of any Default or a mandatory reduction in Commitments is not considered an extension or increase in Commitments of any Lender)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;postpone any date fixed by this Agreement or any other Loan Document for any payment of principal (excluding voluntary prepayments), interest, fees or other amounts due to the Lenders (or any of them) hereunder or under any other Loan Document without the written consent of each Lender entitled to receive such payment (subject to an extension of the Maturity Date of any Lender in accordance with Section 2.16)&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;reduce the principal of, or the rate of interest specified herein on, any Loan or L&#47;C Borrowing, or (subject to clause (i) of the final proviso to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) any fees or other amounts payable hereunder or under any other Loan Document without the written consent of each Lender entitled to receive such payment of principal, interest, fees or other amounts&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that only the consent of the Required Lenders shall be necessary (i) to amend the definition of &#8220;Default Rate&#8221; or to waive any obligation of the Borrower to pay interest or Letter of Credit Fees at the Default Rate or (ii) to amend any financial covenant hereunder (or any defined term used therein) even if the effect of such amendment would be to reduce the rate of interest on any Loan or L&#47;C Borrowing or to reduce any fee payable hereunder so long as the primary purpose of the amendments thereto was not to reduce the interest or fees payable hereunder&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;change any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or the definition of &#8220;Required Lenders&#8221; without the written consent of each Lender directly affected thereby&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;release the Borrower from its obligations to pay principal or interest on the Loans or any other amounts or obligations payable by the Borrower hereunder (unless otherwise permitted by clauses (i), (ii) and (iii) above without the consent of each Lender) or permit the Borrower to assign or otherwise transfer any of its rights or obligations hereunder or under the other Loan Documents, without the written consent of each Lender directly affected thereby&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)&#160;&#160;&#160;&#160;affect the pro rata sharing of payments among Lenders as provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or change any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of each Lender directly affected thereby&#59; or</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)&#160;&#160;&#160;&#160;release the Guaranty provided by the Parent or any Intermediate Holding Company or all or substantially all of the value of the Guaranties without the written consent of each Lender (other than a release pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.09(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;unless also signed by the relevant L&#47;C Issuer, no amendment, waiver or consent shall affect the rights or duties of such L&#47;C Issuer under this Agreement or any Issuer Document relating to any Letter of Credit issued or to be issued by it&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;unless also signed by the Swing Line Lender, no amendment, waiver or consent shall affect the rights or duties of the Swing Line Lender under this Agreement&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d) &#160;&#160;&#160;&#160;unless also signed by the Administrative Agent, no amendment, waiver or consent shall affect the rights or duties of the Administrative Agent under this Agreement or any other Loan Document&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that notwithstanding anything to the contrary herein, (i) the Facilities Fee Letter may be amended, or rights or privileges thereunder waived, in a writing executed only by the parties thereto, (ii) no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder (and any amendment, waiver or consent which by its terms requires the consent of all Lenders or each affected Lender may be effected with the consent of the applicable Lenders other than Defaulting Lenders), except that (x) the Commitment of any Defaulting Lender may not be increased or extended without the consent of such Lender and (y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that by its terms affects any Defaulting Lender more adversely than other affected Lenders shall require the consent of such Defaulting Lender, (iii) each Lender is entitled to vote as such Lender sees fit on any bankruptcy reorganization plan that affects the Loans, and each Lender acknowledges that the provisions of Section 1126(c) of the Bankruptcy Code of the United States supersedes the unanimous consent provisions set forth herein, (iv) the Required Lenders shall determine whether or not to allow the Borrower to use cash collateral in the context of a bankruptcy or insolvency proceeding and such determination shall be binding on all of the Lenders and (v) the L&#47;C Issuers and the Borrower may amend this Agreement to increase the Letter of Credit Sublimit and&#47;or the L&#47;C Fronting Sublimit in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the consent of any other Lenders, provided that such amendment shall not take effect until acknowledged in writing by the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if the Administrative Agent and the Borrower shall have jointly identified an obvious error or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent of any other party to any Loan Document if the same is not objected to in writing by the Required Lenders to the Administrative Agent within 10 Business Days following receipt of notice thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing, this Agreement may be amended (or amended and restated) with the written consent of the Required Lenders, the Administrative Agent and the Borrower (i) to add one or more additional credit facilities to this Agreement, to permit the extensions of credit from time to time outstanding hereunder and the accrued interest and fees in respect thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Revolving Loans and the accrued interest and fees in respect thereof and to include appropriately the Lenders holding such credit facilities in any determination of the Required Lenders and (ii) to change, modify or alter </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other provision hereof relating to pro rata sharing of payments among the Lenders to the extent necessary to effectuate any of the amendments (or amendments and restatements) enumerated in clause (i) above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.02&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices and Other Communications&#59; Facsimile Copies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except in the case of notices and other communications expressly permitted to be given by telephone (and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing (including electronic format such as electronic mail or telecopier) and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopier or electronic mail as follows, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;if to the Borrower, the Administrative Agent, the L&#47;C Issuers or the Swing Line Lender, to the address, telecopier number, electronic mail address or telephone number specified for such Person on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 11.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;if to any Guarantor, to the Borrower&#8217;s address, telecopier number, electronic mail address or telephone number specified for the Borrower in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 11.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;if to any other Lender, to the address, telecopier number, electronic mail address or telephone number specified in its Administrative Questionnaire (including, as appropriate, notices delivered solely to the Person designated by a Lender on its Administrative Questionnaire then in effect for the delivery of notices that may contain material non-public information relating to the Loan Parties).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notices and other communications sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received&#59; notices and other communications sent by telecopier shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next business day for the recipient).  Notices and other communications delivered through electronic communications shall be subject to subsection (b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notices and other communications to the Lenders and the L&#47;C Issuers hereunder may be delivered or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices to any Lender or L&#47;C Issuer pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Article II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if such Lender or L&#47;C Issuer, as applicable, has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next business day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221;  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) have any liability to the Loan Parties, any Lender, any L&#47;C Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Loan Parties&#8217; or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the Platform, any other electronic platform or electronic messaging service, or through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Agent Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in no event shall any Agent Party have any liability to the Loan Parties, any Lender, any L&#47;C Issuer or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Address, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each of the Loan Parties, the Administrative Agent, the L&#47;C Issuers and the Swing Line Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the other parties hereto.  Each other Lender may change its address, telecopier or telephone number for notices and other communications hereunder by notice to the Loan Parties, the Administrative Agent, the L&#47;C Issuers and the Swing Line Lender.  In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reliance by Administrative Agent, L&#47;C Issuers and Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Administrative Agent, the L&#47;C Issuers and the Lenders shall be entitled to rely and act upon any notices (including telephonic notices, Loan Notices and Swing Line Loan Notices) purportedly given by or on behalf of the Borrower even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof.  The Borrower shall indemnify the Administrative Agent, each L&#47;C Issuer, each Lender and the Related Parties of each of them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by or on behalf of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to such Person, be available to the extent that such losses, costs, expenses and liabilities are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from the gross negligence or willful misconduct of such Person (or the gross negligence or willful misconduct of such Person&#8217;s controlled affiliates, officers, directors or employees).  All telephonic notices to and other telephonic communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Private Side Designation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the &#8220;Private Side Information&#8221; or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender&#8217;s compliance procedures and applicable law, including United States Federal and state securities laws, to make reference to Borrower Materials that are not made available through the &#8220;Public Side Information&#8221; portion of the Platform and that may contain material non-public information with respect to the Company, its Affiliates or their respective securities for purposes of United States Federal or state securities laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.03&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Waiver&#59; Cumulative Remedies&#59; Enforcement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No failure by any Lender, any L&#47;C Issuer or the Administrative Agent to exercise, and no delay by any such Person in exercising, any right, remedy, power or privilege hereunder shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.  The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Loan Parties or any of them shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for the benefit of all the Lenders and the L&#47;C Issuers&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the foregoing shall not prohibit (a) the Administrative Agent from exercising on its own behalf the rights and remedies that inure to its benefit (solely in its capacity as Administrative Agent) hereunder and under the other Loan Documents, (b) any L&#47;C Issuer or the Swing Line Lender from exercising the rights and remedies that inure to its benefit (solely in its capacity as L&#47;C Issuer or Swing Line Lender, as the case may be) hereunder and under the other Loan Documents, (c) any Lender from exercising setoff rights in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (subject to the terms of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), or (d) any Lender from filing proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding relative to any Loan Party under any Debtor Relief Law&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if at any time there is no Person acting as Administrative Agent hereunder and under the other Loan Documents, then (i) the Required Lenders shall have the rights otherwise ascribed to the Administrative Agent pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) in addition to the matters set forth in clauses (b), (c) and (d) of the preceding proviso and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any Lender may, with the consent of the Required Lenders, enforce any rights and remedies available to it and as authorized by the Required Lenders.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.04&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses&#59; Indemnity&#59; and Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Costs and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall pay (i) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent and its Affiliates (including the reasonable fees, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">charges and disbursements of counsel for the Administrative Agent), in connection with the preparation, due diligence, negotiation, execution, delivery, administration and syndication of this Agreement and the other Loan Documents or the preparation, negotiation, execution, delivery and administration of any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii) to the extent not already paid pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, all reasonable and documented out-of-pocket expenses incurred by an L&#47;C Issuer in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all reasonable and documented out-of-pocket expenses incurred by the Administrative Agent, any Lender or any L&#47;C Issuer (including the reasonable and documented out-of-pocket fees, charges and disbursements of any counsel for the Administrative Agent, any Lender or any L&#47;C Issuer), in connection with the enforcement or protection of its rights following the occurrence and during the continuance of an Event of Default (A) in connection with this Agreement and the other Loan Documents, including its rights under this Section, or (B) in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit.  Notwithstanding the foregoing, the obligation to reimburse the Lenders and the L&#47;C Issuers for fees, charges and disbursements of counsel in connection with the matters described in clause (iii) above shall be limited to one separate law firm for the Administrative Agent, the Lenders and the L&#47;C Issuers in each relevant jurisdiction (unless there shall exist an actual or perceived conflict of interest among the Administrative Agent, the Lenders and the L&#47;C Issuers, in which case, one or more additional law firms in each relevant jurisdiction shall be permitted to the extent necessary to eliminate such conflict).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Borrower shall indemnify the Administrative Agent (and any sub-agent thereof), each Lender, each Joint Lead Arranger, each syndication agent hereunder, each documentation agent hereunder and each L&#47;C Issuer, and each Related Party of any of the foregoing Persons (each such Person being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses (including the reasonable and documented out-of-pocket fees, charges and disbursements of any counsel for any Indemnitee), incurred by any Indemnitee or asserted against any Indemnitee by any third party or by a Loan Party arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the transactions contemplated hereby or thereby, or, in the case of the Administrative Agent (and any sub-agent thereof) and its Related Parties only, the administration of this Agreement and the other Loan Documents, (ii) any Loan or Letter of Credit or the use or proposed use of the proceeds therefrom (including any refusal by an L&#47;C Issuer to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or release of Hazardous Materials on or from any property owned, leased or operated by the Company or any of its Subsidiaries, or any Environmental Liability related in any way to the Company or any of its Subsidiaries, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by a Loan Party, and regardless of whether any Indemnitee is a party thereto, in all cases, whether or not caused by or arising, in whole or in part, out of the comparative, contributory or sole negligence of the Indemnitee&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (I) are determined by a court of competent jurisdiction by final and nonappealable judgment to have resulted from (x) the gross negligence or willful misconduct of such Indemnitee (or the gross negligence or willful misconduct of such Indemnitee&#8217;s controlled affiliates, officers, directors or employees) or (y) a breach in bad faith of such Indemnitee&#8217;s obligations under the Loan Documents, in each case if the Borrower has obtained a final and nonappealable judgment in its favor on such claim as determined by a court of competent jurisdiction or (II) result from any dispute solely among the Indemnitees other than any claims against an Indemnitee in its capacity or in fulfilling its role as Administrative Agent or any similar role under this Agreement and other than any claims arising out of any act or omission of the Borrower or any of its Affiliates.  Notwithstanding the foregoing, the Borrower shall not be liable for the fees, charges and disbursements of more than one separate law firm for all Indemnitees in each relevant jurisdiction with respect to the same matter (unless there shall exist an actual or perceived conflict of interest among the Indemnitees, in which case, one or more additional law firms shall be permitted in each relevant jurisdiction to the extent necessary to eliminate such conflict).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without limiting the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.04(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply with respect to Taxes other than any Taxes that represent losses, claims, damages, etc. arising from any non-Tax claim.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent that the Borrower for any reason fails to indefeasibly pay any amount required under subsection (a) or (b) of this Section to be paid by them to the Administrative Agent (or any sub-agent thereof), an L&#47;C Issuer or any Related Party of any of the foregoing, each Lender severally agrees to pay to the Administrative Agent (or any such sub-agent), the relevant L&#47;C Issuer or such Related Party, as the case may be, such Lender&#8217;s Applicable Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) or the relevant L&#47;C Issuer in its capacity as such, or against any Related Party of any of the foregoing acting for the Administrative Agent (or any such sub-agent) or the relevant L&#47;C Issuer in connection with such capacity.  The obligations of the Lenders under this subsection (c) are subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Consequential Damages, Etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  To the fullest extent permitted by applicable law, (i) the Loan Parties shall not assert, and the Loan Parties hereby waive, any claim against any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any other Loan Document or any agreement or instrument contemplated hereby, the transactions contemplated hereby or thereby, any Loan or Letter of Credit or the use of the proceeds thereof and (ii) the Loan Parties shall not assert, and the Loan Parties hereby waive, any claim against any Indemnitee, on any theory of liability, for direct or actual damages arising out of, in connection with, or as a result of, this Agreement, any other Loan Document, or any agreement or instrument contemplated hereby, except to the extent such damages are determined in a final, nonappealable judgment by a court of competent jurisdiction to have resulted from (x) such Indemnitee&#8217;s gross negligence, bad faith or willful misconduct or (y) such Indemnitee&#8217;s material breach of this Agreement or any other Loan Document.  No Indemnitee referred to in subsection (b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby, in each case not resulting from such Indemnitee&#8217;s gross negligence, bad faith or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All amounts due under this Section shall be payable not later than ten Business Days after demand therefor.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The agreements in this Section shall survive the resignation of the Administrative Agent and the L&#47;C Issuers, the replacement of any Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all the other Obligations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.05&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Payments Set Aside</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that any payment by or on behalf of a Loan Party is made to the Administrative Agent, any L&#47;C Issuer or any Lender, or the Administrative Agent, any L&#47;C Issuer or any Lender exercises its right of setoff, and such payment or the proceeds of such setoff or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent, such L&#47;C Issuer or such Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Law or otherwise, then (a) to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such setoff had not occurred, and (b) each Lender and each L&#47;C Issuer severally agrees to pay to the Administrative Agent upon demand its applicable share (without duplication) of any amount so recovered from or repaid by the Administrative Agent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to the Federal Funds Rate from time to time in effect.  The obligations of the Lenders and the L&#47;C Issuers under clause (b) of the preceding sentence shall survive the payment in full of the Obligations and the termination of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.06&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The provisions of this Agreement and the other Loan Documents shall be binding upon and inure to the benefit of the parties hereto and thereto and their respective successors and assigns permitted hereby, except that the Loan Parties may not assign or otherwise transfer any of its rights or obligations hereunder or thereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of subsection (b) of this Section, (ii) by way of participation in accordance with the provisions of subsection (d) of this Section or (iii) by way of pledge or assignment of a security interest subject to the restrictions of subsection (f) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void).  Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in subsection (d) of this Section and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the L&#47;C Issuers and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement and the other Loan Documents (including all or a portion of its Commitment and the Loans (including for purposes of this subsection (b), participations in L&#47;C Obligations and Swing Line Loans) at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(i) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of the Trade Date, shall not be less than $5,000,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unless each of the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that concurrent assignments to members of an Assignee Group and concurrent assignments from members of an Assignee Group to a single assignee (or to an assignee and members of its Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has been met&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No consent shall be required for any assignment except to the extent required by subsection (b)(i)(B) of this Section and, in addition&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (1) an Event of Default pursuant to Section 8.01(b), (f) or (g) has occurred and is continuing at the time of such assignment or (2) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund&#59; provided that the Borrower shall have been deemed to have consented to any such assignment unless it shall have objected thereto by written notice to the Administrative Agent within 10 Business Days after receiving written notice thereof&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required if such assignment is to a Person that </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is not a Lender, an Affiliate of such Lender or an Approved Fund with respect to such Lender&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;the consent of the L&#47;C Issuers (such consent not to be unreasonably withheld or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or more Letters of Credit (whether or not then outstanding)&#59; and</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(D)&#160;&#160;&#160;&#160;the consent of the Swing Line Lender (such consent not to unreasonably withheld or delayed) shall be required for any assignment if such assignment is to a Person that is not a Lender, an Affiliate of such Lender or an Approved Fund with respect to such Lender.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(iii) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment.  The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Assignment to Certain Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No such assignment shall be made (A) to the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries, or (B) to any Defaulting Lender or any of its Subsidiaries, or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B) or (C) to a natural person.  </font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent or any Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Applicable Percentage.  Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable Law without compliance with the provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs. </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be (x) entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to facts and circumstances occurring prior to the effective date of such assignment and (y) otherwise subject to the obligations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon written request of the Borrower to the assigning Lender, such assigning Lender shall use commercially reasonable efforts to (x) return any related Note issued to the assigning Lender, or (y) in the case of any loss, theft or destruction of any such Note, provide a customary lost note affidavit from the assigning Lender in form and substance reasonably satisfactory to the Borrower.  Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender.  Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this subsection shall be treated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section.  Upon request by the Borrower, the Administrative Agent shall promptly notify the Borrower of any transfer by a Lender of its rights or obligations under this Agreement not subject to the Borrower&#8217;s consent in the form of a list of current Lenders, although the failure to give any such information shall not affect any assignments or result in any liability by the Administrative Agent.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrative Agent, acting solely for this purpose as an agent of the Borrower (and such agency being solely for tax purposes), shall maintain at the Administrative Agent&#8217;s Office a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans and L&#47;C Obligations owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary.  In addition, the Administrative Agent shall maintain on the Register information regarding the designation, and revocation of designation, of any Lender as a Defaulting Lender.  The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Lender may at any time, without the consent of, or notice to, the Borrower or the Administrative Agent, sell participations to any Person (other than a natural person, a Defaulting Lender or the Borrower or any of the Borrower&#8217;s Affiliates or Subsidiaries) (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in all or a portion of such Lender&#8217;s rights and&#47;or obligations under this Agreement (including all or a portion of its Commitment and&#47;or the Loans (including such Lender&#8217;s participations in L&#47;C Obligations and&#47;or Swing Line Loans) owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Lender&#8217;s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii) the Borrower, the Administrative Agent, the other Lenders and the L&#47;C Issuers shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement.  Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or other modification described in clauses (i) through (v) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that affects such Participant.  Subject to subsection (e) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section.  To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as though it were a Lender, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender.  Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans or other obligations under the Loan Documents (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant's interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.  The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.  For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limitation on Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant if such Lender had not sold the participation, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent.  A Participant that would be a Foreign Lender if it were a Lender shall not be entitled to the benefits of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of the Borrower, to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation as L&#47;C Issuer or Swing Line Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary contained herein, if at any time Bank of America assigns all of its Commitment and Loans pursuant to subsection (b) above, Bank of America may, (i) upon thirty days&#8217; notice to the Borrower and the Lenders, resign as L&#47;C Issuer and&#47;or (ii) upon thirty days&#8217; notice to the Borrower, resign as Swing Line Lender.  In the event of any such resignation as L&#47;C Issuer or Swing Line Lender, the Borrower shall be entitled to appoint from among the Lenders a successor L&#47;C Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no failure by the Borrower to appoint any such successor shall affect the resignation of Bank of America as L&#47;C Issuer or Swing Line Lender, as the case may be.  If Bank of America resigns as L&#47;C Issuer, it shall retain all the rights, powers, privileges and duties of an L&#47;C Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its resignation as L&#47;C Issuer and all L&#47;C Obligations with respect thereto (including the right to require the Lenders to make Base Rate Loans or fund risk participations in Unreimbursed Amounts pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.03(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).  If Bank of America resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make Base Rate Loans or fund risk participations in outstanding Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.04(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon the appointment and acceptance of a successor L&#47;C Issuer and&#47;or Swing Line Lender, (1) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring L&#47;C Issuer or Swing Line Lender, as the case may be, and (2) the successor L&#47;C Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to Bank of America to effectively assume the obligations of Bank of America with respect to such Letters of Credit.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.07&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Certain Information&#59; Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Administrative Agent, the Lenders and the L&#47;C Issuers agrees to maintain the confidentiality of, and not disclose, the Information (as defined below), except that Information may be disclosed (a) to its Affiliates, to its auditors and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and representatives who need to know such Information in connection with this Agreement and to its and its Affiliates&#8217; insurance brokers, insurers and reinsurers in connection with credit risk insurance (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and will be subject to customary confidentiality obligations of professional practice or agree to be bound by the terms of this Section (or language substantially similar to this Section) with the disclosing party responsible for such person&#8217;s compliance with this Section), (b) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), in which case the disclosing party agrees, to the extent permitted by law, rule or regulation and reasonably practicable, to inform the Borrower, except with respect to any customary audit or customary examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority, in advance thereof, (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Person required to disclose such information shall take reasonable efforts (at the Borrower&#8217;s expense) to ensure that any Information so disclosed shall be afforded confidential treatment, to the extent permitted by law, rule or regulation and reasonably practicable, to inform the Borrower, except with respect to any customary audit or customary examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority, promptly in advance thereof, (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">hereunder or thereunder, (f) subject to such Person agreeing to be subject to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or an agreement containing provisions at least as restrictive as those of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction under which payments are to be made by reference to the Borrower and its obligations, this Agreement or payments hereunder, (g) with the consent of the Borrower, (h) to any rating agency when required by it in connection with rating the Borrower or the credit facility provided hereunder, provided, that prior to any disclosure, such rating agency shall undertake in writing to preserve the confidentiality of any Information received by it from the Administrative Agent, any L&#47;C Issuer or any Lender, (i) on a confidential basis to the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of CUSIP numbers with respect to the Loans or (j) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender, any L&#47;C Issuer or any of their respective Affiliates on a nonconfidential basis from a source other than the Borrower who is not, to the knowledge of the Administrative Agent, such L&#47;C Issuer or such Lender, under an obligation of confidentiality to the Borrower with respect to such Information. In addition, the Administrative Agent, the Lenders and the L&#47;C Issuers may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Administrative Agent or any of the Lenders or L&#47;C Issuers in connection with the administration or servicing of this Agreement, the other Loan Documents and the Commitments.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all information received from the Company or any Subsidiary relating to the Company or any Subsidiary or any of their respective businesses.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each of the Administrative Agent, the Lenders and the L&#47;C Issuers acknowledges that (a) the Information may include material non-public information concerning the Company or any Subsidiary, as the case may be, (b) it has developed compliance procedures regarding the use of material non-public information and (c) it will handle such material non-public information in accordance with applicable Law, including United States Federal and state securities Laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.08&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Setoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If an Event of Default shall have occurred and be continuing, each Lender, each L&#47;C Issuer and each of their respective Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable law, to set off and apply any and all deposits (general or special, time or demand, provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by such Lender, such L&#47;C Issuer or any such Affiliate to or for the credit or the account of the Loan Parties against any and all of the obligations of the Loan Parties now or hereafter existing under this Agreement or any other Loan Document to such Lender or L&#47;C Issuer, irrespective of whether or not such Lender or L&#47;C Issuer shall have made any demand under this Agreement or any other Loan Document and although such obligations of the Borrower may be contingent or unmatured or are owed to a branch or office of such Lender or L&#47;C Issuer different from the branch or office holding such deposit or obligated on such indebtedness&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event that any Defaulting Lender shall exercise any such right of setoff, (x) all amounts so set off shall be paid over immediately to the Administrative Agent for further application in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed held in trust for the benefit of the Administrative Agent and the Lenders and (y) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the Obligations owing to such Defaulting Lender as to which it exercised such right of setoff.  The rights of each Lender, each L&#47;C Issuer and their respective Affiliates under this Section are in addition to other rights and remedies (including other rights of setoff) that such Lender, such L&#47;C Issuer or their respective Affiliates may have.  Each Lender and L&#47;C Issuer agrees to notify the Borrower and the Administrative Agent promptly after any such setoff and application, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the failure to give such notice shall not affect the validity of such setoff and application.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.09&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Rate Limitation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable Law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  If the Administrative Agent or any Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrower.  In determining whether the interest contracted for, charged, or received by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable Law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts&#59; Integration&#59; Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract.  This Agreement and the other Loan Documents constitute the entire contract among the parties relating to the subject matter hereof and thereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof and thereof.  Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto.  Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival of Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof.  Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default at the time of any Credit Extension, and shall continue in full force and effect as long as any Loan or any other Obligation hereunder shall remain unpaid or unsatisfied or any Letter of Credit shall remain outstanding.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions.  The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.  Without limiting the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if and to the extent that the enforceability of any provisions in this Agreement relating to Defaulting Lenders shall be limited by Debtor Relief Laws, as determined in good faith by the Administrative Agent, the L&#47;C Issuers or the Swing Line Lender, as applicable, then such provisions shall be deemed to be in effect only to the extent not so limited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If (i) any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iii) a Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Consenting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) does not consent to a proposed change, waiver, discharge or termination with respect to any Loan Document that has been approved by the Required Lenders as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> but requires the unanimous consent of all Lenders or all Lenders directly affected thereby (as applicable), (iv) any Lender is a Defaulting Lender or a Non-</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Accepting Lender, or (v) any Lender delivers a notice pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (each Lender described in the foregoing clauses (i) through (v), a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replaced Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents required by, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), all of its interests, rights and obligations under this Agreement and the related Loan Documents to an assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;the Borrower shall have paid to the Administrative Agent the assignment fee specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.06(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;such Lender shall have received payment of an amount equal to one hundred percent (100%) of the outstanding principal of its Loans and L&#47;C Advances, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any amounts under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.05</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;in the case of any such assignment resulting from a claim for compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or payments required to be made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such assignment will result in a reduction in such compensation or payments thereafter&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;such assignment does not conflict with applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;in the case of any such assignment resulting from a Non-Consenting Lender&#8217;s failure to consent to a proposed change, waiver, discharge or termination with respect to any Loan Document, the applicable replacement bank, financial institution or Fund consents to the proposed change, waiver, discharge or termination&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the failure by such Replaced Lender to execute and deliver an Assignment and Assumption shall not impair the validity of the removal of such Replaced Lender and the mandatory assignment of such Replaced Lender&#8217;s Commitments and outstanding Loans and participations in L&#47;C Obligations and Swing Line Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall nevertheless be effective without the execution by such Replaced Lender of an Assignment and Assumption.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#59; Jurisdiction&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (INCLUDING SECTION 5-1401 AND SECTION 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK) WITHOUT REGARD TO CONFLICTS OF LAW PRINCIPLES THAT WOULD REQUIRE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SUBMISSION TO JURISDICTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  EACH LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE EXCLUSIVE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY AND OF THE UNITED STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL COURT.  EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW.  NOTHING IN THIS AGREEMENT OR IN ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT, ANY LENDER OR ANY L&#47;C ISSUER MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST ANY LOAN PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">WAIVER OF VENUE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  EACH LOAN PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH (B) OF THIS SECTION.  EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SERVICE OF PROCESS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 11.02</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Right to Trial by Jury</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY).  EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature&#8221;, &#8220;delivery&#8221; and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation Assignment and Assumptions, amendments or other modifications, Loan Notices, Swing Line Loan Notices, waivers and consents) shall be deemed to include Electronic Signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act&#59; provided that notwithstanding anything contained herein to the contrary the Administrative Agent is under no obligation to agree to accept Electronic Signatures in any form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it. Without limiting the generality of the foregoing, the Borrower hereby (i) agrees that, for all purposes, including without limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Administrative Agent, the Lenders and the Borrower, electronic images of this Agreement (including with respect to any signature pages hereto) shall have the same legal effect, validity and enforceability as any paper original and (ii) waives any argument, defense or right to contest the validity or enforceability of this Agreement based solely on the lack of paper </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">original copies thereof, including with respect to any signature pages hereto. Upon the reasonable request of the Administrative Agent or any Lender, any Electronic Signature of any party to this Agreement shall, as promptly as practicable, be followed by such manually executed counterpart (which may be by fax or other electronic imaging). For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning assigned to it by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">USA PATRIOT Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Lender</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that is subject to the USA PATRIOT Act and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Loan Parties that pursuant to the requirements of the USA PATRIOT Act and the Beneficial Ownership Regulation, it is required to (a) obtain, verify and record information that identifies the Loan Parties, which information includes the name and address of the Loan Parties and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Loan Parties in accordance with the USA PATRIOT Act and (b) obtain a certification from the Borrower regarding the beneficial ownership of the Borrower to the extent required by the Beneficial Ownership Regulation. The Loan Parties shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or such Lender requests in order to comply with its ongoing obligations under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Advisory or Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower acknowledges and agrees, and acknowledges its Affiliates&#8217; understanding, that&#58; (a)(i) the arranging and other services regarding this Agreement provided by the Administrative Agent, the Lenders and the Joint Lead Arrangers, are arm&#8217;s-length commercial transactions between the Borrower and its Affiliates, on the one hand, and the Administrative Agent, the Lenders and the Joint Lead Arrangers, on the other hand, (ii) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (iii) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents&#59; (b)(i) the Administrative Agent, each Lender and each of the Joint Lead Arrangers each is and has been acting solely as a principal and, except as expressly agreed in writing by the relevant parties, has not been, is not and will not be acting as an advisor, agent or fiduciary, for the Borrower or any of Affiliates or any other Person and (ii) neither the Administrative Agent nor any Lender nor any Joint Lead Arranger has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents&#59; and (c) the Administrative Agent, the Lenders and the Joint Lead Arrangers and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its Affiliates, and neither the Administrative Agent nor any Lender nor any Joint Lead Arranger has any obligation to disclose any of such interests to the Borrower or its Affiliates.  To the fullest extent permitted by law, the Borrower hereby waives and releases any claims that it may have against the Administrative Agent, the Lenders or the Joint Lead Arrangers with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lender ERISA Representation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;Each Lender and each L&#47;C Issuer (x) represents and warrants, as of the Third Amendment and Restatement Effective Date (or, if later, the date that such Lender or L&#47;C Issuer became a Lender or L&#47;C Issuer party hereto), to, and (y) covenants, from the Third Amendment and Restatement Effective Date (or, if later, the date that such Lender or L&#47;C Issuer became a Lender or L&#47;C Issuer party hereto) to the date such Lender or L&#47;C Issuer ceases being a Lender or L&#47;C Issuer party hereto, for the benefit of, the Administrative Agent, the Joint Lead Arrangers and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Loan Parties, that at least one of the following is and will be true&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;such Lender or L&#47;C Issuer is not using &#8220;plan assets&#8221; (within the meaning of 29 CFR &#167; 2510.3-101, as modified by Section 3(42) of ERISA) of one or more Benefit Plans in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">connection with entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments or this Agreement, </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s or such L&#47;C Issuer&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;(A) such Lender or L&#47;C Issuer is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender or L&#47;C Issuer to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender or L&#47;C Issuer, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s or such L&#47;C Issuer&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender or L&#47;C Issuer.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In addition, unless sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or L&#47;C Issuer or such Lender or L&#47;C Issuer has not provided another representation, warranty and covenant as provided in sub-clause (iv) in the immediately preceding clause (a), such Lender or L&#47;C Issuer further (x) represents and warrants, as of the Third Amendment and Restatement Effective Date (or, if later, the date that such Lender or L&#47;C Issuer became a Lender or L&#47;C Issuer party hereto), to, and (y) covenants, from the Third Amendment and Restatement Effective Date (or, if later, the date that such Lender or L&#47;C Issuer became a Lender or L&#47;C Issuer party hereto) to the date such Lender or L&#47;C Issuer ceases being a Lender or L&#47;C Issuer party hereto, for the benefit of, the Administrative Agent, the Joint Lead Arrangers and their respective Affiliates, and not, for the avoidance of doubt, to or for the benefit of the Loan Parties, that none of the Administrative Agent, the Joint Lead Arrangers or any of their respective Affiliates is a fiduciary with respect to the assets of such Lender or L&#47;C Issuer involved in such Lender&#8217;s or L&#47;C Issuer&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Solely to the extent any Lender or L&#47;C Issuer that is an Affected Financial Institution is a party to this Agreement and notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender or L&#47;C Issuer that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the write-down and conversion powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender or L&#47;C Issuer that is an Affected Financial Institution&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of the applicable Resolution Authority.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Third Amendment and Restatement of Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the execution and delivery of this Agreement, the Existing Credit Agreement shall be amended and restated to read in its entirety as set forth herein.  With effect from and including the Third Amendment and Restatement Effective Date, (i) the Commitments of each Lender party hereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consenting Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall be as set forth on Schedule 2.01 (and any Lender under the Existing Credit Agreement that is not listed on Schedule 2.01 shall cease to be a Lender under the Existing Credit Agreement and its commitment under the Existing Credit Agreement shall be terminated), and (ii) the Applicable Percentage of the Consenting Lenders shall be redetermined based on the Commitments set forth in Schedule 2.01 and the participations of the Consenting Lenders in, and the obligations of the Consenting Lenders in respect of, any Swing Line Loans outstanding on the Third Amendment and Restatement Effective Date shall be reallocated to reflect such redetermined Applicable Percentage.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Regarding Any Supported QFCs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any swap contract or any other agreement or instrument that is a QFC (such support, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, and each such QFC, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States.  In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;As used in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the following terms have the following meanings&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">BHC Act Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of a party means an &#8220;affiliate&#8221; (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58;  (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;47.3(b)&#59; or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;&#160;382.2(b).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has the meaning assigned to the term &#8220;qualified financial contract&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Holdco Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary set forth herein, the Borrower may become a Wholly Owned Subsidiary of the Parent by means of a merger of the Borrower with and into a newly organized Wholly Owned Subsidiary of the Parent which shall be organized under the laws of a jurisdiction of the United States (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Reorganization Merger Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or another transaction or series of transactions that result in the Borrower becoming a Wholly Owned Subsidiary of the Parent, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)        each of the Parent and the Permitted Reorganization Merger Subsidiary shall be newly organized solely for the purpose of engaging in the Permitted Holdco Reorganization and, prior to the consummation of the Permitted Holdco Reorganization, (x) shall not have been engaged in any business activities or conducted any operations other than in connection with or as contemplated by the Permitted Holdco Reorganization and (y) shall not have owned any material assets&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)       not less than ten (10) Business Days prior to the Holdco Reorganization Effective Date, the Borrower shall have provided notice in writing to the Administrative Agent describing the Permitted Holdco Reorganization (including the identity of the Parent) in detail reasonably satisfactory to the Administrative Agent&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)       prior to or substantially concurrently with the consummation of the Permitted Holdco Reorganization, (i) the Parent and each Intermediate Holding Company (if any) shall execute and deliver to the Administrative Agent a Joinder Agreement, pursuant to which the Parent and each such Intermediate Holding Company shall unconditionally and irrevocably Guarantee all the Obligations of the Borrower (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Guarantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Parent shall become party hereto as the Parent, the Company, a Guarantor and a Loan Party, and assume the obligations applicable to it in such capacities, and (ii) the Parent and each such Intermediate Holding Company shall deliver to the Administrative Agent such other documents, certificates and opinions as are required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.09(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)       in the event the Borrower is to merge with and into the Permitted Reorganization Merger Subsidiary, the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.03</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such merger shall have been, or substantially concurrently with the consummation of the Permitted Holdco Reorganization shall be, satisfied&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (e)      no Default or Event of Default shall be continuing on the Holdco Reorganization Effective Date, including giving effect to such Permitted Holdco Reorganization.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGES FOLLOW&#93;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the parties hereto have caused this Agreement to be duly executed as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">BORROWER&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;LABORATORY CORPORATION OF AMERICA HOLDINGS,</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a Delaware corporation</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ADMINISTRATIVE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AGENT&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BANK OF AMERICA, N.A.,</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Administrative Agent</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LENDERS&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;BANK OF AMERICA, N.A.,</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as a Lender, Swing Line Lender and L&#47;C Issuer</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as a Lender and L&#47;C Issuer</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>3
<FILENAME>exhibit1018thomaspikeemplo.htm
<DESCRIPTION>EX-10.18
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iafd7fd6f9fb3457eb8d168f72da8ffca_1"></div><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:128%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:128%">Exhibit 10.18</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:128%">Execution Version</font></div></div><div><font><br></font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This EXECUTIVE EMPLOYMENT AGREEMENT (&#8220;Agreement&#8221;) is entered into as of the 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of January 2023, by and among Laboratory Corporation of America Holdings, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Thomas H. Pike, an individual (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company desires to employ the Executive as the President and Chief Executive Officer of the Company&#8217;s Clinical Development Business Unit and the Executive desires to accept such employment as the President and Chief Executive Officer of the Company&#8217;s Clinical Development Business Unit&#59; </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Company and the Executive acknowledge and agree that the Clinical Development Business Unit is contemplated to be spun off to the Company&#8217;s shareholders through a tax-free transaction consistent with the Company&#8217;s public announcement dated July 28, 2022 (such transaction, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and that, if such Spinoff is completed, this Agreement will be assigned to one or more entities comprising part of such Spinoff (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinco</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and that the Executive will, no later than the time of the Spinoff, become the President and Chief Executive Officer, and Chairman of the Board of Directors of Spinco&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, consistent with Section 15, following the Spinoff and Spinco&#8217;s assumption of this Agreement, all references herein to the Company shall be deemed as able to be references to Spinco, as applicable unless context dictates otherwise.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties hereto agree as follows&#58; </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  On the terms and conditions set forth in this Agreement, and subject to Section 6 hereof, the Company agrees to employ the Executive and the Executive agrees to be employed by the Company for the Employment Period set forth in Section 2 and in the positions and with the duties set forth in Section 3.  </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The initial term of employment under this Agreement shall be for a period beginning on January 9, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and ending on December 31, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), unless sooner terminated as hereinafter set forth&#59; provided that, on the Expiration Date and on each annual anniversary thereafter (such date and each annual anniversary thereof, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Renewal Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Agreement shall be deemed to be automatically extended upon the same terms and conditions (except for such terms and conditions that expire prior to any extension period), for successive periods of one year, unless the Company or the Executive provides written notice of its intention not to extend the term of the Agreement at least 180 days&#8217; prior to the applicable Renewal Date.  The period during which the Executive is employed by the Company hereunder is hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#8221;  Any termination of the Executive&#8217;s employment upon the expiration of the Term following notice by the Company to Executive that the Term shall not be renewed shall constitute a termination by the Company without Cause or constitute Good Reason (each as defined below).  For the avoidance of doubt, the Executive&#8217;s employment shall terminate upon the expiration of the Term following notice by either the Company or the Executive, unless the parties shall at such time otherwise agree in writing.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%">  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10.5pt;font-weight:400;line-height:128%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Positions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For the period commencing on the Effective Date until the completion of the Spinoff, Executive will be employed as the President and Chief Executive Officer of the Company&#8217;s Clinical Development Business Unit.  In such capacities, the Executive shall report to the Company&#8217;s Chief Executive Officer and perform the reasonable and lawful duties and responsibilities as the Company&#8217;s Chief Executive Officer may from time to time determine to assign to the Executive, consistent with his position and experience, which shall include the management and oversight of the Clinical Development Business Unit.  In such role, Executive will have substantial involvement in the circumstances and terms of the Spinoff, including but not limited to substantial involvement in strategic operational decision making, selection of a senior leadership team and participation in the interview and selection of future members of the Spinco Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinco Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), provided that all decision making prior to the Spinoff is subject to approval of the Company&#8217;s Chief Executive Officer.  Subject to the completion of the Spinoff, this Agreement, all of the obligations hereunder, and Executive&#8217;s employment will be assigned to Spinco, effective upon completion of the Spinoff.  Immediately upon completion of the Spinoff and Spinco&#8217;s assumption of this Agreement, Executive will serve as Chairman of the Spinco Board and President and Chief Executive Officer of Spinco.  In such capacities, the Executive shall report to the Spinco Board and perform the reasonable and lawful duties and responsibilities, consistent with his position and experience, as the Spinco Board may from time to time determine to assign to the Executive.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Location</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. During the Employment Period, the Executive&#8217;s primary office location shall be in Maricopa County, Arizona.  Executive hereby represents that he has a dedicated space in his personal residence that will be used for the performance of his duties hereunder.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Executive&#8217;s employment shall be subject to the policies maintained and established by the Company, as the same may be amended from time to time.  The Executive acknowledges and agrees that the Executive owes a fiduciary duty of loyalty, fidelity and allegiance to act at all times in the best interests of the Company and to do no act that would intentionally injure the business, interests, or reputation of the Company or its subsidiaries and affiliates.  In keeping with these duties, the Executive shall make full disclosure to the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of all business opportunities pertaining to the business of the Company and shall not appropriate for the Executive&#8217;s own benefit business opportunities that fall within the scope of the businesses conducted by the Company.  The Executive shall also devote the Executive&#8217;s reasonable best efforts and full business time to the performance of the Executive&#8217;s duties hereunder and the advancement of the business and affairs of the Company.  Subject to the prior written approval of the Board, the Executive may serve on boards of directors of other publicly traded and private companies. The Executive has previously disclosed to the Board, and the Board hereby approves, those boards of directors on which he serves as of the date of this Agreement.</font></div><div><font><br></font></div><div style="padding-left:4.5pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Subject to and contingent upon the completion of the Spingoff and the assumption of this Agreement, the Board will cause the Executive to be appointed to the Spinco Board and the Executive will serve as its Chairman immediately upon completion of the Spinoff.  The Executive will serve in this capacity without additional compensation, and in advance of the expiration of each term as a director, in due course, and, subject to the annual approval of the applicable nominating committee of the Spinco Board in accordance with its duties and responsibilities, shall be nominated for re-election to the Spinco Board so long as he is then serving as Chief Executive Officer of Spinco and is eligible to be a member of the Spinco Board under applicable law or rules of the national securities exchange on which Spinco&#8217;s common stock is then listed, if any.  The Executive&#8217;s continued membership on the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Spinco Board shall be subject to election in accordance with the by-laws of Spinco and applicable law, and shall not be considered a condition to Executive&#8217;s performance of his obligations hereunder, nor shall failure to be elected to the Spinco Board be considered a diminution of Executive&#8217;s duties or responsibilities, pursuant to the Good Reason definition set forth in Section 6(a)(y)(iii) below, provided Executive has been nominated for re-election to the Spinco Board.  The Executive also agrees to serve without additional compensation, if elected or appointed thereto, as a director or member of any of the Company&#8217;s or Spinco&#8217;s subsidiaries or affiliates and in one or more executive offices of any of the Company&#8217;s or Spinco&#8217;s subsidiaries or affiliates.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Executive acknowledges that Executive shall be subject to and must comply with the Company&#8217;s policy with respect to ownership of Company common stock as it may be in effect from time to time.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation and Benefits.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   Commencing on the Effective Date, the Company shall pay to the Executive a base salary at the initial rate of $1,100,000 per calendar year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), prorated for any partial year of employment.  The Base Salary shall be reviewed for increase by the compensation committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) no less frequently than annually during the customary annual review period for other senior executives and may be increased in the discretion of the Compensation Committee.  Any such increase in Base Salary shall constitute the &#8220;Base Salary&#8221; for purposes of this Agreement.  The Base Salary shall be paid in substantially equal installments in accordance with the Company&#8217;s regular payroll procedures and policies in effect from time to time.  The Executive&#8217;s Base Salary may not be decreased during the Employment Period other than pursuant to a like proportionate reduction of base salaries of other senior executives of the Company.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sign-On Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.   Following the Effective Date, the Executive shall be granted equity awards under the Company&#8217;s 2016 Omnibus Incentive Plan, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Omnibus Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) with an aggregate grant date fair value of approximately $4,000,000 (subject to rounding), consistent with the Company&#8217;s practice for determining such value (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sign-On Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Sign-On Equity Grant will be comprised of time-vesting restricted stock units, which are eligible to vest and be settled in shares of common stock of the Company in substantially equal installments on each of the first through third anniversaries of the date of grant and will be subject to an adjustment provision where any unvested portion of such Sign-On Equity Grant may, in connection with the Spinoff, be converted into Spinco equity awards and assumed by Spinco (or otherwise equitably adjusted under the terms of the Omnibus Plan).  The Sign-On Equity Grant shall be subject to the terms and conditions of the Omnibus Plan and substantially the form of award agreement attached hereto as Exhibit 1.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delayed Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If by July 3, 2023, the Spinoff has not been completed but the Board has not made a determination not to complete the Spinoff, the Executive will receive an additional one-time equity award under the Omnibus Plan with an aggregate grant date fair value of approximately $4,000,000 (subject to rounding), consistent with the Company&#8217;s practice for determining such value (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delayed Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Delayed Equity Grant will be comprised of time-vesting restricted stock units, which are eligible to vest and be settled in shares of common stock of the Company in substantially equal installments on each of the first through third anniversaries of the date of grant and may be subject to an adjustment provision where any unvested portion of such Delayed Equity Grant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will, upon completion of the Spinoff, be converted into Spinco equity awards and assumed by Spinco (or otherwise equitably adjusted under the terms of the Omnibus Plan).  The Delayed Equity Grant shall be subject to the terms and conditions of the Omnibus Plan and a form of award agreement that will be substantially in the form attached as Exhibit 1, subject to such changes as the Company makes to its regular grant agreements for other senior executives of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinco Equity Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Following completion of the Spinoff and subject to approval of the Spinco Board or the applicable committee thereof, Executive shall receive one or more equity awards of Spinco equity with an aggregate grant date fair value of approximately $20,000,000 (subject to rounding), consistent with Spinco&#8217;s practice for determining such value (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Initial Spinco Equity Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), comprised of 30% in restricted stock units and 70% in stock options which will have a maximum term of ten (10) years, which, in the case of both restricted stock units and stock options will be eligible to vest and be settled in (or, with respect to stock options, exercised for) shares of common stock of Spinco as follows&#58; (i) if the Spinoff occurs on or before December 31, 2023, in substantially equal installments on each of the first through third anniversaries of the date of grant, (ii) if the Spinoff occurs at any time during 2024, in substantially equal installments on each of January 1, 2025, January 1, 2026 and January 1, 2027 or (iii) pursuant to any other vesting schedule established by the Spinco Board in its unfettered discretion so long as all shares vest within 3 years of the grant date. The Initial Spinco Equity Grant shall be subject to the terms and conditions of the Spinco equity incentive plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinco Omnibus Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and form of award agreement.  Equity awards following the completion of the Spinoff will be determined by the Spinco Board or the applicable committee thereof, provided that the first Spinco equity award following the expiration of the Initial Term will have an aggregate target grant date fair value of approximately $8,000,000 (subject to rounding).  Notwithstanding the foregoing, in the event that Executive receives a Delayed Equity Grant, then the amount of the Initial Spinco Equity Grant will be reduced by the grant date fair value of the Delayed Equity Grant.   In other words, if Executive receives a Delayed Equity Grant of $4,000,000, the $20,000,000 grant date fair value of the Initial Spinco Equity Grant will be reduced by $4,000,000 to equal approximately $16,000,000 (subject to rounding).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Grants During Initial Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For the avoidance of doubt, other than the Sign-On Equity Grant, the Delayed Equity and the Initial Spinco Equity Grant, no other equity grants of either the Company or Spinco equity will be made during the Initial Term.</font></div><div style="padding-left:36pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For each calendar year that ends during the Employment Period beginning with calendar year 2023, the Executive shall be eligible to receive an annual bonus pursuant to the Company&#8217;s management incentive bonus plan or any successor plan that is in effect from time to time (any such bonus, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incentive Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Executive&#8217;s target Incentive Bonus amount for a particular calendar year of the Company shall equal one hundred and fifty percent (150%) of the Executive&#8217;s Base Salary for that calendar year (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Target Bonus Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; provided that the Executive&#8217;s actual Incentive Bonus payout for a particular calendar year shall be determined by the Compensation Committee in its sole and unfettered discretion taking into account performance objectives (which may include corporate and individual objectives initially established with respect to a particular calendar year by the Compensation Committee in consultation with Executive and, in connection with the Spinoff, converted or paid-out on the same basis as similar awards held by Spinco senior executives who participate in the Company&#8217;s management incentive bonus plan or its successor,) and may be more or less than the Target Bonus Amount.  For the calendar year 2023, the Executive&#8217;s Target Bonus Amount shall be pro-rated (calculated as the Target Bonus Amount for the entire 2023 calendar year multiplied by a fraction the numerator of which is equal to the number of days the Executive was employed as an employee in the 2023 calendar year and the denominator of which is 365).  The Target Bonus Amount shall be reviewed for increase by the Compensation </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Committee no less frequently than annually during the customary annual review period for other senior executives and may be increased in the discretion of the Compensation Committee.  Any such increase in the Target Bonus Amount shall constitute the &#8220;Target Bonus Amount&#8221; for purposes of this Agreement.  Notwithstanding the foregoing, for calendar year 2023, Executive&#8217;s Incentive Bonus payout shall be no less than 100% of Executive&#8217;s Base Salary, provided that such 2023 Incentive Bonus payout shall be subject to proration, consistent with Section 7(e) if Executive is terminated by the Company without Cause or if Executive terminates employment for Good Reason during 2023.  Except as otherwise set forth herein, the Executive must be actively employed by the Company throughout the applicable bonus measurement period and shall not have given notice of termination (other than for Good Reason (as set forth below), or been given notice by the Company of the termination of this Agreement for Cause (as set forth below) where such breach giving rise to Cause or Good Reason is not cured, at any time during the applicable bonus measurement period to be eligible to receive the Incentive Bonus. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the Employment Period, the Executive shall be entitled to participate in all employee benefit plans, practices and programs maintained by the Company, as in effect from time to time, that are generally made available to senior executives of the Company, provided that Executive will not participate in the Labcorp Master Senior Executive Severance Plan or any similar such Spinco severance plan, if established.  The Company reserves the right to amend, modify or cancel any employee benefit plans, practices and programs, and any fringe benefits and perquisites, as applicable to executives of the Company generally, at any time and without the consent of the Executive.  </font></div><div style="padding-left:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company Compensation Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise provided herein, all compensation provided to the Executive pursuant to this Section 4 shall be in accordance with the Company&#8217;s compensation plans and policies.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Clawback&#47;Recoupment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation, including the Incentive Bonus, the Sign-On Equity Grant and the Delayed Equity Grant, or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or arrangement with the Company shall be subject to the terms of the Company&#8217;s Incentive Compensation Recoupment Policy, as separately provided to Executive, and as the same may be amended from time to time or replaced by any successor Company policy, including to implement Section 10D of the Securities Exchange Act of 1934, as amended and any applicable rules or regulations promulgated thereunder (including applicable rules and regulations of any applicable national securities exchange).Except as otherwise provided herein, all compensation provided to the Executive pursuant to this Section 4 shall be in accordance with the Company&#8217;s compensation plans and policies</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall reimburse the Executive for all expenses reasonably and actually incurred in accordance with policies which may be adopted from time to time by the Company promptly upon periodic presentation by the Executive of an itemized account, including reasonable substantiation, of such expenses.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (x) This Agreement may be terminated by the Company prior to the Effective Date under the following circumstances&#58; (i) the Executive&#8217;s death or Disability (as defined below), (ii) if an event that would constitute Cause, as defined below, had the Executive then been employed by the Company occurs, whether or not the Executive is then employed by the Company, or (iii) by the Company for any other reason.  (y) The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive&#8217;s employment hereunder may be terminated during the Employment Period under the following circumstances&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive&#8217;s employment hereunder shall terminate upon the Executive&#8217;s death.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">By the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  The Company may terminate the Executive&#8217;s employment if the Executive is unable to perform each of the essential duties of his position by reason of a medically determinable physical or mental impairment which is potentially permanent in character or which can be expected to last for a continuous period of not less than twelve (12)&#160;months (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; or</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Company may terminate the Executive's employment for Cause or without Cause. If the Company terminates the Executive's employment without Cause, the Company shall not be required to give advance notice. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Agreement (including the Sign-On Equity Grant and Delayed Equity Grant), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be limited to the following events&#58; (i) an intentional act of fraud, embezzlement, theft, or any other material violation of law in connection with Executive&#8217;s duties or in the course of his employment with the Company&#58; (ii) Executive&#8217;s conviction of or entering of a plea of nolo contendere to a felony&#59; (iii) Executive&#8217;s alcohol intoxication on the job or current illegal drug use&#59; (iv) Executive&#8217;s intentional wrongful damage to tangible assets of the Company&#59; (v) Executive&#8217;s intentional wrongful disclosure of material confidential information of the Company and&#47;or material breach of the provisions of the Company&#8217;s Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement or any other noncompetition or confidentiality provisions covering the activities of Executive&#59; (vi) Executive&#8217;s knowing and intentional breach of any employment policy of the Company&#59; (vii) gross neglect or gross misconduct, disloyalty, dishonesty, or breach of trust in the performance of the Executive&#8217;s duties that is not corrected to the Board&#8217;s satisfaction within 30 days of the Executive receiving notice thereof&#59; or (viii) Executive&#8217;s misconduct that causes reputational harm to the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">By the Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Executive may terminate this Agreement for any reason prior to the Effective Date, and may terminate his employment for any reason (including Good Reason) or for no reason during the Employment Period.  If the Executive terminates his employment without Good Reason, then he shall provide written notice to the Company at least thirty (30) days prior to the Date of Termination, provided that the Company may, in its sole discretion, waive the provision of all or any portion of the notice period and immediately terminate the Executive, which termination shall not be deemed a termination without Cause or constitute grounds for termination for Good Reason.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Agreement (including the Sign-On Equity Grant and Delayed Equity Grant), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without the Executive&#8217;s prior written consent (i) a material reduction in the Executive&#8217;s Base Salary or any reduction of the Target Bonus Amount&#59; (ii) relocation to an office location more than 75 miles from either the Executive&#8217;s principal office location or his principal residence as of the date of notice of relocation&#59; (iii) the Board shall fail to appoint the Executive as Chairman of the Spinco Board upon completion of the Spinoff&#59; (iv) the Spinco Board shall fail to re-nominate the Executive for re-election to the Spinco Board&#59; or (v) a material diminution in title, duties, or responsibilities, including reporting responsibilities, of the Executive in his capacity as an employee (for which purpose such a material diminution shall be deemed to occur in the event of a Change in Control (as defined in the Omnibus Plan) in which Spinco ceases to be a publicly traded company, except in the case that the Executive is the most senior officer and a member of the board of directors of the top-most publicly traded parent company of which Spinco is a subsidiary resulting from such Change in Control).  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, &#8220;Good Reason&#8221; shall not include a reduction in Base Salary where such reduction is pursuant to a like proportionate reduction of base salaries of other senior executives of the Company.  Further, for the avoidance of doubt, &#8220;Good Reason&#8221; shall not include (i) Executive&#8217;s failure to be re-elected to the Spinco Board by the Spinco shareholders provided the Spinco Board nominates him for re-election to the Spinco Board&#59; (ii) Executive&#8217;s </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ceasing to serve as the Chairman of the Spinco Board following his initial appointment as the Chairman&#59; or (iii) any determination made by the Board in good faith that Executive&#8217;s residence is not properly treated as his principal place of business for tax purposes and any resulting change in tax consequences to Executive resulting from such determination.  In order to invoke a termination for Good Reason, the Executive&#8217;s termination must occur within 90 days after the occurrence of the Good Reason and after the Company has received notice of the Good Reason event and failed to cure within 30 days after receiving such notice. Otherwise, such termination shall be considered voluntary termination without Good Reason.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) if this Agreement or Executive&#8217;s employment is terminated due to the Executive&#8217;s death, the date of the Executive&#8217;s death&#59; (ii) if this Agreement or Executive&#8217;s employment is terminated because of the Executive&#8217;s Disability, 30&#160;days after Notice of Termination is given by the Company&#59; or (iii) if the Executive&#8217;s employment is terminated by the Company for any other reason or by the Executive pursuant to Section 6(a)(y)(iii), the date specified in the Notice of Termination.  Notwithstanding any provision of this Agreement to the contrary, for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon or following a termination of employment that are considered deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Treasury Regulations thereunder (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), references to Executive&#8217;s termination of employment (and corollary terms) with the Company shall be construed to refer to Executive&#8217;s &#8220;separation from service&#8221; (within the meaning of Treas. Reg. Section 1.409A-1(h)) with the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any termination of this Agreement prior to the Effective Date or of Executive&#8217;s employment by the Company or the Executive (other than because of the Executive&#8217;s death) shall be communicated by a written Notice of Termination to the other party hereto in accordance with the requirements of this Agreement.  For purposes of this Agreement, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon, if any, and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated.  Termination of the Executive&#8217;s employment shall take effect on the Date of Termination.  The Executive agrees, in the event of any dispute as to whether a Disability exists, and if requested by the Company, to submit to a physical examination by a licensed physician selected by mutual consent of the Company and the Executive, the cost of such examination to be paid by the Company.  The written medical opinion of such physician shall be conclusive and binding upon each of the parties hereto as to whether a Disability exists and the date when such Disability arose.  This Section shall be interpreted and applied so as to comply with the provisions of the Americans with Disabilities Act (to the extent applicable) and any applicable state or local laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Resignation of All Other Positions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon termination of the Executive's employment for any reason, the Executive shall, unless otherwise requested, resign from all positions that the Executive holds as an officer or member of the Spinco Board (or a committee thereof) and as an officer or member of the board of directors (or a committee thereof) of any Company subsidiaries or affiliates.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If this Agreement or the Executive&#8217;s employment is terminated as a result of the Executive&#8217;s death, this Agreement and the Employment Period shall terminate without further notice or any action required by the Company or the Executive&#8217;s legal representatives.  If the Date of Termination is after the Effective Date, within 30 days following the Executive&#8217;s death, the Company shall pay to the Executive&#8217;s legal representative or estate, as applicable, (i) the Executive&#8217;s Base Salary and accrued unused vacation due through the Date of Termination&#59; (ii) all Accrued Benefits, if any, to which the Executive is entitled as of the Date of Termination at the time such payments are due&#59; (iii) payment of any Incentive Bonus earned for a prior completed performance period and unpaid on the Date of Termination&#59; and (iv) a Partial Year Bonus (defined below) in the manner provided in Section 7(e) (such amounts in clauses (i) through (iv), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The rights of the Executive&#8217;s legal representative or estate, as applicable, with respect to the Executive&#8217;s equity or equity-related awards shall be governed by the applicable terms of the related plan or award agreement.  Except as set forth herein, the Company and the Company&#8217;s subsidiaries and affiliates shall have no further obligation to the Executive or his legal representatives, estate or heirs upon his death under this Agreement.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Accrued Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (w) any compensation deferred by the Executive prior to the Date of Termination and not paid by the Company or otherwise specifically addressed by this Agreement&#59; (x) any amounts or benefits owing to the Executive or to the Executive&#8217;s beneficiaries under the then applicable benefit plans of the Company&#59; (y) any amounts owing to the Executive for reimbursement of expenses properly incurred by the Executive through the Date of Termination and which are reimbursable in accordance with Section 5&#59; and (z) any other benefits or amounts due and owing to the Executive under the terms of any plan, program or arrangement of the Company. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company terminates this Agreement prior to the Effective Date because of the Executive&#8217;s Disability, the Company shall have no further obligations to the Executive under this Agreement upon such termination. If the Company terminates the Executive&#8217;s employment during the Employment Period because of the Executive&#8217;s Disability pursuant to Section 6(a)(y)(ii)(A), the Company shall pay to the Executive the Accrued Amounts.  The rights of the Executive with respect to the Executive&#8217;s equity or equity-related awards shall be governed by the applicable terms of the related plan or award agreement.  Except as set forth herein, the Company shall have no further obligations to the Executive under this Agreement upon Executive&#8217;s termination due to Disability pursuant to Section 6(a)(y)(ii)(A).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination by the Company for Cause or by the Executive without Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If prior to the Effective Date, either the Company terminates this Agreement pursuant to Section 6(a)(x)(ii) or the Executive terminates this Agreement pursuant to Section 6(a)(y)(iii), the Company shall have no further obligations to the Executive under this Agreement upon such termination.  If during the Employment Period the Company terminates the Executive&#8217;s employment for Cause pursuant to Section 6(a)(y)(ii)(B) or the Executive terminates his employment without Good Reason pursuant to Section 6(a)(y)(iii), the Company shall pay to the Executive the Executive&#8217;s Base Salary and accrued unused vacation due through the Date of Termination and all Accrued Benefits, if any, to which the Executive is entitled as of the Date of Termination, at the time such payments are due,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the Executive&#8217;s rights with respect to then vested or exercisable equity or equity-related awards shall be governed by the applicable terms of the related plan or award agreements.  Except as set forth herein, the Company shall have no further obligations to the Executive under this Agreement upon such termination.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">without Cause, by the Executive with Good Reason, or termination following notice by the Company of non-renewal of the Term, in each case, prior to Spinoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If prior to the Effective Date the Company terminates this Agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pursuant to Section 6(a)(x)(iii) or during the Employment Period but prior to completion of the Spinoff the Company terminates the Executive&#8217;s employment other than for Cause pursuant to Section 6(a)(y)(ii)(B), the Executive terminates his employment with Good Reason pursuant to Section 6(a)(y)(iii), or the Executive&#8217;s employment terminates upon the expiration of the Term following a notice by the Company to not renew the Term pursuant to Section 2, the Company shall pay to the Executive (w) the Executive&#8217;s Base Salary and accrued unused vacation due through the Date of Termination&#59; (x) all Accrued Benefits, if any, to which the Executive is entitled as of the Date of Termination, in each case at the time such payments are due&#59; (y) payment of any Incentive Bonus earned for a previous completed performance period and unpaid on the Date of Termination&#59; and (z) subject to Executive&#8217;s execution of the Labcorp Release Agreement, as defined below, a Partial Year Bonus, as defined below.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination by Spinco without Cause, by the Executive with Good Reason, or termination following notice by Spinco of non-renewal of the Term, in each case, following Spinoff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If during the Employment Period and following completion of the Spinoff, Spinco terminates the Executive&#8217;s employment other than for Cause pursuant to Section 6(a)(y)(ii)(B), the Executive terminates his employment with Good Reason pursuant to Section 6(a)(y)(iii), or the Executive&#8217;s employment terminates upon the expiration of the Term following a notice by Spinco to not renew the Term pursuant to Section 2 (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Spinco shall pay to the Executive (x) the Executive&#8217;s Base Salary and accrued unused vacation due through the Date of Termination&#59; (y) all Accrued Benefits, if any, to which the Executive is entitled as of the Date of Termination, in each case at the time such payments are due&#59; and (z) payment of any Incentive Bonus earned for a previous completed performance period and unpaid on the Date of Termination.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> The Executive shall also be entitled to receive, subject to his execution of a Spinco Release Agreement (as defined below), the following severance benefits (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;an amount equal to the product of (A) two (2), if the Qualifying Termination is not within thirty-six months following a Change in Control of Spinco, as such term is defined in the Spinco Omnibus Plan, or (B) three (3), if the Qualifying Termination is within thirty-six months following a Change in Control of Spinco, multiplied by the sum of (1) Executive&#8217;s Base Salary plus (2) the total dollar amount of the last three Incentive Bonuses paid to the Executive divided by three (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Average Incentive Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if the Executive has received less than three Incentive Bonus payments during the term of the Executive&#8217;s employment, then the Average Incentive Bonus shall equal the total dollar amount of Incentive Bonuses paid to the Executive divided by the number of Incentive Bonuses received by the Executive&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that any prorated bonuses Executive has received will be annualized for purposes of</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Section (by dividing the amount of the Incentive Bonus by the proration &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;factor that was applied to determine such Incentive Bonus under Section 4(c)) and that if a Qualifying Termination occurs prior to the payment of any Incentive Bonus under this Agreement, the Average Incentive Bonus shall be deemed to be the Target Bonus Amount (the amount determined pursuant to this subparagraph (i), the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:127%">(ii)&#160;&#160;&#160;&#160;a Partial Year Bonus, as defined below.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For the avoidance of doubt, if during the Employment Period and following completion of the Spinoff, Spinco terminates the Executive&#8217;s employment other than for Cause pursuant to Section 6(a)(y)(ii)(B) or the Executive terminates his employment with Good Reason pursuant to Section 6(a)(y)(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, in either case, Executive continues as a member of the Spinco Board, Executive will be entitled to payment of the Severance Benefits set forth above.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Spinco shall pay the Executive the Cash Severance Benefits to which he is entitled under this Section 7(e) as follows&#58; (a) 50 percent of the total Cash Severance Benefits due, less statutory deductions, shall be paid within 30 days following the execution of the Spinco Release Agreement, but in no event shall be paid later than March 15 of the year following the year in which the Termination Date occurred&#59; and (b) the remaining 50 percent of the total Cash Severance Benefits, less statutory deductions, shall be paid within 30 days following the one-year anniversary of the execution of the Spinco Release Agreement, but only if the Executive has complied in all material respects with the terms and conditions of the Spinco Release Agreement.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Partial Year Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; is payable to the Executive for the year of the Executive&#8217;s employment termination in the event the Company or Spinco, as applicable, performance criteria for payment of an Incentive Bonus are achieved as of the close of the year based on the actual performance level achieved for such year (as determined (x) treating any individual factors as fully satisfied and (y) without regard for any exercise of negative discretion unless such exercise is applicable to all similarly situated executives with like force and effect)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if a Qualifying Termination occurs after a Change in Control, the performance criteria shall be deemed satisfied at the target level. Any such Partial Year Bonus shall equal the Executive&#8217;s Incentive Bonus compensation so earned multiplied by a fraction, the numerator of which is the number of days the Executive was employed by the Company in the annual or other performance period for the Incentive Bonus award in which such termination occurs and the denominator of which is the total number of days included within such annual or partial year performance period. Should any such Partial Year Bonus become payable under this Agreement, payment shall be made to the Executive at the same time as payment is made to all other participants under the Incentive Bonus compensation program following the close of the year.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive&#8217;s voluntary resignation following July 3, 2024</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Spinoff has not been completed by July 3, 2024 and Executive desires to terminate his employment on or after July 3, 2024, Executive and the Board, or its designee, shall negotiate reasonably and in good faith over the terms of Executive&#8217;s severance benefits aligned with the spirit and principles of this Agreement.</font></div><div style="text-indent:72pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;The Executive&#8217;s rights with respect to equity or equity-related awards (including as provided above for the Sign-On Equity Grant, the Delayed Equity Grant and the Initial Spinco Equity Grant) shall be governed by the applicable terms of the related plan or award agreements.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Liquidated Damages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The parties acknowledge and agree that damages that will result to the Executive for termination by the Company of this Agreement under Section 6(a)(x)(iii) or the Executive&#8217;s employment without Cause under Section 6(a)(y)(ii)(B) or by the Executive for Good Reason under Section 6(a)(y)(iii) shall be extremely difficult or impossible to establish or prove, and agree that the payments set forth in Section 7(d) or Section 7(e), as applicable, shall constitute liquidated damages for any such termination.  The Executive agrees that, except for such other payments and benefits to which the Executive may be entitled as expressly provided by the terms of this Agreement or any other applicable benefit plan, such liquidated damages shall be in lieu of all other claims that the Executive may make by reason of any such termination of his employment and that, as a condition to receiving the payments set forth in Section 7(d), the Executive will execute a release of claims in substantially the form attached as Exhibit 2-A (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labcorp Release Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and that, as a condition to receiving the payments set forth in Section 7(e), the Executive will execute a release of claims in substantially the form attached as Exhibit 2-B (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Spinco Release Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) (the Labcorp Release Agreement and the Spinco Release Agreement, as applicable, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Within five business days of the Date of Termination, the Company shall deliver to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive the applicable Release Agreement for the Executive to execute. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Executive will forfeit all rights to the payments set forth in Section 7(d) or Section 7(e), as applicable, unless, within 30 days of delivery of the Release Agreement by the Company to the Executive, the Executive executes and delivers the Release Agreement to the Company and the releases contained therein have become irrevocable by virtue of the expiration of the revocation period without the release having been revoked (the first such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  In the event that the Release Effective Date could occur in one of two taxable years of the Executive, the Release Effective Date shall be deemed to occur in the earliest date in the later such taxable year as otherwise would apply thereunder.  The Company and Company subsidiaries and affiliates shall have no obligation to provide the payments set forth in Section 7(d) or Section 7(e), as applicable, prior to the Release Effective Date. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  To the extent the Executive would be subject to the additional 20% tax imposed on certain deferred compensation arrangements pursuant to Section 409A as a result of any provision of this Agreement, such provision shall be deemed amended to the minimum extent necessary to avoid application of such tax and preserve to the maximum extent possible the original intent and economic benefit to the Executive and the Company, and the parties shall promptly execute any amendment reasonably necessary to implement this Section 7(i).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;For purposes of Section 409A, the Executive&#8217;s right to receive any installment payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;The Executive will be deemed to have a Date of Termination for purposes of determining the timing of any payments or benefits hereunder that are classified as deferred compensation only upon a &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;Notwithstanding any other provision of this Agreement to the contrary, if at the time of the Executive&#8217;s separation from service, (i) the Executive is a specified employee (within the meaning of Section 409A and using the identification methodology selected by the Company from time to time), and (ii) the Company makes a good faith determination that an amount payable on account of such separation from service to the Executive constitutes deferred compensation (within the meaning of Section 409A) the payment of which is required to be delayed pursuant to the six-month delay rule set forth in Section 409A in order to avoid taxes or penalties under Section 409A (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delay Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Company will not pay such amount on the otherwise scheduled payment date but will instead pay it in a lump sum on the first business day after such six-month period (or upon the Executive&#8217;s death, if earlier), together with interest for the period of delay, compounded annually, equal to the prime rate (as published in the Wall Street Journal) in effect as of the dates the payments should otherwise have been provided.   To the extent that any benefits to be provided during the Delay Period are considered deferred compensation under Section 409A provided on account of a &#8220;separation from service,&#8221; and such benefits are not otherwise exempt from Section 409A, the Executive shall pay the cost of such benefit during the Delay Period, and the Company shall reimburse the Executive, to the extent that such costs would otherwise have been paid by the Company or to the extent that such benefits would otherwise have been provided by the Company at no cost to the Executive, the Company&#8217;s share of the cost of such benefits upon expiration of the Delay Period, and any remaining benefits shall be reimbursed or provided by the Company in accordance with the procedures specified herein.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;(A) Any amount that the Executive is entitled to be reimbursed under this Agreement will be reimbursed to the Executive as promptly as practical </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and in any event not later than the last day of the calendar year after the calendar year in which the expenses are incurred, (B) any right to reimbursement or in kind benefits will not be subject to liquidation or exchange for another benefit, and (C) the amount of the expenses eligible for reimbursement during any taxable year will not affect the amount of expenses eligible for reimbursement in any other taxable year.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;Whenever a payment under this Agreement specifies a payment period with reference to a number of days (e.g., &#8220;payment shall be made within thirty (30) days following the date of termination&#8221;), the actual date of payment within the specified period shall be within the sole discretion of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Confidentiality, Non-Competition and Non-Solicitation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In consideration of the employment and compensation terms set forth in this Agreement, the Executive agrees to execute and be bound by the terms of the Company&#8217;s Confidentiality, Non-Competition and Non-Solicitation Agreement attached as Exhibit 3.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parachute Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything herein to the contrary, in the event that the payments or distributions to be made by the Company to or for the benefit of the Executive (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement, under some other plan, agreement, or arrangement, or otherwise) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Code, then the Payment to the Executive shall be reduced to $1 below the safe harbor limit (as described in Section 280G(b)(2)(A)(ii) of the Code) if said reduction in Payment would result in the Executive retaining a larger amount, on an after-tax basis, taking into account the excise and income taxes imposed on the payments and benefits.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall indemnify the Executive to the maximum extent that its officers, directors and employees are entitled to indemnification pursuant to the Company&#8217;s certificate of incorporation, bylaws, and any indemnification agreements then in force, subject to applicable law. The Executive shall also be covered as an insured under any contract of directors and officers liability insurance to the same extent as such contract covers members of the Board.  The Executive&#8217;s rights under this Section 10 shall survive any termination or expiration of this Agreement and any termination of the Executive&#8217;s employment for all periods thereafter during which the Executive may be subject to liability for any acts or omissions occurring during his employment or service as a member of the Board that is otherwise subject to indemnification and coverage under directors and officers liability insurance.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Professional Fees Incurred in Negotiating the Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company shall pay or the Executive shall be reimbursed for the Executive's reasonable professional fees and costs incurred in connection with this Agreement up to a maximum of $35,000.  Any payment required under this Section 11 shall be made within sixty (60) days following the Effective Date.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;12.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All notices, demands, requests, or other communications which may be or are required to be given or made by any party to any other party pursuant to this Agreement shall be in writing and shall be hand delivered, mailed by first-class registered or certified mail, return receipt requested, postage prepaid, delivered by overnight air courier, addressed as follows&#58; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;If to the Company&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Laboratory Corporation of America Holdings</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;358 South Main Street</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Burlington, North Carolina 27215</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attention&#58; Sandra van der Vaart, </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Executive Vice President, Chief Legal Officer</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;and</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Hogan Lovells US LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;100 International Drive, Suite 2000</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Baltimore, Maryland 21202</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attention&#58; William Intner </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;If to the Executive&#58; </font></div><div style="padding-left:72pt;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:127%">At the last address shown on the payroll records of the Company</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each party may designate by notice in writing a new address to which any notice, demand, request or communication may thereafter be so given, served or sent.  Each notice, demand, request, or communication that shall be given or made in the manner described above shall be deemed sufficiently given or made for all purposes at such time as it is delivered to the addressee (with the return receipt, the delivery receipt, confirmation of facsimile transmission or the affidavit of messenger being deemed conclusive but not exclusive evidence of such delivery) or at such time as delivery is refused by the addressee upon presentation. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The invalidity or unenforceability of any one or more provisions of this Agreement shall not affect the validity or enforceability of the other provisions of this Agreement, which shall remain in full force and effect. </font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effect on Other Agreements&#59; Inconsistency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement (including the Exhibits hereto) and all other agreements identified hereunder constitute the entire agreement between the parties respecting the employment of the Executive and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral, with respect to such subject matter.  In the event of any inconsistency between this Agreement (and Exhibits) and any other plan, program, practice or agreement of the Company in which the Executive is a participant or a party, whether applicable on the Effective Date or at any time thereafter, this Agreement (and Exhibits) shall control unless, with the Executive&#8217;s prior written consent, such other plan, program or practice, or in such agreement with the Executive, specifically refers to this Agreement (or Exhibits) as not so controlling.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The rights and obligations of the parties to this Agreement shall not be assignable or delegable, except that (i) the Company shall assign its rights and obligations hereunder to Spinco in connection with the Spinoff, (ii) in the event of the Executive&#8217;s death, the personal representative or legatees or distributees of the Executive&#8217;s estate, as the case may be, shall have the right to receive any amount owing and unpaid to the Executive hereunder, and (iii) the rights and obligations of the Company hereunder shall be assignable and may be assumed by a successor entity in connection with (a) any subsequent merger, consolidation, sale of all or substantially all of the assets or equity interests of the Company or similar transaction involving the Company or a successor entity or (b) the formation of a holding company or similar corporate reorganization approved by the Board. If the Company&#8217;s rights and obligations are assigned or assumed as provided in the preceding sentence, the term &#8220;Company&#8221; as used herein shall refer to such successor entity, including, following the Spinoff, to Spinco.  Executive acknowledges and agrees that the assignment of this Agreement to Spinco does not create any termination &#8220;without Cause&#8221; or &#8220;Good Reason&#8221; rights, or any right to payments or benefits from the Company by virtue of such assignment.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to any provisions hereof restricting assignment, this Agreement shall be binding upon the parties hereto and shall inure to the benefit of the parties and their respective heirs, devisees, executors, administrators, legal representatives and permitted successors and assigns. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall not be amended, altered or modified except by an instrument in writing duly executed by the party against whom enforcement is sought.  Neither the waiver by either of the parties hereto of a breach of or a default under any of the provisions of this Agreement, nor the failure of either of the parties, on one or more occasions, to enforce any of the provisions of this Agreement or to exercise any right or privilege hereunder, shall thereafter be construed as a waiver of any subsequent breach or default of a similar nature, or as a waiver of any such provisions, rights or privileges hereunder. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Section and subsection headings contained in this Agreement are inserted for convenience of reference only, shall not be deemed to be a part of this Agreement for any purpose, and shall not in any way define or affect the meaning, construction or scope of any of the provisions hereof. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;19.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law&#58; Jurisdiction and Venue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement, for all purposes, shall be construed in accordance with the laws of Delaware without regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce this Agreement shall be brought only in a state or federal court located in the state of Delaware. The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such action or proceeding in such venue.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;20.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement constitutes the entire agreement between the parties respecting the employment of the Executive, there being no representations, warranties or commitments except as set forth herein. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;21.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in two counterparts, each of which shall be an original and all of which shall be deemed to constitute one and the same instrument. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may withhold from any benefit payment or any other payment or amount under this Agreement all federal, state, city or other taxes as shall be required pursuant to any law or governmental regulation or ruling.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Representations of the Executive. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Executive represents and warrants to the Company that (i) the Executive has furnished to the Company all agreements respecting any post-employment restrictions applicable to the Executive with his immediately preceding employer&#59; and (ii) there are no other agreements to which the Executive is a party that conflict with the Executive&#8217;s acceptance of employment with the Company or would be violated or breached by Executive&#8217;s acceptance of employment with the Company, including any non-solicitation, non-competition or other similar covenant or agreement.  The Executive agrees that the Executive will perform his duties to the Company in a manner that complies with all such agreements.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned have duly executed and delivered this Agreement, or have caused this Agreement to be duly executed and delivered on their behalf. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">LABORATORY CORPORATION OF AMERICA HOLDINGS</font></div><div style="padding-left:72pt;text-indent:36pt"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:127%">&#47;s&#47; Adam H. Schechter</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">________________________</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Adam H. Schechter</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; President and Chief Executive Officer</font></div><div style="padding-left:288pt;text-align:right"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="padding-left:324pt;text-align:right"><font><br></font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas H. Pike</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">________________________</font></div><div style="padding-left:180pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Thomas H. Pike</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:127%">EXHIBIT 1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sign-On Equity Grant</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">LABORATORY CORPORATION OF AMERICA HOLDINGS</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">2016 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Laboratory Corporation of America Holdings, a Delaware corporation (the &#8220;Company&#8221;), hereby grants restricted stock units relating to its shares of common stock, par value $0.10 (the &#8220;Restricted Stock Units&#8221;) to the Grantee named below, subject to the vesting and other conditions set forth below. Additional terms and conditions of the grant are set forth in this cover sheet and in the attachment (collectively, the &#8220;Agreement&#8221;) and in the Company&#8217;s 2016 Omnibus Incentive Plan (the &#8220;Plan&#8221;).  Certain capitalized terms used but not defined in this Agreement have the meanings given such terms in the Plan.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">     January ___, 2023 </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name of Grantee&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Thomas H. Pike</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grantee&#8217;s Social Security Number&#58;  _____-____-_____</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Number of Shares of Stock underlying Restricted Stock Units&#58; ______________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Purchase Price Per Share of Stock&#58; ____________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting Schedule&#58;  </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The Restricted Stock Units will be subject to three twelve-month vesting periods and will be eligible to vest as follows&#58; one-third of the Restricted Stock Units vest on January ___, 2024, an additional one-third of the Restricted Stock Units will vest on January __, 2025 and the remaining one-third of the Restricted Stock Units will vest on January __, 2026 (each, a &#8220;Vesting Date&#8221;), provided Grantee has not had a Separation from Service (as defined below) prior to each such Vesting Date. The number of vested Restricted Stock Units on each Vesting Date will be rounded to the nearest whole number, and Grantee cannot vest in more than the number of Restricted Stock Units set forth above. </font></div><div style="margin-bottom:24pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">This grant of Restricted Stock Units is subject to all of the terms and conditions described in this Agreement and in the Plan, a copy of which is also attached. You acknowledge that you have carefully reviewed the Plan, and agree that the Plan will control in the event any provision of this cover sheet or Agreement should appear inconsistent.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grantee&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">___________________________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Signature)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company&#58;&#160;&#160;&#160;&#160;___________________________________ Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">      January __, 2023     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Adam Schechter</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">President &#38; Chief Executive Officer</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Attachment</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">This is not a stock certificate or a negotiable instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">LABORATORY CORPORATION OF AMERICA HOLDING</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2016 OMNIBUS INCENTIVE PLAN </font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTRICTED STOCK UNIT AGREEMENT</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restricted Stock Units</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement evidences an award of Restricted Stock Units in the number of shares set forth on the cover sheet, and subject to the vesting and other conditions described below, in the Plan and on the cover sheet (the &#8220;Restricted Stock Units&#8221;). </font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Purchase Price for the shares of Stock underlying the Restricted Stock Units is deemed paid by your prior services to the Company.  </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transfer of Restricted Stock Units</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent not yet vested, your Restricted Stock Units may not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of, whether by operation of law or otherwise, nor may your Restricted Stock Units be made subject to execution, attachment or similar process.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting Schedule</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Your Restricted Stock Units shall vest in accordance with the vesting schedule shown on the cover sheet so long as you have not had a Separation from Service prior to the Vesting Dates set forth on the cover sheet.</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No additional Restricted Stock Units will vest after you have had a Separation from Service for any reason except as set forth in this Agreement.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Death, Disability, or Specified Terminations following Change in Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the vesting schedule set forth above, if you have a Separation from Service as a result of your (1)&#160;death, (2)&#160;Disability, or (3)&#160;a Separation from Service for Good Reason or without Cause within 24 months after a Change in Control, 100% of the Restricted Stock Units will vest on the date of your Separation from Service.  For purposes of your Restricted Stock Units, &#8220;Disability,&#8221; &#8220;Good Reason&#8221; and &#8220;Cause&#8221; shall have the meaning given such terms in the Executive Employment Agreement entered into as of January __, 2023 by and among you and the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Further, if you are employed by a legal entity that is contemplated to be part of the spin-off of the Company&#8217;s Clinical Development business to Company shareholders through a tax-free transaction consistent with the Company&#8217;s public announcement dated July 28, 2022 of such transaction (such transaction, the &#8220;Spinoff&#8221;) and your employing entity is sold by the Company to a third party on or before December 31, 2023 in a transaction that does not constitute a Change in Control, the Committee shall have the right to cause the Restricted Stock Units to be assumed or continued by the purchasing entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares subject to the Restricted Stock Units, and, if your Restricted Stock Units are so assumed or continued and you have a Separation from Service as a result</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of your (1) death, (2) Disability, or (3) Separation from Service for Good Reason or without Cause within 12 months after such transaction, 100% of the Restricted Stock Units will vest on the date of your Separation from Service, provided that whether or not you have had a Separation from Service will be determined by reference to whether you have had a Separation from Service from such assuming entity. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Termination by the Company without Cause prior to Spinoff&#59; Service solely as member of the Spinco Board of Directors</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the vesting schedule set forth above, (i) if, prior to the Spinoff, you are terminated by the Company without Cause and you do not, in connection with the Spinoff, serve as a member of the Board of Directors of Spinco (the &#8220;Spinco Board&#8221;), 100% of the Restricted Stock Units will vest on the date of your Separation from Service, and (ii) if, prior to or in connection with the Spinoff, you are terminated by the Company without Cause but, in connection with the Spinoff, it is determined that you will serve as a member of the Spinco Board (and not as an employee of Spinco), you will, notwithstanding the definition of Separation from Service set forth herein or any other terms herein, not receive acceleration of vesting upon your termination from Labcorp, but your Restricted Stock Units will be eligible to continue to vest subject to your continued Service on the Spinco Board.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Retirement at Age 65 Plus 5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the vesting schedule set forth above, if you have a Separation from Service, other than a Separation from Service by the Company for Cause, at a time when you have attained age 65 and completed five full years of Service (&#8220;Retirement at Age 65 Plus 5&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:75.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;Your Separation from Service occurs on or after 6 months following the Grant Date, but before 9 months following the Grant Date, the Restricted Stock Units that were scheduled to vest in accordance with the original vesting schedule within 12 months immediately following such Separation from Service will vest on the date of your Separation from Service&#59; or</font></div><div style="margin-bottom:12pt;padding-left:75.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;Your Separation from Service occurs on or after 9 months following the Grant Date, 100% of the Restricted Stock Units will vest on the date of your Separation from Service.</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of determining eligibility for Retirement at Age 65 Plus 5, Service shall be calculated in accordance with the terms of the Laboratory Corporation of America Holdings Reinstatement Policy, as it may be amended from time to time, and shall mean the time in which you are employed by the Company and&#47;or an Affiliate of the Company but only while the Affiliate is owned, controlled or under common control by or with the Company.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Separation Without Cause or for Good Reason following Spinoff and not Related to a Change in Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify;text-indent:-0.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the vesting schedule set forth above, if, following the Spinoff but unrelated to a Change in Control, (i) you have an involuntary Separation from Service without Cause or a voluntary Separation from Service for any reason including Good Reason but, it is determined that you will serve as a member of the Spinco Board (and not as an employee of Spinco), you will, notwithstanding the definition of Separation from Service set forth herein or any other terms herein, not receive acceleration of vesting upon your termination of employment, but your Restricted Stock Units will be eligible to continue to vest subject to your continued Service on the Spinco Board or (ii) you have either received notice of or have incurred an involuntary Separation</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Separation Without Cause or for Good Reason following Spinoff and not Related to a Change in Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify;text-indent:-0.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">from Service without Cause, or you have either given notice of, or have incurred a, voluntary Separation from Service for Good Reason and you do not continue to serve as a member of the Spinco Board immediately following such Separation from Service, in each case, on or after 6 months following the Grant Date, the Restricted Stock Units that were scheduled to vest in accordance with the original vesting schedule within 12 months immediately following said Separation from Service will vest on the date of your Separation from Service.  For the avoidance of doubt, if you are given notice of your involuntary Separation from Service prior to 6 months following the Grant Date, you shall not receive any acceleration of vesting pursuant to this section, even if your Separation from Service occurs on or after 6 months following the Grant Date. Similarly, for the avoidance of doubt, if you provide notice of your voluntary Separation of Service for Good Reason prior to 6 months following the Grant Date, you shall not receive any continuation of vesting pursuant to this section, even if your Separation from Service occurs on or after 6 months following the Grant Date.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Separation due to Retirement at Age 55 (Rule of 70)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the vesting schedule set forth above, if you have a Separation from Service on or after 6 months following the Grant Date, other than a Separation from Service by the Company for Cause, at a time when you have attained age 55 and the sum of your age and full years of Service equals or exceeds 70 (&#8220;Retirement at Age 55 (Rule of 70)&#8221;) the Restricted Stock Units that were scheduled to vest in accordance with the original vesting schedule within 12 months immediately following said Separation from Service will vest upon the occurrence of such event.</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of determining eligibility for Retirement at Age 55 (Rule of 70), Service shall be calculated in accordance with the terms of the Company&#8217;s Reinstatement Policy, as it may be amended from time to time, and shall mean the time in which you are employed by the Company and&#47;or an Affiliate of the Company but only while the Affiliate is owned, controlled or under common control by or with the Company.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture of Unvested Restricted Stock Units</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless your Separation from Service triggers accelerated vesting or other treatment of your Restricted Stock Units pursuant to the terms of this Agreement, the Plan, or any other written agreement between the Company or an Affiliate and you, you will automatically forfeit to the Company all of the Restricted Stock Units that have not yet vested as of your Separation from Service.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Forfeiture of Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you should take actions in violation or breach of or in conflict with any (a)&#160;employment agreement, (b)&#160;non-competition agreement, (c)&#160;agreement prohibiting solicitation of employees or clients of the Company or any Affiliate, (d)&#160;confidentiality obligation with respect to the Company or any Affiliate, (e)&#160;Company policy or procedure, (f)&#160;other agreement, or (g)&#160;if you incur a Separation from Service for Cause, the Company has the right to cause an immediate forfeiture of (i) your rights to any outstanding Restricted Stock Units, and (ii) with respect to the period commencing thirty-six (36) months prior to your Separation from Service with the Company or any Affiliate and ending thirty-six (36) months following such Separation from Service (A) a forfeiture of any gain recognized by you upon the sale of any shares of Stock received as a result of the vesting of any Restricted Stock Units, and (B) a forfeiture of any vested shares of Stock held by you as a result of the vesting of any Restricted Stock Units.  For the avoidance of doubt, the Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation Agreement set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> is covered by this provision.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Leaves of Absence</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Agreement, you do not have a Separation from Service when you go on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> employee leave of absence that was approved by your employer in writing, if the terms of the leave provide for continued Service crediting, or when continued Service crediting is required by applicable law.  However, your Service will be treated as terminating 90 days after you went on employee leave, unless your right to return to active work is guaranteed by law or by a contract.  You will incur a Separation from Service in any event when the approved leave ends unless you immediately return to active employee work. </font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Your employer determines, in its sole discretion, which leaves count for this purpose, and when you have a Separation from Service for all purposes under the Plan.  Notwithstanding the foregoing, the Company may determine, in its discretion, that a leave counts for this purpose even if your employer does not agree. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Issuance</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The shares of Stock underlying your vested Restricted Stock Units will be issued as soon as practicable following the earlier of (i)&#160;the date that your Restricted Stock Units vest pursuant to the vesting schedule, or (ii)&#160;the date of your Separation from Service, but in no event later than 60 days following the first of such events.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Withholding Taxes</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You agree, as a condition of this grant, that you will make acceptable arrangements to pay any withholding or other taxes that may be due as a result of grant or vesting of Restricted Stock Units, the payment of dividends or the issuance of Stock acquired under this grant. In the event that the Company or any Affiliate determines that any federal, state, local or foreign tax or withholding payment is required relating to the grant or vesting of Restricted Stock Units, the payment of dividends or the issuance of Stock acquired from this grant, the Company or any Affiliate shall have the right to require such payments from you, or withhold such amounts from other payments due to you from the Company or any Affiliate. <br></font><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To satisfy this withholding obligation, the Company may provide you with the opportunity to satisfy the withholding obligation in cash or to have the Company withhold shares of Stock otherwise issuable to you.  If you fail to make an election to use either of the preceding methods or fail to fully satisfy the obligation in cash, the Company will withhold shares of Stock otherwise issuable to you.  The shares of Stock so withheld will have an aggregate Fair Market Value equal to the withholding obligation.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Retention Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement and the Restricted Stock Units do not give you the right to be retained by the Company or any Affiliate in any capacity.  The Company or any Affiliate reserves the right to terminate your Service at any time and for any reason.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Stockholder Rights</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You, or your estate or heirs, have no rights as a stockholder of the Company until the Stock has been issued upon vesting of your Restricted Stock Units and either a certificate evidencing your Stock has been issued or an appropriate entry has been made on the Company&#8217;s books. </font></div><div style="margin-bottom:12pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You will, however, be entitled to receive an amount of cash or shares of Stock (as determined by the Company from time to time) payable at the time the shares underlying your vested Restricted Stock Units are delivered, equal to the amount or value of the cumulative per-share dividends, if any, paid on shares of Stock equal to the number of Restricted Stock Units in which you vest that were outstanding as of the record date for such dividend. </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Insider Trading Policy</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You acknowledge receipt of the Company&#8217;s Insider Trading Policy (the &#8220;Policy&#8221;), attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree to comply fully with the standards contained in the Policy (and related policies and procedures adopted by the company).  You further understand that compliance with these standards, policies, and procedures is a condition of continued employment or association with the Company or any of its subsidiaries and that the Policy is only a statement of principles for individual and business conduct and does not, in any way, constitute an employment contract, an assurance of continued employment, or employment other than at-will.  By acceptance of the Restricted Stock Units granted hereunder, you certify to your understanding of and intent to comply with the Policy.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation Agreement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration of the award of Restricted Stock Units granted pursuant to this Agreement, you agree to be bound by the obligations in, and covenant to comply with, the Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation  Agreement set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, which is attached hereto and made a part hereof, and you further understand that a failure to comply with the Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation Agreement&#8217;s terms and conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> may result in consequences as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit&#160;B.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Clawback</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Restricted Stock Units are subject to mandatory repayment by you to the Company to the extent you are or in the future become subject to any Company &#8220;clawback&#8221; or recoupment policy that requires the repayment by you to the Company of compensation paid by the Company to you in the event that you fail to comply with, or violate, the terms or requirements of such policy.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Applicable Law</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement will be interpreted and enforced under the laws of the State of Delaware, other than any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">The Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The text of the Plan is incorporated in this Agreement by reference. </font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement and the Plan constitute the entire understanding between you and the Company regarding this grant of Restricted Stock Units.  Any prior agreements, commitments or negotiations concerning this grant are superseded&#59; except that any written employment, and&#47;or severance agreement between you and the Company or any Affiliate shall supersede this Agreement with respect to its subject matter.</font></div><div style="padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If there is any conflict between this Agreement and the Plan, or if there is any ambiguity in this Agreement, any term which is not defined in this Agreement or any matter as to which this Agreement is silent, in any such case, the Plan shall govern, including, without limitation, the provisions thereof pursuant to which the Committee has the power, among others, to (i)&#160;interpret the Plan, (ii)&#160;prescribe, amend and rescind rules and regulations relating to the Plan and (iii)&#160;make all other determinations deemed necessary or advisable for the administration of the Plan.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In order to administer the Plan, the Company or any Affiliate may process personal data about you. Such data includes, but is not limited to, information provided in this Agreement and any changes thereto, other appropriate personal and financial data about you such as your home and business addresses and other contact information, payroll information and any other information that might be deemed appropriate by the Company and any Affiliate to facilitate the administration of the Plan.</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By accepting this grant, you give explicit consent to the Company and any Affiliate to process any such personal data.  You also give explicit consent to the Company and any Affiliate to transfer any such personal data outside the country in which you work or are employed, including, with respect to non-U.S. resident participants, to the United States, to transferees who shall include the Company, any Affiliate and other persons who are designated by the Company to administer the Plan.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Notices</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any notices to be given under the terms of this Agreement shall be in writing and addressed to the Company at 531&#160;South Spring Street, Burlington, North Carolina&#160;27215, Attention&#58; Corporate Secretary and Securities Compliance Officer, and to you at the address in the Company&#8217;s books and records, or at such address as either party may hereafter designate in writing to the other.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Consent to Electronic Delivery</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company may choose to deliver certain statutory materials relating to the Plan in electronic form.  By accepting this grant you agree that the Company may deliver the Plan prospectus and the Company&#8217;s annual report to you in an electronic format.  If at any time you would prefer to receive paper copies of these documents, as you are entitled to, the Company would be pleased to provide copies.  Please email your request for paper copies to StockCompliance&#64;Labcorp.com.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.485%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Electronic Signature</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All references to signatures and delivery of documents in this Agreement can be satisfied by procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents, including this Agreement.  Your electronic signature is the same as, and shall have the same force and effect as, your manual signature.  Any such procedures and delivery may be effected by a third party engaged by the Company to provide administrative services related to the Plan.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Code Section 409A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Separation from Service&#8221; shall have the meaning set forth in Section 409A of the Code and the guidance and regulations promulgated thereunder (&#8220;Section 409A&#8221;) which includes when the Company reasonably anticipates that your level of Services will permanently decrease to no more than 20 percent of the average level of Services you have performed over the immediately preceding 36-month period (or such lesser period of your Service with the Company and its Affiliates), which shall be interpreted consistently with the provisions of Section 409A, provided, however, that, notwithstanding the terms of Section 409A if you continue employment with a former subsidiary of the Company following the sale of the subsidiary in a stock sale, merger, spin-off or other similar transaction and your Restricted Stock Units are not assumed in connection with such transaction, you will be deemed to have a Separation from Service as of the consummation of such transaction and your vesting will cease and the terms in this Agreement regarding the effect of a Separation from Service will be given effect. It is intended that the Agreement comply with Section&#160;409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Agreement will be interpreted and administered to be in compliance with Section&#160;409A.  To the extent that the Company determines that you would be subject to the additional taxes or penalties imposed on certain nonqualified deferred compensation plans pursuant to Section&#160;409A as a result of any provision of this Agreement, such provision shall be deemed amended to the minimum extent necessary to avoid application of such additional taxes or penalties.  The nature of any such amendment shall be determined by the Company.  Notwithstanding anything to the contrary in this Agreement or the Plan, to the extent required to avoid accelerated taxation and penalties under Section&#160;409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Agreement during the six-month period immediately following your Separation from Service will instead be paid on the first payroll date after the six-month anniversary of your Separation from Service (or your death, if earlier).  Each installment of Restricted Stock Units that vests under this Agreement (if there is more than one installment) will be considered one of a series of separate payments for purposes of Section 409A.</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">By electronically acknowledging this Agreement, you agree to all of the terms and conditions described above, in the Plan, in the Company&#8217;s Insider Trading Policy attached as Exhibit A and in the Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation Agreement attached hereto as Exhibit B.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:23.6pt;margin-top:0.9pt;padding-right:336.95pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT B</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">CONFIDENTIALITY&#47;NON-COMPETITION&#47;NON-SOLICITATION AGREEMENT</font></div><div style="margin-top:6pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;During the course of your employment with Laboratory Corporation of America Holdings (&#8220;Labcorp&#8221;) or its subsidiaries, divisions, or affiliates, you will have access to, or will acquire, highly confidential information and trade secrets concerning Labcorp's and the Employer Company&#8217;s business, including, but not limited to, customer lists, pricing, methods of pricing, marketing practices, advertising strategy, methods of operation and the needs and requirements of Employer Company&#8217;s and&#47;or Labcorp's customers.  In addition, you will receive from Labcorp or Employer Company and&#47;or be exposed to Labcorp&#8217;s or the Employer Company&#8217;s valuable technical and marketing information that will materially aid you in the performance of your duties on behalf of the Employer Company, and assist you and&#47;or the Employer Company in furthering the Employer Company&#8217;s business interests, including establishing and retaining the Employer Company&#8217;s customers.  The support furnished to you by the Employer Company will enable you to increase the value of the Employer Company&#8217;s goodwill with the Employer Company&#8217;s customers, which is a valuable asset of the Employer Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;As indicated by the foregoing, the services you will be performing for the Employer Company will be of a special, unique and extraordinary nature.  Accordingly, in consideration of Labcorp extending to you, as applicable, certain incentive compensation in the form of Restricted Stock Units, Performance Shares, Restricted Stock and&#47;or Stock Options, as set forth in the Agreement(s) to which this Exhibit is made a part thereof and which governs the grant of said benefits, any and all of which benefits otherwise would not be provided to you absent your agreement to be bound by the terms of this Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement (&#8220;Restrictive Covenant Agreement&#8221;), you agree that&#58;</font></div><div><font><br></font></div><div style="padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Property Rights and Workproduct</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All ideas, inventions, discoveries, developments, standard operating procedures, designs, algorithms, improvements, formulae, processes, techniques, programs, know-how, data, databases, notes, business plans, reports, presentations, and any other work product relating to the Employer Company&#8217;s business or anticipated business, together with all printed, physical and electronic copies and other tangible embodiments thereof (hereafter collectively referred to as &#8220;Work Product&#8221;) created, generated, developed, conceived or reduced to practice by you individually or jointly with others as part of your employment with the Employer Company shall (to the extent consisting of copyrightable subject matter) be deemed to be work made for hire, and the Employer Company shall be the sole owner of all rights, title and interest in and to the Work Product.&#160; To the extent such Work Product, or any part thereof, does not constitute &#8220;work made for hire&#8221; as defined in the Copyright Act of 1976 (17 U.S.C. &#167; 101) or equivalent laws of a non-US jurisdiction, you agree to permanently and irrevocably assign, and hereby permanently and irrevocably assign, to the Employer Company all of your right, title and interest in and to the Work Product, together with all goodwill therein and the right to sue, counterclaim and recover for past, present and future infringement misappropriation and dilution thereof.&#160; The Employer Company may, at its own expense, prepare and process applications for copyrights, trademarks, service marks, or patents and other intellectual property rights therein arising in any jurisdiction, and may take other actions that it deems necessary or appropriate to protect its rights in and to the aforementioned items.&#160; You shall cooperate with the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer Company in protecting and enforcing its rights therein, including by executing such applications and other documentation prepared for the protection and enforcement of its rights, title and interest in such Work Product  and assigning such documentation to the Employer Company, and delivering to the Employer Company all printed, physical and electronic copies and other tangible embodiments of the Work Product that may come into your possession.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that during the term of your employment and for any time after your termination, you shall not, without the prior written consent of the Employer Company, divulge to any third party or use for your own benefit, or for any purpose other than the exclusive benefit of the Employer Company, any Confidential Information of the Employer Company, Labcorp and its subsidiaries, divisions, or affiliates.  In this Restrictive Covenant Agreement, Confidential Information shall mean information that concerns the Employer Company&#8217;s, Labcorp's and its subsidiaries', divisions', or affiliates' prices, pricing methods, costs, profits, profit margins, suppliers, methods, procedures, processes or combinations or applications thereof developed in, by, or for the Employer Company&#8217;s business, research and development projects, data, business strategies, marketing strategies, sales techniques, customer lists, customer information, financial information, or any other information concerning the Employer Company or its business that is not readily and easily available to the public or to those persons in the same business, trade, or industry of the Employer Company.  The term &#8220;customer information&#8221; as used in this Restrictive Covenant Agreement shall mean information that concerns the course of dealing between the Employer Company and its customers or potential customers solicited by the Employer Company, customer preferences, particular contracts or locations of customers or potential customers, negotiations with customers, and any other information concerning customers or potential customers obtained by the Employer Company that is not readily and easily available to the public or to those in the business, trade, or industry of the Employer Company.  Your obligation not to disclose Confidential Information does not prohibit you from (a) disclosing the information to a government agency if you are required to produce the information pursuant to a subpoena, court order, administrative order or other legal process, (b) discussing terms and conditions of employment or engaging in other activities protected by the National Labor Relations Act, (c) communicating with the Securities and Exchange Commission about securities law violations, or (d) communicating with any other government entity or agency if such communication is to report a violation of applicable law.  However, you shall notify the Employer Company in writing within three (3) calendar days of the receipt of any subpoena, court order, administrative order or other legal process requiring disclosure of Confidential Information and shall provide the Employer Company with a copy of said subpoena, court order, administrative order or other legal process.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Non-Solicitation of Labcorp Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the term of your employment and for a period of twelve (12) months following the term of your employment, you shall not, directly or indirectly through a subordinate, co-worker, peer, or any other person or entity contact, solicit, encourage or induce any officer, director or employee of Labcorp or its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">subsidiaries and affiliates to work for or provide services to you and&#47;or any other person or entity that either (i)&#160;directly provides products or services that compete with the products or services provided by the Employer Company in a geographic market serviced by the Employer Company or (ii)&#160;supplies, services, advises or consults with a person, trade or business that products or services that compete with the products or services provided by the Employer Company in a geographic market serviced by the Employer Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45.67pt">Non-Solicitation of Customers.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">During your employment and for a period of twelve (12) months following the voluntary or involuntary termination of your employment, you will not either directly or indirectly through a subordinate, co-worker, peer or other person or entity, call upon, contact, or solicit or attempt to call upon, contact or solicit any customer or customer prospect of the Employer Company, with a view toward the sale or providing of any service or product competitive with the products and services offered by the Employer Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the restrictions set forth in Paragraph&#160;4 shall apply only to customers or prospects of the Employer Company, or representatives of the same, with which you had contact during the last twenty-four (24) months of your employment with the Employer Company.  The parties agree and affirm that their intention with respect to Paragraph 4&#160;is that your activities be limited only for a twelve (12) month period after termination of your employment with the Employer Company for any reason.  The provisions calling for a &#8220;look back&#8221; of twenty-four (24) calendar months prior to the termination of employment are intended solely as a means of identifying the customers and potential customers to which such restrictions apply and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45.67pt">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">During your employment and for a period of twelve (12) months following your voluntary or involuntary termination of employment, you shall not become an owner in, shareholder with more than a 2% equity interest in, investor in, or an employee, contractor, consultant, advisor, representative, officer, director, or agent of, a trade or business that offers products and services that are the same or substantially similar to the products and services provided by the Employer Company in any geographic market in which the Employer Company conducts business (&#8220;Competitor&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the duties and responsibilities of said employment or engagement as an owner in, shareholder with more than 2% equity interest in, investor in, employee, contractor, consultant, advisor, representative, officer, director or agent are (i)&#160;the same, similar, or substantially related to your current duties and responsibilities or duties or responsibilities performed by you while employed by the Employer Company at any time during a six (6) month period prior to your date of termination of employment and (ii)&#160;related to or concerning the Competitor&#8217;s business activities in the Restricted Territory.  The parties agree and affirm that their intention with respect to Paragraph 5 is that your activities shall be limited only for the twelve (12) month period after termination of employment for any reason.  The provisions calling for a &#8220;look back&#8221; of six (6) calendar months prior to the date of termination of employment are intended solely as a means of identifying the duties and responsibilities that will define the restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">activities covered by Paragraph&#160;5 and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.  For purposes of Paragraph&#160;5, the term &#8220;Restricted Territory&#8221; means the geographic area that is part of your current duties and responsibilities or the geographic area that was part of your duties and responsibilities within a period of six (6) month period prior to the date of your termination of employment.  If a court of competent jurisdiction determines that the Restricted Territory as defined herein is too restrictive, then the parties agree that said court may reduce or limit the Restricted Territory to the largest acceptable area so as to enable the enforcement of Paragraph 5.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45.67pt">Return of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At any time upon the request of the Employer Company or upon your termination of your employment, you shall return to the Employer Company any and all Employer Company property including but not limited to laptops, phones, smart phones and documents or materials in your possession, custody and control that contain Confidential Information.  You also agree that upon termination of employment, you shall destroy any Confidential Information stored on your personal computer or other data storage device.  Along with the return of said documents and materials, you shall provide the Employer Company (upon the Employer Company&#8217;s request) with a sworn or written statement indicating that you do not have possession, custody and control of any of the Employer Company&#8217;s Confidential Information and have destroyed all of the Employer Company&#8217;s data electronically stored on your personal computer or other data storage device.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45.67pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notice shall be effective only if it is made in writing and actually or constructively received by the individuals below.  To be effective, any notice required under this Restrictive Covenant Agreement must be sent by nationally recognized express delivery courier or by certified mail, return receipt requested, to the person(s) and address(es) listed below. </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">General Counsel</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Laboratory Corporation of America Holdings</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">531 South Spring Street</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Burlington, North Carolina 27215</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with a copy to&#58;</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Legal Officer </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Laboratory Corporation of America Holdings</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">531 South Spring Street</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Burlington, North Carolina 27215</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and, if to you, notice shall be sent to your last known mailing address on record at the Employer Company.  You have an obligation to ensure that the Employer Company&#8217;s records contain your most recent address.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Breach&#47;Available Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Except as otherwise provided in this subparagraph, if any provision of this Restrictive Covenant Agreement shall be determined to be invalid or unenforceable by a court of competent jurisdiction, that part shall be ineffective to the extent of such invalidity or unenforceability only, without in any way affecting the remaining parts of said provision or the remaining provisions of this Restrictive Covenant Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any provision contained in this Restrictive Covenant Agreement shall be adjudicated to be invalid or unenforceable because such provision is held to be excessively broad as to duration, geographic scope, activity or subject, the parties agree that the said provision shall be limited and reduced to the maximum extent compatible with the applicable laws of such jurisdiction, and such amendment only to apply with respect to the operation of such provision in the applicable jurisdiction in which the adjudication is made.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You agree that as part of this Restrictive Covenant Agreement, you will have access to the Employer Company&#8217;s Confidential Information, personnel, and existing and potential customers of the Employer Company.  You further agree that the Employer Company maintains a competitive advantage over other persons or entities in the trade or business of providing commercial medical laboratory testing services as a result of the Employer Company&#8217;s Confidential Information, personnel, and existing and potential customer contacts.  You further agree that the Employer Company will be placed at a competitive disadvantage in the event that you breach this Restrictive Covenant Agreement and that damages would not be an adequate or reasonable remedy in the event of such breach.  Accordingly, you stipulate that in the event that you breach one or more of the provisions set forth in this Restrictive Covenant Agreement, the Employer Company will be entitled to an injunction restraining you from violating the terms of those paragraphs.  Nothing herein shall be construed as prohibiting the Employer Company from pursuing any other remedy available for such breach or prospective breach.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45.67pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Absent any other agreement to the contrary nothing herein shall be construed as giving you the right to continued service or employment relationship with the Employer Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement does not alter or amend in any way the Employer Company's right to terminate the employment relationship in accordance with any offer letter, employment contract or applicable law.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You represent and warrant that you are not a party to any contract, agreement or understanding that prevents or prohibits you from entering into and fully performing under this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">In the event a court of law declares any provision of this Restrictive Covenant Agreement to be null and void, it is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">understood and agreed by you and the Employer Company that such clause shall be severed from this Restrictive Covenant Agreement and that the remaining provisions of this Restrictive Covenant Agreement shall continue to be binding on you.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">It is understood and agreed by you and Laboratory Corporation of America Holdings (&#8220;Labcorp&#8221;) that this Exhibit B Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement constitutes the agreement in its entirety and supersedes any previous Exhibit B Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement previously executed by you as part of an Equity Award Agreement with Labcorp.   This Exhibit B Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement replaces any other non-compete, non-solicitation and confidentiality agreement which you may have previously executed in favor of Labcorp or one of its subsidiary companies incorporated within the United States.  This Exhibit B Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement shall not replace, amend, restrict, otherwise modify or supersede any employment contract or agreement between you and a foreign subsidiary of Labcorp and shall not amend, alter or affect any non-compete, non-solicitation or confidentiality agreement executed by you and Labcorp or an Employer Company in connection with a merger or acquisition agreement of a business entity with whom you were previously employed or affiliated, including, but not limited to, an ownership or investment interest in said entity.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">For purposes of this Restrictive Covenant Agreement, the Employer Company shall mean Laboratory Corporation of America Holdings or its subsidiary and affiliated companies with whom you are employed at the commencement of your employment, as well as any subsequent parent, subsidiary or affiliated company that becomes the employing entity in the event of a transfer, promotion, assignment, reassignment or corporate restructuring.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">As used herein, &#8220;affiliate&#8221; shall mean a current or future company or other business entity that, directly or indirectly, is controlled by, controls or is under common control with Laboratory Corporation of America Holdings.  For the purposes of the preceding sentence, the meaning of the word &#8220;control&#8221; shall include, but not necessarily be limited to, ownership of more than fifty percent (50%) of the voting shares or other interest of the Employer Company or other business entity.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Restrictive Covenant Agreement shall be binding upon you and shall inure to the benefit of the parties and their respective personal representatives, heirs, affiliates, successors, and assigns.  Labcorp may at its sole discretion assign its rights under this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You affirm by signing this Restrictive Covenant Agreement that you have completely read this entire Restrictive Covenant Agreement and understand the terms and conditions included </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">within this Restrictive Covenant Agreement.  You also agree that this Restrictive Covenant Agreement may not be modified or altered in any respect except in writing, signed by you and Labcorp.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">This Restrictive Covenant Agreement shall be deemed to have been entered into in the State of North Carolina and shall be construed in accordance with and governed by the laws of North Carolina, to the exclusion of the laws of any other forum including but not limited to the laws of the State of California.  You agree, acknowledge and recognize that by virtue of your employment with the Employer Company, either a North Carolina corporation or a subsidiary of a North Carolina corporation, with its principal place of business in North Carolina, and your own contacts and business dealings with Labcorp and the Employer Company in North Carolina, North Carolina has a substantial relationship to this Restrictive Covenant Agreement and a materially greater interest in applying its laws, over and to the exclusion of the laws of any other forum, to the resolution of any dispute arising out of or relating to this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Any action, special proceeding or other proceeding, including without limitation any request for temporary, preliminary, or permanent injunctive relief with respect to this Restrictive Covenant Agreement shall be brought </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">exclusively</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in the federal or state courts of the State of North Carolina.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You and the Employer Company irrevocably consent to the jurisdiction of the Federal and State courts of North Carolina and you hereby consent and submit to personal jurisdiction in the State of North Carolina.  You and the Employer Company irrevocably waive any objection, including an objection or defense based on lack of personal jurisdiction, improper venue or forum non-conveniens which either may now or hereafter have to the bringing of any action or proceeding in connection with this Restrictive Covenant Agreement.  You acknowledge and recognize that in the event that you breach this Restrictive Covenant Agreement, the Employer Company may initiate a lawsuit against you in North Carolina, that you waive your right to have that lawsuit be brought in a court located closer to where you may reside, and that you will be required to travel to and defend yourself in North Carolina.  You likewise agree that to the extent you institute any action arising out of or relating to this Restrictive Covenant Agreement, it shall be brought in North Carolina and doing so does not present any undue burden or inconvenience to you.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You shall at all times abide by such laws and regulations, including but not limited to such laws which relate to the improper inducement for referrals of items or Services reimbursable by the Federal health care programs 42&#160;U.S.C. &#167;&#160;1320a-7b(b) (the &#8220;anti-kickback statute&#8221;).  You acknowledge that you are (i)&#160;aware that the United States securities laws prohibit any person who has material nonpublic information about the Employer Company from purchasing or selling securities of such Employer Company, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities and (ii)&#160;familiar with the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder and agrees that it will neither use, nor cause any third party to use, any Information in contravention of such Act or any such rules and regulations, including Rules&#160;10b-5 and 14e-3.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Except as stated otherwise herein, this Restrictive Covenant Agreement contains the entire agreement between the parties hereto with respect to the subject matter hereof, and there are no representations, warranties, covenants, conditions, understandings or agreements other than those expressly set forth herein.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">By electronically acknowledging this Agreement, you agree to all of the terms and conditions described above, in the Plan, in the Company&#8217;s Insider Trading Policy attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> and in the Confidentiality Agreement&#47;Non-Competition&#47;Non-Solicitation Agreement attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Exhibit&#160;B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">.</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT 2-A</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Labcorp Release Agreement</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Confidential Separation Agreement and General Release (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Release Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is being entered into between Thomas H. Pike (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and Laboratory Corporation of America Holdings, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), with each party intending to be bound by the terms and conditions of this Release Agreement.  Executive and the Company are collectively referred to as the Parties throughout this Release Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the Executive was employed by the Company pursuant to the terms of an Executive Employment Agreement between the Company and the Executive dated as of January 4, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, capitalized terms used in this Release Agreement and not defined herein shall have the meanings ascribed to them in the Employment Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, the termination of Executive&#8217;s employment with the Company satisfies the conditions to receive the payments set forth in Section 7(d) of the Employment Agreement&#59;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">WHEREAS, this Release Agreement is the &#8220;Labcorp Release Agreement&#8221; referred to in the Employment Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants and agreements contained herein, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Separation of Employment</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Effective ________, 20__ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Executive&#8217;s employment with the Company will terminate&#59; he shall perform no further services for the Company and his status as an Executive and Officer of the Company shall cease on that date.  &#91;Executive also hereby resigns from all positions that Executive holds as an officer or member of the Board of Directors of the Company (or a committee thereof) and as an officer or member of the board of directors (or a committee thereof) of any Company subsidiaries or affiliates.&#93;&#91;Executive also hereby resigns from all positions that Executive holds as an officer of the Company and as an officer or member of the board of directors (or a committee thereof) of any Company subsidiaries or affiliates, provided that Executive and the Company agree that Executive will continue to serve as a member of the Board of Directors of the Company as of the Separation Date, subject to the terms and conditions of the Company&#8217;s by-laws.&#93;  Executive and the Company further agree that the relationship created by this Agreement is purely contractual and that no employer-Executive relationship is intended, nor shall such be inferred from the performance of obligations under this Agreement.  Executive further agrees that any payments and&#47;or benefits payable pursuant to this Agreement are contingent upon Executive&#8217;s execution and fulfillment of his obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Separation Pay</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration for Executive executing this Release Agreement no later than twenty-one (21) days from the Date of Termination, not exercising Executive&#8217;s revocation rights </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pursuant to Section 11(b) below and abiding at all times with the terms hereof, the Company will pay to Executive the Severance Benefits pursuant to Section 7(d) of the Employment Agreement.  The Company&#8217;s obligation to pay the Severance Benefits shall automatically terminate upon Executive&#8217;s breach of any of the provisions of this Release Agreement, and any Severance Benefits already paid to Executive prior to such breach shall become immediately due and repayable to the Company. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Benefits</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive, his spouse, and his other dependent(s) may be eligible to elect continued health care coverage under the welfare plans sponsored by the Company, as provided in the applicable provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which provides generally that certain Executives and their dependents may elect to continue coverage under employer-sponsored group health plans for a period of at least eighteen (18) months under certain conditions, including payment by Executive of the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Applicable Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; as defined in Section 604 of the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. &#167;&#167; 1001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive shall be eligible for such benefits under the Company&#8217;s existing qualified plans as are provided under the circumstances (taking into account separation of employment as of the Separation Date) pursuant to the terms of the plan documents governing each of these plans.  Except as otherwise provided herein or in the terms of any documents governing any Executive benefit plan maintained by the Company, Executive will cease to be a participant in and will no longer have any coverage or entitlement to benefits, accruals, or contributions under any of the Company&#8217;s Executive benefit plans effective upon the separation of his employment.  Executive agrees that the payments made to him by the Company pursuant to this Agreement do not constitute compensation for purposes of calculating the amount of benefits Executive may be entitled to under the terms of any pension plan or for the purposes of accruing any benefit, receiving any allocation of any contribution, or having the right to defer any income in any profit-sharing or other Executive pension benefit plan, including any cash or deferred arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive also understands that his grants of restricted stock units are governed by the terms and conditions of the Company&#8217;s 2016 Omnibus  Incentive  Plan and applicable grant agreements and that this Agreement does not in any modify, change, alter or amend the terms and conditions of those grants.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive shall submit for reimbursement any and all unpaid business expenses to the Company within 30 days of the Separation Date.  The Company will reimburse said expenses provided that they are consistent with, and reimbursable under, the Company&#8217;s travel and entertainment expense policy. The Company will not be responsible for reimbursing the Executive for any business expenses incurred during employment but submitted after said 30-day period.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement shall never be construed as an admission by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of any liability, wrongdoing or responsibility on its part or on the part of any other person or entity described in Section 4.1 of this Agreement.  The Company expressly denies any such liability, wrongdoing or responsibility.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Release</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive, on behalf of himself and his heirs, assigns, transferees and representatives, hereby releases and forever discharges the Company, and its predecessors, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">successors, parents, subsidiaries, affiliates, assigns, representatives and agents, as well as all of their present and former directors, officers, Executives, agents, shareholders, representatives, attorneys and insurers (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), from any and all claims, causes of actions, demands, damages or liability of any nature whatsoever, known or unknown, which Executive has or may have which arise out of his employment or cessation of employment with the Company, or which concern or relate in any way to any acts or omissions done or occurring prior to and including the date of this Agreement, including, but not limited to, claims arising under the Fair Labor Standards Act, 29 U.S.C. &#167;&#160;201 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Equal Pay Act , 29 U.S.C. &#167;&#160;206(a) and interpretive regulations&#59; Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. &#167;&#160;2000e </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; 42 U.S.C. &#167;&#160;1981 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Americans with Disabilities Act, 42 U.S.C. &#167;&#160;12101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Family and Medical Leave Act, 29 U.S.C. &#167;&#160;2601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. &#167;&#160;1001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Worker Adjustment and Retraining Notification Act, 29 U.S.C. &#167;&#167;&#160;2101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Age Discrimination in Employment Act, as amended, 29 U.S.C. &#167;&#167;&#160;621 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; any and all claims for wrongful termination and&#47;or retaliation&#59; claims for breach of contract, express or implied&#59; claims for breach of the covenant of good faith and fair dealing&#59; claims for compensation, including but not limited to wages, bonuses, or commissions except as otherwise contained herein&#59; claims for benefits or fringe benefits, including, but not limited to, claims for severance pay and&#47;or termination pay, except as otherwise contained herein&#59; claims for, or relating to stock or stock options (except that nothing in this Agreement shall prohibit Executive from exercising any vested stock options or affect Executive&#8217;s claims to vested benefits in the Company&#8217;s retirement plans, if any, in accordance with the terms of the applicable stock option agreement(s) and applicable plan documents)&#59; claims for unaccrued vacation pay&#59; claims arising in tort, including, but not limited to, claims for invasion of privacy, intentional infliction of emotional distress and defamation&#59; claims for quantum meruit and&#47;or unjust enrichment&#59; and any and all other claims arising under any other federal, state, local or foreign laws (including securities laws), as well as any and all other common law legal or equitable claims.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive represents that he has not initiated any action or charge against any of the Releasees with any Federal, State or local court or administrative agency.   If such an action or charge has been filed by Executive, or on Executive&#8217;s behalf, he will use his best efforts to cause it immediately to be withdrawn and dismissed with prejudice.  Failure to cause the withdrawal and dismissal with prejudice of any action or charge shall render this Agreement null and void, and any consideration paid hereunder shall be repaid immediately by the Executive upon receipt of such notice. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive further agrees that he will not institute any lawsuits, either individually or as a class representative or member, against any of the Releasees as to any matter based upon, arising from or relating to his employment relationship with the Company, from the beginning of time to the date of execution of this Agreement.  Executive knowingly and intentionally waives any rights to any additional recovery that might be sought on his behalf by any other person, entity, local, state or federal government or agency thereof, including specifically and without limitation, the North Carolina Department of Labor, the United States Department of Labor, or the Equal Employment Opportunity Commission.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive is hereby advised that&#58;  (i) he should consult with an attorney (at his own expense) prior to executing this Agreement&#59; (ii) he is waiving, among other things, any age discrimination claims under the Age Discrimination in Employment Act, provided, however, he is not waiving any claims that may arise after the date this Agreement is executed&#59; (iii) he has twenty-one (21) days within which to consider the execution of this Agreement, before signing it&#59; and (iv) for a period of seven (7) days following the execution of this Agreement, he may revoke this Agreement by delivering written notice (by the close of business on the seventh day) to the Company in accordance with Section 10.7 herein. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the provisions of Section 4.1, said release does not apply to any and all statutory or other claims (a) that are prohibited from waiver by Federal, State or local law, (b) for enforcement of any covenant under this Agreement, (c) for any claim for any vested, accrued benefits to which Executive is (or becomes) otherwise entitled pursuant to the terms and conditions of any of the benefit plans in which Executive participated prior to the Separation Date (but not any incentive or severance plans except as provided in Section 2 or 3, above) or any other benefit due by operation of law&#59; (d) for unemployment insurance benefits&#59; (e) for indemnification under applicable statutory, or common law or any insurance, charter, or bylaws of the Company or any of its affiliates, including under the Employment Agreement, it being understood and agreed that this Agreement does not create or expand upon any such rights, (if any) to indemnification&#59; or (f) for any federal securities law claim asserted solely in Executive&#8217;s capacity as a shareholder of the Company, that does not concern or relate in any way to Executive&#8217;s employment or other service with the Company or any of its affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Return of Company Property</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive agrees that within 10 days after execution of this Agreement, he will return any and all Company documents and any copies thereof, in any form whatsoever, including computer records or files, containing secret, confidential and&#47;or proprietary information or ideas, and any other Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">property (including, but not limited to, any cell phones, pagers and&#47;or computer equipment) in Executive&#8217;s possession or control, except that Executive may keep possession, custody and control of his currently issued Company laptop.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Duty to Cooperate and of Loyalty&#47;Nondisparagement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation as to time, Executive agrees to cooperate and make all reasonable and lawful efforts to assist the Company in addressing any issues which may arise concerning any matter with which he was involved during his employment with the Company, including, but not limited to cooperating in any litigation arising therefrom.  The Company shall reimburse Executive at a fair and reasonable rate for services provided by the Executive to the Company in connection with services provided under this provision.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive will not (except as required by law) communicate to anyone, whether by word or deed, whether directly or indirectly through an intermediary, and whether expressly or by suggestion or innuendo, any statement, whether characterized as one of fact or opinion, that is intended to cause or that reasonably would be expected to cause any person to whom it is communicated to have (1) a lowered opinion of the Company or any affiliates, including a lowered opinion of any products manufactured, sold or used by, or services offered or rendered by the Company or its affiliates&#59; and (2)  a lowered opinion of the Company&#8217;s creditworthiness or business prospects.  Executive&#8217;s obligations in this regard extends to the reputation of the Company and any of its officers and directors.  To the extent permitted by law, the Company agrees (i) to instruct, as of the Separation Date, its then current Section 16 officers and directors not to publish or communicate to any person or entity or in any public forum (including social media) at any time any defamatory or disparaging remarks, comments, or statements concerning Executive and (ii) not to disparage or criticize Executive in authorized corporate communications.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provisions of this Agreement to the contrary, if the Executive is a &#8220;specified Executive&#8221; (within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and determined pursuant to procedures adopted by the Company) at the Separation  Date and if any portion of the payments or benefits </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to be received by the Executive would be considered deferred compensation under Section 409A of the Code, amounts that would otherwise be payable pursuant to this Agreement during the six-month period immediately following the Executive&#8217;s Separation  Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delayed Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and benefits that would otherwise be provided pursuant to this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delayed Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) during the six-month period immediately following the Executive&#8217;s Separation  Date (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delay Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall instead be paid or made available on the earlier of (i) the first business day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) month following the Separation  Date or (ii) the Executive&#8217;s death (the applicable date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Permissible Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Company shall also reimburse the Executive for the after-tax cost incurred by the Executive in independently obtaining any Delayed Benefits (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Additional Delayed Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to any amount of expenses eligible for reimbursement under Sections 3.1, 3.3 and 9.1, such expenses shall be reimbursed by the Company within thirty (30) calendar days following the date on which the Company receives the applicable invoice from the Executive but in no event later than December 31 of the year following the year in which the Executive incurs the related expenses&#59; provided, that with respect to reimbursement relating to the Additional Delayed Payments, such reimbursement shall be made on the Permissible Payment Date.  In no event shall the reimbursements or in-kind benefits to be provided by the Company in one taxable year affect the amount of reimbursements or in-kind benefits to be provided in any other taxable year, nor shall the Executive&#8217;s right to reimbursement or in-kind benefits be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">It is the intention of the parties that payments or benefits payable under this Agreement not be subject to the additional tax imposed pursuant to Section 409A of the Code.  To the extent such potential payments or benefits could become subject to such Section, the Company may amend this Agreement with the goal of giving the Covered Executive the economic benefits described herein in a manner that does not result in such tax being imposed.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of Section 409A of the Code, an Executive&#8217;s right to receive any &#8220;installment&#8221; payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Miscellaneous</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement is binding on, and shall inure to the benefit of, the Parties hereto and their heirs, representatives, transferees, principals, executors, administrators, predecessors, successors, parents, subsidiaries, affiliates, assigns, agents, directors, officers and Executives.  In the event that Executive dies before payment of all amounts described in this Agreement is made, and the Agreement has been executed and not revoked, the Company agrees to pay unpaid amounts to Executive&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement constitutes the complete agreement between, and contains all of the promises and undertakings by the Parties.  Executive agrees that the only considerations for signing this Agreement are the terms stated herein above and that no other representations, promises, or assurances of any kind have been made to him by the Company, its attorneys, or any other person as an inducement to sign this Agreement.  Any and all prior agreements, representations, negotiations and understandings among the Parties, oral or written, express or implied, with respect to the subject matter hereof are hereby superseded and merged herein, except to the extent provided in Section 10 of the Employment Agreement, and provided that this Agreement supplements and does not amend, alter, void, replace, or otherwise override any confidentiality, non-solicitation, non-compete agreement executed by Executive that is part of any equity award agreement executed by the Executive.  To be clear and to avoid any doubt, the parties expressly agree that any confidentiality, non-solicitation, non-compete agreement </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">executed by Executive that is part of any equity award agreement executed by the Executive remains in full force and effect and is not modified in any way by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement may not be revised or modified without the mutual written consent of the Parties.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Parties acknowledge and agree that they have each had sufficient time to consider this Agreement and consult with legal counsel of their choosing concerning its meaning prior to entering into this Agreement.  In entering into this Agreement, no Party has relied on any representations or warranties of any other Party other than the representations or warranties expressly set forth in this Agreement.  Executive acknowledges that he has read this Agreement and that he possesses sufficient education and experience to fully understand the terms of this Agreement as it has been written, the legal and binding effect of this Agreement, and the exchange of benefits and payments for promises hereunder, and that he has had a full opportunity to discuss or ask questions about all such terms.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section, if any provision of this Agreement shall be determined to be invalid or unenforceable by a court of competent jurisdiction, that part shall be ineffective to the extent of such invalidity or unenforceability only, without in any way affecting the remaining parts of said provision or the remaining provisions of this Agreement&#59; provided that, if any provision contained in this Agreement shall be adjudicated to be invalid or unenforceable because such provision is held to be excessively broad as to duration, geographic scope, activity or subject, such provision shall be deemed amended by limiting and reducing it so as to be valid and enforceable to the maximum extent compatible with the applicable laws of such jurisdiction, and such amendment only to apply with respect to the operation of such provision in the applicable jurisdiction in which the adjudication is made.  If Section 6.0 or any of its sub-parts of this Agreement is deemed invalid or unenforceable, in whole or in part, by a court of competent jurisdiction, this entire Agreement shall be null and void, and any consideration paid hereunder shall be repaid immediately by Executive upon receipt of notice thereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive agrees that because he has rendered services of a special, unique, and extraordinary character, damages may not be an adequate or reasonable remedy for breach of his obligations under this Agreement.  Accordingly, in the event of a breach or threatened breach by Executive of the provisions of this Agreement, the Company shall be entitled to (a) an injunction restraining Executive from violating the terms hereof, or from rendering services to any person, firm, corporation, association, or other entity to which any confidential information, trade secrets, or proprietary materials of the Company have been disclosed or are threatened to be disclosed, or for which Executive is working or rendering services, or threatens to work or render services (b) all such other remedies available at law or in equity, including without limitation the recovery of damages, reasonable attorneys&#8217; fees and costs, and (c) withhold any further payments under this Agreement which become due and owing after the occurrence of said violation, breach or threatened breach.  Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies available to it for such breach or threatened breach of this Agreement, including the right to terminate any payments to Executive pursuant to this Agreement or the recovery of damages from Executive.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Such notice and any other notices required under this Agreement shall be served upon the Company by certified mail, return receipt requested, or by expressed delivery by a nationally recognized delivery service company such as Federal Express as follows&#58;</font></div><div style="padding-left:144pt;text-indent:-36pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:127%">If to the Company&#58;</font></div><div style="padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sandra D. van der Vaart</font></div><div style="padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive Vice President and Chief Legal Officer</font></div><div style="padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Labcorp</font></div><div style="padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">531 S. Spring Street</font></div><div style="padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Burlington, NC 27215<br></font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">If to the Executive&#58;</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tom Pike</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At last address shown on payroll records of the Company</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Consistent with the requirements of this Section, each party shall notify the other party of any change of address for the receipt of a notice under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement shall be construed in accordance with and governed by the laws, except choice of law provisions, of the State of Delaware and shall govern to the exclusion of the laws of any other forum.  The parties further agree that any action, special proceeding or other proceeding with respect to this Agreement shall be brought exclusively in the federal or state courts of the State of Delaware. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Executive and Company irrevocably consent to the jurisdiction of the Federal and State courts of Delaware and that Executive hereby consents and submits to personal jurisdiction in the State of Delaware. Executive and Company irrevocably waive any objection, including an objection or defense based on lack of personal jurisdiction, improper venue or forum non-conveniens which either may now or hereafter have to the bringing of any action or proceeding in connection with this Agreement.  Executive acknowledges and recognizes that in the event that he has breached this Agreement, the Company may initiate a lawsuit against him in North Carolina, that Executive waives his right to have that lawsuit be brought in a court located closer to where he may reside, and that Executive will be required to travel to and defend himself in Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Effective Date of this Agreement shall be either (a) the Separation Date or (b) the day after expiration of the seven (7) day revocation period set forth in Section 4.4 of this Agreement, whichever date is later.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you agree with the foregoing, please sign below and return two (2) originals to me.  You should retain one (1) original copy of this Agreement for your records.</font></div><div style="margin-bottom:12pt;padding-left:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-bottom:12pt;padding-left:270pt"><font><br></font></div><div style="padding-left:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Name&#93;<br>&#91;Title&#93;</font></div><div style="padding-left:270pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Agreed to and accepted&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_________________________________</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Thomas H. Pike</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; ____________________________</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:232%">EXHIBIT 2-B</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:232%">Spinco Release Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tom Pike</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Address</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Re&#58;&#160;&#160;&#160;&#160;Employment Separation Agreement and General Release</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dear Tom,</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On behalf of &#91;Spinco&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), I write to offer you (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the following Employment Separation Agreement and General Release (the &#8220;Agreement&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Separation of Employment</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Effective ________, 20__ (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Employee&#8217;s employment with the Company will terminate&#59; he shall perform no further services for the Company and his status as an employee and Officer of the Company shall cease on that date.  &#91;Employee also hereby resigns from all positions that Employee holds as an officer or member of the Board of Directors of the Company (or a committee thereof) and as an officer or member of the board of directors (or a committee thereof) of any Company subsidiaries or affiliates.&#93;&#91;Employee also hereby resigns from all positions that Employee holds as an officer of the Company and as an officer or member of the board of directors (or a committee thereof) of any Company subsidiaries or affiliates, provided that Employee and the Company agree that Employee will continue to serve as a member of the Board of Directors of the Company as of the Separation Date, subject to the terms and conditions of the Company&#8217;s by-laws.&#93;  Employee and the Company further agree that the relationship created by this Agreement is purely contractual and that no employer-employee relationship is intended, nor shall such be inferred from the performance of obligations under this Agreement.  Employee further agrees that any payments and&#47;or benefits payable pursuant to this Agreement are contingent upon Employee&#8217;s execution and fulfillment of his obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Separation Pay</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration for the covenants, promises and agreements herein and in particular Employee&#8217;s release of claims as well as covenants not to solicit, not to compete and not to disclose confidential information, the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will pay Employee a severance in the total amount of $__________ less applicable taxes and withholdings, which represents &#91;two&#93;&#91;three&#93; times the sum of Employee&#8217;s Base Salary of $________ plus $_______, representing the Employee&#8217;s Average Incentive Bonus as defined under the terms of the Executive Employment Agreement entered into as of January 4, 2023 between Employee and the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The severance shall be paid in two installments, with the first installment of $__________, less taxes and withholding, made payable within 30 days following the date of this Agreement and the second installment of $_________, less taxes and withholding, made payable 30 days following the one-year anniversary of date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the compensation payable under Section 2.1 of the Agreement, Employee shall be eligible to receive a prorated amount equal to the earned portion of the management incentive bonus that he would have received under the Company&#8217;s management </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">incentive bonus program had he remained eligible for said bonus.   The additional payment shall be made at the time that bonuses are normally paid under the MIB Plan but no later than March 15, 20___. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Benefits</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee, his spouse, and his other dependent(s) may be eligible to elect continued health care coverage under the welfare plans sponsored by the Company, as provided in the applicable provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which provides generally that certain employees and their dependents may elect to continue coverage under employer-sponsored group health plans for a period of at least eighteen (18) months under certain conditions, including payment by Employee of the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Applicable Premium</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; as defined in Section 604 of the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. &#167;&#167; 1001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee shall be eligible for such benefits under the Company&#8217;s existing qualified plans as are provided under the circumstances (taking into account separation of employment as of the Separation Date) pursuant to the terms of the plan documents governing each of these plans.  Except as otherwise provided herein or in the terms of any documents governing any employee benefit plan maintained by the Company, Employee will cease to be a participant in and will no longer have any coverage or entitlement to benefits, accruals, or contributions under any of the Company&#8217;s employee benefit plans effective upon the separation of his employment.  Employee agrees that the payments made to him by the Company pursuant to this Agreement do not constitute compensation for purposes of calculating the amount of benefits Employee may be entitled to under the terms of any pension plan or for the purposes of accruing any benefit, receiving any allocation of any contribution, or having the right to defer any income in any profit-sharing or other employee pension benefit plan, including any cash or deferred arrangement. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee also understands that his grants of performance shares, restricted stock units and stock options are governed by the terms and conditions of the Company&#8217;s 2016 Omnibus  Incentive  Plan and applicable grant agreements and that this Agreement does not in any modify, change, alter or amend the terms and conditions of those grants.   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee shall submit for reimbursement any and all unpaid business expenses to the Company within 30 days of the Separation Date.  The Company will reimburse said expenses provided that they are consistent with, and reimbursable under, the Company&#8217;s travel and entertainment expense policy. The Company will not be responsible for reimbursing the Employee for any business expenses incurred during employment but submitted after said 30-day period.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement shall never be construed as an admission by the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of any liability, wrongdoing or responsibility on its part or on the part of any other person or entity described in Section 4.1 of this Agreement.  The Company expressly denies any such liability, wrongdoing or responsibility.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Release</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee, on behalf of himself and his heirs, assigns, transferees and representatives, hereby releases and forever discharges the Company, and its predecessors, successors, parents, subsidiaries, affiliates, assigns, representatives and agents, as well as all of their present and former directors, officers, employees, agents, shareholders, representatives, attorneys and insurers (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), from any and all claims, causes of actions, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">demands, damages or liability of any nature whatsoever, known or unknown, which Employee has or may have which arise out of his employment or cessation of employment with the Company, or which concern or relate in any way to any acts or omissions done or occurring prior to and including the date of this Agreement, including, but not limited to, claims arising under the Fair Labor Standards Act, 29 U.S.C. &#167;&#160;201 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Equal Pay Act , 29 U.S.C. &#167;&#160;206(a) and interpretive regulations&#59; Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. &#167;&#160;2000e </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; 42 U.S.C. &#167;&#160;1981 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Americans with Disabilities Act, 42 U.S.C. &#167;&#160;12101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Family and Medical Leave Act, 29 U.S.C. &#167;&#160;2601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. &#167;&#160;1001 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; the Worker Adjustment and Retraining Notification Act, 29 U.S.C. &#167;&#167;&#160;2101 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; the Age Discrimination in Employment Act, as amended, 29 U.S.C. &#167;&#167;&#160;621 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">et&#160;seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#59; any and all claims for wrongful termination and&#47;or retaliation&#59; claims for breach of contract, express or implied&#59; claims for breach of the covenant of good faith and fair dealing&#59; claims for compensation, including but not limited to wages, bonuses, or commissions except as otherwise contained herein&#59; claims for benefits or fringe benefits, including, but not limited to, claims for severance pay and&#47;or termination pay, except as otherwise contained herein&#59; claims for, or relating to stock or stock options (except that nothing in this Agreement shall prohibit Employee from exercising any vested stock options or affect Employee&#8217;s claims to vested benefits in the Company&#8217;s retirement plans, if any, in accordance with the terms of the applicable stock option agreement(s) and applicable plan documents)&#59; claims for unaccrued vacation pay&#59; claims arising in tort, including, but not limited to, claims for invasion of privacy, intentional infliction of emotional distress and defamation&#59; claims for quantum meruit and&#47;or unjust enrichment&#59; and any and all other claims arising under any other federal, state, local or foreign laws (including securities laws), as well as any and all other common law legal or equitable claims.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee represents that he has not initiated any action or charge against any of the Releasees with any Federal, State or local court or administrative agency.   If such an action or charge has been filed by Employee, or on Employee&#8217;s behalf, he will use his best efforts to cause it immediately to be withdrawn and dismissed with prejudice.  Failure to cause the withdrawal and dismissal with prejudice of any action or charge shall render this Agreement null and void, and any consideration paid hereunder shall be repaid immediately by the Employee upon receipt of such notice. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee further agrees that he will not institute any lawsuits, either individually or as a class representative or member, against any of the Releasees as to any matter based upon, arising from or relating to his employment relationship with the Company, from the beginning of time to the date of execution of this Agreement.  Employee knowingly and intentionally waives any rights to any additional recovery that might be sought on his behalf by any other person, entity, local, state or federal government or agency thereof, including specifically and without limitation, the North Carolina Department of Labor, the United States Department of Labor, or the Equal Employment Opportunity Commission.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee is hereby advised that&#58;  (i) he should consult with an attorney (at his own expense) prior to executing this Agreement&#59; (ii) he is waiving, among other things, any age discrimination claims under the Age Discrimination in Employment Act, provided, however, he is not waiving any claims that may arise after the date this Agreement is executed&#59; (iii) he has twenty-one (21) days within which to consider the execution of this Agreement, before signing it&#59; and (iv) for a period of seven (7) days following the execution of this Agreement, he may revoke this Agreement by delivering written notice (by the close of business on the seventh day) to the Company in accordance with Section 10.7 herein. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the provisions of Section 4.1, said release does not apply to any and all statutory or other claims (a) that are prohibited from waiver by Federal, State or local law, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) for enforcement of any covenant under this Agreement, (c) for any claim for any vested, accrued benefits to which Employee is (or becomes) otherwise entitled pursuant to the terms and conditions of any of the benefit plans in which Employee participated prior to the Separation Date (but not any incentive or severance plans except as provided in Section 2 or 3, above) or any other benefit due by operation of law&#59; (d) for unemployment insurance benefits&#59; (e) for indemnification under applicable statutory, or common law or any insurance, charter, or bylaws of the Company or any of its affiliates, including under the Employment Agreement, it being understood and agreed that this Agreement does not create or expand upon any such rights, (if any) to indemnification&#59; or (f) for any federal securities law claim asserted solely in Employee&#8217;s capacity as a shareholder of the Company, that does not concern or relate in any way to Employee&#8217;s employment or other service with the Company or any of its affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">It is specifically understood and agreed that the payments set forth above in Sections 2.0 and 3.0 (including the sub-parts thereto), and each of them, are good and adequate consideration to support the waivers, releases and obligations contained herein, including, without limitation, Sections 5.0, 6.0, 7.0, and 8.0, and their respective sub-parts, and that all of the payments set forth Sections 2.0 and 3.0 (including the sub-parts thereto) are of value in addition to anything to which Employee already was entitled prior to the execution of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Confidentiality</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The parties acknowledge that during the course of Employee&#8217;s employment with the Company, he was given access, on a confidential basis, to Confidential Information which the Company has for years collected, developed, and&#47;or discovered through a significant amount of effort and at great expense.  The parties acknowledge that the Confidential Information of the Company is not generally known or easily obtained in the Company&#8217;s trade, industry, business, or otherwise and that maintaining the secrecy of the Confidential Information is extremely important to the Company&#8217;s ability to compete with its competitors.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee agrees that for a period of seven (7) years from the date of this Agreement, Employee shall not, without the prior written consent of the Company, divulge to any third party or use for his own benefit, or for any purpose other than the exclusive benefit of the Company, any Confidential Information of the Company&#59; provided however, that nothing herein contained shall restrict Employee&#8217;s ability to make such disclosures as such disclosures may be required by law&#59; and further providing that nothing herein contained shall restrict Employee from divulging information that is readily available to the general public as long as such information did not become available to the general public as a direct or indirect result of Employee&#8217;s breach of this section of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; in this Agreement shall mean information that is not readily and easily available to the public or to persons in the same business, trade, or industry of the Company, and that concerns the Company&#8217;s prices, pricing methods, costs, profits, profit margins, suppliers, methods, procedures, processes or combinations or applications thereof developed in, by, or for the Company&#8217;s business, research and development projects, data, business strategies, marketing strategies, sales techniques, customer lists, customer information, or any other information concerning the Company or its business that is not readily and easily available to the public or to those persons in the same business, trade, or industry of the Company.  The term &#8220;customer information&#8221; as used in this Agreement shall mean information that is not readily and easily available to the public or to those persons in the same business, trade, or industry and that concerns the course of dealing between the Company and its customers or potential customers solicited by the Company, customer preferences, particular contracts or locations of customers, negotiations with customers, and any other information </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">concerning customers obtained by the Company that is not readily and easily available to the public or to those in the business, trade, or industry of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee acknowledges that all information, the disclosure of which is prohibited hereby, is of a confidential and proprietary character and of great value to the Company, and upon the execution of this Agreement (or as soon thereafter as is reasonably practicable), Employee shall forthwith deliver up to the Company all records, memoranda, data, and documents of any description that refer to or relate in any way to such information and shall return to the Company any of its equipment and property which may then be in Employee&#8217;s possession or under Employee&#8217;s personal control.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee hereby agrees that any failure to fully and completely comply with this provision shall entitle the Company to seek damages for a demonstrated breach of the confidentiality provision, to include recoupment of monies paid hereunder.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the restrictions set forth in Section 5.0 and its subparts, Employee may disclose information protected under Section 5.0 and its subparts if and only if such is (i) lawfully required by any government agency&#59; (ii) otherwise required to be disclosed by law (including legally required financial reporting) and&#47;or by court order&#59; (iii) necessary in any legal proceeding in order to enforce any provision of this Agreement or (iv) made to the Securities Exchange Commission regarding security law issues.  Employee further agrees that he will notify the Company in writing within five (5) calendar days of the receipt of any subpoena, court order, administrative order or other legal process requiring disclosure of information subject to Section 5.0 and sub-parts thereto.  Employee may also disclose the contents of Section 6.0 and its sub-parts and only those contents to any subsequent and&#47;or prospective employer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Non-Solicitation&#47;Non-Compete</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For a period of twenty-four (24) months following the separation of Employee&#8217;s employment for any reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Restriction Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Employee shall not become an owner in, shareholder with more than a 2% equity interest in, investor in, or an employee, contractor, consultant, advisor, representative, officer, director, or agent of, a trade or business that offers products and services that are the same or substantially similar to the products and services provided by the Company in any geographic market in which the Company conducts business (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the duties and responsibilities of said employment or engagement as an owner in, shareholder with more than 2% equity interest in, investor in, contractor, consultant, advisor, representative, officer, director or agent are (i)&#160;the same, similar, or substantially related to your current duties and responsibilities or duties or responsibilities performed by Employee while employed by the Company at any time during a six (6) month period prior to Employee&#8217;s separation of employment and (ii)&#160;related to or concerning the Competitor&#8217;s business activities in the Restricted Territory.  The parties agree and affirm that their intention with respect to Paragraph 6.1 is that Employee&#8217;s activities shall be limited only for the twenty-four (24) month period after the separation of employment for any reason.  The provisions calling for a &#34;look back&#34; of six (6) calendar months prior to the separation of employment are intended solely as a means of identifying the duties and responsibilities that will define the restricted activities covered by Paragraph&#160;6.1 and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.  For purposes of Paragraph&#160;6.1, the term &#8220;Restricted Territory&#8221; means the geographic area that is part of your current duties and responsibilities or the geographic area that was part of your duties and responsibilities within a period of six (6) month period prior to the date of your termination of employment.  If a court of competent jurisdiction determines that the Restricted Territory as defined herein is too restrictive, then the parties agree that said court may reduce or limit the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Restricted Territory to the largest acceptable area so as to enable the enforcement of Paragraph 6.1.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For a period of twenty-four (24) months following the Separation  Date, Employee will not, either directly or indirectly, or on behalf of any person, business, partnership, or other entity, call upon, contact, or solicit any customer or customer prospect of the Company, or any representative of the same, with a view toward the sale or providing of any service or product competitive with the Company&#8217;s Business&#59; provided, however, the restrictions set forth in this Section shall apply only to customers or prospects of the Company, or representatives of the same, with which during the past 12 month period the Employee had contact or about whom Employee received Confidential Information as part of his duties and responsibilities while employed with the Company within the 12 month period prior to his separation of employment. The parties agree and affirm that their intention with respect to Section 6.2 of this Agreement is that Employee's activities be limited only for a twenty-four (24) month period after the Separation Date for any reason.  The provisions calling for a &#34;look back&#34; of 12 calendar months prior to the Separation Date are intended solely as a means of identifying the clients to which such restrictions apply and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For a period of twenty-four (24) months following the Separation Date, Employee shall not directly or indirectly through a subordinate, co-worker, peer, or any other person or entity contact, solicit, encourage or induce any officer, director or employee of the Company to work for or provide services to Employee and&#47;or any other person or entity.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee acknowledges and agrees that the foregoing restrictions are necessary for the reasonable and proper protection of the Company&#59; are reasonable in respect to subject matter, length of time, geographic scope, customer scope, and scope of activity to be restrained&#59; and are not unduly harsh and oppressive so as to deprive Employee of his livelihood or to unduly restrict Employee&#8217;s opportunity to earn a living after separation of Employee&#8217;s employment with the Company.  Employee further acknowledges and agrees that if any restrictions set forth in this Section are found by any court of competent jurisdiction to be unenforceable or otherwise against public policy, the restriction shall be interpreted to extend only over the maximum period of time or other restriction as to which it would otherwise be enforceable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee acknowledges and agrees that because the violation, breach, or threatened breach of this Section and its sub-parts would result in immediate and irreparable injury to the Company, the Company shall be entitled, without limitation of remedy, to (a) temporary and permanent injunctive and other equitable relief restraining Employee from activities constituting a violation, breach or threatened breach of this Section and its sub-parts to the fullest extent allowed by law&#59; (b) all such other remedies available at law or in equity, including without limitation the recovery of damages, reasonable attorneys&#8217; fees and costs&#59; and (c) withhold any further rights, payments or benefits under this Agreement which become due and owing after the occurrence of said violation, breach, or threatened breach, including, without limitation, any rights or claims under Sections 2.0 and 3.0 and the sub-parts thereto.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Return of Company Property</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee agrees that within 10 days after execution of this Agreement, he will return any and all Company documents and any copies thereof, in any form whatsoever, including computer records or files, containing secret, confidential and&#47;or proprietary information or ideas, and any other Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">property (including, but not limited to, any cell phones, pagers and&#47;or computer equipment) in Employee&#8217;s possession or control, except that Employee may keep possession, custody and control of his currently issued Company laptop.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Duty to Cooperate and of Loyalty&#47;Nondisparagement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation as to time, Employee agrees to cooperate and make all reasonable and lawful efforts to assist the Company in addressing any issues which may arise concerning any matter with which he was involved during his employment with the Company, including, but not limited to cooperating in any litigation arising therefrom.  The Company shall reimburse Employee at a fair and reasonable rate for services provided by the Employee to the Company in connection with services provided under this provision.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee will not (except as required by law) communicate to anyone, whether by word or deed, whether directly or indirectly through an intermediary, and whether expressly or by suggestion or innuendo, any statement, whether characterized as one of fact or opinion, that is intended to cause or that reasonably would be expected to cause any person to whom it is communicated to have (1) a lowered opinion of the Company or any affiliates, including a lowered opinion of any products manufactured, sold or used by, or services offered or rendered by the Company or its affiliates&#59; and (2)  a lowered opinion of the Company&#8217;s creditworthiness or business prospects.  Employee&#8217;s obligations in this regard extends to the reputation of the Company and any of its officers and directors.  To the extent permitted by law, the Company agrees (i) to instruct, as of the Separation Date, its then current Section 16 officers and directors not to publish or communicate to any person or entity or in any public forum (including social media) at any time any defamatory or disparaging remarks, comments, or statements concerning Employee and (ii) not to disparage or criticize Employee in authorized corporate communications.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any provisions of this Agreement to the contrary, if the Employee is a &#8220;specified employee&#8221; (within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and determined pursuant to procedures adopted by the Company) at the Separation  Date and if any portion of the payments or benefits to be received by the Employee would be considered deferred compensation under Section 409A of the Code, amounts that would otherwise be payable pursuant to this Agreement during the six-month period immediately following the Employee&#8217;s Separation  Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delayed Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and benefits that would otherwise be provided pursuant to this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delayed Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) during the six-month period immediately following the Employee&#8217;s Separation  Date (such period, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Delay Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall instead be paid or made available on the earlier of (i) the first business day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) month following the Separation  Date or (ii) the Employee&#8217;s death (the applicable date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Permissible Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Company shall also reimburse the Employee for the after-tax cost incurred by the Employee in independently obtaining any Delayed Benefits (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Additional Delayed Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to any amount of expenses eligible for reimbursement under Sections 3.1, 3.3 and 9.1, such expenses shall be reimbursed by the Company within thirty (30) calendar days following the date on which the Company receives the applicable invoice from the Employee but in no event later than December 31 of the year following the year in which the Employee incurs the related expenses&#59; provided, that with respect to reimbursement relating to the Additional Delayed Payments, such reimbursement shall be made on the Permissible Payment Date.  In no event shall the reimbursements or in-kind benefits to be provided by the Company in one taxable year affect the amount of reimbursements or in-kind benefits to be provided in any other taxable year, nor shall the Employee&#8217;s right to reimbursement or in-kind benefits be subject to liquidation or exchange for another benefit.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">It is the intention of the parties that payments or benefits payable under this Agreement not be subject to the additional tax imposed pursuant to Section 409A of the Code.  To the extent such potential payments or benefits could become subject to such Section, the Company may amend this Agreement with the goal of giving the Covered Employee the economic benefits described herein in a manner that does not result in such tax being imposed.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of Section 409A of the Code, an Employee&#8217;s right to receive any &#8220;installment&#8221; payments pursuant to this Agreement shall be treated as a right to receive a series of separate and distinct payments.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.0&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Miscellaneous</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement is binding on, and shall inure to the benefit of, the Parties hereto and their heirs, representatives, transferees, principals, executors, administrators, predecessors, successors, parents, subsidiaries, affiliates, assigns, agents, directors, officers and employees.  In the event that Employee dies before payment of all amounts described in this Agreement is made, and the Agreement has been executed and not revoked, the Company agrees to pay unpaid amounts to Employee&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement constitutes the complete agreement between, and contains all of the promises and undertakings by the Parties.  Employee agrees that the only considerations for signing this Agreement are the terms stated herein above and that no other representations, promises, or assurances of any kind have been made to him by the Company, its attorneys, or any other person as an inducement to sign this Agreement.  Any and all prior agreements, representations, negotiations and understandings among the Parties, oral or written, express or implied, with respect to the subject matter hereof are hereby superseded and merged herein, except to the extent provided in Section 10 of the Employment Agreement, and provided that this Agreement supplements and does not amend, alter, void, replace, or otherwise override any confidentiality, non-solicitation, non-compete agreement executed by Employee that is part of any equity award agreement executed by the Employee.  To be clear and to avoid any doubt, the parties expressly agree that any confidentiality, non-solicitation, non-compete agreement executed by Employee that is part of any equity award agreement executed by the Employee remains in full force and effect and is not modified in any way by this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement may not be revised or modified without the mutual written consent of the Parties.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Parties acknowledge and agree that they have each had sufficient time to consider this Agreement and consult with legal counsel of their choosing concerning its meaning prior to entering into this Agreement.  In entering into this Agreement, no Party has relied on any representations or warranties of any other Party other than the representations or warranties expressly set forth in this Agreement.  Employee acknowledges that he has read this Agreement and that he possesses sufficient education and experience to fully understand the terms of this Agreement as it has been written, the legal and binding effect of this Agreement, and the exchange of benefits and payments for promises hereunder, and that he has had a full opportunity to discuss or ask questions about all such terms.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise provided in this Section, if any provision of this Agreement shall be determined to be invalid or unenforceable by a court of competent jurisdiction, that part shall be ineffective to the extent of such invalidity or unenforceability only, without in any way affecting the remaining parts of said provision or the remaining provisions of this Agreement&#59; provided that, if any provision contained in this Agreement shall be adjudicated to be invalid or unenforceable because such provision is held to be excessively broad as to duration, geographic </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">scope, activity or subject, such provision shall be deemed amended by limiting and reducing it so as to be valid and enforceable to the maximum extent compatible with the applicable laws of such jurisdiction, and such amendment only to apply with respect to the operation of such provision in the applicable jurisdiction in which the adjudication is made.  If Section 6.0 or any of its sub-parts of this Agreement is deemed invalid or unenforceable, in whole or in part, by a court of competent jurisdiction, this entire Agreement shall be null and void, and any consideration paid hereunder shall be repaid immediately by Employee upon receipt of notice thereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee agrees that because he has rendered services of a special, unique, and extraordinary character, damages may not be an adequate or reasonable remedy for breach of his obligations under this Agreement.  Accordingly, in the event of a breach or threatened breach by Employee of the provisions of this Agreement, the Company shall be entitled to (a) an injunction restraining Employee from violating the terms hereof, or from rendering services to any person, firm, corporation, association, or other entity to which any confidential information, trade secrets, or proprietary materials of the Company have been disclosed or are threatened to be disclosed, or for which Employee is working or rendering services, or threatens to work or render services (b) all such other remedies available at law or in equity, including without limitation the recovery of damages, reasonable attorneys&#8217; fees and costs, and (c) withhold any further payments under this Agreement which become due and owing after the occurrence of said violation, breach or threatened breach.  Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies available to it for such breach or threatened breach of this Agreement, including the right to terminate any payments to Employee pursuant to this Agreement or the recovery of damages from Employee.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Such notice and any other notices required under this Agreement shall be served upon the Company by certified mail, return receipt requested, or by expressed delivery by a nationally recognized delivery service company such as Federal Express as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">If to the Company&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">With a copy to&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br><br></font></div><div style="padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">If to the Employee&#58;</font></div><div style="padding-left:72pt;text-indent:36pt"><font><br></font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tom Pike</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">At last address shown on payroll records of the Company</font></div><div style="padding-left:108pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Consistent with the requirements of this Section, each party shall notify the other party of any change of address for the receipt of a notice under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement shall be construed in accordance with and governed by the laws, except choice of law provisions, of the State of Delaware and shall govern to the exclusion of the laws of any other forum.  The parties further agree that any action, special proceeding or other proceeding with respect to this Agreement shall be brought exclusively in the federal or state courts of the State of Delaware. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Employee and Company irrevocably consent to the jurisdiction of the Federal and State courts of Delaware and that Employee hereby consents and submits to personal jurisdiction in the State of Delaware. Employee and Company irrevocably waive any objection, including an objection or defense based on lack of personal jurisdiction, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">improper venue or forum non-conveniens which either may now or hereafter have to the bringing of any action or proceeding in connection with this Agreement.  Employee acknowledges and recognizes that in the event that he has breached this Agreement, the Company may initiate a lawsuit against him in North Carolina, that Employee waives his right to have that lawsuit be brought in a court located closer to where he may reside, and that Employee will be required to travel to and defend himself in Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Effective Date of this Agreement shall be either (a) the Separation Date or (b) the day after expiration of the seven (7) day revocation period set forth in Section 4.4 of this Agreement, whichever date is later.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you agree with the foregoing, please sign below and return two (2) originals to me.  You should retain one (1) original copy of this Agreement for your records.</font></div><div style="margin-bottom:12pt;padding-left:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-bottom:12pt;padding-left:270pt"><font><br></font></div><div style="padding-left:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;Name&#93;<br>&#91;Title&#93;</font></div><div style="margin-bottom:12pt;padding-left:270pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:270pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Agreed to and accepted&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_________________________________</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Thomas H. Pike</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; ____________________________</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10.5pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT 3</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Confidentiality, Non-Competition and Non-Solicitation Agreement</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">CONFIDENTIALITY&#47;NON-COMPETITION&#47;NON-SOLICITATION AGREEMENT</font></div><div style="margin-top:6pt;padding-left:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">During the course of your employment with Laboratory Corporation of America Holdings (&#8220;Labcorp&#8221;) or its subsidiaries, divisions, or affiliates, you will have access to, or will acquire, highly confidential information and trade secrets concerning Labcorp's and the Employer Company&#8217;s business, including, but not limited to, customer lists, pricing, methods of pricing, marketing practices, advertising strategy, methods of operation and the needs and requirements of Employer Company&#8217;s and&#47;or Labcorp's customers.  In addition, you will receive from Labcorp or Employer Company and&#47;or be exposed to Labcorp&#8217;s or the Employer Company&#8217;s valuable technical and marketing information that will materially aid you in the performance of your duties on behalf of the Employer Company, and assist you and&#47;or the Employer Company in furthering the Employer Company&#8217;s business interests, including establishing and retaining the Employer Company&#8217;s customers.  The support furnished to you by the Employer Company will enable you to increase the value of the Employer Company&#8217;s goodwill with the Employer Company&#8217;s customers, which is a valuable asset of the Employer Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;As indicated by the foregoing, the services you will be performing for the Employer Company will be of a special, unique and extraordinary nature.  Accordingly, in consideration of Labcorp extending to you, as applicable, certain incentive compensation, as set forth in the Agreement(s) to which this Exhibit is made a part thereof and which governs the grant of said benefits, any and all of which benefits otherwise would not be provided to you absent your agreement to be bound by the terms of this Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement (&#8220;Restrictive Covenant Agreement&#8221;), you agree that&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Property Rights and Workproduct</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All ideas, inventions, discoveries, computer programs, developments, standard operating procedures, designs, improvements, formulae, processes, techniques, programs, know-how, data, business plans, reports, presentations, or any other work product of possible technical or commercial importance relating to the Employer Company&#8217;s business or anticipated business (hereafter collectively referred to as &#8220;Work Product&#8221;) created or developed by you as part of your employment with the Employer Company shall be deemed to be work made for hire and that the Employer Company shall be the sole owner of all rights, including copyright, in and to the Work Product.  If such Work Product, or any part thereof, does not qualify as work made for hire, you agree to assign, and hereby assign, to the Employer Company for the full term of the copyright and all extensions thereof all of your right, title and interest in and to the Work Product.  The Employer Company may, at its own expense, prepare and process applications for copyrights, trademarks, service marks, or letter patents, or may take other actions that it deems necessary or appropriate to protect itself with respect to the aforementioned items.  You shall cooperate with the Employer Company in enforcing and protecting its rights by executing such applications or other documentation prepared for the protection of such interests and assigning them to the Employer Company, as well as executing all papers pertaining to said inventions, documents, marks, improvements, discoveries, trade secrets, applications and protective actions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You agree that during the term of your employment and for any time after your termination, you shall not, without the prior written consent of the Employer Company, divulge to any third party or use for your own benefit, or for any purpose other than the exclusive benefit of the Employer Company, any Confidential Information of the Employer Company, Labcorp and its subsidiaries, divisions, or affiliates.  In this Restrictive Covenant Agreement, Confidential Information shall mean information that concerns the Employer Company&#8217;s, Labcorp's and its subsidiaries', divisions', or affiliates' prices, pricing methods, costs, profits, profit margins, suppliers, methods, procedures, processes or combinations or applications thereof developed in, by, or for the Employer Company&#8217;s business, research and development projects, data, business strategies, marketing strategies, sales techniques, customer lists, customer information, financial information, or any other information concerning the Employer Company or its business that is not readily and easily available to the public or to those persons in the same business, trade, or industry of the Employer Company.  The term &#8220;customer information&#8221; as used in this Restrictive Covenant Agreement shall mean information that concerns the course of dealing between the Employer Company and its customers or potential customers solicited by the Employer Company, customer preferences, particular contracts or locations of customers or potential customers, negotiations with customers, and any other information concerning customers or potential customers obtained by the Employer Company that is not readily and easily available to the public or to those in the business, trade, or industry of the Employer Company.  Your obligation not to disclose Confidential Information does not prohibit you from (a) disclosing the information to a government agency if you are required to produce the information pursuant to a subpoena, court order, administrative order or other legal process, (b) discussing terms and conditions of employment or engaging in other activities protected by the National Labor Relations Act, (c) communicating with the Securities and Exchange Commission about securities law violations, or (d) communicating with any other government entity or agency if such communication is to report a violation of applicable law.  However, you shall notify the Employer Company in writing within three (3) calendar days of the receipt of any subpoena, court order, administrative order or other legal process requiring disclosure of Confidential Information and shall provide the Employer Company with a copy of said subpoena, court order, administrative order or other legal process.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Non-Solicitation of Labcorp Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  During the term of your employment and for a period of twelve (12) months following the term of your employment, you shall not, directly or indirectly through a subordinate, co-worker, peer, or any other person or entity contact, solicit, encourage or induce any officer, director or employee of Labcorp or its subsidiaries and affiliates to work for or provide services to you and&#47;or any other person or entity that either (i)&#160;directly provides products or services that compete with the products or services provided by the Employer Company in a geographic market serviced by the Employer Company or (ii)&#160;supplies, services, advises or consults with a person, trade or business that products or services that compete with the products or services provided by the Employer Company in a geographic market serviced by the Employer Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Non-Solicitation of Customers.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">During your employment and for a period of twelve (12) months following the voluntary or involuntary termination of your employment, you will not either directly or indirectly through a subordinate, co-worker, peer or other person or entity, call upon, contact, or solicit or attempt to call upon, contact or solicit any customer or customer prospect of the Employer Company, with a view toward the sale or providing of any service or product competitive with the products and services offered by the Employer Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the restrictions set forth in Paragraph&#160;4 shall apply only to customers or prospects of the Employer Company, or representatives of the same, with which you had contact during the last twenty-four (24) months of your employment with the Employer Company.  The parties agree and affirm that their intention with respect to Paragraph 4&#160;is that your activities be limited only for a twelve (12) month period after termination of your employment with the Employer Company for any reason.  The provisions calling for a &#8220;look back&#8221; of twenty-four (24) calendar months prior to the termination of employment are intended solely as a means of identifying the customers and potential customers to which such restrictions apply and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Noncompetition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">During your employment and for a period of twelve (12) months following your voluntary or involuntary termination of employment, you shall not become an owner in, shareholder with more than a 2% equity interest in, investor in, or an employee, contractor, consultant, advisor, representative, officer, director, or agent of, a trade or business that offers products and services that are the same or substantially similar to the products and services provided by the Employer Company in any geographic market in which the Employer Company conducts business (&#8220;Competitor&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the duties and responsibilities of said employment or engagement as an owner in, shareholder with more than 2% equity interest in, investor in, employee, contractor, consultant, advisor, representative, officer, director or agent are (i)&#160;the same, similar, or substantially related to your current duties and responsibilities or duties or responsibilities performed by you while employed by the Employer Company at any time during a six (6) month period prior to your date of termination of employment and (ii)&#160;related to or concerning the Competitor&#8217;s business activities in the Restricted Territory.  The parties agree and affirm that their intention with respect to Paragraph 5 is that your activities shall be limited only for the twelve (12) month period after termination of employment for any reason.  The provisions calling for a &#8220;look back&#8221; of six (6) calendar months prior to the date of termination of employment are intended solely as a means of identifying the duties and responsibilities that will define the restricted activities covered by Paragraph&#160;5 and are not intended to nor shall they, under any circumstances, be construed to define the length or term of any such restriction.  For purposes of Paragraph&#160;5, the term &#8220;Restricted Territory&#8221; means the geographic area that is part of your current duties and responsibilities or the geographic area that was part of your duties and responsibilities within a period of six (6) month period prior to the date of your termination of employment.  If a court of competent jurisdiction determines that the Restricted Territory as defined herein is too restrictive, then the parties agree that said court may reduce or limit the Restricted </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Territory to the largest acceptable area so as to enable the enforcement of Paragraph 5.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Return of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  At any time upon the request of the Employer Company or upon your termination of your employment, you shall return to the Employer Company any and all Employer Company property including but not limited to laptops, phones, smart phones and documents or materials in your possession, custody and control that contain Confidential Information.  You also agree that upon termination of employment, you shall destroy any Confidential Information stored on your personal computer or other data storage device.  Along with the return of said documents and materials, you shall provide the Employer Company (upon the Employer Company&#8217;s request) with a sworn or written statement indicating that you do not have possession, custody and control of any of the Employer Company&#8217;s Confidential Information and have destroyed all of the Employer Company&#8217;s data electronically stored on your personal computer or other data storage device.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notice shall be effective only if it is made in writing and actually or constructively received by the individuals below.  To be effective, any notice required under this Restrictive Covenant Agreement must be sent by nationally recognized express delivery courier or by certified mail, return receipt requested, to the person(s) and address(es) listed below. </font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Senior Vice President, Global General Counsel</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Laboratory Corporation of America Holdings</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">531 South Spring Street</font></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Burlington, North Carolina 27215</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and, if to you, notice shall be sent to your last known mailing address on record at the Employer Company.  You have an obligation to ensure that the Employer Company&#8217;s records contain your most recent address.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Breach&#47;Available Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Except as otherwise provided in this subparagraph, if any provision of this Restrictive Covenant Agreement shall be determined to be invalid or unenforceable by a court of competent jurisdiction, that part shall be ineffective to the extent of such invalidity or unenforceability only, without in any way affecting the remaining parts of said provision or the remaining provisions of this Restrictive Covenant Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that if any provision contained in this Restrictive Covenant Agreement shall be adjudicated to be invalid or unenforceable because such provision is held to be excessively broad as to duration, geographic scope, activity or subject, the parties agree that the said provision shall be limited and reduced to the maximum extent compatible with the applicable laws of such jurisdiction, and such amendment only to apply with respect to the operation of such provision in the applicable jurisdiction in which the adjudication is made.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You agree that as part of this Restrictive Covenant Agreement, you will have access to the Employer Company&#8217;s Confidential Information, personnel, and existing and potential customers of the Employer Company.  You further agree that the Employer Company maintains a competitive advantage over other persons or entities in the trade or business of providing commercial medical laboratory testing services as a result of the Employer Company&#8217;s Confidential Information, personnel, and existing and potential customer contacts.  You further agree that the Employer Company will be placed at a competitive disadvantage in the event that you breach this Restrictive Covenant Agreement and that damages would not be an adequate or reasonable remedy in the event of such breach.  Accordingly, you stipulate that in the event that you breach one or more of the provisions set forth in this Restrictive Covenant Agreement, the Employer Company will be entitled to an injunction restraining you from violating the terms of those paragraphs.  Nothing herein shall be construed as prohibiting the Employer Company from pursuing any other remedy available for such breach or prospective breach.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:45pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">Absent any other agreement to the contrary nothing herein shall be construed as giving you the right to continued service or employment relationship with the Employer Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement does not alter or amend in any way the Employer Company's right to terminate the employment relationship in accordance with any offer letter, employment contract or applicable law.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You represent and warrant that you are not a party to any contract, agreement or understanding that prevents or prohibits you from entering into and fully performing under this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">In the event a court of law declares any provision of this Restrictive Covenant Agreement to be null and void, it is understood and agreed by you and the Employer Company that such clause shall be severed from this Restrictive Covenant Agreement and that the remaining provisions of this Restrictive Covenant Agreement shall continue to be binding on you.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">It is understood and agreed by you and Laboratory Corporation of America Holdings (&#8220;Labcorp&#8221;) that this Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement constitutes the agreement in its entirety and supersedes any previous Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement previously executed by you as part of an Equity Award Agreement with Labcorp.  This Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement replaces any other non-compete, non-solicitation and confidentiality agreement which you may have previously executed in favor of Labcorp or one of its subsidiary companies incorporated within the United States.  This </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Confidentiality&#47;Non-Competition&#47;Non-Solicitation Agreement shall not replace, amend, restrict, otherwise modify or supersede any employment contract or agreement between you and a foreign subsidiary of Labcorp and shall not amend, alter or affect any non-compete, non-solicitation or confidentiality agreement executed by you and Labcorp or an Employer Company in connection with a merger or acquisition agreement of a business entity with whom you were previously employed or affiliated, including, but not limited to, an ownership or investment interest in said entity.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27.68pt">For purposes of this Restrictive Covenant Agreement, the Employer Company shall mean Laboratory Corporation of America Holdings or its subsidiary and affiliated companies with whom you are employed at the commencement of your employment, as well as any subsequent parent, subsidiary or affiliated company that becomes the employing entity in the event of a transfer, promotion, assignment, reassignment or corporate restructuring.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.01pt">As used herein, &#8220;affiliate&#8221; shall mean a current or future company or other business entity that, directly or indirectly, is controlled by, controls or is under common control with Laboratory Corporation of America Holdings.  For the purposes of the preceding sentence, the meaning of the word &#8220;control&#8221; shall include, but not necessarily be limited to, ownership of more than fifty percent (50%) of the voting shares or other interest of the Employer Company or other business entity.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">This Restrictive Covenant Agreement shall be binding upon you and shall inure to the benefit of the parties and their respective personal representatives, heirs, affiliates, successors, and assigns.  Labcorp may at its sole discretion assign its rights under this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You affirm by signing this Restrictive Covenant Agreement that you have completely read this entire Restrictive Covenant Agreement and understand the terms and conditions included within this Restrictive Covenant Agreement.  You also agree that this Restrictive Covenant Agreement may not be modified or altered in any respect except in writing, signed by you and Labcorp.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">This Restrictive Covenant Agreement shall be deemed to have been entered into in the State of North Carolina and shall be construed in accordance with and governed by the laws of North Carolina, to the exclusion of the laws of any other forum including but not limited to the laws of the State of California.  You agree, acknowledge and recognize that by virtue of your employment with the Employer Company, either a North Carolina corporation or a subsidiary of a North Carolina corporation, with its principal place of business in North Carolina, and your own contacts and business dealings with Labcorp and the Employer Company in North Carolina, North Carolina has a substantial relationship to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">this Restrictive Covenant Agreement and a materially greater interest in applying its laws, over and to the exclusion of the laws of any other forum, to the resolution of any dispute arising out of or relating to this Restrictive Covenant Agreement.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Any action, special proceeding or other proceeding, including without limitation any request for temporary, preliminary, or permanent injunctive relief with respect to this Restrictive Covenant Agreement shall be brought </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">exclusively</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> in the federal or state courts of the State of North Carolina.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">You and the Employer Company irrevocably consent to the jurisdiction of the Federal and State courts of North Carolina and you hereby consent and submit to personal jurisdiction in the State of North Carolina.  You and the Employer Company irrevocably waive any objection, including an objection or defense based on lack of personal jurisdiction, improper venue or forum non-conveniens which either may now or hereafter have to the bringing of any action or proceeding in connection with this Restrictive Covenant Agreement.  You acknowledge and recognize that in the event that you breach this Restrictive Covenant Agreement, the Employer Company may initiate a lawsuit against you in North Carolina, that you waive your right to have that lawsuit be brought in a court located closer to where you may reside, and that you will be required to travel to and defend yourself in North Carolina.  You likewise agree that to the extent you institute any action arising out of or relating to this Restrictive Covenant Agreement, it shall be brought in North Carolina and doing so does not present any undue burden or inconvenience to you.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">You shall at all times abide by such laws and regulations, including but not limited to such laws which relate to the improper inducement for referrals of items or Services reimbursable by the Federal health care programs 42&#160;U.S.C. &#167;&#160;1320a-7b(b) (the &#8220;anti-kickback statute&#8221;).  You acknowledge that you are (i)&#160;aware that the United States securities laws prohibit any person who has material nonpublic information about the Employer Company from purchasing or selling securities of such Employer Company, or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities and (ii)&#160;familiar with the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder and agrees that it will neither use, nor cause any third party to use, any Information in contravention of such Act or any such rules and regulations, including Rules&#160;10b-5 and 14e-3.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:29.67pt">Except as stated otherwise herein, this Restrictive Covenant Agreement contains the entire agreement between the parties hereto with respect to the subject matter hereof, and there are no representations, warranties, covenants, conditions, understandings or agreements other than those expressly set forth herein.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:73.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned have duly executed and delivered this Agreement, or have caused this Agreement to be duly executed and delivered on their behalf.</font></div><div style="text-align:center"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">LABORATORY CORPORATION OF AMERICA HOLDINGS</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Adam Schechter </font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">President and CEO</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXECUTIVE</font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">_________________________</font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Thomas H. Pike</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>exhibit212022.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ide1d250a65194c359434e16e7ab84b53_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:16pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibit 21&#160;&#160;&#160;&#160;LIST OF SUBSIDIARIES</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2248848 Ontario Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3065619 Nova Scotia Company</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3257959 Nova Scotia Company</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">896988 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accupath Diagnostic Laboratories, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beacon Laboratory Benefit Solutions, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">BeaconLBS IPA, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CannAmm GP Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CannAmm Limited Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Center for Disease Detection, LLC </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Centrex Clinical Laboratories, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearstone Central Laboratories (U.S.) Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clearstone Holdings (International) Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clipper Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colorado Coagulation Consultants, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Colorado Laboratory Services, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Correlagen Diagnostics, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Curalab Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cytometry Associates, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Czura Thornton (Hong Kong) Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DCL Acquisition, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DCL Medical Laboratories, LLC (FL)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DCL Medical Laboratories, LLC (DE)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DCL Sub LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diagnostic Services, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DIANON Systems, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DL Holdings Limited Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare - Gamma Laboratory Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Company</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare G.P. Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Holdco LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Laboratories Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Laboratories Limited Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Northwest Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Realty Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DynaLifeDX</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Endocrine Sciences, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Esoterix Genetic Counseling, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Esoterix Genetic Laboratories, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Esoterix, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Execmed Health Services Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">FirstSource Laboratory Solutions, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gamma Dynacare Central Medical Laboratories GP Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gamma Dynacare Central Medical Laboratory Limited Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GDML Medical Laboratories Inc</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HHLA Lab-In-An-Envelope, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Home Healthcare Laboratory of America, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IDX Pathology, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impact Genetics, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lab Delivery Service of New York City, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Belgium Holdings, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp BV</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Central Laboratories (Canada) Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Central Laboratories (China) Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Drug Development (f-Covance Inc.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Development Company</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Employer Services, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Health System Diagnostics, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Japan, G.K.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Kansas, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Michigan, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Nebraska, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Neon Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Neon Switzerland S.&#224; r.l. (Renamed from LabCorp Neon Luxenbourg S.&#224; r.l.)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Oklahoma, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Specialty Testing Billing Service, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Specialty Testing Group, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Staffing Solutions, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp Tennessee, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabCorp UK Holdings, Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratoire Bio-Medic Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Laboratory Corporation of America </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LabWest, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LipoScience, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litholink Corporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Neurogenetics, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medtox Diagnostics, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medtox Laboratories, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MEDTOX Scientific, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Monogram Biosciences, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">National Genetics Institute</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Brighton Business Center LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Imaging Diagnostics, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New Molecular Diagnostics Ventures LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NWT Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Omniseq, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ovuline, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PA Labs, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Path Lab Incorporated</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pathology Associates Medical Lab, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Personal Genome Diagnostics Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Persys Technology Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pixel by LabCorp</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Princeton Diagnostic Laboratories of America, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Protedyne Corporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Saint Joseph-PAML, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sequenom Center for Molecular Medicine, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sequenom, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SW&#47;DL LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tandem Labs Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The LabCorp Charitable Foundation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tri-Cities Laboratory, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Viro-Med Laboratories, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Visiun Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yakima Medical Arts, Inc.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Labcorp Drug Development Inc. Operating Entities&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chiltern International Limited (CIL)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chiltern Pesquisa Clinica Ltda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance (Barbados) Holdings Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance (Barbados) Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fairfax Storage Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Havenfern Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hazpen Trustees Ltd.</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp (Argentina) S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp (Canada) Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp (Polska) Sp. z o.o.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Asia-Pacific Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Austria GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Bedford LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Bioanalytical Services LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Brazil Pharmaceutical Services Limitada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Central Laboratory Services Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Central Laboratory Services Limited Partnership</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Central Laboratory Services S.&#224; r.l.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Chile Services Limitada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development (Pty) Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development AG</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development ApS</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Hungaria Consultancy Limited Liability Company</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Private Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development SARL</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development SRL</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development SRL</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development Ukraine LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Development, S. DE R. L. De C.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Research Unit Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Research Unit Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Clinical Research, LP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp CLS Holdings Limited LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp CLS Holdings Partnership LP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Colombia Services Ltda.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp CRU Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Data Sciences Ukraine LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Development (Asia) Pte. Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Development Japan K.K.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Development Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Development Pty Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Development S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Drug Development India Private Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Early Development Corporation</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Early Development Laboratories Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Early Development Laboratories Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Early Development Services GmbH</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Endpoint (UK) Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Endpoint Clinical Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Endpoint India Private Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Global Specimen Solutions Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Guatemala Services, S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Hong Kong Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Hong Kong Services Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp International Holdings B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp International Holdings Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Korea Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Latin America Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Luxembourg Sarl</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Neon Luxembourg Sarl</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp New Zealand Limited</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Peri-Approval and Commercialization Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Peru Services S.A.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Pharmaceutical Research and Development (Beijing) Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Pharmaceutical Research and Development (Shanghai) Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Pharmaceutical Research and Development (Suzhou) Co., Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Research Holdings, LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Scientific Services &#38; Solutions Private Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Scientific Services and Solutions, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Services (Thailand) Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Services Malaysia Sdn. Bdn.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Specialty Pharmacy LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Taiwan Services Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp US Holdings Limited LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp US Holdings Partnership LP</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LSR Pension Scheme Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SnapIoT Europe s.r.l.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SnapIOT, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Texas Covance GP, Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theorem Clinical Research Holdings B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theorem Clinical Research International B.V</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theorem Clinical Research Latin America B.V.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theorem Research Associates, Inc.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Labcorp Drug Development Inc. Inactive Entities</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chiltern Clinical Research (Philippines) Inc</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chiltern International AB</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Chiltern International Sro</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Clinical and Periapproval Services LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Clinical Development SRL</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Consulting Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Covance CRS Analytics Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance CRS Developments Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance CRS International Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Genomics Laboratory LLC</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Laboratories Korea Company Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance NPA Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Covance Pharma Consulting Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Integrated Development Associates Philippines, Inc</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp International Group Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp Research Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Labcorp UK Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ockham Development Group (Holdings) UK Ltd</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ockham Europe Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Theorem Clinical Research Co., Ltd.</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Dynacare non-operating entities identified subsequent to the acquisition of Dynacare Inc. on July 25, 2002</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1004679 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563911 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794475 Ontario Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829318 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">854512 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">879606 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900747 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">925893 Ontario Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942487 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942489 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942491 Ontario Limited</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">942492 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">947342 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">949235 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">958069 Ontario Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">977681 Ontario Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978550 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">978551 Ontario Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amherstview Medical Centre Developments Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DHG Place Du Centre Clinique</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare Canada Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dynacare International Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glen Davis Equities Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">L.R.C. Management Service Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lawrence-Curlew Medical Centre Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roselat Developments Limited</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">St. Joseph's Health Centre</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockwin Corporation Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thistle Place Care Corp.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Toronto Argyro Medical Laboratories Ltd.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Woodstock Medical Arts Building Inc.</font></td></tr></table></div><div style="margin-bottom:16pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit2312022.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iede4fc81dcff4b5eb93cbeb234634a40_1"></div><div style="min-height:56.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%">Exhibit 23.1</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We consent to the incorporation by reference in Registration Statement No. 333-268472 on Form S-3 and Registration Statement Nos. 333-150704, 333-181107, 333-211324, and 333-211323 on Forms S-8 of our reports dated February&#160;28, 2023, relating to the consolidated financial statements of Laboratory Corporation of America Holdings and the effectiveness of Laboratory Corporation of America Holdings&#8217; internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Deloitte &#38; Touche LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Raleigh, North Carolina </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">February&#160;28, 2023</font></div><div style="height:60.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>6
<FILENAME>exhibit2322022.htm
<DESCRIPTION>EX-23.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i13db6a4ea6304a249489b51fb3b3e30d_1"></div><div style="min-height:56.25pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:111%">Exhibit 23.2</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-268472) and Form S-8 (No. 333-150704, No. 333-181107, No. 333-211324 and No. 333-211323) of Laboratory Corporation of America Holdings of our report dated February 25, 2021, except for the effects of the revision discussed in Note 1 (not presented herein) to the consolidated financial statements appearing under Item 8 of the Company&#8217;s 2021 annual report on Form 10-K, as to which the date is February 25, 2022, and except for the effects of the change in the segment performance measure discussed in Note 19, as to which the date is February&#160;28, 2023, relating to the financial statements, which appears in this Form 10-K</font><font style="color:#000000;font-family:'Georgia',serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div style="margin-bottom:7pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raleigh, North Carolina</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2023 </font></div><div style="height:60.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>7
<FILENAME>exhibit2412022.htm
<DESCRIPTION>EX-24.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id82b0b1b0d034226855c00bff01e7a74_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart her true and lawful attorney-in-fact and agent, with full power of substitution, for her and in her name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or she substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KERRII B. ANDERSON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kerrii B. Anderson</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.2
<SEQUENCE>8
<FILENAME>exhibit2422022.htm
<DESCRIPTION>EX-24.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8ed4f1adcbfb48b3837db7d5d8dc85a1_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.2</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:54.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.313%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEAN-LUC B&#201;LINGARD</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Luc B&#233;lingard</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3
<SEQUENCE>9
<FILENAME>exhibit2432022.htm
<DESCRIPTION>EX-24.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i357bd3862a704d66b3091d63f452ab67_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.3</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEFFREY A. DAVIS</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey A. Davis</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.4
<SEQUENCE>10
<FILENAME>exhibit2442022.htm
<DESCRIPTION>EX-24.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i45ae8154f00d4bd880fea6cb705fd0eb_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.4</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; D. GARY GILLILAND, M.D., Ph.D</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D. Gary Gilliland, M.D., Ph.D</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.5
<SEQUENCE>11
<FILENAME>exhibit2452022.htm
<DESCRIPTION>EX-24.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i92bcacae110e4ba0ae2c2fdf50bc8518_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.5</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart her true and lawful attorney-in-fact and agent, with full power of substitution, for her and in her name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:54.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.313%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KIRSTEN M. KLIPHOUSE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kirsten M. Kliphouse</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.6
<SEQUENCE>12
<FILENAME>exhibit2462022.htm
<DESCRIPTION>EX-24.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i66a6941bc4e248d381c875c3176537eb_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.6</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:54.167%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.313%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GARHENG KONG, M.D., Ph.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garheng Kong, M.D., Ph.D.</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.7
<SEQUENCE>13
<FILENAME>exhibit2472022.htm
<DESCRIPTION>EX-24.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie50da433f8f944c5bddfe56a8731b8d6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.7</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PETER M. NEUPERT</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Neupert</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.8
<SEQUENCE>14
<FILENAME>exhibit2482022.htm
<DESCRIPTION>EX-24.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i14c8debc56b8419389b1f636cea88dd0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.8</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart her true and lawful attorney-in-fact and agent, with full power of substitution, for her and in her name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; RICHELLE P. PARHAM</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richelle P. Parham</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.9
<SEQUENCE>15
<FILENAME>exhibit2492022.htm
<DESCRIPTION>EX-24.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0cdcd44f2ca84ef3bb14084153089086_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.9</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart her true and lawful attorney-in-fact and agent, with full power of substitution, for her and in her name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KATHRYN E. WENGEL</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kathryn E. Wengel</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.10
<SEQUENCE>16
<FILENAME>exhibit24102022.htm
<DESCRIPTION>EX-24.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9ff907d94a914e32abaa1378cf39700e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:102%">Exhibit 24.10</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December&#160;31, 2022, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:102%">IN WITNESS WHEREOF, the undersigned has signed these presents in this 28th day of February, 2023.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; R. SANDERS WILLIAMS, M.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R. Sanders Williams, M.D.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>17
<FILENAME>lh10-kex3112022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i748b816363754d24859cf35564c2360d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Adam H. Schechter, certify that&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Laboratory Corporation of America Holdings&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;&#160;and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>18
<FILENAME>lh10-kex3122022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib7e6d71c713243799e2c136a202322aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn A. Eisenberg, certify that&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of Laboratory Corporation of America Holdings&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59;&#160;&#160;and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>19
<FILENAME>lh10-kex322022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if81bb36644f4447aa5e017c68893664c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written Statement of</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chief Financial Officer</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The undersigned, the Chief Executive Officer and the Chief Financial Officer of Laboratory Corporation of America Holdings (Company), each hereby certifies that, to his knowledge on the date hereof&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;the Form 10-K of the Company for the Period Ended December&#160;31, 2022, filed on the date hereof with the Securities and Exchange Commission (Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ADAM H. SCHECHTER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adam H. Schechter</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; GLENN A. EISENBERG</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn A. Eisenberg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2023</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Laboratory Corporation of America Holdings and will be retained by Laboratory Corporation of America Holdings and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>20
<FILENAME>lh-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lh="http://www.labcorp.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.labcorp.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lh-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.labcorp.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000002 - Document - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Cover" roleURI="http://www.labcorp.com/role/Cover">
        <link:definition>0000003 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERLIABILITIES" roleURI="http://www.labcorp.com/role/OTHERLIABILITIES">
        <link:definition>0000004 - Document - OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERLIABILITIES_1" roleURI="http://www.labcorp.com/role/OTHERLIABILITIES_1">
        <link:definition>0000005 - Document - OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERLIABILITIES_2" roleURI="http://www.labcorp.com/role/OTHERLIABILITIES_2">
        <link:definition>0000006 - Document - OTHER LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000007 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParentheticals" roleURI="http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals">
        <link:definition>0000008 - Statement - Consolidated Balance Sheet (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS">
        <link:definition>0000010 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0000011 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE">
        <link:definition>0000012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT">
        <link:definition>0000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS">
        <link:definition>0000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENotes" roleURI="http://www.labcorp.com/role/REVENUENotes">
        <link:definition>0000016 - Disclosure - REVENUE (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS">
        <link:definition>0000017 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandRelatedActivities" roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivities">
        <link:definition>0000018 - Disclosure - Restructuring and Related Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNotes" roleURI="http://www.labcorp.com/role/LEASESNotes">
        <link:definition>0000019 - Disclosure - LEASES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTNET" roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET">
        <link:definition>0000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>0000021 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESANDOTHER" roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER">
        <link:definition>0000022 - Disclosure - ACCRUED EXPENSES AND OTHER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.labcorp.com/role/DEBT">
        <link:definition>0000023 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY">
        <link:definition>0000024 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.labcorp.com/role/INCOMETAXES">
        <link:definition>0000025 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKCOMPENSATIONPLANS" roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS">
        <link:definition>0000026 - Disclosure - STOCK COMPENSATION PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENTLIABILITIES" roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES">
        <link:definition>0000027 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANS" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS">
        <link:definition>0000028 - Disclosure - PENSION AND POSTRETIREMENT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000029 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES">
        <link:definition>0000030 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATION" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION">
        <link:definition>0000031 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>0000032 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.labcorp.com/role/SubsequentEvents">
        <link:definition>0000033 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.labcorp.com/role/REVENUETables">
        <link:definition>0000036 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables">
        <link:definition>0000037 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS Business Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandRelatedActivitiesTables" roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables">
        <link:definition>0000038 - Disclosure - Restructuring and Related Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.labcorp.com/role/LEASESTables">
        <link:definition>0000039 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTNETTables" roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables">
        <link:definition>0000040 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>0000041 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESANDOTHERTables" roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables">
        <link:definition>0000042 - Disclosure - ACCRUED EXPENSES AND OTHER (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.labcorp.com/role/DEBTTables">
        <link:definition>0000043 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables">
        <link:definition>0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.labcorp.com/role/INCOMETAXESTables">
        <link:definition>0000045 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKCOMPENSATIONPLANSTables" roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables">
        <link:definition>0000046 - Disclosure - STOCK COMPENSATION PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables">
        <link:definition>0000047 - Disclosure - PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000048 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
        <link:definition>0000049 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATIONTables" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables">
        <link:definition>0000050 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>0000051 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsTables" roleURI="http://www.labcorp.com/role/SubsequentEventsTables">
        <link:definition>0000052 - Disclosure - Subsequent Events (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>0000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEDetails" roleURI="http://www.labcorp.com/role/REVENUEDetails">
        <link:definition>0000054 - Disclosure - REVENUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReceivablesLoansNotesReceivableandOthersDetails" roleURI="http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails">
        <link:definition>0000055 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails">
        <link:definition>0000056 - Disclosure - BUSINESS ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails">
        <link:definition>0000057 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS DISPOSITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails" roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails">
        <link:definition>0000058 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS Envigo (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandRelatedActivitiesDetails" roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails">
        <link:definition>0000059 - Disclosure - Restructuring and Related Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetails" roleURI="http://www.labcorp.com/role/LEASESDetails">
        <link:definition>0000060 - Disclosure - LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseCostDetails" roleURI="http://www.labcorp.com/role/LEASESLeaseCostDetails">
        <link:definition>0000061 - Disclosure - LEASES - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalCashFlowDetails" roleURI="http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails">
        <link:definition>0000062 - Disclosure - LEASES - Supplemental Cash Flow (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalBalanceSheetDetails" roleURI="http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails">
        <link:definition>0000063 - Disclosure - LEASES - Supplemental Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityofLeasesDetails" roleURI="http://www.labcorp.com/role/LEASESMaturityofLeasesDetails">
        <link:definition>0000064 - Disclosure - LEASES - Maturity of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTNETDetails" roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails">
        <link:definition>0000065 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails">
        <link:definition>0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails">
        <link:definition>0000067 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails">
        <link:definition>0000068 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails" roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails">
        <link:definition>0000069 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESANDOTHERDetails" roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails">
        <link:definition>0000070 - Disclosure - ACCRUED EXPENSES AND OTHER (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSCHEDULEOFSHORTTERMDEBTDetails" roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails">
        <link:definition>0000071 - Disclosure - DEBT - SCHEDULE OF SHORT-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSCHEDULEOFLONGTERMDEBTDetails" roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails">
        <link:definition>0000072 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCREDITFACILITIESDetails" roleURI="http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails">
        <link:definition>0000073 - Disclosure - DEBT - CREDIT FACILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCOVERTIBLESUBORDINATEDNOTESDetails" roleURI="http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails">
        <link:definition>0000074 - Disclosure - DEBT - COVERTIBLE SUBORDINATED NOTES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSENIORNOTESDetails" roleURI="http://www.labcorp.com/role/DEBTSENIORNOTESDetails">
        <link:definition>0000075 - Disclosure - DEBT - SENIOR NOTES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
        <link:definition>0000076 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.labcorp.com/role/INCOMETAXESDetails">
        <link:definition>0000077 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKCOMPENSATIONPLANSDetails" roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails">
        <link:definition>0000078 - Disclosure - STOCK COMPENSATION PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails" roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails">
        <link:definition>0000079 - Disclosure - STOCK COMPENSATION PLANS (Schedule of Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Details" roleURI="http://www.labcorp.com/role/Details">
        <link:definition>0000080 - Disclosure - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails">
        <link:definition>0000081 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails">
        <link:definition>0000082 - Disclosure - PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails">
        <link:definition>0000083 - Disclosure - PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails" roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails">
        <link:definition>0000084 - Disclosure - PENSION AND POSTRETIREMENT PLANS - Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetails" roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails">
        <link:definition>0000085 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails">
        <link:definition>0000086 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails" roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails">
        <link:definition>0000087 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWINFORMATIONDetails" roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails">
        <link:definition>0000088 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>0000089 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.labcorp.com/role/SubsequentEventsDetails">
        <link:definition>0000090 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lh_A2022SwapAgreementsMember" abstract="true" name="A2022SwapAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ShortTermLeaseMember" abstract="true" name="ShortTermLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_IncomeAbstract" abstract="true" name="IncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_DrugDevelopmentMember" abstract="true" name="DrugDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_AccruedPassThroughExpenses" abstract="false" name="AccruedPassThroughExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_RestrictedStockAndPerformanceSharesMember" abstract="true" name="RestrictedStockAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SeniorNotesFairValue" abstract="false" name="SeniorNotesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CostMethodInvestmentsMaximumOwnershipPercentage" abstract="false" name="CostMethodInvestmentsMaximumOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_MutualFundsMember" abstract="true" name="MutualFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ClientMember" abstract="true" name="ClientMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" abstract="false" name="CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" abstract="false" name="Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_LongTermDebtExcludingDebtIssuanceCosts" abstract="false" name="LongTermDebtExcludingDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DefinedBenefitPlanAmortizationAndDeferral" abstract="false" name="DefinedBenefitPlanAmortizationAndDeferral" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Propertyplantandequipmentusefullifesoftwareminimum" abstract="false" name="Propertyplantandequipmentusefullifesoftwareminimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_IntangibleAssetsFiniteLivedPolicyTextBlock" abstract="false" name="IntangibleAssetsFiniteLivedPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_IncrementalCommonSharesAttributableToStockOptions" abstract="false" name="IncrementalCommonSharesAttributableToStockOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_FacilityRelatedRestructuringReserveAccrualAdjustment" abstract="false" name="FacilityRelatedRestructuringReserveAccrualAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PGDxMember" abstract="true" name="PGDxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_DeferredTaxAssetRightOfUseAsset" abstract="false" name="DeferredTaxAssetRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_AscensionAcquisitionMember" abstract="true" name="AscensionAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_LongTermContractsDurationMaximum" abstract="false" name="LongTermContractsDurationMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_ThirdpartyMember" abstract="true" name="ThirdpartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A2022ShareRepurchasesMember" abstract="true" name="A2022ShareRepurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Longtermdebtissuancecosts" abstract="false" name="Longtermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" abstract="false" name="DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_FederalandStateAttributeCarryforwardValuationAllowance" abstract="false" name="FederalandStateAttributeCarryforwardValuationAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NetRestructuringCharges" abstract="false" name="NetRestructuringCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CashBalanceRetirementPlanMember" abstract="true" name="CashBalanceRetirementPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_OtheracquireesMember" abstract="true" name="OtheracquireesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NoteReceivableCreditLossExpenseReversal" abstract="false" name="NoteReceivableCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2019TermLoan" abstract="false" name="A2019TermLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_MeasurementPeriodAdjustmentsMember" abstract="true" name="MeasurementPeriodAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_FederalTaxLossCarryovers" abstract="false" name="FederalTaxLossCarryovers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NoteReceivableAllowanceforCreditLoss" abstract="false" name="NoteReceivableAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanExpense" abstract="false" name="EmployeeStockPurchasePlanExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_GoodwillImpairmentCumulative" abstract="false" name="GoodwillImpairmentCumulative" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2018SwapAgreementsMember" abstract="true" name="A2018SwapAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SwapTypeAxis" abstract="true" name="SwapTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="lh_NetRestructuringAndOtherSpecialCharges" abstract="false" name="NetRestructuringAndOtherSpecialCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" abstract="false" name="ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_OutstandingStockRepurchaseAuthorizationAbstract" abstract="true" name="OutstandingStockRepurchaseAuthorizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_A155SeniorNotesDue2026" abstract="false" name="A155SeniorNotesDue2026" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Seniornotesdue2024" abstract="false" name="Seniornotesdue2024" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" abstract="false" name="EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_OtherLiabilitiesNoncurrentOther" abstract="false" name="OtherLiabilitiesNoncurrentOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Maximumdeferralpercentageofannualcashincentivepay" abstract="false" name="Maximumdeferralpercentageofannualcashincentivepay" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_A4.00Seniornotesdue2023" abstract="false" name="A4.00Seniornotesdue2023" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorNotesDue2022Member" abstract="true" name="SeniorNotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SalesCommissionAmortizationPeriodMinimum" abstract="false" name="SalesCommissionAmortizationPeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_LongTermContractsDurationMinimum" abstract="false" name="LongTermContractsDurationMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_Seniornotesdue2027" abstract="false" name="Seniornotesdue2027" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SoftwareDepreciation" abstract="false" name="SoftwareDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" abstract="false" name="ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" abstract="false" name="BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" abstract="false" name="Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" abstract="false" name="DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" abstract="false" name="DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PercentofRevenueContributed" abstract="false" name="PercentofRevenueContributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_UnbilledContractsReceivableMember" abstract="true" name="UnbilledContractsReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_NoncontrollingInterestMezzanineEquity" abstract="false" name="NoncontrollingInterestMezzanineEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CreditFacilityMaximumLettersofCredit" abstract="false" name="CreditFacilityMaximumLettersofCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" abstract="false" name="EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="lh_DefinedBenefitPlanActualAssetAllocation" abstract="false" name="DefinedBenefitPlanActualAssetAllocation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_InternationalDevelopedMember" abstract="true" name="InternationalDevelopedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SeniorNotesDue2024Member" abstract="true" name="SeniorNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_A2022ASRSettlementMember" abstract="true" name="A2022ASRSettlementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" abstract="false" name="UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" abstract="false" name="GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2020AcquisitionsMember" abstract="true" name="A2020AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_IncomeTaxBenefitMinimumCertaintyPercentage" abstract="false" name="IncomeTaxBenefitMinimumCertaintyPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_NetProceedsFromIssuanceOfStockToEmployees" abstract="false" name="NetProceedsFromIssuanceOfStockToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Propertyplantandequipmentusefullifesoftwaremaximum" abstract="false" name="Propertyplantandequipmentusefullifesoftwaremaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_InternalUseSoftwarePolicyTextBlock" abstract="false" name="InternalUseSoftwarePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_RestrictedStockPerformanceSharesExpense" abstract="false" name="RestrictedStockPerformanceSharesExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" abstract="false" name="ExcessTaxBenefitShareBasedCompensationFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SalesCommissionAmortizationPeriodMaximum" abstract="false" name="SalesCommissionAmortizationPeriodMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lh_IssuanceOfCommonStockUnderEmployeeStockPlans" abstract="false" name="IssuanceOfCommonStockUnderEmployeeStockPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_OthercountriesMember" abstract="true" name="OthercountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_CreditFacilityOptiontoIncrease" abstract="false" name="CreditFacilityOptiontoIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A2021AcquisitionsMember" abstract="true" name="A2021AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_PerShareAmountAbstract" abstract="true" name="PerShareAmountAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Seniornotesdue2027Member" abstract="true" name="Seniornotesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" abstract="true" name="ScheduleOfOtherIntangibleAssetsByMajorClassDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_FederalLossCarryoverDomain" abstract="true" name="FederalLossCarryoverDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_InterestPaidInCash" abstract="false" name="InterestPaidInCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" abstract="false" name="ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_BiopharmaceuticalandmedicaldevicecompaniesMember" abstract="true" name="BiopharmaceuticalandmedicaldevicecompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SharesAbstract" abstract="true" name="SharesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Contingentconsiderationadjustment" abstract="false" name="Contingentconsiderationadjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" abstract="false" name="ConcentrationRiskAccountsReceivableMedicareAndMedicaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" abstract="false" name="PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="lh_SwapTypeDomain" abstract="true" name="SwapTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_SeniorNotesDue2020Member" abstract="true" name="SeniorNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_CommonStockRepurchaseAuthorizationOutstanding" abstract="false" name="CommonStockRepurchaseAuthorizationOutstanding" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A270SeniorNotesDue2031" abstract="false" name="A270SeniorNotesDue2031" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorLongTermNotesDue2020Member" abstract="true" name="SeniorLongTermNotesDue2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Percentofgrossaccountsreceivableduefrompatients" abstract="false" name="Percentofgrossaccountsreceivableduefrompatients" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" abstract="false" name="Longtermdebtfutureminimumpaymentsinterestincludedinpayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_DepreciationAndAmortizationOfLeasedAssets" abstract="false" name="DepreciationAndAmortizationOfLeasedAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ConcentrationOfCreditRiskPolicyTextBlock" abstract="false" name="ConcentrationOfCreditRiskPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_DeferredIncomeTaxesAndOtherTaxLiabilities" abstract="false" name="DeferredIncomeTaxesAndOtherTaxLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A4.70Seniornotesdue2045" abstract="false" name="A4.70Seniornotesdue2045" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_CreditFacilityMaximumSwingLineBorrowings" abstract="false" name="CreditFacilityMaximumSwingLineBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_A3.60Seniornotesdue2025" abstract="false" name="A3.60Seniornotesdue2025" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_SeniorNotesDue2023Member" abstract="true" name="SeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" abstract="true" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_GainRecognizedonExitofInterestRateSwapArrangement" abstract="false" name="GainRecognizedonExitofInterestRateSwapArrangement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ConsolidatedStatementsofOperationsAbstract" abstract="true" name="ConsolidatedStatementsofOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_AllowanceforCreditLoss" abstract="false" name="AllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ForeignTaxLossCarryoverValuationAllowance" abstract="false" name="ForeignTaxLossCarryoverValuationAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_AccumulatedOtherComprehensiveEarningsAbstract" abstract="true" name="AccumulatedOtherComprehensiveEarningsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_DefinedContributionPlanTotalExpense" abstract="false" name="DefinedContributionPlanTotalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_NotePayableCurrentMember" abstract="true" name="NotePayableCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanPercentOfMarketPrice" abstract="false" name="EmployeeStockPurchasePlanPercentOfMarketPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_A2.95seniornotesdue2029" abstract="false" name="A2.95seniornotesdue2029" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" abstract="false" name="AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" abstract="false" name="EmployeeStockPurchasePlanNumberOfAuthorizedShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_CommonSharesHeldInTreasuryRollforwardAbstract" abstract="true" name="CommonSharesHeldInTreasuryRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_PatentsLicensesAndTechnologyMember" abstract="true" name="PatentsLicensesAndTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_AssumedBenefitPaymentsByYearTableTextBlock" abstract="false" name="AssumedBenefitPaymentsByYearTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_LeaseDisclosureTableTextBlockTableTextBlock" abstract="false" name="LeaseDisclosureTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_CashPaidDuringPeriodForAbstract" abstract="true" name="CashPaidDuringPeriodForAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" abstract="false" name="UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" abstract="false" name="ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_A2.30seniornotesdue2024" abstract="false" name="A2.30seniornotesdue2024" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ProfessionalLiabilityPolicyTextBlock" abstract="false" name="ProfessionalLiabilityPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_UnbilledServicesAllowanceforCreditLoss" abstract="false" name="UnbilledServicesAllowanceforCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_UsFixedIncomeMember" abstract="true" name="UsFixedIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_CommonSharesIssuedRollforwardAbstract" abstract="true" name="CommonSharesIssuedRollforwardAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lh_Shorttermdebtissuancecosts" abstract="false" name="Shorttermdebtissuancecosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_TotalShortandLongTermDebtIssuanceCosts" abstract="false" name="TotalShortandLongTermDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ForeignTaxLossCarryovers" abstract="false" name="ForeignTaxLossCarryovers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_UnbilledServicesCreditLossExpenseReversal" abstract="false" name="UnbilledServicesCreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_UKPlanMember" abstract="true" name="UKPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" abstract="false" name="ReversalofAccruedIncomeTaxPenaltiesAndInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_Maximumdeferralpercentageofannualbasesalary" abstract="false" name="Maximumdeferralpercentageofannualbasesalary" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_AllowanceforCreditLossWriteOff" abstract="false" name="AllowanceforCreditLossWriteOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ForeignTaxLossCarryoversExpirein2034" abstract="false" name="ForeignTaxLossCarryoversExpirein2034" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_MedicareandMedicaidMember" abstract="true" name="MedicareandMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ShortTermDebtAndLongTermDebtCurrentMaturities" abstract="false" name="ShortTermDebtAndLongTermDebtCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" abstract="false" name="EmployeeStockPurchasePlanNumberOfSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="lh_A2019AcquisitionsMember" abstract="true" name="A2019AcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_Post2017Member" abstract="true" name="Post2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_ExcludingEnvigoMember" abstract="true" name="ExcludingEnvigoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" abstract="false" name="PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lh_CreditLossExpenseReversal" abstract="false" name="CreditLossExpenseReversal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FederalandStateAttributeCarryforwards" abstract="false" name="FederalandStateAttributeCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_PercentOfDomesticRevenue" abstract="false" name="PercentOfDomesticRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lh_IncreaseDecreaseInNoncontrollingInterestPut" abstract="false" name="IncreaseDecreaseInNoncontrollingInterestPut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_BalanceOfSeniorNotesMatureDuringQ42020" abstract="false" name="BalanceOfSeniorNotesMatureDuringQ42020" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lh_ShortTermDebtIssueCostsMember" abstract="true" name="ShortTermDebtIssueCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" abstract="false" name="DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>21
<FILENAME>lh-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_75465ce5-e0c8-4064-9d62-b89d53364a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_75465ce5-e0c8-4064-9d62-b89d53364a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9c5d28e5-15c7-4c1d-ae5d-c1605155dc19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9c5d28e5-15c7-4c1d-ae5d-c1605155dc19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_63c5aa4e-094e-4dde-8499-6bbad5eee550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_63c5aa4e-094e-4dde-8499-6bbad5eee550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80c661cb-f155-44fe-b207-e14b14993fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_80c661cb-f155-44fe-b207-e14b14993fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_31ededbe-822a-4bb0-a92f-f3588d6b5d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_31ededbe-822a-4bb0-a92f-f3588d6b5d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_3d83e77b-52f4-497f-87d4-2e47b92e7580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_3d83e77b-52f4-497f-87d4-2e47b92e7580" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_57d90725-ab18-4075-909d-43f0a2a2f36e" xlink:href="lh-20221231.xsd#lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_57d90725-ab18-4075-909d-43f0a2a2f36e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_629b88bb-70c5-41e6-897e-bf4b11cd8c73" xlink:href="lh-20221231.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_629b88bb-70c5-41e6-897e-bf4b11cd8c73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f2d81960-7ea9-4bfc-9088-a8341183061a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f2d81960-7ea9-4bfc-9088-a8341183061a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_15371cab-90a3-4167-8d96-b845f95e7e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e1e40624-a490-4a27-a9c6-cecbc99eca65" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_15371cab-90a3-4167-8d96-b845f95e7e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bdfbf24-0433-4e2b-8bc4-a97bdd1e5eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6249b295-7416-4c3a-8060-806fc584e3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bdfbf24-0433-4e2b-8bc4-a97bdd1e5eb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6249b295-7416-4c3a-8060-806fc584e3e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dffe2ef0-728d-4807-9169-ca0a2f06ad36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bdfbf24-0433-4e2b-8bc4-a97bdd1e5eb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dffe2ef0-728d-4807-9169-ca0a2f06ad36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0053e526-7faa-4a8c-b02a-db7043ca5234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bdfbf24-0433-4e2b-8bc4-a97bdd1e5eb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0053e526-7faa-4a8c-b02a-db7043ca5234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d5817ae7-e1b0-450a-b6f6-56aebd851b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2bdfbf24-0433-4e2b-8bc4-a97bdd1e5eb4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d5817ae7-e1b0-450a-b6f6-56aebd851b8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d1f67c4-4f1b-400f-839c-f15d49971194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3d1f67c4-4f1b-400f-839c-f15d49971194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3e3db8cc-8fd0-4f0c-9140-836bcf309c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_3e3db8cc-8fd0-4f0c-9140-836bcf309c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cad59fe-7732-4249-8b45-75d6a5db3a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_8cad59fe-7732-4249-8b45-75d6a5db3a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_ae630c31-604f-4b8a-abbe-411c521a80ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_ae630c31-604f-4b8a-abbe-411c521a80ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c03f9f3a-7a79-4ee9-a8a1-5eba2a80d01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_c03f9f3a-7a79-4ee9-a8a1-5eba2a80d01d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ddec9ef-7a7f-4580-a861-f2bd2ab4b1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1ddec9ef-7a7f-4580-a861-f2bd2ab4b1c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_0f88038d-b109-44dd-b858-11e80bb5bada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_de399efc-15a1-4f30-adfe-0585c2e44943" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_0f88038d-b109-44dd-b858-11e80bb5bada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c0382fd6-6e0d-488c-b00c-8c73814353db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c0382fd6-6e0d-488c-b00c-8c73814353db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_1836d493-6d25-43c6-8241-b99610c00f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_1836d493-6d25-43c6-8241-b99610c00f61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fb4db54c-7037-4c1a-a448-c2d6e9f8bd89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fb4db54c-7037-4c1a-a448-c2d6e9f8bd89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8993abd8-797d-4e99-a66d-ab5feae1b8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_ShareBasedCompensation_8993abd8-797d-4e99-a66d-ab5feae1b8a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_aad69190-eb18-4dcd-a39c-b6e9bbd423ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_aad69190-eb18-4dcd-a39c-b6e9bbd423ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_838c1771-a36a-453a-b7a4-c5330c1b1a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_838c1771-a36a-453a-b7a4-c5330c1b1a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ccf93cad-8c8a-4f05-9cdb-0e6959535151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ccf93cad-8c8a-4f05-9cdb-0e6959535151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1cffc6fa-c3df-438a-b381-f493d5aea4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1cffc6fa-c3df-438a-b381-f493d5aea4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_7c9ec1a6-f15c-4e73-aa31-947441c3edb6" xlink:href="lh-20221231.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_7c9ec1a6-f15c-4e73-aa31-947441c3edb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7114a40c-9fdd-4649-a170-c15440c4de9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7114a40c-9fdd-4649-a170-c15440c4de9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3213fb6a-159d-4def-83d7-d3d3a06eda29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3213fb6a-159d-4def-83d7-d3d3a06eda29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f039bf97-938d-429c-abb6-573c978b777d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_ProfitLoss_f039bf97-938d-429c-abb6-573c978b777d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8c63861b-abc5-4546-9cab-e2ce50f97aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_8c63861b-abc5-4546-9cab-e2ce50f97aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e3236109-aecd-4c38-9787-d3fc60975821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bf94b0cf-b721-45c1-8fff-68a53e4fcf60" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e3236109-aecd-4c38-9787-d3fc60975821" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e3366e23-1244-4dc6-912a-5636acf75d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8c8f40e9-9178-4aaf-89cb-09ea3037b9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e3366e23-1244-4dc6-912a-5636acf75d07" xlink:to="loc_us-gaap_Liabilities_8c8f40e9-9178-4aaf-89cb-09ea3037b9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_c40b4272-9b67-46a7-8e1f-de743221376d" xlink:href="lh-20221231.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e3366e23-1244-4dc6-912a-5636acf75d07" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_c40b4272-9b67-46a7-8e1f-de743221376d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a49d9449-be37-4f38-8b82-a47dd60257fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e3366e23-1244-4dc6-912a-5636acf75d07" xlink:to="loc_us-gaap_StockholdersEquity_a49d9449-be37-4f38-8b82-a47dd60257fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7664e466-6aba-4a5f-9f44-cef266c4c374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e3366e23-1244-4dc6-912a-5636acf75d07" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7664e466-6aba-4a5f-9f44-cef266c4c374" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7bb06cd9-1383-4cc9-ba12-caba4dd159fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7bb06cd9-1383-4cc9-ba12-caba4dd159fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d4783743-1ec3-4f5b-9550-6973871e5283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d4783743-1ec3-4f5b-9550-6973871e5283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_677da8e3-a4cc-45b6-a910-58f33dd253e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:to="loc_us-gaap_UnbilledContractsReceivable_677da8e3-a4cc-45b6-a910-58f33dd253e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_38f4dac0-3f65-4365-a776-b230c386728b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:to="loc_us-gaap_InventoryNet_38f4dac0-3f65-4365-a776-b230c386728b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_457e2d52-86a7-4607-b8d9-2ef0365688de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2acdac06-75ea-4acd-bf44-4d781d773ea5" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_457e2d52-86a7-4607-b8d9-2ef0365688de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2da14cd6-4a4d-49f3-a47b-b0f65a9680cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_32f4b361-0552-4090-854e-2b06c501af1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2da14cd6-4a4d-49f3-a47b-b0f65a9680cc" xlink:to="loc_us-gaap_CommonStockValue_32f4b361-0552-4090-854e-2b06c501af1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dbb28126-caf4-44af-9921-645b7de613a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2da14cd6-4a4d-49f3-a47b-b0f65a9680cc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dbb28126-caf4-44af-9921-645b7de613a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_285ff452-3eff-4ee8-abf1-223d44766448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2da14cd6-4a4d-49f3-a47b-b0f65a9680cc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_285ff452-3eff-4ee8-abf1-223d44766448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0ccad9b-d080-426a-b7fd-aec3eb80c0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2da14cd6-4a4d-49f3-a47b-b0f65a9680cc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0ccad9b-d080-426a-b7fd-aec3eb80c0f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_11b54223-3a12-4b29-8c3f-14ce2314d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_us-gaap_AccountsPayableCurrent_11b54223-3a12-4b29-8c3f-14ce2314d59f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a7f4f726-84a7-4449-b050-efec803dcf66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a7f4f726-84a7-4449-b050-efec803dcf66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_66fb1871-68a6-4388-aceb-86ee70308531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_us-gaap_DeferredRevenueCurrent_66fb1871-68a6-4388-aceb-86ee70308531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_7f32aa9d-3d13-42c1-a91e-27c98ae4741a" xlink:href="lh-20221231.xsd#lh_ShortTermDebtAndLongTermDebtCurrentMaturities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_7f32aa9d-3d13-42c1-a91e-27c98ae4741a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e6fe6c55-e6e5-4aed-bf2c-0be5822975e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e6fe6c55-e6e5-4aed-bf2c-0be5822975e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6ef8b43a-a3ad-42a5-90ea-afef7c62d04d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_542d1429-cd4f-4cac-88cb-e26cbca8f6b0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6ef8b43a-a3ad-42a5-90ea-afef7c62d04d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5fec9c17-531f-406b-86b1-c18907c4f123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_AssetsCurrent_5fec9c17-531f-406b-86b1-c18907c4f123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aeb7da0b-5ffa-4d97-bbc5-c8fc3a47b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_aeb7da0b-5ffa-4d97-bbc5-c8fc3a47b7be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_488be9a9-d3b1-44da-91f2-ff1e580da2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_Goodwill_488be9a9-d3b1-44da-91f2-ff1e580da2e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d39a2951-6d90-4833-b9c5-43c1552b70ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d39a2951-6d90-4833-b9c5-43c1552b70ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_65628f1f-f54f-4b40-9dbf-2dfd598c5f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_65628f1f-f54f-4b40-9dbf-2dfd598c5f38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb7224ee-9bae-40e3-94b2-5040176307a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb7224ee-9bae-40e3-94b2-5040176307a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_69bba013-8a6d-44e1-bba6-6fa475c39280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_da002aa7-ac48-4500-97ec-72f93ae79122" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_69bba013-8a6d-44e1-bba6-6fa475c39280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_92592b9d-4609-49a5-8d39-f3f8b65f50db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_us-gaap_LiabilitiesCurrent_92592b9d-4609-49a5-8d39-f3f8b65f50db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_90566b82-960a-404d-8335-84f36da94fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_90566b82-960a-404d-8335-84f36da94fe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ea3a7d14-3410-4a94-8ccf-dcdd032a51d8" xlink:href="lh-20221231.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ea3a7d14-3410-4a94-8ccf-dcdd032a51d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c0cbce7c-c1a0-4e8e-8a28-7a7baf555725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c0cbce7c-c1a0-4e8e-8a28-7a7baf555725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d53a24b-a2b4-425a-a8b0-9213f6e47fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7d53a24b-a2b4-425a-a8b0-9213f6e47fa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8e4081d8-9b5e-4c85-bb34-84570f33b4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_8bd565ba-186a-44ee-988a-1463bf8f8b64" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8e4081d8-9b5e-4c85-bb34-84570f33b4ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0ec76393-e4f2-4e36-b105-cc2245154df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:to="loc_us-gaap_OperatingIncomeLoss_0ec76393-e4f2-4e36-b105-cc2245154df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_4dc7d648-2362-4296-976d-806f6103e5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:to="loc_us-gaap_InterestExpense_4dc7d648-2362-4296-976d-806f6103e5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_360b6a61-3e22-4fee-9858-a3550504eb05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_360b6a61-3e22-4fee-9858-a3550504eb05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_af75dca7-0bb6-40d5-9cb9-14a91a819e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:to="loc_us-gaap_InvestmentIncomeNet_af75dca7-0bb6-40d5-9cb9-14a91a819e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6991a2aa-3fb3-41c0-abbb-25a74c1d6604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_29946b78-2f3f-4fad-b468-6958818b97e8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6991a2aa-3fb3-41c0-abbb-25a74c1d6604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ab50316e-e7df-41fb-8e28-fd0a560e4950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_4a26f022-6718-4939-9a1c-6b26457ed19c" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ab50316e-e7df-41fb-8e28-fd0a560e4950" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_4a26f022-6718-4939-9a1c-6b26457ed19c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5249dd2e-c661-4ff4-a5e7-3dfc822536c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_ab50316e-e7df-41fb-8e28-fd0a560e4950" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5249dd2e-c661-4ff4-a5e7-3dfc822536c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_c40d4718-bd1f-4fe8-b478-bdf2815b3151" xlink:href="lh-20221231.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_c40d4718-bd1f-4fe8-b478-bdf2815b3151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b5644677-e2a9-4baf-a9ac-1c8a9c984b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:to="loc_us-gaap_GrossProfit_b5644677-e2a9-4baf-a9ac-1c8a9c984b0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cdbaa8db-318a-462f-98c3-75931b7519c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cdbaa8db-318a-462f-98c3-75931b7519c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_404396aa-d5d8-4c33-bf14-8c7d4170c1da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_404396aa-d5d8-4c33-bf14-8c7d4170c1da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ecf3cc03-2a0e-4d7f-8537-626b7cabce87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_bc03b6ee-1526-44ec-a4e7-9d67a258701e" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_ecf3cc03-2a0e-4d7f-8537-626b7cabce87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_519ad9dc-0203-47dc-a3c3-6eff8829b695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_af2c22f9-a1dd-4bb3-a3b7-b2114430ec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_519ad9dc-0203-47dc-a3c3-6eff8829b695" xlink:to="loc_us-gaap_ProfitLoss_af2c22f9-a1dd-4bb3-a3b7-b2114430ec7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_60aed88d-809f-4e6c-83f7-d7600bfde2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_519ad9dc-0203-47dc-a3c3-6eff8829b695" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_60aed88d-809f-4e6c-83f7-d7600bfde2ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3e4be283-f907-49b3-a264-635bbe7abc76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_100341dc-a9bb-4cd1-9374-d9b3fcf56073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_3e4be283-f907-49b3-a264-635bbe7abc76" xlink:to="loc_us-gaap_Revenues_100341dc-a9bb-4cd1-9374-d9b3fcf56073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ce46c179-87c9-4fc5-9311-f8df331e6fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_3e4be283-f907-49b3-a264-635bbe7abc76" xlink:to="loc_us-gaap_CostOfRevenue_ce46c179-87c9-4fc5-9311-f8df331e6fec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ff1c3b48-6080-4e23-8c59-60bd6fc019f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_ca097c9a-e94c-456c-afd2-73ca0fad573e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ff1c3b48-6080-4e23-8c59-60bd6fc019f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_ca097c9a-e94c-456c-afd2-73ca0fad573e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_fcd47b0f-6483-4e4a-b20a-62c7c34e9e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_ff1c3b48-6080-4e23-8c59-60bd6fc019f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_fcd47b0f-6483-4e4a-b20a-62c7c34e9e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5ae229-3e3c-4a60-9efc-ff236130d91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_80003ba2-e347-40a8-a2b4-dc7a45c4290a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5ae229-3e3c-4a60-9efc-ff236130d91d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_80003ba2-e347-40a8-a2b4-dc7a45c4290a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_6c264293-aa67-4bab-8fa8-24d8957851db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5ae229-3e3c-4a60-9efc-ff236130d91d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_6c264293-aa67-4bab-8fa8-24d8957851db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f726907f-2d48-47c7-a41e-7846d0248fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d6401201-f8c8-4f60-ac08-2802b68c706c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f726907f-2d48-47c7-a41e-7846d0248fe4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d6401201-f8c8-4f60-ac08-2802b68c706c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_166785bf-9e6c-4875-a2b7-23c5794d23c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_f726907f-2d48-47c7-a41e-7846d0248fe4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_166785bf-9e6c-4875-a2b7-23c5794d23c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESMaturityofLeasesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESMaturityofLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/LEASESMaturityofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4921e3c4-3315-40e9-bca0-c717e57c91f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4921e3c4-3315-40e9-bca0-c717e57c91f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e20179aa-12c6-4f89-82b1-51c98560e534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_e20179aa-12c6-4f89-82b1-51c98560e534" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_eaad13f9-9f93-4baf-aef1-15ad5fa62b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_eaad13f9-9f93-4baf-aef1-15ad5fa62b16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_8281a294-d016-4248-8d7c-22b35b47fd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_8281a294-d016-4248-8d7c-22b35b47fd64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9eb5edfe-3729-4063-9bec-f82eaed79be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9eb5edfe-3729-4063-9bec-f82eaed79be9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_8561fa35-3500-45f3-b231-9b036338e7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f53f83b9-8f99-469f-9c9f-1a58cfcc5da6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_8561fa35-3500-45f3-b231-9b036338e7a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_ba67b5b9-d449-478b-b5ea-151f375792dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_ba67b5b9-d449-478b-b5ea-151f375792dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_8fa56343-c3a7-4e82-9b35-a07f681b1dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_8fa56343-c3a7-4e82-9b35-a07f681b1dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2242c47d-dd3f-4d52-8b48-ec84161b4816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2242c47d-dd3f-4d52-8b48-ec84161b4816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_b963f90d-f619-415b-93e0-02371e050b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_b963f90d-f619-415b-93e0-02371e050b82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2a7d64a8-1abf-4568-b7ad-59b60b5ba0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2a7d64a8-1abf-4568-b7ad-59b60b5ba0ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_ec47ebfc-c9d5-42b1-a81e-11e5ebda3289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d9dfa2a-72e6-4c23-9b97-7dc5a686674b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_ec47ebfc-c9d5-42b1-a81e-11e5ebda3289" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PROPERTYPLANTANDEQUIPMENTNETDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_73c22eed-97e1-4556-8117-6f1018538c81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b8689743-91c0-41d1-98a9-75b4c1b723f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_73c22eed-97e1-4556-8117-6f1018538c81" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b8689743-91c0-41d1-98a9-75b4c1b723f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8926e1ea-4116-4f81-99eb-8f61d9cbd475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_73c22eed-97e1-4556-8117-6f1018538c81" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8926e1ea-4116-4f81-99eb-8f61d9cbd475" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_20bd989b-7044-42f9-b018-053a49b5b93a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ce764839-0ccf-4815-9ed6-d6d0c3e1bddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_20bd989b-7044-42f9-b018-053a49b5b93a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ce764839-0ccf-4815-9ed6-d6d0c3e1bddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0ab1c081-b6df-4f16-ab3a-cda9106654b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_20bd989b-7044-42f9-b018-053a49b5b93a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0ab1c081-b6df-4f16-ab3a-cda9106654b9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#ACCRUEDEXPENSESANDOTHERDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2e0d029e-3822-49a6-ad1a-47d4164dbf37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_889b3298-2bb5-41b5-a7ef-b39087c4ed96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2e0d029e-3822-49a6-ad1a-47d4164dbf37" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_889b3298-2bb5-41b5-a7ef-b39087c4ed96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_4c37d026-4694-48d6-9c44-82c008543969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2e0d029e-3822-49a6-ad1a-47d4164dbf37" xlink:to="loc_us-gaap_TaxesPayableCurrent_4c37d026-4694-48d6-9c44-82c008543969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25a9f377-3939-4610-bf47-3b1151f75358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2e0d029e-3822-49a6-ad1a-47d4164dbf37" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_25a9f377-3939-4610-bf47-3b1151f75358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedPassThroughExpenses_ab6b8312-9e0f-405d-9368-88d7132da99b" xlink:href="lh-20221231.xsd#lh_AccruedPassThroughExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_2e0d029e-3822-49a6-ad1a-47d4164dbf37" xlink:to="loc_lh_AccruedPassThroughExpenses_ab6b8312-9e0f-405d-9368-88d7132da99b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSCHEDULEOFSHORTTERMDEBTDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_add5ee76-afb0-49c7-9c5c-29d70fb9d14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_33f9ab54-8a43-4b2d-893e-bc702ab0210a" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_add5ee76-afb0-49c7-9c5c-29d70fb9d14c" xlink:to="loc_lh_Shorttermdebtissuancecosts_33f9ab54-8a43-4b2d-893e-bc702ab0210a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_27e19228-ad34-432d-b8f0-e1d8f358ef88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_add5ee76-afb0-49c7-9c5c-29d70fb9d14c" xlink:to="loc_us-gaap_NotesPayableCurrent_27e19228-ad34-432d-b8f0-e1d8f358ef88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXESDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_89517ed1-a430-4dd5-bd05-5946a74bedaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_41c76b49-c625-4ed7-8ae9-2658af52cf82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_89517ed1-a430-4dd5-bd05-5946a74bedaf" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_41c76b49-c625-4ed7-8ae9-2658af52cf82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_171c8213-7e00-44a1-8723-4d5181141fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_89517ed1-a430-4dd5-bd05-5946a74bedaf" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_171c8213-7e00-44a1-8723-4d5181141fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_22f1ed67-3b50-41bd-b0d8-013cf6d759e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_22f1ed67-3b50-41bd-b0d8-013cf6d759e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_0bd6af33-0842-41d8-88d3-8d216398eda7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_0bd6af33-0842-41d8-88d3-8d216398eda7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredTaxAssetRightOfUseAsset_9c53627c-b7f1-4979-9316-fe91f68a47a3" xlink:href="lh-20221231.xsd#lh_DeferredTaxAssetRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_lh_DeferredTaxAssetRightOfUseAsset_9c53627c-b7f1-4979-9316-fe91f68a47a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_683a6d90-1157-42c1-9f40-5f11ef550a78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_683a6d90-1157-42c1-9f40-5f11ef550a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2ffc8216-bcad-49b6-bb26-298720e0efee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2ffc8216-bcad-49b6-bb26-298720e0efee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_cbb89aea-572a-4fdc-942c-9ad21b6c02f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_cbb89aea-572a-4fdc-942c-9ad21b6c02f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_09e6b51a-87c8-4bb2-a82d-79dfe878dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_58579219-6e94-47c4-b7b2-de91add5b5ba" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_09e6b51a-87c8-4bb2-a82d-79dfe878dee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_129a97f1-6b9c-4c17-be95-30d2889bb2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8d428d32-8198-443f-848a-aa4814bbb02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_129a97f1-6b9c-4c17-be95-30d2889bb2eb" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8d428d32-8198-443f-848a-aa4814bbb02a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7d604edf-e14d-49f0-93ed-02f46937c98e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_129a97f1-6b9c-4c17-be95-30d2889bb2eb" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7d604edf-e14d-49f0-93ed-02f46937c98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ec853f32-9d84-47f2-8010-9bc81a4854fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_339cf6ec-2b97-401c-95b2-dc7998414fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ec853f32-9d84-47f2-8010-9bc81a4854fb" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_339cf6ec-2b97-401c-95b2-dc7998414fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a1ef6d9e-29eb-4084-952c-f5a3fa1ffe71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ec853f32-9d84-47f2-8010-9bc81a4854fb" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_a1ef6d9e-29eb-4084-952c-f5a3fa1ffe71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a1b5706e-c93d-4ace-a3e7-e981c99155a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ec853f32-9d84-47f2-8010-9bc81a4854fb" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a1b5706e-c93d-4ace-a3e7-e981c99155a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3936914c-16de-463e-b7df-a4046d274e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_45514df6-3c57-41a5-a088-6922a18f6a11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3936914c-16de-463e-b7df-a4046d274e8d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_45514df6-3c57-41a5-a088-6922a18f6a11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5c1b714e-96a6-41d1-b470-0172163447ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3936914c-16de-463e-b7df-a4046d274e8d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_5c1b714e-96a6-41d1-b470-0172163447ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_03959692-706d-4aa9-9831-6a5b01d604d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_3936914c-16de-463e-b7df-a4046d274e8d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_03959692-706d-4aa9-9831-6a5b01d604d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fd59044c-d3c7-4b3c-b9c0-4d1c377168ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fd59044c-d3c7-4b3c-b9c0-4d1c377168ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_06a7dae9-b8ca-4700-b45e-72c187bf463b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_06a7dae9-b8ca-4700-b45e-72c187bf463b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ea23b6e3-68ae-4530-99a6-c8b4a032257d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_ea23b6e3-68ae-4530-99a6-c8b4a032257d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_25c4a8ba-8e9c-4b5d-aec4-8583afabb849" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_25c4a8ba-8e9c-4b5d-aec4-8583afabb849" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_9c08fd05-2376-4f4a-9f0d-43e1a35369c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_9c08fd05-2376-4f4a-9f0d-43e1a35369c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_32b6c467-c90b-42ec-8c4b-cd2106d3cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_32b6c467-c90b-42ec-8c4b-cd2106d3cf5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a96165ec-a8fa-4ff9-834e-eaea5925e26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d5d9827d-a1e2-4cdf-9280-79eef1cf5978" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a96165ec-a8fa-4ff9-834e-eaea5925e26b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d304f6a-35d9-411e-91f6-62d28bf98af2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_95d0c6a5-211c-4679-949a-f118017ac545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6d304f6a-35d9-411e-91f6-62d28bf98af2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_95d0c6a5-211c-4679-949a-f118017ac545" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6bce7ac5-4157-4ffa-8076-573044c2be65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6d304f6a-35d9-411e-91f6-62d28bf98af2" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6bce7ac5-4157-4ffa-8076-573044c2be65" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:calculationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_dea0a5d9-d490-43c5-96fe-74599883a875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_dea0a5d9-d490-43c5-96fe-74599883a875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_c244169f-bb6b-4b6d-8e80-5a8d37f30636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_c244169f-bb6b-4b6d-8e80-5a8d37f30636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a0c1a56d-0653-4c85-a47d-61ce3582badc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_a0c1a56d-0653-4c85-a47d-61ce3582badc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_11f9ef2d-5492-4468-b202-10c6a2c9b5c1" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_11f9ef2d-5492-4468-b202-10c6a2c9b5c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_65713281-cf63-4f6d-9547-9f54b73e1d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_65713281-cf63-4f6d-9547-9f54b73e1d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_4de2e18a-0b0a-404f-86b6-bbabd19a8fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_76f84251-8d8c-4ea9-a396-4f47b62f33ff" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_4de2e18a-0b0a-404f-86b6-bbabd19a8fc9" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>22
<FILENAME>lh-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.labcorp.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="lh-20221231.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DocumentandEntityInformationDocument" xlink:type="extended" id="ic58968ca58a540e897914f57eeef9e7d_DocumentandEntityInformationDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_05df7cdb-f0c6-4d6e-91c2-c8c623347200" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorFirmId_05df7cdb-f0c6-4d6e-91c2-c8c623347200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_a247c771-e7b2-44b4-bac5-d3f9867f2d9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorLocation_a247c771-e7b2-44b4-bac5-d3f9867f2d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_66f27c48-8b25-4ea5-9179-f56802133312" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorName_66f27c48-8b25-4ea5-9179-f56802133312" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_39e5ce87-582e-4e4d-80fe-575758654a96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_IcfrAuditorAttestationFlag_39e5ce87-582e-4e4d-80fe-575758654a96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8424d15c-cc1a-40c6-8463-cd4ec524b50d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_EntityVoluntaryFilers_8424d15c-cc1a-40c6-8463-cd4ec524b50d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:to="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_24032494-3e17-46bd-84af-f47d1fb526b0_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:to="loc_dei_DocumentDomain_24032494-3e17-46bd-84af-f47d1fb526b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_baa52890-deb2-49aa-98ed-71a5996f179b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:to="loc_dei_DocumentDomain_baa52890-deb2-49aa-98ed-71a5996f179b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals" xlink:type="simple" xlink:href="lh-20221231.xsd#ConsolidatedBalanceSheetParentheticals"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals" xlink:type="extended" id="iffa95f22356644efb53cab95c188c74d_ConsolidatedBalanceSheetParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_db2ca9a0-d13d-4b12-9245-6b6e3f7749af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_db2ca9a0-d13d-4b12-9245-6b6e3f7749af" xlink:to="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:to="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a714e327-5951-40e1-908e-01bb743e1df7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a714e327-5951-40e1-908e-01bb743e1df7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b459315e-82c7-471c-9df2-7da274d282f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b459315e-82c7-471c-9df2-7da274d282f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:to="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_db3caece-ec71-44d8-8b6b-969fb5ae3dd9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:to="loc_us-gaap_ClassOfStockDomain_db3caece-ec71-44d8-8b6b-969fb5ae3dd9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f54b9a47-970c-45e2-98a4-9ee55968da63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:to="loc_us-gaap_ClassOfStockDomain_f54b9a47-970c-45e2-98a4-9ee55968da63" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="extended" id="idd4708c052be4f13ac2722e1cd2ebb24_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1b6e750d-c236-4a31-9639-28f3a6143c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ProfitLoss_1b6e750d-c236-4a31-9639-28f3a6143c33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d72c3be7-e760-4420-aefa-cd2fe3dd3862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d72c3be7-e760-4420-aefa-cd2fe3dd3862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b67fc76c-51e1-40a9-a02a-665984d8f57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b67fc76c-51e1-40a9-a02a-665984d8f57e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_78844766-88e8-47c3-82e0-e8a62066bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_78844766-88e8-47c3-82e0-e8a62066bfb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_9ebda8b0-e237-41c2-963c-d85d791fc609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_9ebda8b0-e237-41c2-963c-d85d791fc609" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3fe9fff-47e5-4704-a1b5-50016af33230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3fe9fff-47e5-4704-a1b5-50016af33230" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b40420a3-53c0-49d8-96ef-3189dfa11299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b40420a3-53c0-49d8-96ef-3189dfa11299" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0c70ca1e-ba4c-47d2-a911-363acc9922f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0c70ca1e-ba4c-47d2-a911-363acc9922f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_67434791-d02d-41d0-8c52-ec1a1fc5e6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_67434791-d02d-41d0-8c52-ec1a1fc5e6cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:to="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c2ccd9e2-01da-4f16-9e76-3939fd6945de_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c2ccd9e2-01da-4f16-9e76-3939fd6945de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_680f0e9a-7df7-49f5-8e32-2a7f3308e5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:to="loc_srt_ScenarioUnspecifiedDomain_680f0e9a-7df7-49f5-8e32-2a7f3308e5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_87a22847-a6f6-4054-b3fa-60732fa6df20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_87a22847-a6f6-4054-b3fa-60732fa6df20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_55134284-14ca-45eb-ae9d-bfe8dafa7e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_55134284-14ca-45eb-ae9d-bfe8dafa7e50" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended" id="i3e4fe57668ea47e9ba75461472879192_CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_170ad94d-96ff-4de7-a79f-b51bc31788b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_CommonStockValue_170ad94d-96ff-4de7-a79f-b51bc31788b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2a6ec4bb-480f-4cf1-9de9-09856294a5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockholdersEquity_2a6ec4bb-480f-4cf1-9de9-09856294a5e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dee65b33-3615-419a-9492-8212802296fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_NetIncomeLoss_dee65b33-3615-419a-9492-8212802296fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_960f75d6-db83-4d6c-ab8f-42995f09e79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_960f75d6-db83-4d6c-ab8f-42995f09e79d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_4a79e054-3a94-4bde-aaf9-866dc577de16" xlink:href="lh-20221231.xsd#lh_IssuanceOfCommonStockUnderEmployeeStockPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_4a79e054-3a94-4bde-aaf9-866dc577de16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d1f74b4b-77b3-42b9-8e21-64785672d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d1f74b4b-77b3-42b9-8e21-64785672d72f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_314cb3f4-8c7d-4f36-adee-a13fa39a460d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_314cb3f4-8c7d-4f36-adee-a13fa39a460d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_58a77afb-2f48-479e-91a9-dfd7023545db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_58a77afb-2f48-479e-91a9-dfd7023545db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_37fbec98-27b2-4965-91db-80faa8a8a99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1d1ff0d0-0f00-40ce-8405-479cf0f9b153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1d1ff0d0-0f00-40ce-8405-479cf0f9b153" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b45185a6-157d-4f2d-a0bd-818e560fb7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b45185a6-157d-4f2d-a0bd-818e560fb7e3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fac7ae6f-6a5a-48b8-91b9-21c77fdcf91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fac7ae6f-6a5a-48b8-91b9-21c77fdcf91d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_ea1010ef-4118-4c13-a52c-a10878abe980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_Dividends_ea1010ef-4118-4c13-a52c-a10878abe980" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_a8c71271-85e6-4027-b58f-cdfbe80e18ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_DividendsCash_a8c71271-85e6-4027-b58f-cdfbe80e18ad" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b0a75e3-ac26-4165-84db-406047a57771_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:to="loc_us-gaap_EquityComponentDomain_2b0a75e3-ac26-4165-84db-406047a57771_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:to="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5caa4323-921c-4dc9-9ad8-46a97276accb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_CommonStockMember_5caa4323-921c-4dc9-9ad8-46a97276accb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f1b7c4c8-a452-40a9-972b-34c972729e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f1b7c4c8-a452-40a9-972b-34c972729e73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cab65e9f-b883-4fe7-95b2-d63a03b40a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_RetainedEarningsMember_cab65e9f-b883-4fe7-95b2-d63a03b40a5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac32e564-5753-43ad-a9fd-102414135906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac32e564-5753-43ad-a9fd-102414135906" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:to="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_16f554aa-0b3f-4379-8f38-f1d1369e5e24_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:to="loc_srt_RestatementDomain_16f554aa-0b3f-4379-8f38-f1d1369e5e24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:to="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_0adde79c-1077-42a2-9355-ac937530d423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_0adde79c-1077-42a2-9355-ac937530d423" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT" xlink:type="extended" id="iecf5461a5b7a405aa9df33d9f1dc8a45_SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum_ba17ec1a-257f-4546-8c14-8256671c187f" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwareminimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum_ba17ec1a-257f-4546-8c14-8256671c187f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum_52a7de22-0cda-44e2-805c-94c0c881f58f" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwaremaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum_52a7de22-0cda-44e2-805c-94c0c881f58f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cac56af2-8207-4816-899a-680ce2b8a0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cac56af2-8207-4816-899a-680ce2b8a0d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_8482c7b0-1fa6-42aa-8f76-b8c8f534a6f1" xlink:href="lh-20221231.xsd#lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_8482c7b0-1fa6-42aa-8f76-b8c8f534a6f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:to="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:to="loc_srt_RangeMember_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:to="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4817b34d-e1dd-4543-bcce-1cf00ec90e40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:to="loc_srt_MinimumMember_4817b34d-e1dd-4543-bcce-1cf00ec90e40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c266f4d-f279-4451-bb18-ca8743a3ae4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:to="loc_srt_MaximumMember_7c266f4d-f279-4451-bb18-ca8743a3ae4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b133ac58-6f91-43b3-b582-452e4467ad56_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b133ac58-6f91-43b3-b582-452e4467ad56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2991d9a6-70b0-473e-b18f-17d002a9840c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2991d9a6-70b0-473e-b18f-17d002a9840c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_47171fb1-dd5e-4dec-83f0-185867a0b0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_47171fb1-dd5e-4dec-83f0-185867a0b0e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f60a6a54-e607-45f6-92d1-6a61b71066db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f60a6a54-e607-45f6-92d1-6a61b71066db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e548f325-e7c1-47df-ae43-893833cce591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e548f325-e7c1-47df-ae43-893833cce591" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS" xlink:type="extended" id="i9d71115a5bbe4978b69a0b2ce7ddc815_SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0a4b41b4-6cc5-4e8d-81b4-3792b76d8ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:to="loc_us-gaap_Goodwill_0a4b41b4-6cc5-4e8d-81b4-3792b76d8ac2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_09176ffb-2d14-4850-9fc1-bfbb3cd2793e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_09176ffb-2d14-4850-9fc1-bfbb3cd2793e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e2f472fc-25ec-4799-8e50-4b9d66c18694_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:to="loc_us-gaap_SegmentDomain_e2f472fc-25ec-4799-8e50-4b9d66c18694_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8df34d4-ef9c-4a57-8bcb-65d688c8417f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:to="loc_us-gaap_SegmentDomain_d8df34d4-ef9c-4a57-8bcb-65d688c8417f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9910bdba-b15e-4283-bc0d-b6c95e3a8592_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:to="loc_srt_RangeMember_9910bdba-b15e-4283-bc0d-b6c95e3a8592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:to="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ccf9ccf-6e12-4541-9bde-5631528ad54b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:to="loc_srt_MinimumMember_7ccf9ccf-6e12-4541-9bde-5631528ad54b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9398dd0b-04b0-4731-90df-4dff8551ec4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:to="loc_srt_MaximumMember_9398dd0b-04b0-4731-90df-4dff8551ec4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef19307-1211-4a6b-8a1d-8b06b3d15f46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ef19307-1211-4a6b-8a1d-8b06b3d15f46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7f0c2a02-5973-4624-9ef8-e49f1d2295bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7f0c2a02-5973-4624-9ef8-e49f1d2295bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_f2ff0327-46de-4c03-9c60-5d09c6c22a02" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_f2ff0327-46de-4c03-9c60-5d09c6c22a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e2010281-cddc-4818-82d7-02b3219f2360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e2010281-cddc-4818-82d7-02b3219f2360" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0e500f3c-4cf3-474a-8a13-47498659fe21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_TradeNamesMember_0e500f3c-4cf3-474a-8a13-47498659fe21" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20221231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended" id="i1b80dd11b828418890cb7cf6d6e50ee2_FAIRVALUEMEASUREMENTS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_694d2b6a-f150-40cb-81ae-5b6c82103823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_694d2b6a-f150-40cb-81ae-5b6c82103823" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_557a5471-0cb1-4035-85af-2a9abea4295e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_557a5471-0cb1-4035-85af-2a9abea4295e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_18df26bb-e4df-4d5a-94c1-79612dd70b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_18df26bb-e4df-4d5a-94c1-79612dd70b34" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables" xlink:type="extended" id="ic89e0df889e448edaf9ef4d6f1bcf142_BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15e789ee-fe9d-4f55-b0d7-2b1d576b9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_15e789ee-fe9d-4f55-b0d7-2b1d576b9cd4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_90801fca-1974-4fd0-a213-018b75efd750_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_90801fca-1974-4fd0-a213-018b75efd750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c7e1af-6be9-4219-918a-2c26882fc242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c7e1af-6be9-4219-918a-2c26882fc242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3139495d-db5b-4598-98f6-60b9324b75a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3139495d-db5b-4598-98f6-60b9324b75a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e6356b10-9e7c-4107-b65c-dd80b2a8a4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e6356b10-9e7c-4107-b65c-dd80b2a8a4a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_18ebfa7d-5168-4583-9f97-7b138bc3956a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:to="loc_srt_OwnershipDomain_18ebfa7d-5168-4583-9f97-7b138bc3956a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9ea4df34-b33a-44ab-a8f2-6af617375d63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:to="loc_srt_OwnershipDomain_9ea4df34-b33a-44ab-a8f2-6af617375d63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ad0b1501-978e-4a3a-bc5b-944b013a699e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:to="loc_us-gaap_ClassOfStockDomain_ad0b1501-978e-4a3a-bc5b-944b013a699e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a77c3ed-0d25-4205-821f-69faec3fa906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:to="loc_us-gaap_ClassOfStockDomain_8a77c3ed-0d25-4205-821f-69faec3fa906" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXESTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/INCOMETAXESTables" xlink:type="extended" id="ifbfe9f5f699b4f4d80f3e51c42a297a8_INCOMETAXESTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_267a4003-02cf-43d5-a1a2-a3b9e837a079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_267a4003-02cf-43d5-a1a2-a3b9e837a079" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:to="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_9b3e5084-3660-43f6-8479-17ebbd6f898a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_9b3e5084-3660-43f6-8479-17ebbd6f898a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables" xlink:type="extended" id="i6639db492d11404ab005465d85926f3c_STOCKCOMPENSATIONPLANSTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a9b69fc3-8de4-418d-ba21-38bbac1a2370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a9b69fc3-8de4-418d-ba21-38bbac1a2370" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_8f15f7e9-2682-4c7c-9207-765eadffe664" xlink:href="lh-20221231.xsd#lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_8f15f7e9-2682-4c7c-9207-765eadffe664" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6aed534e-9844-4d55-8bb0-88178780256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6aed534e-9844-4d55-8bb0-88178780256d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_74f26936-fcb6-4627-8090-9baa5be02123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_74f26936-fcb6-4627-8090-9baa5be02123" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9f1adfe0-cb8f-4346-8845-1ffaa97ec738_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_9f1adfe0-cb8f-4346-8845-1ffaa97ec738_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_41eaf179-6a9b-4fd0-8c37-34f51c8e319f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_41eaf179-6a9b-4fd0-8c37-34f51c8e319f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended" id="ib2c49378b3804130a6d924e02bbadedd_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_06c424da-4331-41e2-a3f7-5188bb207675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_06c424da-4331-41e2-a3f7-5188bb207675" xlink:to="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_116f40b7-7ff0-4efa-9864-251b89a5f3da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:to="loc_srt_EnergyDomain_116f40b7-7ff0-4efa-9864-251b89a5f3da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_75992aa3-5aa8-49a9-a318-4a6d46669f05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:to="loc_srt_EnergyDomain_75992aa3-5aa8-49a9-a318-4a6d46669f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1ddc1b1e-bb74-405e-8000-2a2651414168_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:to="loc_us-gaap_VariableRateDomain_1ddc1b1e-bb74-405e-8000-2a2651414168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ad993a37-c102-4e97-9d1d-c768ed824820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:to="loc_us-gaap_VariableRateDomain_ad993a37-c102-4e97-9d1d-c768ed824820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1a1645e3-74a7-412d-8f0e-c165a79eec78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1a1645e3-74a7-412d-8f0e-c165a79eec78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fac771e0-e76a-45ce-8c23-6222dab13214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fac771e0-e76a-45ce-8c23-6222dab13214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:to="loc_us-gaap_PositionDomain_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_03bc96ba-a645-4f2a-a8aa-dfc570ec0b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:to="loc_us-gaap_PositionDomain_03bc96ba-a645-4f2a-a8aa-dfc570ec0b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_672777c2-8b7e-4971-84c0-e8287c07eecf_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:to="loc_srt_RangeMember_672777c2-8b7e-4971-84c0-e8287c07eecf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9caaddc8-3b42-48e7-819f-c5cd41d00651" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:to="loc_srt_RangeMember_9caaddc8-3b42-48e7-819f-c5cd41d00651" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="ic2388588310b4920853489d5162904fd_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2c44862c-3e21-41e3-b494-da33d2c77696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2c44862c-3e21-41e3-b494-da33d2c77696" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:to="loc_us-gaap_EquityComponentDomain_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:to="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f57ceeec-c385-438c-ba2d-b736b70f242a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:to="loc_us-gaap_RetainedEarningsMember_f57ceeec-c385-438c-ba2d-b736b70f242a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#REVENUEDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended" id="i8403271c789f4b8f9b216c596a5fa5ae_REVENUEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_78153e78-297e-49f6-b565-8373ec10c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_78153e78-297e-49f6-b565-8373ec10c9aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum_c23cba88-3052-4579-bcb9-9044b18c22ee" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMinimum_c23cba88-3052-4579-bcb9-9044b18c22ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_bdb061fd-7d8f-4141-8883-2d6d5fdf2d09" xlink:href="lh-20221231.xsd#lh_PercentofRevenueContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_PercentofRevenueContributed_bdb061fd-7d8f-4141-8883-2d6d5fdf2d09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum_fd5b54a0-077a-421f-917d-5b8d8c87625b" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMaximum_fd5b54a0-077a-421f-917d-5b8d8c87625b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e45c08d4-7160-4729-9c7c-4ca51699f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_us-gaap_Revenues_e45c08d4-7160-4729-9c7c-4ca51699f48f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentOfDomesticRevenue_1cc36038-2175-4704-a157-ebbc6d71321f" xlink:href="lh-20221231.xsd#lh_PercentOfDomesticRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_PercentOfDomesticRevenue_1cc36038-2175-4704-a157-ebbc6d71321f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f6ae619f-3741-41f8-aa2b-6ffb6285ca61_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:to="loc_srt_RangeMember_f6ae619f-3741-41f8-aa2b-6ffb6285ca61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:to="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_53e158f1-3e48-4585-99a0-f076f7e0c421" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:to="loc_srt_MaximumMember_53e158f1-3e48-4585-99a0-f076f7e0c421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1308009-60a0-4d34-9a81-2bb277bd38a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:to="loc_srt_MinimumMember_b1308009-60a0-4d34-9a81-2bb277bd38a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_08ffb1a6-dc06-4feb-9c16-529e092dc218_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:to="loc_us-gaap_SegmentDomain_08ffb1a6-dc06-4feb-9c16-529e092dc218_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:to="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_0425ddea-717d-4789-be62-884ee66b85b5" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:to="loc_lh_DrugDevelopmentMember_0425ddea-717d-4789-be62-884ee66b85b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_50092549-aab9-42e6-b962-c6fa162ea717" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:to="loc_lh_DiagnosticsMember_50092549-aab9-42e6-b962-c6fa162ea717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1bd49c76-a62c-463c-832f-dd00507d826c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:to="loc_srt_ProductsAndServicesDomain_1bd49c76-a62c-463c-832f-dd00507d826c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_275970a0-1fd3-4cfb-970b-0a2cc30f2092" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:to="loc_srt_ProductsAndServicesDomain_275970a0-1fd3-4cfb-970b-0a2cc30f2092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:to="loc_srt_SegmentGeographicalDomain_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:to="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_38dba398-090d-4818-ac88-bd11a9f9e2c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_srt_EuropeMember_38dba398-090d-4818-ac88-bd11a9f9e2c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_ebf4deb2-d564-4163-a845-db9f68959e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_srt_NorthAmericaMember_ebf4deb2-d564-4163-a845-db9f68959e57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_a9232d03-c0ed-4428-aef5-e98973b469ff" xlink:href="lh-20221231.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_lh_OthercountriesMember_a9232d03-c0ed-4428-aef5-e98973b469ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_5616a216-1465-464e-9932-aeabba772ee8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_5616a216-1465-464e-9932-aeabba772ee8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1ec75e7c-957e-46ed-82b3-01d6fcf4402c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1ec75e7c-957e-46ed-82b3-01d6fcf4402c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_a1118939-8f62-498e-9651-09a274cd1611_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_a1118939-8f62-498e-9651-09a274cd1611_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_13b09007-4c44-40e0-bff8-768c42d6ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_13b09007-4c44-40e0-bff8-768c42d6ac72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_32e410d1-cf15-49bd-aecd-424d6b004354_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_32e410d1-cf15-49bd-aecd-424d6b004354_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_21320bae-2877-4e7a-bb99-d56b2eb8e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_21320bae-2877-4e7a-bb99-d56b2eb8e5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2f60331f-eb81-443e-9aec-75aa74d1c9ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_2f60331f-eb81-443e-9aec-75aa74d1c9ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_a12a9821-a80b-4e91-91b8-890acbbbde65" xlink:href="lh-20221231.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_a12a9821-a80b-4e91-91b8-890acbbbde65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_c4cc9358-d20c-4cb7-ae49-918c7204538c" xlink:href="lh-20221231.xsd#lh_ThirdpartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_ThirdpartyMember_c4cc9358-d20c-4cb7-ae49-918c7204538c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_0bc7447e-8936-42ad-895d-544589a991f3" xlink:href="lh-20221231.xsd#lh_MedicareandMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_MedicareandMedicaidMember_0bc7447e-8936-42ad-895d-544589a991f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_9e509ad2-161b-43a4-9ccc-29f6c7929053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_us-gaap_SelfPayMember_9e509ad2-161b-43a4-9ccc-29f6c7929053" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_9f001eed-96c1-48e5-9be0-09403ab5ece0" xlink:href="lh-20221231.xsd#lh_ClientMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_ClientMember_9f001eed-96c1-48e5-9be0-09403ab5ece0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_91d55ff5-4684-447f-a957-e0dbf25e9427_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:to="loc_srt_NameOfMajorCustomerDomain_91d55ff5-4684-447f-a957-e0dbf25e9427_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_31dba8da-7782-4bae-803a-b0a6cf94bc67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:to="loc_srt_NameOfMajorCustomerDomain_31dba8da-7782-4bae-803a-b0a6cf94bc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_a379825f-f687-4b07-a635-88164ed3bce1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:to="loc_us-gaap_GeographicDistributionDomain_a379825f-f687-4b07-a635-88164ed3bce1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:to="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_53b7a7bd-7326-455d-9d62-7682c7e5c476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_53b7a7bd-7326-455d-9d62-7682c7e5c476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_d985b0d5-06a1-4d6c-9cb6-200b0a5c49ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_d985b0d5-06a1-4d6c-9cb6-200b0a5c49ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_a7598361-248f-44a3-b772-9468a9cc8db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_a7598361-248f-44a3-b772-9468a9cc8db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_4a6edeaf-7aee-4384-826e-43120c68846f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_CapitalizedContractCostNet_4a6edeaf-7aee-4384-826e-43120c68846f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_f78266e1-0923-4bd8-b65c-807e78b671df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_f78266e1-0923-4bd8-b65c-807e78b671df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_913d0b6e-e2b1-4114-a903-b4b1d9389661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_913d0b6e-e2b1-4114-a903-b4b1d9389661" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_a4fd8e34-4ae0-4bfb-9629-54375f045443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_a4fd8e34-4ae0-4bfb-9629-54375f045443" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5928ff64-7944-440e-9997-55ea3b6ec425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5928ff64-7944-440e-9997-55ea3b6ec425" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e3c9af8-5d7e-453d-aad0-cd07b709b07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e3c9af8-5d7e-453d-aad0-cd07b709b07c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_45273b98-33da-4696-b33a-1ee08be3325f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_45273b98-33da-4696-b33a-1ee08be3325f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_bd297814-1993-415e-b071-6aa1a8347399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_bd297814-1993-415e-b071-6aa1a8347399" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d1958090-7d09-405b-834b-3888a2d7b4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d1958090-7d09-405b-834b-3888a2d7b4b9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_cea3ce6a-e8d3-49aa-acc7-ba5d4fec785d" xlink:href="lh-20221231.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_cea3ce6a-e8d3-49aa-acc7-ba5d4fec785d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_73a5f5a1-2e34-4141-a196-435fa4eef83c" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_LongTermContractsDurationMinimum_73a5f5a1-2e34-4141-a196-435fa4eef83c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_a8390edb-25e3-4564-b739-674c960df7c0" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_LongTermContractsDurationMaximum_a8390edb-25e3-4564-b739-674c960df7c0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_9f0293a5-b9e8-4974-9b21-b89418e9163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_9f0293a5-b9e8-4974-9b21-b89418e9163b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0d3bc7e2-0b2f-490b-9318-6dc95a530129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0d3bc7e2-0b2f-490b-9318-6dc95a530129" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_e963d2f5-7c8e-4047-a4fa-001aa0f9bd5d" xlink:href="lh-20221231.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_e963d2f5-7c8e-4047-a4fa-001aa0f9bd5d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_3b5b7e18-b545-4d17-83f2-c9463166264d" xlink:href="lh-20221231.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_3b5b7e18-b545-4d17-83f2-c9463166264d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_ae2d7fe8-451e-4f98-be98-b52d97334d80" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_AllowanceforCreditLoss_ae2d7fe8-451e-4f98-be98-b52d97334d80" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_d13dfeae-f22a-4766-9b04-338dfce01137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_d13dfeae-f22a-4766-9b04-338dfce01137" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal_a5e9a339-4093-44c6-b994-f8f52aad6655" xlink:href="lh-20221231.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_UnbilledServicesCreditLossExpenseReversal_a5e9a339-4093-44c6-b994-f8f52aad6655" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal_d5709263-34ba-43f5-b27b-71f807393269" xlink:href="lh-20221231.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_NoteReceivableCreditLossExpenseReversal_d5709263-34ba-43f5-b27b-71f807393269" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal_f8c414a9-182f-4beb-815f-be99e8d15c5d" xlink:href="lh-20221231.xsd#lh_CreditLossExpenseReversal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_CreditLossExpenseReversal_f8c414a9-182f-4beb-815f-be99e8d15c5d" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_20b05b65-cdd2-44d2-87cc-9e2ef3d0e813" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_20b05b65-cdd2-44d2-87cc-9e2ef3d0e813" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ad83faf-dc3e-421a-b400-880009bd1596_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ad83faf-dc3e-421a-b400-880009bd1596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_3b71ff91-50be-46ec-b01a-20b6fb28566b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_us-gaap_AccountsReceivableMember_3b71ff91-50be-46ec-b01a-20b6fb28566b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_347b786b-a4e1-434a-b542-8d252fcf43d4" xlink:href="lh-20221231.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_lh_UnbilledContractsReceivableMember_347b786b-a4e1-434a-b542-8d252fcf43d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_599cc3a1-3dfd-428f-9ee3-a60567e37f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_us-gaap_NotesReceivableMember_599cc3a1-3dfd-428f-9ee3-a60567e37f37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_49625183-06bc-4ee3-a5b8-7d22acef4043_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_49625183-06bc-4ee3-a5b8-7d22acef4043_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3bdd365f-3b96-4e73-8b9a-9c34a1f16e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3bdd365f-3b96-4e73-8b9a-9c34a1f16e35" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#ReceivablesLoansNotesReceivableandOthersDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails" xlink:type="extended" id="id7f99eb5f44f4f36bb5595382656defa_ReceivablesLoansNotesReceivableandOthersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_293f3e71-8320-41cc-b7b5-7a1cf46be0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AccountsReceivableGross_293f3e71-8320-41cc-b7b5-7a1cf46be0cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f0807a40-8afc-4392-b535-8036a709bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f0807a40-8afc-4392-b535-8036a709bc44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_4987e504-1b83-4f17-bbe7-f71727fcb6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_4987e504-1b83-4f17-bbe7-f71727fcb6d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_17e73222-8687-45bc-8350-721c6e2a3bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_17e73222-8687-45bc-8350-721c6e2a3bf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_de39de0f-3aed-498c-864e-e453d4fedf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_de39de0f-3aed-498c-864e-e453d4fedf51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c8934db3-7e9a-43f0-b631-fad17cf1ec8f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:to="loc_us-gaap_SegmentDomain_c8934db3-7e9a-43f0-b631-fad17cf1ec8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:to="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_3b1b9e7e-9e74-4060-9b65-12c9ef88f98c" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:to="loc_lh_DiagnosticsMember_3b1b9e7e-9e74-4060-9b65-12c9ef88f98c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_4d5066ce-2645-496a-91e1-2c47607a651f" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:to="loc_lh_DrugDevelopmentMember_4d5066ce-2645-496a-91e1-2c47607a651f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended" id="i1787aa5193264e4bbe8570a0ed1b5858_BUSINESSACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26073e56-48c2-434c-9a36-a8064d87c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26073e56-48c2-434c-9a36-a8064d87c98b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_cdcdb9c6-c978-45d2-a22c-0cc38a63c12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_cdcdb9c6-c978-45d2-a22c-0cc38a63c12b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_ac609b12-1ab5-4425-9030-cfec6940a681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_ac609b12-1ab5-4425-9030-cfec6940a681" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aedbf463-42be-4ac3-9532-fa66e752e140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aedbf463-42be-4ac3-9532-fa66e752e140" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d271b20e-4cd8-44a4-ac16-a3456c0a621c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d271b20e-4cd8-44a4-ac16-a3456c0a621c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9f85c525-95e9-4171-9d93-cbc8951c7296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9f85c525-95e9-4171-9d93-cbc8951c7296" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5b263da1-f178-4ade-a84e-76f72fe301c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5b263da1-f178-4ade-a84e-76f72fe301c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d1fcf186-2241-4a1f-8066-13ba7e4627e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d1fcf186-2241-4a1f-8066-13ba7e4627e0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_cd752b8a-4e16-4bb7-8c1b-15d9f9f4b3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_cd752b8a-4e16-4bb7-8c1b-15d9f9f4b3f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_97ade382-04da-46f3-8115-f4e80359286b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_97ade382-04da-46f3-8115-f4e80359286b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f440af-49ee-477f-a6fe-906a3dbe9943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f440af-49ee-477f-a6fe-906a3dbe9943" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_969bea27-a867-4136-a025-924978222a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_969bea27-a867-4136-a025-924978222a87" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_181d9c82-3146-470a-bd4c-2a972ef2f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_181d9c82-3146-470a-bd4c-2a972ef2f5c4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_28f4e5cb-9a65-46ed-8bc3-98d863b5cdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_28f4e5cb-9a65-46ed-8bc3-98d863b5cdef" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_da4b87f6-c2a1-4fcb-b281-e05c97e79297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_da4b87f6-c2a1-4fcb-b281-e05c97e79297" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8fae84a8-2edb-415d-874f-3d02f7b283eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8fae84a8-2edb-415d-874f-3d02f7b283eb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_a52668ab-4229-485c-a2f6-89bd5c498331" xlink:href="lh-20221231.xsd#lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_a52668ab-4229-485c-a2f6-89bd5c498331" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2d70655d-4fa7-4946-90f8-8dabc5264db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2d70655d-4fa7-4946-90f8-8dabc5264db0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cc78215e-2f7c-476d-b6db-b868aaee6ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cc78215e-2f7c-476d-b6db-b868aaee6ae4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e75e7d80-76da-48cd-8332-245df0aa9ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e75e7d80-76da-48cd-8332-245df0aa9ace" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02848c7b-6101-4554-bb71-00e7117a1c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02848c7b-6101-4554-bb71-00e7117a1c6f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e798323f-04cc-4791-82d8-98f69ac5c343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e798323f-04cc-4791-82d8-98f69ac5c343" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e03bde76-e727-4189-a6a0-75cec2bcd82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e03bde76-e727-4189-a6a0-75cec2bcd82b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8f5ce4f9-e9e4-4285-9ccc-1d40859314a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8f5ce4f9-e9e4-4285-9ccc-1d40859314a1" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26354cce-340c-43a9-94a5-64792f9b3bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_Goodwill_26354cce-340c-43a9-94a5-64792f9b3bf6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4077fc66-3c08-4c47-9b30-96d88d61b4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4077fc66-3c08-4c47-9b30-96d88d61b4be" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_02ab3068-ea90-4b8c-9db9-6eca60f192db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_02ab3068-ea90-4b8c-9db9-6eca60f192db" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_092d35cf-787a-42d9-844a-ef4e444dc20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_092d35cf-787a-42d9-844a-ef4e444dc20d" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cd429063-880f-4ec9-a2f8-1f21f09be217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cd429063-880f-4ec9-a2f8-1f21f09be217" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7035be7c-949e-417c-aff6-a839dcc7d9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_Revenues_7035be7c-949e-417c-aff6-a839dcc7d9dd" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71292c26-1164-42e9-90d9-e51d95f82bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_OperatingIncomeLoss_71292c26-1164-42e9-90d9-e51d95f82bad" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fc0542cb-f6a4-4982-aaa7-0c64909a0390_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fc0542cb-f6a4-4982-aaa7-0c64909a0390_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c4f77b53-5b90-4ac5-82e1-04cf82cd9e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c4f77b53-5b90-4ac5-82e1-04cf82cd9e45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_868fda51-e895-4886-baeb-2542aae3eed3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_868fda51-e895-4886-baeb-2542aae3eed3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_5050f548-72fd-4129-aeac-5d687c7bc0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_5050f548-72fd-4129-aeac-5d687c7bc0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c116f0f5-50ce-4c7f-8993-1c9e09d1f8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c116f0f5-50ce-4c7f-8993-1c9e09d1f8a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_9ed7e27e-ee1f-467d-be09-7862d00306bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_UseRightsMember_9ed7e27e-ee1f-467d-be09-7862d00306bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_8f69eef7-ea11-415f-a1d7-d26ff4037aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_TradeNamesMember_8f69eef7-ea11-415f-a1d7-d26ff4037aba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e0bcf9d2-af9a-45f3-8392-1da2de4d296c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e0bcf9d2-af9a-45f3-8392-1da2de4d296c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4032d3b8-8115-4baf-bc32-07701f7edbdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4032d3b8-8115-4baf-bc32-07701f7edbdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_8812af92-8172-473e-9da8-a969772e7691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_8812af92-8172-473e-9da8-a969772e7691" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_2073ad2d-6bf1-458f-ab31-658945b6c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_2073ad2d-6bf1-458f-ab31-658945b6c2e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_b1f514c4-2151-4d0c-95d6-53f2137f18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_OtherLiabilitiesMember_b1f514c4-2151-4d0c-95d6-53f2137f18ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_c88e052c-642c-4553-b474-56e91d20392b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_c88e052c-642c-4553-b474-56e91d20392b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_52e2cadf-1d27-4abd-ad06-604fe7d9229a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_52e2cadf-1d27-4abd-ad06-604fe7d9229a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c68f6e3f-b782-4973-8fb2-1ca62af98c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c68f6e3f-b782-4973-8fb2-1ca62af98c4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_8c282b6b-5217-4af3-b6c6-c7ba0ac5e09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_8c282b6b-5217-4af3-b6c6-c7ba0ac5e09f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5e1f1117-3f55-4085-9a52-b95c41d56d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_TradeNamesMember_5e1f1117-3f55-4085-9a52-b95c41d56d11" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5d1aa146-f079-41b2-8a28-9e9dd5b2c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5d1aa146-f079-41b2-8a28-9e9dd5b2c84f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_eba8d585-641c-4cbc-9dfa-62753926e794_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:to="loc_srt_ScenarioUnspecifiedDomain_eba8d585-641c-4cbc-9dfa-62753926e794_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fa7e5518-3a76-459e-bdfa-5e7b1261f65b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fa7e5518-3a76-459e-bdfa-5e7b1261f65b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f80ac305-6711-410f-a144-a12952f3db33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:to="loc_us-gaap_CreditFacilityDomain_f80ac305-6711-410f-a144-a12952f3db33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8fd07f00-9dd3-4960-9b37-e45a8c3e5e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:to="loc_us-gaap_CreditFacilityDomain_8fd07f00-9dd3-4960-9b37-e45a8c3e5e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_caf671ec-bdb6-46a6-b52f-a019d20e37f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_caf671ec-bdb6-46a6-b52f-a019d20e37f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_514fe29a-80c8-45f9-af64-2a71ceafeeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_514fe29a-80c8-45f9-af64-2a71ceafeeae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcludingEnvigoMember_c09b081e-c881-4c6e-bd9b-1fc1e0fd5ab9" xlink:href="lh-20221231.xsd#lh_ExcludingEnvigoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_ExcludingEnvigoMember_c09b081e-c881-4c6e-bd9b-1fc1e0fd5ab9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_88843ca4-3cda-40cf-8527-d73378d66445" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_OtheracquireesMember_88843ca4-3cda-40cf-8527-d73378d66445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2021AcquisitionsMember_715b5ed7-1000-40dc-b64a-48f5e4743926" xlink:href="lh-20221231.xsd#lh_A2021AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_A2021AcquisitionsMember_715b5ed7-1000-40dc-b64a-48f5e4743926" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2020AcquisitionsMember_e3a05aa9-39f5-438a-8f9f-f106a0bb9f83" xlink:href="lh-20221231.xsd#lh_A2020AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_A2020AcquisitionsMember_e3a05aa9-39f5-438a-8f9f-f106a0bb9f83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AscensionAcquisitionMember_df1436c1-604c-489a-8bfc-2e7f5ee07a23" xlink:href="lh-20221231.xsd#lh_AscensionAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_AscensionAcquisitionMember_df1436c1-604c-489a-8bfc-2e7f5ee07a23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MeasurementPeriodAdjustmentsMember_9a5045a6-af81-4616-8bae-16db4e84c6f2" xlink:href="lh-20221231.xsd#lh_MeasurementPeriodAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_MeasurementPeriodAdjustmentsMember_9a5045a6-af81-4616-8bae-16db4e84c6f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PGDxMember_a4537d82-6da9-43d9-aefe-79c7e0e5fecf" xlink:href="lh-20221231.xsd#lh_PGDxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_PGDxMember_a4537d82-6da9-43d9-aefe-79c7e0e5fecf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7e9620d7-14eb-4057-9e77-c447d961c19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7e9620d7-14eb-4057-9e77-c447d961c19f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41960ba7-35c1-4328-87d9-05ddee7854c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41960ba7-35c1-4328-87d9-05ddee7854c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_73997997-03b9-490e-a564-a2615ad5d09e" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_73997997-03b9-490e-a564-a2615ad5d09e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails" xlink:type="extended" id="i2b648cbbc2d04fbda48f7dbf2d70c169_BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0173eb4c-b98b-4ebc-8e6e-67c65cad5e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0173eb4c-b98b-4ebc-8e6e-67c65cad5e7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_8e4916c3-56a8-4eda-aa70-7833c59ea5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_8e4916c3-56a8-4eda-aa70-7833c59ea5d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9e3c34f1-c379-4067-b067-df7df4c52ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9e3c34f1-c379-4067-b067-df7df4c52ad3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7fcec6c1-98d9-47b8-9b80-b0cdefc7daa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7fcec6c1-98d9-47b8-9b80-b0cdefc7daa9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_806098ab-643a-4c24-b22e-a8d8be804bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_806098ab-643a-4c24-b22e-a8d8be804bc3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a962fd60-a4e4-4ac5-8940-c88c7aea02c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a962fd60-a4e4-4ac5-8940-c88c7aea02c8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5604e93d-0c0f-4855-b31e-0045323066c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5604e93d-0c0f-4855-b31e-0045323066c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ba4212fd-7553-4091-8e96-8f572a4f83a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ba4212fd-7553-4091-8e96-8f572a4f83a2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7be4db55-73c8-42b7-a11a-6b26df3d526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7be4db55-73c8-42b7-a11a-6b26df3d526e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f6a98d-a42f-48c1-bac5-685c74a29679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f6a98d-a42f-48c1-bac5-685c74a29679" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_98b5be6b-50f4-4441-a8f6-b1b47060ea81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_98b5be6b-50f4-4441-a8f6-b1b47060ea81" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7f68d5ba-ec48-443f-984b-f009bf32e222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7f68d5ba-ec48-443f-984b-f009bf32e222" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_23807a42-8ed4-40bc-8333-44b908ddaebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_23807a42-8ed4-40bc-8333-44b908ddaebb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2cfda02e-f83c-40ad-8b44-0c055894950f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2cfda02e-f83c-40ad-8b44-0c055894950f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a7610a4-a5a5-4799-a411-17eaa77c3966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a7610a4-a5a5-4799-a411-17eaa77c3966" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ca36ce71-ac43-468b-b229-9042510fd0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ca36ce71-ac43-468b-b229-9042510fd0bf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_fd7f129e-e754-4675-afaf-a3a9c24de0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessExitCosts1_fd7f129e-e754-4675-afaf-a3a9c24de0f8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9727db0d-9f04-4508-9036-12c73b88d8f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9727db0d-9f04-4508-9036-12c73b88d8f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2020AcquisitionsMember_f24be22c-a72d-4b45-b12d-9b6af6d2f04f" xlink:href="lh-20221231.xsd#lh_A2020AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_A2020AcquisitionsMember_f24be22c-a72d-4b45-b12d-9b6af6d2f04f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019AcquisitionsMember_db91a3ce-a682-4e04-8aec-acf7468cada1" xlink:href="lh-20221231.xsd#lh_A2019AcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_A2019AcquisitionsMember_db91a3ce-a682-4e04-8aec-acf7468cada1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_b8f72b27-9365-4c3a-8717-f486b93af646" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_OtheracquireesMember_b8f72b27-9365-4c3a-8717-f486b93af646" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails" xlink:type="extended" id="i64306a8287e34d38aef54659dcfe01e7_BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9bb57275-3604-4ed6-9792-ef6df466df7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_OperatingIncomeLoss_9bb57275-3604-4ed6-9792-ef6df466df7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_730fb11a-a951-41b9-928d-00f2e489ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_730fb11a-a951-41b9-928d-00f2e489ea5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eadb738f-d0d9-4991-aeda-fcc15a747372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eadb738f-d0d9-4991-aeda-fcc15a747372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_74c1c6ae-3112-4029-8a88-8ff7b06f4d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_74c1c6ae-3112-4029-8a88-8ff7b06f4d85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b3753a76-ef55-4b27-9c05-fb1dcf937325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b3753a76-ef55-4b27-9c05-fb1dcf937325" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0833a87f-6605-46d1-85c8-97b3e27482a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0833a87f-6605-46d1-85c8-97b3e27482a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_037cb0b3-9733-46f7-822f-5d03ca521af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_037cb0b3-9733-46f7-822f-5d03ca521af8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32604b97-04bb-4614-9976-80688fe24acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32604b97-04bb-4614-9976-80688fe24acb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_fac95e1a-4fc1-4075-9ad4-3f197de75e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_fac95e1a-4fc1-4075-9ad4-3f197de75e9c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2bf93cd5-777b-42e0-8660-ef56e4c06a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2bf93cd5-777b-42e0-8660-ef56e4c06a36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d1a41532-cd8e-4768-9fdb-105c74fc5825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d1a41532-cd8e-4768-9fdb-105c74fc5825" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0481b518-0716-4ccc-bd31-51ec8b0c8919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0481b518-0716-4ccc-bd31-51ec8b0c8919" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5c8c5dc-8c67-441b-87f7-081e3fa16fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5c8c5dc-8c67-441b-87f7-081e3fa16fc7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f48ac010-d41e-404a-92ed-0445e8b35f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f48ac010-d41e-404a-92ed-0445e8b35f52" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2d3ec6d0-f6a0-4136-97b6-3a49140e040b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2d3ec6d0-f6a0-4136-97b6-3a49140e040b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_850b4fb7-95d0-4733-9185-728f042df977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_850b4fb7-95d0-4733-9185-728f042df977" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8bfc6a16-26fe-4316-ba43-2e7df8d10804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8bfc6a16-26fe-4316-ba43-2e7df8d10804" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1112461-7d95-4929-8b10-2646b2da8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1112461-7d95-4929-8b10-2646b2da8c7f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bd873b0-7000-4445-9193-6341a5925f88_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6bd873b0-7000-4445-9193-6341a5925f88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b95fb37b-4b7c-4da7-8dfd-8a22e2961f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b95fb37b-4b7c-4da7-8dfd-8a22e2961f61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e7240b8b-743f-4c62-b436-5b053d2dbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:to="loc_us-gaap_TradeNamesMember_e7240b8b-743f-4c62-b436-5b053d2dbe7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b5240f03-c7cd-407f-b8f1-32bbf9555720_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b5240f03-c7cd-407f-b8f1-32bbf9555720_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_48e035db-708c-4ce2-a5ca-8b4fe1113c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_48e035db-708c-4ce2-a5ca-8b4fe1113c0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_40c262e9-f968-4456-a3c4-d803b94a2355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_40c262e9-f968-4456-a3c4-d803b94a2355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_826d7c8b-c14e-4771-98c6-fdaa5ff3a2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_826d7c8b-c14e-4771-98c6-fdaa5ff3a2e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_2274dc9f-09ae-45a8-8804-9a0e5c7c2fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_2274dc9f-09ae-45a8-8804-9a0e5c7c2fe9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_885fffbd-e0e1-43dd-8ec5-60090aa2e932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_885fffbd-e0e1-43dd-8ec5-60090aa2e932" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e8be299-c4d3-4902-b4a6-cdd0be8ac232_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4e8be299-c4d3-4902-b4a6-cdd0be8ac232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_8e6048f9-9ede-426b-b9d5-a42126bc615f" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:to="loc_lh_OtheracquireesMember_8e6048f9-9ede-426b-b9d5-a42126bc615f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0fc99afa-ccf8-493c-99fb-dafff8bfbb77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0fc99afa-ccf8-493c-99fb-dafff8bfbb77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c8930797-7550-48ee-94a5-2c8d407d3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c8930797-7550-48ee-94a5-2c8d407d3935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_71c5584d-e907-489c-b3bc-22b43187cad1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:to="loc_srt_OwnershipDomain_71c5584d-e907-489c-b3bc-22b43187cad1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9081a481-c53d-480a-b424-27d23c4b1244" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:to="loc_srt_OwnershipDomain_9081a481-c53d-480a-b424-27d23c4b1244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:to="loc_us-gaap_ClassOfStockDomain_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0466234d-4ffe-4924-baa8-d795f7d71cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:to="loc_us-gaap_ClassOfStockDomain_0466234d-4ffe-4924-baa8-d795f7d71cdb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#RestructuringandRelatedActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails" xlink:type="extended" id="ie4ef163d2ca34a3988ce767476a95c94_RestructuringandRelatedActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cb8dd8c9-b18f-4eff-a85e-9bc5bbd15545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringReserve_cb8dd8c9-b18f-4eff-a85e-9bc5bbd15545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_3bbcd96c-03f0-44d2-9905-3c98fc60a325" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_lh_NetRestructuringCharges_3bbcd96c-03f0-44d2-9905-3c98fc60a325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_41e58b00-470d-4325-b460-b0e72e80bdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_SeveranceCosts1_41e58b00-470d-4325-b460-b0e72e80bdd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_df9c8d36-8631-4ed3-8883-b743014d766c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_df9c8d36-8631-4ed3-8883-b743014d766c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_9e8a5ee9-f711-4e9b-8df8-7de3a20c1662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_9e8a5ee9-f711-4e9b-8df8-7de3a20c1662" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_bd3491ca-c10e-4957-ae25-77936091d208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_PaymentsForRestructuring_bd3491ca-c10e-4957-ae25-77936091d208" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d61b0dee-62d8-458b-a3f6-729654145746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringCharges_d61b0dee-62d8-458b-a3f6-729654145746" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c19b59cc-08b1-40fd-9f9c-4a391aba7288_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c19b59cc-08b1-40fd-9f9c-4a391aba7288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_0302796d-a7ac-4075-961f-38339a6c408e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:to="loc_us-gaap_EmployeeSeveranceMember_0302796d-a7ac-4075-961f-38339a6c408e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_23425876-6e26-4073-b199-c48e144ea00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:to="loc_us-gaap_FacilityClosingMember_23425876-6e26-4073-b199-c48e144ea00b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_566ee6e0-45c1-4bef-958b-00cf56c7daca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:to="loc_us-gaap_SegmentDomain_566ee6e0-45c1-4bef-958b-00cf56c7daca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:to="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_209e49ed-7994-489b-81e8-5cf36ded6072" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_lh_DiagnosticsMember_209e49ed-7994-489b-81e8-5cf36ded6072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_f191a2c4-3699-40ea-bdb8-61fe00a79d59" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_lh_DrugDevelopmentMember_f191a2c4-3699-40ea-bdb8-61fe00a79d59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_7dbe8511-acb3-41c1-802b-771e5d98c23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_us-gaap_CorporateMember_7dbe8511-acb3-41c1-802b-771e5d98c23b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/LEASESDetails" xlink:type="extended" id="ie562e371c4c74f22a4d2a17dcdbbf616_LEASESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d6380c7-3b2c-4947-9a15-6b05eb866636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d6380c7-3b2c-4947-9a15-6b05eb866636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_554aace4-670e-4856-beda-efc14433c97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_554aace4-670e-4856-beda-efc14433c97f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1255c92c-063a-4bb6-aa22-fc5f6f633b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_OperatingLeaseExpense_1255c92c-063a-4bb6-aa22-fc5f6f633b87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeasePayment_851ddea9-41c2-44e4-aa4d-7ac96ef6de14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_VariableLeasePayment_851ddea9-41c2-44e4-aa4d-7ac96ef6de14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b70ea40a-fc6e-4a2c-97dc-36acf760654d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b70ea40a-fc6e-4a2c-97dc-36acf760654d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermLeaseMember_fe58d30e-879d-4df0-b32c-13b28aeb37a2" xlink:href="lh-20221231.xsd#lh_ShortTermLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:to="loc_lh_ShortTermLeaseMember_fe58d30e-879d-4df0-b32c-13b28aeb37a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:to="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_0b984826-b5b2-47dc-91ea-99f8db96594e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:to="loc_us-gaap_LeaseContractualTermDomain_0b984826-b5b2-47dc-91ea-99f8db96594e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:to="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermLeaseMember_464857fe-c32a-4712-8207-e55765da3882" xlink:href="lh-20221231.xsd#lh_ShortTermLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:to="loc_lh_ShortTermLeaseMember_464857fe-c32a-4712-8207-e55765da3882" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PROPERTYPLANTANDEQUIPMENTNETDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="extended" id="i0fb1c1f22d8d4c10aba919938fd54855_PROPERTYPLANTANDEQUIPMENTNETDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a5c675f0-5995-4008-aeaf-a1ef68642051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a5c675f0-5995-4008-aeaf-a1ef68642051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c51ccc62-2a4b-4a19-a2a5-f3813d17e9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c51ccc62-2a4b-4a19-a2a5-f3813d17e9a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0ea20cf9-0a5e-4ac6-b3e4-a3927244f904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0ea20cf9-0a5e-4ac6-b3e4-a3927244f904" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_859c27a2-3a00-4ecb-a89c-8af98e46e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_859c27a2-3a00-4ecb-a89c-8af98e46e8d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SoftwareDepreciation_0655e60f-61b0-4b05-990e-ba43198705b7" xlink:href="lh-20221231.xsd#lh_SoftwareDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_lh_SoftwareDepreciation_0655e60f-61b0-4b05-990e-ba43198705b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3b9313fc-6d58-4a1e-96da-ce856d42952c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3b9313fc-6d58-4a1e-96da-ce856d42952c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_31a7f7ed-ed40-4759-b9cb-c78c33694869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_31a7f7ed-ed40-4759-b9cb-c78c33694869" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_85ca5ab9-607a-4fcc-ac7f-98a5e93a955e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_LandMember_85ca5ab9-607a-4fcc-ac7f-98a5e93a955e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1073473d-3622-4487-b10c-6641dc134609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1073473d-3622-4487-b10c-6641dc134609" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2754b388-edd3-4231-866e-03f7a445febe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2754b388-edd3-4231-866e-03f7a445febe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17ce05ab-ea84-48dc-a9d8-122c6cc503c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17ce05ab-ea84-48dc-a9d8-122c6cc503c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_63fb9489-7980-44b7-9840-92a6efa6b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_63fb9489-7980-44b7-9840-92a6efa6b1b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_40b29b30-adf1-4a8d-89aa-88a11ee56cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_40b29b30-adf1-4a8d-89aa-88a11ee56cc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8ef41cb9-b305-40d6-84f1-de7e2412f7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_ConstructionInProgressMember_8ef41cb9-b305-40d6-84f1-de7e2412f7ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_772a61c5-9a44-4d10-a562-84b7a3e1f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_772a61c5-9a44-4d10-a562-84b7a3e1f9e5" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended" id="i57eda2a871e941cc9bfbab0a94da9f2f_GOODWILLANDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01a46392-37b9-44ba-9ab0-8b7528971659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01a46392-37b9-44ba-9ab0-8b7528971659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9cf8053e-4b62-4c91-8234-7cfc86de7428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9cf8053e-4b62-4c91-8234-7cfc86de7428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f32d6e3d-907e-4f9a-8af5-7f61d7426a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f32d6e3d-907e-4f9a-8af5-7f61d7426a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fb47c4fe-fbfd-4873-a225-fa8510d1eb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fb47c4fe-fbfd-4873-a225-fa8510d1eb9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9ca8b00-d27f-43d9-9aa9-ddcfcda99949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9ca8b00-d27f-43d9-9aa9-ddcfcda99949" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a98a9400-d696-40aa-9e2b-39c5224f2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a98a9400-d696-40aa-9e2b-39c5224f2b5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a705564-a54b-4ca0-8a5b-bc382a9ce08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a705564-a54b-4ca0-8a5b-bc382a9ce08d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_467f3c4d-29d8-4fad-88b1-5e30ee37ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_467f3c4d-29d8-4fad-88b1-5e30ee37ae93" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_22e8b409-42bd-404f-bc46-e3065d9212ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_22e8b409-42bd-404f-bc46-e3065d9212ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_871319f5-10ba-4137-bf94-f7f25b1a9d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_871319f5-10ba-4137-bf94-f7f25b1a9d92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b33dd69a-b2ea-4b5e-8107-2113fd1d8542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b33dd69a-b2ea-4b5e-8107-2113fd1d8542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5f9cd97b-50b7-45df-a607-f4e264e1f871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_AdjustmentForAmortization_5f9cd97b-50b7-45df-a607-f4e264e1f871" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillImpairmentCumulative_05eac1c3-65d2-4842-a0fc-4a5a02366a1b" xlink:href="lh-20221231.xsd#lh_GoodwillImpairmentCumulative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_lh_GoodwillImpairmentCumulative_05eac1c3-65d2-4842-a0fc-4a5a02366a1b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_541a7c9a-2511-4adf-8214-f2322fa0dbe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_541a7c9a-2511-4adf-8214-f2322fa0dbe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_fb3387d3-15e2-469b-b4f8-d7979f392efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:to="loc_us-gaap_LicensingAgreementsMember_fb3387d3-15e2-469b-b4f8-d7979f392efb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6919eb0a-48b1-4a3c-bca5-82a546e0cd42_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6919eb0a-48b1-4a3c-bca5-82a546e0cd42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_191c24ba-f1c4-4c12-90ed-397739e572e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_191c24ba-f1c4-4c12-90ed-397739e572e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_568902c5-67f6-4729-a2fb-7543ebd527fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:to="loc_us-gaap_SegmentDomain_568902c5-67f6-4729-a2fb-7543ebd527fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:to="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_f61733d9-1487-40df-8896-72a8f5a84876" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:to="loc_lh_DrugDevelopmentMember_f61733d9-1487-40df-8896-72a8f5a84876" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_1dcce6a1-93ea-44c9-a3a5-49bfc73d7b7d" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:to="loc_lh_DiagnosticsMember_1dcce6a1-93ea-44c9-a3a5-49bfc73d7b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_667c660e-322c-4057-ba0b-2a3ad521a398_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_667c660e-322c-4057-ba0b-2a3ad521a398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f0c1ac38-d727-4a3e-b4d3-aeffffc87aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f0c1ac38-d727-4a3e-b4d3-aeffffc87aca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails" xlink:type="extended" id="id117fcded57143089d8482891bac9022_GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e147504d-f28d-4724-b331-97b57bcc96cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_Goodwill_e147504d-f28d-4724-b331-97b57bcc96cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_849f80fc-f622-4a9d-879e-d5c5ab297c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_849f80fc-f622-4a9d-879e-d5c5ab297c18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2a2488d2-37b8-4340-9210-9a421bfc5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2a2488d2-37b8-4340-9210-9a421bfc5e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a2b63c9c-346d-4afd-af06-f50f83e2561c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a2b63c9c-346d-4afd-af06-f50f83e2561c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8791c806-81cd-4a51-8d2e-c0f84ca75058_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:to="loc_us-gaap_SegmentDomain_8791c806-81cd-4a51-8d2e-c0f84ca75058_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:to="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_77d9f2e3-8585-46c6-9cca-26ebd021957a" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:to="loc_lh_DiagnosticsMember_77d9f2e3-8585-46c6-9cca-26ebd021957a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_425a2f59-17b5-47b9-a35a-bb80c7f4ea08" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:to="loc_lh_DrugDevelopmentMember_425a2f59-17b5-47b9-a35a-bb80c7f4ea08" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="extended" id="i740c92c5eedb4912a818e59d6f0eba0a_GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e59340f-8ec8-44cf-8b8c-8d87dc275085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e59340f-8ec8-44cf-8b8c-8d87dc275085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9391580c-68e8-43a6-a0ca-70e00701dc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9391580c-68e8-43a6-a0ca-70e00701dc3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f52db74f-fbea-4a20-ae2b-1e6d34f4e70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f52db74f-fbea-4a20-ae2b-1e6d34f4e70c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_08041f5e-c6ed-42a1-8a45-5c2bd71d5063_default" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_08041f5e-c6ed-42a1-8a45-5c2bd71d5063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_5a598d64-cac2-45be-8da9-403b806b5b64" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_5a598d64-cac2-45be-8da9-403b806b5b64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4b1a7a9a-f900-4bac-8fcd-93f2d49982f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4b1a7a9a-f900-4bac-8fcd-93f2d49982f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_b93780f4-4042-47cb-8358-bdf9cdd0d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_UseRightsMember_b93780f4-4042-47cb-8358-bdf9cdd0d22c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b3b16292-bc4c-4896-bedd-9c1434d03e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_TradeNamesMember_b3b16292-bc4c-4896-bedd-9c1434d03e70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_72cb0fd6-0d16-41f9-b120-31a098d874cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_72cb0fd6-0d16-41f9-b120-31a098d874cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_ab83402c-16c9-4fd1-8238-45c7629282dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_LicensingAgreementsMember_ab83402c-16c9-4fd1-8238-45c7629282dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e63a8f38-f16c-4f63-8c25-056ce32b2a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e63a8f38-f16c-4f63-8c25-056ce32b2a19" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediaContentMember_5d9cc3b3-1ec4-4c24-8615-c282ac619fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediaContentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_MediaContentMember_5d9cc3b3-1ec4-4c24-8615-c282ac619fb6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a92a4377-4bf7-449f-9191-c36c86b28171_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a92a4377-4bf7-449f-9191-c36c86b28171_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7e40e42b-411a-45fd-992c-415f7f131f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7e40e42b-411a-45fd-992c-415f7f131f9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_dc2404a0-d93a-49ed-9ffb-946e213d5269" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_dc2404a0-d93a-49ed-9ffb-946e213d5269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_067d93b4-c804-4da2-b5ee-0a77531e3f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_067d93b4-c804-4da2-b5ee-0a77531e3f11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d3605d2b-bcf3-4b4c-80e1-b7d1a2d7ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_TradeNamesMember_d3605d2b-bcf3-4b4c-80e1-b7d1a2d7ee09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_954aedd9-a065-4faf-825f-03a1a4a4f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_LicensingAgreementsMember_954aedd9-a065-4faf-825f-03a1a4a4f6c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediaContentMember_9ad7bf9e-e757-405e-a767-1c5fea150a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediaContentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_MediaContentMember_9ad7bf9e-e757-405e-a767-1c5fea150a94" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails" xlink:type="extended" id="iafd76e68dbbd473da1a6dad5ef3e853d_GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_56f4319d-98e8-422a-8c7b-1e5d5b50c52b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_56f4319d-98e8-422a-8c7b-1e5d5b50c52b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_19cf9089-d37f-4812-b805-f1487b068532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_19cf9089-d37f-4812-b805-f1487b068532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c9b94a50-8c5b-4a7a-8388-c19895e1e504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c9b94a50-8c5b-4a7a-8388-c19895e1e504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7882b6fe-ffc1-41c1-ada7-588751bd6622_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7882b6fe-ffc1-41c1-ada7-588751bd6622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9ab00447-303e-405d-950a-77e4edc23615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9ab00447-303e-405d-950a-77e4edc23615" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_202065e6-b394-4062-bd6c-8d50fc2e8091" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_202065e6-b394-4062-bd6c-8d50fc2e8091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_633cf1d2-ac21-43e2-b86c-d20cd9a4a5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_633cf1d2-ac21-43e2-b86c-d20cd9a4a5e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_113b2ef8-41d5-4186-b71b-499ece5fd124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_TradeNamesMember_113b2ef8-41d5-4186-b71b-499ece5fd124" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_72fca140-c52e-4c24-b5ec-1d1efa7251fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_UseRightsMember_72fca140-c52e-4c24-b5ec-1d1efa7251fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a128fc77-e43e-457c-a504-4914cc6b4135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a128fc77-e43e-457c-a504-4914cc6b4135" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_e5ea5444-10c2-4e0a-9095-2e6faf8d7716_default" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_e5ea5444-10c2-4e0a-9095-2e6faf8d7716_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_4253246f-e668-4177-9992-f725b94aa76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_4253246f-e668-4177-9992-f725b94aa76f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSCHEDULEOFSHORTTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="extended" id="i96ac139d153e4ff2a153440c26522ca4_DEBTSCHEDULEOFSHORTTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_ec4c557f-bc2e-498c-acf7-62e1ce28a2ed" xlink:href="lh-20221231.xsd#lh_A2019TermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_A2019TermLoan_ec4c557f-bc2e-498c-acf7-62e1ce28a2ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_4c333b95-935f-45ab-8dd8-3fcf8a5369b3" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_Shorttermdebtissuancecosts_4c333b95-935f-45ab-8dd8-3fcf8a5369b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_a93902cf-83eb-420b-817d-9be1f2017a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_us-gaap_NotesPayableCurrent_a93902cf-83eb-420b-817d-9be1f2017a8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_feab5e51-6d5c-450c-8a0c-a9e9592b24b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_us-gaap_DebtCurrent_feab5e51-6d5c-450c-8a0c-a9e9592b24b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_34886a49-4df6-48c0-9e4f-c5c6d199dc5e" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_A4.00Seniornotesdue2023_34886a49-4df6-48c0-9e4f-c5c6d199dc5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_6c03604e-6b5d-4087-a9cb-4c0f4085547b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_6c03604e-6b5d-4087-a9cb-4c0f4085547b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtIssueCostsMember_c8cdde9d-1bee-4ccd-8f02-cbbfb1b696fc" xlink:href="lh-20221231.xsd#lh_ShortTermDebtIssueCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_ShortTermDebtIssueCostsMember_c8cdde9d-1bee-4ccd-8f02-cbbfb1b696fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NotePayableCurrentMember_e7a44f46-d302-412e-8ca0-63e7d3a02008" xlink:href="lh-20221231.xsd#lh_NotePayableCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_NotePayableCurrentMember_e7a44f46-d302-412e-8ca0-63e7d3a02008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2023Member_49fb48f5-23c9-42f0-83fe-84f0cc9b3554" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_SeniorNotesDue2023Member_49fb48f5-23c9-42f0-83fe-84f0cc9b3554" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSCHEDULEOFLONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="extended" id="ifd0d798ec6d24a60ad34334cb4015277_DEBTSCHEDULEOFLONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8c065efe-097e-4c4f-b587-792f199428f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8c065efe-097e-4c4f-b587-792f199428f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_b70a550f-df60-4879-9b7e-6d7b79545066" xlink:href="lh-20221231.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_b70a550f-df60-4879-9b7e-6d7b79545066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_855cd525-4b34-411e-bd5d-4e7657771a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_855cd525-4b34-411e-bd5d-4e7657771a58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_96f49d89-ad31-4402-ae2e-788812f907eb" xlink:href="lh-20221231.xsd#lh_A2.30seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A2.30seniornotesdue2024_96f49d89-ad31-4402-ae2e-788812f907eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_3c423825-5a30-45ff-8a37-fa626ddfcb9b" xlink:href="lh-20221231.xsd#lh_A2.95seniornotesdue2029"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A2.95seniornotesdue2029_3c423825-5a30-45ff-8a37-fa626ddfcb9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027_1e706b0d-0db7-40d8-884a-1390bc5e416d" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Seniornotesdue2027_1e706b0d-0db7-40d8-884a-1390bc5e416d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.70Seniornotesdue2045_c751edfb-72a5-4861-87d0-84776a7e6a14" xlink:href="lh-20221231.xsd#lh_A4.70Seniornotesdue2045"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A4.70Seniornotesdue2045_c751edfb-72a5-4861-87d0-84776a7e6a14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024_bf8ae82e-0ac3-49d6-a6f6-b51014ac29f6" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Seniornotesdue2024_bf8ae82e-0ac3-49d6-a6f6-b51014ac29f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A3.60Seniornotesdue2025_05d615b8-8132-4761-933d-c6881746e684" xlink:href="lh-20221231.xsd#lh_A3.60Seniornotesdue2025"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A3.60Seniornotesdue2025_05d615b8-8132-4761-933d-c6881746e684" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_f756e97e-b6cc-4269-8dd8-a8f5ba5ed5d8" xlink:href="lh-20221231.xsd#lh_A155SeniorNotesDue2026"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A155SeniorNotesDue2026_f756e97e-b6cc-4269-8dd8-a8f5ba5ed5d8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermDebtExcludingDebtIssuanceCosts_bc9b7e89-da63-46d7-9ce4-90fc9b4e9d78" xlink:href="lh-20221231.xsd#lh_LongTermDebtExcludingDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_LongTermDebtExcludingDebtIssuanceCosts_bc9b7e89-da63-46d7-9ce4-90fc9b4e9d78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_6f164173-de80-4a36-b4eb-19588d63abf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermNotesPayable_6f164173-de80-4a36-b4eb-19588d63abf2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_7700202d-6ead-4736-a5e5-f47f906e1853" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A4.00Seniornotesdue2023_7700202d-6ead-4736-a5e5-f47f906e1853" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_cdb3e79f-b59b-4055-b360-3e71f921bcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_cdb3e79f-b59b-4055-b360-3e71f921bcb0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_32a3dcb1-aeaf-44e2-9af3-c37af4d3ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_32a3dcb1-aeaf-44e2-9af3-c37af4d3ea90" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_371494f6-4144-4c31-a039-5bf4915470aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_371494f6-4144-4c31-a039-5bf4915470aa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_951ced61-0c71-4bcd-9d77-f8e2d4819f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_951ced61-0c71-4bcd-9d77-f8e2d4819f20" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_01ea1b4c-cf5d-4c73-ad86-f5f5c866ff0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_01ea1b4c-cf5d-4c73-ad86-f5f5c866ff0f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_40f90f32-0999-4e81-a417-50494f9ae8e6" xlink:href="lh-20221231.xsd#lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_40f90f32-0999-4e81-a417-50494f9ae8e6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_000733a8-d3e1-4b87-95a8-43262bc146ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_000733a8-d3e1-4b87-95a8-43262bc146ab" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ec6b83c6-70f8-4b43-9300-b6264d5a2613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ec6b83c6-70f8-4b43-9300-b6264d5a2613" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4ab6ba3f-64f9-4973-8090-5dddbe56b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DebtCurrent_4ab6ba3f-64f9-4973-8090-5dddbe56b27e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_a48c055f-9632-4345-a221-ec0ae9c411a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_a48c055f-9632-4345-a221-ec0ae9c411a8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_457729f3-07d0-4de9-acf9-cafff841d713_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_457729f3-07d0-4de9-acf9-cafff841d713_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b65681ac-5b6b-4176-98fb-26fe58531cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b65681ac-5b6b-4176-98fb-26fe58531cec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_ccb868aa-afcb-4ace-8b64-f0549eee8ba2" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:to="loc_lh_SeniorNotesDue2020Member_ccb868aa-afcb-4ace-8b64-f0549eee8ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:to="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c671ef9c-3d7e-47af-a702-07e9c8207183_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c671ef9c-3d7e-47af-a702-07e9c8207183_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c25d4868-1117-41de-a2cd-04bde6b48690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c25d4868-1117-41de-a2cd-04bde6b48690" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTCREDITFACILITIESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails" xlink:type="extended" id="i32401cb588fe47289ebd3c081142e1a5_DEBTCREDITFACILITIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_4e696b7b-1d0d-49ad-af92-e826e2e7abec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_NotesPayableCurrent_4e696b7b-1d0d-49ad-af92-e826e2e7abec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_225ff0ed-be5b-4162-970e-da6bdc6e6e49" xlink:href="lh-20221231.xsd#lh_Longtermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_Longtermdebtissuancecosts_225ff0ed-be5b-4162-970e-da6bdc6e6e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_9b849911-962b-4d35-9048-00dd8c1e9c1d" xlink:href="lh-20221231.xsd#lh_A2019TermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_A2019TermLoan_9b849911-962b-4d35-9048-00dd8c1e9c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_de4df530-3380-41b1-8777-441ec6bea6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_de4df530-3380-41b1-8777-441ec6bea6e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c5b2cd44-c6e8-4abd-96e2-c8d45a9b2147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c5b2cd44-c6e8-4abd-96e2-c8d45a9b2147" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8fd38139-f03a-40de-80ec-55b6fb64a8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8fd38139-f03a-40de-80ec-55b6fb64a8fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_e5123331-f8a9-4c8a-b255-513d982d4c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_e5123331-f8a9-4c8a-b255-513d982d4c73" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_4b50b64e-314c-4102-a479-c6b906240371" xlink:href="lh-20221231.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_4b50b64e-314c-4102-a479-c6b906240371" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_6f96e669-3185-44d8-9dcc-db2abf094cb9" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_6f96e669-3185-44d8-9dcc-db2abf094cb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_adcb6282-d8fa-43ab-85e5-39983de7f5d2" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_adcb6282-d8fa-43ab-85e5-39983de7f5d2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_3fc6e5d1-a17b-40b4-a83e-0a4ceb52cc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_3fc6e5d1-a17b-40b4-a83e-0a4ceb52cc2a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_30fa9b02-ce79-491c-85d8-75416d2ff836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_30fa9b02-ce79-491c-85d8-75416d2ff836" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9da889de-f612-4c58-b2c1-9e7014cde68f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9da889de-f612-4c58-b2c1-9e7014cde68f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_393cb81e-faf6-4531-af44-07f21205ef2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_393cb81e-faf6-4531-af44-07f21205ef2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_7ba164cd-f046-42f8-8d83-1b2af5ac2186_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_7ba164cd-f046-42f8-8d83-1b2af5ac2186_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b36dcdb9-0971-4450-9cad-01b568650c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b36dcdb9-0971-4450-9cad-01b568650c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b24c5d99-b34e-4602-a7ee-c1773fbc12ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b24c5d99-b34e-4602-a7ee-c1773fbc12ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4706cf90-24ae-4dbd-bdeb-38273356d3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4706cf90-24ae-4dbd-bdeb-38273356d3b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b57c0f79-a378-49f1-b35c-4e897e092133_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:to="loc_srt_RangeMember_b57c0f79-a378-49f1-b35c-4e897e092133_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:to="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_13d7c06c-eb36-40cc-834c-aac57e81b116" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:to="loc_srt_MinimumMember_13d7c06c-eb36-40cc-834c-aac57e81b116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e7956ee1-faae-48d8-bd85-4479593e6235" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:to="loc_srt_MaximumMember_e7956ee1-faae-48d8-bd85-4479593e6235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fed147e6-e8e7-4f72-b4a1-765abf5a1b15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:to="loc_us-gaap_CreditFacilityDomain_fed147e6-e8e7-4f72-b4a1-765abf5a1b15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:to="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b9360dca-90e4-47ae-b33b-a40af2bb190a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b9360dca-90e4-47ae-b33b-a40af2bb190a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_92fd7bde-d718-409d-a013-05339d734999_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_92fd7bde-d718-409d-a013-05339d734999_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3558f120-f846-423b-888a-268ced512dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3558f120-f846-423b-888a-268ced512dc0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTCOVERTIBLESUBORDINATEDNOTESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails" xlink:type="extended" id="i8c64db5e2e094a3d8427d84234b64236_DEBTCOVERTIBLESUBORDINATEDNOTESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_8bb3ef7b-c171-41bd-bb4c-ed1e071daffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_LongTermNotesPayable_8bb3ef7b-c171-41bd-bb4c-ed1e071daffd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_984abc51-e3dd-4379-b0e5-7e73b5d7bfe2" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_lh_Shorttermdebtissuancecosts_984abc51-e3dd-4379-b0e5-7e73b5d7bfe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_ceb6a84e-e906-44bc-973f-1deba517bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_NotesPayableCurrent_ceb6a84e-e906-44bc-973f-1deba517bf59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a0492b89-b214-4423-944d-623f358e5021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a0492b89-b214-4423-944d-623f358e5021" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024_36c4604e-e7e5-4c98-abf1-162dbc3d24ce" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2024"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_lh_Seniornotesdue2024_36c4604e-e7e5-4c98-abf1-162dbc3d24ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f4501d3a-5c66-4b8d-bf1b-b1754e10232c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f4501d3a-5c66-4b8d-bf1b-b1754e10232c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0659b24c-0fc9-4ce1-b680-6818ad88f5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0659b24c-0fc9-4ce1-b680-6818ad88f5d8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_05851a9f-90c3-4b01-b92f-a6b2daa34cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_DebtCurrent_05851a9f-90c3-4b01-b92f-a6b2daa34cf3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4de2d738-3b0a-4d41-bcfa-df365e3e464c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4de2d738-3b0a-4d41-bcfa-df365e3e464c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43afc94a-ae77-4ae6-b160-aebda7a485ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43afc94a-ae77-4ae6-b160-aebda7a485ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74a79c45-f3f2-4768-beed-8aefd3fdebf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_74a79c45-f3f2-4768-beed-8aefd3fdebf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35efbc20-9947-4876-8745-290a7b0e21f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35efbc20-9947-4876-8745-290a7b0e21f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5bcddd5a-31e3-40c4-9046-f1be6e0d776c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:to="loc_srt_RangeMember_5bcddd5a-31e3-40c4-9046-f1be6e0d776c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:to="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b60be22-fab0-4f40-97b0-09e9b4234b9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:to="loc_srt_MaximumMember_9b60be22-fab0-4f40-97b0-09e9b4234b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_90c9967a-4c8f-4537-a5ba-7860b673cc5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_90c9967a-4c8f-4537-a5ba-7860b673cc5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e49e41fd-2e99-4f37-b966-b75dcbb318ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e49e41fd-2e99-4f37-b966-b75dcbb318ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1f1750da-04df-4407-bebe-6936bab04671_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:to="loc_us-gaap_CreditFacilityDomain_1f1750da-04df-4407-bebe-6936bab04671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:to="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9af68560-c67d-4660-803c-a450fcd740b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9af68560-c67d-4660-803c-a450fcd740b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cb3ffa39-6fdd-43e8-a08c-c222154a91b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cb3ffa39-6fdd-43e8-a08c-c222154a91b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_e8b7975a-533e-4c65-9f37-919970d28ddf" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:to="loc_lh_Seniornotesdue2027Member_e8b7975a-533e-4c65-9f37-919970d28ddf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ac26ffad-82b6-4f22-9967-76eaf9167e14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ac26ffad-82b6-4f22-9967-76eaf9167e14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7694b3c-09bf-47de-8474-32653b0bd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7694b3c-09bf-47de-8474-32653b0bd2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2f295cba-711b-464f-a7e0-323044263bc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:to="loc_us-gaap_VariableRateDomain_2f295cba-711b-464f-a7e0-323044263bc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8948347b-45a8-4ede-9314-e070dbdbb5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:to="loc_us-gaap_VariableRateDomain_8948347b-45a8-4ede-9314-e070dbdbb5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_f6e1b5b7-5f44-4283-b368-406a65540c22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_f6e1b5b7-5f44-4283-b368-406a65540c22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_70b209f1-5303-4cc2-aae3-8cc644b5b559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_70b209f1-5303-4cc2-aae3-8cc644b5b559" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSENIORNOTESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSENIORNOTESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DEBTSENIORNOTESDetails" xlink:type="extended" id="i7f76b82800db42bfbd30d6a3459a95c6_DEBTSENIORNOTESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5d8a5aea-a361-4ed4-9e17-2836eff970cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtCurrent_5d8a5aea-a361-4ed4-9e17-2836eff970cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TotalShortandLongTermDebtIssuanceCosts_7421b989-4924-469e-9d65-23bfa4b19421" xlink:href="lh-20221231.xsd#lh_TotalShortandLongTermDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_TotalShortandLongTermDebtIssuanceCosts_7421b989-4924-469e-9d65-23bfa4b19421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_cf41226b-8a7c-4b3f-bff8-cf27d6b1b973" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_cf41226b-8a7c-4b3f-bff8-cf27d6b1b973" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_283c5814-6b58-42c8-b6b3-f40720719877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_283c5814-6b58-42c8-b6b3-f40720719877" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ceb63abf-1516-4bde-bba1-776c5daa7258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ceb63abf-1516-4bde-bba1-776c5daa7258" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2de3d416-79d6-4ff3-86f4-dbf2d7859253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2de3d416-79d6-4ff3-86f4-dbf2d7859253" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_e4951a0e-2c10-4811-9133-a29da6de1d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_e4951a0e-2c10-4811-9133-a29da6de1d36" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2af9e77-64b9-4725-8e7b-9caae7b3b62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2af9e77-64b9-4725-8e7b-9caae7b3b62d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_83091479-cfef-4ce6-8410-4cd134f5c832" xlink:href="lh-20221231.xsd#lh_A270SeniorNotesDue2031"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A270SeniorNotesDue2031_83091479-cfef-4ce6-8410-4cd134f5c832" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0fcd7aa-fcc1-43b5-b079-2cb2f2ef000c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0fcd7aa-fcc1-43b5-b079-2cb2f2ef000c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_8c2334bc-16b5-4979-b87a-fc019caba4fe" xlink:href="lh-20221231.xsd#lh_A155SeniorNotesDue2026"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A155SeniorNotesDue2026_8c2334bc-16b5-4979-b87a-fc019caba4fe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_11b101ce-e2d6-4a21-b80e-b03cec70e2a0" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A4.00Seniornotesdue2023_11b101ce-e2d6-4a21-b80e-b03cec70e2a0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_173c772b-4cdc-41c7-a9fa-79d77932c0e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_173c772b-4cdc-41c7-a9fa-79d77932c0e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c3b3949-6843-43a2-95cd-96129f02799b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c3b3949-6843-43a2-95cd-96129f02799b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b786393-bf13-4802-aa96-049aacce13c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b786393-bf13-4802-aa96-049aacce13c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0fb2b95f-a53d-4be4-a117-7fa96c1f5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0fb2b95f-a53d-4be4-a117-7fa96c1f5cf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3e84d14a-e699-4973-aabc-70824b06baec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3e84d14a-e699-4973-aabc-70824b06baec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9dbb741e-6c09-462c-be41-b8b566b628cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9dbb741e-6c09-462c-be41-b8b566b628cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9a45d3ec-327d-4265-af74-4ab1c1d9bb33_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:to="loc_us-gaap_CreditFacilityDomain_9a45d3ec-327d-4265-af74-4ab1c1d9bb33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_16bcff1d-c112-457c-9f54-50a9431c8293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:to="loc_us-gaap_CreditFacilityDomain_16bcff1d-c112-457c-9f54-50a9431c8293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8e85ee8-4321-43da-aee7-5e8587805379_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b8e85ee8-4321-43da-aee7-5e8587805379_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b1359e7-9f4f-4a34-adfe-f4e5ff39c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b1359e7-9f4f-4a34-adfe-f4e5ff39c9dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_00db4283-8bad-403c-8bf9-ec8c991baa95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_00db4283-8bad-403c-8bf9-ec8c991baa95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_f383ddc5-2686-4cda-9b3d-d5d57dd1b404" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2020Member_f383ddc5-2686-4cda-9b3d-d5d57dd1b404" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_2d49a867-88a7-4cfc-9424-66598b6df01a" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_2d49a867-88a7-4cfc-9424-66598b6df01a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_7d9bd780-9ef1-4dd6-93ea-72b8fb481027" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_Seniornotesdue2027Member_7d9bd780-9ef1-4dd6-93ea-72b8fb481027" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member_66f3281a-1dad-4bcf-a799-1cdc5da592cc" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2024Member_66f3281a-1dad-4bcf-a799-1cdc5da592cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_927bfb36-6833-4b61-b925-e37d3333fd8b" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2022Member_927bfb36-6833-4b61-b925-e37d3333fd8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2023Member_203e7f95-b2ad-4fcc-9414-33acd9d4f647" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2023Member_203e7f95-b2ad-4fcc-9414-33acd9d4f647" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_fd4b2602-7606-4a90-a571-023ec629a9d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_fd4b2602-7606-4a90-a571-023ec629a9d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4b83ae38-06bb-4297-9e6a-21abebfd530f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4b83ae38-06bb-4297-9e6a-21abebfd530f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_ee7beed1-e1c4-4144-b19a-118dfe81954b_default" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_ee7beed1-e1c4-4144-b19a-118dfe81954b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d9a390a1-3ddc-43dd-ae22-af4b82f7591c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d9a390a1-3ddc-43dd-ae22-af4b82f7591c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_46887539-688a-4b0f-9ffd-220ac90d1efe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:to="loc_us-gaap_HedgingRelationshipDomain_46887539-688a-4b0f-9ffd-220ac90d1efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3f91b870-a2cf-4541-85fa-59c0945e3799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:to="loc_us-gaap_InterestRateSwapMember_3f91b870-a2cf-4541-85fa-59c0945e3799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_81cb2184-872c-4ca8-8777-03e144072592_default" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:to="loc_lh_SwapTypeDomain_81cb2184-872c-4ca8-8777-03e144072592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:to="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember_0cbf44f3-3c9a-42fe-b485-80c7a6490a0b" xlink:href="lh-20221231.xsd#lh_A2022SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:to="loc_lh_A2022SwapAgreementsMember_0cbf44f3-3c9a-42fe-b485-80c7a6490a0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_1691cfd3-27a4-4185-9072-70d812498f21" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:to="loc_lh_A2018SwapAgreementsMember_1691cfd3-27a4-4185-9072-70d812498f21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended" id="i5261b553a6e5415fab379a0868df937d_PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_087fd69e-b181-46b2-971d-1b06c6611e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_087fd69e-b181-46b2-971d-1b06c6611e76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef0c7bf-6817-40e4-abf7-075185339e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef0c7bf-6817-40e4-abf7-075185339e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b7bfb821-f6b8-4f11-aa59-18c24285abb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b7bfb821-f6b8-4f11-aa59-18c24285abb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d5129a27-0c57-4c0d-9290-b3f5d37b1bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d5129a27-0c57-4c0d-9290-b3f5d37b1bea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_3f2c1153-8b86-4b8c-b861-cadda2ba56e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_Dividends_3f2c1153-8b86-4b8c-b861-cadda2ba56e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c0ed7528-ceca-4a45-9977-d366c0d2cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c0ed7528-ceca-4a45-9977-d366c0d2cd27" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_5f07dd19-d2a9-4b9a-9cd8-fe13d12909d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_5f07dd19-d2a9-4b9a-9cd8-fe13d12909d4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_99b559a7-d49d-4f6d-b604-bc8a1b50d823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_99b559a7-d49d-4f6d-b604-bc8a1b50d823" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_4d2e4cca-4368-48f8-94be-20ccf5f59398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_4d2e4cca-4368-48f8-94be-20ccf5f59398" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_eac884f3-d5a1-43c9-b1ee-b51c6a410817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_eac884f3-d5a1-43c9-b1ee-b51c6a410817" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_db78440b-c970-4eb8-950b-55b931afda2f" xlink:href="lh-20221231.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_db78440b-c970-4eb8-950b-55b931afda2f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_024b0b00-ef0b-45be-baa3-c1df086b6166_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:to="loc_us-gaap_EquityComponentDomain_024b0b00-ef0b-45be-baa3-c1df086b6166_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:to="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5e6c20ac-06d2-4417-896a-3d77f41c4c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5e6c20ac-06d2-4417-896a-3d77f41c4c98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f1ef1d09-cb54-4e7c-9264-1da987dace4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f1ef1d09-cb54-4e7c-9264-1da987dace4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_3d6e797e-8310-478e-b388-ec801d1f7a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_3d6e797e-8310-478e-b388-ec801d1f7a3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_7471fc4b-a53b-41e6-acdd-f46f511bad9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_7471fc4b-a53b-41e6-acdd-f46f511bad9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ASRSettlementMember_54eb81ca-50a2-4006-8e45-5b3059aa3adb" xlink:href="lh-20221231.xsd#lh_A2022ASRSettlementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:to="loc_lh_A2022ASRSettlementMember_54eb81ca-50a2-4006-8e45-5b3059aa3adb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ed09d279-df31-496a-8a0a-458a820e65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:to="loc_us-gaap_SubsequentEventMember_ed09d279-df31-496a-8a0a-458a820e65a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_89597732-6911-4c34-bd0d-5ecfacc459f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_89597732-6911-4c34-bd0d-5ecfacc459f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ShareRepurchasesMember_c8a044c3-637d-4f66-9a2b-912155750a8c" xlink:href="lh-20221231.xsd#lh_A2022ShareRepurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:to="loc_lh_A2022ShareRepurchasesMember_c8a044c3-637d-4f66-9a2b-912155750a8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended" id="i6da39fb540964dee994a60f6664148e2_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_5a96464f-0435-4b93-aa4f-ba628d469388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_5a96464f-0435-4b93-aa4f-ba628d469388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e31b429b-6275-4ca8-b408-0439fb9b9941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e31b429b-6275-4ca8-b408-0439fb9b9941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_d692ca49-0563-47fe-bd6b-7d83d4f5c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_d692ca49-0563-47fe-bd6b-7d83d4f5c17b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dcbfcc85-478e-47ff-9f66-69ad81293113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dcbfcc85-478e-47ff-9f66-69ad81293113" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_efe9381b-3b53-43ae-9d6f-1004e0f4cf47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_efe9381b-3b53-43ae-9d6f-1004e0f4cf47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalTaxLossCarryovers_5659be82-4995-4d9b-92a0-106600fc8f42" xlink:href="lh-20221231.xsd#lh_FederalTaxLossCarryovers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_lh_FederalTaxLossCarryovers_5659be82-4995-4d9b-92a0-106600fc8f42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_4c22d330-3a1b-4ef8-ab38-5ebc322792f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_4c22d330-3a1b-4ef8-ab38-5ebc322792f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_73bdbc56-a1ce-41e3-91d4-1f132aa2b6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_73bdbc56-a1ce-41e3-91d4-1f132aa2b6fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_de8532e6-0b7a-4998-9d31-3104427214b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_de8532e6-0b7a-4998-9d31-3104427214b4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9697d25d-a638-4d5a-a8fc-235bf1f50b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9697d25d-a638-4d5a-a8fc-235bf1f50b46" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_28fe61fd-bdd4-4329-b771-1ab82a5add0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_28fe61fd-bdd4-4329-b771-1ab82a5add0c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_53fbdc73-52a5-4c13-a235-7e6a342ee826_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_53fbdc73-52a5-4c13-a235-7e6a342ee826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_4f17500e-4ff9-4f35-be29-4e5ae9faba65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_4f17500e-4ff9-4f35-be29-4e5ae9faba65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_c3c3595b-c226-4768-8368-e50632b2f3de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_c3c3595b-c226-4768-8368-e50632b2f3de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalLossCarryoverDomain_a948a80e-6256-426e-918b-2abec4fff0b3" xlink:href="lh-20221231.xsd#lh_FederalLossCarryoverDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:to="loc_lh_FederalLossCarryoverDomain_a948a80e-6256-426e-918b-2abec4fff0b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e7db6a07-145b-4c16-89c9-1c72608b1fd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e7db6a07-145b-4c16-89c9-1c72608b1fd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReductionInTaxesMember_7caad680-ce90-455b-9075-2a55114083b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReductionInTaxesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:to="loc_us-gaap_ReductionInTaxesMember_7caad680-ce90-455b-9075-2a55114083b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_d2051c90-6e4e-4622-bee8-5fb4e0b79228_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:to="loc_us-gaap_TaxPeriodDomain_d2051c90-6e4e-4622-bee8-5fb4e0b79228_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:to="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Post2017Member_b1c751ae-ab45-46b5-90af-e4f882817df1" xlink:href="lh-20221231.xsd#lh_Post2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:to="loc_lh_Post2017Member_b1c751ae-ab45-46b5-90af-e4f882817df1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails" xlink:type="extended" id="ie2af27bcbd3940cbad1bdc04cae1291d_STOCKCOMPENSATIONPLANSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90b106af-5336-4f5f-b18d-711d4eef5c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90b106af-5336-4f5f-b18d-711d4eef5c27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7bccc17f-36c6-4c94-a50e-138ecccf9646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7bccc17f-36c6-4c94-a50e-138ecccf9646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_4ebb7259-46dd-4a30-9d95-ab7015c23fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_4ebb7259-46dd-4a30-9d95-ab7015c23fcd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_c2995189-a678-4f7a-a2be-4cd0cc7a52fb" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_c2995189-a678-4f7a-a2be-4cd0cc7a52fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb676002-a3ed-4b1d-97bc-0199de96f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb676002-a3ed-4b1d-97bc-0199de96f2d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d761-baaa-4179-bf8e-90ee5dbee933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d761-baaa-4179-bf8e-90ee5dbee933" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e0ab8be4-a971-4e38-afd5-f924c649eba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e0ab8be4-a971-4e38-afd5-f924c649eba2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35cabe36-7b4f-4939-a60f-f653ee150f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35cabe36-7b4f-4939-a60f-f653ee150f09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59fb4c20-6d17-4897-9ed8-794a6017b096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59fb4c20-6d17-4897-9ed8-794a6017b096" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_13053622-6851-4f08-b0d1-382240528de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_13053622-6851-4f08-b0d1-382240528de8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_35596a5b-dda2-4df6-8940-81be269e4d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_35596a5b-dda2-4df6-8940-81be269e4d5a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_ba4fb637-e7ec-497f-b07d-0ec1f56ad096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_ba4fb637-e7ec-497f-b07d-0ec1f56ad096" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_090bb658-891d-4fff-a80b-d9bb80d9097f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_090bb658-891d-4fff-a80b-d9bb80d9097f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b43fef66-c5f3-4e2b-8ad1-df3fedfd1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b43fef66-c5f3-4e2b-8ad1-df3fedfd1c4e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_684c0c39-d386-49c0-bdf3-5aa1363172a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_684c0c39-d386-49c0-bdf3-5aa1363172a7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e2ce23d9-15ba-42e9-aff1-bf5ba407ea16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e2ce23d9-15ba-42e9-aff1-bf5ba407ea16" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_207a8e24-c3cc-4b04-aafa-328a75ab7ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_207a8e24-c3cc-4b04-aafa-328a75ab7ce8" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_657ef011-f681-470f-b3d3-0c51d285dd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_657ef011-f681-470f-b3d3-0c51d285dd94" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c9260e59-e73b-4218-82db-4bcf5986513c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c9260e59-e73b-4218-82db-4bcf5986513c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca2d2837-2546-4014-a19a-451e0b5429b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca2d2837-2546-4014-a19a-451e0b5429b3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe8d6d59-2017-4f23-9af0-2d501d6b2f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe8d6d59-2017-4f23-9af0-2d501d6b2f42" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ee7f7049-84c6-4568-94bb-c30654fcb3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ee7f7049-84c6-4568-94bb-c30654fcb3bf" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_92c4d852-9438-47e3-8c48-904a9da222b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_92c4d852-9438-47e3-8c48-904a9da222b8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_accf0623-e95e-43fb-a54b-510c208caeec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_accf0623-e95e-43fb-a54b-510c208caeec" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3ee960c2-1959-46cd-81ae-2f0ca4a05ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3ee960c2-1959-46cd-81ae-2f0ca4a05ca6" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_a1eaeceb-1078-40fb-9d66-7a31b28e210d" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_a1eaeceb-1078-40fb-9d66-7a31b28e210d" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_108ec34f-0457-4444-a157-8618c70a20b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_108ec34f-0457-4444-a157-8618c70a20b5" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_804725dd-4825-4048-9d89-9ab31871e1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_804725dd-4825-4048-9d89-9ab31871e1c2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f7364da0-8992-40fc-b821-d992f71d8c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f7364da0-8992-40fc-b821-d992f71d8c28" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_8c81a7ac-4d43-4ecd-b7c8-6952411c9a99" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_8c81a7ac-4d43-4ecd-b7c8-6952411c9a99" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_b83bea41-789f-4d62-a11f-755488918661" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanPercentOfMarketPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_b83bea41-789f-4d62-a11f-755488918661" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanExpense_756454df-0c77-441e-af3d-6f3f150f854a" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanExpense_756454df-0c77-441e-af3d-6f3f150f854a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e5e9baf1-face-460a-b5c6-35652d945e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e5e9baf1-face-460a-b5c6-35652d945e2f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_77d68101-6cfa-49a7-9199-a263b22c2fef" xlink:href="lh-20221231.xsd#lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_77d68101-6cfa-49a7-9199-a263b22c2fef" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_31eaf41b-6114-4b57-92e4-f6730a71628c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_31eaf41b-6114-4b57-92e4-f6730a71628c" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_83f03803-a57c-421a-b618-87b5f6edac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_83f03803-a57c-421a-b618-87b5f6edac4a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_53e4d30a-088b-4847-9840-65ba6896b2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_53e4d30a-088b-4847-9840-65ba6896b2d6" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b52307a-8f5c-4467-a2b1-7c762c9d09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b52307a-8f5c-4467-a2b1-7c762c9d09b7" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_54997357-cc2d-4941-a2be-48d54e36b6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_54997357-cc2d-4941-a2be-48d54e36b6ea" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockPerformanceSharesExpense_a0bb9415-d947-496b-815d-b795338580d0" xlink:href="lh-20221231.xsd#lh_RestrictedStockPerformanceSharesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_RestrictedStockPerformanceSharesExpense_a0bb9415-d947-496b-815d-b795338580d0" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b853714-d1b4-4ec7-9fd4-309502bd21d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b853714-d1b4-4ec7-9fd4-309502bd21d6" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_51608766-5cac-4403-aa15-de043de197d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_51608766-5cac-4403-aa15-de043de197d0" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_5f604fac-a01b-4e00-bd8d-0e5b7a763a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_StockOptionPlanExpense_5f604fac-a01b-4e00-bd8d-0e5b7a763a3f" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockAndPerformanceSharesMember_6fcc2f48-23c2-4d3f-bb17-8d8d1bed677d" xlink:href="lh-20221231.xsd#lh_RestrictedStockAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_lh_RestrictedStockAndPerformanceSharesMember_6fcc2f48-23c2-4d3f-bb17-8d8d1bed677d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0de53b91-64d3-494b-9e25-65e7a176ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0de53b91-64d3-494b-9e25-65e7a176ad33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanMember_04d049b9-e917-40a9-85e5-40fa556b87c8" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_lh_EmployeeStockPurchasePlanMember_04d049b9-e917-40a9-85e5-40fa556b87c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ef664215-821e-48bc-a081-24cfae17a72b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:to="loc_us-gaap_PlanNameDomain_ef664215-821e-48bc-a081-24cfae17a72b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:to="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanMember_9ba20e9e-abcf-4a54-8596-34875f390f97" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:to="loc_lh_EmployeeStockPurchasePlanMember_9ba20e9e-abcf-4a54-8596-34875f390f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0defae29-86d0-4155-8307-1621a24b3f5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_0defae29-86d0-4155-8307-1621a24b3f5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_09a8d091-197f-4e05-8584-0793c9b0ea4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_09a8d091-197f-4e05-8584-0793c9b0ea4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails" xlink:type="extended" id="i9a51764d2adf437693dcde722d7f1f3a_STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_f75ff652-c517-46b0-8402-8aa6fe5efc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_f75ff652-c517-46b0-8402-8aa6fe5efc8d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f0383667-8906-4b38-8ba3-a902193e9b0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_f0383667-8906-4b38-8ba3-a902193e9b0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_d9016035-d24e-461f-b833-c4c2b338cdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_d9016035-d24e-461f-b833-c4c2b338cdc9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/Details" xlink:type="simple" xlink:href="lh-20221231.xsd#Details"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/Details" xlink:type="extended" id="i14a4c026465c420cabc4a2e521308f2c_Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_07be1206-92ca-4ced-bf3d-768f0bae602b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_07be1206-92ca-4ced-bf3d-768f0bae602b" xlink:to="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_48f80844-dbcd-4023-806c-59ab85aa1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:to="loc_us-gaap_LossContingencyNatureDomain_48f80844-dbcd-4023-806c-59ab85aa1b9b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended" id="i9751dd67a4544ed5a3673ca9fc726c04_PENSIONANDPOSTRETIREMENTPLANSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_64e0130f-a52a-4362-9f24-e3a53570b4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_64e0130f-a52a-4362-9f24-e3a53570b4cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_43a90b37-d1eb-4abd-8ecf-bfba447f0708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_43a90b37-d1eb-4abd-8ecf-bfba447f0708" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b49c1ea5-b37a-4f70-a1b2-513c39ba929a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b49c1ea5-b37a-4f70-a1b2-513c39ba929a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2ba8019c-9bc9-4acb-a58a-3dd128471211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2ba8019c-9bc9-4acb-a58a-3dd128471211" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualbasesalary_0b32f8a2-e9bb-44a6-b2e5-bada02fcf3d6" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualbasesalary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_Maximumdeferralpercentageofannualbasesalary_0b32f8a2-e9bb-44a6-b2e5-bada02fcf3d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dd0e548c-6cbc-4095-a320-aa54495caa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dd0e548c-6cbc-4095-a320-aa54495caa2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4da5215a-ab0b-4f80-898f-431d8722dc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4da5215a-ab0b-4f80-898f-431d8722dc65" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1ccdc322-349d-4a80-8acb-173bb415fdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1ccdc322-349d-4a80-8acb-173bb415fdbf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_7b78df74-c5fe-4f82-b7ad-24f99cd01800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_7b78df74-c5fe-4f82-b7ad-24f99cd01800" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1ba7882e-d95e-4551-810d-1a9158978707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1ba7882e-d95e-4551-810d-1a9158978707" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_398a6408-6a70-4e9b-9ee8-114f37c185d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_398a6408-6a70-4e9b-9ee8-114f37c185d9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_f0ff2f7a-454d-4336-84f6-cadec36d81a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_f0ff2f7a-454d-4336-84f6-cadec36d81a2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7538d280-7bb8-462e-a300-f1952f49d931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7538d280-7bb8-462e-a300-f1952f49d931" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6414d1d1-4056-4b39-bd8e-5781c4f35aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6414d1d1-4056-4b39-bd8e-5781c4f35aa6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8c459dab-874e-4e11-aa48-6bc2a7bd2ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8c459dab-874e-4e11-aa48-6bc2a7bd2ecd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_1397d795-c2c9-426a-b5e3-2099264d41ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_1397d795-c2c9-426a-b5e3-2099264d41ee" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_50cdd1fa-64e9-4ef7-bef3-c02269f8a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_50cdd1fa-64e9-4ef7-bef3-c02269f8a367" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0439ffa2-6ced-4fad-93d2-20e66fc6c089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0439ffa2-6ced-4fad-93d2-20e66fc6c089" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2d964f70-bb98-4f20-ab0b-0c2bba5bcb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2d964f70-bb98-4f20-ab0b-0c2bba5bcb6c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_a50482d0-e8eb-4256-acb2-637a722c20f7" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_a50482d0-e8eb-4256-acb2-637a722c20f7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_dfa87760-4238-4246-987e-1b25eb31d151" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_dfa87760-4238-4246-987e-1b25eb31d151" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_160aa98c-3db1-431c-b6aa-66790fce00d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_160aa98c-3db1-431c-b6aa-66790fce00d7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5e8c31ed-88dd-4681-96a0-bdc2e3ab7254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5e8c31ed-88dd-4681-96a0-bdc2e3ab7254" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_47fcd4b8-a9a7-4a6b-8bfd-728951e8de32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_47fcd4b8-a9a7-4a6b-8bfd-728951e8de32" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3d06b0d1-88c2-422c-b8f4-56dd4b00c159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3d06b0d1-88c2-422c-b8f4-56dd4b00c159" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33b0e84d-b287-4757-a5cb-76f32c45a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33b0e84d-b287-4757-a5cb-76f32c45a92a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_a43818e8-ef4b-4dc4-a619-02b5c6a1a159" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_a43818e8-ef4b-4dc4-a619-02b5c6a1a159" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3f9456b2-50ce-4d9e-9a8f-1cafe4d47c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3f9456b2-50ce-4d9e-9a8f-1cafe4d47c37" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_78a2c85a-f47d-4945-9d65-a507d8bd00d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_78a2c85a-f47d-4945-9d65-a507d8bd00d3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_8487ed62-d89e-4774-bac9-d4d1010e9d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_8487ed62-d89e-4774-bac9-d4d1010e9d3f" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fa59b6b0-25bc-4512-956f-c876eb50aa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fa59b6b0-25bc-4512-956f-c876eb50aa8a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_552d2bb9-1da0-4768-a629-469f9d780714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_552d2bb9-1da0-4768-a629-469f9d780714" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_4be13fa5-cf4b-4cbe-8456-d8ae5a3f1d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_4be13fa5-cf4b-4cbe-8456-d8ae5a3f1d0d" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2168ca48-b4c5-486d-b2c7-f26ad7d93c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2168ca48-b4c5-486d-b2c7-f26ad7d93c51" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_4d393e78-da73-439d-a635-efe433fa7f43" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6566cf21-a2fb-407c-b7cd-bbe0dd77f499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0e912d90-a0a6-4704-9e8a-b232e6742fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_74aa5d88-af39-4c67-b2cf-0c9f7f9dc513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_9fa9d61f-94c8-4712-b9f6-8801b6aa23cf" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_9fa9d61f-94c8-4712-b9f6-8801b6aa23cf" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_abe46a4d-ed0a-4265-babe-4b8ecaa75bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ee99db61-0b90-4742-86af-ad76ff4c6915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_70b09c05-76ec-4874-a4ce-812fddbdbf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b9608e11-f274-4fa2-a404-d8c97cfa4618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_76931f0c-b9a1-4f2c-9ea6-507472d030fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_39d27759-b502-4fb5-be18-4a1e4457c03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_89dbcd75-b73f-465c-8271-511beada48b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_288eab79-0f88-41c5-938f-c8993e18d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_801c8add-0677-48d5-8b6c-bfe893b74e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_3b151666-a461-41c1-a334-3f1e128617f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_3b151666-a461-41c1-a334-3f1e128617f3" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_63beac12-e4d5-4e6b-9a1a-0916a41d09de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_894ffc8b-e24b-4083-a269-f530763fa5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_894ffc8b-e24b-4083-a269-f530763fa5b5" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_acef9c72-9b51-4236-a5d2-8693368fccb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e0ac2aab-8aab-4de6-a178-aa5705cfa6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_cf9df5f8-daca-477c-bc78-7f8f705164c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7b9e8d63-0ff3-4535-afdf-fbf83622f090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_92dd45f9-7e6d-4c7c-ae26-1c07c394eb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c7c6ff70-3044-4e3b-8f87-8a6f57baed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_594c1355-1104-43a8-8ac5-dad1930ab441" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_c76e79af-029f-4945-8a31-815eb1d422e7" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_4b59928a-b72c-465b-848b-93aa27a3fe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1e2f1307-80c4-4cb1-8f23-5c091e594b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_d445ac29-16f0-422d-9b3c-1daee403015a" xlink:href="lh-20221231.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_d445ac29-16f0-422d-9b3c-1daee403015a" xlink:type="arc" order="61"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_2fa0fd1c-8bd8-40b6-9c9e-6d59f645dd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_2fa0fd1c-8bd8-40b6-9c9e-6d59f645dd9e" xlink:type="arc" order="62"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_393b31ea-355c-4045-a32f-d1cc81bb0258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_393b31ea-355c-4045-a32f-d1cc81bb0258" xlink:type="arc" order="63"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualcashincentivepay_94b36643-9ed2-43e8-9fac-5fea84e05d33" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualcashincentivepay"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_Maximumdeferralpercentageofannualcashincentivepay_94b36643-9ed2-43e8-9fac-5fea84e05d33" xlink:type="arc" order="64"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_6c08fbed-2492-49de-9dbb-25d6d2e16db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_6c08fbed-2492-49de-9dbb-25d6d2e16db1" xlink:type="arc" order="65"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_4a7a2281-a1ba-4055-9602-d4a19fa1c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_4a7a2281-a1ba-4055-9602-d4a19fa1c5d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9dda76de-0d9c-4286-aada-26815211ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9dda76de-0d9c-4286-aada-26815211ebab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_61003a76-f6a4-48ce-92c6-bd6d3c6c9157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_61003a76-f6a4-48ce-92c6-bd6d3c6c9157" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e6876c00-b24a-4599-a2fe-91998aa15f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e6876c00-b24a-4599-a2fe-91998aa15f69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_875dd096-a875-472f-a813-d740c0c1914a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_875dd096-a875-472f-a813-d740c0c1914a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_20359312-ee7c-4ae2-9e6a-e68fceaeb08e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_20359312-ee7c-4ae2-9e6a-e68fceaeb08e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_2efe92b2-b9e1-464c-a755-9ed67e5f88d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_OtherInvestmentsMember_2efe92b2-b9e1-464c-a755-9ed67e5f88d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_29b305d9-f9d4-4927-834d-57399ea8bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_EquitySecuritiesMember_29b305d9-f9d4-4927-834d-57399ea8bf90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_059bd822-ff3b-4032-94ef-7de6932e7900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_059bd822-ff3b-4032-94ef-7de6932e7900" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_34b9764e-de92-4c86-a8e6-74f51506e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_DebtSecuritiesMember_34b9764e-de92-4c86-a8e6-74f51506e93e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_bc7146f6-341f-48d4-8d2c-488f9ba197f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeAndAnnuityInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_bc7146f6-341f-48d4-8d2c-488f9ba197f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_bf51d2f4-2e3d-4448-9e99-770baad6e12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_RealEstateFundsMember_bf51d2f4-2e3d-4448-9e99-770baad6e12e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_a0f15a0d-d771-4acb-9afa-5775fb681d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_VariableAnnuityMember_a0f15a0d-d771-4acb-9afa-5775fb681d96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_fa0b433a-b04d-4d9b-b4a6-971e22c3a2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_fa0b433a-b04d-4d9b-b4a6-971e22c3a2c3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_0fae8a14-58da-435b-acef-d8ade59c0a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_EquityFundsMember_0fae8a14-58da-435b-acef-d8ade59c0a0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternationalDevelopedMember_9e2116bd-4e51-4f1f-a532-913f21b91e1e" xlink:href="lh-20221231.xsd#lh_InternationalDevelopedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_InternationalDevelopedMember_9e2116bd-4e51-4f1f-a532-913f21b91e1e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UsFixedIncomeMember_708601de-e9a8-4ee9-ba4f-7eaedf5f1593" xlink:href="lh-20221231.xsd#lh_UsFixedIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_UsFixedIncomeMember_708601de-e9a8-4ee9-ba4f-7eaedf5f1593" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MutualFundsMember_ae3b11a8-35b9-49d8-a47f-23d45212706d" xlink:href="lh-20221231.xsd#lh_MutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_MutualFundsMember_ae3b11a8-35b9-49d8-a47f-23d45212706d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6d8d63c-230e-4517-b8d6-e67e94687ef6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6d8d63c-230e-4517-b8d6-e67e94687ef6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cc843bf-c0c6-4f57-a441-a463c00ac1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cc843bf-c0c6-4f57-a441-a463c00ac1af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d719d88c-e448-4455-bd0c-8642a3e7e037_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d719d88c-e448-4455-bd0c-8642a3e7e037_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e60370e0-7885-4af0-aea6-ed7c37e183cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e60370e0-7885-4af0-aea6-ed7c37e183cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2528ba39-7254-4e80-97c6-86eed1376033_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:to="loc_srt_RangeMember_2528ba39-7254-4e80-97c6-86eed1376033_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:to="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9bc778e9-a3fd-47e7-a684-d3b931fdc256" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:to="loc_srt_MaximumMember_9bc778e9-a3fd-47e7-a684-d3b931fdc256" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eecabb4b-e926-4584-806e-d6704de13029" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:to="loc_srt_MinimumMember_eecabb4b-e926-4584-806e-d6704de13029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9ed3c090-777f-48ce-91ea-d0ab4921e9cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9ed3c090-777f-48ce-91ea-d0ab4921e9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_66f9594b-8d3d-4cd3-ade6-96ecfce04101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:to="loc_us-gaap_OtherLiabilitiesMember_66f9594b-8d3d-4cd3-ade6-96ecfce04101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_4e47b1de-e37a-44bc-a9c0-9b469723257a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_4e47b1de-e37a-44bc-a9c0-9b469723257a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_afd89510-0a83-4e22-aff3-afbfa2ce0108_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:to="loc_dei_DocumentDomain_afd89510-0a83-4e22-aff3-afbfa2ce0108_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_fe93aa44-e800-44e1-a938-c9d853bc10fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:to="loc_dei_DocumentDomain_fe93aa44-e800-44e1-a938-c9d853bc10fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_b6377915-51a2-411f-b989-2c8317be75d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:to="loc_us-gaap_RetirementPlanNameDomain_b6377915-51a2-411f-b989-2c8317be75d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UKPlanMember_e5625bee-7eb0-41f7-a40f-71befc8bc5e0" xlink:href="lh-20221231.xsd#lh_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:to="loc_lh_UKPlanMember_e5625bee-7eb0-41f7-a40f-71befc8bc5e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d1e9d06d-c637-4f0d-b43f-b9c27434091f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d1e9d06d-c637-4f0d-b43f-b9c27434091f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0c295a2e-1f90-4e3b-8ee4-f79ae00ffda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_NonUsMember_0c295a2e-1f90-4e3b-8ee4-f79ae00ffda2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8fdc100a-d67c-4479-99dc-27ebf7b73623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_ForeignPlanMember_8fdc100a-d67c-4479-99dc-27ebf7b73623" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8043d35e-4179-498f-93b0-4c27ff690df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8043d35e-4179-498f-93b0-4c27ff690df2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_272b87b4-42b6-4c3e-a9d2-a1c3fd668d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_DomesticPlanMember_272b87b4-42b6-4c3e-a9d2-a1c3fd668d3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_60af08ea-8399-4217-875f-ca19589d0a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:to="loc_us-gaap_ForeignPlanMember_60af08ea-8399-4217-875f-ca19589d0a83" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails" xlink:type="extended" id="i62c192ab4c154008a910cbeac1da6b05_PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f854cc01-fc52-4aca-9a16-449b2ac142db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f854cc01-fc52-4aca-9a16-449b2ac142db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_773d2b10-a5e4-48e8-8812-bf36d74dfcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_773d2b10-a5e4-48e8-8812-bf36d74dfcc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8bdd4dfa-9312-4be0-b379-f267bb9cbcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8bdd4dfa-9312-4be0-b379-f267bb9cbcfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_3fa85ed5-a4c3-427a-8df3-946e54a33ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_3fa85ed5-a4c3-427a-8df3-946e54a33ba2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_80f361dd-ec47-4871-9c3a-66fc2d1a66eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_80f361dd-ec47-4871-9c3a-66fc2d1a66eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e6203fa3-bf99-4789-8df0-2c1057cd4180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e6203fa3-bf99-4789-8df0-2c1057cd4180" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_58b9b49e-baf1-4139-a49f-0527221fcaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_58b9b49e-baf1-4139-a49f-0527221fcaf1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f6428f75-d8af-408d-ae2e-dfce16e917a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f6428f75-d8af-408d-ae2e-dfce16e917a4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d442d98b-f3a4-4a38-a403-623628307d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d442d98b-f3a4-4a38-a403-623628307d6b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0f8ea325-1e1b-4d96-b269-c96f2c3eaf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0f8ea325-1e1b-4d96-b269-c96f2c3eaf2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_9d00a17c-addb-447d-a0f8-1260b4c02c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_9d00a17c-addb-447d-a0f8-1260b4c02c4b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_584ab624-5cf8-4449-8050-ef480a801fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_584ab624-5cf8-4449-8050-ef480a801fae" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b5a526a6-6a28-47d7-b507-7aa12bacac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b5a526a6-6a28-47d7-b507-7aa12bacac7e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_79212ddb-9897-48d7-bb86-4bbf6b34eb92" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_79212ddb-9897-48d7-bb86-4bbf6b34eb92" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_99a5e7f6-0428-462f-86a6-f87f0009b3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_99a5e7f6-0428-462f-86a6-f87f0009b3a8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_08f02c62-b60b-4f99-91e6-c5ca32d37241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_08f02c62-b60b-4f99-91e6-c5ca32d37241" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_3bf21b5e-1251-4cea-a7e8-ec92c0a6a2f3" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_3bf21b5e-1251-4cea-a7e8-ec92c0a6a2f3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8c7f6d30-4208-4ec9-8bfe-5e5ffbb540ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8c7f6d30-4208-4ec9-8bfe-5e5ffbb540ab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_feefbdda-ac64-47e5-a092-326de0447a87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_feefbdda-ac64-47e5-a092-326de0447a87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternationalDevelopedMember_539f17aa-5637-4529-8bfa-3a350e2abbde" xlink:href="lh-20221231.xsd#lh_InternationalDevelopedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_InternationalDevelopedMember_539f17aa-5637-4529-8bfa-3a350e2abbde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_f6f938c3-e134-4af4-b7bb-41a1e6f1b764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_EquityFundsMember_f6f938c3-e134-4af4-b7bb-41a1e6f1b764" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_7f1bb9d3-5739-433a-801f-0437a6902257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_RealEstateFundsMember_7f1bb9d3-5739-433a-801f-0437a6902257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_d2c39fcf-0e11-40d1-864d-1f9355764138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeAndAnnuityInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_d2c39fcf-0e11-40d1-864d-1f9355764138" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MutualFundsMember_6a39ee9d-c774-4a28-aea0-6c6003e825ce" xlink:href="lh-20221231.xsd#lh_MutualFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_MutualFundsMember_6a39ee9d-c774-4a28-aea0-6c6003e825ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9e6bf4f4-3db4-4ebf-82e6-d29b70ca9646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_EquitySecuritiesMember_9e6bf4f4-3db4-4ebf-82e6-d29b70ca9646" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_190e23ef-d5a1-4927-963a-6c2462132709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_190e23ef-d5a1-4927-963a-6c2462132709" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_26180b17-fa44-49e5-b13a-93b108ec817d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_DebtSecuritiesMember_26180b17-fa44-49e5-b13a-93b108ec817d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_e680678f-3bc3-4ddd-ade5-18cb756e65ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_OtherInvestmentsMember_e680678f-3bc3-4ddd-ade5-18cb756e65ab" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UsFixedIncomeMember_296c5408-4d9d-41a9-8e76-47c70eb755c7" xlink:href="lh-20221231.xsd#lh_UsFixedIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_UsFixedIncomeMember_296c5408-4d9d-41a9-8e76-47c70eb755c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_cd71435a-1184-48dd-b739-3534f91209c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_cd71435a-1184-48dd-b739-3534f91209c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0c853fb-7066-4bad-9bb5-71e3e47fe034_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:to="loc_srt_RangeMember_f0c853fb-7066-4bad-9bb5-71e3e47fe034_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:to="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_63f325bf-485e-4f4c-8034-b0d4055fc6d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:to="loc_srt_MinimumMember_63f325bf-485e-4f4c-8034-b0d4055fc6d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a504ddd9-3e71-415d-bf4d-42c5f1c791fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:to="loc_srt_MaximumMember_a504ddd9-3e71-415d-bf4d-42c5f1c791fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_472e375b-67eb-41a7-80b0-f8a757df8e91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_472e375b-67eb-41a7-80b0-f8a757df8e91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ce2291ca-d4c5-4733-96b6-31e94c362aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:to="loc_us-gaap_DomesticPlanMember_ce2291ca-d4c5-4733-96b6-31e94c362aef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_221fb383-eab9-476d-9a8e-8339c9e2f2f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_221fb383-eab9-476d-9a8e-8339c9e2f2f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_20768ebf-007b-41fb-9cf4-cdff9a3e91ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_20768ebf-007b-41fb-9cf4-cdff9a3e91ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a749ba06-54da-432b-a4ee-206512607500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a749ba06-54da-432b-a4ee-206512607500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e0f296a5-7c7b-48a3-bf36-fd4c671b0181_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e0f296a5-7c7b-48a3-bf36-fd4c671b0181_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashBalanceRetirementPlanMember_e0b191ff-7f11-4b97-a1ba-507006f499f1" xlink:href="lh-20221231.xsd#lh_CashBalanceRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:to="loc_lh_CashBalanceRetirementPlanMember_e0b191ff-7f11-4b97-a1ba-507006f499f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a7335fa3-fc74-40ca-859b-a4898a4d2e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a7335fa3-fc74-40ca-859b-a4898a4d2e7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_979f60bd-3391-4c8e-a34b-d0fb225be3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_979f60bd-3391-4c8e-a34b-d0fb225be3af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_ca823a2e-4591-462e-abe2-d0662db33783" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_ca823a2e-4591-462e-abe2-d0662db33783" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2d62cb96-88e1-465e-b595-e43db5201462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2d62cb96-88e1-465e-b595-e43db5201462" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0cf0db60-06c1-40f4-a04b-4f4d723b37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0cf0db60-06c1-40f4-a04b-4f4d723b37bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2e3aace0-b570-49be-ae27-27346837dced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2e3aace0-b570-49be-ae27-27346837dced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2e3aace0-b570-49be-ae27-27346837dced_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9fd7093d-2ac8-4dd5-8ae0-b42871d25be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_3d963328-8ce7-47c7-9ca7-9e104078d7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_abb7763c-7a04-4672-8c97-cf4650e2b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9fd7093d-2ac8-4dd5-8ae0-b42871d25be3" xlink:to="loc_us-gaap_NonUsMember_abb7763c-7a04-4672-8c97-cf4650e2b239" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails" xlink:type="extended" id="idf3698c4487a4e98997836071b2a2c7e_PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cd66c5b0-bd68-4bc9-ab17-b5ec5fb1251d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cd66c5b0-bd68-4bc9-ab17-b5ec5fb1251d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_e5c8579d-48df-47af-921f-e17179ab335d" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_e5c8579d-48df-47af-921f-e17179ab335d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_3e83589d-a32e-46f6-95f0-abad7f4707f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_3e83589d-a32e-46f6-95f0-abad7f4707f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1a18559e-af78-42e6-adfa-2e6eed6a8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1a18559e-af78-42e6-adfa-2e6eed6a8a4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_06f5869f-fad1-47e8-91a5-32d50ef8276f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_06f5869f-fad1-47e8-91a5-32d50ef8276f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_bf5f8bae-d1bb-44ea-a45b-99edfdb470bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_bf5f8bae-d1bb-44ea-a45b-99edfdb470bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_36ab8968-9392-4478-a151-af4e0b9fa38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_36ab8968-9392-4478-a151-af4e0b9fa38d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3b9edaef-0ba8-4195-a6cf-9e2ec6111ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3b9edaef-0ba8-4195-a6cf-9e2ec6111ee7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_99aa0ca3-0be5-4347-b37c-7c4cbb266f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_99aa0ca3-0be5-4347-b37c-7c4cbb266f14" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ea844b94-aa44-485d-b11a-7c5acdcc9133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ea844b94-aa44-485d-b11a-7c5acdcc9133" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c05b9c9c-1bcd-4f49-ac18-f5cca0503302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c05b9c9c-1bcd-4f49-ac18-f5cca0503302" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7371b33b-5156-4010-8cff-3a07db0e1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7371b33b-5156-4010-8cff-3a07db0e1d02" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9ed9416-79d4-453a-a945-dee8e1bc15ae_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:to="loc_srt_RangeMember_f9ed9416-79d4-453a-a945-dee8e1bc15ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1592a065-76f8-4192-a3e6-80b0e8356bee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:to="loc_srt_RangeMember_1592a065-76f8-4192-a3e6-80b0e8356bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b71afd5e-700e-4a70-8013-9f62dffdf4e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b71afd5e-700e-4a70-8013-9f62dffdf4e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4c8f8bb1-1e5b-439a-8e12-2c196a504548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4c8f8bb1-1e5b-439a-8e12-2c196a504548" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9f725f1c-6370-4198-aa9d-f18c5443766d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9f725f1c-6370-4198-aa9d-f18c5443766d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9f50d69b-ca13-488e-825d-261458194777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9f50d69b-ca13-488e-825d-261458194777" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_17d7e80b-3002-449e-80bb-01e20f9d75e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_17d7e80b-3002-449e-80bb-01e20f9d75e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0838c350-8eb8-49b0-a15a-817217559ce7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0838c350-8eb8-49b0-a15a-817217559ce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_045206de-b0cd-4345-b37e-7796365db1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_045206de-b0cd-4345-b37e-7796365db1d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d2d7575f-6f77-47c8-9a9e-56b0f4e315da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d2d7575f-6f77-47c8-9a9e-56b0f4e315da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_028f5d6c-3043-4ad2-9ddc-daae79e5e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_OtherAssetsMember_028f5d6c-3043-4ad2-9ddc-daae79e5e2fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_17c08a83-38fb-4fba-ad26-d2e41f3bdf78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_17c08a83-38fb-4fba-ad26-d2e41f3bdf78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d3a94467-311c-4e5e-a8f9-89d45b104115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:to="loc_us-gaap_NonUsMember_d3a94467-311c-4e5e-a8f9-89d45b104115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f115fcf1-8132-4f6a-8c37-e8c0567bd605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:to="loc_us-gaap_DomesticPlanMember_f115fcf1-8132-4f6a-8c37-e8c0567bd605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UKPlanMember_3fc27b04-1980-4cc2-ae9e-ec6a1f99d389" xlink:href="lh-20221231.xsd#lh_UKPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:to="loc_lh_UKPlanMember_3fc27b04-1980-4cc2-ae9e-ec6a1f99d389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashBalanceRetirementPlanMember_89f942fe-12b6-41c5-b13e-c6f328e9fb92" xlink:href="lh-20221231.xsd#lh_CashBalanceRetirementPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:to="loc_lh_CashBalanceRetirementPlanMember_89f942fe-12b6-41c5-b13e-c6f328e9fb92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_aea80015-bfe8-407c-adc9-c0d90c6b1e85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_aea80015-bfe8-407c-adc9-c0d90c6b1e85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ad72fe83-7bb8-4b66-b45a-47fe58a79538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_EquitySecuritiesMember_ad72fe83-7bb8-4b66-b45a-47fe58a79538" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_eecaad99-4f4b-4fe7-a080-c38070443737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_DebtSecuritiesMember_eecaad99-4f4b-4fe7-a080-c38070443737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_31ab5968-4029-49f0-ba64-788204cebd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_VariableAnnuityMember_31ab5968-4029-49f0-ba64-788204cebd49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_da31a8b3-98f1-4efd-b144-4416fee0d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_RealEstateFundsMember_da31a8b3-98f1-4efd-b144-4416fee0d2c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_9e2a791b-9380-42e6-88d0-ca7729047eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_OtherInvestmentsMember_9e2a791b-9380-42e6-88d0-ca7729047eb2" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails" xlink:type="extended" id="i400cd58985db4147b7c244f102520677_PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e0e50b4f-fcf2-4e64-a687-2d6ba725ff78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e0e50b4f-fcf2-4e64-a687-2d6ba725ff78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_64995d26-5706-4c13-aa4b-3e9787ee035e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_64995d26-5706-4c13-aa4b-3e9787ee035e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_cd98c131-943e-468b-b0e5-e1b4016dc4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_OtherLiabilitiesMember_cd98c131-943e-468b-b0e5-e1b4016dc4c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_9ab7b40c-6b09-40e2-b330-245cc907de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_9ab7b40c-6b09-40e2-b330-245cc907de17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_04084e6b-86c2-412f-959d-ed4515327f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_OtherAssetsMember_04084e6b-86c2-412f-959d-ed4515327f06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a410b094-bee0-4df3-b15f-fc1bd59482f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a410b094-bee0-4df3-b15f-fc1bd59482f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_58bedf51-45d7-45d0-8d0c-99accbe5bd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:to="loc_us-gaap_DomesticPlanMember_58bedf51-45d7-45d0-8d0c-99accbe5bd1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0bbef703-599e-4356-9ae5-819791b8fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:to="loc_us-gaap_NonUsMember_0bbef703-599e-4356-9ae5-819791b8fdf0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended" id="ia404766f36574f298fc4b4340afc7f82_FAIRVALUEMEASUREMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut_ebcd9516-1714-434b-b90e-d6e1cf59d35f" xlink:href="lh-20221231.xsd#lh_IncreaseDecreaseInNoncontrollingInterestPut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut_ebcd9516-1714-434b-b90e-d6e1cf59d35f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7e5b4963-4953-455a-837e-a3ce6f802f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7e5b4963-4953-455a-837e-a3ce6f802f5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_7ed0ba1e-379d-48c2-af10-22ca8698767a" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_7ed0ba1e-379d-48c2-af10-22ca8698767a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_57d39d20-5a89-4b9c-8ca2-aaa172099f74" xlink:href="lh-20221231.xsd#lh_SeniorNotesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_SeniorNotesFairValue_57d39d20-5a89-4b9c-8ca2-aaa172099f74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_63a48ab0-77c5-4e77-a88e-1a3be61be324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_63a48ab0-77c5-4e77-a88e-1a3be61be324" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_09e39e89-aede-4456-9c68-e5f0e221633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_09e39e89-aede-4456-9c68-e5f0e221633d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_d3a47a3d-afaf-428b-8c7d-64c29fe24bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_d3a47a3d-afaf-428b-8c7d-64c29fe24bc1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4c88e83c-d9a6-4dfd-aec5-a77bae731c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4c88e83c-d9a6-4dfd-aec5-a77bae731c00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c99825ad-4d4e-4030-9aed-f0a1e1686d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c99825ad-4d4e-4030-9aed-f0a1e1686d74" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_9e276a66-1582-49ea-957c-be8cb83b4712" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_9e276a66-1582-49ea-957c-be8cb83b4712" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ba2a3d50-11ad-4da7-8764-08beca399540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ba2a3d50-11ad-4da7-8764-08beca399540" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_18633307-2a81-45a1-a8b8-2bf1e11adb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_18633307-2a81-45a1-a8b8-2bf1e11adb74" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_4918b25b-b0cc-4cf1-b248-b6e1b43f4f3e" xlink:href="lh-20221231.xsd#lh_Contingentconsiderationadjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_Contingentconsiderationadjustment_4918b25b-b0cc-4cf1-b248-b6e1b43f4f3e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_31ffd714-df3e-4733-a33b-bb5101df1bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_DerivativeNotionalAmount_31ffd714-df3e-4733-a33b-bb5101df1bd7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10284273-b683-44cd-8069-e0c9fb5ee724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10284273-b683-44cd-8069-e0c9fb5ee724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0be3d491-222e-4220-a6d0-d2b949d52901_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0be3d491-222e-4220-a6d0-d2b949d52901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e4e16a0b-0829-4fd5-821d-84c5c7b6ddc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e4e16a0b-0829-4fd5-821d-84c5c7b6ddc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74064cc8-edf2-4f24-bade-06e68096246a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74064cc8-edf2-4f24-bade-06e68096246a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_228fc3ca-0d3e-494a-8935-410b2b44460a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_228fc3ca-0d3e-494a-8935-410b2b44460a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_16063f83-00f3-439a-9ed7-d3b772692529_default" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:to="loc_lh_SwapTypeDomain_16063f83-00f3-439a-9ed7-d3b772692529_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:to="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_6e37b505-fb1c-45b2-9450-b812a14f5df0" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:to="loc_lh_A2018SwapAgreementsMember_6e37b505-fb1c-45b2-9450-b812a14f5df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c97e83f0-e090-41a0-aea7-74fdbb34f809_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c97e83f0-e090-41a0-aea7-74fdbb34f809_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_f2825357-c741-4ce3-a23a-c2e09a2f123a" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:to="loc_lh_SeniorNotesDue2022Member_f2825357-c741-4ce3-a23a-c2e09a2f123a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails" xlink:type="extended" id="i4912bb5a4fb14c0fbc2ed3bc22c14624_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_34d138b5-b758-434e-8f99-c6bf78b3b6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_34d138b5-b758-434e-8f99-c6bf78b3b6f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_453466a3-7c6f-4a98-aa47-ddc3879be9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_453466a3-7c6f-4a98-aa47-ddc3879be9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09639321-69ed-49dc-b1ba-e04af33c7c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09639321-69ed-49dc-b1ba-e04af33c7c86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_62db6525-b9d4-4d03-9784-34bcd3de5e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_62db6525-b9d4-4d03-9784-34bcd3de5e0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b5a5a9ac-3e0f-4229-ae9b-590a403d1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b5a5a9ac-3e0f-4229-ae9b-590a403d1e7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0315f5b8-818b-4f55-bba3-58554d800bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0315f5b8-818b-4f55-bba3-58554d800bef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_647fa14a-848a-4283-b7ea-b0def54b521f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_647fa14a-848a-4283-b7ea-b0def54b521f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_3db0d232-ef52-4182-9752-5f5bb6632694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_3db0d232-ef52-4182-9752-5f5bb6632694" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_4a9751c0-dd8e-432a-bb4e-97c73cc81292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_4a9751c0-dd8e-432a-bb4e-97c73cc81292" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_7f17927f-9511-40bf-9272-868457da67d4" xlink:href="lh-20221231.xsd#lh_GainRecognizedonExitofInterestRateSwapArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_7f17927f-9511-40bf-9272-868457da67d4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_97a3d077-a177-455f-a2d0-5fb7b40f3fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_97a3d077-a177-455f-a2d0-5fb7b40f3fc7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_03524293-5dc2-411d-9e8b-9b6daf28a783_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_03524293-5dc2-411d-9e8b-9b6daf28a783_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_477b872f-0f59-4e29-b2cb-aa81317a9dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_477b872f-0f59-4e29-b2cb-aa81317a9dcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_083db11c-3d7c-4242-a8a8-599cb442b1a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_083db11c-3d7c-4242-a8a8-599cb442b1a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_0cfcad01-d18d-4669-8507-cbfcdda1eb37" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:to="loc_lh_SeniorNotesDue2020Member_0cfcad01-d18d-4669-8507-cbfcdda1eb37" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a2647ab8-7103-45c1-aea6-1d195835c998_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a2647ab8-7103-45c1-aea6-1d195835c998_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_aad1caa0-61b9-4357-99c4-3c586ca61ccd" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_SeniorNotesDue2020Member_aad1caa0-61b9-4357-99c4-3c586ca61ccd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_9d3a2618-2f7e-4f29-a03f-4fbb6cbead16" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_9d3a2618-2f7e-4f29-a03f-4fbb6cbead16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_19756d8b-2c6d-4bba-8c17-ebf96b21e856" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_Seniornotesdue2027Member_19756d8b-2c6d-4bba-8c17-ebf96b21e856" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_721f8ac2-a784-4b57-8784-de7431d0c1f0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:to="loc_srt_EnergyDomain_721f8ac2-a784-4b57-8784-de7431d0c1f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_519ad7d8-5d30-4cb8-879b-cabe75cc48bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:to="loc_srt_EnergyDomain_519ad7d8-5d30-4cb8-879b-cabe75cc48bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5d5735a1-0caa-4188-adcd-377f8a5c72ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5d5735a1-0caa-4188-adcd-377f8a5c72ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fefe2ef3-986b-46a9-a254-c69339327e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:to="loc_us-gaap_InterestRateSwapMember_fefe2ef3-986b-46a9-a254-c69339327e14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_985716d0-0f95-4761-adb8-d59c84d08a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:to="loc_us-gaap_CurrencySwapMember_985716d0-0f95-4761-adb8-d59c84d08a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_a69e7d4d-be54-4be9-a83b-12e8118535c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:to="loc_us-gaap_PositionDomain_a69e7d4d-be54-4be9-a83b-12e8118535c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_afe262c7-b1f7-43f7-a9ed-7f711ce0d927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:to="loc_us-gaap_PositionDomain_afe262c7-b1f7-43f7-a9ed-7f711ce0d927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_41130e00-8d5a-44dc-8886-8f9316e5c63b_default" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:to="loc_lh_SwapTypeDomain_41130e00-8d5a-44dc-8886-8f9316e5c63b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:to="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_a59ccc7c-fe8c-4012-9662-2831ecb61dce" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:to="loc_lh_A2018SwapAgreementsMember_a59ccc7c-fe8c-4012-9662-2831ecb61dce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails" xlink:type="extended" id="ic6e05eba61b84ac391c1f933b196cd68_DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_1b0ead8b-f70d-4e1e-9bd2-b618451d88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_1b0ead8b-f70d-4e1e-9bd2-b618451d88f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_193efc13-09a7-4145-8d79-03dcf7a0f194" xlink:href="lh-20221231.xsd#lh_GainRecognizedonExitofInterestRateSwapArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_193efc13-09a7-4145-8d79-03dcf7a0f194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_9595d27d-c08f-4dfb-be15-186da8e53001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_9595d27d-c08f-4dfb-be15-186da8e53001" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_a48abbd2-c0a5-4f21-9400-c0082045ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_a48abbd2-c0a5-4f21-9400-c0082045ce97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6bc706b3-4a59-47fc-8d0e-818e9a2e069c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6bc706b3-4a59-47fc-8d0e-818e9a2e069c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_57358ab0-fd20-437f-ba4e-b76336361ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_57358ab0-fd20-437f-ba4e-b76336361ebe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_07912590-5fe8-424c-93a9-29e2e728c3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_07912590-5fe8-424c-93a9-29e2e728c3e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_51a42507-4ac6-43d3-9775-141a63ca21d5" xlink:href="lh-20221231.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_51a42507-4ac6-43d3-9775-141a63ca21d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_61b56b23-f164-4956-899b-4c31234a46dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_61b56b23-f164-4956-899b-4c31234a46dd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9080d98d-a865-4171-b26f-b6c37715a831_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9080d98d-a865-4171-b26f-b6c37715a831_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_62c6ef83-fa76-427c-a146-af575c4fe444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:to="loc_us-gaap_InterestRateSwapMember_62c6ef83-fa76-427c-a146-af575c4fe444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_55ec59a1-b4c0-453a-a616-700a967fa64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:to="loc_us-gaap_CurrencySwapMember_55ec59a1-b4c0-453a-a616-700a967fa64f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b5689741-3a12-4f8b-8997-761b3cf6d84b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b5689741-3a12-4f8b-8997-761b3cf6d84b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_6e9c1742-5d1b-4482-9268-cb8cd38e7ab3" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:to="loc_lh_SeniorNotesDue2020Member_6e9c1742-5d1b-4482-9268-cb8cd38e7ab3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_facf0874-80fe-4cb5-8df5-2a93784de7f9" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_facf0874-80fe-4cb5-8df5-2a93784de7f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="ib3bb3a59ee3a40b2b05a43d47c1df51c_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_63dbc058-fdc7-42c6-b34a-6abd384a39e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_63dbc058-fdc7-42c6-b34a-6abd384a39e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1b961fe7-ad62-4c49-8252-eb24e5c70bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:to="loc_us-gaap_Depreciation_1b961fe7-ad62-4c49-8252-eb24e5c70bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8f449e17-043e-4dca-b7b3-ef7d8234bd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_Revenues_8f449e17-043e-4dca-b7b3-ef7d8234bd0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ab122fb1-e5f6-46a1-8643-b92f8128f2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ab122fb1-e5f6-46a1-8643-b92f8128f2a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6bc11f7c-da19-4668-a210-71003704221e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6bc11f7c-da19-4668-a210-71003704221e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_d2064850-97a8-47a8-bd74-71ea2d3448be" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_lh_NetRestructuringCharges_d2064850-97a8-47a8-bd74-71ea2d3448be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22a9970b-7d42-42a0-9f13-54f6bd8770f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22a9970b-7d42-42a0-9f13-54f6bd8770f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_6f1e6712-b5f4-42cf-a612-b52349eac9e6" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_6f1e6712-b5f4-42cf-a612-b52349eac9e6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cb51cd5a-c475-4513-86ec-f4c81a0000f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cb51cd5a-c475-4513-86ec-f4c81a0000f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fd500572-aebb-4657-9504-b0519a867611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_ProfitLoss_fd500572-aebb-4657-9504-b0519a867611" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6809e5ab-bf8e-4314-96f3-e7504e5d9878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6809e5ab-bf8e-4314-96f3-e7504e5d9878" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ec22941-00da-4ba5-8f33-044a8e3416f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_NetIncomeLoss_0ec22941-00da-4ba5-8f33-044a8e3416f1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_52f1a9d5-128e-455d-88f7-a10300f8cc6f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:to="loc_srt_SegmentGeographicalDomain_52f1a9d5-128e-455d-88f7-a10300f8cc6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:to="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_2c5c3b76-5cf0-48ee-b905-e00f90605558" xlink:href="lh-20221231.xsd#lh_OthercountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_lh_OthercountriesMember_2c5c3b76-5cf0-48ee-b905-e00f90605558" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_4d5eacea-e23e-41ef-9a5d-a92e6fcaca28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_srt_NorthAmericaMember_4d5eacea-e23e-41ef-9a5d-a92e6fcaca28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_18b1c21d-4c9c-431f-84da-cc193a893c24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_srt_EuropeMember_18b1c21d-4c9c-431f-84da-cc193a893c24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f13be9ec-701c-4e19-89ac-973df8a14cda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:to="loc_us-gaap_SegmentDomain_f13be9ec-701c-4e19-89ac-973df8a14cda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:to="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_cc5fe79a-05ed-47c2-935d-63200cb6c9d2" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_lh_DiagnosticsMember_cc5fe79a-05ed-47c2-935d-63200cb6c9d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_0b93126b-f35f-45e1-aaea-974995fa831e" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_lh_DrugDevelopmentMember_0b93126b-f35f-45e1-aaea-974995fa831e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_3d4bddcc-9435-463b-a7bf-2213e5141684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_us-gaap_CorporateMember_3d4bddcc-9435-463b-a7bf-2213e5141684" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_67dc9a20-23cf-4c8f-b00a-7d06f651332e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:to="loc_srt_ConsolidationItemsDomain_67dc9a20-23cf-4c8f-b00a-7d06f651332e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:to="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e75a46af-94d8-45d6-acb1-2b2ab3e5a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:to="loc_us-gaap_OperatingSegmentsMember_e75a46af-94d8-45d6-acb1-2b2ab3e5a02d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_cef538b3-697e-441d-a040-001877182a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:to="loc_us-gaap_IntersegmentEliminationMember_cef538b3-697e-441d-a040-001877182a48" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="extended" id="i057d94e0be3e4857b731a72ec9c18b28_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_eef2742c-d07a-4f91-b4dd-f9f1d332b592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_eef2742c-d07a-4f91-b4dd-f9f1d332b592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_86eb203b-1f2d-45d6-b2a2-367a6e3c06fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_86eb203b-1f2d-45d6-b2a2-367a6e3c06fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_ec770424-396d-4842-90b1-318848f8d5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_ec770424-396d-4842-90b1-318848f8d5e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_e42c0258-20dc-4152-a4cb-eb6883d3e91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_e42c0258-20dc-4152-a4cb-eb6883d3e91a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_13b7c1c9-a427-4576-a23f-a7d4da387c6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_13b7c1c9-a427-4576-a23f-a7d4da387c6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_407410e5-76ff-4166-a877-308e2b5d5b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:to="loc_us-gaap_SubsequentEventMember_407410e5-76ff-4166-a877-308e2b5d5b16" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>23
<FILENAME>lh-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e76ab3d1-c69b-4b31-a87f-6623731c8966_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_56aebb9e-c902-4c78-ba57-7299b6a159f5_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_44fad62f-0095-4445-b814-38468fc71594_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_cf095a3a-b4b8-425f-b823-aff75f80956d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_7ff884e9-c051-4247-b49e-f62612bbf13f_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_6926494d-d8f6-4f06-bc62-80f51d867ac7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_14e6f121-79a3-4c3b-a504-0da0915cde12_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PerShareAmountAbstract_a746da6e-7256-4260-a240-040c91dfe0ed_terseLabel_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:label id="lab_lh_PerShareAmountAbstract_label_en-US" xlink:label="lab_lh_PerShareAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per Share Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract" xlink:href="lh-20221231.xsd#lh_PerShareAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PerShareAmountAbstract" xlink:to="lab_lh_PerShareAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_645a2fad-6f44-49d0-b8bd-a3a6868e3e94_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_6696dbac-4927-49dd-87cc-c916693cde83_terseLabel_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock plans (in shares)</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_label_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commons Stock Issued During Period Shares Employee Stock Plans</link:label>
    <link:label id="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_documentation_en-US" xlink:label="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:href="lh-20221231.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:to="lab_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_785b4db9-97c5-4275-b8ad-9051f5e7a517_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_813dd6f5-d1f0-4ff0-b6da-6950df147163_verboseLabel_en-US" xlink:label="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current portion of long-term debt</link:label>
    <link:label id="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_label_en-US" xlink:label="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt And Long-Term Debt, Current Maturities</link:label>
    <link:label id="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_documentation_en-US" xlink:label="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt And Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:href="lh-20221231.xsd#lh_ShortTermDebtAndLongTermDebtCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:to="lab_lh_ShortTermDebtAndLongTermDebtCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_5fcdc0ba-da1d-4d62-ba37-f9b4e521277d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax expense/(benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_677819e8-f515-4a27-a5b0-69c743ff0b99_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_fca5feaf-09a6-4521-9c39-3f58cdbfe58d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c14fe34c-b674-41d8-bb10-523e9b63fbfd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e4b521e3-0968-421d-b951-44699b716e31_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_eb884072-b78c-4760-a4c6-9ee693ff251b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_8301e7da-e175-44a4-8079-d1972e517362_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_cd005e63-f5c7-4a07-ba6f-d68dcf26d422_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_TotalShortandLongTermDebtIssuanceCosts_8f53e28d-1b52-427a-9013-1646a0882196_terseLabel_en-US" xlink:label="lab_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Short and Long Term Debt Issuance Costs</link:label>
    <link:label id="lab_lh_TotalShortandLongTermDebtIssuanceCosts_label_en-US" xlink:label="lab_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Short and Long Term Debt Issuance Costs</link:label>
    <link:label id="lab_lh_TotalShortandLongTermDebtIssuanceCosts_documentation_en-US" xlink:label="lab_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Short and Long Term Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:href="lh-20221231.xsd#lh_TotalShortandLongTermDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:to="lab_lh_TotalShortandLongTermDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ConsolidatedStatementsofOperationsAbstract_6c919105-683b-4d47-a99b-699258e4532f_terseLabel_en-US" xlink:label="lab_lh_ConsolidatedStatementsofOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</link:label>
    <link:label id="lab_lh_ConsolidatedStatementsofOperationsAbstract_label_en-US" xlink:label="lab_lh_ConsolidatedStatementsofOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</link:label>
    <link:label id="lab_lh_ConsolidatedStatementsofOperationsAbstract_documentation_en-US" xlink:label="lab_lh_ConsolidatedStatementsofOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Statements of Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConsolidatedStatementsofOperationsAbstract" xlink:href="lh-20221231.xsd#lh_ConsolidatedStatementsofOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract" xlink:to="lab_lh_ConsolidatedStatementsofOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_b9a49e02-a642-4cad-bc75-b1177375252b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_2762e34c-85f2-43ef-bd7e-75cadfc29ee6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net share settlement tax payments from issuance of stock to employees</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_49f39205-85a1-446d-af08-c37f9c6a24d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_4f398485-dd2c-4cdb-b0a8-7e287b3e1d92_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3d342a5d-1c7f-452d-bf98-9943357b0063_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0db65228-b84b-43d2-b6b5-d023b2cee6e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InterestPaidInCash_5e4291da-31b8-4bf3-9f36-2faec9caa11e_terseLabel_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_lh_InterestPaidInCash_label_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid In Cash</link:label>
    <link:label id="lab_lh_InterestPaidInCash_documentation_en-US" xlink:label="lab_lh_InterestPaidInCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of cash paid during the current period for interest owed on money borrowed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash" xlink:href="lh-20221231.xsd#lh_InterestPaidInCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InterestPaidInCash" xlink:to="lab_lh_InterestPaidInCash" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum_fb187eed-c72e-417c-aae0-4f01a83427b3_terseLabel_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software maximum</link:label>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum_label_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software maximum</link:label>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum_documentation_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwaremaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:to="lab_lh_Propertyplantandequipmentusefullifesoftwaremaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_2361d475-3edf-498b-ae9a-39e1e86dc8c0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (in hundredths)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_15292d28-728c-418a-a10c-fdca8b0b7ecd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_5db102ba-e797-4fed-8a46-74f3c3c1e0b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_4f134a02-c789-410b-95bb-0df7334cb13f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8d920338-bfbc-44af-80f4-4f5e61d089d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_e1695560-9b3c-4504-b377-f87ba32e866d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_537a0b72-fd70-40a4-a4b0-ce36ebfc3eb1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_961a636a-4b84-488e-9a21-9a212ce9a52a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_ac13d346-cb3d-443b-b020-a72f3fe08832_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_eafe9ce0-dca1-4f8c-a09a-4ba7e2018b64_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_1e878bc3-80ae-4c96-8adf-21f05ec2a991_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_beda0024-d6c2-41fb-8c91-1f66ed8fe508_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_757e3cb1-8546-4fb7-8073-8c0d74d3654d_terseLabel_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_label_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMinimum_documentation_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SalesCommissionAmortizationPeriodMinimum" xlink:to="lab_lh_SalesCommissionAmortizationPeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d9281d36-31d2-4752-8317-1b5a1f711b02_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ThirdpartyMember_8a7dbe15-3e75-4725-bb2f-553839185771_terseLabel_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_label_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:label id="lab_lh_ThirdpartyMember_documentation_en-US" xlink:label="lab_lh_ThirdpartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember" xlink:href="lh-20221231.xsd#lh_ThirdpartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ThirdpartyMember" xlink:to="lab_lh_ThirdpartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_30f86af2-9067-4c60-b80c-ff03c4674338_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_beb789a4-804d-4cc4-8d47-5c0fb980a428_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_ccbda770-4df3-43b4-b267-f7c6ae995594_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_d8df0adc-7bbf-4d6d-ae4d-c3e3a7e2773d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_c40ac9fe-c4f5-49c7-b913-59dc8a57cb94_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_aaec24a7-4762-45a5-b3ff-04c312c4d384_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ebf8051e-c20f-4f6e-a6dc-9f44f670ff06_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_d6c41e0d-b318-46a3-940d-267900d6953d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ShortTermLeaseMember_f070d251-a5de-4251-b18f-a5522f1c62d7_terseLabel_en-US" xlink:label="lab_lh_ShortTermLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease</link:label>
    <link:label id="lab_lh_ShortTermLeaseMember_label_en-US" xlink:label="lab_lh_ShortTermLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease [Member]</link:label>
    <link:label id="lab_lh_ShortTermLeaseMember_documentation_en-US" xlink:label="lab_lh_ShortTermLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermLeaseMember" xlink:href="lh-20221231.xsd#lh_ShortTermLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ShortTermLeaseMember" xlink:to="lab_lh_ShortTermLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_c6b5862c-08e8-400e-aea8-1d137677e3db_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_09a5aa0e-8627-4d63-839f-3ca10ea4298f_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLoss_0323fa3f-fece-41a2-a35d-de9dd5b27180_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_AllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLoss" xlink:to="lab_lh_AllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_cf8927a0-2e32-4c0a-9826-1ba26054456d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in reserve for tax positions taken in the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6efeceb3-ee94-4d32-a43f-7f05eed930d2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2885564c-58ed-42d5-bdf7-d638ebc0fd3f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal statutory tax rate reconciliation [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_fcb6b3df-fdf1-43a1-a1a6-5d25796e6245_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_34f85a49-6d05-46a3-ae3c-fc3c8e1a39df_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UsFixedIncomeMember_a6ef0a0f-e1b6-4b79-b38c-8617d18bc521_terseLabel_en-US" xlink:label="lab_lh_UsFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. fixed income [Member]</link:label>
    <link:label id="lab_lh_UsFixedIncomeMember_label_en-US" xlink:label="lab_lh_UsFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Us Fixed Income [Member]</link:label>
    <link:label id="lab_lh_UsFixedIncomeMember_documentation_en-US" xlink:label="lab_lh_UsFixedIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plan assets invested in the U.S. fixed income securities category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UsFixedIncomeMember" xlink:href="lh-20221231.xsd#lh_UsFixedIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UsFixedIncomeMember" xlink:to="lab_lh_UsFixedIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_2d161dd7-82cf-44d2-9770-3a329566e213_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_6f1bc5b1-cd9e-4fbb-99bd-e5a1c8390150_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_b28b9098-5e92-4435-bc20-ade11d488959_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_5208a6d2-26a4-4ed4-973e-0aaf32613e28_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_fa9aeedf-f02f-4e99-b16e-928e4d9caef4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_8f069467-957c-40cd-9535-802ec3b4321e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_7f507244-ae08-40fa-83ef-e376cabb1d4f_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_10d5f926-7f69-448b-be6a-5eea1192f79a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="lab_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_bf47f4f1-a5e9-40ca-b7e8-0306abdd4d20_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_f492c367-2d28-4796-bf5c-73a1c7362609_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_886bf236-e18c-48d1-99ed-f3e0ae73eca2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncrementalCommonSharesAttributableToStockOptions_c6623079-20fa-4b8c-af19-1c9a0bcda07d_terseLabel_en-US" xlink:label="lab_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of stock options (in shares)</link:label>
    <link:label id="lab_lh_IncrementalCommonSharesAttributableToStockOptions_label_en-US" xlink:label="lab_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Stock Options</link:label>
    <link:label id="lab_lh_IncrementalCommonSharesAttributableToStockOptions_documentation_en-US" xlink:label="lab_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate awards of stock options and nonvested options to be issued to an employee under a stock option arrangement. Such stock options shall be considered to be outstanding as of the grant date for purposes of computing diluted earnings per share even though their exercise may be contingent upon vesting. Those options are included in the diluted Earnings Per Share (EPS) computation even if the employee may not receive (or be able to sell) the stock until some future date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:href="lh-20221231.xsd#lh_IncrementalCommonSharesAttributableToStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:to="lab_lh_IncrementalCommonSharesAttributableToStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_a77fbbb5-5132-4625-b598-cffd7145f5e3_terseLabel_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of Senior Notes Mature During Q4 2020</link:label>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_label_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of Senior Notes Mature During Q4 2020</link:label>
    <link:label id="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020_documentation_en-US" xlink:label="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of Senior Notes Mature During Q4 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:href="lh-20221231.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:to="lab_lh_BalanceOfSeniorNotesMatureDuringQ42020" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c4905d3d-7e06-4cab-bf54-b466d5a8346b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_cf8f77f6-43c0-4d5f-8f78-45a0f75865bc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term of options outstanding (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2023Member_3e6ca449-7119-498a-977f-2b6107808b9d_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2023</link:label>
    <link:label id="lab_lh_SeniorNotesDue2023Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2023 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2023Member" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2023Member" xlink:to="lab_lh_SeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_81a9ad05-63f8-42c0-8008-89e18e9d9378_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_71cbf615-3298-4ca1-b779-2ce720149533_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_04462a03-ebf8-4393-9213-910a8a9927db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_898b6af3-c9dd-4e80-b1d4-a86e920bf208_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_3c1837ab-5d90-4b17-9cf6-8e32da40f7b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net benefit plan adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_60f259fa-6cc5-499a-8704-9081d22673f6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b3768fab-380e-4731-8874-28a4e7423114_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f0a9dcdf-a347-4d57-99cb-3a61be2816b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DeferredTaxAssetRightOfUseAsset_60ad306c-05bd-4c06-a778-f736abec0ee5_terseLabel_en-US" xlink:label="lab_lh_DeferredTaxAssetRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Right Of Use Asset</link:label>
    <link:label id="lab_lh_DeferredTaxAssetRightOfUseAsset_label_en-US" xlink:label="lab_lh_DeferredTaxAssetRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Right Of Use Asset</link:label>
    <link:label id="lab_lh_DeferredTaxAssetRightOfUseAsset_documentation_en-US" xlink:label="lab_lh_DeferredTaxAssetRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredTaxAssetRightOfUseAsset" xlink:href="lh-20221231.xsd#lh_DeferredTaxAssetRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DeferredTaxAssetRightOfUseAsset" xlink:to="lab_lh_DeferredTaxAssetRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_724153db-3599-4849-932c-5a2f54926e6e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_2e7b7628-6a64-4675-a011-5b7044a939d6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_5ab1091f-a516-4e60-88ba-9ee90ac7ecdb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_032ce071-9e28-4c44-b3f8-07af23c5e0bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b2266353-25b2-4eca-af2e-cfb8d16d586b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_f6bdfd94-7c74-46f4-b447-3c79c8a23c6b_terseLabel_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_c42e0161-50c0-49c5-8dcb-0129da374acf_netLabel_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, licenses and technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_c843036f-b70d-4d63-9e18-e70c92cffb5b_verboseLabel_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, licenses and technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_label_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents, Licenses And Technology [Member]</link:label>
    <link:label id="lab_lh_PatentsLicensesAndTechnologyMember_documentation_en-US" xlink:label="lab_lh_PatentsLicensesAndTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PatentsLicensesAndTechnologyMember" xlink:to="lab_lh_PatentsLicensesAndTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_03673f75-c094-44ba-a6cc-07374eb73b3d_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_label_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:label id="lab_lh_CreditFacilityOptiontoIncrease_documentation_en-US" xlink:label="lab_lh_CreditFacilityOptiontoIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility Option to Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease" xlink:href="lh-20221231.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityOptiontoIncrease" xlink:to="lab_lh_CreditFacilityOptiontoIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_20c3317a-f87d-4e69-9b4b-b7aeafd3fca9_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_42562584-ca07-4722-b60e-55e65dea5ead_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesFairValue_ba1ff374-6410-4924-8bf1-01470a518784_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair market value of senior notes</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_label_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Fair Value</link:label>
    <link:label id="lab_lh_SeniorNotesFairValue_documentation_en-US" xlink:label="lab_lh_SeniorNotesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue" xlink:href="lh-20221231.xsd#lh_SeniorNotesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesFairValue" xlink:to="lab_lh_SeniorNotesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5ca2c6a9-08b3-4cf1-a3cb-e990ec91f3be_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_262248b0-4d2d-40b6-9952-0687c5414e51_terseLabel_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding common stock repurchase authorization</link:label>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_label_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Authorization Outstanding</link:label>
    <link:label id="lab_lh_CommonStockRepurchaseAuthorizationOutstanding_documentation_en-US" xlink:label="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:href="lh-20221231.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:to="lab_lh_CommonStockRepurchaseAuthorizationOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2109fc40-502e-4921-aad3-999906e9df90_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_7d3ae5e2-caa5-4097-b77f-77be8c379f40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_107de8e0-8c71-4aeb-8339-758625959d6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7ad65c7f-3ad5-4059-ae8f-df8749b3f71f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14498f82-8784-4c29-b3ec-bda58b223c35_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionAxis_528c959d-fa7e-459e-8ae5-a0f52fbee7dc_terseLabel_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:label id="lab_us-gaap_PositionAxis_label_en-US" xlink:label="lab_us-gaap_PositionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionAxis" xlink:to="lab_us-gaap_PositionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_d1fccc45-a8ee-424f-9132-14bf022b5c67_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e49c40b1-68e0-4124-bbe9-b86ea48bb684_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_dc2aab0a-ced5-473d-8a59-3c7ab6e30c47_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1e4cc622-6e03-4d06-b300-be0d51ad426f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_1566c9c4-fadd-4dcf-8673-b13d59b9c2cb_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedBenefitPlanActualAssetAllocation_309122d8-50e4-4462-b3fc-ae2194486425_terseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanActualAssetAllocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actual Asset Allocation</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanActualAssetAllocation_label_en-US" xlink:label="lab_lh_DefinedBenefitPlanActualAssetAllocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actual Asset Allocation</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanActualAssetAllocation_documentation_en-US" xlink:label="lab_lh_DefinedBenefitPlanActualAssetAllocation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Actual Asset Allocation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedBenefitPlanActualAssetAllocation" xlink:to="lab_lh_DefinedBenefitPlanActualAssetAllocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_3810f36b-6726-4ca1-a009-c48c772b9f8d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current tax expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_e80b2745-672d-4380-91c1-2a308ebc7c4d_terseLabel_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_label_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Of Leased Assets</link:label>
    <link:label id="lab_lh_DepreciationAndAmortizationOfLeasedAssets_documentation_en-US" xlink:label="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:href="lh-20221231.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:to="lab_lh_DepreciationAndAmortizationOfLeasedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_905a7a85-7527-43f7-99ef-7f0e1d1c769f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_2185e29e-e8c4-4380-875e-bc5e4ceb02ff_terseLabel_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life of capitalized software costs (in years)</link:label>
    <link:label id="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_label_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software average</link:label>
    <link:label id="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_documentation_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software costs are amortized over the estimated useful life of the underlying system.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:href="lh-20221231.xsd#lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:to="lab_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_858d505e-c840-4bff-b22b-c943ca7cb5c8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3ff388aa-c502-4768-89b3-b4a421f57790_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life, minimum (years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_100c8bba-492d-40ec-bb6d-9cdda9038da9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options cancelled</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6cfb10c6-07f7-4c37-9531-9d2578fd1395_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_6c5d9528-d33e-4ff3-ac66-9f577a4fccae_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges related to severance and other employee costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_79daa7ba-8a9b-47dc-825f-2710d0cae41b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_bde3ee62-7703-454c-94b4-4c5a4c68b72c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_6c367a68-7758-45f2-a768-6616f115afc4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_c238b19e-9dee-4623-bb6c-cfaef313ada8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_311760d0-0ef4-48f4-a26e-a53ef9faece9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_fd9ecb3b-043a-4687-a9b0-cc4b683f042f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_43a2a0c8-495f-47b1-ab2d-3d7d6dd75446_terseLabel_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2020 [Member]</link:label>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_label_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Long Term Notes Due2020 Member</link:label>
    <link:label id="lab_lh_SeniorLongTermNotesDue2020Member_documentation_en-US" xlink:label="lab_lh_SeniorLongTermNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorLongTermNotesDue2020Member" xlink:to="lab_lh_SeniorLongTermNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ClientMember_53540f26-e86c-4039-9a31-38c56d54b2f4_terseLabel_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_label_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:label id="lab_lh_ClientMember_documentation_en-US" xlink:label="lab_lh_ClientMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember" xlink:href="lh-20221231.xsd#lh_ClientMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ClientMember" xlink:to="lab_lh_ClientMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_59870049-12b1-44d8-9991-8bb1eaf18811_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_53ec987e-1e63-4a1f-9d8b-d8be4d8b1b72_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_5bfe91c9-64a7-47cf-8bb7-8c650cea85b4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameDomain" xlink:to="lab_us-gaap_RetirementPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_9b632ee6-aa49-4f74-8398-d78fd5099cbf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_b180c8ec-7bab-413d-880a-44d7ed4715f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ed90ec85-c565-4dd7-acd9-a407e609f130_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_64475b6e-999c-436a-85c9-af35e9a7feca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a2572b85-4924-406f-8b9b-0dd2b9f3b866_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_12b793a9-a9cb-492a-a802-a272240fa248_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_c0a79ae6-9aab-440d-9c9d-7c33a3375582_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.30seniornotesdue2024_21b3b190-de42-4d39-847e-c56aee7ceb2a_terseLabel_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_label_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:label id="lab_lh_A2.30seniornotesdue2024_documentation_en-US" xlink:label="lab_lh_A2.30seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.30% senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024" xlink:href="lh-20221231.xsd#lh_A2.30seniornotesdue2024"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.30seniornotesdue2024" xlink:to="lab_lh_A2.30seniornotesdue2024" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_dfc374b2-505e-434f-8e3f-13f8679b3e88_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_83f31db7-00b6-49e5-ae17-1f5b8b3c5ea6_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_a67f8428-5a7a-419b-a350-abdea0240428_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Post2017Member_c0b6ee57-ac4c-41ee-a8f3-206229e033fa_terseLabel_en-US" xlink:label="lab_lh_Post2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 2017</link:label>
    <link:label id="lab_lh_Post2017Member_label_en-US" xlink:label="lab_lh_Post2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 2017 [Member]</link:label>
    <link:label id="lab_lh_Post2017Member_documentation_en-US" xlink:label="lab_lh_Post2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post 2017</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Post2017Member" xlink:href="lh-20221231.xsd#lh_Post2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Post2017Member" xlink:to="lab_lh_Post2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_447443c7-e409-41fa-82d8-9498b8a6dcef_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveNoncurrent" xlink:to="lab_us-gaap_RestructuringReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_d5efe124-a782-45f4-b1f5-41ff0f56f243_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_28650009-54bb-4c97-8192-65ab77647881_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_995d1517-c693-4556-a1ab-a154312cff72_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_806a0496-106c-4bb2-ba7d-9f691a11fa83_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1926b276-afcd-42f7-a158-9da5d273d6e9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyDomain_d9117945-559e-4aef-b782-cc5c87f6e2e9_terseLabel_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:label id="lab_srt_EnergyDomain_label_en-US" xlink:label="lab_srt_EnergyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyDomain" xlink:to="lab_srt_EnergyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e738e5b9-52ed-4d5c-a789-e00b1ceede3d_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_3b389df6-1ae3-4c3f-b8b5-35530dedcdd3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_ad677fe5-4d74-4f9b-a48b-7681f0473e81_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share Based Compensation Arrangements by Share Based Payment Awards</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_2e2247c7-0631-4b53-aa1f-0e1b570b7e67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_59e6423e-1854-4234-92e8-3ef268caf621_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total maturities, due beyond one year</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_82121174-eb6b-4beb-8793-898cd49fb4ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2b3a8d4a-46b4-42b8-8015-b1a87c9641d0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9f10c01b-101c-42c5-8b41-fd6b707e597a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost weighted average expected future recognition period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e31192a4-4900-4f89-845d-81bd66a72dd1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_c75b75c4-a6a3-405a-bd62-8e714ef0855f_terseLabel_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in common shares issued and held in treasury [Text Block]</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_label_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Common Shares Issued And Held In Treasury [Table Text Block]</link:label>
    <link:label id="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_documentation_en-US" xlink:label="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule is used to show the changes in common shares issued and held in treasury by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:href="lh-20221231.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:to="lab_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ee872007-8d7c-42c1-9e67-e01d18c6f016_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a7c5684e-003c-4e6c-b200-d9005e07b568_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d9ab1b25-1c72-48d8-a45f-c201cc74de8f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d6800fe3-4490-4995-b0e5-260d5ce24624_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock_9d1ac190-f90d-4846-be7d-095253aea54f_terseLabel_en-US" xlink:label="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock_label_en-US" xlink:label="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Of Credit Risk [Policy Text Block]</link:label>
    <link:label id="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A description of the company's credit risk accounting policy with respect to financial instruments. An entity shall disclose its policy for including whether the entity's cash and cash equivalents are insured or expose the entity to credit risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:href="lh-20221231.xsd#lh_ConcentrationOfCreditRiskPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:to="lab_lh_ConcentrationOfCreditRiskPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_23f7f75c-1994-480d-a211-d44fe9023f24_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_6503c9d1-07ea-462e-ae90-c8a346f08ec8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_73aadde4-ca74-45a9-b1da-7e36e51d58bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_b04c2322-aa3b-4093-b8d5-6757bd940930_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_223f476c-16d2-4b88-b3f4-657204568f01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d2544d56-c034-45e3-95cb-312893a37911_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENSION AND POSTRETIREMENT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c55c1789-3534-4ca3-b7de-899c64225f76_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_3b071347-588c-44ac-b75c-f68dfb764cd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_24985a7c-fee5-46dd-87f8-678013088aa7_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_43316d54-a166-4df1-b181-6f136676a1ee_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2022ShareRepurchasesMember_ba55c599-59de-4d4a-b713-33717c8c4625_terseLabel_en-US" xlink:label="lab_lh_A2022ShareRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Share Repurchases</link:label>
    <link:label id="lab_lh_A2022ShareRepurchasesMember_label_en-US" xlink:label="lab_lh_A2022ShareRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Share Repurchases [Member]</link:label>
    <link:label id="lab_lh_A2022ShareRepurchasesMember_documentation_en-US" xlink:label="lab_lh_A2022ShareRepurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Share Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ShareRepurchasesMember" xlink:href="lh-20221231.xsd#lh_A2022ShareRepurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2022ShareRepurchasesMember" xlink:to="lab_lh_A2022ShareRepurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4252b902-4298-48ac-bd40-edd6f6eb89cc_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c0e11184-c8ed-40c7-b61b-c6d0342c98c7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_68aba8e7-40bb-4992-a3e2-2e0d894f6059_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_6953a832-8f73-4c55-b893-d2ab8ec66656_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3134b385-eb76-4b99-ade2-8a2963169c8b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_69e627db-f0e6-44c8-afdc-272d6b79b522_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_27db3fd9-b949-4357-bc80-1e62036d888e_terseLabel_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during period for:</link:label>
    <link:label id="lab_lh_CashPaidDuringPeriodForAbstract_label_en-US" xlink:label="lab_lh_CashPaidDuringPeriodForAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid During Period For [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract" xlink:href="lh-20221231.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract" xlink:to="lab_lh_CashPaidDuringPeriodForAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_f3a3cb85-aa31-4f9c-988a-f5d0b7b2080a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5e3da038-e779-46a7-b9fe-f7243e2c0245_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d1017b7a-298b-49df-9689-0fce7e795c62_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UKPlanMember_bed88b7c-e3da-4068-aca3-ed5751baaa29_terseLabel_en-US" xlink:label="lab_lh_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Plan</link:label>
    <link:label id="lab_lh_UKPlanMember_label_en-US" xlink:label="lab_lh_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Plan [Member]</link:label>
    <link:label id="lab_lh_UKPlanMember_documentation_en-US" xlink:label="lab_lh_UKPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UK Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UKPlanMember" xlink:href="lh-20221231.xsd#lh_UKPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UKPlanMember" xlink:to="lab_lh_UKPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NotePayableCurrentMember_b6a66045-c133-4be3-8d34-f615b3edba3e_terseLabel_en-US" xlink:label="lab_lh_NotePayableCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, current</link:label>
    <link:label id="lab_lh_NotePayableCurrentMember_label_en-US" xlink:label="lab_lh_NotePayableCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, current [Member]</link:label>
    <link:label id="lab_lh_NotePayableCurrentMember_documentation_en-US" xlink:label="lab_lh_NotePayableCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NotePayableCurrentMember" xlink:href="lh-20221231.xsd#lh_NotePayableCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NotePayableCurrentMember" xlink:to="lab_lh_NotePayableCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_e487c9fd-db5b-428c-8e8f-9eb7c6cd32ce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_fcf0204f-5210-4ea7-bea4-4c8dd383405a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_41fb26c2-027b-4d74-8a35-b2e26ec230ca_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of identifiable intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_5989791e-95f0-4c80-b399-85a54b5f5fb9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_43bb2752-1aa2-4b87-9d7f-58bdcc130513_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_376ca3c0-5b02-4d31-91a8-29738fbbfc2c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1a1d5cdb-c0d4-432a-a9f2-ab491dd7f792_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2016</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2d1086ee-7b3e-4dbf-976b-12b1bfb64202_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments, Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_24c61821-5310-487f-9ba5-cd57070867de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to the noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_98b96f86-fab6-4135-ab7d-cbb4b8eff3d2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_83913162-b85a-4c65-9e66-42fd41836293_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_a19cba0a-94e2-45aa-8293-ad94a1ea5698_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6226c1a4-6e2f-41d4-bd9c-badbaa4bd6b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c175402d-c9b4-4c25-9fb6-f93cc8c6c07b_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CashBalanceRetirementPlanMember_774dcaa7-015c-4ec9-9cd1-f443b7bfe0ee_terseLabel_en-US" xlink:label="lab_lh_CashBalanceRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Balance Retirement Plan</link:label>
    <link:label id="lab_lh_CashBalanceRetirementPlanMember_label_en-US" xlink:label="lab_lh_CashBalanceRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Balance Retirement Plan [Member]</link:label>
    <link:label id="lab_lh_CashBalanceRetirementPlanMember_documentation_en-US" xlink:label="lab_lh_CashBalanceRetirementPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Balance Retirement Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashBalanceRetirementPlanMember" xlink:href="lh-20221231.xsd#lh_CashBalanceRetirementPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CashBalanceRetirementPlanMember" xlink:to="lab_lh_CashBalanceRetirementPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a83692d2-c30e-4784-87ef-214a73899605_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_746ec286-85f2-4026-817b-06dd605fc6bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_636cc5b6-5549-4aa9-8360-4896d6be9d9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_5f68ff43-3a4f-46bb-bb2c-31b8e127d61a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_79dbf4ea-fb4c-41b5-8250-ffc94d3648ed_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_1d4596f3-aa61-4aa7-b777-0020f2d5fc3c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_692d1b9c-428f-4469-9434-a14797ecb2cd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_0ef4f22e-e16f-4f85-b7e2-82a523aefa06_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_120a5102-0634-4884-ad17-ecceb4a9d3da_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The employee stock purchase plan permits employees to purchase shares of common stock at a certain percentage of the market price (in hundredths)</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Percent Of Market Price</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of the market price of common stock participating employees are able to purchase company stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanPercentOfMarketPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:to="lab_lh_EmployeeStockPurchasePlanPercentOfMarketPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9290129a-4681-4b61-8d6d-56d34ac70e7e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ff5f270e-d093-4c77-8a72-8001ce4dfd0e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_b7dad6c7-ca7d-47fc-9a90-62d8f718c4f3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_f7e92d59-2856-4328-8ad5-b6e131b3ec50_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_b74a5f84-524b-46bd-90cb-71100d78734b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d79cacd9-1dbb-44d2-8264-80395c4b83cb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2021AcquisitionsMember_acb64468-5b59-4eda-89c1-f0b79344bfb5_terseLabel_en-US" xlink:label="lab_lh_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 acquisitions</link:label>
    <link:label id="lab_lh_A2021AcquisitionsMember_label_en-US" xlink:label="lab_lh_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 acquisitions [Member]</link:label>
    <link:label id="lab_lh_A2021AcquisitionsMember_documentation_en-US" xlink:label="lab_lh_A2021AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2021AcquisitionsMember" xlink:href="lh-20221231.xsd#lh_A2021AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2021AcquisitionsMember" xlink:to="lab_lh_A2021AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d7265ccc-edb5-4eaa-8e18-181a0ff0e1e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_502b8ee4-e27a-44c9-b7c2-163140bd830e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_7286c049-683b-44cb-8a2e-6ce554e91c85_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_627e3d26-2242-49dc-9827-7af4400a981b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_d44051d8-ae6c-4e37-9363-c1c320f33a40_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_f3dd3d87-d21a-4715-a10a-ad9b19ae1f1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_203d3594-cc0e-41ac-b7a6-d30a39b879da_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InternalUseSoftwarePolicyTextBlock_badc42ca-38df-42b2-af54-d5876c7196b5_terseLabel_en-US" xlink:label="lab_lh_InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Software Costs</link:label>
    <link:label id="lab_lh_InternalUseSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_lh_InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software [Policy Text Block]</link:label>
    <link:label id="lab_lh_InternalUseSoftwarePolicyTextBlock_documentation_en-US" xlink:label="lab_lh_InternalUseSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternalUseSoftwarePolicyTextBlock" xlink:href="lh-20221231.xsd#lh_InternalUseSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InternalUseSoftwarePolicyTextBlock" xlink:to="lab_lh_InternalUseSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cdbf1545-ebdb-48d9-b561-739523e86b61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_04c58bbe-9d31-4eb5-9d2f-2e8e8f68ebfc_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f9b9895e-0468-4128-8258-06101d15b11a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in assets and liabilities (net of effects of acquisitions and divestitures):</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ee69543f-b508-4d6e-8423-5a91f9684c2d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities_c64bc803-79d6-40ed-bc12-6beb2bfcb4aa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options (in shares)</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Potentially Dilutive Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePotentiallyDilutiveSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities" xlink:to="lab_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditLossExpenseReversal_52b490f2-f009-454b-a79e-3321047845fa_terseLabel_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_CreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_CreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_CreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal" xlink:href="lh-20221231.xsd#lh_CreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditLossExpenseReversal" xlink:to="lab_lh_CreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ShortTermDebtIssueCostsMember_2218f263-d9b8-4ed3-87d7-d8a9405875cc_terseLabel_en-US" xlink:label="lab_lh_ShortTermDebtIssueCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issue costs</link:label>
    <link:label id="lab_lh_ShortTermDebtIssueCostsMember_label_en-US" xlink:label="lab_lh_ShortTermDebtIssueCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issue costs [Member]</link:label>
    <link:label id="lab_lh_ShortTermDebtIssueCostsMember_documentation_en-US" xlink:label="lab_lh_ShortTermDebtIssueCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issue costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtIssueCostsMember" xlink:href="lh-20221231.xsd#lh_ShortTermDebtIssueCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ShortTermDebtIssueCostsMember" xlink:to="lab_lh_ShortTermDebtIssueCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_ad3dd902-adfb-49c9-a598-99b67abe2ef3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_86307293-0703-4c2c-8796-ba5aed6e37cb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermDebtExcludingDebtIssuanceCosts_86841022-2698-445b-885d-6902e465731c_terseLabel_en-US" xlink:label="lab_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt excluding debt issuance costs</link:label>
    <link:label id="lab_lh_LongTermDebtExcludingDebtIssuanceCosts_label_en-US" xlink:label="lab_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt excluding debt issuance costs</link:label>
    <link:label id="lab_lh_LongTermDebtExcludingDebtIssuanceCosts_documentation_en-US" xlink:label="lab_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt excluding debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:href="lh-20221231.xsd#lh_LongTermDebtExcludingDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:to="lab_lh_LongTermDebtExcludingDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_acff1d34-c248-40ba-a727-8b716db22879_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_c9a35d63-85ff-4883-b043-6acab6b7cd89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_be95293d-b0c6-43b4-a5b1-e897b8c76823_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_ef044dd5-bf7d-4b8a-8373-e464612a56c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_e3484749-3ea0-4539-b861-3a48e40f1732_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_494976fd-c003-4838-bc79-a0cd6611fd55_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_eac6f45a-6e0b-440d-a8b9-741def37ac73_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_b67f2dc1-e019-4464-8f19-5c49c0392048_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Receivable, Other, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5e8675b1-f915-4c88-8b48-8d93e000b0d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_92537684-9bb7-4a09-b930-47dfd47ca7ef_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_1adc065a-e1e7-407c-ba88-d98493e4b8dd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock_2b3edc6e-43aa-47de-83fa-8503d45272d1_terseLabel_en-US" xlink:label="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursable Out of Pocket Expenses Policy</link:label>
    <link:label id="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursable Out of Pocket Expenses Policy [Policy Text Block]</link:label>
    <link:label id="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursable Out of Pocket Expenses Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:href="lh-20221231.xsd#lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:to="lab_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_97fe5f2f-9573-41f4-a172-288311d02fe5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_f77cc1ab-e8bf-4047-990e-b7536d096983_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ba169b03-4cb0-4979-a354-2dd5aa0b1db8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e805df51-4b3c-4ab9-abdf-bcc220f9edeb_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_dbfcb626-4ff0-404d-9abe-5a17dacb138e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3d2c92a4-75d2-41e5-8a56-df2f30ccdd67_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_77051c88-9dd6-4689-bb9e-e9afea5f89c2_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_279619c6-4610-4220-9f8a-d5086af704c6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ForeignTaxLossCarryoverValuationAllowance_26367023-3f54-4844-b5f7-4e362fd8b609_terseLabel_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryover with Valuation Allowance</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryoverValuationAllowance_label_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryover Valuation Allowance</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryoverValuationAllowance_documentation_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryover Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryoverValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:to="lab_lh_ForeignTaxLossCarryoverValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8186047d-6bf3-4442-978e-8cb15c03e313_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_e07bb5c1-1daa-49f9-b6db-cd0871f3d3fd_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_8084ecd5-7408-46d9-be1f-3ad183b36503_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock_91bfb560-01f5-40f8-a2f7-a3b9fd5e294c_terseLabel_en-US" xlink:label="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Current Year Acquisition ProForma Information Table Text Block</link:label>
    <link:label id="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Current Year ProForma Information Table Text Block [Table Text Block]</link:label>
    <link:label id="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Current Year ProForma Information Table Text Block</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:href="lh-20221231.xsd#lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:to="lab_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fc28e3d7-3ca6-4215-9370-0c3b45ccb595_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_89512f2b-68c8-4f90-be76-8d9114d096aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_74628797-14e9-4773-a2fa-9737017d6263_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c26a7573-d81a-4a3d-aaba-b514cf7afafa_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans, Fair Value of Plan Assets by Category [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ForeignTaxLossCarryovers_72842744-620a-41fd-88bc-1951f199f432_terseLabel_en-US" xlink:label="lab_lh_ForeignTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax loss carryovers</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryovers_label_en-US" xlink:label="lab_lh_ForeignTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryovers</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryovers_documentation_en-US" xlink:label="lab_lh_ForeignTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The foreign loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryovers" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryovers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ForeignTaxLossCarryovers" xlink:to="lab_lh_ForeignTaxLossCarryovers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_5e61a4a9-0eac-4188-b234-b666a6859125_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0f2d1331-d959-48d0-b0c7-28ab0da55910_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_3cbaf096-af70-45d1-b84e-510ad3596282_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Limitations on Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_5ec13ab8-d74f-4bf7-8e07-a67e8ad688be_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_1d220613-dc1c-4300-b772-fe717657457b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_MedicareandMedicaidMember_aafc169c-49c4-4fe6-b31b-81b7eb94086c_terseLabel_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_label_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:label id="lab_lh_MedicareandMedicaidMember_documentation_en-US" xlink:label="lab_lh_MedicareandMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember" xlink:href="lh-20221231.xsd#lh_MedicareandMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_MedicareandMedicaidMember" xlink:to="lab_lh_MedicareandMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_cd37bf53-9960-410f-aa02-812ecc5afcaa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsAbstract_e526eda7-5708-44b8-a56c-88931ef4dac2_terseLabel_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Abstract]</link:label>
    <link:label id="lab_lh_AccumulatedOtherComprehensiveEarningsAbstract_label_en-US" xlink:label="lab_lh_AccumulatedOtherComprehensiveEarningsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsAbstract" xlink:href="lh-20221231.xsd#lh_AccumulatedOtherComprehensiveEarningsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsAbstract" xlink:to="lab_lh_AccumulatedOtherComprehensiveEarningsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A3.60Seniornotesdue2025_1b0b448c-e43a-432c-95ed-f65cc1054722_terseLabel_en-US" xlink:label="lab_lh_A3.60Seniornotesdue2025" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% Senior notes due 2025</link:label>
    <link:label id="lab_lh_A3.60Seniornotesdue2025_label_en-US" xlink:label="lab_lh_A3.60Seniornotesdue2025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% Senior notes due 2025</link:label>
    <link:label id="lab_lh_A3.60Seniornotesdue2025_documentation_en-US" xlink:label="lab_lh_A3.60Seniornotesdue2025" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.60% Senior notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A3.60Seniornotesdue2025" xlink:href="lh-20221231.xsd#lh_A3.60Seniornotesdue2025"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A3.60Seniornotesdue2025" xlink:to="lab_lh_A3.60Seniornotesdue2025" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_e8fe332d-a35d-40f5-a86c-42373a74f8e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_GoodwillImpairmentCumulative_420dcae7-bcba-471d-90c6-fce6909e4a7a_terseLabel_en-US" xlink:label="lab_lh_GoodwillImpairmentCumulative" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Cumulative</link:label>
    <link:label id="lab_lh_GoodwillImpairmentCumulative_label_en-US" xlink:label="lab_lh_GoodwillImpairmentCumulative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Cumulative</link:label>
    <link:label id="lab_lh_GoodwillImpairmentCumulative_documentation_en-US" xlink:label="lab_lh_GoodwillImpairmentCumulative" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Impairment, Cumulative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillImpairmentCumulative" xlink:href="lh-20221231.xsd#lh_GoodwillImpairmentCumulative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_GoodwillImpairmentCumulative" xlink:to="lab_lh_GoodwillImpairmentCumulative" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_a5cf4621-3908-4d6a-a618-28b9f723bf48_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositionDomain_7b4aa2f8-decd-46d7-93ae-97c833c205db_terseLabel_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:label id="lab_us-gaap_PositionDomain_label_en-US" xlink:label="lab_us-gaap_PositionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositionDomain" xlink:to="lab_us-gaap_PositionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_3dfbc96c-7f12-4b2d-87c2-bdde24ce31e0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture partnerships and equity method investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_05d78266-751d-4c09-b77d-a77b5704c070_netLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_eaf2b9ce-69a1-4f84-b60e-999d69945966_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_8e19c96e-1141-4100-8547-091100167d02_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_b4a54470-1b0d-46c0-b10c-f8de77b7335d_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1</link:label>
    <link:label id="lab_us-gaap_Goodwill_c1527f88-69f9-41ad-8e51-8d16a8d2e040_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, net</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10cf7e6a-df85-436a-8817-b35e86f81c0a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5888a549-aa18-4d3e-8f83-7590d9661a03_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_f7414746-671a-4970-9dd9-74e3f1baa27a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFundsMember_021cb4b6-d398-4a12-af25-b05be940d501_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Funds</link:label>
    <link:label id="lab_us-gaap_EquityFundsMember_label_en-US" xlink:label="lab_us-gaap_EquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFundsMember" xlink:to="lab_us-gaap_EquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedBenefitPlanAmortizationAndDeferral_5728fb86-b433-4fdb-8f5d-b43ed6711e33_terseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferral</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanAmortizationAndDeferral_a59a5f28-5798-4b0c-9f49-777a67132534_negatedTerseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amortization and deferral</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanAmortizationAndDeferral_label_en-US" xlink:label="lab_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Amortization And Deferral</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanAmortizationAndDeferral_documentation_en-US" xlink:label="lab_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An amount calculated as a basis for determining the effects of amortization expenses and other deferrals.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:to="lab_lh_DefinedBenefitPlanAmortizationAndDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_13b8ed31-0c21-4b09-9fbe-ce02dca141e7_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock authorized for issuance under the employee stock purchase plan</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Number Of Authorized Shares</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The maximum number of shares originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for purchase under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:to="lab_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ForeignTaxLossCarryoversExpirein2034_6c512f9d-8f40-478c-a1db-c4d768e4c5f8_terseLabel_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoversExpirein2034" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryovers Expire in 2034</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryoversExpirein2034_label_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoversExpirein2034" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryovers Expire in 2034</link:label>
    <link:label id="lab_lh_ForeignTaxLossCarryoversExpirein2034_documentation_en-US" xlink:label="lab_lh_ForeignTaxLossCarryoversExpirein2034" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Loss Carryovers Expire in 2034</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryoversExpirein2034" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryoversExpirein2034"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ForeignTaxLossCarryoversExpirein2034" xlink:to="lab_lh_ForeignTaxLossCarryoversExpirein2034" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_da02ff1b-2728-4206-a64c-8bc4d1056b8d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bd6c4c16-96b2-4fcf-8d58-eac5790ae66b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_7e073c75-588e-4f78-95a8-65d5b28f87ef_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_4c5940b0-ebf0-453a-ada4-267101dadde3_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7366f39d-1a08-4052-95f3-d3fd42f995eb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_dd4d02ad-fa7a-4183-af61-345a5d7fe9b1_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_b9e5688f-f400-431c-8fe6-ac4bb441cb89_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c2b7e740-7b0e-4382-ae92-40a8a6cbe192_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_3e38a115-2156-45f0-8793-2d1cf0b27709_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Benefit Plan Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_1dd732ba-089c-4a5f-a74d-8a779bc3083a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b752a575-dca0-4a3e-b0e2-e310144003e1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_2f5bb3ad-b762-4b72-a15e-82a5b5d6539b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2022Member_8f342ffe-1fce-42a6-898e-66c4f8bca6ff_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2022Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2022Member" xlink:to="lab_lh_SeniorNotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_6cc6a207-d882-48ad-9521-004068aace58_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_70b63f28-7606-4660-a839-f69b4475e5c4_negatedTerseLabel_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:label id="lab_lh_Shorttermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Shorttermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Shorttermdebtissuancecosts" xlink:to="lab_lh_Shorttermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_7e3ce671-ff09-4503-8bc4-2d28961bfc95_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 88.2 and 93.1 shares outstanding at December 31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_a24bb344-b825-4c44-b114-5b0c7dd96bc7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_863bf4bd-5e4d-41b0-b62b-f189482580f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ad68866c-fad6-4be7-8dc8-105064484199_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediaContentMember_e1008396-84f4-459d-85e1-e2a8f1680560_terseLabel_en-US" xlink:label="lab_us-gaap_MediaContentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Media Content</link:label>
    <link:label id="lab_us-gaap_MediaContentMember_label_en-US" xlink:label="lab_us-gaap_MediaContentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Media Content [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediaContentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediaContentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediaContentMember" xlink:to="lab_us-gaap_MediaContentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_905be71d-ae6b-464c-b834-590b29400cbe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RestrictedStockAndPerformanceSharesMember_3c1a0c46-c13e-4716-af9b-0b1032f934f3_terseLabel_en-US" xlink:label="lab_lh_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock and Performance Shares [Member]</link:label>
    <link:label id="lab_lh_RestrictedStockAndPerformanceSharesMember_label_en-US" xlink:label="lab_lh_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Shares [Member]</link:label>
    <link:label id="lab_lh_RestrictedStockAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_lh_RestrictedStockAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock and performance shares in the entity's stock incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockAndPerformanceSharesMember" xlink:href="lh-20221231.xsd#lh_RestrictedStockAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RestrictedStockAndPerformanceSharesMember" xlink:to="lab_lh_RestrictedStockAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3697ac9e-ae47-434d-8b24-a7bc37aff406_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential common shares not included in computation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_8752c586-bf52-40b4-92db-fda395da5d47_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad495d67-79f5-49f7-a124-61392414dc0d_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_36d59f83-334c-4a8d-bbea-6da070f967df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_33e19ecf-523b-4883-a884-752953c7951b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_79dc3a76-eb54-493f-ae27-cb151f696510_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received by the Company</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_68fe4cdf-a55d-4a6e-9a1a-6d21d8343020_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_8a9ee409-032d-4528-ae93-d2e4f2096c0e_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_8956329c-0196-4049-98a2-15595019ed7f_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3e64127e-dddf-4684-9901-3991eaae5aed_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_aab96d15-ac88-482c-9913-a75a2015c6be_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b4bb865c-562a-4aae-81c8-95705cb84a35_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of finite-lived intangible assets, minimum (years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_699da520-1f7b-47e9-94e6-b35df6225778_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_679f0786-4e7a-4a87-8767-cb563a2f6c6c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2188ff33-c1cf-4999-a5ab-d089f57b6606_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_25bed20c-4253-4d1b-9aca-7b4f809c339d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_6bb66b54-c392-43ed-b10d-ec57d7c1e435_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Population of Financial Assets and Liabilities Subject to Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_1129b5e0-16e5-47d3-b93e-52d8cd48ab07_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_499327c6-3cc0-4e4d-8ce2-0448002b4eed_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_cc1502f4-27f3-4d6c-ae0e-157a25df53bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_8023f664-6fea-4885-aac9-956802cb7791_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b37fd9d0-82fb-4115-b1cd-f88820da0cfe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_85f2cc42-5e6a-4aa9-a301-87c5ddc96311_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress [Member]</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5fca8033-1b46-4d83-82ee-b0bb80f6dd3b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_2920212b-5042-44f2-a03a-4b299a2ff696_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_74c9b49d-8b8b-4dd2-93dc-5d2861038c53_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c37516d9-16a9-45c8-b255-e0b620ee3adf_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_47ac95d9-cb28-450f-9835-575d74c63bf3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e491d74b-361b-4ac2-8634-903eaaac14d1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_cea44273-3c92-4787-9c3c-d7599ffda490_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_dfc583e6-6fb2-4a8b-b37f-e5ef7fc51983_terseLabel_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_label_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Plant And Equipment Estimated Useful Lives [Table Text Block]</link:label>
    <link:label id="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_documentation_en-US" xlink:label="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:href="lh-20221231.xsd#lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="lab_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_c7deb378-dce3-4462-9984-c8458cc8c9aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e288c66f-33b6-4c6b-9be1-69840aa31f03_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A4.70Seniornotesdue2045_09739a99-3465-410f-b2a4-0929f2a01ea2_terseLabel_en-US" xlink:label="lab_lh_A4.70Seniornotesdue2045" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70 % Senior notes due 2045</link:label>
    <link:label id="lab_lh_A4.70Seniornotesdue2045_label_en-US" xlink:label="lab_lh_A4.70Seniornotesdue2045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70 % Senior notes due 2045</link:label>
    <link:label id="lab_lh_A4.70Seniornotesdue2045_documentation_en-US" xlink:label="lab_lh_A4.70Seniornotesdue2045" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.70 % Senior notes due 2045</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.70Seniornotesdue2045" xlink:href="lh-20221231.xsd#lh_A4.70Seniornotesdue2045"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A4.70Seniornotesdue2045" xlink:to="lab_lh_A4.70Seniornotesdue2045" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f838d984-d939-4d0f-b67b-b586f4f2def0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement_990dd719-0d4c-4d33-a326-709fd00845df_terseLabel_en-US" xlink:label="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Recognized on Exit of Interest Rate Swap Arrangement</link:label>
    <link:label id="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement_label_en-US" xlink:label="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Recognized on Exit of Interest Rate Swap Arrangement</link:label>
    <link:label id="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement_documentation_en-US" xlink:label="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Recognized on Exit of Interest Rate Swap Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:href="lh-20221231.xsd#lh_GainRecognizedonExitofInterestRateSwapArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:to="lab_lh_GainRecognizedonExitofInterestRateSwapArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_ab56f97c-3a34-4135-a463-4afb9df2dc2d_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_6f390dfe-2c59-46f0-8cc2-8246d81f4c5c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_001ad169-f71c-4587-b2bd-7579b21cc406_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ed32ed25-f2ab-4d18-bddb-d516ed26b7fb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_f5bcac80-32fb-4f1d-b503-b384fad8809a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticPlanMember_13606a45-4ded-4f18-975b-0071d5fedf50_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:label id="lab_us-gaap_DomesticPlanMember_label_en-US" xlink:label="lab_us-gaap_DomesticPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticPlanMember" xlink:to="lab_us-gaap_DomesticPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_abcd67d7-84e7-42e1-adc1-a538b153bb05_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4c36db8a-8d4e-4d38-8a3c-911a05bed503_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_1411afcc-563e-4b95-94a0-e538602ad4e0_terseLabel_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_label_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other tax liabilities</link:label>
    <link:label id="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_documentation_en-US" xlink:label="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:href="lh-20221231.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:to="lab_lh_DeferredIncomeTaxesAndOtherTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ce22080b-b15b-4006-9a7e-302d1139060c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_90ab038f-f64f-42aa-8fa4-f281bc4a3550_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_c5383513-1fb6-44d3-b5ca-ad92a702d2f0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_d189ca31-a537-47a0-a37b-26f50c20547d_terseLabel_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage below which investments are generally accounted for on the cost method (in hundredths)</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_label_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Method Investments Maximum Ownership Percentage</link:label>
    <link:label id="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage_documentation_en-US" xlink:label="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:href="lh-20221231.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:to="lab_lh_CostMethodInvestmentsMaximumOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5817b311-7f6d-45b0-970c-b05de235ed1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_ba5dfaaa-6dbd-4035-b0bc-c691cbf3aad4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_88d353bf-fb25-4a64-8b3e-38a52692be47_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_8a4cf5d9-f234-4df0-8075-33c57603f9f4_terseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average expected long-term rate of return for other assets (in hundredths)</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_label_en-US" xlink:label="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Expected Rate Of Return On Assets Other Assets</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_documentation_en-US" xlink:label="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested in other assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:to="lab_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_72286677-ed22-427b-811b-b1217a7c37ce_terseLabel_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_label_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:label id="lab_lh_AllowanceforCreditLossWriteOff_documentation_en-US" xlink:label="lab_lh_AllowanceforCreditLossWriteOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss, Write Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AllowanceforCreditLossWriteOff" xlink:to="lab_lh_AllowanceforCreditLossWriteOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_e0bfface-d4cb-4a47-b156-39c24c74414d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_fb730756-17f8-4809-904f-8f7e862e4a7e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_0e1e0fc2-998a-4e75-aecf-028ac32fa086_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_90c39cc4-4c07-4b30-b1d4-ee67d36b05b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8d5a03c4-0427-4374-990a-06eeb3bf6885_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_eef7a05d-39f5-4f32-b90c-35d74a0673ac_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_a7b13634-0efb-4d18-9251-138daf63cdf1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_82b6647a-01b4-495b-a8fe-82a4508639ca_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMinimum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMinimum" xlink:to="lab_lh_LongTermContractsDurationMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_31dd1861-b492-401e-937b-809a922c3b4e_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software [Member]</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_25c3a85e-7c01-46aa-8a3b-1d86815f0491_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SharesAbstract_5b1452a3-ad01-4cb1-82eb-d1bf63db41ae_terseLabel_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:label id="lab_lh_SharesAbstract_label_en-US" xlink:label="lab_lh_SharesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract" xlink:href="lh-20221231.xsd#lh_SharesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SharesAbstract" xlink:to="lab_lh_SharesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_3f9c47f2-a492-4495-8c3c-9e568100a5bf_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumLettersofCredit_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Letters of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumLettersofCredit" xlink:to="lab_lh_CreditFacilityMaximumLettersofCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_33386cdc-bb8d-40a9-b6c0-4251f60fd0ac_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_437beef7-6489-457e-a3d2-2ed074d92fe4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_6a3679b0-aabe-4b82-8181-b3258d5530cb_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b1f855ff-36be-43f6-b9b0-3cd4317b0de8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Increase) decrease in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a7856bc3-c30d-4928-9934-b890b0694ceb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_06062bad-23a2-45bd-ba80-2ce4934cd04b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_51c11770-2ccf-48f1-882f-adb23bf0d907_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans, Fair Value of Plan Assets by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_f67f5c1a-e88d-4d78-8279-c1fe541d943b_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeasePayment_d3f82979-294a-4967-aa8a-bd1c0a6a7fc1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeasePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Payment</link:label>
    <link:label id="lab_us-gaap_VariableLeasePayment_label_en-US" xlink:label="lab_us-gaap_VariableLeasePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeasePayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeasePayment" xlink:to="lab_us-gaap_VariableLeasePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2024Member_69089f6a-4e66-4565-9627-0bee64b1e7ba_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:label id="lab_lh_SeniorNotesDue2024Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2024Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2024Member" xlink:to="lab_lh_SeniorNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_b1d267da-1312-4011-b84f-9fe003202cfc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_0c890764-9932-4d43-a22a-bcd12849e954_terseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long term rate of return for the Company Plan</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Assumptions Used Expected Long Term Return On Assets</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_documentation_en-US" xlink:label="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:to="lab_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_98161f92-4842-4cf6-89c9-5dda4b7c05c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_0929313f-5554-49c1-9bed-fc17bc4916b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_e2ca18df-02ac-42a3-8380-ca7c504f9726_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_40736410-d941-46a2-9d5b-340f67eb2d76_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_d290c602-805e-4df8-99df-0b3c3a6303ae_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_a2991dac-a8b0-48d1-9e43-912facb6849f_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_82d4ece3-9ec3-4b07-8d95-03e83812fe98_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_dc017613-53ee-41e5-84ca-3e723d6df43f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_569c0b54-bde9-48c0-a437-5f6b4ee22766_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price per option cancelled</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_08e345dc-b60f-4e89-babd-4a0559a71bbc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0ceb7383-5420-4046-ab8e-d7d91ba9f390_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityNumberOfEmployees_b5c5781c-3673-4c24-a276-f59e662cba1e_terseLabel_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:label id="lab_dei_EntityNumberOfEmployees_label_en-US" xlink:label="lab_dei_EntityNumberOfEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Number of Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityNumberOfEmployees" xlink:to="lab_dei_EntityNumberOfEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A4.00Seniornotesdue2023_706e9283-7b5e-425d-9255-2ea8f34270f0_terseLabel_en-US" xlink:label="lab_lh_A4.00Seniornotesdue2023" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior notes due 2023</link:label>
    <link:label id="lab_lh_A4.00Seniornotesdue2023_label_en-US" xlink:label="lab_lh_A4.00Seniornotesdue2023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior notes due 2023</link:label>
    <link:label id="lab_lh_A4.00Seniornotesdue2023_documentation_en-US" xlink:label="lab_lh_A4.00Seniornotesdue2023" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.00% Senior notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A4.00Seniornotesdue2023" xlink:to="lab_lh_A4.00Seniornotesdue2023" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_8c67ab0c-d550-4454-aa61-bb0dea4c5d83_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5c57e0f6-5f9b-4c6b-9642-6aa8a429b76b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_c72d0631-ed9c-4a04-acac-03df38a8890f_terseLabel_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_label_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:label id="lab_lh_SalesCommissionAmortizationPeriodMaximum_documentation_en-US" xlink:label="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commission Amortization Period Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SalesCommissionAmortizationPeriodMaximum" xlink:to="lab_lh_SalesCommissionAmortizationPeriodMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_263c6cf8-2359-423e-b447-37198960c957_terseLabel_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax income [Abstract]</link:label>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_label_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes And Minority Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" xlink:to="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_5c8c09da-142b-4247-9b7b-32ae111e6fc1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentOfDomesticRevenue_549eae86-fa10-4a6c-9dce-7ee96afe8173_terseLabel_en-US" xlink:label="lab_lh_PercentOfDomesticRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Domestic Revenue</link:label>
    <link:label id="lab_lh_PercentOfDomesticRevenue_label_en-US" xlink:label="lab_lh_PercentOfDomesticRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Domestic Revenue</link:label>
    <link:label id="lab_lh_PercentOfDomesticRevenue_documentation_en-US" xlink:label="lab_lh_PercentOfDomesticRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Domestic Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentOfDomesticRevenue" xlink:href="lh-20221231.xsd#lh_PercentOfDomesticRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentOfDomesticRevenue" xlink:to="lab_lh_PercentOfDomesticRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_cd114d9f-9887-4df8-b5da-3840bc2cf267_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plan expense</link:label>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_label_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock or Unit Option Plan Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionPlanExpense" xlink:to="lab_us-gaap_StockOptionPlanExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_295cab59-e117-4534-952d-699758a4821c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_c01dc52c-4c83-4226-ba3a-74452255c581_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_2d5e3bd7-c758-4bbf-bd0c-07c914672ee8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Description</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_9bd27183-4d39-42c6-a085-1a3e384569df_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_6e78e9d2-4832-4869-8c1c-adc425a41c9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_c846ad5d-b62f-4360-a295-e26c89bd1071_terseLabel_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:label id="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:to="lab_us-gaap_DividendPayableDateToBePaidDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_5e63caf8-6578-46eb-a5a4-2bacad864035_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DrugDevelopmentMember_f537a035-3fe0-4a3f-8ed0-9184a0f23b8a_terseLabel_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:label id="lab_lh_DrugDevelopmentMember_label_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drug Development [Member]</link:label>
    <link:label id="lab_lh_DrugDevelopmentMember_documentation_en-US" xlink:label="lab_lh_DrugDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covance Drug Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DrugDevelopmentMember" xlink:to="lab_lh_DrugDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_4d98998b-46d8-4efd-89c6-fac24aba30b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_fe8bb2e3-7835-4bfc-a691-743f5aa8a7af_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_783648f6-ae8b-45b0-9ca5-c3a0d0450434_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_46943fba-500e-461a-b365-ee7eda86e6ae_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_23cc33ae-80ac-4483-840b-4cda19596cf9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_142c8644-5c8b-4769-85d3-b57eba4e0058_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_193874e1-1f42-4da2-958b-72557d737e64_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_22e8f488-eec1-4c35-a4c0-f44e027ef025_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_433c7fff-f5eb-420e-a199-5b635f3a2e29_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK COMPENSATION PLANS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_09dd89bc-38de-466b-807d-00f4bae1d0d5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4fb04e1b-7fd5-4b3e-bb21-223c4b1607cb_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_24361e4e-33e7-4be1-aceb-daf368849b20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_47ead5c3-4516-4fc8-87cd-7ce42fee40a8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_238dc0b6-4e94-4d95-923c-ce7312df2632_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a5d71704-2b38-409d-92cf-5b2d215e7dc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_06d7349e-7442-48b7-a4d2-b72d15b97522_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_a247c2cd-a1f9-4ea4-9fe6-62e0e1ea0814_terseLabel_en-US" xlink:label="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the Impact of Stock Options Exercised</link:label>
    <link:label id="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_label_en-US" xlink:label="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Share Based Compensation Arrangements Stock Options Exercised [Table Text Block]</link:label>
    <link:label id="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_documentation_en-US" xlink:label="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the financial impact of select activity related to the exercise of stock options. This activity includes cash received from option exercises, the corresponding tax benefits realized, and the aggregate intrinsic value of options exercised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:href="lh-20221231.xsd#lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:to="lab_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SoftwareDepreciation_7ec40f01-78f4-44e5-a4cb-ca174cc1e455_terseLabel_en-US" xlink:label="lab_lh_SoftwareDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software depreciation</link:label>
    <link:label id="lab_lh_SoftwareDepreciation_label_en-US" xlink:label="lab_lh_SoftwareDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Depreciation</link:label>
    <link:label id="lab_lh_SoftwareDepreciation_documentation_en-US" xlink:label="lab_lh_SoftwareDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of depreciation recognized in the current period that reflects the allocation of the cost of software related assets over the assets' useful lives.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SoftwareDepreciation" xlink:href="lh-20221231.xsd#lh_SoftwareDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SoftwareDepreciation" xlink:to="lab_lh_SoftwareDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_672866d4-ff68-40fe-8cbb-b4ba7166acb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_69d74f61-51f2-4bb6-95a6-20ba9279348c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_e4d49c8a-3c9b-40f7-a6b2-f7211c10d8b1_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_1f88fe1c-a27c-44c4-8bd2-e7039b5384e1_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_3696e426-69a2-4273-8daa-82eae742bba2_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8237c842-076e-4db3-a5cd-732da3eb5367_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2733b0a9-b85a-4cbe-93d5-0969022dbb56_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_29b06175-1dcf-4466-ae43-a374b35eab2e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6815b7d3-af24-4084-8302-1ceef771687e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_cc1dfba6-1664-4a3d-a82b-cd557df81acd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_b38a0762-599d-4517-b705-c6dba3b57f2b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2ecc572f-857d-4d22-ad52-090687f69028_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_024a8f9a-b205-4bb4-a785-4929b45c2927_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d8b34206-67ad-45f0-8acb-27e900cf74c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b73d310b-8ea9-4c0e-b61f-9b036ed152eb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4a082488-68e3-4a7e-9176-9ab90b687d0f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_83dac937-a25e-4e46-b138-fd70d53a8f00_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8a9b7f00-cd2c-4aba-9786-7156cca3e42f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_21c9db77-0149-48b4-ad0c-0d548862e755_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participants contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_53dfdddb-e91f-44c8-a2cd-5858803bbe23_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherInvestments_bca8a3aa-8499-481f-90b3-ef605cb85cdf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_f80f59e0-b98c-4bb3-be05-c8105b2be5e5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_f5be8ab1-27df-4c7b-bb16-fdd5522db75d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_de7d4164-9cb8-412b-894a-ddf455cb7f36_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_d7046e72-50fb-4477-bd0f-fe0bd0c7a23d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_7847eb4f-9326-415f-b01c-5b9d5439fb04_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized income tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_dfac2c9f-bdf9-43b2-86ca-5822f1eaaf95_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualbasesalary_79d9b5ad-68d6-4831-8f12-a17c3167f774_terseLabel_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualbasesalary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual base salary</link:label>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualbasesalary_label_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualbasesalary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual base salary</link:label>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualbasesalary_documentation_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualbasesalary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual base salary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualbasesalary" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualbasesalary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Maximumdeferralpercentageofannualbasesalary" xlink:to="lab_lh_Maximumdeferralpercentageofannualbasesalary" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2019AcquisitionsMember_97e6b22f-4b2d-46d9-8c80-8e495c83bcd9_terseLabel_en-US" xlink:label="lab_lh_A2019AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions</link:label>
    <link:label id="lab_lh_A2019AcquisitionsMember_label_en-US" xlink:label="lab_lh_A2019AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions [Member]</link:label>
    <link:label id="lab_lh_A2019AcquisitionsMember_documentation_en-US" xlink:label="lab_lh_A2019AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019AcquisitionsMember" xlink:href="lh-20221231.xsd#lh_A2019AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2019AcquisitionsMember" xlink:to="lab_lh_A2019AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_e1999345-e93b-4a17-9b88-5d15b5b46bcf_terseLabel_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase program [Abstract]</link:label>
    <link:label id="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract_label_en-US" xlink:label="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Repurchase Authorization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:href="lh-20221231.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:to="lab_lh_OutstandingStockRepurchaseAuthorizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2018SwapAgreementsMember_9ad8c3d6-7f4f-42b1-bd89-899eec9112eb_terseLabel_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements</link:label>
    <link:label id="lab_lh_A2018SwapAgreementsMember_label_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements [Member]</link:label>
    <link:label id="lab_lh_A2018SwapAgreementsMember_documentation_en-US" xlink:label="lab_lh_A2018SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2018SwapAgreementsMember" xlink:to="lab_lh_A2018SwapAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_d45c096e-c664-49c7-801f-08f09cd02b94_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_175bdb04-6d29-4b51-bf5f-add23c92a44a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ff412234-b552-4c36-bad3-9e7e5bf7cfe1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_3ddfd74c-29ed-4f97-9975-7aefde5ad901_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_873536b5-6b64-4a07-a45c-6ce9facc6ce8_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f52a72d0-dcf8-47a9-a077-9c6848650cc5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_f6272293-7b3f-47c0-8dc8-e84b34972a1e_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_78fd7ea6-d1e8-439b-a619-c3a9c8a341a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_35762910-e136-4a6f-bf28-c7594439eaa3_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b91331a4-c1b3-477a-85c1-f71cecca1583_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, exercisable options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_250ec310-9679-4e92-9776-e2f3826f9ac2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_50a6fd27-d140-4e0c-afee-c07600342d45_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_edfe19e3-5bd4-4a3f-8c24-660413a7f770_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_2e7958b4-2882-4c38-8c2f-17d5e36bd788_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_d3355410-d248-4b3e-b089-54c6d58a9648_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_581f9289-aada-4dda-8528-8238a4e21c67_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_015b18de-9b5b-4840-b57a-e41de1b203f0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut_dd0db68e-a96a-45c5-9dea-c5853db03db6_terseLabel_en-US" xlink:label="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Noncontrolling Interest Put</link:label>
    <link:label id="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut_label_en-US" xlink:label="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Noncontrolling Interest Put</link:label>
    <link:label id="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut_documentation_en-US" xlink:label="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Noncontrolling Interest Put</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:href="lh-20221231.xsd#lh_IncreaseDecreaseInNoncontrollingInterestPut"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:to="lab_lh_IncreaseDecreaseInNoncontrollingInterestPut" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_3516b260-4832-4635-b22a-2ca864975161_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased by eligible employees</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Number Of Shares Purchased</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of shares under the employee stock purchase plan purchased by eligible employees during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:to="lab_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_07bd3569-1b33-4ed8-9cec-2a160c297bc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_7f1deef7-44c7-43d3-baca-e8bbb1466c1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualcashincentivepay_f7d045fb-60b7-4c85-9539-061defeaf614_terseLabel_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual cash incentive pay</link:label>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualcashincentivepay_label_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual cash incentive pay</link:label>
    <link:label id="lab_lh_Maximumdeferralpercentageofannualcashincentivepay_documentation_en-US" xlink:label="lab_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum deferral percentage of annual cash incentive pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualcashincentivepay"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:to="lab_lh_Maximumdeferralpercentageofannualcashincentivepay" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_078e1827-8f57-451d-a148-ec4f6e0fe58d_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_fe2fefcd-6f86-4172-a187-59526b7cc8b5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized net gain included in accumulated other comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_97e96d9c-ad1a-4c9c-bda6-6fc009d6a277_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_540c9fc7-3b9a-4d35-92fc-6fbc894e89bf_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A270SeniorNotesDue2031_c5ac755d-8451-4dc8-a034-5bbec5ef8245_terseLabel_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:label id="lab_lh_A270SeniorNotesDue2031_label_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:label id="lab_lh_A270SeniorNotesDue2031_documentation_en-US" xlink:label="lab_lh_A270SeniorNotesDue2031" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% senior notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031" xlink:href="lh-20221231.xsd#lh_A270SeniorNotesDue2031"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A270SeniorNotesDue2031" xlink:to="lab_lh_A270SeniorNotesDue2031" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_dfa2149e-6726-48d9-9aaa-c14665fd2d2d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2d0f8f66-67a8-485e-97f5-c0918ff434ec_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_11d7c574-2c72-45ad-9cf7-11504fa3dc7a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_526c46b1-4c09-4986-8a2e-da2f413b8b79_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7722a5cf-c57f-4b31-b09c-81a75d30492e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_71a60e5e-545d-4f21-b6bf-010b1a93853d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1491f8b9-604f-43e8-8a99-2101b8cd0591_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_ea815bb8-2360-4da7-ac6d-96bf930205d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_ae7f496a-f1ca-4caf-bd4c-df28f2ce54cb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_52e3db5b-43c0-413c-80f0-72b39165be94_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year adjustments, Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_c9ced4dd-1f4b-42e0-b04c-e25d8da90809_terseLabel_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:label id="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Intangible Assets By Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:to="lab_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_475d8033-7253-4218-af52-e87ab034d45d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8e8babf2-5bde-4a74-b8e3-97350db657eb_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of non-cash financing and investing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2bb98cd5-91ef-4192-9760-98d014de7ceb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_5462e95d-c5c9-47ba-8783-8019475e814e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_206a9bc5-d245-4dac-85a7-c08bd6ba0a9a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_9660c8fb-a062-426d-ab0e-66a226d2f58f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_caab2029-78fc-42ec-8433-ed8888b1a389_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_cf299c6a-b268-4d84-9239-d74684522d98_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_a393b603-ff6d-47e6-a0da-b7bea5ac0e86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1ec5520-ef2b-4333-94d2-0e32ebc2ba55_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_cf53d9a4-98d5-4e71-844f-fb733bce5125_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization:</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract" xlink:to="lab_us-gaap_DepreciationAndAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock_2c62727d-713c-4232-a8ee-d217a667ac9d_terseLabel_en-US" xlink:label="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock_label_en-US" xlink:label="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Finite Lived [Policy Text Block]</link:label>
    <link:label id="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for finite-lived intangible assets. This accounting policy also may address: (1) the amortization method used (2) the useful lives of such assets (3) how the entity assesses and measures impairment of such assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:href="lh-20221231.xsd#lh_IntangibleAssetsFiniteLivedPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:to="lab_lh_IntangibleAssetsFiniteLivedPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5557c260-a4d9-45c7-b0b0-dee7bf07aaad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2013</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_c5f95dd5-4c93-4ae7-9353-b3f9fcbeb90c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_7671f3d5-35b7-4df9-8275-b24bf75d3138_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d4463692-a0f1-4b07-968e-d33d13b51cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_fc456fa9-466c-497a-828a-0f8c74e1ff5a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a5a568bc-8eda-4ad8-829d-4d14026f74d1_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_a3a9d857-5a5b-49fa-85c2-8a4fc1b10a62_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1206128d-8659-4f4c-9ca1-8115791181d6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_ca560423-545a-4556-b936-b0f0053434c6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bb735f31-34fd-4ef5-ac8e-ad35fc5ccba4_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_37ca26a6-ab0b-4fe6-95ed-1588f3a5e72a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4b567d0a-db07-4615-b2ab-1b21d512fc6a_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ExcludingEnvigoMember_84a2b63e-36e2-44f0-a3c8-e8e8612f2e68_terseLabel_en-US" xlink:label="lab_lh_ExcludingEnvigoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Envigo [Member]</link:label>
    <link:label id="lab_lh_ExcludingEnvigoMember_label_en-US" xlink:label="lab_lh_ExcludingEnvigoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Envigo [Member]</link:label>
    <link:label id="lab_lh_ExcludingEnvigoMember_documentation_en-US" xlink:label="lab_lh_ExcludingEnvigoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Envigo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcludingEnvigoMember" xlink:href="lh-20221231.xsd#lh_ExcludingEnvigoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ExcludingEnvigoMember" xlink:to="lab_lh_ExcludingEnvigoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_980841fa-29d2-4c25-a770-c9251e75ae06_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_5e62202e-e65b-44f1-8552-e5cf9cff052d_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8a888100-ceec-4b61-89d7-955ae920c631_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of unrecognized tax benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_a06a1dfe-2ed2-4e7d-9618-6a784922d566_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceLineItems" xlink:to="lab_us-gaap_ValuationAllowanceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fefef808-2fd0-49c6-9aac-9ee15f101cb7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_077f2ff9-5509-496a-9574-55eb14637d30_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_66b91fa8-db33-451f-a078-dc3db78efcf2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c6b75169-4612-410a-8993-0e184b8f10c9_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_1e145c13-2bff-4e9f-b819-59f00ed0ffd0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_c375fdc9-1fe1-4a05-9d0b-b18903c7ebd0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_28f89ee8-ed51-4a61-ac63-9c8c3191fd2d_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LifeAndAnnuityInsuranceProductLineMember_0bea8f4b-0f74-4a3d-a4f6-8d79cf081b3f_terseLabel_en-US" xlink:label="lab_us-gaap_LifeAndAnnuityInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life and Annuity Insurance Product Line [Member]</link:label>
    <link:label id="lab_us-gaap_LifeAndAnnuityInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_LifeAndAnnuityInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Life and Annuity Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeAndAnnuityInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember" xlink:to="lab_us-gaap_LifeAndAnnuityInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_852d7911-8bc5-4ce1-a421-b80bee974ca8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_42668418-3287-4093-a904-d8d5e3c2e552_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_7510af46-02fe-4e16-aaf1-73f185bbdd0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_301b7ff1-26be-4b2c-aec2-fd2e581014d9_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0c44b1fd-fae1-4745-b725-468b5e838bf4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8e66f3b7-2fcf-41a9-92dd-9fff3cfda972_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_6689db5f-5a6d-415c-a3fb-92f9bdce75b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ca329330-b090-4534-b64e-331332255dcf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c5e65811-0901-44c3-af7c-094d630e6a00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in reserve as a result of lapses in the statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_e9b97399-91c3-43b4-bca1-5ac2a4de6eaa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05327d2a-70b8-4fd9-bc64-b0b8f7436ad9_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined-benefit plan costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_b6744356-26e0-4fcd-966f-83ca04764c8f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_8072fd03-e9a7-42a1-83bd-a47f4e0c40a5_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits from Uncertain Tax Positions</link:label>
    <link:label id="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:to="lab_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_ec3a2850-aade-4c92-a13c-2c942b8767e4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_86d370fa-b764-4cb6-b3b3-25cb70dce1ae_terseLabel_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_label_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_documentation_en-US" xlink:label="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:href="lh-20221231.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:to="lab_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e52b6e2a-9e1b-4b01-a4d0-e3772941319f_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f34de26f-7222-425d-9631-09819e3da270_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_65f8e2ae-dda5-49ec-b934-df0858d39a7f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanExpense_04d56ba2-058a-4ff0-b722-a826337d748f_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense related to the Company's employee stock purchase plan</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanExpense_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Expense</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanExpense_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The expense amount recognized during the period related to the Company's employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanExpense" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanExpense" xlink:to="lab_lh_EmployeeStockPurchasePlanExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_30361d94-e3b7-43c0-85b5-2a3ebebce157_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_70c20e04-53bc-4bf6-b808-9dfa4ab6b871_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ed2325b7-7ea1-48b5-83e3-4fb7836fcf4c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_06064f5c-6139-4ba7-9b0f-444922d7cc28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_f44ac293-3dea-46e8-b2b9-97d24084fad8_terseLabel_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_label_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:label id="lab_lh_DefinedContributionPlanTotalExpense_documentation_en-US" xlink:label="lab_lh_DefinedContributionPlanTotalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Total Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense" xlink:href="lh-20221231.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedContributionPlanTotalExpense" xlink:to="lab_lh_DefinedContributionPlanTotalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_1f2d358e-798b-41cd-a46d-79943f367f56_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_f4cc04e9-78f6-4760-8c4a-becc46e1ce2e_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_ba3e3529-40dd-4a4f-97bc-e6751161ee37_verboseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_6e47f5af-fd43-44a9-a289-7c5eb3d9c062_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A155SeniorNotesDue2026_238b091a-c1fa-4422-8399-af83cacd4d38_terseLabel_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:label id="lab_lh_A155SeniorNotesDue2026_label_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:label id="lab_lh_A155SeniorNotesDue2026_documentation_en-US" xlink:label="lab_lh_A155SeniorNotesDue2026" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.55% senior notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026" xlink:href="lh-20221231.xsd#lh_A155SeniorNotesDue2026"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A155SeniorNotesDue2026" xlink:to="lab_lh_A155SeniorNotesDue2026" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DiagnosticsMember_bb807f2e-5936-4b03-bf33-73ac41f74da1_terseLabel_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LabCorp Diagnostics [Member]</link:label>
    <link:label id="lab_lh_DiagnosticsMember_label_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_lh_DiagnosticsMember_documentation_en-US" xlink:label="lab_lh_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DiagnosticsMember" xlink:to="lab_lh_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9558cd08-c0a4-41ab-90f5-a3fcb3a0ca00_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases of Lessee Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Longtermdebtissuancecosts_69dadce1-9221-478a-a97b-412ea288b23e_terseLabel_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_label_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:label id="lab_lh_Longtermdebtissuancecosts_documentation_en-US" xlink:label="lab_lh_Longtermdebtissuancecosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts" xlink:href="lh-20221231.xsd#lh_Longtermdebtissuancecosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Longtermdebtissuancecosts" xlink:to="lab_lh_Longtermdebtissuancecosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8325b01b-ee79-49f5-b9ac-2fce94a1c9d9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwards_a3cbe5e2-8cb2-4684-87d7-1602b05bb389_terseLabel_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforwards</link:label>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwards_label_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforwards</link:label>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwards_documentation_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalandStateAttributeCarryforwards" xlink:href="lh-20221231.xsd#lh_FederalandStateAttributeCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FederalandStateAttributeCarryforwards" xlink:to="lab_lh_FederalandStateAttributeCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_5fec308f-0a4c-4508-89c1-c515fe5ca1d5_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_06fd3f9f-b6a1-402e-b1c1-c8d4bcac4719_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_b3b0ec8c-8c03-413e-9409-6856941dadb1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_e3ce4158-20a4-4b1d-88b2-d031fc216964_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_e8280ac6-9b6d-4c3b-8d28-7268d73a3318_netLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2024_c39b0c7c-5861-46f1-8cb6-10eee840bcb6_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:label id="lab_lh_Seniornotesdue2024_label_en-US" xlink:label="lab_lh_Seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:label id="lab_lh_Seniornotesdue2024_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2024" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2024"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2024" xlink:to="lab_lh_Seniornotesdue2024" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2027_b028fa06-b6d3-40c3-a0c6-0e68362f357b_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2027" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027</link:label>
    <link:label id="lab_lh_Seniornotesdue2027_label_en-US" xlink:label="lab_lh_Seniornotesdue2027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027</link:label>
    <link:label id="lab_lh_Seniornotesdue2027_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2027" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2027" xlink:to="lab_lh_Seniornotesdue2027" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_db6a1e90-5e36-4bf3-8385-9d714b687219_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_56ef0a6d-e233-4a90-8703-d018dbb2e72a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f40d4f76-3946-48a4-bfaa-b206ef7d95a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_49461e1b-fe72-45b4-b83c-de83a2412f36_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c435678f-f465-43bf-b879-66f94366688f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_fe6bc71e-03e4-4d5a-bb9d-8852332c0fa6_negatedTerseLabel_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_NoteReceivableCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal" xlink:href="lh-20221231.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoteReceivableCreditLossExpenseReversal" xlink:to="lab_lh_NoteReceivableCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeAssetsAtFairValue_084f7887-c80d-423e-aaae-684dac599114_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Assets</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeAssetsAtFairValue_ca1082ef-abbc-4124-bddd-c3b806695766_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Assets</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock_9f014741-27b8-4dee-9ac5-c63568afff91_terseLabel_en-US" xlink:label="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation Plans</link:label>
    <link:label id="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock_label_en-US" xlink:label="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Option And Incentive Plans [Policy Text Block]</link:label>
    <link:label id="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:href="lh-20221231.xsd#lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:to="lab_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover_ee79dddc-84df-4a24-924c-582b20149d24_terseLabel_en-US" xlink:label="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of years restructuring liabilities expected to be paid out over</link:label>
    <link:label id="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover_label_en-US" xlink:label="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of years restructuring liabilities expected to be paid out over</link:label>
    <link:label id="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover_documentation_en-US" xlink:label="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of years restructuring liabilities expected to be paid out over</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:href="lh-20221231.xsd#lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:to="lab_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_bd04f3dd-02bd-40e1-8baa-4a49dde12a0f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_88140441-2da7-4abe-96e6-809683c788c9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_42051873-25a8-417c-9f9a-0bda6b1357ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_c231b679-c0e6-4101-8910-a84fc90a341b_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_9e40479c-1b67-4190-b663-4158af062209_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_15e90f65-bd61-41c9-a901-c0d80256283a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_337baac0-1df4-4da8-a63b-8d915ee00f03_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_222b8aaf-10a8-4923-8a5d-5aa2566ec595_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_74f297bf-b88d-4c93-9c6b-fae050ed6f81_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Cost (Credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanOtherCosts_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Other Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanOtherCosts" xlink:to="lab_us-gaap_DefinedBenefitPlanOtherCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_26934bbf-d3f9-428c-b2e1-ade812396fe3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_249e65d0-39f9-452b-85ff-490319a48c6c_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_282647d5-29f2-443c-8f12-7756ba3692aa_terseLabel_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_NoteReceivableAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:href="lh-20221231.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoteReceivableAllowanceforCreditLoss" xlink:to="lab_lh_NoteReceivableAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b7342e2c-0f6c-413e-a069-06abf4906372_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_0d0b5bd7-bc1b-44c8-b642-924ae9839c2a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock, vesting increment</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_04e292ff-4f8b-44d8-914e-aa15f8d7bfe8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_947e7a0a-3828-4107-81de-048b896c39d5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2020AcquisitionsMember_11222d10-3f66-46af-9333-04146bafcb59_terseLabel_en-US" xlink:label="lab_lh_A2020AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Acquisitions</link:label>
    <link:label id="lab_lh_A2020AcquisitionsMember_label_en-US" xlink:label="lab_lh_A2020AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Acquisitions [Member]</link:label>
    <link:label id="lab_lh_A2020AcquisitionsMember_documentation_en-US" xlink:label="lab_lh_A2020AcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2020AcquisitionsMember" xlink:href="lh-20221231.xsd#lh_A2020AcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2020AcquisitionsMember" xlink:to="lab_lh_A2020AcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f752ad50-d361-486a-8f91-8bda45d544e9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_a2690558-6943-423b-b6c5-c106e8bc65e0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, by Type [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_ae76035a-8db1-4d42-8c55-0825e57f95a9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, by Type of Restructuring [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_48876cc5-e3e2-4800-86a0-f36a9bb99f48_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_82d03948-443b-42f3-a842-999a03f05bcb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_6c0401ee-36ac-45e9-b76a-adddf8504128_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c4e7064a-2cee-498e-bb4a-cc4ab5637cca_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a90b0b4c-5762-4efb-aaf5-18a734d21c17_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_b0004667-dccc-46f5-93c8-4bc4cfad4b59_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedges, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_label_en-US" xlink:label="lab_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Fair Value Hedge Derivative at Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:to="lab_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment_2823a0c6-4dfc-4199-a64d-7a7bf888e7b3_terseLabel_en-US" xlink:label="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment_label_en-US" xlink:label="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Related Restructuring Reserve Accrual Adjustment</link:label>
    <link:label id="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment_documentation_en-US" xlink:label="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for facility related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:href="lh-20221231.xsd#lh_FacilityRelatedRestructuringReserveAccrualAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:to="lab_lh_FacilityRelatedRestructuringReserveAccrualAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_b2fc8a6a-a812-424e-abaf-fa37d87c9283_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_f9b8c472-3e71-4164-9e27-4fda5d1a9617_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_72d8f8c9-c8e2-46a2-a22d-d885b61a7529_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ff838e30-2fe9-40d3-997a-03be81a693d6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_adb6dafb-4b8e-43e5-9cce-18168c110d96_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_57b370ad-218a-4e96-a86c-63c59b7c10a6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_e5dffd56-3219-4a2b-8ddb-a95c473a8244_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_222cc249-a2e4-4c3f-9630-b2078db38a8b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredSalesCommissions_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Sales Commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:to="lab_us-gaap_AmortizationOfDeferredSalesCommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_a0630e9f-8873-4096-895d-dac24ec9eaac_terseLabel_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_label_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring and other special charges</link:label>
    <link:label id="lab_lh_NetRestructuringAndOtherSpecialCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:href="lh-20221231.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringAndOtherSpecialCharges" xlink:to="lab_lh_NetRestructuringAndOtherSpecialCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_ce08e47e-1116-44f4-842b-9afeef970b21_terseLabel_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_label_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:label id="lab_lh_UnbilledContractsReceivableMember_documentation_en-US" xlink:label="lab_lh_UnbilledContractsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Contracts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember" xlink:href="lh-20221231.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledContractsReceivableMember" xlink:to="lab_lh_UnbilledContractsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_InternationalDevelopedMember_02b6ecd0-5f6e-4db0-8e20-d9eb0446d1c3_terseLabel_en-US" xlink:label="lab_lh_InternationalDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International - developed [Member]</link:label>
    <link:label id="lab_lh_InternationalDevelopedMember_label_en-US" xlink:label="lab_lh_InternationalDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Developed [Member]</link:label>
    <link:label id="lab_lh_InternationalDevelopedMember_documentation_en-US" xlink:label="lab_lh_InternationalDevelopedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plan assets invested in the international capitalization equity securities- developed category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternationalDevelopedMember" xlink:href="lh-20221231.xsd#lh_InternationalDevelopedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_InternationalDevelopedMember" xlink:to="lab_lh_InternationalDevelopedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_6378a841-6cf2-4625-b1fb-2b61c3ed8dc1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_dcdc9d09-495c-4d07-b7fd-c3d670ca884f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_01d26290-5c15-4213-a48e-ec38af52f5c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_6acb36af-0298-4192-b1dd-9309ad452f22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_335f2d9d-7ec8-47ae-ae65-f7773214ed17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price per option exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78ee9dc6-e55e-441b-8487-6f945d4aefe3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_edea14b5-9f7e-4300-9b44-7adcdc38b1b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_86f9e8b9-756d-4ac2-b008-0ae046e7ab6c_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_687c232f-0784-4eb0-bc2d-a49b479d9d0a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_64d46774-b046-44dd-b42d-d872e0eb1358_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_6e76dff7-7148-47ad-b362-40c3c0e74c4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ProfessionalLiabilityPolicyTextBlock_6ea296f7-9bf8-4db9-a109-1a2e0f089e46_terseLabel_en-US" xlink:label="lab_lh_ProfessionalLiabilityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Liability</link:label>
    <link:label id="lab_lh_ProfessionalLiabilityPolicyTextBlock_label_en-US" xlink:label="lab_lh_ProfessionalLiabilityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Liability [Policy Text Block]</link:label>
    <link:label id="lab_lh_ProfessionalLiabilityPolicyTextBlock_documentation_en-US" xlink:label="lab_lh_ProfessionalLiabilityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an entity's accounting policy for self-insurance of professional liability claims, which may include policies for calculating a liability amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ProfessionalLiabilityPolicyTextBlock" xlink:href="lh-20221231.xsd#lh_ProfessionalLiabilityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ProfessionalLiabilityPolicyTextBlock" xlink:to="lab_lh_ProfessionalLiabilityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_c5618267-c12b-4b0f-981a-10ad34b3bed5_terseLabel_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares issued [Abstract]</link:label>
    <link:label id="lab_lh_CommonSharesIssuedRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Issued Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:href="lh-20221231.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract" xlink:to="lab_lh_CommonSharesIssuedRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_88ccf09d-ed1e-4dc0-a6a5-999d61e76652_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_f0011c4c-9033-4265-9b11-d17821edbd14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings and current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d6cf2f35-fed6-4a63-b3cc-04f8cf6de10a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f5ee62ee-26cd-418c-bff1-6147d5e53671_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3abf6532-c5b1-4312-af62-99067013dd2a_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_b44b1f38-cda1-4b93-896e-c811491085a5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_0097560b-b9a7-466f-b64c-6940c39b6e4c_terseLabel_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_label_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:label id="lab_lh_UnbilledServicesCreditLossExpenseReversal_documentation_en-US" xlink:label="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal" xlink:href="lh-20221231.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledServicesCreditLossExpenseReversal" xlink:to="lab_lh_UnbilledServicesCreditLossExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ef6a000a-39b9-40da-8a2f-91f35a371ad4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PGDxMember_2d1d41bd-79ae-41e6-b565-639542569c25_terseLabel_en-US" xlink:label="lab_lh_PGDxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PGDx</link:label>
    <link:label id="lab_lh_PGDxMember_label_en-US" xlink:label="lab_lh_PGDxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PGDx [Member]</link:label>
    <link:label id="lab_lh_PGDxMember_documentation_en-US" xlink:label="lab_lh_PGDxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PGDx</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PGDxMember" xlink:href="lh-20221231.xsd#lh_PGDxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PGDxMember" xlink:to="lab_lh_PGDxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_d08df613-95f1-445a-a5c8-145dd65bc9c0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfPayMember_cdd18e4c-8bf7-413d-8186-0ef10a8ee9ee_terseLabel_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:label id="lab_us-gaap_SelfPayMember_label_en-US" xlink:label="lab_us-gaap_SelfPayMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Pay [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfPayMember" xlink:to="lab_us-gaap_SelfPayMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_1cab6a96-51f1-49cd-b3b7-4b73af8b50fd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_20906d5f-eb39-42da-af43-3f6cad05aafc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_99bd0a9d-6339-4a31-9538-45db1f25b9ca_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_3f43cf5b-cb15-482d-8cc1-9e58a1aa20c7_terseLabel_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_label_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Mezzanine Equity</link:label>
    <link:label id="lab_lh_NoncontrollingInterestMezzanineEquity_documentation_en-US" xlink:label="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:href="lh-20221231.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NoncontrollingInterestMezzanineEquity" xlink:to="lab_lh_NoncontrollingInterestMezzanineEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_02b11191-95d1-4523-8e0b-f03b2755c390_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_4f1a89d1-6f7f-49f8-bfee-9a4d61a681aa_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_c8a466f8-81f0-4379-b7d7-3fe67391b70a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_8af73c10-a3c9-49df-8e22-6a889c2cf9b6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_32ba2ba1-7337-4a5d-ac46-2a055f8d3f75_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5fae3723-ca58-4b6f-b8e8-0f41842f6266_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0d3a71ec-7f5e-4fde-84af-9c3ddb059abd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_6c59018b-9486-489f-83e2-a560cf3c0d64_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_4547f109-1f57-4abf-b87d-661304dc69d2_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_00994e53-4e10-4a67-a412-a22f0f753cdf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_0025b6fc-d507-49e0-8917-3c645cfa79de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and restructuring reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventorySupplies_0679a2a3-1fb8-42e2-bc4c-827bcda389f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventorySupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Supplies, Gross</link:label>
    <link:label id="lab_us-gaap_OtherInventorySupplies_label_en-US" xlink:label="lab_us-gaap_OtherInventorySupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventorySupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventorySupplies" xlink:to="lab_us-gaap_OtherInventorySupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_89e4ea8f-13db-435e-92e1-fb913d7df6c1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, exercisable options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_d963f914-22e3-4b30-81fb-f8407e9424f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AscensionAcquisitionMember_bc78b206-f799-4cff-af86-c9c1d2c0d0be_terseLabel_en-US" xlink:label="lab_lh_AscensionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascension Acquisition</link:label>
    <link:label id="lab_lh_AscensionAcquisitionMember_label_en-US" xlink:label="lab_lh_AscensionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascension Acquisition [Member]</link:label>
    <link:label id="lab_lh_AscensionAcquisitionMember_documentation_en-US" xlink:label="lab_lh_AscensionAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascension Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AscensionAcquisitionMember" xlink:href="lh-20221231.xsd#lh_AscensionAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AscensionAcquisitionMember" xlink:to="lab_lh_AscensionAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_18965672-0804-4896-9071-fdb03446f1b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_35ac9097-b138-4ec0-be59-d41a54c9591a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_75160672-9074-4474-ba36-d1c2fb981391_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e3d4f0f0-2d3e-4a61-997f-881d20e1e1c0_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c8ef6e99-3687-4d02-a8a3-fd89bdc667a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_860d8604-c7d1-45e8-ab09-5a7306f4ecea_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SeniorNotesDue2020Member_c80246da-695d-4e02-bce8-af60c835c334_terseLabel_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2020 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2020Member_label_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2020 [Member]</link:label>
    <link:label id="lab_lh_SeniorNotesDue2020Member_documentation_en-US" xlink:label="lab_lh_SeniorNotesDue2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SeniorNotesDue2020Member" xlink:to="lab_lh_SeniorNotesDue2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d178af06-a29c-49fa-ac4e-0396eb1cf344_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_b885add2-09cc-4dc6-86ef-4a2a9d35da1d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date of Record</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccruedPassThroughExpenses_83acb536-611d-44d1-b32a-8fd6dcf3795b_terseLabel_en-US" xlink:label="lab_lh_AccruedPassThroughExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pass through expenses</link:label>
    <link:label id="lab_lh_AccruedPassThroughExpenses_label_en-US" xlink:label="lab_lh_AccruedPassThroughExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pass through expenses</link:label>
    <link:label id="lab_lh_AccruedPassThroughExpenses_documentation_en-US" xlink:label="lab_lh_AccruedPassThroughExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pass through expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedPassThroughExpenses" xlink:href="lh-20221231.xsd#lh_AccruedPassThroughExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccruedPassThroughExpenses" xlink:to="lab_lh_AccruedPassThroughExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2c00cf3b-8622-4853-92c8-9d39d48149a7_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles and other assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_846e0fa0-5053-4ee1-87bb-e3d2b983024a_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7782531e-d6d4-44fa-820f-43e35bb6160f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles and other assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_ad5a159d-cb2d-4110-a44e-d3ea0044683c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Carrying Amount of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_d3782469-d70b-419d-a8b9-43f5c9ddb036_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_a5eb8eec-e6a5-47e3-99eb-e51557792e3f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseRightsMember_79416e8e-d39a-4668-ba64-d12637efb808_terseLabel_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:label id="lab_us-gaap_UseRightsMember_label_en-US" xlink:label="lab_us-gaap_UseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseRightsMember" xlink:to="lab_us-gaap_UseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_c3ad2296-d130-4c3d-9ee6-ebcddfbf0a03_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_15da2f4f-0477-4ba0-804e-2898164f26e3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Statement of Financial Position at Fair Value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_dc71ceb4-700d-429c-be53-91af0505f69c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_00caf5aa-a6fb-495c-8992-3d8886e8a639_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_abf10c98-8caf-482d-8d56-d62ab33b702e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_07c30160-6b27-4e2c-9ab9-004d6a43a4bd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_846a0b07-f4d6-4b46-9efb-44626076ee85_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1b6bfffb-7ea5-4c78-ba4a-9cb6bc24f819_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_cab16288-e933-4e36-aafa-0d4611fddf57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_b7fc0e3a-c73b-4ea8-96c1-2b618e6cf7f7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_10789145-27d9-4bf8-ab81-eda432787aed_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6fac75dd-82c2-4f9a-aac9-246801017f78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_91fb5397-db07-4079-bcd0-1a88e9e98960_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetDomain_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetDomain" xlink:to="lab_us-gaap_DeferredTaxAssetDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_4fc0f202-bfb7-4bb2-b9d9-778275de2ca5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_7df722b3-9dbd-4d23-8558-8c4ddebfd335_terseLabel_en-US" xlink:label="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, future minimum payments, interest included in payments</link:label>
    <link:label id="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_label_en-US" xlink:label="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, future minimum payments, interest included in payments</link:label>
    <link:label id="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_documentation_en-US" xlink:label="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt, future minimum payments, interest included in payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:href="lh-20221231.xsd#lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:to="lab_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_6eec1b17-626b-4bda-9ffa-528ec9c3a126_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a8741013-17e8-4de0-ad9a-56b9b4600681_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2015</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_f00454ef-e5d4-4a05-b661-de08ac332c5b_terseLabel_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_label_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:label id="lab_lh_CreditFacilityMaximumSwingLineBorrowings_documentation_en-US" xlink:label="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Maximum Swing Line Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:to="lab_lh_CreditFacilityMaximumSwingLineBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_74edaac5-7fc8-4778-9a74-cb0146513b84_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_47d63235-757f-4c26-935a-081c64396ce9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_7c8371a6-7797-4cf8-8d95-cbda0d109bd2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_e7d636bc-24e3-40a2-9450-ed3195e7a210_terseLabel_en-US" xlink:label="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period, net of measurement period adjustments</link:label>
    <link:label id="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_label_en-US" xlink:label="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period, net of measurement period adjustments</link:label>
    <link:label id="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_documentation_en-US" xlink:label="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period, net of measurement period adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:href="lh-20221231.xsd#lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:to="lab_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1a04ee1e-bcc9-4260-992c-1fe95ab0050a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2.95seniornotesdue2029_3022576a-6611-4bfd-8fcf-632bae74f230_terseLabel_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_label_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:label id="lab_lh_A2.95seniornotesdue2029_documentation_en-US" xlink:label="lab_lh_A2.95seniornotesdue2029" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% senior notes due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029" xlink:href="lh-20221231.xsd#lh_A2.95seniornotesdue2029"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2.95seniornotesdue2029" xlink:to="lab_lh_A2.95seniornotesdue2029" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_37af4873-2439-4875-b753-c58a8a1d0422_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceTable" xlink:to="lab_us-gaap_ValuationAllowanceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1cb9ce9e-4171-43fb-80c4-1508eeed053b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_579565bb-29ea-4023-a4bd-085681d638a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant under the Company's stock option plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5233883a-bf3f-4035-ab65-f338e23b5666_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_39f22ed1-f7c8-4772-beae-dfb64a208f6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value, vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_d0e93b41-02f4-4d76-bd8a-16ca3a2e2fd3_terseLabel_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rollforward of common shares held in treasury [Abstract]</link:label>
    <link:label id="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract_label_en-US" xlink:label="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares Held In Treasury Rollforward [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:href="lh-20221231.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:to="lab_lh_CommonSharesHeldInTreasuryRollforwardAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Seniornotesdue2027Member_7c19f86a-1908-4375-b8d8-1877bbae1687_terseLabel_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_label_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:label id="lab_lh_Seniornotesdue2027Member_documentation_en-US" xlink:label="lab_lh_Seniornotesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Seniornotesdue2027Member" xlink:to="lab_lh_Seniornotesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_46926f91-ab6b-4dd7-be23-3b3c6878e310_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_bc8ab4a0-9843-445e-8d38-e92067448a77_netLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ff0bdeb7-6303-4f7c-83d4-2e26ac038b81_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total maturities, due beyond one year</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtherLiabilitiesNoncurrentOther_88c2b0b3-8c88-4385-9bff-a94578a1f684_terseLabel_en-US" xlink:label="lab_lh_OtherLiabilitiesNoncurrentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lh_OtherLiabilitiesNoncurrentOther_label_en-US" xlink:label="lab_lh_OtherLiabilitiesNoncurrentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Noncurrent, Other</link:label>
    <link:label id="lab_lh_OtherLiabilitiesNoncurrentOther_documentation_en-US" xlink:label="lab_lh_OtherLiabilitiesNoncurrentOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Noncurrent, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherLiabilitiesNoncurrentOther" xlink:href="lh-20221231.xsd#lh_OtherLiabilitiesNoncurrentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtherLiabilitiesNoncurrentOther" xlink:to="lab_lh_OtherLiabilitiesNoncurrentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_aa0e4956-7765-486b-b002-504dd6939021_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_86cf2b44-81fb-4746-91f2-e66c5eb95120_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_0bf68134-5963-4a94-9d0f-280022ed571a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (loss) before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_1397bfa4-1ea5-416f-9e90-eb3180604598_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements [Member]</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aca64474-06ec-42d1-bf13-8209ee67467b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_388f9f56-80fe-4739-95fd-b091a25367f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b35efdbd-11ad-4264-9bd1-722cfc7b6374_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SwapTypeAxis_e44c3132-c915-4f2f-acff-5f951fd0e2d7_terseLabel_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Axis]</link:label>
    <link:label id="lab_lh_SwapTypeAxis_label_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Axis]</link:label>
    <link:label id="lab_lh_SwapTypeAxis_documentation_en-US" xlink:label="lab_lh_SwapTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SwapTypeAxis" xlink:to="lab_lh_SwapTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_083aad77-748c-40b1-b13b-e7144e0225d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_25d3810d-d80f-4c41-a13d-79f92b5f0f03_terseLabel_en-US" xlink:label="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_label_en-US" xlink:label="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock plans</link:label>
    <link:label id="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_documentation_en-US" xlink:label="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate change in value for stock issued during the period as a result of employee stock purchase plan, combined the value of stock issued during the period as a result of the exercise of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:href="lh-20221231.xsd#lh_IssuanceOfCommonStockUnderEmployeeStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:to="lab_lh_IssuanceOfCommonStockUnderEmployeeStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_82d69430-e2bf-482d-9474-8ff5351b999b_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_217f3b77-8d85-412a-b5f5-ba415c63b87c_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_52bb4991-dc61-4aa3-89b6-74f9d70dffbb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired amortizable intangible assets and their respective weighted average amortization periods</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_d6cabaaf-4b58-44ec-acd0-acd46d68f3c4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1faa40ca-585b-40c6-8364-427c2a4ed6b6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OthercountriesMember_be45799f-a046-457b-8efa-d264d3ece0d8_terseLabel_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_label_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:label id="lab_lh_OthercountriesMember_documentation_en-US" xlink:label="lab_lh_OthercountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember" xlink:href="lh-20221231.xsd#lh_OthercountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OthercountriesMember" xlink:to="lab_lh_OthercountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_537e9936-b180-41dc-9069-ad9b6119a2f5_terseLabel_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_label_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of stock to employees</link:label>
    <link:label id="lab_lh_NetProceedsFromIssuanceOfStockToEmployees_documentation_en-US" xlink:label="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:href="lh-20221231.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:to="lab_lh_NetProceedsFromIssuanceOfStockToEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cb7ac7f3-89ec-40ef-a29b-3161f09bfbd4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_8cb23a41-8127-4e9d-98e6-0019092e0f10_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_367819bd-f077-46cf-b2bc-0d6c3fbd55c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_657fde2b-dec6-4236-b5c9-a48c28d7f656_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7a2da643-f67b-4c47-b4c7-f663fecf0d2d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_96e0c3ec-c6c8-49af-8aee-92f6be33a844_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_4bec8636-4cca-44ba-9418-31c0e0e70ad6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_37d3b102-1307-4567-8d35-3be404fc42df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_3f712ded-0083-4e8d-8222-b9cb915d2bc4_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_572bd3ba-d2e5-4076-8344-22664b7b8cd9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_367806bf-35f1-4a4d-a208-2eb2c55f0731_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_787b3e1e-755d-484f-9f37-003007e73140_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings Components [Text Block]</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_a338c1e4-df42-464c-8676-7037fdc5de56_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueRevenueRecognized1_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueRevenueRecognized1" xlink:to="lab_us-gaap_DeferredRevenueRevenueRecognized1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_b13a5dde-e3ed-4b8e-a81e-36736977b12e_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_f05cd467-a4d9-4c5a-bada-3eac644c9530_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d9637e8b-75b2-4770-a5ad-919a5fea887f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_a6ce8efe-d1e6-4958-b80f-7aaad235d993_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_38cf4d69-4ac4-4909-bff6-98b36bf4b9cf_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a68d02a5-d91c-4ae8-8023-3a9e60ff5514_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d8a67508-5a1a-413d-a25e-4ee0ba8e8c9b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_OtheracquireesMember_eeffda61-2485-48c5-8944-793d075a81da_terseLabel_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:label id="lab_lh_OtheracquireesMember_label_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:label id="lab_lh_OtheracquireesMember_documentation_en-US" xlink:label="lab_lh_OtheracquireesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other acquirees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_OtheracquireesMember" xlink:to="lab_lh_OtheracquireesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_304dd273-f180-45c2-80c7-23cc5d20d1d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_15c826c4-4e49-4566-9582-f77d26e93f8e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_b6339733-4b52-4dd2-8f11-79889052f6fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_9afa3a71-b61a-4f1d-9aeb-92684ddb1014_terseLabel_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_label_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:label id="lab_lh_LongTermContractsDurationMaximum_documentation_en-US" xlink:label="lab_lh_LongTermContractsDurationMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Contracts Duration Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LongTermContractsDurationMaximum" xlink:to="lab_lh_LongTermContractsDurationMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79c06bd8-eebf-435e-9629-84ac1e1b56e3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_4564f8c1-911d-46ac-8ef7-24c78b112593_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_22f06c78-602e-4fe9-bb68-14c34041a936_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_02bff4ed-3160-483d-9a36-fe33586ab3b8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_80937e65-d207-41c9-99c4-82e743afaf80_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3e08046f-354d-4f5d-8bb8-892760b0ccd1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3784d465-4d56-497c-be60-f7beb2eab629_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_673ea370-07ae-4f2f-af87-1dd54a08090f_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_5240e240-c40a-4875-9180-a4572a5021ba_verboseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian licenses [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_17133cb3-26a3-4945-9457-2c2d6bf89269_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b432e69e-78bc-4386-bd69-01c88443b9f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_c9d445f1-2175-477d-81e1-b1eb8ca6b411_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16c83c0e-5fc4-423d-8109-ed30efb3b508_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding shares, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_a8665a07-15b8-4f02-a9c5-db6733f48023_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d1e33cfb-6506-44d7-9c9e-c50ed8eab4c2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_4d6f008d-85e7-4cd8-abc2-dc996ce925be_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_ba702a66-04e3-4657-a3d6-893c673c007d_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69f40d85-d707-4b00-838b-464e9345a3a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Amendment [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Amendment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_5296fd36-9fe0-4797-8aa9-e3a4d90ed4b1_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_fca8c252-622c-4a20-b7d0-54191b820251_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_SwapTypeDomain_6f61ca80-cc5f-4e59-b23e-daa3e824a2da_terseLabel_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:label id="lab_lh_SwapTypeDomain_label_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:label id="lab_lh_SwapTypeDomain_documentation_en-US" xlink:label="lab_lh_SwapTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swap, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_SwapTypeDomain" xlink:to="lab_lh_SwapTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b3dea23c-ca70-4e25-bbb5-f0b7cefffb79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value, granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Percentofgrossaccountsreceivableduefrompatients_7e89d319-12e6-42f5-bc1d-540c3645876d_terseLabel_en-US" xlink:label="lab_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of gross accounts receivable due from patients</link:label>
    <link:label id="lab_lh_Percentofgrossaccountsreceivableduefrompatients_label_en-US" xlink:label="lab_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of gross accounts receivable due from patients</link:label>
    <link:label id="lab_lh_Percentofgrossaccountsreceivableduefrompatients_documentation_en-US" xlink:label="lab_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of gross accounts receivable due from patients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:href="lh-20221231.xsd#lh_Percentofgrossaccountsreceivableduefrompatients"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:to="lab_lh_Percentofgrossaccountsreceivableduefrompatients" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_31bfb908-512c-465d-a508-2c0f787af575_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_9fbe83dd-c0d2-4e0f-a2b5-444b5e264a15_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Contingentconsiderationadjustment_451c125c-31e3-4bad-afd0-fbcf6543fc11_negatedTerseLabel_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_label_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:label id="lab_lh_Contingentconsiderationadjustment_documentation_en-US" xlink:label="lab_lh_Contingentconsiderationadjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment" xlink:href="lh-20221231.xsd#lh_Contingentconsiderationadjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Contingentconsiderationadjustment" xlink:to="lab_lh_Contingentconsiderationadjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition_651530e6-e803-424f-a7f6-818f21f23676_terseLabel_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increase in Reserve From Acquisition</link:label>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition_label_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increase in Reserve From Acquisition</link:label>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition_documentation_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increase in Reserve From Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:href="lh-20221231.xsd#lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:to="lab_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_e05b7f37-1a09-46b4-b9b3-6629c21b0f0f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_8ee76419-374e-4364-9753-2e6280b7b669_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_310d8bbf-8cd4-40eb-9a05-92aa4349c6f3_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net earnings attributable to the noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e421563d-052f-41ca-9575-f8536fbfd1c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_594248fc-3c36-4e86-821f-0a4981663eca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d596779a-d4d8-4dbf-8179-2339898af2c1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from senior note offerings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_11eb67ec-da03-45bf-b879-9ab549d6fc7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_152fe130-36d4-4e06-8801-9707050da946_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid_baaf7b7d-f353-4406-b7c6-70982b0c0444_terseLabel_en-US" xlink:label="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable balances (gross) from Medicare and Medicaid</link:label>
    <link:label id="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid_label_en-US" xlink:label="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Accounts Receivable Medicare And Medicaid</link:label>
    <link:label id="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid_documentation_en-US" xlink:label="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross receivable balance due from Medicare and Medicaid programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:href="lh-20221231.xsd#lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:to="lab_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3b84b7f3-ee0e-4489-85db-60e320c9a2b7_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrued property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FederalLossCarryoverDomain_92b14190-3744-4680-96f1-ba7c34d8a4d0_terseLabel_en-US" xlink:label="lab_lh_FederalLossCarryoverDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Loss Carryover [Domain]</link:label>
    <link:label id="lab_lh_FederalLossCarryoverDomain_label_en-US" xlink:label="lab_lh_FederalLossCarryoverDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Loss Carryover [Domain]</link:label>
    <link:label id="lab_lh_FederalLossCarryoverDomain_documentation_en-US" xlink:label="lab_lh_FederalLossCarryoverDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Loss Carryover [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalLossCarryoverDomain" xlink:href="lh-20221231.xsd#lh_FederalLossCarryoverDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FederalLossCarryoverDomain" xlink:to="lab_lh_FederalLossCarryoverDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_43799e1e-f44e-41c6-8087-6667585b8e31_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostTableTextBlock" xlink:to="lab_us-gaap_CapitalizedContractCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_a9cfb7cc-d131-4bd4-adbe-b1f0bfd2aba7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_e5f95222-054b-4b13-94f0-ede34d85b0cb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_d31c34c4-4b42-45cb-9092-021dc4abd439_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_f96e0edc-54e9-46dd-8177-b4f7ef01e389_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d9bfece9-f107-41fe-8e2a-45c2077cd97e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6b9044b-5116-48a1-ba37-bc61e4b0df88_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Total</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_ea1a12b2-087b-4141-9d24-57d7ed6532f2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_38de2eea-2bf4-41cf-99cc-49e0e576c530_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-Term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_6705e92c-c7c8-47a8-a9b3-da2a4efd0da2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bded407a-e23a-48ef-a76a-c0208a6af51f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a1863a81-5c91-46db-8445-7f2b2e1001e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments, Net Benefit Plan Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e4e7774e-8cd0-493c-88ad-dafe36db50c7_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_fb13ff57-db2c-4508-ab02-025cf508ecbe_terseLabel_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:label id="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_label_en-US" xlink:label="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Uncertainty [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="lab_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_2e7a1e63-f556-427d-a729-53f0cf92da52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_f9cbb8e4-543f-417c-8324-609b8dd6092c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_e2e9e570-6edf-4b81-90a5-78d8727bf156_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Funded Status [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetFundedStatusTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_aa02b628-7da7-4786-9f82-3adc5e3b65ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_1b30ac73-6898-4f04-97fc-48a0864d428a_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_45684636-56b5-4513-b0a1-7c31a6f8570f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_8548e677-954e-454c-a23c-5f1f8f1e7107_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis" xlink:to="lab_us-gaap_ContractWithCustomerDurationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d7e7fa71-8d7a-4f99-9a79-0324303b6b7e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory U.S. rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_a3351e28-085b-43bf-854d-5dfeae998acd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2019TermLoan_e8cf77b9-b793-412f-b0a4-366be1b0f177_terseLabel_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:label id="lab_lh_A2019TermLoan_label_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:label id="lab_lh_A2019TermLoan_documentation_en-US" xlink:label="lab_lh_A2019TermLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan" xlink:href="lh-20221231.xsd#lh_A2019TermLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2019TermLoan" xlink:to="lab_lh_A2019TermLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_201788d3-2e58-4245-ab47-42e22a11d31f_terseLabel_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_label_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:label id="lab_lh_UnbilledServicesAllowanceforCreditLoss_documentation_en-US" xlink:label="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Services, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:href="lh-20221231.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnbilledServicesAllowanceforCreditLoss" xlink:to="lab_lh_UnbilledServicesAllowanceforCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_f78e46db-a015-4dec-a3da-5bc73b1e82ca_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_24cd2510-df93-4d3c-b528-8303e90c1fa7_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the employee's purchase right</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Fair Value Employee Purchase Right</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The fair value of the employee's purchase right calculated using the Black-Scholes model.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:to="lab_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_38e025e3-8fbb-4dfd-8722-1ec71194282a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_e5bce3b6-251d-47cd-8472-a085e3ed716d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Hedging Activity</link:label>
    <link:label id="lab_us-gaap_GainLossOnOilAndGasHedgingActivity_label_en-US" xlink:label="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Hedging Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:to="lab_us-gaap_GainLossOnOilAndGasHedgingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d1eef836-deb9-45e7-b524-ea8d8a6d1c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0c2569ba-ca48-4b39-8eb4-8d200032c940_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_285ffb22-9045-49f8-a3e2-e8a93476836b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of U.S. federal income tax effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_61483173-ced2-4719-985f-719385b82a00_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_1719403c-6e2c-4568-bc44-5400b3f47761_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of deferred tax assets and liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock_885e73a6-a15a-4f58-af81-67c56c082240_terseLabel_en-US" xlink:label="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Disclosure Table Text Block</link:label>
    <link:label id="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Disclosure Table Text Block [Table Text Block]</link:label>
    <link:label id="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock_documentation_en-US" xlink:label="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Disclosure Table Text Block</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:href="lh-20221231.xsd#lh_LeaseDisclosureTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:to="lab_lh_LeaseDisclosureTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8f7a3fa8-9341-4d0e-8ab4-f0790846332a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Financial Statement Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4fde6c4f-ff16-47d9-8663-d634cbe11300_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9720bbea-177a-42f9-8ef8-fdf55e03aa4e_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7155ec3f-b57a-4c20-a1df-130d106704a1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_081ddd8e-3ef3-404f-93e9-e405533655fc_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under capital leases [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_label_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held under Capital Leases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:to="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_2be1e903-a090-4ded-9cec-e6bac7cd762c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_84f14c92-a968-4096-9f69-a3a230fc9b47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_71fe29ab-d243-488a-b40d-24f0acfabdf4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_19547ff3-6c01-4c1f-8bef-43fd6e8fa117_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c2e25ec0-c899-4260-9669-4f89dae17e74_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_5dba1a59-512b-4f81-b1ee-9072c2e0eba1_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_1fb68530-172c-4628-af15-0116523ff3a0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RESTRUCTURING AND OTHER SPECIAL CHARGES</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_c1df1fe8-9a63-4f08-8efe-99f65b0e0a20_terseLabel_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_label_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts</link:label>
    <link:label id="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_documentation_en-US" xlink:label="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:to="lab_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7054df24-f774-49cc-8489-385b64decf4c_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d0adf39f-f5c3-45a2-b802-d7e93b76b158_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_52ef6c8a-c1b7-48ad-82e8-b1119d671bf4_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Earnings, balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e93bc156-b8fe-4aeb-895c-6f585013fda0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_ba21a159-4553-498b-8030-c5a33631fbca_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_MeasurementPeriodAdjustmentsMember_c20ae718-2858-4508-af7a-b926a16cb1da_terseLabel_en-US" xlink:label="lab_lh_MeasurementPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments</link:label>
    <link:label id="lab_lh_MeasurementPeriodAdjustmentsMember_label_en-US" xlink:label="lab_lh_MeasurementPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments [Member]</link:label>
    <link:label id="lab_lh_MeasurementPeriodAdjustmentsMember_documentation_en-US" xlink:label="lab_lh_MeasurementPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MeasurementPeriodAdjustmentsMember" xlink:href="lh-20221231.xsd#lh_MeasurementPeriodAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_MeasurementPeriodAdjustmentsMember" xlink:to="lab_lh_MeasurementPeriodAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_cb727f1d-4428-47f7-bb20-01aa5327a4fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance_f672e790-d53e-4e43-9f2a-58eff3bba97c_terseLabel_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforward Valuation Allowance</link:label>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance_label_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforward Valuation Allowance</link:label>
    <link:label id="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance_documentation_en-US" xlink:label="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal and State Attribute Carryforward Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:href="lh-20221231.xsd#lh_FederalandStateAttributeCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:to="lab_lh_FederalandStateAttributeCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3f0a9e81-5ea7-4f3d-9d74-62a656fc589d_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock_90b4f905-af28-4264-904c-24547e42e43e_terseLabel_en-US" xlink:label="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Benefit Payments By Year [Table Text Block]</link:label>
    <link:label id="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock_label_en-US" xlink:label="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Benefit Payments By Year [Table Text Block]</link:label>
    <link:label id="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock_documentation_en-US" xlink:label="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A schedule of assumed benefit payments for future periods by year. This element may be used for defined benefit, nonqualified supplemental retirement, and post-retirement benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:href="lh-20221231.xsd#lh_AssumedBenefitPaymentsByYearTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:to="lab_lh_AssumedBenefitPaymentsByYearTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_f9a8da5a-bc73-4796-a3e4-e572ab52ac6f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerDurationDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Duration [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerDurationDomain" xlink:to="lab_us-gaap_ContractWithCustomerDurationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_34da234a-e756-49af-91df-4ea276559c8a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1d7f919f-f699-4bd3-9d08-5d3b53d08fa1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_7d62221f-3689-4ad2-b7d0-a69092727fb2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_eaacb08f-7c6e-4cae-b3f0-a8a37a4a6161_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested restricted stock and performance share-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage_5b9b20bd-a943-4416-a1b5-5bc3438884cc_terseLabel_en-US" xlink:label="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum threshold percentage required to recognize income tax benefit (in hundredths)</link:label>
    <link:label id="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage_label_en-US" xlink:label="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Benefit Minimum Certainty Percentage</link:label>
    <link:label id="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage_documentation_en-US" xlink:label="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For tax positions that are more likely than not to be sustained on audit by the taxing authority, the entity recognizes the largest amount of tax benefit that it believes exceeds a minimum likelihood of being recognized. This element represents the minimum percentage of likelihood that a tax benefit will be realized that the entity uses to assess if a benefit should be recognized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:href="lh-20221231.xsd#lh_IncomeTaxBenefitMinimumCertaintyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:to="lab_lh_IncomeTaxBenefitMinimumCertaintyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeAbstract_2e0f37b0-8a3c-47ec-94e3-46635841548e_terseLabel_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:label id="lab_lh_IncomeAbstract_label_en-US" xlink:label="lab_lh_IncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract" xlink:href="lh-20221231.xsd#lh_IncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeAbstract" xlink:to="lab_lh_IncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_6ad1fa9a-2e73-43c8-a9c1-b2744969de3c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT, NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_67463bfb-ec79-4b0a-8aed-7054b0867b74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_91501b68-18b0-40be-b67f-1b83618fa6e6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_1778f3c1-eed9-40a3-94f0-749ede184e23_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_07a1fdcc-343c-4aa7-996c-40d2a3aa660c_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_0eade1fe-955c-496b-b348-027389cbfaee_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_394821f8-aafb-4ba4-90fd-08e9f08db5b8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_767642a4-5feb-495e-8c29-14add9dc1556_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_03c705fb-489b-4570-9e94-d818f28bd2b8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_3517ddd0-6d2e-4b11-980c-119be210324f_terseLabel_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-term Contracts</link:label>
    <link:label id="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_label_en-US" xlink:label="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of Deferred Costs Related to Long-Term Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:to="lab_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_46ed0b16-2262-480c-b82f-c96572199e8a_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fb9d1682-af73-4178-a9ca-b8c20a3d914d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2014</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReductionInTaxesMember_535b888a-d794-4f51-832d-e7b13b448632_terseLabel_en-US" xlink:label="lab_us-gaap_ReductionInTaxesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Taxes</link:label>
    <link:label id="lab_us-gaap_ReductionInTaxesMember_label_en-US" xlink:label="lab_us-gaap_ReductionInTaxesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reduction in Taxes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReductionInTaxesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReductionInTaxesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReductionInTaxesMember" xlink:to="lab_us-gaap_ReductionInTaxesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_965eaaee-8760-4e40-8e2e-590662034f0c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price per option granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_0eda3b39-84a2-461d-8072-6df4e8963d56_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_849b3172-9ee8-4aa1-a5d8-6004dbbb912b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest_daf0d301-6222-42a3-a931-2c5118a5856e_terseLabel_en-US" xlink:label="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of Accrued Income Tax Penalties And Interest</link:label>
    <link:label id="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest_label_en-US" xlink:label="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of Accrued Income Tax Penalties And Interest</link:label>
    <link:label id="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest_documentation_en-US" xlink:label="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of Accrued Income Tax Penalties And Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:href="lh-20221231.xsd#lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:to="lab_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_de19c93d-b3e6-45b1-82d3-52f44009583d_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_12859289-75b6-4b80-bdc5-93e78cb93da8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined-benefit plan obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d546e18a-1de1-40ba-abcc-e120981c7361_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_9ef5713b-b994-45fe-8359-b360e620d92c_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c8b92ead-9703-4cd4-801d-273f8a78f7b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price per exercisable option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ae0c8225-198d-4fac-af63-285049939c03_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingent liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d9156969-0a9a-4cb1-9af5-5a7c80c5b3f3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fb59ac00-9100-45e8-bbaa-47d5150ab37b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan_b2da6433-407b-424a-963a-2b7f6f2e082c_terseLabel_en-US" xlink:label="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from Ontario government sponsored healthcare plan</link:label>
    <link:label id="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan_label_en-US" xlink:label="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from Ontario government sponsored healthcare plan</link:label>
    <link:label id="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan_documentation_en-US" xlink:label="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable from Ontario government sponsored healthcare plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:href="lh-20221231.xsd#lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:to="lab_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3b02dc3b-a0ca-4aa8-b8dd-4361e8f1aeea_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fc14c501-965b-4d9c-91e3-f6806600d856_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_b699c215-4664-4e2c-8cee-e872919bc7b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_91c51ef3-faf9-43e0-96dc-ff4bae343344_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_59e3414f-0ccb-4231-b230-eecadae118fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_a2318384-0e1e-45ad-8e6a-7650b67e83db_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_b1c2a6b3-b56e-4df6-8c6f-d86582298357_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:label id="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_label_en-US" xlink:label="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Date Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="lab_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_01317dfd-a9da-4dc0-8eae-c1798cca8078_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e629b36d-dfd8-4f55-b8cf-823eec3e8bf2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_909b82d8-2967-4e7b-ad11-468bd35cb311_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum_58302ae6-8201-439b-92e0-23782c6719a3_terseLabel_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software minimum</link:label>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum_label_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software minimum</link:label>
    <link:label id="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum_documentation_en-US" xlink:label="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property plant and equipment useful life software minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwareminimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:to="lab_lh_Propertyplantandequipmentusefullifesoftwareminimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_e576a6e9-95d6-43eb-80f0-2d9acbbccb7e_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_e20cf599-0255-475c-ad0d-e0d8e1f667eb_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_9e626fc3-ef57-4145-b665-1961b051853d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_9aa06c53-10d2-41eb-bced-40a77707851c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_c8039b35-a896-484d-8c20-5cc33408dd9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_dffb7650-373d-4fb8-9dcc-d1ee648be52d_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d09142d0-6444-4af3-83d8-7165e40cd600_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b679a9f8-e307-491f-ada0-47bb92cb3e7d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_81bbd4fc-32e2-4a92-adb2-8484fdb25d3a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2022SwapAgreementsMember_6a7e10a7-00cc-4e70-8948-1fe078d4fb06_terseLabel_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements</link:label>
    <link:label id="lab_lh_A2022SwapAgreementsMember_label_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements [Member]</link:label>
    <link:label id="lab_lh_A2022SwapAgreementsMember_documentation_en-US" xlink:label="lab_lh_A2022SwapAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Swap Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember" xlink:href="lh-20221231.xsd#lh_A2022SwapAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2022SwapAgreementsMember" xlink:to="lab_lh_A2022SwapAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_d2975fd3-3590-463a-b42e-e83cb0e6f861_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_a82718f3-acdc-40f3-9dda-67d94dbd7e3f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_1a66d7f9-ea06-4376-8372-84e259634257_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_b55f56c0-b16b-4978-b137-8a658dc8afce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_c3d27365-8d11-4e56-b4bf-dba3cadcacaf_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_c0c14439-6323-4bee-8682-e7b99f309979_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate for the Company Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_9dd269a0-45a1-488b-b28b-7ab9330be36b_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanNameAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanNameAxis" xlink:to="lab_us-gaap_RetirementPlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_7acc9d96-1e87-4f9c-9149-6ac8ed64d504_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_5f4adb92-78aa-4b57-a9a0-f40cdee12ab3_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_7763dda2-31b1-41d3-a45d-a33503b6e45f_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_ef9f63a9-54ea-481b-9962-e3ea32c96dbb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_63e520cc-e2d6-4865-ba6e-9e402d15ab05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_RestrictedStockPerformanceSharesExpense_714e6a34-20f5-4b73-b141-2af82f8414da_terseLabel_en-US" xlink:label="lab_lh_RestrictedStockPerformanceSharesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock and performance share compensation expense</link:label>
    <link:label id="lab_lh_RestrictedStockPerformanceSharesExpense_label_en-US" xlink:label="lab_lh_RestrictedStockPerformanceSharesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Performance Shares Expense</link:label>
    <link:label id="lab_lh_RestrictedStockPerformanceSharesExpense_documentation_en-US" xlink:label="lab_lh_RestrictedStockPerformanceSharesExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The noncash expense that represents the cost of restricted stock and performance shares distributed to employees as compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockPerformanceSharesExpense" xlink:href="lh-20221231.xsd#lh_RestrictedStockPerformanceSharesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_RestrictedStockPerformanceSharesExpense" xlink:to="lab_lh_RestrictedStockPerformanceSharesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_MutualFundsMember_fb4f322b-754d-49a6-a47b-adf671753014_terseLabel_en-US" xlink:label="lab_lh_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:label id="lab_lh_MutualFundsMember_label_en-US" xlink:label="lab_lh_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:label id="lab_lh_MutualFundsMember_documentation_en-US" xlink:label="lab_lh_MutualFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MutualFundsMember" xlink:href="lh-20221231.xsd#lh_MutualFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_MutualFundsMember" xlink:to="lab_lh_MutualFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_2c7d231b-df5d-408f-aa70-e48802ca831b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties related to unrecognized income tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_0b35dae7-f585-406e-b7ae-e639c55170df_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCRUED EXPENSES AND OTHER</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions_cfe0bca3-ecac-4bab-bc7e-e0e31c61c073_negatedTerseLabel_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in reserve as a result of payments</link:label>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions</link:label>
    <link:label id="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions_documentation_en-US" xlink:label="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change in unrecognized tax benefits resulting from tax positions taken in prior period tax returns, excluding amounts pertaining to examined tax returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="lh-20221231.xsd#lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9ceb0265-5fc7-444e-8018-efd45295e119_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_39bc2ca3-8241-4a3f-b520-fe30ad87279f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e3c091c1-0745-47dc-b410-c9583687011a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_1bc325ec-6870-4ec8-9c55-b7560c7ed283_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_a42ad39f-a19b-41b8-a14b-5c969858a1f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_bd8c3e66-2e35-4cd0-85da-aeedadc43cd8_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_6cffd6d6-7f87-435f-9fad-51726d19b845_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issued and outstanding [Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_7bb74dca-4eec-4686-8b44-9fdf8584f6af_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_7296b553-7a18-4040-ad35-57084b79abb9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_aeab3a9c-9658-426a-8b1a-743ebea4fb44_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrecognized income tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_97c40432-4111-42c1-a3e9-ca9b7f970589_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f023506b-8cd7-44b8-816d-302e24849082_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_46ac0421-7409-4ad4-a742-3140904c56a3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_a22ca156-1b87-4877-84b7-beee2dba207e_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EnergyAxis_5cc4c422-9a45-4e18-bdb8-7209e9630c98_terseLabel_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:label id="lab_srt_EnergyAxis_label_en-US" xlink:label="lab_srt_EnergyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Energy [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EnergyAxis" xlink:to="lab_srt_EnergyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_0b466d36-0f63-466b-aaba-f04e480dff27_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_8f7282df-3bb2-4287-bc2d-bfbf357bcec6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_8fdd9c53-6b49-4767-a0f8-27956bd58b96_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b7ccb79d-9acc-44e0-bbe7-db17056f29a3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_4fcc3b62-bcd5-4b31-ba01-41ef1133b318_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_cfcf38a3-a724-410f-83ca-9692467ed8db_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_A2022ASRSettlementMember_b41ef6ab-86bc-4599-bc49-94147c88bea2_terseLabel_en-US" xlink:label="lab_lh_A2022ASRSettlementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR Settlement</link:label>
    <link:label id="lab_lh_A2022ASRSettlementMember_label_en-US" xlink:label="lab_lh_A2022ASRSettlementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR Settlement [Member]</link:label>
    <link:label id="lab_lh_A2022ASRSettlementMember_documentation_en-US" xlink:label="lab_lh_A2022ASRSettlementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 ASR Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ASRSettlementMember" xlink:href="lh-20221231.xsd#lh_A2022ASRSettlementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_A2022ASRSettlementMember" xlink:to="lab_lh_A2022ASRSettlementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_9aca56bf-e648-43ec-83b2-fa074e074a3d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_3b95b0da-622d-44da-90b0-77742f60686c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_90acd9c7-0201-4b1e-9acf-642dd14030bc_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cf2ebca7-fa0c-4532-bffa-076b132a4754_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_51297f56-ebfb-4606-b402-d03bd0780271_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Provision) benefit for income tax related to items of comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_8c4c62c1-a903-40a6-8c6f-6b9ebeeb857a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect of adjustments, Accumulated Other Comprehensive Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_debfaf8c-4fd3-4cd5-937c-f01f3cc7e1b4_negatedTerseLabel_en-US" xlink:label="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:label id="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_label_en-US" xlink:label="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Tax Benefit - Share-based Compensation, Financing Activities</link:label>
    <link:label id="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_documentation_en-US" xlink:label="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Tax Benefit - Share-based Compensation, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:href="lh-20221231.xsd#lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:to="lab_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableAnnuityMember_908546da-06a4-46fd-a055-1996a6f440db_terseLabel_en-US" xlink:label="lab_us-gaap_VariableAnnuityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Annuity [Member]</link:label>
    <link:label id="lab_us-gaap_VariableAnnuityMember_label_en-US" xlink:label="lab_us-gaap_VariableAnnuityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Annuity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableAnnuityMember" xlink:to="lab_us-gaap_VariableAnnuityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_15c90f27-9476-4574-a7fe-9a6e9f5e94c7_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_141993ec-0f4a-4e9b-9e9b-4451a4b7ea1a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_a0f4a5cd-8c16-4785-908e-253c9e7f52f3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_2640cf9c-45a9-4019-9861-258ebf6381d7_terseLabel_en-US" xlink:label="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance share awards, vesting conditions</link:label>
    <link:label id="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_label_en-US" xlink:label="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement Performance Share Awards Vesting Conditions</link:label>
    <link:label id="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_documentation_en-US" xlink:label="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of performance share award terms as to how many shares or portion of an award are no longer contingent on satisfaction of certain performance conditions, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:href="lh-20221231.xsd#lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:to="lab_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_ace4a5a6-c814-4dc3-a192-8296a5c68351_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_796f71e0-6fe9-4acd-bbe6-4eee1cdb5ef7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_4a8cab23-aee9-4773-96ff-2ab8d9980715_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_16283d23-8cc7-45fe-8127-b76954277131_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_NetRestructuringCharges_7495c377-853c-475b-aca2-d62d4510ca73_terseLabel_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_1c482768-c232-473b-b9cb-2dce53efade4_negatedTerseLabel_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_label_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Restructuring Charges</link:label>
    <link:label id="lab_lh_NetRestructuringCharges_documentation_en-US" xlink:label="lab_lh_NetRestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_NetRestructuringCharges" xlink:to="lab_lh_NetRestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_cb01e5d1-5d68-4760-9e51-3b9510c1f794_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_d8d9c5ad-3873-4eeb-a287-e4710f3ad67f_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_72b42b33-74ad-425b-8b82-6d6b897cf8a2_netLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_d12853cb-37c5-4277-973f-f29d7a7b0309_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_28111ad6-e05d-41b7-9e8f-6cd515253855_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateFairValueHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Fair Value Hedge Asset at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateFairValueHedgeAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Fair Value Hedge Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue" xlink:to="lab_us-gaap_InterestRateFairValueHedgeAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_01765e68-379e-41da-a3fe-1fe402f34427_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_967c0419-57b5-4de2-9407-67c4b1ed0620_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_6cc65226-2c2e-47b8-8e56-27da1b164182_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_9ce5fc33-ec49-4272-82be-4a9858f997c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_480a2af1-90e7-4330-92f6-4310b106432d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7f66f1b7-b5b6-46ee-b7fa-784b664ec0d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_173b1373-afe8-406e-9bfe-c2fe542a027e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_b7a4d651-14c3-4df7-934a-08cd2c20e46f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_FederalTaxLossCarryovers_47e06577-a847-4e6e-9bf4-73a21a212c5d_terseLabel_en-US" xlink:label="lab_lh_FederalTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax loss carryovers</link:label>
    <link:label id="lab_lh_FederalTaxLossCarryovers_label_en-US" xlink:label="lab_lh_FederalTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Tax Loss Carryovers</link:label>
    <link:label id="lab_lh_FederalTaxLossCarryovers_documentation_en-US" xlink:label="lab_lh_FederalTaxLossCarryovers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The federal loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalTaxLossCarryovers" xlink:href="lh-20221231.xsd#lh_FederalTaxLossCarryovers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_FederalTaxLossCarryovers" xlink:to="lab_lh_FederalTaxLossCarryovers" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_EmployeeStockPurchasePlanMember_04faa5de-2390-4c2c-bfb6-6005f1214c00_terseLabel_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lh_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_lh_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan in the entity's stock incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanMember" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_EmployeeStockPurchasePlanMember" xlink:to="lab_lh_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ebc9da6d-b872-4ade-8380-c776017d968a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_7eff322f-ba0c-4f1f-9576-5959cb967cd6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_555f0f62-b92e-446f-88d2-08a630a348be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e9dd0b27-a44f-4166-8f27-87375b699061_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_6723c16b-0e61-43a1-9728-c94eac90b46d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_1a1fb4aa-7708-4626-8355-a94282c50a0c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesExpense_6a7eb183-c6b6-4020-91e1-c5c9477611dd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties Expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_6125e84e-51af-4a1f-9103-3e3461c9271e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_bd3e651c-9083-41b2-9c85-ce322f448261_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_f532973c-1fe7-42a2-83ef-a8d54bdf17aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserves</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d82ca97c-34a4-4a93-87a2-b2b6e49ecca8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated amortization expense, 2017</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_760fb47e-5c09-4657-8afe-b1e5f5dda0ee_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_5ab471bc-1f79-4d69-9204-5f7f2e53491d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_0d3fb5b5-780e-4306-b539-f0dfd89a9e4c_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_6127ba3f-7ced-442c-b30b-405f25caa065_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_47b188ca-a4a5-4f1c-bd65-87890531263d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies by Nature of Contingency [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_b5c928e6-3e58-41ec-bf8b-7c74bccf0a6d_totalLabel_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_71906306-21d5-4ecf-af4c-d3c2fcd493bb_terseLabel_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total pre-tax income</link:label>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_label_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss from Continuing Operations Before Income Taxes and Minority Interest</link:label>
    <link:label id="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_documentation_en-US" xlink:label="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:to="lab_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_9a40e67b-5591-4a3a-ac7e-6f42862aa269_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_60d6185a-58a4-4462-bbe1-b950974661f3_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_2dc2a7d6-c34b-45cb-80b5-8c1ca99a0f2f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_922944db-4df7-4733-8de3-b55cd8435a29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_090aa9c8-c721-49be-b3b9-12484f58b860_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_8e0843e3-58d6-4c81-8398-686b1fba1f4b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock_5b296ffa-4f32-4ec2-87cc-d7b3e88ef69a_terseLabel_en-US" xlink:label="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Fair Value Of Plan Assets By Category [Table Text Block]</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock_label_en-US" xlink:label="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Fair Value Of Plan Assets By Category [Table Text Block]</link:label>
    <link:label id="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock_documentation_en-US" xlink:label="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A schedule of plan assets at fair value by asset category.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:to="lab_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_52585c3d-903f-451b-86eb-392155ce40e9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_18beae08-c165-4555-8c32-c25070f8af47_terseLabel_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_label_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:label id="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_documentation_en-US" xlink:label="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biopharmaceutical and medical device companies [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:href="lh-20221231.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:to="lab_lh_BiopharmaceuticalandmedicaldevicecompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_PercentofRevenueContributed_a7111bff-b010-46c2-b94c-a2673b31a705_terseLabel_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_label_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:label id="lab_lh_PercentofRevenueContributed_documentation_en-US" xlink:label="lab_lh_PercentofRevenueContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Revenue Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed" xlink:href="lh-20221231.xsd#lh_PercentofRevenueContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_PercentofRevenueContributed" xlink:to="lab_lh_PercentofRevenueContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_1d5ac605-5e3f-4351-b20b-b914bd86742b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_b8253fab-9d30-4627-a1ef-8cc38b29d086_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3b804ed9-3558-40ee-8d7a-c3d08cca7a67_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_ad9fc8ae-dc04-4593-a418-d804e3b93bc3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_27289425-3609-45f5-b217-f93567c4cbe7_terseLabel_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_label_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:label id="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_documentation_en-US" xlink:label="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of remaining performance obligations recognized as revenue in next year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:href="lh-20221231.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:to="lab_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>24
<FILENAME>lh-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:4664d68f-34ba-4bef-ab9c-f02b1398a970,g:e4c54786-8b07-43b9-9b9c-94607999a3b5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.labcorp.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="lh-20221231.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:to="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_baa52890-deb2-49aa-98ed-71a5996f179b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_24032494-3e17-46bd-84af-f47d1fb526b0" xlink:to="loc_dei_DocumentDomain_baa52890-deb2-49aa-98ed-71a5996f179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_b2ee35ff-bc5e-408d-bfb7-2abc52f9ef09" xlink:to="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_05df7cdb-f0c6-4d6e-91c2-c8c623347200" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorFirmId_05df7cdb-f0c6-4d6e-91c2-c8c623347200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_a247c771-e7b2-44b4-bac5-d3f9867f2d9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorLocation_a247c771-e7b2-44b4-bac5-d3f9867f2d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_66f27c48-8b25-4ea5-9179-f56802133312" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_AuditorName_66f27c48-8b25-4ea5-9179-f56802133312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_39e5ce87-582e-4e4d-80fe-575758654a96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_IcfrAuditorAttestationFlag_39e5ce87-582e-4e4d-80fe-575758654a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_8424d15c-cc1a-40c6-8463-cd4ec524b50d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_46dfbe42-ac4c-44b6-a3c1-ce4b9e62e49f" xlink:to="loc_dei_EntityVoluntaryFilers_8424d15c-cc1a-40c6-8463-cd4ec524b50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_5abf5471-89d9-4342-abfc-0edd6b8d00ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentType_5abf5471-89d9-4342-abfc-0edd6b8d00ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_278904b2-3bc7-487c-b66c-c0a29d63d9a5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentAnnualReport_278904b2-3bc7-487c-b66c-c0a29d63d9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ffddd4e2-f00c-47bc-9110-8f34905afc21" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentPeriodEndDate_ffddd4e2-f00c-47bc-9110-8f34905afc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8944d98a-4e6e-4235-ae87-d568db6cf5ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentTransitionReport_8944d98a-4e6e-4235-ae87-d568db6cf5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f1f671a-43ad-4812-a980-087547dfbee7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityFileNumber_2f1f671a-43ad-4812-a980-087547dfbee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ad0b93a9-e065-4f3c-8c3f-273b867752be" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityRegistrantName_ad0b93a9-e065-4f3c-8c3f-273b867752be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_96bab548-9fe6-4cc2-a9b6-903c6099c65a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityCentralIndexKey_96bab548-9fe6-4cc2-a9b6-903c6099c65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a855e0d3-b7fa-4371-9126-10742f96b63e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_CurrentFiscalYearEndDate_a855e0d3-b7fa-4371-9126-10742f96b63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_67a96b71-a974-4deb-8df6-d84916811b34" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentFiscalYearFocus_67a96b71-a974-4deb-8df6-d84916811b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e29a1140-53c2-486b-ae95-47760f162423" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e29a1140-53c2-486b-ae95-47760f162423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c7a72509-6044-4898-9aae-84856e511b86" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_AmendmentFlag_c7a72509-6044-4898-9aae-84856e511b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_942ad37d-8342-4665-af7a-1f50ad67eb44" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityIncorporationStateCountryCode_942ad37d-8342-4665-af7a-1f50ad67eb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a1d144f0-ba39-446f-831f-232c63bedcaa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityTaxIdentificationNumber_a1d144f0-ba39-446f-831f-232c63bedcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_31ddfeb5-e1b8-47bd-9e89-a556a1133781" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityAddressAddressLine1_31ddfeb5-e1b8-47bd-9e89-a556a1133781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2944cfc3-cc76-4cb3-bf0b-18fc6024e51d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityAddressCityOrTown_2944cfc3-cc76-4cb3-bf0b-18fc6024e51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b35e4d77-cb22-4695-914e-cd65e4f0b8d3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityAddressStateOrProvince_b35e4d77-cb22-4695-914e-cd65e4f0b8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a08c4cb-1db3-4137-8213-4efb371bcc91" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityAddressPostalZipCode_6a08c4cb-1db3-4137-8213-4efb371bcc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b06aad0e-2261-462c-80dd-2fc1cdd3f4d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_CityAreaCode_b06aad0e-2261-462c-80dd-2fc1cdd3f4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_79b41ca9-69ba-47c4-9646-39cd35adf30a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_LocalPhoneNumber_79b41ca9-69ba-47c4-9646-39cd35adf30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d7bfcdd1-21d6-40fa-a63f-0f615da5de75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_Security12bTitle_d7bfcdd1-21d6-40fa-a63f-0f615da5de75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d5e2aaab-cf51-4913-a5d8-bdb84ea86722" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_TradingSymbol_d5e2aaab-cf51-4913-a5d8-bdb84ea86722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fb4599fb-b537-43c4-a0d1-c4f5157a9956" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_SecurityExchangeName_fb4599fb-b537-43c4-a0d1-c4f5157a9956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_e442fc5e-4449-4151-872e-8272a95349bc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityInteractiveDataCurrent_e442fc5e-4449-4151-872e-8272a95349bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0a2044df-e3ef-409d-9853-88b574497f01" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityFilerCategory_0a2044df-e3ef-409d-9853-88b574497f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_f4f19cad-2d9e-4636-9180-d176b637e61e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntitySmallBusiness_f4f19cad-2d9e-4636-9180-d176b637e61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cc75b936-6769-44f4-b6c9-7844e2ead86e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityEmergingGrowthCompany_cc75b936-6769-44f4-b6c9-7844e2ead86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ae3afa24-2f33-4882-b2d2-22580d863502" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityShellCompany_ae3afa24-2f33-4882-b2d2-22580d863502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_8c501f4a-091c-49e2-9bb0-5784a9461ff7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityPublicFloat_8c501f4a-091c-49e2-9bb0-5784a9461ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_79220626-9515-4662-ba0e-baff4dc91818" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_79220626-9515-4662-ba0e-baff4dc91818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f2ca4243-54e4-4cc3-aedf-b4f79aa11e57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f54e3b6-d7f4-4798-85c9-0ab3d96c64ce" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f2ca4243-54e4-4cc3-aedf-b4f79aa11e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2cb4d10b-38cf-47f6-b703-cf012bea8ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2cb4d10b-38cf-47f6-b703-cf012bea8ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7d92428c-f35e-480e-ab5a-63a6d412a5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2cb4d10b-38cf-47f6-b703-cf012bea8ea8" xlink:to="loc_us-gaap_ProfitLoss_7d92428c-f35e-480e-ab5a-63a6d412a5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2cb4d10b-38cf-47f6-b703-cf012bea8ea8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9887951f-62e7-4889-a25b-efb4faf714e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9887951f-62e7-4889-a25b-efb4faf714e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_00995e79-e575-44c3-b554-b9212e0c2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_ShareBasedCompensation_00995e79-e575-44c3-b554-b9212e0c2f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DepreciationAndAmortizationOfLeasedAssets_71898969-b8c6-4f8e-be77-6847176e6ad6" xlink:href="lh-20221231.xsd#lh_DepreciationAndAmortizationOfLeasedAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_lh_DepreciationAndAmortizationOfLeasedAssets_71898969-b8c6-4f8e-be77-6847176e6ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_12dd899e-e34b-4a31-a052-f4d3df79d6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_12dd899e-e34b-4a31-a052-f4d3df79d6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a6476437-ab18-41dd-93d4-859878b6d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_a6476437-ab18-41dd-93d4-859878b6d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_355867df-48c1-4724-9080-c7d8c71e164f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_355867df-48c1-4724-9080-c7d8c71e164f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_30b8cc75-311d-4add-9e07-6f7efbfea6b6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6fae4678-da6a-4ac2-af71-82ebc725406e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6fae4678-da6a-4ac2-af71-82ebc725406e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_231cf849-cb41-4423-9073-cb349b4e39e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_231cf849-cb41-4423-9073-cb349b4e39e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_25543fd5-ea0d-4d32-93ee-d8fb5de4aff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_25543fd5-ea0d-4d32-93ee-d8fb5de4aff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fb4c068b-e547-4258-bc39-2e59f2fe6e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fb4c068b-e547-4258-bc39-2e59f2fe6e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f8220953-e6e4-416d-ae43-eab17b8d3b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f8220953-e6e4-416d-ae43-eab17b8d3b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5bbcbf5c-31a0-4720-befd-643dc06745e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5bbcbf5c-31a0-4720-befd-643dc06745e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_948996e8-4d6a-4ea3-8511-5e7b4e6b33be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_74f346a1-e40b-438a-8d9c-1b0f088b6bc0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_948996e8-4d6a-4ea3-8511-5e7b4e6b33be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7afee1a1-1f63-42d2-9c22-01675ff9f74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2cb4d10b-38cf-47f6-b703-cf012bea8ea8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7afee1a1-1f63-42d2-9c22-01675ff9f74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_888a0186-905e-4eaa-b2d9-beda7e7d275f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_888a0186-905e-4eaa-b2d9-beda7e7d275f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_83399542-b051-4eff-a099-b38f01a5fd4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_83399542-b051-4eff-a099-b38f01a5fd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_e1457593-2199-4b03-8a41-db81eb2d4f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_ProceedsFromSaleOfOtherInvestments_e1457593-2199-4b03-8a41-db81eb2d4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d13bb275-618b-4dc1-bf01-8f344a98b373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_d13bb275-618b-4dc1-bf01-8f344a98b373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_fd43b0f0-1cee-48b7-af04-f807c0bd8e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities_fd43b0f0-1cee-48b7-af04-f807c0bd8e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6918d75f-9811-423f-8ad2-46e7d3045e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_6918d75f-9811-423f-8ad2-46e7d3045e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_663b1f91-7620-4009-8b4a-0892493895ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_663b1f91-7620-4009-8b4a-0892493895ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_deca54b5-4bf1-40bf-b94d-5696b78a674b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0e9a8812-d37a-40fa-8c96-76b0482f155a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_deca54b5-4bf1-40bf-b94d-5696b78a674b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1d6c7291-37b9-4933-9749-f7d687bc0f22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1d6c7291-37b9-4933-9749-f7d687bc0f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_1b9812b4-b078-45b1-8f7f-894177118edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_1b9812b4-b078-45b1-8f7f-894177118edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d06e6ef4-a7d9-4e84-8c38-9b7def5c9132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d06e6ef4-a7d9-4e84-8c38-9b7def5c9132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_e118a099-2fba-492e-bb68-530f64035989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_e118a099-2fba-492e-bb68-530f64035989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_4190aa8b-5def-49d0-b027-1525fdbd67c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_4190aa8b-5def-49d0-b027-1525fdbd67c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_1c246d8c-e6cb-47c0-917d-cc13550169c0" xlink:href="lh-20221231.xsd#lh_NetProceedsFromIssuanceOfStockToEmployees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_lh_NetProceedsFromIssuanceOfStockToEmployees_1c246d8c-e6cb-47c0-917d-cc13550169c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_e38806e4-845b-461c-a0ba-57df4cb52953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_e38806e4-845b-461c-a0ba-57df4cb52953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_26798e3a-998e-43e5-abe4-ebcd5f949e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_26798e3a-998e-43e5-abe4-ebcd5f949e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4b76a4a2-5e02-4832-aa52-78a9ad09533e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4b76a4a2-5e02-4832-aa52-78a9ad09533e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a00dd77-6dae-4196-a3fe-43e9d9ff5317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f58981b7-5157-4eb7-9573-339a7ae78f05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a00dd77-6dae-4196-a3fe-43e9d9ff5317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcc28539-3db4-4bf7-9acc-a27cb6778592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcc28539-3db4-4bf7-9acc-a27cb6778592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee04b2c8-173c-4187-ad8c-2753a7e7c604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ee04b2c8-173c-4187-ad8c-2753a7e7c604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d44ad4c-d47b-47e8-a2fe-cd74f007ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d44ad4c-d47b-47e8-a2fe-cd74f007ffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_fb8f35a3-3d6d-4df5-8c78-3c4249a7543c" xlink:href="lh-20221231.xsd#lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_518ebcb2-cf55-4df2-8f0a-c1e4e51f9d47" xlink:to="loc_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities_fb8f35a3-3d6d-4df5-8c78-3c4249a7543c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/Cover" xlink:type="simple" xlink:href="lh-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ba740ade-f011-457c-8aa0-210990953146" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_4d2e5cf2-b678-4f39-95ca-b7140da88570" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba740ade-f011-457c-8aa0-210990953146" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_4d2e5cf2-b678-4f39-95ca-b7140da88570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_80e3938f-3b54-43ed-872a-4feb9e345640" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ba740ade-f011-457c-8aa0-210990953146" xlink:to="loc_dei_EntityCurrentReportingStatus_80e3938f-3b54-43ed-872a-4feb9e345640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/OTHERLIABILITIES" xlink:type="simple" xlink:href="lh-20221231.xsd#OTHERLIABILITIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/OTHERLIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_78eb0064-854e-4509-a837-3c9f1b8bb4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_af46603b-6ef8-43a2-93d2-ec16fd849238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_78eb0064-854e-4509-a837-3c9f1b8bb4ac" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_af46603b-6ef8-43a2-93d2-ec16fd849238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/OTHERLIABILITIES_1" xlink:type="simple" xlink:href="lh-20221231.xsd#OTHERLIABILITIES_1"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/OTHERLIABILITIES_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_48ac0261-4121-4c9a-bad0-4649a9f7b218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_a0753641-e462-483d-b3ad-a71c7c2f1583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_48ac0261-4121-4c9a-bad0-4649a9f7b218" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_a0753641-e462-483d-b3ad-a71c7c2f1583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/OTHERLIABILITIES_2" xlink:type="simple" xlink:href="lh-20221231.xsd#OTHERLIABILITIES_2"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/OTHERLIABILITIES_2" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_3d897f8f-8a40-4ed0-93fb-6a2499e0d207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_3d897f8f-8a40-4ed0-93fb-6a2499e0d207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b44b8835-e564-41ee-b499-8874b83facc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b44b8835-e564-41ee-b499-8874b83facc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_cace854e-f631-43b3-affa-ff892cb22443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_cace854e-f631-43b3-affa-ff892cb22443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_32635f98-a143-413d-b185-8a2e399d298f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_32635f98-a143-413d-b185-8a2e399d298f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_142681ce-8092-4ee3-a151-15847471e5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_142681ce-8092-4ee3-a151-15847471e5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtherLiabilitiesNoncurrentOther_59794fd7-3644-4dc3-b5df-fb115e95ed7d" xlink:href="lh-20221231.xsd#lh_OtherLiabilitiesNoncurrentOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_88db055d-bbaf-40d6-9e28-7334479059fe" xlink:to="loc_lh_OtherLiabilitiesNoncurrentOther_59794fd7-3644-4dc3-b5df-fb115e95ed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ff59c348-d835-4a66-a116-8c9c015b3b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_c1a0d351-ec30-46c6-b782-34e5e03ae3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ff59c348-d835-4a66-a116-8c9c015b3b02" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_c1a0d351-ec30-46c6-b782-34e5e03ae3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ff59c348-d835-4a66-a116-8c9c015b3b02" xlink:to="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7f02233e-f834-42a2-b78a-cd699fa3c84c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7f02233e-f834-42a2-b78a-cd699fa3c84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7d20d0ef-0d33-4eb4-8849-9790ca714a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7d20d0ef-0d33-4eb4-8849-9790ca714a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_a9cdfe02-5da2-45e7-885d-f9c06a706aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_UnbilledContractsReceivable_a9cdfe02-5da2-45e7-885d-f9c06a706aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_515d3573-6537-4138-a76a-9e04b4e50c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_InventoryNet_515d3573-6537-4138-a76a-9e04b4e50c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3703de15-a11f-42f3-8eb2-3357d8e62234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3703de15-a11f-42f3-8eb2-3357d8e62234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2bf0ba2e-c562-4370-9bcc-abe03fd7ef1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_0318b26a-f3ea-41de-a4e4-daca563ed83e" xlink:to="loc_us-gaap_AssetsCurrent_2bf0ba2e-c562-4370-9bcc-abe03fd7ef1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be64d1f2-6e82-4748-a952-8112b727dc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_be64d1f2-6e82-4748-a952-8112b727dc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3aa36cca-d656-4a47-ac97-ea3850e0c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_Goodwill_3aa36cca-d656-4a47-ac97-ea3850e0c87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5e9e8553-6436-43b5-8895-3aa2494dbdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5e9e8553-6436-43b5-8895-3aa2494dbdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fe1ae00b-da21-4318-a99a-7c7d3cecea9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_fe1ae00b-da21-4318-a99a-7c7d3cecea9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2d75f53-8a23-4598-9f1e-0477b2f9cb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b2d75f53-8a23-4598-9f1e-0477b2f9cb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6738e119-5668-4667-b681-4076a8196ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6738e119-5668-4667-b681-4076a8196ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_72a240e1-b5b6-4975-a39f-94eb775b9232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_464d89e2-52ff-4d9b-9248-359d1ccd4b5b" xlink:to="loc_us-gaap_Assets_72a240e1-b5b6-4975-a39f-94eb775b9232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ff59c348-d835-4a66-a116-8c9c015b3b02" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9b1c66a6-899e-455c-aac8-dd4120064376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9b1c66a6-899e-455c-aac8-dd4120064376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_442b3e2d-09fb-4e06-bbff-9f6a7ad660c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_AccountsPayableCurrent_442b3e2d-09fb-4e06-bbff-9f6a7ad660c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9862ac9e-5664-4562-af05-4afa0eeee84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9862ac9e-5664-4562-af05-4afa0eeee84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_a195d660-0358-40b7-af26-5bc81acb75e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_DeferredRevenueCurrent_a195d660-0358-40b7-af26-5bc81acb75e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2242b65f-6f37-42e8-badb-dfb0dd28a44c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2242b65f-6f37-42e8-badb-dfb0dd28a44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_46ee39a7-6dfe-4633-ba9b-44f84b3e749f" xlink:href="lh-20221231.xsd#lh_ShortTermDebtAndLongTermDebtCurrentMaturities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_lh_ShortTermDebtAndLongTermDebtCurrentMaturities_46ee39a7-6dfe-4633-ba9b-44f84b3e749f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5a597c02-50d4-432d-b3f6-3057ffdef4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9c1928ff-a9c7-4c3d-8d14-b77d04cd041a" xlink:to="loc_us-gaap_LiabilitiesCurrent_5a597c02-50d4-432d-b3f6-3057ffdef4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bf921994-9602-4247-b7da-22cacf7ef437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_bf921994-9602-4247-b7da-22cacf7ef437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_58503069-28a0-48b6-951f-11e37a22dd63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_58503069-28a0-48b6-951f-11e37a22dd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eeb9aa76-50b9-4c11-b993-71925fa566e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_eeb9aa76-50b9-4c11-b993-71925fa566e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ac34ec36-9ba4-4aca-8406-b7aeee0bc9c9" xlink:href="lh-20221231.xsd#lh_DeferredIncomeTaxesAndOtherTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_lh_DeferredIncomeTaxesAndOtherTaxLiabilities_ac34ec36-9ba4-4aca-8406-b7aeee0bc9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_92d2e292-877a-44b8-8ac8-0a619b06952b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_92d2e292-877a-44b8-8ac8-0a619b06952b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e952ec8b-68b3-4802-982f-f6a0158eea73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_Liabilities_e952ec8b-68b3-4802-982f-f6a0158eea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_218bb24e-6b10-4e18-8bb6-15cc464475fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_218bb24e-6b10-4e18-8bb6-15cc464475fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoncontrollingInterestMezzanineEquity_7beeca3c-4106-44ce-b784-c50977ffa4a2" xlink:href="lh-20221231.xsd#lh_NoncontrollingInterestMezzanineEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_lh_NoncontrollingInterestMezzanineEquity_7beeca3c-4106-44ce-b784-c50977ffa4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bb8959f3-3f01-4194-9f24-b770d6a9a83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:to="loc_us-gaap_CommonStockValue_bb8959f3-3f01-4194-9f24-b770d6a9a83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1e5fd6b1-bf14-4132-925e-6ee572399451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1e5fd6b1-bf14-4132-925e-6ee572399451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60ac4c80-8ac3-4f4e-b4cf-3240a254a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_60ac4c80-8ac3-4f4e-b4cf-3240a254a6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0553a56b-942a-4415-94ff-0d6a25c91a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0553a56b-942a-4415-94ff-0d6a25c91a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c6e02f59-12ce-46fe-b21c-8074bddd34bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2ee52e4f-0435-4b50-93ca-bf19f3ccbb09" xlink:to="loc_us-gaap_StockholdersEquity_c6e02f59-12ce-46fe-b21c-8074bddd34bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_95ac7e60-14ce-4e33-8a38-94b843c3f883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e89786a3-ffa3-4153-8c3b-9bd46f91a0f2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_95ac7e60-14ce-4e33-8a38-94b843c3f883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals" xlink:type="simple" xlink:href="lh-20221231.xsd#ConsolidatedBalanceSheetParentheticals"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8db74ee6-a007-4d92-b41a-960641507d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8db74ee6-a007-4d92-b41a-960641507d17" xlink:to="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:to="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b459315e-82c7-471c-9df2-7da274d282f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a714e327-5951-40e1-908e-01bb743e1df7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b459315e-82c7-471c-9df2-7da274d282f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:to="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f54b9a47-970c-45e2-98a4-9ee55968da63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_db3caece-ec71-44d8-8b6b-969fb5ae3dd9" xlink:to="loc_us-gaap_ClassOfStockDomain_f54b9a47-970c-45e2-98a4-9ee55968da63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_db2ca9a0-d13d-4b12-9245-6b6e3f7749af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_477255ac-0a4b-4569-9c22-58eb0ded91de" xlink:to="loc_us-gaap_StatementLineItems_db2ca9a0-d13d-4b12-9245-6b6e3f7749af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_73ffa763-ddea-451e-8c73-7812f508576f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8db74ee6-a007-4d92-b41a-960641507d17" xlink:to="loc_us-gaap_AssetsAbstract_73ffa763-ddea-451e-8c73-7812f508576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_33bf352f-b649-4ee1-9895-07e512fe4ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_73ffa763-ddea-451e-8c73-7812f508576f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_33bf352f-b649-4ee1-9895-07e512fe4ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86bfdaf6-5ab2-4608-a275-40265c1fe2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8db74ee6-a007-4d92-b41a-960641507d17" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86bfdaf6-5ab2-4608-a275-40265c1fe2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_ce5412f7-bed7-4d70-b900-ee982e2ce2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_86bfdaf6-5ab2-4608-a275-40265c1fe2bd" xlink:to="loc_us-gaap_StockholdersEquityAbstract_ce5412f7-bed7-4d70-b900-ee982e2ce2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:href="lh-20221231.xsd#lh_ConsolidatedStatementsofOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_633dd839-1f9f-4262-a598-7301e42a8dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_Revenues_633dd839-1f9f-4262-a598-7301e42a8dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_527a0079-59f7-40ec-98e9-f5dac46ea3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_CostOfRevenue_527a0079-59f7-40ec-98e9-f5dac46ea3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_11627b56-abfe-42dd-8b28-2a7adb2433ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_GrossProfit_11627b56-abfe-42dd-8b28-2a7adb2433ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_51cf02b8-aa56-4c24-854b-2a2f03df561e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_51cf02b8-aa56-4c24-854b-2a2f03df561e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_84f72cb5-b7f2-4883-8af7-388d27ba5d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_84f72cb5-b7f2-4883-8af7-388d27ba5d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_02543963-2ace-448e-b723-d640ca8f2f41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_02543963-2ace-448e-b723-d640ca8f2f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringAndOtherSpecialCharges_2676e0da-59fa-4ebb-bd36-1d442d8d0e48" xlink:href="lh-20221231.xsd#lh_NetRestructuringAndOtherSpecialCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_lh_NetRestructuringAndOtherSpecialCharges_2676e0da-59fa-4ebb-bd36-1d442d8d0e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9602e42c-bacc-4376-b189-f02cb7a4073b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_OperatingIncomeLoss_9602e42c-bacc-4376-b189-f02cb7a4073b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_726f0cc8-2c82-40d2-b654-033aa6583304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_InterestExpense_726f0cc8-2c82-40d2-b654-033aa6583304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73fac18c-2a02-4f72-b135-5dc774c92120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_73fac18c-2a02-4f72-b135-5dc774c92120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_132283fb-af45-47cc-8005-974f2b5a7018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_InvestmentIncomeNet_132283fb-af45-47cc-8005-974f2b5a7018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28520359-9a82-4fc2-9af8-719802b57c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28520359-9a82-4fc2-9af8-719802b57c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_1c7cbe2f-e09c-4056-8d88-1b008a1f9895" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_1c7cbe2f-e09c-4056-8d88-1b008a1f9895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_42be2e48-e744-4727-8b1f-fe71b99566bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_42be2e48-e744-4727-8b1f-fe71b99566bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c39dc67-cd13-48da-ba9b-2271b8d5381c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_ProfitLoss_6c39dc67-cd13-48da-ba9b-2271b8d5381c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4520ae7a-0de3-4de9-a629-0a7063bc210b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_4520ae7a-0de3-4de9-a629-0a7063bc210b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48d7e38f-a5fb-4789-ab93-07a282e4e03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ConsolidatedStatementsofOperationsAbstract_2d1b124f-f383-4bb8-bd40-14c43951ceee" xlink:to="loc_us-gaap_NetIncomeLoss_48d7e38f-a5fb-4789-ab93-07a282e4e03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_819d89d0-1a34-4999-bb76-47306b6d559e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_819d89d0-1a34-4999-bb76-47306b6d559e" xlink:to="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:to="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_680f0e9a-7df7-49f5-8e32-2a7f3308e5d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c2ccd9e2-01da-4f16-9e76-3939fd6945de" xlink:to="loc_srt_ScenarioUnspecifiedDomain_680f0e9a-7df7-49f5-8e32-2a7f3308e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_87a22847-a6f6-4054-b3fa-60732fa6df20" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_55134284-14ca-45eb-ae9d-bfe8dafa7e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_f24aaaf6-7077-4c25-8672-bde179e80eaf" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_55134284-14ca-45eb-ae9d-bfe8dafa7e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dff2d24e-84bd-4485-8cb3-8f3df968fdf6" xlink:to="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1b6e750d-c236-4a31-9639-28f3a6143c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ProfitLoss_1b6e750d-c236-4a31-9639-28f3a6143c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d72c3be7-e760-4420-aefa-cd2fe3dd3862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_d72c3be7-e760-4420-aefa-cd2fe3dd3862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b67fc76c-51e1-40a9-a02a-665984d8f57e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_b67fc76c-51e1-40a9-a02a-665984d8f57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_78844766-88e8-47c3-82e0-e8a62066bfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_78844766-88e8-47c3-82e0-e8a62066bfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_9ebda8b0-e237-41c2-963c-d85d791fc609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_9ebda8b0-e237-41c2-963c-d85d791fc609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3fe9fff-47e5-4704-a1b5-50016af33230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3fe9fff-47e5-4704-a1b5-50016af33230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b40420a3-53c0-49d8-96ef-3189dfa11299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b40420a3-53c0-49d8-96ef-3189dfa11299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0c70ca1e-ba4c-47d2-a911-363acc9922f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_0c70ca1e-ba4c-47d2-a911-363acc9922f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_67434791-d02d-41d0-8c52-ec1a1fc5e6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c7533fc6-0fa8-4d6a-9e15-da3db649f543" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_67434791-d02d-41d0-8c52-ec1a1fc5e6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4d2cea63-c280-4147-9a62-0ba8a93590d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4d2cea63-c280-4147-9a62-0ba8a93590d6" xlink:to="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2b0a75e3-ac26-4165-84db-406047a57771" xlink:to="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5caa4323-921c-4dc9-9ad8-46a97276accb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_CommonStockMember_5caa4323-921c-4dc9-9ad8-46a97276accb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f1b7c4c8-a452-40a9-972b-34c972729e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f1b7c4c8-a452-40a9-972b-34c972729e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cab65e9f-b883-4fe7-95b2-d63a03b40a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_RetainedEarningsMember_cab65e9f-b883-4fe7-95b2-d63a03b40a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac32e564-5753-43ad-a9fd-102414135906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3d3fe0d7-6f9b-485e-91bc-9426e27c3905" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ac32e564-5753-43ad-a9fd-102414135906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:to="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_16f554aa-0b3f-4379-8f38-f1d1369e5e24" xlink:to="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_0adde79c-1077-42a2-9355-ac937530d423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f95f3f6c-9cae-4dab-af16-79a5b9a27023" xlink:to="loc_srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember_0adde79c-1077-42a2-9355-ac937530d423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f609421b-29c4-41f8-8cb2-6a6e791472c9" xlink:to="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_170ad94d-96ff-4de7-a79f-b51bc31788b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_CommonStockValue_170ad94d-96ff-4de7-a79f-b51bc31788b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2a6ec4bb-480f-4cf1-9de9-09856294a5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockholdersEquity_2a6ec4bb-480f-4cf1-9de9-09856294a5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dee65b33-3615-419a-9492-8212802296fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_NetIncomeLoss_dee65b33-3615-419a-9492-8212802296fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_960f75d6-db83-4d6c-ab8f-42995f09e79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_960f75d6-db83-4d6c-ab8f-42995f09e79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_4a79e054-3a94-4bde-aaf9-866dc577de16" xlink:href="lh-20221231.xsd#lh_IssuanceOfCommonStockUnderEmployeeStockPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_lh_IssuanceOfCommonStockUnderEmployeeStockPlans_4a79e054-3a94-4bde-aaf9-866dc577de16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d1f74b4b-77b3-42b9-8e21-64785672d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_d1f74b4b-77b3-42b9-8e21-64785672d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_314cb3f4-8c7d-4f36-adee-a13fa39a460d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_314cb3f4-8c7d-4f36-adee-a13fa39a460d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_58a77afb-2f48-479e-91a9-dfd7023545db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_58a77afb-2f48-479e-91a9-dfd7023545db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_37fbec98-27b2-4965-91db-80faa8a8a99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_StockholdersEquity_37fbec98-27b2-4965-91db-80faa8a8a99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1d1ff0d0-0f00-40ce-8405-479cf0f9b153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1d1ff0d0-0f00-40ce-8405-479cf0f9b153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b45185a6-157d-4f2d-a0bd-818e560fb7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b45185a6-157d-4f2d-a0bd-818e560fb7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fac7ae6f-6a5a-48b8-91b9-21c77fdcf91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fac7ae6f-6a5a-48b8-91b9-21c77fdcf91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_ea1010ef-4118-4c13-a52c-a10878abe980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_Dividends_ea1010ef-4118-4c13-a52c-a10878abe980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_a8c71271-85e6-4027-b58f-cdfbe80e18ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_abfd7cac-2cb0-48bb-b4d5-4e61d820d4a8" xlink:to="loc_us-gaap_DividendsCash_a8c71271-85e6-4027-b58f-cdfbe80e18ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bb4ec195-bd4e-40ce-91d2-7b13224c1462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeAbstract_5677f72a-10e8-4400-8a32-6886af2ab4ab" xlink:href="lh-20221231.xsd#lh_IncomeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bb4ec195-bd4e-40ce-91d2-7b13224c1462" xlink:to="loc_lh_IncomeAbstract_5677f72a-10e8-4400-8a32-6886af2ab4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28c3ac6b-3a26-4306-a259-5203c3af7b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeAbstract_5677f72a-10e8-4400-8a32-6886af2ab4ab" xlink:to="loc_us-gaap_NetIncomeLoss_28c3ac6b-3a26-4306-a259-5203c3af7b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9c736a9a-252b-4d7a-a324-7fc95a2c5ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeAbstract_5677f72a-10e8-4400-8a32-6886af2ab4ab" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_9c736a9a-252b-4d7a-a324-7fc95a2c5ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SharesAbstract_956b81da-8ae4-4e18-88ff-3ccb73672b1b" xlink:href="lh-20221231.xsd#lh_SharesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bb4ec195-bd4e-40ce-91d2-7b13224c1462" xlink:to="loc_lh_SharesAbstract_956b81da-8ae4-4e18-88ff-3ccb73672b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2316194-9695-458c-bf09-166868c655e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_956b81da-8ae4-4e18-88ff-3ccb73672b1b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b2316194-9695-458c-bf09-166868c655e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4cd118bb-145f-4ea0-be41-4cc637075450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_956b81da-8ae4-4e18-88ff-3ccb73672b1b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4cd118bb-145f-4ea0-be41-4cc637075450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncrementalCommonSharesAttributableToStockOptions_8d351da3-7d46-47f7-8986-1b221ade8276" xlink:href="lh-20221231.xsd#lh_IncrementalCommonSharesAttributableToStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SharesAbstract_956b81da-8ae4-4e18-88ff-3ccb73672b1b" xlink:to="loc_lh_IncrementalCommonSharesAttributableToStockOptions_8d351da3-7d46-47f7-8986-1b221ade8276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PerShareAmountAbstract_3f9c25bd-f164-4edc-8259-6db31407112e" xlink:href="lh-20221231.xsd#lh_PerShareAmountAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bb4ec195-bd4e-40ce-91d2-7b13224c1462" xlink:to="loc_lh_PerShareAmountAbstract_3f9c25bd-f164-4edc-8259-6db31407112e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8ff07207-7f4e-4435-b417-01e99f29de0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_3f9c25bd-f164-4edc-8259-6db31407112e" xlink:to="loc_us-gaap_EarningsPerShareBasic_8ff07207-7f4e-4435-b417-01e99f29de0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9b077427-15c5-41c4-bf99-4df290527719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_PerShareAmountAbstract_3f9c25bd-f164-4edc-8259-6db31407112e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9b077427-15c5-41c4-bf99-4df290527719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_304bc3a9-cd96-4acf-811c-b8cf0624b150" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_304bc3a9-cd96-4acf-811c-b8cf0624b150" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:to="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a8b6ac7d-222c-4c92-bc34-19c5c7bac03b" xlink:to="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4817b34d-e1dd-4543-bcce-1cf00ec90e40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:to="loc_srt_MinimumMember_4817b34d-e1dd-4543-bcce-1cf00ec90e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7c266f4d-f279-4451-bb18-ca8743a3ae4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_510aeacf-11ac-4256-be69-eee7ef91215d" xlink:to="loc_srt_MaximumMember_7c266f4d-f279-4451-bb18-ca8743a3ae4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b133ac58-6f91-43b3-b582-452e4467ad56" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2991d9a6-70b0-473e-b18f-17d002a9840c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2991d9a6-70b0-473e-b18f-17d002a9840c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_47171fb1-dd5e-4dec-83f0-185867a0b0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_47171fb1-dd5e-4dec-83f0-185867a0b0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f60a6a54-e607-45f6-92d1-6a61b71066db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f60a6a54-e607-45f6-92d1-6a61b71066db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_e548f325-e7c1-47df-ae43-893833cce591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_31ff862f-b17c-4214-a0a3-672bcb22cdd5" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_e548f325-e7c1-47df-ae43-893833cce591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a09eca93-3579-43ca-95d7-76d155cee661" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum_ba17ec1a-257f-4546-8c14-8256671c187f" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwareminimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_Propertyplantandequipmentusefullifesoftwareminimum_ba17ec1a-257f-4546-8c14-8256671c187f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum_52a7de22-0cda-44e2-805c-94c0c881f58f" xlink:href="lh-20221231.xsd#lh_Propertyplantandequipmentusefullifesoftwaremaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_Propertyplantandequipmentusefullifesoftwaremaximum_52a7de22-0cda-44e2-805c-94c0c881f58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cac56af2-8207-4816-899a-680ce2b8a0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_cac56af2-8207-4816-899a-680ce2b8a0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_8482c7b0-1fa6-42aa-8f76-b8c8f534a6f1" xlink:href="lh-20221231.xsd#lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2c68f0e6-76aa-4426-bb18-4d1709e02291" xlink:to="loc_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage_8482c7b0-1fa6-42aa-8f76-b8c8f534a6f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b431af41-a944-4239-b1b2-6e960c868a00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b431af41-a944-4239-b1b2-6e960c868a00" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8df34d4-ef9c-4a57-8bcb-65d688c8417f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e2f472fc-25ec-4799-8e50-4b9d66c18694" xlink:to="loc_us-gaap_SegmentDomain_d8df34d4-ef9c-4a57-8bcb-65d688c8417f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9910bdba-b15e-4283-bc0d-b6c95e3a8592" xlink:to="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ccf9ccf-6e12-4541-9bde-5631528ad54b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:to="loc_srt_MinimumMember_7ccf9ccf-6e12-4541-9bde-5631528ad54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9398dd0b-04b0-4731-90df-4dff8551ec4e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0ceb8711-9b90-4e28-8455-c1c84ec108a8" xlink:to="loc_srt_MaximumMember_9398dd0b-04b0-4731-90df-4dff8551ec4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0ef19307-1211-4a6b-8a1d-8b06b3d15f46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7f0c2a02-5973-4624-9ef8-e49f1d2295bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7f0c2a02-5973-4624-9ef8-e49f1d2295bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_f2ff0327-46de-4c03-9c60-5d09c6c22a02" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_f2ff0327-46de-4c03-9c60-5d09c6c22a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e2010281-cddc-4818-82d7-02b3219f2360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e2010281-cddc-4818-82d7-02b3219f2360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_0e500f3c-4cf3-474a-8a13-47498659fe21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d45c7c73-d785-412b-a004-df128e4fb2ad" xlink:to="loc_us-gaap_TradeNamesMember_0e500f3c-4cf3-474a-8a13-47498659fe21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2c2152c9-8313-4132-8cae-5453d8d25a24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0a4b41b4-6cc5-4e8d-81b4-3792b76d8ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:to="loc_us-gaap_Goodwill_0a4b41b4-6cc5-4e8d-81b4-3792b76d8ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_09176ffb-2d14-4850-9fc1-bfbb3cd2793e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_30f5e88f-b9aa-4359-9ece-edcb8a4cecfc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_09176ffb-2d14-4850-9fc1-bfbb3cd2793e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cfcf1f61-b4dc-4994-933f-ed2b81a0bfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7b9c3380-520a-449e-9ac1-6ee723bcfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfcf1f61-b4dc-4994-933f-ed2b81a0bfaf" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7b9c3380-520a-449e-9ac1-6ee723bcfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUENotes" xlink:type="simple" xlink:href="lh-20221231.xsd#REVENUENotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUENotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b4f3b49-cb1b-45e4-862a-6860bcde2d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_64ee5375-e727-40c7-b392-5e964914cb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b4f3b49-cb1b-45e4-862a-6860bcde2d89" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_64ee5375-e727-40c7-b392-5e964914cb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1f6fcb80-a789-4472-a21c-e4a05de4a0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_97bc93c2-ff49-4fb6-9108-73137429ee07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1f6fcb80-a789-4472-a21c-e4a05de4a0c6" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_97bc93c2-ff49-4fb6-9108-73137429ee07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivities" xlink:type="simple" xlink:href="lh-20221231.xsd#RestructuringandRelatedActivities"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RestructuringandRelatedActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7ecf3d2f-85f4-4cf5-a326-84252ef54117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b1b508bc-1a31-4d9e-8e1e-340d291a8be8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7ecf3d2f-85f4-4cf5-a326-84252ef54117" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b1b508bc-1a31-4d9e-8e1e-340d291a8be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESNotes" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESNotes"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dc2e5a51-036b-4d26-8913-1877e2e5d2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_02e5fe35-2da2-43e1-91f1-686888c77180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dc2e5a51-036b-4d26-8913-1877e2e5d2d1" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_02e5fe35-2da2-43e1-91f1-686888c77180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET" xlink:type="simple" xlink:href="lh-20221231.xsd#PROPERTYPLANTANDEQUIPMENTNET"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6983720d-d334-4c4d-8122-b375a1f24d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bfb681b2-0516-45c1-88fa-cb45b115c221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6983720d-d334-4c4d-8122-b375a1f24d2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_bfb681b2-0516-45c1-88fa-cb45b115c221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b93fc877-14c7-45d4-9eb7-05433b412e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dfb87818-5481-4455-a766-48d8d7800f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b93fc877-14c7-45d4-9eb7-05433b412e4b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dfb87818-5481-4455-a766-48d8d7800f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER" xlink:type="simple" xlink:href="lh-20221231.xsd#ACCRUEDEXPENSESANDOTHER"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_3de7ed62-1e1e-40b1-b910-979dcba0462f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_4d6fbb63-6dd0-4110-b106-b9a0e67a2f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_3de7ed62-1e1e-40b1-b910-979dcba0462f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_4d6fbb63-6dd0-4110-b106-b9a0e67a2f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBT" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e01ad138-854a-480d-8aee-f8ae9a5f9bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_940e48a7-5315-4606-9926-89aded381886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e01ad138-854a-480d-8aee-f8ae9a5f9bad" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_940e48a7-5315-4606-9926-89aded381886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="lh-20221231.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_532540ce-4257-4e6d-882a-98a1d9a46257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7a76fb11-6386-4e07-a9f1-c29e00dc6297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_532540ce-4257-4e6d-882a-98a1d9a46257" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7a76fb11-6386-4e07-a9f1-c29e00dc6297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXES" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ea1c68ce-f64a-48af-b7cd-8684ea396cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_bf109f0b-eda9-4d24-a193-fc731951527d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ea1c68ce-f64a-48af-b7cd-8684ea396cf0" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_bf109f0b-eda9-4d24-a193-fc731951527d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_310d46b3-05a4-403f-ad7c-7598bd9bc1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5c6a6a26-8110-45d6-b8c6-707ebe43e1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_310d46b3-05a4-403f-ad7c-7598bd9bc1d4" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5c6a6a26-8110-45d6-b8c6-707ebe43e1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_be6e231c-f6c9-4568-af31-63a03412447a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_310d46b3-05a4-403f-ad7c-7598bd9bc1d4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_be6e231c-f6c9-4568-af31-63a03412447a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES" xlink:type="simple" xlink:href="lh-20221231.xsd#COMMITMENTSANDCONTINGENTLIABILITIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3bb44312-8461-4c80-ad58-6d61c0b471c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3cf88bdc-aa3e-42f2-a38d-7991f05977ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3bb44312-8461-4c80-ad58-6d61c0b471c7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3cf88bdc-aa3e-42f2-a38d-7991f05977ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_9d3dca78-0eea-4d0f-8ddf-a1984819a865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b016e5ec-6f41-4937-aa84-71d0110caa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_9d3dca78-0eea-4d0f-8ddf-a1984819a865" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b016e5ec-6f41-4937-aa84-71d0110caa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="lh-20221231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a49fe747-2c4b-433b-865a-4a3ffb2b9fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a49fe747-2c4b-433b-865a-4a3ffb2b9fc6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_18df26bb-e4df-4d5a-94c1-79612dd70b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_557a5471-0cb1-4035-85af-2a9abea4295e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_18df26bb-e4df-4d5a-94c1-79612dd70b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8cde5a05-d168-4fb4-ac7f-be17eef35e9e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_694d2b6a-f150-40cb-81ae-5b6c82103823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a32473fd-e17f-42a2-8e55-c100bc416f03" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_694d2b6a-f150-40cb-81ae-5b6c82103823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0e8b1463-04c1-45a8-9b5b-2aa327d52082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a49fe747-2c4b-433b-865a-4a3ffb2b9fc6" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0e8b1463-04c1-45a8-9b5b-2aa327d52082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01cddf5a-bea5-4ab2-9a50-2e9c32b1fcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a9284d19-9567-450c-a77f-b0ccb2724f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01cddf5a-bea5-4ab2-9a50-2e9c32b1fcae" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a9284d19-9567-450c-a77f-b0ccb2724f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="simple" xlink:href="lh-20221231.xsd#SUPPLEMENTALCASHFLOWINFORMATION"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_709a6c1a-e4a2-4fcc-b2d6-1bbaa2a2a354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e9be31a5-6142-49b9-ad93-e28d7379466b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_709a6c1a-e4a2-4fcc-b2d6-1bbaa2a2a354" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_e9be31a5-6142-49b9-ad93-e28d7379466b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_de7bdcf5-1fa7-46aa-b81b-6f72319532e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7a6c905a-d23d-4432-afca-e93a180f8dca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_de7bdcf5-1fa7-46aa-b81b-6f72319532e8" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_7a6c905a-d23d-4432-afca-e93a180f8dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEvents" xlink:type="simple" xlink:href="lh-20221231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9d8bbc88-0a7a-458b-89a4-eb6efc40b0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_e57906c7-a6ea-4617-b508-6b111c7c2ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_9d8bbc88-0a7a-458b-89a4-eb6efc40b0eb" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_e57906c7-a6ea-4617-b508-6b111c7c2ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8abfae41-686b-4c9d-baf1-03c9c513229e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8abfae41-686b-4c9d-baf1-03c9c513229e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock_9142056d-a453-4d2a-a073-647971ce3d9f" xlink:href="lh-20221231.xsd#lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock_9142056d-a453-4d2a-a073-647971ce3d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_9bbf2c2a-a7e1-49cf-b577-ce0ffd6ec9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_9bbf2c2a-a7e1-49cf-b577-ce0ffd6ec9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5c3d9634-007a-4e37-83ce-31405919be92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_UseOfEstimates_5c3d9634-007a-4e37-83ce-31405919be92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConcentrationOfCreditRiskPolicyTextBlock_6986b2ad-7afe-4d30-a454-2e91d5033f23" xlink:href="lh-20221231.xsd#lh_ConcentrationOfCreditRiskPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_ConcentrationOfCreditRiskPolicyTextBlock_6986b2ad-7afe-4d30-a454-2e91d5033f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b861700d-0346-4659-bbf1-553a60a880c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b861700d-0346-4659-bbf1-553a60a880c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock_b9788f2b-bce7-4cf4-a0a7-dc346694b9c6" xlink:href="lh-20221231.xsd#lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock_b9788f2b-bce7-4cf4-a0a7-dc346694b9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_961e3b44-8723-4871-bc60-61f45e7968eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_961e3b44-8723-4871-bc60-61f45e7968eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_fe9d65e5-7c93-423e-a1a0-641f98acff81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_fe9d65e5-7c93-423e-a1a0-641f98acff81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9adf0b2d-d96d-427b-b832-25212d50f003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_9adf0b2d-d96d-427b-b832-25212d50f003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternalUseSoftwarePolicyTextBlock_e69813f0-c6ab-4525-836f-2506129af6c7" xlink:href="lh-20221231.xsd#lh_InternalUseSoftwarePolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_InternalUseSoftwarePolicyTextBlock_e69813f0-c6ab-4525-836f-2506129af6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IntangibleAssetsFiniteLivedPolicyTextBlock_a771ff9c-8a77-4b74-a82f-a37ffac85a4b" xlink:href="lh-20221231.xsd#lh_IntangibleAssetsFiniteLivedPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_IntangibleAssetsFiniteLivedPolicyTextBlock_a771ff9c-8a77-4b74-a82f-a37ffac85a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_c6e1fa5a-8708-4d88-9cac-8c88117c6513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_DebtPolicyTextBlock_c6e1fa5a-8708-4d88-9cac-8c88117c6513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ProfessionalLiabilityPolicyTextBlock_85c435f5-8852-43bb-bcc8-6ae2a62383a9" xlink:href="lh-20221231.xsd#lh_ProfessionalLiabilityPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_ProfessionalLiabilityPolicyTextBlock_85c435f5-8852-43bb-bcc8-6ae2a62383a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_e6d864ae-0f80-481f-be78-726d2d391634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_e6d864ae-0f80-481f-be78-726d2d391634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage_eac1a3b7-a691-4075-9fb2-75a0db8318be" xlink:href="lh-20221231.xsd#lh_IncomeTaxBenefitMinimumCertaintyPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage_eac1a3b7-a691-4075-9fb2-75a0db8318be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_346d5d6f-665c-47ad-a2f6-467926f94fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_346d5d6f-665c-47ad-a2f6-467926f94fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_a351622c-b275-4f83-bcf7-97734cf5bcff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_a351622c-b275-4f83-bcf7-97734cf5bcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityNumberOfEmployees_953dbc4b-357d-46ad-a2e4-05935d3782ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityNumberOfEmployees"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_dei_EntityNumberOfEmployees_953dbc4b-357d-46ad-a2e4-05935d3782ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bddaf314-cd2f-4b9f-a0ed-23edb94d6605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bddaf314-cd2f-4b9f-a0ed-23edb94d6605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_76d4bc56-8500-4c60-82cc-6b3f7356f438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_76d4bc56-8500-4c60-82cc-6b3f7356f438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_8560a7ed-13bd-4db3-aa1c-e19453b5973b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_8560a7ed-13bd-4db3-aa1c-e19453b5973b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_82cb4639-8b1c-4fb1-929b-b8a5a1db00dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9e8ca3c4-6510-413e-947c-8ff84e715453" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_82cb4639-8b1c-4fb1-929b-b8a5a1db00dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a2bc6eea-cf08-4e9d-aeeb-3d77d0cd5b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fae20ae-aeb9-466d-872a-b5ff468bc556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2bc6eea-cf08-4e9d-aeeb-3d77d0cd5b9e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fae20ae-aeb9-466d-872a-b5ff468bc556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_00c7a4d9-905f-4169-9b46-8668121b73de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2bc6eea-cf08-4e9d-aeeb-3d77d0cd5b9e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_00c7a4d9-905f-4169-9b46-8668121b73de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_99b1278c-fca1-42bf-8cd2-bc52357cffa0" xlink:href="lh-20221231.xsd#lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2bc6eea-cf08-4e9d-aeeb-3d77d0cd5b9e" xlink:to="loc_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock_99b1278c-fca1-42bf-8cd2-bc52357cffa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2d9e99e0-3701-4081-a9cb-3f202162375c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a2bc6eea-cf08-4e9d-aeeb-3d77d0cd5b9e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2d9e99e0-3701-4081-a9cb-3f202162375c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUETables" xlink:type="simple" xlink:href="lh-20221231.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e9e4bd47-8997-4bab-9ab7-97b5bce0e069" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_34d6a0c3-d901-4b7e-8ecd-725ebdb84fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e9e4bd47-8997-4bab-9ab7-97b5bce0e069" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_34d6a0c3-d901-4b7e-8ecd-725ebdb84fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostTableTextBlock_14a703ca-b84e-4a42-9f30-b2bbb1f2d542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e9e4bd47-8997-4bab-9ab7-97b5bce0e069" xlink:to="loc_us-gaap_CapitalizedContractCostTableTextBlock_14a703ca-b84e-4a42-9f30-b2bbb1f2d542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0498c134-804e-4ac4-ab85-049d85e03f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e9e4bd47-8997-4bab-9ab7-97b5bce0e069" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0498c134-804e-4ac4-ab85-049d85e03f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_cfd98c17-1107-4379-900d-f2ef250cc4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cfd98c17-1107-4379-900d-f2ef250cc4cc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c7e1af-6be9-4219-918a-2c26882fc242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_90801fca-1974-4fd0-a213-018b75efd750" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_81c7e1af-6be9-4219-918a-2c26882fc242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e6356b10-9e7c-4107-b65c-dd80b2a8a4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3139495d-db5b-4598-98f6-60b9324b75a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e6356b10-9e7c-4107-b65c-dd80b2a8a4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9ea4df34-b33a-44ab-a8f2-6af617375d63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_18ebfa7d-5168-4583-9f97-7b138bc3956a" xlink:to="loc_srt_OwnershipDomain_9ea4df34-b33a-44ab-a8f2-6af617375d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8a77c3ed-0d25-4205-821f-69faec3fa906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ad0b1501-978e-4a3a-bc5b-944b013a699e" xlink:to="loc_us-gaap_ClassOfStockDomain_8a77c3ed-0d25-4205-821f-69faec3fa906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_15e789ee-fe9d-4f55-b0d7-2b1d576b9cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a19a8ce6-3a19-4e43-8340-d6afa17e3802" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_15e789ee-fe9d-4f55-b0d7-2b1d576b9cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock_494c6305-6de0-4811-ab7f-74f16cca0797" xlink:href="lh-20221231.xsd#lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cfd98c17-1107-4379-900d-f2ef250cc4cc" xlink:to="loc_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock_494c6305-6de0-4811-ab7f-74f16cca0797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables" xlink:type="simple" xlink:href="lh-20221231.xsd#RestructuringandRelatedActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e50ecaf6-a721-4143-99fb-413e95dfa07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_88df8ba5-988f-4add-9363-cd27dd4eac19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e50ecaf6-a721-4143-99fb-413e95dfa07b" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_88df8ba5-988f-4add-9363-cd27dd4eac19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b218a3e8-1563-477d-b372-38c061a4b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b218a3e8-1563-477d-b372-38c061a4b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_8e66554a-5087-4934-94e8-2b66bdd56859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_8e66554a-5087-4934-94e8-2b66bdd56859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f1c95e21-caca-444e-83a3-08132203ca98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_f1c95e21-caca-444e-83a3-08132203ca98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_cf8af353-0d20-4301-b0a5-50d51e511dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_cf8af353-0d20-4301-b0a5-50d51e511dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LeaseDisclosureTableTextBlockTableTextBlock_5db8f130-4f46-456a-825f-4a25f99500fc" xlink:href="lh-20221231.xsd#lh_LeaseDisclosureTableTextBlockTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6591fbdc-157e-4154-9314-a5f8d6ae5bbb" xlink:to="loc_lh_LeaseDisclosureTableTextBlockTableTextBlock_5db8f130-4f46-456a-825f-4a25f99500fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables" xlink:type="simple" xlink:href="lh-20221231.xsd#PROPERTYPLANTANDEQUIPMENTNETTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_821f0beb-e991-4db2-8612-4963095db0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9bf6fa95-3d56-4e06-ab31-d37936e35431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_821f0beb-e991-4db2-8612-4963095db0ce" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_9bf6fa95-3d56-4e06-ab31-d37936e35431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f301f8c4-2c37-4eae-8345-4350ddac85d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_4a1aa1c8-3677-4697-b093-1e4df6abd9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f301f8c4-2c37-4eae-8345-4350ddac85d8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_4a1aa1c8-3677-4697-b093-1e4df6abd9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_c4645b34-bdc7-474b-b979-471ae4298ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f301f8c4-2c37-4eae-8345-4350ddac85d8" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_c4645b34-bdc7-474b-b979-471ae4298ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_856254bf-2a50-494e-98ee-a4c91817e131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f301f8c4-2c37-4eae-8345-4350ddac85d8" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_856254bf-2a50-494e-98ee-a4c91817e131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables" xlink:type="simple" xlink:href="lh-20221231.xsd#ACCRUEDEXPENSESANDOTHERTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_c63a9a6a-4251-4f98-99b7-7f7bb0e7c391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_f5c286a1-520e-4f1d-a5bb-51b7443e49a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c63a9a6a-4251-4f98-99b7-7f7bb0e7c391" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_f5c286a1-520e-4f1d-a5bb-51b7443e49a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTTables" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe8c53b1-402e-448f-a133-9a5b7fdfdd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_838df813-d798-4bbd-b6cb-a6b7cd5e3f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe8c53b1-402e-448f-a133-9a5b7fdfdd4a" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_838df813-d798-4bbd-b6cb-a6b7cd5e3f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8d404caf-0e39-4344-9c4e-0b0f8df27196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe8c53b1-402e-448f-a133-9a5b7fdfdd4a" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_8d404caf-0e39-4344-9c4e-0b0f8df27196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_47ef9ff9-04e6-4afc-b748-d077a928d29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe8c53b1-402e-448f-a133-9a5b7fdfdd4a" xlink:to="loc_us-gaap_LongTermDebtTextBlock_47ef9ff9-04e6-4afc-b748-d077a928d29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_98593532-2292-4730-85ed-bea33cfd5dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe8c53b1-402e-448f-a133-9a5b7fdfdd4a" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_98593532-2292-4730-85ed-bea33cfd5dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables" xlink:type="simple" xlink:href="lh-20221231.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_e6e75376-1cea-40fc-afd4-bcb69bcf8101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_4809dda2-bf4b-48bf-b5f2-3f672e7611a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e6e75376-1cea-40fc-afd4-bcb69bcf8101" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_4809dda2-bf4b-48bf-b5f2-3f672e7611a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_af5b6d40-5828-4a40-af90-27fd9166ba15" xlink:href="lh-20221231.xsd#lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e6e75376-1cea-40fc-afd4-bcb69bcf8101" xlink:to="loc_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock_af5b6d40-5828-4a40-af90-27fd9166ba15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3c0772c1-32e8-485b-bf0d-b439198c5019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_e6e75376-1cea-40fc-afd4-bcb69bcf8101" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3c0772c1-32e8-485b-bf0d-b439198c5019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_9b3e5084-3660-43f6-8479-17ebbd6f898a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_bf38a49c-9655-4ea0-b7aa-26e0fff1fcfe" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_9b3e5084-3660-43f6-8479-17ebbd6f898a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_db85da2a-7fe8-4a2f-a747-37ffa3968a52" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_267a4003-02cf-43d5-a1a2-a3b9e837a079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_ab526e99-bc8f-458e-9687-1d15cf2c8b86" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_267a4003-02cf-43d5-a1a2-a3b9e837a079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4d17ec88-fb09-4130-813c-6545b2f3cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_4d17ec88-fb09-4130-813c-6545b2f3cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_093bbdb1-eff7-443f-aad3-ff2297b5df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_093bbdb1-eff7-443f-aad3-ff2297b5df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bead6278-343b-462a-97e7-7e051ea9bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_bead6278-343b-462a-97e7-7e051ea9bbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0ea92944-4852-4c0e-a131-930d7d6b7fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0ea92944-4852-4c0e-a131-930d7d6b7fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_f915c38a-2551-4121-95d2-c50580ef789f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_29c6daa5-da5c-4970-8278-753d2d5a34c0" xlink:to="loc_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock_f915c38a-2551-4121-95d2-c50580ef789f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2e892b2-61e6-4c91-976e-a79e7e1a266f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2e892b2-61e6-4c91-976e-a79e7e1a266f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_41eaf179-6a9b-4fd0-8c37-34f51c8e319f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_9f1adfe0-cb8f-4346-8845-1ffaa97ec738" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_41eaf179-6a9b-4fd0-8c37-34f51c8e319f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bea159d2-e47e-4b65-9029-70f9b90cd2b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a9b69fc3-8de4-418d-ba21-38bbac1a2370" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a9b69fc3-8de4-418d-ba21-38bbac1a2370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_8f15f7e9-2682-4c7c-9207-765eadffe664" xlink:href="lh-20221231.xsd#lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock_8f15f7e9-2682-4c7c-9207-765eadffe664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6aed534e-9844-4d55-8bb0-88178780256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6aed534e-9844-4d55-8bb0-88178780256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_74f26936-fcb6-4627-8090-9baa5be02123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7e1b4ed-f732-4ac4-bb90-c9d0133be8ea" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_74f26936-fcb6-4627-8090-9baa5be02123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_6e826051-f06e-4135-a2b8-e56cba44fc1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_6e826051-f06e-4135-a2b8-e56cba44fc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_a3611e49-4b98-4c15-bf61-d9d91b2794db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_a3611e49-4b98-4c15-bf61-d9d91b2794db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_fed2c9fb-a9d9-4b7b-8875-7e9bc333ebb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetFundedStatusTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_us-gaap_ScheduleOfNetFundedStatusTableTextBlock_fed2c9fb-a9d9-4b7b-8875-7e9bc333ebb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_ea368f58-0bdf-4df9-a4c2-7763591b1e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_ea368f58-0bdf-4df9-a4c2-7763591b1e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock_ed053fdf-1bc3-4536-b7e7-56083cc5a716" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock_ed053fdf-1bc3-4536-b7e7-56083cc5a716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AssumedBenefitPaymentsByYearTableTextBlock_636fdf0a-04dc-427a-bef6-914e91fbb1eb" xlink:href="lh-20221231.xsd#lh_AssumedBenefitPaymentsByYearTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract_69238c73-6af6-4c12-be26-59cfa761987f" xlink:to="loc_lh_AssumedBenefitPaymentsByYearTableTextBlock_636fdf0a-04dc-427a-bef6-914e91fbb1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="lh-20221231.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cce7c7ff-f319-443e-92c4-305c9464ab41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_a5d02e7c-9e6a-45db-ab8b-56690e40f6c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cce7c7ff-f319-443e-92c4-305c9464ab41" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_a5d02e7c-9e6a-45db-ab8b-56690e40f6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b956351d-a785-475a-aebd-f40031a188e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b956351d-a785-475a-aebd-f40031a188e4" xlink:to="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_75992aa3-5aa8-49a9-a318-4a6d46669f05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EnergyAxis_116f40b7-7ff0-4efa-9864-251b89a5f3da" xlink:to="loc_srt_EnergyDomain_75992aa3-5aa8-49a9-a318-4a6d46669f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_ad993a37-c102-4e97-9d1d-c768ed824820" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1ddc1b1e-bb74-405e-8000-2a2651414168" xlink:to="loc_us-gaap_VariableRateDomain_ad993a37-c102-4e97-9d1d-c768ed824820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fac771e0-e76a-45ce-8c23-6222dab13214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1a1645e3-74a7-412d-8f0e-c165a79eec78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fac771e0-e76a-45ce-8c23-6222dab13214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_03bc96ba-a645-4f2a-a8aa-dfc570ec0b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_e2ef8ec9-b24d-4818-a5b8-d2257ebe98d2" xlink:to="loc_us-gaap_PositionDomain_03bc96ba-a645-4f2a-a8aa-dfc570ec0b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9caaddc8-3b42-48e7-819f-c5cd41d00651" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_672777c2-8b7e-4971-84c0-e8287c07eecf" xlink:to="loc_srt_RangeMember_9caaddc8-3b42-48e7-819f-c5cd41d00651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_06c424da-4331-41e2-a3f7-5188bb207675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2c7dafe9-ae17-4f03-af18-96e1ef3b0ffb" xlink:to="loc_us-gaap_DerivativeLineItems_06c424da-4331-41e2-a3f7-5188bb207675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_f2349756-d5b0-4ac4-ab65-52bdf3a18efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b956351d-a785-475a-aebd-f40031a188e4" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_f2349756-d5b0-4ac4-ab65-52bdf3a18efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ce6c876e-1774-4ad2-8307-dd3e8c9ba83c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b956351d-a785-475a-aebd-f40031a188e4" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_ce6c876e-1774-4ad2-8307-dd3e8c9ba83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables" xlink:type="simple" xlink:href="lh-20221231.xsd#SUPPLEMENTALCASHFLOWINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_af950df1-78a4-4b75-80cd-c28de797931d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bcb9b48b-e4b6-4759-a598-2a57bbcf4dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_af950df1-78a4-4b75-80cd-c28de797931d" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bcb9b48b-e4b6-4759-a598-2a57bbcf4dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ce6ebbbb-7352-407d-a24f-d2e03afe9eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ee1eda13-e116-4c5a-9526-b54a5213eae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ce6ebbbb-7352-407d-a24f-d2e03afe9eec" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_ee1eda13-e116-4c5a-9526-b54a5213eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEventsTables" xlink:type="simple" xlink:href="lh-20221231.xsd#SubsequentEventsTables"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEventsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_4c09c185-f818-4b44-b89e-dfb4fd6bbc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_1f7bdb85-fc4e-4c25-8d14-9fd975ad112c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_1f7bdb85-fc4e-4c25-8d14-9fd975ad112c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan_5d64681e-7bde-4a87-a224-7d4b087ed7b1" xlink:href="lh-20221231.xsd#lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan_5d64681e-7bde-4a87-a224-7d4b087ed7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_2c939e45-9d08-4836-bccb-78886b1729bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_InventoryValuationReserves_2c939e45-9d08-4836-bccb-78886b1729bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid_a2151e94-fb2a-454a-9709-10298e309c86" xlink:href="lh-20221231.xsd#lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid_a2151e94-fb2a-454a-9709-10298e309c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dcad9e0d-03bc-4cf8-bab8-bee1b95addab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_dcad9e0d-03bc-4cf8-bab8-bee1b95addab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_e7217b96-e35c-4d49-bda8-d7a1201ad808" xlink:href="lh-20221231.xsd#lh_CostMethodInvestmentsMaximumOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_lh_CostMethodInvestmentsMaximumOwnershipPercentage_e7217b96-e35c-4d49-bda8-d7a1201ad808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_5b07ecbc-39d0-4d7a-9de3-aea307529ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_CashUninsuredAmount_5b07ecbc-39d0-4d7a-9de3-aea307529ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage_e61e6d97-faba-4860-ae2a-ac43e737968d" xlink:href="lh-20221231.xsd#lh_IncomeTaxBenefitMinimumCertaintyPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_lh_IncomeTaxBenefitMinimumCertaintyPercentage_e61e6d97-faba-4860-ae2a-ac43e737968d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofgrossaccountsreceivableduefrompatients_e7cbf501-5d91-446f-9173-ce0a983d02f3" xlink:href="lh-20221231.xsd#lh_Percentofgrossaccountsreceivableduefrompatients"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_lh_Percentofgrossaccountsreceivableduefrompatients_e7cbf501-5d91-446f-9173-ce0a983d02f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_d61b64e4-40e0-4a24-bc9e-be817e4243dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_InventoryFinishedGoods_d61b64e4-40e0-4a24-bc9e-be817e4243dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventorySupplies_e249c5ac-754a-4656-99e6-11e0af018379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_OtherInventorySupplies_e249c5ac-754a-4656-99e6-11e0af018379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_8de6b775-7593-48e0-bc15-de6753c1a5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_8de6b775-7593-48e0-bc15-de6753c1a5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c4091e25-3d26-49ff-a2a2-92b333813fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_Goodwill_c4091e25-3d26-49ff-a2a2-92b333813fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_e8c144e4-b922-49ff-aac1-a2a7e05131cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_e8c144e4-b922-49ff-aac1-a2a7e05131cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities_e788506e-8f3f-4658-8716-0f892ae536a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePotentiallyDilutiveSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_e8c144e4-b922-49ff-aac1-a2a7e05131cb" xlink:to="loc_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities_e788506e-8f3f-4658-8716-0f892ae536a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e1f0d2c1-b92b-4604-b5db-9a9c942a07f7" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e27f4cff-1aa8-4789-a2d6-9f9bb50693f7" xlink:to="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f57ceeec-c385-438c-ba2d-b736b70f242a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_66645e15-e15d-43ec-b2bb-10889103a43e" xlink:to="loc_us-gaap_RetainedEarningsMember_f57ceeec-c385-438c-ba2d-b736b70f242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a0cabc67-4d1c-49ad-a1d7-4966deccb738" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2c44862c-3e21-41e3-b494-da33d2c77696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b884117-310d-437d-a3a6-98d41f71285a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2c44862c-3e21-41e3-b494-da33d2c77696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/REVENUEDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#REVENUEDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/REVENUEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f65d1f64-5594-44a7-8718-0452b6b275ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f65d1f64-5594-44a7-8718-0452b6b275ac" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f6ae619f-3741-41f8-aa2b-6ffb6285ca61" xlink:to="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_53e158f1-3e48-4585-99a0-f076f7e0c421" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:to="loc_srt_MaximumMember_53e158f1-3e48-4585-99a0-f076f7e0c421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b1308009-60a0-4d34-9a81-2bb277bd38a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1aa7dc63-452e-426c-b92d-262e7d0d2d06" xlink:to="loc_srt_MinimumMember_b1308009-60a0-4d34-9a81-2bb277bd38a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08ffb1a6-dc06-4feb-9c16-529e092dc218" xlink:to="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_0425ddea-717d-4789-be62-884ee66b85b5" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:to="loc_lh_DrugDevelopmentMember_0425ddea-717d-4789-be62-884ee66b85b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_50092549-aab9-42e6-b962-c6fa162ea717" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5981a5c2-e288-49de-9676-4873bad87fb3" xlink:to="loc_lh_DiagnosticsMember_50092549-aab9-42e6-b962-c6fa162ea717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_275970a0-1fd3-4cfb-970b-0a2cc30f2092" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1bd49c76-a62c-463c-832f-dd00507d826c" xlink:to="loc_srt_ProductsAndServicesDomain_275970a0-1fd3-4cfb-970b-0a2cc30f2092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1c13a9b8-59ff-45a6-b602-e4b0e48ccc6a" xlink:to="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_38dba398-090d-4818-ac88-bd11a9f9e2c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_srt_EuropeMember_38dba398-090d-4818-ac88-bd11a9f9e2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_ebf4deb2-d564-4163-a845-db9f68959e57" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_srt_NorthAmericaMember_ebf4deb2-d564-4163-a845-db9f68959e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_a9232d03-c0ed-4428-aef5-e98973b469ff" xlink:href="lh-20221231.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_89a2247c-7f55-4600-bb84-5d7c80eb0d05" xlink:to="loc_lh_OthercountriesMember_a9232d03-c0ed-4428-aef5-e98973b469ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1ec75e7c-957e-46ed-82b3-01d6fcf4402c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_5616a216-1465-464e-9932-aeabba772ee8" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1ec75e7c-957e-46ed-82b3-01d6fcf4402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerDurationDomain_13b09007-4c44-40e0-bff8-768c42d6ac72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerDurationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerDurationAxis_a1118939-8f62-498e-9651-09a274cd1611" xlink:to="loc_us-gaap_ContractWithCustomerDurationDomain_13b09007-4c44-40e0-bff8-768c42d6ac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_21320bae-2877-4e7a-bb99-d56b2eb8e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_32e410d1-cf15-49bd-aecd-424d6b004354" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_21320bae-2877-4e7a-bb99-d56b2eb8e5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_2f60331f-eb81-443e-9aec-75aa74d1c9ff" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_a12a9821-a80b-4e91-91b8-890acbbbde65" xlink:href="lh-20221231.xsd#lh_BiopharmaceuticalandmedicaldevicecompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_BiopharmaceuticalandmedicaldevicecompaniesMember_a12a9821-a80b-4e91-91b8-890acbbbde65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ThirdpartyMember_c4cc9358-d20c-4cb7-ae49-918c7204538c" xlink:href="lh-20221231.xsd#lh_ThirdpartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_ThirdpartyMember_c4cc9358-d20c-4cb7-ae49-918c7204538c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MedicareandMedicaidMember_0bc7447e-8936-42ad-895d-544589a991f3" xlink:href="lh-20221231.xsd#lh_MedicareandMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_MedicareandMedicaidMember_0bc7447e-8936-42ad-895d-544589a991f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfPayMember_9e509ad2-161b-43a4-9ccc-29f6c7929053" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfPayMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_us-gaap_SelfPayMember_9e509ad2-161b-43a4-9ccc-29f6c7929053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ClientMember_9f001eed-96c1-48e5-9be0-09403ab5ece0" xlink:href="lh-20221231.xsd#lh_ClientMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_7131bdf9-2006-4b74-9769-7401ca3a7629" xlink:to="loc_lh_ClientMember_9f001eed-96c1-48e5-9be0-09403ab5ece0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_31dba8da-7782-4bae-803a-b0a6cf94bc67" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_91d55ff5-4684-447f-a957-e0dbf25e9427" xlink:to="loc_srt_NameOfMajorCustomerDomain_31dba8da-7782-4bae-803a-b0a6cf94bc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_a379825f-f687-4b07-a635-88164ed3bce1" xlink:to="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_53b7a7bd-7326-455d-9d62-7682c7e5c476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_541ef545-9cc4-4a31-a21a-e9fd1fa17eac" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_53b7a7bd-7326-455d-9d62-7682c7e5c476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_74ee1a08-5f3e-4f67-b005-334f7422da78" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_78153e78-297e-49f6-b565-8373ec10c9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_78153e78-297e-49f6-b565-8373ec10c9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMinimum_c23cba88-3052-4579-bcb9-9044b18c22ee" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMinimum_c23cba88-3052-4579-bcb9-9044b18c22ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentofRevenueContributed_bdb061fd-7d8f-4141-8883-2d6d5fdf2d09" xlink:href="lh-20221231.xsd#lh_PercentofRevenueContributed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_PercentofRevenueContributed_bdb061fd-7d8f-4141-8883-2d6d5fdf2d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SalesCommissionAmortizationPeriodMaximum_fd5b54a0-077a-421f-917d-5b8d8c87625b" xlink:href="lh-20221231.xsd#lh_SalesCommissionAmortizationPeriodMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_SalesCommissionAmortizationPeriodMaximum_fd5b54a0-077a-421f-917d-5b8d8c87625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e45c08d4-7160-4729-9c7c-4ca51699f48f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_us-gaap_Revenues_e45c08d4-7160-4729-9c7c-4ca51699f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PercentOfDomesticRevenue_1cc36038-2175-4704-a157-ebbc6d71321f" xlink:href="lh-20221231.xsd#lh_PercentOfDomesticRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f204e88f-99c6-44f1-ab2e-0c5b370bd979" xlink:to="loc_lh_PercentOfDomesticRevenue_1cc36038-2175-4704-a157-ebbc6d71321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f65d1f64-5594-44a7-8718-0452b6b275ac" xlink:to="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ad83faf-dc3e-421a-b400-880009bd1596" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_3b71ff91-50be-46ec-b01a-20b6fb28566b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_us-gaap_AccountsReceivableMember_3b71ff91-50be-46ec-b01a-20b6fb28566b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledContractsReceivableMember_347b786b-a4e1-434a-b542-8d252fcf43d4" xlink:href="lh-20221231.xsd#lh_UnbilledContractsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_lh_UnbilledContractsReceivableMember_347b786b-a4e1-434a-b542-8d252fcf43d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_599cc3a1-3dfd-428f-9ee3-a60567e37f37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4f2837f6-87cd-46b7-a362-ace441a838b6" xlink:to="loc_us-gaap_NotesReceivableMember_599cc3a1-3dfd-428f-9ee3-a60567e37f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3bdd365f-3b96-4e73-8b9a-9c34a1f16e35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_49625183-06bc-4ee3-a5b8-7d22acef4043" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3bdd365f-3b96-4e73-8b9a-9c34a1f16e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5ee8bdbf-cd86-43d5-bf76-64f425e88698" xlink:to="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredSalesCommissions_d985b0d5-06a1-4d6c-9cb6-200b0a5c49ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDeferredSalesCommissions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AmortizationOfDeferredSalesCommissions_d985b0d5-06a1-4d6c-9cb6-200b0a5c49ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_a7598361-248f-44a3-b772-9468a9cc8db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent_a7598361-248f-44a3-b772-9468a9cc8db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_4a6edeaf-7aee-4384-826e-43120c68846f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_CapitalizedContractCostNet_4a6edeaf-7aee-4384-826e-43120c68846f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_f78266e1-0923-4bd8-b65c-807e78b671df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_f78266e1-0923-4bd8-b65c-807e78b671df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_913d0b6e-e2b1-4114-a903-b4b1d9389661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_913d0b6e-e2b1-4114-a903-b4b1d9389661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_a4fd8e34-4ae0-4bfb-9629-54375f045443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_a4fd8e34-4ae0-4bfb-9629-54375f045443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5928ff64-7944-440e-9997-55ea3b6ec425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_5928ff64-7944-440e-9997-55ea3b6ec425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e3c9af8-5d7e-453d-aad0-cd07b709b07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5e3c9af8-5d7e-453d-aad0-cd07b709b07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_45273b98-33da-4696-b33a-1ee08be3325f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerLiability_45273b98-33da-4696-b33a-1ee08be3325f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueRevenueRecognized1_bd297814-1993-415e-b071-6aa1a8347399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueRevenueRecognized1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_DeferredRevenueRevenueRecognized1_bd297814-1993-415e-b071-6aa1a8347399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d1958090-7d09-405b-834b-3888a2d7b4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d1958090-7d09-405b-834b-3888a2d7b4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_cea3ce6a-e8d3-49aa-acc7-ba5d4fec785d" xlink:href="lh-20221231.xsd#lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear_cea3ce6a-e8d3-49aa-acc7-ba5d4fec785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMinimum_73a5f5a1-2e34-4141-a196-435fa4eef83c" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMinimum"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_LongTermContractsDurationMinimum_73a5f5a1-2e34-4141-a196-435fa4eef83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermContractsDurationMaximum_a8390edb-25e3-4564-b739-674c960df7c0" xlink:href="lh-20221231.xsd#lh_LongTermContractsDurationMaximum"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_LongTermContractsDurationMaximum_a8390edb-25e3-4564-b739-674c960df7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_9f0293a5-b9e8-4974-9b21-b89418e9163b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_9f0293a5-b9e8-4974-9b21-b89418e9163b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0d3bc7e2-0b2f-490b-9318-6dc95a530129" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_0d3bc7e2-0b2f-490b-9318-6dc95a530129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesAllowanceforCreditLoss_e963d2f5-7c8e-4047-a4fa-001aa0f9bd5d" xlink:href="lh-20221231.xsd#lh_UnbilledServicesAllowanceforCreditLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_UnbilledServicesAllowanceforCreditLoss_e963d2f5-7c8e-4047-a4fa-001aa0f9bd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableAllowanceforCreditLoss_3b5b7e18-b545-4d17-83f2-c9463166264d" xlink:href="lh-20221231.xsd#lh_NoteReceivableAllowanceforCreditLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_NoteReceivableAllowanceforCreditLoss_3b5b7e18-b545-4d17-83f2-c9463166264d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLoss_ae2d7fe8-451e-4f98-be98-b52d97334d80" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_AllowanceforCreditLoss_ae2d7fe8-451e-4f98-be98-b52d97334d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_d13dfeae-f22a-4766-9b04-338dfce01137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_d13dfeae-f22a-4766-9b04-338dfce01137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnbilledServicesCreditLossExpenseReversal_a5e9a339-4093-44c6-b994-f8f52aad6655" xlink:href="lh-20221231.xsd#lh_UnbilledServicesCreditLossExpenseReversal"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_UnbilledServicesCreditLossExpenseReversal_a5e9a339-4093-44c6-b994-f8f52aad6655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NoteReceivableCreditLossExpenseReversal_d5709263-34ba-43f5-b27b-71f807393269" xlink:href="lh-20221231.xsd#lh_NoteReceivableCreditLossExpenseReversal"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_NoteReceivableCreditLossExpenseReversal_d5709263-34ba-43f5-b27b-71f807393269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditLossExpenseReversal_f8c414a9-182f-4beb-815f-be99e8d15c5d" xlink:href="lh-20221231.xsd#lh_CreditLossExpenseReversal"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_CreditLossExpenseReversal_f8c414a9-182f-4beb-815f-be99e8d15c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AllowanceforCreditLossWriteOff_20b05b65-cdd2-44d2-87cc-9e2ef3d0e813" xlink:href="lh-20221231.xsd#lh_AllowanceforCreditLossWriteOff"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5b810d9d-8a54-43a1-8456-05e6d512956e" xlink:to="loc_lh_AllowanceforCreditLossWriteOff_20b05b65-cdd2-44d2-87cc-9e2ef3d0e813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#ReceivablesLoansNotesReceivableandOthersDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_b282351a-f08a-4d64-9256-910cd14e52fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_be84ffbb-33e8-4bbc-9083-d03379e0d048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b282351a-f08a-4d64-9256-910cd14e52fd" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_be84ffbb-33e8-4bbc-9083-d03379e0d048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_b282351a-f08a-4d64-9256-910cd14e52fd" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c8934db3-7e9a-43f0-b631-fad17cf1ec8f" xlink:to="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_3b1b9e7e-9e74-4060-9b65-12c9ef88f98c" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:to="loc_lh_DiagnosticsMember_3b1b9e7e-9e74-4060-9b65-12c9ef88f98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_4d5066ce-2645-496a-91e1-2c47607a651f" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4137b842-2f5e-4dbd-8d6b-357543596a01" xlink:to="loc_lh_DrugDevelopmentMember_4d5066ce-2645-496a-91e1-2c47607a651f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_5e9ff065-99bc-4448-8e9b-b44c55fc75bc" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_293f3e71-8320-41cc-b7b5-7a1cf46be0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AccountsReceivableGross_293f3e71-8320-41cc-b7b5-7a1cf46be0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f0807a40-8afc-4392-b535-8036a709bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f0807a40-8afc-4392-b535-8036a709bc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_4987e504-1b83-4f17-bbe7-f71727fcb6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_4987e504-1b83-4f17-bbe7-f71727fcb6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_17e73222-8687-45bc-8350-721c6e2a3bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent_17e73222-8687-45bc-8350-721c6e2a3bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_de39de0f-3aed-498c-864e-e453d4fedf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_207eaa81-d5a3-430d-93d9-1e762886c44a" xlink:to="loc_us-gaap_ContractWithCustomerLiability_de39de0f-3aed-498c-864e-e453d4fedf51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8a0f1a4d-bc7e-4bf3-ae65-094e8c3104b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8a0f1a4d-bc7e-4bf3-ae65-094e8c3104b4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c4f77b53-5b90-4ac5-82e1-04cf82cd9e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_fc0542cb-f6a4-4982-aaa7-0c64909a0390" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c4f77b53-5b90-4ac5-82e1-04cf82cd9e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_5050f548-72fd-4129-aeac-5d687c7bc0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_868fda51-e895-4886-baeb-2542aae3eed3" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_5050f548-72fd-4129-aeac-5d687c7bc0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e0f6cd7d-a5fa-4b94-a3c6-49dffbba5aac" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c116f0f5-50ce-4c7f-8993-1c9e09d1f8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_c116f0f5-50ce-4c7f-8993-1c9e09d1f8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_9ed7e27e-ee1f-467d-be09-7862d00306bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_UseRightsMember_9ed7e27e-ee1f-467d-be09-7862d00306bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_8f69eef7-ea11-415f-a1d7-d26ff4037aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_TradeNamesMember_8f69eef7-ea11-415f-a1d7-d26ff4037aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_e0bcf9d2-af9a-45f3-8392-1da2de4d296c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_189dc620-8a69-4540-8f87-98b16dcde9d5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_e0bcf9d2-af9a-45f3-8392-1da2de4d296c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_4032d3b8-8115-4baf-bc32-07701f7edbdf" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_8812af92-8172-473e-9da8-a969772e7691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_8812af92-8172-473e-9da8-a969772e7691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_2073ad2d-6bf1-458f-ab31-658945b6c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_2073ad2d-6bf1-458f-ab31-658945b6c2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_b1f514c4-2151-4d0c-95d6-53f2137f18ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_OtherLiabilitiesMember_b1f514c4-2151-4d0c-95d6-53f2137f18ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_c88e052c-642c-4553-b474-56e91d20392b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_c88e052c-642c-4553-b474-56e91d20392b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_52e2cadf-1d27-4abd-ad06-604fe7d9229a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_52e2cadf-1d27-4abd-ad06-604fe7d9229a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c68f6e3f-b782-4973-8fb2-1ca62af98c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_c68f6e3f-b782-4973-8fb2-1ca62af98c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_8c282b6b-5217-4af3-b6c6-c7ba0ac5e09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_8c282b6b-5217-4af3-b6c6-c7ba0ac5e09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5e1f1117-3f55-4085-9a52-b95c41d56d11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_TradeNamesMember_5e1f1117-3f55-4085-9a52-b95c41d56d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_5d1aa146-f079-41b2-8a28-9e9dd5b2c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3b663d38-eb4b-45c5-a29d-321b471b2bc1" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_5d1aa146-f079-41b2-8a28-9e9dd5b2c84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_fa7e5518-3a76-459e-bdfa-5e7b1261f65b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_eba8d585-641c-4cbc-9dfa-62753926e794" xlink:to="loc_srt_ScenarioUnspecifiedDomain_fa7e5518-3a76-459e-bdfa-5e7b1261f65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8fd07f00-9dd3-4960-9b37-e45a8c3e5e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f80ac305-6711-410f-a144-a12952f3db33" xlink:to="loc_us-gaap_CreditFacilityDomain_8fd07f00-9dd3-4960-9b37-e45a8c3e5e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_514fe29a-80c8-45f9-af64-2a71ceafeeae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_caf671ec-bdb6-46a6-b52f-a019d20e37f8" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_514fe29a-80c8-45f9-af64-2a71ceafeeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7789b5b5-1b20-4bfe-a62c-7dd1784dc08a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ExcludingEnvigoMember_c09b081e-c881-4c6e-bd9b-1fc1e0fd5ab9" xlink:href="lh-20221231.xsd#lh_ExcludingEnvigoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_ExcludingEnvigoMember_c09b081e-c881-4c6e-bd9b-1fc1e0fd5ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_88843ca4-3cda-40cf-8527-d73378d66445" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_OtheracquireesMember_88843ca4-3cda-40cf-8527-d73378d66445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2021AcquisitionsMember_715b5ed7-1000-40dc-b64a-48f5e4743926" xlink:href="lh-20221231.xsd#lh_A2021AcquisitionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_A2021AcquisitionsMember_715b5ed7-1000-40dc-b64a-48f5e4743926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2020AcquisitionsMember_e3a05aa9-39f5-438a-8f9f-f106a0bb9f83" xlink:href="lh-20221231.xsd#lh_A2020AcquisitionsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_A2020AcquisitionsMember_e3a05aa9-39f5-438a-8f9f-f106a0bb9f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AscensionAcquisitionMember_df1436c1-604c-489a-8bfc-2e7f5ee07a23" xlink:href="lh-20221231.xsd#lh_AscensionAcquisitionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_AscensionAcquisitionMember_df1436c1-604c-489a-8bfc-2e7f5ee07a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MeasurementPeriodAdjustmentsMember_9a5045a6-af81-4616-8bae-16db4e84c6f2" xlink:href="lh-20221231.xsd#lh_MeasurementPeriodAdjustmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_MeasurementPeriodAdjustmentsMember_9a5045a6-af81-4616-8bae-16db4e84c6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PGDxMember_a4537d82-6da9-43d9-aefe-79c7e0e5fecf" xlink:href="lh-20221231.xsd#lh_PGDxMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1d9777bc-9dcd-40d5-8e01-f03f03c2c8c5" xlink:to="loc_lh_PGDxMember_a4537d82-6da9-43d9-aefe-79c7e0e5fecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7e9620d7-14eb-4057-9e77-c447d961c19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a2f7aa40-0741-4bcb-81b3-ad545ca6e6ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7e9620d7-14eb-4057-9e77-c447d961c19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41960ba7-35c1-4328-87d9-05ddee7854c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_73997997-03b9-490e-a564-a2615ad5d09e" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4224af08-4bfc-4480-9371-4d1572d2b4a0" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_73997997-03b9-490e-a564-a2615ad5d09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_87735820-e38d-4c73-9fcd-4617e752a1a3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26073e56-48c2-434c-9a36-a8064d87c98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26073e56-48c2-434c-9a36-a8064d87c98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_cdcdb9c6-c978-45d2-a22c-0cc38a63c12b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_cdcdb9c6-c978-45d2-a22c-0cc38a63c12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_ac609b12-1ab5-4425-9030-cfec6940a681" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_ac609b12-1ab5-4425-9030-cfec6940a681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aedbf463-42be-4ac3-9532-fa66e752e140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_aedbf463-42be-4ac3-9532-fa66e752e140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d271b20e-4cd8-44a4-ac16-a3456c0a621c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d271b20e-4cd8-44a4-ac16-a3456c0a621c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9f85c525-95e9-4171-9d93-cbc8951c7296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_9f85c525-95e9-4171-9d93-cbc8951c7296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5b263da1-f178-4ade-a84e-76f72fe301c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5b263da1-f178-4ade-a84e-76f72fe301c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d1fcf186-2241-4a1f-8066-13ba7e4627e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_d1fcf186-2241-4a1f-8066-13ba7e4627e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_cd752b8a-4e16-4bb7-8c1b-15d9f9f4b3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_cd752b8a-4e16-4bb7-8c1b-15d9f9f4b3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_97ade382-04da-46f3-8115-f4e80359286b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_97ade382-04da-46f3-8115-f4e80359286b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f440af-49ee-477f-a6fe-906a3dbe9943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f440af-49ee-477f-a6fe-906a3dbe9943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_969bea27-a867-4136-a025-924978222a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_969bea27-a867-4136-a025-924978222a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_181d9c82-3146-470a-bd4c-2a972ef2f5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_181d9c82-3146-470a-bd4c-2a972ef2f5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_28f4e5cb-9a65-46ed-8bc3-98d863b5cdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_28f4e5cb-9a65-46ed-8bc3-98d863b5cdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_da4b87f6-c2a1-4fcb-b281-e05c97e79297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_da4b87f6-c2a1-4fcb-b281-e05c97e79297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8fae84a8-2edb-415d-874f-3d02f7b283eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_8fae84a8-2edb-415d-874f-3d02f7b283eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_a52668ab-4229-485c-a2f6-89bd5c498331" xlink:href="lh-20221231.xsd#lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments_a52668ab-4229-485c-a2f6-89bd5c498331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2d70655d-4fa7-4946-90f8-8dabc5264db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2d70655d-4fa7-4946-90f8-8dabc5264db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cc78215e-2f7c-476d-b6db-b868aaee6ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cc78215e-2f7c-476d-b6db-b868aaee6ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e75e7d80-76da-48cd-8332-245df0aa9ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_e75e7d80-76da-48cd-8332-245df0aa9ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02848c7b-6101-4554-bb71-00e7117a1c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_02848c7b-6101-4554-bb71-00e7117a1c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e798323f-04cc-4791-82d8-98f69ac5c343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_e798323f-04cc-4791-82d8-98f69ac5c343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e03bde76-e727-4189-a6a0-75cec2bcd82b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e03bde76-e727-4189-a6a0-75cec2bcd82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8f5ce4f9-e9e4-4285-9ccc-1d40859314a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8f5ce4f9-e9e4-4285-9ccc-1d40859314a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_26354cce-340c-43a9-94a5-64792f9b3bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_Goodwill_26354cce-340c-43a9-94a5-64792f9b3bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4077fc66-3c08-4c47-9b30-96d88d61b4be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4077fc66-3c08-4c47-9b30-96d88d61b4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_02ab3068-ea90-4b8c-9db9-6eca60f192db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_02ab3068-ea90-4b8c-9db9-6eca60f192db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_092d35cf-787a-42d9-844a-ef4e444dc20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_092d35cf-787a-42d9-844a-ef4e444dc20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cd429063-880f-4ec9-a2f8-1f21f09be217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cd429063-880f-4ec9-a2f8-1f21f09be217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7035be7c-949e-417c-aff6-a839dcc7d9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_Revenues_7035be7c-949e-417c-aff6-a839dcc7d9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_71292c26-1164-42e9-90d9-e51d95f82bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_96690163-225a-48e1-b236-b8a03d43dce1" xlink:to="loc_us-gaap_OperatingIncomeLoss_71292c26-1164-42e9-90d9-e51d95f82bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93650a53-0a99-4466-97ce-7b4e00bccabf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93650a53-0a99-4466-97ce-7b4e00bccabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_f1bc8b33-0334-4a47-8665-8aca45ab3229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_f1bc8b33-0334-4a47-8665-8aca45ab3229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a1b2ec0-f3c0-4be8-8d7a-0b5523752903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_3a1b2ec0-f3c0-4be8-8d7a-0b5523752903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e56314ce-ba1a-463d-a52c-9968d173f48d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_e56314ce-ba1a-463d-a52c-9968d173f48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_584f3f9a-7ff0-463d-b09b-6d1d3cd8819f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9727db0d-9f04-4508-9036-12c73b88d8f5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2020AcquisitionsMember_f24be22c-a72d-4b45-b12d-9b6af6d2f04f" xlink:href="lh-20221231.xsd#lh_A2020AcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_A2020AcquisitionsMember_f24be22c-a72d-4b45-b12d-9b6af6d2f04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019AcquisitionsMember_db91a3ce-a682-4e04-8aec-acf7468cada1" xlink:href="lh-20221231.xsd#lh_A2019AcquisitionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_A2019AcquisitionsMember_db91a3ce-a682-4e04-8aec-acf7468cada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_b8f72b27-9365-4c3a-8717-f486b93af646" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6513ca11-d785-4abb-b72b-26f121f51d39" xlink:to="loc_lh_OtheracquireesMember_b8f72b27-9365-4c3a-8717-f486b93af646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7a4bcf03-edf4-4cb7-9e8f-fd5c64623040" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0173eb4c-b98b-4ebc-8e6e-67c65cad5e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_0173eb4c-b98b-4ebc-8e6e-67c65cad5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_8e4916c3-56a8-4eda-aa70-7833c59ea5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_8e4916c3-56a8-4eda-aa70-7833c59ea5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9e3c34f1-c379-4067-b067-df7df4c52ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_9e3c34f1-c379-4067-b067-df7df4c52ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7fcec6c1-98d9-47b8-9b80-b0cdefc7daa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_7fcec6c1-98d9-47b8-9b80-b0cdefc7daa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_806098ab-643a-4c24-b22e-a8d8be804bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_806098ab-643a-4c24-b22e-a8d8be804bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a962fd60-a4e4-4ac5-8940-c88c7aea02c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a962fd60-a4e4-4ac5-8940-c88c7aea02c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5604e93d-0c0f-4855-b31e-0045323066c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_5604e93d-0c0f-4855-b31e-0045323066c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ba4212fd-7553-4091-8e96-8f572a4f83a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ba4212fd-7553-4091-8e96-8f572a4f83a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7be4db55-73c8-42b7-a11a-6b26df3d526e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_7be4db55-73c8-42b7-a11a-6b26df3d526e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f6a98d-a42f-48c1-bac5-685c74a29679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_13f6a98d-a42f-48c1-bac5-685c74a29679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_98b5be6b-50f4-4441-a8f6-b1b47060ea81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_98b5be6b-50f4-4441-a8f6-b1b47060ea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7f68d5ba-ec48-443f-984b-f009bf32e222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_7f68d5ba-ec48-443f-984b-f009bf32e222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_23807a42-8ed4-40bc-8333-44b908ddaebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_23807a42-8ed4-40bc-8333-44b908ddaebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2cfda02e-f83c-40ad-8b44-0c055894950f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2cfda02e-f83c-40ad-8b44-0c055894950f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a7610a4-a5a5-4799-a411-17eaa77c3966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_7a7610a4-a5a5-4799-a411-17eaa77c3966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ca36ce71-ac43-468b-b229-9042510fd0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_ca36ce71-ac43-468b-b229-9042510fd0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_fd7f129e-e754-4675-afaf-a3a9c24de0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c25b3f84-aaf4-4446-9c7d-495114b22cf5" xlink:to="loc_us-gaap_BusinessExitCosts1_fd7f129e-e754-4675-afaf-a3a9c24de0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6cf909b0-d30a-4f3d-9e79-9245af2bf60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6cf909b0-d30a-4f3d-9e79-9245af2bf60a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6bd873b0-7000-4445-9193-6341a5925f88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_b95fb37b-4b7c-4da7-8dfd-8a22e2961f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:to="loc_us-gaap_CustomerRelationshipsMember_b95fb37b-4b7c-4da7-8dfd-8a22e2961f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_e7240b8b-743f-4c62-b436-5b053d2dbe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e51fb4e0-42c7-4737-b997-af00d012ba90" xlink:to="loc_us-gaap_TradeNamesMember_e7240b8b-743f-4c62-b436-5b053d2dbe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b5240f03-c7cd-407f-b8f1-32bbf9555720" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_48e035db-708c-4ce2-a5ca-8b4fe1113c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_48e035db-708c-4ce2-a5ca-8b4fe1113c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_40c262e9-f968-4456-a3c4-d803b94a2355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_40c262e9-f968-4456-a3c4-d803b94a2355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_826d7c8b-c14e-4771-98c6-fdaa5ff3a2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_CustomerRelationshipsMember_826d7c8b-c14e-4771-98c6-fdaa5ff3a2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_2274dc9f-09ae-45a8-8804-9a0e5c7c2fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_2274dc9f-09ae-45a8-8804-9a0e5c7c2fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_885fffbd-e0e1-43dd-8ec5-60090aa2e932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_74aac06e-be78-4e1d-9135-d14e545408ad" xlink:to="loc_us-gaap_OtherLiabilitiesMember_885fffbd-e0e1-43dd-8ec5-60090aa2e932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4e8be299-c4d3-4902-b4a6-cdd0be8ac232" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OtheracquireesMember_8e6048f9-9ede-426b-b9d5-a42126bc615f" xlink:href="lh-20221231.xsd#lh_OtheracquireesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c5f0461a-d123-4c26-a63c-8d91f1982c4e" xlink:to="loc_lh_OtheracquireesMember_8e6048f9-9ede-426b-b9d5-a42126bc615f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c8930797-7550-48ee-94a5-2c8d407d3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_0fc99afa-ccf8-493c-99fb-dafff8bfbb77" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c8930797-7550-48ee-94a5-2c8d407d3935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_9081a481-c53d-480a-b424-27d23c4b1244" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_71c5584d-e907-489c-b3bc-22b43187cad1" xlink:to="loc_srt_OwnershipDomain_9081a481-c53d-480a-b424-27d23c4b1244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0466234d-4ffe-4924-baa8-d795f7d71cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cc1de95d-7e2d-4cd5-a282-7f3460f9ee4f" xlink:to="loc_us-gaap_ClassOfStockDomain_0466234d-4ffe-4924-baa8-d795f7d71cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cdcdcb49-674f-4baa-9245-82dbb2d37b82" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9bb57275-3604-4ed6-9792-ef6df466df7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_OperatingIncomeLoss_9bb57275-3604-4ed6-9792-ef6df466df7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_730fb11a-a951-41b9-928d-00f2e489ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_730fb11a-a951-41b9-928d-00f2e489ea5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eadb738f-d0d9-4991-aeda-fcc15a747372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_eadb738f-d0d9-4991-aeda-fcc15a747372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_74c1c6ae-3112-4029-8a88-8ff7b06f4d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_74c1c6ae-3112-4029-8a88-8ff7b06f4d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b3753a76-ef55-4b27-9c05-fb1dcf937325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_b3753a76-ef55-4b27-9c05-fb1dcf937325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0833a87f-6605-46d1-85c8-97b3e27482a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0833a87f-6605-46d1-85c8-97b3e27482a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_037cb0b3-9733-46f7-822f-5d03ca521af8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_037cb0b3-9733-46f7-822f-5d03ca521af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32604b97-04bb-4614-9976-80688fe24acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_32604b97-04bb-4614-9976-80688fe24acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_fac95e1a-4fc1-4075-9ad4-3f197de75e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_fac95e1a-4fc1-4075-9ad4-3f197de75e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2bf93cd5-777b-42e0-8660-ef56e4c06a36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2bf93cd5-777b-42e0-8660-ef56e4c06a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d1a41532-cd8e-4768-9fdb-105c74fc5825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d1a41532-cd8e-4768-9fdb-105c74fc5825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0481b518-0716-4ccc-bd31-51ec8b0c8919" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0481b518-0716-4ccc-bd31-51ec8b0c8919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5c8c5dc-8c67-441b-87f7-081e3fa16fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_f5c8c5dc-8c67-441b-87f7-081e3fa16fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f48ac010-d41e-404a-92ed-0445e8b35f52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_f48ac010-d41e-404a-92ed-0445e8b35f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2d3ec6d0-f6a0-4136-97b6-3a49140e040b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_2d3ec6d0-f6a0-4136-97b6-3a49140e040b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_850b4fb7-95d0-4733-9185-728f042df977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_850b4fb7-95d0-4733-9185-728f042df977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8bfc6a16-26fe-4316-ba43-2e7df8d10804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_8bfc6a16-26fe-4316-ba43-2e7df8d10804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1112461-7d95-4929-8b10-2646b2da8c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a4aa778-1214-4316-bb3a-00ca4ed7b005" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e1112461-7d95-4929-8b10-2646b2da8c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#RestructuringandRelatedActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover_5cb2c50b-398b-4afb-af40-ab8354f5edf6" xlink:href="lh-20221231.xsd#lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover_5cb2c50b-398b-4afb-af40-ab8354f5edf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_c5079891-86fa-41c2-898d-c55044d42ef5" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_lh_NetRestructuringCharges_c5079891-86fa-41c2-898d-c55044d42ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_68c4a674-2bb3-4c39-bc29-5e999a2257a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_SeveranceCosts1_68c4a674-2bb3-4c39-bc29-5e999a2257a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_c9b61974-9f95-43ef-b7c7-6df18bb95206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_c9b61974-9f95-43ef-b7c7-6df18bb95206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_3d302afa-eff1-4b2d-82f0-600d5ec4e37a" xlink:href="lh-20221231.xsd#lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment_3d302afa-eff1-4b2d-82f0-600d5ec4e37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FacilityRelatedRestructuringReserveAccrualAdjustment_3d14363f-2dad-4674-98c5-3afcf13df2c6" xlink:href="lh-20221231.xsd#lh_FacilityRelatedRestructuringReserveAccrualAdjustment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_lh_FacilityRelatedRestructuringReserveAccrualAdjustment_3d14363f-2dad-4674-98c5-3afcf13df2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_1bb48df1-7117-4d67-9269-804b7d5c86e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_BusinessExitCosts1_1bb48df1-7117-4d67-9269-804b7d5c86e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_41722561-66f7-4df1-b3e9-60e9aba5acfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringReserve_41722561-66f7-4df1-b3e9-60e9aba5acfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_de0ee0e1-c8df-4917-9374-1e2c7f4787b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringReserveCurrent_de0ee0e1-c8df-4917-9374-1e2c7f4787b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveNoncurrent_7ea81dee-3ecc-440c-9797-c327125cfc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringReserveNoncurrent_7ea81dee-3ecc-440c-9797-c327125cfc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_2f4a52e4-7574-4025-956b-98d0627b6961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringCharges_2f4a52e4-7574-4025-956b-98d0627b6961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_3b981403-3227-40f0-a93d-cf60793f9551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_3b981403-3227-40f0-a93d-cf60793f9551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_e1d21821-8f86-4cd9-baf8-d4f11c9af6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_PaymentsForRestructuring_e1d21821-8f86-4cd9-baf8-d4f11c9af6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_59a398e7-54ea-4530-b3bd-b3f9862bf24b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_c19b59cc-08b1-40fd-9f9c-4a391aba7288" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_0302796d-a7ac-4075-961f-38339a6c408e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:to="loc_us-gaap_EmployeeSeveranceMember_0302796d-a7ac-4075-961f-38339a6c408e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_23425876-6e26-4073-b199-c48e144ea00b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_afd50d5a-e5b1-4e73-b9e1-1523cb4d7080" xlink:to="loc_us-gaap_FacilityClosingMember_23425876-6e26-4073-b199-c48e144ea00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_566ee6e0-45c1-4bef-958b-00cf56c7daca" xlink:to="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_209e49ed-7994-489b-81e8-5cf36ded6072" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_lh_DiagnosticsMember_209e49ed-7994-489b-81e8-5cf36ded6072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_f191a2c4-3699-40ea-bdb8-61fe00a79d59" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_lh_DrugDevelopmentMember_f191a2c4-3699-40ea-bdb8-61fe00a79d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_7dbe8511-acb3-41c1-802b-771e5d98c23b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8019cbca-e9fc-455a-9865-e67a3d5ecab3" xlink:to="loc_us-gaap_CorporateMember_7dbe8511-acb3-41c1-802b-771e5d98c23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1ddd3c81-7a4d-4d70-adbf-1f3fb14438c7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cb8dd8c9-b18f-4eff-a85e-9bc5bbd15545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringReserve_cb8dd8c9-b18f-4eff-a85e-9bc5bbd15545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_3bbcd96c-03f0-44d2-9905-3c98fc60a325" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_lh_NetRestructuringCharges_3bbcd96c-03f0-44d2-9905-3c98fc60a325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_41e58b00-470d-4325-b460-b0e72e80bdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_SeveranceCosts1_41e58b00-470d-4325-b460-b0e72e80bdd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_df9c8d36-8631-4ed3-8883-b743014d766c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_df9c8d36-8631-4ed3-8883-b743014d766c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_9e8a5ee9-f711-4e9b-8df8-7de3a20c1662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_9e8a5ee9-f711-4e9b-8df8-7de3a20c1662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_bd3491ca-c10e-4957-ae25-77936091d208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_PaymentsForRestructuring_bd3491ca-c10e-4957-ae25-77936091d208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_d61b0dee-62d8-458b-a3f6-729654145746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_36558fbf-7caf-4828-ae8c-e76ee9008e21" xlink:to="loc_us-gaap_RestructuringCharges_d61b0dee-62d8-458b-a3f6-729654145746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7c79331e-feb8-40ee-8763-040bc9c6a534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7c79331e-feb8-40ee-8763-040bc9c6a534" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_b70ea40a-fc6e-4a2c-97dc-36acf760654d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermLeaseMember_fe58d30e-879d-4df0-b32c-13b28aeb37a2" xlink:href="lh-20221231.xsd#lh_ShortTermLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1b5dd3bc-d248-4691-9b52-775d98baca80" xlink:to="loc_lh_ShortTermLeaseMember_fe58d30e-879d-4df0-b32c-13b28aeb37a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:to="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_0b984826-b5b2-47dc-91ea-99f8db96594e" xlink:to="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermLeaseMember_464857fe-c32a-4712-8207-e55765da3882" xlink:href="lh-20221231.xsd#lh_ShortTermLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_fc388b0f-33ce-424c-976c-18633834b7b0" xlink:to="loc_lh_ShortTermLeaseMember_464857fe-c32a-4712-8207-e55765da3882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_47418f58-8e2e-4497-bb9b-586cf860a2bd" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d6380c7-3b2c-4947-9a15-6b05eb866636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_7d6380c7-3b2c-4947-9a15-6b05eb866636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_554aace4-670e-4856-beda-efc14433c97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_554aace4-670e-4856-beda-efc14433c97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1255c92c-063a-4bb6-aa22-fc5f6f633b87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_OperatingLeaseExpense_1255c92c-063a-4bb6-aa22-fc5f6f633b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeasePayment_851ddea9-41c2-44e4-aa4d-7ac96ef6de14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6e830fa0-c5f7-4944-9799-78f49d305b7a" xlink:to="loc_us-gaap_VariableLeasePayment_851ddea9-41c2-44e4-aa4d-7ac96ef6de14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESLeaseCostDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5adb4539-548f-4a90-85d6-e1dd0b098d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_223c4654-8034-4ad2-b4d3-6ca6095a2e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5adb4539-548f-4a90-85d6-e1dd0b098d89" xlink:to="loc_us-gaap_OperatingLeaseCost_223c4654-8034-4ad2-b4d3-6ca6095a2e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_139bb558-f846-4a93-8e32-e57a853fe204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5adb4539-548f-4a90-85d6-e1dd0b098d89" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_139bb558-f846-4a93-8e32-e57a853fe204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_d43449ff-ba67-49d6-952a-5265e0d9deff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5adb4539-548f-4a90-85d6-e1dd0b098d89" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_d43449ff-ba67-49d6-952a-5265e0d9deff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_7c7f48fb-371c-41e8-8077-3f6997ee05d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5adb4539-548f-4a90-85d6-e1dd0b098d89" xlink:to="loc_us-gaap_LeaseCost_7c7f48fb-371c-41e8-8077-3f6997ee05d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESSupplementalCashFlowDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_21898c8d-7eed-4a98-8fec-dbe57c182fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:to="loc_us-gaap_OperatingLeasePayments_21898c8d-7eed-4a98-8fec-dbe57c182fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3f309985-0540-4ebf-bd0d-30861e956a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_3f309985-0540-4ebf-bd0d-30861e956a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_f4e56a45-a845-4f5d-b896-8745dc643308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_f4e56a45-a845-4f5d-b896-8745dc643308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c7a58bf2-f4de-4ba0-9490-8640f9dd1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c7a58bf2-f4de-4ba0-9490-8640f9dd1e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_4feac51d-1890-477d-bb13-30f9111e4910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_29d98f17-af6a-4bc4-84b5-10484f6d2306" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_4feac51d-1890-477d-bb13-30f9111e4910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESSupplementalBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_32138210-75f3-4352-ba73-79a5f290c223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_32138210-75f3-4352-ba73-79a5f290c223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c4e9375-0bd6-4ced-bf46-a9f70bad8c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8c4e9375-0bd6-4ced-bf46-a9f70bad8c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4130f099-2736-49e5-938d-4f37fc485f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4130f099-2736-49e5-938d-4f37fc485f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2c940192-21f8-4f79-820d-f1aaa22521a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseLiability_2c940192-21f8-4f79-820d-f1aaa22521a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f639970b-d926-4c37-bd59-85b036dac50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f639970b-d926-4c37-bd59-85b036dac50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e4136970-9e59-49d5-87fe-c26497c820e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e4136970-9e59-49d5-87fe-c26497c820e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b1d88313-3402-46c9-8888-6ddf06301fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b1d88313-3402-46c9-8888-6ddf06301fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_09db8a99-ef48-4748-b382-1ba84f331a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseLiability_09db8a99-ef48-4748-b382-1ba84f331a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f8dcb7fd-1a3c-43dc-8748-85e94786e157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f8dcb7fd-1a3c-43dc-8748-85e94786e157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_70f725ed-e80a-4061-8566-43400225f2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_70f725ed-e80a-4061-8566-43400225f2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09d6d69b-73b5-475b-8099-877513be76c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09d6d69b-73b5-475b-8099-877513be76c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d9b8cc46-52c7-4e16-8b37-e83a7670b02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_d9b8cc46-52c7-4e16-8b37-e83a7670b02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3f8c645d-6975-44c1-9e87-dcb3ed7fbe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3f8c645d-6975-44c1-9e87-dcb3ed7fbe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c2fc0375-391e-407e-940d-7024013ef93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e35cc193-fdd5-46fb-9378-6273b0020e48" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_c2fc0375-391e-407e-940d-7024013ef93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/LEASESMaturityofLeasesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#LEASESMaturityofLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/LEASESMaturityofLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d5cf3767-6851-4e5f-afba-7da8dbed60da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d5cf3767-6851-4e5f-afba-7da8dbed60da" xlink:to="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_10bf575d-cb33-4b77-a45c-4f4ac87522f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_10bf575d-cb33-4b77-a45c-4f4ac87522f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_1f71a097-4f91-46a2-bf93-b895bf1687a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_1f71a097-4f91-46a2-bf93-b895bf1687a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_8d6ce97a-77be-46d1-aad3-5da7c7537472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_8d6ce97a-77be-46d1-aad3-5da7c7537472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_6c254f78-569f-4fc3-b09e-80bcf4a997d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_6c254f78-569f-4fc3-b09e-80bcf4a997d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_a77ad7e2-e541-453c-a2e3-1acca24a78c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_a77ad7e2-e541-453c-a2e3-1acca24a78c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9c5ae1a8-3397-4af8-873e-363bacf28106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9c5ae1a8-3397-4af8-873e-363bacf28106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8777501-fe1c-435a-8554-1663a365786d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d8777501-fe1c-435a-8554-1663a365786d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_012a85e4-86be-4a64-9274-ccfe4eba04d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_012a85e4-86be-4a64-9274-ccfe4eba04d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_228506ab-1e08-455f-b9d6-e2af5eedc47e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_228506ab-1e08-455f-b9d6-e2af5eedc47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d6858520-d90c-40ed-9356-ca0516421422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilityAbstract_8ff95ac4-2a74-4ae9-a0c5-a5dea0f3fa47" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d6858520-d90c-40ed-9356-ca0516421422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d5cf3767-6851-4e5f-afba-7da8dbed60da" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dae20f9f-d86b-433d-b33a-2655282f672e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dae20f9f-d86b-433d-b33a-2655282f672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_db87908d-8359-43ef-9dfe-91e3737c8f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_db87908d-8359-43ef-9dfe-91e3737c8f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_24e1fc0f-dec1-4bd2-87bf-def05fbec5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_24e1fc0f-dec1-4bd2-87bf-def05fbec5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_954528a9-1502-4722-bdb9-22756fd1349f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_954528a9-1502-4722-bdb9-22756fd1349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_da41af57-55c1-47dc-848b-12a813682892" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_da41af57-55c1-47dc-848b-12a813682892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ea792d5e-9041-4f05-8586-4c10bfb6f342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_ea792d5e-9041-4f05-8586-4c10bfb6f342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0705e742-ae1c-455c-80bc-91596d513ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0705e742-ae1c-455c-80bc-91596d513ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_dc89258a-0b5c-45ff-a282-948deb7463f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_dc89258a-0b5c-45ff-a282-948deb7463f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a0906e7c-40da-4b2d-89ba-3660d9bb4a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a0906e7c-40da-4b2d-89ba-3660d9bb4a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8d0da790-6f45-478d-b318-8a72d1b6e17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_ebe5e123-1d63-481a-ba75-2262b6b0f340" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8d0da790-6f45-478d-b318-8a72d1b6e17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PROPERTYPLANTANDEQUIPMENTNETDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bbd30aa7-6589-41f9-9a76-094c08bfd18f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bbd30aa7-6589-41f9-9a76-094c08bfd18f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3b9313fc-6d58-4a1e-96da-ce856d42952c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_31a7f7ed-ed40-4759-b9cb-c78c33694869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_31a7f7ed-ed40-4759-b9cb-c78c33694869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_85ca5ab9-607a-4fcc-ac7f-98a5e93a955e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_LandMember_85ca5ab9-607a-4fcc-ac7f-98a5e93a955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_1073473d-3622-4487-b10c-6641dc134609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_1073473d-3622-4487-b10c-6641dc134609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_2754b388-edd3-4231-866e-03f7a445febe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_2754b388-edd3-4231-866e-03f7a445febe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17ce05ab-ea84-48dc-a9d8-122c6cc503c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17ce05ab-ea84-48dc-a9d8-122c6cc503c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_63fb9489-7980-44b7-9840-92a6efa6b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_63fb9489-7980-44b7-9840-92a6efa6b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_40b29b30-adf1-4a8d-89aa-88a11ee56cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_40b29b30-adf1-4a8d-89aa-88a11ee56cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8ef41cb9-b305-40d6-84f1-de7e2412f7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_ConstructionInProgressMember_8ef41cb9-b305-40d6-84f1-de7e2412f7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_772a61c5-9a44-4d10-a562-84b7a3e1f9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_81f592f0-9a2b-4df7-bd20-84cbe913b05b" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_772a61c5-9a44-4d10-a562-84b7a3e1f9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b066584-71f4-4014-8e5a-24473546b6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a5c675f0-5995-4008-aeaf-a1ef68642051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a5c675f0-5995-4008-aeaf-a1ef68642051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f451d2c2-40f5-4e54-b25d-ef363191ed5c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c51ccc62-2a4b-4a19-a2a5-f3813d17e9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c51ccc62-2a4b-4a19-a2a5-f3813d17e9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0ea20cf9-0a5e-4ac6-b3e4-a3927244f904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0ea20cf9-0a5e-4ac6-b3e4-a3927244f904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_859c27a2-3a00-4ecb-a89c-8af98e46e8d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_859c27a2-3a00-4ecb-a89c-8af98e46e8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SoftwareDepreciation_0655e60f-61b0-4b05-990e-ba43198705b7" xlink:href="lh-20221231.xsd#lh_SoftwareDepreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract_b6bfe4d3-8e44-493f-9120-7a4fb639d2a5" xlink:to="loc_lh_SoftwareDepreciation_0655e60f-61b0-4b05-990e-ba43198705b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f50883bd-bda4-4cd7-819d-5f2d74982a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f50883bd-bda4-4cd7-819d-5f2d74982a1e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_541a7c9a-2511-4adf-8214-f2322fa0dbe6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_fb3387d3-15e2-469b-b4f8-d7979f392efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6957050b-b390-47cc-8054-92593f0ccaa6" xlink:to="loc_us-gaap_LicensingAgreementsMember_fb3387d3-15e2-469b-b4f8-d7979f392efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_191c24ba-f1c4-4c12-90ed-397739e572e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6919eb0a-48b1-4a3c-bca5-82a546e0cd42" xlink:to="loc_srt_ScenarioUnspecifiedDomain_191c24ba-f1c4-4c12-90ed-397739e572e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568902c5-67f6-4729-a2fb-7543ebd527fd" xlink:to="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_f61733d9-1487-40df-8896-72a8f5a84876" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:to="loc_lh_DrugDevelopmentMember_f61733d9-1487-40df-8896-72a8f5a84876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_1dcce6a1-93ea-44c9-a3a5-49bfc73d7b7d" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_65bdb658-362c-4466-b0bc-a3ee905ff44e" xlink:to="loc_lh_DiagnosticsMember_1dcce6a1-93ea-44c9-a3a5-49bfc73d7b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_667c660e-322c-4057-ba0b-2a3ad521a398" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_f0c1ac38-d727-4a3e-b4d3-aeffffc87aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8d924e9a-7561-4940-abfb-6d6e6cf5d7dc" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_f0c1ac38-d727-4a3e-b4d3-aeffffc87aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2697caab-2dea-4c8c-85f3-c1dd7325d416" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_01a46392-37b9-44ba-9ab0-8b7528971659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_01a46392-37b9-44ba-9ab0-8b7528971659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9cf8053e-4b62-4c91-8234-7cfc86de7428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9cf8053e-4b62-4c91-8234-7cfc86de7428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f32d6e3d-907e-4f9a-8af5-7f61d7426a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f32d6e3d-907e-4f9a-8af5-7f61d7426a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fb47c4fe-fbfd-4873-a225-fa8510d1eb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fb47c4fe-fbfd-4873-a225-fa8510d1eb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9ca8b00-d27f-43d9-9aa9-ddcfcda99949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d9ca8b00-d27f-43d9-9aa9-ddcfcda99949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a98a9400-d696-40aa-9e2b-39c5224f2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_a98a9400-d696-40aa-9e2b-39c5224f2b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a705564-a54b-4ca0-8a5b-bc382a9ce08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_7a705564-a54b-4ca0-8a5b-bc382a9ce08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_467f3c4d-29d8-4fad-88b1-5e30ee37ae93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_4568c8ac-b694-4165-aa9a-bf2521fc1903" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_467f3c4d-29d8-4fad-88b1-5e30ee37ae93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_22e8b409-42bd-404f-bc46-e3065d9212ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_22e8b409-42bd-404f-bc46-e3065d9212ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_871319f5-10ba-4137-bf94-f7f25b1a9d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_871319f5-10ba-4137-bf94-f7f25b1a9d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b33dd69a-b2ea-4b5e-8107-2113fd1d8542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b33dd69a-b2ea-4b5e-8107-2113fd1d8542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5f9cd97b-50b7-45df-a607-f4e264e1f871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_us-gaap_AdjustmentForAmortization_5f9cd97b-50b7-45df-a607-f4e264e1f871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GoodwillImpairmentCumulative_05eac1c3-65d2-4842-a0fc-4a5a02366a1b" xlink:href="lh-20221231.xsd#lh_GoodwillImpairmentCumulative"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0092e07f-2bb3-449b-94a6-ada62ba64065" xlink:to="loc_lh_GoodwillImpairmentCumulative_05eac1c3-65d2-4842-a0fc-4a5a02366a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f53a5ee-bb6c-4484-bd3d-add8f3e26abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f53a5ee-bb6c-4484-bd3d-add8f3e26abd" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8791c806-81cd-4a51-8d2e-c0f84ca75058" xlink:to="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_77d9f2e3-8585-46c6-9cca-26ebd021957a" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:to="loc_lh_DiagnosticsMember_77d9f2e3-8585-46c6-9cca-26ebd021957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_425a2f59-17b5-47b9-a35a-bb80c7f4ea08" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_594e868c-4911-4bea-ba13-a48a252000e6" xlink:to="loc_lh_DrugDevelopmentMember_425a2f59-17b5-47b9-a35a-bb80c7f4ea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d4c9ab0-9b64-47ee-b6e5-ef8014e18295" xlink:to="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e147504d-f28d-4724-b331-97b57bcc96cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_Goodwill_e147504d-f28d-4724-b331-97b57bcc96cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_849f80fc-f622-4a9d-879e-d5c5ab297c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_849f80fc-f622-4a9d-879e-d5c5ab297c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_2a2488d2-37b8-4340-9210-9a421bfc5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_2a2488d2-37b8-4340-9210-9a421bfc5e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a2b63c9c-346d-4afd-af06-f50f83e2561c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_db0a96a6-d3d5-43fa-a44b-b06d4f81280d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a2b63c9c-346d-4afd-af06-f50f83e2561c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d9f8899b-01b6-4de6-9fcb-f017031881cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f53a5ee-bb6c-4484-bd3d-add8f3e26abd" xlink:to="loc_us-gaap_GoodwillRollForward_d9f8899b-01b6-4de6-9fcb-f017031881cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_eb2aefee-77ad-4cde-91ce-19601496b6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d9f8899b-01b6-4de6-9fcb-f017031881cb" xlink:to="loc_us-gaap_Goodwill_eb2aefee-77ad-4cde-91ce-19601496b6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d853fa8d-1ff1-4044-b8f0-d694890eb7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d9f8899b-01b6-4de6-9fcb-f017031881cb" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d853fa8d-1ff1-4044-b8f0-d694890eb7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_91ec0679-3841-4e7d-8187-f46474efb3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d9f8899b-01b6-4de6-9fcb-f017031881cb" xlink:to="loc_us-gaap_Goodwill_91ec0679-3841-4e7d-8187-f46474efb3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fdd2f2-096e-4eb7-8e89-ec5495d4d2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68fdd2f2-096e-4eb7-8e89-ec5495d4d2b9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_08041f5e-c6ed-42a1-8a45-5c2bd71d5063" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_5a598d64-cac2-45be-8da9-403b806b5b64" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_5a598d64-cac2-45be-8da9-403b806b5b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4b1a7a9a-f900-4bac-8fcd-93f2d49982f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4b1a7a9a-f900-4bac-8fcd-93f2d49982f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_b93780f4-4042-47cb-8358-bdf9cdd0d22c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_UseRightsMember_b93780f4-4042-47cb-8358-bdf9cdd0d22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b3b16292-bc4c-4896-bedd-9c1434d03e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_TradeNamesMember_b3b16292-bc4c-4896-bedd-9c1434d03e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_72cb0fd6-0d16-41f9-b120-31a098d874cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_72cb0fd6-0d16-41f9-b120-31a098d874cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_ab83402c-16c9-4fd1-8238-45c7629282dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_LicensingAgreementsMember_ab83402c-16c9-4fd1-8238-45c7629282dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_e63a8f38-f16c-4f63-8c25-056ce32b2a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_e63a8f38-f16c-4f63-8c25-056ce32b2a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediaContentMember_5d9cc3b3-1ec4-4c24-8615-c282ac619fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediaContentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_baaf1b49-e7bb-4c9f-a0e1-4f31aaac77c7" xlink:to="loc_us-gaap_MediaContentMember_5d9cc3b3-1ec4-4c24-8615-c282ac619fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a92a4377-4bf7-449f-9191-c36c86b28171" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7e40e42b-411a-45fd-992c-415f7f131f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7e40e42b-411a-45fd-992c-415f7f131f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_dc2404a0-d93a-49ed-9ffb-946e213d5269" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_dc2404a0-d93a-49ed-9ffb-946e213d5269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_067d93b4-c804-4da2-b5ee-0a77531e3f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_067d93b4-c804-4da2-b5ee-0a77531e3f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_d3605d2b-bcf3-4b4c-80e1-b7d1a2d7ee09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_TradeNamesMember_d3605d2b-bcf3-4b4c-80e1-b7d1a2d7ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_954aedd9-a065-4faf-825f-03a1a4a4f6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_LicensingAgreementsMember_954aedd9-a065-4faf-825f-03a1a4a4f6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediaContentMember_9ad7bf9e-e757-405e-a767-1c5fea150a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MediaContentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4421b683-ee56-4746-97b4-7d47f3fe9b64" xlink:to="loc_us-gaap_MediaContentMember_9ad7bf9e-e757-405e-a767-1c5fea150a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_361eb2cb-8886-4144-92c4-703ae894f3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_44c1fe9e-6675-425a-8c0c-979fe627a921" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e59340f-8ec8-44cf-8b8c-8d87dc275085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2e59340f-8ec8-44cf-8b8c-8d87dc275085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9391580c-68e8-43a6-a0ca-70e00701dc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_9391580c-68e8-43a6-a0ca-70e00701dc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f52db74f-fbea-4a20-ae2b-1e6d34f4e70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_a402fa50-f55b-4c59-abed-48508a75b09c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f52db74f-fbea-4a20-ae2b-1e6d34f4e70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_834cc0c6-fdfd-4d9d-8cbc-1c6661469c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_834cc0c6-fdfd-4d9d-8cbc-1c6661469c78" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7882b6fe-ffc1-41c1-ada7-588751bd6622" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_9ab00447-303e-405d-950a-77e4edc23615" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_CustomerRelationshipsMember_9ab00447-303e-405d-950a-77e4edc23615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_PatentsLicensesAndTechnologyMember_202065e6-b394-4062-bd6c-8d50fc2e8091" xlink:href="lh-20221231.xsd#lh_PatentsLicensesAndTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_lh_PatentsLicensesAndTechnologyMember_202065e6-b394-4062-bd6c-8d50fc2e8091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_633cf1d2-ac21-43e2-b86c-d20cd9a4a5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_633cf1d2-ac21-43e2-b86c-d20cd9a4a5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_113b2ef8-41d5-4186-b71b-499ece5fd124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_TradeNamesMember_113b2ef8-41d5-4186-b71b-499ece5fd124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseRightsMember_72fca140-c52e-4c24-b5ec-1d1efa7251fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_UseRightsMember_72fca140-c52e-4c24-b5ec-1d1efa7251fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_a128fc77-e43e-457c-a504-4914cc6b4135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_91d8251c-c332-452a-b9aa-c77b2bee1cf6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_a128fc77-e43e-457c-a504-4914cc6b4135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_e5ea5444-10c2-4e0a-9095-2e6faf8d7716" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_4253246f-e668-4177-9992-f725b94aa76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_42a1ad1c-4124-470f-8b9e-761498799380" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_4253246f-e668-4177-9992-f725b94aa76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_63bc4b63-03ac-4ac0-9862-2be1810a83cb" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_56f4319d-98e8-422a-8c7b-1e5d5b50c52b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_56f4319d-98e8-422a-8c7b-1e5d5b50c52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_19cf9089-d37f-4812-b805-f1487b068532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_19cf9089-d37f-4812-b805-f1487b068532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c9b94a50-8c5b-4a7a-8388-c19895e1e504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_ba1e85f6-effa-4ac4-8cb3-254de1e07e52" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c9b94a50-8c5b-4a7a-8388-c19895e1e504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#ACCRUEDEXPENSESANDOTHERDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_45a5e1f3-51e2-4ff6-8fcd-b1c8d74bc062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45a5e1f3-51e2-4ff6-8fcd-b1c8d74bc062" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3e4f967b-c6c6-4f9d-9f1c-7351c0441ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_3e4f967b-c6c6-4f9d-9f1c-7351c0441ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_bf909bfb-ed26-417a-b46a-94c81f949932" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:to="loc_us-gaap_TaxesPayableCurrent_bf909bfb-ed26-417a-b46a-94c81f949932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccruedPassThroughExpenses_aedbc361-2f34-40a2-a4b4-95da3622d177" xlink:href="lh-20221231.xsd#lh_AccruedPassThroughExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:to="loc_lh_AccruedPassThroughExpenses_aedbc361-2f34-40a2-a4b4-95da3622d177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3a90f630-2a02-4475-80d8-3fabc88987a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3a90f630-2a02-4475-80d8-3fabc88987a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_693a2a88-8098-4d35-a08e-622e8db8f17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_ad8910bd-0748-4cfa-9b6a-a402f980d7f7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_693a2a88-8098-4d35-a08e-622e8db8f17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSCHEDULEOFSHORTTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c35330ef-e463-47d1-b012-fd2cd0a8a47e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c35330ef-e463-47d1-b012-fd2cd0a8a47e" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_6c03604e-6b5d-4087-a9cb-4c0f4085547b" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShortTermDebtIssueCostsMember_c8cdde9d-1bee-4ccd-8f02-cbbfb1b696fc" xlink:href="lh-20221231.xsd#lh_ShortTermDebtIssueCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_ShortTermDebtIssueCostsMember_c8cdde9d-1bee-4ccd-8f02-cbbfb1b696fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NotePayableCurrentMember_e7a44f46-d302-412e-8ca0-63e7d3a02008" xlink:href="lh-20221231.xsd#lh_NotePayableCurrentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_NotePayableCurrentMember_e7a44f46-d302-412e-8ca0-63e7d3a02008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2023Member_49fb48f5-23c9-42f0-83fe-84f0cc9b3554" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_17618b8d-17ba-45f7-ac90-896df24be2f5" xlink:to="loc_lh_SeniorNotesDue2023Member_49fb48f5-23c9-42f0-83fe-84f0cc9b3554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_19fa844a-a28e-41a8-b930-e4d958e4a181" xlink:to="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_ec4c557f-bc2e-498c-acf7-62e1ce28a2ed" xlink:href="lh-20221231.xsd#lh_A2019TermLoan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_A2019TermLoan_ec4c557f-bc2e-498c-acf7-62e1ce28a2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_4c333b95-935f-45ab-8dd8-3fcf8a5369b3" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_Shorttermdebtissuancecosts_4c333b95-935f-45ab-8dd8-3fcf8a5369b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_a93902cf-83eb-420b-817d-9be1f2017a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_us-gaap_NotesPayableCurrent_a93902cf-83eb-420b-817d-9be1f2017a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_feab5e51-6d5c-450c-8a0c-a9e9592b24b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_us-gaap_DebtCurrent_feab5e51-6d5c-450c-8a0c-a9e9592b24b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_34886a49-4df6-48c0-9e4f-c5c6d199dc5e" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_9c5c9e04-5c48-499e-92e0-597f6b394cbb" xlink:to="loc_lh_A4.00Seniornotesdue2023_34886a49-4df6-48c0-9e4f-c5c6d199dc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSCHEDULEOFLONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_70f6cf89-26d9-4ed4-969a-febd5f5c9923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_70f6cf89-26d9-4ed4-969a-febd5f5c9923" xlink:to="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_457729f3-07d0-4de9-acf9-cafff841d713" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b65681ac-5b6b-4176-98fb-26fe58531cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b65681ac-5b6b-4176-98fb-26fe58531cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_ccb868aa-afcb-4ace-8b64-f0549eee8ba2" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0bf7ae49-cfb1-4ea6-9e06-6fea0f2e282e" xlink:to="loc_lh_SeniorNotesDue2020Member_ccb868aa-afcb-4ace-8b64-f0549eee8ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:to="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c25d4868-1117-41de-a2cd-04bde6b48690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c671ef9c-3d7e-47af-a702-07e9c8207183" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c25d4868-1117-41de-a2cd-04bde6b48690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_91780444-e70e-4cab-b2a7-ca62989e96f6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8c065efe-097e-4c4f-b587-792f199428f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8c065efe-097e-4c4f-b587-792f199428f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_b70a550f-df60-4879-9b7e-6d7b79545066" xlink:href="lh-20221231.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_b70a550f-df60-4879-9b7e-6d7b79545066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_855cd525-4b34-411e-bd5d-4e7657771a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_855cd525-4b34-411e-bd5d-4e7657771a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.30seniornotesdue2024_96f49d89-ad31-4402-ae2e-788812f907eb" xlink:href="lh-20221231.xsd#lh_A2.30seniornotesdue2024"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A2.30seniornotesdue2024_96f49d89-ad31-4402-ae2e-788812f907eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2.95seniornotesdue2029_3c423825-5a30-45ff-8a37-fa626ddfcb9b" xlink:href="lh-20221231.xsd#lh_A2.95seniornotesdue2029"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A2.95seniornotesdue2029_3c423825-5a30-45ff-8a37-fa626ddfcb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027_1e706b0d-0db7-40d8-884a-1390bc5e416d" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Seniornotesdue2027_1e706b0d-0db7-40d8-884a-1390bc5e416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.70Seniornotesdue2045_c751edfb-72a5-4861-87d0-84776a7e6a14" xlink:href="lh-20221231.xsd#lh_A4.70Seniornotesdue2045"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A4.70Seniornotesdue2045_c751edfb-72a5-4861-87d0-84776a7e6a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024_bf8ae82e-0ac3-49d6-a6f6-b51014ac29f6" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2024"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Seniornotesdue2024_bf8ae82e-0ac3-49d6-a6f6-b51014ac29f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A3.60Seniornotesdue2025_05d615b8-8132-4761-933d-c6881746e684" xlink:href="lh-20221231.xsd#lh_A3.60Seniornotesdue2025"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A3.60Seniornotesdue2025_05d615b8-8132-4761-933d-c6881746e684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_f756e97e-b6cc-4269-8dd8-a8f5ba5ed5d8" xlink:href="lh-20221231.xsd#lh_A155SeniorNotesDue2026"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A155SeniorNotesDue2026_f756e97e-b6cc-4269-8dd8-a8f5ba5ed5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_LongTermDebtExcludingDebtIssuanceCosts_bc9b7e89-da63-46d7-9ce4-90fc9b4e9d78" xlink:href="lh-20221231.xsd#lh_LongTermDebtExcludingDebtIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_LongTermDebtExcludingDebtIssuanceCosts_bc9b7e89-da63-46d7-9ce4-90fc9b4e9d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_6f164173-de80-4a36-b4eb-19588d63abf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermNotesPayable_6f164173-de80-4a36-b4eb-19588d63abf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_7700202d-6ead-4736-a5e5-f47f906e1853" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_A4.00Seniornotesdue2023_7700202d-6ead-4736-a5e5-f47f906e1853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_cdb3e79f-b59b-4055-b360-3e71f921bcb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo_cdb3e79f-b59b-4055-b360-3e71f921bcb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_32a3dcb1-aeaf-44e2-9af3-c37af4d3ea90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree_32a3dcb1-aeaf-44e2-9af3-c37af4d3ea90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_371494f6-4144-4c31-a039-5bf4915470aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour_371494f6-4144-4c31-a039-5bf4915470aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_951ced61-0c71-4bcd-9d77-f8e2d4819f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive_951ced61-0c71-4bcd-9d77-f8e2d4819f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_01ea1b4c-cf5d-4c73-ad86-f5f5c866ff0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive_01ea1b4c-cf5d-4c73-ad86-f5f5c866ff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_40f90f32-0999-4e81-a417-50494f9ae8e6" xlink:href="lh-20221231.xsd#lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments_40f90f32-0999-4e81-a417-50494f9ae8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_000733a8-d3e1-4b87-95a8-43262bc146ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_000733a8-d3e1-4b87-95a8-43262bc146ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ec6b83c6-70f8-4b43-9300-b6264d5a2613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ec6b83c6-70f8-4b43-9300-b6264d5a2613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_4ab6ba3f-64f9-4973-8090-5dddbe56b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_DebtCurrent_4ab6ba3f-64f9-4973-8090-5dddbe56b27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_a48c055f-9632-4345-a221-ec0ae9c411a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7fb16ffb-0a5e-47f2-be0f-06a278e7295e" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_a48c055f-9632-4345-a221-ec0ae9c411a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTCREDITFACILITIESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6f9d4517-9175-425e-b3d2-16708df1e03a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6f9d4517-9175-425e-b3d2-16708df1e03a" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_393cb81e-faf6-4531-af44-07f21205ef2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9da889de-f612-4c58-b2c1-9e7014cde68f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_393cb81e-faf6-4531-af44-07f21205ef2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_b36dcdb9-0971-4450-9cad-01b568650c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_7ba164cd-f046-42f8-8d83-1b2af5ac2186" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_b36dcdb9-0971-4450-9cad-01b568650c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4706cf90-24ae-4dbd-bdeb-38273356d3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b24c5d99-b34e-4602-a7ee-c1773fbc12ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4706cf90-24ae-4dbd-bdeb-38273356d3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b57c0f79-a378-49f1-b35c-4e897e092133" xlink:to="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_13d7c06c-eb36-40cc-834c-aac57e81b116" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:to="loc_srt_MinimumMember_13d7c06c-eb36-40cc-834c-aac57e81b116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e7956ee1-faae-48d8-bd85-4479593e6235" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1607ca4c-fd33-4a2c-9787-032655766423" xlink:to="loc_srt_MaximumMember_e7956ee1-faae-48d8-bd85-4479593e6235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_fed147e6-e8e7-4f72-b4a1-765abf5a1b15" xlink:to="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b9360dca-90e4-47ae-b33b-a40af2bb190a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_366958df-bb95-40a5-b6be-6122d1e3fa45" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b9360dca-90e4-47ae-b33b-a40af2bb190a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3558f120-f846-423b-888a-268ced512dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_92fd7bde-d718-409d-a013-05339d734999" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3558f120-f846-423b-888a-268ced512dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_906f0320-b12f-4090-86e0-26f241096fb5" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_4e696b7b-1d0d-49ad-af92-e826e2e7abec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_NotesPayableCurrent_4e696b7b-1d0d-49ad-af92-e826e2e7abec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Longtermdebtissuancecosts_225ff0ed-be5b-4162-970e-da6bdc6e6e49" xlink:href="lh-20221231.xsd#lh_Longtermdebtissuancecosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_Longtermdebtissuancecosts_225ff0ed-be5b-4162-970e-da6bdc6e6e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2019TermLoan_9b849911-962b-4d35-9048-00dd8c1e9c1d" xlink:href="lh-20221231.xsd#lh_A2019TermLoan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_A2019TermLoan_9b849911-962b-4d35-9048-00dd8c1e9c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_de4df530-3380-41b1-8777-441ec6bea6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_de4df530-3380-41b1-8777-441ec6bea6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c5b2cd44-c6e8-4abd-96e2-c8d45a9b2147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c5b2cd44-c6e8-4abd-96e2-c8d45a9b2147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8fd38139-f03a-40de-80ec-55b6fb64a8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8fd38139-f03a-40de-80ec-55b6fb64a8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_e5123331-f8a9-4c8a-b255-513d982d4c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_e5123331-f8a9-4c8a-b255-513d982d4c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityOptiontoIncrease_4b50b64e-314c-4102-a479-c6b906240371" xlink:href="lh-20221231.xsd#lh_CreditFacilityOptiontoIncrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityOptiontoIncrease_4b50b64e-314c-4102-a479-c6b906240371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_6f96e669-3185-44d8-9dcc-db2abf094cb9" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_6f96e669-3185-44d8-9dcc-db2abf094cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumLettersofCredit_adcb6282-d8fa-43ab-85e5-39983de7f5d2" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumLettersofCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_lh_CreditFacilityMaximumLettersofCredit_adcb6282-d8fa-43ab-85e5-39983de7f5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_3fc6e5d1-a17b-40b4-a83e-0a4ceb52cc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeDescription"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeDescription_3fc6e5d1-a17b-40b4-a83e-0a4ceb52cc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_30fa9b02-ce79-491c-85d8-75416d2ff836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c735a134-999d-497e-a71d-225fc600aa2c" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_30fa9b02-ce79-491c-85d8-75416d2ff836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTCOVERTIBLESUBORDINATEDNOTESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9f59d74a-f82e-4491-9d46-b072177dd02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9f59d74a-f82e-4491-9d46-b072177dd02a" xlink:to="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_43afc94a-ae77-4ae6-b160-aebda7a485ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4de2d738-3b0a-4d41-bcfa-df365e3e464c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_43afc94a-ae77-4ae6-b160-aebda7a485ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35efbc20-9947-4876-8745-290a7b0e21f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_74a79c45-f3f2-4768-beed-8aefd3fdebf3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_35efbc20-9947-4876-8745-290a7b0e21f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5bcddd5a-31e3-40c4-9046-f1be6e0d776c" xlink:to="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9b60be22-fab0-4f40-97b0-09e9b4234b9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_930345f5-6ec4-4121-905f-a85ca44eee8f" xlink:to="loc_srt_MaximumMember_9b60be22-fab0-4f40-97b0-09e9b4234b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e49e41fd-2e99-4f37-b966-b75dcbb318ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_90c9967a-4c8f-4537-a5ba-7860b673cc5d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e49e41fd-2e99-4f37-b966-b75dcbb318ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1f1750da-04df-4407-bebe-6936bab04671" xlink:to="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9af68560-c67d-4660-803c-a450fcd740b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c557b72a-0288-43df-8782-d4cf222e53b7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9af68560-c67d-4660-803c-a450fcd740b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cb3ffa39-6fdd-43e8-a08c-c222154a91b5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_e8b7975a-533e-4c65-9f37-919970d28ddf" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ca8a2ff-df56-4dca-be33-f2a54a6e418e" xlink:to="loc_lh_Seniornotesdue2027Member_e8b7975a-533e-4c65-9f37-919970d28ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c7694b3c-09bf-47de-8474-32653b0bd2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ac26ffad-82b6-4f22-9967-76eaf9167e14" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c7694b3c-09bf-47de-8474-32653b0bd2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8948347b-45a8-4ede-9314-e070dbdbb5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2f295cba-711b-464f-a7e0-323044263bc4" xlink:to="loc_us-gaap_VariableRateDomain_8948347b-45a8-4ede-9314-e070dbdbb5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_70b209f1-5303-4cc2-aae3-8cc644b5b559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_f6e1b5b7-5f44-4283-b368-406a65540c22" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_70b209f1-5303-4cc2-aae3-8cc644b5b559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_933040ad-fab0-452c-b4bb-5f5867008c74" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_8bb3ef7b-c171-41bd-bb4c-ed1e071daffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_LongTermNotesPayable_8bb3ef7b-c171-41bd-bb4c-ed1e071daffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Shorttermdebtissuancecosts_984abc51-e3dd-4379-b0e5-7e73b5d7bfe2" xlink:href="lh-20221231.xsd#lh_Shorttermdebtissuancecosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_lh_Shorttermdebtissuancecosts_984abc51-e3dd-4379-b0e5-7e73b5d7bfe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_ceb6a84e-e906-44bc-973f-1deba517bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_NotesPayableCurrent_ceb6a84e-e906-44bc-973f-1deba517bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a0492b89-b214-4423-944d-623f358e5021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a0492b89-b214-4423-944d-623f358e5021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2024_36c4604e-e7e5-4c98-abf1-162dbc3d24ce" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2024"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_lh_Seniornotesdue2024_36c4604e-e7e5-4c98-abf1-162dbc3d24ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f4501d3a-5c66-4b8d-bf1b-b1754e10232c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f4501d3a-5c66-4b8d-bf1b-b1754e10232c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0659b24c-0fc9-4ce1-b680-6818ad88f5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_0659b24c-0fc9-4ce1-b680-6818ad88f5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_05851a9f-90c3-4b01-b92f-a6b2daa34cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dbf71acb-0e58-4b71-8bbd-0b51b7081928" xlink:to="loc_us-gaap_DebtCurrent_05851a9f-90c3-4b01-b92f-a6b2daa34cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DEBTSENIORNOTESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DEBTSENIORNOTESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DEBTSENIORNOTESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c5eeb9c6-742e-45cf-9576-a770336071b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c5eeb9c6-742e-45cf-9576-a770336071b8" xlink:to="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5c3b3949-6843-43a2-95cd-96129f02799b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_173c772b-4cdc-41c7-a9fa-79d77932c0e0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5c3b3949-6843-43a2-95cd-96129f02799b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3b786393-bf13-4802-aa96-049aacce13c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0fb2b95f-a53d-4be4-a117-7fa96c1f5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a10b3371-793a-415e-9feb-8d0af8214959" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0fb2b95f-a53d-4be4-a117-7fa96c1f5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9dbb741e-6c09-462c-be41-b8b566b628cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3e84d14a-e699-4973-aabc-70824b06baec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9dbb741e-6c09-462c-be41-b8b566b628cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_16bcff1d-c112-457c-9f54-50a9431c8293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9a45d3ec-327d-4265-af74-4ab1c1d9bb33" xlink:to="loc_us-gaap_CreditFacilityDomain_16bcff1d-c112-457c-9f54-50a9431c8293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b1359e7-9f4f-4a34-adfe-f4e5ff39c9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b8e85ee8-4321-43da-aee7-5e8587805379" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1b1359e7-9f4f-4a34-adfe-f4e5ff39c9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_00db4283-8bad-403c-8bf9-ec8c991baa95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_f383ddc5-2686-4cda-9b3d-d5d57dd1b404" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2020Member_f383ddc5-2686-4cda-9b3d-d5d57dd1b404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_2d49a867-88a7-4cfc-9424-66598b6df01a" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_2d49a867-88a7-4cfc-9424-66598b6df01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_7d9bd780-9ef1-4dd6-93ea-72b8fb481027" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_Seniornotesdue2027Member_7d9bd780-9ef1-4dd6-93ea-72b8fb481027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2024Member_66f3281a-1dad-4bcf-a799-1cdc5da592cc" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2024Member_66f3281a-1dad-4bcf-a799-1cdc5da592cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_927bfb36-6833-4b61-b925-e37d3333fd8b" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2022Member_927bfb36-6833-4b61-b925-e37d3333fd8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2023Member_203e7f95-b2ad-4fcc-9414-33acd9d4f647" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fbc1be8e-7d62-49f8-b9cb-f7542881a945" xlink:to="loc_lh_SeniorNotesDue2023Member_203e7f95-b2ad-4fcc-9414-33acd9d4f647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_fd4b2602-7606-4a90-a571-023ec629a9d9" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4b83ae38-06bb-4297-9e6a-21abebfd530f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_6305ca7b-f17f-48fa-92dd-43869462935a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4b83ae38-06bb-4297-9e6a-21abebfd530f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:href="lh-20221231.xsd#lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis_ee7beed1-e1c4-4144-b19a-118dfe81954b" xlink:to="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_d9a390a1-3ddc-43dd-ae22-af4b82f7591c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain_fd0adedd-3109-4046-84e0-4522e05fdbc2" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_d9a390a1-3ddc-43dd-ae22-af4b82f7591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_46887539-688a-4b0f-9ffd-220ac90d1efe" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3f91b870-a2cf-4541-85fa-59c0945e3799" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_2a557605-d06a-4d8b-92f4-2d5c8b0ef4d8" xlink:to="loc_us-gaap_InterestRateSwapMember_3f91b870-a2cf-4541-85fa-59c0945e3799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeAxis_81cb2184-872c-4ca8-8777-03e144072592" xlink:to="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022SwapAgreementsMember_0cbf44f3-3c9a-42fe-b485-80c7a6490a0b" xlink:href="lh-20221231.xsd#lh_A2022SwapAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:to="loc_lh_A2022SwapAgreementsMember_0cbf44f3-3c9a-42fe-b485-80c7a6490a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_1691cfd3-27a4-4185-9072-70d812498f21" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_2b12cd6a-1e91-482b-aa73-989d9075aea7" xlink:to="loc_lh_A2018SwapAgreementsMember_1691cfd3-27a4-4185-9072-70d812498f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5b8e4962-8b57-459f-90f7-a9aa42788bb1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_5d8a5aea-a361-4ed4-9e17-2836eff970cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtCurrent_5d8a5aea-a361-4ed4-9e17-2836eff970cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_TotalShortandLongTermDebtIssuanceCosts_7421b989-4924-469e-9d65-23bfa4b19421" xlink:href="lh-20221231.xsd#lh_TotalShortandLongTermDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_TotalShortandLongTermDebtIssuanceCosts_7421b989-4924-469e-9d65-23bfa4b19421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CreditFacilityMaximumSwingLineBorrowings_cf41226b-8a7c-4b3f-bff8-cf27d6b1b973" xlink:href="lh-20221231.xsd#lh_CreditFacilityMaximumSwingLineBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_CreditFacilityMaximumSwingLineBorrowings_cf41226b-8a7c-4b3f-bff8-cf27d6b1b973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_283c5814-6b58-42c8-b6b3-f40720719877" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_283c5814-6b58-42c8-b6b3-f40720719877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ceb63abf-1516-4bde-bba1-776c5daa7258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ceb63abf-1516-4bde-bba1-776c5daa7258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2de3d416-79d6-4ff3-86f4-dbf2d7859253" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2de3d416-79d6-4ff3-86f4-dbf2d7859253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_e4951a0e-2c10-4811-9133-a29da6de1d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_e4951a0e-2c10-4811-9133-a29da6de1d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2af9e77-64b9-4725-8e7b-9caae7b3b62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d2af9e77-64b9-4725-8e7b-9caae7b3b62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A270SeniorNotesDue2031_83091479-cfef-4ce6-8410-4cd134f5c832" xlink:href="lh-20221231.xsd#lh_A270SeniorNotesDue2031"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A270SeniorNotesDue2031_83091479-cfef-4ce6-8410-4cd134f5c832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0fcd7aa-fcc1-43b5-b079-2cb2f2ef000c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0fcd7aa-fcc1-43b5-b079-2cb2f2ef000c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A155SeniorNotesDue2026_8c2334bc-16b5-4979-b87a-fc019caba4fe" xlink:href="lh-20221231.xsd#lh_A155SeniorNotesDue2026"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A155SeniorNotesDue2026_8c2334bc-16b5-4979-b87a-fc019caba4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A4.00Seniornotesdue2023_11b101ce-e2d6-4a21-b80e-b03cec70e2a0" xlink:href="lh-20221231.xsd#lh_A4.00Seniornotesdue2023"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e2f57a8a-3b54-48eb-8a76-1a4df0777676" xlink:to="loc_lh_A4.00Seniornotesdue2023_11b101ce-e2d6-4a21-b80e-b03cec70e2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4e89737-e95f-4f12-be8a-5de57da264b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4e89737-e95f-4f12-be8a-5de57da264b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_91e5adab-3f5e-482a-8cb4-c03be8b28232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_91e5adab-3f5e-482a-8cb4-c03be8b28232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ba4ea31-e21e-43c0-824e-6f91ae3c6c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ba4ea31-e21e-43c0-824e-6f91ae3c6c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:href="lh-20221231.xsd#lh_CommonSharesIssuedRollforwardAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4f7ff1fa-c71f-4b7f-98b7-a86287ca1523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:to="loc_us-gaap_CommonStockSharesIssued_4f7ff1fa-c71f-4b7f-98b7-a86287ca1523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_a7ff2c32-d0db-4c4c-b269-a4e0d1a8e814" xlink:href="lh-20221231.xsd#lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:to="loc_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans_a7ff2c32-d0db-4c4c-b269-a4e0d1a8e814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_530e8038-0afd-4a86-a411-2e43b742f70d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_530e8038-0afd-4a86-a411-2e43b742f70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_41d58c6b-d62e-4d1c-a94a-ec43a5ef4188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CommonSharesIssuedRollforwardAbstract_83353455-0e9d-4bd6-a591-dfbf7a026a32" xlink:to="loc_us-gaap_CommonStockSharesIssued_41d58c6b-d62e-4d1c-a94a-ec43a5ef4188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_51dd0aed-9959-4eb7-8f99-250e79f9453d" xlink:href="lh-20221231.xsd#lh_CommonSharesHeldInTreasuryRollforwardAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_lh_CommonSharesHeldInTreasuryRollforwardAbstract_51dd0aed-9959-4eb7-8f99-250e79f9453d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_fe9348d0-e872-44f7-bfd6-3dee73beab87" xlink:href="lh-20221231.xsd#lh_OutstandingStockRepurchaseAuthorizationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_fe9348d0-e872-44f7-bfd6-3dee73beab87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_5877d31f-6e49-4fae-a091-fa9987ecdf5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_fe9348d0-e872-44f7-bfd6-3dee73beab87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_5877d31f-6e49-4fae-a091-fa9987ecdf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_41169cd7-9938-4e1e-bcf5-f96db49b17c4" xlink:href="lh-20221231.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_OutstandingStockRepurchaseAuthorizationAbstract_fe9348d0-e872-44f7-bfd6-3dee73beab87" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_41169cd7-9938-4e1e-bcf5-f96db49b17c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_AccumulatedOtherComprehensiveEarningsAbstract_b4f1e5fe-e683-4539-8d7b-127bc4f3027d" xlink:href="lh-20221231.xsd#lh_AccumulatedOtherComprehensiveEarningsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_lh_AccumulatedOtherComprehensiveEarningsAbstract_b4f1e5fe-e683-4539-8d7b-127bc4f3027d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_AccumulatedOtherComprehensiveEarningsAbstract_b4f1e5fe-e683-4539-8d7b-127bc4f3027d" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d75d9a14-2d07-4053-bdea-6f29b6dae5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d75d9a14-2d07-4053-bdea-6f29b6dae5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f9bd02cc-1abb-4c97-aa97-f7c66f1d3b78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f9bd02cc-1abb-4c97-aa97-f7c66f1d3b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_74cd5aeb-e4e7-4dbb-b164-510e1d335333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_74cd5aeb-e4e7-4dbb-b164-510e1d335333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_9a411637-6caa-4a32-b421-096254cfc48a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_9a411637-6caa-4a32-b421-096254cfc48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_92074977-7414-4caa-bf6e-3bb0a0b1442c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_620cf2cf-c6e9-4d08-a4f9-4c45097274d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_92074977-7414-4caa-bf6e-3bb0a0b1442c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_ceb65645-069c-421e-9547-1b90325a6aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_ceb65645-069c-421e-9547-1b90325a6aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_63631792-10b0-48bd-9875-b9feefdd247e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_ceb65645-069c-421e-9547-1b90325a6aed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_63631792-10b0-48bd-9875-b9feefdd247e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_bd3ebb99-f2a7-4620-a10f-eee99fb6da47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_ceb65645-069c-421e-9547-1b90325a6aed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_bd3ebb99-f2a7-4620-a10f-eee99fb6da47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9e34b53e-314b-462a-81ca-a0502f7f5baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract_ceb65645-069c-421e-9547-1b90325a6aed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9e34b53e-314b-462a-81ca-a0502f7f5baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_66138360-fb11-4375-bf05-fd23fae8e1b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_66138360-fb11-4375-bf05-fd23fae8e1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_977ebdcf-ef0b-4f85-b35c-800b4a265749" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1b353be4-3ae5-49d5-89f6-060b73ba4199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1b353be4-3ae5-49d5-89f6-060b73ba4199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2d3fc7e3-2548-4a32-a330-ea5b7da3f25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_2d3fc7e3-2548-4a32-a330-ea5b7da3f25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_9a1db523-38eb-43d0-8835-0ca976de19de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax_9a1db523-38eb-43d0-8835-0ca976de19de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_e19bf53f-0a4f-4436-bd02-638296c14c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax_e19bf53f-0a4f-4436-bd02-638296c14c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_de984e11-94b9-435c-b34a-2289a714c680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_de984e11-94b9-435c-b34a-2289a714c680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_f3b75ced-fb5b-4828-bb29-e3cab2abe8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_f3b75ced-fb5b-4828-bb29-e3cab2abe8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fc24ed18-325b-45f9-8887-d2c6365e2764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_522fed01-8314-4647-a6d4-38bcc63fcb55" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fc24ed18-325b-45f9-8887-d2c6365e2764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_fe6e5f91-7a38-45a9-8200-16ffe0a51a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_fe6e5f91-7a38-45a9-8200-16ffe0a51a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fe49ff3c-6838-4d24-bc35-bc5903e15920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_fe49ff3c-6838-4d24-bc35-bc5903e15920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_178700a6-807a-424c-a345-f7834659a886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_178700a6-807a-424c-a345-f7834659a886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7630a6d4-06f7-49ec-85df-7491da8e65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_7630a6d4-06f7-49ec-85df-7491da8e65d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_f3307696-ffd5-470d-9f66-8470165f5bfa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_024b0b00-ef0b-45be-baa3-c1df086b6166" xlink:to="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5e6c20ac-06d2-4417-896a-3d77f41c4c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d30bf99c-0873-40db-b071-cce7144fde1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5e6c20ac-06d2-4417-896a-3d77f41c4c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_50b0e8aa-95ff-4bc5-a612-3f23e22da0ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_f1ef1d09-cb54-4e7c-9264-1da987dace4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_f1ef1d09-cb54-4e7c-9264-1da987dace4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_3d6e797e-8310-478e-b388-ec801d1f7a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_b60c760e-6033-4ec0-8b5d-1155095f9701" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_3d6e797e-8310-478e-b388-ec801d1f7a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_7471fc4b-a53b-41e6-acdd-f46f511bad9d" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ASRSettlementMember_54eb81ca-50a2-4006-8e45-5b3059aa3adb" xlink:href="lh-20221231.xsd#lh_A2022ASRSettlementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_23d84445-accd-43c5-bb0a-79bc7b91fc50" xlink:to="loc_lh_A2022ASRSettlementMember_54eb81ca-50a2-4006-8e45-5b3059aa3adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccba9aac-2c08-450d-9aa3-cdb7f0c8de70" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ed09d279-df31-496a-8a0a-458a820e65a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e45d2412-6ab2-459d-8a57-434fc1f0ef01" xlink:to="loc_us-gaap_SubsequentEventMember_ed09d279-df31-496a-8a0a-458a820e65a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89597732-6911-4c34-bd0d-5ecfacc459f7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2022ShareRepurchasesMember_c8a044c3-637d-4f66-9a2b-912155750a8c" xlink:href="lh-20221231.xsd#lh_A2022ShareRepurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_df25fd96-2219-4de0-9482-8447d23ed63a" xlink:to="loc_lh_A2022ShareRepurchasesMember_c8a044c3-637d-4f66-9a2b-912155750a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ceccc826-ee43-462e-828e-b64c4041bd53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_087fd69e-b181-46b2-971d-1b06c6611e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_087fd69e-b181-46b2-971d-1b06c6611e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef0c7bf-6817-40e4-abf7-075185339e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef0c7bf-6817-40e4-abf7-075185339e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b7bfb821-f6b8-4f11-aa59-18c24285abb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_b7bfb821-f6b8-4f11-aa59-18c24285abb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d5129a27-0c57-4c0d-9290-b3f5d37b1bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d5129a27-0c57-4c0d-9290-b3f5d37b1bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_3f2c1153-8b86-4b8c-b861-cadda2ba56e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_Dividends_3f2c1153-8b86-4b8c-b861-cadda2ba56e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c0ed7528-ceca-4a45-9977-d366c0d2cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_c0ed7528-ceca-4a45-9977-d366c0d2cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_5f07dd19-d2a9-4b9a-9cd8-fe13d12909d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_5f07dd19-d2a9-4b9a-9cd8-fe13d12909d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_99b559a7-d49d-4f6d-b604-bc8a1b50d823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_99b559a7-d49d-4f6d-b604-bc8a1b50d823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_4d2e4cca-4368-48f8-94be-20ccf5f59398" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_4d2e4cca-4368-48f8-94be-20ccf5f59398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_eac884f3-d5a1-43c9-b1ee-b51c6a410817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_eac884f3-d5a1-43c9-b1ee-b51c6a410817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_db78440b-c970-4eb8-950b-55b931afda2f" xlink:href="lh-20221231.xsd#lh_CommonStockRepurchaseAuthorizationOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e95ae99a-98fe-49ff-8e9d-f6e51b3910f0" xlink:to="loc_lh_CommonStockRepurchaseAuthorizationOutstanding_db78440b-c970-4eb8-950b-55b931afda2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_4f17500e-4ff9-4f35-be29-4e5ae9faba65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_53fbdc73-52a5-4c13-a235-7e6a342ee826" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_4f17500e-4ff9-4f35-be29-4e5ae9faba65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetDomain_c3c3595b-c226-4768-8368-e50632b2f3de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_dd67c1e2-b114-4ffc-bfdd-d990cfc7cff6" xlink:to="loc_us-gaap_DeferredTaxAssetDomain_c3c3595b-c226-4768-8368-e50632b2f3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_a4c6a0a5-cd7e-49e4-b923-9ed1948f62cf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalLossCarryoverDomain_a948a80e-6256-426e-918b-2abec4fff0b3" xlink:href="lh-20221231.xsd#lh_FederalLossCarryoverDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_770edf91-b47f-46b1-be6e-0ee947a9a0a7" xlink:to="loc_lh_FederalLossCarryoverDomain_a948a80e-6256-426e-918b-2abec4fff0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_e7db6a07-145b-4c16-89c9-1c72608b1fd6" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReductionInTaxesMember_7caad680-ce90-455b-9075-2a55114083b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReductionInTaxesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_e011d4d8-9c54-4492-9e04-d88252436819" xlink:to="loc_us-gaap_ReductionInTaxesMember_7caad680-ce90-455b-9075-2a55114083b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_d2051c90-6e4e-4622-bee8-5fb4e0b79228" xlink:to="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Post2017Member_b1c751ae-ab45-46b5-90af-e4f882817df1" xlink:href="lh-20221231.xsd#lh_Post2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_b685ef00-48a3-4532-be94-6c8ca7455c49" xlink:to="loc_lh_Post2017Member_b1c751ae-ab45-46b5-90af-e4f882817df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_f78f8fb0-792b-4d73-b9b7-8b2e1bd67fd4" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_5a96464f-0435-4b93-aa4f-ba628d469388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_5a96464f-0435-4b93-aa4f-ba628d469388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e31b429b-6275-4ca8-b408-0439fb9b9941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_e31b429b-6275-4ca8-b408-0439fb9b9941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_d692ca49-0563-47fe-bd6b-7d83d4f5c17b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_d692ca49-0563-47fe-bd6b-7d83d4f5c17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dcbfcc85-478e-47ff-9f66-69ad81293113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dcbfcc85-478e-47ff-9f66-69ad81293113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_efe9381b-3b53-43ae-9d6f-1004e0f4cf47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_efe9381b-3b53-43ae-9d6f-1004e0f4cf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalTaxLossCarryovers_5659be82-4995-4d9b-92a0-106600fc8f42" xlink:href="lh-20221231.xsd#lh_FederalTaxLossCarryovers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_lh_FederalTaxLossCarryovers_5659be82-4995-4d9b-92a0-106600fc8f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_4c22d330-3a1b-4ef8-ab38-5ebc322792f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLimitationsOnUse_4c22d330-3a1b-4ef8-ab38-5ebc322792f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_73bdbc56-a1ce-41e3-91d4-1f132aa2b6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_73bdbc56-a1ce-41e3-91d4-1f132aa2b6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_de8532e6-0b7a-4998-9d31-3104427214b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_de8532e6-0b7a-4998-9d31-3104427214b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9697d25d-a638-4d5a-a8fc-235bf1f50b46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_9697d25d-a638-4d5a-a8fc-235bf1f50b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_28fe61fd-bdd4-4329-b771-1ab82a5add0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_feca0f35-a6a9-490a-9b51-8a4c3500cc5a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_28fe61fd-bdd4-4329-b771-1ab82a5add0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_19837269-ce65-46c1-aa75-e0bb3cbd9927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_19837269-ce65-46c1-aa75-e0bb3cbd9927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_d9c43c98-39a0-4270-998a-7c50afae572d" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_d9c43c98-39a0-4270-998a-7c50afae572d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b17a5c50-5196-462a-b9b5-044b0cf5adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_d9c43c98-39a0-4270-998a-7c50afae572d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_b17a5c50-5196-462a-b9b5-044b0cf5adbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_92d8abd6-216a-4bcb-b9a5-9a00ad8edb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_d9c43c98-39a0-4270-998a-7c50afae572d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_92d8abd6-216a-4bcb-b9a5-9a00ad8edb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_52ce8d96-7249-4227-8d7a-d15850dfe6d7" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract_d9c43c98-39a0-4270-998a-7c50afae572d" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_52ce8d96-7249-4227-8d7a-d15850dfe6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0d9d451c-9ae7-46dc-8b59-aa5ff215dacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_0d9d451c-9ae7-46dc-8b59-aa5ff215dacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_afd2ae70-4076-4f17-9057-28f16bab5bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_afd2ae70-4076-4f17-9057-28f16bab5bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7a260686-e9e5-4bfd-89cb-d7c7eecefadd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7a260686-e9e5-4bfd-89cb-d7c7eecefadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_12b3c2af-e6d1-4b84-acf0-046cc326c935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b2c83bf2-21a8-4cca-8e32-0e2d6b08c6fb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_12b3c2af-e6d1-4b84-acf0-046cc326c935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_05bea699-ed69-4568-bd92-9ade4fb3a4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_05bea699-ed69-4568-bd92-9ade4fb3a4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8aad4099-1247-4240-ac19-bc679829fc57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8aad4099-1247-4240-ac19-bc679829fc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_3b674c53-e556-4e40-8a3a-3ad9af4b3d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8aad4099-1247-4240-ac19-bc679829fc57" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_3b674c53-e556-4e40-8a3a-3ad9af4b3d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b81cc642-5c95-4dff-9da6-e9302accd336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8aad4099-1247-4240-ac19-bc679829fc57" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b81cc642-5c95-4dff-9da6-e9302accd336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_bbc88080-927c-4476-9eff-553a45e0e2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8aad4099-1247-4240-ac19-bc679829fc57" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_bbc88080-927c-4476-9eff-553a45e0e2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3eee25e6-673e-46c1-85c1-465b52d7957e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3eee25e6-673e-46c1-85c1-465b52d7957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6bd35810-47cb-4eb5-9ce9-a305348b49ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_206e2bc5-b7cc-41d4-b74b-381d7a5c5672" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6bd35810-47cb-4eb5-9ce9-a305348b49ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a99b5de6-a45f-4083-8381-556ab8701f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_a99b5de6-a45f-4083-8381-556ab8701f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_9e485186-d6d3-44ad-9343-140876cbfde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_9e485186-d6d3-44ad-9343-140876cbfde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalandStateAttributeCarryforwards_dfa3b2dc-236a-4c4c-b717-e9e4b3475961" xlink:href="lh-20221231.xsd#lh_FederalandStateAttributeCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_FederalandStateAttributeCarryforwards_dfa3b2dc-236a-4c4c-b717-e9e4b3475961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalandStateAttributeCarryforwardValuationAllowance_9569da9a-b679-4de8-b465-7312bdecc33b" xlink:href="lh-20221231.xsd#lh_FederalandStateAttributeCarryforwardValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_FederalandStateAttributeCarryforwardValuationAllowance_9569da9a-b679-4de8-b465-7312bdecc33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0fa493af-c520-4ee0-a923-c54da05adcef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0fa493af-c520-4ee0-a923-c54da05adcef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3f60dff6-8fa3-4a88-96fc-89bcc4993c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_3f60dff6-8fa3-4a88-96fc-89bcc4993c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2f35067a-cd16-48a1-a01a-da9c094beab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2f35067a-cd16-48a1-a01a-da9c094beab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_a9edf50f-c24f-4548-b5a2-cb0e9b7c5b60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_a9edf50f-c24f-4548-b5a2-cb0e9b7c5b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_25276f56-a657-4a6f-a3f2-ebc25330e413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_25276f56-a657-4a6f-a3f2-ebc25330e413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7abe19f-752e-410f-88f2-33d646fe2e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_2d86d81f-ebd5-4ed1-8bec-2c8f5498abb7" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b7abe19f-752e-410f-88f2-33d646fe2e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_ff1d5093-0ddb-4e40-b6fd-f0b77c0a8aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_ff1d5093-0ddb-4e40-b6fd-f0b77c0a8aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_ff1d5093-0ddb-4e40-b6fd-f0b77c0a8aa7" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2449a0f9-0845-400d-9edc-6cc15aed8007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2449a0f9-0845-400d-9edc-6cc15aed8007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_0b1aaf62-9802-42ae-92d6-1498974b8c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_0b1aaf62-9802-42ae-92d6-1498974b8c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DeferredTaxAssetRightOfUseAsset_9c5ac9ea-d702-4f55-912f-c751f824b7b7" xlink:href="lh-20221231.xsd#lh_DeferredTaxAssetRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_lh_DeferredTaxAssetRightOfUseAsset_9c5ac9ea-d702-4f55-912f-c751f824b7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_5dbc6889-87d0-4137-971f-09a587e9ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges_5dbc6889-87d0-4137-971f-09a587e9ea05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_43126fd6-2c5a-4482-9824-8909a1b36d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts_43126fd6-2c5a-4482-9824-8909a1b36d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_01b6f278-0ee2-44cb-b901-fe98984c35cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_01b6f278-0ee2-44cb-b901-fe98984c35cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7a34fde4-ca6f-475f-a387-80cc9efd74ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7a34fde4-ca6f-475f-a387-80cc9efd74ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_aed1af42-4e1f-46cf-aeb4-37118d3a9b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_aed1af42-4e1f-46cf-aeb4-37118d3a9b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3705e2b7-9817-424c-ad1a-1fca16a6ec51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3705e2b7-9817-424c-ad1a-1fca16a6ec51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_6221ca19-6770-4ee4-ad2c-35aa2566e1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_ac3b68a8-00f6-4e14-80cf-64115706b5cd" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_6221ca19-6770-4ee4-ad2c-35aa2566e1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_ff1d5093-0ddb-4e40-b6fd-f0b77c0a8aa7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e1297d9b-880a-4b25-8a9a-725897365835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_e1297d9b-880a-4b25-8a9a-725897365835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2541528c-1bd1-494e-9d35-a14d65c8e911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2541528c-1bd1-494e-9d35-a14d65c8e911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4e1be522-edab-4c2e-88ff-ff5663021b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4e1be522-edab-4c2e-88ff-ff5663021b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_8e333b34-d715-4412-91d2-0923b3bf4a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_8e333b34-d715-4412-91d2-0923b3bf4a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_718e7fb5-ce00-450e-9702-0e583a6cec4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredTaxLiabilities_718e7fb5-ce00-450e-9702-0e583a6cec4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b0b3e008-afc5-4887-8476-08a3b707d661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_4dd1232b-01a3-4ffa-b20a-72ef47582dcd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b0b3e008-afc5-4887-8476-08a3b707d661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryovers_961e132f-6c16-4db8-8727-fb65d96066e3" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryovers"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_ForeignTaxLossCarryovers_961e132f-6c16-4db8-8727-fb65d96066e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryoverValuationAllowance_98169f74-62ec-417b-8c23-93b3793dc627" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryoverValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_ForeignTaxLossCarryoverValuationAllowance_98169f74-62ec-417b-8c23-93b3793dc627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ForeignTaxLossCarryoversExpirein2034_0104b064-80de-4b31-ac4f-7d9c362fc8cb" xlink:href="lh-20221231.xsd#lh_ForeignTaxLossCarryoversExpirein2034"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_ForeignTaxLossCarryoversExpirein2034_0104b064-80de-4b31-ac4f-7d9c362fc8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_4a2bd7c4-0ec7-41b5-8b2c-45ffb2c1d505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_4a2bd7c4-0ec7-41b5-8b2c-45ffb2c1d505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FederalTaxLossCarryovers_9fd2ae56-2343-444c-8894-5c5c2c986cc5" xlink:href="lh-20221231.xsd#lh_FederalTaxLossCarryovers"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_FederalTaxLossCarryovers_9fd2ae56-2343-444c-8894-5c5c2c986cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_f9a867c1-38fc-4bb0-bb19-af457961afe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_f9a867c1-38fc-4bb0-bb19-af457961afe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8c353d11-f60d-4ef8-9475-a676c79144cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_8c353d11-f60d-4ef8-9475-a676c79144cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesExpense_5ba9dd16-5388-4859-a9d6-c70fb8990983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesExpense_5ba9dd16-5388-4859-a9d6-c70fb8990983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest_a45316b9-5aa9-4e4a-9c55-1670fffd4337" xlink:href="lh-20221231.xsd#lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest_a45316b9-5aa9-4e4a-9c55-1670fffd4337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_91647097-8bc6-4acf-bb56-b028ca389d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_91647097-8bc6-4acf-bb56-b028ca389d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d1568eb-9be3-41a7-9ee3-d9c95b13d863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5d1568eb-9be3-41a7-9ee3-d9c95b13d863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition_a8823f83-bf30-4448-bd22-73bf0faee873" xlink:href="lh-20221231.xsd#lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition_a8823f83-bf30-4448-bd22-73bf0faee873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions_d5ce3dfb-32ee-424b-96fd-750d9a446a96" xlink:href="lh-20221231.xsd#lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions_d5ce3dfb-32ee-424b-96fd-750d9a446a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c63f0cf0-fd7a-47d9-a013-7cf6b73f11b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c63f0cf0-fd7a-47d9-a013-7cf6b73f11b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_910d9918-2c11-4b9c-a2f5-63a5e8e00ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b324ce92-84d2-4752-9e96-f6be6bee8bb0" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_910d9918-2c11-4b9c-a2f5-63a5e8e00ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1cedcdd1-62f2-410c-86f4-d6f9ee0d7b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8583d7fb-ea4c-418f-b3cd-4bdfc4b7f872" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1cedcdd1-62f2-410c-86f4-d6f9ee0d7b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9249049e-2bfd-46f7-93d3-4d4580cd8828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9249049e-2bfd-46f7-93d3-4d4580cd8828" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ff6c2ebc-dea6-4eda-b4e5-c69f937a2e18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockAndPerformanceSharesMember_6fcc2f48-23c2-4d3f-bb17-8d8d1bed677d" xlink:href="lh-20221231.xsd#lh_RestrictedStockAndPerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_lh_RestrictedStockAndPerformanceSharesMember_6fcc2f48-23c2-4d3f-bb17-8d8d1bed677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0de53b91-64d3-494b-9e25-65e7a176ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0de53b91-64d3-494b-9e25-65e7a176ad33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanMember_04d049b9-e917-40a9-85e5-40fa556b87c8" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27ddd6af-e777-4907-b071-a638863b2fb4" xlink:to="loc_lh_EmployeeStockPurchasePlanMember_04d049b9-e917-40a9-85e5-40fa556b87c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ef664215-821e-48bc-a081-24cfae17a72b" xlink:to="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanMember_9ba20e9e-abcf-4a54-8596-34875f390f97" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a904036a-bba4-4aab-ac98-61273ac629be" xlink:to="loc_lh_EmployeeStockPurchasePlanMember_9ba20e9e-abcf-4a54-8596-34875f390f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_09a8d091-197f-4e05-8584-0793c9b0ea4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_0defae29-86d0-4155-8307-1621a24b3f5c" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_09a8d091-197f-4e05-8584-0793c9b0ea4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_105afe92-3731-472e-9320-e0fb5ad28122" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90b106af-5336-4f5f-b18d-711d4eef5c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_90b106af-5336-4f5f-b18d-711d4eef5c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7bccc17f-36c6-4c94-a50e-138ecccf9646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7bccc17f-36c6-4c94-a50e-138ecccf9646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_4ebb7259-46dd-4a30-9d95-ab7015c23fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_4ebb7259-46dd-4a30-9d95-ab7015c23fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_c2995189-a678-4f7a-a2be-4cd0cc7a52fb" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfSharesPurchased"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased_c2995189-a678-4f7a-a2be-4cd0cc7a52fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb676002-a3ed-4b1d-97bc-0199de96f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb676002-a3ed-4b1d-97bc-0199de96f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d761-baaa-4179-bf8e-90ee5dbee933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dee5d761-baaa-4179-bf8e-90ee5dbee933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e0ab8be4-a971-4e38-afd5-f924c649eba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e0ab8be4-a971-4e38-afd5-f924c649eba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35cabe36-7b4f-4939-a60f-f653ee150f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_35cabe36-7b4f-4939-a60f-f653ee150f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59fb4c20-6d17-4897-9ed8-794a6017b096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59fb4c20-6d17-4897-9ed8-794a6017b096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_13053622-6851-4f08-b0d1-382240528de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_13053622-6851-4f08-b0d1-382240528de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_35596a5b-dda2-4df6-8940-81be269e4d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_35596a5b-dda2-4df6-8940-81be269e4d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_ba4fb637-e7ec-497f-b07d-0ec1f56ad096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_ba4fb637-e7ec-497f-b07d-0ec1f56ad096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_090bb658-891d-4fff-a80b-d9bb80d9097f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_090bb658-891d-4fff-a80b-d9bb80d9097f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b43fef66-c5f3-4e2b-8ad1-df3fedfd1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b43fef66-c5f3-4e2b-8ad1-df3fedfd1c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_684c0c39-d386-49c0-bdf3-5aa1363172a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_684c0c39-d386-49c0-bdf3-5aa1363172a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e2ce23d9-15ba-42e9-aff1-bf5ba407ea16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e2ce23d9-15ba-42e9-aff1-bf5ba407ea16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_207a8e24-c3cc-4b04-aafa-328a75ab7ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_207a8e24-c3cc-4b04-aafa-328a75ab7ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_657ef011-f681-470f-b3d3-0c51d285dd94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_657ef011-f681-470f-b3d3-0c51d285dd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c9260e59-e73b-4218-82db-4bcf5986513c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_c9260e59-e73b-4218-82db-4bcf5986513c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca2d2837-2546-4014-a19a-451e0b5429b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ca2d2837-2546-4014-a19a-451e0b5429b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe8d6d59-2017-4f23-9af0-2d501d6b2f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fe8d6d59-2017-4f23-9af0-2d501d6b2f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ee7f7049-84c6-4568-94bb-c30654fcb3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ee7f7049-84c6-4568-94bb-c30654fcb3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_92c4d852-9438-47e3-8c48-904a9da222b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_92c4d852-9438-47e3-8c48-904a9da222b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_accf0623-e95e-43fb-a54b-510c208caeec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_accf0623-e95e-43fb-a54b-510c208caeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3ee960c2-1959-46cd-81ae-2f0ca4a05ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_3ee960c2-1959-46cd-81ae-2f0ca4a05ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_a1eaeceb-1078-40fb-9d66-7a31b28e210d" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight_a1eaeceb-1078-40fb-9d66-7a31b28e210d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_108ec34f-0457-4444-a157-8618c70a20b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_108ec34f-0457-4444-a157-8618c70a20b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_804725dd-4825-4048-9d89-9ab31871e1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_804725dd-4825-4048-9d89-9ab31871e1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f7364da0-8992-40fc-b821-d992f71d8c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_f7364da0-8992-40fc-b821-d992f71d8c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_8c81a7ac-4d43-4ecd-b7c8-6952411c9a99" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares_8c81a7ac-4d43-4ecd-b7c8-6952411c9a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_b83bea41-789f-4d62-a11f-755488918661" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanPercentOfMarketPrice"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanPercentOfMarketPrice_b83bea41-789f-4d62-a11f-755488918661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_EmployeeStockPurchasePlanExpense_756454df-0c77-441e-af3d-6f3f150f854a" xlink:href="lh-20221231.xsd#lh_EmployeeStockPurchasePlanExpense"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_EmployeeStockPurchasePlanExpense_756454df-0c77-441e-af3d-6f3f150f854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e5e9baf1-face-460a-b5c6-35652d945e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e5e9baf1-face-460a-b5c6-35652d945e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_77d68101-6cfa-49a7-9199-a263b22c2fef" xlink:href="lh-20221231.xsd#lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions_77d68101-6cfa-49a7-9199-a263b22c2fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_31eaf41b-6114-4b57-92e4-f6730a71628c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_31eaf41b-6114-4b57-92e4-f6730a71628c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_83f03803-a57c-421a-b618-87b5f6edac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_83f03803-a57c-421a-b618-87b5f6edac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_53e4d30a-088b-4847-9840-65ba6896b2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_53e4d30a-088b-4847-9840-65ba6896b2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b52307a-8f5c-4467-a2b1-7c762c9d09b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b52307a-8f5c-4467-a2b1-7c762c9d09b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_54997357-cc2d-4941-a2be-48d54e36b6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_54997357-cc2d-4941-a2be-48d54e36b6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_RestrictedStockPerformanceSharesExpense_a0bb9415-d947-496b-815d-b795338580d0" xlink:href="lh-20221231.xsd#lh_RestrictedStockPerformanceSharesExpense"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_lh_RestrictedStockPerformanceSharesExpense_a0bb9415-d947-496b-815d-b795338580d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b853714-d1b4-4ec7-9fd4-309502bd21d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3b853714-d1b4-4ec7-9fd4-309502bd21d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_51608766-5cac-4403-aa15-de043de197d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_51608766-5cac-4403-aa15-de043de197d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_5f604fac-a01b-4e00-bd8d-0e5b7a763a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c818503-3bc2-4589-8bf1-a3597796ec4a" xlink:to="loc_us-gaap_StockOptionPlanExpense_5f604fac-a01b-4e00-bd8d-0e5b7a763a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ccd909f-73c0-43fc-a2c0-835a686386e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ccd909f-73c0-43fc-a2c0-835a686386e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_d9016035-d24e-461f-b833-c4c2b338cdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_f0383667-8906-4b38-8ba3-a902193e9b0a" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_d9016035-d24e-461f-b833-c4c2b338cdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_f75ff652-c517-46b0-8402-8aa6fe5efc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_9079243b-84b8-4a24-b08f-1c95764ed60d" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_f75ff652-c517-46b0-8402-8aa6fe5efc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/Details" xlink:type="simple" xlink:href="lh-20221231.xsd#Details"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ec54101b-f3bc-469d-9d87-1cc7e62062f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ec54101b-f3bc-469d-9d87-1cc7e62062f6" xlink:to="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_48f80844-dbcd-4023-806c-59ab85aa1b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1cbcb3a4-004a-4854-b6d3-002b8fa43ba2" xlink:to="loc_us-gaap_LossContingencyNatureDomain_48f80844-dbcd-4023-806c-59ab85aa1b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_07be1206-92ca-4ced-bf3d-768f0bae602b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_caa319d7-674d-4a0e-b826-d97000607a12" xlink:to="loc_us-gaap_LossContingenciesLineItems_07be1206-92ca-4ced-bf3d-768f0bae602b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_61fe2899-b069-43a3-b048-63465952f9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_61fe2899-b069-43a3-b048-63465952f9eb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0d8ed117-bd4a-4cd0-aad4-1a0860696c5f" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_4a7a2281-a1ba-4055-9602-d4a19fa1c5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_4a7a2281-a1ba-4055-9602-d4a19fa1c5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9dda76de-0d9c-4286-aada-26815211ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9dda76de-0d9c-4286-aada-26815211ebab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_61003a76-f6a4-48ce-92c6-bd6d3c6c9157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_61003a76-f6a4-48ce-92c6-bd6d3c6c9157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e6876c00-b24a-4599-a2fe-91998aa15f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e6876c00-b24a-4599-a2fe-91998aa15f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_875dd096-a875-472f-a813-d740c0c1914a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_eb3c4897-7621-49a8-84e9-a342a19c1e70" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_875dd096-a875-472f-a813-d740c0c1914a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_20359312-ee7c-4ae2-9e6a-e68fceaeb08e" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_2efe92b2-b9e1-464c-a755-9ed67e5f88d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_OtherInvestmentsMember_2efe92b2-b9e1-464c-a755-9ed67e5f88d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_29b305d9-f9d4-4927-834d-57399ea8bf90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_EquitySecuritiesMember_29b305d9-f9d4-4927-834d-57399ea8bf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_059bd822-ff3b-4032-94ef-7de6932e7900" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_059bd822-ff3b-4032-94ef-7de6932e7900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_34b9764e-de92-4c86-a8e6-74f51506e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_DebtSecuritiesMember_34b9764e-de92-4c86-a8e6-74f51506e93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_bc7146f6-341f-48d4-8d2c-488f9ba197f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeAndAnnuityInsuranceProductLineMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_bc7146f6-341f-48d4-8d2c-488f9ba197f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_bf51d2f4-2e3d-4448-9e99-770baad6e12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_RealEstateFundsMember_bf51d2f4-2e3d-4448-9e99-770baad6e12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_a0f15a0d-d771-4acb-9afa-5775fb681d96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_VariableAnnuityMember_a0f15a0d-d771-4acb-9afa-5775fb681d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_fa0b433a-b04d-4d9b-b4a6-971e22c3a2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_fa0b433a-b04d-4d9b-b4a6-971e22c3a2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_0fae8a14-58da-435b-acef-d8ade59c0a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_us-gaap_EquityFundsMember_0fae8a14-58da-435b-acef-d8ade59c0a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternationalDevelopedMember_9e2116bd-4e51-4f1f-a532-913f21b91e1e" xlink:href="lh-20221231.xsd#lh_InternationalDevelopedMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_InternationalDevelopedMember_9e2116bd-4e51-4f1f-a532-913f21b91e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UsFixedIncomeMember_708601de-e9a8-4ee9-ba4f-7eaedf5f1593" xlink:href="lh-20221231.xsd#lh_UsFixedIncomeMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_UsFixedIncomeMember_708601de-e9a8-4ee9-ba4f-7eaedf5f1593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MutualFundsMember_ae3b11a8-35b9-49d8-a47f-23d45212706d" xlink:href="lh-20221231.xsd#lh_MutualFundsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d619c0aa-dbd3-4d03-a687-ef8d7db7d42f" xlink:to="loc_lh_MutualFundsMember_ae3b11a8-35b9-49d8-a47f-23d45212706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cc843bf-c0c6-4f57-a441-a463c00ac1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e6d8d63c-230e-4517-b8d6-e67e94687ef6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4cc843bf-c0c6-4f57-a441-a463c00ac1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e60370e0-7885-4af0-aea6-ed7c37e183cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d719d88c-e448-4455-bd0c-8642a3e7e037" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e60370e0-7885-4af0-aea6-ed7c37e183cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2528ba39-7254-4e80-97c6-86eed1376033" xlink:to="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9bc778e9-a3fd-47e7-a684-d3b931fdc256" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:to="loc_srt_MaximumMember_9bc778e9-a3fd-47e7-a684-d3b931fdc256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eecabb4b-e926-4584-806e-d6704de13029" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_202d67b7-50d7-46c8-ab84-875e184a9571" xlink:to="loc_srt_MinimumMember_eecabb4b-e926-4584-806e-d6704de13029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9ed3c090-777f-48ce-91ea-d0ab4921e9cb" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_66f9594b-8d3d-4cd3-ade6-96ecfce04101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:to="loc_us-gaap_OtherLiabilitiesMember_66f9594b-8d3d-4cd3-ade6-96ecfce04101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_4e47b1de-e37a-44bc-a9c0-9b469723257a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a6be9794-6522-45b3-bdea-e7b2f79f63d1" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_4e47b1de-e37a-44bc-a9c0-9b469723257a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_fe93aa44-e800-44e1-a938-c9d853bc10fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_afd89510-0a83-4e22-aff3-afbfa2ce0108" xlink:to="loc_dei_DocumentDomain_fe93aa44-e800-44e1-a938-c9d853bc10fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_b6377915-51a2-411f-b989-2c8317be75d6" xlink:to="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UKPlanMember_e5625bee-7eb0-41f7-a40f-71befc8bc5e0" xlink:href="lh-20221231.xsd#lh_UKPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_e1cee0b8-046b-4247-9177-f91364677299" xlink:to="loc_lh_UKPlanMember_e5625bee-7eb0-41f7-a40f-71befc8bc5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d1e9d06d-c637-4f0d-b43f-b9c27434091f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0c295a2e-1f90-4e3b-8ee4-f79ae00ffda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_NonUsMember_0c295a2e-1f90-4e3b-8ee4-f79ae00ffda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_8fdc100a-d67c-4479-99dc-27ebf7b73623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_ForeignPlanMember_8fdc100a-d67c-4479-99dc-27ebf7b73623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_8043d35e-4179-498f-93b0-4c27ff690df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_8043d35e-4179-498f-93b0-4c27ff690df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_272b87b4-42b6-4c3e-a9d2-a1c3fd668d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_aeac6bae-b020-4f50-9da9-19a554b7887c" xlink:to="loc_us-gaap_DomesticPlanMember_272b87b4-42b6-4c3e-a9d2-a1c3fd668d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_9cb3ae15-4fef-4ed3-aba4-776c8b1aba8a" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_60af08ea-8399-4217-875f-ca19589d0a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_76d84b48-5839-455a-81b2-933a8c7415be" xlink:to="loc_us-gaap_ForeignPlanMember_60af08ea-8399-4217-875f-ca19589d0a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_b3a39169-2e34-40ab-bb13-4347034eb044" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_64e0130f-a52a-4362-9f24-e3a53570b4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_64e0130f-a52a-4362-9f24-e3a53570b4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_43a90b37-d1eb-4abd-8ecf-bfba447f0708" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_43a90b37-d1eb-4abd-8ecf-bfba447f0708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b49c1ea5-b37a-4f70-a1b2-513c39ba929a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_b49c1ea5-b37a-4f70-a1b2-513c39ba929a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2ba8019c-9bc9-4acb-a58a-3dd128471211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_2ba8019c-9bc9-4acb-a58a-3dd128471211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualbasesalary_0b32f8a2-e9bb-44a6-b2e5-bada02fcf3d6" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualbasesalary"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_Maximumdeferralpercentageofannualbasesalary_0b32f8a2-e9bb-44a6-b2e5-bada02fcf3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dd0e548c-6cbc-4095-a320-aa54495caa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_dd0e548c-6cbc-4095-a320-aa54495caa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4da5215a-ab0b-4f80-898f-431d8722dc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_4da5215a-ab0b-4f80-898f-431d8722dc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1ccdc322-349d-4a80-8acb-173bb415fdbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_1ccdc322-349d-4a80-8acb-173bb415fdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_7b78df74-c5fe-4f82-b7ad-24f99cd01800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_7b78df74-c5fe-4f82-b7ad-24f99cd01800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1ba7882e-d95e-4551-810d-1a9158978707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_1ba7882e-d95e-4551-810d-1a9158978707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_398a6408-6a70-4e9b-9ee8-114f37c185d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_398a6408-6a70-4e9b-9ee8-114f37c185d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_f0ff2f7a-454d-4336-84f6-cadec36d81a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_f0ff2f7a-454d-4336-84f6-cadec36d81a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7538d280-7bb8-462e-a300-f1952f49d931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7538d280-7bb8-462e-a300-f1952f49d931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6414d1d1-4056-4b39-bd8e-5781c4f35aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6414d1d1-4056-4b39-bd8e-5781c4f35aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8c459dab-874e-4e11-aa48-6bc2a7bd2ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_8c459dab-874e-4e11-aa48-6bc2a7bd2ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_1397d795-c2c9-426a-b5e3-2099264d41ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_1397d795-c2c9-426a-b5e3-2099264d41ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_50cdd1fa-64e9-4ef7-bef3-c02269f8a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_50cdd1fa-64e9-4ef7-bef3-c02269f8a367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0439ffa2-6ced-4fad-93d2-20e66fc6c089" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_0439ffa2-6ced-4fad-93d2-20e66fc6c089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2d964f70-bb98-4f20-ab0b-0c2bba5bcb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_2d964f70-bb98-4f20-ab0b-0c2bba5bcb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_a50482d0-e8eb-4256-acb2-637a722c20f7" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_a50482d0-e8eb-4256-acb2-637a722c20f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_dfa87760-4238-4246-987e-1b25eb31d151" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_dfa87760-4238-4246-987e-1b25eb31d151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_160aa98c-3db1-431c-b6aa-66790fce00d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_160aa98c-3db1-431c-b6aa-66790fce00d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5e8c31ed-88dd-4681-96a0-bdc2e3ab7254" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_5e8c31ed-88dd-4681-96a0-bdc2e3ab7254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_47fcd4b8-a9a7-4a6b-8bfd-728951e8de32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_47fcd4b8-a9a7-4a6b-8bfd-728951e8de32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_3d06b0d1-88c2-422c-b8f4-56dd4b00c159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_3d06b0d1-88c2-422c-b8f4-56dd4b00c159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33b0e84d-b287-4757-a5cb-76f32c45a92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_33b0e84d-b287-4757-a5cb-76f32c45a92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_a43818e8-ef4b-4dc4-a619-02b5c6a1a159" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_a43818e8-ef4b-4dc4-a619-02b5c6a1a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3f9456b2-50ce-4d9e-9a8f-1cafe4d47c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_3f9456b2-50ce-4d9e-9a8f-1cafe4d47c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_78a2c85a-f47d-4945-9d65-a507d8bd00d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_78a2c85a-f47d-4945-9d65-a507d8bd00d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_8487ed62-d89e-4774-bac9-d4d1010e9d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_8487ed62-d89e-4774-bac9-d4d1010e9d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fa59b6b0-25bc-4512-956f-c876eb50aa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_fa59b6b0-25bc-4512-956f-c876eb50aa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_552d2bb9-1da0-4768-a629-469f9d780714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_552d2bb9-1da0-4768-a629-469f9d780714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_4be13fa5-cf4b-4cbe-8456-d8ae5a3f1d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_4be13fa5-cf4b-4cbe-8456-d8ae5a3f1d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2168ca48-b4c5-486d-b2c7-f26ad7d93c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2168ca48-b4c5-486d-b2c7-f26ad7d93c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_4d393e78-da73-439d-a635-efe433fa7f43" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_4d393e78-da73-439d-a635-efe433fa7f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_6566cf21-a2fb-407c-b7cd-bbe0dd77f499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0e912d90-a0a6-4704-9e8a-b232e6742fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_74aa5d88-af39-4c67-b2cf-0c9f7f9dc513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_9fa9d61f-94c8-4712-b9f6-8801b6aa23cf" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_9fa9d61f-94c8-4712-b9f6-8801b6aa23cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_abe46a4d-ed0a-4265-babe-4b8ecaa75bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ee99db61-0b90-4742-86af-ad76ff4c6915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_70b09c05-76ec-4874-a4ce-812fddbdbf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b9608e11-f274-4fa2-a404-d8c97cfa4618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_b9608e11-f274-4fa2-a404-d8c97cfa4618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_76931f0c-b9a1-4f2c-9ea6-507472d030fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_39d27759-b502-4fb5-be18-4a1e4457c03c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_89dbcd75-b73f-465c-8271-511beada48b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_288eab79-0f88-41c5-938f-c8993e18d399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_801c8add-0677-48d5-8b6c-bfe893b74e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_801c8add-0677-48d5-8b6c-bfe893b74e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_3b151666-a461-41c1-a334-3f1e128617f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_3b151666-a461-41c1-a334-3f1e128617f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_63beac12-e4d5-4e6b-9a1a-0916a41d09de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_894ffc8b-e24b-4083-a269-f530763fa5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_894ffc8b-e24b-4083-a269-f530763fa5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_acef9c72-9b51-4236-a5d2-8693368fccb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_e0ac2aab-8aab-4de6-a178-aa5705cfa6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_cf9df5f8-daca-477c-bc78-7f8f705164c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7b9e8d63-0ff3-4535-afdf-fbf83622f090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_7b9e8d63-0ff3-4535-afdf-fbf83622f090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_92dd45f9-7e6d-4c7c-ae26-1c07c394eb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_c7c6ff70-3044-4e3b-8f87-8a6f57baed5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets_594c1355-1104-43a8-8ac5-dad1930ab441" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_c76e79af-029f-4945-8a31-815eb1d422e7" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate_4b59928a-b72c-465b-848b-93aa27a3fe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1e2f1307-80c4-4cb1-8f23-5c091e594b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedContributionPlanTotalExpense_d445ac29-16f0-422d-9b3c-1daee403015a" xlink:href="lh-20221231.xsd#lh_DefinedContributionPlanTotalExpense"/>
    <link:presentationArc order="62" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_DefinedContributionPlanTotalExpense_d445ac29-16f0-422d-9b3c-1daee403015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_2fa0fd1c-8bd8-40b6-9c9e-6d59f645dd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear"/>
    <link:presentationArc order="63" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear_2fa0fd1c-8bd8-40b6-9c9e-6d59f645dd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_393b31ea-355c-4045-a32f-d1cc81bb0258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="64" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_393b31ea-355c-4045-a32f-d1cc81bb0258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Maximumdeferralpercentageofannualcashincentivepay_94b36643-9ed2-43e8-9fac-5fea84e05d33" xlink:href="lh-20221231.xsd#lh_Maximumdeferralpercentageofannualcashincentivepay"/>
    <link:presentationArc order="65" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_lh_Maximumdeferralpercentageofannualcashincentivepay_94b36643-9ed2-43e8-9fac-5fea84e05d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanOtherCosts_6c08fbed-2492-49de-9dbb-25d6d2e16db1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanOtherCosts"/>
    <link:presentationArc order="66" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_628377b9-43b4-4dfe-9cc2-047f730765d0" xlink:to="loc_us-gaap_DefinedBenefitPlanOtherCosts_6c08fbed-2492-49de-9dbb-25d6d2e16db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_3f596261-c8f0-4729-a9c9-6239de869a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_3f596261-c8f0-4729-a9c9-6239de869a5c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_feefbdda-ac64-47e5-a092-326de0447a87" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InternationalDevelopedMember_539f17aa-5637-4529-8bfa-3a350e2abbde" xlink:href="lh-20221231.xsd#lh_InternationalDevelopedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_InternationalDevelopedMember_539f17aa-5637-4529-8bfa-3a350e2abbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFundsMember_f6f938c3-e134-4af4-b7bb-41a1e6f1b764" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_EquityFundsMember_f6f938c3-e134-4af4-b7bb-41a1e6f1b764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_7f1bb9d3-5739-433a-801f-0437a6902257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_RealEstateFundsMember_7f1bb9d3-5739-433a-801f-0437a6902257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_d2c39fcf-0e11-40d1-864d-1f9355764138" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LifeAndAnnuityInsuranceProductLineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_LifeAndAnnuityInsuranceProductLineMember_d2c39fcf-0e11-40d1-864d-1f9355764138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_MutualFundsMember_6a39ee9d-c774-4a28-aea0-6c6003e825ce" xlink:href="lh-20221231.xsd#lh_MutualFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_MutualFundsMember_6a39ee9d-c774-4a28-aea0-6c6003e825ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_9e6bf4f4-3db4-4ebf-82e6-d29b70ca9646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_EquitySecuritiesMember_9e6bf4f4-3db4-4ebf-82e6-d29b70ca9646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_190e23ef-d5a1-4927-963a-6c2462132709" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_190e23ef-d5a1-4927-963a-6c2462132709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_26180b17-fa44-49e5-b13a-93b108ec817d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_DebtSecuritiesMember_26180b17-fa44-49e5-b13a-93b108ec817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_e680678f-3bc3-4ddd-ade5-18cb756e65ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_OtherInvestmentsMember_e680678f-3bc3-4ddd-ade5-18cb756e65ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UsFixedIncomeMember_296c5408-4d9d-41a9-8e76-47c70eb755c7" xlink:href="lh-20221231.xsd#lh_UsFixedIncomeMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_lh_UsFixedIncomeMember_296c5408-4d9d-41a9-8e76-47c70eb755c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_cd71435a-1184-48dd-b739-3534f91209c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_83563e7b-29a3-4fb0-a6a9-13b6808ceefb" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_cd71435a-1184-48dd-b739-3534f91209c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f0c853fb-7066-4bad-9bb5-71e3e47fe034" xlink:to="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_63f325bf-485e-4f4c-8034-b0d4055fc6d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:to="loc_srt_MinimumMember_63f325bf-485e-4f4c-8034-b0d4055fc6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a504ddd9-3e71-415d-bf4d-42c5f1c791fc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d60ead45-bf26-4015-81ca-0afa1c01e0bf" xlink:to="loc_srt_MaximumMember_a504ddd9-3e71-415d-bf4d-42c5f1c791fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_472e375b-67eb-41a7-80b0-f8a757df8e91" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_ce2291ca-d4c5-4733-96b6-31e94c362aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_a47b4e3c-ef74-433d-a361-10d081860f8d" xlink:to="loc_us-gaap_DomesticPlanMember_ce2291ca-d4c5-4733-96b6-31e94c362aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_221fb383-eab9-476d-9a8e-8339c9e2f2f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_20768ebf-007b-41fb-9cf4-cdff9a3e91ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_20768ebf-007b-41fb-9cf4-cdff9a3e91ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a749ba06-54da-432b-a4ee-206512607500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845f8fa6-ad50-4b5f-acf6-b81aff07d9a1" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_a749ba06-54da-432b-a4ee-206512607500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_e0f296a5-7c7b-48a3-bf36-fd4c671b0181" xlink:to="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashBalanceRetirementPlanMember_e0b191ff-7f11-4b97-a1ba-507006f499f1" xlink:href="lh-20221231.xsd#lh_CashBalanceRetirementPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_5036e5fd-6ff7-4688-97db-6aca987099ed" xlink:to="loc_lh_CashBalanceRetirementPlanMember_e0b191ff-7f11-4b97-a1ba-507006f499f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_566eea69-592f-4f37-b067-089f3b5d4567" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f854cc01-fc52-4aca-9a16-449b2ac142db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f854cc01-fc52-4aca-9a16-449b2ac142db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_773d2b10-a5e4-48e8-8812-bf36d74dfcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_773d2b10-a5e4-48e8-8812-bf36d74dfcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8bdd4dfa-9312-4be0-b379-f267bb9cbcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_8bdd4dfa-9312-4be0-b379-f267bb9cbcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_3fa85ed5-a4c3-427a-8df3-946e54a33ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_3fa85ed5-a4c3-427a-8df3-946e54a33ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_80f361dd-ec47-4871-9c3a-66fc2d1a66eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_80f361dd-ec47-4871-9c3a-66fc2d1a66eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e6203fa3-bf99-4789-8df0-2c1057cd4180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e6203fa3-bf99-4789-8df0-2c1057cd4180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_58b9b49e-baf1-4139-a49f-0527221fcaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_58b9b49e-baf1-4139-a49f-0527221fcaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f6428f75-d8af-408d-ae2e-dfce16e917a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f6428f75-d8af-408d-ae2e-dfce16e917a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d442d98b-f3a4-4a38-a403-623628307d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d442d98b-f3a4-4a38-a403-623628307d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0f8ea325-1e1b-4d96-b269-c96f2c3eaf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_0f8ea325-1e1b-4d96-b269-c96f2c3eaf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_9d00a17c-addb-447d-a0f8-1260b4c02c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_9d00a17c-addb-447d-a0f8-1260b4c02c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_584ab624-5cf8-4449-8050-ef480a801fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_584ab624-5cf8-4449-8050-ef480a801fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b5a526a6-6a28-47d7-b507-7aa12bacac7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_b5a526a6-6a28-47d7-b507-7aa12bacac7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_79212ddb-9897-48d7-bb86-4bbf6b34eb92" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets_79212ddb-9897-48d7-bb86-4bbf6b34eb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_99a5e7f6-0428-462f-86a6-f87f0009b3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_99a5e7f6-0428-462f-86a6-f87f0009b3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_08f02c62-b60b-4f99-91e6-c5ca32d37241" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_08f02c62-b60b-4f99-91e6-c5ca32d37241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_3bf21b5e-1251-4cea-a7e8-ec92c0a6a2f3" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_3bf21b5e-1251-4cea-a7e8-ec92c0a6a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8c7f6d30-4208-4ec9-8bfe-5e5ffbb540ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_843becc4-7a12-4f67-8abf-7cd6d5b4ab96" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_8c7f6d30-4208-4ec9-8bfe-5e5ffbb540ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_3f596261-c8f0-4729-a9c9-6239de869a5c" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2e3aace0-b570-49be-ae27-27346837dced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2e3aace0-b570-49be-ae27-27346837dced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9fd7093d-2ac8-4dd5-8ae0-b42871d25be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_3d963328-8ce7-47c7-9ca7-9e104078d7f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_abb7763c-7a04-4672-8c97-cf4650e2b239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9fd7093d-2ac8-4dd5-8ae0-b42871d25be3" xlink:to="loc_us-gaap_NonUsMember_abb7763c-7a04-4672-8c97-cf4650e2b239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_ae6adc69-766f-4465-929a-cc71f0b000e6" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a7335fa3-fc74-40ca-859b-a4898a4d2e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a7335fa3-fc74-40ca-859b-a4898a4d2e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_979f60bd-3391-4c8e-a34b-d0fb225be3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_979f60bd-3391-4c8e-a34b-d0fb225be3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_ca823a2e-4591-462e-abe2-d0662db33783" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanAmortizationAndDeferral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_lh_DefinedBenefitPlanAmortizationAndDeferral_ca823a2e-4591-462e-abe2-d0662db33783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2d62cb96-88e1-465e-b595-e43db5201462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_2d62cb96-88e1-465e-b595-e43db5201462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0cf0db60-06c1-40f4-a04b-4f4d723b37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_204ad480-08c0-4924-8396-97fe5470e7f8" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0cf0db60-06c1-40f4-a04b-4f4d723b37bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_8a7ff089-4d90-4593-8efa-a3dd6a5b5299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_8a7ff089-4d90-4593-8efa-a3dd6a5b5299" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1592a065-76f8-4192-a3e6-80b0e8356bee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f9ed9416-79d4-453a-a945-dee8e1bc15ae" xlink:to="loc_srt_RangeMember_1592a065-76f8-4192-a3e6-80b0e8356bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b71afd5e-700e-4a70-8013-9f62dffdf4e5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4c8f8bb1-1e5b-439a-8e12-2c196a504548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4c8f8bb1-1e5b-439a-8e12-2c196a504548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9f725f1c-6370-4198-aa9d-f18c5443766d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9f725f1c-6370-4198-aa9d-f18c5443766d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9f50d69b-ca13-488e-825d-261458194777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9f50d69b-ca13-488e-825d-261458194777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_17d7e80b-3002-449e-80bb-01e20f9d75e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f938d166-6a97-4f50-a8d6-55d7fd468e80" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_17d7e80b-3002-449e-80bb-01e20f9d75e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0838c350-8eb8-49b0-a15a-817217559ce7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_045206de-b0cd-4345-b37e-7796365db1d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_045206de-b0cd-4345-b37e-7796365db1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d2d7575f-6f77-47c8-9a9e-56b0f4e315da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d2d7575f-6f77-47c8-9a9e-56b0f4e315da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_028f5d6c-3043-4ad2-9ddc-daae79e5e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c44e2b83-cff5-4345-b479-ac78a7922fe2" xlink:to="loc_us-gaap_OtherAssetsMember_028f5d6c-3043-4ad2-9ddc-daae79e5e2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_17c08a83-38fb-4fba-ad26-d2e41f3bdf78" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d3a94467-311c-4e5e-a8f9-89d45b104115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:to="loc_us-gaap_NonUsMember_d3a94467-311c-4e5e-a8f9-89d45b104115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_f115fcf1-8132-4f6a-8c37-e8c0567bd605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_02750d4e-0d7c-4a4c-8d3d-5eed80a82f93" xlink:to="loc_us-gaap_DomesticPlanMember_f115fcf1-8132-4f6a-8c37-e8c0567bd605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameAxis_d5cb8a0a-d049-486b-84a4-c5c5ac4bd0d0" xlink:to="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_UKPlanMember_3fc27b04-1980-4cc2-ae9e-ec6a1f99d389" xlink:href="lh-20221231.xsd#lh_UKPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:to="loc_lh_UKPlanMember_3fc27b04-1980-4cc2-ae9e-ec6a1f99d389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashBalanceRetirementPlanMember_89f942fe-12b6-41c5-b13e-c6f328e9fb92" xlink:href="lh-20221231.xsd#lh_CashBalanceRetirementPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanNameDomain_d218b539-7d79-409b-869d-d01919dec8c0" xlink:to="loc_lh_CashBalanceRetirementPlanMember_89f942fe-12b6-41c5-b13e-c6f328e9fb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aea80015-bfe8-407c-adc9-c0d90c6b1e85" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_ad72fe83-7bb8-4b66-b45a-47fe58a79538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_EquitySecuritiesMember_ad72fe83-7bb8-4b66-b45a-47fe58a79538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_eecaad99-4f4b-4fe7-a080-c38070443737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_DebtSecuritiesMember_eecaad99-4f4b-4fe7-a080-c38070443737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableAnnuityMember_31ab5968-4029-49f0-ba64-788204cebd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableAnnuityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_VariableAnnuityMember_31ab5968-4029-49f0-ba64-788204cebd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_da31a8b3-98f1-4efd-b144-4416fee0d2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_RealEstateFundsMember_da31a8b3-98f1-4efd-b144-4416fee0d2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_9e2a791b-9380-42e6-88d0-ca7729047eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_78a50cb1-1dc8-40bb-bcd9-27acb0484cab" xlink:to="loc_us-gaap_OtherInvestmentsMember_9e2a791b-9380-42e6-88d0-ca7729047eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2c40d4c0-d7fa-4e60-b7f4-01ea3b6e359d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cd66c5b0-bd68-4bc9-ab17-b5ec5fb1251d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_cd66c5b0-bd68-4bc9-ab17-b5ec5fb1251d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DefinedBenefitPlanActualAssetAllocation_e5c8579d-48df-47af-921f-e17179ab335d" xlink:href="lh-20221231.xsd#lh_DefinedBenefitPlanActualAssetAllocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_lh_DefinedBenefitPlanActualAssetAllocation_e5c8579d-48df-47af-921f-e17179ab335d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_3e83589d-a32e-46f6-95f0-abad7f4707f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_3e83589d-a32e-46f6-95f0-abad7f4707f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1a18559e-af78-42e6-adfa-2e6eed6a8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_1a18559e-af78-42e6-adfa-2e6eed6a8a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_06f5869f-fad1-47e8-91a5-32d50ef8276f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_06f5869f-fad1-47e8-91a5-32d50ef8276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_bf5f8bae-d1bb-44ea-a45b-99edfdb470bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_bf5f8bae-d1bb-44ea-a45b-99edfdb470bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_36ab8968-9392-4478-a151-af4e0b9fa38d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_36ab8968-9392-4478-a151-af4e0b9fa38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3b9edaef-0ba8-4195-a6cf-9e2ec6111ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_3b9edaef-0ba8-4195-a6cf-9e2ec6111ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_99aa0ca3-0be5-4347-b37c-7c4cbb266f14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_99aa0ca3-0be5-4347-b37c-7c4cbb266f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ea844b94-aa44-485d-b11a-7c5acdcc9133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_ea844b94-aa44-485d-b11a-7c5acdcc9133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c05b9c9c-1bcd-4f49-ac18-f5cca0503302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c05b9c9c-1bcd-4f49-ac18-f5cca0503302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7371b33b-5156-4010-8cff-3a07db0e1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_818304ed-b7e9-42d0-a54d-57c83a9b49e5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7371b33b-5156-4010-8cff-3a07db0e1d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ba94253-2b2a-4808-8359-6ec161318cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_0ba94253-2b2a-4808-8359-6ec161318cd6" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_64995d26-5706-4c13-aa4b-3e9787ee035e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_cd98c131-943e-468b-b0e5-e1b4016dc4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_OtherLiabilitiesMember_cd98c131-943e-468b-b0e5-e1b4016dc4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_9ab7b40c-6b09-40e2-b330-245cc907de17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_9ab7b40c-6b09-40e2-b330-245cc907de17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_04084e6b-86c2-412f-959d-ed4515327f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1f58d4ce-8ecb-4371-9d15-e0e5a1fa419f" xlink:to="loc_us-gaap_OtherAssetsMember_04084e6b-86c2-412f-959d-ed4515327f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a410b094-bee0-4df3-b15f-fc1bd59482f7" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticPlanMember_58bedf51-45d7-45d0-8d0c-99accbe5bd1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:to="loc_us-gaap_DomesticPlanMember_58bedf51-45d7-45d0-8d0c-99accbe5bd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_0bbef703-599e-4356-9ae5-819791b8fdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_38c82d2b-7dba-4b07-b9d4-b8ebf501f084" xlink:to="loc_us-gaap_NonUsMember_0bbef703-599e-4356-9ae5-819791b8fdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_edadf7fe-b665-4fae-a66a-47c8a11554d4" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e0e50b4f-fcf2-4e64-a687-2d6ba725ff78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_5440cf9a-4ac0-42c0-b17d-b7056d599aef" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e0e50b4f-fcf2-4e64-a687-2d6ba725ff78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_05192ee9-3721-4946-bfb5-ca02b67aa5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_05192ee9-3721-4946-bfb5-ca02b67aa5a4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_10284273-b683-44cd-8069-e0c9fb5ee724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_5e7d8e2f-c968-456b-a9a7-a7ffe47bf6a8" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_10284273-b683-44cd-8069-e0c9fb5ee724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0be3d491-222e-4220-a6d0-d2b949d52901" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e4e16a0b-0829-4fd5-821d-84c5c7b6ddc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e4e16a0b-0829-4fd5-821d-84c5c7b6ddc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74064cc8-edf2-4f24-bade-06e68096246a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74064cc8-edf2-4f24-bade-06e68096246a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_228fc3ca-0d3e-494a-8935-410b2b44460a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_44b0c9b7-7979-4957-a2db-b1be5a2f54bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_228fc3ca-0d3e-494a-8935-410b2b44460a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeAxis_16063f83-00f3-439a-9ed7-d3b772692529" xlink:to="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_6e37b505-fb1c-45b2-9450-b812a14f5df0" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_1f80c787-1d2f-41cb-85f5-52c99f548833" xlink:to="loc_lh_A2018SwapAgreementsMember_6e37b505-fb1c-45b2-9450-b812a14f5df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c97e83f0-e090-41a0-aea7-74fdbb34f809" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2022Member_f2825357-c741-4ce3-a23a-c2e09a2f123a" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e3f20f29-dde4-4ed5-a85c-13a7beb92a63" xlink:to="loc_lh_SeniorNotesDue2022Member_f2825357-c741-4ce3-a23a-c2e09a2f123a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_09146f95-c810-4f9d-b0e0-4ba16520999c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut_ebcd9516-1714-434b-b90e-d6e1cf59d35f" xlink:href="lh-20221231.xsd#lh_IncreaseDecreaseInNoncontrollingInterestPut"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_IncreaseDecreaseInNoncontrollingInterestPut_ebcd9516-1714-434b-b90e-d6e1cf59d35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7e5b4963-4953-455a-837e-a3ce6f802f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7e5b4963-4953-455a-837e-a3ce6f802f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_7ed0ba1e-379d-48c2-af10-22ca8698767a" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts_7ed0ba1e-379d-48c2-af10-22ca8698767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesFairValue_57d39d20-5a89-4b9c-8ca2-aaa172099f74" xlink:href="lh-20221231.xsd#lh_SeniorNotesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_SeniorNotesFairValue_57d39d20-5a89-4b9c-8ca2-aaa172099f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_63a48ab0-77c5-4e77-a88e-1a3be61be324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet_63a48ab0-77c5-4e77-a88e-1a3be61be324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_09e39e89-aede-4456-9c68-e5f0e221633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_09e39e89-aede-4456-9c68-e5f0e221633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_d3a47a3d-afaf-428b-8c7d-64c29fe24bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateFairValueHedgeAssetAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_InterestRateFairValueHedgeAssetAtFairValue_d3a47a3d-afaf-428b-8c7d-64c29fe24bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4c88e83c-d9a6-4dfd-aec5-a77bae731c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4c88e83c-d9a6-4dfd-aec5-a77bae731c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c99825ad-4d4e-4030-9aed-f0a1e1686d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_c99825ad-4d4e-4030-9aed-f0a1e1686d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_9e276a66-1582-49ea-957c-be8cb83b4712" xlink:href="lh-20221231.xsd#lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability_9e276a66-1582-49ea-957c-be8cb83b4712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ba2a3d50-11ad-4da7-8764-08beca399540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ba2a3d50-11ad-4da7-8764-08beca399540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_18633307-2a81-45a1-a8b8-2bf1e11adb74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_18633307-2a81-45a1-a8b8-2bf1e11adb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Contingentconsiderationadjustment_4918b25b-b0cc-4cf1-b248-b6e1b43f4f3e" xlink:href="lh-20221231.xsd#lh_Contingentconsiderationadjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_lh_Contingentconsiderationadjustment_4918b25b-b0cc-4cf1-b248-b6e1b43f4f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_31ffd714-df3e-4733-a33b-bb5101df1bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9ee8356f-9a67-433b-802c-3f35ff3706ec" xlink:to="loc_us-gaap_DerivativeNotionalAmount_31ffd714-df3e-4733-a33b-bb5101df1bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1ada8b4-bab0-4765-bc6c-c36dda6369cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1ada8b4-bab0-4765-bc6c-c36dda6369cf" xlink:to="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_477b872f-0f59-4e29-b2cb-aa81317a9dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_03524293-5dc2-411d-9e8b-9b6daf28a783" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_477b872f-0f59-4e29-b2cb-aa81317a9dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_083db11c-3d7c-4242-a8a8-599cb442b1a8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_0cfcad01-d18d-4669-8507-cbfcdda1eb37" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1b48d9c2-9bf4-4abc-a0fb-90dbb1b0e311" xlink:to="loc_lh_SeniorNotesDue2020Member_0cfcad01-d18d-4669-8507-cbfcdda1eb37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_a2647ab8-7103-45c1-aea6-1d195835c998" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_aad1caa0-61b9-4357-99c4-3c586ca61ccd" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_SeniorNotesDue2020Member_aad1caa0-61b9-4357-99c4-3c586ca61ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_9d3a2618-2f7e-4f29-a03f-4fbb6cbead16" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_9d3a2618-2f7e-4f29-a03f-4fbb6cbead16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_Seniornotesdue2027Member_19756d8b-2c6d-4bba-8c17-ebf96b21e856" xlink:href="lh-20221231.xsd#lh_Seniornotesdue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_41ee3887-9764-461b-9cc6-060d7e5a8e54" xlink:to="loc_lh_Seniornotesdue2027Member_19756d8b-2c6d-4bba-8c17-ebf96b21e856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EnergyDomain_519ad7d8-5d30-4cb8-879b-cabe75cc48bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EnergyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EnergyAxis_721f8ac2-a784-4b57-8784-de7431d0c1f0" xlink:to="loc_srt_EnergyDomain_519ad7d8-5d30-4cb8-879b-cabe75cc48bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5d5735a1-0caa-4188-adcd-377f8a5c72ea" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fefe2ef3-986b-46a9-a254-c69339327e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:to="loc_us-gaap_InterestRateSwapMember_fefe2ef3-986b-46a9-a254-c69339327e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_985716d0-0f95-4761-adb8-d59c84d08a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_acd82432-9e04-4712-875f-ba603e6b866f" xlink:to="loc_us-gaap_CurrencySwapMember_985716d0-0f95-4761-adb8-d59c84d08a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositionDomain_afe262c7-b1f7-43f7-a9ed-7f711ce0d927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PositionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PositionAxis_a69e7d4d-be54-4be9-a83b-12e8118535c6" xlink:to="loc_us-gaap_PositionDomain_afe262c7-b1f7-43f7-a9ed-7f711ce0d927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:href="lh-20221231.xsd#lh_SwapTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:href="lh-20221231.xsd#lh_SwapTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeAxis_41130e00-8d5a-44dc-8886-8f9316e5c63b" xlink:to="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_A2018SwapAgreementsMember_a59ccc7c-fe8c-4012-9662-2831ecb61dce" xlink:href="lh-20221231.xsd#lh_A2018SwapAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_SwapTypeDomain_3ba99bd4-c960-488e-a1ed-68bec0db9423" xlink:to="loc_lh_A2018SwapAgreementsMember_a59ccc7c-fe8c-4012-9662-2831ecb61dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_aa2af084-b10c-4590-bdd4-0eb833ddb9b5" xlink:to="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_34d138b5-b758-434e-8f99-c6bf78b3b6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_34d138b5-b758-434e-8f99-c6bf78b3b6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeAssetsAtFairValue_453466a3-7c6f-4a98-aa47-ddc3879be9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueHedgeAssetsAtFairValue_453466a3-7c6f-4a98-aa47-ddc3879be9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09639321-69ed-49dc-b1ba-e04af33c7c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_09639321-69ed-49dc-b1ba-e04af33c7c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_62db6525-b9d4-4d03-9784-34bcd3de5e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_62db6525-b9d4-4d03-9784-34bcd3de5e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b5a5a9ac-3e0f-4229-ae9b-590a403d1e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b5a5a9ac-3e0f-4229-ae9b-590a403d1e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0315f5b8-818b-4f55-bba3-58554d800bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_0315f5b8-818b-4f55-bba3-58554d800bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_647fa14a-848a-4283-b7ea-b0def54b521f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_647fa14a-848a-4283-b7ea-b0def54b521f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_3db0d232-ef52-4182-9752-5f5bb6632694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_3db0d232-ef52-4182-9752-5f5bb6632694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_4a9751c0-dd8e-432a-bb4e-97c73cc81292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_4a9751c0-dd8e-432a-bb4e-97c73cc81292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_7f17927f-9511-40bf-9272-868457da67d4" xlink:href="lh-20221231.xsd#lh_GainRecognizedonExitofInterestRateSwapArrangement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_7f17927f-9511-40bf-9272-868457da67d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_97a3d077-a177-455f-a2d0-5fb7b40f3fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnOilAndGasHedgingActivity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8bb92c08-eab9-4bac-88c8-5f47930db659" xlink:to="loc_us-gaap_GainLossOnOilAndGasHedgingActivity_97a3d077-a177-455f-a2d0-5fb7b40f3fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_43c3c2ba-57b3-4176-a6f5-d33bfff9eaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d1ada8b4-bab0-4765-bc6c-c36dda6369cf" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNetAbstract_43c3c2ba-57b3-4176-a6f5-d33bfff9eaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a371bb31-5414-4c17-9b3e-08e44592d74e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a371bb31-5414-4c17-9b3e-08e44592d74e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9080d98d-a865-4171-b26f-b6c37715a831" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_62c6ef83-fa76-427c-a146-af575c4fe444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:to="loc_us-gaap_InterestRateSwapMember_62c6ef83-fa76-427c-a146-af575c4fe444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_55ec59a1-b4c0-453a-a616-700a967fa64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5b1ce7a3-f312-41a8-967e-99bfbdab7fb4" xlink:to="loc_us-gaap_CurrencySwapMember_55ec59a1-b4c0-453a-a616-700a967fa64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b5689741-3a12-4f8b-8997-761b3cf6d84b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorNotesDue2020Member_6e9c1742-5d1b-4482-9268-cb8cd38e7ab3" xlink:href="lh-20221231.xsd#lh_SeniorNotesDue2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:to="loc_lh_SeniorNotesDue2020Member_6e9c1742-5d1b-4482-9268-cb8cd38e7ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_SeniorLongTermNotesDue2020Member_facf0874-80fe-4cb5-8df5-2a93784de7f9" xlink:href="lh-20221231.xsd#lh_SeniorLongTermNotesDue2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34da9f18-ea44-4270-9fc2-53e6ea088343" xlink:to="loc_lh_SeniorLongTermNotesDue2020Member_facf0874-80fe-4cb5-8df5-2a93784de7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c19ecc36-f04d-4a76-bdce-b8588069453c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_1b0ead8b-f70d-4e1e-9bd2-b618451d88f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_1b0ead8b-f70d-4e1e-9bd2-b618451d88f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_193efc13-09a7-4145-8d79-03dcf7a0f194" xlink:href="lh-20221231.xsd#lh_GainRecognizedonExitofInterestRateSwapArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_lh_GainRecognizedonExitofInterestRateSwapArrangement_193efc13-09a7-4145-8d79-03dcf7a0f194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_9595d27d-c08f-4dfb-be15-186da8e53001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_9595d27d-c08f-4dfb-be15-186da8e53001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_a48abbd2-c0a5-4f21-9400-c0082045ce97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_a48abbd2-c0a5-4f21-9400-c0082045ce97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6bc706b3-4a59-47fc-8d0e-818e9a2e069c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6bc706b3-4a59-47fc-8d0e-818e9a2e069c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_57358ab0-fd20-437f-ba4e-b76336361ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_57358ab0-fd20-437f-ba4e-b76336361ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_07912590-5fe8-424c-93a9-29e2e728c3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_07912590-5fe8-424c-93a9-29e2e728c3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_51a42507-4ac6-43d3-9775-141a63ca21d5" xlink:href="lh-20221231.xsd#lh_BalanceOfSeniorNotesMatureDuringQ42020"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_lh_BalanceOfSeniorNotesMatureDuringQ42020_51a42507-4ac6-43d3-9775-141a63ca21d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_61b56b23-f164-4956-899b-4c31234a46dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_965e0567-eb47-424d-8779-69f50843411e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_61b56b23-f164-4956-899b-4c31234a46dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#SUPPLEMENTALCASHFLOWINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_984a016d-fcfe-4690-93fe-7d8c46fca4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_CashPaidDuringPeriodForAbstract_8b00ff7a-2c51-4686-9b35-705b757b411f" xlink:href="lh-20221231.xsd#lh_CashPaidDuringPeriodForAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_984a016d-fcfe-4690-93fe-7d8c46fca4e1" xlink:to="loc_lh_CashPaidDuringPeriodForAbstract_8b00ff7a-2c51-4686-9b35-705b757b411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_InterestPaidInCash_ffe561da-a1c9-4143-9010-c899087a8943" xlink:href="lh-20221231.xsd#lh_InterestPaidInCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_8b00ff7a-2c51-4686-9b35-705b757b411f" xlink:to="loc_lh_InterestPaidInCash_ffe561da-a1c9-4143-9010-c899087a8943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_4c88bf91-e4db-4330-94f1-e1f15187f986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lh_CashPaidDuringPeriodForAbstract_8b00ff7a-2c51-4686-9b35-705b757b411f" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_4c88bf91-e4db-4330-94f1-e1f15187f986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9876df58-a381-44f6-b1a1-198f9614d5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_984a016d-fcfe-4690-93fe-7d8c46fca4e1" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9876df58-a381-44f6-b1a1-198f9614d5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b82ae43f-d3ba-43da-8546-53a05864160f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_9876df58-a381-44f6-b1a1-198f9614d5ee" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b82ae43f-d3ba-43da-8546-53a05864160f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4141879d-3490-4493-a6f0-4cc6b5eda76c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4141879d-3490-4493-a6f0-4cc6b5eda76c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_52f1a9d5-128e-455d-88f7-a10300f8cc6f" xlink:to="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_OthercountriesMember_2c5c3b76-5cf0-48ee-b905-e00f90605558" xlink:href="lh-20221231.xsd#lh_OthercountriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_lh_OthercountriesMember_2c5c3b76-5cf0-48ee-b905-e00f90605558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_4d5eacea-e23e-41ef-9a5d-a92e6fcaca28" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_srt_NorthAmericaMember_4d5eacea-e23e-41ef-9a5d-a92e6fcaca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_18b1c21d-4c9c-431f-84da-cc193a893c24" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_63b14ce0-9cb5-4a0a-a296-89bafc6d2901" xlink:to="loc_srt_EuropeMember_18b1c21d-4c9c-431f-84da-cc193a893c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_f13be9ec-701c-4e19-89ac-973df8a14cda" xlink:to="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DiagnosticsMember_cc5fe79a-05ed-47c2-935d-63200cb6c9d2" xlink:href="lh-20221231.xsd#lh_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_lh_DiagnosticsMember_cc5fe79a-05ed-47c2-935d-63200cb6c9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_DrugDevelopmentMember_0b93126b-f35f-45e1-aaea-974995fa831e" xlink:href="lh-20221231.xsd#lh_DrugDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_lh_DrugDevelopmentMember_0b93126b-f35f-45e1-aaea-974995fa831e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_3d4bddcc-9435-463b-a7bf-2213e5141684" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e9b09d85-3f55-413f-abd8-7db20c5fe303" xlink:to="loc_us-gaap_CorporateMember_3d4bddcc-9435-463b-a7bf-2213e5141684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_67dc9a20-23cf-4c8f-b00a-7d06f651332e" xlink:to="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e75a46af-94d8-45d6-acb1-2b2ab3e5a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:to="loc_us-gaap_OperatingSegmentsMember_e75a46af-94d8-45d6-acb1-2b2ab3e5a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_cef538b3-697e-441d-a040-001877182a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_77dd886e-3003-4421-a4e8-f23136a4b22b" xlink:to="loc_us-gaap_IntersegmentEliminationMember_cef538b3-697e-441d-a040-001877182a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_219d422e-10a0-4a3d-9060-7a1ba7ea6510" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_63dbc058-fdc7-42c6-b34a-6abd384a39e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_63dbc058-fdc7-42c6-b34a-6abd384a39e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortizationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1b961fe7-ad62-4c49-8252-eb24e5c70bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DepreciationAndAmortizationAbstract_368fb8bd-b380-490b-bc93-288bd2ed8bc9" xlink:to="loc_us-gaap_Depreciation_1b961fe7-ad62-4c49-8252-eb24e5c70bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_8f449e17-043e-4dca-b7b3-ef7d8234bd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_Revenues_8f449e17-043e-4dca-b7b3-ef7d8234bd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ab122fb1-e5f6-46a1-8643-b92f8128f2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_OperatingIncomeLoss_ab122fb1-e5f6-46a1-8643-b92f8128f2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6bc11f7c-da19-4668-a210-71003704221e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6bc11f7c-da19-4668-a210-71003704221e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_NetRestructuringCharges_d2064850-97a8-47a8-bd74-71ea2d3448be" xlink:href="lh-20221231.xsd#lh_NetRestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_lh_NetRestructuringCharges_d2064850-97a8-47a8-bd74-71ea2d3448be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22a9970b-7d42-42a0-9f13-54f6bd8770f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_22a9970b-7d42-42a0-9f13-54f6bd8770f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_6f1e6712-b5f4-42cf-a612-b52349eac9e6" xlink:href="lh-20221231.xsd#lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest_6f1e6712-b5f4-42cf-a612-b52349eac9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cb51cd5a-c475-4513-86ec-f4c81a0000f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cb51cd5a-c475-4513-86ec-f4c81a0000f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fd500572-aebb-4657-9504-b0519a867611" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_ProfitLoss_fd500572-aebb-4657-9504-b0519a867611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6809e5ab-bf8e-4314-96f3-e7504e5d9878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6809e5ab-bf8e-4314-96f3-e7504e5d9878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ec22941-00da-4ba5-8f33-044a8e3416f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a689387-4add-4666-bc0b-c3186201c68d" xlink:to="loc_us-gaap_NetIncomeLoss_0ec22941-00da-4ba5-8f33-044a8e3416f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="lh-20221231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.labcorp.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d6080ba3-efd2-4d6a-aa07-5165ac97b463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d6080ba3-efd2-4d6a-aa07-5165ac97b463" xlink:to="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_13b7c1c9-a427-4576-a23f-a7d4da387c6a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_407410e5-76ff-4166-a877-308e2b5d5b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_82dca4c2-8705-46ae-a2ed-a39b8bc646c8" xlink:to="loc_us-gaap_SubsequentEventMember_407410e5-76ff-4166-a877-308e2b5d5b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_593e8756-b2a2-4de6-b450-862f37c1e490" xlink:to="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_eef2742c-d07a-4f91-b4dd-f9f1d332b592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendPayableDateToBePaidDayMonthAndYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendPayableDateToBePaidDayMonthAndYear_eef2742c-d07a-4f91-b4dd-f9f1d332b592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_86eb203b-1f2d-45d6-b2a2-367a6e3c06fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_86eb203b-1f2d-45d6-b2a2-367a6e3c06fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_ec770424-396d-4842-90b1-318848f8d5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_ec770424-396d-4842-90b1-318848f8d5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_e42c0258-20dc-4152-a4cb-eb6883d3e91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_8caab0a1-fd95-481b-bcbd-a453aa0551b9" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_e42c0258-20dc-4152-a4cb-eb6883d3e91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>lh-20221231_g1.jpg
<TEXT>
begin 644 lh-20221231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "< RH# 2(  A$! Q$!_\0
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M5<U;#R2[V=OO6AA#%4*FD9K[ST:BD5@RAE.0>012UXIU!1110 4444 %%%%
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M/8K(ZG[SWJ;VDMO1]GY?=<^MPN,IXI>[H^QMT445\N=X4444 %%%% !1110
M4444 %%%% !1110!1N?]<W^>U15+<_ZYO\]JB)P,G@4 5=2U&+3+5II/HJ]V
M/I7GU]?2ZA<--,V6;H.P'H*?XR\1[EN+H13W4%NI\N"VC+R2>RKZD^N .Y R
M:X%_BC:+<W-G_9.I-J5J9C<6*^1YD211P2.Y/F["-MU!PK$_/TX. #LZ*XRR
M^+&BZE<PQ6L=U.MT&-C*BIMO=CQHXC&[<-K2IG>%XR1D*2.SH **NZ;I%SJD
MF(4^0?>D;A175V/A.SM0#-FYD_VN%_+_ !H XA5+' &3[5\;_P#!0K0-4U&Y
M\$RVFFW=U%#%>&5X8&<)DPXW$#C.#U]*_1>*".!=L<:QCT50*?7LY/F3RG&P
MQBCS<M]+VW36^O<YL31^L4G3O:Y^",D;PR,CJR.I*LK#!!'4$4VOW2\5> ?#
M7CJV-OXB\/Z9KD.W:%U"TCFVCV+ XZ]1TKYB^+W_  3D\$>+8)KOP5<2^#]4
MY86[,UQ92'T*L2R?53@9^[7[%@>/L#7DH8JFZ=^OQ+]'^!\W5RFK!7IOF_ _
M,JBNY^+7P5\7?!+Q =)\5Z6]F[DFWNXSOMKI0?O12#@]N#AAD9 KAJ_2J-:G
MB*:JT9*47LUJCPY1E!\LE9A7I/P%^.VO_ 'QQ#KNCN9[23;'J&FNY$5Y#G[I
M]&&25;&5)[@D'S:BIQ%"EBJ4J-:/-&6C3'"<J<E*+LT?N;\._B#HGQ2\&Z;X
MF\/W7VK3+^/>A. \;=&C< G#J<@CU'?K71U^6?[!O[0S_"KXAIX5U>YV^%O$
M4RQ$R-\EK=G"QR^P;A&Z?PDG"U^IE?S#Q!DT\EQCH;P>L7W7^:V?W]3[K!XE
M8JES=>I/9_ZP_2KE4[/_ %A^E7*^:.X3IR>E9%]>&X;:I_=C]:LZG=;5\I3R
M?O?2LN@ HHHH **<B-(P51DGL*T+?2AP93_P%: ,VO-OVD;.XO?@?XMAMX))
MYGME"1Q(69CYB< #K7M$=O'%]U%'X5)75A:_U7$4ZZ5^1IV]'<SJ1]I!P[H_
M&2\T^ZTV7R[NVFM9/[DT90_D:KU^SMY9V^H6[074$=S"WWHYD#J?J#7C_P 0
M/V1_AKX^BE?^PTT"_8?+>:+BW(/O&!Y9SWRN?<5^T83Q!PU22CBJ#@NZ?-^%
ME^I\S4R>:5Z<K_@?F%17N'QN_9,\6?!^.74HL>(?#B<MJ-I&5: ?]-H\DI_O
M E?4CI7A]?I>#QN'S"DJ^%FI1?;]>J?DSPZE*=&7+45F%6=-U*ZT?4+>^L;B
M2TO+>1989X6*O&X.0P(Z$&JU%=K2DK,S/TQ_9;_:(B^-GAM[+4WCA\6Z:@^U
MQ(-HN(\@"=!VR2 P'1CV# 5[E7X_?#[QWJGPU\8:;XCT>7R[VRDWA6^[(IX:
M-AW5E)!^OK7ZP^ ?&VG?$;P=I7B/2GWV6H0B55)!:-NCQMC^)6!4^X-?SKQ=
MD"RG$+$8=?NI_P#DK[>G5?-=#[++L9]8AR3^)?BCH****_/SV!DDBQ(78X K
M%NKEKF3<>!V7TJ;4;KSI-BGY%_4U3H **** "BGQ0O,VU%W&M"'2E',K;CZ+
MTH S*^2_^"@'_((\%_\ 7>Z_]!BK[22VBC^[&H_"DN+.WNX]D\$<R?W9$##\
MC7LY/F']E8ZGC''FY;Z7MNFM]>YS8FC]8I2I7M<_&*BOUO\ $GP8\">+H2FK
M>$M(NB?^6OV1$E'T=0&'X&O /B5^P!H.K1S77@G59=#N^2EA?LT]LQ[*'YD0
M>YW].E?M&"X[R[$24,1%TWW>J^]:_@?,5<IK05X-2/@^BNG^(/PT\2?"[7&T
MKQ+I<VG7/)C=AF*91_%&XX8=.G3H<'BN8K]%I5:=:"J4I*47LUJF>-*+B^62
MLPKT#X+?&;6_@KXNBU;2Y#+9R%4OM/9L1W40/0^C#)VMU!]02#Y_148C#TL5
M2E1K1YHRT:8X3E3DI1=FC]A/ OCC2/B-X5T_Q#H=Q]HTZ\3>A88=#T9''9E.
M01ZCO6_7YQ?L<_'5_ACXW3P_JD^WPSKDJQN7;Y;:X/"2CL >%;VP?X:_1VOY
MBX@R:>2XQT=X/6+[K_-;/[^I]U@\2L53YNJW"BBBOF3N&2RK#&78X K$N+AK
MB3<W3L/2IM0NO.DVJ?D7]37D7Q L+'7/&UE9?V/>1WB&TGD\0?V=<3B!8YBZ
M16[JC*CL0P=\J%5P3OX  /4J*^?_  5X(OKO24TN^T^&SOFT^.;5K\Z)<ION
MH;F*5HY]SA+[S6$V7C P-V,"4"MOX7P^)_"NN:?I-[I\MQ;3P00O=2VLH:&V
M2WD:,F7<8TVR!4,'+!IG8,5 H&>RT4^&%YVVHN36C#I2K@R-N/H.!0(RZ^/O
M^"@GWO ?TO\ _P!MZ^WTMXH_NQJ/PIMQ96]XFR>"*9?[LB!A^M>UDV8K*<=3
MQCAS<M]+VW36]GW.7$T?K%)TKVO_ )GXQT5^MOB3X)^ O%T;KJOA#1[EW^],
MMHD<O3'^L4!A^=?/?Q-_X)_Z/J$,MUX'U672KOJNGZDYEMVXZ+)C>GU.^OVC
M \=9=B9*&(BZ;[O5?>M?P/F:N4UH*\'S'PM171^//AYXA^&>NR:1XCTR;3;M
M2=GF+F.50<;XWZ.ON/YUSE?HE.I"M!5*<DXO9K5,\:47%VDK,*])^!7QPUGX
M'^+$U&Q+76EW!5-0TUFPEQ'GJ/1UYVMVZ'()!\VHK/$X>EBZ,J%>/-&6C14)
MRIR4X.S1^Q7A#Q=I7COPW8:]HMTMYIM[&)(I5Z^A4CLP.00>A!%;-?GA^Q;\
M=)/ 'C)/"6JW!'A[7)0D6\\6UV<!&]E? 0^^T\ '/Z'U_,.?Y//)<8Z#U@]8
MONO\UL_OZGW6$Q*Q5+GZ]0HHHKYL[2.:98(R[=!^M<IXB\36FCK#/?R2#SY?
M(AB@@DGDD?:S;41%9F.U68X' 4D\ UJWUU]HEP/N+P/\:Y7QM;^(KS2H8/#<
MEK!<2SA;F:YG,3QP;6+&(^5(/,W; -RX +'J " '_"P/#_D:%*=14+KD_P!F
MT]6C</-)M9BNW&5("-G<!M(P<'BC2?B!H.N21)97QEDEE6*-#!(C.6C,BLH9
M1E"BLP<?*0#@UPT_PBU==4\-7FGW6EV,&F75N_V*:*6Y:WA1)!(D4^Y2Y=WW
MLS("QQN8[%%0:]\%=1M[BYNO"=XFBW&TVMJ/M]POE0_9RB'?\S827RV$(_=E
M85'&6R#/8:*DAMWN&PBY]^U:,.EHO,AWGT' H$95?&G_  4 _P"0MX+_ .N%
MU_Z%%7W4EO%']V-1^%1W6GVM]'LN+:&X3^[+&&'ZU[F2YDLHQT,8X<W+?2]M
MTUO9]SEQ5'ZQ2=.]KGXR45^M'B;X$_#WQA$Z:KX.TB9G&TS16RPS8_ZZ1[7'
MYU\[_$__ ()^V%S#+>>!-7DL[@#<-,U5M\3>R2@;E_X$&R>XK]HP/'66XJ2A
M73IM]7JOO7^5CYBKE5>FKP]X^'Z*W?&G@77OAWKLVC^(M,GTO4(^?+F'#KG&
MY&'#J<'YE)'%85?H=.I"K%3INZ>S6S/':<79K4*]6_9]^/FJ_ WQ0)X]]YH%
MVRKJ&G9X=?\ GHG82*.GKT/J/*:*PQ6%HXVC+#UX\T9;HJG4E2DIP=FC]D/#
M7B33O%^@V&M:1=)>Z;?1":">,\,I]?0@Y!!Y!!!Y%:=? ?[$'QT?PGXG7P+J
M]P?[&U>3-B\C<6UT>BC/19.F/[VW^\QK[\K^8,]RBIDN,EAY:QWB^Z_S6S/N
M\+B%BJ2FM^H4445\\=@4444 %%%% !1110 4444 %%%% %&Y_P!<W^>U8'BK
M4#9Z?Y:'$DWRCV'?_/O6_<_ZYO\ /:N \57GVG5G0'Y81L'UZG_/M0!R^O6E
M]?Z/=VVFWZZ9?2H4BO&A$WDD_P 6PD G&<9.,XZ]*XN^^%,M]H]O9_;-/2XB
M:8-<_8)6:190N_>3<;W8E 6+NRN,!D. :]#HH \_U+X-:1<6MO#9QVMF+6"V
MAA)LU??Y,B-F;!4RADC6/&1A6D&?FX]#^'7@I[/1-.TV6YDN8+&!(7N&&#(0
M,<#)P/;)P,#)I]K;/>7$<,8R[M@5Z-96<=C:QP1C"H,?7WH ?!!';0K%$@1%
M& HJ2BB@ HHHH **** .:^(GPY\/_%3PK>>'?$NGQZCIMR/NL,/$W:2-NJN.
MQ'\B17Y(?M)_L[ZQ^SSXW;3;HO>Z'=[I=,U3;@3QCJK8X$BY 8?0C@BOV4KS
MC]H+X-:?\=?AAJGAF\5([QE\_3KMA_Q[72@^6_3H<E6]59A7VG#/$%3)L0H5
M'>C)^\NW]Y>:Z]U\CS,=@XXF%U\2V_R/Q6HJUJNEW>AZI>:;?V[VE]9S/;W%
MO(,-'(C%64CU!!'X55K^EDU)71\0*"5((.#7[#?L@_%]OC-\#]'U.ZE,NLZ>
M3IFI,PY::,+A_?=&T;$^K$=J_'BOL?\ X)G_ !$.A_%#6_"$\^VUUVR\^"-N
M]Q!EL#ZQM*3_ +@]*^#XSRY8W*Y54O>I>\O3[7X:_(];+*WLJZB]I:?Y'Z86
M?^L/TJU(XC1F/0#-5;/_ %A^E)JDNV$(.K&OYQ/M#+DD,DC.W5CFFUQNM?%;
M1=$\0WVBNEU<W]I;1S.L"*5:226.*.W5F8#S6::+"G  D4D@$57F^,&E6M\E
MG=6.H6EVMREK=13+%FS9Y(8XS(1(058W$1!0O@-DXP: .ZIT<;32!%&2:H:-
MJL>N:7;W\$<D<%POF1><H#,A/RMC/ 8889YP1D Y%=)IMOY46\CYF_E0!+:V
MJVR8'+=VJ>BB@ HHHH **** &LJR*590RL,%2,@BOAG]KC]E.'PQ#=>-_!EI
MY>E F34M*A7Y;7/_ "UB Z1_WE_AZCY<A?NBH[BWBNH)()XTFAD4H\<BAE92
M,$$'J".U>[D^;XC)L2J]%Z?:71K^MGT.3$X>&)AR2^3['XP45ZU^TW\'O^%-
M_$Z[L+5"-$OP;S3FYPL;,<Q9/4H<KZXVD]:\EK^H\)BJ6-H0Q-%WC)71\'4I
MRI3<);H*^P/V ?BHUEK&I^ KV;]Q>!K_ $\,>DJC]Z@_WD ;';RV/>OC^NB^
M'?C"?X?^.M"\16Q/F:==QSE1_&@/SI]&7<OXUYV=9?'-,!5PK6K6G^):K\?P
M-L+6="M&?]6/V!JO>S^1;L1]X\"I+>XCNK>.:%UDAD4.CJ<AE(R"/PK.U67=
M,J=E'\Z_E#8_03S;XL:MJNDZ+<W.B:J]O?VEC<70L(!;;Y=H7$KF;.(8^=P0
M;CO7!'0X/B+Q-XC&J6K>'M8;5(-7%W%:$):BVCF2*1DMXQCS/.7R78M*?+!!
M4@$A5]'UCPWI'B)8AJNE66IB$DQB\MTFV9QG&X''0=/040^&='M]8DU:+2K&
M/59 0]\EL@G8$ $%\;CD =^PH&>:>"OBAJ/]OOI?B!;S,,YLQ)Y<!!,MW.EN
M\Q0XW;8/*_= J'24M@;#7L=K;-<R;1P.Y]*R%\,Z0UU83C2;+[38KY=G+]G3
M?;J1@B,XR@P<8&*ZZUMQ;PA1UZD^] AT,*0(%08'\ZDHHH **** "BBB@#F_
MB!\.]!^)WAN?1/$-@E[92\J>DD+XX>-NJL/4?0Y!(K\S/CS\#=6^!OBTZ?=E
MKO2;G,FGZB%PLZ \J?1UXR/H>A%?JO7#?&;X5Z?\8O &H^'KT(D[KYME=,N3
M;7 !V2#VYP<=59AWK[7AKB&KDV(5.H[T9/5=O[R_7NOD>9CL''$PNOB6W^1^
M2M%7-9T>[\/ZO>Z9J$+6U]9S/;SPMU21&*L/P(-4Z_I2,E)*47=,^(VT85^G
M_P"RC\5'^*GPBT^>\F\[6=+/]GWS'J[(!LD/KN0J2?[VZOS KZ7_ &"_'#>'
M_BU<^'Y'(MM>M&15R0/.A!D0_P#?'FC_ (%7Q'&.7+'97.HE[U+WEZ?:_#7Y
M(]3+:SI5TNDM/\C]#*K7\_DVYQ]YN!5FLC5)=]P$[*/UK^;3[8IT444 %3VM
MJUU)@<*.K5"JEV"@9).!6[;PBWB"#\3ZF@!T4*PH%08%/HHH **** "BBB@#
ME/B1\,?#WQ8\-RZ+XBL5N[=LF*9>)K=\</&_56'Y'H01D5^97QO^"NL_!#Q<
MVDZE_I-E.#+8:@BX2YC!QG'9AD!E[9'4$$_K!7GOQT^$=E\9OA[?:%<!([Y1
MY^GW3?\ +"X .T_[IR5/L3W K[CAGB*ID]=4JKO1D]5V_O+]>Z\['E8[!QQ,
M.:*]Y?CY'Y/459U+3KG1]1NK"]@>VO+65H)X9!AHY%)5E/N""*K5_22:DKH^
M* $CD<&OU-_9E^*C?%OX2Z7JEU)YFKV9-AJ#'JTT8'S_ / U*.>V6([5^65?
M4W[ /CQM&^(VJ>%YI,6VM6OFQ(3_ ,MX<MQ]8S)G']T>E?!\9Y<L=EDJR7O4
MO>7I]K\-?D>MEE;V5=1>TM/\C[]JKJ$_DP8!^9N!5JL?4I?,N"O91BOYQ/M"
MI1110 5/:6K73^B#J:BC0R.%7J3BMV&%8(PB]!0 L<:PJ%08 I]%% !1110
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MWJ:*@4<DFZ2SX'I^-<KX:\1:O\#?ACJ_A]?$5SHGB?4/&MU#)JD<UI!!-?\
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MJCI*_N7/JW]*S/$7C[1O"]]#97LEW-?31F9;/3K"XOIQ&"%\QHX$=E3)QN(
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M>%[<6MZL5E9J))"(S,/WL#*4\Q5(C&5(.6[[29-LCI_>&1^%:E '@FB?!_\
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M[I+ZS@N8UD6.9%D59HFB< C(#(P#*>>58 CH0*\?\5_!F3QO\?V\0:F-8M=
MC\,16$5YH^OW6F.UR+N5VC;[+/'(P",I^;*\\<UY]JGP-\57/[4<_BZYL-9O
MH9-;M+W3]?L[O2H+6QT^.T1);65I('OQETE4PPD0RBX#,T;&1J^&/6/J>HKJ
MZBL;6:YG;9#"C2.V"<*!DG ]J^$M0_8\\02?#LP0^"+5O$3>![^!Y#<V_FMK
M@NT:R<R&3F6.(RK'*3B-24#*,+7=?$#X.>.O$G[0\7BFV\'PV\-AJ[;-:L/[
M/C^VZ<^F2PYEF=S>/()9=ABS'"$C!"2-AP ?4OAGQ)IWC+PWI.OZ/<?;-)U6
MTAOK.XV,GFPRH'C?:P#+E6!P0",\@5IU\0>#_P!FKQWIOB;X>WFLZ/K$]YI6
ME>&8+6]T^^TB.'11:6T27EM+/+#+=@>9'*Q2U)BG$Y1F4%FK[?H ****!%&Y
M_P!<W^>U? G[:'[2'C[X/_%"\\-:+;:;IUA=VD5[::D\)FN&5\JY&X[!B1)!
M@J> #WK[[N?]<W^>U?('_!1SX1/XR^%MEXPL+?S-1\-2DW!4?,UG)@.??8X1
MO8%SZU]5PR\)_:E.GC8*4)::[)O9_?I\S@QWM/82=)V:/ST\8?%;QCX_,@\0
M^)=2U2%WWFVFN&\@-ZB(81?P KE***_IRE2IT8\E**BNR5D?"RDY.\G<[+X/
M?$N^^#_Q*T'Q=8+YDNFW >2'./.A8%98_;<C,,]B0>U?M1X3\4Z;XW\,Z9K^
MCW*W>EZE;I<V\R]T89&1V(Z$'D$$'D5^$M?6'[$W[6P^#^I#P?XKN&/@V^FW
M0W3DG^S9F/+?]<F/WAV/S#^+/YYQED,\SHK%X97J06W\T>WJMU\_(]G+<6J$
MO9S^%_@S]0**BM+N#4+6&ZM9H[FVF19(IH6#)(A&0RD<$$$$$5+7\^[:,^P"
MBBBD 4444 %<C\5_B7I/PA\ ZOXJUF0+:V,6Y(LX:>4\)$ONS$#VY/0&M_7M
M>T[POHUYJVKWL.G:;9QF:XNKAPJ1H.I)K\L?VIOVC-0_:<\;0Z-H4D-AX2TU
MF-E%?7<5JMS( 09Y'E95!(X52>![DU]5P_DE3.,2N;2E'64O+MZO\-S@QF*6
M&AI\3V1X%XN\47_C;Q1JNOZI+YVHZE<R74[]M[L20/0#. .P K)KL+KX1^+;
M/4-5LFTGSIM*LAJ%\UM<13Q6\!C,H9I$<H"4!(7.XXX%17'PM\3VNFVNH2:9
M_H5Q;/=K,EQ$X2-84G)DPQ\LF*2-@KX9MZ[020*_I6%?#1C&$)QMTU6UM+?+
M\#X=QFVVTSE*^M/^";OP_?Q)\:[SQ)+%NM/#MB[JY&<3S QH/^^/./X5\EU^
MM7[#/P@?X4_ ^QGOH/)UKQ _]IW09<.B,H$,9^B8;'8NPKY/C#,%@<JG!/WJ
MGNKY[_A^:/1RVC[7$)](Z_Y'T;9_ZP_2F:M'NB5Q_"<'\:?9_P"L/TJS-&)H
MV0]&&*_FP^V.?HI64HQ4C!!P:2@ K9T^X\Z$ GYUX/\ C6-4EO.UO('7\1ZT
M ;]%1PS+<1AD.1W]JDH **** "BBB@ I"<#)X%+7R5^U]^U!#X>L;WP-X4N]
M^L3 Q:E?0G(M4/WHE/\ ST(X)_A!/?IZV5Y9B,VQ,<-AUJ]WT2[O^O(YZ]>&
M'@YS/!OVP/B]'\4?BA);:?/Y^A:&&L[5D;*2R9_>RCV+ *#W" ]ZIK\:=!.I
M6FK3Z=)<:B?L\<@73H(6M4%JT$Y2=7\R<L&RJR8 P/05XM17]-4LHPU'#4\*
ME[L%;UOO][5W_DV?#2Q$Y3E4>[/3-+^*5OX6FT^WTB:YN--L=/: B\L8<W4_
MF73H64L_E(!=NA*/N*[@"-WRN\07NF_&#Q=X>TS0-/>UU74[_P J622VCC(,
MODJJ%D),VUQ*YE?#-YG(XKS&OJ?]@GX8MX@\=WOC&[BS8Z(AAMF8<-<R*1Q_
MNH6/L74UQYH\/E.'J9B_CBG\V]K]]7\O0UH<^(G&CT9]Y:7IT&CZ;:6%LNRV
MM84@B7T55"@?D!5#4H_+NB>S#-;-4]3A\R#>.J<_A7\N-N3NS[PR**YCQW\3
M/#/PTTX7GB/5[?3D8$QQ,=TTN/[D8RS=1T&!GG%?(/Q8_;:UWQ$TUAX+@;P_
MII^7[=,%:\D&.<#E8^IZ9;@$,.E?1Y5P_C\X?^SPM#^9Z1^_K\KG%B,91PR]
M]Z]NI]7?$3XW^$OA'%YNNZK&EX%WQZ=;_O+F3@XP@Z XQN;"^]>B^%?$VG>-
M/#FG:YI,XN=.OX5GAD'7:>Q'8@Y!'8@BOQWO;ZXU*[ENKNXENKJ9B\DTSEW=
MCU)8\D_6OI#]D/\ :53X8:D?"WB6Y*^%KV3=!</R+&8GDGTC;^+T//&6S]SF
M? WU7 >UPLW.K'5KNO[J[KUU^X\JAFOM*W+45HO^M3]#:*9#-'<0I+$ZRQ2*
M&1T(*L",@@CJ*?7Y$?1'G/B[X7:GXMU*2.XUZUET*2]AOEMKS3/.O+-XS&<6
MMR)5$(+1A@3&[*68@_="\Q+^SC-<ZE?W<WB"U:2YTZ^T\W*Z4?M<PN;F"?S+
MB8S$RL@MU0 !%PQP!P![;10!Y):_ 4VLMU$=;6XTW_3VM+6ZMY;E86N2^0Z2
MSO"Z!99$VK$FY6P3U)[#X<^"9_ NDWEE-J$=ZL]T;B*&VA>&VM$\M$$4,;RR
M%$RA?&XC=(Y  .!U=% !6=XB\06/A70K_6-3G6VL+&%IYI6_A51D_C5^218H
MV=V"(HRS,< #U-?G]^U_^TQ'\1+Q_!_ABY$GANUD!NKR,G%]*O0#UC4]/[Q&
M>@%?19'DU;.L6J,%:*UD^R_S?1?I<X\5B8X6FY/?H>$?%#QY=_$[Q]K7B6\R
MLE_.72,G/E1CY8T_X"H4?A7+5ZO/X/TBS\"6%Q:V>EZGJ?\ 8Z:Q.9;BZ2YQ
M]K*OPI\DQA!Y97<LF<L#T4ZFGZ-X)_X3+3_#^L:'::??^1:K.L,EXT<L\\D3
M21*!*["1(F*+GY3)O+<;0/Z,IXZA0I*G2IRY875DEM&RO:][;'Q<J4IRO)J[
M_4\4KW+]C/P6_B[X[:/.T;/::.CZC,P' *C;'S_OLA_ UQ/Q%^'H\*VMK=V4
M]I=6"+!;2S02NSM-)")UD;< NUT;<NPD!0H;#YS]E?L'_#(^%_AS=^*;R'9?
M:_(/)W+RMM&2%^FYBQ]P%->/Q'FU/#Y/4K4WK-<J^?\ P+LZ<%AY3Q,8OIK]
MQ].U^97[9'@QO!_QXUN18Q'::NL>IP;>^\;9"??S4D_,5^FM?,'[>7PS?Q1\
M.[+Q39Q![S0)3Y^!\S6TA 8^^U@A]@6/U_(>#<P6!S6$9OW:BY?F]OQ27S/H
MLRH^UP[:W6I^?=%%%?TF?$G6?"KX@77PO^(6B>)K53(UA.&EB'_+6)@5D3\4
M9@/0D'M7ZNVM_8^.O""W6FW:RZ?JUF6@N5&X;)$X;'MGI[8K\=J^H_V/_P!I
MF/X>W2>#?%%SY?ARZES9WDA^6QE8\JWI&QYST4\]"2/S7C/(9YC06,PRO4IK
M5=7'_-;KU?D>YEF+5&3IS>C_ #/K#6O@O/?6OAW[!KS6%[I.CG1GF*7 2>,B
M/YMD-Q$008L@,S+AB"#P18TKX3W_ (>M[[2](\01V/AZ\82/:?V>'N 1;)"4
M$IDVB,^6C$>7NY8!QD;?1HY%EC5T8.C#*LIR"/44ZOY^/KSS)_@ONOO#EQ_;
M&/['M--M=OV7_6_9)3)NSO\ EWYQCG'O5*]^ \DVMSZM;Z\L-Z+N6^M?,LBZ
M12M>1W*[QY@WJ/+*$ J2&)!4@5ZU10!Y?XB^$.K>*+@7FH>*5EOC!Y#JFG[+
M=T^U13^48UE#&(K%L92Y+;VRV/EJ+PA\#3X7VG^U;4XMM7M_)L=-%K GVZ:W
ME/EQB0[5C-N5"Y)(89.1EO5:*!GF'A?X,S^&?$^CZI'K-OY=C#'#-]FT\V]Q
M?!+3[.J3R++MDC! =0T98%(QOPO/<^+/%&G^"?#6I:[JLXM]/L(6GF<^@Z >
MI)P .Y(%:4\\=K#)--(L4,:EWDD8*JJ!DDD] !7YY?M=?M*+\4M4_P"$8\.W
M!;PK8R[I+A<C[=,.-W_7->=OJ>?3'TF0Y+5SK%JE%6@M9/LO\WT_R1PXO%1P
MM/F>_0\-^('C2]^(GC36/$FH<76HW#3%0<B->B(/95"J/85S]%%?U'3IQI0C
M3@K)*R7DCX.4G)MO=A7T!^Q#X+;Q1\<+2_>/=:Z);27SD]-Y'EQCZY?=_P
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M^ DM_P!M#7QG%^8+ Y54BG[U3W5\]_PN>GEM%U<0GT6I[Y1117\U'VX4444
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M[\#[/]H3X\7]_#I;6'@/3;U]1GM6&56(R%H+3/<D8!_V5;VK]7U4(H50%4#
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M/K]Z%FU*\4?>?'$:G^XF2!ZG)[UZO7\W\4YU'-L7R4/X4+I>;ZR^?3R]3[;
M85X>G>?Q/?\ R"JVI:;:ZQIUU87L*W-G=1-#-"X^5T8$,I]B":LT5\6FXNZW
M/3/R;^.7PHO?@W\1-1T"X#O9[O/L+EA_K[=B=C?4<J?]I37 5^I?[1WP,M/C
MAX(:S3R[?7['=-IMVXP Y',;'&=CX ..A"GG&#^8>O:%J'AC6+S2=5M)+'4;
M.0PSV\HPR,.H_P#KC@CD5_3'#.>PSG")3?[V&DEW_O>C_!_(^'QV$>&J:?"]
MO\BA1117V1YA]!? ']KW7OA)';Z+K,<GB#PJF%2 L!<6BY_Y9,>JC^XW'3!7
MG/W3\.?C5X-^*MJDOAW7+>ZG(RUC(WEW,?KNB;YNQY&1QP:_)2G1R/#(LD;,
MCJ0RLIP01T(-?!YQP?@<TDZU-^SJ/=I:/U7?S37G<];#9E5PZY7[R/VAHK\I
M?#?[2'Q-\*1I'I_C/4_*082.[<72J/0"4, ..E=/_P -I?%WR]O_  DL.[^_
M_9MMG_T7C]*_/ZGA_F,9?NZL&O-R7_MK_,]B.<4;:Q?X?YGZ9UP'Q*^.W@GX
M3VTC:_K<*7BCY=.MB);ISC( C'3ZM@>]?F_XF_:'^)/BZ-HM3\8ZF\3?>BMI
M1;(WL5B"@_C7GC,TC%F)9F.2Q.237K8'P^?,I8ZMIVBOU?\ D<]7.-+4H_>>
M[_'S]K3Q!\8EETG3XVT'PN3@V:/F6YYX,SCM_L#CUW<&O,--\,:3>>#=1UJ?
M5+ZVGLRL0A_L]&AEG<MY<2R><#RB,Y)3"A2.3MW<M6S9^+=0T_3=,LK5U@73
M[]]2AD49;SF6( L"2I"^4,<<;FZYK]/H9?3P%".'P,>1)_?WO=.]]K[_ ''A
M2K2K3<ZKNSO;/X#3R3:-!<:G)]KO;-[F>UL;/[1+;NMRD!BV[UW,OF;GZ;-C
MCG;7*>./AYJ'@5K<72RSI)N#74<#"VW;FVK'*?ED)0!N.F[!Y4@2:S\3M3\1
M+H*:C9:5<IH\CRQHMBD2SEY/,82A H8$]0, \YR236A#XF\4?%A-,\(064>I
MZG=W,06>-7^T7#(TY3>2VT!?M,Q+;1P<L3BL:?U^BU4Q$URZWV22N];]DOT\
MRG[*6D%KT+O[/7P?N?C-\1['2=C+I-N1<ZE..-D"D94'^\WW1]<]C7ZHVEK#
M86L-M;Q+#;PHL<<:#"HH&  /0 5YS\ ?@GI_P1\#Q:7"4N=6N,3:C?*/]=+C
MH,]$4< ?4]2:],K\$XISS^V<9^Z?[J&D?/N_G^5CZW 87ZM3][XGO_D%9_B#
M0K+Q1H=_I&I0BXL+Z![>>(_Q(P((]C@]>U:%%?'1DX24HNS1Z35U9GY(?&#X
M8ZA\(?'VI>&[\,ZPMYEK<%<"XMV)\N0?4#! Z,&':N+K]/OVG/@'!\;O!H^Q
MB.#Q/IH:33[AL 29'S0.?[K8&#_"0#TR#^96I:;=Z/J%S87UO):7EM(T4T$R
ME7C<'!4@]"#7]-\-YY#.L(G)_O8Z27Z^C_!Z'PV-PKPM33X7L5J***^N/./H
M_P" 7[96M?#&"WT/Q+%-XA\-QX2)@P^UVB^B$G#J!T1B,<88 8K[B^'OQ@\'
M_%*S$_AO7;6_DQE[4MY=Q'_O1-A@.O.,'!P37Y'4^&>2VF26&1HI8V#)(C$,
MI'0@CH:^ SC@W YG-UJ3]E4>[2T?JO\ )KSN>OALRJT%RR]Y?UU/V@HK\J=
M_:8^*'AJ)([+QIJ3(G"K>,MU@>G[T-Q71G]M+XN^7M_X22$'^]_9MMG_ -%X
MKX*IX?YBI>Y5@UZR7_MK/76<4;:Q?X?YGZ9UYO\ $[]H3P/\);=_[:UB.6_
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MZ9;MXJT%26%UIZ$SQ+G_ ):0_>Z<DKN4 9)%?T!DG%V#S.*IUVJ=7L]GZ/\
M1Z^I\ABLNJT'S0]Z/];G@E%*RE6((P1P0:2OO3R HHHH **** "BG1QM(ZHB
MEW8X"J,DGT%?0GPA_8M\9_$":"]UZ%_"FAD@L]XA%U(O^Q$>1]7QZX->=C<P
MPN74_:XJHHKSZ^BW?R-J5&I6ERTU<\5\&>"=:^(/B"VT70+"74=1G/RQQCA1
MW9CT51W)XK]'OV=?V:M*^!^EM=3O'JGBBZ3%SJ 3"Q+WBBSR%SU/5L<XX [;
MX7_"'PQ\(=$_LWPYIZV^_!GNY/GGN&'=W[^P& .P%=G7X/Q%Q95S:^&PUX4?
MQEZ]EY??Y?6X++XX?WYZR_(****_/3V HHHH *^?OVFOV6K+XQVCZWHGDZ?X
MO@3 =AMCOE X20]F'17_  /&"OT#17H8''8C+:\<3AI6DOQ\GW1C5HPK0<)J
MZ/QL\0>']3\*ZQ<Z5K%C/IVHVS;);:X0JZGZ>AZ@C@@Y%9]?K!\7O@7X5^-6
MEK!KUGMOH4*VNI6YVSP9]#_$N?X6R/H>:^#_ (O?LB^-_A=)<7=K:MXDT%"2
MM_I\9+HOK)%RR_4;E]Z_H')>+<%FB5.L_9U>SV?^%_H]?7<^0Q67U<.^:.L?
MZW/#Z***^Z/)"BBB@ HHHH **DM[>6ZFCAAC>::1@J1QJ69B>@ '4U]$_!S]
MBGQ;X^DAO_$BR>%-$.&Q.G^ES#/18S]S_>?U! ->;CLQPF6T_:XJHHK\7Z+=
M_(WI4:E>7+35SQ3P'\/]>^)7B*#1?#VGR7][*>=HPD2YY=VZ*H]3_.OTE_9]
M_9WT?X%Z&VQDU'Q%=J!>:F4QQU\N,'[J _BQY/8#K_AK\*_#7PFT%=*\-Z>M
MI$<&:=OFFN&'\4C]6/Z#L *ZVOP7B+BNMF]\/AUR4?QEZ^7E]_E];@LOCA_?
MGK+\@HHHKX ]<**** "BBB@ HHHH **** "BBB@ HHHH HW/^N;_ #VJ*I;G
M_7-_GM45 !1110 4444 <=\0/@[X)^*EMY/BOPSI^LX&%FFBVS(,8PLJX=?P
M85\X>,/^"9WP_P!8D:7P_KFL^'7;_EB[)=PK] P#^O5SV_'[ HKV<'G&89>K
M8:M**[7NON=U^!S5,-1K?'%,_.O6/^"7/B2&1AI?CG2KR/C:UY9RVY/KD*9,
M?G6(/^"8OQ(WC/B3PL%]?/N<_EY%?I?17T4>-LYBK.HG_P!NK]+'$\KPSZ?B
M?GEHO_!+?7)F']K>/=/M%SR+*PDG./\ @3I7K?@O_@FW\,_#[)+KM[J_BB4?
M>CFG%M ?^ Q@/_X_7UE17%B.+,YQ"Y95VE_=27XI7_$UAE^&AJH??J<UX'^&
MGA7X:V!L_"_A_3]#@8 /]C@5'DQT+O\ ><^[$FNEHHKY6I4G5DYU&VWU>K/0
M45%62"BBBLQA1110!/9_ZP_2KE4[/_6'Z5<H **** "BBB@"EJ^BZ?X@L9++
M5+"UU*RD^_;WD*RQM]58$&O#O&'[$/PQ\3L\EG97GAVX;G=IER=F?]R0,H'L
MN*]^HKT<)F.,P#OA:LH>CT^:V9C4HTZW\2*9\3ZY_P $Z;E69M&\:Q2*2<17
MU@4*^GSJYS_WR*YF7_@GKXZ5AY?B#PZZ^K2SJ?\ T4:^_J*^HI\:9U!6=1/U
MBOT2."6689_9M\SX,L/^">'BN1U%[XIT:W3/)MTEE(_ JM=WX;_X)X>'[5D?
M7O%6H:CCDQV,"6R_3+;SC\J^N**RK<89U65O;<J\DE^-KE1RW#1UY;_-GG/@
M/]GGX??#?RI-&\-6@O(^1?7:_:)\^H=\[3_NXKT:BBODZ^)K8J?M*\W*7=MO
M\ST(0C35H*R"BBBN<L**** "BBB@ HHHH **** .!^('P)\"?$[?)X@\.6ES
M>,,?;H08;GIP3(A#-CL&)'M7S_XL_P"">&CW3/)X;\5WFG\Y$&I0+<+]-ZE"
M/R/]:^OJ*][!9]F>7I1P]=I+H]5]SNCDJX2A6UG'4_/?5O\ @G_\0K-R;+4]
M!U"//&+B6-_Q#1X_4UB_\,,_%/=C[%IN/[WV]<?RK](J*^EAQUF\59\K]8_Y
M-'"\IP[[_>?GII?[ /Q$O&4W>HZ#I\?\6ZYDD8?0+'@_G7IGA7_@G?I%M)')
MXC\67=^.K0:=;K /IO8N2/P%?7]%<>(XRSFNK*HHK^ZE^;NS6&68:/V;^IY[
M\/O@#X#^&/ERZ%X>MHKU!C[=< SW'?)#ODKG)^[@5Z%117R%?$5L5-U*\W*7
M=N[_ !/1C"--<L%9!1117.6%%%% !1110 4444 %%%% 'GWQ ^ 7@+XG%Y->
M\.VLMZW)OK<&"XSZF1,%OHV17@/BS_@G?I%PSR>&O%=Y8]UM]3MUG'TWH4('
M_ 3_ %KZ_HKW\%GV9Y>E'#UVDNCU7W.Z.2KA*%;6<=3\]=4_X)__ !#LV)M-
M2T'4(\X7;<RQOCU(:/ _ FLC_AACXI[@/L>F8_O?;UP/TK](:*^DCQUF\59\
MK_[=_P FCA>4X=]_O/SVTG_@G_\ $&\<?;=3T+3X^,YN))&_)8\?K7IGA/\
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,% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>lh-20221231_g2.jpg
<TEXT>
begin 644 lh-20221231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "9 T4# 2(  A$! Q$!_\0
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M1110!9L_X_PJU56S_C_"K5 !1110 444UG6-<L0H]30 ZBJ$VJHO$:[_ '/
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M/8FOA<QR#,<K][$TGR_S+5?>MOG8]6CC*.(TA+7L=K1117SQV!1110 4444
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% &=+_K'^IIM.E_UC_4TV@
MI'=8U+,P55&2Q. *22188V=V"HHR6/85P^O>('U20Q1DI:J>!W;W- %_6/%I
M;=#8_*.AF/4_3_&N9DD:1BSL68]68Y)IM% !1110 5^>W[??_):[#_L"0?\
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M55;/^/\ "K+,%4D\ <U\.>J5[ZZ^SQX'WVZ>WO6+UY/6I;B8W$S.>G;Z5%0
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M= !1110 4444 %%%% !7YW?\%!/V8X?#=TWQ-\,62PZ==RA=:M8$PL4S'BX
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MPEDT&XDWWOAZ?R!N.2;>3+Q$\]CYB^P1:_.ROH_]@_Q:=#^-3:2['R=:L98
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M_P#MS_\ 2R"O::I:SHFG>(]-FT[5K"UU33YMOFVEY"LT3X8,-R,"#@@$9'4
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M7NQV;?;RMU[%8?"SQ%3DCMU9W_[*WP&3X,^"1<:A&I\3ZJJRWK8Y@7JL /\
MLYY]6SV KV^BBOYCQN,K9AB)XFN[RD[_ / ]%LC[FE3C1@H0V04445Q&H444
M4 %%%% !1110 4444 %%%% !1110 4444 9TO^L?ZFFTZ7_6/]33: "J.MZ'
MI_B32;K2]5LH-1TZZ0Q3VMU&)(Y%/9E/!J]13C)Q::=F@WT9^</[2'_!/;5O
M"\MUK_PSCFUK1OOOH;,9+RW]?*/_ "U7V^^./O=:^,;FVFL[B6WN(G@GB<QR
M12*59&!P5(/((/:OWLKRCXQ?LO\ P]^."O+XAT80ZL5"KK&G,(+M<<#+8(?
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MK)'HJ'$\PSG$Q'W%/]T?-S_#7V_IFF6FBZ?;V%A;16=E;H(X;>! B1J.@ '
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M9L_X_P *M55L_P"/\*M4 %%%% !1110 4444 0W5I!?0F*YACN(CUCE0,I_
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0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>lh-20221231_g3.jpg
<TEXT>
begin 644 lh-20221231_g3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "C W8# 2(  A$! Q$!_\0
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M@M_0?>;ZFL6@#<O/%U[.2(MMNO\ LC)_,UE3WUQ=',L\DG^\Q-044 %?EO\
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M2-6FW=:>3]4ETZ>B.65>4XN+05]5_LD?M27/A&\L_!7BF>2YT"4^78WK99K
M_P!UO^F7O_!_N]/E_3-+N-6N/)@4<#<[L<*B^I/I^IZ#)KN=-TV#1[=HK?YF
M88DF88:3!S^ ]O89S7'G>'PN.PTL+B(WOMW3[^7Z[;'F5LU65M3B[R[=_7R/
MU>5@ZAE(92,@CH:6OFK]DKXT-KEB/!6L3E[^TC+:=-(<F6%1S$2>Z#D?[/\
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M(J<=F%%%(S!02> *YBQD\ZV\9=OP'K6)<7#W$FYC]!Z4^\N3<RD_P#[HJ"@
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MK]3V2S_U9^M/N)A!"SGMTIEG_JS]:J:M-\R1CZFOQ\^C,]F+L6/))R:2BB@
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MU4AHHHH *GM;5KI\#A1U:HX8C-(J+U-;L,*PQA%Z"@!L%NENN$'U/<U+110
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MDDT ?/\ H?A3QAJTUG=ZY?\ BL7SZ[IMM.+>_N[:$V@TF!IG\M&555K@R!V
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MMYU0FT*D "0H[+\^<KM)R%;H5('=Z=>>8HB<_,.GN* +U%%% !1110 4444
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M1O%I&GV&B*PXEP9Y5^A;"_\ CM>)>(O%.K^+M0:^UK4KG4[H\>9<2%L#T Z
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MUE>$5.7QO67KV^053U*W\V'>H^9/Y5<HKP#Z(YRBK5]:_9Y-RC]VW3V]JJT
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %RS_U9^M3T44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>lh-20221231_g4.jpg
<TEXT>
begin 644 lh-20221231_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[31M2\13-#X;\.VEG<:AJ^L2+]Y;33[..6ZNB.,^5$P&1G&17DOP!_X+:?\
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M4UOQ;XR\+VTMSXMT+X;>!-7\2R:#!%Q+)>MIMM,EN(SPX9@R'A@*]=_99_;
M_9E_;:^%\7QE_94^,^B^-O#DLQA>^TB9M]M, "89X9 LMO+@@^7*B/A@<8(-
M &G^T%^T?\!OV4OAE>?&7]I#XM:'X+\+V#*EQK.OWZP1&1L[8DSS)(V#MC0,
M[8X!KQ_X(_\ !8#_ ()T_M"_'FW_ &8/AO\ M$"/X@7MFEWIWA3Q/X3U?0;N
M_A>$7$;VZZG:6XN \)$J>66WQ_.N5YK\"O\ @[F_X*#_  P_:\_:R\$?![X
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M_I(3\/\ _P #)O\ XW7X'_\ !X3_ ,I@IO\ LF&A_P#H5S7]!'C7]B/X(_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!_&'_ ,$KY=3^%G_!</X.6'Q@W0ZI
MIWQ]LM-UO[9D,E^VH_9VWYZ$3MSGH17]GE?@?_P<%_\ !NK^T=K_ .TO?_\
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MC>V?+]/^!'PE\8?\'7>K? ;7_!%E)X.U7]H;5+?4O#D*&&TN;:3SI9+9XXR
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MM8Z;_9<=W<(OV7>Z*;68C:IWA05R",^H_P#!W=\/_C#^UK^UY\,8OV:_V?\
MXC^-+?PQ\/6CUG4= ^'NJ3VT,MU<&>*(2K;[7?RBK,%)V[P&PV0 #]\_V5-<
MU/Q/^R]\-_$NMW;W%YJ/@+1[F[GE8EI)9+*%W8D]222<^]>3?\%B_P!IKQK^
MQW_P3$^-'[1/PWNWMO$6@^#9(M"O8QEK.\NI8[.&Y7_:B>X609XR@SQ7;?\
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M+&L$/F-M$K1"@#[LHHJMK.K6&@:1=:[JLK1VME;//<R)$SE8T4LQ"J"S' /
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M0_#"S\":D-2TJYTF2TDNYIU: *D)DLEVL6Y$RGHLFP ]6_X-A/VH/B#\>/\
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M&]1G.0 "G\?/VR_^"U?_  3R_P"")?[.GQ)^ 'QG\+_\*C\9?#ZVTM]=\/\
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M".01F1B@;QK_ ((>_P#!>GX_?!O]G#P[_P $YOC'_P $ZOC5X]^(O@F#^Q?
M_P#PA_AY5^T6B'%O;ZE]K>'^SU@4B(W&'18D4LJE69@#T7_@I#X7_:L\!_\
M!H?<_#S]MKPK=Z-\2_#>E^'M'U^QOM2@O)A%:^*K2WLW>:"21)&>SCMG+!R<
ML=WS9KH/^#*C_E%IX_\ ^R_ZI_Z9-#KZ-_X*^_LI?MA_MC?\$//B'\![W2=-
MU[XP:QI=CK,^A>'1BV,]OK%OJ3Z9:,P!G\JWB:VBD8!YVB1B%:0@?$G_  :;
M?&'X]_L]_ ?Q-^PKK7[$OQ1@\4:A\8WU_5?$/B'PS-I>AZ+I,MEI]M<M<75P
MH872"QE$=LL;/+)+&,H@EDC /D#_ (.+8XT_X.1M"9$ +WO@<N0.IS;C)_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI8A5#98X'04 >ZT5C_\ "2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16/\
M\)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\ "2ZO_P!"A>_]]+1_PDNK
M_P#0H7O_ 'TM &Q16/\ \)+J_P#T*%[_ -]+1_PDNK_]"A>_]]+0!L45C_\
M"2ZO_P!"A>_]]+1_PDNK_P#0H7O_ 'TM &Q16'-XOOK>2.*?PM=(TK;8U:10
M6/H.:D_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
MV**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M5L5C^!_^01+_ -?LW_H5 &Q1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A4 ;%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/9?\CO>_
M]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6/XE_Y"^C_]?I_]!-;%8_B7_D+Z/_U^G_T$T ;%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %>%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\
MV/<O_I,U 'NE%%% !1110 4444 %%%% !1110!C^)?\ D+Z/_P!?I_\ 036Q
M6/XE_P"0OH__ %^G_P!!-;% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\ R+%[_P!<
M#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0J -BBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\#_\@B7_ *_9
MO_0JV*Q_ _\ R")?^OV;_P!"H V**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "L>R_P"1WO?^O*+^9K8K'LO^1WO?^O*+^9H V***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_ ,A?
M1_\ K]/_ *":V*Q_$O\ R%]'_P"OT_\ H)H V**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP+4_P#@J?\ \$XM&^/)_9BU
M7]MCX<6_CQ=0%@_AV7Q1 )4O-VW[*S[O+6?=\GDE@^[Y=N>*]H\=>';[Q?X(
MUGPEI?B:\T6YU32KBTM]9TX@7%A))$R+<1;N-Z%@ZYXRHK\_O^"RW_!.?_@G
MMX!_X(Z_$_PII7[,?A#1O^$3\&LW@"\TCP_$NIQZ]N6+3Q'<*OGS3W%V\,3D
MLSSF=@Y8N<@'Z&ZUK6C^&]'N_$/B+5K:PT^PMGN+Z^O9UBAMX44L\DCL0J(J
M@DL2  "37GWP3_;#_9?_ &C=:N/#?P0^./A_Q)J%OIZ:@;+3[T&6:Q=MJ7D2
ML 9[9F^5;B/=$QX#$U^;7_!4O6_CGX0_8>_8/_X)J?&?Q!=3Z_\ &CX@>!/"
M'QEN9+DO)J-I:1V2ZG;22 YD$EQ)&7;/SB-@<AR*]/\ ^#A#QY<_LD6G[+?[
M</P[VZ?KGP^_:'TO096ME"?:/#VJ6ES'J-@<8_=RI:PC;T!0,,%0: /N[XS_
M +0OP2_9XTBQUOXU?$O2_#T6J7OV/2(KZ?\ ?ZC<[2WDVT*@RW$FT,Q2-68*
MI8C )K2^%WQ8^&?QN\$6?Q)^$/CS2O$F@W^\6FK:->I/"[(Q1TW*3AT=61D.
M&5E*L 017Y^?LH?$/5/VIO\ @XT_:-USQ9(;O2OV>OAGHOA#P):3',=A+J@C
MN[^Y1#PDTDD+Q&0?,8D5"<#%3?L:?$74O@S_ ,'#W[4/[&?A^X,7A+QU\/-'
M^*-OI"G$%CJZK8V%]-&O17NFG264_P 31*>U 'Z.T444 %>%_M8?\EL^!_\
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M[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\
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M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
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M &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 9=GX2TVQNDNX;BZ+1ME0]RQ'XBM2BB@ HHHH **** "BBB@
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M "6SX'_]CW+_ .DS5[I7A?[6'_);/@?_ -CW+_Z3-0![I1110 4444 %%%%
M!1110 4444 8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\ D+Z/_P!?I_\ 036Q0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9OC'_ )%B
M]_ZX&KFG?\@^#_KBO\A5/QC_ ,BQ>_\ 7 U<T[_D'P?]<5_D* )J*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?P/_R")?\ K]F_
M]"K8K'\#_P#((E_Z_9O_ $*@#8HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0J -
MBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKG?BC\6_AK\%?"4_CKXJ
M^,['0]*M_OW5]-MWMC(1%&6D<XX106/8&M:%"MB:T:5&+E*3LDDVV^R2U;,J
M]>AAJ,JM:2C"*NVVDDN[;T2.BKYL_;7_ &\M)^!MU'\%_A';2^(?B/JP$=II
M&E6QNI;'>,JS1KG=*1RL9[?,W& WFGBK]LS]IO\ ;,\=?\*3_8V\+77@_1IX
MP^H^.-;M]MZEJW_+:.+D6R,#E6;,CAE*;#7T3^S+^QY\(/V7M'=O">FOJ7B*
M_!?7?%^KGSM0U*5CN=FD;)12W.Q<#@$[FRQ[JV7Y-"-3#XW$MU(OEG3H27-%
M]83K:QIRZ2C#GJPUC+V,W&2^)EG>9\4*5'(O<H[2Q$T[>:HP=G-_WWRP6ZY]
MCY\^!7[!'QP^*FBRWW[5'BZZ\.Z#K$_VO6/!FAZ@3J&NR$[LZI?*<LO)Q!&=
MH!S\K[F;Z<UK]F+X"Z]\%I_V=KSX:6,/@RY6(3Z%I[26D;F.5)E8O R/N\R-
M&+;LL1\Q.3GO*YKXA_%SP%\+[59?%FN)'/+_ ,>NGP#S+FX/0!(UY.3QG@9Z
MD5RXOB2ED>64HTYPP6$PS4J<8/V=.FT[J5[\SJ7U=2<I5)2U<FSW,DX*RVA&
M6'I47B*E6+C.4U[2<XO>+TLH/6\(I0W]W5GS=\:_^"<O_!/3X3_#?4?&4WP#
M4SQ1>781-XJU7][<-PBX^U<C/S'V4U\^_P!E:;_97]B?8H_LGV?R/L^WY/+V
M[=F/3'%>O?M1_'K7_BUKT/AVY\/S:/8Z3(Q6PN7S,TI !:4#A6 XV=5RP))/
M'E-?PGX\^+F<^(O$U*E]=K5</@[JFYSJ/]X[<\TIN\7=1BM$_=OU/Z8\,?#O
M(N#,IJ3H8*E1JXBW/R0A&\5?EBW%6DM6^J]X]@^&'[%W_!+'QCX)T[6?$'P\
MT;3=1EMP+ZRO?'>HPM',/E;"O>#Y21D>Q%?27P=L/V>?@S\/]/\ A9\(?$&B
M6&@Z9YOV"PC\0"X\OS9GE?YY97=LR2.>6.,X&  *^:?V/M:\#M\0F\"^/_"V
ME:C:ZT@2RDU*PCF,-RN2H!=3M#@E>.K;:^H[G]GSX(7>?-^%FB#/_/*P5/\
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M^DU%<I\%/B5:?%CX;Z=XRA*B>6+R[^)?^65PO#KCL,_,/9A75U^[9=C\)FN
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MR#X/^N*_R% &;]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\
M0;LO_ 8_XUF>%;7Q3)ITC6&J6T:?:9 5D@).[=R:ZNL?P/\ \@B7_K]F_P#0
MJ #[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
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M4 %%%% !1110 4444 %%%% !1110 5C^!_\ D$2_]?LW_H5;%8_@?_D$2_\
M7[-_Z%0!L4444 %%%% !1110 4444 %%17M[9Z;9RZCJ-W%;V\$;23SSR!$C
M0#)9F/  '))KYS\5_MM>+OC!XANOA?\ L(^ X_&>HV\IAU/QSJ1:+P]I#>IF
M'-TXZ[(^HP07 (KU<KR7,,WE+V$?<CK*<FHP@N\INR7DKW>R3>AY.:YWEV3Q
MC]8E[\](0BG*<WVC!7;\W:RWDTM3VGXN?&GX6? CPC+XY^+?C:QT/38L@37<
MGS3-C.R-!EY7_P!E 3[5X+_PL']KK]M/_1_@[IMY\(OAS/P_C#6K8?V]JT1[
MV=OG%LC#I*QS@AE;.5KJ/A'^POX>TKQ=#\9_VD?&%S\3?'PPT6JZY$!8Z8<Y
MV65I_JX5!Y#8)R-PV$D5[O<7%O:0/=74Z111J6DDD8*J@=22>@KV'CLBX?7^
MQ)8BLO\ E[./[J/G3IR^*W\]56_Z=IV9XJP.?<0N^.D\-0?_ "ZA+][)?]/*
MD7[M_P"2D[]ZK5T>>?L__LK?!C]FO3)K?X<>&RVI7I+:MXCU.7[1J6HN3EGF
MG;YCD\[1A<Y(49KB_C'\;_$7Q.\17_P3^!7B2#3+;3_E\<?$"60+;:+$>&@A
M<D!KD\C@_+Z@@LE;XU_%_P"(GQMN9_@[^S 9I(V_=Z]XJM6VI#&>#'#*?E4D
M _O.3@'8&^\-?X0?L8^%O!N@6.F>/K\:M%9-YEOHL&4T^&0_><IUG<]W?DC
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M&Y\6Z[X<ANK?4?%=Z[-<:TYNYI!>S%F9O-F5Q*X+,0[L"S8R?6*\>_8$T_\
M:(TO]DCPA8?M:W F^)<<=Y_PFTZ9\J74#>W!E>'('[AB<Q8 7RBFT!<"O8:
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MEL^!_P#V/<O_ *3-7NE>%_M8?\EL^!__ &/<O_I,U 'NE%%% !1110 4444
M%%%% !1110!C^)?^0OH__7Z?_036Q6/XE_Y"^C_]?I_]!-;% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F^,?^18O?^N!JYIW_
M "#X/^N*_P A5/QC_P BQ>_]<#5S3O\ D'P?]<5_D* )J*** "BBB@ HHHH
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MLTE[6LO^7-.2LO\ K[45U'SA#FET<J;/EO[5SC/_ '<IA[*B_P#E_4B[M?\
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M5O#OQD^)NC6_B_P6?!>H)'I?@RUO8Q=6%E$A_>ND,,D((AE@&0PY.9&_3O\
MX)]>//B]\2/V,?A]XF^/VH6U[XW30_L'BO4K-0(K^_M)7M)KM   %F>$RC
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M/E\7Q(IXF6#RJG]8K1=I6=J=-_\ 3RI9I/\ N14JG]VVI7U[]N/XG?'6_N_
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M_:F)8V7#?\32[/?\OPK\<*_:'_@DW_RC^\ ?]Q7_ -.MY7X5](/_ )(S#_\
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MCG(U?$7B+P_X0T"]\5^+-=L]+TO3+22ZU'4M1N4AM[6"-2SRR2.0J(J@DLQ
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MHHH **** "BBB@ HHHH *Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0J
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSI_X+\?\
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M% !1110 4444 %%%% !6/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,T ;%%%%
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M^0OH_P#U^G_T$UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\2^'=*\6Z#=^&];M_-M;R$QS(#@X/<'L0<$'L0*M6<,MM:16\]TT\B1A7G<
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ML_'[]D[X/?M&VR2^.='E@U."/9;:UIL@CN8UZ[22"LBY[,#C)QC)-?/&I_\
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M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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M'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\
MGQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T_
M_GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57
M/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?
M]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* ,/Q1XH\/WGA^[M;758GD>(A$4\
MDU;L?%WAJ.RAC?680RQ*"">AQ1XNL;*/PU>/'9Q*PA."L8!%6]/T^P:P@)LH
M23"N28QZ"@"'_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^JR_"7B70;'3)(;O5(HV-U*P5CV+<&N@_L[3_ /GQA_[]"LCP796<
MNE2-+:1,?MDHRT8/&Z@"W_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?
M&'_OT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^
M?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_
ML[3_ /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_W
MU5S^SM/_ .?&'_OT*CNXM$L+=KN^CM88D&7EE"JJCW)X%*4HQBVW9(:3;LBO
M_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5Q7C+]I7]G;P/%(^K>-],F:,$F/3T^
MT=.Q9 57_@1%<K_PT+\1?B+ 1\!_V>+NZAE@$EMK7B%%M[8\XR!D)*/]V8'V
MKYVIQ;P[&HZ=/$*K):.-)2K23\XTE-KYH]%91F2BI3I\B>JYVH)^CFXI_>>O
M_P#"8^&/^@U!_P!]5QOQ._:U_9N^#<1;XD_&'1M-F RMB9S+=/\ [L$8:5_P
M4UY]K'[-/[2/Q=+#XL?'5=&L)>3I'A1&MT4'JA>+RI&';#RR#ZUI_#W_ ()Y
M_LW> 7-TOAN6_N'.Z:6>01>8QZD^4%9N?[S-GO750SNM6UHY?5G_ -?)PH0?
M_;W[ZJK=4\.O(XL1@<0M%B*</-*=62_[<3IP?RK_ "/.?&__  5$N]6E?3/V
M??V?]9U4[Q&-;\72C2K1<])%B(:>=/8*IKB[J]_;;_:!<CXA_%G7-,T^4D/H
M7PYMDT.V*GTU&ZW3L,<%2GKBOM#PY\,OAWX10)X9\#Z59$#'F6]BBN?JV,G\
M36M_9VG_ //C#_WZ%>G'-.+;6PTZ&#7>E15:M_X-Q3J4T^SIX>FT>7/(LFK.
M^-G6Q/\ =E4]C2_\%X=0FUY5*U1'R/\ "3]B[PWX&O!K6C:1X&\/Z@[^8^MW
MUK)KVJE^[F6\+(CGUCVCVKUX?!+X>:X1)\3?BYK_ (G)^_;7NJM%;'Z118V_
MG7K7]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%>+CN',-G=;VV=UZV.GWQ%6=5?
M^"V_9)>2@D>W@,9')J'L<JHT\+#M1IQIO_P)+G;\W)G(^%?"WP+\$[6\*^']
M%LY%Z3QVRF7_ +^$%C^==%_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT*];"8'!9?15'"THTX+I&*BON22,:^(KXFISUIN4N[;;^]E/_A,?#'_0
M:@_[ZKAOCUX1TWXU>%8?"%I\3X-&M1=":\Q8F<W&T?(O^L3 !Y[Y(7ICGT7^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0K#-LJP.>9=5P&-BY4JBM)*4HW7:\6I)/K
M9JZT>C9I@L9B,OQ4,30=IQ=T[)V?>S37X'RW_P ,.>&/^B]P?^"#_P"WU7T[
M]B;0;R!I;OXVQ6["1E"-H6<@'@_Z_O7U9_9VG_\ /C#_ -^A61X+LK.72I&E
MM(F/VR49:,'C=7YQ_P 0.\+O^A?_ .5:_P#\L/J?^(@\7_\ 03_Y)3_^0/!?
M!G[)&F^!O%5AXOT3X_P+=:?=+-%G03AL'E3_ *1T(R#[$U]"_P#"8^&/^@U!
M_P!]5<_L[3_^?&'_ +]"L?Q[XM\!?#'PG>>-_'%Y:6&FV,6^>XEC'X*HQEF)
MX"CDDX%?6\/\*\+<"X*LLMI^PI/WYWJ3E%<J^+]Y*2CINU:Z2OLCP,YS_,LY
MDJV85%)P3UM&-EOJXI:>NQ'XI^+/PY\%>'[KQ1XH\6VMG8V<1DN)Y&.%'H !
MDDG@ 9)) '->'^'XKG]KSQ1;_$;XOL=*^'VG7 F\+^#;EL2:JX^[>7@'5>ZQ
M=,'TR9-#P1\./$O[5?BBS^,7QH\.MI?@VQE$_@_P1/& UU_=O;U1PQ(Y6,\
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M7\*:OX[^%OB7P/X>ULZ9?ZSH%Y8V.I+G-I-- \:2\<_*S!N/2@#YE_9_^/\
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M]XJOK2.TNO%D.H^*KW2T_P"85<:OJ5UJDNGL"!M>VDO&MF7 VM PP,8KZ&H
M**** "BBB@ HHHH **** "O"_P!K#_DMGP/_ .Q[E_\ 29J]TKPO]K#_ )+9
M\#_^Q[E_])FH ]THHHH **** "BBB@ HHHH **** ,?Q+_R%]'_Z_3_Z":V*
MQ_$O_(7T?_K]/_H)K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** ,WQC_R+%[_UP-7-._Y!\'_7%?Y"J?C'_D6+W_K@:N:=_P @
M^#_KBO\ (4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVI3C7\(8\;TL)7DI6FJ2C%U71<N134%.SN_?^*_L_>L?J117YN?L??MF?\%
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M@ HHHH **** "L>R_P"1WO?^O*+^9K8K'LO^1WO?^O*+^9H V**** "BBB@
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M&S)+&V00P=% /6J*** "O"_VL/\ DMGP/_['N7_TF:O=*\+_ &L/^2V? _\
M['N7_P!)FH ]THHHH **** "BBB@ HHHH **** ,?Q+_ ,A?1_\ K]/_ *":
MV*Q_$O\ R%]'_P"OT_\ H)K8H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** ,WQC_ ,BQ>_\ 7 U<T[_D'P?]<5_D*I^,?^18O?\
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M>\I-R;^;NS] PF"P>7T%0PM.-."VC%**7HDD@HHHKF.D**** "BBB@ HHHH
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M]%?7YW_ ****_H@^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M D &OI.@ K\[?VW0/^(B;]B%L<GP-\1,G_N%&OT2K\[OVS]!^+.M_P#!</\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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MG^WA^SEX!U\^ /!:77Q \6L2L/A?P'IW]HW&X<$2.G[N, XW9;<O]TXKF/\
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M9)$7A3C.3@ FOTY_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
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MH_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\
MOT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
M\^,/_?H4?V=I_P#SXP_]^A0!6MO%'A^\G6UM=5B>1SA$4\DU?J)+&RC8/'9Q
M*PZ%8P"*EH **** "BBB@ K!^*DWQ'MOACXCN/@Y;:5-XNCT&\;PM#KJNUE)
MJ(A<VRW C=',)EV!]K*=N<,#S6]10!^4?B[]MS_@YQ\%_##P5\0]5_9%_9>:
M_P#B!J6GZ=X<\&QW6NKK#W=W$TX@EC>[6*%H8(YYIB\H6-+>4DDK@]WJ/C#_
M (.D(+"[U[3?V<?V,/[3:R8KY.K:\;AV"Y6/+3JI.0  SA<XRP'-?:7[6GP
M\1_M"?"^'1?AW\3[CP1XT\/ZO#K?@7QC;V*7?]DZI"LB*\ENY"W$$D,L]O-$
M2-\-Q*H96(8?#'Q9D_X.J?B5'<_ 7PYH'[,'@NTU!&M+KXQ>&[_4FDMX6^4W
M%M;7,DCQ3;<D!H' ;HRX#  ^O_\ @F%\3OBE\8_^"?GPD^(OQN\1Z7K'BZ_\
M&6J^(=5TBZDFBO+J+,+RN941UF8QYFC908YC(G\->[UXQ_P3U_9L\ _L>_L:
M^!?V8_AMX[E\3Z=X+TZ;3KCQ#.WSZC?K=3&^F89;:6NVN#LW-M^[N;&3[/0
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M6JI7]8TX/LP]AF-;^+54%V@M?_ I7_"*/$O^&>?V@OB/^\^-_P"TS?VML_\
MK-#\!6PL(0.Z_:&!ED4],,.E=1\/?V3?V?/AG.-0\._#2PFOMVYM3U4&\N6?
MN_F3%BI/^SBO1:*Z,+PED&&KJO*E[6JMIU7*K->DJCDX^D;+LBZ>6X.G/G<>
M:7>3<G\G*]OE8  !@"BBBOI#O"BBB@ HHHH **** "BBB@ K'\#_ /((E_Z_
M9O\ T*MBL?P/_P @B7_K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH
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MVML?4$&C_A*/VJ=1_P"//X6>&=.ST_M#7&FQ]?*%'^N65S_@T<1/TPV(2_\
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M":V*Q_$O_(7T?_K]/_H)H V**** "BBB@ HHHH **** "BBB@ HHHH ****
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MHX^A-'PU^!7Q<^+VIQZ7\/? .HZ@7<*UREN5MXO=Y6PB#ZD5^K__  @^D?\
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MYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJ -BBL?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:@#8HK'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJ -BBL?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:@#8K'\2_\A?1_P#K]/\
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MOH4444 %%%% !17"?%#]I;X)?!YS9^-O'MI'?YQ'I-F3<7CL>BB&/+#)X!8
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M .Q[E_\ 29J]TKPO]K#_ )+9\#_^Q[E_])FH ]THHHH **** "BBB@ HHHH
M**** ,?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)K8H **** "BBB@ HHHH
M**** ,OQ7X'\%^.]/.D^-O">FZO;$']QJ5DDRC/<!P<'W%>6:A^P_P##+2[R
M36/@]XI\2^ KYVWL_AK69%@D;_;AD+*R_P"R-HKV>BO&S+A[(\WFIXO#QG-;
M2M::_P ,U:4?DT<M?!83$N]6";[]5Z/=?)GB7]E?MS?#/_D&^)/"OQ(L8_\
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MQ/YJ/J9EQ^V'=^/9WTO]F?X/:YXVD#%/[9FB-AI<9Z$F>8 L1_="C..#3/\
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M_P"-?-/@[+,.[Y=.IA7_ -.IVA_X*DI4?_*9P?V7AX:T'*G_ (79?^ N\?\
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MKU?P9X \#_#K21H7@/PEI^D6@QF#3[18@Q]6VCYC[G)I/L7C?_H-V7_@,?\
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M_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\
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MWSW>I:]J<^/.O;RXD):65MJJ.B(BJB*B*JCT.B@ HHHH *\+_:P_Y+9\#_\
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M^2V? _\ ['N7_P!)FH ]THHHH **** "BBB@ HHHH **** ,?Q+_ ,A?1_\
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M\-<_'#_HQGQW_P"!,% 'O5%>"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\
M@3!0![U17@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P4 >]45X+_P -
M<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,% 'O5%>"_\ #7/QP_Z,9\=_^!,%
M'_#7/QP_Z,9\=_\ @3!0![U17@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_
M ($P4 >]45X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,% 'O5%>"_\
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M-<_'#_HQGQW_ .!,% 'O5%>"_P##7/QP_P"C&?'?_@3!1_PUS\</^C&?'?\
MX$P4 >]45X+_ ,-<_'#_ *,9\=_^!,%'_#7/QP_Z,9\=_P#@3!0![U17@O\
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MPUS\</\ HQGQW_X$P4 >]5C^)?\ D+Z/_P!?I_\ 037CO_#7/QP_Z,9\=_\
M@3!7->./VW/B9HGB+PWI^M_L=>+[.XU'4VATZWN;V$/=RA"2D8 .6QSSB@#Z
M?HKP7_AKGXX?]&,^._\ P)@H_P"&N?CA_P!&,^.__ F"@#WJBO!?^&N?CA_T
M8SX[_P# F"C_ (:Y^.'_ $8SX[_\"8* />J*\%_X:Y^.'_1C/CO_ ,"8*/\
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MW<L826Z6%1(ZCHI;&2!Z4 3T444 %%%% !1110 4444 %%%% !1110 4444
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M-0^+-SX<O]:GTOPT^I?V-H\(>ZU"5(/,%M IX,DC81 3C<PYK\X_VT_VK/\
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M\PO,> 0J$Y'C?[:*ZGJ'_!T)^QS;>'0Q>P^$_BZYUTQ_PV3V.I1QE\?P^?M
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MX/OW[7WQ)_:'\#?#VP\._LF_#_1M?^(?BO5UTOP])XIFFCT;1QY,LTVHZ@T
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M[X8N? ^F?$^'0Q::5J%Q)=WFBQW84(MRZ;(IF3J_DCN GF$9:OAOX1?L%?\
M!P%\%/#NH:)X,_X**? MKK6=3GU/7M=U'X5W%Q?ZK?RX#W5Q,[_O'VJB*,!(
MXXHXHU2.-$7]+J* /GSX+?LI_&CP_P#%/X;_ !$^/WQ@A\;77P^^%UUICZO,
M&2XU3Q/J=S#)JNI&$((X(5CM8XK:-"?+CNKB(*BJN[AO^"GO[*?_  4/_:TN
M_#'@[]E7]H#X;>#?!&ESI?\ B?1O&?AJZU)O$5W&[&*"Y2-E1[)"(Y# <B5U
MQ(&0;&^O** /C3]G#]G'_@LG;?'CPYXH_;+_ &]/A]K_ ( T66>ZU+PK\/?
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MC2/$?AY[F*2X6[O)KIXYK>:/"[&F8!UD.X8!48R?'_&?[$O_  70U/\ :?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4O/$'B37M'U)+F_L3;/;6L:6-Q<&%U,AG#N4),(V9VL5^7O^"DGAWX\^)_\
M@M5^RU^T[\,?V3?B?XO\#_!>V\0P>-M<T#PH^Q);ZWDMXUMUG:(W(4X9GCRA
M5@49SQ7TC\;/VY?COXD\,V_@O]FG]A7XPCQIXAU&#2='\1^*_!L%GI7AG[3(
ML,FK7;RSDM%;H[3&)$8R>6$.T,6 !Y/\7?VM?^"D47_!:W_AW=\,OB/\-;;P
MIKOP#N/&FA:C?>#+@OHI;5C9+-<I]K9]2FB$#A8XY+.*0W"E@/+PVC_P3_\
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M1J>L:YI&EV5SJNN:GJD:S1"(W\$\$=G!"RA@(3(\K?ZQ%7:W,_\ !'S]LO\
M;O\ VLOB?\;_  #^U'XM^&MWIOP/^)6K?#^9_"_@:]L=0UF]M)8A%J;W+ZC+
M;JDD?G;[=+9"K&,AP,J?%_VW?BC\6_AQ_P %=_$_QD^&7["7QD\32^&?A;H^
MB0>/OV<KG3[C4KI+UY;F>UUNTO$DBD*"*#[/#)&)(ES-DB> Q^]?\$D/VE/V
M<KFZUW]DWP!^Q1\:/@5XM;[=XTU32_C5X8EM[[Q?)-=1)J&LK?/++_:$OGSV
MZS.S!E\Z)578%"@'V]1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\0WO_  34_;@^"7[0/Q%^,7["7_!1V'PKH/Q5\8S>*/%?@/XD_#6+Q);6
M^JS1Q12W%I<I=6T\2>7#%&L!)54B1<X45] _L^_LV>./A]XCD^+7[07QTNOB
M7\09M*;2X]?;08-)L=+L6D262UL+&%G^SI+)%%)*TDLTLC0Q!I"D42)Z[10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG=CDL3IR<D^IK=_X+>V=HW[97[ M^UNAG3]IRV1)=HW!6A4L ?0E%S_NCTH
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M%#<"%B0!+Y>PD@;N17QA_P %&/B7JVE?\%[/V%_AO\27,7P^N8/%]]I NO\
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M73?[.:(2B[^T%A&(3&0V\G&.<U^9/_!"WX5_#:Y_X)I_M3RS^!=)>36/B_\
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MQ\(OX7U:[^*'C:YUL)H\C^9-90+,=L$,K;2Z( &*J2.*^AJ* /A6U_X-WO\
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MB#XD:1X4AT%?$/B'XFZC,]Y"EQ).9+D1R)]HWF15:"3-KMAC"P+MR=SX(_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%8OQ%OO'6F^"-2O_ (9Z'9:GK\5L6TNP
MU&Y,,$\N1A7<<J,9YKP__A97_!37_HVCX<_^%G)_\37KY=DU;,J3G"K2A9VM
M.K"#^2DTVO,\?,LZH9955.=*K.ZO>G2G-?-Q32?EN?15%?.O_"RO^"FO_1M'
MPY_\+.3_ .)H_P"%E?\ !37_ *-H^'/_ (6<G_Q->A_JKB_^@G#_ /A12_\
MDCSO];<)_P! V(_\)ZO_ ,B?G1_P5D_Y2 ^/_P#N%?\ IJLZ^=*]H_X*&:E\
M3=8_;!\7ZC\8_#.G:/XDD_L_^T=.TF]-Q;PXT^V$>R0@%LQA&/H6([5XO7]W
M\(4G0X2R^DVFXT*2NFFG:G%736C79K1K5'\ <95EB.,,QJI-*5>L[---7J2=
MFGJGW3U3T85^BW_! ?\ YJQ_W ?_ '(U^=-?:/\ P2%\2_M-^'O^%A?\,Y_#
M3PYXB\[^R?[9_P"$@UEK3[/C[;Y7E[0=^[,N?3:OK7SOBQA)X[@#&4(RC%OV
M>LY*,5:K!ZRDTEMI=ZO0^E\(L7# ^(>"KRC*27M-(1<Y.]&HM(Q3;WULM%=[
M(_5NBOG7_A97_!37_HVCX<_^%G)_\31_PLK_ (*:_P#1M'PY_P#"SD_^)K^,
MO]5<7_T$X?\ \**7_P D?VU_K;A/^@;$?^$]7_Y$^BJJ:_>:CIVA7NH:/IAO
M;N"TDDM;,.%\^15)6/<>FX@#/;->,_#OQY^WWJ7C?3;#XF? 7P/IF@RW(75+
M_3O%,DT\$6#ED0KACG'%>TZMJ,.CZ5<ZO<(S1VMN\SJG4A5+$#/?BO(S'+JF
M6U5"=2$[J]X3C-?-Q;2?D>QEN94LSI.I"G.%G:U2$H/Y*23:\]C\G?\ @BUX
MI_9-_P""L'P$U7QK^T[\:O%NK_M.C6]4D^(>F?\ "Q-7T/5_"3B]E6VCTFUM
MKF+[%9Q0^0%,"X\S>)27W+7W?_P3D^!WQH_9T_9]O_A-\=_B?X@\:ZU8>/\
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M:*64)! J>9;RW;,9)I=Q^L_^":_Q1^!__!7#XR6'_!7_ $WPM8VUMX4\(_\
M"%_#W1+ZY@N-0T2ZDVW&LW5R(R?(E:1TM8 =K?9X9)L;+T  'EW_  <%6OB;
MP[^TO^QM:^!OB[\0?"UO\2_VBM(\)^.K7P?\1M7T>+5])N;FSBE@=;*YB"G9
MN42)MD7>Q# G-<W_ ,%*O&_QF_X([?MU?LQ^-/V4?C[\1-;\%_&3Q^/"7C?X
M.>._'VI>);2[1Y[2/[58-JD]Q<6LP%R<F.3;O6$;=K.C[7_!Q(=%^(7QG_8
M_L/Q,[:?KG[5?A[['K&AWX#&&:YM-EQ;SQD@':P=)%)[,*^QM$_X)<?LR']I
MK0_VP?BK>>+OB3\0/"EL8/!VL?$+Q-+?P^'@WWGL[10EM#(3@^;Y9DRH8,",
MT ?1M?CQ^WC^W3^PC^UY_P %*/$/[&_[2'_!4;XT?LYV/PU>WT'PFWPQ\43>
M'++Q#J\N7U*>_P!0-K-#Y<3BWM8EE,:QO;73;V$R@?L/7F7[6O['O[.'[;WP
M:U7X&?M._"[2_$WA_4K62,?;K9#/8.RD"XM9B-]O,O59$((([C(H ^7/VYOC
M)#_P0T_X(U>*/&_PO^+7C/XB:_H-K]C\'^*OBEXE.N:IJ.JZE=[89[FX9569
M(!,9%C550Q6P3&22?./V]O 'Q(_X)5?\$Z_#G_!0KX9?$7Q;K/Q4^%U]X>U'
MXL7^N^*[VZ'C^UO+JWM-5L[V&:5H=C/=&6$JBFT\E1#L4%3\G?M9_ _X]^*O
M^#272=/\0:M>^*O^%7^-#J6B:C,"\VI^%+'7[NSLKG'.8192Q3(1P+:-&' S
M7W!_P<<_$?1/%_\ P0L^(NI>"9#J;_$*W\,6?A&WM%\R34I+W6-/DB2)1R[-
M%N8 9SMXH ;^U7^UI?\ [7/_  4I_9]_X)M_"WQOJVF> /%WPZN/BE\4+W0-
M1ELKS6=$\N1=,TP7$#+)!!+<)ON%1@TD91-P5F#7_ ?QAU3]AO\ X+2:+_P3
MRT?6]1N/A5\;_A;/XD\"Z'J>IS7?_"->(M.>?[;;6;SNSQV<]I!YYAW%$F4F
M-4#OGQ+X4? OQ-^R1_P<(_L[:;\05/V?Q3^Q6G@O2+YVRD^L:,%>\MT;HS+!
M$DIQVES7<_M4>$]7^+G_  = ?LQV?A>%YH_A7\#_ !'XH\421#(M;6]6_P!,
M@WD?=+3R1C!Y(/I0!^D?B#0=-\3Z+<^']829K:[B,<P@NI(7VG^[)&RNA]U(
M/O7Y<_\ ! ;7;Z3XJ?MC^,_C;\>?&>LZ;\+OV@]<\.^'+OQ]\2=2OK+0=$M)
M+@!<7MR\2*J'YI7&[" EN,U^J5?F!_P;F@-\9/V[@0"/^&O_ !)_Z434 ?4O
MB3_@LM_P2Y\*?"ZX^-.K?MM>"'\+V_B6YT$:O87KW:7-_;Q02SQVZP([7*1I
M<P,\T0>)?-7+C->Z>'OC-\)/%?PEMOCWX>^)6AW7@F\T0:S;^+$U.,:>VGF/
MS?M1G)"+$(\L7)  !)Q@U^;W_! SX6?#:^_9K_;&N;SP+I4DNJ?M0_$+1=1F
M>PC+W&G)%;;;1VQDPCS9<1_=!D8XY-?&&E_&'6O!?_!KK^QCH/BK5)(_ ?C#
M]HBVT+XJW,LA\I_#D?B?6[B6WF/:%C:0AL_+MCVGAL4 ?3W_  7A_:J_9@^/
M7AW]FZZ^$GQ?\0/X@N?VC_!TNF6,AUK3-/\ $&B-=2F6ZMH+E8K35(5F^S'[
M5"LNW,8$@5P&_4'XS?M&_!G]G^"P/Q4\9?8KK5FE&D:18Z?<:AJ.H>4H:4V]
ME:1RW$XC4JSM'&P0,"Q (KX8_P"#D;1M NO@%^S?K+:=;/+8?M=>"/L%R(QF
M!'-V&",.BE0,@<':/08JZ9XUUSQS_P '#_QA^!'BS]ICQ3\.]:;X(>&#\*X]
M#M=&=M4TM)+F?4HXO[4L+L%OM,H<K#L9Q;,7WB!=@!]@^%O^"AO[&'C?]GW4
MOVJ/!OQ\TG5? 6B74MMK^OZ?;W$PT>:(9ECO(EC,UFT8P7$R)L!!; ()HV?_
M  4Q_88U'X!6/[4VG_M":;<?#O4]?&B:=XO@T^[>RNK\OY:P1N(?G)DS$",J
M9 8P2X*UQ'[&/[ '[.7['_[4OQM\5>#/CQXV\8^-?B]!IWB'XF:'XMDTQK./
M=)>10W:V]AI]K% T["[4AL^9Y3G'RDU^?'['MK\*OV'/^"FGAKX5^(UUX_L>
M_$WXD:OJ_P"RO>:H\7]@Z=XW*0PR!1RYM68W:::[E8W,@GC24LMRH!^U>DZG
M::WI5MK-AYOD7=NDT/GV[Q/L=0PW)( R'!&58!@>" >*L444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HJCXFN/$%KH-U<>%=/@NM12+-I;W,NR.1_1F'05P/\
MPE'[57_1+/#/_@\;_"O%S//*&5U8TYT:L[J]Z=*=1?-QBTGY;G?A,NJ8R#E&
M<(VT]Z<8O[FT>F45YG_PE'[57_1+/#/_ (/&_P */^$H_:J_Z)9X9_\ !XW^
M%>;_ *WX/_H%Q/\ X35O_D#K_L.O_P _J7_@V'_R1Z97B7[:OQCN_ /@^T\&
M^&]1:#5=7E$CRPOAX+>-@2P/8LP"CU >MR]\:_M/Z;9S:C?_  T\+Q001-)-
M*^NL%1%&2Q..@ S7R)\6/B7KGQ:\;W7C37A&DDP6.&"$DI#&HPJKGG'4^Y8G
MO7Y-XP^)U/+.%IX'!PJTL1B/=3G3G3:A]N47)*[M:.FW-?H?9\#\)3Q><1Q%
M>4)TJ6KY91E>7V4[-^NO:Q]P_!3XE6GQ8^&^G>,H2HGEB\N_B7_EE<+PZX[#
M/S#V85U=?$_[+'QB\>>!?$,G@;PA8V%[_;LRB"VU.Y:*-9U!P58="P^7!ZD*
M*^C/^$H_:J_Z)9X9_P#!XW^%?2>'_BAAN(N&*-:M2K3KP7)5<*-2:YUUO&+7
MO*TK=+V/*XEX0K97F]2G3G"-.3YH<TXQ?*^EFT]'=7\CTRBO,_\ A*/VJO\
MHEGAG_P>-_A1_P )1^U5_P!$L\,_^#QO\*^U_P!;\'_T"XG_ ,)JW_R!X/\
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M:O\ %'CKQ7\3+"YL_P!K+Q1:PQ>"?C5XH\,V[1CR'W/;Z/J-M#+)EC^]=&?
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M]\L1U33KLA8KZ\=V6$IN,C%P_E@J ?</PG_;'_98^.7P*NOVFOA7\>_#&K>
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MAX'OOAO?^(+)=0?_ $;4?%(\/^5:22;N'GA9T\H_>62[&.6%>D_MTZ/I%O\
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MWP]B;]F74/'RPQS7'PZEE:?[+#%'D0ZC&4B6[3>[[+.*$?)9$G]<: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP#+J?@KQI;R+XIBO]6N;B^U2=RC&\GO99&N)KH/%$PG=V<&&/!PB@>#WW_!
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463799584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information Document - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 27, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
<td class="text">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Raleigh, North Carolina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LABORATORY CORPORATION OF AMERICA HOLDINGS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000920148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3757370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">358 South Main Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Burlington,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">229-1127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">List hereunder the following documents if incorporated by reference and the Part of the Form&#160;10-K into which the document is incorporated:</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the Registrant&#8217;s Notice of Annual Meeting and Proxy Statement to be filed no later than 120&#160;days following December&#160;31, 2022, are incorporated by reference into Part III.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462654960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,280.6<span></span>
</td>
<td class="nump">$ 2,379.5<span></span>
</td>
<td class="nump">$ 1,557.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633.9<span></span>
</td>
<td class="nump">745.1<span></span>
</td>
<td class="nump">624.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144.1<span></span>
</td>
<td class="nump">153.7<span></span>
</td>
<td class="nump">111.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DepreciationAndAmortizationOfLeasedAssets', window );">Depreciation And Amortization Of Leased Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194.4<span></span>
</td>
<td class="nump">194.9<span></span>
</td>
<td class="nump">200.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">462.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Increase (Decrease) in Deferred Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
<td class="num">(75.9)<span></span>
</td>
<td class="num">(47.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other Operating Activities, Cash Flow Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.5<span></span>
</td>
<td class="num">(24.0)<span></span>
</td>
<td class="nump">83.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in assets and liabilities (net of effects of acquisitions and divestitures):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">(Increase) decrease in accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">222.0<span></span>
</td>
<td class="num">(913.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Increase (Decrease) in Contract with Customer, Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
<td class="num">(179.2)<span></span>
</td>
<td class="num">(42.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase (Decrease) in Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45.5)<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
<td class="num">(196.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Increase in prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256.9)<span></span>
</td>
<td class="num">(68.2)<span></span>
</td>
<td class="num">(5.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (Decrease) in Accounts Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307.1<span></span>
</td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(5.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.3<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(559.3)<span></span>
</td>
<td class="num">(275.9)<span></span>
</td>
<td class="nump">257.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,955.9<span></span>
</td>
<td class="nump">3,109.6<span></span>
</td>
<td class="nump">2,135.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(481.9)<span></span>
</td>
<td class="num">(460.4)<span></span>
</td>
<td class="num">(381.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">87.3<span></span>
</td>
<td class="nump">42.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherInvestments', window );">Proceeds from Sale of Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities', window );">Proceeds from Derivative Instrument, Investing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to Acquire Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
<td class="nump">27.8<span></span>
</td>
<td class="nump">40.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,164.0)<span></span>
</td>
<td class="num">(496.9)<span></span>
</td>
<td class="num">(267.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by (Used in) Investing Activities, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,652.2)<span></span>
</td>
<td class="num">(884.6)<span></span>
</td>
<td class="num">(643.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from senior note offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayments of Senior Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,000.0)<span></span>
</td>
<td class="num">(412.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of Lines of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(787.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(151.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of Other Long-term Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(375.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Payments on revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">151.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetProceedsFromIssuanceOfStockToEmployees', window );">Net proceeds from issuance of stock to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.6<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">55.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Payments of Ordinary Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195.2<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of common stock</a></td>
<td class="num">$ (1,000.0)<span></span>
</td>
<td class="num">(1,100.0)<span></span>
</td>
<td class="num">(1,668.5)<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Proceeds from (Payments for) Other Financing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.0)<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
<td class="num">(26.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,322.2)<span></span>
</td>
<td class="num">(2,065.8)<span></span>
</td>
<td class="num">(517.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.2)<span></span>
</td>
<td class="num">(7.3)<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,042.7)<span></span>
</td>
<td class="nump">151.9<span></span>
</td>
<td class="nump">983.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,472.7)<span></span>
</td>
<td class="num">(1,320.8)<span></span>
</td>
<td class="num">(337.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities', window );">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (50.6)<span></span>
</td>
<td class="num">$ (47.4)<span></span>
</td>
<td class="num">$ (34.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DepreciationAndAmortizationOfLeasedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DepreciationAndAmortizationOfLeasedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excess Tax Benefit - Share-based Compensation, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetProceedsFromIssuanceOfStockToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetProceedsFromIssuanceOfStockToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466843536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461376912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER LIABILITIES</a></td>
<td class="text">OTHER LIABILITIES<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan obligation</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worker's compensation and auto</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461291328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Other liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation plan obligation</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan obligation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Worker's compensation and auto</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">422.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466690496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER LIABILITIES - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred Compensation Liability, Classified, Noncurrent</a></td>
<td class="nump">$ 96.9<span></span>
</td>
<td class="nump">$ 104.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">422.8<span></span>
</td>
<td class="nump">402.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Defined-benefit plan obligation</a></td>
<td class="nump">55.6<span></span>
</td>
<td class="nump">136.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Workers' Compensation Liability, Noncurrent</a></td>
<td class="nump">46.4<span></span>
</td>
<td class="nump">47.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="nump">32.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_OtherLiabilitiesNoncurrentOther', window );">Other</a></td>
<td class="nump">$ 178.2<span></span>
</td>
<td class="nump">$ 81.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_OtherLiabilitiesNoncurrentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities Noncurrent, Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_OtherLiabilitiesNoncurrentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462805456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="nump">$ 330,500,000<span></span>
</td>
<td class="nump">$ 319,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="nump">430,000,000.0<span></span>
</td>
<td class="nump">1,472,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">2,222,000,000<span></span>
</td>
<td class="nump">2,261,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="nump">795,400,000<span></span>
</td>
<td class="nump">716,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Supplies inventory</a></td>
<td class="nump">470,600,000<span></span>
</td>
<td class="nump">401,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">707,000,000.0<span></span>
</td>
<td class="nump">478,100,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,625,000,000<span></span>
</td>
<td class="nump">5,330,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,956,200,000<span></span>
</td>
<td class="nump">2,815,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">8,121,000,000<span></span>
</td>
<td class="nump">7,958,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">3,946,900,000<span></span>
</td>
<td class="nump">3,735,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Joint venture partnerships and equity method investments</a></td>
<td class="nump">65,700,000<span></span>
</td>
<td class="nump">60,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets, Net</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">21,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, net</a></td>
<td class="nump">432,700,000<span></span>
</td>
<td class="nump">462,600,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">20,155,100,000<span></span>
</td>
<td class="nump">20,385,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">934,800,000<span></span>
</td>
<td class="nump">621,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other</a></td>
<td class="nump">1,068,800,000<span></span>
</td>
<td class="nump">1,404,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred Revenue, Current</a></td>
<td class="nump">582,100,000<span></span>
</td>
<td class="nump">558,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">185,500,000<span></span>
</td>
<td class="nump">187,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ShortTermDebtAndLongTermDebtCurrentMaturities', window );">Short-term borrowings and current portion of long-term debt</a></td>
<td class="nump">301,300,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">3,078,500,000<span></span>
</td>
<td class="nump">2,782,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">5,038,800,000<span></span>
</td>
<td class="nump">5,416,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">679,700,000<span></span>
</td>
<td class="nump">642,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">83,600,000<span></span>
</td>
<td class="nump">84,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities', window );">Deferred income taxes and other tax liabilities</a></td>
<td class="nump">736,200,000<span></span>
</td>
<td class="nump">762,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">422,800,000<span></span>
</td>
<td class="nump">402,000,000.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">10,039,600,000<span></span>
</td>
<td class="nump">10,091,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingent liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NoncontrollingInterestMezzanineEquity', window );">Noncontrolling interest</a></td>
<td class="nump">18,900,000<span></span>
</td>
<td class="nump">20,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, 88.2 and 93.1 shares outstanding at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">10,581,700,000<span></span>
</td>
<td class="nump">10,456,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(493,200,000)<span></span>
</td>
<td class="num">(191,900,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">10,096,600,000<span></span>
</td>
<td class="nump">10,273,400,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 20,155,100,000<span></span>
</td>
<td class="nump">$ 20,385,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DeferredIncomeTaxesAndOtherTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DeferredIncomeTaxesAndOtherTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoncontrollingInterestMezzanineEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoncontrollingInterestMezzanineEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ShortTermDebtAndLongTermDebtCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term Debt And Long-Term Debt, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ShortTermDebtAndLongTermDebtCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55302-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462624592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ConsolidatedStatementsofOperationsAbstract', window );"><strong>Consolidated Statements of Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 14,876.8<span></span>
</td>
<td class="nump">$ 16,120.9<span></span>
</td>
<td class="nump">$ 13,978.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Revenue</a></td>
<td class="nump">10,491.7<span></span>
</td>
<td class="nump">10,496.6<span></span>
</td>
<td class="nump">9,025.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">4,385.1<span></span>
</td>
<td class="nump">5,624.3<span></span>
</td>
<td class="nump">4,952.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,996.6<span></span>
</td>
<td class="nump">1,952.1<span></span>
</td>
<td class="nump">1,729.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="nump">259.3<span></span>
</td>
<td class="nump">369.6<span></span>
</td>
<td class="nump">275.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="nump">271.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">462.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringAndOtherSpecialCharges', window );">Restructuring and other special charges</a></td>
<td class="nump">83.8<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,773.9<span></span>
</td>
<td class="nump">3,259.5<span></span>
</td>
<td class="nump">2,445.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(180.3)<span></span>
</td>
<td class="num">(212.1)<span></span>
</td>
<td class="num">(207.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method income, net</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(25.3)<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="num">(32.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest', window );">Earnings before income taxes</a></td>
<td class="nump">1,582.6<span></span>
</td>
<td class="nump">3,126.6<span></span>
</td>
<td class="nump">2,219.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">302.0<span></span>
</td>
<td class="nump">747.1<span></span>
</td>
<td class="nump">662.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,280.6<span></span>
</td>
<td class="nump">2,379.5<span></span>
</td>
<td class="nump">1,557.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 1,279.1<span></span>
</td>
<td class="nump">$ 2,377.3<span></span>
</td>
<td class="nump">$ 1,556.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ConsolidatedStatementsofOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consolidated Statements of Operations [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ConsolidatedStatementsofOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringAndOtherSpecialCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringAndOtherSpecialCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462656544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,280.6<span></span>
</td>
<td class="nump">$ 2,379.5<span></span>
</td>
<td class="nump">$ 1,557.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(336.4)<span></span>
</td>
<td class="num">(104.6)<span></span>
</td>
<td class="nump">264.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Net benefit plan adjustments</a></td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">91.7<span></span>
</td>
<td class="num">(65.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other comprehensive earnings (loss) before tax</a></td>
<td class="num">(291.6)<span></span>
</td>
<td class="num">(12.9)<span></span>
</td>
<td class="nump">198.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">(Provision) benefit for income tax related to items of comprehensive earnings</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="num">(301.3)<span></span>
</td>
<td class="num">(30.0)<span></span>
</td>
<td class="nump">210.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="nump">979.3<span></span>
</td>
<td class="nump">2,349.5<span></span>
</td>
<td class="nump">1,767.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Net earnings attributable to the noncontrolling interest</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">$ 977.8<span></span>
</td>
<td class="nump">$ 2,347.3<span></span>
</td>
<td class="nump">$ 1,766.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459049328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Earnings (Loss)</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Outstanding</a></td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid in Capital</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">7,980.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(372.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2019</a></td>
<td class="nump">7,643.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">1,556.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 1,556.1<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="nump">210.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">210.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IssuanceOfCommonStockUnderEmployeeStockPlans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="nump">55.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">55.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Net share settlement tax payments from issuance of stock to employees</a></td>
<td class="num">(34.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(34.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">111.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">111.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(100.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(49.6)<span></span>
</td>
<td class="num">(50.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2020</a></td>
<td class="nump">9,436.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,479.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(161.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">2,377.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2,377.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="num">(30.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(30.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IssuanceOfCommonStockUnderEmployeeStockPlans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Net share settlement tax payments from issuance of stock to employees</a></td>
<td class="num">(47.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(47.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">153.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">153.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(1,668.5)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(268.3)<span></span>
</td>
<td class="num">(1,399.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2021</a></td>
<td class="nump">10,273.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Outstanding</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">10,456.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,456.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">(191.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">1,279.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,279.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (loss), net of tax</a></td>
<td class="num">(301.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(301.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IssuanceOfCommonStockUnderEmployeeStockPlans', window );">Issuance of common stock under employee stock plans</a></td>
<td class="nump">50.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">50.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Net share settlement tax payments from issuance of stock to employees</a></td>
<td class="num">(50.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(50.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock compensation</a></td>
<td class="nump">144.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">144.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="num">(1,100.0)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(144.1)<span></span>
</td>
<td class="num">(955.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Dec. 31, 2022</a></td>
<td class="nump">10,096.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(198.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends, Cash</a></td>
<td class="num">(198.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Outstanding</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="nump">10,581.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,581.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (493.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (493.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IssuanceOfCommonStockUnderEmployeeStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan, combined the value of stock issued during the period as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IssuanceOfCommonStockUnderEmployeeStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501460707856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeAbstract', window );"><strong>Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings, basic</a></td>
<td class="nump">$ 1,279.1<span></span>
</td>
<td class="nump">$ 2,377.3<span></span>
</td>
<td class="nump">$ 1,556.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net earnings, diluted</a></td>
<td class="nump">$ 1,279.1<span></span>
</td>
<td class="nump">$ 2,377.3<span></span>
</td>
<td class="nump">$ 1,556.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SharesAbstract', window );"><strong>Shares [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Outstanding shares, diluted (in shares)</a></td>
<td class="nump">91.6<span></span>
</td>
<td class="nump">97.5<span></span>
</td>
<td class="nump">98.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Outstanding shares, basic (in shares)</a></td>
<td class="nump">91.1<span></span>
</td>
<td class="nump">96.7<span></span>
</td>
<td class="nump">97.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncrementalCommonSharesAttributableToStockOptions', window );">Dilutive effect of stock options (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PerShareAmountAbstract', window );"><strong>Per Share Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings Per Share, Basic</a></td>
<td class="nump">$ 14.05<span></span>
</td>
<td class="nump">$ 24.60<span></span>
</td>
<td class="nump">$ 15.99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in dollars per share)</a></td>
<td class="nump">$ 13.97<span></span>
</td>
<td class="nump">$ 24.39<span></span>
</td>
<td class="nump">$ 15.88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncrementalCommonSharesAttributableToStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate awards of stock options and nonvested options to be issued to an employee under a stock option arrangement. Such stock options shall be considered to be outstanding as of the grant date for purposes of computing diluted earnings per share even though their exercise may be contingent upon vesting. Those options are included in the diluted Earnings Per Share (EPS) computation even if the employee may not receive (or be able to sell) the stock until some future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncrementalCommonSharesAttributableToStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PerShareAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PerShareAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462691184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>yr</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Propertyplantandequipmentusefullifesoftwareminimum', window );">Property plant and equipment useful life software minimum</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Propertyplantandequipmentusefullifesoftwaremaximum', window );">Property plant and equipment useful life software maximum</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage', window );">Estimated useful life of capitalized software costs (in years)</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Buildings and building improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Buildings and building improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life, minimum (years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized software costs are amortized over the estimated useful life of the underlying system.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Propertyplantandequipmentusefullifesoftwaremaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment useful life software maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Propertyplantandequipmentusefullifesoftwaremaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Propertyplantandequipmentusefullifesoftwareminimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment useful life software minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Propertyplantandequipmentusefullifesoftwareminimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459713904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,121,000,000<span></span>
</td>
<td class="nump">$ 7,958,900,000<span></span>
</td>
<td class="nump">$ 7,751,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Non-compete agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">36 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Patents, Licenses And Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Non-compete agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful life of finite-lived intangible assets, minimum (years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461426928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than 80,000 employees, the Company serves clients in more than 100 countries. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, including information for each of the last three fiscal years regarding revenue, operating income, and other important information, see Note 19 Business Segment Information. In 2022, Dx and DD contributed 61% and 39%, respectively, of revenues to the Company, and in 2021 contributed 64% and 36%, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reimbursable Out-of-Pocket Expenses</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD pays on behalf of its customers certain out-of-pocket costs for which the Company is reimbursed at cost, without mark-up or profit. Out-of-pocket costs paid by DD are reflected in cost of revenues, while the reimbursements received are reflected in revenues in the consolidated statements of operations. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes direct labor and related benefit charges, reimbursable expenses, other direct costs, shipping and handling fees, and an allocation of facility charges and information technology costs. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, advertising and promotional expenses, administrative travel and an allocation of facility charges and information technology costs. Cost of advertising is expensed as incurred.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Significant estimates include implicit price concessions, revenue estimates, the allowances for doubtful accounts, deferred tax assets, fair values of acquired assets and assumed liabilities in business combinations, fair value of goodwill and indefinite-lived intangible assets, amortization lives for acquired intangible assets, and accruals for self-insurance reserves, litigation reserves and pensions. Actual results could differ from those estimates.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will continue to impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2022, and through the date of this Annual Report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">concessions and credit losses, equity investments, and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could impact the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. The total cash and cash equivalent balances that exceeded the balances insured by the Federal Deposit Insurance Commission, were approximately $428.1 and $1,471.0 at December&#160;31, 2022, and 2021, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s accounts receivable are with companies in the healthcare or pharmaceutical industry and individuals. However, concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many different geographic regions. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Dx has receivables due from U.S. and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by U.S. and state governments, and payment is primarily dependent upon submitting appropriate documentation. Accounts receivable balances (gross) from Medicare and Medicaid were $85.8 and $94.5 at December&#160;31, 2022, and 2021, respectively.  </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company's operations in Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (Ministry) determines who can establish a licensed community medical laboratory and caps the amount that each of these licensed laboratories can bill the government sponsored healthcare plan. The Ontario government-sponsored healthcare plan covers the cost of commercial laboratory testing performed by the licensed laboratories. The provincial government discounts the annual testing volumes based on certain utilization discounts and establishes an annual maximum it will pay for all community laboratory tests. The agreed-upon reimbursement rates are subject to Ministry review at the end of year and can be adjusted (at the government's discretion) based upon the actual volume and mix of test work performed by the licensed healthcare providers in the province during the year. There were no capitated accounts receivable balances from the Ontario government sponsored healthcare plan at December&#160;31, 2022. The balance was CAD 7.2 at December&#160;31, 2021.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.&#160;At December&#160;31, 2022, and 2021, receivables due from patients represented approximately 15.3% and 16.7% of the Company's consolidated gross accounts receivable, respectively.&#160;The Company applies assumptions and judgments including historical collection experience and reasonable and supportable forecasts for assessing collectability and determining allowances for doubtful accounts for accounts receivable from patients.&#160; </span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.60&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.99&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.97&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.39&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.88&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Compensation Plans</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units is determined based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and the Company's determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and the Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 Stock Compensation Plans for assumptions used in calculating compensation expense for the Company&#8217;s stock compensation plans.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Equivalents</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits, and other money market instruments, which have maturities when purchased of three months or less. </span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplies Inventory</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inventories, consisting primarily of purchased laboratory and customer supplies and finished goods, are stated at the lower of cost (first-in, first-out) or net realizable value. Supplies accounted for $412.8 and $371.5 and finished goods accounted for $57.8 and $29.9 of total inventory at December&#160;31, 2022, and 2021, respectively. The Company's inventory reserve balance was $23.3 and $40.1, as of December&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using the straight-line method.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:89.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capitalized Software Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes purchased software that is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and the Company commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development (R&amp;D) costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system ranging from three to </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fifteen years, generally five years. Amortization begins once the underlying system is substantially complete and ready for its intended use.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Indefinite-lived Intangibles</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#8217;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. </span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.</span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:468.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:15.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Issuance Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs related to the issuance of debt are capitalized, netted against the related debt for presentation purposes and amortized to interest expense over the terms of the related debt.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Professional Liability</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured (up to certain limits) for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is based on assumptions and factors for known and incurred but not reported claims, including the frequency and payment trends of historical claims. </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All leases with a lease term greater than 12 months, regardless of lease type classification, are recorded as an obligation on the balance sheet with a corresponding right-of-use asset. Both finance and operating leases are reflected as liabilities on the commencement date of the lease based on the present value of the lease payments to be made over the lease term. Right-of-use assets are valued at the initial measurement of the lease liability, plus any initial direct costs or rent prepayments, minus lease incentives and any deferred lease payments. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A certain number of these leases contain rent escalation clauses either fixed or adjusted periodically for inflation or market rates that are factored into the Company's determination of lease payments. The Company also has variable lease payments that do not depend on a rate or index, for items such as volume purchase commitments, which are recorded as variable cost when incurred. As most of the Company's leases do not provide an implicit rate, the Company estimates an incremental borrowing rate based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company uses this rate to discount payments to present value. Some operating leases contain renewal options, some of which also include options to early terminate the leases. The exercise of these options is at the Company's discretion and the Company evaluates each renewal option to determine if it is reasonably possible to be exercised and should be included in the accounting lease term. See Note 5 Leases to the Consolidated Financial Statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Income Taxes</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.&#160;If the recognition threshold is met, the Company recognizes a tax benefit </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized. The Company records interest and penalties in income tax expense.</span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments. The Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements, which have been used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative financial instruments are accounted for as fair value hedges that increase or decrease the value of the Senior Notes with the offset being recorded as a component of other long-term assets or liabilities, as applicable. As the specific terms and notional amounts of the derivative financial instruments match those of the fixed-rate debt being hedged, the derivative instruments are assumed to be perfectly effective hedges and accordingly, there is no impact to the Company's consolidated statements of operations. Cash flows from the interest rate swaps are including in operating activities.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross currency swap agreements, which have been used by the Company to hedge the foreign currency exposure of its net investment in a foreign subsidiary denominated in non-U.S. currency, are accounted for at fair value. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statements of Comprehensive Earnings.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts, which have been used by the Company to hedge foreign currency receivables, are recognized as assets or liabilities at their fair value. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The fair value of these contracts is not significant as of December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements for financial assets and liabilities are determined based on the assumptions that a market participant would use in pricing an asset or liability. A three-tiered fair value hierarchy draws distinctions between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2), and (iii) unobservable inputs that require the Company to use present value and other valuation techniques in the determination of fair value (Level 3).</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses R&amp;D costs as incurred.</span></div><div style="margin-bottom:3pt;margin-top:7pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries outside of the U.S. that operate in a local currency environment, income and expense items are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders&#8217; equity in the consolidated balance sheets and are included in the determination of comprehensive income in the consolidated statements of comprehensive earnings and consolidated statements of changes in shareholders&#8217; equity. Transaction gains and losses are included in the determination of net income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461380048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUES<div style="margin-bottom:3pt;margin-top:4pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Revenues</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dx attributes revenues to a geographical region based upon where the diagnostic test is performed, while DD attributes revenues to a geographical region based upon where the services are performed. The Company's revenue by segment payers/customer groups for the years ended December&#160;31, 2022, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"/><td style="width:94.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:34.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:33.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:33.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2022</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues in the U.S. were $11,530.5 (77.5%), $12,566.2 (77.9%) and $11,192.3 (80.1%) for the years ended December&#160;31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the current revenue recognition policies of the Company:</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dx Revenues</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dx is an independent clinical laboratory business. It offers a comprehensive menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the U.S. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx also offered a range of other testing services.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Dx segment, a revenue transaction is initiated when Dx receives a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. Dx recognizes revenue and satisfies its performance obligation for services rendered when the testing process is complete and the associated results are reported. Revenues are distributed among four payer portfolios - clients, patients, Medicare and Medicaid and third party. Dx considers negotiated discounts and anticipated adjustments, including historical collection experience for the payer portfolio, when revenues are recorded.</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are descriptions of the Dx payer portfolios:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clients</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Client payers represent the portion of Dx&#8217;s revenue related to physicians, hospitals, health systems, accountable care organizations (ACOs), employers and other entities where payment is received exclusively from the entity ordering the testing service. Generally, client sales are recorded on a fee-for-service basis at Dx&#8217;s client list price, less any negotiated discount. A portion of client billing is for laboratory management services, collection kits and other non-testing services or products. In these cases, revenue is recognized when services are rendered or delivered. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patients</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio includes revenue from uninsured patients and member cost-share for insured patients (e.g., coinsurance, deductibles and non-covered services). Uninsured patients are billed based upon Dx&#8217;s patient list fee schedules, net of any discounts negotiated with physicians on behalf of their patients. Dx bills insured patients as directed by their health plan and after consideration of the fees and terms associated with an established health plan contract.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare and Medicaid</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This portfolio relates to fee-for-service revenue from traditional Medicare and Medicaid programs. Revenue from these programs is based on the fee schedule established by the related government authority. In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#8217;s results of operations in any period presented</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Party</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third party includes revenue related to managed care organizations (MCOs). The majority of Dx's third-party revenue is reimbursed on a fee-for-service basis. These payers are billed at Dx's established list price and revenue is recorded net of contractual discounts. The majority of Dx&#8217;s MCO sales are recorded based upon contractually negotiated fee schedules with sales for non-contracted MCOs recorded based on historical reimbursement experience. </span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#8217;s results of operations in any period presented.  </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party reimbursement is also received through capitation agreements with MCOs and independent physician associations (IPAs). Under capitated agreements, revenue is recognized based on a negotiated per-member, per-month payment for an agreed upon menu of tests, or based upon the proportionate share earned by Dx from a capitation pool. When the agreed upon reimbursement is based solely on an established rate per member, revenue is not impacted by the volume of testing performed. Under a capitation pool arrangement, the aggregate value of an established rate per member is distributed based on the volume and complexity of the procedures performed by laboratories participating in the agreement. Dx recognizes revenue monthly, based upon the established capitation rate or anticipated distribution from a capitated pool.  </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DD Revenues</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD is a global contract research organization (CRO) business that provides end-to-end drug development services. DD provides these services predominantly to pharmaceutical, biotechnology, and medical device companies worldwide. A majority of DD&#8217;s revenues are earned under contracts that are long term in nature, ranging in duration from a few months to many years.  The majority of DD's contracts contain a single performance obligation, as DD provides a significant service of integrating all promises in the contract and the promises are highly interdependent and interrelated with one another. For contracts that include multiple performance obligations, DD allocates the contract value to the goods and services based on a customer price list, if available. If a price list is not available, DD will estimate the transaction price using either market prices or an &#8220;expected cost plus margin&#8221; approach. The total contract value is estimated at the beginning of the contract, and is equal to the amount expected to be billed to the customer. Other payments and billing adjustments may also factor into the calculation of total contract value, such as the reimbursement of out-of-pocket costs and volume-based rebates. These contracts generally take the form of fixed-price or fee-for-service arrangements subject to pricing adjustments based on changes in scope.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fixed-price contracts are typically recognized as revenue over time based on a proportional-performance basis, using either input or output methods that are specific to the service provided.  In an output method, revenue is determined by dividing the actual units of output achieved by the total units of output required under the contract and multiplying that percentage by the total contract value. When using an input method, revenue is recognized by dividing the actual costs incurred by the total estimated cost expected to complete the contract, and multiplying that percentage by the total contract value. Contract costs principally include direct labor and reimbursable out-of-pocket costs.  The estimate of total costs expected to complete the contract requires significant judgment and estimates are based on various assumptions of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee-for-service contracts are typically priced based on transaction volume or time and materials. For volume based contracts the contract value is entirely variable and revenue is recognized as the specific product or service is completed. For services billed based on time and materials, revenue is recognized using the right to invoice practical expedient.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts are often modified to account for changes in contract specifications and requirements. Generally, when contract modifications create new performance obligations, the modification is considered to be a separate contract and revenue is recognized prospectively. When contract modifications change existing performance obligations, the impact on the existing transaction price and measure of progress for the performance obligation to which it relates is generally recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most contracts are terminable with or without cause by the customer, either immediately or upon notice. These contracts often require payment to DD of expenses to wind-down the study or project, fees earned to date and, in some cases, a termination fee or a payment to DD of some portion of the fees or profits that could have been earned by DD under the contract if it had not been terminated early. Termination fees are included in revenues when services are performed and realization is assured. </span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">DD Contract costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately 1 to 5 years, depending on the business. For businesses that enter primarily short-term contracts, DD applies the practical expedient which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain services. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from 2 to 5 years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:331.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization related to sales commission assets and associated payroll taxes for the years ended December&#160;31, 2022, 2021, and 2020 was $33.9, $27.5 and $23.2, respectively. Amortization related to deferred contract fulfillment costs for the years ended December&#160;31, 2022, 2021 and 2020 was $12.4, $14.2 and $10.1, respectively. Impairment expense related to contract costs was insignificant to the Company&#8217;s consolidated statements of operations. DD applies the practical expedient to not recognize the effect of financing in its contracts with customers, when the difference in timing of payment and performance is one year or less. </span></div><div style="margin-bottom:7pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Accounts Receivable, Unbilled Services and Unearned Revenue</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Differences in the timing of revenue recognition and associated billing and cash collections result in recording accounts receivable, unbilled services and unearned revenue in the consolidated balance sheet. Payments received in advance of services being provided are contract liabilities recognized as unearned revenue. Revenue recognized in advance of billing are recognized as unbilled services and the majority of DD's unbilled services represent unbilled receivables. Once a customer is invoiced, the contract asset is reduced for the amount billed, and a corresponding accounts receivable is recognized. All contract assets are billable to customers within one year from the respective balance sheet date. The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:325.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized during the period, that was included in the unearned revenue balance at the beginning of the period, for the years ended December&#160;31, 2022, 2021, and 2020 was $330.5,  $319.4, and $262.6, respectively.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Credit Loss Rollforward</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the year ended December&#160;31, 2022, is as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%">Performance Obligations Under Long-Term Contracts</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term contracts at DD consist primarily of fully managed clinical studies within the DD segment. The amount of existing performance obligations under such long-term contracts unsatisfied as of December&#160;31, 2022, was $5,122.1. DD expects to recognize approximately 30.0% of the remaining performance obligations as of December&#160;31, 2022, as revenue over the next 12 months, and the balance thereafter. DD's long-term contracts generally range from 1 to 8 years.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DD applied the practical expedient and does not disclose information about remaining performance obligations that have original expected durations of one year or less. DD also did not disclose information about remaining performance obligations when the variable consideration was related to a wholly unsatisfied performance obligation within a series of obligations.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within DD, revenue of $73.0 and $69.8 was recognized during the year ended December&#160;31, 2022, and December&#160;31, 2021, respectively, from performance obligations that were partially satisfied in previous periods. This revenue comes primarily from adjustments related to changes in scope.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461522752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS AND DISPOSITIONS<div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2022</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2022, the Company acquired various businesses and related assets for approximately $1,164.0 in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $542.3 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $598.5. The amortization periods for intangible assets acquired from these transactions range from 15 to 19 years for customer relationships, 15 years for patents and technology, 5 years for non-compete agreements, and 5 to 10 years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill reflects the Company's expectations to utilize the acquired businesses&#8217; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2022 for these businesses is included below:</span></div><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:24.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.057%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preliminary Personal Genome Diagnostics Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preliminary Ascension Healthcare</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Acquisitions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Acquired During Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price allocation for several transactions are still preliminary and subject to change. The areas of the purchase price allocation that are not yet finalized relate primarily to property, plant and equipment, intangible assets, goodwill, and the impact of finalizing deferred taxes. Accordingly, adjustments may be made as additional information is obtained about the facts and circumstances that existed as of the valuation date. Any adjustments will be recorded in the period in which they are identified.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2022 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2022 acquisitions been completed as of January 1, 2021, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:70.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.273%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,997.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,310.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,362.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">2021</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the Company acquired various businesses and related assets for approximately $496.9 in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $198.5 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $298.4. The amortization periods for intangible assets acquired from these businesses range from 15 to 19 years for customer relationships, 5 to 15 years for patents and technology, 5 years for non-compete agreements, and 10 years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill reflects the Company's expectations to utilize the acquired businesses&#8217; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2021 for these businesses is included below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:66.113%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amounts Acquired During Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets acquired</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities acquired</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2021 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2021 acquisitions been completed as of January 1, 2020, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:70.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.273%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,216.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,112.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461431648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Related Activities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">RESTRUCTURING AND OTHER SPECIAL CHARGES</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. RESTRUCTURING AND OTHER CHARGES </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company recorded net restructuring charges of $83.8. The charges were comprised of $39.3 in severance and other personnel costs, $45.7 in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $0.3 in unused severance and $0.9 in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the Company recorded net restructuring charges of $43.1. The charges were comprised of $16.3 in severance and other personnel costs and $28.0 in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $0.4 in unused severance and $0.8 in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company recorded net restructuring charges of $40.6. The charges were comprised of $14.1 in severance and other personnel costs, $17.4 for facility, operating lease right-of-use and equipment impairments, and $18.9 in facility closures and general integration activities. The charges were offset by the reversal of previously established liability of $0.6 in unused severance and $9.2 in unused facility-related costs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring activities for the period indicated:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:38.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.719%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other<br/>Employee Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and Other<br/>Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The non-current portion of the restructuring liabilities is expected to be paid out over 10.7 years. Cash payments and other adjustments include the reclassification of profit sharing, pension, and holiday accrual.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461291760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases of Lessee Disclosure [Text Block]</a></td>
<td class="text">LEASES<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for patient service centers, laboratories and testing facilities, clinical facilities, general office spaces, vehicles, and office and laboratory equipment. Leases have remaining lease terms of less than a year to 16 years, some of which include options to extend the leases for up to 15 years.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:2pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:63.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.133%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f">Operating lease ROU assets (included in Property, plant and equipment, net)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a">Finance lease ROU assets (included in Other assets)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities are as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities, due beyond one year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rent expense for short term leases with a term less than one year for the years ended December&#160;31, 2022, 2021, and 2020  amounted to $22.2, $19.5, $6.8, respectively. The Company has variable lease payments that do not depend on a rate index, primarily for purchase volume commitments, which are recorded as variable cost when incurred. Total variable payments for the year ended December&#160;31, 2022, 2021 and 2020 were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$27.9</span>,  $28.4, and $26.7, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461279664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT, NET</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT, NET<div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,679.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,228.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,722.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,413.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense and amortization of property, plant and equipment was $374.6, $375.6 and $349.3 for 2022, 2021 and 2020, respectively, including software amortization of $84.2, $82.4, and $84.7 for 2022, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461279664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill (net of impairment) for the years ended December&#160;31, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,046.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,751.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,046.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,121.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:2pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.435%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,362.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,973.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,423.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,688.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, the Company recorded goodwill and other asset impairment charges of $271.5 which was primarily comprised of goodwill impairment and the impairment of a technology intangible asset.</span></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company recorded goodwill and other asset impairment charges of $462.1, $450.5 within DD and $11.6 within Dx. The Company concluded that the fair value was less than the carrying value for two of its reporting units and recorded goodwill impairment of $418.7 and $3.7 for DD and Dx, respectively. Additional impairment of identifiable intangible and tangible assets of $31.8 and $7.9 was recorded for DD and Dx, respectively, in 2020, for impairment of a tradename, software, customer relationships, and technology assets.</span></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative goodwill impairment for the Company through December&#160;31, 2022 is $733.6.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company undertook a rebranding initiative and reduced the estimated useful life of its trade name assets to reflect their anticipated use through December 2021. This change in estimated useful life resulted in accelerated amortization of $88.4 and $27.5 in 2021 and 2020.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of amortizable intangible assets acquired during 2022, and their respective weighted average amortization periods are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average<br/>Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets was $259.3, $369.6 and $275.4 in 2022, 2021 and 2020, respectively.&#160;Amortization expense of intangible assets is estimated to be $273.5 in fiscal 2023, $268.9 in fiscal 2024, $256.7 in fiscal 2025, $246.9 in fiscal 2026, $232.5 in fiscal 2027, and $2,055.6 thereafter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461321296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED EXPENSES AND OTHER</a></td>
<td class="text">ACCRUED EXPENSES AND OTHER<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pass through expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461350160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and current portion of long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55% senior notes due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% senior notes due 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2019, the Company entered into a $850.0 term loan (the 2019 Term Loan). The Company fully repaid the remaining 2019 Term Loan balance during the first quarter of 2021. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains a senior revolving credit facility, which was amended and restated on April 30, 2021. It consists of a five-year revolving facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $500.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $100.0 for swing line borrowings and a subfacility of up to $150.0 for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from 0.10% to 0.225%, depending on the Company's debt ratings. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions, and other investments. There were no balances outstanding on the Company's current revolving credit facility at December&#160;31, 2022, or December&#160;31, 2021. As of December&#160;31, 2022, the effective interest rate on the revolving credit facility was 5.39%. The credit facility expires on April 30, 2026. </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants in its term loans and the revolving credit facility at December&#160;31, 2022, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.  </span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revolving credit facility is not encumbered by any of the Company's outstanding letters of credit. There were $84.5 in outstanding letters of credit as of December&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2021, the Company issued new senior notes representing $1,000.0 in debt securities consisting of $500.0 aggregate principal amount of 1.55% senior notes due 2026 and $500.0 aggregate principal amount of 2.70% senior notes due 2031. Interest on these notes is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2021. Net proceeds from the offering of these notes were $989.4 after deducting underwriting discounts and other expenses of the offering. The net proceeds were used, along with cash on hand, to redeem, prior to maturity, the Company's outstanding 3.20% senior notes due February 1, 2022 and 3.75% senior notes due August 23, 2022.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706% to hedge against changes in the fair value of a portion of the Company's long-term debt. These interest rate swaps are included in other long-term liabilities and deducted from the value of the senior notes with an aggregate fair value of $79.7 at December&#160;31, 2022.</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled payments of long-term debt at the end of 2022 are summarized as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:82.331%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total scheduled payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373.9&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term debt issuance costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,340.1&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, due beyond one year</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461348160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</a></td>
<td class="text">PREFERRED STOCK AND COMMON SHAREHOLDERS&#8217; EQUITY<div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of December&#160;31, 2022 and 2021.&#160;</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued and held in treasury are summarized below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s treasury shares are recorded at aggregate cost. </span></div><div style="margin-bottom:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of  2021, the board of directors (the Board) adopted a new share repurchase plan authorizing up to $2,500.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. Under this plan, the Company commenced an Accelerated Share Repurchase (ASR) program. At inception, the Company paid $1,000.0 and received 2.7 shares based on a calculation using 80% of the shares calculated at the price at the inception of the ASR agreements with two different banks, Goldman Sachs &amp; Co. LLC and Barclays Bank PLC. The initial shares received under the ASR program were removed from the outstanding share count in 2021. During the twelve months ended December&#160;31, 2022, 0.9 shares were retired as part of this ASR program.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, during the twelve months ended December&#160;31, 2022, the Company repurchased 4.7 shares of its common stock at an average price of $233.48 for a total cost of $1,100.0. At the end of 2022, the Company had outstanding authorization from the board of directors to purchase up to $531.5 of the Company's common stock.</span></div><div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2023, the Board approved an additional $1,000.0 for share repurchases, bringing the total available authorization to $1,531.5. The repurchase authorization has no expiration.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended  December&#160;31, 2022, the Company paid $195.2 in common stock dividends. On January 12, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the first quarter, or approximately $64.8 in the aggregate. The dividend will be payable on March 13, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on February 23, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's Board.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Earnings</span></div><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.559%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Benefit<br/>Plan<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.6)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125.9)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.0)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191.9)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a) The amortization of prior service cost is included in the computation of net periodic benefit cost. Refer to Note&#160;15 Pension and Postretirement Plans for additional information regarding the Company's net periodic benefit cost.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461426928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of income before taxes, classified between domestic and foreign entities, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,580.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,126.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of  income tax expense attributable to continuing operations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.8&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense/(benefit):</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.0)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The effective tax rates on earnings before income taxes are reconciled to statutory U.S. income tax rates as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of U.S. federal income tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign earnings taxed at lower rates than the statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:61.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and restructuring reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;      Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net of valuation allowance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(811.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.7)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182.2)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(661.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(691.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a rollforward of the valuation allowance:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has U.S. federal tax loss carryforwards of approximately $161.5, which expire periodically through 2037, as well as post-2017 carryforwards of $202.7 that are limited to 80% of taxable income and have an indefinite carryforward period. The utilization of tax loss carryforwards is limited due to change of ownership rules; however, at this time, the Company expects to fully utilize substantially all U.S. federal tax loss carryforwards with the exception of approximately $6.5 for which a full valuation allowance has been provided. The Company has U.S. state tax loss carryforwards of $485.5, a portion of which expire annually, and on which a valuation allowance of $340.0 has been provided. In addition to federal and state tax loss carryforwards, the Company has other federal and state attribute carryforwards of $129.6. A portion of these attribute carryforwards will expire through 2027 and have a valuation allowance of $88.1 while the remainder have indefinite carryforward periods. The Company has foreign tax loss carryforwards of $115.7, the majority of which have indefinite carryforward periods, but a valuation allowance of $20.3 has been provided for jurisdictions where the future tax benefits of the attributes are not more likely than not to be realized.  Additionally, the Company has foreign tax loss carryforwards of $444.2 which expire periodically through 2034 that have a full valuation allowance. In addition to the foreign net operating losses, the Company has a foreign capital loss carryforward of $26.6 with an indefinite carryforward period and a full valuation allowance. </span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance increased from $149.2 in 2021 to $151.3 in 2022 primarily due to the establishment of valuation allowances related to acquired attributes and U.K. losses, offset by the partial release of the valuation allowance on U.S. capital losses.  </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized income tax benefits were $44.0 and $52.4 at December&#160;31, 2022, and 2021, respectively. It is anticipated that the amount of the unrecognized income tax benefits will decrease by $10.6 within the next 12 months due to statute of limitation lapses and anticipated audit settlements; however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $4.7 and $6.5 as of December&#160;31, 2022, and 2021, respectively. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $1.6, $1.6 and $4.4, respectively, in </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest and penalties expense, which was offset by a benefit from reversing previous accruals for interest and penalties of $3.3, $3.4 and $3.0, respectively. </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a reconciliation of the unrecognized income tax benefits, excluding interest and penalties, from uncertain tax positions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve for tax positions taken in the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve from an acquisition's opening balance sheet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of lapses in the statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also included in the balance of unrecognized tax benefits as of December&#160;31, 2022, 2021 and 2020, are $0.0, $0.9 and $2.1, respectively, of tax benefits that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes. As of December&#160;31, 2022, 2021 and 2020 there are $44.0, $51.5 and $46.7, respectively, of tax benefits that, if recognized, would favorably impact the effective income tax rate. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has substantially concluded all U.S. federal income tax matters for years through 2018 and is currently under IRS examination for tax years 2019 and 2020.&#160;Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2012, respectively.  The Company has various state and foreign income tax examinations ongoing throughout the year.  The Company believes adequate provisions have been recorded related to all open tax years.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a result of the Tax Cuts and Jobs Act (TCJA), the Company was effectively taxed on all of its previously unremitted foreign earnings. The TCJA also enacts a territorial tax system that allows, for the most part, tax-free repatriation of foreign earnings. The Company still considers the earnings of its foreign subsidiaries to be permanently reinvested, but, if repatriation were to occur, the Company would be required to accrue U.S. taxes, if any, and remit applicable withholding taxes as appropriate. The Company has unremitted earnings and profits of $1,726.3 and $1,291.8 that are permanently reinvested in its foreign subsidiaries as of December&#160;31, 2022, and 2021, respectively. A determination of the amount of the unrecognized deferred tax liability related to these undistributed earnings is not practicable due to the complexity and variety of assumptions necessary based on the manner in which the undistributed earnings would be repatriated.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461316464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to calculate the fair value of the employee&#8217;s purchase right. The fair value of the employee&#8217;s purchase right and the assumptions used in its calculation are as follows:</span></div><div style="margin-bottom:2pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of the employee&#8217;s purchase right</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.89&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.49&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK COMPENSATION PLANS</a></td>
<td class="text">STOCK COMPENSATION PLANS<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the shareholders approved the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the Plan). Under the Plan, as of December&#160;31, 2022, there are 8.6 shares authorized for issuance and 3.6 shares available for grant. </span></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes grants of non-qualified options made by the Company to officers, key employees, and non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Also, for each grant, options vest ratably over a period of three years on the anniversaries of the grant date, and have a contractual exercise period of 10 years subject to their earlier expiration or termination.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in options outstanding under the plans for the period indicated were as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.03&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company&#8217;s closing stock price on the last trading day of 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2022. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received by the Company from option exercises, the actual tax benefit realized for the tax deductions and the aggregate intrinsic value of options exercised from option exercises under all share-based payment arrangements during the years ended December&#160;31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received by the Company</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black Scholes model incorporates assumptions to value stock-based awards. The risk-free interest rate for periods within the contractual life of the option is based on a zero-coupon U.S. government instrument over the contractual term of the equity instrument. Expected volatility of the Company&#8217;s stock is based on historical volatility of the Company&#8217;s stock. The Company estimates expected option terms through an analysis of actual, historical post-vesting exercise, cancellation and expiration behavior by employees and projected post-vesting activity of outstanding options. Groups of employees and non-employee directors that have similar exercise behavior with regard to option exercise timing and forfeiture rates are considered separately for valuation purposes. For 2022, 2021 and 2020, expense related to the Company&#8217;s stock option plan totaled $4.3, $3.6 and $3.4, respectively, and is included in selling, general and administrative expenses. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock, Restricted Stock Units and Performance Shares</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock, restricted stock units, and performance shares (non-vested shares) to officers and key employees and grants restricted stock and restricted stock units to non-employee directors. Restricted stock and units typically vest annually in equal one-third increments beginning on the first anniversary of the grant. A performance share grant in 2020 represents a three-year award opportunity for the period 2020-2022, and if earned, vests fully (to the extent earned) in the first quarter of 2023. A performance share grant in 2021 represents a three-year award opportunity for the period of 2021-2023 and, if earned, vests fully (to the extent earned) in the first quarter of 2024. A performance share grant in 2022 represents a three-year award opportunity for the period of 2022-2024 and, if earned, vests fully (to the extent earned) in the first quarter of 2025. Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned restricted stock and performance share compensation is amortized to expense, when probable, over the applicable vesting periods. For 2022, 2021, and 2020, total restricted stock, restricted stock unit, and performance share compensation expense was $125.0, $135.4 and $98.1, respectively.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of non-vested shares for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.82&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized Compensation Cost</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $155.3 of total unrecognized compensation cost related to non-vested stock options, restricted stock, restricted stock unit and performance share-based compensation arrangements granted under the Company's stock incentive plans. That cost is expected to be recognized over a weighted average period of 1.9 years and will be included in cost of revenues and selling, general and administrative expenses.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2016 Employee Stock Purchase Plan, the Company is authorized to issue 1.8 shares of common stock. The plan permits substantially all U.S. and Canada employees to purchase a limited number of shares of Company stock at 85% of market value. The Company issues shares to participating employees semi-annually in January and July of each year. Approximately 0.2, 0.2 and 0.3 shares were purchased by eligible employees in 2022, 2021 and 2020, respectively. For 2022, 2021 and 2020, expense related to the Company&#8217;s employee stock purchase plan was $14.8, $14.6 and $10.3, respectively.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to calculate the fair value of the employee&#8217;s purchase right. The fair value of the employee&#8217;s purchase right and the assumptions used in its calculation are as follows:</span></div><div style="margin-bottom:2pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of the employee&#8217;s purchase right</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.89&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.49&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461426928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENT LIABILITIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES <div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes, commercial and contract disputes, professional liability claims, employee-related matters, transaction related disputes, securities and corporate law matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also is named from time to time in suits brought under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these </span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#8220;Contingencies,&#8221; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages, (ii) there is uncertainty as to the outcome of pending appeals or motions, (iii) there are significant factual issues to be resolved, and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the adverse outcomes are probable and estimable, and it does not believe they will have a material adverse effect on the Company's financial statements. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the Southern District of New York unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviewed the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. On August 24, 2021, the U.S. government filed a notice indicating that it did not intend to intervene in the matter. On October 27, 2021, the Fourth Amended Complaint was unsealed. The Fourth Amended Complaint is similar to the Third Amended Complaint in that it alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare and Medicaid business, and it further alleges that the Company unlawfully charged Medicare amounts substantially in excess of its alleged usual charges. Similar to the Third Amended Complaint, the Fourth Amended Complaint alleges violations of the federal False Claims Act and the False Claims Act of 14 states and the District of Columbia. On February 3, 2022, the Company filed a Motion to Dismiss all claims. On August 29, 2022, the Court entered an order granting the Motion to Dismiss and declining to exercise supplemental jurisdiction over the state law claims. Plaintiff did not appeal the Court's order.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On January 26, 2021, the Company was notified that a qui tam Petition was pending under seal in the District Court, 250th Judicial District, Travis County, Texas, and that the State of Texas has intervened. On April 14, 2021, the Petition was unsealed. The Petition alleges that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid&#8217;s alleged &#8220;best price&#8221; regulations, and that the Company offered remuneration to Texas health care providers in the form of discounted pricing for certain laboratory testing services in exchange for the providers&#8217; referral of Texas Medicaid business to the Company. The Petition seeks actual and double damages and civil penalties, as well as recovery of costs, attorney's fees, and legal expenses. On August 1, 2022, the District Court entered an order granting the Company's Motion for Partial Summary Judgment with respect to the claim that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid's alleged &#8220;best price&#8221; regulations. Plaintiffs filed a Notice of Non-Suit and Motion for Entry of Final Judgment and, on November 11, 2022, the Court entered a Judgment. Plaintiffs filed a Notice of Appeal with respect to the Court's order granting the Company's Motion for Partial Summary Judgment, referenced above. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2015, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patty Davis v. Laboratory Corporation of America, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#8217;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#8217;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Florida Second District Court of Appeal reversed the Circuit Court&#8217;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court held oral arguments on December 9, 2020. On May 26, 2022, the Florida Supreme Court issued an opinion approving the result of the Florida Second District Court of Appeal in favor of the Plaintiff. The Company will vigorously defend the lawsuit.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. On March 12, 2021, the Company filed a Motion for Summary Judgment related to all remaining claims. On June 16, 2021, the Court denied the Company&#8217;s Motion for Summary Judgment. In December 2022, the parties reached a settlement to resolve the lawsuit. </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2017, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bouffard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anderson</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. On August 26, 2021, Plaintiffs filed a Motion for Class Certification. On February 13, 2023, the Court entered an order denying Plaintiffs' Motion for Class Certification. On December 29, 2021, a related lawsuit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Nathaniel J. Nolan, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient acknowledgement of estimated financial responsibility form is misleading. The lawsuit seeks a declaratory judgment under the consumer protection laws of Nevada and Florida that the form is materially misleading and deceptive, an injunction barring the use of the form, damages on behalf of an alleged class, and attorney's fees and expenses. On February 28, 2022, the Company filed a Motion to Dismiss all claims. On February 13, 2023, the Court entered an order granting the Company's Motion to Dismiss. The Company will vigorously defend the lawsuits.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-</span></div><div style="margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#8217;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#8217;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#8217;s system was at risk during that time period. Information on AMCA&#8217;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#8217;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for some individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge for 24 months.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits were consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleged that the Company did not adequately protect its patients&#8217; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserted various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint sought damages on behalf of a class of all affected Company customers. On December 16, 2021, the Court granted in part and denied in part the Company's Motion to Dismiss. On March 31, 2022, the Plaintiffs filed an Amended Complaint alleging claims for negligence, negligence </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">per se</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, breach of confidence, invasion of privacy, and various state statutory claims, including a claim under the California Confidentiality of Medical Information Act. The Company filed a Motion to Dismiss certain claims of the Amended Complaint. The Company will vigorously defend the remaining claims in the multi-district litigation.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was served with a shareholder derivative lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#8217;s behalf against the Company&#8217;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#8217;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. On April 26, 2021, the Plaintiffs and the Company each filed Motions for Summary Judgment and the Plaintiffs filed a Motion for Class Certification. On May 23, 2022, the Court entered an order granting Plaintiffs&#8217; Motion for Class Certification. On June 6, 2022, the Company </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed a Petition for Permission to Appeal the Order Granting Class Certification with the Ninth Circuit Court of Appeals. On September 22, 2022, the Ninth Circuit Court of Appeals granted the Company's Petition for Permission to Appeal the Order Granting Class Certification. The Company will vigorously defend the lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2020, Ravgen Inc. filed a patent infringement lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ravgen Inc. v. Laboratory Corporation of America Holdings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the U.S. District Court&#8239;for the Western District of&#8239;Texas, alleging infringement of two Ravgen-owned U.S. patents.  The lawsuit seeks monetary damages, enhancement of those damages for willfulness, and recovery of attorney&#8217;s fees and costs. On September 28, 2022, a jury rendered a verdict in favor of the Plaintiff on the remaining patent at issue, finding that the Company willfully infringed Ravgen's patent, and awarded damages of $272 million. Plaintiff has filed post-trial motions seeking enhanced damages of up to $817 million based on the finding of willfulness, as well as attorney's fees and costs. The Company strongly disagrees with the verdict, based on a number of legal factors, and will vigorously defend the lawsuit through the appeal process. On June 4, 2021, the Company also instituted proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challenging the validity of the Ravgen patent at issue in the trial. In November 2022, the Patent Trial and Appeal Board issued a decision upholding the validity of the Ravgen patent, and the Company has filed an appeal of this decision.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 14, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo I)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jose Bermejo v. Laboratory Corporation of America (Bermejo II), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On October 28, 2020, the court issued an order staying proceedings in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending resolution of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On February 24, 2022, the parties entered into a Memorandum of Understanding of the terms of a settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, subject to court approval. If approved, the settlement will also resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits discussed below.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, a single plaintiff filed a Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Superior Court of California, County of Orange, alleging various violations of the California Labor Code, including that the Plaintiff was not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, and received inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#8217;s fees and costs. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Becker</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 23, 2021, the Company was served with a single plaintiff Private Attorney General Act lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole v. Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Kern, alleging various violations of the California Labor Code, including that Plaintiff was not properly paid wages owed, not properly paid meal and rest break premiums, not reimbursed for certain business related expenses, and other allegations including the untimely payment of wages and receipt of inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney's fees and costs. The case was removed to the U.S. District Court for the Eastern District of California. A settlement of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bermejo II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, if approved by the court, will resolve the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poole</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit.</span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2020, the Company was served with a putative class action lawsuit, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Williams v. LabCorp Employer Services, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. On November 4, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. On June 24, 2021, the District Court remanded the case to the Superior Court of California, County of Los Angeles on the grounds that potential damages did not meet the Class Action Fairness Act (CAFA), 28 U.S.C. &#167; 1332(d), jurisdictional threshold. The parties entered into a settlement agreement dated September 9, 2022, which is pending court approval.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Camden, New Jersey requiring the production of documents related to non-invasive prenatal screening tests. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Boston, Massachusetts requiring the production of documents related to urine drug testing. The Company is cooperating with the DOJ.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various other pending legal proceedings involving the Company including, but not limited to, additional employment-related lawsuits, professional liability lawsuits, and commercial lawsuits. While it is not feasible to predict the outcome of such proceedings, in the opinion of the Company, the likelihood of loss is remote and any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#8217;s financial condition, results of operations, or cash flows, either individually or in the aggregate.</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461522752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">PENSION AND POSTRETIREMENT PLANS</a></td>
<td class="text">PENSION AND POSTRETIREMENT PLANS<div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Contribution Retirement Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has various U.S. defined contribution retirement plans (401K Plans). Under these 401K Plans, employees can contribute a portion of their salary to the plan and the Company makes minimum non-elective contributions, discretionary contributions, and matching contributions, depending on the terms of the specific plan. On January 1, 2021, all of the 401K Plans were modified to provide for 100% match of employee contributions up to 5% of their salary. Total expense, for the years ended December 31, 2022, 2021, and 2020, was $183.1, $168.9 and $141.8, respectively.</span></div><div style="margin-bottom:7pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors both funded and unfunded defined benefit pension plans which provide benefits based on various criteria such as years of service and salary. The Company maintained two plans in the United States, three plans in the United Kingdom and one in Germany.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The two plans in the United States (U.S. Plans) were closed to new entrants and the accrual of service credits at the end of 2009. The U.K. pension plans were closed to new entrants and the accrual of service credits for one plan as of December 31, 2002, and the accrual of service credits for the other two plans as of December 31, 2019. The German plan was closed to new entrants on December 31, 2009 but participants continue to accrue service credits. The U.K. and German plans are aggregated for disclosure as the Non-U.S. Plans.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Costs</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the net periodic benefit costs for the defined benefit pension plans are as follows:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service costs are the only component of net periodic benefit costs recorded within Operating income. For the year ended December&#160;31, 2022, the Company recognized a partial plan settlement charge of $3.0 as a component of Other, net.   </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss in accumulated other comprehensive earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Projected Benefit Obligation</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the projected benefit obligation as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:52.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of the year</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated benefit obligation as of December&#160;31, 2022 and 2021 was $259.5 and $333.3, respectively for the U.S. Plans and $352.6 and $633.8, respectively for the Non-U.S. Plans. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Fair Value of Plan Assets&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in plan assets as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Funded Status and Reconciliation of Amounts Recorded in the Balance Sheet</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the funded status of the plan and a reconciliation of such funded status to the amounts reported in the consolidated balance sheet as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:</span></div><div style="text-align:center;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:282.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assumptions</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit costs are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long term rate of return </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest credit rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $0.8 for the U.S. Plans. A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $2.8 for the Non-U.S. Plans.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit obligations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:65.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using the weighted-average yields on high-quality fixed income securities that have maturities consistent with the timing of benefit payments. Lower discount rates increase the size of the benefit obligation and generally increase pension expense in the following year; higher discount rates reduce the size of the benefit obligation and generally reduce subsequent-year pension expense. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected return on plan assets is the estimated long-term rate of return that will be earned on the investments used to fund the pension obligations. To determine this rate, the Company considers the composition of plan investments, historical returns earned, and expectations about the future. Actual asset over/under performance compared to expected returns will respectively decrease/increase unrecognized loss. The change in the unrecognized loss will change amortization cost in upcoming periods. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $3.0 for the U.S. Plans. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $5.0 for the Non-U.S. Plans.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The salary increase assumptions are used to estimate the annual rate at which pay of plan participants will grow. If the rate of growth assumed increases, the size of the pension obligations will increase, as will the amount recorded in Accumulated other comprehensive income (loss) in the Company's Consolidated Statement of Financial Position and amortized into earnings in subsequent periods. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates other assumptions periodically, such as retirement age, mortality and turnover, and updates them as necessary to reflect the Company's actual experience and expectations for the future. Differences between actual results and assumptions utilized are recorded in Accumulated other comprehensive income each period. These differences are amortized into earnings over the remaining average future service of active participating employees or the expected life of inactive participants, as applicable.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Assets</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the assets at December&#160;31, 2022, and 2021, by asset category are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate index fund</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of index funds and pooled investment funds are valued using the net asset value (NAV) unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund. The fair value of annuity investments are based on discounted cash flow techniques using unobservable valuation inputs such as discount rates and actuarial mortality tables.</span></div><div style="margin-bottom:4pt;margin-top:5pt;text-align:center;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.001%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement of Level 3 Pension Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Investment Policies</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan fiduciaries of various plans set investment policies and strategies, based on consultation with professional advisors, and oversee investment allocation, which includes selecting investment managers and setting long-term strategic targets. The primary strategic investment objectives are balancing investment risk and return and monitoring the plan&#8217;s liquidity position in order to meet the near-term benefit payment and other cash needs. Target allocation percentages are established at an asset class level by plan fiduciaries. Target allocation ranges are guidelines, not limitations, and occasionally plan fiduciaries will approve allocations above or below a target range.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocation of the plan assets as of December&#160;31, 2022, by asset category is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:63.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average target asset allocation of the plan assets is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:60.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Funding and Cash Flows</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to make approximately $18.2 in required contributions to its defined benefit pension plans during 2023. The Company targets funding the minimum required contributions but may make additional contributions into the pension plans in 2023, depending upon factors such as how the funded status of those plans change or to reduce the administrative costs of the plan.</span></div><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated benefit payments, which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U. S. Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 to 2037</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-employment Retiree Health and Welfare Plan</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a post-employment retiree health and welfare plan for the benefit of eligible employees at certain U.S. subsidiaries who retire after satisfying service and age requirements. This plan is funded on a pay-as-you-go basis and the cost of providing these benefits is shared with the retirees.</span></div><div style="margin-bottom:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-retirement Medical Plan</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assumed obligations under a subsidiary's post-retirement medical plan. Coverage under this plan is restricted to a limited number of existing employees of the subsidiary. This plan is unfunded and the Company&#8217;s policy is to fund benefits as claims are incurred. The effect on operations of the post-retirement medical plan is shown in the following table:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-retirement medical plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts included in accumulated other comprehensive earnings consist of unamortized net (income) loss of $(0.2) and $0.8. </span></div><div style="text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the changes in the accumulated post-retirement benefit obligation follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average discount rates used in the calculation of the accumulated post-retirement benefit obligation were 5.5% and 2.7% as of December&#160;31, 2022, and 2021, respectively. The healthcare cost trend rate was removed due to the expectation of future funding to be at the same level as the previous year's funding. </span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumed benefit payments under the Company's post-retirement benefit plan, which reflect expected future service, as appropriate, and which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Deferred Compensation Plan</span></div>The Company has Deferred Compensation Plans (DCP) under which certain of its executives may elect to defer up to 100.0% of their annual cash incentive pay and/or up to 50.0% of their annual base salary and/or eligible commissions subject to annual limits established by the U.S. government. The DCP provides executives a tax efficient strategy for retirement savings and capital accumulation without significant cost to the Company. The Company makes no contributions to the DCP. Amounts deferred by a participant are credited to a bookkeeping account maintained on behalf of each participant, which is used for measurement and determination of amounts to be paid to a participant, or his or her designated beneficiary, pursuant to the terms of the DCP. The amounts accrued under these plans were $96.9 and $104.4 at December&#160;31, 2022, and 2021, respectively. Deferred amounts are the Company's general unsecured obligations and are subject to claims by the Company's creditors. The Company's general assets may be used to fund obligations and pay DCP benefits.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461486336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:75.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.140%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of December&#160;31, 2022, and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:75.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.830%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.140%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurement of Level 3 Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#8217;s consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value. During the year ended December&#160;31, 2022, the carrying value of the noncontrolling interest put decreased by $0.2 for foreign currency translation.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain employees the opportunity to participate in a DCP. A participant's deferrals are allocated by the participant to one or more of 16 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.</span></div>The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $4,973.9 and $5,841.1 as of December&#160;31, 2022, and 2021, respectively. The Company's note and debt instruments are considered Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461419728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</a></td>
<td class="text">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES<div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%. These agreements were designated as hedges against changes in the fair value of a portion of the Company's long-term debt. </span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2013, the Company entered into two fixed-to-variable interest rate swap agreements for the 4.625% Senior Notes due 2020 with an aggregate notional amount of $600.0 and variable interest rates based on one-month LIBOR plus 2.298% to hedge against changes in the fair value of a portion of the Company's long-term debt.&#160;The Company exited the remaining fixed-to-variable interest rate swap agreement in August 2020, in connection with the redemption of the remaining $412.2 of its 4.625% Senior Notes due November 15, 2020, and recorded a gain of $1.6 on the extinguishment. The gain was included in Other, net on the Consolidated Statement of Operations.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cross Currency Swaps</span></div><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2018, the Company entered into U.S. Dollar (USD) to Swiss Franc cross-currency swap agreements with an aggregate notional value of $600.0. During the second quarter of 2022, the Company terminated $300.0 of those cross-currency swap agreements and entered into new USD to Swiss Franc cross-currency swap agreements with an aggregate notional value of $300.0 that mature in 2024. These instruments are designated as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary.   </span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:17.255%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:9pt"><span><br/></span></div><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging relationships:</span></div><div style="margin-bottom:7.1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The Company recognized a gain of $1.6 on the extinguishment of its interest rate swap agreement in the year December 31, 2020 in connection with the redemption of the 4.625% Senior Notes due 2020. No gains or losses from derivative instruments classified as hedging instruments were recognized into income for the year ended December 31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461366528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461280992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">.&#160;&#160;BUSINESS SEGMENT INFORMATIONThe following table is a summary of segment information for the years ended December&#160;31, 2022, 2021, and 2020. The &#8220;management approach&#8221; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing <div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#8217;s chief executive officer has been identified as the CODM. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19 costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability. Segment asset information is not presented because it is not used by the CODM at the segment level. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,363.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,845.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,876.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,120.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,978.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Earnings:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,205.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Geographic Distribution of property, plant and equipment, net:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:503.25pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:63.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466681216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">20.&#160;&#160;SUBSEQUENT EVENTS<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462761728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>Employee</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Financial Statement Presentation</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Financial Statement Presentation</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Corporation of America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Holdings (Labcorp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than 80,000 employees, the Company serves clients in more than 100 countries. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, including information for each of the last three fiscal years regarding revenue, operating income, and other important information, see Note 19 Business Segment Information. In 2022, Dx and DD contributed 61% and 39%, respectively, of revenues to the Company, and in 2021 contributed 64% and 36%, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financial statements.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.&#160;Resulting translation adjustments are included in &#8220;Accumulated other comprehensive income.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock', window );">Reimbursable Out of Pocket Expenses Policy</a></td>
<td class="text">Reimbursable Out-of-Pocket ExpensesDD pays on behalf of its customers certain out-of-pocket costs for which the Company is reimbursed at cost, without mark-up or profit. Out-of-pocket costs paid by DD are reflected in cost of revenues, while the reimbursements received are reflected in revenues in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenues</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Revenues</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes direct labor and related benefit charges, reimbursable expenses, other direct costs, shipping and handling fees, and an allocation of facility charges and information technology costs. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, advertising and promotional expenses, administrative travel and an allocation of facility charges and information technology costs. Cost of advertising is expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Significant estimates include implicit price concessions, revenue estimates, the allowances for doubtful accounts, deferred tax assets, fair values of acquired assets and assumed liabilities in business combinations, fair value of goodwill and indefinite-lived intangible assets, amortization lives for acquired intangible assets, and accruals for self-insurance reserves, litigation reserves and pensions. Actual results could differ from those estimates.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic has and will continue to impact the Company&#8217;s business and financial results depend on numerous evolving factors including, but not limited to the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2022, and through the date of this Annual Report. The accounting matters assessed included, but were not limited to, the Company&#8217;s implicit price </span></div>concessions and credit losses, equity investments, and the carrying value of goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could impact the Company&#8217;s consolidated financial statements in future reporting periods.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ConcentrationOfCreditRiskPolicyTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit Risk<div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents with various major financial institutions. The total cash and cash equivalent balances that exceeded the balances insured by the Federal Deposit Insurance Commission, were approximately $428.1 and $1,471.0 at December&#160;31, 2022, and 2021, respectively. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s accounts receivable are with companies in the healthcare or pharmaceutical industry and individuals. However, concentrations of credit risk are mitigated due to the number of the Company&#8217;s customers as well as their dispersion across many different geographic regions. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although Dx has receivables due from U.S. and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by U.S. and state governments, and payment is primarily dependent upon submitting appropriate documentation. Accounts receivable balances (gross) from Medicare and Medicaid were $85.8 and $94.5 at December&#160;31, 2022, and 2021, respectively.  </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Company's operations in Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (Ministry) determines who can establish a licensed community medical laboratory and caps the amount that each of these licensed laboratories can bill the government sponsored healthcare plan. The Ontario government-sponsored healthcare plan covers the cost of commercial laboratory testing performed by the licensed laboratories. The provincial government discounts the annual testing volumes based on certain utilization discounts and establishes an annual maximum it will pay for all community laboratory tests. The agreed-upon reimbursement rates are subject to Ministry review at the end of year and can be adjusted (at the government's discretion) based upon the actual volume and mix of test work performed by the licensed healthcare providers in the province during the year. There were no capitated accounts receivable balances from the Ontario government sponsored healthcare plan at December&#160;31, 2022. The balance was CAD 7.2 at December&#160;31, 2021.</span></div>The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.&#160;At December&#160;31, 2022, and 2021, receivables due from patients represented approximately 15.3% and 16.7% of the Company's consolidated gross accounts receivable, respectively.&#160;The Company applies assumptions and judgments including historical collection experience and reasonable and supportable forecasts for assessing collectability and determining allowances for doubtful accounts for accounts receivable from patients.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.60&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.99&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.97&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.39&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.88&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock', window );">Stock Compensation Plans</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Compensation Plans</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units is determined based on the number of shares granted and the quoted price of the Company&#8217;s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and the Company's determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and the Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 13 Stock Compensation Plans for assumptions used in calculating compensation expense for the Company&#8217;s stock compensation plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">Cash EquivalentsCash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits, and other money market instruments, which have maturities when purchased of three months or less.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Supplies InventoryInventories, consisting primarily of purchased laboratory and customer supplies and finished goods, are stated at the lower of cost (first-in, first-out) or net realizable value. Supplies accounted for $412.8 and $371.5 and finished goods accounted for $57.8 and $29.9 of total inventory at December&#160;31, 2022, and 2021, respectively. The Company's inventory reserve balance was $23.3 and $40.1, as of December&#160;31, 2022 and 2021, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property, Plant and Equipment</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are recorded at cost. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using the straight-line method.</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:89.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations.</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_InternalUseSoftwarePolicyTextBlock', window );">Capitalized Software Costs</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capitalized Software Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes purchased software that is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and the Company commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development (R&amp;D) costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system ranging from three to </span></div>fifteen years, generally five years. Amortization begins once the underlying system is substantially complete and ready for its intended use.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IntangibleAssetsFiniteLivedPolicyTextBlock', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:468.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:15.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Issuance Costs</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs related to the issuance of debt are capitalized, netted against the related debt for presentation purposes and amortized to interest expense over the terms of the related debt.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ProfessionalLiabilityPolicyTextBlock', window );">Professional Liability</a></td>
<td class="text">Professional LiabilityThe Company is self-insured (up to certain limits) for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is based on assumptions and factors for known and incurred but not reported claims, including the frequency and payment trends of historical claims.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Income Taxes</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.&#160;If the recognition threshold is met, the Company recognizes a tax benefit </span></div>measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized. The Company records interest and penalties in income tax expense.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeTaxBenefitMinimumCertaintyPercentage', window );">Minimum threshold percentage required to recognize income tax benefit (in hundredths)</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments. The Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company&#8217;s financial position or results of operations.</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swap agreements, which have been used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative financial instruments are accounted for as fair value hedges that increase or decrease the value of the Senior Notes with the offset being recorded as a component of other long-term assets or liabilities, as applicable. As the specific terms and notional amounts of the derivative financial instruments match those of the fixed-rate debt being hedged, the derivative instruments are assumed to be perfectly effective hedges and accordingly, there is no impact to the Company's consolidated statements of operations. Cash flows from the interest rate swaps are including in operating activities.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross currency swap agreements, which have been used by the Company to hedge the foreign currency exposure of its net investment in a foreign subsidiary denominated in non-U.S. currency, are accounted for at fair value. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statements of Comprehensive Earnings.</span></div>Foreign currency forward contracts, which have been used by the Company to hedge foreign currency receivables, are recognized as assets or liabilities at their fair value. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The fair value of these contracts is not significant as of December&#160;31, 2022 and 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements for financial assets and liabilities are determined based on the assumptions that a market participant would use in pricing an asset or liability. A three-tiered fair value hierarchy draws distinctions between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2), and (iii) unobservable inputs that require the Company to use present value and other valuation techniques in the determination of fair value (Level 3).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityNumberOfEmployees', window );">Entity Number of Employees</a></td>
<td class="nump">80,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses R&amp;D costs as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Lessee, Leases</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Leases</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All leases with a lease term greater than 12 months, regardless of lease type classification, are recorded as an obligation on the balance sheet with a corresponding right-of-use asset. Both finance and operating leases are reflected as liabilities on the commencement date of the lease based on the present value of the lease payments to be made over the lease term. Right-of-use assets are valued at the initial measurement of the lease liability, plus any initial direct costs or rent prepayments, minus lease incentives and any deferred lease payments. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A certain number of these leases contain rent escalation clauses either fixed or adjusted periodically for inflation or market rates that are factored into the Company's determination of lease payments. The Company also has variable lease payments that do not depend on a rate or index, for items such as volume purchase commitments, which are recorded as variable cost when incurred. As most of the Company's leases do not provide an implicit rate, the Company estimates an incremental borrowing rate based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company uses this rate to discount payments to present value. Some operating leases contain renewal options, some of which also include options to early terminate the leases. The exercise of these options is at the Company's discretion and the Company evaluates each renewal option to determine if it is reasonably possible to be exercised and should be included in the accounting lease term. See Note 5 Leases to the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill and Intangible Assets, Goodwill, Policy</a></td>
<td class="text"><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. </span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#8217;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.</span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. </span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.</span></div><div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.</span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years </span></div>vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions and Translations Policy</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currencies</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries outside of the U.S. that operate in a local currency environment, income and expense items are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders&#8217; equity in the consolidated balance sheets and are included in the determination of comprehensive income in the consolidated statements of comprehensive earnings and consolidated statements of changes in shareholders&#8217; equity. Transaction gains and losses are included in the determination of net income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityNumberOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of persons employed by the Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityNumberOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ConcentrationOfCreditRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the company's credit risk accounting policy with respect to financial instruments. An entity shall disclose its policy for including whether the entity's cash and cash equivalents are insured or expose the entity to credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ConcentrationOfCreditRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeTaxBenefitMinimumCertaintyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For tax positions that are more likely than not to be sustained on audit by the taxing authority, the entity recognizes the largest amount of tax benefit that it believes exceeds a minimum likelihood of being recognized. This element represents the minimum percentage of likelihood that a tax benefit will be realized that the entity uses to assess if a benefit should be recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeTaxBenefitMinimumCertaintyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IntangibleAssetsFiniteLivedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for finite-lived intangible assets. This accounting policy also may address: (1) the amortization method used (2) the useful lives of such assets (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IntangibleAssetsFiniteLivedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_InternalUseSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_InternalUseSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ProfessionalLiabilityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for self-insurance of professional liability claims, which may include policies for calculating a liability amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ProfessionalLiabilityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reimbursable Out of Pocket Expenses Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an entity's accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463730064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic earnings per Share to Diluted Earnings per Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.60&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.99&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.97&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.39&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.88&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential common shares not included in computation of diluted earnings per share</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:89.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.411%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:468.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:7.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:15.25pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466485264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The Company's revenue by segment payers/customer groups for the years ended December&#160;31, 2022, 2021 and 2020 is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"/><td style="width:94.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:34.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:33.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0pt"/><td style="width:33.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:28.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2022</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2021</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Year Ended <br/>December 31, 2020</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">North America</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payer/Customer</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Clients</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Patients</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Medicare and Medicaid</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Third party</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Total Dx revenues by payer</span></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies</span></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostTableTextBlock', window );">Capitalized Contract Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:331.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:85.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales commission assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract fulfillment costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Contract Asset, Contract Liability, and Receivable</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:325.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:88.00pt"/><td style="width:1.0pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less DD allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,222.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross unbilled services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less reserve for unbilled services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled services</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">795.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461588768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS &amp; DISPOSITIONS Business Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock', window );">Business Current Year Acquisition ProForma Information Table Text Block</a></td>
<td class="text"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information for 2021 Acquisitions</span></div><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Had the aggregate of the Company's 2021 acquisitions been completed as of January 1, 2020, the Company's pro forma results would have been as follows:</span><span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:70.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.273%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,216.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,112.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Laboratory Corporation of America Holdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,378.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Current Year ProForma Information Table Text Block</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461592608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Related Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserves</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company&#8217;s restructuring activities for the period indicated:</span></div><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:38.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.719%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and Other<br/>Employee Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and Other<br/>Facility Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of prior restructuring accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501454356432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.469%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.471%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total maturities, due beyond one year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:63.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.133%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f">Operating lease ROU assets (included in Property, plant and equipment, net)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a">Finance lease ROU assets (included in Other assets)</span></span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LeaseDisclosureTableTextBlockTableTextBlock', window );">Lease Disclosure Table Text Block</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.006%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-top:2pt;padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.908%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Year Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(225.9)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LeaseDisclosureTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Disclosure Table Text Block</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LeaseDisclosureTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461512208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment, net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">954.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,893.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease ROU assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,679.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,228.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,722.8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,413.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501467376912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Carrying Amount of Goodwill</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amount of goodwill (net of impairment) for the years ended December&#160;31, 2022 and 2021 are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:35.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,046.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,751.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency impact and other adjustments to goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,533.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,046.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,587.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,912.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,121.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,958.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Components of identifiable intangible assets</a></td>
<td class="text"><div style="margin-top:2pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of identifiable intangible assets are as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.435%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,546.4)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,134.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,362.1)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,973.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canadian licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,946.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,423.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,688.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,735.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Acquired amortizable intangible assets and their respective weighted average amortization periods</a></td>
<td class="text"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of amortizable intangible assets acquired during 2022, and their respective weighted average amortization periods are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.254%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average<br/>Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents, licenses and technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461552128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accrued expenses and other</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pass through expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466319840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled payments of long-term debt at the end of 2022 are summarized as follows:</span></div><div style="margin-bottom:7pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:82.331%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total scheduled payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373.9&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less long-term debt issuance costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,340.1&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(301.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, due beyond one year</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Short-term borrowings and current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term borrowings and current portion of long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term borrowings and current portion of long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55% senior notes due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% senior notes due 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.00% senior notes due 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30% senior notes due 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25% senior notes due 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55% senior notes due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.60% senior notes due 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.95% senior notes due 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% senior notes due 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.70% senior notes due 2045</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Note payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461349488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Common shares issued and outstanding [Text Block]</a></td>
<td class="text">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of December&#160;31, 2022 and 2021.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock', window );">Changes in common shares issued and held in treasury [Text Block]</a></td>
<td class="text"><div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in common shares issued and held in treasury are summarized below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Earnings Components [Text Block]</a></td>
<td class="text"><div style="margin-bottom:7pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:59.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.559%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net<br/>Benefit<br/>Plan<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Earnings</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.3)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140.6)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.9)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125.9)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.0)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191.9)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year adjustments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlement charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive earnings (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(493.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule is used to show the changes in common shares issued and held in treasury by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459722176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance [Table Text Block]</a></td>
<td class="text"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a rollforward of the valuation allowance:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions charged to expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions and other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sources of income before taxes, classified between domestic and foreign entities, are as follows:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,580.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pre-tax income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,582.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,126.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of  income tax expense attributable to continuing operations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current tax expense:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.8&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax expense/(benefit):</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.0)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.0)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">The effective tax rates on earnings before income taxes are reconciled to statutory U.S. income tax rates as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of U.S. federal income tax effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign earnings taxed at lower rates than the statutory U.S. rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"><tr><td style="width:1.0%"/><td style="width:61.834%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and restructuring reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized R&amp;D costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;      Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(151.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net of valuation allowance</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(811.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax liabilities</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,259.7)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182.2)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(661.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(691.3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock', window );">Reconciliation of Unrecognized Tax Benefits from Uncertain Tax Positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a reconciliation of the unrecognized income tax benefits, excluding interest and penalties, from uncertain tax positions for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:3pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve for tax positions taken in the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in reserve from an acquisition's opening balance sheet</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in reserve as a result of lapses in the statute of limitations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459246480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share Based Compensation Arrangements by Share Based Payment Awards</a></td>
<td class="text">hanges in options outstanding under the plans for the period indicated were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:41.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.493%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169.03&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock', window );">Disclosure of the Impact of Stock Options Exercised</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received by the Company from option exercises, the actual tax benefit realized for the tax deductions and the aggregate intrinsic value of options exercised from option exercises under all share-based payment arrangements during the years ended December&#160;31, 2022, 2021, and 2020 were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received by the Company</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefits realized</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</a></td>
<td class="text"><div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value per option</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life (in years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes model to calculate the fair value of the employee&#8217;s purchase right. The fair value of the employee&#8217;s purchase right and the assumptions used in its calculation are as follows:</span></div><div style="margin-bottom:2pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:64.492%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of the employee&#8217;s purchase right</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.89&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.49&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Share Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of non-vested shares for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at January 1, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.83&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.82&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the financial impact of select activity related to the exercise of stock options. This activity includes cash received from option exercises, the corresponding tax benefits realized, and the aggregate intrinsic value of options exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459738288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract', window );"><strong>Defined Benefit Plan, Plan Amendment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost for benefits earned</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected participant contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined-benefit plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:9pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service costs are the only component of net periodic benefit costs recorded within Operating income. For the year ended December&#160;31, 2022, the Company recognized a partial plan settlement charge of $3.0 as a component of Other, net.   </span></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in accumulated other comprehensive earnings are as follows:</span></div><div style="margin-bottom:2pt;margin-top:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.632%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial loss in accumulated other comprehensive earnings</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:52.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.964%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of the year</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333.3&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633.8&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated benefit payments, which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U. S. Plans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 to 2037</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The effect on operations of the post-retirement medical plan is shown in the following table:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net amortization and deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-retirement medical plan costs</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the changes in the accumulated post-retirement benefit obligation follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost on benefit obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued expenses and other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at beginning of the year</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company contributions </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits and administrative expenses paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate changes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock', window );">Schedule of Net Funded Status [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:282.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recorded as:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.6</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Defined Benefit Plan, Assumptions [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit costs are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.192%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long term rate of return </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash balance interest credit rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average assumptions used to determine net periodic benefit obligations are as follows:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:65.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.740%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U. S. Plans</span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average asset allocation of the plan assets as of December&#160;31, 2022, by asset category is as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:63.760%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.448%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. Plans</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average target asset allocation of the plan assets is as follows:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:60.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.043%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0%</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">to</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock', window );">Defined Benefit Plan Fair Value Of Plan Assets By Category [Table Text Block]</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the assets at December&#160;31, 2022, and 2021, by asset category are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.9&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset Category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level of Valuation Input</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments valued using NAV per share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">U.S Plans</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equity index funds </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equity index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate index fund</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General bond index funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non U.S. Plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pooled investment funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair market value of index funds and pooled investment funds are valued using the net asset value (NAV) unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund. The fair value of annuity investments are based on discounted cash flow techniques using unobservable valuation inputs such as discount rates and actuarial mortality tables.</span></div><div style="margin-bottom:4pt;margin-top:5pt;text-align:center;text-indent:15.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.001%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value Measurement of Level 3 Pension Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annuities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AssumedBenefitPaymentsByYearTableTextBlock', window );">Assumed Benefit Payments By Year [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumed benefit payments under the Company's post-retirement benefit plan, which reflect expected future service, as appropriate, and which were used in the calculation of projected benefit obligations, are expected to be paid as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years 2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AssumedBenefitPaymentsByYearTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A schedule of assumed benefit payments for future periods by year. This element may be used for defined benefit, nonqualified supplemental retirement, and post-retirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AssumedBenefitPaymentsByYearTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A schedule of plan assets at fair value by asset category.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetFundedStatusTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetFundedStatusTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461549808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Population of Financial Assets and Liabilities Subject to Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s population of financial assets and liabilities subject to fair value measurements as of December&#160;31, 2022, and 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.235%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.688%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other; Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.290%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Measurements as of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value as of December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Using Fair Value Hierarchy</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest put</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461532128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</a></td>
<td class="text"><div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:17.255%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.317%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.095%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value of Derivative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liability</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar Notional</span></td></tr><tr><td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, net/Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging relationships:</span></div><div style="margin-bottom:7.1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.703%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount included in other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to the <br/>Statement of Operations</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross currency swaps</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501461500816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:65.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental schedule of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosure of non-cash financing and investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in accrued property, plant and equipment </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462641152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,363.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,710.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,845.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,877.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intercompany eliminations and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,876.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,120.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,978.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Earnings:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,205.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD segment operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and unallocated expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(299.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and other charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill and other asset impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,773.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,445.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  Geographic Distribution of property, plant and equipment, net:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:503.25pt"><tr><td style="width:1.0pt"/><td style="width:322.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730.0&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,399.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,669.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956.2&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:63.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.781%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dx</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DD</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670.2&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177.5&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,507.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,308.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815.4&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462810144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 260,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan', window );">Accounts receivable from Ontario government sponsored healthcare plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory Valuation Reserves</a></td>
<td class="nump">23,300,000<span></span>
</td>
<td class="nump">40,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid', window );">Accounts receivable balances (gross) from Medicare and Medicaid</a></td>
<td class="nump">$ 85,800,000<span></span>
</td>
<td class="nump">94,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage', window );">Ownership percentage below which investments are generally accounted for on the cost method (in hundredths)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, Uninsured Amount</a></td>
<td class="nump">$ 428,100,000<span></span>
</td>
<td class="nump">$ 1,471,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeTaxBenefitMinimumCertaintyPercentage', window );">Minimum threshold percentage required to recognize income tax benefit (in hundredths)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Percentofgrossaccountsreceivableduefrompatients', window );">Percent of gross accounts receivable due from patients</a></td>
<td class="nump">15.30%<span></span>
</td>
<td class="nump">16.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Inventory, Finished Goods, Gross</a></td>
<td class="nump">$ 57,800,000<span></span>
</td>
<td class="nump">$ 29,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Other Inventory, Supplies, Gross</a></td>
<td class="nump">412,800,000<span></span>
</td>
<td class="nump">371,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="nump">271,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 462,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,121,000,000<span></span>
</td>
<td class="nump">$ 7,958,900,000<span></span>
</td>
<td class="nump">$ 7,751,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings per Share</span></div><div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#8217;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.654%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Per Share<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic earnings per share</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.05&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.60&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.99&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options and stock awards</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,279.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.97&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,377.3&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.5&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.39&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,556.1&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.88&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.272%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities', window );">Stock Options (in shares)</a></td>
<td class="text">0.2<span></span>
</td>
<td class="text">0.1<span></span>
</td>
<td class="text">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Increase (Decrease) in Deferred Liabilities</a></td>
<td class="num">$ (18,300,000)<span></span>
</td>
<td class="nump">$ 75,900,000<span></span>
</td>
<td class="nump">$ 47,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from Ontario government sponsored healthcare plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross receivable balance due from Medicare and Medicaid programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CostMethodInvestmentsMaximumOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CostMethodInvestmentsMaximumOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeTaxBenefitMinimumCertaintyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For tax positions that are more likely than not to be sustained on audit by the taxing authority, the entity recognizes the largest amount of tax benefit that it believes exceeds a minimum likelihood of being recognized. This element represents the minimum percentage of likelihood that a tax benefit will be realized that the entity uses to assess if a benefit should be recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeTaxBenefitMinimumCertaintyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Percentofgrossaccountsreceivableduefrompatients">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of gross accounts receivable due from patients</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Percentofgrossaccountsreceivableduefrompatients</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePotentiallyDilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would have been antidilutive for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePotentiallyDilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501454118512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SalesCommissionAmortizationPeriodMinimum', window );">Sales Commission Amortization Period Minimum</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SalesCommissionAmortizationPeriodMaximum', window );">Sales Commission Amortization Period Maximum</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 14,876,800,000<span></span>
</td>
<td class="nump">$ 16,120,900,000<span></span>
</td>
<td class="nump">$ 13,978,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentOfDomesticRevenue', window );">Percent of Domestic Revenue</a></td>
<td class="nump">77.50%<span></span>
</td>
<td class="nump">77.90%<span></span>
</td>
<td class="nump">80.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredSalesCommissions', window );">Amortization of Deferred Sales Commissions</a></td>
<td class="nump">$ 33,900,000<span></span>
</td>
<td class="nump">$ 27,500,000<span></span>
</td>
<td class="nump">$ 23,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent', window );">Accrued Sales Commission</a></td>
<td class="nump">38,200,000<span></span>
</td>
<td class="nump">36,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized Contract Cost, Net</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts', window );">Amount of Deferred Costs Related to Long-term Contracts</a></td>
<td class="nump">53,200,000<span></span>
</td>
<td class="nump">50,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Capitalized Contract Cost, Amortization</a></td>
<td class="nump">12,400,000<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract with Customer, Asset, before Allowance for Credit Loss</a></td>
<td class="nump">805,900,000<span></span>
</td>
<td class="nump">730,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for Credit Loss, Receivable, Other, Current</a></td>
<td class="num">(10,500,000)<span></span>
</td>
<td class="num">(14,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract with Customer, Asset, after Allowance for Credit Loss, Current</a></td>
<td class="nump">795,400,000<span></span>
</td>
<td class="nump">716,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">582,100,000<span></span>
</td>
<td class="nump">558,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueRevenueRecognized1', window );">Deferred Revenue, Revenue Recognized</a></td>
<td class="nump">330,500,000<span></span>
</td>
<td class="nump">319,400,000<span></span>
</td>
<td class="nump">262,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 5,122,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear', window );">Percent of remaining performance obligations recognized as revenue in next year</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LongTermContractsDurationMinimum', window );">Long Term Contracts Duration Minimum</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LongTermContractsDurationMaximum', window );">Long Term Contracts Duration Maximum</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">$ 73,000,000.0<span></span>
</td>
<td class="nump">69,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">43,500,000<span></span>
</td>
<td class="nump">21,500,000<span></span>
</td>
<td class="nump">22,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_UnbilledServicesAllowanceforCreditLoss', window );">Unbilled Services, Allowance for Credit Loss</a></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NoteReceivableAllowanceforCreditLoss', window );">Note Receivable, Allowance for Credit Loss</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">54,700,000<span></span>
</td>
<td class="nump">36,100,000<span></span>
</td>
<td class="nump">39,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Accounts Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="nump">15,100,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_UnbilledServicesCreditLossExpenseReversal', window );">Unbilled Services, Credit Loss Expense (Reversal)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NoteReceivableCreditLossExpenseReversal', window );">Note Receivable, Credit Loss Expense (Reversal)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditLossExpenseReversal', window );">Credit Loss Expense (Reversal)</a></td>
<td class="nump">15,100,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">Geographic Distribution, Domestic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 11,530,500,000<span></span>
</td>
<td class="nump">$ 12,566,200,000<span></span>
</td>
<td class="nump">$ 11,192,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember', window );">Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | Europe [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | North America | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | Other countries [Member] | Biopharmaceutical and medical device companies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Europe [Member] | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America | Self-Pay [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | North America | Client [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member] | Third party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Other countries [Member] | Medicare and Medicaid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_PercentofRevenueContributed', window );">Percent of Revenue Contributed</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized Contract Cost, Amortization Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">$ 6,900,000<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember', window );">Unbilled Contracts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AllowanceforCreditLossWriteOff', window );">Allowance for Credit Loss, Write Off</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AllowanceforCreditLossWriteOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Allowance for Credit Loss, Write Off</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AllowanceforCreditLossWriteOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermContractsDurationMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Contracts Duration Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermContractsDurationMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoteReceivableAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoteReceivableAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NoteReceivableCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Note Receivable, Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NoteReceivableCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentOfDomesticRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Domestic Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentOfDomesticRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_PercentofRevenueContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of Revenue Contributed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_PercentofRevenueContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percent of remaining performance obligations recognized as revenue in next year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SalesCommissionAmortizationPeriodMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Commission Amortization Period Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SalesCommissionAmortizationPeriodMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SalesCommissionAmortizationPeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales Commission Amortization Period Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SalesCommissionAmortizationPeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnbilledServicesAllowanceforCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Services, Allowance for Credit Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnbilledServicesAllowanceforCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnbilledServicesCreditLossExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled Services, Credit Loss Expense (Reversal)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnbilledServicesCreditLossExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredSalesCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredSalesCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(d)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueRevenueRecognized1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously reported as deferred or unearned revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueRevenueRecognized1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_MedicareandMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lh_OthercountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lh_OthercountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_BiopharmaceuticalandmedicaldevicecompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ThirdpartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SelfPayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=lh_ClientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=lh_UnbilledContractsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462811024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Receivables, Loans, Notes Receivable, and Others (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.753%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accounts Receivable</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unbilled Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Note and Other Receivables</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2020</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses as of December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit loss expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write offs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending allowance for credit losses as of December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="num">$ (43.5)<span></span>
</td>
<td class="num">$ (21.5)<span></span>
</td>
<td class="num">$ (22.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract with Customer, Asset, before Allowance for Credit Loss</a></td>
<td class="nump">805.9<span></span>
</td>
<td class="nump">730.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent', window );">Allowance for Credit Loss, Receivable, Other, Current</a></td>
<td class="num">(10.5)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">582.1<span></span>
</td>
<td class="nump">558.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts Receivable, before Allowance for Credit Loss</a></td>
<td class="nump">1,046.9<span></span>
</td>
<td class="nump">1,193.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts Receivable, before Allowance for Credit Loss</a></td>
<td class="nump">$ 1,218.6<span></span>
</td>
<td class="nump">$ 1,089.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on receivable, classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451994304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 19, 2014</div></th>
<th class="th"><div>Mar. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">$ 27,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">94,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">5,038,800,000<span></span>
</td>
<td class="nump">$ 5,416,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">14,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">72,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">1,258,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">1,164,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">53,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">32,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments', window );">Goodwill, Acquired During Period, net of measurement period adjustments</a></td>
<td class="nump">558,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">572,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">16 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">$ 8,121,000,000<span></span>
</td>
<td class="nump">7,958,900,000<span></span>
</td>
<td class="nump">$ 7,751,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">1,164,000,000<span></span>
</td>
<td class="nump">496,900,000<span></span>
</td>
<td class="nump">267,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">542,300,000<span></span>
</td>
<td class="nump">198,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">598,500,000<span></span>
</td>
<td class="nump">298,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">14,876,800,000<span></span>
</td>
<td class="nump">16,120,900,000<span></span>
</td>
<td class="nump">13,978,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,773,900,000<span></span>
</td>
<td class="nump">3,259,500,000<span></span>
</td>
<td class="nump">2,445,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_ExcludingEnvigoMember', window );">Excluding Envigo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,400,000<span></span>
</td>
<td class="nump">166,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,200,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="nump">75,200,000<span></span>
</td>
<td class="nump">28,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,900,000<span></span>
</td>
<td class="nump">267,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">15,400,000<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">300,600,000<span></span>
</td>
<td class="nump">572,100,000<span></span>
</td>
<td class="nump">296,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">285,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">56,600,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="num">(1,300,000)<span></span>
</td>
<td class="num">(10,800,000)<span></span>
</td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,200,000)<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">172,500,000<span></span>
</td>
<td class="nump">198,500,000<span></span>
</td>
<td class="nump">121,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">542,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">126,700,000<span></span>
</td>
<td class="nump">298,400,000<span></span>
</td>
<td class="nump">166,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_A2021AcquisitionsMember', window );">2021 acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">14,997,600,000<span></span>
</td>
<td class="nump">16,310,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="nump">1,282,400,000<span></span>
</td>
<td class="nump">2,362,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember', window );">2020 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,216,600,000<span></span>
</td>
<td class="nump">14,112,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,378,300,000<span></span>
</td>
<td class="nump">$ 1,554,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_AscensionAcquisitionMember', window );">Ascension Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">426,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">423,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">43,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">233,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">125,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_MeasurementPeriodAdjustmentsMember', window );">Measurement Period Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="num">(2,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="num">(2,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="num">(2,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">30,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="num">(2,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="num">(40,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_PGDxMember', window );">PGDx</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">79,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="nump">14,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">57,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">534,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">455,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">17,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="num">(4,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="num">(2,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">136,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">$ 346,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets | Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements [Member] | Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">18 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 408,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Acquired During Period, net of measurement period adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_ExcludingEnvigoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_ExcludingEnvigoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_A2021AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_A2021AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_AscensionAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_AscensionAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_MeasurementPeriodAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_MeasurementPeriodAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_PGDxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_PGDxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459824832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS &amp; DISPOSITIONS DISPOSITIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">$ 1,164,000<span></span>
</td>
<td class="nump">$ 496,900<span></span>
</td>
<td class="nump">$ 267,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">542,300<span></span>
</td>
<td class="nump">198,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">598,500<span></span>
</td>
<td class="nump">298,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">27,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">572,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">1,258,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">72,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">598,500<span></span>
</td>
<td class="nump">298,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">94,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="nump">18,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember', window );">2020 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,216,600<span></span>
</td>
<td class="nump">14,112,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,216,600<span></span>
</td>
<td class="nump">14,112,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,378,300<span></span>
</td>
<td class="nump">1,554,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_A2019AcquisitionsMember', window );">2019 Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,032,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,032,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,564,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">542,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">126,700<span></span>
</td>
<td class="nump">298,400<span></span>
</td>
<td class="nump">166,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">10,800<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">56,600<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">172,500<span></span>
</td>
<td class="nump">198,500<span></span>
</td>
<td class="nump">121,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">300,600<span></span>
</td>
<td class="nump">572,100<span></span>
</td>
<td class="nump">296,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="nump">22,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,600<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,200<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">126,700<span></span>
</td>
<td class="nump">298,400<span></span>
</td>
<td class="nump">166,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">$ 15,400<span></span>
</td>
<td class="nump">75,200<span></span>
</td>
<td class="nump">28,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496,900<span></span>
</td>
<td class="nump">$ 267,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_A2020AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_A2019AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_A2019AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463965744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS &amp; DISPOSITIONS Envigo (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">$ 1,773.9<span></span>
</td>
<td class="nump">$ 3,259.5<span></span>
</td>
<td class="nump">$ 2,445.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">27.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">1,164.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="nump">1,164.0<span></span>
</td>
<td class="nump">496.9<span></span>
</td>
<td class="nump">267.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">53.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">572.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">1,258.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">72.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">$ 94.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">16 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember', window );">Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</a></td>
<td class="nump">285.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">56.6<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">172.5<span></span>
</td>
<td class="nump">198.5<span></span>
</td>
<td class="nump">121.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</a></td>
<td class="nump">300.6<span></span>
</td>
<td class="nump">572.1<span></span>
</td>
<td class="nump">296.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</a></td>
<td class="nump">15.4<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.2<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</a></td>
<td class="nump">$ 15.4<span></span>
</td>
<td class="nump">75.2<span></span>
</td>
<td class="nump">28.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 496.9<span></span>
</td>
<td class="nump">$ 267.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Other acquirees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">18 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lh_OtheracquireesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451940672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Related Activities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover', window );">Number of years restructuring liabilities expected to be paid out over</a></td>
<td class="text">10 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="nump">$ 83.8<span></span>
</td>
<td class="nump">$ 43.1<span></span>
</td>
<td class="nump">$ 40.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Restructuring charges related to severance and other employee costs</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment', window );">Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FacilityRelatedRestructuringReserveAccrualAdjustment', window );">Facility Related Restructuring Reserve Accrual Adjustment</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">18.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring Reserve, Current</a></td>
<td class="nump">7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveNoncurrent', window );">Restructuring Reserve, Noncurrent</a></td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">85.0<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="num">(73.8)<span></span>
</td>
<td class="num">(42.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="nump">83.8<span></span>
</td>
<td class="nump">43.1<span></span>
</td>
<td class="nump">40.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Restructuring charges related to severance and other employee costs</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring Costs and Asset Impairment Charges</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">73.8<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">85.0<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member] | LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="num">(39.3)<span></span>
</td>
<td class="num">(14.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">39.3<span></span>
</td>
<td class="nump">16.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member] | LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">45.7<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">28.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Restructuring Reserve, Accrual Adjustment</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="num">(34.5)<span></span>
</td>
<td class="num">(28.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">$ 45.7<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FacilityRelatedRestructuringReserveAccrualAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for facility related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FacilityRelatedRestructuringReserveAccrualAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of years restructuring liabilities expected to be paid out over</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph 210-10-S99-1(SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463893536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lessee, Operating Lease, Renewal Term</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeasePayment', window );">Variable Lease, Payment</a></td>
<td class="nump">$ 27,900,000<span></span>
</td>
<td class="nump">$ 28,400,000<span></span>
</td>
<td class="nump">$ 26,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=lh_ShortTermLeaseMember', window );">Short term lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,500,000<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=lh_ShortTermLeaseMember', window );">Short term lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating Lease, Expense</a></td>
<td class="nump">$ 22,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeasePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for variable lease payment excluded from lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeasePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=lh_ShortTermLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=lh_ShortTermLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=lh_ShortTermLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=lh_ShortTermLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501462688160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 220.0<span></span>
</td>
<td class="nump">$ 220.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 13.2<span></span>
</td>
<td class="nump">$ 14.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466846320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flow (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="num">$ (225,900,000)<span></span>
</td>
<td class="num">$ (219,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="num">(5,200,000)<span></span>
</td>
<td class="num">(5,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="num">(12,300,000)<span></span>
</td>
<td class="num">(13,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">178,200,000<span></span>
</td>
<td class="nump">164,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459812384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Supplemental Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 773.6<span></span>
</td>
<td class="nump">$ 746.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">185.5<span></span>
</td>
<td class="nump">187.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">679.7<span></span>
</td>
<td class="nump">642.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">865.2<span></span>
</td>
<td class="nump">829.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">81.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">10.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">83.6<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 89.6<span></span>
</td>
<td class="nump">$ 95.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">15 years 7 months 6 days<span></span>
</td>
<td class="text">15 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property, plant and equipment, net<span></span>
</td>
<td class="text">Property, plant and equipment, net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets, net<span></span>
</td>
<td class="text">Other assets, net<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501464052368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Maturity of Leases (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 213.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">2024</a></td>
<td class="nump">160.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">2025</a></td>
<td class="nump">119.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">2026</a></td>
<td class="nump">89.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive', window );">2027</a></td>
<td class="nump">72.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">369.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">1,024.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(159.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current portion</a></td>
<td class="num">(185.5)<span></span>
</td>
<td class="num">$ (187.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">679.7<span></span>
</td>
<td class="nump">642.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance Lease Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">9.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">85.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">129.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(39.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less current portion</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Total maturities, due beyond one year</a></td>
<td class="nump">$ 83.6<span></span>
</td>
<td class="nump">$ 84.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501454446784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation, Depletion and Amortization</a></td>
<td class="nump">$ 633,900,000<span></span>
</td>
<td class="nump">$ 745,100,000<span></span>
</td>
<td class="nump">$ 624,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">5,679,000,000<span></span>
</td>
<td class="nump">5,228,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(2,722,800,000)<span></span>
</td>
<td class="num">(2,413,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,956,200,000<span></span>
</td>
<td class="nump">2,815,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SoftwareDepreciation', window );">Software depreciation</a></td>
<td class="nump">84,200,000<span></span>
</td>
<td class="nump">82,400,000<span></span>
</td>
<td class="nump">84,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property, Plant and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation, Depletion and Amortization</a></td>
<td class="nump">374,600,000<span></span>
</td>
<td class="nump">375,600,000<span></span>
</td>
<td class="nump">$ 349,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">99,200,000<span></span>
</td>
<td class="nump">101,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and building improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">1,023,700,000<span></span>
</td>
<td class="nump">954,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">1,893,200,000<span></span>
</td>
<td class="nump">1,670,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">906,300,000<span></span>
</td>
<td class="nump">840,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">514,000,000.0<span></span>
</td>
<td class="nump">459,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">118,200,000<span></span>
</td>
<td class="nump">111,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">350,800,000<span></span>
</td>
<td class="nump">344,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember', window );">Equipment under capital leases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract', window );"><strong>Property, plant and equipment, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">$ 773,600,000<span></span>
</td>
<td class="nump">$ 746,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SoftwareDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation recognized in the current period that reflects the allocation of the cost of software related assets over the assets' useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SoftwareDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451983664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 259,300,000<span></span>
</td>
<td class="nump">$ 369,600,000<span></span>
</td>
<td class="nump">$ 275,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</a></td>
<td class="nump">68,300,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated amortization expense, 2013</a></td>
<td class="nump">273,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated amortization expense, 2014</a></td>
<td class="nump">268,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated amortization expense, 2015</a></td>
<td class="nump">256,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated amortization expense, 2016</a></td>
<td class="nump">246,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated amortization expense, 2017</a></td>
<td class="nump">232,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Estimated amortization expense, Thereafter</a></td>
<td class="nump">2,055,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">260,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="nump">271,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">462,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_GoodwillImpairmentCumulative', window );">Goodwill Impairment, Cumulative</a></td>
<td class="nump">733,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">260,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">418,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | Trademarks and Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">88.4<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Future Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_GoodwillImpairmentCumulative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill Impairment, Cumulative</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_GoodwillImpairmentCumulative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501454023648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 8,121,000,000<span></span>
</td>
<td class="nump">$ 7,958,900,000<span></span>
</td>
<td class="nump">$ 7,751,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(176,400,000)<span></span>
</td>
<td class="num">(91,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">598,500,000<span></span>
</td>
<td class="nump">298,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(260,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">7,958,900,000<span></span>
</td>
<td class="nump">7,751,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(176,400,000)<span></span>
</td>
<td class="num">(91,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">8,121,000,000<span></span>
</td>
<td class="nump">7,958,900,000<span></span>
</td>
<td class="nump">7,751,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,533,500,000<span></span>
</td>
<td class="nump">4,046,200,000<span></span>
</td>
<td class="nump">3,800,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(70,600,000)<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">557,900,000<span></span>
</td>
<td class="nump">245,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">4,046,200,000<span></span>
</td>
<td class="nump">3,800,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(70,600,000)<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">4,533,500,000<span></span>
</td>
<td class="nump">4,046,200,000<span></span>
</td>
<td class="nump">3,800,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,587,500,000<span></span>
</td>
<td class="nump">3,912,700,000<span></span>
</td>
<td class="nump">3,951,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(105,800,000)<span></span>
</td>
<td class="num">(91,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">40,600,000<span></span>
</td>
<td class="nump">53,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, Impairment Loss</a></td>
<td class="num">(260,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(418,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance as of January 1</a></td>
<td class="nump">3,912,700,000<span></span>
</td>
<td class="nump">3,951,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Adjustments to goodwill</a></td>
<td class="num">(105,800,000)<span></span>
</td>
<td class="num">(91,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, net</a></td>
<td class="nump">$ 3,587,500,000<span></span>
</td>
<td class="nump">$ 3,912,700,000<span></span>
</td>
<td class="nump">$ 3,951,300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459624128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,851.4<span></span>
</td>
<td class="nump">$ 5,423.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,904.5)<span></span>
</td>
<td class="num">(1,688.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">3,946.9<span></span>
</td>
<td class="nump">3,735.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,336.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,362.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,973.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, licenses and technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(267.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember', window );">Media Content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, licenses and technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">574.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(291.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">283.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">4,681.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,546.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">3,134.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember', window );">Use Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(8.8)<span></span>
</td>
<td class="num">(7.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">86.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(50.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">36.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Canadian licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">468.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">468.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember', window );">Media Content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_MediaContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501464370288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 542.3<span></span>
</td>
<td class="nump">$ 198.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">16 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,851.4<span></span>
</td>
<td class="nump">5,423.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 408.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">18 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,336.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember', window );">Patents, licenses and technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 106.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">13 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived Intangible Assets Acquired</a></td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=lh_PatentsLicensesAndTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501630451536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES AND OTHER (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued expenses and other [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">$ 527.1<span></span>
</td>
<td class="nump">$ 735.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
<td class="nump">146.1<span></span>
</td>
<td class="nump">239.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_AccruedPassThroughExpenses', window );">Accrued pass through expenses</a></td>
<td class="nump">136.5<span></span>
</td>
<td class="nump">149.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">259.1<span></span>
</td>
<td class="nump">279.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses and other</a></td>
<td class="nump">$ 1,068.8<span></span>
</td>
<td class="nump">$ 1,404.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_AccruedPassThroughExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued pass through expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_AccruedPassThroughExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466063088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - SCHEDULE OF SHORT-TERM DEBT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 03, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2019TermLoan', window );">2019 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">$ 301.3<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=lh_ShortTermDebtIssueCostsMember', window );">Short term debt issue costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Shorttermdebtissuancecosts', window );">Short term debt issuance costs</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=lh_NotePayableCurrentMember', window );">Note payable, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes Payable, Current</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=lh_SeniorNotesDue2023Member', window );">Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="nump">$ 300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2019TermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2019 Term Loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2019TermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A4.00Seniornotesdue2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.00% Senior notes due 2023</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A4.00Seniornotesdue2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Shorttermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Shorttermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=lh_ShortTermDebtIssueCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=lh_ShortTermDebtIssueCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=lh_NotePayableCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=lh_NotePayableCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=lh_SeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=lh_SeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501464288592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - SCHEDULE OF LONG-TERM DEBT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 19, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months</a></td>
<td class="nump">$ 301.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">5,038.8<span></span>
</td>
<td class="nump">$ 5,416.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.30seniornotesdue2024', window );">2.30% senior notes due 2024</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2.95seniornotesdue2029', window );">2.95% senior notes due 2029</a></td>
<td class="nump">650.0<span></span>
</td>
<td class="nump">650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Seniornotesdue2027', window );">Senior notes due 2027</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.70Seniornotesdue2045', window );">4.70 % Senior notes due 2045</a></td>
<td class="nump">900.0<span></span>
</td>
<td class="nump">900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Seniornotesdue2024', window );">Senior notes due 2024</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A3.60Seniornotesdue2025', window );">3.60% Senior notes due 2025</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A155SeniorNotesDue2026', window );">1.55% senior notes due 2026</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_LongTermDebtExcludingDebtIssuanceCosts', window );">Long term debt excluding debt issuance costs</a></td>
<td class="nump">5,340.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes Payable, Noncurrent</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree', window );">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour', window );">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive', window );">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five</a></td>
<td class="nump">1,972.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments', window );">Long term debt, future minimum payments, interest included in payments</a></td>
<td class="nump">$ 5,373.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="num">$ (301.3)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A155SeniorNotesDue2026">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>1.55% senior notes due 2026</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A155SeniorNotesDue2026</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.30seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.30% senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.30seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2.95seniornotesdue2029">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.95% senior notes due 2029</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2.95seniornotesdue2029</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A3.60Seniornotesdue2025">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>3.60% Senior notes due 2025</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A3.60Seniornotesdue2025</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A4.00Seniornotesdue2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.00% Senior notes due 2023</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A4.00Seniornotesdue2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A4.70Seniornotesdue2045">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.70 % Senior notes due 2045</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A4.70Seniornotesdue2045</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_LongTermDebtExcludingDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt excluding debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_LongTermDebtExcludingDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt, future minimum payments, interest included in payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Seniornotesdue2027">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Senior notes due 2027</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Seniornotesdue2027</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463810368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - CREDIT FACILITIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 03, 2019</div></th>
<th class="th"><div>Dec. 19, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Longtermdebtissuancecosts', window );">Long term debt issuance costs</a></td>
<td class="nump">$ 33.8<span></span>
</td>
<td class="nump">$ 41.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A2019TermLoan', window );">2019 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments of Other Long-term Debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">375.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 5,038.8<span></span>
</td>
<td class="nump">$ 5,416.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityOptiontoIncrease', window );">Credit Facility Option to Increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeDescription', window );">Line of Credit Facility, Commitment Fee Description</a></td>
<td class="text">0.10% to 0.225%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of Credit Outstanding, Amount</a></td>
<td class="nump">$ 84.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Line of Credit Facility, Interest Rate at Period End</a></td>
<td class="nump">5.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumLettersofCredit', window );">Credit Facility, Maximum Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A2019TermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2019 Term Loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A2019TermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumLettersofCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Letters of Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumLettersofCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityOptiontoIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility Option to Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityOptiontoIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Longtermdebtissuancecosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Longtermdebtissuancecosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the fees for amounts available, but unused under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466103632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - COVERTIBLE SUBORDINATED NOTES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes Payable, Noncurrent</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">5,038.8<span></span>
</td>
<td class="nump">5,416.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Seniornotesdue2024', window );">Senior notes due 2024</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">600.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="num">(45.7)<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">301.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Seniornotesdue2024">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Senior notes due 2024</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Seniornotesdue2024</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463936352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - SENIOR NOTES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 19, 2014</div></th>
<th class="th"><div>Mar. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="num">$ (301.3)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_TotalShortandLongTermDebtIssuanceCosts', window );">Total Short and Long Term Debt Issuance Costs</a></td>
<td class="nump">33.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CreditFacilityMaximumSwingLineBorrowings', window );">Credit Facility, Maximum Swing Line Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 5,038.8<span></span>
</td>
<td class="nump">5,416.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A270SeniorNotesDue2031', window );">2.70% senior notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">$ 3,946.9<span></span>
</td>
<td class="nump">3,735.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A155SeniorNotesDue2026', window );">1.55% senior notes due 2026</a></td>
<td class="nump">500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A270SeniorNotesDue2031', window );">2.70% senior notes due 2031</a></td>
<td class="nump">420.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">9.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (in hundredths)</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 500.0<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member', window );">Senior notes due 2024 | 2022 Swap Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member', window );">Senior notes due 2022 | 2018 Swap Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2023Member', window );">Senior Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_A4.00Seniornotesdue2023', window );">4.00% Senior notes due 2023</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A155SeniorNotesDue2026">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>1.55% senior notes due 2026</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A155SeniorNotesDue2026</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A270SeniorNotesDue2031">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2.70% senior notes due 2031</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A270SeniorNotesDue2031</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_A4.00Seniornotesdue2023">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>4.00% Senior notes due 2023</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_A4.00Seniornotesdue2023</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CreditFacilityMaximumSwingLineBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit Facility, Maximum Swing Line Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CreditFacilityMaximumSwingLineBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_TotalShortandLongTermDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Short and Long Term Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_TotalShortandLongTermDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2022SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2022SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2018SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451316960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 13, 2023</div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th"><div>Jan. 12, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,100,000<span></span>
</td>
<td class="nump">97,500,000<span></span>
</td>
<td class="nump">97,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans', window );">Common stock issued under employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,700,000)<span></span>
</td>
<td class="num">(5,600,000)<span></span>
</td>
<td class="num">(5,200,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued, ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,100,000<span></span>
</td>
<td class="nump">88,200,000<span></span>
</td>
<td class="nump">93,100,000<span></span>
</td>
<td class="nump">97,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_OutstandingStockRepurchaseAuthorizationAbstract', window );"><strong>Share repurchase program [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,100.0)<span></span>
</td>
<td class="num">$ (1,668.5)<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonStockRepurchaseAuthorizationOutstanding', window );">Outstanding common stock repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Foreign Currency Translation Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign Currency Translation Adjustments, balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (125.9)<span></span>
</td>
<td class="num">(462.3)<span></span>
</td>
<td class="num">(125.9)<span></span>
</td>
<td class="num">(21.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(335.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Current year adjustments, Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(336.4)<span></span>
</td>
<td class="num">(104.6)<span></span>
</td>
<td class="nump">264.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Tax effect of adjustments, Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Net Benefit Plan Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66.0)<span></span>
</td>
<td class="num">(140.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Tax effect of adjustments, Net Benefit Plan Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Net Benefit Plan Adjustments, balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66.0)<span></span>
</td>
<td class="num">(30.9)<span></span>
</td>
<td class="num">(66.0)<span></span>
</td>
<td class="num">(140.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Earnings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.5)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52.5<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax', window );">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(283.0)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Tax effect of adjustments, Accumulated Other Comprehensive Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(17.1)<span></span>
</td>
<td class="nump">12.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
<td class="nump">$ 493.2<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 372.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury Stock Acquired, Average Cost Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 233.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for Repurchase of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="nump">$ 1,100.0<span></span>
</td>
<td class="nump">1,668.5<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (191.9)<span></span>
</td>
<td class="num">(493.2)<span></span>
</td>
<td class="num">(191.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (372.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other Comprehensive Income (Loss), before Reclassifications, before Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (283.0)<span></span>
</td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonStockRepurchaseAuthorizationOutstanding', window );">Outstanding common stock repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 531.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=lh_A2022ShareRepurchasesMember', window );">2022 Share Repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_OutstandingStockRepurchaseAuthorizationAbstract', window );"><strong>Share repurchase program [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonStockRepurchaseAuthorizationOutstanding', window );">Outstanding common stock repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,531.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Earnings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Dividends Payable, Date Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 12,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">Mar. 13,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 23,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonStockRepurchaseAuthorizationOutstanding', window );">Outstanding common stock repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,531.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=lh_A2022ASRSettlementMember', window );">2022 ASR Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CommonSharesIssuedRollforwardAbstract', window );"><strong>Rollforward of common shares issued [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Common shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock Repurchased and Retired During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Foreign Currency Translation Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.1)<span></span>
</td>
<td class="num">$ (3.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.1)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_ForeignCurrencyGainLossMember', window );">Foreign Currency Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Foreign Currency Translation Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_OutstandingStockRepurchaseAuthorizationAbstract', window );"><strong>Share repurchase program [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Earnings</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Earnings, balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.9<span></span>
</td>
<td class="nump">493.2<span></span>
</td>
<td class="nump">191.9<span></span>
</td>
<td class="nump">161.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (191.9)<span></span>
</td>
<td class="num">(493.2)<span></span>
</td>
<td class="num">$ (191.9)<span></span>
</td>
<td class="num">$ (161.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonSharesIssuedRollforwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonSharesIssuedRollforwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonStockRepurchaseAuthorizationOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonStockRepurchaseAuthorizationOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_OutstandingStockRepurchaseAuthorizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_OutstandingStockRepurchaseAuthorizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 40<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116633155&amp;loc=d3e31531-110899<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e709-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=lh_A2022ShareRepurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=lh_A2022ShareRepurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=lh_A2022ASRSettlementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=lh_A2022ASRSettlementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501455047440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed Earnings of Foreign Subsidiaries</a></td>
<td class="nump">$ 1,726.3<span></span>
</td>
<td class="nump">$ 1,291.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</a></td>
<td class="nump">$ 10.2<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized income tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalTaxLossCarryovers', window );">Federal tax loss carryovers</a></td>
<td class="nump">$ 161.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating Loss Carryforwards, Limitations on Use</a></td>
<td class="text">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</a></td>
<td class="num">(4.40%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</a></td>
<td class="num">(1.90%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</a></td>
<td class="nump">$ 10.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</a></td>
<td class="num">(8.1)<span></span>
</td>
<td class="num">$ (25.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract', window );"><strong>Pre-tax income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="nump">1,321.0<span></span>
</td>
<td class="nump">2,580.6<span></span>
</td>
<td class="nump">$ 1,846.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">261.6<span></span>
</td>
<td class="nump">546.0<span></span>
</td>
<td class="nump">372.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest', window );">Total pre-tax income</a></td>
<td class="nump">1,582.6<span></span>
</td>
<td class="nump">3,126.6<span></span>
</td>
<td class="nump">2,219.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">189.4<span></span>
</td>
<td class="nump">545.5<span></span>
</td>
<td class="nump">455.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">40.1<span></span>
</td>
<td class="nump">171.9<span></span>
</td>
<td class="nump">172.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">65.3<span></span>
</td>
<td class="nump">107.7<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income taxes</a></td>
<td class="nump">294.8<span></span>
</td>
<td class="nump">825.1<span></span>
</td>
<td class="nump">709.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred Federal Income Tax Expense (Benefit)</a></td>
<td class="nump">7.8<span></span>
</td>
<td class="num">(64.6)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax expense/(benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(5.4)<span></span>
</td>
<td class="num">(13.7)<span></span>
</td>
<td class="num">(28.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="num">(78.0)<span></span>
</td>
<td class="num">(47.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">302.0<span></span>
</td>
<td class="nump">$ 747.1<span></span>
</td>
<td class="nump">$ 662.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</a></td>
<td class="nump">485.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating Loss Carryforwards, Valuation Allowance</a></td>
<td class="nump">340.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalandStateAttributeCarryforwards', window );">Federal and State Attribute Carryforwards</a></td>
<td class="nump">129.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalandStateAttributeCarryforwardValuationAllowance', window );">Federal and State Attribute Carryforward Valuation Allowance</a></td>
<td class="nump">$ 88.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Federal statutory tax rate reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory U.S. rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of U.S. federal income tax effect</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses', window );">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective rate</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">23.90%<span></span>
</td>
<td class="nump">29.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Accounts receivable</a></td>
<td class="nump">$ 22.5<span></span>
</td>
<td class="nump">$ 22.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Employee compensation and benefits</a></td>
<td class="nump">114.2<span></span>
</td>
<td class="nump">145.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DeferredTaxAssetRightOfUseAsset', window );">Deferred Tax Asset, Right Of Use Asset</a></td>
<td class="nump">189.4<span></span>
</td>
<td class="nump">176.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges', window );">Acquisition and restructuring reserves</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts', window );">Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs</a></td>
<td class="nump">54.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Tax loss carryforwards</a></td>
<td class="nump">242.6<span></span>
</td>
<td class="nump">184.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Deferred Tax Assets, Other</a></td>
<td class="nump">116.4<span></span>
</td>
<td class="nump">92.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">749.8<span></span>
</td>
<td class="nump">640.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(151.3)<span></span>
</td>
<td class="num">(149.2)<span></span>
</td>
<td class="num">$ (167.6)<span></span>
</td>
<td class="num">$ (145.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="nump">598.5<span></span>
</td>
<td class="nump">490.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Deferred Tax Liabilities, Leasing Arrangements</a></td>
<td class="num">(172.7)<span></span>
</td>
<td class="num">(166.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(811.1)<span></span>
</td>
<td class="num">(823.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="num">(188.0)<span></span>
</td>
<td class="num">(143.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Deferred Tax Liabilities, Other</a></td>
<td class="num">(87.9)<span></span>
</td>
<td class="num">(47.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total gross deferred tax liabilities</a></td>
<td class="num">(661.2)<span></span>
</td>
<td class="num">(691.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred Tax Liabilities, Gross</a></td>
<td class="num">(1,259.7)<span></span>
</td>
<td class="num">(1,182.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ForeignTaxLossCarryovers', window );">Foreign tax loss carryovers</a></td>
<td class="nump">115.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ForeignTaxLossCarryoverValuationAllowance', window );">Foreign Tax Loss Carryover with Valuation Allowance</a></td>
<td class="nump">20.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ForeignTaxLossCarryoversExpirein2034', window );">Foreign Tax Loss Carryovers Expire in 2034</a></td>
<td class="nump">444.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Deferred Tax Assets, Capital Loss Carryforwards</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalTaxLossCarryovers', window );">Federal tax loss carryovers</a></td>
<td class="nump">161.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Gross unrecognized income tax benefits</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
<td class="nump">$ 31.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to unrecognized income tax benefits</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesExpense', window );">Income Tax Examination, Penalties Expense</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest', window );">Reversal of Accrued Income Tax Penalties And Interest</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of unrecognized tax benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of January 1</a></td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
<td class="nump">31.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase in reserve for tax positions taken in the current year</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">31.1<span></span>
</td>
<td class="nump">17.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition', window );">Unrecognized Tax Benefits Increase in Reserve From Acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in reserve as a result of payments</a></td>
<td class="num">(13.5)<span></span>
</td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease in reserve as a result of lapses in the statute of limitations</a></td>
<td class="num">(7.3)<span></span>
</td>
<td class="num">(20.4)<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of December 31</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">52.4<span></span>
</td>
<td class="nump">48.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized income tax benefits that would impact effective tax rate</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=lh_Post2017Member', window );">Post 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalTaxLossCarryovers', window );">Federal tax loss carryovers</a></td>
<td class="nump">202.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FederalTaxLossCarryovers', window );">Federal tax loss carryovers</a></td>
<td class="nump">202.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_ReductionInTaxesMember', window );">Reduction in Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized income tax benefits that would impact effective tax rate</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of unrecognized tax benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized income tax benefits that would impact effective tax rate</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">$ 51.5<span></span>
</td>
<td class="nump">$ 46.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=lh_FederalLossCarryoverDomain', window );">Federal Loss Carryover [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Federal</a></td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred tax expense/(benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Federal</a></td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DeferredTaxAssetRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DeferredTaxAssetRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FederalTaxLossCarryovers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The federal loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FederalTaxLossCarryovers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FederalandStateAttributeCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal and State Attribute Carryforward Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FederalandStateAttributeCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FederalandStateAttributeCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal and State Attribute Carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FederalandStateAttributeCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ForeignTaxLossCarryoverValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Tax Loss Carryover Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ForeignTaxLossCarryoverValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ForeignTaxLossCarryovers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The foreign loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ForeignTaxLossCarryovers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ForeignTaxLossCarryoversExpirein2034">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Tax Loss Carryovers Expire in 2034</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ForeignTaxLossCarryoversExpirein2034</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reversal of Accrued Income Tax Penalties And Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits Increase in Reserve From Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in unrecognized tax benefits resulting from tax positions taken in prior period tax returns, excluding amounts pertaining to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126928070&amp;loc=d3e28200-109314<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=lh_Post2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=lh_Post2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_ReductionInTaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=us-gaap_ReductionInTaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=lh_FederalLossCarryoverDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=lh_FederalLossCarryoverDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501459219712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK COMPENSATION PLANS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</a></td>
<td class="nump">$ 76.23<span></span>
</td>
<td class="nump">$ 62.18<span></span>
</td>
<td class="nump">$ 40.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased', window );">Number of shares purchased by eligible employees</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight', window );">Fair value of the employee's purchase right</a></td>
<td class="nump">$ 62.50<span></span>
</td>
<td class="nump">$ 59.89<span></span>
</td>
<td class="nump">$ 35.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares', window );">Shares of common stock authorized for issuance under the employee stock purchase plan</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeStockPurchasePlanPercentOfMarketPrice', window );">The employee stock purchase plan permits employees to purchase shares of common stock at a certain percentage of the market price (in hundredths)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_EmployeeStockPurchasePlanExpense', window );">Expense related to the Company's employee stock purchase plan</a></td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="nump">$ 14,600,000<span></span>
</td>
<td class="nump">$ 10,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested restricted stock and performance share-based compensation arrangements</a></td>
<td class="nump">$ 155,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions', window );">Performance share awards, vesting conditions</a></td>
<td class="text">Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Restricted stock, vesting increment</a></td>
<td class="text">one-third increments beginning on the first anniversary of the grant<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received by the Company</a></td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="nump">6,800,000<span></span>
</td>
<td class="nump">17,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 8,200,000<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="nump">18,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost weighted average expected future recognition period (in years)</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_RestrictedStockPerformanceSharesExpense', window );">Restricted stock and performance share compensation expense</a></td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
<td class="nump">135,400,000<span></span>
</td>
<td class="nump">98,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under the Company's stock option plans</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option plan expense</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lh_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=lh_RestrictedStockAndPerformanceSharesMember', window );">Restricted Stock and Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 252.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</a></td>
<td class="nump">$ 254.82<span></span>
</td>
<td class="nump">$ 212.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of options granted</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, granted</a></td>
<td class="nump">$ 270.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of options vested</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, vested</a></td>
<td class="nump">$ 177.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangements by Share-based Payment Award</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value, exercisable options</a></td>
<td class="nump">$ 23,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 188.84<span></span>
</td>
<td class="nump">$ 169.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price per option granted</a></td>
<td class="nump">$ 276.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options exercised</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price per option exercised</a></td>
<td class="nump">$ 118.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of options cancelled</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price per option cancelled</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term of options outstanding (in years)</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">$ 25,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of options exercisable</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price per exercisable option</a></td>
<td class="nump">$ 168.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, exercisable options (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeStockPurchasePlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense amount recognized during the period related to the Company's employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeStockPurchasePlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of the employee's purchase right calculated using the Black-Scholes model.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for purchase under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeStockPurchasePlanNumberOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under the employee stock purchase plan purchased by eligible employees during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeStockPurchasePlanNumberOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_EmployeeStockPurchasePlanPercentOfMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of the market price of common stock participating employees are able to purchase company stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_EmployeeStockPurchasePlanPercentOfMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_RestrictedStockPerformanceSharesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncash expense that represents the cost of restricted stock and performance shares distributed to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_RestrictedStockPerformanceSharesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of performance share award terms as to how many shares or portion of an award are no longer contingent on satisfaction of certain performance conditions, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lh_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lh_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=lh_RestrictedStockAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=lh_RestrictedStockAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501448320784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Maximumdeferralpercentageofannualbasesalary', window );">Maximum deferral percentage of annual base salary</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Tax effect of adjustments, Net Benefit Plan Adjustments</a></td>
<td class="num">(9,700,000)<span></span>
</td>
<td class="num">$ (17,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Net of Tax</a></td>
<td class="num">$ (493,200,000)<span></span>
</td>
<td class="num">$ (191,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (372,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">331,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedContributionPlanTotalExpense', window );">Defined Contribution Plan Total Expense</a></td>
<td class="nump">183,100,000<span></span>
</td>
<td class="nump">168,900,000<span></span>
</td>
<td class="nump">$ 141,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear', window );">Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year</a></td>
<td class="nump">18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred Compensation Liability, Classified, Noncurrent</a></td>
<td class="nump">$ 96,900,000<span></span>
</td>
<td class="nump">104,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Maximumdeferralpercentageofannualcashincentivepay', window );">Maximum deferral percentage of annual cash incentive pay</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">$ 16,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">95,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="nump">$ 20,700,000<span></span>
</td>
<td class="num">$ (89,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="nump">$ 352,600,000<span></span>
</td>
<td class="nump">$ 633,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">17,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">$ 17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">$ (60,400,000)<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">$ (54,000,000.0)<span></span>
</td>
<td class="num">$ (5,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets', window );">Weighted average expected long-term rate of return for other assets (in hundredths)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="num">(18,000,000.0)<span></span>
</td>
<td class="num">(16,300,000)<span></span>
</td>
<td class="num">(16,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="num">(5,500,000)<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="num">(3,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">352,600,000<span></span>
</td>
<td class="nump">633,800,000<span></span>
</td>
<td class="nump">690,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(212,000,000.0)<span></span>
</td>
<td class="num">(34,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(21,500,000)<span></span>
</td>
<td class="num">(22,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">331,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
<td class="nump">535,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="nump">22,000,000.0<span></span>
</td>
<td class="nump">58,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="nump">$ 16,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">21,500,000<span></span>
</td>
<td class="nump">22,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">15,700,000<span></span>
</td>
<td class="nump">14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(157,500,000)<span></span>
</td>
<td class="nump">22,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(20,700,000)<span></span>
</td>
<td class="nump">89,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Defined Benefit Plan, Other Cost (Credit)</a></td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Defined Benefit Plan, Other Cost (Credit)</a></td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan [Member] | Foreign Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Defined Benefit Plan, Other Cost (Credit)</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">25,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">106,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">25,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">25,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (32,700,000)<span></span>
</td>
<td class="num">$ (33,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Defined Benefit Plan, Accumulated Benefit Obligation</a></td>
<td class="nump">$ 259,500,000<span></span>
</td>
<td class="nump">$ 333,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">24,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">23,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets', window );">Expected long term rate of return for the Company Plan</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</a></td>
<td class="num">$ (4,100,000)<span></span>
</td>
<td class="num">$ (3,700,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,800,000<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="num">(12,900,000)<span></span>
</td>
<td class="num">(17,300,000)<span></span>
</td>
<td class="num">(14,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">10,000,000.0<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="nump">11,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">259,500,000<span></span>
</td>
<td class="nump">333,300,000<span></span>
</td>
<td class="nump">369,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(58,400,000)<span></span>
</td>
<td class="num">(18,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(27,300,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">226,800,000<span></span>
</td>
<td class="nump">299,900,000<span></span>
</td>
<td class="nump">300,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="nump">60,900,000<span></span>
</td>
<td class="nump">66,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="num">(4,600,000)<span></span>
</td>
<td class="num">(10,000,000.0)<span></span>
</td>
<td class="num">(9,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="nump">12,900,000<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">27,300,000<span></span>
</td>
<td class="nump">30,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(48,200,000)<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">32,700,000<span></span>
</td>
<td class="nump">33,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanOtherCosts', window );">Defined Benefit Plan, Other Cost (Credit)</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=lh_UKPlanMember', window );">UK Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(16,900,000)<span></span>
</td>
<td class="num">(21,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">16,900,000<span></span>
</td>
<td class="nump">21,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">3,300,000<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(27,100,000)<span></span>
</td>
<td class="num">(88,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">27,100,000<span></span>
</td>
<td class="nump">88,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(32,500,000)<span></span>
</td>
<td class="num">(44,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">32,500,000<span></span>
</td>
<td class="nump">44,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(600,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="num">(2,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Minimum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">24.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">32.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Minimum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember', window );">Variable Annuity [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 63,500,000<span></span>
</td>
<td class="nump">117,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">3,400,000<span></span>
</td>
<td class="nump">19,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">222,900,000<span></span>
</td>
<td class="nump">295,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Real Estate Funds [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Equity Funds | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">39,600,000<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | International - developed [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="nump">22,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | U.S. fixed income [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">161,300,000<span></span>
</td>
<td class="nump">213,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Mutual Funds [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Life and Annuity Insurance Product Line [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">60,100,000<span></span>
</td>
<td class="nump">97,900,000<span></span>
</td>
<td class="nump">$ 58,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</a></td>
<td class="num">$ (37,800,000)<span></span>
</td>
<td class="nump">$ 39,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanActualAssetAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actual Asset Allocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanActualAssetAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanAmortizationAndDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An amount calculated as a basis for determining the effects of amortization expenses and other deferrals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanAmortizationAndDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested in other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedContributionPlanTotalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan Total Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedContributionPlanTotalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Maximumdeferralpercentageofannualbasesalary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum deferral percentage of annual base salary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Maximumdeferralpercentageofannualbasesalary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Maximumdeferralpercentageofannualcashincentivepay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum deferral percentage of annual cash incentive pay</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Maximumdeferralpercentageofannualcashincentivepay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(A)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanOtherCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of defined benefit plan cost (credit), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanOtherCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=lh_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=lh_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_InternationalDevelopedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_InternationalDevelopedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_UsFixedIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_UsFixedIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_MutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_MutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501450944480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">331,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(900,000)<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined-benefit plan costs</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 331,900,000<span></span>
</td>
<td class="nump">$ 544,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member', window );">Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">63,500,000<span></span>
</td>
<td class="nump">117,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">63,500,000<span></span>
</td>
<td class="nump">117,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">259,500,000<span></span>
</td>
<td class="nump">333,300,000<span></span>
</td>
<td class="nump">369,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,800,000<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">226,800,000<span></span>
</td>
<td class="nump">299,900,000<span></span>
</td>
<td class="nump">300,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">27,300,000<span></span>
</td>
<td class="nump">30,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="nump">11,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(58,400,000)<span></span>
</td>
<td class="num">(18,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="num">(12,900,000)<span></span>
</td>
<td class="num">(17,300,000)<span></span>
</td>
<td class="num">$ (14,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(48,200,000)<span></span>
</td>
<td class="nump">27,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined-benefit plan costs</a></td>
<td class="num">(7,700,000)<span></span>
</td>
<td class="num">(8,600,000)<span></span>
</td>
<td class="num">(11,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 226,800,000<span></span>
</td>
<td class="nump">$ 299,900,000<span></span>
</td>
<td class="nump">300,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="nump">7,700,000<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="nump">11,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="nump">60,900,000<span></span>
</td>
<td class="nump">66,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Cash Balance Retirement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="nump">28,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">222,900,000<span></span>
</td>
<td class="nump">295,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">222,900,000<span></span>
</td>
<td class="nump">295,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation</a></td>
<td class="nump">352,600,000<span></span>
</td>
<td class="nump">633,800,000<span></span>
</td>
<td class="nump">690,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">331,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
<td class="nump">535,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">15,700,000<span></span>
</td>
<td class="nump">14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="nump">21,500,000<span></span>
</td>
<td class="nump">22,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(60,400,000)<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Defined Benefit Plan, Interest Cost</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(212,000,000.0)<span></span>
</td>
<td class="num">(34,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="num">(18,000,000.0)<span></span>
</td>
<td class="num">(16,300,000)<span></span>
</td>
<td class="num">$ (16,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(157,500,000)<span></span>
</td>
<td class="nump">22,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">$ (54,000,000.0)<span></span>
</td>
<td class="num">$ (5,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets', window );">Weighted average expected long-term rate of return for other assets (in hundredths)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Participants contributions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined-benefit plan costs</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 331,900,000<span></span>
</td>
<td class="nump">$ 544,600,000<span></span>
</td>
<td class="nump">535,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate for the Company Plan</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanAmortizationAndDeferral', window );">Net amortization and deferral</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Defined benefit plan costs</a></td>
<td class="num">(5,500,000)<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
<td class="num">$ (3,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unamortized net gain included in accumulated other comprehensive earnings</a></td>
<td class="nump">22,000,000.0<span></span>
</td>
<td class="nump">58,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_InternationalDevelopedMember', window );">International - developed [Member] | Domestic Plan [Member] | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="nump">22,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="nump">22,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember', window );">Equity Funds | Domestic Plan [Member] | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">39,600,000<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 39,600,000<span></span>
</td>
<td class="nump">52,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Domestic Plan [Member] | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember', window );">Real Estate Funds [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Minimum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember', window );">Life and Annuity Insurance Product Line [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_MutualFundsMember', window );">Mutual Funds [Member] | Non-US | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">24.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">32.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember', window );">Fixed Income Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember', window );">Debt Securities [Member] | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Minimum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Minimum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Maximum [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments | Maximum [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_UsFixedIncomeMember', window );">U.S. fixed income [Member] | Domestic Plan [Member] | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 161,300,000<span></span>
</td>
<td class="nump">213,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 161,300,000<span></span>
</td>
<td class="nump">$ 213,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanActualAssetAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actual Asset Allocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanActualAssetAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanAmortizationAndDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An amount calculated as a basis for determining the effects of amortization expenses and other deferrals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanAmortizationAndDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested in other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=lh_CashBalanceRetirementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=lh_CashBalanceRetirementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_InternationalDevelopedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_InternationalDevelopedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_LifeAndAnnuityInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_MutualFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_MutualFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_UsFixedIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=lh_UsFixedIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451096176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 331,900,000<span></span>
</td>
<td class="nump">$ 544,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanNameAxis=lh_UKPlanMember', window );">UK Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(16,900,000)<span></span>
</td>
<td class="num">(21,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">331,900,000<span></span>
</td>
<td class="nump">544,600,000<span></span>
</td>
<td class="nump">$ 535,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">(60,400,000)<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">16,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">17,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">17,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">95,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(20,700,000)<span></span>
</td>
<td class="nump">89,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(21,500,000)<span></span>
</td>
<td class="num">(22,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="nump">$ 18,000,000.0<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="nump">16,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">43.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US | Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US | Variable Annuity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US | Real Estate Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US | Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 226,800,000<span></span>
</td>
<td class="nump">299,900,000<span></span>
</td>
<td class="nump">300,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months</a></td>
<td class="nump">25,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</a></td>
<td class="nump">25,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</a></td>
<td class="nump">25,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</a></td>
<td class="nump">24,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</a></td>
<td class="nump">23,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter</a></td>
<td class="nump">106,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">32,700,000<span></span>
</td>
<td class="nump">33,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">(27,300,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</a></td>
<td class="nump">$ 12,900,000<span></span>
</td>
<td class="nump">17,300,000<span></span>
</td>
<td class="nump">$ 14,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">24.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Variable Annuity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Real Estate Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_DefinedBenefitPlanActualAssetAllocation', window );">Defined Benefit Plan, Actual Asset Allocation</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member] | Cash Balance Retirement Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Defined Benefit Plan, Benefit Obligation, Benefits Paid</a></td>
<td class="num">$ (24,900,000)<span></span>
</td>
<td class="num">(28,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">27,100,000<span></span>
</td>
<td class="nump">88,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">32,500,000<span></span>
</td>
<td class="nump">44,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">7,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="nump">427,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">222,900,000<span></span>
</td>
<td class="nump">295,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember', window );">Fair Value Measured at Net Asset Value Per Share | Domestic Plan [Member] | Real Estate Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plans Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined Benefit Plan, Plan Assets, Amount</a></td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="nump">$ 7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_DefinedBenefitPlanActualAssetAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Actual Asset Allocation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_DefinedBenefitPlanActualAssetAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=lh_UKPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=lh_UKPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_VariableAnnuityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanNameAxis=lh_CashBalanceRetirementPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanNameAxis=lh_CashBalanceRetirementPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501458288976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PENSION AND POSTRETIREMENT PLANS - Funded Status (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember', window );">Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (32.7)<span></span>
</td>
<td class="num">$ (33.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember', window );">Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="num">(89.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(32.5)<span></span>
</td>
<td class="num">(44.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(27.1)<span></span>
</td>
<td class="num">(88.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(2.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member] | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Domestic Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(13.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets | Non-US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Defined Benefit Plan, Funded (Unfunded) Status of Plan</a></td>
<td class="num">$ (7.0)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_DomesticPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501451943408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncreaseDecreaseInNoncontrollingInterestPut', window );">Increase (Decrease) in Noncontrolling Interest Put</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">5,038,800,000<span></span>
</td>
<td class="nump">$ 5,416,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SeniorNotesFairValue', window );">Fair market value of senior notes</a></td>
<td class="nump">4,973,900,000<span></span>
</td>
<td class="nump">5,841,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">79,700,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">45,700,000<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">100,700,000<span></span>
</td>
<td class="nump">106,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">77,400,000<span></span>
</td>
<td class="nump">21,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">96,900,000<span></span>
</td>
<td class="nump">104,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</a></td>
<td class="nump">68,300,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_Contingentconsiderationadjustment', window );">Contingent consideration adjustment</a></td>
<td class="num">(12,800,000)<span></span>
</td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember', window );">2018 Swap Agreements | Senior notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">15,000,000.0<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">45,700,000<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeAssetAtFairValue', window );">Interest Rate Fair Value Hedge Asset at Fair Value</a></td>
<td class="nump">79,700,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">100,700,000<span></span>
</td>
<td class="nump">106,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts', window );">Noncontrolling interest puts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet', window );">Fair Value Hedges, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash Surrender Value, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent Consideration Classified as Equity, Fair Value Disclosure</a></td>
<td class="nump">77,400,000<span></span>
</td>
<td class="nump">21,900,000<span></span>
</td>
<td class="nump">$ 13,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability', window );">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_Contingentconsiderationadjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_Contingentconsiderationadjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncreaseDecreaseInNoncontrollingInterestPut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Noncontrolling Interest Put</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncreaseDecreaseInNoncontrollingInterestPut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SeniorNotesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of the debt instrument (senior notes) at the balance-sheet date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SeniorNotesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateFairValueHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all derivative assets designated as interest rate fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateFairValueHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivatives designated as interest rate fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126966630&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2018SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501454046032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 5,038,800,000<span></span>
</td>
<td class="nump">$ 5,038,800,000<span></span>
</td>
<td class="nump">$ 5,416,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">45,700,000<span></span>
</td>
<td class="nump">$ 45,700,000<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_GainRecognizedonExitofInterestRateSwapArrangement', window );">Gain Recognized on Exit of Interest Rate Swap Arrangement</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember', window );">2018 Swap Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnOilAndGasHedgingActivity', window );">Gain (Loss) on Hedging Activity</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair Value Hedge Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="num">(79,700,000)<span></span>
</td>
<td class="num">(79,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,900,000)<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="num">(43,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeAssetsAtFairValue', window );">Fair Value Hedge Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="num">$ (45,700,000)<span></span>
</td>
<td class="num">(45,700,000)<span></span>
</td>
<td class="num">(32,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="num">(4.625%)<span></span>
</td>
<td class="num">(4.625%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member', window );">Senior notes due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_GainRecognizedonExitofInterestRateSwapArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Recognized on Exit of Interest Rate Swap Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_GainRecognizedonExitofInterestRateSwapArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnOilAndGasHedgingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) incurred in hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnOilAndGasHedgingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_SwapTypeAxis=lh_A2018SwapAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_SwapTypeAxis=lh_A2018SwapAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_Seniornotesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466192560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2013</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_GainRecognizedonExitofInterestRateSwapArrangement', window );">Gain Recognized on Exit of Interest Rate Swap Arrangement</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 5,038,800,000<span></span>
</td>
<td class="nump">5,416,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="nump">2.298%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_BalanceOfSeniorNotesMatureDuringQ42020', window );">Balance of Senior Notes Mature During Q4 2020</a></td>
<td class="nump">$ 412,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">$ 45,700,000<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt Instrument, Interest Rate, Stated Percentage</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member', window );">Senior notes due 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, less current portion</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">79,700,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember', window );">Currency Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair Value Hedge Liabilities</a></td>
<td class="nump">45,700,000<span></span>
</td>
<td class="nump">32,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</a></td>
<td class="num">(12,900,000)<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
<td class="num">(43,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_BalanceOfSeniorNotesMatureDuringQ42020">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance of Senior Notes Mature During Q4 2020</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_BalanceOfSeniorNotesMatureDuringQ42020</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_GainRecognizedonExitofInterestRateSwapArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Recognized on Exit of Interest Rate Swap Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_GainRecognizedonExitofInterestRateSwapArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=lh_SeniorLongTermNotesDue2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501464079232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_CashPaidDuringPeriodForAbstract', window );"><strong>Cash paid during period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_InterestPaidInCash', window );">Interest</a></td>
<td class="nump">$ 197,100,000<span></span>
</td>
<td class="nump">$ 194,700,000<span></span>
</td>
<td class="nump">$ 216,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes, net of refunds</a></td>
<td class="nump">504,700,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">500,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Disclosure of non-cash financing and investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Change in accrued property, plant and equipment</a></td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_CashPaidDuringPeriodForAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_CashPaidDuringPeriodForAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_InterestPaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period for interest owed on money borrowed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_InterestPaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501450907424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 2,956.2<span></span>
</td>
<td class="nump">$ 2,815.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">374.6<span></span>
</td>
<td class="nump">375.6<span></span>
</td>
<td class="nump">$ 349.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">14,876.8<span></span>
</td>
<td class="nump">16,120.9<span></span>
</td>
<td class="nump">13,978.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">1,773.9<span></span>
</td>
<td class="nump">3,259.5<span></span>
</td>
<td class="nump">2,445.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles and other assets</a></td>
<td class="num">(259.3)<span></span>
</td>
<td class="num">(369.6)<span></span>
</td>
<td class="num">(275.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_NetRestructuringCharges', window );">Net restructuring charges</a></td>
<td class="num">(83.8)<span></span>
</td>
<td class="num">(43.1)<span></span>
</td>
<td class="num">(40.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="num">(271.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(462.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest', window );">Total pre-tax income</a></td>
<td class="nump">1,582.6<span></span>
</td>
<td class="nump">3,126.6<span></span>
</td>
<td class="nump">2,219.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">302.0<span></span>
</td>
<td class="nump">747.1<span></span>
</td>
<td class="nump">662.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">1,280.6<span></span>
</td>
<td class="nump">2,379.5<span></span>
</td>
<td class="nump">1,557.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income (Loss) Attributable to Noncontrolling Interest</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Laboratory Corporation of America Holdings</a></td>
<td class="nump">1,279.1<span></span>
</td>
<td class="nump">2,377.3<span></span>
</td>
<td class="nump">1,556.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">2,826.6<span></span>
</td>
<td class="nump">4,092.7<span></span>
</td>
<td class="nump">3,522.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">36.9<span></span>
</td>
<td class="nump">88.2<span></span>
</td>
<td class="nump">152.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember', window );">LabCorp Diagnostics [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,669.2<span></span>
</td>
<td class="nump">1,507.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">227.1<span></span>
</td>
<td class="nump">238.7<span></span>
</td>
<td class="nump">222.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">9,203.5<span></span>
</td>
<td class="nump">10,363.6<span></span>
</td>
<td class="nump">9,253.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">2,025.5<span></span>
</td>
<td class="nump">3,205.6<span></span>
</td>
<td class="nump">2,801.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and Intangible Asset Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(450.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember', window );">Covance Drug Development [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,287.0<span></span>
</td>
<td class="nump">1,308.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">143.8<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
<td class="nump">124.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">5,710.2<span></span>
</td>
<td class="nump">5,845.5<span></span>
</td>
<td class="nump">4,877.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="nump">801.1<span></span>
</td>
<td class="nump">887.1<span></span>
</td>
<td class="nump">721.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortizationAbstract', window );"><strong>Depreciation and amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="num">(438.1)<span></span>
</td>
<td class="num">(420.5)<span></span>
</td>
<td class="num">$ (299.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">131.5<span></span>
</td>
<td class="nump">188.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member] | LabCorp Diagnostics [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lh_OthercountriesMember', window );">Other countries [Member] | Covance Drug Development [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">131.5<span></span>
</td>
<td class="nump">188.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,399.2<span></span>
</td>
<td class="nump">2,177.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America | LabCorp Diagnostics [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,669.2<span></span>
</td>
<td class="nump">1,507.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">North America | Covance Drug Development [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">730.0<span></span>
</td>
<td class="nump">670.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">425.5<span></span>
</td>
<td class="nump">449.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | LabCorp Diagnostics [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | Covance Drug Development [Member] | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 425.5<span></span>
</td>
<td class="nump">$ 449.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lh_NetRestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lh_NetRestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lh_DrugDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lh_OthercountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lh_OthercountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501466748224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 13, 2023</div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th"><div>Jan. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear', window );">Dividends Payable, Date to be Paid</a></td>
<td class="text">Mar. 13,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Dividends Payable, Date Declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 12,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Dividends Payable, Date of Record</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 23,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends Payable, Amount Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 720,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendPayableDateToBePaidDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the declared dividend will be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendPayableDateToBePaidDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140501463856896">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="num">(7,000,000.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member] | Revision of Prior Period, Accounting Standards Update, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings (Accumulated Deficit)</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>lh-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lh="http://www.labcorp.com/20221231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lh-20221231.xsd" xlink:type="simple"/>
    <context id="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04baeb7b9b0c4b62bc8ac723f9759148_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3df4ce9e79c24b838b1688ef5f97af09_I20230227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2023-02-27</instant>
        </period>
    </context>
    <context id="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic711bbfcced34e89878863bb09676b90_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieabfe2258e1446b192ef394f16489167_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i52733785e36d4fe69241ec49519c9770_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62b91351337c44079b374875b323d3e4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49a7f666344b43219373509023b86a61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ClientMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia00703317297439a899a69e868562330_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7efbc2922164408c936797e755136d6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i174342f325564eb4800f5d7bafca1841_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SelfPayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i91139fb3405c40e89005a42835b1528e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a6714ab30154ab7adf7919442029308_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:MedicareandMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41204750b78b41e99bbfcab862d31763_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22ae928d35a54533906182c59b812aa3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icba36eacc3c943cca03f3598759b2674_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0855e4e7139742529986707c444dfb8e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:ThirdpartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d6cb383b4834da09d62346a62279532_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a5e69b64f4d470b8506561651160652_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">lh:BiopharmaceuticalandmedicaldevicecompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0144819236674d5b8f8b30016911bccd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if4525567f3af4381925d303df86c2fd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib253ed0180004b288aff33fe175b56f2_I20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2014-12-19</instant>
        </period>
    </context>
    <context id="i84486f7fd7d2438aa00664a5e0482b1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice6b446a0be14f92ad87a9e60cdfb741_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i77657f2f79234f079d9a8cd7d6c65a76_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="ie7a4f1d89351477a9562246200d846a1_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i0bfd8f9f712d4be1a34741259880f138_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i59610a560d54411f901c49edcd62d761_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8132459128c444ab29724e750a1d08f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29cec420761b431ca0cff711e7a085bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5185fa2e825b418aaad59fc411dd8793_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82508c48b8e24f59b776527555dac0a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i716799a1a7a34a15b3e9adffdce6996d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icff6b868a72748489c76618831c34913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i56cc8aeb3db74b298d1f3c1cc41c86b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9537d406d674d4bbf0f98e30498723b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d55b4cb03d64378863d2e96d420a6d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i987c089c7729424e85f27edd60bcf505_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic5992090c6544fff806f38f287f9a733_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9f313e3a123c4e398f0c391421791a68_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id782ff201d364db6a73b7f362d0a9678_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i061db6fec9f94dce9fe88b9a6f4fc138_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab6bb1719c3747d69b101c25f39073a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b6a6d5c6ce048f5affe8b3f830295da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i94949d3130ed4a5799cf762de995588d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5a92509bdd1c40ecb4512f86503921ae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia5ba3c1e35eb464c897bb213112248c3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a192c3cef59471da28f4a1f91336aa3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id8df4fdf2ac64fa69822e22b9afd91f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c8d59fa396741e39a1c2b4ec07bf248_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4750c2997b414c319516d7f0f3c2d043_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib808cf79e1a9467cb239ce57e26f5d7a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08dd77efa97448c782606eca830b8ac9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if8553f543bdb4c5ea631132f326bb1fb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib05bf67d55164f34a2b82099cdad4337_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01d2be985d134f92a0588488c2ad06b2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5bb990f93a5446cc99f3cafcfb16a8c7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i70260250d8b54b01818e471ec885d017_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id0a5f472de164e8dbe46d04714a66b05_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c371a44ae834a938c2eab8e3804c578_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0c412272fff644b58159484e9b5ae929_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia869d1147bc1446495aafb25f926c462_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i965638d43bce41e3b02735b64f560508_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia91cd079354742c0867df4a66528389e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19585208fde04b1c81981c0ca9f09061_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3128ec1b43564e2d96eb81597c02d663_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibacdf9de7116494789ce8f50dcb91a04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5219a3f22dd9428d97614fe3e7a1a766_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id19f57dcee3c4712a2023169a0f785c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibcd8265eb4614ca3a1c91f1a4b31e2c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia997b5615fe74d49820b0e37481079c8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6d6b5e93fe48483fa4d489a84eb90fcb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">lh:UnbilledContractsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if90cdd4fb44c490e8db96e23d840e242_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i604cb92437094b8da834d312ee51fefc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia2cf3a400b1f476ea5787c60f96898cd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i71debf6a8f0d4523940cba33bbfde672_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:PGDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i27f5e6facf76444c9bb8e6cc52c08091_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:AscensionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6cfbec5b67f468491aadef03bde4c4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bcda50b59314d499c99aefc300d073a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:MeasurementPeriodAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd6fa1609f454ee999006a2ca5c7fbf4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:PGDxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifab204c91683402d8304f351f2d9d8b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:AscensionAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib16467344b1b432cbe4bb34ac4e88ed2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:MeasurementPeriodAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2021AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i252781e154ce4ee68f3712bac1795dba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:ExcludingEnvigoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad3c9245830049a8a009561519bdef0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib748907fa89944549ecc3829559ec590_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i346bf5e89d8c47e791d9565de78267f2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2020AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2020AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:ExcludingEnvigoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id29c59dc621c4fc5a3ef2e75514684f8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f418d9de6144d5faff8fb13ade9ed0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:OtheracquireesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lh:A2019AcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93f046cd09934cefaa22ced67e90f4fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife7be025871a46fd9996d5ad9debe4f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie7ab45a11aea4219a7df41bd1d97f0ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb2ae9f163ab4ccfb154f4e3d2b57376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ba475ac08fc422a97df2c8e89234910_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9115627d081a4e7f8da9645e6c6e0dbd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15ec77218cf94460acd857ca3fc42292_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id32383bcdde34b8fbc97617bf62c3dd2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7758f5f025ff42db97476f45552e5168_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">lh:ShortTermLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea6006a8e5f2488bbb8e13dc157b4650_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1624bc86da8f4e7c97d88cbeedab552c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i761a366fe39c434287e8300df93759d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34a480df3781456c930f1c1d2bf6e6d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i811cf99c6ab84718b8ec51529c8c38e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b1af064155a4d36999ebf514f2fb89f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i950679da32524bd98789e95cea30a39a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if213a3c74f2f48209419ad339b5b7d96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia778a92aafcf4f3b86b6acf7a5f3bd00_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a6f1b47c1da4a07a4d90f7f6d9d6873_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida4c96b0a864423fb6941c990f0bd412_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i06896b17e3534bd886142dad93e0126c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7047efd7d9e048fc9d889f0909b29db0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica2d22758b6b4c40aba801d1dee0b10e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07c4ccb6a1234b26931a664345261420_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i467dc562a91848b1b0ce1f13ff671106_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id565f2f485384d39b6ede80e66028f65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if2ab483bf28244679437409e834f6f56_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab7460360be9421682235ca8d2d1749e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibec9e46526e14376968e12d3425dfbdc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i394a9bbf406443b3a0435107240e0db4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4cde614e4cb446986b4fbfecce3dcce_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i46d54c5d3e8640c59106fdafc1864dc7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40cd958885374ef0bb6f568bdbc00731_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4ced70fc3e4428cb308d3a5643870c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3297036cb7294fb5ad2fc2995880b522_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6584c6c572e74242b54ad664f78e8847_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34801d131d6f4e44960ce44490a04267_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2265572a137642caacddaf6582838a7e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i653a67810f964ce0b55ec76d45884668_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:UseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibea8da233e774824b5531b77c20884c5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:MediaContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:MediaContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8e23aae794934b8d8478e5f0a45bacac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic421e408749148f891c6d7f1c116e693_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:ScheduleOfOtherIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icfe4125fff374c76adf4d24857926f50_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie3735b80739147d5a271f0e1938aabc1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i89543227f0574d3080d3504a668d3480_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">lh:PatentsLicensesAndTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8ab31968f0e34f71a97366c123d49ff0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:SeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79ba87d3d0c7416484b4fcb375524965_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermDebtIssueCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i065eee6e47b54c3090870de60295f740_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:ShortTermDebtIssueCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd89f07e99954cd38ca792abfb00c002_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:NotePayableCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i75e40fe043084cb7ba090e2fc3810877_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">lh:NotePayableCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d9f832f2302410f92ba15e850ffaa63_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i76b64d538c794125b25d372f3e739448_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7ebdf7872d5a46479565341763836748_I20190603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <instant>2019-06-03</instant>
        </period>
    </context>
    <context id="ied82a46b37fa415f996b1384457e6076_I20141219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-19</instant>
        </period>
    </context>
    <context id="i241890ceccc848f18d43631185197134_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22a0f88f6f224901b84e2ba995acd60f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">lh:A2022ASRSettlementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a95541978174baabe4f6bf28dc42c4e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">lh:A2022ShareRepurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2257a78dc611411cbe54235fc9161d50_I20230207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-07</instant>
        </period>
    </context>
    <context id="i612c1ffa3dbf48b1ba151c5142988893_D20230112-20230112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-12</startDate>
            <endDate>2023-01-12</endDate>
        </period>
    </context>
    <context id="icb5d5fbbddd149d0a71aea12be2f36ad_I20230112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-12</instant>
        </period>
    </context>
    <context id="i9deaf97408a241ccbbd50fa1238da6cd_D20230313-20230313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-13</startDate>
            <endDate>2023-03-13</endDate>
        </period>
    </context>
    <context id="i042ee9fdbf47424cb316cf8e47c149ca_D20230223-20230223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <context id="i536124e79a094520854fc8863d11ccad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7178226fd2c74faf83c80dbbaa06de64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherComprehensiveIncomeLocationAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifbadcad8fa62418ba708fec2acad3e8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">lh:Post2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaaa411a036c347a7814b3b8f3d7473d6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">lh:FederalLossCarryoverDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibc08ff0a0d474d61afc14770005abe03_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i973ac99fa8bc44b7b6e05a3777b91219_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90bbd94ee3fd44f1a0f4ecc350cc8574_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">us-gaap:ReductionInTaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i514823945de04d5ca0f42a63418890ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie3da55bd06384e75ba2d8ca0fef28489_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9e8b4d8b13a24d3298f7077d489fb327_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3e10f76783344eadb4cecdca2d63df8b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">lh:RestrictedStockAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i804964d2063644ac808d8d6365286160_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i390fbbf533d04684b80801b69914f782_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lh:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i04e385461a9c44a4839852c62f92193a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e0669932f004c748144af0bb609d89a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6477f78893c34d85af3901463d34cacf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic1bc0781f34c41a480538dd92da69d4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i154d50b63f0143c3ad531d1848bf9e2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic49569d8604944a6835acbc1ac8e6491_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60896f9da0414bb28b3e4a6cb0503006_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i121f72a018ec4c9f8b54ddf0db87bf57_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:CashBalanceRetirementPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i883357ce9ee9480da21af5fa83f5e410_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:CashBalanceRetirementPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2273640650a44965b54c030f812dcedd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i804f88e2691b4702a7deef00d5e7453d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanNameAxis">lh:UKPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7f604723897e4eb18b2d274c0a3e642e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b51bec3994e47d28d92a02668477358_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb1ac24816154f94bf39eb4750cfb55d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2f42b96cf07842bf9fa62fba969481aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0963421655a043af8a2b5bbb8989a17c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05fb58427b7c4800985757cce94eaf0d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i891ad191af8840378b461971806bc9ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie883fffe23064af6952bf1c7966447d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id75b0f3b14f749a2a2501b3580890929_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i44818990a4aa4815b47c3efcb5d6ae2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6af7b58ae38646cf89971672cf01e93e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i446afb2f73d045dda711f7c831299b78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9e08d02460648ceb4f5d1073cf29452_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30b8718e15b74da59c3573b8d71f7af5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34f729a2b5424259b6e99e69e9d72ff9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic24dd8a27e334839bd22287ccd572072_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i192893a861a0482dad94f453f9c613a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:InternationalDevelopedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7439af4f1d3a4692b0653838638d8af8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:UsFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if84b6a0f91f946deb9c23815d77889ba_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8df3c43a8db540988490dbc3e564ddea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51e1165a52a6489db2d1942fb682beb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia678cf83b6f6441dad461ad8e5dd1bd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02645e959c074c3f93e3d43221951719_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3662d054eed4f3eb5eafc0e90748600_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i28a1ab53d5f946889e265c64121dfdef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4323784b9ba6471abb2b94652c3bbd60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i911d298b24e044ba8bf3996c13022e04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:InternationalDevelopedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia533eccefe7c42269410fcbf42b37fbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0179f13a6a7141e6a26b122221a62bff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:UsFixedIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie90d8ce237094025b4a5a63bbeb2766e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd158ee242794532a7ea7bd54577418d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f7b3a1a2f964982926273037d0b54b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">lh:MutualFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i099c0ee08c294db19c4ae5023b72d7bc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8343104e0af14f108a0fbe74beca5c54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ec771cc41634795906fe138e1c81da2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7cf312ecfe346bc8025109327803b22_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0255c909ecf4062be8e1ef4d572ecce_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i460a5c47a3364d9fb3e031edfbfbabf3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibfdcdc0c2f94425c91be11297fbb8ce7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia240fb91ddb54361a789dbb9530b8f1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8760f818f2b14f7fbcf0a940eec93d45_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0f143c0038649379b2fa66b119f8d69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i692e176a76174874b466ab85db6c1c50_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:VariableAnnuityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if52b7c1c428d4e3eb3aaf9e375478112_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib97b7437ac9d4146bc2f4ed185519c80_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6813336b6e7e427a800450b3823e6bec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0fe63c273ca4dc4a880fceff9e1b046_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9b971586ec34065819f0eebea18797c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic020e345f5144121aead1d17fd7809f2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea4ad6f940d54031b324772fcccbf937_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d404caf16a542c58ecb2494a483b6d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd89c14ab1bc418b95827960d8faf263_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6911f4e40cef4e0daf420e676d7ec31a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0f3586c7f5d42f880ddfd468ec2f11f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3cd1a0cfffa24ae3b00be3abc0a69934_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i74347e5ffa2b413b99cd4565f3bf9e5e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8535bd9bae349cda74905f20fef9702_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibae84d9b5d624724bd2b3879c40582be_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95215116016547b1b171fa14b5466684_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:LifeAndAnnuityInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb5709179a954534b3ce4e1599336837_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c42916431b444feabb231e74e766011_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e8799065c4f474b92bc1ecf19ea0d73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b1e06d6958940bf87696cd12422aa1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2e111bc212c4b4b8fa775e86b3df66c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:DomesticPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb1897fa2127453ea83329424c5d5a7c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e936d64daeb461b84ea45f5f4b467e5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6bfb61b234a44fe89faf7bfc24db3774_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id8d1e82ad70f4603a498897f322acee1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbe23aa99b6847ed961d4fb0f516aeb5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide46a6b378da475296703e0ec9e436bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i471286d90c4d438bb8e6af11b7d82b62_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i09d960808d8d4f428d66f07f05dab5ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6eeb4246efc64a0cb377026f549a6398_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i499f72b196a94fd5ad14338aeaee2727_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6761ac2c526642dd8202c09476f40e82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6496b6e7dad462cbf7891c975366ed1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8742ac35d38745ad93ae0f53d955fd73_I20130331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-03-31</instant>
        </period>
    </context>
    <context id="i62637e2f6fb743b9ae7a0465221d295a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72fecf8a9a614c76a5f20c1427477921_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i402e968b57904d3c829927474cb21229_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2022SwapAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34dcbd66606a4b4bbdf2c53cc57f54e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib3e361c43a754d01b7cfa82e6747efc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d4a564210ff40f48048c331cff9cf8b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:SeniorLongTermNotesDue2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d9c8469896f45ecba498b0ede39dbb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50138a8641f3407a9f5402ee74004755_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">lh:Seniornotesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3097c8bb523449408d110548f79bebbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i109abf7ae534497d9389f80792db885b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4b210f3dae2a47ea886765221136d822_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i93446d1780df4a17825fb9e3f5392c19_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="lh:SwapTypeAxis">lh:A2018SwapAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c02350e7d7648358cd4fcc8dac9614c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i009fbbaa1fa344c2b260736d3d45ab4b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i264e173e323a4a219f6dc0e8e01fa43f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc8674bb0c33459fbc4f9f5bbe2b7c1e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0f2ec3658b894ce2949ed8539bf599fb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4fbdfe4753ce4100b31ceb13d3703285_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia768e38536fd419f880dba505b33374f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i536e737a10ed408381b0090740cf262a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42e70f9eae14480099b40da70d85557b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if8003dc869194e32943cb16d8eb14897_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a321f32243f4029afccd94fb3812764_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida3e59b3cfa94c3a8576e7a963f623b4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieacd7dfc507846ec8b5ce92f17564027_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2e71eb1cfbd34d7fb34466d92877d3c6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idcbab8d63eb841018519ada24b99d545_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56c5cb78f4904c6aacf992f36ac8a90c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64aa8e649bdb4c108b75103b2eb4a2fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56daedd82c3646baa58c1523980c51f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide1d0653044641ba893251b0fd4296c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i502b3fc0ff254fd1bf2c37a2fa0d8698_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15d2c61db1f64f1b9741884acf529ebf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17669eb64069457a845cbd59f00480e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ae52be303bc4ee4954f1fb18ca47961_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51a7562319b848598560ae7b3eb035ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4de2a6c8c4714f6c8bfd3e3f4c4ff1f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id75f25869b5146e58f626502da7c7971_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ce077a3e4744e96a9f84ad3d59a2424_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic98ae2d3393544a89fec8d3f7e79ceb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lh:OthercountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia62a4bb28ea746489ab2bda95c3e5be5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib64989aa30ef4d9295e8155f32cda7f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000920148</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lh:DrugDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="employee">
        <measure>lh:Employee</measure>
    </unit>
    <unit id="y">
        <measure>utr:Y</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF80LTEtMS0xLTExNzAyOQ_2335c0ab-db80-4c17-84ee-adab86ba7fbe">0000920148</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF81LTEtMS0xLTExNzAyOQ_39f344a7-1320-4254-bfab-b8260503d5dc">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF84LTEtMS0xLTExNzAyOQ_1b45a3e2-6804-4b10-a08d-3427f4ffcd9f">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF85LTEtMS0xLTExNzAyOQ_cb343bf5-4c9b-4032-81ff-b3c6b743e232">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF8xMC0xLTEtMS0xMTcwMjk_df499d52-374d-4220-b88d-ab5873410e73">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80L2ZyYWc6YTA3NzkyOWNjNTg1NGI2ZTgwMGUzNTM5ZjY3MWM3OWMvdGFibGU6ZGRhMTZkMzI0NjhmNDA2NGIzYTVhNDgyMTgxMDM4MjgvdGFibGVyYW5nZTpkZGExNmQzMjQ2OGY0MDY0YjNhNWE0ODIxODEwMzgyOF8xMS0xLTEtMS0xMTcwMjk_a2b79077-2b41-4425-8f4f-2c0703472a7b">false</dei:AmendmentFlag>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzItMS0xLTEtMTE3MDI5_5bee593b-47f3-4b57-b723-174cb931b6ea"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzItMy0xLTEtMTE3MDI5_2248baec-71c6-42ea-96de-e2ef71539061"
      unitRef="usd">21500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:CommonStockSharesIssued
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzUtMS0xLTEtMTE3MDI5_022934dc-6776-44c0-8aa3-1daff8d6f7e5"
      unitRef="shares">88200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjkvZnJhZzpkMzZhOGE3MzkzZTk0ZWVkYjA4NmVhNGQ1YzIxZWVhMS90YWJsZTpkNzVkOGFhMzVkOGE0NWVmYjgyMDQ3MTc4MGU2YjRmNi90YWJsZXJhbmdlOmQ3NWQ4YWEzNWQ4YTQ1ZWZiODIwNDcxNzgwZTZiNGY2XzUtMy0xLTEtMTE3MDI5_5b97fdfe-a8ee-42ba-abd7-a48f646c59d2"
      unitRef="shares">93100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgz_d437eedd-a60e-49b6-8abf-57f6aa3caa7f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg0_fce0c7fa-2017-4af9-bab2-db582913ccbf">true</dei:DocumentAnnualReport>
    <dei:DocumentTransitionReport
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc4_c9d6ed54-d7f7-42a7-afe2-f2ccfaef6011">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg1_221c68b1-b99e-4b2d-9c7d-5dd6943b7a94">1-11353</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg2_eea1b153-30ab-4b4c-9905-8c2f860aafb7">LABORATORY CORPORATION OF AMERICA HOLDINGS</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6ZjhhMTAyMGMwYmRiNGE1ZTk3MWQ5OGY5NmE1M2YyNTUvdGFibGVyYW5nZTpmOGExMDIwYzBiZGI0YTVlOTcxZDk4Zjk2YTUzZjI1NV8wLTAtMS0xLTExNzAyOQ_29521173-5b92-4f48-924e-d42520eabb44">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6ZjhhMTAyMGMwYmRiNGE1ZTk3MWQ5OGY5NmE1M2YyNTUvdGFibGVyYW5nZTpmOGExMDIwYzBiZGI0YTVlOTcxZDk4Zjk2YTUzZjI1NV8wLTItMS0xLTExNzAyOQ_e724134b-68c4-46c4-bea0-c8acb607c9fb">13-3757370</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8wLTAtMS0xLTExNzAyOQ_975e90bf-3866-4fd2-bf2e-24c7cc645e56">358 South Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTAtMS0xLTExNzAyOQ_ebe590a6-55ec-4c37-8ab2-36fb4b3cca3d">Burlington,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTEtMS0xLTExNzAyOQ_a7b92f49-735e-41f6-a1b7-d22aced14a01">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6NTM1ZDhlNTZjZGM2NDk2NjgzNTU4NDI2M2NmMzZjZTAvdGFibGVyYW5nZTo1MzVkOGU1NmNkYzY0OTY2ODM1NTg0MjYzY2YzNmNlMF8xLTMtMS0xLTExNzAyOQ_a1d9720d-805f-4c27-9ba9-3c738579d648">27215</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc0_e64a3f9f-2298-4425-865c-7a022b31ec51">336</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc1_b52ce19e-46f2-469d-891c-5cab0e431fc7">229-1127</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTAtMS0xLTExNzAyOQ_03edfa8c-be6a-4137-814a-e27699ab4277">Common Stock, $0.10 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTEtMS0xLTExNzAyOQ_800146d3-0af7-476c-9736-ab5e6e5cc615">LH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YTAzMjdjMWFiZDAyNDk0Yjg4N2QwMmRhNDZkNjVjMDQvdGFibGVyYW5nZTphMDMyN2MxYWJkMDI0OTRiODg3ZDAyZGE0NmQ2NWMwNF8xLTItMS0xLTExNzAyOQ_1996f8a0-38b2-423f-bfc5-026c6a377338">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc5_192e40cd-831e-4a16-8322-f6c662459b82">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg3_3be64ec0-f174-43bc-b4b5-cbdc003d283d">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc3_3fd67593-0c5a-4553-856a-a442c1e9cee9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgw_ac6442da-33f5-4021-bce0-bb57fc4eadb7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8wLTAtMS0xLTExNzAyOQ_688bed30-0ff3-4696-8b2c-945fe8a2121e">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8xLTMtMS0xLTExNzAyOQ_ed36906f-fd59-4fb8-a540-f729f7689fd3">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGFibGU6YjUwZTg4ODBjYzMwNDllZDlkNTY4ZGI0YmQzNzJhYTgvdGFibGVyYW5nZTpiNTBlODg4MGNjMzA0OWVkOWQ1NjhkYjRiZDM3MmFhOF8yLTMtMS0xLTExNzAyOQ_4c6ebbc6-eae2-4251-9b5c-8e2c5d114b67">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDgy_c369acb4-69d4-42f8-ac53-5ee5864dee10">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDc2_55f3d903-7082-46d8-b13f-38daf09cf9e4">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i04baeb7b9b0c4b62bc8ac723f9759148_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8yODY3_a0826877-09a8-4801-b086-96684029aeac"
      unitRef="usd">20200000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3df4ce9e79c24b838b1688ef5f97af09_I20230227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zMTA3_11e47222-d3dd-4d5d-afe1-4179797ffdfe"
      unitRef="shares">88500000</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xL2ZyYWc6YTZlZDJlZDc5NTdjNDRjODkzOWMxNmM1MDBhMGFkZTgvdGV4dHJlZ2lvbjphNmVkMmVkNzk1N2M0NGM4OTM5YzE2YzUwMGEwYWRlOF8zNDg5_d12b5485-a9cf-409b-9fa9-8b48fad45363">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;List hereunder the following documents if incorporated by reference and the Part of the Form&#160;10-K into which the document is incorporated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portions of the Registrant&#x2019;s Notice of Annual Meeting and Proxy Statement to be filed no later than 120&#160;days following December&#160;31, 2022, are incorporated by reference into Part III.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:Revenues
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMi0xLTEtMS0xMTcwMjk_f02d3f7e-93e6-4a21-8bcc-953fb6556130"
      unitRef="usd">14876800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMi0zLTEtMS0xMTcwMjk_b1b6fb31-f9f6-4069-b3b2-4d9d9c3d850e"
      unitRef="usd">16120900000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMy0xLTEtMS0xMTcwMjk_414b2651-844a-40d1-9e2a-9cc3fc012519"
      unitRef="usd">4385100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfMy0zLTEtMS0xMTcwMjk_8d6eb6e6-13fb-454e-8c95-d06eecf9b483"
      unitRef="usd">5624300000</us-gaap:GrossProfit>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNC0xLTEtMS0xMTcwMjk_77e12ae7-49ce-4bab-8e8b-de5fcc7b7d81"
      unitRef="usd">1773900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNC0zLTEtMS0xMTcwMjk_118fad5f-102e-4974-8764-5010abdfaf5f"
      unitRef="usd">3259500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNS0xLTEtMS0xMTcwMjk_a648e5fa-167d-48bd-9b66-6a6ff1f04bcd"
      unitRef="usd">1279100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNS0zLTEtMS0xMTcwMjk_a7c0966d-8759-47fc-83f1-391bc08f1ef0"
      unitRef="usd">2377300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNi0xLTEtMS0xMTcwMjk_9173d25d-6494-423a-8f66-2f2d307ad7c8"
      unitRef="usd">1955900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNi0zLTEtMS0xMTcwMjk_d1f4f905-3646-4b99-969a-b636bd9c2d56"
      unitRef="usd">3109600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNy0xLTEtMS0xMTcwMjk_3d467232-2984-4d36-be98-65e82f53d2d7"
      unitRef="usdPerShare">14.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfNy0zLTEtMS0xMTcwMjk_dbaf8495-e4a7-4752-8d1f-e320357f2df3"
      unitRef="usdPerShare">24.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfOC0xLTEtMS0xMTcwMjk_124eaada-abe6-4543-86ad-651f961eafca"
      unitRef="usdPerShare">13.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjBlNjdhMTAwYjg5NTQ1ZWE4NzZkNzk3OTIyMTQ1YjVkL3RhYmxlcmFuZ2U6MGU2N2ExMDBiODk1NDVlYTg3NmQ3OTc5MjIxNDViNWRfOC0zLTEtMS0xMTcwMjk_a364f97f-1356-46af-af58-894d5264fb1c"
      unitRef="usdPerShare">24.39</us-gaap:EarningsPerShareDiluted>
    <lh:PercentofRevenueContributed
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RleHRyZWdpb246NjU1YmZjOTljMGU3NDI4ODg1MjYxMTRlOTQzMmYzYmNfMTY0OTI2NzQ0MjczOA_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RleHRyZWdpb246NjU1YmZjOTljMGU3NDI4ODg1MjYxMTRlOTQzMmYzYmNfMTY0OTI2NzQ0Mjc0Mg_afc9324a-33dc-46c5-9679-e8205e4a8f3f"
      unitRef="number">0.39</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xLTEtMS0xMTcwMjk_ffc564ba-8c08-4e02-9e36-4cfcf25da42c"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ieabfe2258e1446b192ef394f16489167_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC01LTEtMS0xMTcwMjk_b63d29fd-58e7-41a0-90db-8742148ecf6b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xMS0xLTEtMTE3MDI5_13409024-b8e3-476d-9198-58552d60e9ef"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xMy0xLTEtMTE3MDI5_6b38d010-9e52-4de0-883f-c880cc44e098"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNS0xLTEtMTE3MDI5_07b9660a-b5f8-43fc-929c-9e7cd9237695"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNS0xLTEtMTE3MDI5_626eb1b8-cde0-433c-9a5c-0582f25db4b6"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNy0xLTEtMTE3MDI5_6073ba1f-ad2e-4cb9-827d-dd2892784277"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xNy0xLTEtMTE3MDI5_d12b806a-8dcf-42a4-b103-6bc2c46af939"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0xOS0xLTEtMTE3MDI5_08fee676-7298-42f2-8979-ba5ac9530b0f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yMS0xLTEtMTE3MDI5_12c3a73d-ffc2-460c-b492-f6f0e84e52ed"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yNi0xLTEtMTE3MDI5_d0a4dde7-6ce1-4ae4-941c-81c6984a18c5"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0yOC0xLTEtMTE3MDI5_0033e698-efea-453a-b32b-565fd7769b1b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0zMC0xLTEtMTE3MDI5_4574c43c-fd5c-46bb-8068-2f89e424d107"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i49a7f666344b43219373509023b86a61_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNC0zMi0xLTEtMTE3MDI5_6ca3ffa6-06ac-4718-931c-d4190a6121cb"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia00703317297439a899a69e868562330_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xLTEtMS0xMTcwMjk_ef97beb1-888f-42d9-ae8d-9979489a819a"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS01LTEtMS0xMTcwMjk_60bfad80-1852-4063-bb23-ba78d8484bda"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xMS0xLTEtMTE3MDI5_b3615c40-cf3a-4401-9f2e-e2fbc73ea475"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xMy0xLTEtMTE3MDI5_bd2e2dc1-cdb1-4e5a-be2c-5a9f0045617a"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNS0xLTEtMTE3MDI5_b4618336-8de7-4c99-8f44-1afe835df481"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNS0xLTEtMTE3MDI5_df747fb9-cdb5-4c5c-a6a9-d416d133c9ab"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNy0xLTEtMTE3MDI5_0eb6022d-a832-402d-91ee-5d68f01b747d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xNy0xLTEtMTE3MDI5_2ed3078a-cda5-435b-885e-cc7fe72d3caf"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0xOS0xLTEtMTE3MDI5_40c782aa-8fce-4bbd-b307-78d4654e0c27"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yMS0xLTEtMTE3MDI5_9efee418-80ce-409f-8629-af8e491f90c5"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yNi0xLTEtMTE3MDI5_90f2575d-3455-4c87-9f85-6aa3fe6fff5d"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i174342f325564eb4800f5d7bafca1841_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0yOC0xLTEtMTE3MDI5_267a854d-e4f7-4d0e-8790-e5ad4a2aadea"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0zMC0xLTEtMTE3MDI5_4ff9c6a3-e335-4262-a979-9a92fb978ed9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNS0zMi0xLTEtMTE3MDI5_12644480-1493-43b0-bcf8-84c48a043fe7"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xLTEtMS0xMTcwMjk_67e351da-d65a-4295-a8cc-ece7f1f99a38"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi01LTEtMS0xMTcwMjk_f646bbc9-b8b6-48b0-a1c5-b50997ce3c83"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xMS0xLTEtMTE3MDI5_34b02f11-9cd6-45f7-baea-f0b0491afd9e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xMy0xLTEtMTE3MDI5_8ed16f25-da28-41c6-afef-6869fbf47139"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xNS0xLTEtMTE3MDI5_f973d042-f777-48a0-a891-e29bfda029b6"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xNy0xLTEtMTE3MDI5_91e8b979-b035-46c7-9e52-c2b260bb8fbe"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0xOS0xLTEtMTE3MDI5_871a9ce1-825c-4f28-9a5c-728bc0ec2050"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i91139fb3405c40e89005a42835b1528e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yMS0xLTEtMTE3MDI5_2960cd61-5005-442c-9d7f-be8ed330f94c"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yNi0xLTEtMTE3MDI5_64b01766-aabe-4261-a609-4d55644aaf75"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0yOC0xLTEtMTE3MDI5_4a75ef98-1a52-423f-8a2c-0b73b3bf9c27"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2a6714ab30154ab7adf7919442029308_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0zMC0xLTEtMTE3MDI5_4cdec5cc-324d-46d8-8413-a8c5cead4ef9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNi0zMi0xLTEtMTE3MDI5_e9e15cb8-fdb5-438c-9198-1f99fe6320cb"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i41204750b78b41e99bbfcab862d31763_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xLTEtMS0xMTcwMjk_63813dc7-22b0-4a7d-9a8b-fd9090a0b7be"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy01LTEtMS0xMTcwMjk_70d61c3a-3e16-4a0a-95d5-37cd6c9d135d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xMS0xLTEtMTE3MDI5_13ca5584-843c-4ae3-a6b9-2e745ede783e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xMy0xLTEtMTE3MDI5_0a4ba1e5-b42b-4f23-a67d-cbcd8e3e94ed"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNS0xLTEtMTE3MDI5_70729d38-b348-4dd0-afa1-1a00f039691e"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNS0xLTEtMTE3MDI5_ff99a912-0abb-48d1-8d0f-5ec2ab08ea63"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNy0xLTEtMTE3MDI5_85f65e7c-332f-432a-b53a-7cb88cac73ac"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xNy0xLTEtMTE3MDI5_97d013f3-a788-472d-a26d-2c1998700fe6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0xOS0xLTEtMTE3MDI5_4b70d3fb-a907-4b5a-adfa-4b6c5a823426"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yMS0xLTEtMTE3MDI5_39c638c6-bee2-4791-928b-d85fd3398a89"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="icba36eacc3c943cca03f3598759b2674_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yNi0xLTEtMTE3MDI5_e5d5ad7e-2525-47de-8f31-7efb3615015f"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0855e4e7139742529986707c444dfb8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0yOC0xLTEtMTE3MDI5_52547e93-e813-481b-9d65-fee6d2958cb6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0zMC0xLTEtMTE3MDI5_3954c7ba-fe0e-4984-a8d1-ae0cbbd82172"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfNy0zMi0xLTEtMTE3MDI5_c0762774-d1f9-4e55-ac60-5a875c84e108"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xLTEtMS0xMTcwMjk_1df03a3a-3473-4142-8290-de28e08c71b8"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC01LTEtMS0xMTcwMjk_8d8e043e-5e46-48b2-a6bb-b62b8f05e94d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xMS0xLTEtMTE3MDI5_40b117a3-3b9c-4f4c-ae9b-db27e72b7930"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xMy0xLTEtMTE3MDI5_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNS0xLTEtMTE3MDI5_459fb7af-ea71-46b1-9421-9014ef0e075c"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNS0xLTEtMTE3MDI5_9b353615-beba-4a6c-b30d-8ca80952dd95"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNy0xLTEtMTE3MDI5_0d3b4240-9e6b-4e1a-8123-ae947e718326"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xNy0xLTEtMTE3MDI5_af6cef02-8ffc-4923-963b-ca0aeb989cc6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0xOS0xLTEtMTE3MDI5_8b829856-5fdb-442b-8a81-b5ad38c20ee0"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yMS0xLTEtMTE3MDI5_fd1d06cd-0880-47e1-8150-f015cfcf2156"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yNi0xLTEtMTE3MDI5_6fa054ce-c676-4930-8d75-2cccdeaf3d65"
      unitRef="number">0.65</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0yOC0xLTEtMTE3MDI5_d96f4e69-3b29-4eb7-a9b3-953b42eee06c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0zMC0xLTEtMTE3MDI5_dd5313ff-22fa-4bbb-80d5-ceb07e723aa5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfOC0zMi0xLTEtMTE3MDI5_e67c0e10-1410-47f0-a90f-0ea6c273b1b5"
      unitRef="number">0.65</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6d6cb383b4834da09d62346a62279532_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMS0xLTEtMTE3MDI5_e131afc4-2553-49a8-8c2f-dc4bd0f75154"
      unitRef="number">0.19</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtNS0xLTEtMTE3MDI5_9a407ba3-fa15-43c6-b033-6b8312a87745"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTEtMS0xLTExNzAyOQ_036beacc-c9dd-4559-9188-54df60e51a22"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTMtMS0xLTExNzAyOQ_afc9324a-33dc-46c5-9679-e8205e4a8f3f"
      unitRef="number">0.39</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTUtMS0xLTExNzAyOQ_20acbe51-b459-4b87-b617-11ab6216626c"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTUtMS0xLTExNzAyOQ_879f0a87-5a50-41fc-8f1d-dbf58b56e8a5"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTctMS0xLTExNzAyOQ_d79968d6-ce59-43f0-9dc5-cd16d6cffb73"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMTktMS0xLTExNzAyOQ_1e78b6da-23c4-4f45-9d78-d44e3e8ccdf0"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjEtMS0xLTExNzAyOQ_52fe24e0-75d3-4fe4-a6d8-89237790a347"
      unitRef="number">0.36</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjYtMS0xLTExNzAyOQ_b6a25641-78f7-4516-ab75-e80b637a8582"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMjgtMS0xLTExNzAyOQ_f1a23581-874c-4fcd-ab66-2d26297114f2"
      unitRef="number">0.11</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMzAtMS0xLTExNzAyOQ_56277e88-def6-4dc2-a1dd-76cd7ca6adef"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTEtMzItMS0xLTExNzAyOQ_33a05168-7621-4556-83b6-de53c125691d"
      unitRef="number">0.35</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMS0xLTEtMTE3MDI5_612a8796-4e7e-4e04-b1ca-0198692185a3"
      unitRef="number">0.80</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtNS0xLTEtMTE3MDI5_c469b4e7-a1e4-49b5-9420-f8dcbbf09f01"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTEtMS0xLTExNzAyOQ_f68c79a3-a685-40ca-8dc5-98fcc0ea280c"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTMtMS0xLTExNzAyOQ_bfa7e972-0219-45bc-a914-44231b26c937"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTUtMS0xLTExNzAyOQ_46045b06-3430-4017-9a0a-5c0d447afab8"
      unitRef="number">0.81</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTUtMS0xLTExNzAyOQ_ad0d209e-2de6-407e-b7e2-0db9f088d21e"
      unitRef="number">0.81</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTctMS0xLTExNzAyOQ_003c51be-60ae-468a-a7b5-f3f331d06e35"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTctMS0xLTExNzAyOQ_e88f5c8e-7c19-4729-94a5-4ee6e181e3b4"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMTktMS0xLTExNzAyOQ_cbfd13a0-9667-47cb-a51d-2614a6e840cf"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjEtMS0xLTExNzAyOQ_f1776bcb-6186-42f3-8e06-a6acd66b5946"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjYtMS0xLTExNzAyOQ_370a4c43-c13d-443c-8cfd-7d01f5614536"
      unitRef="number">0.82</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMjgtMS0xLTExNzAyOQ_fa6e2047-c3a0-4938-bcd9-fdcb3f93f6ad"
      unitRef="number">0.11</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMzAtMS0xLTExNzAyOQ_d9f50ece-a52d-4a8f-9fe9-8c3eab0c8c38"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8zNy9mcmFnOjY1NWJmYzk5YzBlNzQyODg4NTI2MTE0ZTk0MzJmM2JjL3RhYmxlOjMwNmQzOTNlMWJiZTQ1MDBiNjRjMTljZjNmZGQ0Y2E3L3RhYmxlcmFuZ2U6MzA2ZDM5M2UxYmJlNDUwMGI2NGMxOWNmM2ZkZDRjYTdfMTMtMzItMS0xLTExNzAyOQ_de74e993-a7fa-4325-8015-5903478ed42a"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <us-gaap:Revenues
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RleHRyZWdpb246MzUxYmNlNmEzNDc2NDQyODlkNDUwNDIwYjNiNmJiYWVfNTM_30f32314-7ae3-4f09-b0d9-3c2e086e63af"
      unitRef="usd">9203500000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RleHRyZWdpb246MzUxYmNlNmEzNDc2NDQyODlkNDUwNDIwYjNiNmJiYWVfODY_458408f8-72f6-480d-998a-f67b133babd9"
      unitRef="usd">2025500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMi0xLTEtMS0xMTcwMjk_30f32314-7ae3-4f09-b0d9-3c2e086e63af"
      unitRef="usd">9203500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMi0zLTEtMS0xMTcwMjk_4fec45df-805b-48fd-8373-f5f46650fedd"
      unitRef="usd">10363600000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMy0xLTEtMS0xMTcwMjk_458408f8-72f6-480d-998a-f67b133babd9"
      unitRef="usd">2025500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80MC9mcmFnOjM1MWJjZTZhMzQ3NjQ0Mjg5ZDQ1MDQyMGIzYjZiYmFlL3RhYmxlOjFkYjJhMzVkZTU0MzRlMmJiMWQ1YjUzZGQxYTQ3YzE4L3RhYmxlcmFuZ2U6MWRiMmEzNWRlNTQzNGUyYmIxZDViNTNkZDFhNDdjMThfMy0zLTEtMS0xMTcwMjk_779620f1-60ea-43df-b065-615153a31746"
      unitRef="usd">3205600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RleHRyZWdpb246NjU2ZmVmM2ZmN2RjNDM5NDk4M2QxZWU2MmM1ODc2NzRfNTQ_88d88882-f1b2-4c91-81b6-71096c0d9524"
      unitRef="usd">5710200000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RleHRyZWdpb246NjU2ZmVmM2ZmN2RjNDM5NDk4M2QxZWU2MmM1ODc2NzRfODY_6f9ffa4b-d948-4818-b060-bec59c92a0e9"
      unitRef="usd">801100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMi0xLTEtMS0xMTcwMjk_88d88882-f1b2-4c91-81b6-71096c0d9524"
      unitRef="usd">5710200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMi0zLTEtMS0xMTcwMjk_e903ff10-b2cf-48ad-a344-3fd8bc1637d7"
      unitRef="usd">5845500000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMy0xLTEtMS0xMTcwMjk_6f9ffa4b-d948-4818-b060-bec59c92a0e9"
      unitRef="usd">801100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80My9mcmFnOjY1NmZlZjNmZjdkYzQzOTQ5ODNkMWVlNjJjNTg3Njc0L3RhYmxlOmEyOTE2NThhNmM5YzRjMGFiYjQyMzVkNDc1YjMyMzcwL3RhYmxlcmFuZ2U6YTI5MTY1OGE2YzljNGMwYWJiNDIzNWQ0NzViMzIzNzBfMy0zLTEtMS0xMTcwMjk_7c9dc5f1-7242-49a3-a711-d9905ce8b60f"
      unitRef="usd">887100000</us-gaap:OperatingIncomeLoss>
    <dei:EntityNumberOfEmployees
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV80Ni9mcmFnOjZhMDUyMTQxMjAxZjQ3ODc4OTFjMGE1YjBlYTBhZTcyL3RleHRyZWdpb246NmEwNTIxNDEyMDFmNDc4Nzg5MWMwYTViMGVhMGFlNzJfMTY0OTI2NzQ5ODk2Mw_81e39c35-370e-4198-aa43-087366bb81b2"
      unitRef="employee">80000</dei:EntityNumberOfEmployees>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV83My9mcmFnOmU3NWRlZjNhMzcwZjQ4ODM5MGExNjJhYzZmYTVlOWY0L3RleHRyZWdpb246ZTc1ZGVmM2EzNzBmNDg4MzkwYTE2MmFjNmZhNWU5ZjRfNjA0NzMxNDMyMzg2Mg_7718d4b5-2602-4814-bf17-844c9ef16a28"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dei:AuditorFirmId
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNTcvZnJhZzozYmFjMzE5YWY0YjM0NGNhOWVlYTBmMTE0NTllZTY2Ny90YWJsZTozNzMyOTNjNWU0MTE0ZTIxOTA4NDYyZGU4N2FlZDIzYS90YWJsZXJhbmdlOjM3MzI5M2M1ZTQxMTRlMjE5MDg0NjJkZTg3YWVkMjNhXzItMi0xLTEtMTE3MDI5_ba3eee71-7ff8-44b0-b6c9-1e1e30d21864">34</dei:AuditorFirmId>
    <dei:AuditorFirmId
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNTcvZnJhZzozYmFjMzE5YWY0YjM0NGNhOWVlYTBmMTE0NTllZTY2Ny90YWJsZTozNzMyOTNjNWU0MTE0ZTIxOTA4NDYyZGU4N2FlZDIzYS90YWJsZXJhbmdlOjM3MzI5M2M1ZTQxMTRlMjE5MDg0NjJkZTg3YWVkMjNhXzQtMi0xLTEtMTE3MDI5_b56b8030-2fef-4e51-845e-badd83ec692b">238</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzkyNjQ_e0d24a53-7ee3-4fd5-938b-85693f39e709">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzkyNjg_8d7b3a51-b7ed-4111-8d0c-c47d48da78bb">Raleigh, North Carolina</dei:AuditorLocation>
    <dei:AuditorName
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjAvZnJhZzo4ZDQwNTUzZjkwNWI0NDUxODc0NmZkZmUxNzI1NzBjYy90ZXh0cmVnaW9uOjhkNDA1NTNmOTA1YjQ0NTE4NzQ2ZmRmZTE3MjU3MGNjXzEwOTk1MTE2NTY2NTg_e0d24a53-7ee3-4fd5-938b-85693f39e709">Deloitte &amp; Touche LLP</dei:AuditorName>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMtMS0xLTEtMTE3MDI5_d3a0058d-93d3-4a3d-a26b-16d898c1ab91"
      unitRef="usd">430000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMtMy0xLTEtMTE3MDI5_f26128bf-d652-4425-80bb-aa947f3b2e70"
      unitRef="usd">1472700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQtMS0xLTEtMTE3MDI5_39848748-d178-4782-9c9a-2d4f746edb2b"
      unitRef="usd">2222000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQtMy0xLTEtMTE3MDI5_5fb65c46-0213-49dc-b39c-42f8acdbe7c5"
      unitRef="usd">2261500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledContractsReceivable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzUtMS0xLTEtMTE3MDI5_1d689de6-82b6-43f2-8c5a-9cc633d520c0"
      unitRef="usd">795400000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzUtMy0xLTEtMTE3MDI5_909112b3-c216-4619-89d3-524f951b214a"
      unitRef="usd">716800000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:InventoryNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzYtMS0xLTEtMTE3MDI5_9ec6a82b-7203-4299-a455-5a550ba47ffe"
      unitRef="usd">470600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzYtMy0xLTEtMTE3MDI5_23c225fb-4c01-4791-b41d-b3124ec86283"
      unitRef="usd">401400000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzctMS0xLTEtMTE3MDI5_ec4bc904-2f1e-4e0e-b10a-7875917312f9"
      unitRef="usd">707000000.0</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzctMy0xLTEtMTE3MDI5_e11567fb-7c37-4627-82f8-d7bd0f85b31b"
      unitRef="usd">478100000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzktMS0xLTEtMTE3MDI5_138b546e-d3e3-4822-89de-082efc5b8650"
      unitRef="usd">4625000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzktMy0xLTEtMTE3MDI5_cfc76232-45f2-42c8-81ff-ea46cddb96cb"
      unitRef="usd">5330500000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEwLTEtMS0xLTExNzAyOQ_bea5130b-fcfa-4ea7-91bf-2e52c8753550"
      unitRef="usd">2956200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEwLTMtMS0xLTExNzAyOQ_d185207e-e465-41ea-aa73-033a77a39f13"
      unitRef="usd">2815400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzExLTEtMS0xLTExNzAyOQ_280832d2-73c6-4c45-b8d8-922f1c9d3afa"
      unitRef="usd">8121000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzExLTMtMS0xLTExNzAyOQ_fc1f8afb-ab16-49ba-8d23-8c3763334bf7"
      unitRef="usd">7958900000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEyLTEtMS0xLTExNzAyOQ_84feb2ae-3606-416d-a049-1e727dac0404"
      unitRef="usd">3946900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEyLTMtMS0xLTExNzAyOQ_0abc04ee-2ea3-4fde-8727-d3b2fe3f6977"
      unitRef="usd">3735500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEzLTEtMS0xLTExNzAyOQ_55c7f46a-5de0-4bea-806b-259cbe1855b7"
      unitRef="usd">65700000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzEzLTMtMS0xLTExNzAyOQ_7277a8ed-9bdd-43da-8f66-a45fbc98941b"
      unitRef="usd">60900000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE0LTEtMS0xLTExNzAyOQ_376c9b6b-0733-4ad1-b672-e7c5833b810f"
      unitRef="usd">7600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE0LTMtMS0xLTExNzAyOQ_273622b8-21bf-49e1-a123-9aa7b1feaa99"
      unitRef="usd">21600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE1LTEtMS0xLTExNzAyOQ_1d40f257-1001-4748-9eab-b1bf16104f85"
      unitRef="usd">432700000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE1LTMtMS0xLTExNzAyOQ_aa04c84a-231d-482b-9e04-12b46df92081"
      unitRef="usd">462600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE3LTEtMS0xLTExNzAyOQ_0021c342-72c8-4582-9272-4972fef81d21"
      unitRef="usd">20155100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzE3LTMtMS0xLTExNzAyOQ_a48ad7af-66df-48db-ad40-6be85cfdc32b"
      unitRef="usd">20385400000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIwLTEtMS0xLTExNzAyOQ_1d35ab0f-2d1b-4475-973d-14f9bbafca5a"
      unitRef="usd">934800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIwLTMtMS0xLTExNzAyOQ_8e29c96a-0f50-452c-9a4a-ecec13fd5a38"
      unitRef="usd">621300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIxLTEtMS0xLTExNzAyOQ_1c9529d2-81b4-4a56-aeee-d9af7305e5c6"
      unitRef="usd">1068800000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIxLTMtMS0xLTExNzAyOQ_63a8274b-2a3d-4445-8f52-3b7b6c233d46"
      unitRef="usd">1404100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIyLTEtMS0xLTExNzAyOQ_103c76d1-cb53-45b2-bd5a-63142fd11ccc"
      unitRef="usd">582100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIyLTMtMS0xLTExNzAyOQ_cc080f9e-2a0c-42df-86d9-fb17d86449a9"
      unitRef="usd">558500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIzLTEtMS0xLTExNzAyOQ_64bf13b7-299d-4fbf-9082-c11925180667"
      unitRef="usd">185500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzIzLTMtMS0xLTExNzAyOQ_14197753-fb95-4f4a-9186-a1c1634ced1d"
      unitRef="usd">187000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI0LTEtMS0xLTExNzAyOQ_102be517-3a54-40db-b1fa-2a51a56ae1c1"
      unitRef="usd">6000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI0LTMtMS0xLTExNzAyOQ_a5123ddb-dc78-433a-a6e7-835dc14ed789"
      unitRef="usd">10500000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lh:ShortTermDebtAndLongTermDebtCurrentMaturities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI2LTEtMS0xLTExNzAyOQ_1da9799f-5fb1-40a6-a114-bed8986111c1"
      unitRef="usd">301300000</lh:ShortTermDebtAndLongTermDebtCurrentMaturities>
    <lh:ShortTermDebtAndLongTermDebtCurrentMaturities
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI2LTMtMS0xLTExNzAyOQ_6431adb3-8991-40b4-9dfb-4f23dcc7c499"
      unitRef="usd">1500000</lh:ShortTermDebtAndLongTermDebtCurrentMaturities>
    <us-gaap:LiabilitiesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI4LTEtMS0xLTExNzAyOQ_66fdf978-323b-4dc4-b86e-581427602d4c"
      unitRef="usd">3078500000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI4LTMtMS0xLTExNzAyOQ_18e2c13d-6226-43e0-92c5-226df42cb188"
      unitRef="usd">2782900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI5LTEtMS0xLTExNzAyOQ_8b813eff-b9a2-4fbd-b0be-cdf0fa25f6ad"
      unitRef="usd">5038800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzI5LTMtMS0xLTExNzAyOQ_9847adc3-b295-4ec6-bddf-506f9317e003"
      unitRef="usd">5416500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMwLTEtMS0xLTExNzAyOQ_2a33db96-17e5-404d-8408-5247ef0d9532"
      unitRef="usd">679700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMwLTMtMS0xLTExNzAyOQ_d24e74c4-edd5-41ca-a993-5f37b5ef94ac"
      unitRef="usd">642500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMxLTEtMS0xLTExNzAyOQ_fbc6605d-5777-485b-b063-6328b7065382"
      unitRef="usd">83600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMxLTMtMS0xLTExNzAyOQ_dd08b24a-8a21-49f3-9cf6-c7f803204745"
      unitRef="usd">84600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMyLTEtMS0xLTExNzAyOQ_4c3fd5f9-ff19-4696-b159-c36ff6167c82"
      unitRef="usd">736200000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <lh:DeferredIncomeTaxesAndOtherTaxLiabilities
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMyLTMtMS0xLTExNzAyOQ_244abb11-9ae0-44ce-8c2a-9e1e2edcdfda"
      unitRef="usd">762900000</lh:DeferredIncomeTaxesAndOtherTaxLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMzLTEtMS0xLTExNzAyOQ_a7f59e79-f43a-47d0-8808-674d4492689a"
      unitRef="usd">422800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzMzLTMtMS0xLTExNzAyOQ_52403ebb-7597-4e36-a27b-d121aa2d75fa"
      unitRef="usd">402000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM1LTEtMS0xLTExNzAyOQ_5edff649-9726-426c-98ba-44740ae22503"
      unitRef="usd">10039600000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM1LTMtMS0xLTExNzAyOQ_4051a9f1-b821-417c-83f0-7deaeea4beba"
      unitRef="usd">10091400000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM2LTEtMS0xLTExNzAyOQ_c0e29716-bdc8-44f8-929f-8fc8667c2e7b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM2LTMtMS0xLTExNzAyOQ_2bfa567a-d787-4dc8-9f7f-77b000332e26"
      unitRef="usd"
      xsi:nil="true"/>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM3LTEtMS0xLTExNzAyOQ_bda369f1-a701-4b90-adb2-79e033b9a6af"
      unitRef="usd">18900000</lh:NoncontrollingInterestMezzanineEquity>
    <lh:NoncontrollingInterestMezzanineEquity
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM3LTMtMS0xLTExNzAyOQ_f5b16f17-acb8-450e-a654-a4f76b9eb114"
      unitRef="usd">20600000</lh:NoncontrollingInterestMezzanineEquity>
    <us-gaap:CommonStockValue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM5LTEtMS0xLTExNzAyOQ_b50f073d-2eb1-432f-a9e1-cd8181115836"
      unitRef="usd">8100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzM5LTMtMS0xLTExNzAyOQ_47b7c8e5-af5c-41a8-a5c2-80591d4ef3b9"
      unitRef="usd">8500000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQxLTEtMS0xLTExNzAyOQ_28a2b739-5924-4df0-993f-e4a46f8ab5da"
      unitRef="usd">10581700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQxLTMtMS0xLTExNzAyOQ_3cad82bd-0293-4a2c-8a18-f106aa4ba5e2"
      unitRef="usd">10456800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQzLTEtMS0xLTExNzAyOQ_cfa43b07-d936-42b6-9c80-f128135e8cf8"
      unitRef="usd">-493200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQzLTMtMS0xLTExNzAyOQ_f5e997fe-20c4-4cd1-a1f2-f3a214f23e4d"
      unitRef="usd">-191900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ0LTEtMS0xLTExNzAyOQ_4c4af3c3-12b5-4c0b-9084-423f84703ab2"
      unitRef="usd">10096600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ0LTMtMS0xLTExNzAyOQ_1507328e-a3c8-49ba-9428-893deb6c0b41"
      unitRef="usd">10273400000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ1LTEtMS0xLTExNzAyOQ_d9acf7aa-91e4-4ddb-908c-ce3df6382d32"
      unitRef="usd">20155100000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNjYvZnJhZzo1OTc1NjQ1MGRiMzM0NjI2YjYwNGE5YWVlY2NlYTE5Yi90YWJsZTowNWUyZDVkOTNjODM0NzBlYmY0NTUwYjE0MzdmNTRmMi90YWJsZXJhbmdlOjA1ZTJkNWQ5M2M4MzQ3MGViZjQ1NTBiMTQzN2Y1NGYyXzQ1LTMtMS0xLTExNzAyOQ_0840c502-2419-49e0-be5e-d267bc732561"
      unitRef="usd">20385400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItMS0xLTEtMTE3MDI5_f02d3f7e-93e6-4a21-8bcc-953fb6556130"
      unitRef="usd">14876800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItMy0xLTEtMTE3MDI5_b1b6fb31-f9f6-4069-b3b2-4d9d9c3d850e"
      unitRef="usd">16120900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzItNS0xLTEtMTE3MDI5_25c5ed2c-1570-4d01-b849-f3bdf263947e"
      unitRef="usd">13978500000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtMS0xLTEtMTE3MDI5_75a0a920-e896-405e-b336-8169d1f6af57"
      unitRef="usd">10491700000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtMy0xLTEtMTE3MDI5_0a1e3f3b-c347-4fd1-8c85-1ef7a27e1b60"
      unitRef="usd">10496600000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzMtNS0xLTEtMTE3MDI5_1a3d1d78-ca34-4096-b9e0-7d8baf7821c9"
      unitRef="usd">9025700000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtMS0xLTEtMTE3MDI5_414b2651-844a-40d1-9e2a-9cc3fc012519"
      unitRef="usd">4385100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtMy0xLTEtMTE3MDI5_8d6eb6e6-13fb-454e-8c95-d06eecf9b483"
      unitRef="usd">5624300000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzQtNS0xLTEtMTE3MDI5_433778b4-ab99-407f-b2ef-8630bef103f1"
      unitRef="usd">4952800000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtMS0xLTEtMTE3MDI5_8cb81d45-2ea0-48eb-9631-bd8ee1c7063b"
      unitRef="usd">1996600000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtMy0xLTEtMTE3MDI5_8e823644-145c-4327-bf97-31fb427dfcd4"
      unitRef="usd">1952100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzUtNS0xLTEtMTE3MDI5_08645b8b-0bec-4749-896c-15f42b3f72cf"
      unitRef="usd">1729300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtMS0xLTEtMTE3MDI5_aa615816-7afb-4fb6-a562-cf6a67fce7c6"
      unitRef="usd">259300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtMy0xLTEtMTE3MDI5_958e26b1-2e8a-4378-9901-3fb4ba28d903"
      unitRef="usd">369600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzYtNS0xLTEtMTE3MDI5_72ea0087-e8e9-4a76-b519-1f5c8add9b9e"
      unitRef="usd">275400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctMS0xLTEtMTE3MDI5_4729479a-d0ab-4b46-bf34-fbc30bbc0c58"
      unitRef="usd">271500000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctMy0xLTEtMTE3MDI5_2ae93eff-4f35-475a-9ae2-19031f49afd0"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzctNS0xLTEtMTE3MDI5_6e049b46-452e-4955-aa7d-fc39818f0486"
      unitRef="usd">462100000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtMS0xLTEtMTE3MDI5_d6c4c36b-0737-4602-8cec-3910db4b981f"
      unitRef="usd">83800000</lh:NetRestructuringAndOtherSpecialCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtMy0xLTEtMTE3MDI5_b43138b8-beb4-4a2c-b575-9e81563b2dac"
      unitRef="usd">43100000</lh:NetRestructuringAndOtherSpecialCharges>
    <lh:NetRestructuringAndOtherSpecialCharges
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzgtNS0xLTEtMTE3MDI5_a5e35ea9-31a0-4534-8e68-1f8fb56c9735"
      unitRef="usd">40600000</lh:NetRestructuringAndOtherSpecialCharges>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktMS0xLTEtMTE3MDI5_77e12ae7-49ce-4bab-8e8b-de5fcc7b7d81"
      unitRef="usd">1773900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktMy0xLTEtMTE3MDI5_118fad5f-102e-4974-8764-5010abdfaf5f"
      unitRef="usd">3259500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzktNS0xLTEtMTE3MDI5_755e095c-9779-47ae-9f66-4959e2733b2d"
      unitRef="usd">2445400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTEtMS0xLTExNzAyOQ_52365995-fba8-480b-903a-62a66555a456"
      unitRef="usd">180300000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTMtMS0xLTExNzAyOQ_04781d49-441f-4a3d-acb6-8bb89a0d6bcb"
      unitRef="usd">212100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzExLTUtMS0xLTExNzAyOQ_72d21cf6-04fe-4def-a1d8-25b8a147ba9f"
      unitRef="usd">207400000</us-gaap:InterestExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTEtMS0xLTExNzAyOQ_a62e319e-a23b-4e72-86ef-4d52a1ce0757"
      unitRef="usd">5400000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTMtMS0xLTExNzAyOQ_6966f306-5d97-405d-b9f9-9220804138a9"
      unitRef="usd">26500000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEyLTUtMS0xLTExNzAyOQ_7014ca8a-4f2f-48dd-8c03-f089d4e8c940"
      unitRef="usd">2900000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeNet
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTEtMS0xLTExNzAyOQ_1e1118a3-9db8-491b-b626-8365670e99d4"
      unitRef="usd">8900000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTMtMS0xLTExNzAyOQ_051ac375-267d-42ef-84de-cf6c78cdfd4e"
      unitRef="usd">10200000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzEzLTUtMS0xLTExNzAyOQ_f8463c3c-77f9-4a1e-8a4e-607045ea3d31"
      unitRef="usd">10300000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTEtMS0xLTExNzAyOQ_f090d029-f859-4f78-946b-ff3d552f0746"
      unitRef="usd">-25300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTMtMS0xLTExNzAyOQ_b800425c-29f5-4cb8-a43a-3bab2539a89c"
      unitRef="usd">42500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE0LTUtMS0xLTExNzAyOQ_72aa637b-2427-418f-8102-bc80350bb471"
      unitRef="usd">-32100000</us-gaap:OtherNonoperatingIncomeExpense>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTEtMS0xLTExNzAyOQ_955ac377-a460-4426-b970-6c6f873439f8"
      unitRef="usd">1582600000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTMtMS0xLTExNzAyOQ_d5f7ba27-c403-4f24-b416-a8a42c4479dc"
      unitRef="usd">3126600000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE1LTUtMS0xLTExNzAyOQ_5e7942ca-c587-4a72-8f65-ead2d988ce74"
      unitRef="usd">2219100000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTEtMS0xLTExNzAyOQ_20ca11ef-a71e-481d-9d06-fa816cbc06b6"
      unitRef="usd">302000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTMtMS0xLTExNzAyOQ_a916b30a-b037-4572-8862-95b0200bc003"
      unitRef="usd">747100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE2LTUtMS0xLTExNzAyOQ_6f67fd3b-7166-4221-b038-2a8887699fb4"
      unitRef="usd">662100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTEtMS0xLTExNzAyOQ_1840ea73-e5c1-480b-ad35-34196084a195"
      unitRef="usd">1280600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTMtMS0xLTExNzAyOQ_b5d362c9-8e1d-47df-9e38-f302c4874dd4"
      unitRef="usd">2379500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE3LTUtMS0xLTExNzAyOQ_d392bde8-bfe6-4568-8081-76c718de3ad4"
      unitRef="usd">1557000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTEtMS0xLTExNzAyOQ_4d656c67-03c9-4b72-9b82-b85e59487df1"
      unitRef="usd">1500000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTMtMS0xLTExNzAyOQ_da56c9fe-8ced-4486-b813-08269b0e1727"
      unitRef="usd">2200000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE4LTUtMS0xLTExNzAyOQ_59e55cb6-bf38-43c5-82fc-8544a091b589"
      unitRef="usd">900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTEtMS0xLTExNzAyOQ_a648e5fa-167d-48bd-9b66-6a6ff1f04bcd"
      unitRef="usd">1279100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTMtMS0xLTExNzAyOQ_a7c0966d-8759-47fc-83f1-391bc08f1ef0"
      unitRef="usd">2377300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzE5LTUtMS0xLTExNzAyOQ_6fd29664-31fc-4bfc-bc03-9bd056632b10"
      unitRef="usd">1556100000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTEtMS0xLTExNzAyOQ_3d467232-2984-4d36-be98-65e82f53d2d7"
      unitRef="usdPerShare">14.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTMtMS0xLTExNzAyOQ_dbaf8495-e4a7-4752-8d1f-e320357f2df3"
      unitRef="usdPerShare">24.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIxLTUtMS0xLTExNzAyOQ_677563fe-67ac-4fed-9828-6d847d642f12"
      unitRef="usdPerShare">15.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTEtMS0xLTExNzAyOQ_124eaada-abe6-4543-86ad-651f961eafca"
      unitRef="usdPerShare">13.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTMtMS0xLTExNzAyOQ_a364f97f-1356-46af-af58-894d5264fb1c"
      unitRef="usdPerShare">24.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzIvZnJhZzowMWIzYzBhZDMzMzE0MzU1YmE5ZGUyMDgwMWQ3Y2QyZS90YWJsZTo3NTQzNDEyYmY1ODY0M2Q5YTI4ZWU3N2JiNzc2MzFmYS90YWJsZXJhbmdlOjc1NDM0MTJiZjU4NjQzZDlhMjhlZTc3YmI3NzYzMWZhXzIyLTUtMS0xLTExNzAyOQ_f0b1ac48-903e-47d5-a901-f46b07c7de55"
      unitRef="usdPerShare">15.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItMS0xLTEtMTE3MDI5_58990259-d62c-4024-ba7e-1b9a10899421"
      unitRef="usd">1280600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItMy0xLTEtMTE3MDI5_ca825183-0347-4877-9c49-009c78e50438"
      unitRef="usd">2379500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzItNS0xLTEtMTE3MDI5_47a7ae89-5b75-472a-b83e-f68d5f17184b"
      unitRef="usd">1557000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtMS0xLTEtMTE3MDI5_bc837c12-4210-4e70-9112-216ba4882627"
      unitRef="usd">-336400000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtMy0xLTEtMTE3MDI5_c116365d-0e1f-44e8-bfda-a59f3b303604"
      unitRef="usd">-104600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzMtNS0xLTEtMTE3MDI5_a1a01119-d678-4e53-b24a-139886501d8f"
      unitRef="usd">264100000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtMS0xLTEtMTE3MDI5_933a25c0-6e80-4657-b7b8-68bda24d9571"
      unitRef="usd">-44800000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtMy0xLTEtMTE3MDI5_d97430e6-b1b7-4bf6-afe8-d96b565ded55"
      unitRef="usd">-91700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzQtNS0xLTEtMTE3MDI5_4c5b7b7a-9dc4-4cf8-84dd-c84415f19797"
      unitRef="usd">65700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtMS0xLTEtMTE3MDI5_891e245d-999a-48b1-87b4-7e52167bddf9"
      unitRef="usd">-291600000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtMy0xLTEtMTE3MDI5_a296612a-2297-4ede-98ff-c56a902bde78"
      unitRef="usd">-12900000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzUtNS0xLTEtMTE3MDI5_d4639ad7-d234-4622-889b-1696d10e3ff6"
      unitRef="usd">198400000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtMS0xLTEtMTE3MDI5_af242c5e-71b9-4c27-a741-ca19e45fbdc9"
      unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtMy0xLTEtMTE3MDI5_6f8036de-611b-4349-a2f9-fa99f55ab63a"
      unitRef="usd">17100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzYtNS0xLTEtMTE3MDI5_43bb0bde-ef78-4ee9-bd20-a41c90b5ebe0"
      unitRef="usd">-12100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctMS0xLTEtMTE3MDI5_05922529-2ba8-4713-843f-0a8c6dac88e1"
      unitRef="usd">-301300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctMy0xLTEtMTE3MDI5_82d10e96-1097-46a8-8a8f-af0298cf422d"
      unitRef="usd">-30000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzctNS0xLTEtMTE3MDI5_f5bfb15a-32f7-440e-afeb-9bdf9cc9f2b1"
      unitRef="usd">210500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtMS0xLTEtMTE3MDI5_2de92550-e814-4e7d-aa95-7a8fcffa5831"
      unitRef="usd">979300000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtMy0xLTEtMTE3MDI5_15f3a6c5-98a4-45f2-9227-ca67aa05a311"
      unitRef="usd">2349500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzgtNS0xLTEtMTE3MDI5_90837cba-5091-4b1a-be13-04e05b6c3482"
      unitRef="usd">1767500000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktMS0xLTEtMTE3MDI5_68f992ea-4ea3-45b2-8bbf-6eb767efe987"
      unitRef="usd">1500000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktMy0xLTEtMTE3MDI5_fc4ef3fc-0db2-4a0e-afe4-f99d613955ce"
      unitRef="usd">2200000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzktNS0xLTEtMTE3MDI5_c8bdd3d2-7092-405f-aac6-de2d18804896"
      unitRef="usd">900000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTEtMS0xLTExNzAyOQ_907dda24-81d5-4e6d-980a-d1a83892475f"
      unitRef="usd">977800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTMtMS0xLTExNzAyOQ_2adc2915-5288-4a7a-bb24-e9687b5e3127"
      unitRef="usd">2347300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzUvZnJhZzpjNmQxZmE5OGY4YmQ0NDNmYWQ5M2FiM2ZmZWFlMjZhMC90YWJsZTpkMDhiOTJhYmJkMGM0NDE4YThkNTZhN2VkODU2ZjdiNS90YWJsZXJhbmdlOmQwOGI5MmFiYmQwYzQ0MThhOGQ1NmE3ZWQ4NTZmN2I1XzEwLTUtMS0xLTExNzAyOQ_6ee66995-3bec-4841-80ff-1b71b794c293"
      unitRef="usd">1766600000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockValue
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMS0xLTEtMTE3MDI5_5310de7f-4ee1-4733-b2cf-79bc97ded7d4"
      unitRef="usd">9000000.0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMy0xLTEtMTE3MDI5_5fd317c2-6634-4934-9089-bc1ecd1332ff"
      unitRef="usd">26800000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtNS0xLTEtMTE3MDI5_349d3ac6-d619-425b-8d95-fa01392c006f"
      unitRef="usd">7980500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtOS0xLTEtMTE3MDI5_ca92a65a-11c4-4ec8-af8d-c27db02e157a"
      unitRef="usd">-372400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEtMTEtMS0xLTExNzAyOQ_1a1dae31-86bf-4e52-b271-bc3bded9f4e7"
      unitRef="usd">7643900000</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i77657f2f79234f079d9a8cd7d6c65a76_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMS0xLTEtMTE3MDI5_608da403-c356-457b-ba0a-5e9aa8ec9e3c"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie7a4f1d89351477a9562246200d846a1_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMy0xLTEtMTE3MDI5_2682fef1-f196-4cc0-9e1f-acbca38b0e46"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0bfd8f9f712d4be1a34741259880f138_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItNS0xLTEtMTE3MDI5_ca1b211b-fdff-428e-a42b-ac26e7bcc699"
      unitRef="usd">-7000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i59610a560d54411f901c49edcd62d761_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItOS0xLTEtMTE3MDI5_fb7d0365-39b6-4ac7-8f71-a69eb466e351"
      unitRef="usd">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0bfd8f9f712d4be1a34741259880f138_I20200101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzItMTEtMS0xLTExNzAyOQ_9682ff79-43ae-470a-a608-695bf8a8211c"
      unitRef="usd">-7000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMS0xLTEtMTE3MDI5_6e6bbefa-9305-473e-a7f4-59a421fcdff1"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMy0xLTEtMTE3MDI5_1808dc14-f614-4069-8923-c3194e6ed748"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtNS0xLTEtMTE3MDI5_aa37f0b0-8db5-499e-bc12-028a8fab3c9c"
      unitRef="usd">1556100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtOS0xLTEtMTE3MDI5_038cacb9-5ba9-41ab-9e75-8443117009c4"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMtMTEtMS0xLTExNzAyOQ_4d011b29-fee5-466d-a4ff-ec086fafcb82"
      unitRef="usd">1556100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMS0xLTEtMTE3MDI5_792b3095-fc5c-41af-ba63-4be3469866cb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMy0xLTEtMTE3MDI5_8778efcc-8ee2-449a-af80-85e3d3e88c5c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtNS0xLTEtMTE3MDI5_7b41155d-abd6-42b7-93a4-67619da9d841"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtOS0xLTEtMTE3MDI5_32c46738-0e8c-4d8b-b21d-ca9f95b73474"
      unitRef="usd">210500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzQtMTEtMS0xLTExNzAyOQ_d6386370-b0f3-4bc3-9200-86900fe3f59c"
      unitRef="usd">210500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMS0xLTEtMTE3MDI5_8b0596ab-808e-434a-9285-322fc03d5543"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMy0xLTEtMTE3MDI5_2b80e813-872c-487f-94cf-ab3bc6e2299e"
      unitRef="usd">55900000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtNS0xLTEtMTE3MDI5_fa0ab15f-7a24-4601-9c6b-a3b88c29bf86"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtOS0xLTEtMTE3MDI5_3ba0aaec-d743-45f3-9e0b-bd992961b97a"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzYtMTEtMS0xLTExNzAyOQ_51e2442a-6a1a-45b9-ac1d-f5a76be3dc79"
      unitRef="usd">55900000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMS0xLTEtMTE3MDI5_d44df1a4-0121-4655-bacb-6e3b6bceec1f"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMy0xLTEtMTE3MDI5_e1e55758-0c22-4bbb-a92b-e3efead53740"
      unitRef="usd">34500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctNS0xLTEtMTE3MDI5_7fc96432-3246-4dcd-a37e-04ccfe412b7d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctOS0xLTEtMTE3MDI5_121a04f7-a4f7-4b4f-8580-cbe857a5d64b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzctMTEtMS0xLTExNzAyOQ_efeafce5-07dd-4df4-abcc-7ca74e2b8f74"
      unitRef="usd">34500000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMS0xLTEtMTE3MDI5_305cbe42-ae5f-482b-b9a3-805b2c56741c"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMy0xLTEtMTE3MDI5_1f1d50db-e517-494b-bed6-e828375e6057"
      unitRef="usd">111700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtNS0xLTEtMTE3MDI5_b0f8843d-8a8d-48d6-b076-315fd1f88708"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtOS0xLTEtMTE3MDI5_13a8e4e3-4abd-47d1-8fc0-54b47e4d2421"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzgtMTEtMS0xLTExNzAyOQ_eae3f6c5-7711-4cbb-92b8-ccc9cbc46df8"
      unitRef="usd">111700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i5ee2684f7a92446cb8f8ae26499c4362_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTEtMS0xLTExNzAyOQ_4c52993d-97aa-4b0b-a632-4ed4e32907f0"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i414b4ad31bfa426081eab969a11e8648_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTMtMS0xLTExNzAyOQ_d426df7e-ff2d-47d8-b5a5-b0cf4af2a89e"
      unitRef="usd">49600000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="if8132459128c444ab29724e750a1d08f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTUtMS0xLTExNzAyOQ_625049a7-d63d-4016-934d-c328f7e1317b"
      unitRef="usd">50400000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie0c9b47cf5204faebb66e41a5fa4d735_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTktMS0xLTExNzAyOQ_e9932188-ac03-44c9-b762-e11f81f61f00"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEwLTExLTEtMS0xMTcwMjk_8bed66bf-1d8e-4371-a12f-76a4fb3b0037"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockValue
      contextRef="i29cec420761b431ca0cff711e7a085bb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTEtMS0xLTExNzAyOQ_0d7b5a34-73a2-431d-8b8a-cbd2fc1de909"
      unitRef="usd">9000000.0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5185fa2e825b418aaad59fc411dd8793_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTMtMS0xLTExNzAyOQ_33ea29d2-84d4-40f3-a1f4-ecbd6df068b5"
      unitRef="usd">110300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i82508c48b8e24f59b776527555dac0a5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTUtMS0xLTExNzAyOQ_41bccf7d-196e-4bc7-936a-d27973dfc989"
      unitRef="usd">9479200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i716799a1a7a34a15b3e9adffdce6996d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTktMS0xLTExNzAyOQ_787f6597-b8d2-400e-a291-248b75b9a032"
      unitRef="usd">-161900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzExLTExLTEtMS0xMTcwMjk_3c98b4c4-da18-411b-955d-a7c6bfb2be77"
      unitRef="usd">9436600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTEtMS0xLTExNzAyOQ_f64c3f4f-fa3d-4696-8f76-d9d8423126e0"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTMtMS0xLTExNzAyOQ_c4a7b085-4e25-448a-a27e-3bb99f701fef"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTUtMS0xLTExNzAyOQ_37b1a024-08ab-4bd3-90fc-e7c9efe509d4"
      unitRef="usd">2377300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTktMS0xLTExNzAyOQ_d268c18c-03f0-4c72-8f6f-5fab62155376"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzEzLTExLTEtMS0xMTcwMjk_d0b5f40d-9d20-4415-b1e9-c146c5503a0f"
      unitRef="usd">2377300000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTEtMS0xLTExNzAyOQ_3f269b90-d2a0-438d-b3e8-b59b6788bb80"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTMtMS0xLTExNzAyOQ_3ce92735-17b7-4c54-8936-c8afa0a64cc1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTUtMS0xLTExNzAyOQ_118954ba-b6bf-4b89-90af-69490c6f9468"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTktMS0xLTExNzAyOQ_10af1339-99ab-4092-9f12-bb19a4f19203"
      unitRef="usd">-30000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE0LTExLTEtMS0xMTcwMjk_0859c590-5a4c-4bc2-b77c-8270c848ee0b"
      unitRef="usd">-30000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTEtMS0xLTExNzAyOQ_9a434179-f6cd-4096-8d26-34dd0c607e48"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTMtMS0xLTExNzAyOQ_b8d234d9-e988-478e-b45d-778e7d1c5636"
      unitRef="usd">51700000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTUtMS0xLTExNzAyOQ_1cee322d-40e5-49f1-ac9c-57de70ad0cce"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTktMS0xLTExNzAyOQ_82ddc685-5166-43e2-80a6-1fe390bedf00"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE2LTExLTEtMS0xMTcwMjk_e4c3e660-22e7-4a64-84fb-c608e90e575d"
      unitRef="usd">51700000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTEtMS0xLTExNzAyOQ_02c24251-2fbf-4c81-ab29-c1474018b898"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTMtMS0xLTExNzAyOQ_82d154da-f55b-49bd-a886-c7a830faf8fd"
      unitRef="usd">47400000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTUtMS0xLTExNzAyOQ_b332108e-4c0a-4d07-8bbb-029226bdca00"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTktMS0xLTExNzAyOQ_da13bc67-ee8a-48f9-ac02-66db28cf8c95"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE3LTExLTEtMS0xMTcwMjk_7774efc9-fe7b-4ea8-928e-a9e08484ec90"
      unitRef="usd">47400000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTEtMS0xLTExNzAyOQ_32dc0f8b-2c80-4b69-9c52-7173d0ccbf25"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTMtMS0xLTExNzAyOQ_3ac5d52f-b2d6-41f6-9b35-36f6e0456e42"
      unitRef="usd">153700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTUtMS0xLTExNzAyOQ_2266555e-facf-466a-91ed-1ce845dbfaad"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTktMS0xLTExNzAyOQ_e601000b-b44c-4cab-a401-8c41f7183e02"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzE5LTExLTEtMS0xMTcwMjk_5f79d850-b830-4fdb-bdec-c484c7238e68"
      unitRef="usd">153700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icd57f394ad1b43e3b52b492923f9ff9e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTEtMS0xLTExNzAyOQ_3fc80e94-1bac-46ce-b68d-586f46d01a68"
      unitRef="usd">500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic89e048f9c6a4c0f8939cc1d851ac1dd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTMtMS0xLTExNzAyOQ_d455fb39-6722-412f-91f3-11fa8bdcbbf0"
      unitRef="usd">268300000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i96848b6e57c34685b8bea5b1dea5635a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTUtMS0xLTExNzAyOQ_5d1786c9-5816-4575-b288-e9ab987c0aaa"
      unitRef="usd">1399700000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i4826654762ff4ba2956ccc0f618c9f46_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTktMS0xLTExNzAyOQ_c28d8519-f0d0-41d2-8b05-556a47762665"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIxLTExLTEtMS0xMTcwMjk_1597c6ca-6847-41b9-9456-a39a04006b84"
      unitRef="usd">1668500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockValue
      contextRef="i56cc8aeb3db74b298d1f3c1cc41c86b7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTEtMS0xLTExNzAyOQ_4cae7e78-08ee-4b9b-a483-5194bb8e74b5"
      unitRef="usd">8500000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="id9537d406d674d4bbf0f98e30498723b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTMtMS0xLTExNzAyOQ_ec3d5628-fda7-42f5-a33b-cbabc95c20a3"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2d55b4cb03d64378863d2e96d420a6d0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTUtMS0xLTExNzAyOQ_5e5f2990-0d40-40b9-9fbc-709480ca08c9"
      unitRef="usd">10456800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTktMS0xLTExNzAyOQ_58abfeda-6bad-4bb7-93b6-c52d0ed5c3e7"
      unitRef="usd">-191900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIyLTExLTEtMS0xMTcwMjk_cafc1d92-b60f-4daa-933d-b855d970f751"
      unitRef="usd">10273400000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTEtMS0xLTExNzAyOQ_decda89c-aedd-4eef-8b6d-bad5c2735f78"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTMtMS0xLTExNzAyOQ_ebea39cf-f4e1-4f6c-b55d-5a69e7e7f4a9"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTUtMS0xLTExNzAyOQ_bbd5361a-94ca-4b38-b178-d0e039d5a4e7"
      unitRef="usd">1279100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTktMS0xLTExNzAyOQ_9f796bee-96ba-4857-8782-7c341eddae12"
      unitRef="usd">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzIzLTExLTEtMS0xMTcwMjk_e21a2c5a-4431-4df9-817e-e7d8c8e640b1"
      unitRef="usd">1279100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTEtMS0xLTExNzAyOQ_70f5dbeb-58b8-4a38-97fc-04cd045cf899"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTMtMS0xLTExNzAyOQ_124d135d-0063-422b-9d64-4d4abe7ab1b5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTUtMS0xLTExNzAyOQ_a40d0b9d-c23f-40e1-950d-0bdfca67196b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTktMS0xLTExNzAyOQ_fa957c36-3fd2-4b72-80db-77d585cbd7cb"
      unitRef="usd">-301300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI0LTExLTEtMS0xMTcwMjk_b8520daa-8721-4428-bd13-b2d66b5b788d"
      unitRef="usd">-301300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:Dividends
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTEtMS0xLTE3MTM1Mg_90a3c869-6867-48c9-8b07-a5db5e236f07"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTMtMS0xLTE3MTM1Mg_4787bbb8-37b8-4429-bdae-2b1ae7b3d296"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTUtMS0xLTE3MTM1Mg_6d2ae627-76f5-4d16-a8c3-db105895f8cd"
      unitRef="usd">198700000</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTktMS0xLTE3MTM1Mg_efb65d4e-2cd2-4c75-9559-b31f97fbd896"
      unitRef="usd">0</us-gaap:Dividends>
    <us-gaap:DividendsCash
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTExLTEtMS0xNzEzNTI_e6e0aba3-00ed-4276-ab18-c9bac541c762"
      unitRef="usd">198700000</us-gaap:DividendsCash>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTEtMS0xLTExNzAyOQ_ec08c097-629f-4ae8-b78a-3c0422240eed"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTMtMS0xLTExNzAyOQ_f88716bc-42bc-4fa9-866f-567357aaa871"
      unitRef="usd">50600000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTUtMS0xLTExNzAyOQ_5332fcac-3d78-4fbd-8070-30354f323a92"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTktMS0xLTExNzAyOQ_eb02fb47-96bf-4e9f-831f-af25e29d47d5"
      unitRef="usd">0</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <lh:IssuanceOfCommonStockUnderEmployeeStockPlans
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI2LTExLTEtMS0xMTcwMjk_0450bbf2-14c6-40c3-b56f-11ec5f9d3080"
      unitRef="usd">50600000</lh:IssuanceOfCommonStockUnderEmployeeStockPlans>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTEtMS0xLTExNzAyOQ_a04c707b-a6c5-4da5-af75-7f21fb7433a2"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTMtMS0xLTExNzAyOQ_2093b03f-d414-4c4f-835b-26353135d3ca"
      unitRef="usd">50600000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTUtMS0xLTExNzAyOQ_31877fe3-6d0e-4705-b188-d5969002a695"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTktMS0xLTExNzAyOQ_ecf482d1-f37d-4020-ab77-28d9d6435168"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI3LTExLTEtMS0xMTcwMjk_8a91d059-e9f5-4675-86f4-38327e4e8f0a"
      unitRef="usd">50600000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTEtMS0xLTExNzAyOQ_d3aca269-86e8-4bd0-8f91-6d486c9179cf"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTMtMS0xLTExNzAyOQ_7840f0b4-0b1a-4a83-9155-a04a0fc40f00"
      unitRef="usd">144100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTUtMS0xLTExNzAyOQ_9e05a210-be6b-48ae-ad48-4ed5db9404a9"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTktMS0xLTExNzAyOQ_10caf214-56d3-45a9-a7da-ef26694ccd2b"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzI4LTExLTEtMS0xMTcwMjk_f7789a92-0409-4912-a5dd-3d9f5f6c8092"
      unitRef="usd">144100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i6c179a85979044aba9808b5aa5afe0cf_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTEtMS0xLTExNzAyOQ_d99280d6-f483-4c8b-9ff8-8fd4ab8f8aec"
      unitRef="usd">400000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic3640e0615df47eea24af226b74d7c56_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTMtMS0xLTExNzAyOQ_e3cab06f-031e-4ce2-b0f7-215051522498"
      unitRef="usd">144100000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i987c089c7729424e85f27edd60bcf505_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTUtMS0xLTExNzAyOQ_f010735d-cae6-4047-bb42-93dc29729542"
      unitRef="usd">955500000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ic5992090c6544fff806f38f287f9a733_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTktMS0xLTExNzAyOQ_a041c095-be2d-4bb8-a16f-2a8ca17d9640"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMwLTExLTEtMS0xMTcwMjk_dae67fc2-6e7b-4d19-ba26-88eee2eed52c"
      unitRef="usd">1100000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:CommonStockValue
      contextRef="i9f313e3a123c4e398f0c391421791a68_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTEtMS0xLTExNzAyOQ_5d8d916e-d600-4845-a449-a7c1fa78cf28"
      unitRef="usd">8100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9f313e3a123c4e398f0c391421791a68_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTEtMS0xLTExNzAyOQ_6659ea2d-a720-4374-9f18-a8c8cc6233df"
      unitRef="usd">8100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="id782ff201d364db6a73b7f362d0a9678_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTMtMS0xLTExNzAyOQ_dff287bf-d017-4e62-a81b-d6c0a5e66a8c"
      unitRef="usd">0</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i061db6fec9f94dce9fe88b9a6f4fc138_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTUtMS0xLTExNzAyOQ_c7498f39-28de-4a76-b1ef-c477dc307ddd"
      unitRef="usd">10581700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iab6bb1719c3747d69b101c25f39073a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTktMS0xLTExNzAyOQ_d1a06825-c71d-465e-8590-272f845fffb5"
      unitRef="usd">-493200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xNzgvZnJhZzpkYjFiYTU1ZTYzZjI0MzZmOTM2YWRhZjI5OTcyOWQ2MS90YWJsZToxNjJmN2U3ZDdkMWE0Mjg3OWFjMDBlMzMzMGIwNjk5YS90YWJsZXJhbmdlOjE2MmY3ZTdkN2QxYTQyODc5YWMwMGUzMzMwYjA2OTlhXzMxLTExLTEtMS0xMTcwMjk_a230c102-5d24-4b06-a5fe-1bc27bbb8560"
      unitRef="usd">10096600000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtMS0xLTEtMTE3MDI5_6c9ff166-f483-4bc4-8a83-78f131b0105e"
      unitRef="usd">1280600000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtMy0xLTEtMTE3MDI5_3c501244-91af-4fa7-8b82-b1826c728151"
      unitRef="usd">2379500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMtNS0xLTEtMTE3MDI5_95c58bc0-58fe-4e4e-84e5-6879a022447a"
      unitRef="usd">1557000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtMS0xLTEtMTE3MDI5_895fe350-7a27-45d0-9f8c-e998b5644f59"
      unitRef="usd">633900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtMy0xLTEtMTE3MDI5_9c69ce36-f767-413b-b5a9-72dc7cf8822b"
      unitRef="usd">745100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzUtNS0xLTEtMTE3MDI5_b0decfd6-7b2f-4b1f-babc-246174593793"
      unitRef="usd">624700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtMS0xLTEtMTE3MDI5_5949ccb8-37cd-4992-8821-62122949cb87"
      unitRef="usd">144100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtMy0xLTEtMTE3MDI5_e9ffadd1-db62-4be1-a1db-01e9f46c6945"
      unitRef="usd">153700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzYtNS0xLTEtMTE3MDI5_6ac7ca3c-192f-4ce8-968d-87ab681d8581"
      unitRef="usd">111700000</us-gaap:ShareBasedCompensation>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtMS0xLTEtMTE3MDI5_6089e5e0-8eab-44af-906a-3c8c79cf1652"
      unitRef="usd">194400000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtMy0xLTEtMTE3MDI5_a4e7dd25-baab-4176-87f5-d051b24d509b"
      unitRef="usd">194900000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <lh:DepreciationAndAmortizationOfLeasedAssets
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzgtNS0xLTEtMTE3MDI5_8782cb7a-ccb2-4497-a382-8d4df5bbbe51"
      unitRef="usd">200300000</lh:DepreciationAndAmortizationOfLeasedAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktMS0xLTEtMTE3MDI5_95560979-6991-4816-a152-8e3868e9b905"
      unitRef="usd">271500000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktMy0xLTEtMTE3MDI5_97334796-ff3b-49c9-94dc-0041f0a33090"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzktNS0xLTEtMTE3MDI5_0c7d0038-68b9-4861-8069-0eb2cd0cca5e"
      unitRef="usd">462100000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTEtMS0xLTExNzAyOQ_4b9ad95d-5588-42e4-902a-29d9318cfdf3"
      unitRef="usd">-18300000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTMtMS0xLTExNzAyOQ_f56c2e71-25b5-475e-a0bf-ec6900044111"
      unitRef="usd">75900000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzEwLTUtMS0xLTExNzAyOQ_577fdbdd-e31b-4b06-b7ab-5d94e1784b78"
      unitRef="usd">47000000.0</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTEtMS0xLTExNzAyOQ_48b7df12-4ff8-4515-8f70-c4ba57321211"
      unitRef="usd">16500000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTMtMS0xLTExNzAyOQ_a7c6b214-87ca-493f-a05f-2bed2ed47e6c"
      unitRef="usd">-24000000.0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzExLTUtMS0xLTExNzAyOQ_397c5bc1-a9ce-4a6c-ba34-d4c4444106cb"
      unitRef="usd">83400000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTEtMS0xLTExNzAyOQ_60559a10-f8f7-4936-9201-ce419cf30f22"
      unitRef="usd">-15900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTMtMS0xLTExNzAyOQ_5edd853b-938f-447a-8a9e-6b99f5d2f1b7"
      unitRef="usd">-222000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE0LTUtMS0xLTExNzAyOQ_82d85aa3-ed00-4e0b-84e1-61f474dd2f4d"
      unitRef="usd">913400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTEtMS0xLTExNzAyOQ_dc049ad0-35dc-42f7-8918-0d604ff5f82c"
      unitRef="usd">100000000.0</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTMtMS0xLTExNzAyOQ_3855ff46-3257-4554-84a2-9b2c235deaf6"
      unitRef="usd">179200000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE1LTUtMS0xLTExNzAyOQ_ddbf2470-6259-4edf-9226-86b41f371534"
      unitRef="usd">42500000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTEtMS0xLTExNzAyOQ_84644a8e-e9c5-4fea-91e7-f38e35b2630a"
      unitRef="usd">45500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTMtMS0xLTExNzAyOQ_214c4c3e-6acb-477f-adb4-aaa000cfa315"
      unitRef="usd">-2800000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE2LTUtMS0xLTExNzAyOQ_e544447e-1d2d-4eba-929a-9b7fcdd2d2cd"
      unitRef="usd">196600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTEtMS0xLTExNzAyOQ_ab32311a-ddd6-485a-9a25-25b1055a14da"
      unitRef="usd">256900000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTMtMS0xLTExNzAyOQ_d105b3b7-4311-495e-a694-2bdb9ef394bc"
      unitRef="usd">68200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE3LTUtMS0xLTExNzAyOQ_30ba40c6-b055-422f-89cb-812bcc7a3fa5"
      unitRef="usd">5400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTEtMS0xLTExNzAyOQ_2120af7a-c945-452f-b9d8-d794b95c46ad"
      unitRef="usd">307100000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTMtMS0xLTExNzAyOQ_7b0918b8-a14e-470e-9f47-967caac9a273"
      unitRef="usd">-10200000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE4LTUtMS0xLTExNzAyOQ_93bbe5e9-5259-4167-9673-7dc57b5a7639"
      unitRef="usd">-5300000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTEtMS0xLTExNzAyOQ_ca9c60a8-f660-4457-8280-d9b595a7f473"
      unitRef="usd">35300000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTMtMS0xLTExNzAyOQ_51694ea2-5db8-4c62-945b-f53b531ae0d6"
      unitRef="usd">45000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzE5LTUtMS0xLTExNzAyOQ_5a31e26d-4b7b-46a7-b15c-4e49ca782fa2"
      unitRef="usd">48400000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTEtMS0xLTExNzAyOQ_d3b72b52-5e4e-4367-96b4-f76239b7479e"
      unitRef="usd">-559300000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTMtMS0xLTExNzAyOQ_61bdae03-83b2-4428-b773-170b6647b6bd"
      unitRef="usd">-275900000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIwLTUtMS0xLTExNzAyOQ_4c80f29c-b38b-45a6-8c1b-e78e0575c490"
      unitRef="usd">257900000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTEtMS0xLTExNzAyOQ_9173d25d-6494-423a-8f66-2f2d307ad7c8"
      unitRef="usd">1955900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTMtMS0xLTExNzAyOQ_d1f4f905-3646-4b99-969a-b636bd9c2d56"
      unitRef="usd">3109600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIxLTUtMS0xLTExNzAyOQ_b4738aa9-25d1-4f07-8aa9-04555b6de67b"
      unitRef="usd">2135300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTEtMS0xLTExNzAyOQ_80fc3efa-4bde-4941-9645-1e2dbf7ca873"
      unitRef="usd">481900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTMtMS0xLTExNzAyOQ_30621b0c-34b7-4037-8d2c-35d69b25b88f"
      unitRef="usd">460400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzIzLTUtMS0xLTExNzAyOQ_13831d73-a3c5-4ec0-bc64-7a55cd07fd0f"
      unitRef="usd">381700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTEtMS0xLTExNzAyOQ_d6506857-e5dd-4f53-98cc-4257756d409b"
      unitRef="usd">17400000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTMtMS0xLTExNzAyOQ_3ee90854-1753-4a41-a323-afe6bfc55b7c"
      unitRef="usd">27800000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI0LTUtMS0xLTExNzAyOQ_375101bd-dce8-4593-9613-b2d588ba089e"
      unitRef="usd">40100000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTEtMS0xLTExNzAyOQ_28c4a76b-75eb-40a4-8d74-cf2ff6748ec0"
      unitRef="usd">1400000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTMtMS0xLTExNzAyOQ_ea3c5875-0add-475a-bcb1-2642680ee583"
      unitRef="usd">87300000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI1LTUtMS0xLTExNzAyOQ_c7f7f2eb-fa30-43bd-9884-448e68cdf32f"
      unitRef="usd">42100000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTEtMS0xLTExNzAyOQ_46337047-47b8-4906-a7b0-9d7e608a12c5"
      unitRef="usd">5200000</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTMtMS0xLTExNzAyOQ_52d2b0a0-5332-48bd-90f3-3f2af505e003"
      unitRef="usd">13200000</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:ProceedsFromSaleOfOtherInvestments
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI2LTUtMS0xLTExNzAyOQ_96aa5ea0-698a-435e-93e3-fe37c11ae3ca"
      unitRef="usd">1000000.0</us-gaap:ProceedsFromSaleOfOtherInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTEtMS0xLTExNzAyOQ_16a3accc-abf7-4b72-95cc-036c46e150a4"
      unitRef="usd">2900000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTMtMS0xLTExNzAyOQ_6c4daae6-d706-4925-967a-f5ff666b09bc"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI3LTUtMS0xLTExNzAyOQ_678877f4-8247-474c-b691-846501ab6211"
      unitRef="usd">3100000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTEtMS0xLTExNzAyOQ_0c6b898c-ab45-46af-8ce2-4c2bbec07007"
      unitRef="usd">1600000</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTMtMS0xLTExNzAyOQ_54469adf-cdac-45fe-b764-d16eb8eb5daa"
      unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzI4LTUtMS0xLTExNzAyOQ_1c0eb515-712c-4ccd-83c7-197a2b03e8f9"
      unitRef="usd">0</us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTEtMS0xLTExNzAyOQ_76694034-4c4f-4f1c-b82d-8f4ca6537906"
      unitRef="usd">1164000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTMtMS0xLTExNzAyOQ_acbf2d04-9f3b-4e1f-8aa4-315f3bce49de"
      unitRef="usd">496900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMwLTUtMS0xLTExNzAyOQ_a353cb41-b15d-4045-b89f-e7fa421ab0b0"
      unitRef="usd">267600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTEtMS0xLTExNzAyOQ_a28b531a-84f3-4a7f-8623-4c3c1a595101"
      unitRef="usd">-1652200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTMtMS0xLTExNzAyOQ_63450bfb-5f0d-429a-816f-d5c81684e73b"
      unitRef="usd">-884600000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMxLTUtMS0xLTExNzAyOQ_88a0a69e-a518-4f16-8652-f5a26c128235"
      unitRef="usd">-643200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTEtMS0xLTExNzAyOQ_390a44c1-40ca-471b-9c5d-a4df7a5a4945"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTMtMS0xLTExNzAyOQ_a2730fc3-a0ee-489e-b5f7-7902cc39fea4"
      unitRef="usd">1000000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzMzLTUtMS0xLTExNzAyOQ_036a36ba-5b75-439d-983e-400d7095991a"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTEtMS0xLTExNzAyOQ_78d45773-078d-461f-bdd9-e8ae336c1fce"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTMtMS0xLTExNzAyOQ_41900365-6bef-4fc8-8baa-4dd1bd3ea386"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM0LTUtMS0xLTExNzAyOQ_3044f449-f7ed-4f0a-8bc5-e931c2bd3971"
      unitRef="usd">412200000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTEtMS0xLTExNzAyOQ_9aa581ab-679e-4a16-b014-56eb8dfcbfd5"
      unitRef="usd">0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTMtMS0xLTExNzAyOQ_bc7dfa99-ec76-44e3-ba67-664c258a3bfc"
      unitRef="usd">375000000.0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM2LTUtMS0xLTExNzAyOQ_958917e9-1082-4e7f-806c-8c0b406cb5a0"
      unitRef="usd">0</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTEtMS0xLTExNzAyOQ_03b142fb-1930-45e0-8c86-d7e4b4092b6c"
      unitRef="usd">787400000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTMtMS0xLTExNzAyOQ_ac1321aa-7a7f-466a-8063-3629c492156f"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM3LTUtMS0xLTExNzAyOQ_a4a81604-6e7f-453f-8de0-1c801d821320"
      unitRef="usd">151700000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTEtMS0xLTExNzAyOQ_0365a918-5377-4cc7-9d53-68929ed206f6"
      unitRef="usd">787400000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTMtMS0xLTExNzAyOQ_9d3785cc-8316-4961-9e51-f982ba4b81f5"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzM4LTUtMS0xLTExNzAyOQ_c9457b20-851d-4519-8b72-23e3fd9ebb9b"
      unitRef="usd">151700000</us-gaap:RepaymentsOfLinesOfCredit>
    <lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTEtMS0xLTExNzAyOQ_2c23b128-8c5d-4e5a-b481-bdfd6ba1b685"
      unitRef="usd">50600000</lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities>
    <lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTMtMS0xLTExNzAyOQ_06c3482e-9c9d-4e30-98c3-6613293f1fd8"
      unitRef="usd">47400000</lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities>
    <lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQwLTUtMS0xLTExNzAyOQ_a448752b-790a-41a9-b4c0-edb6d5683426"
      unitRef="usd">34500000</lh:ExcessTaxBenefitShareBasedCompensationFinancingActivities>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTEtMS0xLTExNzAyOQ_2508a813-476a-46f9-8b9d-871170680cf7"
      unitRef="usd">50600000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTMtMS0xLTExNzAyOQ_017c904e-424d-49f0-825a-74e63ca61d18"
      unitRef="usd">51700000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <lh:NetProceedsFromIssuanceOfStockToEmployees
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQxLTUtMS0xLTExNzAyOQ_529358cb-13c1-4a0f-ba91-aaaf41ec110c"
      unitRef="usd">55900000</lh:NetProceedsFromIssuanceOfStockToEmployees>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTEtMS0xLTE3MTM2MA_b7d25101-fd19-4fbc-812d-f19e650920a1"
      unitRef="usd">195200000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTMtMS0xLTE3MTM2MA_6b07c7ee-7047-40a8-83fe-f8a639a9308b"
      unitRef="usd">0</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTUtMS0xLTE3MTM2MA_79acf21c-96a8-4c23-a59c-41d3fb2256f7"
      unitRef="usd">0</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTEtMS0xLTExNzAyOQ_997fb769-c154-489d-8059-424ce1541b5c"
      unitRef="usd">1100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTMtMS0xLTExNzAyOQ_2f23f481-6963-4153-807b-eac74a51f22e"
      unitRef="usd">1668500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQyLTUtMS0xLTExNzAyOQ_0601d04b-4f3c-4176-be2a-aacdda9b5740"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTEtMS0xLTExNzAyOQ_bcadcc88-f12a-4163-b2b2-41ab1aa63494"
      unitRef="usd">-27000000.0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTMtMS0xLTExNzAyOQ_df55c7e3-56ef-40b3-b7bb-9e16e00369c6"
      unitRef="usd">-26600000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQzLTUtMS0xLTExNzAyOQ_2191ec67-c3d9-45b3-a941-94ffca82bda1"
      unitRef="usd">-26600000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTEtMS0xLTExNzAyOQ_785e153c-9444-4e39-9d09-f4c149dcb9bc"
      unitRef="usd">-1322200000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTMtMS0xLTExNzAyOQ_22b7a90b-5d3c-4f30-b569-ca29a88e069a"
      unitRef="usd">-2065800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ0LTUtMS0xLTExNzAyOQ_1d043645-e53d-439d-8367-03938db12e0c"
      unitRef="usd">-517400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTEtMS0xLTExNzAyOQ_6389bf17-cc17-40c6-b2ea-7020f0134ba6"
      unitRef="usd">-24200000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTMtMS0xLTExNzAyOQ_c8afdffb-2d15-4cf9-9d3f-0cb17d3dde70"
      unitRef="usd">-7300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ1LTUtMS0xLTExNzAyOQ_7b64cc71-fb2b-4b8a-b4a8-206ffc625c0c"
      unitRef="usd">8600000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTEtMS0xLTExNzAyOQ_54fae651-3e5d-4d27-94db-479fee9e4214"
      unitRef="usd">-1042700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTMtMS0xLTExNzAyOQ_1e69941f-20bb-4448-8d23-1857864a5567"
      unitRef="usd">151900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ2LTUtMS0xLTExNzAyOQ_54101907-83f3-485d-b61f-1a0a5a9d5494"
      unitRef="usd">983300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTEtMS0xLTExNzAyOQ_f96b8d96-f74c-4845-9b90-8091b2552a20"
      unitRef="usd">1472700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTMtMS0xLTExNzAyOQ_7b9784fd-12dc-4cda-a072-04c1b58c454b"
      unitRef="usd">1320800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ3LTUtMS0xLTExNzAyOQ_f934f54d-3cea-45df-ab5a-ecb780889b82"
      unitRef="usd">337500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTEtMS0xLTExNzAyOQ_d3a0058d-93d3-4a3d-a26b-16d898c1ab91"
      unitRef="usd">430000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTMtMS0xLTExNzAyOQ_be8e1167-05fd-44cb-ab72-a153de7e00c4"
      unitRef="usd">1472700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODEvZnJhZzo4NGQ4MzExMDc0NWY0YzYyYTA4ODBmMTQ5YjRkZjgxNC90YWJsZTpkNDhiNGFiNWMzOTc0Mjg3ODMzM2U3Mzk0OTkwZDE1NS90YWJsZXJhbmdlOmQ0OGI0YWI1YzM5NzQyODc4MzMzZTczOTQ5OTBkMTU1XzQ4LTUtMS0xLTExNzAyOQ_1deb2f08-72e3-44ae-81c7-9062c22dcf9f"
      unitRef="usd">1320800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDIw_b219f4d3-5a21-4fc8-8a02-210e30006174">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Financial Statement Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings (Labcorp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than 80,000 employees, the Company serves clients in more than 100 countries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, including information for each of the last three fiscal years regarding revenue, operating income, and other important information, see Note 19 Business Segment Information. In 2022, Dx and DD contributed 61% and 39%, respectively, of revenues to the Company, and in 2021 contributed 64% and 36%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reimbursable Out-of-Pocket Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD pays on behalf of its customers certain out-of-pocket costs for which the Company is reimbursed at cost, without mark-up or profit. Out-of-pocket costs paid by DD are reflected in cost of revenues, while the reimbursements received are reflected in revenues in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue includes direct labor and related benefit charges, reimbursable expenses, other direct costs, shipping and handling fees, and an allocation of facility charges and information technology costs. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, advertising and promotional expenses, administrative travel and an allocation of facility charges and information technology costs. Cost of advertising is expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Significant estimates include implicit price concessions, revenue estimates, the allowances for doubtful accounts, deferred tax assets, fair values of acquired assets and assumed liabilities in business combinations, fair value of goodwill and indefinite-lived intangible assets, amortization lives for acquired intangible assets, and accruals for self-insurance reserves, litigation reserves and pensions. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extent to which the COVID-19 pandemic has and will continue to impact the Company&#x2019;s business and financial results depend on numerous evolving factors including, but not limited to the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2022, and through the date of this Annual Report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s implicit price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;concessions and credit losses, equity investments, and the carrying value of goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could impact the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash and cash equivalents with various major financial institutions. The total cash and cash equivalent balances that exceeded the balances insured by the Federal Deposit Insurance Commission, were approximately $428.1 and $1,471.0 at December&#160;31, 2022, and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of the Company&#x2019;s accounts receivable are with companies in the healthcare or pharmaceutical industry and individuals. However, concentrations of credit risk are mitigated due to the number of the Company&#x2019;s customers as well as their dispersion across many different geographic regions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although Dx has receivables due from U.S. and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by U.S. and state governments, and payment is primarily dependent upon submitting appropriate documentation. Accounts receivable balances (gross) from Medicare and Medicaid were $85.8 and $94.5 at December&#160;31, 2022, and 2021, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company's operations in Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (Ministry) determines who can establish a licensed community medical laboratory and caps the amount that each of these licensed laboratories can bill the government sponsored healthcare plan. The Ontario government-sponsored healthcare plan covers the cost of commercial laboratory testing performed by the licensed laboratories. The provincial government discounts the annual testing volumes based on certain utilization discounts and establishes an annual maximum it will pay for all community laboratory tests. The agreed-upon reimbursement rates are subject to Ministry review at the end of year and can be adjusted (at the government's discretion) based upon the actual volume and mix of test work performed by the licensed healthcare providers in the province during the year. There were no capitated accounts receivable balances from the Ontario government sponsored healthcare plan at December&#160;31, 2022. The balance was CAD 7.2 at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.&#160;At December&#160;31, 2022, and 2021, receivables due from patients represented approximately 15.3% and 16.7% of the Company's consolidated gross accounts receivable, respectively.&#160;The Company applies assumptions and judgments including historical collection experience and reasonable and supportable forecasts for assessing collectability and determining allowances for doubtful accounts for accounts receivable from patients.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#x2019;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options and stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units is determined based on the number of shares granted and the quoted price of the Company&#x2019;s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and the Company's determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and the Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 13 Stock Compensation Plans for assumptions used in calculating compensation expense for the Company&#x2019;s stock compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits, and other money market instruments, which have maturities when purchased of three months or less. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplies Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Inventories, consisting primarily of purchased laboratory and customer supplies and finished goods, are stated at the lower of cost (first-in, first-out) or net realizable value. Supplies accounted for $412.8 and $371.5 and finished goods accounted for $57.8 and $29.9 of total inventory at December&#160;31, 2022, and 2021, respectively. The Company's inventory reserve balance was $23.3 and $40.1, as of December&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capitalized Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes purchased software that is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and the Company commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development (R&amp;amp;D) costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system ranging from three to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;fifteen years, generally five years. Amortization begins once the underlying system is substantially complete and ready for its intended use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill and Indefinite-lived Intangibles&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#x2019;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:468.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:13.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:7.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:15.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs related to the issuance of debt are capitalized, netted against the related debt for presentation purposes and amortized to interest expense over the terms of the related debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Professional Liability&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is self-insured (up to certain limits) for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is based on assumptions and factors for known and incurred but not reported claims, including the frequency and payment trends of historical claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All leases with a lease term greater than 12 months, regardless of lease type classification, are recorded as an obligation on the balance sheet with a corresponding right-of-use asset. Both finance and operating leases are reflected as liabilities on the commencement date of the lease based on the present value of the lease payments to be made over the lease term. Right-of-use assets are valued at the initial measurement of the lease liability, plus any initial direct costs or rent prepayments, minus lease incentives and any deferred lease payments. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A certain number of these leases contain rent escalation clauses either fixed or adjusted periodically for inflation or market rates that are factored into the Company's determination of lease payments. The Company also has variable lease payments that do not depend on a rate or index, for items such as volume purchase commitments, which are recorded as variable cost when incurred. As most of the Company's leases do not provide an implicit rate, the Company estimates an incremental borrowing rate based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company uses this rate to discount payments to present value. Some operating leases contain renewal options, some of which also include options to early terminate the leases. The exercise of these options is at the Company's discretion and the Company evaluates each renewal option to determine if it is reasonably possible to be exercised and should be included in the accounting lease term. See Note 5 Leases to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.&#160;If the recognition threshold is met, the Company recognizes a tax benefit &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized. The Company records interest and penalties in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments. The Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swap agreements, which have been used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative financial instruments are accounted for as fair value hedges that increase or decrease the value of the Senior Notes with the offset being recorded as a component of other long-term assets or liabilities, as applicable. As the specific terms and notional amounts of the derivative financial instruments match those of the fixed-rate debt being hedged, the derivative instruments are assumed to be perfectly effective hedges and accordingly, there is no impact to the Company's consolidated statements of operations. Cash flows from the interest rate swaps are including in operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross currency swap agreements, which have been used by the Company to hedge the foreign currency exposure of its net investment in a foreign subsidiary denominated in non-U.S. currency, are accounted for at fair value. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statements of Comprehensive Earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency forward contracts, which have been used by the Company to hedge foreign currency receivables, are recognized as assets or liabilities at their fair value. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The fair value of these contracts is not significant as of December&#160;31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements for financial assets and liabilities are determined based on the assumptions that a market participant would use in pricing an asset or liability. A three-tiered fair value hierarchy draws distinctions between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2), and (iii) unobservable inputs that require the Company to use present value and other valuation techniques in the determination of fair value (Level 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses R&amp;amp;D costs as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;padding-left:54pt;text-align:justify;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For subsidiaries outside of the U.S. that operate in a local currency environment, income and expense items are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders&#x2019; equity in the consolidated balance sheets and are included in the determination of comprehensive income in the consolidated statements of comprehensive earnings and consolidated statements of changes in shareholders&#x2019; equity. Transaction gains and losses are included in the determination of net income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDE0_be0ed146-d3f3-404d-8cd1-a4c4621bfcf9">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Financial Statement Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Holdings (Labcorp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; or the Company) is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. With more than 80,000 employees, the Company serves clients in more than 100 countries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reports its business in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). For further financial information about these segments, including information for each of the last three fiscal years regarding revenue, operating income, and other important information, see Note 19 Business Segment Information. In 2022, Dx and DD contributed 61% and 39%, respectively, of revenues to the Company, and in 2021 contributed 64% and 36%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries for which it exercises control. Long-term investments in affiliated companies in which the Company exercises significant influence, but which it does not control, are accounted for using the equity method. Investments in which the Company does not exercise significant influence (generally, when the Company has an investment of less than 20% and no representation on the investee's board of directors) are accounted for at fair value or at cost minus impairment adjusted for observable price changes in orderly transactions for an identical or similar investment of the same issuer for those investments that do not have readily determinable fair values. All significant inter-company transactions and accounts have been eliminated. The Company does not have any variable interest entities or special purpose entities whose financial results are not included in the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company's operating foreign subsidiaries are measured using the local currency as the functional currency.&#160;Assets and liabilities are translated at exchange rates as of the balance sheet date.&#160;Revenues and expenses are translated at average monthly exchange rates prevailing during the year.&#160;Resulting translation adjustments are included in &#x201c;Accumulated other comprehensive income.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <dei:EntityNumberOfEmployees
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzUzMg_81e39c35-370e-4198-aa43-087366bb81b2"
      unitRef="employee">80000</dei:EntityNumberOfEmployees>
    <lh:PercentofRevenueContributed
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0Nzk0NjI_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0Nzk0NjY_afc9324a-33dc-46c5-9679-e8205e4a8f3f"
      unitRef="number">0.39</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyOTY_45cfe58f-f40f-45d7-a53f-7b2947417913"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEzMDM_fd465a4f-9db9-42d8-a50d-5049df0e0196"
      unitRef="number">0.36</lh:PercentofRevenueContributed>
    <lh:CostMethodInvestmentsMaximumOwnershipPercentage
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE3NzE_560bf21c-2b47-4ebb-8772-c9a5139fd622"
      unitRef="number">0.20</lh:CostMethodInvestmentsMaximumOwnershipPercentage>
    <lh:ReimbursableOutofPocketExpensesPolicyPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU1_d6d7b173-b1a1-4fa7-be86-b184f62589a9">Reimbursable Out-of-Pocket ExpensesDD pays on behalf of its customers certain out-of-pocket costs for which the Company is reimbursed at cost, without mark-up or profit. Out-of-pocket costs paid by DD are reflected in cost of revenues, while the reimbursements received are reflected in revenues in the consolidated statements of operations.</lh:ReimbursableOutofPocketExpensesPolicyPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzY2_5716d0a6-e885-4db0-b4af-75281cd99537">&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cost of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue includes direct labor and related benefit charges, reimbursable expenses, other direct costs, shipping and handling fees, and an allocation of facility charges and information technology costs. Selling, general and administrative expenses consist primarily of administrative payroll and related benefit charges, advertising and promotional expenses, administrative travel and an allocation of facility charges and information technology costs. Cost of advertising is expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzQ2_d67d767a-59d5-41ac-bcf7-8d9bfac4d3b1">&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported periods. Significant estimates include implicit price concessions, revenue estimates, the allowances for doubtful accounts, deferred tax assets, fair values of acquired assets and assumed liabilities in business combinations, fair value of goodwill and indefinite-lived intangible assets, amortization lives for acquired intangible assets, and accruals for self-insurance reserves, litigation reserves and pensions. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The extent to which the COVID-19 pandemic has and will continue to impact the Company&#x2019;s business and financial results depend on numerous evolving factors including, but not limited to the magnitude and duration of the COVID-19 pandemic, the impact to worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2022, and through the date of this Annual Report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s implicit price &lt;/span&gt;&lt;/div&gt;concessions and credit losses, equity investments, and the carrying value of goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could impact the Company&#x2019;s consolidated financial statements in future reporting periods.</us-gaap:UseOfEstimates>
    <lh:ConcentrationOfCreditRiskPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU4_be7d1347-5f10-4537-a460-c58ad47afe22">Concentration of Credit Risk&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains cash and cash equivalents with various major financial institutions. The total cash and cash equivalent balances that exceeded the balances insured by the Federal Deposit Insurance Commission, were approximately $428.1 and $1,471.0 at December&#160;31, 2022, and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of the Company&#x2019;s accounts receivable are with companies in the healthcare or pharmaceutical industry and individuals. However, concentrations of credit risk are mitigated due to the number of the Company&#x2019;s customers as well as their dispersion across many different geographic regions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although Dx has receivables due from U.S. and state governmental agencies, the Company does not believe that such receivables represent a credit risk since the related healthcare programs are funded by U.S. and state governments, and payment is primarily dependent upon submitting appropriate documentation. Accounts receivable balances (gross) from Medicare and Medicaid were $85.8 and $94.5 at December&#160;31, 2022, and 2021, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Company's operations in Ontario, Canada, the Ontario Ministry of Health and Long-Term Care (Ministry) determines who can establish a licensed community medical laboratory and caps the amount that each of these licensed laboratories can bill the government sponsored healthcare plan. The Ontario government-sponsored healthcare plan covers the cost of commercial laboratory testing performed by the licensed laboratories. The provincial government discounts the annual testing volumes based on certain utilization discounts and establishes an annual maximum it will pay for all community laboratory tests. The agreed-upon reimbursement rates are subject to Ministry review at the end of year and can be adjusted (at the government's discretion) based upon the actual volume and mix of test work performed by the licensed healthcare providers in the province during the year. There were no capitated accounts receivable balances from the Ontario government sponsored healthcare plan at December&#160;31, 2022. The balance was CAD 7.2 at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;The portion of the Company's accounts receivable due from patients comprises the largest portion of credit risk.&#160;At December&#160;31, 2022, and 2021, receivables due from patients represented approximately 15.3% and 16.7% of the Company's consolidated gross accounts receivable, respectively.&#160;The Company applies assumptions and judgments including historical collection experience and reasonable and supportable forecasts for assessing collectability and determining allowances for doubtful accounts for accounts receivable from patients.</lh:ConcentrationOfCreditRiskPolicyTextBlock>
    <us-gaap:CashUninsuredAmount
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzYwNjM_50cac80e-1eb4-4651-90d0-17f26a6676a1"
      unitRef="usd">428100000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzYwNzA_f0599e31-9d50-49a6-a640-c794e8ed0efd"
      unitRef="usd">1471000000</us-gaap:CashUninsuredAmount>
    <lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzY3ODU_5e87ade5-aa9a-4df6-9a0e-5c15b752ed24"
      unitRef="usd">85800000</lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid>
    <lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzY3OTI_563b8f6d-eaeb-4237-9dd6-f0df646fb302"
      unitRef="usd">94500000</lh:ConcentrationRiskAccountsReceivableMedicareAndMedicaid>
    <lh:AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzE2NDkyNjc0NzkyNDQ_3c20a754-6f70-4a4d-af01-e997064a1094"
      unitRef="usd">7200000</lh:AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan>
    <lh:Percentofgrossaccountsreceivableduefrompatients
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzgwNDI_aa0c0588-7384-4b7c-b8f7-ae405862fb25"
      unitRef="number">0.153</lh:Percentofgrossaccountsreceivableduefrompatients>
    <lh:Percentofgrossaccountsreceivableduefrompatients
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzgwNDk_9c139232-4e7c-4016-b6aa-2a963525803c"
      unitRef="number">0.167</lh:Percentofgrossaccountsreceivableduefrompatients>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDMz_96108e79-2a9a-4f42-9294-7817ba411ee8">&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net earnings attributable to Laboratory Corporation of America Holdings by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing net earnings including the impact of dilutive adjustments by the weighted average number of common shares outstanding plus potentially dilutive shares, as if they had been issued at the earlier of the date of issuance or the beginning of the period presented. Potentially dilutive common shares result primarily from the Company&#x2019;s outstanding stock options, restricted stock awards, performance share awards, and accelerated share repurchases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options and stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the potential common shares not included in the computation of diluted earnings per share because their impact would have been antidilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzUx_3f4fcfa4-2ef0-400e-a3bc-2bde64241f73">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents a reconciliation of basic earnings per share to diluted earnings per share:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.917%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Per Share&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options and stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,279.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,377.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,556.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMS0xLTEtMTE3MDI5_6c9c432c-2f80-4387-b977-fe870e83c900"
      unitRef="usd">1279100000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMy0xLTEtMTE3MDI5_7ea63d9c-b69f-4e9b-9b79-3edb5c132fca"
      unitRef="shares">91100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItNS0xLTEtMTE3MDI5_f7152bd0-027d-4c40-84a0-b4c298eb7ea5"
      unitRef="usdPerShare">14.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItNy0xLTEtMTE3MDI5_5f7cb0ed-49f8-4444-ab62-60c63f84b6e4"
      unitRef="usd">2377300000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItOS0xLTEtMTE3MDI5_3838bc8c-611e-401a-b667-8433a71c1497"
      unitRef="shares">96700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTEtMS0xLTExNzAyOQ_d8b67f9a-a70b-40e7-ab41-1f14100f603b"
      unitRef="usdPerShare">24.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTMtMS0xLTExNzAyOQ_73c47453-2556-4ba8-8d95-017fda5027d7"
      unitRef="usd">1556100000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTUtMS0xLTExNzAyOQ_7b869233-48ea-49d1-b7b5-6127b4a4f4c9"
      unitRef="shares">97300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzItMTctMS0xLTExNzAyOQ_0d11ea3d-a409-4d22-ad96-4c070379f440"
      unitRef="usdPerShare">15.99</us-gaap:EarningsPerShareBasic>
    <lh:IncrementalCommonSharesAttributableToStockOptions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtMy0xLTEtMTE3MDI5_6596c32c-ff74-4961-b5af-8b53b57f0838"
      unitRef="shares">500000</lh:IncrementalCommonSharesAttributableToStockOptions>
    <lh:IncrementalCommonSharesAttributableToStockOptions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtOS0xLTEtMTE3MDI5_9c6d4745-c03c-4461-a391-e4aa75c7056f"
      unitRef="shares">800000</lh:IncrementalCommonSharesAttributableToStockOptions>
    <lh:IncrementalCommonSharesAttributableToStockOptions
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzMtMTUtMS0xLTExNzAyOQ_e90a18ee-af77-47b0-80b7-553fcba98370"
      unitRef="shares">700000</lh:IncrementalCommonSharesAttributableToStockOptions>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMS0xLTEtMTE3MDI5_e05371cf-58b4-4ffe-b4b1-6722a73dc14a"
      unitRef="usd">1279100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMy0xLTEtMTE3MDI5_63b78522-290a-4fff-911f-7399c90aa1dd"
      unitRef="shares">91600000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtNS0xLTEtMTE3MDI5_831c88e8-3795-4a2f-b3c0-ec658dbbb428"
      unitRef="usdPerShare">13.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtNy0xLTEtMTE3MDI5_ea11cc6c-f56b-4c82-9e67-1d9c5f2dc97c"
      unitRef="usd">2377300000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtOS0xLTEtMTE3MDI5_107103f8-6daa-4c00-98ab-a172500cd26f"
      unitRef="shares">97500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTEtMS0xLTExNzAyOQ_eb1d2596-80bb-43f1-976f-e86cf9921c66"
      unitRef="usdPerShare">24.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTMtMS0xLTExNzAyOQ_399edced-e8c1-42a1-a6d0-0e671dccac6b"
      unitRef="usd">1556100000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTUtMS0xLTExNzAyOQ_08bdf5af-ee19-4d46-9236-98955f0a5a0e"
      unitRef="shares">98000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTo5ODc1Zjk1MTNjNDA0NWM5OGIzMzkxNjFiYTdjNTNiYS90YWJsZXJhbmdlOjk4NzVmOTUxM2M0MDQ1Yzk4YjMzOTE2MWJhN2M1M2JhXzYtMTctMS0xLTExNzAyOQ_40d82b1c-7c85-4009-93fa-f6b67373dd46"
      unitRef="usdPerShare">15.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDQ4_e32eb58e-0962-4b86-b296-26ad2b95ecb1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePotentiallyDilutiveSecurities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItMS0xLTEtMTE3MDI5_97f89b55-c69c-4378-a8c9-af110c95f8bb">0.2</us-gaap:EarningsPerSharePotentiallyDilutiveSecurities>
    <us-gaap:EarningsPerSharePotentiallyDilutiveSecurities
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItMy0xLTEtMTE3MDI5_4debc57e-3388-41d1-b219-c48b2bc70996">0.1</us-gaap:EarningsPerSharePotentiallyDilutiveSecurities>
    <us-gaap:EarningsPerSharePotentiallyDilutiveSecurities
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTpmYzQ3ZTBmZmIzZTk0Y2NiOGRhZmZhNjkxNTk0OGE2NS90YWJsZXJhbmdlOmZjNDdlMGZmYjNlOTRjY2I4ZGFmZmE2OTE1OTQ4YTY1XzItNS0xLTEtMTE3MDI5_a6da5e5d-1ffc-4dea-a7dd-be8e0239ca4d">0.2</us-gaap:EarningsPerSharePotentiallyDilutiveSecurities>
    <lh:ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzYy_80bbd136-2a24-48e1-a8d6-e01b73f7774e">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures stock compensation cost for all equity awards at fair value on the date of grant and recognizes compensation expense over the service period for awards expected to vest. The fair value of restricted stock units is determined based on the number of shares granted and the quoted price of the Company&#x2019;s common stock on the grant date. The grant date fair value of performance awards is based on a Monte Carlo simulated fair value for the relative (as compared to the peer companies) total shareholder return component of the performance awards. Such value is recognized as an expense over the service period, net of estimated forfeitures and the Company's determination of whether it is probable that the performance targets will be achieved. At the end of each reporting period, the Company reassesses the probability of achieving performance targets. The estimation of equity awards that will ultimately vest requires judgment and the Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Forfeitures are recognized as a reduction of compensation expense in earnings in the period in which they occur. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 13 Stock Compensation Plans for assumptions used in calculating compensation expense for the Company&#x2019;s stock compensation plans.&lt;/span&gt;&lt;/div&gt;</lh:ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzYz_cd8a96ca-85ce-4598-8064-8bea164c9e29">Cash EquivalentsCash and cash equivalents consist of highly liquid instruments, such as commercial paper, time deposits, and other money market instruments, which have maturities when purchased of three months or less.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzIx_03ced079-31f0-4717-bb02-fce26be6c01e">Supplies InventoryInventories, consisting primarily of purchased laboratory and customer supplies and finished goods, are stated at the lower of cost (first-in, first-out) or net realizable value. Supplies accounted for $412.8 and $371.5 and finished goods accounted for $57.8 and $29.9 of total inventory at December&#160;31, 2022, and 2021, respectively. The Company's inventory reserve balance was $23.3 and $40.1, as of December&#160;31, 2022 and 2021, respectively.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:OtherInventorySupplies
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMTYx_c3bdb2f7-215b-4939-a587-d76f30a95ec1"
      unitRef="usd">412800000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMTY5_12b9300b-4ca1-464c-ab80-81c46df27771"
      unitRef="usd">371500000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryFinishedGoods
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMjA2_0cd51d69-c21b-470d-b33f-6d28e4533b49"
      unitRef="usd">57800000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMjE0_4bcb9a88-d267-41ca-8d8a-8ad65b9817ed"
      unitRef="usd">29900000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryValuationReserves
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMzEw_fd896f84-20c1-4599-8246-4a9a29d7273f"
      unitRef="usd">23300000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzExMzE4_9aa231af-8832-4574-b289-7d95620c66c0"
      unitRef="usd">40100000</us-gaap:InventoryValuationReserves>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzI5_73a8867b-68ce-4806-b865-aa0386626bef">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are recorded at cost. Depreciation and amortization expense is computed on all classes of assets based on their estimated useful lives, as indicated below, using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements are amortized over the shorter of their estimated useful lives or the term of the related leases. Expenditures for repairs and maintenance are charged to operations as incurred. Retirements, sales and other disposals of assets are recorded by removing the cost and accumulated depreciation from the related accounts with any resulting gain or loss reflected in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If the carrying value is no longer recoverable based upon the undiscounted future cash flows of the asset, the amount of the impairment is the difference between the carrying amount and the fair value of the asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <lh:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDI1_0cb112b0-8a9d-4608-8359-576c1768eeed">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:89.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.411%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</lh:PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9b6a6d5c6ce048f5affe8b3f830295da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzEtMS0xLTEtMTE3MDI5_ed7126a9-96e2-4f72-aa93-1dabf133a152">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i94949d3130ed4a5799cf762de995588d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzEtMy0xLTEtMTE3MDI5_73c5b060-f157-4d88-ba38-4fd216445ffc">P35Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5a92509bdd1c40ecb4512f86503921ae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzItMS0xLTEtMTE3MDI5_0dade6d1-5acf-4c1e-b37b-f2e4544164bd">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia5ba3c1e35eb464c897bb213112248c3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzItMy0xLTEtMTE3MDI5_8e1547c4-0252-4944-a8c1-56abf5e8e665">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9a192c3cef59471da28f4a1f91336aa3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzMtMS0xLTEtMTE3MDI5_424721a6-c494-40b5-bfc7-a8c2bb9054ad">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id8df4fdf2ac64fa69822e22b9afd91f3_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzMtMy0xLTEtMTE3MDI5_85649d8c-72c0-4859-9113-00a430e8a96e">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1c8d59fa396741e39a1c2b4ec07bf248_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzQtMS0xLTEtMTE3MDI5_a59022fb-86d9-4753-8da2-1adfeb5c0cbe">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4750c2997b414c319516d7f0f3c2d043_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTphMmUxMTE5ZjRkM2Q0MzQzOTFjOGU4ZTZjMDczNDQxZC90YWJsZXJhbmdlOmEyZTExMTlmNGQzZDQzNDM5MWM4ZThlNmMwNzM0NDFkXzQtMy0xLTEtMTE3MDI5_f996c0dd-fa1b-4972-be55-8649eaf139bd">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <lh:InternalUseSoftwarePolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDE3_00b028be-0617-4953-984d-090af0219b65">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capitalized Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes purchased software that is ready for service and capitalizes software development costs incurred on significant projects starting from the time that the preliminary project stage is completed and the Company commits to funding a project until the project is substantially complete and the software is ready for its intended use. Capitalized costs include direct material and service costs and payroll and payroll-related costs. Research and development (R&amp;amp;D) costs and other computer software maintenance costs related to software development are expensed as incurred. Capitalized software costs are amortized using the straight-line method over the estimated useful life of the underlying system ranging from three to &lt;/span&gt;&lt;/div&gt;fifteen years, generally five years. Amortization begins once the underlying system is substantially complete and ready for its intended use.</lh:InternalUseSoftwarePolicyTextBlock>
    <lh:Propertyplantandequipmentusefullifesoftwareminimum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyNzky_f745a0d3-4fbb-4e3b-a612-33a176f52086"
      unitRef="y">3</lh:Propertyplantandequipmentusefullifesoftwareminimum>
    <lh:Propertyplantandequipmentusefullifesoftwaremaximum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyNzk4_10b6658e-0792-41d8-af1b-b8843bfbd3c3"
      unitRef="y">15</lh:Propertyplantandequipmentusefullifesoftwaremaximum>
    <lh:PropertyPlantAndEquipmentUsefulLifeSoftwareAverage
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEyODE4_34d6d32a-4f8d-4bbb-a094-f2b38556eb39"
      unitRef="y">5</lh:PropertyPlantAndEquipmentUsefulLifeSoftwareAverage>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjky_827f874d-2d6f-491c-87a6-52fad186593e">&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#x2019;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years &lt;/span&gt;&lt;/div&gt;vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjky_bb14ca00-b852-40b6-a2f6-51c709eb980a">&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses goodwill and indefinite-lived intangibles, which are not amortized, for impairment at least annually or whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. The annual impairment test for goodwill includes an option to perform a qualitative assessment of whether it is more likely than not that a reporting unit's fair value is less than its carrying value. Reporting units are businesses with discrete financial information that is available and reviewed by management. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then the Company performs the quantitative goodwill impairment test. The Company may also choose to bypass the qualitative assessment for any reporting unit in its goodwill assessment and proceed directly to performing the quantitative assessment. The Company recognizes an impairment charge for the amount by which the reporting unit's carrying amount exceeds its fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the qualitative assessment, the Company considers relevant events and circumstances for each reporting unit, including (i) current year results, (ii) financial performance versus management&#x2019;s annual and five-year strategic plans, (iii) changes in the reporting unit carrying value since prior year, (iv) industry and market conditions in which the reporting unit operates, (v) macroeconomic conditions, including discount rate changes, and (vi) changes in products or services offered by the reporting unit. If applicable, performance in recent years is compared to forecasts included in prior quantitative valuations. Based on the results of the qualitative assessment, if the Company concludes that it is not more likely than not that the fair value of the reporting unit is less than its carrying values of the reporting unit, then no quantitative assessment is performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quantitative assessment includes the estimation of the fair value of each reporting unit as compared to the carrying value of the reporting unit. The Company estimates the fair value of a reporting unit using both income-based and market-based valuation methods. The income-based approach is based on the reporting unit's forecasted future cash flows that are discounted to the present value using the reporting unit's weighted average cost of capital. For the market-based approach, the Company utilizes a number of factors such as publicly available information regarding the market capitalization of the Company as well as operating results, business plans, market multiples, and present value techniques. Based upon the range of estimated values developed from the income and market-based methods, the Company determines the estimated fair value for the reporting unit. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired and no further review is required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management performed its annual goodwill and intangible asset impairment testing as of the beginning of the fourth quarter of 2022. The Company elected to perform the qualitative assessment for goodwill and intangible assets for the domestic Dx reporting units, and a quantitative assessment for all of the DD reporting units, and the Canadian reporting unit which includes indefinite-lived assets consisting of acquired Canadian licenses. Based upon the results of the qualitative and quantitative assessments, the Company concluded that the fair values of each of its reporting units, as of October 1, 2022, were greater than the carrying values. For the early development reporting unit, which is part of the DD segment, the fair value of the business exceeded the book value by approximately 10%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:11pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, a significant supplier of the early development reporting unit was no longer able to provide critical testing supplies resulting in an expectation of lower near term revenue and profitability and potential higher future costs. Based on this information, management prepared a new forecast and updated the impairment testing valuations as of December 31, 2022. Based on the quantitative impairment assessment performed in the same manner as the Company's annual quantitative assessment, the Company concluded that the fair value was less than carrying value for the early development reporting unit and recorded a goodwill impairment of $260.0 in the DD segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company believes that the current assumptions and estimates used in its goodwill analysis are reasonable, supportable, and appropriate, continued efforts to maintain or improve the performance of these businesses could be impacted by unfavorable or unforeseen changes which could impact the existing assumptions used in the impairment analysis. Various factors could reasonably be expected to unfavorably impact existing assumptions: primarily delays in new customer bookings and the related delay in revenue from new customers, increases in customer termination activity or increases in operating costs.  Accordingly, there can be no assurance that the estimates and assumptions made for the purposes of the goodwill impairment analysis will prove to be accurate predictions of future performance. It is possible that the Company's conclusions regarding impairment or recoverability of goodwill or intangible assets in any reporting unit could change in future periods. There can be no assurance that the estimates and assumptions used in the Company's goodwill and intangible asset impairment testing performed as of the beginning of the fourth quarter of 2022 or at the end of the year will prove to be accurate predictions of the future, if, for example, (i) the businesses do not perform as projected, (ii) overall economic conditions in 2023 or future years &lt;/span&gt;&lt;/div&gt;vary from current assumptions (including changes in discount rates), (iii) business conditions or strategies for a specific reporting unit change from current assumptions, including loss of major customers, (iv) investors require higher rates of return on equity investments in the marketplace or (v) enterprise values of comparable publicly traded companies, or actual sales transactions of comparable companies, were to decline, resulting in lower multiples of revenues and EBITDA.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzEwOTk1MTE2NzcwNjA_e829c17a-e2ec-407d-a615-0d4f9008c522"
      unitRef="usd">260000000.0</us-gaap:GoodwillImpairmentLoss>
    <lh:IntangibleAssetsFiniteLivedPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzU2_519df5de-a92b-4ab1-ae4b-2f2b053bdeea">&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:468.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:13.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:7.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:15.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:IntangibleAssetsFiniteLivedPolicyTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzE0_d986a1c9-5edb-4438-a7eb-65faaf07868e">&lt;div style="margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives are amortized on a straight-line basis over the expected periods to be benefited, as set forth in the table below, such as legal life for patents and technology and contractual lives for non-compete agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:468.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:13.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:7.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:15.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib808cf79e1a9467cb239ce57e26f5d7a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzEtMS0xLTEtMTE3MDI5_5cdeaddb-30c9-4bab-9751-85dd3ca73e56">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i08dd77efa97448c782606eca830b8ac9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzEtMy0xLTEtMTE3MDI5_f40cbd7e-2a68-43ce-9a4e-121e8c1b2f71">P36Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if8553f543bdb4c5ea631132f326bb1fb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzItMS0xLTEtMTE3MDI5_2f1505c7-ebc3-47a5-8294-c7820e7994c3">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib05bf67d55164f34a2b82099cdad4337_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzItMy0xLTEtMTE3MDI5_22e67571-a944-4e24-a01b-cbd08dca6cd2">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i01d2be985d134f92a0588488c2ad06b2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzMtMS0xLTEtMTE3MDI5_36a86842-d6a5-4122-ad90-318fb9b7d3fd">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5bb990f93a5446cc99f3cafcfb16a8c7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzMtMy0xLTEtMTE3MDI5_e0a06336-60e4-449d-a4b7-e91741f80c26">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i70260250d8b54b01818e471ec885d017_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzQtMS0xLTEtMTE3MDI5_4f8c26d0-9496-4bbd-a9ec-8834a3b43a37">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id0a5f472de164e8dbe46d04714a66b05_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90YWJsZTowYmJjYjZmNDY2MDI0YjI3YjY0MWUyMThjZGY1ODAwZi90YWJsZXJhbmdlOjBiYmNiNmY0NjYwMjRiMjdiNjQxZTIxOGNkZjU4MDBmXzQtMy0xLTEtMTE3MDI5_37f118f5-44f7-4c49-8af6-3d017d11f14c">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:DebtPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzE1_c41ec9a1-579b-4a62-af3d-3e892c0cf2e0">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Issuance Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs related to the issuance of debt are capitalized, netted against the related debt for presentation purposes and amortized to interest expense over the terms of the related debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <lh:ProfessionalLiabilityPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mzk2_ada2303b-6b3a-48ad-8c07-fe384b3c35e7">Professional LiabilityThe Company is self-insured (up to certain limits) for professional liability claims arising in the normal course of business, generally related to the testing and reporting of laboratory test results. The Company estimates a liability that represents the ultimate exposure for aggregate losses below those limits. The liability is based on assumptions and factors for known and incurred but not reported claims, including the frequency and payment trends of historical claims.</lh:ProfessionalLiabilityPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzMx_15733664-0d1d-42c9-93eb-fbf70bea4129">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All leases with a lease term greater than 12 months, regardless of lease type classification, are recorded as an obligation on the balance sheet with a corresponding right-of-use asset. Both finance and operating leases are reflected as liabilities on the commencement date of the lease based on the present value of the lease payments to be made over the lease term. Right-of-use assets are valued at the initial measurement of the lease liability, plus any initial direct costs or rent prepayments, minus lease incentives and any deferred lease payments. The classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A certain number of these leases contain rent escalation clauses either fixed or adjusted periodically for inflation or market rates that are factored into the Company's determination of lease payments. The Company also has variable lease payments that do not depend on a rate or index, for items such as volume purchase commitments, which are recorded as variable cost when incurred. As most of the Company's leases do not provide an implicit rate, the Company estimates an incremental borrowing rate based on the credit quality of the Company and by comparing interest rates available in the market for similar borrowings, and adjusting this amount based on the impact of collateral over the term of each lease. The Company uses this rate to discount payments to present value. Some operating leases contain renewal options, some of which also include options to early terminate the leases. The exercise of these options is at the Company's discretion and the Company evaluates each renewal option to determine if it is reasonably possible to be exercised and should be included in the accounting lease term. See Note 5 Leases to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0Mjg0_9bcbf98c-8edb-4cf6-813f-fd420eb7089b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes utilizing the asset and liability method. Under this method deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for tax loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company does not recognize a tax benefit unless the Company concludes that it is more likely than not that the benefit will be sustained on audit by the taxing authority based solely on the technical merits of the associated tax position.&#160;If the recognition threshold is met, the Company recognizes a tax benefit &lt;/span&gt;&lt;/div&gt;measured at the largest amount of the tax benefit that the Company believes is greater than 50% likely to be realized. The Company records interest and penalties in income tax expense.</us-gaap:IncomeTaxPolicyTextBlock>
    <lh:IncomeTaxBenefitMinimumCertaintyPercentage
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzIwNjYy_eb9c9945-f1aa-45df-9cb2-1265364e255c"
      unitRef="number">0.50</lh:IncomeTaxBenefitMinimumCertaintyPercentage>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0NDM2_b67726fd-4e39-42f3-80a1-a12b5bd693dd">&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company addresses its exposure to market risks, principally the market risk associated with changes in interest rates and currency exchange rates, through a controlled program of risk management that includes, from time to time, the use of derivative financial instruments. The Company does not hold or issue derivative financial instruments for trading purposes. The Company does not believe that its exposure to market risk is material to the Company&#x2019;s financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate swap agreements, which have been used by the Company from time to time in the management of interest rate exposure, are accounted for at fair value. These derivative financial instruments are accounted for as fair value hedges that increase or decrease the value of the Senior Notes with the offset being recorded as a component of other long-term assets or liabilities, as applicable. As the specific terms and notional amounts of the derivative financial instruments match those of the fixed-rate debt being hedged, the derivative instruments are assumed to be perfectly effective hedges and accordingly, there is no impact to the Company's consolidated statements of operations. Cash flows from the interest rate swaps are including in operating activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross currency swap agreements, which have been used by the Company to hedge the foreign currency exposure of its net investment in a foreign subsidiary denominated in non-U.S. currency, are accounted for at fair value. Changes in the fair value of the cross-currency swaps are charged or credited through accumulated other comprehensive income in the Consolidated Balance Sheet until the hedged item is recognized in earnings. The cumulative amount of the fair value hedging adjustments are recognized as currency translation within the Consolidated Statements of Comprehensive Earnings.&lt;/span&gt;&lt;/div&gt;Foreign currency forward contracts, which have been used by the Company to hedge foreign currency receivables, are recognized as assets or liabilities at their fair value. These contracts do not qualify for hedge accounting and the changes in fair value are recorded directly to earnings. The contracts are short-term in nature and the fair value of these contracts is based on market prices for comparable contracts. The fair value of these contracts is not significant as of December&#160;31, 2022 and 2021.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzUw_4c3f77f6-4a50-4b1f-800f-3b517fcc6c7f">&lt;div style="margin-bottom:3pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements for financial assets and liabilities are determined based on the assumptions that a market participant would use in pricing an asset or liability. A three-tiered fair value hierarchy draws distinctions between market participant assumptions based on (i) observable inputs such as quoted prices in active markets (Level 1), (ii) inputs other than quoted prices in active markets that are observable either directly or indirectly (Level 2), and (iii) unobservable inputs that require the Company to use present value and other valuation techniques in the determination of fair value (Level 3).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MjM2_ea828661-77e7-4f54-9b5b-6142f4e01114">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses R&amp;amp;D costs as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xODcvZnJhZzphZjk1MDM5ZTVhZjg0MTg5OTM0ZTBiYmQ0NGRkMjE3Ny90ZXh0cmVnaW9uOmFmOTUwMzllNWFmODQxODk5MzRlMGJiZDQ0ZGQyMTc3XzI0MzA2_e33bc3da-ea64-4618-b787-da5fad45365c">&lt;div style="margin-bottom:3pt;margin-top:7pt;padding-left:54pt;text-align:justify;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For subsidiaries outside of the U.S. that operate in a local currency environment, income and expense items are translated to U.S. dollars at the monthly average rates of exchange prevailing during the period, assets and liabilities are translated at period-end exchange rates and equity accounts are translated at historical exchange rates. Translation adjustments are accumulated in a separate component of shareholders&#x2019; equity in the consolidated balance sheets and are included in the determination of comprehensive income in the consolidated statements of comprehensive earnings and consolidated statements of changes in shareholders&#x2019; equity. Transaction gains and losses are included in the determination of net income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDI3_de7c7bf7-f7f7-43aa-b3ae-fafe83415e4f">REVENUES&lt;div style="margin-bottom:3pt;margin-top:4pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Description of Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dx attributes revenues to a geographical region based upon where the diagnostic test is performed, while DD attributes revenues to a geographical region based upon where the services are performed. The Company's revenue by segment payers/customer groups for the years ended December&#160;31, 2022, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:94.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:34.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:33.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:33.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total Dx revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues in the U.S. were $11,530.5 (77.5%), $12,566.2 (77.9%) and $11,192.3 (80.1%) for the years ended December&#160;31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the current revenue recognition policies of the Company:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dx Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dx is an independent clinical laboratory business. It offers a comprehensive menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the U.S. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx also offered a range of other testing services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within the Dx segment, a revenue transaction is initiated when Dx receives a requisition order to perform a diagnostic test. The information provided on the requisition form is used to determine the party that will be billed for the testing performed and the expected reimbursement. Dx recognizes revenue and satisfies its performance obligation for services rendered when the testing process is complete and the associated results are reported. Revenues are distributed among four payer portfolios - clients, patients, Medicare and Medicaid and third party. Dx considers negotiated discounts and anticipated adjustments, including historical collection experience for the payer portfolio, when revenues are recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are descriptions of the Dx payer portfolios:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Clients&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Client payers represent the portion of Dx&#x2019;s revenue related to physicians, hospitals, health systems, accountable care organizations (ACOs), employers and other entities where payment is received exclusively from the entity ordering the testing service. Generally, client sales are recorded on a fee-for-service basis at Dx&#x2019;s client list price, less any negotiated discount. A portion of client billing is for laboratory management services, collection kits and other non-testing services or products. In these cases, revenue is recognized when services are rendered or delivered. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patients&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This portfolio includes revenue from uninsured patients and member cost-share for insured patients (e.g., coinsurance, deductibles and non-covered services). Uninsured patients are billed based upon Dx&#x2019;s patient list fee schedules, net of any discounts negotiated with physicians on behalf of their patients. Dx bills insured patients as directed by their health plan and after consideration of the fees and terms associated with an established health plan contract.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medicare and Medicaid&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This portfolio relates to fee-for-service revenue from traditional Medicare and Medicaid programs. Revenue from these programs is based on the fee schedule established by the related government authority. In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#x2019;s results of operations in any period presented&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Third Party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Third party includes revenue related to managed care organizations (MCOs). The majority of Dx's third-party revenue is reimbursed on a fee-for-service basis. These payers are billed at Dx's established list price and revenue is recorded net of contractual discounts. The majority of Dx&#x2019;s MCO sales are recorded based upon contractually negotiated fee schedules with sales for non-contracted MCOs recorded based on historical reimbursement experience. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to contractual discounts, other adjustments including anticipated payer denials are considered when determining revenue. Any remaining adjustments to revenue are recorded at the time of final collection and settlement. These adjustments are not material to Dx&#x2019;s results of operations in any period presented.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Third-party reimbursement is also received through capitation agreements with MCOs and independent physician associations (IPAs). Under capitated agreements, revenue is recognized based on a negotiated per-member, per-month payment for an agreed upon menu of tests, or based upon the proportionate share earned by Dx from a capitation pool. When the agreed upon reimbursement is based solely on an established rate per member, revenue is not impacted by the volume of testing performed. Under a capitation pool arrangement, the aggregate value of an established rate per member is distributed based on the volume and complexity of the procedures performed by laboratories participating in the agreement. Dx recognizes revenue monthly, based upon the established capitation rate or anticipated distribution from a capitated pool.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;DD Revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD is a global contract research organization (CRO) business that provides end-to-end drug development services. DD provides these services predominantly to pharmaceutical, biotechnology, and medical device companies worldwide. A majority of DD&#x2019;s revenues are earned under contracts that are long term in nature, ranging in duration from a few months to many years.  The majority of DD's contracts contain a single performance obligation, as DD provides a significant service of integrating all promises in the contract and the promises are highly interdependent and interrelated with one another. For contracts that include multiple performance obligations, DD allocates the contract value to the goods and services based on a customer price list, if available. If a price list is not available, DD will estimate the transaction price using either market prices or an &#x201c;expected cost plus margin&#x201d; approach. The total contract value is estimated at the beginning of the contract, and is equal to the amount expected to be billed to the customer. Other payments and billing adjustments may also factor into the calculation of total contract value, such as the reimbursement of out-of-pocket costs and volume-based rebates. These contracts generally take the form of fixed-price or fee-for-service arrangements subject to pricing adjustments based on changes in scope.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Fixed-price contracts are typically recognized as revenue over time based on a proportional-performance basis, using either input or output methods that are specific to the service provided.  In an output method, revenue is determined by dividing the actual units of output achieved by the total units of output required under the contract and multiplying that percentage by the total contract value. When using an input method, revenue is recognized by dividing the actual costs incurred by the total estimated cost expected to complete the contract, and multiplying that percentage by the total contract value. Contract costs principally include direct labor and reimbursable out-of-pocket costs.  The estimate of total costs expected to complete the contract requires significant judgment and estimates are based on various assumptions of events that often span several years. These estimates are reviewed periodically and any adjustments are recognized on a cumulative catch-up basis in the period they become known.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fee-for-service contracts are typically priced based on transaction volume or time and materials. For volume based contracts the contract value is entirely variable and revenue is recognized as the specific product or service is completed. For services billed based on time and materials, revenue is recognized using the right to invoice practical expedient.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts are often modified to account for changes in contract specifications and requirements. Generally, when contract modifications create new performance obligations, the modification is considered to be a separate contract and revenue is recognized prospectively. When contract modifications change existing performance obligations, the impact on the existing transaction price and measure of progress for the performance obligation to which it relates is generally recognized as an adjustment to revenue (either as an increase in or a reduction of revenue) on a cumulative catch-up basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Most contracts are terminable with or without cause by the customer, either immediately or upon notice. These contracts often require payment to DD of expenses to wind-down the study or project, fees earned to date and, in some cases, a termination fee or a payment to DD of some portion of the fees or profits that could have been earned by DD under the contract if it had not been terminated early. Termination fees are included in revenues when services are performed and realization is assured. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;DD Contract costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD incurs sales commissions in the process of obtaining contracts with customers, which are recoverable through the service fees in the contract. Sales commissions that are payable upon contract award are recognized as assets and amortized over the expected contract term, along with related payroll tax expense. The amortization of commission expense is based on the weighted average contract duration for all commissionable awards in the respective business in which the commission expense is paid, which approximates the period over which goods and services are transferred to the customer. The amortization period of sales commissions ranges from approximately 1 to 5 years, depending on the business. For businesses that enter primarily short-term contracts, DD applies the practical expedient which allows costs to obtain a contract to be expensed when incurred if the amortization period of the assets that would otherwise have been recognized is one year or less. Amortization of assets from sales commissions is included in selling, general, and administrative expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD incurs costs to fulfill contracts with customers, which are recoverable through the service fees in the contract. Contract fulfillment costs include software implementation costs and setup costs for certain services. These costs are recognized as assets and amortized over the expected term of the contract to which the implementation relates, which is the period over which services are expected to be provided to the customer. This period typically ranges from 2 to 5 years. Amortization of deferred contract fulfillment costs is included in cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:331.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization related to sales commission assets and associated payroll taxes for the years ended December&#160;31, 2022, 2021, and 2020 was $33.9, $27.5 and $23.2, respectively. Amortization related to deferred contract fulfillment costs for the years ended December&#160;31, 2022, 2021 and 2020 was $12.4, $14.2 and $10.1, respectively. Impairment expense related to contract costs was insignificant to the Company&#x2019;s consolidated statements of operations. DD applies the practical expedient to not recognize the effect of financing in its contracts with customers, when the difference in timing of payment and performance is one year or less. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Accounts Receivable, Unbilled Services and Unearned Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Differences in the timing of revenue recognition and associated billing and cash collections result in recording accounts receivable, unbilled services and unearned revenue in the consolidated balance sheet. Payments received in advance of services being provided are contract liabilities recognized as unearned revenue. Revenue recognized in advance of billing are recognized as unbilled services and the majority of DD's unbilled services represent unbilled receivables. Once a customer is invoiced, the contract asset is reduced for the amount billed, and a corresponding accounts receivable is recognized. All contract assets are billable to customers within one year from the respective balance sheet date. The following table provides information about accounts receivable, unbilled services, and unearned revenue from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:325.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less DD allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less reserve for unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized during the period, that was included in the unearned revenue balance at the beginning of the period, for the years ended December&#160;31, 2022, 2021, and 2020 was $330.5,  $319.4, and $262.6, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Credit Loss Rollforward&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD estimates future expected losses on accounts receivable, unbilled services and notes receivable over the remaining collection period of the instrument. The rollforward for the allowance for credit losses for the year ended December&#160;31, 2022, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending allowance for credit losses as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:110%"&gt;Performance Obligations Under Long-Term Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term contracts at DD consist primarily of fully managed clinical studies within the DD segment. The amount of existing performance obligations under such long-term contracts unsatisfied as of December&#160;31, 2022, was $5,122.1. DD expects to recognize approximately 30.0% of the remaining performance obligations as of December&#160;31, 2022, as revenue over the next 12 months, and the balance thereafter. DD's long-term contracts generally range from 1 to 8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DD applied the practical expedient and does not disclose information about remaining performance obligations that have original expected durations of one year or less. DD also did not disclose information about remaining performance obligations when the variable consideration was related to a wholly unsatisfied performance obligation within a series of obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Within DD, revenue of $73.0 and $69.8 was recognized during the year ended December&#160;31, 2022, and December&#160;31, 2021, respectively, from performance obligations that were partially satisfied in previous periods. This revenue comes primarily from adjustments related to changes in scope.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDMz_ef5adad3-e55b-43c5-b723-e52094a673d9">The Company's revenue by segment payers/customer groups for the years ended December&#160;31, 2022, 2021 and 2020 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:94.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:34.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:33.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:33.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:28.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:27.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="21" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payer/Customer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Medicare and Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Third party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;Total Dx revenues by payer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Pharmaceutical, biotechnology and medical device companies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <lh:PercentofRevenueContributed
      contextRef="i0f9c987b80f84514ab0f5a8179f498e7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMS0xLTEtMTE3MDI5_ffc564ba-8c08-4e02-9e36-4cfcf25da42c"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ieabfe2258e1446b192ef394f16489167_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtNS0xLTEtMTE3MDI5_b63d29fd-58e7-41a0-90db-8742148ecf6b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTEtMS0xLTExNzAyOQ_13409024-b8e3-476d-9198-58552d60e9ef"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ib5d9c0a345404c24a4a4e43524421de4_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTMtMS0xLTExNzAyOQ_6b38d010-9e52-4de0-883f-c880cc44e098"
      unitRef="number">0.18</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTUtMS0xLTExNzAyOQ_07b9660a-b5f8-43fc-929c-9e7cd9237695"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1e731a9507b44113a0151f73f4b46a81_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTUtMS0xLTExNzAyOQ_626eb1b8-cde0-433c-9a5c-0582f25db4b6"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTctMS0xLTExNzAyOQ_6073ba1f-ad2e-4cb9-827d-dd2892784277"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i62b91351337c44079b374875b323d3e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTctMS0xLTExNzAyOQ_d12b806a-8dcf-42a4-b103-6bc2c46af939"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMTktMS0xLTExNzAyOQ_08fee676-7298-42f2-8979-ba5ac9530b0f"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97c8066769b0429ea4ac450b653b569a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjEtMS0xLTExNzAyOQ_12c3a73d-ffc2-460c-b492-f6f0e84e52ed"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if54fdf6e96454bf5a5135ce9fc049e2e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjYtMS0xLTExNzAyOQ_d0a4dde7-6ce1-4ae4-941c-81c6984a18c5"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i92c836aa2b6c4d9c9d2cbb62d348119f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMjgtMS0xLTExNzAyOQ_0033e698-efea-453a-b32b-565fd7769b1b"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMzAtMS0xLTExNzAyOQ_4574c43c-fd5c-46bb-8068-2f89e424d107"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i49a7f666344b43219373509023b86a61_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzQtMzItMS0xLTExNzAyOQ_6ca3ffa6-06ac-4718-931c-d4190a6121cb"
      unitRef="number">0.20</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia00703317297439a899a69e868562330_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMS0xLTEtMTE3MDI5_ef97beb1-888f-42d9-ae8d-9979489a819a"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iec1d5156f16f4a8ab3e8702905ca4c63_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtNS0xLTEtMTE3MDI5_60bfad80-1852-4063-bb23-ba78d8484bda"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTEtMS0xLTExNzAyOQ_b3615c40-cf3a-4401-9f2e-e2fbc73ea475"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b271df130df4c45b105ac235f0c2f50_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTMtMS0xLTExNzAyOQ_bd2e2dc1-cdb1-4e5a-be2c-5a9f0045617a"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTUtMS0xLTExNzAyOQ_b4618336-8de7-4c99-8f44-1afe835df481"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i11e9a7d10b6441ceaf6b8040bf4fb580_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTUtMS0xLTExNzAyOQ_df747fb9-cdb5-4c5c-a6a9-d416d133c9ab"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTctMS0xLTExNzAyOQ_0eb6022d-a832-402d-91ee-5d68f01b747d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i7efbc2922164408c936797e755136d6b_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTctMS0xLTExNzAyOQ_2ed3078a-cda5-435b-885e-cc7fe72d3caf"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMTktMS0xLTExNzAyOQ_40c782aa-8fce-4bbd-b307-78d4654e0c27"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id0397d247ecf459b9c6c770b238b57e4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjEtMS0xLTExNzAyOQ_9efee418-80ce-409f-8629-af8e491f90c5"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic6f3cd2f746b4849b78836022d98129d_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjYtMS0xLTExNzAyOQ_90f2575d-3455-4c87-9f85-6aa3fe6fff5d"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i174342f325564eb4800f5d7bafca1841_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMjgtMS0xLTExNzAyOQ_267a854d-e4f7-4d0e-8790-e5ad4a2aadea"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMzAtMS0xLTExNzAyOQ_4ff9c6a3-e335-4262-a979-9a92fb978ed9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i82fb8b48d60246df8510e33e9e0e39b4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzUtMzItMS0xLTExNzAyOQ_12644480-1493-43b0-bcf8-84c48a043fe7"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3d7bcd46830c4c4080ce6c8adfe99717_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMS0xLTEtMTE3MDI5_67e351da-d65a-4295-a8cc-ece7f1f99a38"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i5ae555abd3724f958bcdc920e12d75cf_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtNS0xLTEtMTE3MDI5_f646bbc9-b8b6-48b0-a1c5-b50997ce3c83"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0a955983ee194f7cad4f3eae08d120a2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTEtMS0xLTExNzAyOQ_34b02f11-9cd6-45f7-baea-f0b0491afd9e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4a425320aa5c45f7aae2fcf3852d514c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTMtMS0xLTExNzAyOQ_8ed16f25-da28-41c6-afef-6869fbf47139"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i88d0f71185154581b7b6bd61bfa9407f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTUtMS0xLTExNzAyOQ_f973d042-f777-48a0-a891-e29bfda029b6"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i89d1c1e4e74747668fee112945a5767d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTctMS0xLTExNzAyOQ_91e8b979-b035-46c7-9e52-c2b260bb8fbe"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i01ebdcbe560c4a2b85aba4117c46390d_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMTktMS0xLTExNzAyOQ_871a9ce1-825c-4f28-9a5c-728bc0ec2050"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i91139fb3405c40e89005a42835b1528e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjEtMS0xLTExNzAyOQ_2960cd61-5005-442c-9d7f-be8ed330f94c"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i4a41b4f6eda5422dbcac01d56dfcc2d4_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjYtMS0xLTExNzAyOQ_64b01766-aabe-4261-a609-4d55644aaf75"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1cc23f06f1124a9fab11aec744beb1bf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMjgtMS0xLTExNzAyOQ_4a75ef98-1a52-423f-8a2c-0b73b3bf9c27"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2a6714ab30154ab7adf7919442029308_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMzAtMS0xLTExNzAyOQ_4cdec5cc-324d-46d8-8413-a8c5cead4ef9"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i61ded0a4ea294279b769de13bcdb64db_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzYtMzItMS0xLTExNzAyOQ_e9e15cb8-fdb5-438c-9198-1f99fe6320cb"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i41204750b78b41e99bbfcab862d31763_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMS0xLTEtMTE3MDI5_63813dc7-22b0-4a7d-9a8b-fd9090a0b7be"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8d02e56840324f358ea2c669aa8b3b44_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctNS0xLTEtMTE3MDI5_70d61c3a-3e16-4a0a-95d5-37cd6c9d135d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if5ae13d6b66e4d66ac8cb763d6d9e622_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTEtMS0xLTExNzAyOQ_13ca5584-843c-4ae3-a6b9-2e745ede783e"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6f951d95ffa74fb2b314fc4d60162eb5_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTMtMS0xLTExNzAyOQ_0a4ba1e5-b42b-4f23-a67d-cbcd8e3e94ed"
      unitRef="number">0.31</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTUtMS0xLTExNzAyOQ_70729d38-b348-4dd0-afa1-1a00f039691e"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i97484afcfb0246cf9b71a2beaddc53c3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTUtMS0xLTExNzAyOQ_ff99a912-0abb-48d1-8d0f-5ec2ab08ea63"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTctMS0xLTExNzAyOQ_85f65e7c-332f-432a-b53a-7cb88cac73ac"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i22ae928d35a54533906182c59b812aa3_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTctMS0xLTExNzAyOQ_97d013f3-a788-472d-a26d-2c1998700fe6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6076f297572c4f5f8f73ff6c6576d927_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMTktMS0xLTExNzAyOQ_4b70d3fb-a907-4b5a-adfa-4b6c5a823426"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0477c5d75ed44d0aaaf47ac682931659_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjEtMS0xLTExNzAyOQ_39c638c6-bee2-4791-928b-d85fd3398a89"
      unitRef="number">0.34</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="icba36eacc3c943cca03f3598759b2674_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjYtMS0xLTExNzAyOQ_e5d5ad7e-2525-47de-8f31-7efb3615015f"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0855e4e7139742529986707c444dfb8e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMjgtMS0xLTExNzAyOQ_52547e93-e813-481b-9d65-fee6d2958cb6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b188d6d9bc64163a734588d0bc5f219_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMzAtMS0xLTExNzAyOQ_3954c7ba-fe0e-4984-a8d1-ae0cbbd82172"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic7b108654a344436ad1bc7dd4447688f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzctMzItMS0xLTExNzAyOQ_c0762774-d1f9-4e55-ac60-5a875c84e108"
      unitRef="number">0.32</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ifa358a04a1f14908b4f4972033b8d1b7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMS0xLTEtMTE3MDI5_1df03a3a-3473-4142-8290-de28e08c71b8"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic1c9faeea8854e2c9d6f9171879616e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtNS0xLTEtMTE3MDI5_8d8e043e-5e46-48b2-a6bb-b62b8f05e94d"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i52733785e36d4fe69241ec49519c9770_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTEtMS0xLTExNzAyOQ_40b117a3-3b9c-4f4c-ae9b-db27e72b7930"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTMtMS0xLTExNzAyOQ_df0e9cc5-d0e4-46c6-819e-6814e4ebdfa9"
      unitRef="number">0.61</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTUtMS0xLTExNzAyOQ_459fb7af-ea71-46b1-9421-9014ef0e075c"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iaa28c1ff744d455fb6bc27f69de76354_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTUtMS0xLTExNzAyOQ_9b353615-beba-4a6c-b30d-8ca80952dd95"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTctMS0xLTExNzAyOQ_0d3b4240-9e6b-4e1a-8123-ae947e718326"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="id816df3ef476487bb1728a93ee3fd0a0_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTctMS0xLTExNzAyOQ_af6cef02-8ffc-4923-963b-ca0aeb989cc6"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i60668faa46f04bf3add5dd0876c5ec61_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMTktMS0xLTExNzAyOQ_8b829856-5fdb-442b-8a81-b5ad38c20ee0"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjEtMS0xLTExNzAyOQ_fd1d06cd-0880-47e1-8150-f015cfcf2156"
      unitRef="number">0.64</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idbf69b4fd55b4891aae7c2a7b3866555_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjYtMS0xLTExNzAyOQ_6fa054ce-c676-4930-8d75-2cccdeaf3d65"
      unitRef="number">0.65</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iae1cb15f7c404bafa858134a46d49c7f_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMjgtMS0xLTExNzAyOQ_d96f4e69-3b29-4eb7-a9b3-953b42eee06c"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ife9f9b5eabda4004a022ff0e4baeaff0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMzAtMS0xLTExNzAyOQ_dd5313ff-22fa-4bbb-80d5-ceb07e723aa5"
      unitRef="number">0</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzgtMzItMS0xLTExNzAyOQ_e67c0e10-1410-47f0-a90f-0ea6c273b1b5"
      unitRef="number">0.65</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i6d6cb383b4834da09d62346a62279532_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTEtMS0xLTExNzAyOQ_e131afc4-2553-49a8-8c2f-dc4bd0f75154"
      unitRef="number">0.19</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i335582cfdd6b4ffb929ff466aadb4db2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTUtMS0xLTExNzAyOQ_9a407ba3-fa15-43c6-b033-6b8312a87745"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i2f70aa9b7b144a3e8e0d9090c1f72648_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTExLTEtMS0xMTcwMjk_036beacc-c9dd-4559-9188-54df60e51a22"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic711bbfcced34e89878863bb09676b90_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTEzLTEtMS0xMTcwMjk_afc9324a-33dc-46c5-9679-e8205e4a8f3f"
      unitRef="number">0.39</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE1LTEtMS0xMTcwMjk_20acbe51-b459-4b87-b617-11ab6216626c"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i1a5e69b64f4d470b8506561651160652_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE1LTEtMS0xMTcwMjk_879f0a87-5a50-41fc-8f1d-dbf58b56e8a5"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia9d2c478caa14c12be094937b26edd13_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE3LTEtMS0xMTcwMjk_d79968d6-ce59-43f0-9dc5-cd16d6cffb73"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i532c63eac8ab42b2a89c8b9321f38278_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTE5LTEtMS0xMTcwMjk_1e78b6da-23c4-4f45-9d78-d44e3e8ccdf0"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia02b1eec93154a2dabd13289ac865579_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTIxLTEtMS0xMTcwMjk_52fe24e0-75d3-4fe4-a6d8-89237790a347"
      unitRef="number">0.36</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i47bbe6b70ef9417fb826173e2186af9c_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTI2LTEtMS0xMTcwMjk_b6a25641-78f7-4516-ab75-e80b637a8582"
      unitRef="number">0.17</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ia79e541004cf46c99deea20f51fd0ed1_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTI4LTEtMS0xMTcwMjk_f1a23581-874c-4fcd-ab66-2d26297114f2"
      unitRef="number">0.11</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e9621e02cd4432ba23b20c70faf66fe_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTMwLTEtMS0xMTcwMjk_56277e88-def6-4dc2-a1dd-76cd7ca6adef"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibf621aef6ad2416182fcfb3686d2f5ae_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzExLTMyLTEtMS0xMTcwMjk_33a05168-7621-4556-83b6-de53c125691d"
      unitRef="number">0.35</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="iab3fc788db6246d8befa5072a7a8eff2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTEtMS0xLTExNzAyOQ_612a8796-4e7e-4e04-b1ca-0198692185a3"
      unitRef="number">0.80</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ic2669ff621164010847fc66b9f791ff2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTUtMS0xLTExNzAyOQ_c469b4e7-a1e4-49b5-9420-f8dcbbf09f01"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i82c2e6801ef94ad7a4c27f53953c9fe7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTExLTEtMS0xMTcwMjk_f68c79a3-a685-40ca-8dc5-98fcc0ea280c"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTEzLTEtMS0xMTcwMjk_bfa7e972-0219-45bc-a914-44231b26c937"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE1LTEtMS0xMTcwMjk_46045b06-3430-4017-9a0a-5c0d447afab8"
      unitRef="number">0.81</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ibfa318e1fdfb46be9c300d4bd87f9d23_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE1LTEtMS0xMTcwMjk_ad0d209e-2de6-407e-b7e2-0db9f088d21e"
      unitRef="number">0.81</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE3LTEtMS0xMTcwMjk_003c51be-60ae-468a-a7b5-f3f331d06e35"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8e2a4d6690b742549b0cad6ecbc17279_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE3LTEtMS0xMTcwMjk_e88f5c8e-7c19-4729-94a5-4ee6e181e3b4"
      unitRef="number">0.13</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i8b9d9c9d2dfa4b888a90e86b85015f16_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTE5LTEtMS0xMTcwMjk_cbfd13a0-9667-47cb-a51d-2614a6e840cf"
      unitRef="number">0.06</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTIxLTEtMS0xMTcwMjk_f1776bcb-6186-42f3-8e06-a6acd66b5946"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i0fc5a5581bb2482981d38585a9167a3a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTI2LTEtMS0xMTcwMjk_370a4c43-c13d-443c-8cfd-7d01f5614536"
      unitRef="number">0.82</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="if759d237173f4e8f802f8e0baad408a5_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTI4LTEtMS0xMTcwMjk_fa6e2047-c3a0-4938-bcd9-fdcb3f93f6ad"
      unitRef="number">0.11</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="i3ef30dca6bfb46b9b1bc64e4d0d21624_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTMwLTEtMS0xMTcwMjk_d9f50ece-a52d-4a8f-9fe9-8c3eab0c8c38"
      unitRef="number">0.07</lh:PercentofRevenueContributed>
    <lh:PercentofRevenueContributed
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToyNzI4ZTZiZDJlMDA0NzlmODQ4NGE2ZjhkZDFlNTFhNS90YWJsZXJhbmdlOjI3MjhlNmJkMmUwMDQ3OWY4NDg0YTZmOGRkMWU1MWE1XzEzLTMyLTEtMS0xMTcwMjk_de74e993-a7fa-4325-8015-5903478ed42a"
      unitRef="number">1</lh:PercentofRevenueContributed>
    <us-gaap:Revenues
      contextRef="i4c371a44ae834a938c2eab8e3804c578_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM3NA_8f70a3d5-4651-4d16-99df-882fad749393"
      unitRef="usd">11530500000</us-gaap:Revenues>
    <lh:PercentOfDomesticRevenue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM3OA_f6857fb8-225c-409b-9601-1f3475d41149"
      unitRef="number">0.775</lh:PercentOfDomesticRevenue>
    <us-gaap:Revenues
      contextRef="i0c412272fff644b58159484e9b5ae929_D20210101-20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM4Mw_26dab332-2eb0-478c-897d-b86e67e06d24"
      unitRef="usd">12566200000</us-gaap:Revenues>
    <lh:PercentOfDomesticRevenue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM4Nw_e9ce859f-7573-4dd3-a56b-b6b6af71a97d"
      unitRef="number">0.779</lh:PercentOfDomesticRevenue>
    <us-gaap:Revenues
      contextRef="ia869d1147bc1446495aafb25f926c462_D20200101-20201231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM5NQ_0b7b7ff9-271c-4e6f-beae-e4ddb6add241"
      unitRef="usd">11192300000</us-gaap:Revenues>
    <lh:PercentOfDomesticRevenue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzM5OQ_cc436f64-53a8-4b3f-b9e9-343c39d46fad"
      unitRef="number">0.801</lh:PercentOfDomesticRevenue>
    <lh:SalesCommissionAmortizationPeriodMinimum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzkxNDM_ec39e073-b492-4a76-a544-623f62cc0b59">P1Y</lh:SalesCommissionAmortizationPeriodMinimum>
    <lh:SalesCommissionAmortizationPeriodMaximum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzkxNDY_bc981511-ab5e-4d38-a72e-5b2fdaa54d96">P5Y</lh:SalesCommissionAmortizationPeriodMaximum>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i965638d43bce41e3b02735b64f560508_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMDMx_28d8d117-e591-4282-b069-f6bb44722c7f">P2Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="ia91cd079354742c0867df4a66528389e_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMDM0_c68bea15-6b77-4f19-b483-05ea39aae010">P5Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDMx_847a32e8-bc00-4751-bf95-ffb73f7c8425">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:331.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:85.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales commission assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzEtMS0xLTEtMTE3MDI5_c1686821-5345-4d14-a8d0-6cbab33551ae"
      unitRef="usd">38200000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:AccruedSalesCommissionCurrentAndNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzEtMy0xLTEtMTE3MDI5_c39adcb4-fa7f-46bc-8036-cd4198be518c"
      unitRef="usd">36200000</us-gaap:AccruedSalesCommissionCurrentAndNoncurrent>
    <us-gaap:CapitalizedContractCostNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzItMS0xLTEtMTE3MDI5_907c5b9a-4beb-4adb-8a58-6683876ad83c"
      unitRef="usd">15000000.0</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzItMy0xLTEtMTE3MDI5_729d40a6-4ee7-482c-9996-2d8b18b684eb"
      unitRef="usd">14400000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzMtMS0xLTEtMTE3MDI5_8a29b9be-27cd-40f5-acf1-d5a5ef3dd9fe"
      unitRef="usd">53200000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTplYWY3YTJlNTc0OTA0MjExOTNjNTBmOGFmMmZhY2IzZS90YWJsZXJhbmdlOmVhZjdhMmU1NzQ5MDQyMTE5M2M1MGY4YWYyZmFjYjNlXzMtMy0xLTEtMTE3MDI5_f79b7ccd-6fb0-43a1-a487-e8982f2be861"
      unitRef="usd">50600000</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjQ5_614d4958-f2a5-43b9-b7af-e3fa8318a500"
      unitRef="usd">33900000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjUz_4fee2a6f-d959-475d-8927-242d18ecb839"
      unitRef="usd">27500000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:AmortizationOfDeferredSalesCommissions
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMjYw_5987a3f7-863b-406f-8206-8760aa7afe68"
      unitRef="usd">23200000</us-gaap:AmortizationOfDeferredSalesCommissions>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzc2_17d7f3b8-c83c-41d0-a2e6-f661aac6d360"
      unitRef="usd">12400000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzgw_954b47f3-f69f-415a-bd55-35afdac8a8ee"
      unitRef="usd">14200000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEwMzg3_124b93eb-0f35-482f-8558-b1eb60a465f1"
      unitRef="usd">10100000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDE5_36b6ce3e-78b9-414d-adba-d01c5d463e99">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:325.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:88.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less DD allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,222.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less reserve for unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;795.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="i19585208fde04b1c81981c0ca9f09061_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEtMS0xLTEtMTE3MDI5_a0614f07-3ce4-4961-8573-cbe67e471b5c"
      unitRef="usd">1046900000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEtMy0xLTEtMTE3MDI5_89804ae8-5ddb-43a9-a14f-008f0794d222"
      unitRef="usd">1193800000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="i3128ec1b43564e2d96eb81597c02d663_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzItMS0xLTEtMTE3MDI5_5c23372a-c2f0-4950-8393-9afe48fc1538"
      unitRef="usd">1218600000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzItMy0xLTEtMTE3MDI5_65cf276b-2e84-423d-936d-463555151c88"
      unitRef="usd">1089200000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzMtMS0xLTEtMTE3MDI5_68142d5e-b315-485d-a8af-3cccb5256d50"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzMtMy0xLTEtMTE3MDI5_48e6fed0-1bcc-471d-bb51-642a815d6bd1"
      unitRef="usd">21500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzQtMS0xLTEtMTE3MDI5_5a7f1bfa-1154-4bac-b03b-bfee231bb586"
      unitRef="usd">2222000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzQtMy0xLTEtMTE3MDI5_6e1b2ea1-2fbd-47a9-a607-64ed4012b6ff"
      unitRef="usd">2261500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzYtMS0xLTEtMTE3MDI5_a5f16c5d-219a-489c-93db-235830bd7d0a"
      unitRef="usd">805900000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzYtMy0xLTEtMTE3MDI5_fa2e554c-d6f0-435f-bd48-437c530bad96"
      unitRef="usd">730800000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzctMS0xLTEtMTE3MDI5_a2f27860-5bdd-4f98-a524-01a8b4d410f9"
      unitRef="usd">10500000</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzctMy0xLTEtMTE3MDI5_43e37523-a43c-4a0e-849e-489ff310c01c"
      unitRef="usd">14000000.0</us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzgtMS0xLTEtMTE3MDI5_3c14bb0a-6b82-46b8-9295-b8573932f06d"
      unitRef="usd">795400000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzgtMy0xLTEtMTE3MDI5_e99e2891-02e6-4abc-aa34-ee7abc3a45f8"
      unitRef="usd">716800000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEwLTEtMS0xLTExNzAyOQ_b9c95c47-66ee-4ae0-8baf-140d5b5aba31"
      unitRef="usd">582100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZTpmNTU3Nzc4NDRlMjU0ZmI5YjA4YTk2NmQ3MmFiYzNkNy90YWJsZXJhbmdlOmY1NTc3Nzg0NGUyNTRmYjliMDhhOTY2ZDcyYWJjM2Q3XzEwLTMtMS0xLTExNzAyOQ_1d4e4e26-d36e-4f4e-90ed-cbaa5b734fad"
      unitRef="usd">558500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExNzkx_7d41f583-e493-40d9-b79b-abebfed407a1"
      unitRef="usd">330500000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExNzk2_6e1b659c-ae97-4df7-84c1-b87c34dd0a32"
      unitRef="usd">319400000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:DeferredRevenueRevenueRecognized1
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzExODA0_79b9232c-479b-42bb-9f6b-6dbea5388762"
      unitRef="usd">262600000</us-gaap:DeferredRevenueRevenueRecognized1>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzNDIw_88856f5e-d367-49e6-a434-862142490fc5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unbilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Note and Other Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit loss expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending allowance for credit losses as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtMS0xLTEtMTE3MDI5_86d69123-810d-4257-b619-4f8f14cac4b2"
      unitRef="usd">22100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtMy0xLTEtMTE3MDI5_87f6ab28-44eb-4b3b-b279-0f8abd1b4b42"
      unitRef="usd">11300000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtNS0xLTEtMTE3MDI5_900956e4-5a3f-4777-84d0-0f2652c60a24"
      unitRef="usd">5700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzEtNy0xLTEtMTE3MDI5_f9ae7e7c-11d8-4ad4-bf83-6622073924dd"
      unitRef="usd">39100000</lh:AllowanceforCreditLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtMS0xLTEtMTE3MDI5_7822ee94-c545-4011-87d1-7df9457d4b57"
      unitRef="usd">3800000</us-gaap:ProvisionForDoubtfulAccounts>
    <lh:UnbilledServicesCreditLossExpenseReversal
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtMy0xLTEtMTE3MDI5_d0c62bd4-b793-43f8-8233-b55573c1e4d5"
      unitRef="usd">2700000</lh:UnbilledServicesCreditLossExpenseReversal>
    <lh:NoteReceivableCreditLossExpenseReversal
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtNS0xLTEtMTE3MDI5_bcfc94a5-a346-40bc-806c-2a61862ca692"
      unitRef="usd">5000000.0</lh:NoteReceivableCreditLossExpenseReversal>
    <lh:CreditLossExpenseReversal
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzMtNy0xLTEtMTE3MDI5_6596f4a1-91b3-4365-889b-290cb9b689bf"
      unitRef="usd">1500000</lh:CreditLossExpenseReversal>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i5219a3f22dd9428d97614fe3e7a1a766_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtMS0xLTEtMTE3MDI5_82520baf-7f31-4db3-9403-7aca6442741c"
      unitRef="usd">4400000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="id19f57dcee3c4712a2023169a0f785c2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtMy0xLTEtMTE3MDI5_a4f19c03-e7a0-4a09-97bd-2319120adb5c"
      unitRef="usd">100000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ibcd8265eb4614ca3a1c91f1a4b31e2c1_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtNS0xLTEtMTE3MDI5_d5670a82-5bf5-485d-985d-c2a8bd38fedc"
      unitRef="usd">0</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzQtNy0xLTEtMTE3MDI5_013f48c6-3982-41c0-82bf-ee47d98d8fb5"
      unitRef="usd">4500000</lh:AllowanceforCreditLossWriteOff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtMS0xLTEtMTE3MDI5_2248baec-71c6-42ea-96de-e2ef71539061"
      unitRef="usd">21500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtMy0xLTEtMTE3MDI5_e538ab34-1997-44a1-8ad7-7db4dda52a6b"
      unitRef="usd">13900000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtNS0xLTEtMTE3MDI5_783280ab-07c3-4fd1-b016-e4bc5ab477d1"
      unitRef="usd">700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzUtNy0xLTEtMTE3MDI5_68e2d976-6374-4404-9fc8-007d3dd27e25"
      unitRef="usd">36100000</lh:AllowanceforCreditLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctMS0xLTEtMTE3MDI5_2880703c-be6b-432a-ac05-2aa652bedfef"
      unitRef="usd">15100000</us-gaap:ProvisionForDoubtfulAccounts>
    <lh:UnbilledServicesCreditLossExpenseReversal
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctMy0xLTEtMTE3MDI5_d2acfece-7d0b-4781-9ef8-4e8b89d0e145"
      unitRef="usd">0</lh:UnbilledServicesCreditLossExpenseReversal>
    <lh:NoteReceivableCreditLossExpenseReversal
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctNS0xLTEtMTE3MDI5_2a715fd0-f3d8-4f4b-bd56-8324a0ffa238"
      unitRef="usd">0</lh:NoteReceivableCreditLossExpenseReversal>
    <lh:CreditLossExpenseReversal
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzctNy0xLTEtMTE3MDI5_3b5ab47a-c01d-4cf4-bcd7-6f98540d1277"
      unitRef="usd">15100000</lh:CreditLossExpenseReversal>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ia997b5615fe74d49820b0e37481079c8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtMS0xLTEtMTE3MDI5_e7c00914-2e8c-4af5-b0ce-44b799ee38c6"
      unitRef="usd">6900000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="i6d6b5e93fe48483fa4d489a84eb90fcb_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtMy0xLTEtMTE3MDI5_b83003ff-ca05-4be1-b917-733ff7d91dca"
      unitRef="usd">3400000</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="if90cdd4fb44c490e8db96e23d840e242_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtNS0xLTEtMTE3MDI5_4ee7ab3e-10ac-4605-8772-34e113f1a201"
      unitRef="usd">0</lh:AllowanceforCreditLossWriteOff>
    <lh:AllowanceforCreditLossWriteOff
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzgtNy0xLTEtMTE3MDI5_977079eb-b71f-4b2e-bc7d-814d6b4a3d2e"
      unitRef="usd">3500000</lh:AllowanceforCreditLossWriteOff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktMS0xLTEtMTE3MDI5_5bee593b-47f3-4b57-b723-174cb931b6ea"
      unitRef="usd">43500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <lh:UnbilledServicesAllowanceforCreditLoss
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktMy0xLTEtMTE3MDI5_cea05ab3-cd08-44e9-b2b8-766168f18f08"
      unitRef="usd">10500000</lh:UnbilledServicesAllowanceforCreditLoss>
    <lh:NoteReceivableAllowanceforCreditLoss
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktNS0xLTEtMTE3MDI5_a6b3e541-e1c3-47dc-ba2a-3751d79b7412"
      unitRef="usd">700000</lh:NoteReceivableAllowanceforCreditLoss>
    <lh:AllowanceforCreditLoss
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90YWJsZToxMzgzNzMyNjZkNmI0Yzk0ODgwYjQ2NTE5MjNjNjY5ZS90YWJsZXJhbmdlOjEzODM3MzI2NmQ2YjRjOTQ4ODBiNDY1MTkyM2M2NjllXzktNy0xLTEtMTE3MDI5_0a23e3fd-2f38-4445-981c-a744f452b11f"
      unitRef="usd">54700000</lh:AllowanceforCreditLoss>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNDUx_9d02b59d-33f1-46cc-b848-be771876f82e"
      unitRef="usd">5122100000</us-gaap:RevenueRemainingPerformanceObligation>
    <lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNTIz_1fa4c62a-44d8-40c4-bfcc-511a8a78cfb2"
      unitRef="number">0.300</lh:Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear>
    <lh:LongTermContractsDurationMinimum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNjk2_34f24c46-98ce-495c-92ea-d8f963cbfa26">P1Y</lh:LongTermContractsDurationMinimum>
    <lh:LongTermContractsDurationMaximum
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEyNzAy_3c72c314-6d3f-4c5f-a6d9-ffb6188903fb">P8Y</lh:LongTermContractsDurationMaximum>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzMTIw_0062cd85-dbd8-40bc-9a75-1f7501003d41"
      unitRef="usd">73000000.0</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTAvZnJhZzozNWZkZmY1NTYxOTE0N2RiYjZlNGM2ZDI5NjhjNjNkMS90ZXh0cmVnaW9uOjM1ZmRmZjU1NjE5MTQ3ZGJiNmU0YzZkMjk2OGM2M2QxXzEzMTI3_0a2e3211-6b3b-457a-b524-414fb9dfc70c"
      unitRef="usd">69800000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU5ODc_d91a7c01-b678-4c70-acd3-aada4685cbcb">BUSINESS ACQUISITIONS AND DISPOSITIONS&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2022, the Company acquired various businesses and related assets for approximately $1,164.0 in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $542.3 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $598.5. The amortization periods for intangible assets acquired from these transactions range from 15 to 19 years for customer relationships, 15 years for patents and technology, 5 years for non-compete agreements, and 5 to 10 years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill reflects the Company's expectations to utilize the acquired businesses&#x2019; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2022 for these businesses is included below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Preliminary Personal Genome Diagnostics Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Preliminary Ascension Healthcare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Acquired During Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;534.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price allocation for several transactions are still preliminary and subject to change. The areas of the purchase price allocation that are not yet finalized relate primarily to property, plant and equipment, intangible assets, goodwill, and the impact of finalizing deferred taxes. Accordingly, adjustments may be made as additional information is obtained about the facts and circumstances that existed as of the valuation date. Any adjustments will be recorded in the period in which they are identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information for 2022 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Had the aggregate of the Company's 2022 acquisitions been completed as of January 1, 2021, the Company's pro forma results would have been as follows:&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,997.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,310.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,362.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the Company acquired various businesses and related assets for approximately $496.9 in cash (net of cash acquired). The purchase consideration for all acquisitions year to date has been allocated to the estimated fair market value of the net assets acquired, including approximately $198.5 in identifiable intangible assets and a residual amount of non-tax-deductible goodwill of approximately $298.4. The amortization periods for intangible assets acquired from these businesses range from 15 to 19 years for customer relationships, 5 to 15 years for patents and technology, 5 years for non-compete agreements, and 10 years for trade names. These acquisitions were made primarily to extend the Company's geographic reach in important market areas and enhance the Company's scientific differentiation. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill reflects the Company's expectations to utilize the acquired businesses&#x2019; workforce and established relationships and the benefits of being able to leverage operational efficiencies with favorable growth opportunities in these markets. A summary of the net assets acquired in 2021 for these businesses is included below:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amounts Acquired During Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information for 2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Had the aggregate of the Company's 2021 acquisitions been completed as of January 1, 2020, the Company's pro forma results would have been as follows:&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,112.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE1Nw_76694034-4c4f-4f1c-b82d-8f4ca6537906"
      unitRef="usd">1164000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i604cb92437094b8da834d312ee51fefc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzM1OQ_c8f06515-92c9-4cbb-bb4c-b5761c7c7fdb"
      unitRef="usd">542300000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzQ2Ng_43ebcfe1-34cc-4c4a-b7f3-66b91744f586"
      unitRef="usd">598500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU2MQ_f18662a4-7156-440c-b36e-9b3d9c262faf">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU2Nw_f23e02fb-c1f6-48d9-9e6d-1ece2dd0ea83">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzYxMA_ddf5eede-3833-4588-9b0d-099b3fbd86e0">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzY0Nw_ce47dae1-b97c-4c62-8f65-3bf8de3c8415">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia2cf3a400b1f476ea5787c60f96898cd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwNzk_16c86e34-4efa-457a-8572-dbb4da03df67">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzY4OA_faac15a3-4d6d-41c4-8f6f-a1d2eef4364f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMS0xLTEtMTg4ODM3_16cbbf9b-dcf0-4539-aae9-0957bc4de9f2"
      unitRef="usd">4100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMi0xLTEtMTg4ODM3_44c25c33-4245-4c60-b90d-02f89f12e983"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMy0xLTEtMTg4ODM3_b0d17d0e-e446-4987-89ca-0fb628ce5616"
      unitRef="usd">1300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItNC0xLTEtMTg4ODM3_3b21e688-c206-4bd0-9294-0e5effd7542e"
      unitRef="usd">-2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzItMS0xLTEtMTE3MDI5_bca8649c-8902-4b15-9984-41e9899fd951"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMS0xLTEtMTg4ODM3_494e345c-1c8e-4dd2-b3e3-310105953f69"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMi0xLTEtMTg4ODM3_d21616fd-c904-4157-939e-9b5f2068ecec"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMy0xLTEtMTg4ODM3_0b2e265e-e864-4232-b899-b11dcac767da"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtNC0xLTEtMTg4ODM3_d127e61e-a4ad-47a1-bf89-01acd73117b1"
      unitRef="usd">-3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzMtMS0xLTEtMTE3MDI5_8b0e06a6-520f-4a53-807e-7311e5ebf804"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMS0xLTEtMTg4ODM3_7861712a-35de-4d22-a1b9-917d1523294a"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMi0xLTEtMTg4ODM3_18243ac5-883a-4570-a098-3e7e854ab7f2"
      unitRef="usd">24600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMy0xLTEtMTg4ODM3_e9621b57-9491-4c1d-bf24-f00120db4c5b"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtNC0xLTEtMTg4ODM3_02ba09ae-f7ce-4462-b663-29f0bf727035"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzQtMS0xLTEtMTE3MDI5_0054c193-e070-4047-bb02-ce91ccd4e6f5"
      unitRef="usd">27100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMS0xLTEtMTg4ODM3_ccdcb66e-98a5-4a5e-bd02-a3f1468e9ef1"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMi0xLTEtMTg4ODM3_c606397a-ee84-440c-925b-98204c5fc514"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMy0xLTEtMTg4ODM3_66b41253-ba54-44ed-af17-ee4a59c11c61"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtNC0xLTEtMTg4ODM3_4e61811b-cfa1-41dc-b97a-f9e0927ab5e5"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzUtMS0xLTEtMTE3MDI5_aebec458-65f8-4aff-8bf5-f71fcc8f7d9b"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMS0xLTEtMTg4ODM3_bbf973ec-366d-402d-961c-13cb365e7a08"
      unitRef="usd">9900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMi0xLTEtMTg4ODM3_eb2d5de9-81c3-48bc-8be5-03e59ae75023"
      unitRef="usd">43500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMy0xLTEtMTg4ODM3_8870da93-2d7e-4412-86bd-32af880d3e13"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtNC0xLTEtMTg4ODM3_7f282e8c-560b-4f9e-95f3-5abe85568f15"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzYtMS0xLTEtMTE3MDI5_230409ea-1736-4c6b-8130-35043cf1fd12"
      unitRef="usd">53500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMS0xLTEtMTg4ODM3_305a2875-2dfc-4b86-87ab-2fc35975fd8b"
      unitRef="usd">17500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMi0xLTEtMTg4ODM3_c6a01f22-3d6e-443c-847a-43adfde34765"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMy0xLTEtMTg4ODM3_584ab316-bdce-4c3e-bdab-1ae048da566e"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctNC0xLTEtMTg4ODM3_7561ccd2-4222-4d7f-b269-6b9c02fa384c"
      unitRef="usd">15200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzctMS0xLTEtMTE3MDI5_74e500f7-b441-4997-9a4a-bf5eaa53ccef"
      unitRef="usd">32700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibd6fa1609f454ee999006a2ca5c7fbf4_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMS0xLTEtMTg4ODM3_9ee10d23-23aa-4ae2-96ff-23c173e05551"
      unitRef="usd">346800000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifab204c91683402d8304f351f2d9d8b7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMi0xLTEtMTg4ODM3_836c0743-71a4-44ba-8eff-dc7279f72673"
      unitRef="usd">125000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i604cb92437094b8da834d312ee51fefc_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMy0xLTEtMTg4ODM3_31b86239-ba52-44da-8403-f6727f694565"
      unitRef="usd">126700000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib16467344b1b432cbe4bb34ac4e88ed2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtNC0xLTEtMTg4ODM3_b6a7ab4c-e001-4153-986a-2b0427a65f5b"
      unitRef="usd">-40400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <lh:GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzgtMS0xLTEtMTE3MDI5_93dd1af6-9960-469a-ac05-1aabd0d77ce1"
      unitRef="usd">558100000</lh:GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMS0xLTEtMTg4ODM3_522fccb8-6560-448d-8607-74d32aa2c369"
      unitRef="usd">136600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMi0xLTEtMTg4ODM3_f50c4608-3e15-4d1b-ae4f-f1754ea45659"
      unitRef="usd">233200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMy0xLTEtMTg4ODM3_6d84ea61-fd3e-4b53-96d9-b4cda2ba39f1"
      unitRef="usd">172500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktNC0xLTEtMTg4ODM3_2bf54951-694e-47ad-9c32-fe0829e7d45a"
      unitRef="usd">30400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzktMS0xLTEtMTE3MDI5_30e5e7c8-e061-45e8-914c-b319554d47d8"
      unitRef="usd">572700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTEtMS0xLTE4ODgzNw_37b4ed37-ce2c-467f-9a53-638f695dd550"
      unitRef="usd">12500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTItMS0xLTE4ODgzNw_59f5b97c-f551-424c-a7c0-ebe977d3416a"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTMtMS0xLTE4ODgzNw_8ecdbf80-c641-43c0-9a0d-663e8a117270"
      unitRef="usd">2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTQtMS0xLTE4ODgzNw_ccdc3fe8-fccd-4135-ba73-329becba2873"
      unitRef="usd">-2300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEwLTEtMS0xLTExNzAyOQ_647209dd-b913-45e3-b705-66154d43d2a8"
      unitRef="usd">12500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTEtMS0xLTE4ODgzNw_ea676147-2f57-425c-a05d-f033a6c91200"
      unitRef="usd">534000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTItMS0xLTE4ODgzNw_0880a990-69b6-4f05-9851-e21cd6bd1790"
      unitRef="usd">426700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTMtMS0xLTE4ODgzNw_a1a635a5-e10a-4a38-86da-072edad38fa7"
      unitRef="usd">300600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTQtMS0xLTE4ODgzNw_82cc7a19-f3e0-4675-ba6d-9e0d69abc92a"
      unitRef="usd">-2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzExLTEtMS0xLTExNzAyOQ_f3986993-c748-4c8c-bbeb-da620ba25907"
      unitRef="usd">1258700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTEtMS0xLTE4ODgzNw_2c5c1a33-5851-4527-acbd-5e645cb8624f"
      unitRef="usd">3800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTItMS0xLTE4ODgzNw_b4dc9a24-ab2d-41a4-a3b6-1dba30ead3d1"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTMtMS0xLTE4ODgzNw_e9f4f45f-73d9-4ccf-9885-12aab906e4ec"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTQtMS0xLTE4ODgzNw_9a1e7088-1e06-43f1-915b-c5ff5a9d0f74"
      unitRef="usd">-100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEyLTEtMS0xLTExNzAyOQ_d542af5b-d555-4118-b849-9a52ef834f6e"
      unitRef="usd">3700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTEtMS0xLTE4ODgzNw_50fd9eb9-8d50-4232-9232-612cd623c826"
      unitRef="usd">57300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTItMS0xLTE4ODgzNw_2045ecc4-10d4-4a79-97de-44d084186aab"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTMtMS0xLTE4ODgzNw_c510b90f-734e-4401-8311-d789a213082c"
      unitRef="usd">15400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTQtMS0xLTE4ODgzNw_ac740ff0-79c3-41c6-9862-c1a15106e5a4"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzEzLTEtMS0xLTExNzAyOQ_05a1c9d5-b378-4179-a653-81409edac8e4"
      unitRef="usd">72800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTEtMS0xLTE4ODgzNw_76fb0cdf-2a3b-4b47-b0a3-99c648f5baa6"
      unitRef="usd">3300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTItMS0xLTE4ODgzNw_bd4825eb-55b8-4c7d-abb7-0aeb2c6074f2"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTMtMS0xLTE4ODgzNw_be9101fc-9a86-4574-81f6-757cc05d6089"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTQtMS0xLTE4ODgzNw_1db90927-6088-4849-846a-bdd5c114b7e8"
      unitRef="usd">-2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE0LTEtMS0xLTExNzAyOQ_a0d461be-a43a-4887-badd-8d6f43d02cfa"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTEtMS0xLTE4ODgzNw_6f11305f-a4f9-4954-8f3a-546749493235"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTItMS0xLTE4ODgzNw_ce6b2cc0-6ec0-45aa-8b20-d0e85a1ddf2a"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTMtMS0xLTE4ODgzNw_bc32a254-e3c7-49f8-a788-69ce0c589bce"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE1LTQtMS0xLTE4ODgzNw_badd4da3-0ec1-4b46-952f-ef03564b4d8b"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTUtMS0xLTE4ODgzMQ_b0b19a77-9ed6-4915-949e-bbef4a9b9675"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTEtMS0xLTE4ODgzNw_3cd81d3f-d3d3-48d2-b394-dc2a719835a7"
      unitRef="usd">14600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTItMS0xLTE4ODgzNw_2d2ee00e-fd32-4bcc-8113-e0a552032769"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTMtMS0xLTE4ODgzNw_b7ff5fd1-d6ec-4122-9287-0ab85b4a9682"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTQtMS0xLTE4ODgzNw_0ed07567-f113-4269-9874-6d957f3e8cd0"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE2LTEtMS0xLTExNzAyOQ_c03f6470-c655-45c9-848a-6c4346bead3c"
      unitRef="usd">14600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTEtMS0xLTE4ODgzNw_752c6496-e871-4a36-9c19-f84c35ee8825"
      unitRef="usd">79000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTItMS0xLTE4ODgzNw_b1e6fc5b-6152-408f-8c17-9dfae9083669"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTMtMS0xLTE4ODgzNw_aa6a3b75-1e21-4057-8228-3410a1663979"
      unitRef="usd">15400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTQtMS0xLTE4ODgzNw_900ca518-4e6f-4ffc-90ad-50265a5ca223"
      unitRef="usd">-2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE3LTEtMS0xLTExNzAyOQ_75dd6719-daf3-4c8f-84c8-aa4118e83443"
      unitRef="usd">94700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i71debf6a8f0d4523940cba33bbfde672_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTEtMS0xLTE4ODgzNw_1bd1c2ef-c75a-464a-8d21-d347b1c81b07"
      unitRef="usd">455000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i27f5e6facf76444c9bb8e6cc52c08091_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTItMS0xLTE4ODgzNw_53271c5d-cb67-4d82-b466-feb8058ade12"
      unitRef="usd">423800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia6cfbec5b67f468491aadef03bde4c4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTMtMS0xLTE4ODgzNw_ecb90259-6b6e-491e-aeec-7fb96217f660"
      unitRef="usd">285200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i1bcda50b59314d499c99aefc300d073a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTQtMS0xLTE4ODgzNw_c7583945-c9d1-4829-9779-f0559af08bb1"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmMTA2NjE1N2ViYTc0YzVkOGUxZDcwYjU2OWMyZmFmNC90YWJsZXJhbmdlOmYxMDY2MTU3ZWJhNzRjNWQ4ZTFkNzBiNTY5YzJmYWY0XzE4LTEtMS0xLTExNzAyOQ_584606b2-620d-4f5e-8c7b-c1fc9a8b4d42"
      unitRef="usd">1164000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzItMS0xLTEtMTE3MDI5_661fc683-16f9-4495-9e8d-524bc8012399"
      unitRef="usd">14997600000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzItMi0xLTEtMTE3MDI5_5f2bb436-b2e5-41b7-82d5-8b8d6c261988"
      unitRef="usd">16310500000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i58245b35a15d49b1a512f09f43cb8d4d_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzMtMS0xLTEtMTE3MDI5_1fdbf802-4469-4b53-82ba-7d667d104355"
      unitRef="usd">1282400000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ib38f9e44d7ad4c53a024639cb5e95367_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo2ZjZjY2ExMTU1Nzg0Mzk1ODI0NjJkYjg0MmVhZjgyZi90YWJsZXJhbmdlOjZmNmNjYTExNTU3ODQzOTU4MjQ2MmRiODQyZWFmODJmXzMtMi0xLTEtMTE3MDI5_c028b8cc-3dc8-470b-a58d-e30d120dfc22"
      unitRef="usd">2362100000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzIxNTE_acbf2d04-9f3b-4e1f-8aa4-315f3bce49de"
      unitRef="usd">496900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzIzNTM_ecfee67c-6139-4cb5-969c-a9562c284607"
      unitRef="usd">198500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i252781e154ce4ee68f3712bac1795dba_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzI0NjA_55cdfef7-980c-497a-995d-481d9f0af79c"
      unitRef="usd">298400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie1fecc12098644b6b8a3ec84822f4f16_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE4Nzc_f18662a4-7156-440c-b36e-9b3d9c262faf">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzI1NTk_f23e02fb-c1f6-48d9-9e6d-1ece2dd0ea83">P19Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iad3c9245830049a8a009561519bdef0b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE5OTY_6453979d-a140-442d-813e-fd212c0f096d">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ice0ca88db9204a93b870e20b5faf802b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDA_ddf5eede-3833-4588-9b0d-099b3fbd86e0">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i459524d09bb447e38a8bd2c6191b9eae_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDQ_ce47dae1-b97c-4c62-8f65-3bf8de3c8415">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie66c7c30016f434aa44b2c0274441304_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwMDg_faac15a3-4d6d-41c4-8f6f-a1d2eef4364f">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzItMS0xLTEtMTE3MDI5_8ca79e16-026e-4ace-8ffd-784e114a0356"
      unitRef="usd">10800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzMtMS0xLTEtMTE3MDI5_6edb12d8-bb82-4e60-a2f8-9c20d0e7d465"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzQtMS0xLTEtMTE3MDI5_9e35fe8a-56df-42f2-9fe8-823edd797ad5"
      unitRef="usd">1600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzUtMS0xLTEtMTczNDUy_3c5b5b11-bee8-4ecc-ba7c-64cb2c76eb14"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzYtMS0xLTEtMTE3MDI5_33e903ee-3669-47c1-a17b-728936969c27"
      unitRef="usd">56600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i346bf5e89d8c47e791d9565de78267f2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzgtMS0xLTEtMTE3MDI5_daf3cfdf-897f-48ae-b974-b167fac2d1f8"
      unitRef="usd">298400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzktMS0xLTEtMTE3MDI5_329aeeb2-5795-4b8d-a801-b87035e4da97"
      unitRef="usd">198500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzExLTEtMS0xLTExNzAyOQ_9e8de72d-42c7-4f7b-bed6-60adfd2aed42"
      unitRef="usd">572100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzEyLTEtMS0xLTExNzAyOQ_d2c10a79-e5e9-4734-886e-9b80cb99dc1b"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzEzLTEtMS0xLTExNzAyOQ_51f6ac0f-e382-4527-a204-f9966da964a7"
      unitRef="usd">3900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE0LTEtMS0xLTExNzAyOQ_5db16932-c9e8-4a55-b330-095a77501ce4"
      unitRef="usd">6600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE2LTEtMS0xLTExNzAyOQ_4c8241d8-5cb4-4e7c-939e-0966b545e5bd"
      unitRef="usd">62200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE3LTEtMS0xLTExNzAyOQ_2ea24a9a-15fa-497b-8e05-6570df1aa688"
      unitRef="usd">75200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ib748907fa89944549ecc3829559ec590_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmYjI5NWZmMzk1MDI0ZjFlOGEzY2UxNjI4ZTk5M2E5NC90YWJsZXJhbmdlOmZiMjk1ZmYzOTUwMjRmMWU4YTNjZTE2MjhlOTkzYTk0XzE4LTEtMS0xLTExNzAyOQ_6a7973c3-2d2a-4e90-a7ba-b15bd2affef1"
      unitRef="usd">496900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <lh:BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzU5NzQ_312e5dc2-e7f6-418a-9c63-df26cb460966">&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information for 2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Had the aggregate of the Company's 2021 acquisitions been completed as of January 1, 2020, the Company's pro forma results would have been as follows:&lt;/span&gt;&lt;span style="color:#0094ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,112.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Laboratory Corporation of America Holdings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,378.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzItMS0xLTEtMTE3MDI5_86a0bfd8-095d-4c2c-8d6a-9df867b52a19"
      unitRef="usd">16216600000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzItMi0xLTEtMTE3MDI5_3000ed40-b244-4326-804e-d2f0a46ed0fe"
      unitRef="usd">14112800000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i7c9966b42e8c4ab5a508a0fc0f80243b_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzMtMS0xLTEtMTE3MDI5_0d791158-a260-41f9-942e-ca003be2f104"
      unitRef="usd">2378300000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i313d5025b462464592f2d46bcecf5f36_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTpmNGZhMTc4OWFmZTI0MzIzOWI2NjcyYWU3NWJmYjFiZS90YWJsZXJhbmdlOmY0ZmExNzg5YWZlMjQzMjM5YjY2NzJhZTc1YmZiMWJlXzMtMi0xLTEtMTE3MDI5_70d377fd-f030-48e0-96b7-5dc15c3e4ed8"
      unitRef="usd">1554500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MTA_a353cb41-b15d-4045-b89f-e7fa421ab0b0"
      unitRef="usd">267600000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MTY_0bddee86-87b5-45b0-b86c-08480f2a2963"
      unitRef="usd">121300000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia51888503dff465c8ef5c4db1ee5194c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTE2MjE_6b1f68e8-c5f7-4f4e-99ae-c2af65fe4e07"
      unitRef="usd">166200000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id29c59dc621c4fc5a3ef2e75514684f8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTA3MDM_ecaae15e-272a-40cf-891f-41dd30c18832">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6c0ed2f22f984f4da62f26163d9e4900_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90ZXh0cmVnaW9uOjM3MmM3YzkxNzY5YTRlOGM4NTM5ZTZiYThmNzI4MzUwXzE2NDkyNjc0NTIwODM_89c00102-f1b5-4641-8b75-748daf8a422b">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzItMS0xLTEtMjI1MjY1_c9fa00ff-7da0-44ac-96fa-625596558707"
      unitRef="usd">4900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzMtMS0xLTEtMjI1MjY1_600350f3-e916-44b6-ad7e-43b16ad09543"
      unitRef="usd">2400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzYtMS0xLTEtMjI1MjY1_e3e495d3-e9da-4275-8a62-a5d04b3376a3"
      unitRef="usd">1300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8f418d9de6144d5faff8fb13ade9ed0c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzgtMS0xLTEtMjI1MjY1_62a1695e-1d37-4b3c-b244-a2fbbbfddd38"
      unitRef="usd">166200000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzktMS0xLTEtMjI1MjY1_c1cbaf1a-e968-4243-89a3-c6339cf982b3"
      unitRef="usd">121300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzExLTEtMS0xLTIyNTI2NQ_f5d47062-1f43-414e-842f-3db28a412df0"
      unitRef="usd">296100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzEyLTEtMS0xLTIyNTI2NQ_93cfc063-4739-45fe-9d2a-7ddd01bd15dd"
      unitRef="usd">900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzEzLTEtMS0xLTIyNTI2NQ_613d90bd-5fc9-48e7-9f4f-817c88e37c55"
      unitRef="usd">22400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE0LTEtMS0xLTIyNTI2NQ_5799ecce-3069-4406-ae43-43845e38a11a"
      unitRef="usd">1100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE2LTEtMS0xLTIyNTI2NQ_203d71b3-fad5-479d-ad04-344be3b75ddc"
      unitRef="usd">4100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE3LTEtMS0xLTIyNTI2NQ_55bc30e4-5b08-4266-8b72-51a2999b2e71"
      unitRef="usd">28500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ia94cfedc82a34996bbff9391d5f4ddfb_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZTo1MjQ2M2M2MTEyNjQ0OWY1ODhiOWVlYjRjYmQ1ZjA3My90YWJsZXJhbmdlOjUyNDYzYzYxMTI2NDQ5ZjU4OGI5ZWViNGNiZDVmMDczXzE4LTEtMS0xLTIyNTI2NQ_f3bdea71-7539-4155-8a0c-47884a756dbb"
      unitRef="usd">267600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZToyY2IzNzM5ZDI2NmM0NzRmYjJjZmQ3MzA1NDdkYzAyZC90YWJsZXJhbmdlOjJjYjM3MzlkMjY2YzQ3NGZiMmNmZDczMDU0N2RjMDJkXzItMS0xLTEtMTcxNjI0_abd7d159-a877-4f22-860f-8b89effcca93"
      unitRef="usd">14032700000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTMvZnJhZzozNzJjN2M5MTc2OWE0ZThjODUzOWU2YmE4ZjcyODM1MC90YWJsZToyY2IzNzM5ZDI2NmM0NzRmYjJjZmQ3MzA1NDdkYzAyZC90YWJsZXJhbmdlOjJjYjM3MzlkMjY2YzQ3NGZiMmNmZDczMDU0N2RjMDJkXzMtMS0xLTEtMTcxNjI0_e276e040-af1f-4902-af1c-6112e33a8841"
      unitRef="usd">1564600000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2MTQ_c7c69e08-b6ab-4ac1-b08a-06834232595e">&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4. RESTRUCTURING AND OTHER CHARGES &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, the Company recorded net restructuring charges of $83.8. The charges were comprised of $39.3 in severance and other personnel costs, $45.7 in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $0.3 in unused severance and $0.9 in unused facility-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the Company recorded net restructuring charges of $43.1. The charges were comprised of $16.3 in severance and other personnel costs and $28.0 in facility-related costs primarily associated with general integration activities. The charges were offset by the reversal of previously established liability of $0.4 in unused severance and $0.8 in unused facility-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company recorded net restructuring charges of $40.6. The charges were comprised of $14.1 in severance and other personnel costs, $17.4 for facility, operating lease right-of-use and equipment impairments, and $18.9 in facility closures and general integration activities. The charges were offset by the reversal of previously established liability of $0.6 in unused severance and $9.2 in unused facility-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents the Company&#x2019;s restructuring activities for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other&lt;br/&gt;Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and Other&lt;br/&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of prior restructuring accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of prior restructuring accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The non-current portion of the restructuring liabilities is expected to be paid out over 10.7 years. Cash payments and other adjustments include the reclassification of profit sharing, pension, and holiday accrual.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <lh:NetRestructuringCharges
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwMg_b2080884-7fb5-400a-bf1f-bb0ac884e8e8"
      unitRef="usd">83800000</lh:NetRestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDQyMzQ_6e49f270-1109-4e3b-8f9c-26861d55006b"
      unitRef="usd">39300000</us-gaap:SeveranceCosts1>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzIxMw_0d5950f3-d47d-4548-b708-85bb4fcc7655"
      unitRef="usd">45700000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDQyMzA_ebad3dbe-0ef3-4b22-8573-ac6f50c4f986"
      unitRef="usd">300000</lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment>
    <lh:FacilityRelatedRestructuringReserveAccrualAdjustment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzQwNg_41c38d9e-7ac5-4241-8d0b-4e7e2eefaeaa"
      unitRef="usd">900000</lh:FacilityRelatedRestructuringReserveAccrualAdjustment>
    <lh:NetRestructuringCharges
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzUwNA_0e64d288-52d1-4edb-82e4-96e7d764d70b"
      unitRef="usd">43100000</lh:NetRestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzU2OQ_8358b8c1-ddb8-46ba-9206-1f0fb3c2b51e"
      unitRef="usd">16300000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzY4OA_5dfbeca6-5fd5-4e00-9ac5-07d5dcf3cacf"
      unitRef="usd">28000000.0</us-gaap:BusinessExitCosts1>
    <lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzgyNw_c038108f-6e93-4a3d-83b9-d2c1d643d14d"
      unitRef="usd">400000</lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment>
    <lh:FacilityRelatedRestructuringReserveAccrualAdjustment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzgzNA_dee88a83-9103-4aa8-8102-565c6a4ccc0e"
      unitRef="usd">800000</lh:FacilityRelatedRestructuringReserveAccrualAdjustment>
    <lh:NetRestructuringCharges
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3Xzk2Ng_404ecba5-d63e-4c5d-93ea-13cf5958c213"
      unitRef="usd">40600000</lh:NetRestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwMzE_df9ca682-5650-4770-acad-8774b988e4d6"
      unitRef="usd">14100000</us-gaap:SeveranceCosts1>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2NDkyNjc0NDM3MzI_601cf834-c69c-4b7d-9795-59d6270c4b07"
      unitRef="usd">17400000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:BusinessExitCosts1
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEwNzc_a7125b87-90b8-4b37-ad2f-9bbfcb7a5d77"
      unitRef="usd">18900000</us-gaap:BusinessExitCosts1>
    <lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEyNDM_ca966b08-6bb5-4695-ac73-51d985cdc5ab"
      unitRef="usd">600000</lh:EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment>
    <lh:FacilityRelatedRestructuringReserveAccrualAdjustment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzEyNzA_debd3042-3c4e-42af-ac77-4ca208881b4b"
      unitRef="usd">9200000</lh:FacilityRelatedRestructuringReserveAccrualAdjustment>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE2MTY_dd546d1b-ebcc-4959-bf9e-d4ec36d07248">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents the Company&#x2019;s restructuring activities for the period indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and Other&lt;br/&gt;Employee Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and Other&lt;br/&gt;Facility Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of prior restructuring accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of prior restructuring accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i93f046cd09934cefaa22ced67e90f4fa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItMS0xLTEtMTE3MDI5_9e6b347a-dcac-4735-a8e5-64be6ed6e740"
      unitRef="usd">2700000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ife7be025871a46fd9996d5ad9debe4f6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItMy0xLTEtMTE3MDI5_a44559d2-f020-4a11-ba79-0952fb9beb9a"
      unitRef="usd">5100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzItOS0xLTEtMTE3MDI5_1b2d16ab-61af-4bab-a4bb-7e79b5e3968f"
      unitRef="usd">7800000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtMS0xLTEtMTE3MDI5_9d80ec8a-50a5-4187-82d2-a0b51daca3d9"
      unitRef="usd">16300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtMy0xLTEtMTE3MDI5_f0020de6-866c-4803-847d-f963489f4b84"
      unitRef="usd">28000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzMtOS0xLTEtMTE3MDI5_c7b7e5fa-f026-4f28-949b-66a54bf027cc"
      unitRef="usd">44300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMS0xLTEtMTE3MDI5_131f7fd3-f740-4b14-85d9-2322a3f73cf3"
      unitRef="usd">-400000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMy0xLTEtMTE3MDI5_dbbb8031-6cf9-4d55-a374-f573811c7127"
      unitRef="usd">-800000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtMy0xLTEtMTE3MDI5_faae35ac-1e40-42c3-8d4d-b476bc9b8efc"
      unitRef="usd">-800000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzUtOS0xLTEtMTE3MDI5_8a86edaa-c724-4edb-b073-9c500aa511de"
      unitRef="usd">-1200000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:PaymentsForRestructuring
      contextRef="i80f84172048e40818d1227bfa10e7f55_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtMS0xLTEtMTE3MDI5_b418b2e5-6e50-4380-9a68-2aae218a4d4b"
      unitRef="usd">-14300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9d59d51d05e748d193395043f2a09b59_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtMy0xLTEtMTE3MDI5_4cfe10d0-dc64-44b1-a940-5be109d6b027"
      unitRef="usd">-28200000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzYtOS0xLTEtMTE3MDI5_7e239049-1eb5-4f3e-851c-8e9101cf7914"
      unitRef="usd">42500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="ie7ab45a11aea4219a7df41bd1d97f0ec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctMS0xLTEtMTE3MDI5_4610b26e-64f3-4f16-8b0f-bd971005153c"
      unitRef="usd">4300000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ieb2ae9f163ab4ccfb154f4e3d2b57376_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctMy0xLTEtMTE3MDI5_b5e092c5-208d-42f2-ab5e-5f6f8808f9fb"
      unitRef="usd">4100000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzctOS0xLTEtMTE3MDI5_6b36e5ec-4553-4579-90f3-c6c98a0c0979"
      unitRef="usd">8400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtMS0xLTEtMTE3MDI5_ab204a6c-c26f-4e6a-b605-356833de35b0"
      unitRef="usd">39300000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtMy0xLTEtMTE3MDI5_38747a0b-aef2-4fad-9257-e7efff481eb6"
      unitRef="usd">45700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzgtOS0xLTEtMTE3MDI5_7d5020dd-2112-4094-878a-9f1825a30086"
      unitRef="usd">85000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTEtMS0xLTExNzAyOQ_f877ce15-9889-4442-bb27-82304b876781"
      unitRef="usd">-300000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTMtMS0xLTExNzAyOQ_6a5a0923-5f17-45f6-9597-e8e9b92de3a5"
      unitRef="usd">-900000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEwLTktMS0xLTExNzAyOQ_6c3c947d-02d4-4441-a47f-7a0c7eb2c79e"
      unitRef="usd">-1200000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:PaymentsForRestructuring
      contextRef="i4c5f9b1ca29b4449b218ea2c5ec9efab_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTEtMS0xLTExNzAyOQ_2500a624-d88a-4440-9c26-c7542c4aebbd"
      unitRef="usd">-39300000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i47b9b9b078c84bf9aca61ac931775487_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTMtMS0xLTExNzAyOQ_c8afc9a9-67f5-4611-bc69-696e2a5eb936"
      unitRef="usd">-34500000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzExLTktMS0xLTExNzAyOQ_720d8014-31be-474b-b28b-b9fc48171d19"
      unitRef="usd">73800000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i6ba475ac08fc422a97df2c8e89234910_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTEtMS0xLTExNzAyOQ_b7a89c61-12f8-4b12-83cc-ca25d7784791"
      unitRef="usd">4000000.0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i9115627d081a4e7f8da9645e6c6e0dbd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTMtMS0xLTExNzAyOQ_7d58ae55-98cb-496e-b4da-54ecf1d44f04"
      unitRef="usd">14400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEyLTktMS0xLTExNzAyOQ_0369c108-ccdc-4764-a4b1-b2e2ddbb7243"
      unitRef="usd">18400000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzEzLTktMS0xLTExNzAyOQ_301cfc0c-a058-4b85-be72-266ed04fb1ef"
      unitRef="usd">7700000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzE0LTktMS0xLTExNzAyOQ_4a7d35a5-f361-4d23-bc4e-562204d77899"
      unitRef="usd">10700000</us-gaap:RestructuringReserveNoncurrent>
    <us-gaap:RestructuringReserve
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90YWJsZTozNGM3NWM4ZjAxZDI0M2RkOWE0OTY5NDk5YTk1ZjUzMS90YWJsZXJhbmdlOjM0Yzc1YzhmMDFkMjQzZGQ5YTQ5Njk0OTlhOTVmNTMxXzE1LTktMS0xLTExNzAyOQ_2c30e6b0-350e-4573-a6d3-be10ebff7b55"
      unitRef="usd">18400000</us-gaap:RestructuringReserve>
    <lh:Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTYvZnJhZzpjN2EwNWNlNzAyMTY0MzFlOGU1NDViMTEyOWExZjZiNy90ZXh0cmVnaW9uOmM3YTA1Y2U3MDIxNjQzMWU4ZTU0NWIxMTI5YTFmNmI3XzE0OTc_f3e96a99-36b0-4727-8861-55f3e2f90378">P10Y8M12D</lh:Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMzI_f3345263-6722-4c3f-a807-6e8cbf93f328">LEASES&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for patient service centers, laboratories and testing facilities, clinical facilities, general office spaces, vehicles, and office and laboratory equipment. Leases have remaining lease terms of less than a year to 16 years, some of which include options to extend the leases for up to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:2pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f"&gt;Operating lease ROU assets (included in Property, plant and equipment, net)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;865.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a"&gt;Finance lease ROU assets (included in Other assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities, due beyond one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rent expense for short term leases with a term less than one year for the years ended December&#160;31, 2022, 2021, and 2020  amounted to $22.2, $19.5, $6.8, respectively. The Company has variable lease payments that do not depend on a rate index, primarily for purchase volume commitments, which are recorded as variable cost when incurred. Total variable payments for the year ended December&#160;31, 2022, 2021 and 2020 were &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$27.9&lt;/span&gt;,  $28.4, and $26.7, respectively.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzI3NA_a2a7d3d9-4211-40c2-a671-ee35bb0af8ab">P16Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzM0NQ_8f775fb4-4e50-4cb0-9dbf-38d576923807">P15Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lh:LeaseDisclosureTableTextBlockTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMzM_cdff8d6e-a4c3-4362-858a-9479899dddf4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Year Ended &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt;padding-left:13.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the Year Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(225.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ROU assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:LeaseDisclosureTableTextBlockTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzItMS0xLTEtMTE3MDI5_cc263f8b-3f86-45d7-8aa7-895b91656142"
      unitRef="usd">220000000.0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzItMi0xLTEtMTE3MDI5_6fb7e76c-30a5-4461-8aaf-3c930ba36f2e"
      unitRef="usd">220700000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzUtMS0xLTEtMTE3MDI5_014cec33-8037-4a23-9e61-d1fc85cdf7e3"
      unitRef="usd">8000000.0</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzUtMi0xLTEtMTE3MDI5_84509427-7dfd-42a8-8c2d-8a2dcb90f8ba"
      unitRef="usd">9400000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzYtMS0xLTEtMTE3MDI5_476c1d30-92ac-47fd-b358-5d688759b4a0"
      unitRef="usd">5200000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzYtMi0xLTEtMTE3MDI5_d777c242-ce2b-4a4b-8350-ea9502b660ef"
      unitRef="usd">5400000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzctMS0xLTEtMTE3MDI5_1d84c149-6cc5-4c96-99ad-cfc4c3f041cc"
      unitRef="usd">13200000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTphZjIwYzMyNzIwZWE0ZDRlODcwMmE1ZGFkMDllMzRhMC90YWJsZXJhbmdlOmFmMjBjMzI3MjBlYTRkNGU4NzAyYTVkYWQwOWUzNGEwXzctMi0xLTEtMTE3MDI5_b29e141e-0f51-4a6b-a4e9-a55f1ba3031a"
      unitRef="usd">14800000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzMtMS0xLTEtMTE3MDI5_717f614c-a6a7-4733-8308-9b3f0a1fa4a6"
      unitRef="usd">225900000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzMtMi0xLTEtMTE3MDI5_bf770e84-c300-4cee-8352-e940e9a246e4"
      unitRef="usd">219600000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzQtMS0xLTEtMTE3MDI5_e3ae1763-12ff-4716-a6a6-2912c5285163"
      unitRef="usd">5200000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzQtMi0xLTEtMTE3MDI5_53f4ea87-5538-4bc5-9bff-275ea8b479c8"
      unitRef="usd">5400000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzUtMS0xLTEtMTE3MDI5_5c428bc6-4848-42a9-af3e-e5e2adb47361"
      unitRef="usd">12300000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzUtMi0xLTEtMTE3MDI5_a937a474-9339-4d2c-9efb-f989da787b3b"
      unitRef="usd">13100000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzgtMS0xLTEtMTE3MDI5_4c5692b7-6b80-40f8-b03c-53bf40f87f53"
      unitRef="usd">178200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzgtMi0xLTEtMTE3MDI5_4f20342e-2c51-4bcd-b79b-99b9c42a2d58"
      unitRef="usd">164600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzktMS0xLTEtMTE3MDI5_0c6d4ac0-1a42-47ab-bb69-d23614e80efa"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpjNTZmOWJmYzdjODk0Nzc1ODA3YTBlNjc1NTk3YTM4ZS90YWJsZXJhbmdlOmM1NmY5YmZjN2M4OTQ3NzU4MDdhMGU2NzU1OTdhMzhlXzktMi0xLTEtMTE3MDI5_85476ac7-e665-43e1-b1fa-efa880eb7ab4"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMjI_d7551ce7-9ad6-48e6-b47d-e5a99e7ed421">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.133%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_ecc868ca-7592-4318-baed-97a1d81b3b1e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMC0xLTEtMTE3MDI5_f3ce2672-bc06-4f93-b62b-157ff926b73f"&gt;Operating lease ROU assets (included in Property, plant and equipment, net)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;865.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_c4a70597-8698-4ae7-ac10-a8cb6f4bcc1e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTAtMS0xLTExNzAyOQ_ffe587ee-e44f-4b9e-8e53-716a38d6d28a"&gt;Finance lease ROU assets (included in Other assets)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMS0xLTEtMTE3MDI5_d7e51360-ae56-4352-9491-70c8ca8bd6eb"
      unitRef="usd">773600000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzItMi0xLTEtMTE3MDI5_1ebb2b95-6512-421b-aa4e-121f98310047"
      unitRef="usd">746300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzQtMS0xLTEtMTE3MDI5_9d60b77b-6b54-4329-83f5-f91e7ea8d5ce"
      unitRef="usd">185500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzQtMi0xLTEtMTE3MDI5_72ab5a33-c9dc-4afe-9c4b-b421f7a79ec7"
      unitRef="usd">187000000.0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzUtMS0xLTEtMTE3MDI5_a82eb22b-13c1-4361-b287-f7c262e2ff2d"
      unitRef="usd">679700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzUtMi0xLTEtMTE3MDI5_dd17dc81-c386-49db-bf55-cabbc678f38f"
      unitRef="usd">642500000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzYtMS0xLTEtMTE3MDI5_6158a173-df85-4089-9d0d-e99785338d32"
      unitRef="usd">865200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzYtMi0xLTEtMTE3MDI5_57329298-6af5-4ae1-b9d4-e4f20af46992"
      unitRef="usd">829500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTEtMS0xLTExNzAyOQ_c5ec9f06-ed0a-4b2e-9559-6b69d68d5e65"
      unitRef="usd">74900000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEwLTItMS0xLTExNzAyOQ_46f65082-1511-4a79-ba57-02ce33753c9f"
      unitRef="usd">81700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEyLTEtMS0xLTExNzAyOQ_102be517-3a54-40db-b1fa-2a51a56ae1c1"
      unitRef="usd">6000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEyLTItMS0xLTExNzAyOQ_a5123ddb-dc78-433a-a6e7-835dc14ed789"
      unitRef="usd">10500000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEzLTEtMS0xLTExNzAyOQ_fbc6605d-5777-485b-b063-6328b7065382"
      unitRef="usd">83600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzEzLTItMS0xLTExNzAyOQ_dd08b24a-8a21-49f3-9cf6-c7f803204745"
      unitRef="usd">84600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE0LTEtMS0xLTExNzAyOQ_0cd5a64f-3e40-4ba8-a959-6b5279047c30"
      unitRef="usd">89600000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE0LTItMS0xLTExNzAyOQ_7f43c8c8-afd9-425f-80e4-0312e67c2f6d"
      unitRef="usd">95100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE3LTEtMS0xLTExNzAyOQ_21cb837e-b87f-41fe-a1df-e9a41e5e6b4a">P8Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE3LTItMS0xLTExNzAyOQ_50d57322-72aa-4a4c-8dee-e5bbd43a6d24">P8Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE4LTEtMS0xLTExNzAyOQ_27931e86-9c56-434b-8ac6-d26cdaa4773c">P15Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzE4LTItMS0xLTExNzAyOQ_4e86507e-e611-4082-8073-17092a635468">P15Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIxLTEtMS0xLTExNzAyOQ_7ca38074-1e05-44ef-8ff4-d0cc84c6cbb6"
      unitRef="number">0.036</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIxLTItMS0xLTExNzAyOQ_7a086fda-be71-4d8f-b4f9-7aad14b34879"
      unitRef="number">0.030</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIyLTEtMS0xLTExNzAyOQ_ce5fe88b-9857-48b8-98bb-b29aad480788"
      unitRef="number">0.055</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTo4MTYwY2M5YjE4ZjI0ZjQxYjg3YWUxMDkxNTk3NmNjMy90YWJsZXJhbmdlOjgxNjBjYzliMThmMjRmNDFiODdhZTEwOTE1OTc2Y2MzXzIyLTItMS0xLTExNzAyOQ_e01c81e3-cfb7-4009-bcd5-c8098ffe3958"
      unitRef="number">0.056</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzEwMTY_57959557-7c09-41a8-9f75-2321f1fceec9">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.469%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.471%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total maturities, due beyond one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEtMS0xLTEtMTE3MDI5_22affe25-b795-4ae7-9a8f-f9c58ee17a61"
      unitRef="usd">213000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEtMy0xLTEtMTE3MDI5_84eb7c0a-f298-4c31-bcf0-64cdb01a4282"
      unitRef="usd">11400000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzItMS0xLTEtMTE3MDI5_e9ddf924-0f0b-4936-8959-906f165f577c"
      unitRef="usd">160900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzItMy0xLTEtMTE3MDI5_559f8542-74b1-43e0-906a-702054459385"
      unitRef="usd">9900000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzMtMS0xLTEtMTE3MDI5_ba188ece-b344-4035-ab72-d141ac70d9ab"
      unitRef="usd">119400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzMtMy0xLTEtMTE3MDI5_08a214a5-93f3-495c-980a-873e0be6d56f"
      unitRef="usd">7800000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzQtMS0xLTEtMTE3MDI5_0f4f2335-3dff-44c6-9c47-824898252a52"
      unitRef="usd">89000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzQtMy0xLTEtMTE3MDI5_b024b2b5-0a5b-452d-9b06-be472eb49fef"
      unitRef="usd">7200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzUtMS0xLTEtMTE3MDI5_cd64ad19-ac1a-4623-9f13-b61de17bf635"
      unitRef="usd">72500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzUtMy0xLTEtMTE3MDI5_0b66e83a-ad47-4c19-a63b-4e0557dfcb6f"
      unitRef="usd">7200000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzYtMS0xLTEtMTE3MDI5_cdebade1-39d3-44b0-8727-ba4059b3ae02"
      unitRef="usd">369800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzYtMy0xLTEtMTE3MDI5_89aab050-aee8-4e95-8c2e-1383777b1757"
      unitRef="usd">85600000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzctMS0xLTEtMTE3MDI5_dc5fa7b8-a8f9-4faf-b4af-a35ffa93e059"
      unitRef="usd">1024600000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzctMy0xLTEtMTE3MDI5_f855499f-264d-4c69-b0bf-63a6a273aea0"
      unitRef="usd">129100000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzgtMS0xLTEtMTE3MDI5_8130036f-8d65-42b6-9cb3-b137351ebdbb"
      unitRef="usd">159400000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzgtMy0xLTEtMTE3MDI5_63365e7d-344a-4d17-8ecd-705d29720224"
      unitRef="usd">39500000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzktMS0xLTEtMTE3MDI5_c0404fe4-f4f4-40f5-bdab-835dff479672"
      unitRef="usd">185500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzktMy0xLTEtMTE3MDI5_6026e8c4-d519-460d-871d-e03f4108bc69"
      unitRef="usd">6000000.0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEwLTEtMS0xLTExNzAyOQ_6b8d26c1-9aa7-40d6-8ecc-18f08e492099"
      unitRef="usd">679700000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90YWJsZTpmOTkxNWFlNTliNTE0Zjc0OGIyY2U2YzQyZWY2ODk4MC90YWJsZXJhbmdlOmY5OTE1YWU1OWI1MTRmNzQ4YjJjZTZjNDJlZjY4OTgwXzEwLTMtMS0xLTExNzAyOQ_9df5a52e-1a26-4c8a-aa81-de6ad0a9ba7c"
      unitRef="usd">83600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i15ec77218cf94460acd857ca3fc42292_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzcyNg_f4bf513a-018c-41d5-b31f-50016a8e5ff1"
      unitRef="usd">22200000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="id32383bcdde34b8fbc97617bf62c3dd2_D20210101-20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzczMA_88826e5d-d4de-4179-905f-de4bec966fb3"
      unitRef="usd">19500000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i7758f5f025ff42db97476f45552e5168_D20200101-20201231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5XzczNA_340984ce-0ace-4f7b-a840-79488aa6d0cf"
      unitRef="usd">6800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:VariableLeasePayment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk4NA_c6c54462-1158-40e9-a6bd-79ddf9c180ad"
      unitRef="usd">27900000</us-gaap:VariableLeasePayment>
    <us-gaap:VariableLeasePayment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk4OQ_fb6c4071-3d3e-4f1c-9ea8-1200787c4082"
      unitRef="usd">28400000</us-gaap:VariableLeasePayment>
    <us-gaap:VariableLeasePayment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8xOTkvZnJhZzpmNDg5OGE0ZTBkZDc0ZDI5OTY1MzhkNTQ5NGE5YTRkOS90ZXh0cmVnaW9uOmY0ODk4YTRlMGRkNzRkMjk5NjUzOGQ1NDk0YTlhNGQ5Xzk5Nw_678b35cc-b229-4f44-a133-ae6f9839cf83"
      unitRef="usd">26700000</us-gaap:VariableLeasePayment>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzI2MQ_a9972a0d-a9a8-447b-a42e-5e89a4ba5de5">PROPERTY, PLANT AND EQUIPMENT, NET&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,679.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,228.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,722.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,413.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense and amortization of property, plant and equipment was $374.6, $375.6 and $349.3 for 2022, 2021 and 2020, respectively, including software amortization of $84.2, $82.4, and $84.7 for 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzI1OA_b2bf8ff7-fab6-4181-9664-c7dce613a0f2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;954.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,893.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;459.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,679.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,228.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,722.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,413.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iea6006a8e5f2488bbb8e13dc157b4650_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEtMS0xLTEtMTE3MDI5_327b80cf-8c0a-4023-b74c-07c0af870a43"
      unitRef="usd">99200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1624bc86da8f4e7c97d88cbeedab552c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEtMy0xLTEtMTE3MDI5_85020de3-09f0-490e-805d-eb7f54d2d7a4"
      unitRef="usd">101400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i761a366fe39c434287e8300df93759d6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzItMS0xLTEtMTE3MDI5_56df6489-af7c-490b-918a-d3267d71d5e6"
      unitRef="usd">1023700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i34a480df3781456c930f1c1d2bf6e6d9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzItMy0xLTEtMTE3MDI5_c3b2c0b4-3d87-48ca-b83c-296fc75d28e1"
      unitRef="usd">954400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i811cf99c6ab84718b8ec51529c8c38e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzMtMS0xLTEtMTE3MDI5_bde50e1d-3f6a-4f81-95f9-326065cd0fc2"
      unitRef="usd">1893200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0b1af064155a4d36999ebf514f2fb89f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzMtMy0xLTEtMTE3MDI5_97b1b120-255f-4909-a5a7-5b5e1011a34c"
      unitRef="usd">1670400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i950679da32524bd98789e95cea30a39a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzQtMS0xLTEtMTE3MDI5_b343de98-e9b9-4af1-96d5-6650a03ce36c"
      unitRef="usd">906300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if213a3c74f2f48209419ad339b5b7d96_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzQtMy0xLTEtMTE3MDI5_00973a93-3798-4105-aa95-2c80aa4330eb"
      unitRef="usd">840100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia778a92aafcf4f3b86b6acf7a5f3bd00_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzUtMS0xLTEtMTE3MDI5_c9c7f1d8-3f51-402c-96b2-e986bdb19f26"
      unitRef="usd">514000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1a6f1b47c1da4a07a4d90f7f6d9d6873_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzUtMy0xLTEtMTE3MDI5_dfc02efe-8f0a-4ef7-b78e-a266b05b556b"
      unitRef="usd">459900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ida4c96b0a864423fb6941c990f0bd412_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzYtMS0xLTEtMTE3MDI5_3e1c578e-6e4d-4503-ac20-311eb171f138"
      unitRef="usd">118200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i06896b17e3534bd886142dad93e0126c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzYtMy0xLTEtMTE3MDI5_df3d9f86-6247-4770-9b1c-7c1f6d4132a8"
      unitRef="usd">111900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7047efd7d9e048fc9d889f0909b29db0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzctMS0xLTEtMTE3MDI5_91a00293-2cb3-44fd-b36a-6fc6f303d9ca"
      unitRef="usd">350800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ica2d22758b6b4c40aba801d1dee0b10e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzctMy0xLTEtMTE3MDI5_1c70789b-dd1d-494a-821f-2496e3baee25"
      unitRef="usd">344200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i07c4ccb6a1234b26931a664345261420_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzgtMS0xLTEtMTE3MDI5_98e11763-7403-4815-b908-6455880374da"
      unitRef="usd">773600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i467dc562a91848b1b0ce1f13ff671106_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzgtMy0xLTEtMTE3MDI5_171839a9-af76-4f9d-b99d-2195c3e95325"
      unitRef="usd">746300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzktMS0xLTEtMTE3MDI5_102ecf12-1b51-4508-9122-08532eeb7ac9"
      unitRef="usd">5679000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzktMy0xLTEtMTE3MDI5_fe3ae800-277a-47f0-b7ca-a1d96583c46d"
      unitRef="usd">5228600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEwLTEtMS0xLTExNzAyOQ_09f5d711-8fe5-402d-95b3-e1b3b5247271"
      unitRef="usd">2722800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzEwLTMtMS0xLTExNzAyOQ_3fde1cbd-01df-4c22-9ad5-a5d53233ee02"
      unitRef="usd">2413200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzExLTEtMS0xLTExNzAyOQ_40555849-385a-4acd-994e-9cea76720344"
      unitRef="usd">2956200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90YWJsZTplNzY2NTdmMzU5MDk0YTgyYWYzYWUwM2Y1ZWEwOGFlMS90YWJsZXJhbmdlOmU3NjY1N2YzNTkwOTRhODJhZjNhZTAzZjVlYTA4YWUxXzExLTMtMS0xLTExNzAyOQ_bd723bf7-c118-4bbb-a160-2633165499b9"
      unitRef="usd">2815400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id565f2f485384d39b6ede80e66028f65_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEyMg_62fbaa1d-0a1e-4924-8e4c-65c8fe76291d"
      unitRef="usd">374600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if2ab483bf28244679437409e834f6f56_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEyNg_9ae0b9b0-540e-4344-9ac6-ee9784198f67"
      unitRef="usd">375600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab7460360be9421682235ca8d2d1749e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzEzMw_1f6d7079-9574-4c40-a0a6-9657b4a8d7e7"
      unitRef="usd">349300000</us-gaap:DepreciationDepletionAndAmortization>
    <lh:SoftwareDepreciation
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIwNA_46d03327-53bd-4ed4-8cc3-c35377c57982"
      unitRef="usd">84200000</lh:SoftwareDepreciation>
    <lh:SoftwareDepreciation
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIwOA_1affc43a-f304-4822-bad1-4a6656c2a210"
      unitRef="usd">82400000</lh:SoftwareDepreciation>
    <lh:SoftwareDepreciation
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDIvZnJhZzowMjA4ZDJmMjhhMWQ0NzZkYWE1NTY5MzFmZGMxMTRiNy90ZXh0cmVnaW9uOjAyMDhkMmYyOGExZDQ3NmRhYTU1NjkzMWZkYzExNGI3XzIxNg_27522f05-3768-45dc-a276-0a892cbf4e93"
      unitRef="usd">84700000</lh:SoftwareDepreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NDM_5a9096fc-cca6-4dc2-9655-38dc31b2c41a">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill (net of impairment) for the years ended December&#160;31, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,046.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,800.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,751.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,046.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,121.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:2pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of identifiable intangible assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,681.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,336.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,362.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,973.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,423.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,688.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,735.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, the Company recorded goodwill and other asset impairment charges of $271.5 which was primarily comprised of goodwill impairment and the impairment of a technology intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company recorded goodwill and other asset impairment charges of $462.1, $450.5 within DD and $11.6 within Dx. The Company concluded that the fair value was less than the carrying value for two of its reporting units and recorded goodwill impairment of $418.7 and $3.7 for DD and Dx, respectively. Additional impairment of identifiable intangible and tangible assets of $31.8 and $7.9 was recorded for DD and Dx, respectively, in 2020, for impairment of a tradename, software, customer relationships, and technology assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cumulative goodwill impairment for the Company through December&#160;31, 2022 is $733.6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company undertook a rebranding initiative and reduced the estimated useful life of its trade name assets to reflect their anticipated use through December 2021. This change in estimated useful life resulted in accelerated amortization of $88.4 and $27.5 in 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of amortizable intangible assets acquired during 2022, and their respective weighted average amortization periods are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average&lt;br/&gt;Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of intangible assets was $259.3, $369.6 and $275.4 in 2022, 2021 and 2020, respectively.&#160;Amortization expense of intangible assets is estimated to be $273.5 in fiscal 2023, $268.9 in fiscal 2024, $256.7 in fiscal 2025, $246.9 in fiscal 2026, $232.5 in fiscal 2027, and $2,055.6 thereafter.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NTU_bf333c28-bbbd-45e8-976c-0e0c59e95518">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the carrying amount of goodwill (net of impairment) for the years ended December&#160;31, 2022 and 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.826%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,046.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,800.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,751.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency impact and other adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(176.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,533.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,046.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,587.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,912.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,121.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,958.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMS0xLTEtMTE3MDI5_0cc21ff3-1486-4933-b068-3a3588af479c"
      unitRef="usd">4046200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibec9e46526e14376968e12d3425dfbdc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMy0xLTEtMTE3MDI5_16cf0f76-ec9c-4aa9-8cc5-dd314fd1535d"
      unitRef="usd">3800200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItNS0xLTEtMTE3MDI5_913ea126-d11c-4ec7-bfec-384d451b7a3b"
      unitRef="usd">3912700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i394a9bbf406443b3a0435107240e0db4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItNy0xLTEtMTE3MDI5_61f7c7e7-3dab-4c64-ac4f-e37a0655a974"
      unitRef="usd">3951300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItOS0xLTEtMTE3MDI5_3e555066-c247-4680-85e9-7d13d9e65b3a"
      unitRef="usd">7958900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzItMTEtMS0xLTExNzAyOQ_da1872a5-8c9d-4942-8b76-2c82be145a18"
      unitRef="usd">7751500000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMS0xLTEtMTE3MDI5_12f229b9-b1f5-46de-a6b1-435ec0a8ea10"
      unitRef="usd">557900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMy0xLTEtMTE3MDI5_d45c0255-c563-4f8e-b22b-457691d691cc"
      unitRef="usd">245100000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtNS0xLTEtMTE3MDI5_571f770c-4bf0-4c6e-acd6-ae7a7375e411"
      unitRef="usd">40600000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtNy0xLTEtMTE3MDI5_c57c740a-04f1-4fa7-88a2-fcf5c7edc36b"
      unitRef="usd">53300000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtOS0xLTEtMTE3MDI5_339d369f-d6a4-4d7f-97cd-db10cf7aadd5"
      unitRef="usd">598500000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzMtMTEtMS0xLTExNzAyOQ_c8f68747-925f-4c78-9754-ad7559a7fa28"
      unitRef="usd">298400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMS0xLTEtMTE3MDI5_0f5e6703-2192-4d90-aba8-a0ef3e023c73"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMy0xLTEtMTE3MDI5_db66d8d5-1cae-4b1a-9666-dc34468d8d50"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtNS0xLTEtMTE3MDI5_e829c17a-e2ec-407d-a615-0d4f9008c522"
      unitRef="usd">260000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtNy0xLTEtMTE3MDI5_966e5e33-ea15-4dfd-9d9e-622e297a52e2"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtOS0xLTEtMTE3MDI5_1f38e743-6d90-48fa-8684-0cdf035bb549"
      unitRef="usd">260000000.0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzUtMTEtMS0xLTExNzAyOQ_2e85423e-26fe-4d93-9bf5-4b1ab2c57096"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMS0xLTEtMTE3MDI5_3e9c5fbe-0e46-4ea7-beb0-b36054a43b62"
      unitRef="usd">-70600000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMy0xLTEtMTE3MDI5_0c3d46de-7569-4fbf-91f5-adf94a5e1ee8"
      unitRef="usd">900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i35c700e034c743559ba82c79b5d3d27c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctNS0xLTEtMTE3MDI5_9b39cbf0-51a5-48b4-ad4f-6bd86fc91f3c"
      unitRef="usd">-105800000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctNy0xLTEtMTE3MDI5_f6ab61f7-43e0-49aa-899a-9605ed141932"
      unitRef="usd">-91900000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctOS0xLTEtMTE3MDI5_82394ee1-869a-4e58-be78-3ebbf00c886c"
      unitRef="usd">-176400000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzctMTEtMS0xLTExNzAyOQ_0a41943b-1ce4-4bb6-b0df-7d2b62336440"
      unitRef="usd">-91000000.0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i19585208fde04b1c81981c0ca9f09061_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMS0xLTEtMTE3MDI5_8aa67590-bb8b-454c-8d55-27dd9887e3c0"
      unitRef="usd">4533500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3cf8cf4b1c9f41a1989c75ee8c8a3835_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMy0xLTEtMTE3MDI5_ccc818c1-d94c-45b2-b305-fc2eba4497c3"
      unitRef="usd">4046200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3128ec1b43564e2d96eb81597c02d663_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtNS0xLTEtMTE3MDI5_0fa619c7-04c1-4abb-86e1-786e7da188c0"
      unitRef="usd">3587500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibacdf9de7116494789ce8f50dcb91a04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtNy0xLTEtMTE3MDI5_54223fd2-e475-404b-a3c4-94a9de32811f"
      unitRef="usd">3912700000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtOS0xLTEtMTE3MDI5_69653839-116b-49c5-a0ad-5cb74ce636ae"
      unitRef="usd">8121000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZToxYTJhNTg4ODY3MjI0MWI3OWYyN2Y3YzlkMTVmYTdmOS90YWJsZXJhbmdlOjFhMmE1ODg4NjcyMjQxYjc5ZjI3ZjdjOWQxNWZhN2Y5XzgtMTEtMS0xLTExNzAyOQ_db4fb3ae-5ccf-4741-8de3-f8fb0f6afa51"
      unitRef="usd">7958900000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3NzI_7837e292-22c9-4273-90ad-10cb3d6c5a8e">&lt;div style="margin-top:2pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of identifiable intangible assets are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,681.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,546.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,336.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,362.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,973.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canadian licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,946.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,423.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,688.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,735.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMS0xLTEtMTE3MDI5_4d7d89e3-56ba-4083-9f63-31ccd123de46"
      unitRef="usd">4681100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMy0xLTEtMTE3MDI5_1fa51a71-2e83-4fcd-bffc-dbc8c04c7ae1"
      unitRef="usd">1546400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib4cde614e4cb446986b4fbfecce3dcce_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItNS0xLTEtMTE3MDI5_9a6b484e-7502-49b2-b685-ec2d801e7a06"
      unitRef="usd">3134700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItNy0xLTEtMTE3MDI5_bb2b1e33-5232-477b-9de6-22c9fdf1bf0c"
      unitRef="usd">4336000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItOS0xLTEtMTE3MDI5_a97425eb-14bb-4bb3-ade9-505f7c0e1ae2"
      unitRef="usd">1362100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i46d54c5d3e8640c59106fdafc1864dc7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzItMTEtMS0xLTExNzAyOQ_17c9b007-786d-41b3-a126-ce12bbbc5d31"
      unitRef="usd">2973900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMS0xLTEtMTE3MDI5_a57eaa17-5fb2-49bf-b07b-789d68d1695a"
      unitRef="usd">574100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMy0xLTEtMTE3MDI5_7c32d9bf-0c42-4d22-9bd1-abae2bbc2062"
      unitRef="usd">291100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i40cd958885374ef0bb6f568bdbc00731_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtNS0xLTEtMTE3MDI5_95c11c5c-25ec-47fa-9f83-44dd98803c14"
      unitRef="usd">283000000.0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtNy0xLTEtMTE3MDI5_abb8ea95-186e-4dda-b594-31f96871d4e4"
      unitRef="usd">484600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtOS0xLTEtMTE3MDI5_34007617-9f56-4f65-bc52-ce3ba7c4f305"
      unitRef="usd">267400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id4ced70fc3e4428cb308d3a5643870c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzMtMTEtMS0xLTExNzAyOQ_f1004df0-cd9f-4efd-aba2-99525dfa8ff4"
      unitRef="usd">217200000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMS0xLTEtMTE3MDI5_01698fd2-6391-4e2f-aead-933579ac1ebb"
      unitRef="usd">86600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMy0xLTEtMTE3MDI5_afb4c8d4-5fba-4859-92e5-cd9ccfa9be0b"
      unitRef="usd">50500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i3297036cb7294fb5ad2fc2995880b522_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtNS0xLTEtMTE3MDI5_a37b8d74-8b81-47d7-a025-245dfc3345f7"
      unitRef="usd">36100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtNy0xLTEtMTE3MDI5_9508bbad-3a2b-4320-8b5d-42b108c668d3"
      unitRef="usd">70200000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtOS0xLTEtMTE3MDI5_61e686c8-7e1b-4ef0-87a4-733602ec637d"
      unitRef="usd">35500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6584c6c572e74242b54ad664f78e8847_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzQtMTEtMS0xLTExNzAyOQ_4e95549b-97a1-4a18-949f-21d4d55fcacc"
      unitRef="usd">34700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMS0xLTEtMTE3MDI5_91a788d5-1caa-482a-b2dd-73a046e17480"
      unitRef="usd">16400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMy0xLTEtMTE3MDI5_c159e4a6-5731-4703-8dff-3346dd62cffc"
      unitRef="usd">3500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if079c5f1fbbe4a47a276e2a82f1fab12_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtNS0xLTEtMTE3MDI5_da5654f9-26c4-484f-9234-c7151eaa1cab"
      unitRef="usd">12900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i34801d131d6f4e44960ce44490a04267_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtNy0xLTEtMTE3MDI5_80760edc-391b-4060-a912-73a252e4d70f"
      unitRef="usd">19800000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i34801d131d6f4e44960ce44490a04267_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtOS0xLTEtMTE3MDI5_134059ff-9fef-42ce-8ad7-d4462bbac29e"
      unitRef="usd">15500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i34801d131d6f4e44960ce44490a04267_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzUtMTEtMS0xLTExNzAyOQ_eece2ecf-13c7-4e9e-b527-273df7c1510f"
      unitRef="usd">4300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i2265572a137642caacddaf6582838a7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMS0xLTEtMTE3MDI5_6f9cb998-b58e-4eec-bdb8-9a727a868814"
      unitRef="usd">10300000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2265572a137642caacddaf6582838a7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMy0xLTEtMTE3MDI5_c131de58-5614-4522-a59a-8b6797b82c94"
      unitRef="usd">8800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2265572a137642caacddaf6582838a7e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtNS0xLTEtMTE3MDI5_46d52f3e-f840-4fd0-9ac7-228e4e555ac0"
      unitRef="usd">1500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i653a67810f964ce0b55ec76d45884668_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtNy0xLTEtMTE3MDI5_cca95d84-66e5-46fc-99a9-3e4c6f6bea3f"
      unitRef="usd">10400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i653a67810f964ce0b55ec76d45884668_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtOS0xLTEtMTE3MDI5_07136d5d-f7c9-427f-9aab-fc2813584cc7"
      unitRef="usd">7600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i653a67810f964ce0b55ec76d45884668_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzYtMTEtMS0xLTExNzAyOQ_ef37dc4f-9d93-4b8f-b424-beca48615c22"
      unitRef="usd">2800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMS0xLTEtMTE3MDI5_43db4405-5f4e-4e9b-a55a-2d0d7a078258"
      unitRef="usd">468700000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMy0xLTEtMTE3MDI5_87988098-9c39-48c8-a8f6-178a9b1a7775"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1837ca7bdd0649ac827bd7c8aa4b18a8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctNS0xLTEtMTE3MDI5_fcd96248-0d18-4210-b80c-5c2c0be3cae8"
      unitRef="usd">468700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctNy0xLTEtMTE3MDI5_181ef7f1-6e4f-40dd-8e86-b5ac29eaaf11"
      unitRef="usd">493500000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctOS0xLTEtMTE3MDI5_d2f8478a-fb9f-40db-b818-48a5d1e494fd"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i57eb2f4d70bf41d98c2da979a9b5e7df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzctMTEtMS0xLTExNzAyOQ_c95a7da5-81c1-4dd0-a09d-3515f97ed445"
      unitRef="usd">493500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibea8da233e774824b5531b77c20884c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMS0xLTEtMjA3MzQ5_0a254e5f-86ce-4447-9d35-0da5e2299b5e"
      unitRef="usd">5100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibea8da233e774824b5531b77c20884c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMy0xLTEtMjA3MzU2_4f8eb92b-cafa-4d32-954a-78a00bd360b0"
      unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibea8da233e774824b5531b77c20884c5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNS0xLTEtMjA3NDAz_3ec1e885-7a68-4a27-8b88-b889c1c43bcd"
      unitRef="usd">900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNy0xLTEtMjA3NDA4_a98d2c40-c3d5-4a67-9de5-badf9a693631"
      unitRef="usd">0</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtOS0xLTEtMjA3Mzk2_115dfcb7-71fb-4fbc-b27f-83d4b145b0cf"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6b86e8cbe9be4a4b98e32d8f1c434fb8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMTEtMS0xLTIwNzQxNQ_d6c90b14-e829-4a4c-bf10-db86d78a031a"
      unitRef="usd">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMS0xLTEtMTE3MDI5_459fe194-9026-450f-be63-9cd38e80b0a9"
      unitRef="usd">9100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMy0xLTEtMTE3MDI5_4cd0c194-6680-47b6-8000-850bf9aeda63"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8e23aae794934b8d8478e5f0a45bacac_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNS0xLTEtMTE3MDI5_7eb7ff34-5d0e-4bd4-b0ee-f70814cce05f"
      unitRef="usd">9100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic421e408749148f891c6d7f1c116e693_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtNy0xLTEtMTE3MDI5_7d4281fd-8d77-490f-8d1a-f73b5e4f23fb"
      unitRef="usd">9100000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic421e408749148f891c6d7f1c116e693_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtOS0xLTEtMTE3MDI5_c92d774c-ce65-4131-94a0-f07616812d9d"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic421e408749148f891c6d7f1c116e693_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzgtMTEtMS0xLTExNzAyOQ_b27f4061-639c-468d-936c-587df164b988"
      unitRef="usd">9100000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMS0xLTEtMTE3MDI5_b5becc6d-95e9-4c51-ba17-7f388d0ac433"
      unitRef="usd">5851400000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMy0xLTEtMTE3MDI5_0fe40f7f-ca27-4246-a097-3810d02c072f"
      unitRef="usd">1904500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktNS0xLTEtMTE3MDI5_56fa19d3-bbab-42dc-9ec9-e995520fcff6"
      unitRef="usd">3946900000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktNy0xLTEtMTE3MDI5_b8a34c13-ca5f-4a3e-badf-0b9e631c4be5"
      unitRef="usd">5423600000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktOS0xLTEtMTE3MDI5_2b9650b7-0fba-415d-bf48-84bd2192f559"
      unitRef="usd">1688100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTowYTRhZjUwZWFkOWM0ZTE4YmY1ZmM3NjQzMTJiOTE2Ny90YWJsZXJhbmdlOjBhNGFmNTBlYWQ5YzRlMThiZjVmYzc2NDMxMmI5MTY3XzktMTEtMS0xLTExNzAyOQ_7acc4aad-3267-459c-a359-4e0609894e3a"
      unitRef="usd">3735500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzIxOTkwMjMyNTczODY_4729479a-d0ab-4b46-bf34-fbc30bbc0c58"
      unitRef="usd">271500000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1MzA_6811fcf9-ab4a-4b27-870e-207c95b67677"
      unitRef="usd">462100000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1MzU_1b0eb31d-6e47-4a00-8fc4-432d8f5764c8"
      unitRef="usd">450500000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwOTk1MTE2MzE1NTM_6c836512-c9fc-4dac-8b1f-ababbad4cc7e"
      unitRef="usd">11600000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib3f041b50fd94eeb8961274ae6f3b808_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNDU_5faa72d4-66eb-4340-8518-096847ace3db"
      unitRef="usd">418700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if4369eb4011c4dfcb5817d565d68182a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNDk_a607219e-66d4-4e61-a5ff-b1f4b7d85645"
      unitRef="usd">3700000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i4e0b31b6d0ad4b9d92fdd199258803bc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNTM_0c39c72c-fe2d-4507-b92b-6e442f2639ea"
      unitRef="usd">31800000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="ic028605da6cd4f6ca7341a3c8834d0d2_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNTc_a6d7e45e-54c6-4e9f-a8c2-7c336c781de8"
      unitRef="usd">7900000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <lh:GoodwillImpairmentCumulative
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NDkyNjc0NDYxNjY_2b83178c-b072-4094-9bd3-a6692d8a773d"
      unitRef="usd">733600000</lh:GoodwillImpairmentCumulative>
    <us-gaap:AdjustmentForAmortization
      contextRef="icfe4125fff374c76adf4d24857926f50_D20220101-20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwNjk_52bc2b04-8c8e-41de-bde7-94d037a57123"
      unitRef="usd">88.4</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ie3735b80739147d5a271f0e1938aabc1_D20210101-20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzEwNzc_8413b60d-dc7d-48d8-95da-c6a43d843408"
      unitRef="usd">27500000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3ODI_b2275981-2e39-4f65-8317-d7fec26240b8">&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of amortizable intangible assets acquired during 2022, and their respective weighted average amortization periods are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.254%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average&lt;br/&gt;Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents, licenses and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzEtMS0xLTEtMTE3MDI5_3be5a043-73de-4059-9109-6f660c4d3b16"
      unitRef="usd">408500000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2bf8245ff1ec4700a7e6b4d70956a0b7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzEtMy0xLTEtMTE3MDI5_33841120-7d27-4c9c-8bf8-fe3ebc977357">P18Y2M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i89543227f0574d3080d3504a668d3480_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzItMS0xLTEtMTE3MDI5_da012684-22ec-49f0-b276-e7069d55be62"
      unitRef="usd">106400000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i89543227f0574d3080d3504a668d3480_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzItMy0xLTEtMTE3MDI5_1badd8eb-f175-4163-acae-af38af96a786">P13Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzMtMS0xLTEtMTE3MDI5_1412343c-b59d-4044-b2c3-0cf9e9b16925"
      unitRef="usd">16600000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i862fc05d115546418a2eedf242ab51ec_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzMtMy0xLTEtMTE3MDI5_325d6124-dd56-43db-a67b-3df5d8b28301">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzQtMS0xLTEtMTE3MDI5_5a592b8d-113d-487d-9832-3b21457deb27"
      unitRef="usd">10800000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2be8f81b7fbc49cebb4fbf49bd82f02a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzQtMy0xLTEtMTE3MDI5_ffe72ee2-9052-49ae-8b55-d012d46ffdbe">P6Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzYtMS0xLTEtMTE3MDI5_337bdcff-6970-4501-b8c3-eae37d392425"
      unitRef="usd">542300000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90YWJsZTozZjU5ZjcxMDc3NGI0MTg0YjNjOGUwM2VmNTI4MjU0Ni90YWJsZXJhbmdlOjNmNTlmNzEwNzc0YjQxODRiM2M4ZTAzZWY1MjgyNTQ2XzYtMy0xLTEtMTE3MDI5_deffea06-9461-4497-aaaa-c6a74d057add">P16Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MTQ_b20fe0ce-5ef6-41f6-8d6c-491dc5072fb8"
      unitRef="usd">259300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MTg_51d50dda-b8c2-47b5-b307-e11cee34c6f1"
      unitRef="usd">369600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE0MjU_1e102f54-5024-497f-8dbb-ad0f1adf0432"
      unitRef="usd">275400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2Mzg_2a8d3633-d871-45ce-98e8-3dc9a67200a3"
      unitRef="usd">273500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NTU_fc2de64f-65ff-4ee3-964c-01b3d43f9b2b"
      unitRef="usd">268900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2NzI_1a090f0b-e2e2-4e68-b068-9817a929a5b7"
      unitRef="usd">256700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE2ODk_529b7597-b18c-4411-b5b4-77261a931ee4"
      unitRef="usd">246900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3MDY_48c83eeb-cb29-484c-b590-fa098a03dbed"
      unitRef="usd">232500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDUvZnJhZzo1YjE0N2E4NTc5ODA0NTY3ODIwNzU2OGQxMmZkM2FhZS90ZXh0cmVnaW9uOjViMTQ3YTg1Nzk4MDQ1Njc4MjA3NTY4ZDEyZmQzYWFlXzE3Mjc_657d2b2f-f085-4a60-8ee6-cdc0766d4484"
      unitRef="usd">2055600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90ZXh0cmVnaW9uOmNlOGY3MTNkODJjMjRjNDBiMTY1YjQ0ZTdiNDdhYjUzXzQw_5a806a5a-2962-4aa8-aaea-0b54f7ca03dd">ACCRUED EXPENSES AND OTHER&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pass through expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90ZXh0cmVnaW9uOmNlOGY3MTNkODJjMjRjNDBiMTY1YjQ0ZTdiNDdhYjUzXzM3_6d8f9fcb-b811-4e62-9091-cdaf902cdeaa">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pass through expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEtMS0xLTEtMTE3MDI5_7c02f2a4-3dd6-4da4-b4c3-90a70139a550"
      unitRef="usd">527100000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEtMy0xLTEtMTE3MDI5_cbe7d45d-904d-46a7-8cc9-a8af964d2825"
      unitRef="usd">735500000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzMtMS0xLTEtMTE3MDI5_253386dd-a4db-4bc2-b4ee-6468da3e938b"
      unitRef="usd">146100000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzMtMy0xLTEtMTE3MDI5_d9c596e3-1e17-42b2-ab6d-eb777c5959f4"
      unitRef="usd">239600000</us-gaap:TaxesPayableCurrent>
    <lh:AccruedPassThroughExpenses
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzktMS0xLTEtMTE3MDI5_33992932-d20a-4b2d-a9bd-693c6feef46e"
      unitRef="usd">136500000</lh:AccruedPassThroughExpenses>
    <lh:AccruedPassThroughExpenses
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzktMy0xLTEtMTE3MDI5_eccb3bb7-3404-4d98-8cf0-40d335024945"
      unitRef="usd">149100000</lh:AccruedPassThroughExpenses>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEwLTEtMS0xLTExNzAyOQ_c92dfa70-2757-4b57-935e-d362455e9fef"
      unitRef="usd">259100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzEwLTMtMS0xLTExNzAyOQ_b50634cd-4c2a-45b5-b6d8-bdb124f7b953"
      unitRef="usd">279900000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzExLTEtMS0xLTExNzAyOQ_d30e353e-901d-473c-a378-fa514616315d"
      unitRef="usd">1068800000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMDgvZnJhZzpjZThmNzEzZDgyYzI0YzQwYjE2NWI0NGU3YjQ3YWI1My90YWJsZTo3OWEyYTVkODJlYTE0NDNlYmFkMjU3MjMwZWZhM2RkMC90YWJsZXJhbmdlOjc5YTJhNWQ4MmVhMTQ0M2ViYWQyNTcyMzBlZmEzZGQwXzExLTMtMS0xLTExNzAyOQ_e6dccb7e-03fc-428c-895a-4dca3c2b3c06"
      unitRef="usd">1404100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90ZXh0cmVnaW9uOjRjYmNjYmZmYTZlMzRiZGRiOTNmMGQyMDBiYzI4NjhmXzI5_4ba5a126-7b54-45fb-8cda-54446092208c">OTHER LIABILITIES&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined-benefit plan obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Worker's compensation and auto&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90ZXh0cmVnaW9uOjRjYmNjYmZmYTZlMzRiZGRiOTNmMGQyMDBiYzI4NjhmXzQ0_89e99317-b266-49ae-888b-68b93ec8b968">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation plan obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined-benefit plan obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Worker's compensation and auto&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;422.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEtMS0xLTEtMjAxNzk3_cf1ca794-c2bc-4c49-bfa6-c302176980ee"
      unitRef="usd">96900000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEtMy0xLTEtMjAxNzk3_5b5998ab-3d72-461d-9a9e-e63b71277b9a"
      unitRef="usd">104400000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzItMS0xLTEtMTE3MDI5_b7a983a7-b4fa-476a-9828-33dd8d7c42e0"
      unitRef="usd">55600000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzItMy0xLTEtMTE3MDI5_5c461cfc-862b-4d59-af12-4c8ec60344ff"
      unitRef="usd">136500000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzctMS0xLTEtMjAxNzY3_bab8bf62-e44f-4f90-b515-156d8c05a532"
      unitRef="usd">46400000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzctMy0xLTEtMjAxNzY3_6d04e266-bc24-4311-b2ef-c1880ed26dcb"
      unitRef="usd">47200000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzgtMS0xLTEtMjAxNzY3_57ed3e61-9417-434b-9614-273c5af2dced"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzgtMy0xLTEtMjAxNzY3_33c0890b-e698-4d12-9c9b-abad1b2c309a"
      unitRef="usd">32800000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <lh:OtherLiabilitiesNoncurrentOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEwLTEtMS0xLTExNzAyOQ_a915d034-4205-4559-9e10-920517fbfc67"
      unitRef="usd">178200000</lh:OtherLiabilitiesNoncurrentOther>
    <lh:OtherLiabilitiesNoncurrentOther
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzEwLTMtMS0xLTExNzAyOQ_04e5038e-1987-491e-983c-8510cd18a499"
      unitRef="usd">81100000</lh:OtherLiabilitiesNoncurrentOther>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzExLTEtMS0xLTExNzAyOQ_119d8712-cdba-4bb4-84b8-a7eece76c731"
      unitRef="usd">422800000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTEvZnJhZzo0Y2JjY2JmZmE2ZTM0YmRkYjkzZjBkMjAwYmMyODY4Zi90YWJsZTpkMzc0OWViYTg0YTM0ZGZiOTQzNTdmM2FmZmEwZTRhYy90YWJsZXJhbmdlOmQzNzQ5ZWJhODRhMzRkZmI5NDM1N2YzYWZmYTBlNGFjXzExLTMtMS0xLTExNzAyOQ_94aa0d0d-a208-4d04-8631-15a7bfd7bf09"
      unitRef="usd">402000000.0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5NjQ_561a99a7-5bb9-4549-afb9-f9a946156128">DEBT&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and current portion of long-term debt at December&#160;31, 2022, and 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55% senior notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% senior notes due 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% senior notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,416.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2019, the Company entered into a $850.0 term loan (the 2019 Term Loan). The Company fully repaid the remaining 2019 Term Loan balance during the first quarter of 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains a senior revolving credit facility, which was amended and restated on April 30, 2021. It consists of a five-year revolving facility in the principal amount of up to $1,000.0, with the option of increasing the facility by up to an additional $500.0, subject to the agreement of one or more new or existing lenders to provide such additional amounts and certain other customary conditions. The revolving credit facility also provides for a subfacility of up to $100.0 for swing line borrowings and a subfacility of up to $150.0 for issuances of letters of credit. The Company is required to pay a facility fee on the aggregate commitments under the revolving credit facility, at a per annum rate ranging from 0.10% to 0.225%, depending on the Company's debt ratings. The revolving credit facility is permitted to be used for general corporate purposes, including working capital, capital expenditures, funding of share repurchases and certain other payments, acquisitions, and other investments. There were no balances outstanding on the Company's current revolving credit facility at December&#160;31, 2022, or December&#160;31, 2021. As of December&#160;31, 2022, the effective interest rate on the revolving credit facility was 5.39%. The credit facility expires on April 30, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Company's the revolving credit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to maintain certain leverage ratios. The Company was in compliance with all covenants in its term loans and the revolving credit facility at December&#160;31, 2022, and expects that it will remain in compliance with its existing debt covenants for the next twelve months.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revolving credit facility is not encumbered by any of the Company's outstanding letters of credit. There were $84.5 in outstanding letters of credit as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 26, 2021, the Company issued new senior notes representing $1,000.0 in debt securities consisting of $500.0 aggregate principal amount of 1.55% senior notes due 2026 and $500.0 aggregate principal amount of 2.70% senior notes due 2031. Interest on these notes is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2021. Net proceeds from the offering of these notes were $989.4 after deducting underwriting discounts and other expenses of the offering. The net proceeds were used, along with cash on hand, to redeem, prior to maturity, the Company's outstanding 3.20% senior notes due February 1, 2022 and 3.75% senior notes due August 23, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706% to hedge against changes in the fair value of a portion of the Company's long-term debt. These interest rate swaps are included in other long-term liabilities and deducted from the value of the senior notes with an aggregate fair value of $79.7 at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled payments of long-term debt at the end of 2022 are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total scheduled payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,373.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,340.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(301.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, due beyond one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Nzc_97b8639e-ac98-4c21-b650-7de8e1eb4b02">&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term borrowings and current portion of long-term debt at December&#160;31, 2022, and 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term borrowings and current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <lh:A4.00Seniornotesdue2023
      contextRef="i8ab31968f0e34f71a97366c123d49ff0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzUtMS0xLTEtMTE3MDI5_9497a8be-b9be-4998-a2d4-67dcee8f4cc3"
      unitRef="usd">300000000.0</lh:A4.00Seniornotesdue2023>
    <lh:A4.00Seniornotesdue2023
      contextRef="i79ba87d3d0c7416484b4fcb375524965_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzUtMy0xLTEtMTE3MDI5_38cf9543-a190-4595-b09c-fcc27f9683cb"
      unitRef="usd">0</lh:A4.00Seniornotesdue2023>
    <lh:Shorttermdebtissuancecosts
      contextRef="i065eee6e47b54c3090870de60295f740_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzYtMS0xLTEtMTE3MDI5_954b154e-b400-424a-972d-a5bf00eb058d"
      unitRef="usd">400000</lh:Shorttermdebtissuancecosts>
    <lh:Shorttermdebtissuancecosts
      contextRef="i79ba87d3d0c7416484b4fcb375524965_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzYtMy0xLTEtMTE3MDI5_9cb9ba24-001b-4e5b-b035-099dea84195a"
      unitRef="usd">0</lh:Shorttermdebtissuancecosts>
    <us-gaap:NotesPayableCurrent
      contextRef="ibd89f07e99954cd38ca792abfb00c002_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzctMS0xLTEtMTE3MDI5_02b6e4da-b620-4009-bf4d-a7a56c6ff0e9"
      unitRef="usd">1700000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i75e40fe043084cb7ba090e2fc3810877_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzctMy0xLTEtMTE3MDI5_e5de0d30-cca1-49ec-9e05-4edddd31685b"
      unitRef="usd">1500000</us-gaap:NotesPayableCurrent>
    <us-gaap:DebtCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzgtMS0xLTEtMTE3MDI5_bfdcf190-827a-4768-aa50-bb216a9e8cfd"
      unitRef="usd">301300000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo3ZTEwOTA5MzBlZGI0OTJlYWY5MzczNTg4MDA5YTU3Ni90YWJsZXJhbmdlOjdlMTA5MDkzMGVkYjQ5MmVhZjkzNzM1ODgwMDlhNTc2XzgtMy0xLTEtMTE3MDI5_27fc4c97-f81b-4aa0-a53a-c484bfc57ddb"
      unitRef="usd">1500000</us-gaap:DebtCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5NjI_fe358623-4d30-470e-a503-106fb53bfd23">&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55% senior notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% senior notes due 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% senior notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,416.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:LongTermDebtTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Njc_21777285-6290-4952-a1cd-40e947c99900">&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt at December&#160;31, 2022, and 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.00% senior notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55% senior notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.60% senior notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.95% senior notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;650.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% senior notes due 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.70% senior notes due 2045&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Note payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,416.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <lh:A4.00Seniornotesdue2023
      contextRef="i9d9f832f2302410f92ba15e850ffaa63_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzctMS0xLTEtMTE3MDI5_c6de49f6-bc25-4a06-92ae-912227dad940"
      unitRef="usd">0</lh:A4.00Seniornotesdue2023>
    <lh:A4.00Seniornotesdue2023
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzctMy0xLTEtMTE3MDI5_dab37d08-39fe-44ab-9111-830514368261"
      unitRef="usd">300000000.0</lh:A4.00Seniornotesdue2023>
    <lh:A2.30seniornotesdue2024
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMS0xLTEtMjAxMzY3_1fced0ec-4baa-4beb-bb11-0874d22f3b1c"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <lh:A2.30seniornotesdue2024
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMy0xLTEtMjAxMzY3_9af1613f-e4b7-43c0-a914-1f9f134f0086"
      unitRef="usd">400000000.0</lh:A2.30seniornotesdue2024>
    <lh:Seniornotesdue2024
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMS0xLTEtMTE3MDI5_6ea34bd5-1549-49c4-9b73-1cd2b6254676"
      unitRef="usd">600000000.0</lh:Seniornotesdue2024>
    <lh:Seniornotesdue2024
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzgtMy0xLTEtMTE3MDI5_aa9164fd-247e-461c-ab05-91d2d8e408ed"
      unitRef="usd">600000000.0</lh:Seniornotesdue2024>
    <lh:A3.60Seniornotesdue2025
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzktMS0xLTEtMTE3MDI5_884ab129-48c7-450f-844a-3c8f903d9c00"
      unitRef="usd">1000000000</lh:A3.60Seniornotesdue2025>
    <lh:A3.60Seniornotesdue2025
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzktMy0xLTEtMTE3MDI5_3b6ed9e7-9b42-4d00-970d-900348ea2952"
      unitRef="usd">1000000000</lh:A3.60Seniornotesdue2025>
    <lh:A155SeniorNotesDue2026
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEwLTEtMS0xLTExNzAyOQ_b11c6423-b7f9-4cb3-8467-b0c8e0e4c9a4"
      unitRef="usd">500000000.0</lh:A155SeniorNotesDue2026>
    <lh:A155SeniorNotesDue2026
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEwLTMtMS0xLTExNzAyOQ_ea7d8cf0-2247-43f5-a1ce-c565cd4d2d81"
      unitRef="usd">500000000.0</lh:A155SeniorNotesDue2026>
    <lh:Seniornotesdue2027
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzExLTEtMS0xLTExNzAyOQ_2b712a5e-c8c0-4745-a65d-90468e134ef1"
      unitRef="usd">600000000.0</lh:Seniornotesdue2027>
    <lh:Seniornotesdue2027
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzExLTMtMS0xLTExNzAyOQ_487edddf-e2c1-4f43-98f2-32ecd141fc67"
      unitRef="usd">600000000.0</lh:Seniornotesdue2027>
    <lh:A2.95seniornotesdue2029
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTEtMS0xLTIwMTM5MQ_0ffcf4af-8ea0-4443-987b-63918d852d71"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <lh:A2.95seniornotesdue2029
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTMtMS0xLTIwMTM5MQ_41bcc55d-2760-4bc0-9b74-f7c2154ffbe7"
      unitRef="usd">650000000.0</lh:A2.95seniornotesdue2029>
    <lh:A270SeniorNotesDue2031
      contextRef="i76b64d538c794125b25d372f3e739448_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEyLTEtMS0xLTExNzAyOQ_7ccc8a5c-73c8-4ec9-bed8-0a9a469eab5f"
      unitRef="usd">420300000</lh:A270SeniorNotesDue2031>
    <lh:A270SeniorNotesDue2031
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEyLTMtMS0xLTExNzAyOQ_073cf810-aab0-45c0-a8dd-21438e452957"
      unitRef="usd">502900000</lh:A270SeniorNotesDue2031>
    <lh:A4.70Seniornotesdue2045
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTEtMS0xLTExNzAyOQ_12d2bc22-bb35-4402-8878-0d5b3ee97639"
      unitRef="usd">900000000.0</lh:A4.70Seniornotesdue2045>
    <lh:A4.70Seniornotesdue2045
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzEzLTMtMS0xLTExNzAyOQ_7977be02-fd4d-43e4-af3a-b60a4357d8dc"
      unitRef="usd">900000000.0</lh:A4.70Seniornotesdue2045>
    <lh:Longtermdebtissuancecosts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzE5LTEtMS0xLTExNzAyOQ_1a1e0434-1755-4257-b8bc-78ca7d11414a"
      unitRef="usd">33800000</lh:Longtermdebtissuancecosts>
    <lh:Longtermdebtissuancecosts
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzE5LTMtMS0xLTExNzAyOQ_8f21baab-40fc-493f-a09f-9adb147a8e69"
      unitRef="usd">41000000.0</lh:Longtermdebtissuancecosts>
    <us-gaap:LongTermNotesPayable
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIwLTEtMS0xLTExNzAyOQ_cdeda4bd-3fc2-41e2-837e-6166639f6072"
      unitRef="usd">2300000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIwLTMtMS0xLTExNzAyOQ_a30d1a47-79f3-4b6b-a04c-83a029941c72"
      unitRef="usd">4600000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIxLTEtMS0xLTExNzAyOQ_75d8a958-b4f9-492d-a987-e7954d8f6226"
      unitRef="usd">5038800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTowN2I2NzllODFiYjk0ZTU0OGIzYzc2NWY1NjFjODMzOC90YWJsZXJhbmdlOjA3YjY3OWU4MWJiOTRlNTQ4YjNjNzY1ZjU2MWM4MzM4XzIxLTMtMS0xLTExNzAyOQ_6b14b8a1-f98e-48a2-93a1-e36bcfa3fc4a"
      unitRef="usd">5416500000</us-gaap:LongTermDebtNoncurrent>
    <lh:A2019TermLoan
      contextRef="i7ebdf7872d5a46479565341763836748_I20190603"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzI0MA_f03e0483-dda5-4739-9348-9bde4e70461f"
      unitRef="usd">850000000.0</lh:A2019TermLoan>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzU2NA_7718d4b5-2602-4814-bf17-844c9ef16a28"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lh:CreditFacilityOptiontoIncrease
      contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzYzNA_0e6b0112-62a3-44e3-8d6f-5fd9a90a180e"
      unitRef="usd">500000000.0</lh:CreditFacilityOptiontoIncrease>
    <lh:CreditFacilityMaximumSwingLineBorrowings
      contextRef="ib253ed0180004b288aff33fe175b56f2_I20141219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzg0OA_420397b4-3430-44fc-a373-126214384db1"
      unitRef="usd">100000000.0</lh:CreditFacilityMaximumSwingLineBorrowings>
    <lh:CreditFacilityMaximumLettersofCredit
      contextRef="ied82a46b37fa415f996b1384457e6076_I20141219"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzkwNA_77dd0000-4380-4f5d-bcc4-bd3c11b92a75"
      unitRef="usd">150000000.0</lh:CreditFacilityMaximumLettersofCredit>
    <us-gaap:LineOfCreditFacilityCommitmentFeeDescription
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzEwODg_850fac32-c59a-497d-88e8-615bfe2694be">0.10% to 0.225%</us-gaap:LineOfCreditFacilityCommitmentFeeDescription>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i241890ceccc848f18d43631185197134_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzE1Mzc_7ed491d0-2407-46be-aa44-afcefd2b5581"
      unitRef="rate">0.0539</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzIyNTg_2a19ae85-36eb-483c-99fd-e3b8dcf077c3"
      unitRef="usd">84500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM0NjA_eddde4b6-b479-4d1f-be29-ab70e0d59553"
      unitRef="usd">79700000</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90ZXh0cmVnaW9uOjUzMGZlNWNkZWVjNzQ2MTg5M2RhZjA1ZmEwOTJjZDdhXzM5Njk_ff8f33df-3bbf-49a9-9bcb-8a4195856064">&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled payments of long-term debt at the end of 2022 are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.331%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total scheduled payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,373.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less long-term debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,340.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(301.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, due beyond one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzEtMy0xLTEtMTE3MDI5_652b1411-574e-474e-b8aa-6b6bda21b9f7"
      unitRef="usd">301300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzItMy0xLTEtMTE3MDI5_5c5ad481-01b2-4bad-96cd-1bf87bf0307e"
      unitRef="usd">1000000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzMtMy0xLTEtMTE3MDI5_9edd84a2-f5f6-4760-94a1-23bf57307508"
      unitRef="usd">1000000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzQtMy0xLTEtMTE3MDI5_450a19d8-a854-425e-bf58-dff5480d9aaf"
      unitRef="usd">500000000.0</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzUtMy0xLTEtMTE3MDI5_fd7883ce-e6e9-49db-ba7f-08dd548edb4c"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzYtMy0xLTEtMTE3MDI5_1828a106-6cc6-49e5-942c-fe2484559b9e"
      unitRef="usd">1972600000</us-gaap:LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <lh:Longtermdebtfutureminimumpaymentsinterestincludedinpayments
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzctMy0xLTEtMTE3MDI5_0b019dc9-d3ea-4994-b98c-18b02a548faf"
      unitRef="usd">5373900000</lh:Longtermdebtfutureminimumpaymentsinterestincludedinpayments>
    <lh:TotalShortandLongTermDebtIssuanceCosts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzgtMy0xLTEtMTE3MDI5_96923794-6ba1-4278-b453-595228888e05"
      unitRef="usd">33800000</lh:TotalShortandLongTermDebtIssuanceCosts>
    <lh:LongTermDebtExcludingDebtIssuanceCosts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzktMy0xLTEtMTE3MDI5_224dded1-25ba-44e9-8c18-24b96aec61ee"
      unitRef="usd">5340100000</lh:LongTermDebtExcludingDebtIssuanceCosts>
    <us-gaap:DebtCurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzEwLTMtMS0xLTExNzAyOQ_04a4950c-7200-4d32-8a9b-c5b1f437c7cb"
      unitRef="usd">301300000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMTQvZnJhZzo1MzBmZTVjZGVlYzc0NjE4OTNkYWYwNWZhMDkyY2Q3YS90YWJsZTo2OTQ1ZTMzMzRhNGI0MzdlYThlMmNmZmZjZjAzZGY2YS90YWJsZXJhbmdlOjY5NDVlMzMzNGE0YjQzN2VhOGUyY2ZmZmNmMDNkZjZhXzExLTMtMS0xLTExNzAyOQ_528853a9-fc6f-4545-a867-0a9cb71e852d"
      unitRef="usd">5038800000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NjA_d57cd00c-1691-4bcd-ad9e-a12ad61aa74b">PREFERRED STOCK AND COMMON SHAREHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of December&#160;31, 2022 and 2021.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued and held in treasury are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued at January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s treasury shares are recorded at aggregate cost. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of  2021, the board of directors (the Board) adopted a new share repurchase plan authorizing up to $2,500.0 of the Company's shares in addition to the remaining amount outstanding under the previous plan. Under this plan, the Company commenced an Accelerated Share Repurchase (ASR) program. At inception, the Company paid $1,000.0 and received 2.7 shares based on a calculation using 80% of the shares calculated at the price at the inception of the ASR agreements with two different banks, Goldman Sachs &amp;amp; Co. LLC and Barclays Bank PLC. The initial shares received under the ASR program were removed from the outstanding share count in 2021. During the twelve months ended December&#160;31, 2022, 0.9 shares were retired as part of this ASR program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, during the twelve months ended December&#160;31, 2022, the Company repurchased 4.7 shares of its common stock at an average price of $233.48 for a total cost of $1,100.0. At the end of 2022, the Company had outstanding authorization from the board of directors to purchase up to $531.5 of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2023, the Board approved an additional $1,000.0 for share repurchases, bringing the total available authorization to $1,531.5. The repurchase authorization has no expiration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the twelve months ended  December&#160;31, 2022, the Company paid $195.2 in common stock dividends. On January 12, 2023, the Company announced a cash dividend of $0.72 per share of common stock for the first quarter, or approximately $64.8 in the aggregate. The dividend will be payable on March 13, 2023, to stockholders of record of all issued and outstanding shares of common stock as of the close of business on February 23, 2023. The declaration and payment of any future dividends will be at the discretion of the Company's Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Earnings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive earnings are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Benefit&lt;br/&gt;Plan&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a) The amortization of prior service cost is included in the computation of net periodic benefit cost. Refer to Note&#160;15 Pension and Postretirement Plans for additional information regarding the Company's net periodic benefit cost.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NTc_cbf47c01-13f9-45d1-b6dc-33169b28dfb1">The Company is authorized to issue up to 265.0 shares of common stock, par value $0.10 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.10 per share. There were no preferred shares outstanding as of December&#160;31, 2022 and 2021.</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5Xzk5_2ffe9feb-5ba5-474d-8514-87bc6199e5f2"
      unitRef="shares">265000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzEzNg_12242400-33bb-4b58-aca5-36f5fe1594f2"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE5MQ_d72151af-1311-4730-a7b5-15ac684ee2ed"
      unitRef="shares">30000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzIzMQ_2baeff62-d14c-4fe4-87f7-7d9dc24de148"
      unitRef="usdPerShare">0.10</us-gaap:PreferredStockParOrStatedValuePerShare>
    <lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NDI_ee06e93a-1ced-40ef-b6aa-d63aa91fa19c">&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in common shares issued and held in treasury are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued at January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued under employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItMS0xLTEtMTE3MDI5_5b97fdfe-a8ee-42ba-abd7-a48f646c59d2"
      unitRef="shares">93100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItMy0xLTEtMTE3MDI5_a2ed4230-0a51-427e-a74e-2558687d5c73"
      unitRef="shares">97500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzItNS0xLTEtMTE3MDI5_7aef5c4a-5487-4f31-b1a6-7dbd0db494c1"
      unitRef="shares">97200000</us-gaap:CommonStockSharesIssued>
    <lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtMS0xLTEtMTE3MDI5_7cf12849-702f-4397-b559-918c93f2edf5"
      unitRef="shares">700000</lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans>
    <lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtMy0xLTEtMTE3MDI5_952477ba-1e17-4459-806a-45e61f90d5f3"
      unitRef="shares">800000</lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans>
    <lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzMtNS0xLTEtMTE3MDI5_752c747c-5d39-4596-a205-046e93cb0046"
      unitRef="shares">900000</lh:CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtMS0xLTEtMTE3MDI5_703c238c-869d-4f9d-9e14-5ee01504e077"
      unitRef="shares">5600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtMy0xLTEtMTE3MDI5_606fcf08-d20e-43e1-a012-2a0366b4f24d"
      unitRef="shares">5200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzYtNS0xLTEtMTE3MDI5_73713695-02c4-4db6-b7f3-17621a07c115"
      unitRef="shares">600000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctMS0xLTEtMTE3MDI5_022934dc-6776-44c0-8aa3-1daff8d6f7e5"
      unitRef="shares">88200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctMy0xLTEtMTE3MDI5_c61614d4-c86b-44e9-b6b5-63435dff1309"
      unitRef="shares">93100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTphODUzZDkwNzRmOTI0ZDIyYTI2YjIyMDJiYzRmMzJlYy90YWJsZXJhbmdlOmE4NTNkOTA3NGY5MjRkMjJhMjZiMjIwMmJjNGYzMmVjXzctNS0xLTEtMTE3MDI5_70a66768-816e-4156-a82c-5fdae7e862af"
      unitRef="shares">97500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5Xzc2Ng_53bfcfd0-59f8-4d97-b4b5-fc35cb376d79"
      unitRef="usd">2500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDU4Njg_180d0c57-f9ec-4ac9-a531-c2f0c9bee1cc"
      unitRef="usd">1000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i32bf5e75cbbd41808a4267a84614a6f2_D20211201-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDU4ODU_2fa3d1df-f7ea-4cef-a238-448497620ce1"
      unitRef="shares">2700000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i22a0f88f6f224901b84e2ba995acd60f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5NTM_1fcffe0a-0588-4754-a158-0b003e115a97"
      unitRef="shares">900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i9a95541978174baabe4f6bf28dc42c4e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5MjE_a2ed51f7-b1d0-408a-a9e8-87f7625f4b23"
      unitRef="shares">4700000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzEzOTM_05208c4f-ea1a-494f-8709-811d81477cf2"
      unitRef="usdPerShare">233.48</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE0MTY_70f52ebf-b5f3-4971-9079-acd100649e15"
      unitRef="usd">1100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <lh:CommonStockRepurchaseAuthorizationOutstanding
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzMxODM_23c05ce4-cb43-443b-b1d5-15aa5d8bd352"
      unitRef="usd">531500000</lh:CommonStockRepurchaseAuthorizationOutstanding>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i2257a78dc611411cbe54235fc9161d50_I20230207"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTE0NzI_6e06a93d-0920-4607-b61f-3db1fac30daf"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <lh:CommonStockRepurchaseAuthorizationOutstanding
      contextRef="i2257a78dc611411cbe54235fc9161d50_I20230207"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTE0NzY_181be92a-be39-4e79-87d7-c9bcd2c098e1"
      unitRef="usd">1531500000</lh:CommonStockRepurchaseAuthorizationOutstanding>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NDg5MjU_b7d25101-fd19-4fbc-812d-f19e650920a1"
      unitRef="usd">195200000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear
      contextRef="i612c1ffa3dbf48b1ba151c5142988893_D20230112-20230112"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTAyOTU_dbd9574f-84f7-4a09-99d8-d40a227d78fc">2023-01-12</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="icb5d5fbbddd149d0a71aea12be2f36ad_I20230112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTAzNDE_a643288a-aa26-4fb2-9ffe-eb2dc9116843"
      unitRef="usdPerShare">720000</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear
      contextRef="i9deaf97408a241ccbbd50fa1238da6cd_D20230313-20230313"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTA0NjM_02751667-ea4a-46c9-bacc-e8bf7392e17b">2023-03-13</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear
      contextRef="i042ee9fdbf47424cb316cf8e47c149ca_D20230223-20230223"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzE2NDkyNjc0NTA1Nzg_c7eb2e45-0ff7-4829-8d96-8d5ac033ab43">2023-02-23</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90ZXh0cmVnaW9uOjk1YzBiMTEwYzNmYzQ4MjBiMTAwZjc3ZTMzOTA5Y2E5XzM2NTY_1d6727f9-d9bd-4b05-a48c-885ce3c99c70">&lt;div style="margin-bottom:7pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive earnings are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.387%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.559%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;Benefit&lt;br/&gt;Plan&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension settlement charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive earnings (a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect of adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(493.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktMS0xLTEtMTE3MDI5_72da5528-d556-44d4-8d3e-a3993c04c38d"
      unitRef="usd">-21300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktMy0xLTEtMTE3MDI5_ab9eaba4-1302-4719-a9d4-b7c42a0ecfe0"
      unitRef="usd">140600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i716799a1a7a34a15b3e9adffdce6996d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzktNS0xLTEtMTE3MDI5_fc071602-5052-41f8-bd27-143e17b4d852"
      unitRef="usd">-161900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTEtMS0xLTExNzAyOQ_1a678c04-1d9a-4ba9-8f54-589e8328ed3f"
      unitRef="usd">-104600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTMtMS0xLTExNzAyOQ_3522aebd-33a2-44dc-9865-ddcc0b599860"
      unitRef="usd">101700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEwLTUtMS0xLTExNzAyOQ_f57ed13d-1ee1-4beb-9d91-885388e16be2"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i536124e79a094520854fc8863d11ccad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTEtMS0xLTExNzAyOQ_f42ccc22-08a5-41ec-ba4a-441e13404dfb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTMtMS0xLTExNzAyOQ_2e437316-9908-4239-a443-78314aa35507"
      unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i900cc5db2e98419893648b7db51b0e7f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzExLTUtMS0xLTExNzAyOQ_d977ec70-631b-4fce-aaa9-f458fa43ba88"
      unitRef="usd">-3700000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTEtMS0xLTExNzAyOQ_526bb9bf-6bbd-4bd2-b31c-f0d42dc306e3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTMtMS0xLTExNzAyOQ_eea47f39-1397-493e-b9b3-2de7a3771a96"
      unitRef="usd">-6300000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEyLTUtMS0xLTExNzAyOQ_91a1afc3-c2f7-4fb2-b82e-3ffd1e5a3efe"
      unitRef="usd">-6300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTEtMS0xLTExNzAyOQ_c2e91d8e-6f05-443a-a6c0-a8fecf8dc3ff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTMtMS0xLTExNzAyOQ_d3175acf-7ac4-447e-8e7c-3f814cd2d1eb"
      unitRef="usd">-17100000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzEzLTUtMS0xLTExNzAyOQ_a54c32c5-293f-4d90-b3ce-ffe1cf623217"
      unitRef="usd">17100000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTEtMS0xLTExNzAyOQ_cb18c1d4-3d5b-40b1-9e2a-1288f42ea84a"
      unitRef="usd">-125900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTMtMS0xLTExNzAyOQ_e23d91ea-4bb7-4d73-8f22-e50ad1c6ea77"
      unitRef="usd">66000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f4a5385f13b4550a6ecea11fa8c7fbd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE0LTUtMS0xLTExNzAyOQ_6e7d3cea-76e2-4ca7-93d0-8357775287b6"
      unitRef="usd">-191900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTEtMS0xLTE3NDEzNQ_8602f195-d89b-48c7-a274-32dadce1c1ba"
      unitRef="usd">-335500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTMtMS0xLTE3NDE3NA_56e0aab7-9477-4afa-aa46-fee320bc006c"
      unitRef="usd">52500000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE1LTUtMS0xLTE3NDIxMQ_e7b8c0df-a4ec-4ef1-81d7-7dd22c9975f7"
      unitRef="usd">-283000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i7178226fd2c74faf83c80dbbaa06de64_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTEtMS0xLTE3NDEzNQ_4ebf4bfd-9b06-4753-bfe4-4c1830961a0b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTMtMS0xLTE3NDE3NA_edd71ab9-c63f-46dc-954e-a67aa6ce4186"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i600b6077c1774c4a88264bdf99ad2cc0_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE2LTUtMS0xLTE3NDIxMQ_33194d3a-d9ea-4970-9e45-ea479739ca37"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTEtMS0xLTE3NDEzNQ_abb27a68-f0a8-4034-b178-cc18dfac337e"
      unitRef="usd">-900000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTMtMS0xLTE3NDE3NA_2a9d02a7-3d21-4d3e-9ae5-c6635a233781"
      unitRef="usd">-4600000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE3LTUtMS0xLTE3NDIxMQ_ce0c2123-27c9-464c-854a-e4a0bd978230"
      unitRef="usd">-5500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTEtMS0xLTE3NDEzNQ_a46d1c8d-8046-46a9-9bea-9a75b9bef859"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTMtMS0xLTE3NDE3NA_de7c855c-04ff-4249-b14b-77e6c7437597"
      unitRef="usd">-9700000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE4LTUtMS0xLTE3NDIxMQ_fee33208-1da6-4b3a-971c-f66162c3521d"
      unitRef="usd">9700000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTEtMS0xLTE3NDEzNQ_1ffa1b32-73a2-4e1c-8afa-a71e01e22d59"
      unitRef="usd">-462300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTMtMS0xLTE3NDE3NA_63478a9c-8ecf-4125-b41e-be9a02df512e"
      unitRef="usd">30900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjAvZnJhZzo5NWMwYjExMGMzZmM0ODIwYjEwMGY3N2UzMzkwOWNhOS90YWJsZTpiNmUxYmExYmJhOTk0NTg3YjM0ZjliZGMwYTdkM2Q3OS90YWJsZXJhbmdlOmI2ZTFiYTFiYmE5OTQ1ODdiMzRmOWJkYzBhN2QzZDc5XzE5LTUtMS0xLTE3NDIxMQ_102bd21e-c2f5-48a9-aea4-562f7f4d16c3"
      unitRef="usd">-493200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMjI_0d949481-6107-41d0-8f7f-189d83d9424e">INCOME TAXES &lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sources of income before taxes, classified between domestic and foreign entities, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,580.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,126.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of  income tax expense attributable to continuing operations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax expense/(benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The effective tax rates on earnings before income taxes are reconciled to statutory U.S. income tax rates as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory U.S. rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of U.S. federal income tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign earnings taxed at lower rates than the statutory U.S. rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and restructuring reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;      Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(811.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,259.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(661.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(691.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a rollforward of the valuation allowance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has U.S. federal tax loss carryforwards of approximately $161.5, which expire periodically through 2037, as well as post-2017 carryforwards of $202.7 that are limited to 80% of taxable income and have an indefinite carryforward period. The utilization of tax loss carryforwards is limited due to change of ownership rules; however, at this time, the Company expects to fully utilize substantially all U.S. federal tax loss carryforwards with the exception of approximately $6.5 for which a full valuation allowance has been provided. The Company has U.S. state tax loss carryforwards of $485.5, a portion of which expire annually, and on which a valuation allowance of $340.0 has been provided. In addition to federal and state tax loss carryforwards, the Company has other federal and state attribute carryforwards of $129.6. A portion of these attribute carryforwards will expire through 2027 and have a valuation allowance of $88.1 while the remainder have indefinite carryforward periods. The Company has foreign tax loss carryforwards of $115.7, the majority of which have indefinite carryforward periods, but a valuation allowance of $20.3 has been provided for jurisdictions where the future tax benefits of the attributes are not more likely than not to be realized.  Additionally, the Company has foreign tax loss carryforwards of $444.2 which expire periodically through 2034 that have a full valuation allowance. In addition to the foreign net operating losses, the Company has a foreign capital loss carryforward of $26.6 with an indefinite carryforward period and a full valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance increased from $149.2 in 2021 to $151.3 in 2022 primarily due to the establishment of valuation allowances related to acquired attributes and U.K. losses, offset by the partial release of the valuation allowance on U.S. capital losses.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized income tax benefits were $44.0 and $52.4 at December&#160;31, 2022, and 2021, respectively. It is anticipated that the amount of the unrecognized income tax benefits will decrease by $10.6 within the next 12 months due to statute of limitation lapses and anticipated audit settlements; however, these changes are not expected to have a significant impact on the results of operations, cash flows or the financial position of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes interest and penalties related to unrecognized income tax benefits in income tax expense. Accrued interest and penalties related to uncertain tax positions totaled $4.7 and $6.5 as of December&#160;31, 2022, and 2021, respectively. During the years ended December&#160;31, 2022, 2021 and 2020, the Company recognized $1.6, $1.6 and $4.4, respectively, in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest and penalties expense, which was offset by a benefit from reversing previous accruals for interest and penalties of $3.3, $3.4 and $3.0, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a reconciliation of the unrecognized income tax benefits, excluding interest and penalties, from uncertain tax positions for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in reserve for tax positions taken in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in reserve from an acquisition's opening balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in reserve as a result of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in reserve as a result of lapses in the statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also included in the balance of unrecognized tax benefits as of December&#160;31, 2022, 2021 and 2020, are $0.0, $0.9 and $2.1, respectively, of tax benefits that, if recognized, would result in adjustments to other tax accounts, primarily deferred taxes. As of December&#160;31, 2022, 2021 and 2020 there are $44.0, $51.5 and $46.7, respectively, of tax benefits that, if recognized, would favorably impact the effective income tax rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has substantially concluded all U.S. federal income tax matters for years through 2018 and is currently under IRS examination for tax years 2019 and 2020.&#160;Substantially all material state and local and foreign income tax matters have been concluded through 2015 and 2012, respectively.  The Company has various state and foreign income tax examinations ongoing throughout the year.  The Company believes adequate provisions have been recorded related to all open tax years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As a result of the Tax Cuts and Jobs Act (TCJA), the Company was effectively taxed on all of its previously unremitted foreign earnings. The TCJA also enacts a territorial tax system that allows, for the most part, tax-free repatriation of foreign earnings. The Company still considers the earnings of its foreign subsidiaries to be permanently reinvested, but, if repatriation were to occur, the Company would be required to accrue U.S. taxes, if any, and remit applicable withholding taxes as appropriate. The Company has unremitted earnings and profits of $1,726.3 and $1,291.8 that are permanently reinvested in its foreign subsidiaries as of December&#160;31, 2022, and 2021, respectively. A determination of the amount of the unrecognized deferred tax liability related to these undistributed earnings is not practicable due to the complexity and variety of assumptions necessary based on the manner in which the undistributed earnings would be repatriated.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ5OTc_9b40de3c-37c7-4e82-bcdc-5df975d8c5fc">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sources of income before taxes, classified between domestic and foreign entities, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Domestic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,580.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pre-tax income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,582.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,126.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtMS0xLTEtMTE3MDI5_0bdae5df-6540-4e89-b0e3-831cce40f9fc"
      unitRef="usd">1321000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtMy0xLTEtMTE3MDI5_604c99de-1633-4bc0-87f7-25949097599b"
      unitRef="usd">2580600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzEtNS0xLTEtMTE3MDI5_56abdd1f-551e-41ac-a62a-4888023878d6"
      unitRef="usd">1846500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItMS0xLTEtMTE3MDI5_557f4c06-d5e2-40ba-8c21-f6508b656bf3"
      unitRef="usd">261600000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItMy0xLTEtMTE3MDI5_97490ed9-0f8a-4221-978b-878330077037"
      unitRef="usd">546000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzItNS0xLTEtMTE3MDI5_4de9a89b-5d65-43fd-a651-31b89c2d62b1"
      unitRef="usd">372500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtMS0xLTEtMTE3MDI5_6a741d35-b661-4ba4-b846-133731797e7e"
      unitRef="usd">1582600000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtMy0xLTEtMTE3MDI5_3cc87c37-b4d2-45ba-a0f1-417bf8248584"
      unitRef="usd">3126600000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo3NDM5OTZlNjRlOGE0MTQwYWYwMWE1MjRkZmNhYjk1Ny90YWJsZXJhbmdlOjc0Mzk5NmU2NGU4YTQxNDBhZjAxYTUyNGRmY2FiOTU3XzMtNS0xLTEtMTE3MDI5_b4207b1d-b0d9-404a-860d-b75b8d71f034"
      unitRef="usd">2219100000</lh:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMTk_5345eaff-4502-47ea-b66a-b41df9242b4d">&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of  income tax expense attributable to continuing operations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;825.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax expense/(benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtMS0xLTEtMTE3MDI5_a382b409-3a7d-45b0-ac5f-297f4d3deb47"
      unitRef="usd">189400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtMy0xLTEtMTE3MDI5_5743b62a-60fd-4f28-b3d6-3e36c45ba661"
      unitRef="usd">545500000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzMtNS0xLTEtMTE3MDI5_d51e54fe-597c-4191-bdab-507cb1ece358"
      unitRef="usd">455300000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtMS0xLTEtMTE3MDI5_c6d86d55-3ce2-4fab-ab3a-abdc658ca481"
      unitRef="usd">40100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtMy0xLTEtMTE3MDI5_eb7cc06b-f291-49e0-a83a-fa1a13da9456"
      unitRef="usd">171900000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzQtNS0xLTEtMTE3MDI5_4f0d9d12-8f9f-4f89-9ef9-120fd5317ea5"
      unitRef="usd">172800000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtMS0xLTEtMTE3MDI5_d0ab3d7a-b237-4109-bb88-dc187bf11f74"
      unitRef="usd">65300000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtMy0xLTEtMTE3MDI5_5fa68392-3493-4b12-8c02-8021edc67bc4"
      unitRef="usd">107700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzUtNS0xLTEtMTE3MDI5_13d6d984-bbe0-4f84-a7e3-9614bfd118d8"
      unitRef="usd">81000000.0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtMS0xLTEtMTE3MDI5_3433ee4f-84bf-4c08-8bf4-9c347d47e9d4"
      unitRef="usd">294800000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtMy0xLTEtMTE3MDI5_49340618-209a-4250-a9de-7898b5467494"
      unitRef="usd">825100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzYtNS0xLTEtMTE3MDI5_eec6c845-052f-4d09-89c7-a0f61bef7984"
      unitRef="usd">709100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtMS0xLTEtMTE3MDI5_f747f407-dd15-409e-b8ef-2619535fe4bd"
      unitRef="usd">7800000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtMy0xLTEtMTE3MDI5_0510436d-a759-467d-b138-42a54d97321a"
      unitRef="usd">-64600000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzgtNS0xLTEtMTE3MDI5_87f5330b-dde2-4e96-a1a7-caa4c8f8eacf"
      unitRef="usd">-6700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktMS0xLTEtMTE3MDI5_4d520205-4e3f-4746-8af5-fbbdc16c415e"
      unitRef="usd">-5400000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktMy0xLTEtMTE3MDI5_e9e07170-4d65-4e19-bb4c-ee81369cb7d1"
      unitRef="usd">-13700000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzktNS0xLTEtMTE3MDI5_d3589edf-57d7-4814-a311-0b21bd34d5f6"
      unitRef="usd">-28100000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTEtMS0xLTExNzAyOQ_ce9d0cb9-3599-473f-bfce-6707dfaf1d4b"
      unitRef="usd">4800000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTMtMS0xLTExNzAyOQ_1374b2f0-b1e6-437a-ae12-bf4051b5d4b0"
      unitRef="usd">300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEwLTUtMS0xLTExNzAyOQ_04d9b6e7-6a3c-4e76-b952-6af02d31ca7c"
      unitRef="usd">-12200000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTEtMS0xLTExNzAyOQ_44d21646-f980-4c1b-bd43-7d0f0f1efd50"
      unitRef="usd">7200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTMtMS0xLTExNzAyOQ_375f1701-3e11-4bcc-a1df-b2dca23828ff"
      unitRef="usd">-78000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzExLTUtMS0xLTExNzAyOQ_23f86429-f513-4b6e-8e63-aee6b7d90910"
      unitRef="usd">-47000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTEtMS0xLTExNzAyOQ_a986a9e2-2c98-4c4e-a37f-62e88241599f"
      unitRef="usd">302000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTMtMS0xLTExNzAyOQ_a7c434b4-8596-45bf-bd4b-c90ae8a6f932"
      unitRef="usd">747100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2MzcyMzQyZDcxODA0OTZjYjYyOWNlOWQ4ZjY4YmI0Mi90YWJsZXJhbmdlOjYzNzIzNDJkNzE4MDQ5NmNiNjI5Y2U5ZDhmNjhiYjQyXzEyLTUtMS0xLTExNzAyOQ_26baf99e-bc97-43c2-a01e-7aecbc15ddaa"
      unitRef="usd">662100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMDA_1f09f11d-b2dc-49cb-a09f-a60c9cf6aadb">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;The effective tax rates on earnings before income taxes are reconciled to statutory U.S. income tax rates as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory U.S. rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of U.S. federal income tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign earnings taxed at lower rates than the statutory U.S. rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItMS0xLTEtMTE3MDI5_7ad39fc3-b940-44c7-8781-86cf51ac79c0"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItMy0xLTEtMTE3MDI5_6a38af66-1661-47c1-908b-e5c090578d28"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzItNS0xLTEtMTE3MDI5_f2791d90-615b-413f-a272-b5d7551487af"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtMS0xLTEtMTE3MDI5_c70649c6-14c4-4603-b39e-0d70c25d03b8"
      unitRef="number">0.037</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtMy0xLTEtMTE3MDI5_d085e66c-50b7-4d38-93d5-ee774e222bc8"
      unitRef="number">0.039</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzMtNS0xLTEtMTE3MDI5_3663f81b-bcfb-4068-8397-dbdad962c459"
      unitRef="number">0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtMS0xLTEtMTE3MDI5_62286751-0611-4bb9-b722-6cd80164b984"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtMy0xLTEtMTE3MDI5_8da29877-e99d-4e0a-bfc8-31c222a09b5d"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzQtNS0xLTEtMTE3MDI5_0d020980-a667-429d-a282-d8258e0d6923"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtMS0xLTEtMTk5Njc5_90b9ea6a-6976-4bc1-87a0-eec98c176049"
      unitRef="number">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtMy0xLTEtMTk5Njc5_73c15e80-6556-43be-ad2f-f72e698f4bd0"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzUtNS0xLTEtMTk5Njc5_cd89613f-f215-4438-a704-168d867f71b1"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtMS0xLTEtMTE3MDI5_c1df6d84-e030-4acb-a689-18cdcb192d7a"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtMy0xLTEtMTE3MDI5_fd97a0a2-5982-4119-b868-a7668cdb4400"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzgtNS0xLTEtMTE3MDI5_dd713e83-a4c6-4fc6-a7de-35846942fdea"
      unitRef="number">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTEtMS0xLTE5OTY5MQ_38b3fb22-cbea-46dc-9121-3bc1f5b5ab51"
      unitRef="number">-0.019</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTMtMS0xLTE5OTY5MQ_84aa62b6-ba9e-43d2-80f3-a72fb3b89f46"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEyLTUtMS0xLTE5OTY5MQ_7642b8c2-ff00-4b6c-8eff-778d58233ced"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTEtMS0xLTExNzAyOQ_68ffb731-f5e6-4703-af78-f13fa96ca988"
      unitRef="number">-0.016</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTMtMS0xLTExNzAyOQ_1f172666-1c52-48a6-8747-fefecddc723b"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzEwLTUtMS0xLTExNzAyOQ_27b7941d-4ef7-490a-a287-37b09fbc9f5f"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTEtMS0xLTExNzAyOQ_c969112b-260a-43ab-9dfe-c644c4f8271b"
      unitRef="number">0.190</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTMtMS0xLTExNzAyOQ_410e6cc0-e214-4fbb-82ad-9ae0192bc04e"
      unitRef="number">0.239</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpiZDc2MTViODFlMmU0MTkxOTQ1YzQzNjNiM2RmOWU3ZC90YWJsZXJhbmdlOmJkNzYxNWI4MWUyZTQxOTE5NDVjNDM2M2IzZGY5ZTdkXzExLTUtMS0xLTExNzAyOQ_f4889e54-208b-49f0-811c-e1cad105ba6a"
      unitRef="number">0.298</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ5ODQ_5bb329f5-dadd-4556-a07d-778cad7503b5">&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.637%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition and restructuring reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized R&amp;amp;D costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;      Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(151.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(811.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,259.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(661.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(691.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzItMS0xLTEtMTE3MDI5_5b326caa-3ec1-4e6c-a93b-f82c7b4aa68e"
      unitRef="usd">22500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzItMy0xLTEtMTE3MDI5_c4f55298-8192-4138-853c-2145488a1042"
      unitRef="usd">22300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzMtMS0xLTEtMTE3MDI5_7dc1c79b-9291-41c0-8d08-d98f503a998f"
      unitRef="usd">114200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzMtMy0xLTEtMTE3MDI5_ceee200e-aae8-43dd-b2f9-d7916e9d0da1"
      unitRef="usd">145200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <lh:DeferredTaxAssetRightOfUseAsset
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzQtMS0xLTEtMTE3MDI5_ae3ea33c-bd71-4d12-8e86-3564d85d7e1a"
      unitRef="usd">189400000</lh:DeferredTaxAssetRightOfUseAsset>
    <lh:DeferredTaxAssetRightOfUseAsset
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzQtMy0xLTEtMTE3MDI5_ad334211-6eac-4b9b-abec-a8a769665183"
      unitRef="usd">176300000</lh:DeferredTaxAssetRightOfUseAsset>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzctMS0xLTEtMTE3MDI5_3c3a9bd7-ea8b-4a0e-a0aa-d36453265d3c"
      unitRef="usd">10300000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzctMy0xLTEtMTE3MDI5_03ae7d0c-1708-4405-b352-10ced09c2104"
      unitRef="usd">19100000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMS0xLTEtMTk5ODE3_8393ce54-56a5-45e6-a491-fb0535eb9cd8"
      unitRef="usd">54400000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMy0xLTEtMTk5ODE3_27ad4ca9-d971-457c-8e43-3df33c488bd1"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMS0xLTEtMTE3MDI5_9a9463a4-9a68-4179-a745-8dfb74263224"
      unitRef="usd">242600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzgtMy0xLTEtMTE3MDI5_4f9960c2-3cdd-4ea7-8ae3-b7a4736197eb"
      unitRef="usd">184500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzktMS0xLTEtMTE3MDI5_e6b8033c-1e8b-42ee-a791-2e463654521d"
      unitRef="usd">116400000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzktMy0xLTEtMTE3MDI5_e0bfe029-aa47-4ef1-8f64-1253c23bd8f8"
      unitRef="usd">92700000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEwLTEtMS0xLTExNzAyOQ_01db3cd7-496f-4768-990c-2b7dd5782b41"
      unitRef="usd">749800000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEwLTMtMS0xLTExNzAyOQ_b13c7a07-8ced-45cb-9609-e0094fa87f6a"
      unitRef="usd">640100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzExLTEtMS0xLTExNzAyOQ_f8611cc2-7cf3-4878-883d-d7848f142b57"
      unitRef="usd">151300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzExLTMtMS0xLTExNzAyOQ_1905af21-1d82-4248-b0e2-026af6c2c247"
      unitRef="usd">149200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEyLTEtMS0xLTExNzAyOQ_3102c83c-d5f6-4fca-94e0-085d7ae8a0aa"
      unitRef="usd">598500000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzEyLTMtMS0xLTExNzAyOQ_f6b8b463-5331-4416-be03-c91dc5c553b0"
      unitRef="usd">490900000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE2LTEtMS0xLTExNzAyOQ_5d656e27-5ab1-4f0f-b78c-cf080a0d547b"
      unitRef="usd">172700000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE2LTMtMS0xLTExNzAyOQ_7b7ce968-5100-4df2-968e-ba74df95bbc9"
      unitRef="usd">166900000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE3LTEtMS0xLTExNzAyOQ_37eac44a-59af-40c4-84f9-a4f0f73455cd"
      unitRef="usd">811100000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE3LTMtMS0xLTExNzAyOQ_a06ea787-329f-47e9-9713-65fa1885b97b"
      unitRef="usd">823800000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE4LTEtMS0xLTExNzAyOQ_1e7a2512-4a4b-4f61-9556-44169e1a3e10"
      unitRef="usd">188000000.0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzE4LTMtMS0xLTExNzAyOQ_f804bab5-b35a-46ff-aaa7-fab0c115f691"
      unitRef="usd">143900000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIwLTEtMS0xLTExNzAyOQ_45b737f3-81ab-4a8f-b4a0-68ce47bfcd7a"
      unitRef="usd">87900000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIwLTMtMS0xLTExNzAyOQ_df6d83a9-4504-4270-8431-65a514a80436"
      unitRef="usd">47600000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIxLTEtMS0xLTExNzAyOQ_90420d8f-6e23-44ee-b6d3-3257942803c7"
      unitRef="usd">1259700000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIxLTMtMS0xLTExNzAyOQ_cbcf19df-7714-481a-89c5-bb4c46fd66a1"
      unitRef="usd">1182200000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIyLTEtMS0xLTExNzAyOQ_88264de6-8c6b-4dc0-9495-dfd8ac404c50"
      unitRef="usd">661200000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTpjYmQ3M2FhNTMxOGU0NDE2YmFmNDAyY2Y1ODVmZTZhYS90YWJsZXJhbmdlOmNiZDczYWE1MzE4ZTQ0MTZiYWY0MDJjZjU4NWZlNmFhXzIyLTMtMS0xLTExNzAyOQ_b4a0502f-ccb7-4085-9d79-90912ce46099"
      unitRef="usd">691300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMDY_24082f2f-fc85-41ba-84af-5d0629780e9f">&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a rollforward of the valuation allowance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions charged to expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtMS0xLTEtMTE3MDI5_bc1553ac-6896-48b1-9fb2-fca9c24142ef"
      unitRef="usd">149200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtMy0xLTEtMTE3MDI5_958e84c2-b5d9-4456-9b4e-e70d3474bdc2"
      unitRef="usd">167600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzEtNS0xLTEtMTE3MDI5_1dfb5b98-5cc9-4cb1-9db1-7b2f80434ae5"
      unitRef="usd">145400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItMS0xLTEtMTE3MDI5_b040ac85-ffe9-40d7-b452-bbc6862259fe"
      unitRef="usd">10200000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItMy0xLTEtMTE3MDI5_3bddc7c2-a608-400f-a985-0f586aa2e4e7"
      unitRef="usd">6800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzItNS0xLTEtMTE3MDI5_9a8147dd-2d80-41d2-a91a-8c6de47f2016"
      unitRef="usd">5800000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtMS0xLTEtMTE3MDI5_eac1ecc8-679e-444c-bcb4-3c7b9eaea07c"
      unitRef="usd">8100000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtMy0xLTEtMTE3MDI5_ed742617-1a37-4d01-b1bb-4c7c10652ca3"
      unitRef="usd">25200000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzMtNS0xLTEtMTE3MDI5_4c6f3a7f-7664-43c0-a6da-f308429542cf"
      unitRef="usd">-16400000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtMS0xLTEtMTE3MDI5_92f4d02f-577a-442d-a61a-7a484be376bf"
      unitRef="usd">151300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtMy0xLTEtMTE3MDI5_2b48544f-64e6-406d-86c2-08a48e806b6f"
      unitRef="usd">149200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo2OTBiZTQ4YzU0ZDE0YWJkYTc5ZDI4MjhjN2I5YWE3MS90YWJsZXJhbmdlOjY5MGJlNDhjNTRkMTRhYmRhNzlkMjgyOGM3YjlhYTcxXzQtNS0xLTEtMTE3MDI5_88f9c646-530c-4b4a-a619-a2a76c1e5b5b"
      unitRef="usd">167600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <lh:FederalTaxLossCarryovers
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzY3OQ_b21a191c-f59c-48a1-9537-3213c4339cfa"
      unitRef="usd">161500000</lh:FederalTaxLossCarryovers>
    <lh:FederalTaxLossCarryovers
      contextRef="ifbadcad8fa62418ba708fec2acad3e8b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwOTk1MTE2MjgyODQ0_b14465f7-8af2-4a62-8741-c9dd066801eb"
      unitRef="usd">202700000</lh:FederalTaxLossCarryovers>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2Xzc4MQ_0f965d71-a4ea-4786-ad37-d28ed62f1b1d">80</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="iaaa411a036c347a7814b3b8f3d7473d6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwNzQ_4a6d1be7-e789-4206-aa97-ca1b08578c09"
      unitRef="usd">6500000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzExODY_58eefc33-87ee-4409-8bb4-34475dc0919d"
      unitRef="usd">485500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEyNzM_1b2ed34f-b111-4918-adcd-0030d3ca9ae0"
      unitRef="usd">340000000.0</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <lh:FederalandStateAttributeCarryforwards
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE0MjA_b36fa8c5-9185-4781-b5ca-529e4ab9dcf3"
      unitRef="usd">129600000</lh:FederalandStateAttributeCarryforwards>
    <lh:FederalandStateAttributeCarryforwardValuationAllowance
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE1MDU_6aa25b13-fb4e-43b3-8009-a790761d379b"
      unitRef="usd">88100000</lh:FederalandStateAttributeCarryforwardValuationAllowance>
    <lh:ForeignTaxLossCarryovers
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE1NjA_c94aca79-e506-4a5b-8ef7-9aabd4dee351"
      unitRef="usd">115700000</lh:ForeignTaxLossCarryovers>
    <lh:ForeignTaxLossCarryoverValuationAllowance
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE2MzE_34159826-3735-4237-83ac-f73719f9911c"
      unitRef="usd">20300000</lh:ForeignTaxLossCarryoverValuationAllowance>
    <lh:ForeignTaxLossCarryoversExpirein2034
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE2OTg_501f85c5-28cf-4ee9-b04b-e5bfd823a9ae"
      unitRef="usd">444200000</lh:ForeignTaxLossCarryoversExpirein2034>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzE4ODI_2637a467-4921-4b83-a641-4d4ada1949c2"
      unitRef="usd">26600000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIwMjI_bc1553ac-6896-48b1-9fb2-fca9c24142ef"
      unitRef="usd">149200000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIwMzQ_92f4d02f-577a-442d-a61a-7a484be376bf"
      unitRef="usd">151300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIxNjg_f373cad3-ec6e-4a14-a955-219b0ba291d4"
      unitRef="usd">44000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzIxNzU_86968fc2-c03b-4543-a083-cc46389ef320"
      unitRef="usd">52400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzEwOTk1MTE2MjgzODM2_527ee9c8-b538-4f4b-8fb4-e93c94e9f7c9"
      unitRef="usd">10600000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI2NTk_551a7133-d8e9-41b6-a821-d061db189d7c"
      unitRef="usd">4700000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI2NjY_15df0478-cc3c-4469-86c1-9e2fb3f90684"
      unitRef="usd">6500000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NjI_c41b2d0f-5fe3-48ed-a689-555da349f8f2"
      unitRef="usd">1600000</us-gaap:IncomeTaxExaminationPenaltiesExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NjY_f2a9eaa7-5152-4458-8e3c-ca3bb8b80b29"
      unitRef="usd">1600000</us-gaap:IncomeTaxExaminationPenaltiesExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI3NzM_5a138cad-6066-46b5-8cef-ccaadc384aa5"
      unitRef="usd">4400000</us-gaap:IncomeTaxExaminationPenaltiesExpense>
    <lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MTk_19a96867-a4e5-4948-a675-773629ab3cf2"
      unitRef="usd">3300000</lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest>
    <lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MjM_941d556b-eb55-4ab4-896f-db50e6feb93b"
      unitRef="usd">3400000</lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest>
    <lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzI5MzA_f93a8168-1d1d-4500-87d5-3b3f574f2ef3"
      unitRef="usd">3000000.0</lh:ReversalofAccruedIncomeTaxPenaltiesAndInterest>
    <us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzUwMjU_4ec5eee0-8b03-4836-8068-074556e69a18">&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a reconciliation of the unrecognized income tax benefits, excluding interest and penalties, from uncertain tax positions for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in reserve for tax positions taken in the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in reserve from an acquisition's opening balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in reserve as a result of payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in reserve as a result of lapses in the statute of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtMS0xLTEtMTE3MDI5_e74e1e2b-f150-463d-9171-0293348ab950"
      unitRef="usd">52400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtMy0xLTEtMTE3MDI5_3f647b58-3929-4f9c-8adf-57bf1221c0ee"
      unitRef="usd">48800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ice6b446a0be14f92ad87a9e60cdfb741_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzEtNS0xLTEtMTE3MDI5_985efa5c-4deb-4d14-92af-d44b3a1ca7b1"
      unitRef="usd">31700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItMS0xLTEtMTE3MDI5_bd1a36e8-ff4b-43de-8c48-6ab92a72b977"
      unitRef="usd">12400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItMy0xLTEtMTE3MDI5_2e3b9393-e108-457b-8ea5-85973eb6f87e"
      unitRef="usd">31100000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzItNS0xLTEtMTE3MDI5_d79ce25e-6e45-4f13-9f4b-b6c688044208"
      unitRef="usd">17300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtMS0xLTEtMTE3MDI5_2a764e6e-82ef-48f1-8e68-95ea3039d033"
      unitRef="usd">0</lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition>
    <lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtMy0xLTEtMTE3MDI5_d25179d0-a670-42ee-a905-6dc7bd7bb69b"
      unitRef="usd">0</lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition>
    <lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzMtNS0xLTEtMTE3MDI5_55b68aac-2281-4e8d-8df5-1a708ab85937"
      unitRef="usd">8200000</lh:UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition>
    <lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtMS0xLTEtMTE3MDI5_654378c5-2d5d-451e-a4c8-16b132e04170"
      unitRef="usd">13500000</lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions>
    <lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtMy0xLTEtMTE3MDI5_a0192127-0ecd-47be-ae27-dad9f8e70c13"
      unitRef="usd">7100000</lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions>
    <lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzQtNS0xLTEtMTE3MDI5_f733c755-e9ad-41ed-875f-adace6073bf7"
      unitRef="usd">300000</lh:UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtMS0xLTEtMTE3MDI5_1a4f3adc-88b6-4f75-8b83-ab0b0d643f0b"
      unitRef="usd">7300000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtMy0xLTEtMTE3MDI5_2a34b77b-8542-4450-8a98-66113fb97d72"
      unitRef="usd">20400000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzYtNS0xLTEtMTE3MDI5_11baa58a-7580-4f94-a820-0501a3b0b43e"
      unitRef="usd">8100000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctMS0xLTEtMTE3MDI5_563a0656-5765-40de-9882-25a99aa1b146"
      unitRef="usd">44000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctMy0xLTEtMTE3MDI5_2bf548fb-7727-4d2a-a493-7342e75300c9"
      unitRef="usd">52400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90YWJsZTo1ZWM4YzA3Y2ZkOWU0YTc5OTFjZmUzNDk2MTgwMzkwOC90YWJsZXJhbmdlOjVlYzhjMDdjZmQ5ZTRhNzk5MWNmZTM0OTYxODAzOTA4XzctNS0xLTEtMTE3MDI5_2ee5327b-5b15-45b9-965a-8d7e8ed6ecb0"
      unitRef="usd">48800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzNzA_4bf01541-d579-4c8f-8180-86faf47e475c"
      unitRef="usd">0.0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzNzQ_d18fe790-38cb-4c7c-9a03-35fc43ad2650"
      unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzMzODE_1c7900bf-d276-44fb-9696-e48ad513b499"
      unitRef="usd">2100000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ibc08ff0a0d474d61afc14770005abe03_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NDM_5790d702-21f8-4f19-95d2-ace0495ee482"
      unitRef="usd">44000000.0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i973ac99fa8bc44b7b6e05a3777b91219_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NDc_ff04988b-1d4d-458b-93cd-b65e783df415"
      unitRef="usd">51500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i90bbd94ee3fd44f1a0f4ecc350cc8574_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzM1NTQ_c75207f7-f9d7-4415-af29-e8883047f9c9"
      unitRef="usd">46700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ2MTU_29a529c4-401a-4c88-a33c-922fa7be5f0b"
      unitRef="usd">1726300000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjMvZnJhZzo4MGFiZmZhYjkwMjE0NjgzODYwNWY4NjI4NGJjMmRhNi90ZXh0cmVnaW9uOjgwYWJmZmFiOTAyMTQ2ODM4NjA1Zjg2Mjg0YmMyZGE2XzQ2MjI_51caa621-83a1-42eb-800b-e305191de3e9"
      unitRef="usd">1291800000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzMzg_33f82cea-78d0-40c4-9fc7-3e9555b09b1c">STOCK COMPENSATION PLANS&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, the shareholders approved the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan (the Plan). Under the Plan, as of December&#160;31, 2022, there are 8.6 shares authorized for issuance and 3.6 shares available for grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes grants of non-qualified options made by the Company to officers, key employees, and non-employee directors under all plans. Stock options are generally granted at an exercise price equal to or greater than the fair market price per share on the date of grant. Also, for each grant, options vest ratably over a period of three years on the anniversaries of the grant date, and have a contractual exercise period of 10 years subject to their earlier expiration or termination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in options outstanding under the plans for the period indicated were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company&#x2019;s closing stock price on the last trading day of 2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash received by the Company from option exercises, the actual tax benefit realized for the tax deductions and the aggregate intrinsic value of options exercised from option exercises under all share-based payment arrangements during the years ended December&#160;31, 2022, 2021, and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black Scholes model incorporates assumptions to value stock-based awards. The risk-free interest rate for periods within the contractual life of the option is based on a zero-coupon U.S. government instrument over the contractual term of the equity instrument. Expected volatility of the Company&#x2019;s stock is based on historical volatility of the Company&#x2019;s stock. The Company estimates expected option terms through an analysis of actual, historical post-vesting exercise, cancellation and expiration behavior by employees and projected post-vesting activity of outstanding options. Groups of employees and non-employee directors that have similar exercise behavior with regard to option exercise timing and forfeiture rates are considered separately for valuation purposes. For 2022, 2021 and 2020, expense related to the Company&#x2019;s stock option plan totaled $4.3, $3.6 and $3.4, respectively, and is included in selling, general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock, Restricted Stock Units and Performance Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants restricted stock, restricted stock units, and performance shares (non-vested shares) to officers and key employees and grants restricted stock and restricted stock units to non-employee directors. Restricted stock and units typically vest annually in equal one-third increments beginning on the first anniversary of the grant. A performance share grant in 2020 represents a three-year award opportunity for the period 2020-2022, and if earned, vests fully (to the extent earned) in the first quarter of 2023. A performance share grant in 2021 represents a three-year award opportunity for the period of 2021-2023 and, if earned, vests fully (to the extent earned) in the first quarter of 2024. A performance share grant in 2022 represents a three-year award opportunity for the period of 2022-2024 and, if earned, vests fully (to the extent earned) in the first quarter of 2025. Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets, the achievement of which may increase or decrease the number of shares which the grantee earns and therefore receives upon vesting. Unearned restricted stock and performance share compensation is amortized to expense, when probable, over the applicable vesting periods. For 2022, 2021, and 2020, total restricted stock, restricted stock unit, and performance share compensation expense was $125.0, $135.4 and $98.1, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a summary of non-vested shares for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized Compensation Cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, there was $155.3 of total unrecognized compensation cost related to non-vested stock options, restricted stock, restricted stock unit and performance share-based compensation arrangements granted under the Company's stock incentive plans. That cost is expected to be recognized over a weighted average period of 1.9 years and will be included in cost of revenues and selling, general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2016 Employee Stock Purchase Plan, the Company is authorized to issue 1.8 shares of common stock. The plan permits substantially all U.S. and Canada employees to purchase a limited number of shares of Company stock at 85% of market value. The Company issues shares to participating employees semi-annually in January and July of each year. Approximately 0.2, 0.2 and 0.3 shares were purchased by eligible employees in 2022, 2021 and 2020, respectively. For 2022, 2021 and 2020, expense related to the Company&#x2019;s employee stock purchase plan was $14.8, $14.6 and $10.3, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to calculate the fair value of the employee&#x2019;s purchase right. The fair value of the employee&#x2019;s purchase right and the assumptions used in its calculation are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of the employee&#x2019;s purchase right&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzIxNQ_c7756bfb-5442-4cbc-8b1b-f63f6a803c91"
      unitRef="shares">8600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI1Mw_4a0bd172-2bfe-4e0b-b522-9260d5c64dcb"
      unitRef="shares">3600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNTU_006e1b43-d4d3-475c-8350-a8b87aade71d">hanges in options outstanding under the plans for the period indicated were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i514823945de04d5ca0f42a63418890ee_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzEtMS0xLTEtMTE3MDI5_15069e5f-ff52-4622-9641-cfd17843d948"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i514823945de04d5ca0f42a63418890ee_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzEtMy0xLTEtMTE3MDI5_12c84a62-e106-4b61-bba4-3f43fb3dfd24"
      unitRef="usdPerShare">169.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzItMS0xLTEtMTE3MDI5_81e8a780-b1b5-4d7b-bb38-88159a8e0f63"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzItMy0xLTEtMTE3MDI5_10b42feb-21d0-4fec-8ef1-3edfd02d94e5"
      unitRef="usdPerShare">276.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzMtMS0xLTEtMTE3MDI5_83476ae3-b1d7-44fa-a6b8-b58feb9cd932"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzMtMy0xLTEtMTE3MDI5_281ad5ff-636a-4808-8849-af47286d5529"
      unitRef="usdPerShare">118.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzQtMS0xLTEtMTE3MDI5_c334d018-3b9f-492b-a347-716f8e976d14"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzQtMy0xLTEtMTE3MDI5_2ac5374f-b523-4d0e-aacc-487f20f6da00"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtMS0xLTEtMTE3MDI5_793607e8-f1eb-4ab2-97e2-1edcd8745ea3"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtMy0xLTEtMTE3MDI5_428a24d1-b1c3-4fce-a5f4-1df23ae025bb"
      unitRef="usdPerShare">188.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtNS0xLTEtMTE3MDI5_ce29792d-18b5-4362-8a14-d1854a6bf3f1">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzUtNy0xLTEtMTE3MDI5_08bbd1c7-6aba-4a66-b42b-4c7ec047e51f"
      unitRef="usd">25900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctMS0xLTEtMTE3MDI5_9bba9590-bf10-4d25-bf8a-ba3f4081456f"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctMy0xLTEtMTE3MDI5_474ce0fb-8e97-42d7-baf9-244f3b90b53b"
      unitRef="usdPerShare">168.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i1957179960fe490c92f39a54404c5b0a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctNS0xLTEtMTE3MDI5_74f0584e-0876-401e-ae03-ac0a9d71969b">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="ie3da55bd06384e75ba2d8ca0fef28489_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTo0OWIwY2RlMDU1N2Q0YTAyYWY3MzhiYmNjMzZkOTA0My90YWJsZXJhbmdlOjQ5YjBjZGUwNTU3ZDRhMDJhZjczOGJiY2MzNmQ5MDQzXzctNy0xLTEtMTE3MDI5_879cb812-4a0b-445b-abdd-bb0510b1cfe8"
      unitRef="usd">23300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <lh:DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNjE_193bffc3-1670-49df-83c0-9e2718bc50dd">&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash received by the Company from option exercises, the actual tax benefit realized for the tax deductions and the aggregate intrinsic value of options exercised from option exercises under all share-based payment arrangements during the years ended December&#160;31, 2022, 2021, and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received by the Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefits realized&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate intrinsic value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtMS0xLTEtMTE3MDI5_dc0c0453-0591-49df-9463-ab429c196699"
      unitRef="usd">7100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtMy0xLTEtMTE3MDI5_955dfc49-8097-499e-985b-4ca6eba448cc"
      unitRef="usd">6800000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzEtNS0xLTEtMTE3MDI5_e831df02-3329-4a6b-b41d-bf160e2edad0"
      unitRef="usd">17500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItMS0xLTEtMTE3MDI5_b8d5e50a-6c31-44de-8ff7-85ba6a866609"
      unitRef="usd">1800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItMy0xLTEtMTE3MDI5_a6fc8b3b-b49a-49a0-b74d-74c93847d80e"
      unitRef="usd">1700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzItNS0xLTEtMTE3MDI5_c00dd9fc-5838-4179-b0dc-d0ffd26d7b6b"
      unitRef="usd">4600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtMS0xLTEtMTE3MDI5_57d5e86d-e727-47b5-be2e-dae3ba53d37d"
      unitRef="usd">8200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtMy0xLTEtMTE3MDI5_76dc6eea-75a8-4964-a8b2-3bbd14d82107"
      unitRef="usd">13400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTplOTllZmUxNmIzYTU0ODRhOWY4YzJlMTlmZTY2OWI2NS90YWJsZXJhbmdlOmU5OWVmZTE2YjNhNTQ4NGE5ZjhjMmUxOWZlNjY5YjY1XzMtNS0xLTEtMTE3MDI5_d205ee5b-3b4a-4897-bcb0-fe888ac2140a"
      unitRef="usd">18500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNjI_7dd0b20d-fee9-4a41-8fa1-deef31d78754">&lt;div style="margin-top:4pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the weighted average grant-date fair values of options issued during the respective year and the weighted average assumptions that the Company used to develop the fair value estimates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.013%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value per option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes model to calculate the fair value of the employee&#x2019;s purchase right. The fair value of the employee&#x2019;s purchase right and the assumptions used in its calculation are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.492%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of the employee&#x2019;s purchase right&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItMS0xLTEtMTE3MDI5_ac3ded86-fffa-4d81-88ee-d22756e93b92"
      unitRef="usdPerShare">76.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItMy0xLTEtMTE3MDI5_2043d402-b194-4552-a3e5-958bdacecb70"
      unitRef="usdPerShare">62.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzItNS0xLTEtMTE3MDI5_add42ecc-3c35-4c1d-bc62-df31ed693202"
      unitRef="usdPerShare">40.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtMS0xLTEtMTE3MDI5_dd7a1f5c-6c28-4cdb-8a58-66829624f61a">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtMy0xLTEtMTE3MDI5_18e52b83-57cb-477b-9e69-aa86f8da0122">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzQtNS0xLTEtMTE3MDI5_0b6a6744-e0b3-4374-a9a8-133e947b4995">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtMS0xLTEtMTE3MDI5_556d7ae4-f04b-4543-a976-9e143aafd1f5"
      unitRef="number">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtMy0xLTEtMTE3MDI5_da9159e7-54ce-4b51-a670-078fd05972f6"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzUtNS0xLTEtMTE3MDI5_79ee5ecf-6f3e-4631-9a19-5210d28bf4fe"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtMS0xLTEtMTE3MDI5_090f0129-ed83-4a29-bc45-ea050ac8f162"
      unitRef="number">0.286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtMy0xLTEtMTE3MDI5_bbd815e5-b3d1-4550-bee1-dfafa5070ab9"
      unitRef="number">0.286</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzYtNS0xLTEtMTE3MDI5_74775d21-31c4-4642-82da-62259de7329b"
      unitRef="number">0.203</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozZWM2NGZmMmMzZDI0YzExYjAxYTM3ZGEyMjQ5OTcwYS90YWJsZXJhbmdlOjNlYzY0ZmYyYzNkMjRjMTFiMDFhMzdkYTIyNDk5NzBhXzctMS0xLTEtMTE3MDI5_9f7a92a2-9de2-4d86-af87-5378bb668df6"
      unitRef="number">0.0085</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:StockOptionPlanExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MDU_073e169d-eae5-4399-adef-27ac9b32923d"
      unitRef="usd">4300000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MDk_3d28ffb6-2d92-4840-96cd-60388139fc93"
      unitRef="usd">3600000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzI2MTY_3d864e33-1ea1-44a3-9265-1c264461084f"
      unitRef="usd">3400000</us-gaap:StockOptionPlanExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzMwNDA_4a635913-c53b-4d6c-88ee-274523d32557">one-third increments beginning on the first anniversary of the grant</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <lh:ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM1OTA_4b33fe4f-b358-4e55-a05e-4c1d3d4d0610">Performance share awards are subject to certain earnings per share, revenue, and total shareholder return targets</lh:ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions>
    <lh:RestrictedStockPerformanceSharesExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5Nzg_52881d3d-1d73-4eb0-b8f9-48987b0adedb"
      unitRef="usd">125000000.0</lh:RestrictedStockPerformanceSharesExpense>
    <lh:RestrictedStockPerformanceSharesExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5ODI_0188e2e0-eb15-44d1-9840-3e3fb7ebd691"
      unitRef="usd">135400000</lh:RestrictedStockPerformanceSharesExpense>
    <lh:RestrictedStockPerformanceSharesExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzM5ODk_6eb4aa87-1ea7-466c-8ced-9092fe219d7f"
      unitRef="usd">98100000</lh:RestrictedStockPerformanceSharesExpense>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUzNzk_f2f480ce-da46-4e00-b135-a2f884b5af50">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows a summary of non-vested shares for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 19pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9e8b4d8b13a24d3298f7077d489fb327_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzEtMS0xLTEtMTE3MDI5_77a92ff9-5b84-4a76-9729-f3cff315e56c"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9e8b4d8b13a24d3298f7077d489fb327_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzEtMy0xLTEtMTE3MDI5_7e602876-fe64-49ee-8738-d1dbf5699e78"
      unitRef="usdPerShare">212.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzItMS0xLTEtMTE3MDI5_7a1a66a6-3a76-44c9-861e-b347a9a9a369"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzItMy0xLTEtMTE3MDI5_d97f821f-b966-4c44-80f9-9aa11fe3c8fc"
      unitRef="usdPerShare">270.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzMtMS0xLTEtMTE3MDI5_632391b3-8ed6-468b-a6c3-2f4e80e2bcd8"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzMtMy0xLTEtMTE3MDI5_ae074720-5132-4d49-963c-9b66925fde76"
      unitRef="usdPerShare">177.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzQtMS0xLTEtMTE3MDI5_fbb3f5e1-3a52-4a0f-9735-ef2745efd0e5"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id5a5127625a94aa78d093aebbba70e0b_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzQtMy0xLTEtMTE3MDI5_7b754081-634b-4161-bec8-e5f08418f2ac"
      unitRef="usdPerShare">252.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3e10f76783344eadb4cecdca2d63df8b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzUtMS0xLTEtMTE3MDI5_233fc310-cf12-4299-adcf-f37da2784928"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3e10f76783344eadb4cecdca2d63df8b_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTozY2UwNGFmMGUzOGY0OWIzODIwZjE1MWRiNjA1NWE0MC90YWJsZXJhbmdlOjNjZTA0YWYwZTM4ZjQ5YjM4MjBmMTUxZGI2MDU1YTQwXzUtMy0xLTEtMTE3MDI5_55caff86-9beb-411c-ab78-10052ca87846"
      unitRef="usdPerShare">254.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQxNDA_7b51b0d7-9f0f-4c7f-9939-49bc81e7ef44"
      unitRef="usd">155300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ0Mzg_f26599fd-837f-4d6e-9c4f-8647b88a043a">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <lh:EmployeeStockPurchasePlanNumberOfAuthorizedShares
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ2NDc_081935c8-bdf8-434b-b471-5e484165c312"
      unitRef="shares">1800000</lh:EmployeeStockPurchasePlanNumberOfAuthorizedShares>
    <lh:EmployeeStockPurchasePlanPercentOfMarketPrice
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ3ODM_bf82fcfb-7c0d-4387-9802-00d5b7e14915"
      unitRef="number">0.85</lh:EmployeeStockPurchasePlanPercentOfMarketPrice>
    <lh:EmployeeStockPurchasePlanNumberOfSharesPurchased
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5MTg_1b50c39d-70fb-4fa2-a1cf-700031bff964"
      unitRef="shares">200000</lh:EmployeeStockPurchasePlanNumberOfSharesPurchased>
    <lh:EmployeeStockPurchasePlanNumberOfSharesPurchased
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5MjI_07c1387e-1952-4caf-8d73-86098a6c13d8"
      unitRef="shares">200000</lh:EmployeeStockPurchasePlanNumberOfSharesPurchased>
    <lh:EmployeeStockPurchasePlanNumberOfSharesPurchased
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzQ5Mjk_ccd34b7c-967f-42f3-abe3-062665f6f938"
      unitRef="shares">300000</lh:EmployeeStockPurchasePlanNumberOfSharesPurchased>
    <lh:EmployeeStockPurchasePlanExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUwOTM_575f83e9-e62c-4b41-8c30-d64ea11c9b55"
      unitRef="usd">14800000</lh:EmployeeStockPurchasePlanExpense>
    <lh:EmployeeStockPurchasePlanExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUwOTc_aaf20904-768b-4ff7-a4b7-0bdaca5637e0"
      unitRef="usd">14600000</lh:EmployeeStockPurchasePlanExpense>
    <lh:EmployeeStockPurchasePlanExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90ZXh0cmVnaW9uOmU4OWU4M2E5OWRmYjRhZDA4NDQyNmM4Zjg4NDQ5ZjU5XzUxMDQ_88cf4cf7-076b-4c48-b6c1-cf0b649e8f44"
      unitRef="usd">10300000</lh:EmployeeStockPurchasePlanExpense>
    <lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtMS0xLTEtMTE3MDI5_35cff926-db03-4ba9-951d-23a69436b524"
      unitRef="usdPerShare">62.50</lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight>
    <lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtMy0xLTEtMTE3MDI5_931b1cf7-20f9-43cb-b620-e9bff1a92049"
      unitRef="usdPerShare">59.89</lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight>
    <lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzEtNS0xLTEtMTE3MDI5_4dd0b0a1-d0f9-4c59-ad84-5aef27ce4bd7"
      unitRef="usdPerShare">35.49</lh:EmployeeStockPurchasePlanFairValueEmployeePurchaseRight>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtMS0xLTEtMTE3MDI5_874e9f09-3b19-47b8-8c91-07f82894ad8d"
      unitRef="number">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtMy0xLTEtMTE3MDI5_da5b3191-93c0-4d7e-9667-3957f5146453"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzMtNS0xLTEtMTE3MDI5_c11a9f06-255b-43d5-b7d0-6b3c2269f099"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtMS0xLTEtMTE3MDI5_ae5c07a3-212d-4b5e-940e-7d8bb541188a"
      unitRef="number">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtMy0xLTEtMTE3MDI5_6f66ec98-d020-4bee-9428-98437536cd47"
      unitRef="number">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzQtNS0xLTEtMTE3MDI5_3114a5d7-3835-49e5-9c66-d3965d5ec90a"
      unitRef="number">0.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i804964d2063644ac808d8d6365286160_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtMS0xLTEtMTE3MDI5_069b8e7f-01aa-40fd-b8a8-5739f9fe61da"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id42e60a5969942ba84d3e5d5a88c9125_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtMy0xLTEtMTE3MDI5_05012eed-4251-452d-a8b2-772dc4751221"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i390fbbf533d04684b80801b69914f782_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMjYvZnJhZzplODllODNhOTlkZmI0YWQwODQ0MjZjOGY4ODQ0OWY1OS90YWJsZTowMjMxZDQ1OTVjNTI0YzEyOWRiZTE4OWNkNGFjMzY1Ni90YWJsZXJhbmdlOjAyMzFkNDU5NWM1MjRjMTI5ZGJlMTg5Y2Q0YWMzNjU2XzUtNS0xLTEtMTE3MDI5_03e47dcd-9920-46d9-8f1f-ab927bf8146b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzIvZnJhZzo4MGNhZmMyNDVkNGU0MzcyYjQ1NDkyNGVjNDFjZWRlMS90ZXh0cmVnaW9uOjgwY2FmYzI0NWQ0ZTQzNzJiNDU0OTI0ZWM0MWNlZGUxXzMwMzEz_22835765-e6bf-446a-88db-d51ba38aeca7">COMMITMENTS AND CONTINGENCIES &lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is involved from time to time in various claims and legal actions, including arbitrations, class actions, and other litigation (including those described in more detail below), arising in the ordinary course of business. Some of these actions involve claims that are substantial in amount. These matters include, but are not limited to, intellectual property disputes, commercial and contract disputes, professional liability claims, employee-related matters, transaction related disputes, securities and corporate law matters, and inquiries, including subpoenas and other civil investigative demands, from governmental agencies, Medicare or Medicaid payers and MCOs reviewing billing practices or requesting comment on allegations of billing irregularities that are brought to their attention through billing audits or third parties. The Company receives civil investigative demands or other inquiries from various governmental bodies in the ordinary course of its business. Such inquiries can relate to the Company or other parties, including physicians and other health care providers. The Company works cooperatively to respond to appropriate requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also is named from time to time in suits brought under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the False Claims Act and comparable state laws. These suits typically allege that the Company has made false statements and/or certifications in connection with claims for payment from U.S. federal or state healthcare programs. The suits may remain under seal (hence, unknown to the Company) for some time while the government decides whether to intervene on behalf of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiff. Such claims are an inevitable part of doing business in the healthcare field today.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that it is in compliance in all material respects with all statutes, regulations, and other requirements applicable to its commercial laboratory operations and drug development support services. The healthcare diagnostics and drug development industries are, however, subject to extensive regulation, and the courts have not interpreted many of the applicable statutes and regulations. Therefore, the applicable statutes and regulations could be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that would adversely affect the Company. Potential sanctions for violation of these &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;statutes and regulations include significant civil and criminal penalties, fines, the loss of various licenses, certificates and authorizations, additional liabilities from third-party claims, and/or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of the current claims and legal actions against the Company are in preliminary stages, and many of these cases seek an indeterminate amount of damages. The Company records an aggregate legal reserve, which is determined using calculations based on historical loss rates and assessment of trends experienced in settlements and defense costs. In accordance with FASB Accounting Standards Codification Topic 450 &#x201c;Contingencies,&#x201d; the Company establishes reserves for judicial, regulatory, and arbitration matters outside the aggregate legal reserve if and when those matters present loss contingencies that are both probable and estimable and would exceed the aggregate legal reserve. When loss contingencies are not both probable and estimable, the Company does not establish separate reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is unable to estimate a range of reasonably probable loss for the proceedings described in more detail below in which damages either have not been specified or, in the Company's judgment, are unsupported and/or exaggerated and (i) the proceedings are in early stages, (ii) there is uncertainty as to the outcome of pending appeals or motions, (iii) there are significant factual issues to be resolved, and/or (iv) there are novel legal issues to be presented. For these proceedings, however, the Company does not believe, based on currently available information, that the adverse outcomes are probable and estimable, and it does not believe they will have a material adverse effect on the Company's financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, the Company responded to an October 2007 subpoena from the U.S. Department of Health &amp;amp; Human Services Office of Inspector General's regional office in New York. On August 17, 2011, the U.S. District Court for the Southern District of New York unsealed a False Claims Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America ex rel. NPT Associates v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare business. The Plaintiff's Third Amended Complaint further alleges that the Company's billing practices violated the False Claims Acts of 14 states and the District of Columbia. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. The Company's Motion to Dismiss was granted in October 2014 and Plaintiff was granted the right to replead. On January 11, 2016, Plaintiff filed a motion requesting leave to file an amended complaint under seal and to vacate the briefing schedule for the Company's Motion to Dismiss, while the government reviewed the amended complaint. The Court granted the motion and vacated the briefing dates. Plaintiff then filed the Amended Complaint under seal. On August 24, 2021, the U.S. government filed a notice indicating that it did not intend to intervene in the matter. On October 27, 2021, the Fourth Amended Complaint was unsealed. The Fourth Amended Complaint is similar to the Third Amended Complaint in that it alleges that the Company offered UnitedHealthcare kickbacks in the form of discounts in return for Medicare and Medicaid business, and it further alleges that the Company unlawfully charged Medicare amounts substantially in excess of its alleged usual charges. Similar to the Third Amended Complaint, the Fourth Amended Complaint alleges violations of the federal False Claims Act and the False Claims Act of 14 states and the District of Columbia. On February 3, 2022, the Company filed a Motion to Dismiss all claims. On August 29, 2022, the Court entered an order granting the Motion to Dismiss and declining to exercise supplemental jurisdiction over the state law claims. Plaintiff did not appeal the Court's order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has received various other subpoenas since 2007 related to Medicaid billing. In October 2009, the Company received a subpoena from the State of Michigan Department of Attorney General seeking documents related to its billing to Michigan Medicaid. The Company cooperated with this request. In October 2013, the Company received a Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On October 5, 2018, the Company received a second Civil Investigative Demand from the State of Texas Office of the Attorney General requesting documents related to its billing to Texas Medicaid. The Company cooperated with this request. On January 26, 2021, the Company was notified that a qui tam Petition was pending under seal in the District Court, 250th Judicial District, Travis County, Texas, and that the State of Texas has intervened. On April 14, 2021, the Petition was unsealed. The Petition alleges that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid&#x2019;s alleged &#x201c;best price&#x201d; regulations, and that the Company offered remuneration to Texas health care providers in the form of discounted pricing for certain laboratory testing services in exchange for the providers&#x2019; referral of Texas Medicaid business to the Company. The Petition seeks actual and double damages and civil penalties, as well as recovery of costs, attorney's fees, and legal expenses. On August 1, 2022, the District Court entered an order granting the Company's Motion for Partial Summary Judgment with respect to the claim that the Company submitted claims for reimbursement to Texas Medicaid that were higher than permitted under Texas Medicaid's alleged &#x201c;best price&#x201d; regulations. Plaintiffs filed a Notice of Non-Suit and Motion for Entry of Final Judgment and, on November 11, 2022, the Court entered a Judgment. Plaintiffs filed a Notice of Appeal with respect to the Court's order granting the Company's Motion for Partial Summary Judgment, referenced above. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2015, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patty Davis v. Laboratory Corporation of America, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Circuit Court of the Thirteenth Judicial Circuit for Hillsborough County, Florida. The complaint alleges that the Company violated the Florida Consumer Collection Practices Act by billing patients who were collecting benefits under the Workers' Compensation Statutes. The lawsuit seeks injunctive relief and actual and statutory damages, as well as recovery of attorney's fees and legal expenses. In April 2017, the Circuit Court granted the Company&#x2019;s Motion for Judgment on the Pleadings. The Plaintiff appealed the Circuit Court&#x2019;s ruling to the Florida Second District Court of Appeal. On October 16, 2019, the Florida Second District Court of Appeal reversed the Circuit Court&#x2019;s dismissal, but certified a controlling issue of Florida law to the Florida Supreme Court. On February 17, 2020, the Florida Supreme Court accepted jurisdiction of the lawsuit. The Court held oral arguments on December 9, 2020. On May 26, 2022, the Florida Supreme Court issued an opinion approving the result of the Florida Second District Court of Appeal in favor of the Plaintiff. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2014, the Company received a Civil Investigative Demand issued pursuant to the U.S. False Claims Act from the U.S. Attorney's Office for South Carolina, which requested information regarding alleged remuneration and services provided by the Company to physicians who also received draw and processing/handling fees from competitor laboratories Health Diagnostic Laboratory, Inc. (HDL) and Singulex, Inc. (Singulex). The Company cooperated with the request. On April 4, 2018, the U.S. District Court for the District of South Carolina, Beaufort Division, unsealed a False Claims Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States of America ex rel. Scarlett Lutz, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which alleges that the Company's financial relationships with referring physicians violate federal and state anti-kickback statutes. The Plaintiffs' Fourth Amended Complaint further alleges that the Company conspired with HDL and Singulex in violation of the Federal False Claims Act and the California and Illinois insurance fraud prevention acts by facilitating HDL's and Singulex's offers of illegal inducements to physicians and the referral of patients to HDL and Singulex for laboratory testing. The lawsuit seeks actual and treble damages and civil penalties for each alleged false claim, as well as recovery of costs, attorney's fees, and legal expenses. Neither the U.S. government nor any state government has intervened in the lawsuit. The Company filed a Motion to Dismiss seeking the dismissal of the claims asserted under the California and Illinois insurance fraud prevention statutes, the conspiracy claim, the reverse False Claims Act claim, and all claims based on the theory that the Company performed medically unnecessary testing. On January 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss. The Court dismissed the Plaintiffs' claims based on the theory that the Company performed medically unnecessary testing, the claims asserted under the California and Illinois insurance fraud prevention statutes, and the reverse False Claims Act claim. The Court denied the Motion to Dismiss as to the conspiracy claim. On March 12, 2021, the Company filed a Motion for Summary Judgment related to all remaining claims. On June 16, 2021, the Court denied the Company&#x2019;s Motion for Summary Judgment. In December 2022, the parties reached a settlement to resolve the lawsuit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2017, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Victoria Bouffard, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient list prices unlawfully exceed the rates negotiated for the same services with private and public health insurers in violation of various state consumer protection laws. The lawsuit also alleges breach of implied contract or quasi-contract, unjust enrichment, and fraud. The lawsuit seeks statutory, exemplary, and punitive damages, injunctive relief, and recovery of attorney's fees and costs. In May 2017, the Company filed a Motion to Dismiss Plaintiffs' Complaint and Strike Class Allegations; the Motion to Dismiss was granted in March 2018 without prejudice. On October 10, 2017, a second putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheryl Anderson, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint contained similar allegations and sought similar relief to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bouffard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint, and added additional counts regarding state consumer protection laws. On August 10, 2018, the Plaintiffs filed an Amended Complaint, which consolidated the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bouffard&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anderson&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions. On September 10, 2018, the Company filed a Motion to Dismiss Plaintiffs' Amended Complaint and Strike Class Allegations. On August 16, 2019, the Court entered an order granting in part and denying in part the Motion to Dismiss the Amended Complaint, and denying the Motion to Strike the Class Allegations. On August 26, 2021, Plaintiffs filed a Motion for Class Certification. On February 13, 2023, the Court entered an order denying Plaintiffs' Motion for Class Certification. On December 29, 2021, a related lawsuit,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Nathaniel J. Nolan, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was filed in the U.S. District Court for the Middle District of North Carolina. The complaint alleges that the Company's patient acknowledgement of estimated financial responsibility form is misleading. The lawsuit seeks a declaratory judgment under the consumer protection laws of Nevada and Florida that the form is materially misleading and deceptive, an injunction barring the use of the form, damages on behalf of an alleged class, and attorney's fees and expenses. On February 28, 2022, the Company filed a Motion to Dismiss all claims. On February 13, 2023, the Court entered an order granting the Company's Motion to Dismiss. The Company will vigorously defend the lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2019, Covance Research Products was served with a Grand Jury Subpoena issued by the Department of Justice (DOJ) in Miami, Florida requiring the production of documents related to the importation into the United States of live non-&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;human primate shipments originating from or transiting through China, Cambodia, and/or Vietnam from April 1, 2014 through March 28, 2019. The Company is cooperating with the DOJ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2019, Retrieval-Masters Creditors Bureau, Inc. d/b/a American Medical Collection Agency (AMCA), an external collection agency, notified the Company about a security incident AMCA experienced that may have involved certain personal information about some of the Company&#x2019;s patients (the AMCA Incident). The Company referred patient balances to AMCA only when direct collection efforts were unsuccessful. The Company&#x2019;s systems were not impacted by the AMCA Incident. Upon learning of the AMCA Incident, the Company promptly stopped sending new collection requests to AMCA and stopped AMCA from continuing to work on any pending collection requests from the Company. AMCA informed the Company that it appeared that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018, and March 30, 2019, and that AMCA could not rule out the possibility that personal information on AMCA&#x2019;s system was at risk during that time period. Information on AMCA&#x2019;s affected system from the Company may have included name, address, and balance information for the patient and person responsible for payment, along with the patient&#x2019;s phone number, date of birth, referring physician, and date of service. The Company was later informed by AMCA that health insurance information may have been included for some individuals, and because some insurance carriers utilize the Social Security Number as a subscriber identification number, the Social Security Number for some individuals may also have been affected. No ordered tests, laboratory test results, or diagnostic information from the Company were in the AMCA affected system. The Company notified individuals for whom it had a valid mailing address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge for 24 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Twenty-three putative class action lawsuits were filed against the Company related to the AMCA Incident in various U.S. District Courts. Numerous similar lawsuits have been filed against other health care providers who used AMCA. These lawsuits were consolidated into a multidistrict litigation in the District of New Jersey. On November 15, 2019, the Plaintiffs filed a Consolidated Class Action Complaint in the U.S. District Court of New Jersey. On January 22, 2020, the Company filed Motions to Dismiss all claims. The consolidated Complaint generally alleged that the Company did not adequately protect its patients&#x2019; data and failed to timely notify those patients of the AMCA Incident. The Complaint asserted various causes of action, including but not limited to negligence, breach of implied contract, unjust enrichment, and the violation of state data protection statutes. The Complaint sought damages on behalf of a class of all affected Company customers. On December 16, 2021, the Court granted in part and denied in part the Company's Motion to Dismiss. On March 31, 2022, the Plaintiffs filed an Amended Complaint alleging claims for negligence, negligence &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;per se&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, breach of confidence, invasion of privacy, and various state statutory claims, including a claim under the California Confidentiality of Medical Information Act. The Company filed a Motion to Dismiss certain claims of the Amended Complaint. The Company will vigorously defend the remaining claims in the multi-district litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company was served with a shareholder derivative lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Raymond Eugenio, Derivatively on Behalf of Nominal Defendant, Laboratory Corporation of America Holdings v. Lance Berberian, et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Court of Chancery of the State of Delaware on April 23, 2020.&#160;The complaint asserts derivative claims on the Company&#x2019;s behalf against the Company&#x2019;s board of directors and certain executive officers.&#160;The complaint generally alleges that the defendants failed to ensure that the Company utilized proper cybersecurity safeguards and failed to implement a sufficient response to data security incidents, including the AMCA Incident.&#160;The complaint asserts derivative claims for breach of fiduciary duty and seeks relief including damages, certain disclosures, and certain changes to the Company&#x2019;s internal governance practices. On June 2, 2020, the Company filed a Motion to Stay the lawsuit due to its overlap with the multi-district litigation referenced above. On July 2, 2020, the Company filed a Motion to Dismiss. On July 14, 2020, the Court entered an order staying the lawsuit pending the resolution of the multi-district litigation. The lawsuit will be vigorously defended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain governmental entities have requested information from the Company related to the AMCA Incident. The Company received a request for information from the Office for Civil Rights (OCR) of the Department of Health and Human Services.&#160;On April 28, 2020, OCR notified the Company of the closure of its inquiry. The Company has also received requests from a multi-state group of state Attorneys General and is cooperating with these requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 31, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Luke Davis and Julian Vargas, et al. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the U.S. District Court for the Central District of California. The lawsuit alleges that visually impaired patients are unable to use the Company's touchscreen kiosks at Company patient service centers in violation of the Americans with Disabilities Act and similar California statutes. The lawsuit seeks statutory damages, injunctive relief, and attorney's fees and costs. On March 20, 2020, the Company filed a Motion to Dismiss Plaintiffs' Complaint and to Strike Class Allegations. In August 2020, the Plaintiffs filed an Amended Complaint. On April 26, 2021, the Plaintiffs and the Company each filed Motions for Summary Judgment and the Plaintiffs filed a Motion for Class Certification. On May 23, 2022, the Court entered an order granting Plaintiffs&#x2019; Motion for Class Certification. On June 6, 2022, the Company &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;filed a Petition for Permission to Appeal the Order Granting Class Certification with the Ninth Circuit Court of Appeals. On September 22, 2022, the Ninth Circuit Court of Appeals granted the Company's Petition for Permission to Appeal the Order Granting Class Certification. The Company will vigorously defend the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 16, 2020, Ravgen Inc. filed a patent infringement lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ravgen Inc. v. Laboratory Corporation of America Holdings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in the U.S. District Court&#x202f;for the Western District of&#x202f;Texas, alleging infringement of two Ravgen-owned U.S. patents.  The lawsuit seeks monetary damages, enhancement of those damages for willfulness, and recovery of attorney&#x2019;s fees and costs. On September 28, 2022, a jury rendered a verdict in favor of the Plaintiff on the remaining patent at issue, finding that the Company willfully infringed Ravgen's patent, and awarded damages of $272 million. Plaintiff has filed post-trial motions seeking enhanced damages of up to $817 million based on the finding of willfulness, as well as attorney's fees and costs. The Company strongly disagrees with the verdict, based on a number of legal factors, and will vigorously defend the lawsuit through the appeal process. On June 4, 2021, the Company also instituted proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office challenging the validity of the Ravgen patent at issue in the trial. In November 2022, the Patent Trial and Appeal Board issued a decision upholding the validity of the Ravgen patent, and the Company has filed an appeal of this decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 14, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jose Bermejo v. Laboratory Corporation of America (Bermejo I)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain non-exempt California-based employees were not properly compensated for driving time or properly paid wages upon termination of employment. The Plaintiff asserts these actions violate various California Labor Code provisions and Section 17200 of the Business and Professional Code. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#x2019;s fees and costs. On June 15, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. On June 16, 2020, the Company was served with a Private Attorney General Act lawsuit by the same plaintiff in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Jose Bermejo v. Laboratory Corporation of America (Bermejo II), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;filed in the Superior Court of California, County of Los Angeles Central District, alleging that certain Company practices violated California Labor Code penalty provisions related to unpaid and minimum wages, unpaid overtime, unpaid mean and rest break premiums, untimely payment of wages following separation of employment, failure to maintain accurate pay records, and non-reimbursement of business expenses. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On October 28, 2020, the court issued an order staying proceedings in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo II &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;pending resolution of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The second lawsuit seeks to recover civil penalties and recovery of attorney's fees and costs. On February 24, 2022, the parties entered into a Memorandum of Understanding of the terms of a settlement of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo II&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuits, subject to court approval. If approved, the settlement will also resolve the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Becker&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poole&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuits discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 14, 2021, a single plaintiff filed a Private Attorney General Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Becker v. Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, in the Superior Court of California, County of Orange, alleging various violations of the California Labor Code, including that the Plaintiff was not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, and received inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney&#x2019;s fees and costs. A settlement of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo II&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuits, if approved by the court, will resolve the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Becker&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 23, 2021, the Company was served with a single plaintiff Private Attorney General Act lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poole v. Laboratory Corporation of America&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Superior Court of California, County of Kern, alleging various violations of the California Labor Code, including that Plaintiff was not properly paid wages owed, not properly paid meal and rest break premiums, not reimbursed for certain business related expenses, and other allegations including the untimely payment of wages and receipt of inaccurate wage statements. The lawsuit seeks monetary damages, civil penalties, and recovery of attorney's fees and costs. The case was removed to the U.S. District Court for the Eastern District of California. A settlement of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Bermejo II&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuits, if approved by the court, will resolve the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poole&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 5, 2020, the Company was served with a putative class action lawsuit, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Williams v. LabCorp Employer Services, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, filed in the Superior Court of California, County of Los Angeles, alleging that certain non-exempt California-based employees were not properly compensated for work and overtime hours, not properly paid meal and rest break premiums, not reimbursed for certain business-related expenses, not properly paid for driving or wait times, and received inaccurate wage statements. The Plaintiff also asserts claims for unfair competition under Section 17200 of the Business and Professional Code. On November 4, 2020, the lawsuit was removed to the U.S. District Court for the Central District of California. The lawsuit seeks monetary damages, liquidated damages, civil penalties, and recovery of attorney's fees and costs. On June 24, 2021, the District Court remanded the case to the Superior Court of California, County of Los Angeles on the grounds that potential damages did not meet the Class Action Fairness Act (CAFA), 28 U.S.C. &#xa7; 1332(d), jurisdictional threshold. The parties entered into a settlement agreement dated September 9, 2022, which is pending court approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 14, 2020, the Company was served with a Subpoena Duces Tecum issued by the State of Colorado Office of the Attorney General requiring the production of documents related to urine drug testing in all states. The Company is cooperating with this request.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 7, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Camden, New Jersey requiring the production of documents related to non-invasive prenatal screening tests. The Company is cooperating with the DOJ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2022, the Company was served with a Subpoena Duces Tecum issued by the DOJ in Boston, Massachusetts requiring the production of documents related to urine drug testing. The Company is cooperating with the DOJ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are various other pending legal proceedings involving the Company including, but not limited to, additional employment-related lawsuits, professional liability lawsuits, and commercial lawsuits. While it is not feasible to predict the outcome of such proceedings, in the opinion of the Company, the likelihood of loss is remote and any reasonably possible loss associated with the resolution of such proceedings is not expected to be material to the Company&#x2019;s financial condition, results of operations, or cash flows, either individually or in the aggregate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Company's present insurance programs, coverage is obtained for catastrophic exposure as well as those risks required to be insured by law or contract. The Company is responsible for the uninsured portion of losses related primarily to general, professional and vehicle liability, certain medical costs and workers' compensation. The self-insured retentions are on a per-occurrence basis without any aggregate annual limit. Provisions for losses expected under these programs are recorded based upon the Company's estimates of the aggregated liability of claims incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4ODQ_129b3599-e935-4f90-9367-6359e25b2027">PENSION AND POSTRETIREMENT PLANS&lt;div style="margin-bottom:7pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Contribution Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has various U.S. defined contribution retirement plans (401K Plans). Under these 401K Plans, employees can contribute a portion of their salary to the plan and the Company makes minimum non-elective contributions, discretionary contributions, and matching contributions, depending on the terms of the specific plan. On January 1, 2021, all of the 401K Plans were modified to provide for 100% match of employee contributions up to 5% of their salary. Total expense, for the years ended December 31, 2022, 2021, and 2020, was $183.1, $168.9 and $141.8, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors both funded and unfunded defined benefit pension plans which provide benefits based on various criteria such as years of service and salary. The Company maintained two plans in the United States, three plans in the United Kingdom and one in Germany.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The two plans in the United States (U.S. Plans) were closed to new entrants and the accrual of service credits at the end of 2009. The U.K. pension plans were closed to new entrants and the accrual of service credits for one plan as of December 31, 2002, and the accrual of service credits for the other two plans as of December 31, 2019. The German plan was closed to new entrants on December 31, 2009 but participants continue to accrue service credits. The U.K. and German plans are aggregated for disclosure as the Non-U.S. Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the net periodic benefit costs for the defined benefit pension plans are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined-benefit plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service costs are the only component of net periodic benefit costs recorded within Operating income. For the year ended December&#160;31, 2022, the Company recognized a partial plan settlement charge of $3.0 as a component of Other, net.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in accumulated other comprehensive earnings are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss in accumulated other comprehensive earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Projected Benefit Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the projected benefit obligation as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits and administrative expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated benefit obligation as of December&#160;31, 2022 and 2021 was $259.5 and $333.3, respectively for the U.S. Plans and $352.6 and $633.8, respectively for the Non-U.S. Plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Fair Value of Plan Assets&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in plan assets as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits and administrative expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change in Funded Status and Reconciliation of Amounts Recorded in the Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the funded status of the plan and a reconciliation of such funded status to the amounts reported in the consolidated balance sheet as of December&#160;31, 2022, and December&#160;31, 2021, is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:282.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recorded as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit costs are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long term rate of return &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance interest credit rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $0.8 for the U.S. Plans. A one percentage point decrease or increase in the discount rate would have resulted in a respective increase or decrease in 2022 retirement plan expense of $2.8 for the Non-U.S. Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit obligations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate is determined using the weighted-average yields on high-quality fixed income securities that have maturities consistent with the timing of benefit payments. Lower discount rates increase the size of the benefit obligation and generally increase pension expense in the following year; higher discount rates reduce the size of the benefit obligation and generally reduce subsequent-year pension expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected return on plan assets is the estimated long-term rate of return that will be earned on the investments used to fund the pension obligations. To determine this rate, the Company considers the composition of plan investments, historical returns earned, and expectations about the future. Actual asset over/under performance compared to expected returns will respectively decrease/increase unrecognized loss. The change in the unrecognized loss will change amortization cost in upcoming periods. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $3.0 for the U.S. Plans. A one percentage point increase or decrease in the expected return on plan assets would have resulted in a corresponding change in 2022 pension expense of $5.0 for the Non-U.S. Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The salary increase assumptions are used to estimate the annual rate at which pay of plan participants will grow. If the rate of growth assumed increases, the size of the pension obligations will increase, as will the amount recorded in Accumulated other comprehensive income (loss) in the Company's Consolidated Statement of Financial Position and amortized into earnings in subsequent periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates other assumptions periodically, such as retirement age, mortality and turnover, and updates them as necessary to reflect the Company's actual experience and expectations for the future. Differences between actual results and assumptions utilized are recorded in Accumulated other comprehensive income each period. These differences are amortized into earnings over the remaining average future service of active participating employees or the expected life of inactive participants, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the assets at December&#160;31, 2022, and 2021, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level of Valuation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments valued using NAV per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;U.S Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General bond index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pooled investment funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level of Valuation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments valued using NAV per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;U.S Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equity index funds &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate index fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General bond index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pooled investment funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair market value of index funds and pooled investment funds are valued using the net asset value (NAV) unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund. The fair value of annuity investments are based on discounted cash flow techniques using unobservable valuation inputs such as discount rates and actuarial mortality tables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt;text-align:center;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement of Level 3 Pension Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt; Investment Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan fiduciaries of various plans set investment policies and strategies, based on consultation with professional advisors, and oversee investment allocation, which includes selecting investment managers and setting long-term strategic targets. The primary strategic investment objectives are balancing investment risk and return and monitoring the plan&#x2019;s liquidity position in order to meet the near-term benefit payment and other cash needs. Target allocation percentages are established at an asset class level by plan fiduciaries. Target allocation ranges are guidelines, not limitations, and occasionally plan fiduciaries will approve allocations above or below a target range.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocation of the plan assets as of December&#160;31, 2022, by asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average target asset allocation of the plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Funding and Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to make approximately $18.2 in required contributions to its defined benefit pension plans during 2023. The Company targets funding the minimum required contributions but may make additional contributions into the pension plans in 2023, depending upon factors such as how the funded status of those plans change or to reduce the administrative costs of the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated benefit payments, which were used in the calculation of projected benefit obligations, are expected to be paid as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years 2028 to 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Post-employment Retiree Health and Welfare Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors a post-employment retiree health and welfare plan for the benefit of eligible employees at certain U.S. subsidiaries who retire after satisfying service and age requirements. This plan is funded on a pay-as-you-go basis and the cost of providing these benefits is shared with the retirees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Post-retirement Medical Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assumed obligations under a subsidiary's post-retirement medical plan. Coverage under this plan is restricted to a limited number of existing employees of the subsidiary. This plan is unfunded and the Company&#x2019;s policy is to fund benefits as claims are incurred. The effect on operations of the post-retirement medical plan is shown in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-retirement medical plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts included in accumulated other comprehensive earnings consist of unamortized net (income) loss of $(0.2) and $0.8. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the changes in the accumulated post-retirement benefit obligation follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recorded as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average discount rates used in the calculation of the accumulated post-retirement benefit obligation were 5.5% and 2.7% as of December&#160;31, 2022, and 2021, respectively. The healthcare cost trend rate was removed due to the expectation of future funding to be at the same level as the previous year's funding. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumed benefit payments under the Company's post-retirement benefit plan, which reflect expected future service, as appropriate, and which were used in the calculation of projected benefit obligations, are expected to be paid as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years 2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Deferred Compensation Plan&lt;/span&gt;&lt;/div&gt;The Company has Deferred Compensation Plans (DCP) under which certain of its executives may elect to defer up to 100.0% of their annual cash incentive pay and/or up to 50.0% of their annual base salary and/or eligible commissions subject to annual limits established by the U.S. government. The DCP provides executives a tax efficient strategy for retirement savings and capital accumulation without significant cost to the Company. The Company makes no contributions to the DCP. Amounts deferred by a participant are credited to a bookkeeping account maintained on behalf of each participant, which is used for measurement and determination of amounts to be paid to a participant, or his or her designated beneficiary, pursuant to the terms of the DCP. The amounts accrued under these plans were $96.9 and $104.4 at December&#160;31, 2022, and 2021, respectively. Deferred amounts are the Company's general unsecured obligations and are subject to claims by the Company's creditors. The Company's general assets may be used to fund obligations and pay DCP benefits.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYxMQ_8eaeb287-31c5-432c-abc4-11bafd88acde"
      unitRef="usd">183100000</lh:DefinedContributionPlanTotalExpense>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYxNQ_e33f2da5-65bc-41da-8b14-e06871139732"
      unitRef="usd">168900000</lh:DefinedContributionPlanTotalExpense>
    <lh:DefinedContributionPlanTotalExpense
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzYyMg_87bd2d7e-af64-4810-8c75-9dfbca3f4cf1"
      unitRef="usd">141800000</lh:DefinedContributionPlanTotalExpense>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NjM_2f7dcfe0-7dc1-4597-b4f5-caac3e9ddbc5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost for benefits earned&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected participant contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined-benefit plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service costs are the only component of net periodic benefit costs recorded within Operating income. For the year ended December&#160;31, 2022, the Company recognized a partial plan settlement charge of $3.0 as a component of Other, net.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in accumulated other comprehensive earnings are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial loss in accumulated other comprehensive earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;690.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits and administrative expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated benefit payments, which were used in the calculation of projected benefit obligations, are expected to be paid as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years 2028 to 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The effect on operations of the post-retirement medical plan is shown in the following table:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.272%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net amortization and deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Post-retirement medical plan costs&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the changes in the accumulated post-retirement benefit obligation follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost on benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recorded as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMS0xLTEtMTE3MDI5_935924cf-7fb5-4667-b23f-d0e146e5afe7"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMy0xLTEtMTE3MDI5_2f4cdb1d-9d8e-43ba-b47d-2e987a574273"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtNS0xLTEtMTE3MDI5_34d6c047-7e96-444c-9b23-77938943a438"
      unitRef="usd">5100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtNy0xLTEtMTE3MDI5_2488ca20-b796-4528-91ac-d46c22af5ccf"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtOS0xLTEtMTE3MDI5_9eae99c2-5980-42f5-9416-23ea9c8e7cb7"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzMtMTEtMS0xLTExNzAyOQ_3a208e3a-7876-4e80-85d6-a7c2d078da95"
      unitRef="usd">2100000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMS0xLTEtMTE3MDI5_f1aaa62e-61b4-46e2-aa22-73b06bb07901"
      unitRef="usd">9100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMy0xLTEtMTE3MDI5_ed419c03-1581-4cfc-8572-669ca89f949a"
      unitRef="usd">8300000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtNS0xLTEtMTE3MDI5_afb9f740-63dc-4c4b-a568-f51ae4fce3e5"
      unitRef="usd">11100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtNy0xLTEtMTE3MDI5_57525871-3693-443d-90cc-b8332d2989bf"
      unitRef="usd">10100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtOS0xLTEtMTE3MDI5_df342609-91a7-4a62-b9ac-4cf8c7101478"
      unitRef="usd">8100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzQtMTEtMS0xLTExNzAyOQ_ecb086cb-a900-4508-a9ed-1bc381344ae7"
      unitRef="usd">10900000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMS0xLTEtMTE3MDI5_b86ea03c-7d6f-485d-bd19-e7e340df0e1d"
      unitRef="usd">12900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMy0xLTEtMTE3MDI5_d83dae6b-3fba-45a1-8d3d-b07e85b30d8c"
      unitRef="usd">17300000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtNS0xLTEtMTE3MDI5_f8bb37bc-df0e-44ce-b409-45735fde9568"
      unitRef="usd">14900000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtNy0xLTEtMTE3MDI5_03198ddb-cf1c-4cdc-9b60-07d20968f638"
      unitRef="usd">18000000.0</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtOS0xLTEtMTE3MDI5_35be9ee2-5347-4c78-9046-56581492b496"
      unitRef="usd">16300000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzUtMTEtMS0xLTExNzAyOQ_e15af7d0-f120-4354-bce5-8ef9f2ec3a8b"
      unitRef="usd">16600000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMS0xLTEtMTE3MDI5_16ed00cc-2643-4459-916f-76a38d705ea3"
      unitRef="usd">4600000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMy0xLTEtMTE3MDI5_3ead24b2-0a2e-4d3d-82dd-5c7bbaa84e74"
      unitRef="usd">10000000.0</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtNS0xLTEtMTE3MDI5_302ffdd3-f24f-49ee-bf54-bb8281a14da0"
      unitRef="usd">9700000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtNy0xLTEtMTE3MDI5_91164a5f-4f71-49c1-9398-351419307b2f"
      unitRef="usd">900000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtOS0xLTEtMTE3MDI5_6fb6d5f7-fc46-472c-bf9a-2c49c6f8e692"
      unitRef="usd">2100000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzYtMTEtMS0xLTExNzAyOQ_df719fb0-7cf4-41a4-aaab-564fa4186e54"
      unitRef="usd">400000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMS0xLTEtMTE3MDI5_103ba158-1707-493a-9bc1-119e5002eb23"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMy0xLTEtMTE3MDI5_20578442-6502-42b0-b1c9-f6fd26f8ca92"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctNS0xLTEtMTE3MDI5_b3eed85f-ee41-4a48-97c2-a4d025a742a2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctNy0xLTEtMTE3MDI5_1d6fca94-1a4c-427b-ba58-9379585b6d53"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctOS0xLTEtMTE3MDI5_2f0f38ce-a021-4ad2-baaf-28496adc9f84"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzctMTEtMS0xLTExNzAyOQ_3adbf8d6-5b89-478a-b297-9ec3420af612"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMS0xLTEtMTE3MDI5_da0a25d0-a67f-458b-90c0-735d8976f4de"
      unitRef="usd">-4100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMy0xLTEtMTE3MDI5_2675a2e3-215c-4d71-9869-87d3ccfeec79"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtNS0xLTEtMTE3MDI5_e8254cbd-dfd6-4b93-bc65-020b0d3b2c06"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtNy0xLTEtMTE3MDI5_d44c535e-a437-4162-b99f-14e19937ea2e"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtOS0xLTEtMTE3MDI5_2a40f883-99dd-4661-bfc6-cd6ec2afc198"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzgtMTEtMS0xLTExNzAyOQ_55bc84d6-5701-4809-be53-a3ae8c93d276"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMS0xLTEtMTE3MDI5_c451b447-ffa6-48ed-b9b1-e01e1683ed74"
      unitRef="usd">7700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMy0xLTEtMTE3MDI5_bc88f7c1-7cf2-4c5c-8bda-d846db9033ad"
      unitRef="usd">8600000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktNS0xLTEtMTE3MDI5_6bdffdf6-a6b3-42f7-8b6a-b901d15f4cb0"
      unitRef="usd">11000000.0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktNy0xLTEtMTE3MDI5_ea5fd70d-1de0-4b4c-ad97-1628a161ba79"
      unitRef="usd">-5500000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktOS0xLTEtMTE3MDI5_ba331b3d-b14a-4b18-8507-f7367f678678"
      unitRef="usd">-3700000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphODUxOWY2MGVlZTc0MmNiYmFiNjNjNzQ4Y2YxZDdlYy90YWJsZXJhbmdlOmE4NTE5ZjYwZWVlNzQyY2JiYWI2M2M3NDhjZjFkN2VjXzktMTEtMS0xLTExNzAyOQ_e5a78353-cb99-40d9-9439-f2a1ad1cfa75"
      unitRef="usd">-3300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtMS0xLTEtMTE3MDI5_b38fb298-1008-4b48-9cd2-f48e62fb7101"
      unitRef="usd">60900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtMy0xLTEtMTE3MDI5_1e2af235-b1d2-4557-95b5-2d5393d1a403"
      unitRef="usd">66900000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtNy0xLTEtMTE3MDI5_75d2ed3e-084c-4bf9-b5d9-d6f4fc294d6a"
      unitRef="usd">22000000.0</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo3MmEzOTI3MTg4NzY0YTc2OTY4NDY2ZjY3YWYwZWM1MS90YWJsZXJhbmdlOjcyYTM5MjcxODg3NjRhNzY5Njg0NjZmNjdhZjBlYzUxXzMtOS0xLTEtMTE3MDI5_e989040e-be30-4844-9d56-beb2c134b629"
      unitRef="usd">58800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtMS0xLTEtMTE3MDI5_2672a584-7354-401e-ba94-4177e8ff7f3c"
      unitRef="usd">333300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtMy0xLTEtMTE3MDI5_c8b3bd02-9eec-4f7f-9d4f-ea4c5f44f09a"
      unitRef="usd">369800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtNS0xLTEtMTE3MDI5_11172516-043b-4308-b0f2-6b272d961c6d"
      unitRef="usd">633800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i60896f9da0414bb28b3e4a6cb0503006_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzMtNy0xLTEtMTE3MDI5_dc92a096-1b39-46cd-add3-eb1863a6007a"
      unitRef="usd">690100000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtMS0xLTEtMTE3MDI5_366343f1-f241-4428-829b-e3453094550d"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtMy0xLTEtMTE3MDI5_59718674-7a8c-49a5-8457-5a4a8ba5e713"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtNS0xLTEtMTE3MDI5_3a41e546-eb09-41b4-b7f0-b6f5481945f7"
      unitRef="usd">2600000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzUtNy0xLTEtMTE3MDI5_a3c18393-5ef5-4c4d-8527-011bdd932ceb"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtMS0xLTEtMTE3MDI5_03cc05b3-656d-43f7-a83d-f5ffbf0621ba"
      unitRef="usd">9100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtMy0xLTEtMTE3MDI5_e27a15c5-36ac-40dd-8c4a-3d14269f8bcd"
      unitRef="usd">8300000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtNS0xLTEtMTE3MDI5_687b5ee8-afe7-4c88-bd9d-9be1483e5096"
      unitRef="usd">10100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzYtNy0xLTEtMTE3MDI5_5711bd82-67f3-4ed0-9e86-3ecec55905dd"
      unitRef="usd">8100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctMS0xLTEtMTE3MDI5_452af2ef-5908-484b-ba23-107771d9433d"
      unitRef="usd">-58400000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctMy0xLTEtMTE3MDI5_a9cc0f9b-3e32-4375-8f6b-caf19d08577d"
      unitRef="usd">-18000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctNS0xLTEtMTE3MDI5_a8abbb15-d7b7-475d-b935-05b264853ad8"
      unitRef="usd">-212000000.0</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzctNy0xLTEtMTE3MDI5_6695123b-7434-4867-abb5-0b47476dc367"
      unitRef="usd">-34700000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtMS0xLTEtMTE3MDI5_5f899740-3a58-477f-ab20-380056a92205"
      unitRef="usd">27300000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtMy0xLTEtMTE3MDI5_d8e99449-6ffe-4800-8a50-29948fcd7f34"
      unitRef="usd">30700000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtNS0xLTEtMTE3MDI5_26508fae-e9f2-4553-966a-135afc274778"
      unitRef="usd">21500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzgtNy0xLTEtMTE3MDI5_81cae30c-9358-4f4c-99bc-b32045e6136d"
      unitRef="usd">22200000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTEtMS0xLTExNzAyOQ_a282ed67-0ee7-4d5e-a6af-203df5ceb847"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTMtMS0xLTExNzAyOQ_10aee40e-48d7-4499-8628-bde991b53468"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTUtMS0xLTExNzAyOQ_bd89ecaa-d33c-4bfb-8759-de070315252f"
      unitRef="usd">-60400000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzEwLTctMS0xLTExNzAyOQ_46ffa169-fafb-4aac-a6c7-2262d8bd51a1"
      unitRef="usd">9900000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTEtMS0xLTExNzAyOQ_264ea259-31aa-455e-9e6d-bdaa0cd67816"
      unitRef="usd">259500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTMtMS0xLTExNzAyOQ_35e74905-3b8f-4117-9740-cee08dbad851"
      unitRef="usd">333300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTUtMS0xLTExNzAyOQ_f434b62e-f14e-4105-9850-149ce941d572"
      unitRef="usd">352600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0OTMxZTYwMTA0YjM0ZDJmOTM4ZTM5MjA2ZGU4Nzg2Zi90YWJsZXJhbmdlOjQ5MzFlNjAxMDRiMzRkMmY5MzhlMzkyMDZkZTg3ODZmXzExLTctMS0xLTExNzAyOQ_1911bec4-a57b-4fdf-9684-a92bf14a0862"
      unitRef="usd">633800000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxMTA_1d822f1a-df65-4649-b624-4c836cec74bd"
      unitRef="usd">259500000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxMTc_4507760a-c64c-4374-ad3b-bb4a8bb4aafe"
      unitRef="usd">333300000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxNTc_d7bf755a-e715-4e7f-b3c3-60b45cab0fc0"
      unitRef="usd">352600000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzIxNjQ_5630881b-2b01-42a1-94ec-a081fd6432ec"
      unitRef="usd">633800000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4ODU_617052af-89a4-487a-8b07-2df570e09b4a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at beginning of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company contributions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits and administrative expenses paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange rate changes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtMS0xLTEtMTE3MDI5_5eee172a-af6a-488c-9027-230135661896"
      unitRef="usd">299900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtMy0xLTEtMTE3MDI5_a65ead8c-e4b3-4f9f-9610-f8f271f1cad1"
      unitRef="usd">300900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtNS0xLTEtMTE3MDI5_950a1dc2-2420-4483-8e85-ed098536032b"
      unitRef="usd">544600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60896f9da0414bb28b3e4a6cb0503006_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzMtNy0xLTEtMTE3MDI5_3d63209f-2452-42ac-b5a5-06a70c91cab5"
      unitRef="usd">535600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtMS0xLTEtMTE3MDI5_7270e434-efac-4818-8f5e-467fd9120902"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtMy0xLTEtMTE3MDI5_c77e53e1-7bf7-42bc-bdd4-a9f5a2054b79"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtNS0xLTEtMTE3MDI5_7411ac97-6015-4486-80d1-2bde6e363959"
      unitRef="usd">15700000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzUtNy0xLTEtMTE3MDI5_e1903afd-4827-4878-8ea5-117356d31742"
      unitRef="usd">14300000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctMS0xLTEtMTE3MDI5_b8e6671e-45d5-4b74-aeb4-32aef535d61f"
      unitRef="usd">-48200000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctMy0xLTEtMTE3MDI5_4dc30029-5491-4fc6-ae94-5499743a2a64"
      unitRef="usd">27500000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctNS0xLTEtMTE3MDI5_8330f6d7-6556-4eee-b67a-ce968906c046"
      unitRef="usd">-157500000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzctNy0xLTEtMTE3MDI5_07ac2a05-fed5-425f-a3d9-43563d00bbb0"
      unitRef="usd">22300000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i121f72a018ec4c9f8b54ddf0db87bf57_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtMS0xLTEtMTE3MDI5_7491f904-4b74-407e-88ed-9e726edba869"
      unitRef="usd">24900000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i883357ce9ee9480da21af5fa83f5e410_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtMy0xLTEtMTE3MDI5_5bb283cf-59e6-40c8-a2bd-bf9ffdfad3e4"
      unitRef="usd">28500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i2273640650a44965b54c030f812dcedd_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtNS0xLTEtMTE3MDI5_9f281933-21c0-4269-8daf-858405bb9869"
      unitRef="usd">16900000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i804f88e2691b4702a7deef00d5e7453d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzgtNy0xLTEtMTE3MDI5_c9536b33-e6a3-450b-9e65-62d32f372131"
      unitRef="usd">21700000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktMS0xLTEtMTE3MDI5_a20e4dbb-ce1c-4d95-8f0e-3c6e699e8422"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktMy0xLTEtMTE3MDI5_86a19153-c717-4ea7-b388-6944efdeac41"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktNS0xLTEtMTE3MDI5_e9914b22-94b9-47b5-b400-01dd8570f48f"
      unitRef="usd">-54000000.0</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzktNy0xLTEtMTE3MDI5_adc404dc-785d-4405-8f38-63e4738c6776"
      unitRef="usd">-5900000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTEtMS0xLTExNzAyOQ_c44ec052-aa97-45f4-bfa9-b02973516eea"
      unitRef="usd">226800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTMtMS0xLTExNzAyOQ_61b06a22-584f-42f3-8dda-e0333f9b8890"
      unitRef="usd">299900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTUtMS0xLTExNzAyOQ_33bcbacd-13a6-4e5d-8b4f-73552a27dfb1"
      unitRef="usd">331900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0ZDJjYzUyMGM1ZjA0MjdmYmVjYzhlNzU5ZjA2ZDFlMy90YWJsZXJhbmdlOjRkMmNjNTIwYzVmMDQyN2ZiZWNjOGU3NTlmMDZkMWUzXzEwLTctMS0xLTExNzAyOQ_5f488db0-b193-4349-a81c-947d77d6e479"
      unitRef="usd">544600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:ScheduleOfNetFundedStatusTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk5MDc_69e5baad-ffdb-44c0-9f16-7f34fbc84571">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:282.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.00pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recorded as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetFundedStatusTableTextBlock>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtMS0xLTEtMTE3MDI5_58149092-047c-42f2-b767-370035355ec0"
      unitRef="usd">32700000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtMy0xLTEtMTE3MDI5_86b9e27d-9464-4e20-81f0-4aad26818655"
      unitRef="usd">33400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtNS0xLTEtMTE3MDI5_23b7fb84-5fcb-4fb9-90ec-5fb0e1260a9b"
      unitRef="usd">-20700000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzMtNy0xLTEtMTE3MDI5_d34bfbb7-d5b1-4dac-9e6c-c4fd277018a5"
      unitRef="usd">89200000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i7f604723897e4eb18b2d274c0a3e642e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtMS0xLTEtMTE3MDI5_3dc04564-f9d8-4c50-aafb-8f37cf9c4d3a"
      unitRef="usd">2200000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0b51bec3994e47d28d92a02668477358_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtMy0xLTEtMTE3MDI5_a81e5d0a-88c6-43d7-bd87-b6d330ac0450"
      unitRef="usd">13400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ifb1ac24816154f94bf39eb4750cfb55d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtNS0xLTEtMjE2MTAx_3382739e-50da-4dec-86de-d48c53735d86"
      unitRef="usd">7000000.0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i2f42b96cf07842bf9fa62fba969481aa_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzYtNy0xLTEtMjE2MTAx_3ef67817-8ffd-4b59-be59-66cbaf472adf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i0963421655a043af8a2b5bbb8989a17c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctMS0xLTEtMTE3MDI5_74f5b045-a244-4115-9492-b4bbef62a226"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i05fb58427b7c4800985757cce94eaf0d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctMy0xLTEtMTE3MDI5_a093cfde-bbb2-483f-af69-0db7ef650c38"
      unitRef="usd">2400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i891ad191af8840378b461971806bc9ed_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctNS0xLTEtMTE3MDI5_6391c3dd-7f50-4e00-83d9-b90a1592a7c1"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ie883fffe23064af6952bf1c7966447d4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzctNy0xLTEtMTE3MDI5_590e1677-9045-444f-a41e-bddbcae2e170"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id75b0f3b14f749a2a2501b3580890929_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtMS0xLTEtMTE3MDI5_f2195fc9-7ba9-442e-8785-914c7450ebf4"
      unitRef="usd">32500000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i44818990a4aa4815b47c3efcb5d6ae2d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtMy0xLTEtMTE3MDI5_602a3ed7-1d69-4ba0-9967-dcbb1f1285e4"
      unitRef="usd">44400000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i6af7b58ae38646cf89971672cf01e93e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtNS0xLTEtMTE3MDI5_74d3f3e4-6e07-4a5c-b857-49f765644aeb"
      unitRef="usd">27100000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i446afb2f73d045dda711f7c831299b78_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzAyYzU3ZDQyYWI0MTU4YmQzZDk4MzAzMTk3Y2NmZi90YWJsZXJhbmdlOjRjMDJjNTdkNDJhYjQxNThiZDNkOTgzMDMxOTdjY2ZmXzgtNy0xLTEtMTE3MDI5_12a8821f-2369-4f2c-be25-fd3d716299b1"
      unitRef="usd">88600000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NzM_3f90d4a7-53aa-4e6b-be96-4c7ab90cdd5f">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit costs are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long term rate of return &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash balance interest credit rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average assumptions used to determine net periodic benefit obligations are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.740%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.743%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U. S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average asset allocation of the plan assets as of December&#160;31, 2022, by asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.760%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average target asset allocation of the plan assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.043%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;to&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMS0xLTEtMTE3MDI5_26ec3ca7-6f0e-4e2e-8dde-7ab58e13b5f5"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMy0xLTEtMTE3MDI5_43f7a2cf-542e-4298-95a5-b9e2523ac276"
      unitRef="number">0.024</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtNS0xLTEtMTE3MDI5_daf51955-e95e-48d1-9bd9-69b8a80db5bc"
      unitRef="number">0.033</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtNy0xLTEtMTE3MDI5_651173d7-4049-43c6-a427-7c3d355e36bf"
      unitRef="number">0.021</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtOS0xLTEtMTE3MDI5_639e8917-b696-4eb0-a19f-77b89be73163"
      unitRef="number">0.011</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzMtMTEtMS0xLTExNzAyOQ_5cddeb16-e49e-4cc6-be6c-887caca8a04d"
      unitRef="number">0.017</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtNy0xLTEtMTE3MDI5_cfc46142-4510-41ba-b76f-ca43cb5af465"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtOS0xLTEtMTE3MDI5_623b53de-220a-4a12-b807-ba14c65a5ebe"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzQtMTEtMS0xLTExNzAyOQ_ca95b47d-83b4-485b-8c44-743694953793"
      unitRef="number">0.031</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMS0xLTEtMTE3MDI5_366c6635-3429-42c7-b39f-7874cbb4fc9e"
      unitRef="number">0.045</lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets>
    <lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMy0xLTEtMTE3MDI5_d6a6b7f4-ac5f-4660-9663-98f4fe3a4944"
      unitRef="number">0.060</lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets>
    <lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets
      contextRef="ic49569d8604944a6835acbc1ac8e6491_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtNS0xLTEtMTE3MDI5_3c201edb-e24f-4c34-b33e-dbe1e4812b02"
      unitRef="number">0.060</lh:DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets>
    <lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtNy0xLTEtMTE3MDI5_9418047e-9cfc-41e8-af84-9c29bf9b160b"
      unitRef="rate">0.037</lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets>
    <lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets
      contextRef="i3ff7168256eb4662a740f2d743e21a8e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtOS0xLTEtMTE3MDI5_0054c399-e50a-43ca-ba31-689f55f44304"
      unitRef="rate">0.031</lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets>
    <lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets
      contextRef="i6477f78893c34d85af3901463d34cacf_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzUtMTEtMS0xLTExNzAyOQ_5d0b24cf-4717-411c-907e-309900fedd7e"
      unitRef="rate">0.035</lh:DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtMS0xLTEtMTE3MDI5_be043455-2f80-4719-b32f-81e8822493a7"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i3716a9f40840488e9c09458e39b8a4eb_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtMy0xLTEtMTE3MDI5_794d8a93-271b-45b0-b32b-fb813bbbc819"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate
      contextRef="i04e385461a9c44a4839852c62f92193a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0YzMyY2RjMGY3MzE0NTdlYTQ0YjFiMDY0NmUzMjdhOC90YWJsZXJhbmdlOjRjMzJjZGMwZjczMTQ1N2VhNDRiMWIwNjQ2ZTMyN2E4XzYtNS0xLTEtMTE3MDI5_41b677ce-8419-4514-a4be-02f73ead4925"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ie5bfa899cc664f7ea385983e988bc51a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzI4Mjk_93a68b92-102c-4256-bf60-f945ac442d72"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i7e0669932f004c748144af0bb609d89a_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzMwMDc_b32e7d31-32ef-413c-b9c0-cd1ff362e617"
      unitRef="usd">2800000</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtMS0xLTEtMTE3MDI5_8ae81cd8-9c72-4e71-985b-11c4920c336c"
      unitRef="number">0.055</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtMy0xLTEtMTE3MDI5_f03bb004-b54c-4d5a-a93c-6fd84899af1d"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtNS0xLTEtMTE3MDI5_8413f316-93bd-4e0f-85b0-7c524a728fbe"
      unitRef="number">0.048</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzMtNy0xLTEtMTE3MDI5_4ee95141-d507-4131-8e1d-1db197f91aca"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzQtNS0xLTEtMTE3MDI5_7a15fe9f-b047-41b3-a916-3ebf842aaadd"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i154d50b63f0143c3ad531d1848bf9e2b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo2MmE4OGU0MGUzMTM0NGJhYTAwY2NiMDc1NjVlMDMxOC90YWJsZXJhbmdlOjYyYTg4ZTQwZTMxMzQ0YmFhMDBjY2IwNzU2NWUwMzE4XzQtNy0xLTEtMTE3MDI5_9928c0f9-d051-408f-bb53-f9997c03eefa"
      unitRef="number">0.020</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="ic9e08d02460648ceb4f5d1073cf29452_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzQyMTI_a8674434-8338-42af-9e5f-c8fa331f8268"
      unitRef="usd">3000000.0</us-gaap:DefinedBenefitPlanOtherCosts>
    <us-gaap:DefinedBenefitPlanOtherCosts
      contextRef="i30b8718e15b74da59c3573b8d71f7af5_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzQzODg_1925378f-ec1c-4741-bf1f-3ba9aedd1015"
      unitRef="usd">5000000.0</us-gaap:DefinedBenefitPlanOtherCosts>
    <lh:DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk5MzE_5a5dbeae-c951-4d72-b29f-b1b7ff5388d6">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the assets at December&#160;31, 2022, and 2021, by asset category are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level of Valuation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments valued using NAV per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;U.S Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General bond index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pooled investment funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset Category&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level of Valuation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments valued using NAV per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;U.S Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equity index funds &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equity index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate index fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General bond index funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Non U.S. Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pooled investment funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair market value of index funds and pooled investment funds are valued using the net asset value (NAV) unit price provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund. The fair value of annuity investments are based on discounted cash flow techniques using unobservable valuation inputs such as discount rates and actuarial mortality tables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;margin-top:5pt;text-align:center;text-indent:15.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.001%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement of Level 3 Pension Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annuities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzItMi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzItNi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic24dd8a27e334839bd22287ccd572072_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzMtNC0xLTEtMTE3MDI5_90e50b6e-68fc-45a3-a0a6-f027d31041ec"
      unitRef="usd">39600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic24dd8a27e334839bd22287ccd572072_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzMtNi0xLTEtMTE3MDI5_90e50b6e-68fc-45a3-a0a6-f027d31041ec"
      unitRef="usd">39600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i192893a861a0482dad94f453f9c613a6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzQtNC0xLTEtMTE3MDI5_8db49468-70e1-48b8-b5ae-63aced93a464"
      unitRef="usd">17000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i192893a861a0482dad94f453f9c613a6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzQtNi0xLTEtMTE3MDI5_8db49468-70e1-48b8-b5ae-63aced93a464"
      unitRef="usd">17000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzUtNC0xLTEtMTE3MDI5_c807657f-047b-429e-9b7c-4cfe84032e3a"
      unitRef="usd">5000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8672e5a6e83d40ac9ce9616c3df295dd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzUtNi0xLTEtMTE3MDI5_c807657f-047b-429e-9b7c-4cfe84032e3a"
      unitRef="usd">5000000.0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7439af4f1d3a4692b0653838638d8af8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzYtNC0xLTEtMTE3MDI5_b4264e2c-ba76-4250-aa09-56ab0f64209d"
      unitRef="usd">161300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7439af4f1d3a4692b0653838638d8af8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzYtNi0xLTEtMTE3MDI5_b4264e2c-ba76-4250-aa09-56ab0f64209d"
      unitRef="usd">161300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i34f729a2b5424259b6e99e69e9d72ff9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctMi0xLTEtMTE3MDI5_baf4ae36-adda-45df-96b8-65aad26c4677"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if84b6a0f91f946deb9c23815d77889ba_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctNC0xLTEtMTE3MDI5_2d5d13dd-64cb-4df5-89da-706318614d9a"
      unitRef="usd">222900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzctNi0xLTEtMTE3MDI5_24222cab-00cf-46d1-bdbe-b6e4c8575ebd"
      unitRef="usd">226800000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8df3c43a8db540988490dbc3e564ddea_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEwLTItMS0xLTExNzAyOQ_dae7bb4e-6d66-45c7-b2a0-c3567c485d00"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8df3c43a8db540988490dbc3e564ddea_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEwLTYtMS0xLTExNzAyOQ_dae7bb4e-6d66-45c7-b2a0-c3567c485d00"
      unitRef="usd">3400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTItMS0xLTExNzAyOQ_a122ae6f-0ab7-45f2-9671-7f39eaaaf658"
      unitRef="usd">60100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia678cf83b6f6441dad461ad8e5dd1bd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTQtMS0xLTExNzAyOQ_685d2105-3c1a-4d68-a03c-437cb7ee495a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzExLTYtMS0xLTExNzAyOQ_878147fb-5218-45d1-9af8-2f0bb4918572"
      unitRef="usd">60100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i02645e959c074c3f93e3d43221951719_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEyLTQtMS0xLTExNzAyOQ_4d047e5c-dd19-4dee-8bed-83071a4c086f"
      unitRef="usd">268400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i02645e959c074c3f93e3d43221951719_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEyLTYtMS0xLTExNzAyOQ_4d047e5c-dd19-4dee-8bed-83071a4c086f"
      unitRef="usd">268400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3662d054eed4f3eb5eafc0e90748600_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTItMS0xLTExNzAyOQ_9e68c859-505c-4801-a00a-dca7180302d0"
      unitRef="usd">63500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28a1ab53d5f946889e265c64121dfdef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTQtMS0xLTExNzAyOQ_4f515131-3212-414f-a508-acc9064de328"
      unitRef="usd">268400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo5ZjA5ZDBjZjZlYzQ0OGIwYmY5NDBhNDlmYmY0NjhkYS90YWJsZXJhbmdlOjlmMDlkMGNmNmVjNDQ4YjBiZjk0MGE0OWZiZjQ2OGRhXzEzLTYtMS0xLTExNzAyOQ_b32d0bf0-8580-48e7-8f03-df57c68c3732"
      unitRef="usd">331900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzItMi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzItNi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzMtNC0xLTEtMTE3MDI5_6f6f72eb-ed5e-4a7b-b11e-412a68db38f2"
      unitRef="usd">52500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0d8f55e46f7f4ad9abe9a1961c567d36_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzMtNi0xLTEtMTE3MDI5_250daf9f-dabe-4d1b-9220-898fd7ded619"
      unitRef="usd">52500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i911d298b24e044ba8bf3996c13022e04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzQtNC0xLTEtMTE3MDI5_a6ffda9c-bfb2-4a04-9119-acc3cc9ad77c"
      unitRef="usd">22100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i911d298b24e044ba8bf3996c13022e04_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzQtNi0xLTEtMTE3MDI5_293f97a2-77d3-4c9b-910c-20853603a061"
      unitRef="usd">22100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia533eccefe7c42269410fcbf42b37fbe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzUtNC0xLTEtMTE3MDI5_2d468068-6318-4e81-8db5-3e8574490614"
      unitRef="usd">7600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia533eccefe7c42269410fcbf42b37fbe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzUtNi0xLTEtMTE3MDI5_f268ec16-b2a4-428d-b38d-5039f7aeedf9"
      unitRef="usd">7600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0179f13a6a7141e6a26b122221a62bff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzYtNC0xLTEtMTE3MDI5_bfab631e-43d8-4f66-ac07-a600a173e580"
      unitRef="usd">213400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0179f13a6a7141e6a26b122221a62bff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzYtNi0xLTEtMTE3MDI5_84a3ac3c-6c22-4ade-88a8-828f9ec592ed"
      unitRef="usd">213400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4323784b9ba6471abb2b94652c3bbd60_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctMi0xLTEtMTE3MDI5_d61df8f7-19f7-4cd7-a4a6-e51c32674b09"
      unitRef="usd">4300000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie90d8ce237094025b4a5a63bbeb2766e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctNC0xLTEtMTE3MDI5_a09aadad-2cdf-4174-bd0a-f98959ad39fb"
      unitRef="usd">295600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic1bc0781f34c41a480538dd92da69d4e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzctNi0xLTEtMTE3MDI5_babf4c8c-277d-417e-a6aa-7b040da9c6ab"
      unitRef="usd">299900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEwLTItMS0xLTExNzAyOQ_71a0b719-0693-44b1-a7a4-fec368866cd1"
      unitRef="usd">19500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iea51e9bceefc4e9a9987c04b47f28ae5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEwLTYtMS0xLTExNzAyOQ_66ae5f97-b3ee-4c5e-afd3-6ca8b41d95f6"
      unitRef="usd">19500000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd158ee242794532a7ea7bd54577418d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTItMS0xLTExNzAyOQ_230d44c7-05ab-4735-8ece-1f915961887e"
      unitRef="usd">97900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd158ee242794532a7ea7bd54577418d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTItMS0xLTExNzAyOQ_4f13bbf7-0d69-4c64-862d-af446234a242"
      unitRef="usd">97900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd158ee242794532a7ea7bd54577418d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTYtMS0xLTExNzAyOQ_230d44c7-05ab-4735-8ece-1f915961887e"
      unitRef="usd">97900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd158ee242794532a7ea7bd54577418d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzExLTYtMS0xLTExNzAyOQ_4f13bbf7-0d69-4c64-862d-af446234a242"
      unitRef="usd">97900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f7b3a1a2f964982926273037d0b54b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEyLTQtMS0xLTExNzAyOQ_ec0bb876-9cd6-49eb-9364-eaf8faafc7f1"
      unitRef="usd">427200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f7b3a1a2f964982926273037d0b54b5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEyLTYtMS0xLTExNzAyOQ_ec0bb876-9cd6-49eb-9364-eaf8faafc7f1"
      unitRef="usd">427200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i099c0ee08c294db19c4ae5023b72d7bc_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTItMS0xLTExNzAyOQ_688bc9f0-0580-45a9-b0f0-9a5dcea0c706"
      unitRef="usd">117400000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8343104e0af14f108a0fbe74beca5c54_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTQtMS0xLTExNzAyOQ_b64d1833-2568-414d-b7ad-067d05e76931"
      unitRef="usd">427200000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1NjBmYTFlZjdmZDA0ZjRhYjc1OTE4NzMzY2ZjMTcyZi90YWJsZXJhbmdlOjU2MGZhMWVmN2ZkMDRmNGFiNzU5MTg3MzNjZmMxNzJmXzEzLTYtMS0xLTExNzAyOQ_1e0704d2-cc72-44fe-971b-c33c337a6ac9"
      unitRef="usd">544600000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9ec771cc41634795906fe138e1c81da2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzEtMi0xLTEtMTE3MDI5_bc4bc1b2-cb72-402b-b976-2fedd7990a59"
      unitRef="usd">58700000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="ib7cf312ecfe346bc8025109327803b22_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzItMi0xLTEtMTE3MDI5_356e6bcf-8ff2-48d6-b416-04f879d42c30"
      unitRef="usd">39200000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icd158ee242794532a7ea7bd54577418d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzMtMi0xLTEtMTE3MDI5_cfe08951-b284-42b7-a733-f4f27912a93c"
      unitRef="usd">97900000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="ic0255c909ecf4062be8e1ef4d572ecce_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzQtMi0xLTEtMTE3MDI5_547afe52-8c60-44e9-a8c2-7bd20a26ce18"
      unitRef="usd">-37800000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51e1165a52a6489db2d1942fb682beb1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmOWM1YmQ2NzE4N2M0YmJmYWViYTFmODVkNDlhYjU5MS90YWJsZXJhbmdlOmY5YzViZDY3MTg3YzRiYmZhZWJhMWY4NWQ0OWFiNTkxXzUtMi0xLTEtMTE3MDI5_a72744a2-ad8b-45ae-9467-c2f58d885e81"
      unitRef="usd">60100000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="i460a5c47a3364d9fb3e031edfbfbabf3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzItMi0xLTEtMTE3MDI5_05287014-497e-42d6-9046-e79effdbd869"
      unitRef="number">0.245</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="ibfdcdc0c2f94425c91be11297fbb8ce7_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzItNC0xLTEtMTE3MDI5_d71e1026-f321-4218-9600-72dbbcaf607d"
      unitRef="number">0.434</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="ia240fb91ddb54361a789dbb9530b8f1b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzMtMi0xLTEtMTE3MDI5_f8844954-bceb-4206-b459-5a262b4d2779"
      unitRef="number">0.710</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="i8760f818f2b14f7fbcf0a940eec93d45_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzMtNC0xLTEtMTE3MDI5_e765ce87-c27b-4c90-a61f-8cf513a69799"
      unitRef="number">0.339</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="ia0f143c0038649379b2fa66b119f8d69_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzQtMi0xLTEtMTE3MDI5_31b904bc-4af7-4b96-93fd-a00fc43c2aa7"
      unitRef="number">0</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="i692e176a76174874b466ab85db6c1c50_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzQtNC0xLTEtMTE3MDI5_574c875e-ebd2-4e37-bb68-c9ec5a6946a4"
      unitRef="number">0.181</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="if52b7c1c428d4e3eb3aaf9e375478112_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzUtMi0xLTEtMTE3MDI5_1c2b3111-dcee-43bc-8287-6d5569bd92f1"
      unitRef="number">0.025</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="ib97b7437ac9d4146bc2f4ed185519c80_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzUtNC0xLTEtMTE3MDI5_802ec7b4-94b7-4ba7-be97-a3d2ec1eb0d2"
      unitRef="number">0.036</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="i6813336b6e7e427a800450b3823e6bec_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzYtMi0xLTEtMTE3MDI5_e185ea93-ae60-4c87-b4e1-06a9cd86db5b"
      unitRef="number">0.020</lh:DefinedBenefitPlanActualAssetAllocation>
    <lh:DefinedBenefitPlanActualAssetAllocation
      contextRef="id0fe63c273ca4dc4a880fceff9e1b046_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo0MzQ1ZDZjNDY2MzA0YmVlYTczMzY1ODIzYzlmZWI4ZS90YWJsZXJhbmdlOjQzNDVkNmM0NjYzMDRiZWVhNzMzNjU4MjNjOWZlYjhlXzYtNC0xLTEtMTE3MDI5_c88392af-b9d9-4562-9d32-82bf364e88f9"
      unitRef="number">0.010</lh:DefinedBenefitPlanActualAssetAllocation>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if9b971586ec34065819f0eebea18797c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtMi0xLTEtMTE3MDI5_ee245a20-5448-496c-a95b-f94c2e22bb49"
      unitRef="number">0.170</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ic020e345f5144121aead1d17fd7809f2_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtNC0xLTEtMTE3MDI5_473bac78-78e5-449a-a480-f958987a1e39"
      unitRef="number">0.325</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="iea4ad6f940d54031b324772fcccbf937_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtNi0xLTEtMTE3MDI5_d0348269-3a6f-42f3-a906-4ef0a32d429c"
      unitRef="number">0.350</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8d404caf16a542c58ecb2494a483b6d6_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzEtOC0xLTEtMTE3MDI5_e32b79d4-7cae-4de0-8807-f4059256d87e"
      unitRef="number">0.450</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ifd89c14ab1bc418b95827960d8faf263_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItMi0xLTEtMTE3MDI5_75add34c-6656-4cbf-9113-e6bc5d644d2b"
      unitRef="number">0.610</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i6911f4e40cef4e0daf420e676d7ec31a_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItNC0xLTEtMTE3MDI5_08fe058c-1456-4b0f-adf4-140ae9b4c09c"
      unitRef="number">0.810</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ia0f3586c7f5d42f880ddfd468ec2f11f_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItNi0xLTEtMTE3MDI5_270c661b-cf41-40ae-b0fa-8a0ab854e03a"
      unitRef="number">0.300</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i3cd1a0cfffa24ae3b00be3abc0a69934_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzItOC0xLTEtMTE3MDI5_283174e9-ab43-4574-a8f6-4d97e0035e57"
      unitRef="number">0.400</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i74347e5ffa2b413b99cd4565f3bf9e5e_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtMi0xLTEtMTE3MDI5_9541d0b1-0d8a-4e6f-8ca2-3dbdfc4f079d"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ic8535bd9bae349cda74905f20fef9702_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtNC0xLTEtMTE3MDI5_a0e2a07f-c775-4fc0-86c2-03eb02a6cdf7"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ibae84d9b5d624724bd2b3879c40582be_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtNi0xLTEtMTE3MDI5_cbf73eb9-888f-42cc-83b4-f99a7206fdda"
      unitRef="number">0.100</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i95215116016547b1b171fa14b5466684_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzMtOC0xLTEtMTE3MDI5_05f4fc11-b421-4745-ad71-154e712e05aa"
      unitRef="number">0.200</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if52b7c1c428d4e3eb3aaf9e375478112_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtMi0xLTEtMTE3MDI5_21ec10c9-c19d-4ea9-baf6-2625d719d893"
      unitRef="number">0.005</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ibb5709179a954534b3ce4e1599336837_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtNC0xLTEtMTE3MDI5_83209283-a2ed-4e57-a285-2a6027520b7c"
      unitRef="number">0.043</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i1c42916431b444feabb231e74e766011_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtNi0xLTEtMTE3MDI5_2956f699-5d78-49b5-a8b2-de6371bb7046"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i8e8799065c4f474b92bc1ecf19ea0d73_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzQtOC0xLTEtMTE3MDI5_19d1ac9a-0710-4a88-bc28-07464ac68f44"
      unitRef="number">0.100</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i3b1e06d6958940bf87696cd12422aa1e_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtMi0xLTEtMTE3MDI5_f47106a0-4f4b-4bf2-a3ac-2eee7ee96d11"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if2e111bc212c4b4b8fa775e86b3df66c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtNC0xLTEtMTE3MDI5_35bd57c5-a464-4e09-b184-d1099511a046"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="idb1897fa2127453ea83329424c5d5a7c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtNi0xLTEtMTE3MDI5_c97f3a24-bc11-4c99-8574-33cb50144a5a"
      unitRef="number">0</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i4e936d64daeb461b84ea45f5f4b467e5_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTphZTkxZWU3ZWIxMzk0OTJhOTM4N2FmYmE3MWIwNzI0Ni90YWJsZXJhbmdlOmFlOTFlZTdlYjEzOTQ5MmE5Mzg3YWZiYTcxYjA3MjQ2XzUtOC0xLTEtMTE3MDI5_625a6678-facd-488b-97ae-61e303f5a59b"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzY3OTQ_bcebbd0e-cd3e-4de7-b710-1b28d4160586"
      unitRef="usd">18200000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzEtMS0xLTEtMTE3MDI5_f5cedf79-532f-41ed-bd3d-c7cae82689eb"
      unitRef="usd">25700000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzEtMy0xLTEtMTE3MDI5_3d211c25-22b3-4c6c-bb32-aef88a61fe26"
      unitRef="usd">14800000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzItMS0xLTEtMTE3MDI5_130b7816-25e9-47de-a00e-2a3ffd3e3605"
      unitRef="usd">25400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzItMy0xLTEtMTE3MDI5_7a2d3549-f4a5-4dc4-ad62-71b77b37db06"
      unitRef="usd">16100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzMtMS0xLTEtMTE3MDI5_05ca6264-649f-4849-8739-b33dc5740ae5"
      unitRef="usd">25400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzMtMy0xLTEtMTE3MDI5_fee18280-8d4c-4cf5-9142-536145d1879d"
      unitRef="usd">16000000.0</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzQtMS0xLTEtMTE3MDI5_46655590-7c82-4d2f-bb3a-78043fa35694"
      unitRef="usd">24500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzQtMy0xLTEtMTE3MDI5_ab093c8e-c0f7-4a81-b370-e1b05998cb7c"
      unitRef="usd">17100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzUtMS0xLTEtMTE3MDI5_61623d2f-069a-42fa-b1c1-c1de8cc59a63"
      unitRef="usd">23600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzUtMy0xLTEtMTE3MDI5_094c04bd-9941-4453-bb0e-44aebacbef10"
      unitRef="usd">17900000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i6bfe9229fe0440ca8da42020bd1ff07e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzYtMS0xLTEtMTE3MDI5_02b87d13-84ef-4066-ac08-d12a38b507ff"
      unitRef="usd">106600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i27494da11fd44fdfb6e7f8ed0b598a4f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZToyODA2M2VlOWRhM2U0Yjc5OGM1MzY1YWY4MzBlYmIwMy90YWJsZXJhbmdlOjI4MDYzZWU5ZGEzZTRiNzk4YzUzNjVhZjgzMGViYjAzXzYtMy0xLTEtMTE3MDI5_020c90e2-a694-4e72-bb6c-2a8f030b5f2f"
      unitRef="usd">95300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtMS0xLTEtMTE3MDI5_16a622e0-0f26-43b4-a936-12d14048e737"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtMy0xLTEtMTE3MDI5_6ab3a887-cf00-4415-9951-855b8735eaf1"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzMtNS0xLTEtMTE3MDI5_a21e0ff0-7f5b-4128-8288-058c4a9adc8a"
      unitRef="usd">200000</us-gaap:DefinedBenefitPlanInterestCost>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtMS0xLTEtMTE3MDI5_10e0ae4a-56dc-4bf5-b4dc-c0429852f8c2"
      unitRef="usd">200000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtMy0xLTEtMTE3MDI5_0a76e837-e085-40c7-aa99-843e0a734569"
      unitRef="usd">300000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <lh:DefinedBenefitPlanAmortizationAndDeferral
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzQtNS0xLTEtMTE3MDI5_2c6f41f3-06c6-4321-b338-7582a81c2657"
      unitRef="usd">400000</lh:DefinedBenefitPlanAmortizationAndDeferral>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtMS0xLTEtMTE3MDI5_d2182556-94da-4c23-ba70-acf71264cc5f"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtMy0xLTEtMTE3MDI5_a35e94a0-3777-4ce2-9cce-47aec5eb27ab"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpkY2E0NDEzZmI4MDU0YTRmYTkyNDQxZTI1ZmQxYjhiMC90YWJsZXJhbmdlOmRjYTQ0MTNmYjgwNTRhNGZhOTI0NDFlMjVmZDFiOGIwXzUtNS0xLTEtMTE3MDI5_2f2f5274-92fb-474f-a674-cb6fd1a71594"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgxMjU_a05d83bc-6a49-4f19-816b-05da3b69a2d4"
      unitRef="usd">-200000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgxMzI_9ab7de6e-93e5-42ca-b2f6-0c5ee3382b22"
      unitRef="usd">800000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEtMS0xLTEtMTE3MDI5_a18690c3-c2c7-4273-ae2d-75f90739cba4"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="icff6b868a72748489c76618831c34913_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEtMy0xLTEtMTE3MDI5_c54f21d2-41f2-41e9-99d7-e7ef59bed241"
      unitRef="usd">6200000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzMtMS0xLTEtMTE3MDI5_e0e242c7-db27-4ad1-b8d4-a248c1a9e98e"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzMtMy0xLTEtMTE3MDI5_6df4270e-066f-4650-ad31-553aedf4983a"
      unitRef="usd">100000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzQtMS0xLTEtMTE3MDI5_29168319-ace8-4ac3-8151-c15e89f5ee33"
      unitRef="usd">-900000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzQtMy0xLTEtMTE3MDI5_9ceee8ed-9982-441f-87bd-ee7695f4f9ad"
      unitRef="usd">-500000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzUtMS0xLTEtMTE3MDI5_ff89ca7b-f609-4838-95ed-6b3b3a4764de"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzUtMy0xLTEtMTE3MDI5_b4389654-c528-4013-8b55-464719f175ab"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzctMS0xLTEtMTE3MDI5_f2fa654b-915b-40cc-9123-af1e034ddf41"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzctMy0xLTEtMTE3MDI5_4e918f5e-9fb8-450b-817d-7dfb6ee49974"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i6bfb61b234a44fe89faf7bfc24db3774_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEwLTEtMS0xLTExNzAyOQ_7073132b-17fb-4c5b-bbae-ce0a63f163b9"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id8d1e82ad70f4603a498897f322acee1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEwLTMtMS0xLTExNzAyOQ_7c7d993d-de58-487a-9137-74ccb5c7cdd8"
      unitRef="usd">700000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ifbe23aa99b6847ed961d4fb0f516aeb5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzExLTEtMS0xLTExNzAyOQ_472c1623-4756-4b57-b85f-2ffcbd8660c7"
      unitRef="usd">3300000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ide46a6b378da475296703e0ec9e436bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzExLTMtMS0xLTExNzAyOQ_21a4c8ce-b098-4ed4-bde2-b731de582f5a"
      unitRef="usd">4500000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEyLTEtMS0xLTExNzAyOQ_5738b20a-6bba-42d2-8279-f3739ddef97b"
      unitRef="usd">3900000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTo1YmMyNzIyNzgyOWM0YWM0OTE5OGNiMDBhYTk2YzY5Ny90YWJsZXJhbmdlOjViYzI3MjI3ODI5YzRhYzQ5MTk4Y2IwMGFhOTZjNjk3XzEyLTMtMS0xLTExNzAyOQ_82fa0e8c-d930-4084-b2ba-bdf7ad306b89"
      unitRef="usd">5200000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgzNDc_f765b0db-d730-4ebe-a96e-3bdbfdcf17ed"
      unitRef="number">0.055</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2XzgzNTQ_1973aedb-3a93-4745-a9de-b8de8699bb58"
      unitRef="number">0.027</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <lh:AssumedBenefitPaymentsByYearTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk4NTU_e2377a23-9c4f-4f24-aebc-ba56f8c13dcd">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumed benefit payments under the Company's post-retirement benefit plan, which reflect expected future service, as appropriate, and which were used in the calculation of projected benefit obligations, are expected to be paid as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years 2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lh:AssumedBenefitPaymentsByYearTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzAtMS0xLTEtMTE3MDI5_919bb3fe-b00a-4183-a29c-40e6494d368c"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzEtMS0xLTEtMTE3MDI5_b3e6c863-68b5-46d7-b19a-448c744c5bbc"
      unitRef="usd">600000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzItMS0xLTEtMTE3MDI5_02eb99af-c128-4e5c-923e-9b746ecfc1b1"
      unitRef="usd">500000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzMtMS0xLTEtMTE3MDI5_5d0e32c5-5837-4735-b319-e8110f762324"
      unitRef="usd">400000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzQtMS0xLTEtMTE3MDI5_09cae0ce-965e-4149-bb36-0894bd206da6"
      unitRef="usd">300000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90YWJsZTpmNzQ3NjdjOTVhMjk0YmUzYTlmODJlYzhjYjFmODZmZi90YWJsZXJhbmdlOmY3NDc2N2M5NWEyOTRiZTNhOWY4MmVjOGNiMWY4NmZmXzUtMS0xLTEtMTE3MDI5_95bd587d-640a-4b39-b777-e3f15c671908"
      unitRef="usd">1100000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <lh:Maximumdeferralpercentageofannualcashincentivepay
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzg5Mjk_9776f9ba-4e7d-467c-a10a-d08fab7e2f89"
      unitRef="number">1.000</lh:Maximumdeferralpercentageofannualcashincentivepay>
    <lh:Maximumdeferralpercentageofannualbasesalary
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzg5ODA_23140175-0c0a-4a31-8353-e83d97e56b90"
      unitRef="number">0.500</lh:Maximumdeferralpercentageofannualbasesalary>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk2MDY_78aeb035-8aa0-4f98-800a-94c4c26812ac"
      unitRef="usd">96900000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yMzgvZnJhZzozMjdlNGVhYjI1NTc0OGZmYWQ0OGViNDkyZTFlZjk1Ni90ZXh0cmVnaW9uOjMyN2U0ZWFiMjU1NzQ4ZmZhZDQ4ZWI0OTJlMWVmOTU2Xzk2MTM_e909bbb1-a861-4ad9-a4fa-e0253cbb6761"
      unitRef="usd">104400000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3ODM_bbefffe3-20cc-4ccd-ae32-5892b1ffa114">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of December&#160;31, 2022, and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:2pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a noncontrolling interest put related to its Ontario subsidiary that has been classified as mezzanine equity in the Company&#x2019;s consolidated balance sheets. The noncontrolling interest put is valued at its contractually determined value, which approximates fair value. During the year ended December&#160;31, 2022, the carrying value of the noncontrolling interest put decreased by $0.2 for foreign currency translation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers certain employees the opportunity to participate in a DCP. A participant's deferrals are allocated by the participant to one or more of 16 measurement funds, which are indexed to externally managed funds. From time to time, to offset the cost of the growth in the participant's investment accounts, the Company purchases life insurance policies, with the Company named as beneficiary of the policies. Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments, which are typically invested in a similar manner to the participants' allocations. Changes in the fair value of the DCP obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units. The cash surrender value and the DCP obligations are classified within Level 2 because their inputs are derived principally from observable market data by correlation to the hypothetical investments.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent accrued earn-out business acquisition consideration liabilities for which fair values are measured as Level 3 instruments. These contingent consideration liabilities were recorded at fair value on the acquisition date and are remeasured quarterly based on the then assessed fair value and adjusted if necessary. The increases or decreases in the fair value of contingent consideration payable can result from changes in anticipated revenue levels and changes in assumed discount periods and rates. As the fair value measure is based on significant inputs that are not observable in the market, they are categorized as Level 3.&lt;/span&gt;&lt;/div&gt;The carrying amounts of cash and cash equivalents, accounts receivable, income taxes receivable, and accounts payable are considered to be representative of their respective fair values due to their short-term nature. The fair market value of the Senior Notes, based on market pricing, was approximately $4,973.9 and $5,841.1 as of December&#160;31, 2022, and 2021, respectively. The Company's note and debt instruments are considered Level 2 instruments, as the fair market values of these instruments are determined using other observable inputs.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3NzU_2bf6869b-07ba-4208-8790-7430782d33fe">&lt;div style="text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s population of financial assets and liabilities subject to fair value measurements as of December&#160;31, 2022, and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.659%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.688%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other; Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.378%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurements as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Using Fair Value Hierarchy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest put&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtMi0xLTEtMTE3MDI5_225d0985-f546-4b87-afd8-56a86622cd17"
      unitRef="usd">15000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtNC0xLTEtMTE3MDI5_4e249d4f-3c45-4a40-b4e3-69bd73d32613"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtNi0xLTEtMTE3MDI5_7ae21d4f-71ff-449a-92cc-7fe468bd46a5"
      unitRef="usd">15000000.0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzQtOC0xLTEtMTE3MDI5_4720d7d6-16b4-4827-9aaf-3120767ac934"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtMi0xLTEtMTE3MDI5_82cc10f7-9c57-4890-a338-e06b975a04da"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtNC0xLTEtMTE3MDI5_38569d43-fff9-4b2c-8f09-b0159368c785"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtNi0xLTEtMTE3MDI5_c47b505e-1d84-46f0-ac73-2e1b7f2dd342"
      unitRef="usd">45700000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzUtOC0xLTEtMTE3MDI5_47b1e85c-0410-4092-ab8b-615e26aa29e8"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtMi0xLTEtMTE3MDI5_eddde4b6-b479-4d1f-be29-ab70e0d59553"
      unitRef="usd">79700000</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtNC0xLTEtMTE3MDI5_66ca3394-4968-4f14-97c7-78e051be91a1"
      unitRef="usd">0</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:InterestRateFairValueHedgeAssetAtFairValue
      contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtNi0xLTEtMTE3MDI5_5b48389a-f054-49bc-a9ed-ed6cb5092460"
      unitRef="usd">79700000</us-gaap:InterestRateFairValueHedgeAssetAtFairValue>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzYtOC0xLTEtMTE3MDI5_71b81055-314a-491f-b089-a8635c41d05d"
      unitRef="usd">0</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctMi0xLTEtMTE3MDI5_0632689b-e634-4e55-bea7-99fa5e0dad80"
      unitRef="usd">100700000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctNC0xLTEtMTE3MDI5_b36f9316-2dfd-477b-b2de-cfb72c6342c0"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctNi0xLTEtMTE3MDI5_00351135-2b32-4e8b-ac3f-7f2069d91ed2"
      unitRef="usd">100700000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzctOC0xLTEtMTE3MDI5_410dab13-67db-4fc7-b9e7-2f180f4914c2"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtMi0xLTEtMTE3MDI5_f09ca1e8-a5aa-4355-a52b-fd097ac93878"
      unitRef="usd">96900000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtNC0xLTEtMTE3MDI5_74152215-964d-4675-8c2e-b60aba6387af"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtNi0xLTEtMTE3MDI5_cd5f120e-e864-4943-8b0d-f2cf20b82a1d"
      unitRef="usd">96900000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzgtOC0xLTEtMTE3MDI5_234c7dd7-e1cd-46ec-9db4-5a86149cd225"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTItMS0xLTExNzAyOQ_a9c6773b-6701-49cb-9edf-94d36c9a813f"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i9ea8d34307ef4a2aac00f357da7cf5a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTQtMS0xLTExNzAyOQ_b5e16af4-f452-4d45-a097-e0667c726eaa"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i471286d90c4d438bb8e6af11b7d82b62_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTYtMS0xLTExNzAyOQ_0871ccf8-3fc1-48e0-a20a-a56adf977867"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTpiMDMyOThjOGM3MDE0ZjQ0OGI4YTkyMTAwNTU1NWZhZS90YWJsZXJhbmdlOmIwMzI5OGM4YzcwMTRmNDQ4YjhhOTIxMDA1NTU1ZmFlXzEwLTgtMS0xLTExNzAyOQ_5addb5c1-e9e8-4e6f-a266-1832065e1292"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtMi0xLTEtMTE3MDI5_896f1528-4a08-4b17-98d2-ca144612f2f5"
      unitRef="usd">16300000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtNC0xLTEtMTE3MDI5_51e3234a-ba4a-4e2d-bfb5-4cd8bf1ee327"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtNi0xLTEtMTE3MDI5_94cf823e-9b4a-4bc7-a627-5ce9bceaee12"
      unitRef="usd">16300000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzQtOC0xLTEtMTE3MDI5_f14c846d-4831-4320-9d7d-a4349cf8bb10"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtMi0xLTEtMTE3MDI5_d6e47b3a-db4e-425b-8467-7a18b425eeb9"
      unitRef="usd">32800000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtNC0xLTEtMTE3MDI5_0a4cb177-8fd6-4e02-9d64-7e54dcad5044"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtNi0xLTEtMTE3MDI5_a8c174c3-b7c5-4b31-ad07-2f80fd7c64d5"
      unitRef="usd">32800000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzUtOC0xLTEtMTE3MDI5_9938ede8-12c3-4e4c-954d-b63ca5bd3ec8"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtMi0xLTEtMTgyNDE3_136cfadd-06af-4c65-828b-961bf6a34904"
      unitRef="usd">2900000</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNC0xLTEtMTgyNDI0_f9640fb5-5efc-40d1-b8fc-72fd0d310cb5"
      unitRef="usd">0</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:InterestRateFairValueHedgeAssetAtFairValue
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNi0xLTEtMTgyNDQw_b8cf6006-48af-4575-a67f-c4c39c3040fe"
      unitRef="usd">2900000</us-gaap:InterestRateFairValueHedgeAssetAtFairValue>
    <us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtOC0xLTEtMTgyNDQ3_59e550ba-9f41-4b0c-9e39-aa14c43ebd04"
      unitRef="usd">0</us-gaap:InterestRateFairValueHedgeDerivativeAtFairValueNet>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtMi0xLTEtMTE3MDI5_9426dfe2-ffc6-4bdc-b869-26cfc5fbe2ae"
      unitRef="usd">106400000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNC0xLTEtMTE3MDI5_bb3ea0e0-ac58-49ac-b36f-9019249216ee"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtNi0xLTEtMTE3MDI5_6ebc002b-93fa-4bf8-a3ee-4a8831007d02"
      unitRef="usd">106400000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzYtOC0xLTEtMTE3MDI5_439220f5-3fc5-4003-b783-97c6e91c77f9"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctMi0xLTEtMTE3MDI5_c6137b7f-f9a5-4232-837d-db95e579e8f5"
      unitRef="usd">104400000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctNC0xLTEtMTE3MDI5_1e019f58-db07-4089-ba8e-5ff9c38d835b"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctNi0xLTEtMTE3MDI5_31aec1f3-9b7b-4c67-a6b4-e989fe62a6c1"
      unitRef="usd">104400000</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzctOC0xLTEtMTE3MDI5_b44b93be-b659-40fb-8931-ea1161b814f1"
      unitRef="usd">0</lh:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktMi0xLTEtMTgyMzM1_1450c7ad-f99f-4cca-b3be-2b94f987fc7d"
      unitRef="usd">10900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktNC0xLTEtMTgyMzQy_66e26fc5-3d6c-4afa-a407-ea15f5fcff91"
      unitRef="usd">10900000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktNi0xLTEtMTgyMzU4_1fbda211-cf19-43b6-ab1a-359977fd1fd8"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzktOC0xLTEtMTgyMzY1_ffb31f18-99af-43be-89fe-bb271f32c586"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtMi0xLTEtMTE3MDI5_86dce3c2-a33c-42bc-b7fc-1b46eb18b406"
      unitRef="usd">21900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i6eeb4246efc64a0cb377026f549a6398_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtNC0xLTEtMTE3MDI5_65494d16-8ce0-4f59-82c2-8967b652c897"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i499f72b196a94fd5ad14338aeaee2727_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtNi0xLTEtMTE3MDI5_cff364dd-5312-4b2e-9b06-afedd6f5b03f"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZToyOTU1ZWRjY2Y4ZTQ0NTE4OGEwYjEzZGU5MGE4NTY0NC90YWJsZXJhbmdlOjI5NTVlZGNjZjhlNDQ1MTg4YTBiMTNkZTkwYTg1NjQ0XzgtOC0xLTEtMTE3MDI5_55c1587b-14ee-4785-82b3-51f8ed77e956"
      unitRef="usd">21900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI3Nzg_b5165398-87bc-40bd-a24b-22a7601cc3aa">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Measurement of Level 3 Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Addition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i6761ac2c526642dd8202c09476f40e82_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzEtMi0xLTEtMTE3MDI5_50fe9a96-58b5-49fa-91ec-94df8dd875cb"
      unitRef="usd">13900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzItMi0xLTEtMTE3MDI5_49725e80-205a-42d2-9c83-3ff416783506"
      unitRef="usd">9100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <lh:Contingentconsiderationadjustment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzMtMi0xLTEtMTE3MDI5_a7fb675a-6dcc-4111-807f-89989c17c5a3"
      unitRef="usd">1100000</lh:Contingentconsiderationadjustment>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i9bbe0d76624f4cbb8f9fd5d8df74b3da_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzQtMi0xLTEtMTE3MDI5_334816e7-1b8a-4492-abf5-1a22c55da208"
      unitRef="usd">21900000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzUtMi0xLTEtMTE3MDI5_98a6ff52-3b48-4a11-a028-1444aac1729b"
      unitRef="usd">68300000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <lh:Contingentconsiderationadjustment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzYtMi0xLTEtMTE3MDI5_6fbcdc34-db2f-4bb3-a98c-826eef5ebb43"
      unitRef="usd">12800000</lh:Contingentconsiderationadjustment>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i09d960808d8d4f428d66f07f05dab5ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90YWJsZTozYWRiNzQ2YzlmYjA0OTRlYjFmMjNhMTQyYTIzZTJkNS90YWJsZXJhbmdlOjNhZGI3NDZjOWZiMDQ5NGViMWYyM2ExNDJhMjNlMmQ1XzctMi0xLTEtMTE3MDI5_23f0738b-e7de-4211-b99c-63668eef7342"
      unitRef="usd">77400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <lh:IncreaseDecreaseInNoncontrollingInterestPut
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzU2MA_0d6f63cd-6a1a-4d7a-a856-7e97a029f93b"
      unitRef="usd">200000</lh:IncreaseDecreaseInNoncontrollingInterestPut>
    <lh:SeniorNotesFairValue
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI1NTk_634da5e1-fd82-47fa-850e-d766539bcf98"
      unitRef="usd">4973900000</lh:SeniorNotesFairValue>
    <lh:SeniorNotesFairValue
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDEvZnJhZzowYTQwYjVkZDY1N2Q0ZDg3YjcyYzVhOTE5M2Q4ZjM4Mi90ZXh0cmVnaW9uOjBhNDBiNWRkNjU3ZDRkODdiNzJjNWE5MTkzZDhmMzgyXzI1NjY_996039da-c144-4029-a4b1-41650502a7d2"
      unitRef="usd">5841100000</lh:SeniorNotesFairValue>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNjI_153b3973-9772-4468-ade8-59937eb3b6b8">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest Rate Swap&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, the Company entered into fixed-to-variable interest rate swap agreements for its 2.70% senior notes due 2031 with an aggregate notional amount of $500.0 and variable interest rates based on three-month LIBOR plus 1.0706%. These agreements were designated as hedges against changes in the fair value of a portion of the Company's long-term debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2013, the Company entered into two fixed-to-variable interest rate swap agreements for the 4.625% Senior Notes due 2020 with an aggregate notional amount of $600.0 and variable interest rates based on one-month LIBOR plus 2.298% to hedge against changes in the fair value of a portion of the Company's long-term debt.&#160;The Company exited the remaining fixed-to-variable interest rate swap agreement in August 2020, in connection with the redemption of the remaining $412.2 of its 4.625% Senior Notes due November 15, 2020, and recorded a gain of $1.6 on the extinguishment. The gain was included in Other, net on the Consolidated Statement of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cross Currency Swaps&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:7pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2018, the Company entered into U.S. Dollar (USD) to Swiss Franc cross-currency swap agreements with an aggregate notional value of $600.0. During the second quarter of 2022, the Company terminated $300.0 of those cross-currency swap agreements and entered into new USD to Swiss Franc cross-currency swap agreements with an aggregate notional value of $300.0 that mature in 2024. These instruments are designated as a hedge against the impact of foreign exchange movements on its net investment in a Swiss subsidiary.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.255%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net/Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company recognized a gain of $1.6 on the extinguishment of its interest rate swap agreement in the year December 31, 2020 in connection with the redemption of the 4.625% Senior Notes due 2020. No gains or losses from derivative instruments classified as hedging instruments were recognized into income for the year ended December 31, 2021.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEyMTI_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8742ac35d38745ad93ae0f53d955fd73_I20130331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEyNzQ_c8d79798-b75c-4663-b49e-94b7bd41345d"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEzMzU_a4d14128-6958-4868-896a-93bb23a95467"
      unitRef="number">0.02298</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <lh:BalanceOfSeniorNotesMatureDuringQ42020
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3MTQ_7b9a0955-af39-4d20-bf29-332db0ebfc9a"
      unitRef="usd">412200000</lh:BalanceOfSeniorNotesMatureDuringQ42020>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3MjQ_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <lh:GainRecognizedonExitofInterestRateSwapArrangement
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE3ODY_0c8b4855-1fd1-47ee-9246-852e3937e9f7"
      unitRef="usd">1600000</lh:GainRecognizedonExitofInterestRateSwapArrangement>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i62637e2f6fb743b9ae7a0465221d295a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzMxNzM_9ade9715-14d5-47e8-8332-c5643e1867e9"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i72fecf8a9a614c76a5f20c1427477921_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE2NDkyNjc0NDc4NzI_ef26f967-63c0-4182-80b3-a32183ec59ba"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i402e968b57904d3c829927474cb21229_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzE2NDkyNjc0NDg2MjU_3607ee1a-ac78-46d0-8835-37166b82e6d0"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNzQ_db3348cd-d114-4070-bb3b-e5c6ea91926e">&lt;div style="margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of derivatives on a gross basis and the balance sheet classification of those instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.255%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.317%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.095%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value of Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="30" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets, net/Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMy0xLTEtMTE3MDI5_56a138a6-a575-48ce-b20b-3f751a3fc205"
      unitRef="usd">0</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i80c92a7d5c1b4fcf8fe5682759fa9367_I20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtNS0xLTEtMTE3MDI5_eb7878a0-8696-45d8-9808-51cf2485a6dc"
      unitRef="usd">79700000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i34dcbd66606a4b4bbdf2c53cc57f54e9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtNy0xLTEtMTE3MDI5_32c1aee8-b56a-4233-9817-68bd511a3131"
      unitRef="usd">500000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="ib3e361c43a754d01b7cfa82e6747efc3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtOS0xLTEtMTE3MDI5_f3dcdae6-b19f-4d61-be52-928ea422fbaf"
      unitRef="usd">2900000</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="ib3e361c43a754d01b7cfa82e6747efc3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMTEtMS0xLTExNzAyOQ_edda860d-4f78-471d-a671-3afa63876c22"
      unitRef="usd">0</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8d4a564210ff40f48048c331cff9cf8b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzQtMTMtMS0xLTExNzAyOQ_dd429aad-2463-45ac-88b5-0b48c6367c32"
      unitRef="usd">500000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="i7d9c8469896f45ecba498b0ede39dbb8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMy0xLTEtMTE3MDI5_a9f6f848-b240-4f52-8520-3a3cebc3c0aa"
      unitRef="usd">0</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i7d9c8469896f45ecba498b0ede39dbb8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtNS0xLTEtMTE3MDI5_20b506e3-cab3-4c4c-9608-4bc40b355abc"
      unitRef="usd">45700000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i50138a8641f3407a9f5402ee74004755_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtNy0xLTEtMTE3MDI5_dfa1b051-f6db-4d4a-9a56-cb8054839fd4"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueHedgeAssetsAtFairValue
      contextRef="i3097c8bb523449408d110548f79bebbe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtOS0xLTEtMTE3MDI5_4a56634b-b26a-4ad6-8049-210e4c6a3d52"
      unitRef="usd">0</us-gaap:FairValueHedgeAssetsAtFairValue>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue
      contextRef="i3097c8bb523449408d110548f79bebbe_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMTEtMS0xLTExNzAyOQ_55015f12-660e-42a1-8300-42407ee66f87"
      unitRef="usd">32800000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i62637e2f6fb743b9ae7a0465221d295a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTozZjFjODMwZmE4ZGY0MTM3YjE5Njk0OGQ5NzhjY2Y1ZS90YWJsZXJhbmdlOjNmMWM4MzBmYThkZjQxMzdiMTk2OTQ4ZDk3OGNjZjVlXzUtMTMtMS0xLTExNzAyOQ_474e29b0-e9b7-4be3-87bf-1984912d5c4d"
      unitRef="usd">600000000.0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzUwNzI_87be176b-fdcc-4655-9cd6-c871d73d95a9">&lt;div style="text-align:justify;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value hedging relationships:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7.1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to the &lt;br/&gt;Statement of Operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross currency swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMi0xLTEtMTE3MDI5_c2e590c8-6a8a-4601-8df3-69d82751d7ff"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i109abf7ae534497d9389f80792db885b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtNC0xLTEtMTE3MDI5_ba86f799-ce01-404b-a0e6-5f8df7d2abc2"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4b210f3dae2a47ea886765221136d822_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtNi0xLTEtMTE3MDI5_a41e2540-c34b-42fe-b158-7fdda4cc0050"
      unitRef="usd">800000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i9feceef9344f43bb8dc06dc36c22f2f2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtOC0xLTEtMTE3MDI5_3176631b-6601-42f9-9ea0-40fd75d22f34"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i109abf7ae534497d9389f80792db885b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMTAtMS0xLTExNzAyOQ_63a47d66-7158-48e8-aad7-0ea65d400439"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i4b210f3dae2a47ea886765221136d822_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzMtMTItMS0xLTExNzAyOQ_30a6c9da-16f9-48a3-84c5-dc7fa43425fb"
      unitRef="usd">1600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMi0xLTEtMTE3MDI5_0a4cc961-73f4-4ac7-8ba3-2838e46e3563"
      unitRef="usd">-12900000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtNC0xLTEtMTE3MDI5_71cd89f7-25c8-4aeb-a6a5-ac5fcdec2c92"
      unitRef="usd">7600000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtNi0xLTEtMTE3MDI5_27e5b876-58e5-4cf1-ac50-59d6a01aec36"
      unitRef="usd">-43600000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ib6970aa5d04a408bac41e65e6f0b3ec2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtOC0xLTEtMTE3MDI5_04a470c2-1cfa-4414-b020-02858aa8ccfb"
      unitRef="usd">900000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i8fbcefd3a4f44606ac107e4a63a65b9f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMTAtMS0xLTExNzAyOQ_c1e66389-fb21-497a-9e05-355a2433dee4"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="if522bad060f64c8a98d94ae498cdf070_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90YWJsZTpiNjgzMzIxNTIzMmI0MmY2OTM3NDg4Y2MzYzgwYTBjYS90YWJsZXJhbmdlOmI2ODMzMjE1MjMyYjQyZjY5Mzc0ODhjYzNjODBhMGNhXzQtMTItMS0xLTExNzAyOQ_75c46621-b13e-4589-8c77-69ccba160bc5"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <lh:GainRecognizedonExitofInterestRateSwapArrangement
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzQ3Mzg_09be7d88-a6a6-45f2-a8c2-a75323556ef9"
      unitRef="usd">1600000</lh:GainRecognizedonExitofInterestRateSwapArrangement>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6496b6e7dad462cbf7891c975366ed1_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzQ4ODQ_71ad49b4-a5db-4b5e-b5b0-32bf6fa1ddc5"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainLossOnOilAndGasHedgingActivity
      contextRef="i93446d1780df4a17825fb9e3f5392c19_D20221001-20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEwOTk1MTE2MzczMjU_e5a9c0cd-9bfe-4006-bef8-25b22514d136"
      unitRef="usd">900000</us-gaap:GainLossOnOilAndGasHedgingActivity>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i72fecf8a9a614c76a5f20c1427477921_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDQvZnJhZzoyMzQ3OGU5Yjg2Yjk0NDRkOTM2NGZlMjY0NTBjYjU4MS90ZXh0cmVnaW9uOjIzNDc4ZTliODZiOTQ0NGQ5MzY0ZmUyNjQ1MGNiNTgxXzEwOTk1MTE2Mzc0MTE_ef26f967-63c0-4182-80b3-a32183ec59ba"
      unitRef="usd">300000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90ZXh0cmVnaW9uOjVkMDNhOTQ2YzM0ZDQ4ZmRiNjYzMjFhNTUyMzNlMjA0XzQ1_fdc7b6e3-db35-483a-a265-b08c44dc7232">SUPPLEMENTAL CASH FLOW INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental schedule of cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90ZXh0cmVnaW9uOjVkMDNhOTQ2YzM0ZDQ4ZmRiNjYzMjFhNTUyMzNlMjA0XzUw_0b7f1323-3f96-4192-9b91-4a3e6faafeae">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplemental schedule of cash flow information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid during period for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 25.75pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes, net of refunds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disclosure of non-cash financing and investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 12.25pt 2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in accrued property, plant and equipment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <lh:InterestPaidInCash
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtMS0xLTEtMTE3MDI5_92ae5919-db4d-45c5-a1f6-1536ead5bc4a"
      unitRef="usd">197100000</lh:InterestPaidInCash>
    <lh:InterestPaidInCash
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtMy0xLTEtMTE3MDI5_afad16c0-cf04-43db-b9db-964963dc798f"
      unitRef="usd">194700000</lh:InterestPaidInCash>
    <lh:InterestPaidInCash
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzQtNS0xLTEtMTE3MDI5_398b8468-943e-427e-b344-4c60d67c0bbd"
      unitRef="usd">216600000</lh:InterestPaidInCash>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtMS0xLTEtMTE3MDI5_a1f8ab75-3d15-494d-9ed7-086bf20e0086"
      unitRef="usd">504700000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtMy0xLTEtMTE3MDI5_939fd5fe-11d3-4438-8f4a-9c9c605921c7"
      unitRef="usd">1000000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzUtNS0xLTEtMTE3MDI5_41a7c7ef-871d-4b6c-aa2e-8d21121370a7"
      unitRef="usd">500000000.0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktMS0xLTEtMTE3MDI5_de91cca6-0ca1-48ba-860d-c88dc7e0c9ef"
      unitRef="usd">3900000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktMy0xLTEtMTE3MDI5_b1f434ac-70fc-4f5e-9d07-6da1f4d669c2"
      unitRef="usd">11800000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNDcvZnJhZzo1ZDAzYTk0NmMzNGQ0OGZkYjY2MzIxYTU1MjMzZTIwNC90YWJsZTo5YjgyOGZiMzMyMjE0MzQ3YTI2ZjRlZTZkMDdkOTE2ZC90YWJsZXJhbmdlOjliODI4ZmIzMzIyMTQzNDdhMjZmNGVlNmQwN2Q5MTZkXzktNS0xLTEtMTE3MDI5_818a6f1f-70f2-45f1-b78a-50b6ac9a9692"
      unitRef="usd">1200000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90ZXh0cmVnaW9uOmM3NDUxNjM5MDZkODQ3ZWU4NjQ4YWRjMmM1MGNmZDdkXzEwMzM_71a09b4a-819c-43a1-8edf-95dc850740e8">.&#160;&#160;BUSINESS SEGMENT INFORMATIONThe following table is a summary of segment information for the years ended December&#160;31, 2022, 2021, and 2020. The &#x201c;management approach&#x201d; has been used to present the following segment information. This approach is based upon the way the management of the Company organizes segments within an enterprise for making operating decisions and assessing &lt;div style="margin-bottom:7pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;performance. Financial information is reported on the basis that it is used internally by the chief operating decision maker (CODM) for evaluating segment performance and deciding how to allocate resources to segments. The Company&#x2019;s chief executive officer has been identified as the CODM. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2022, the Company modified the segment performance measure to exclude the amortization of intangibles and other assets, restructuring and other charges, goodwill and other asset impairments, and certain corporate charges for items such as transaction costs, COVID-19 costs, and other special items. These changes align with how the CODM now evaluates segment performance and allocates resources. Prior periods have been conformed for comparability. Segment asset information is not presented because it is not used by the CODM at the segment level. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,363.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,845.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,877.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,876.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,120.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,978.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Earnings:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and unallocated expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(420.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  Geographic Distribution of property, plant and equipment, net:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:503.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90ZXh0cmVnaW9uOmM3NDUxNjM5MDZkODQ3ZWU4NjQ4YWRjMmM1MGNmZDdkXzEwMjQ_59749555-554e-4a90-a257-d9efb46d02e6">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,363.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,710.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,845.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,877.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intercompany eliminations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,876.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,120.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,978.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Earnings:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,205.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,522.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and unallocated expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(438.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(420.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(299.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill and other asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,773.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,445.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:504.75pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;  Geographic Distribution of property, plant and equipment, net:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:503.25pt"&gt;&lt;tr&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:322.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:3.25pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;td style="width:52.75pt"/&gt;&lt;td style="width:1.0pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,399.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,669.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.781%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dx&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,507.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,308.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,815.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItMi0xLTEtMTE3MDI5_30f32314-7ae3-4f09-b0d9-3c2e086e63af"
      unitRef="usd">9203500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItNC0xLTEtMTE3MDI5_4fec45df-805b-48fd-8373-f5f46650fedd"
      unitRef="usd">10363600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzItNi0xLTEtMTE3MDI5_0c109c4c-9dde-4001-a000-0c219878fcb2"
      unitRef="usd">9253400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtMi0xLTEtMTE3MDI5_88d88882-f1b2-4c91-81b6-71096c0d9524"
      unitRef="usd">5710200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtNC0xLTEtMTE3MDI5_e903ff10-b2cf-48ad-a344-3fd8bc1637d7"
      unitRef="usd">5845500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzMtNi0xLTEtMTE3MDI5_9e0980a2-52ec-40e4-95dc-75f00fac2be2"
      unitRef="usd">4877700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c02350e7d7648358cd4fcc8dac9614c_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtMi0xLTEtMTE3MDI5_30f77263-6161-47ec-a93e-ddb30a8e7604"
      unitRef="usd">36900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i009fbbaa1fa344c2b260736d3d45ab4b_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtNC0xLTEtMTE3MDI5_bcc90c5a-a932-40e0-b0dc-8e7f881e93ab"
      unitRef="usd">88200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i264e173e323a4a219f6dc0e8e01fa43f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzQtNi0xLTEtMTE3MDI5_f3f451f4-e53f-4112-94e0-ef9b907c5ac8"
      unitRef="usd">152600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtMi0xLTEtMTE3MDI5_e49aa44c-579a-46f6-b3a1-aace21bc634a"
      unitRef="usd">14876800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtNC0xLTEtMTE3MDI5_bada6e0a-c126-4244-b290-4aa0264ef84e"
      unitRef="usd">16120900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzUtNi0xLTEtMTE3MDI5_93f35549-7265-4fb9-99d5-282147e827a8"
      unitRef="usd">13978500000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtMi0xLTEtMTE3MDI5_458408f8-72f6-480d-998a-f67b133babd9"
      unitRef="usd">2025500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtNC0xLTEtMTE3MDI5_779620f1-60ea-43df-b065-615153a31746"
      unitRef="usd">3205600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzgtNi0xLTEtMTE3MDI5_dd73d2b5-b7e7-4f8a-9b6b-11e955e03f9b"
      unitRef="usd">2801300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktMi0xLTEtMTE3MDI5_6f9ffa4b-d948-4818-b060-bec59c92a0e9"
      unitRef="usd">801100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktNC0xLTEtMTE3MDI5_7c9dc5f1-7242-49a3-a711-d9905ce8b60f"
      unitRef="usd">887100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzktNi0xLTEtMTE3MDI5_13d3916f-6180-4e01-b596-147bc2626f38"
      unitRef="usd">721600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icc8674bb0c33459fbc4f9f5bbe2b7c1e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTItMS0xLTE5NTk1NQ_8ee37eb2-d99f-493c-9be1-ad63b13edb5b"
      unitRef="usd">2826600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f2ec3658b894ce2949ed8539bf599fb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTQtMS0xLTE5NTk1Ng_7e5f691e-7e88-4c7d-a107-ae95d108b326"
      unitRef="usd">4092700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4fbdfe4753ce4100b31ceb13d3703285_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTYtMS0xLTE5NTk2NQ_f61c5abc-d25e-4dd7-a404-d2aa4710e5cd"
      unitRef="usd">3522900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia768e38536fd419f880dba505b33374f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTItMS0xLTExNzAyOQ_3260c302-1c19-4871-b408-5b147423b144"
      unitRef="usd">-438100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i536e737a10ed408381b0090740cf262a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTQtMS0xLTExNzAyOQ_3724ef48-386d-4a79-875a-0b37546f18c5"
      unitRef="usd">-420500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEwLTYtMS0xLTExNzAyOQ_f3b59807-028c-47ce-8eef-0c8f59756461"
      unitRef="usd">-299400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTItMS0xLTE5NTk3Mw_13facb12-4af8-437e-a420-c765584cbf03"
      unitRef="usd">259300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTQtMS0xLTE5NTk3Mw_add6e722-8522-43cc-858f-30be9350c875"
      unitRef="usd">369600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEyLTYtMS0xLTE5NTk3Mw_d18c0dd9-c8ed-4ce9-9a40-ca84f23fdb14"
      unitRef="usd">275400000</us-gaap:AmortizationOfIntangibleAssets>
    <lh:NetRestructuringCharges
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTItMS0xLTE5Nzg5MQ_5664251c-625d-4621-bf8e-d7428504aa68"
      unitRef="usd">83800000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTQtMS0xLTE5Nzg5MQ_dd0bf8af-0fb1-4160-85dd-410e58f24aae"
      unitRef="usd">43100000</lh:NetRestructuringCharges>
    <lh:NetRestructuringCharges
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTYtMS0xLTE5Nzg5MQ_9640d554-8ebd-4ac1-a67a-145db6e5614c"
      unitRef="usd">40600000</lh:NetRestructuringCharges>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTItMS0xLTE5NTk3Mw_08a39089-3e83-4263-8378-5b5eac13f4ff"
      unitRef="usd">271500000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTQtMS0xLTE5NTk3Mw_11d76079-5a35-461c-b817-cfbef6de1d8d"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzEzLTYtMS0xLTE5NTk3Mw_2b88b98d-4578-4085-895a-b44284deca4d"
      unitRef="usd">462100000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:OperatingIncomeLoss
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTItMS0xLTExNzAyOQ_e481c7c6-2a27-4162-b8e1-1876401d657e"
      unitRef="usd">1773900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTQtMS0xLTExNzAyOQ_44b485d5-3126-4213-a76e-e6dbccaee533"
      unitRef="usd">3259500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTozYjE0Y2Y3ZmUwMGQ0OWU0YjJjZDk3ZDI3MWRkNTMyZi90YWJsZXJhbmdlOjNiMTRjZjdmZTAwZDQ5ZTRiMmNkOTdkMjcxZGQ1MzJmXzExLTYtMS0xLTExNzAyOQ_42317b1e-c92f-4b00-a582-c671b5889ea1"
      unitRef="usd">2445400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i3d07fb7d3a214ccb8b0482db856230ff_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItMi0xLTEtMTE3MDI5_d59cb94e-2315-4be2-be7d-bbe38feda22b"
      unitRef="usd">227100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0144819236674d5b8f8b30016911bccd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItNC0xLTEtMTE3MDI5_0bfb21bc-a1a2-439b-8b19-e1898891cafe"
      unitRef="usd">238700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i01ac0a8dccdd402a8a591aa763871e65_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzItNi0xLTEtMTE3MDI5_130f2295-5f7f-4355-954f-84c16ba808e5"
      unitRef="usd">222600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i06b2f9abad5c4a33b1d17dcdd6332bc2_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtMi0xLTEtMTE3MDI5_20c1ae37-79e1-4e47-9918-10ecd02073de"
      unitRef="usd">143800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iabf76275f10c45c09d984ba00cfe74cc_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtNC0xLTEtMTE3MDI5_41523277-493b-4b29-97d1-af79dc381ec0"
      unitRef="usd">134300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i11ba8fd1124946d29050022377f70eb3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzMtNi0xLTEtMTE3MDI5_548b2dfd-59c3-4c0f-b13d-561c3b3c92ab"
      unitRef="usd">124700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia768e38536fd419f880dba505b33374f_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtMi0xLTEtMTE3MDI5_f9572a06-033a-4226-ba75-5132c9f32007"
      unitRef="usd">3700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i536e737a10ed408381b0090740cf262a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtNC0xLTEtMTE3MDI5_1bf1f1be-c736-436e-91ac-4216a5587dfc"
      unitRef="usd">2600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1da5726431cb4d6dba83492ad5f21d11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzQtNi0xLTEtMTE3MDI5_7f65b074-b63f-4c8c-a6d8-00f9ac57cd04"
      unitRef="usd">2000000.0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtMi0xLTEtMTE3MDI5_50d90c07-9ad7-4e63-9ba1-82895dee1cd9"
      unitRef="usd">374600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ida74c70113ea42e8b0e85554786fb918_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtNC0xLTEtMTE3MDI5_8f7aba42-89d5-4451-af46-1efca9c74a50"
      unitRef="usd">375600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idf9c8091041d4d618ca366b7d8487850_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZToyM2Y1NTNiYzhiZDI0Y2RjOWQ4NDM1ZjAyZWJhNzgwYy90YWJsZXJhbmdlOjIzZjU1M2JjOGJkMjRjZGM5ZDg0MzVmMDJlYmE3ODBjXzUtNi0xLTEtMTE3MDI5_baf654a3-3e09-44f9-b118-bde23951fdf1"
      unitRef="usd">349300000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i42e70f9eae14480099b40da70d85557b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItMi0xLTEtMTE3MDI5_350c6fa0-f3a6-4699-8305-ce90fc3a7870"
      unitRef="usd">1669200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if8003dc869194e32943cb16d8eb14897_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItNC0xLTEtMTE3MDI5_b52c7444-fe16-4bf7-b709-9d33cb453a14"
      unitRef="usd">730000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7a321f32243f4029afccd94fb3812764_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzItNi0xLTEtMTE3MDI5_162bd871-2a91-476a-99dd-ed3de2f57458"
      unitRef="usd">2399200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ida3e59b3cfa94c3a8576e7a963f623b4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtMi0xLTEtMTE3MDI5_023be1dd-e150-4dc7-ba1d-354fae914659"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ieacd7dfc507846ec8b5ce92f17564027_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtNC0xLTEtMTE3MDI5_92c79ddb-e6b3-4475-8eca-d63ca11b0a9e"
      unitRef="usd">425500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2e71eb1cfbd34d7fb34466d92877d3c6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzMtNi0xLTEtMTE3MDI5_fbc6ce26-1d86-440a-8c4a-6127672dd949"
      unitRef="usd">425500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idcbab8d63eb841018519ada24b99d545_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtMi0xLTEtMTE3MDI5_53b82f16-85ce-4ce5-b5dd-735ae08b07ba"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i56c5cb78f4904c6aacf992f36ac8a90c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtNC0xLTEtMTE3MDI5_897c2e1d-951d-403b-ba45-e14a8877141a"
      unitRef="usd">131500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i64aa8e649bdb4c108b75103b2eb4a2fc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzQtNi0xLTEtMTE3MDI5_22b6995f-3d25-4b97-82e1-f110c450f438"
      unitRef="usd">131500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i56daedd82c3646baa58c1523980c51f9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtMi0xLTEtMTE3MDI5_238fdd09-d300-429b-a774-5abf4bb3b20b"
      unitRef="usd">1669200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ide1d0653044641ba893251b0fd4296c1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtNC0xLTEtMTE3MDI5_c1240b61-ef21-4e65-8440-ba119b6a3375"
      unitRef="usd">1287000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if4525567f3af4381925d303df86c2fd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTpiMWNlNGEzM2UxNmE0MmNmYmMyMjBkMmZiYmY4OTkwMy90YWJsZXJhbmdlOmIxY2U0YTMzZTE2YTQyY2ZiYzIyMGQyZmJiZjg5OTAzXzUtNi0xLTEtMTE3MDI5_33bd3dda-e6a7-4cb3-bca7-e584597b1f17"
      unitRef="usd">2956200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i502b3fc0ff254fd1bf2c37a2fa0d8698_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItMi0xLTEtMjI5NTc5_c4bec827-9139-4c8b-802f-a3ea49420924"
      unitRef="usd">1507300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i15d2c61db1f64f1b9741884acf529ebf_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItNC0xLTEtMjI5NTc5_2d6ed571-a811-4a97-aaf4-339b80a1da72"
      unitRef="usd">670200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i17669eb64069457a845cbd59f00480e0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzItNi0xLTEtMjI5NTc5_b993f514-9c6e-4ccb-b5ab-f2fccea03853"
      unitRef="usd">2177500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ae52be303bc4ee4954f1fb18ca47961_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtMi0xLTEtMjI5NTc5_9ce84c40-9f4b-45d9-b345-ba400d26015f"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i51a7562319b848598560ae7b3eb035ad_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtNC0xLTEtMjI5NTc5_4fa919c1-8bfb-4c23-9890-8e86d86f3289"
      unitRef="usd">449900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4de2a6c8c4714f6c8bfd3e3f4c4ff1f6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzMtNi0xLTEtMjI5NTc5_2e6d19b4-b6b7-466a-a53d-7db2bc8b9e7d"
      unitRef="usd">449900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id75f25869b5146e58f626502da7c7971_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtMi0xLTEtMjI5NTc5_47e340f6-7307-487e-a570-6ef177e228a3"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7ce077a3e4744e96a9f84ad3d59a2424_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtNC0xLTEtMjI5NTc5_e6dd2134-4c6c-49ef-bed8-52816a9abaac"
      unitRef="usd">188000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic98ae2d3393544a89fec8d3f7e79ceb2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzQtNi0xLTEtMjI5NTc5_4757575d-635b-401d-8fd2-6f34f43efb09"
      unitRef="usd">188000000.0</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia62a4bb28ea746489ab2bda95c3e5be5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtMi0xLTEtMjI5NTc5_17bd2630-202a-45e0-baf5-ef313bf0283d"
      unitRef="usd">1507300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib64989aa30ef4d9295e8155f32cda7f8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtNC0xLTEtMjI5NTc5_34b0323b-693f-42ce-92ce-5d13a10e33fb"
      unitRef="usd">1308100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84486f7fd7d2438aa00664a5e0482b1b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTAvZnJhZzpjNzQ1MTYzOTA2ZDg0N2VlODY0OGFkYzJjNTBjZmQ3ZC90YWJsZTplNTE1ZmJmYzkwODQ0YTU0YTAyZjlhNjMwMTQxNzBmMi90YWJsZXJhbmdlOmU1MTVmYmZjOTA4NDRhNTRhMDJmOWE2MzAxNDE3MGYyXzUtNi0xLTEtMjI5NTc5_2d26fccf-b860-4f56-8657-d2d5812ca435"
      unitRef="usd">2815400000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjlhZmZlZjRiMjYzZDRjNzA5NzU0NmUyZWU3MzI2YTRhL3NlYzo5YWZmZWY0YjI2M2Q0YzcwOTc1NDZlMmVlNzMyNmE0YV8yNTMvZnJhZzo2MzdjYWI0ODYzN2E0Yzg1YTA4OTdiZGZiYTZmYzc5YS90ZXh0cmVnaW9uOjYzN2NhYjQ4NjM3YTRjODVhMDg5N2JkZmJhNmZjNzlhXzEyNTc_f1d61ba0-283a-4656-a543-5475b46e2dd9">20.&#160;&#160;SUBSEQUENT EVENTS</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>117
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M&V-/'@1R?"7/IA\_'H5L!=D!TU) 1AZU;JY?RCCE3] CPN:#L/G_"%LW2H%
MLH5:*N0B)SMDV.AKLL8);\CR+IJV I6[T=0DE8W KG^'Z##]RZ[I_Z9W3\<3
M4SD7FI1P,%!_\LD(4MTX=@[*VHW 7J(9*&<6Y@4#91/,_D%*/#OV@.%-3-X
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M! W]\= #W4Z*UK"J:KHS599ZO=D6-%Q1NP Z7RME=X9+T(_K^5]02P,$%
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M+ZC]/=07D-@H\%K(=WV_ 3[X.-S;ACO*9.G4+YWZAB_8YU3.@*,;@L>$$DE
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MUM?MK9OZ]O]WH5=9::!,O@.7P4D""4O7%^KU!ZLVU9WT7%FKBNKM6@H8&6<
MW]\I99\_N!_8_;>&R?\!4$L#!!0    ( +QP7%8]3CKF= 4   X4   8
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MAY\0A"L!?+]E3'[<J!>4/TI&OP!02P,$%     @ O'!<5H0>)/=G"   ;S\
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M65(6(B&K;&7SF&'DIX/"P(:.T[!#1"*KVT[?35FW31,1D A/&>!)&"*VZ^.
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M5U;5%8NF"WMT,T^KNL*41V<+'FY!*D'7,4"8F(31"\Q-JJY;5)J+1=,%9H7
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M<3) O;_B7+X>) WR?7"#OP!02P,$%     @ O'!<5@_,568;)0  WW0  !D
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MBM<P?PZTL6QC^G5;XA 3&'=A\;,[H*9ARIZL3&,@5>@,;]:F2299YY -$4*
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M1X1MS[./3D!B7G-+_I"=G#1GU4Y[@-%;WXT7(6ZZS@DDVE8Y=&YW4!A8 L?
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M<784V"A 'C?Y^%FU(FR"U.]16P3:GIW9'8M*E>:$AK)>P&L_YRX.^)5?281
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M@"<Y4/53(XK!#T:PL6P.:>DN+>1<TS=H9R/YU.4W' H@RM LIO,J)U:/8?3
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M(Y2K+F":A =QBUS\#._>F.U.UH<OX^)B>8 ):P"/1NSD05EW6015KZUI=T[
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MA>A.^+C4SB<DP-O6D.&TUL,OS@"WUL:)"_0S#&F9V/G@EIV(1$Q(C!PDD\*
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M4^3>2OM1^33'L8M2)WHV^2IVD+ ^@^J@=3@:C(C>3[\2<@?BE\6&[:2ASO&
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MCPTK>(?#/["CXM!]HROE#5=:_>#X[0_P?H5.1B0KK?.MA(78?BSN<#9(@W?
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M^=H<]"O_XX!E/E?"-^CM:OO[PSQ\[7Y_//QX\9:;E82+"[$$*6XW:8^9\(-
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;*55VV[C-A#]E8$:%%U
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M4?D#8<)5:OCB=.6O+Q?:X;CC']>$_<4P =XO-<#3?&$%N_OLVW\#4$L#!!0
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M[/,;>P".<RNV >W ;JF#8R\8-/]>\4]@G!%.R#Y<3:>>;_US\E_\$T43;S*
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M9Q.X<GQ^VG5-K))*O61T6:G7BZ=,TK] \><6C5%X$U\$+MFU/OG(H!EUZJC
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M[1>,D*KPO-M8A#SW:YJ01P*2;@W[-@KG4C5K!8^F0A[*"EV^>/,<3_A#7R8
M*6">K(F"7,)=S&IAFX"'':B$9@:5;$K<M+/E!K)$CY0P8:T+6Z G^P6@TZH
MWI*?B(=/P.&NXG5-68/KOXCA?NSR(J;[1%\B+L=1O%LCHF=8MZS_?59?#NV
M;A/&'.5/="+/7A6\WXI$T?Y6 BBQ5]UFQ]P?H)./QNWK@'/1O^A1R_ZC7_D2
M0Z?H2BZBX<7V+L#?$/1'_6@TW-OGL*&/?1<_&D;C/@('$57,<_;]3=NX-^ M
M8O+\)9XW_&@$VDQPS0ZNVA)WW)60Q%;];]NX?3-V&!)/!,GQ& G$>F?KG;ZR
MOFK;7@B%FOV/AJ VUYSAYNZ>>!;KKUM$$V>8<DK6QPVW90?M5>N"*[H,S2SI
MOM;H@Z=JA['P+I@94,A/_&,TYFU=PCUEN:UOX/G.=GM/RS>[S\WM[+2!>N>6
M%F?G?I.;X) BT!I67\+>+:+.)*ZD>SK'UWK$>9UFCD"W -R+T&D0S#*5+1J#
M'9K_'4@T.!" ?0]P$T^UA@'QG!B//J?Q<"G*3==NU\"JVUH$[80ZHA-=2L_^
M&R6L6NINF]34>4LJ?UME#!9\BTI>1>&D6_9'[D@R^A\$4@4O/)N:RQKK*7GJ
MP_$-A,KT7!,6;;<.E?: 2>_BV5\EW W="_=GM<79;3Z_ 10=?@O,.^X1$S^$
MU;__[?5_]V^OL];/'Y8*A(=^Y %3%57N_"\AFM'F=R03__.)[73_(Y3OP9<T
MSI:I&9;VHHO1B;=-_<$5)?^88EHX5RSY<:$DP(HFX/M94;CZ VW0_+KFZC]0
M2P,$%     @ O'!<5@#,\:W@(@  $WD  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C8N>&ULU5WK<]LVMO]7.-F=;3(C/Y,TZ:;MC"TGK7/K)%.[[=RY<S]
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M\2X::)GLO%80H"$^6I$'%YL'UK$K@XK?=QO 3,S5&GM9YB)*H;_@8VW@>;1
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MLUHO8*-( CPY3@$2#_"/N 8#K=F3(V*=E8#&)(U'&B$)O,3%^@(&F^O<1\,
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MZT]O/[Y^]_K])W7[R\W[NZ>7%5:AL9>A@?A"(/I[('J^>I=GU:I4K[-(1UT
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M4NG&SU'.W> 04F:6Q)'HKD%(:HH_A)"_Z6P&?/ Y@(&FCXD[0PEGK@=^0]T
MB[.;M\RE@-.G>$<FS=@96@&YX4 _:B21LS>>+B'I&''=E#\"%.2>@^95C+'
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M;.,*,4S\E=E%F1.2'7A L3[5"FZ+>9K".IJ'9-#A7XE1E'Q)^3).36C@<L*
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M09U:#:=HF%:O@1H)F]B4_99TG^VKOBTH>TTKPA':=BXG"<U>V.KTU<-6+/Z
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M_C>CW%3YFO]!.,^K*D_Y)\0/#*4!>+_(\\K>T +N+Z7/_P]02P,$%     @
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M[]Z+)\?.2YU^W&CS3E2;;5Y#[2 BYQW3.7LK'D3)]D<1N@#'@)LD\&AE)DS
M=\Y+KE+!N&/_YJI!@6&!.C'[EL7[T4LVSS+I15]&,;O@MF U7]%>@0<\^QWI
M%L8_Q%'\KZ%*<%%4"V$Z/L8LB8<JCUY$^W^J,XE>[%2: .GQ<73 =A#@L"?
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M%L0C]L;HBCG<E4F,?O?\3GF.&A'<K*WKG+O$2=(5'97&ILAU#>)IJAM%97#
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MOL%WQM^-.)=%R)(X8#SB_)UXR;;>Q,=+WHAW)U>0E&.W<JV-4^V*_76ZL,Y
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MA)2&#/!^J;7;/%""[:'TY%]02P,$%     @ O'!<5I.3!5T) @  K00  !D
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M+@ DGLR9"Y=LQK(D)EXK(6>L?[),,PB/G9U-;:' ?3#9NJK+>K63.:9DF)6
M.DE4^PK@G,1Y 1\1%I(7'C@Z^AJJC:@+6H4FW7N8Z)Q,B')\$]*<A$Y7M'9Q
M1*";6N6BWY,]R/0OF6O_M97;LPQQ(9;2Z7-(5SI>".E\C!HO'#5>C-+2KZ3
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MC1U /=ADO;,FVAGY:U+"N+;.VKBX=5MM[TAP1Q,TE>BX%%,"G/Z.4YR_?V!
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M6#D^!]?ZBS^"]A('%5C!N2AB9T]&N<17:,S':RS>H#W-+OG95>;9OGW#S"'
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M14EK44=RQWN5<W[+<HB[CJ&"=(@#'!E*KSPAG5K:>&0]>Z-;1.TSU]93Y5I
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M!@_0[\N:#'3]@ G<*W=?_3]02P,$%     @ O'!<5E$YZ,!_!   [0H  !D
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M5Y8ZL9]6]/2A=@9TOE#*WB]<@,UC.OX%4$L#!!0    ( +QP7%:OENM?U@4
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M:ZYH=HV9TK)$H1/H?L.Y.CJZ0;M^H[]02P,$%     @ O'!<5G+@$X(V!
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M$2\*(?0T^:-!F>U% 0I:HKEL)*UL@:&H_9PQTR><\SH#3V=_0O_K][RH/UQ
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M9^AEVIG$V :,21-F2-KN9K<EF2;;/G3V0;$/H(EL>249PO[Z/9*-<1KB;1_
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M2 L3_%_2LD.3G21.*I/*=2I()=K @N=&<3IR$E@S4;K8=VC%IN0'G:@1S(0
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MDL?J"]_^0LN /&TOX+$T?V%;RG9;$.12\:141@\2EA;_R?<2B.<HN*6">Z2
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MI11V<2G<*#SK%T7A66Q7'G(@I+1C@.VO[> 'CF9O"@WM2@WMXAH:9Z^_&F*
MC?O+(?B1H^F;0F2[4F2[!I'=\Q"$[XHB6ZVSZB$3,2T"^9,(ZJS85<?:$\BR
MU[E5"FT)W2C=KKP.$U VX!Y=RI@4ZRXNUD7BWCP8*D5RCM+F;E=P^Q[XU 0L
M70=4$)"E_D12'9:JV\55]]>-D$-Y4ZH07&8+7HUUMZN@>[0V9 D6<!ADZ7B8
MNU)&N[B,_EC4_!G7%I"_H*O#[!A@%T28GU+^NKC\'><6H&5]V+&NI1="THA!
ME@DZ9:6@=7%!"\9HRT7KW;<MWU3<^J$1A&65YN!2H-M5HDX RCS TH-O7NC
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M0N2"R$5@.5V$K0!]$PQH\?D<TMVW_"ZZ<"S<11_>A2YV/^JYH'L&,TW)U?C
MS+,&,#@YL_X+S'  +W:K[D8S><"P#T@7GF:YD_!@":@D+%L@\F:2+A#RO9RD
M8X:<9.##4)<F9\3&RVG2$E@E38(R38+&,K.+V.( *(X#$YV?609.U X]B.;O
MMP" OBJ:RMIB%+19C-H$BUH"JWBY7WJY_S\7HQP_,/BZK=N,+W7 #NW-H<-J
MI'3N5:6B.BFH':54Q<2KTL2K1A,G<)CK(PI:&;5$$]/$4 %60MJI'II2,)*^
MS>9\P?X!S] )K,&1S:=25YYCA4<V-Y(_<_?#TC5A\^Z_9'2O$@_F-.B!ZX2@
MF:IS2'ABZJ4N5T<.R:7"BI1_Y(Y&PF>Z8U"Z8W!6I-PR B<E4S_K3!^<F!Z$
MAS&;FUXC%80G\=]([TSCL;/OO9U&\V_)=,+%"D6,+#(N%8NAP;LSQU%M16V&
M>VM);14M:@NMZLJ#SQC\2P^O8KFV7-TF6M066M75[M[5[MM/L'.*>K'.88YB
MQ^^?E/4Z.3SP3@I[,^]S_;+_2L.-'S%0S#;&\DBL%]!6;FC"5RF4[^:4;O63
MK56TJ"VTJC_W7VW8_[4IW6:G/FD5+6H+K>KJ?>>/&UO>%E,Z.&DHL8M#JW^<
MTC5R3CBPW..4;K55MP_NR:#/6)C[1HF,[?F563E;WFG>F)L\>R^>7XC>$;%@
M$(T)G8,J?"("49'?,>8/BJ_,K=N4*VAJS-\E)3,JM "\GW,(ZN)!+U#>]([_
M!5!+ P04    " "\<%Q6#,05T&06   V+0$ &0   'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6S-G5USVSB6AO\*R[NUU5,5MT7PNS=QE2,",ZE*TMFDLWW1
MM1>,#=N:ED0/23GQUO[X)?4%@CP"#?M5T[GHMBWR$:!S")"/#LC7W_/BS_)6
MRLKYL9@ORS<GMU5U]\O967EY*Q=9^7-^)Y?U*]=YL<BJ^M?BYJR\*V1VM=YI
M,3]CDTEXMLAFRY/SU^N_?2K.7^>K:CY;RD^%4ZX6BZQX>"OG^?<W)^[)[@^?
M9S>W5?.'L_/7=]F-_"*KKW>?BOJWLSWE:K:0RW*6+YU"7K\YN7!_$6[@-7NL
M-_GOF?Q>MGYVFKY\R_,_FU_>7;TYF31-DG-Y636,K/[?O9S*^;Q!U0WYUY9Z
MLG_39L?VSSNZ6/>^[LVWK)33?/[[[*JZ?7,2GSA7\CI;S:O/^?=_R&V/@H9W
MF<_+]7^=[]MM)R?.Y:JL\L5VY[H%B]ER\__LQ_:3:.W P@,[L.T.K+-#_<;T
M#MYV!^^Q._C;'?S'[A!L=PBZ.QSJ0[C=(5Q_]IL/:_U)IUF5G;\N\N].T6Q=
MTYH?UN%:[UU_P+-EDUI?JJ)^=5;O5YV__?KEW4?^Y8MS,?VOK^^^O/OMW:\?
MOS@_I;+*9O/R;\ZI\_5+ZOST[W][?5;5;]?L=':Y1;_=H-D!M,N<#_FRNBT=
MOKR25SK@K&[GOK%LU]BWS$A,Y>7/CN>^<MB$,:)!T\?O[A*[IX_??4+LSA^Q
MNYLTN[L^L;LP[_XA*W;O[GJ&S]+;!]Y;\[Q#@5^5]5_*TKFX_-=J5L[6Q_D?
M[^N_.>\JN2C_APKX!NG3R&84_*6\RR[EFY-ZF"ME<2]/SO_CW]QP\I]4L)"P
M% GC2)@ P;0@^_L@^R:Z"O(T7WR;+;,FR*^<S_(ROUG._E=>.>^NY+*:7<^R
M;W/I7)2EK+8)4=0O9LLKYWW]TFQ>9X<LF]=7"WGURGFWO*]WRXL'*D<V+8K6
M+6HFMOMS%KF3YM_KL_MV_(U-MXT_$L:1, &":?$/]O$/QHA_ZX]4!FS:%+<R
M(/$C*@.,C;?- "2,(V$"!-,R(-QG0&C,@/?Y\N:TDL6B/MWZ5KURYDTV7*Z*
MHHZ[<Y<73490,0Q[,0PF7AQ340Q[!WS@NV% ;)H:VVH;(R1,@&!:C*)]C*(Q
MCM+I-LJM%U\YJ;R61;/;9UF/X2M)Q3[JQ9X\>HV=LCUZD3".A D03,N,>)\9
M,3HSZ,1X: W>LKX0<W[]-I_=9(>._KB7 2RA4L#8>ML40,(X$B9 ,"T%DGT*
M)&,,#A_SY24U/OQ:W<J"2HFDEQ*N'U(Y8>R.;4X@81P)$R"8EA/N1%VU3U[,
ME'%Q>9FOEO7^G[*'!D>:@$DO/3QRTC#WRS8]H#0.I0D43<^0EM=Q7TR&'!PT
MMFW43B48>1)I[HUU7B!I'$H3*)J>%TSE!1LC+S8;DCG ^C,'"V)Z=#"VW3H+
MD#0.I0D43<\")?]<HW9Z7A:\<OZ>YU??9_/Y*\,)AJS(;/#ZV>"&_H3,!J@A
MA-(XE"90-#T;E"5T1]&$GXK\3A;50_W3/%M6FV3A]5YWBQI'9H??UPX>91*F
MYAY9YP94'T)I D73<T,91-=>(3X_-?8:XK?LAVGNZ*M$C]$S!]0E0FD<2A,H
MFIX/RB>Z9J&HAOY]E--5,5O>.)]D,<OKV"YEY>37SD)FY:J0B[5H7+_D9%?_
M7)55\Q<ZVH1T#&+RNP-S(ZW##?624)I T?1P*S7ICNHF-SLT4X6\RV;U[/#C
M3BY+N=YQ?55A&ASZGM(E+96YB];) E654)I T?1D4;;2A>O*IR1+#92S^X9!
MYT7?7I[2YQ!0?0FE<2A-H&AZ7BB%Z8[B,+MY<5A#].7EJ4=F!%1>0FD<2A,H
MFE['H_PE&\5?BMER5LG3][/[!K&LLN7-[- PP?K*,HCHDTMS9VS3 DKC4)I
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M9;T:*1HNOS+WR#HWH&(.2A,HFIX;2LQ%HY1QV2ULBH:7+IJ[89T0T*6+4)I
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M;-XY/=N?R/\N9S>W5?W:Q;TLLAOI?"WE]6I>S^;7])>8YC>V3PNLB!SX6-S
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ML&C&BM) G;_F7-Y_*2^P^3&'T3]02P,$%     @ O'!<5JCU#]\C"   U$
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MH\+*V@]IQ'T6H9ANK@;7UH5C3Y,&*>)/GQYXZ3-*0EDQ]C.Y^+R^&HP3CVA
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MHI;,I#7%$D<A9UO$M;52TP-3&^.MLB%4[^)<<O65*#\9W<]&\]D<7:%[4,5
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M,T"8 /U^P;G:=<P$U8=+_ =02P,$%     @ O'!<5H.\!RDE!   .!   !D
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M"FI<^IYIGR*A4JB=\];GM[Q%P05</:@W*X0[U'U;:0%?D<>U ML'"O.I%1!
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MV!9-%71K X]YQ:)OL+J[ZRV^HUTTUYEZVM55;.YK7RUD.>":RP&YX%?F"\)
M'*T3'J4@K5+C5T+6ZC*$51JV15-5E86%>XQM/J[5VL(J#=NBJ8+*VL(]REZ?
MEJIL^0I=[6JJSM33%KC8W-=#M1AN;0G-"%O66VL+$-,RY\T>R^YJMWWWO-ZT
M^L/U"WB*FTVX$M/L";Z.V#+)"Q'4CP+IO _%PV3--MOFA--UO?'T@7).L_IP
M12+Q/J@,Q.^/E/+GD^H&W6;GZ?]02P,$%     @ O'!<5L-J+IG$!0  6",
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M%0L_BE' GI2E<6ZK^4MD+S%D*Y*OTK_U'[F4/$P7E\SUF$@$:O\3Y_)Y)3E
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MY..8;;$Q^?47V+-^J]-+)\S7"0MTPD)-L(K.W5+G;A-]<D?3)1"8)3( OPI
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M5-[;Y!,C%UE[,)8&FXUL.,=^$)0-P.]3B4>XF-B.H^PPXU]02P,$%     @
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M@OKHW^S@5G['^G(M.4_G0..I C>^];@'W; %I5$HFAVHTB^3"6Q" G7+H+0
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M"JL2_YVJ[\7&SZ0^E)LL^[7^14P_'O7K'JF9FI0U(JG^\Z@NU&Q6DZI^_-9
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M0!4NE"91-#,MM,+UW0KW@+0X<'2X;+8<K)-A3;VL1IE<E6FN5F4WTZK8.YI
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M* W$[P]Y7FT^R O(=]K7U;[Z+U!+ P04    " "\<%Q6#"NC0M *  !K10
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M&% X 8-3B)-LC,!X94> =3"@< D63L#@%,(D!R,X^05P(](@6>SA=K,@UJR
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M7-,'1QQZ@!&&M1:@< (&IQ F60ONR0='<%G,[>0F)XCH"1S1UG-"A\YD6#\
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MGU7.59K?0M2$9H<A7DPSD!2TV1-)B9Y)B2:0\KZH,W&MVKE85>#<B(R>,8B
M_<RX:89-_OBY:S':M?-YO4[+/%TX+^Y% /2'(]QE!74F-BY_#$YSP X:=HXV
M:^)X)L^=3O89S^.;=CP?FWM]+D81['EB]LB#>@[8^5#/ ;L0&4DVDT'*;,(S
M,"UNG<_U0U8Z5Z*'95;G929BTEHS^YK>+#+G:_9#_&&QFO\U^+QL&T/TP"1%
MXU1HW8%0HD5F[XG28D=[/%( T[YG"M[BJ8RXDA$79T0$8DV'G3*M,T<H,4?,
M2.$XEX]I\7/##$C%%I0QI8.S5[,@T'F [=Q()P%MY%029(C*T$CM[)-0J.ER
M5=;Y_Z9;.2=N3:&^LK),%V#_/6-\H<#H K"#/!1O[537XV.>1P:);+\H<3^'
MVH+% \V] .Q APK8H0Y5!H8,CPR_%>UPB:X58O":)Z23%_/%6D@P\8/0X_/U
M<KT0<_K666U\[%Q,Z3)[:#3_4^9D:5GDQ3W,@AD0'L.C:QK&( TVXD8F T>&
M1X[OTKQT_DP7ZZP)C1[7C9?[D#UE"Z=1>9NY[H$\$$5V+5F4:)P*K4NI##M9
M9%G4,C2P'4TN)1JG0NN2*P-?AD>^ASVDS3 W]$!Y U@R%L%^S$9,S&10S)+?
M*7Q$0_31,Y,2C5.A==?E9!SOHN'I83.SQ=YC9@*6?3,3;_!40F0\[>+QM'RT
M.!^SM/%\MTY:.TT\M2&D_=N5F*37#VF9@;P0!< M=Y1HG JM2Z\,SEW7\F/&
M)0JL6W(IT3@56I=<&?2[>-!_V,UL!NQN&$.WZ 5@ZKL1N(Z*MW@J(U(LN/YO
M])QQ4>4R>FI2HG$JM.Y 2'GC6ESX=DU5TCLU3=/>J6E#P[A2P[@#J]^K95;5
M^7Q+PC\_9LN;K(2G%:EJ(47C5&A=$J5J<6VK%I=4M9"B<2JT+KE2M;A35,M^
M^W&N*47<((%C0]/4$__ 6Q8P#1-MA:+;6RE)7'RA_EKPE\^SS5(2V"-S+=V%
MUD8N $-P+Y(#A@%#^N+)J-ZS&-5[9JSN"G<+=14R31*PLX"I&.($ZZZ,V3T\
M9K]</BY6/S<K8D5=YC?K9E:""V$MD-H*HT^#)AQOSL3[TI,QM#>PP$VW;]I>
MJ3. $;A "EAZLP@<:1M!L*<D9TP)@B%VWJW*++\OG(MU66;%_*?SM11/C\5V
MO?R_FO77%Q]6505FT'AF"&PP-FC"\:Y,I4I&Q]Z4A(O!O6;/7 -/P-UFP# &
M_3I@R!CJ"F7@Z>&!Y]Z;SAZP1A[ 029DRK8.TNB9C2#3DT&F-R7%XO+'8S9O
M]A&^9/6ZW$US1\QZY1$!<F0F4!PS%]PO!$U!U\);TZACZJ./!AD@>G@ZQ6;X
M%TZY[:CHX6:[*.WOH9GZ<.S'X%X)8.I&8/X!WL:IDT#&<=[!J\\'N<+8&#Z#
MJD$3CO=A*D<R^O/V2M/0.!+TK)>/FVC"^5:)/U^DBWFS!Y<7]YLEP:NLS%>W
M0L3MOM?XS)?.\Q;TE[0&5PC;UAB[R+%.7(^=K[,'VWD>?/_X,I+T\4CR*BV%
M1LT?TT)$$8/A50N&385A$XZ:=/LA0T1_KS2)/=-P?#,&/(Z@8.<"LHS!K C(
MLGW&]?5.1H3^E%556\M</ND*+"D:IT+K#H0,/GV+*[ ^D(+1([P@TQ[AY9MA
MZ(#P\I6$W8$ <E*J30LZF&K38Z<[28XW<NJ8RPC3QR/,T:DV+9XZ>& BU05@
MV#H,8Y#-B#2)L"&6$:2_7P2YI^,TH[X>OVD:]KA-TW# :\K8T,=C0ZLI-[X9
M'8;Z7==2 5B&\*UL(X[T91SI#\21X(JU\W\B*JH>G+>I^'2>-9IB]YSI=0!$
ML5[+'R4:IT+K<BSC4']*8L28!6V?--F!%(U3H77?O9#!;#!E6732PED K'SJ
MDG7+(&09@S(1;_U4=F2(' R$R'VW-T5*!'[ML;.2%(U3H75YE\%[8#LE(B -
MR$G1.!5:EUP9D <6 _( 2(EPX>4NR#0)X%>N;"SZ!C)F#WZGE(B -"6"%(U3
MH74'0GD5T.:[@$!*1-_4!$S[IJ:-U>I :HT UQJ?5L7QMVNPNZ0I$*1HG JM
M2YI4,8'M%(B - 6"%(U3H77)E9(GL)<"$0#)"H$+"GW -/0\\,T+R#2987ME
M@10?P6$I$ &0 @'W!S $DWTA0ZPOH8SU0XLI$"&0K-#S7AQ@VO=>'&3JZ8ZX
MVUT9O(=4*1"AN0[- G"-!K+TP1T\O'%37R.7$73XMR5$A$!"!(/?)0<L73#1
M$&_]5'9D"!S^#@D1H1D 'X<S</L<,(67KO&.325.1LJAE?2($$AFT!UT2P20
M'P&^CP]"8DOXH8Q"0Z+\B!!ZAY"YT'+T!63K^6"V$-Z\J6.L'$'QMR9(A%#6
M Y@9<@&:AK![A1(D0O3!(</'D#9!(@02),3S W:10(:$"_?01I@7RC O_*49
M$J&9_G <^/"L@$QAYVACH3J4L6+X6R5,A#V)$$SG#[9C3&>OQRZ"[Z=(QIT1
M'G?^8W.N6;-"^I25Z7WF9#M?LE@5]\?BV;'<[I:N[G8W7;-ONMU>VMYVS@LQ
MFQ[6Q6V9W=8/\)1J6V$D?&C'$%STV>E\]-D%/7S(P#3" ]-Q"221><J$<83-
MH D'3#!1$<E ,]HKT-PSBR0R(\0 ]). H0<^+"%##^N9#!*C*6>:V5H5C$@/
M0"-%XU1HW8&006<T)>C<4[>VV/N<YP*8]NG6R(P^!W1K),//:& 1=%(&20NJ
M>RM?3Y_KL6-Z!@G>R*EC+H/0:&#=<VP&260&A/ @FW;Z\DI+@!F,8J>U1,II
M9OL=9[:GQP2"RQZ7"5CV^,S(C*APIRG#Q@@/&ZTFD$3 &U2PV@(L@QA</,3[
M,W6>RY@QPF/&C70N-E-<2(YC,<6?LL7J49"C[#9;W8;&&SCZP4.:'$&%UCV;
M3P:N\903W<;L(\2DI[21HG$JM"ZY,@J.+9[2%@/KL!'H"0!+%W;X>'NG\B$#
MZ?AW2EB.2?,C2-$X%5IW(&3<'UO,CXC-A=R^B0EE4L 3TT;X'<OP.\;#[\M_
MK?/ZI_-.J._*]L,(;\KH:4F:&T&%UAT&*0OBP/;#B"BD;\FE1.-4:%URI=R(
MIZQY[WO/FTK!2\!-8, R<.'S>6UD4,12H\13,BBL/8Q(LRU(T3@56G<@E/.A
M+1Z3%YLKYWT3$]!+/1/3AEZ*I5Z*<;WT)1,RZ;*JFZ61[1-I4">!S)"*'E(T
M3H76/9M;BI[$MNA)2$4/*1JG0NN2*T5/,D7TM!N.VRCI?"%\9F\&58MO;/KH
M+XKA[1C-F@UIE$AIE$Q)9NDXP:]I>=\A[V43:,[%PRF]!R/-!#ZT>F8022IM
MJ-"Z1$IID^#29H+W) KL\8:-]@FDVQM4:-U!D?HJF9)]/LKADJHF4C1.A=8E
M5ZJFQ&)&>6*^;!J 6CXQDWLB<-\(;^U4-J3,2<+?**Q/2#/42=$X%5IW(*2^
M2J:4M-EW6IK;-SW3TMP1ZIF6-D1.(D5.@HL<]+'4_P8$CCIZ?I&^,TN%UF54
MJ;!C^YW9A%0AD:)Q*C2MT(]:Z6=*)OV(,'YW 2.Y*-1NX8&6C*_,8Z4TSTRI
MS3/#%1!ZKW_,BWRY7NYW^P]<:?09]J1PG Q.8]I5F+;]$NWN"F0,DVHI,CB-
M8:6@T.S@G:+1NG1WS::&5F_"WT##QC-I0P&QF5+ :(;O,>%>(?VA>X7]5_H&
MKCQ^#I.J(S(XC7FEQM+,]K;2[@ID#)-N+)'!:0PKA9EF!^\M3? 2(9SNYQF>
M@K8B$Q6<QJ92DVF&*Z>QG@*+'VBK,Y'"<3(XC6FE0-,LMNX92!4:+1PG@],8
M5BH^S::\,'*H9TB ^.&5_E+(0-/&<VE%DJG%5_&BHF<?\KMLLY)U7A2;?)7W
MA9BDF^.WKLK5[7I>.YO9BL8*Q$55B:NJ6BJKJM959;8] E4AU!W#M)K-3IE6
MM4[K4*'60]8%=^#8JT(##1C/F!4-IA9U9;_36SH,KS$[?O[2ZC@J.&TT%!VW
M9R7:B?/7WV/^TNHO*CB-,45_#12Y'?O<@E?)1NAAJCJUN_&@56MVJNBJ9739
ME"VR<<\XVI*ZQ#5U[1355:OJXI5E[42][37Q53/B KIV*NBJ)70':NC2^ Y$
M(5.5Q-WQ3ZO?[!3L52OV3BK9.\Y7T-;A)2[$:Z42+U-*\;+#:_&.]Q7M-8<4
M,E75W99+*T5\F5+%EPV4\9WB+0Y:>:>M^4L+Q\G@M/%0M)[UNK^,MO O+1PG
M@],85K3AX<5_)WB/??;GJ&K\[IBTHNN4FL$,KX5+Y#N02(.V3C M'">#T_A7
M5*)K?9>.JK;OCF%:W6>E\C!32@^SH=K#5GQ%"$4:KN$M:!6>E0+$3*E S/ J
MO&<?UYM$J)Y4/J*,\H%&C)_0M.+02J%BIE0J9J[U[3N\&/)XAFGE'Q6<QK B
M_P;*(Q^VV-F"=PZBZ:G@SH"RR'TEW <:/946I= R\Z:\0&9M11ZO^SQZDI+"
M<3(X;304U3=0"/JP2>J9Q\;U3E*@2G3O)+52+IHI]:+90,'H]E"#ZVR^+O,Z
MSRI<RE(5<-Y112NTK)279DI]:>9-V80;]:RAJON\8YA6@%FI2LV4LM1L4EWJ
M \/3]IKZ0IA^8.9 V\:3:45-*?6OV4 ![/Z;?]P"%U4EZQW-M)+*2IUMIA3:
M9I[UK32\EO=XAFF%%A6<QK BM 9*>1_^'DI[ 2V/U/7UUZ '6C*>.BOR2"D
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MHJ9B7$V!SN"@'07\@J.G+BD<)X/3"%=$6&P] S&F%6:D<)P,3F-8$6;Q+\A
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MNO7FJ%$*SY\Z97;7L/;ZW#TZ,3Y_RUYSUGQ^(F'.3A_%0_^CB AR,3\7V9V
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MVWOT;W'P*I@E%N2:^;]33ZZ'5L\"'EGAK2\?V>Y7D@84#]!EOHC_@UUJZUC
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M1P;J^XHQN7^(KF2R*[C1/U!+ P04    " "\<%Q6<66X!\('  "=-@  &0
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MT5H3WQQ.TW2E-/?>39I[]8OD]2:^.=ZF/*08]\QB_ =%IU>_<EYOXIMC;,I
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MZ]8,N(J'4J!SAQ#.'3J1B26<X:<.[G2HFQU8:";C.E$)X?,W/QG-J!D)*IK
M0C-ONM$9201OHAP6S2THM.#\LHF JW:HZSIGB."<P8YB/,$,/WIHCT-%$UAH
M)NTZ2XGH$4,Y0LU$4-$$%II)K,Y$HA>O;CDDE)EU?L(U,;O,'!,S7,6A%$SV
M;G!46>U]<Q-FN=TCVEZ%N/MT=]OF>7/'9.?S]_X[L;TS4\-LK_"\2HK[-"O)
M4MXI2&\<*0^+[:V8VS=5OF[NB;S-JRI?-2\?9+*016V@OK_+\^KY3?V W=VD
M9_\'4$L#!!0    ( +QP7%9E%4J+G@(    *   9    >&PO=V]R:W-H965T
M<R]S:&5E=#@V+GAM;*V676^;,!2&_XK%IFF3NIA FDX=06K+JG;:I*C1MHMI
M%P9.@E6#J6V2]M_O&"A*)L*:*C?X\WWM\^"O8"/5O<X #'G,1:%G3F9,>4ZI
M3C+(F1[)$@IL64J5,X-%M:*Z5,#26I0+ZKGNE.:,%TX8U'5S%0:R,H(7,%=$
M5WG.U-,E"+F9.6/GN>*.KS)C*V@8E&P%"S _RKG"$NU<4IY#H;DLB(+ES+D8
MGT=3V[_N\)/#1F_EB8TDEO+>%F[3F>/:"8& Q%@'ALD:KD (:X33>&@]G6Y(
M*]S./[M?U[%C+#'3<"7%+YZ:;.9\<D@*2U8)<R<W-]#&<VK]$BET_26;IN_4
M=4A2:2/S5HPSR'G1I.RQY; E0)]^@=<*O)<*_%;@OU0P:063FDP32LTA8H:%
M@9(;HFQO=+.9&F:MQO!Y87_[PBALY:@SX:**-3Q44!CR98U?3=Y'8!@7^@/Y
M2/YMQ:JWA!*=,04ZH 8G8&UHT@YVV0SF[1GL.U,C,O9/B.=Z?H_\:EA^#?&(
M>/OET;#\*RMP=*]/3I%:A\[KT'FUG_]"=.3W-^Q!;@WD^D\?G,9NTF]G]_>Y
M+ED",P<WL :U!B=\]V8\=3_WH3JF670DLQV,?H?1'W(/([[F*12I)G/VQ&(!
M)P17,A C20Q8Q],^EL.>W4+;N](&]8?B.Y+9#KY)AV_R*GP1) )W:2^\0<=#
M%^(QS:+A6+L=_+\M?-K!.WT5/+DD=Y!(U4MOT/)0>L/SZTZ\O4?>D2:S0V_:
MT9L>2N\BEQ6>A'-09&$OB3Y^@Z:'\CNF6=28G=5F]KVT#L_P^>2Z 5UO8Z);
MUZU]&^%IL^*%)@*6*'1'9_A35//>: I&EO4-'$N#]WF=S?")!LIVP/:EE.:Y
M8"_U[M$7_@502P,$%     @ O'!<5E[43SK( @  M0H  !D   !X;"]W;W)K
M<VAE971S+W-H965T.#<N>&ULO5;O;],P$/U7K" AD-B2MEM_C#92UPTQB8FJ
MT\8'A) ;7ULS)P[VI1T2?SQG-XT*M$%LZOJA]ME^S_?\8NOZ*VWN[0( V4.J
M,CL(%HCY61C:9 $IM\<ZAXQF9MJD'"DT\]#F!KCPH%2%S2AJARF761#W_=C8
MQ'U=H)(9C VS19IR\^,<E%X-@D:P&9C(^0+=0!CW<SZ'&\#;?&PH"BL6(5/(
MK-09,S ;!,/&V:CGUOL%=Q)6=JO/G)*IUO<NN!*#('()@8($'0.G9@DC4,H1
M41K?2\Z@VM(!M_L;]G=>.VF9<@LCK3Y)@8M!T V8@!DO%$[TZCV4>DX=7Z*5
M]?]L5:Z- I84%G5:@BF#5&;KEC^4Y[ %.&GM 31+0/,/0&,?H%4"6E[H.C,O
MZX(CC_M&KYAQJXG-=?S9^&U(C<R<BS=H:%82#N,/? JJ'R)1N8$P*6'G:UAC
M#^Q2 5F).X"C^OWNN"K@=UA(*5=Y-ZN\FY[G9 _/2*<I?04WJ)-[]OD:TBF8
M+^PGF\!2^B],S]C82&W8&*@1;]@P2721H<SFA.*9X$98=IL+CD"3XAN=M9-4
MD>W25IN3NW!G-N<)# *Z41;,$H+XY8M&.WI;H[A5*6[5*IX TJ4$P2ZYR4B%
M9:](4I$6BA0(=@$SF4A\O<O+>N+"'LTYS[]N-MCP;[&7Y+N.9,W=\=SNR5C&
M43]<[M!Y4ND\^4^=SV9O;6*/M/>TDGUZ*'OKB9]F[YJ[NV7O42?RO]TNMRNY
M[=JLAD)(]XYSQ<9<BB.9L1'/)5+\;';79OA(NSN5_LZA[*XG?IK=G;_LWN-S
MM]+9K??YX^B*#1&-G!;(IPH8:G+<;'MS<*-K4WRDT;WJ 'J',KJ>^&E&]_[Y
M;(=;184KZ*ZYF<O,,@4SPD3''7H:S+I(6@>H<U\P3#52U>*["ZHKP;@%-#_3
M&C>!*UVJ2C7^!5!+ P04    " "\<%Q6^LFB:T #   (%   #0   'AL+W-T
M>6QE<RYX;6S=6&U/VS 0_BN1&1-($VF;D3:CK;150IJT34CP8=^0VSBM)<?)
M')>U_'I\L9N^X.L8'T:[5!#['C]WSYTOC:%?Z:5@MS/&=+#(A:P&9*9U^2D,
MJ\F,Y;2Z*$HF#9(5*J?:3-4TK$K%:%H!*1=AI]6*PYQR289].<^O<UT%DV(N
M]8!T&U-@;U_3 6G''TE@W8V*E W(_=G[7_-"7[T+[/WDP\E)ZZ)U?WZUBYPY
MZ)R$7L>7VX[7COY$C%^@"-6#.>V^*,U]>:*N>YY$3YL\3S%:XJW/!A,F"+G;
M\I.WV8X>ND88]K-"KOLA(M9@_-.<!0]4#,B("CY6'%@9S;E86G,'#)-"%"K0
MIA%-P#98JD<+M^T,>M3YR;DL5!W;1K"_QV[Y#K":@4 N1".P0ZQAV"^IUDS)
M:S.I%]?&9U#@QG?+TBB<*KIL=R[)FE#?3)!QH5*FFC!MLC(-^X)E($?QZ0SN
MNBA# +4N<C-(.9T6DM8:5@PW,&XG3(A;>(!_9EN^%]G&SM7[)INA$>2&UHV=
M@/]-;];WIMOH57Z#DC\4^LO<I"/K.?0WNU$LXXMZOL@: 9CW-NZ=EJ58?A9\
M*G-FDW]QP&&?KGC!K%#\T42#5ID8 U,D>&!*\\FFY;>BY1U;Z%4[+3)<<^<(
M-?_;.D^99(J*3=&F]P^YRJ]6[-YX;Z&Y_EK958R(O#P&D?'ABXRZAZ_1G4X.
M763O&$0F1R"R^V;?FGM%ANZ4L7&4V3K(--8 #HP#\@,.H&(=-!C/N=!<NMF,
MIRF3S\XSQKVF8_-GSI9_LSYE&9T+?=>  [(>?V<IG^=)L^H&"N%6K<??(+UV
MW)Q632PN4[9@Z<A-U71<#P,S,%'=!81=Y+J^_ C&L9@? 0R+@RG .):%Q?F?
M\NFA^5@,T];S(CV4TT,YEN5#1O4'B^/G).;R9YHD413'6$5'(Z^"$5:W.(8?
MOS=,&S"P.!#I[VJ-[S;>(?O[ -O3?1V"98IW(I8I7FM _'4#1I+X=QN+ PQL
M%[#>@?C^.-!3?DX4P:YBVK G&$>2!$.@%_T]&L=(=6+X^/<'>TJB*$G\"&!^
M!5&$(? TX@BF #1@2!35[\&=]U&X>D^%Z__]#9\ 4$L#!!0    ( +QP7%:7
MBKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E
M\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!
M2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/
M06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3
MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MW_0'.7<">2@>06/Q"!<S7BT63O1)8,7>+/"FWL0)$N),)N$J2#P9$U0&LC-
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MXZ_+KY,3=JXXA_N*X?DO4$L#!!0    ( +QP7%8AV_FQ,0(  ,TQ   3
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M<F]P<R]A<' N>&UL4$L! A0#%     @ O'!<5O8>&_SO    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ O'!<
M5IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " "\<%Q6B,X^;:$(  !N/   &
M@($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ O'!<
M5D)'RFR="@  M#D  !@              ("!Y1   'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( +QP7%8I/M=&(0(  !\%   8
M      " @;@;  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" "\<%Q6#P1>#9,"  "Z!0  &               @($/'@  >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ O'!<5E7>L+V2 @  J 4  !@
M             ("!V"   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( +QP7%89-*"'! ,  )@(   8              " @: C  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "\<%Q6C@<+;6<'  #B
M(   &               @(':)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ O'!<5CU..N9T!0  #A0  !@              ("!=RX
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( +QP7%8QY!TM
M_0,  * ,   8              " @2$T  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " "\<%Q6A!XD]V<(  !O/P  &0
M@(%4.   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( +QP
M7%;KJU<YX ,  '(.   9              " @?)   !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ O'!<5M!FJGXQ!   71<  !D
M         ("!"44  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " "\<%Q6Z"SZ ?P$   3)P  &0              @(%Q20  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( +QP7%8/S%5F&R4  -]T
M   9              " @:1.  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ O'!<5FKAJ!"(%0  L$$  !D              ("!]G,
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "\<%Q6S 8/
M<',(  "A&0  &0              @(&UB0  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( +QP7%9(J$/'J 0  .T,   9
M  " @5^2  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
MO'!<5EXGA= @!@  ^0X  !D              ("!/I<  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " "\<%Q60@4Z06T#  !:!P  &0
M            @(&5G0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( +QP7%9DBP88\08  - 0   9              " @3FA  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ O'!<5H5Z'3Z& @
MG 4  !D              ("!8:@  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " "\<%Q6L(6>-W@(  #;%@  &0              @($>
MJP  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( +QP7%88
MU\B6+@<  . 1   9              " @<VS  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ O'!<5M#N5*,"#0  RR(  !D
M     ("!,KL  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +QP7%:H(M]WW 4  'X/   9              "
M@3T2 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ O'!<
M5BYJRT7< @  )08  !D              ("!4!@! 'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " "\<%Q6H>8^3U0&  "@#@  &0
M        @(%C&P$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( +QP7%:3DP5="0(  *T$   9              " @>XA 0!X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ O'!<5EKNTF;I)   ?G<
M !D              ("!+B0! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " "\<%Q643GHP'\$  #M"@  &0              @(%.20$
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( +QP7%;K'/$2
MBP0  !L,   9              " @01. 0!X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ O'!<5MDK<HH$ P  >@8  !D
M ("!QE(! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "\
M<%Q6?F5PEAP#  !8!P  &0              @($!5@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( +QP7%:OENM?U@4  )L0   9
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M970T,BYX;6Q02P$"% ,4    " "\<%Q6E5/L^'0$  "'"P  &0
M    @(%4;P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M +QP7%;M-J"<&P@  ,@6   9              " @?]S 0!X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ O'!<5LQA;.J[!0  (0\  !D
M             ("!47P! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"
M% ,4    " "\<%Q6/Y;UJ\X*  #C(0  &0              @(%#@@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( +QP7%;)M?^<U ,
M -L*   9              " @4B- 0!X;"]W;W)K<VAE971S+W-H965T-#<N
M>&UL4$L! A0#%     @ O'!<5B;>#RL7!    @L  !D              ("!
M4Y$! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "\<%Q6
M"2JDV]\"   +!@  &0              @(&AE0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Y+GAM;%!+ 0(4 Q0    ( +QP7%89E!,WB 0  .4)   9
M      " @;>8 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%
M  @ O'!<5OZ_&7_*!P  PQP  !D              ("!=IT! 'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6Q02P$"% ,4    " "\<%Q6Q6+9M1H/  #/E
M&0              @(%WI0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+
M 0(4 Q0    ( +QP7%:/:?W*OP0  /45   9              " @<BT 0!X
M;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ O'!<5@S$%=!D
M%@  -BT! !D              ("!OKD! 'AL+W=O<FMS:&5E=',O<VAE970U
M-"YX;6Q02P$"% ,4    " "\<%Q6J4KQ/EX(  #800  &0
M@(%9T $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( +QP
M7%:H]0_?(P@  -1    9              " @>[8 0!X;"]W;W)K<VAE971S
M+W-H965T-38N>&UL4$L! A0#%     @ O'!<5OYM!FB+!P  E#(  !D
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M=#8Q+GAM;%!+ 0(4 Q0    ( +QP7%92&W4/+ 0  %04   9
M  " @1[W 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @
MO'!<5F#3NVTK!@  ^"P  !D              ("!@?L! 'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6Q02P$"% ,4    " "\<%Q6PVHNF<0%  !8(P  &0
M            @('C 0( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4
M Q0    ( +QP7%:J&)&O604  %8B   9              " @=X' @!X;"]W
M;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ O'!<5GC0IW.Y!P
MW$,  !D              ("!;@T" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX
M;6Q02P$"% ,4    " "\<%Q6*#!X1QT%  "1'0  &0              @(%>
M%0( >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( +QP7%::
M21+8R0(  +$'   9              " @;(: @!X;"]W;W)K<VAE971S+W-H
M965T-C@N>&UL4$L! A0#%     @ O'!<5DFC@UJK P  !A0  !D
M     ("!LAT" 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +QP7%9<D!U-G1(  $OU   9              "
M@1DW @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ O'!<
M5I+9/.Z#$   JG\  !D              ("![4D" 'AL+W=O<FMS:&5E=',O
M<VAE970W-2YX;6Q02P$"% ,4    " "\<%Q6#"NC0M *  !K10  &0
M        @(&G6@( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0
M   ( +QP7%9LR_X@82   *>+ 0 9              " @:YE @!X;"]W;W)K
M<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ O'!<5M A%2^M%0  W^X
M !D              ("!1H8" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q0
M2P$"% ,4    " "\<%Q6O/X275X,  !J?P  &0              @($JG (
M>&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( +QP7%8;Y6JA
M3 0  (X;   9              " @;^H @!X;"]W;W)K<VAE971S+W-H965T
M.# N>&UL4$L! A0#%     @ O'!<5G%EN ?"!P  G38  !D
M ("!0JT" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    " "\
M<%Q6F<@&#X,'  "/.   &0              @($[M0( >&PO=V]R:W-H965T
M<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( +QP7%:15OOA,@8  %\F   9
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M970X-RYX;6Q02P$"% ,4    " "\<%Q6^LFB:T #   (%   #0
M    @ $2UP( >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +QP7%:7BKL<P
M !,"   +              "  7W: @!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M +QP7%:C.,:.H08  "@Y   /              "  6;; @!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "\<%Q60,IUT8X"  !,,P  &@
M@ $TX@( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "\
M<%Q6(=OYL3$"  #-,0  $P              @ 'ZY ( 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     7P!? ! :  !<YP(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>418</ContextCount>
  <ElementCount>601</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>117</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Document - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/OTHERLIABILITIES</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Document - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/OTHERLIABILITIES_1</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Document - OTHER LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/OTHERLIABILITIES_2</Role>
      <ShortName>OTHER LIABILITIES</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000010 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000011 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - REVENUE (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/REVENUENotes</Role>
      <ShortName>REVENUE (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Restructuring and Related Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RestructuringandRelatedActivities</Role>
      <ShortName>Restructuring and Related Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - LEASES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/LEASESNotes</Role>
      <ShortName>LEASES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - ACCRUED EXPENSES AND OTHER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - STOCK COMPENSATION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS</Role>
      <ShortName>STOCK COMPENSATION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - PENSION AND POSTRETIREMENT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/REVENUENotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS Business Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables</Role>
      <ShortName>BUSINESS ACQUISITIONS &amp; DISPOSITIONS Business Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Restructuring and Related Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables</Role>
      <ShortName>Restructuring and Related Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/RestructuringandRelatedActivities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/LEASESNotes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - ACCRUED EXPENSES AND OTHER (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DEBT</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/INCOMETAXES</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - STOCK COMPENSATION PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables</Role>
      <ShortName>STOCK COMPENSATION PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - REVENUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/REVENUEDetails</Role>
      <ShortName>REVENUE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/REVENUETables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails</Role>
      <ShortName>Receivables, Loans, Notes Receivable, and Others (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - BUSINESS ACQUISITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS DISPOSITIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS &amp; DISPOSITIONS DISPOSITIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - BUSINESS ACQUISITIONS &amp; DISPOSITIONS Envigo (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails</Role>
      <ShortName>BUSINESS ACQUISITIONS &amp; DISPOSITIONS Envigo (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Restructuring and Related Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails</Role>
      <ShortName>Restructuring and Related Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESDetails</Role>
      <ShortName>LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/LEASESTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - LEASES - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESLeaseCostDetails</Role>
      <ShortName>LEASES - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - LEASES - Supplemental Cash Flow (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flow (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - LEASES - Supplemental Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails</Role>
      <ShortName>LEASES - Supplemental Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - LEASES - Maturity of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/LEASESMaturityofLeasesDetails</Role>
      <ShortName>LEASES - Maturity of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT, NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - ACCRUED EXPENSES AND OTHER (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails</Role>
      <ShortName>ACCRUED EXPENSES AND OTHER (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - DEBT - SCHEDULE OF SHORT-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails</Role>
      <ShortName>DEBT - SCHEDULE OF SHORT-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails</Role>
      <ShortName>DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - DEBT - CREDIT FACILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails</Role>
      <ShortName>DEBT - CREDIT FACILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - DEBT - COVERTIBLE SUBORDINATED NOTES (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails</Role>
      <ShortName>DEBT - COVERTIBLE SUBORDINATED NOTES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - DEBT - SENIOR NOTES (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.labcorp.com/role/DEBTSENIORNOTESDetails</Role>
      <ShortName>DEBT - SENIOR NOTES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails</Role>
      <ShortName>PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/INCOMETAXESTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - STOCK COMPENSATION PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails</Role>
      <ShortName>STOCK COMPENSATION PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - PENSION AND POSTRETIREMENT PLANS - Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails</Role>
      <ShortName>PENSION AND POSTRETIREMENT PLANS - Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails</Role>
      <ShortName>DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.labcorp.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.labcorp.com/role/SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="lh-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - lh-20221231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - lh-20221231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, dei:DocumentPeriodEndDate, us-gaap:AllowanceForDoubtfulAccountsReceivable, us-gaap:CommonStockSharesIssued -  lh-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="lh-20221231.htm">lh-20221231.htm</File>
    <File>exhibit1012thirdarcreditag.htm</File>
    <File>exhibit1018thomaspikeemplo.htm</File>
    <File>exhibit212022.htm</File>
    <File>exhibit2312022.htm</File>
    <File>exhibit2322022.htm</File>
    <File>exhibit24102022.htm</File>
    <File>exhibit2412022.htm</File>
    <File>exhibit2422022.htm</File>
    <File>exhibit2432022.htm</File>
    <File>exhibit2442022.htm</File>
    <File>exhibit2452022.htm</File>
    <File>exhibit2462022.htm</File>
    <File>exhibit2472022.htm</File>
    <File>exhibit2482022.htm</File>
    <File>exhibit2492022.htm</File>
    <File>lh-20221231.xsd</File>
    <File>lh-20221231_cal.xml</File>
    <File>lh-20221231_def.xml</File>
    <File>lh-20221231_lab.xml</File>
    <File>lh-20221231_pre.xml</File>
    <File>lh10-kex3112022.htm</File>
    <File>lh10-kex3122022.htm</File>
    <File>lh10-kex322022.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lh-20221231_g1.jpg</File>
    <File>lh-20221231_g2.jpg</File>
    <File>lh-20221231_g3.jpg</File>
    <File>lh-20221231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1640">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>123
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lh-20221231.htm": {
   "axisCustom": 2,
   "axisStandard": 34,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1640,
    "http://xbrl.sec.gov/dei/2022": 41
   },
   "contextCount": 418,
   "dts": {
    "calculationLink": {
     "local": [
      "lh-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lh-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lh-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lh-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lh-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lh-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 947,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 8,
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 14
   },
   "keyCustom": 106,
   "keyStandard": 495,
   "memberCustom": 39,
   "memberStandard": 65,
   "nsprefix": "lh",
   "nsuri": "http://www.labcorp.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.labcorp.com/role/DocumentandEntityInformationDocument",
     "shortName": "Document and Entity Information Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ice6b446a0be14f92ad87a9e60cdfb741_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000011 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "10",
     "role": "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ice6b446a0be14f92ad87a9e60cdfb741_I20191231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING - EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "lh:InternalUseSoftwarePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:Propertyplantandequipmentusefullifesoftwareminimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "y",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING - PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "lh:InternalUseSoftwarePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "lh:Propertyplantandequipmentusefullifesoftwareminimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "y",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING - INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "lh:IntangibleAssetsFiniteLivedPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ib808cf79e1a9467cb239ce57e26f5d7a_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - REVENUE (Notes)",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.labcorp.com/role/REVENUENotes",
     "shortName": "REVENUE (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - BUSINESS ACQUISITIONS",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Restructuring and Related Activities",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.labcorp.com/role/RestructuringandRelatedActivities",
     "shortName": "Restructuring and Related Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - LEASES (Notes)",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.labcorp.com/role/LEASESNotes",
     "shortName": "LEASES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - ACCRUED EXPENSES AND OTHER",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER",
     "shortName": "ACCRUED EXPENSES AND OTHER",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.labcorp.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.labcorp.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - STOCK COMPENSATION PLANS",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS",
     "shortName": "STOCK COMPENSATION PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES",
     "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - PENSION AND POSTRETIREMENT PLANS",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS",
     "shortName": "PENSION AND POSTRETIREMENT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "menuCat": "Notes",
     "order": "29",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityWellKnownSeasonedIssuer",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000003 - Document - Cover",
     "menuCat": "Cover",
     "order": "3",
     "role": "http://www.labcorp.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityWellKnownSeasonedIssuer",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "menuCat": "Notes",
     "order": "30",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "31",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "32",
     "role": "http://www.labcorp.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "33",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - REVENUE (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.labcorp.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - BUSINESS ACQUISITIONS & DISPOSITIONS Business Acquisitions (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
     "shortName": "BUSINESS ACQUISITIONS & DISPOSITIONS Business Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Restructuring and Related Activities (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables",
     "shortName": "Restructuring and Related Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.labcorp.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000004 - Document - OTHER LIABILITIES",
     "menuCat": "Cover",
     "order": "4",
     "role": "http://www.labcorp.com/role/OTHERLIABILITIES",
     "shortName": "OTHER LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - ACCRUED EXPENSES AND OTHER (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables",
     "shortName": "ACCRUED EXPENSES AND OTHER (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ida74c70113ea42e8b0e85554786fb918_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.labcorp.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ida74c70113ea42e8b0e85554786fb918_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.labcorp.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SummaryOfValuationAllowanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - STOCK COMPENSATION PLANS (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables",
     "shortName": "STOCK COMPENSATION PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)",
     "menuCat": "Tables",
     "order": "46",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables",
     "shortName": "PENSION AND POSTRETIREMENT PLANS Pension and Postretirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "47",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "menuCat": "Tables",
     "order": "48",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "49",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000005 - Document - OTHER LIABILITIES",
     "menuCat": "Cover",
     "order": "5",
     "role": "http://www.labcorp.com/role/OTHERLIABILITIES_1",
     "shortName": "OTHER LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "50",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i84486f7fd7d2438aa00664a5e0482b1b_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:SalesCommissionAmortizationPeriodMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - REVENUE (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.labcorp.com/role/REVENUEDetails",
     "shortName": "REVENUE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:SalesCommissionAmortizationPeriodMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Receivables, Loans, Notes Receivable, and Others (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails",
     "shortName": "Receivables, Loans, Notes Receivable, and Others (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - BUSINESS ACQUISITIONS (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - BUSINESS ACQUISITIONS & DISPOSITIONS DISPOSITIONS (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
     "shortName": "BUSINESS ACQUISITIONS & DISPOSITIONS DISPOSITIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ia47c7c87f6b64fd7a66d9548db579dc1_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - BUSINESS ACQUISITIONS & DISPOSITIONS Envigo (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
     "shortName": "BUSINESS ACQUISITIONS & DISPOSITIONS Envigo (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Restructuring and Related Activities (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails",
     "shortName": "Restructuring and Related Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lh:Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - LEASES (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.labcorp.com/role/LEASESDetails",
     "shortName": "LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lh:LeaseDisclosureTableTextBlockTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - LEASES - Lease Cost (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.labcorp.com/role/LEASESLeaseCostDetails",
     "shortName": "LEASES - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lh:LeaseDisclosureTableTextBlockTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000006 - Document - OTHER LIABILITIES",
     "menuCat": "Cover",
     "order": "6",
     "role": "http://www.labcorp.com/role/OTHERLIABILITIES_2",
     "shortName": "OTHER LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - LEASES - Supplemental Cash Flow (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails",
     "shortName": "LEASES - Supplemental Cash Flow (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - LEASES - Supplemental Balance Sheet (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails",
     "shortName": "LEASES - Supplemental Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - LEASES - Maturity of Leases (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails",
     "shortName": "LEASES - Maturity of Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - PROPERTY, PLANT AND EQUIPMENT, NET (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT, NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "7",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - SCHEDULE OF GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i8a9ef489cb7a41cb9d0480c92ad8a8c9_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - COMPONENTS OF IDENTIFIABLE INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - SUMMARY OF ACQUIRED AMORTIZABLE INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i89543227f0574d3080d3504a668d3480_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - ACCRUED EXPENSES AND OTHER (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails",
     "shortName": "ACCRUED EXPENSES AND OTHER (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i7ebdf7872d5a46479565341763836748_I20190603",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:A2019TermLoan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - DEBT - SCHEDULE OF SHORT-TERM DEBT (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
     "shortName": "DEBT - SCHEDULE OF SHORT-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i065eee6e47b54c3090870de60295f740_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:Shorttermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredRevenueRevenueRecognized1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
     "shortName": "DEBT - SCHEDULE OF LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:Longtermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - DEBT - CREDIT FACILITIES (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
     "shortName": "DEBT - CREDIT FACILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:Longtermdebtissuancecosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongTermDebtTextBlock",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - DEBT - COVERTIBLE SUBORDINATED NOTES (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
     "shortName": "DEBT - COVERTIBLE SUBORDINATED NOTES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - DEBT - SENIOR NOTES (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
     "shortName": "DEBT - SENIOR NOTES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:TotalShortandLongTermDebtIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
     "shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - INCOME TAXES (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.labcorp.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsOfForeignSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - STOCK COMPENSATION PLANS (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails",
     "shortName": "STOCK COMPENSATION PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lh:AssumedBenefitPaymentsByYearTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "lh:Maximumdeferralpercentageofannualbasesalary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS - FAIR VALUE OF PLAN ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lh:DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS, OTHER DISCLOSURES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNetFundedStatusTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i6bfe9229fe0440ca8da42020bd1ff07e_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFundedStatusOfPlan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - PENSION AND POSTRETIREMENT PLANS - Funded Status (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
     "shortName": "PENSION AND POSTRETIREMENT PLANS - Funded Status (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:IncreaseDecreaseInNoncontrollingInterestPut",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:IncreaseDecreaseInNoncontrollingInterestPut",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Schedule of Derivative Instruments in Statement of Financial Position at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i93446d1780df4a17825fb9e3f5392c19_D20221001-20221231",
      "decimals": "1",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnOilAndGasHedgingActivity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:GainRecognizedonExitofInterestRateSwapArrangement",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
     "shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Effects of Interest Rate Swap on Other Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "lh:BalanceOfSeniorNotesMatureDuringQ42020",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:InterestPaidInCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "lh:InterestPaidInCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "if4525567f3af4381925d303df86c2fd0_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i9deaf97408a241ccbbd50fa1238da6cd_D20230313-20230313",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendPayableDateToBePaidDayMonthAndYear",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.labcorp.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000010 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "ief39c4d81108483fa64f80181bbbeeb7_D20220101-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lh-20221231.htm",
      "contextRef": "i77657f2f79234f079d9a8cd7d6c65a76_I20200101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - lh-20221231.htm",
     "menuCat": "Cover",
     "order": "87",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - lh-20221231.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 117,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r933",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r933",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r933",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r933",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
        "label": "Document [Domain]",
        "terseLabel": "Document [Domain]"
       }
      }
     },
     "localname": "DocumentDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationDocumentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Document Information, Document [Axis]",
        "terseLabel": "Document Information, Document [Axis]"
       }
      }
     },
     "localname": "DocumentInformationDocumentAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r931"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityNumberOfEmployees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of persons employed by the Entity",
        "label": "Entity Number of Employees",
        "terseLabel": "Entity Number of Employees"
       }
      }
     },
     "localname": "EntityNumberOfEmployees",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "decimalItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r930"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r933",
      "r934",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.labcorp.com/role/DocumentandEntityInformationDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lh_A155SeniorNotesDue2026": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.55% senior notes due 2026",
        "label": "1.55% senior notes due 2026",
        "terseLabel": "1.55% senior notes due 2026"
       }
      }
     },
     "localname": "A155SeniorNotesDue2026",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2.30seniornotesdue2024": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.30% senior notes due 2024",
        "label": "2.30% senior notes due 2024",
        "terseLabel": "2.30% senior notes due 2024"
       }
      }
     },
     "localname": "A2.30seniornotesdue2024",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2.95seniornotesdue2029": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.95% senior notes due 2029",
        "label": "2.95% senior notes due 2029",
        "terseLabel": "2.95% senior notes due 2029"
       }
      }
     },
     "localname": "A2.95seniornotesdue2029",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2018SwapAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Swap Agreements",
        "label": "2018 Swap Agreements [Member]",
        "terseLabel": "2018 Swap Agreements"
       }
      }
     },
     "localname": "A2018SwapAgreementsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2019AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Acquisitions",
        "label": "2019 Acquisitions [Member]",
        "terseLabel": "2019 Acquisitions"
       }
      }
     },
     "localname": "A2019AcquisitionsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2019TermLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Term Loan",
        "label": "2019 Term Loan",
        "terseLabel": "2019 Term Loan"
       }
      }
     },
     "localname": "A2019TermLoan",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A2020AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Acquisitions",
        "label": "2020 Acquisitions [Member]",
        "terseLabel": "2020 Acquisitions"
       }
      }
     },
     "localname": "A2020AcquisitionsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2021AcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 acquisitions",
        "label": "2021 acquisitions [Member]",
        "terseLabel": "2021 acquisitions"
       }
      }
     },
     "localname": "A2021AcquisitionsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2022ASRSettlementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 ASR Settlement",
        "label": "2022 ASR Settlement [Member]",
        "terseLabel": "2022 ASR Settlement"
       }
      }
     },
     "localname": "A2022ASRSettlementMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2022ShareRepurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Share Repurchases",
        "label": "2022 Share Repurchases [Member]",
        "terseLabel": "2022 Share Repurchases"
       }
      }
     },
     "localname": "A2022ShareRepurchasesMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A2022SwapAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Swap Agreements",
        "label": "2022 Swap Agreements [Member]",
        "terseLabel": "2022 Swap Agreements"
       }
      }
     },
     "localname": "A2022SwapAgreementsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_A270SeniorNotesDue2031": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% senior notes due 2031",
        "label": "2.70% senior notes due 2031",
        "terseLabel": "2.70% senior notes due 2031"
       }
      }
     },
     "localname": "A270SeniorNotesDue2031",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A3.60Seniornotesdue2025": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.60% Senior notes due 2025",
        "label": "3.60% Senior notes due 2025",
        "terseLabel": "3.60% Senior notes due 2025"
       }
      }
     },
     "localname": "A3.60Seniornotesdue2025",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A4.00Seniornotesdue2023": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.00% Senior notes due 2023",
        "label": "4.00% Senior notes due 2023",
        "terseLabel": "4.00% Senior notes due 2023"
       }
      }
     },
     "localname": "A4.00Seniornotesdue2023",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_A4.70Seniornotesdue2045": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.70 % Senior notes due 2045",
        "label": "4.70 % Senior notes due 2045",
        "terseLabel": "4.70 % Senior notes due 2045"
       }
      }
     },
     "localname": "A4.70Seniornotesdue2045",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from Ontario government sponsored healthcare plan",
        "label": "Accounts receivable from Ontario government sponsored healthcare plan",
        "terseLabel": "Accounts receivable from Ontario government sponsored healthcare plan"
       }
      }
     },
     "localname": "AccountsreceivablefromOntariogovernmentsponsoredhealthcareplan",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AccruedPassThroughExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued pass through expenses",
        "label": "Accrued pass through expenses",
        "terseLabel": "Accrued pass through expenses"
       }
      }
     },
     "localname": "AccruedPassThroughExpenses",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AccumulatedOtherComprehensiveEarningsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Earnings [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Earnings [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveEarningsAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_AllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Credit Loss",
        "label": "Allowance for Credit Loss",
        "terseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AllowanceforCreditLossWriteOff": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for Credit Loss, Write Off",
        "label": "Allowance for Credit Loss, Write Off",
        "terseLabel": "Allowance for Credit Loss, Write Off"
       }
      }
     },
     "localname": "AllowanceforCreditLossWriteOff",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_AscensionAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ascension Acquisition",
        "label": "Ascension Acquisition [Member]",
        "terseLabel": "Ascension Acquisition"
       }
      }
     },
     "localname": "AscensionAcquisitionMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_AssumedBenefitPaymentsByYearTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule of assumed benefit payments for future periods by year. This element may be used for defined benefit, nonqualified supplemental retirement, and post-retirement benefit plans.",
        "label": "Assumed Benefit Payments By Year [Table Text Block]",
        "terseLabel": "Assumed Benefit Payments By Year [Table Text Block]"
       }
      }
     },
     "localname": "AssumedBenefitPaymentsByYearTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_BalanceOfSeniorNotesMatureDuringQ42020": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance of Senior Notes Mature During Q4 2020",
        "label": "Balance of Senior Notes Mature During Q4 2020",
        "terseLabel": "Balance of Senior Notes Mature During Q4 2020"
       }
      }
     },
     "localname": "BalanceOfSeniorNotesMatureDuringQ42020",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_BiopharmaceuticalandmedicaldevicecompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biopharmaceutical and medical device companies [Member]",
        "label": "Biopharmaceutical and medical device companies [Member]",
        "terseLabel": "Biopharmaceutical and medical device companies [Member]"
       }
      }
     },
     "localname": "BiopharmaceuticalandmedicaldevicecompaniesMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Current Year ProForma Information Table Text Block",
        "label": "Business Acquisition Current Year ProForma Information Table Text Block [Table Text Block]",
        "terseLabel": "Business Current Year Acquisition ProForma Information Table Text Block"
       }
      }
     },
     "localname": "BusinessAcquisitionCurrentYearProFormaInformationTableTextBlockTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_CashBalanceRetirementPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Balance Retirement Plan",
        "label": "Cash Balance Retirement Plan [Member]",
        "terseLabel": "Cash Balance Retirement Plan"
       }
      }
     },
     "localname": "CashBalanceRetirementPlanMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CashPaidDuringPeriodForAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid During Period For [Abstract]",
        "terseLabel": "Cash paid during period for:"
       }
      }
     },
     "localname": "CashPaidDuringPeriodForAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule is used to show the changes in common shares issued and held in treasury by the entity.",
        "label": "Changes In Common Shares Issued And Held In Treasury [Table Text Block]",
        "terseLabel": "Changes in common shares issued and held in treasury [Text Block]"
       }
      }
     },
     "localname": "ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_ClientMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client [Member]",
        "label": "Client [Member]",
        "terseLabel": "Client [Member]"
       }
      }
     },
     "localname": "ClientMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_CommonSharesHeldInTreasuryRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Held In Treasury Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares held in treasury [Abstract]"
       }
      }
     },
     "localname": "CommonSharesHeldInTreasuryRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonSharesIssuedRollforwardAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Issued Rollforward [Abstract]",
        "terseLabel": "Rollforward of common shares issued [Abstract]"
       }
      }
     },
     "localname": "CommonSharesIssuedRollforwardAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_CommonStockRepurchaseAuthorizationOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.",
        "label": "Common Stock Repurchase Authorization Outstanding",
        "terseLabel": "Outstanding common stock repurchase authorization"
       }
      }
     },
     "localname": "CommonStockRepurchaseAuthorizationOutstanding",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.",
        "label": "Commons Stock Issued During Period Shares Employee Stock Plans",
        "terseLabel": "Common stock issued under employee stock plans (in shares)"
       }
      }
     },
     "localname": "CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_ConcentrationOfCreditRiskPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the company's credit risk accounting policy with respect to financial instruments. An entity shall disclose its policy for including whether the entity's cash and cash equivalents are insured or expose the entity to credit risk.",
        "label": "Concentration Of Credit Risk [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationOfCreditRiskPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_ConcentrationRiskAccountsReceivableMedicareAndMedicaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross receivable balance due from Medicare and Medicaid programs.",
        "label": "Concentration Risk Accounts Receivable Medicare And Medicaid",
        "terseLabel": "Accounts receivable balances (gross) from Medicare and Medicaid"
       }
      }
     },
     "localname": "ConcentrationRiskAccountsReceivableMedicareAndMedicaid",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ConsolidatedStatementsofOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidated Statements of Operations [Abstract]",
        "label": "Consolidated Statements of Operations [Abstract]",
        "terseLabel": "Consolidated Statements of Operations [Abstract]"
       }
      }
     },
     "localname": "ConsolidatedStatementsofOperationsAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "xbrltype": "stringItemType"
    },
    "lh_Contingentconsiderationadjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration adjustment",
        "label": "Contingent consideration adjustment",
        "negatedTerseLabel": "Contingent consideration adjustment"
       }
      }
     },
     "localname": "Contingentconsiderationadjustment",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CostMethodInvestmentsMaximumOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.",
        "label": "Cost Method Investments Maximum Ownership Percentage",
        "terseLabel": "Ownership percentage below which investments are generally accounted for on the cost method (in hundredths)"
       }
      }
     },
     "localname": "CostMethodInvestmentsMaximumOwnershipPercentage",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_CreditFacilityMaximumLettersofCredit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility, Maximum Letters of Credit",
        "label": "Credit Facility, Maximum Letters of Credit",
        "terseLabel": "Credit Facility, Maximum Letters of Credit"
       }
      }
     },
     "localname": "CreditFacilityMaximumLettersofCredit",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityMaximumSwingLineBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility, Maximum Swing Line Borrowings",
        "label": "Credit Facility, Maximum Swing Line Borrowings",
        "terseLabel": "Credit Facility, Maximum Swing Line Borrowings"
       }
      }
     },
     "localname": "CreditFacilityMaximumSwingLineBorrowings",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditFacilityOptiontoIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility Option to Increase",
        "label": "Credit Facility Option to Increase",
        "terseLabel": "Credit Facility Option to Increase"
       }
      }
     },
     "localname": "CreditFacilityOptiontoIncrease",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_CreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Loss Expense (Reversal)",
        "label": "Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "CreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DeferredIncomeTaxesAndOtherTaxLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.",
        "label": "Deferred income taxes and other tax liabilities",
        "terseLabel": "Deferred income taxes and other tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherTaxLiabilities",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DeferredTaxAssetRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Right Of Use Asset",
        "label": "Deferred Tax Asset, Right Of Use Asset",
        "terseLabel": "Deferred Tax Asset, Right Of Use Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetRightOfUseAsset",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DefinedBenefitPlanActualAssetAllocation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Actual Asset Allocation",
        "label": "Defined Benefit Plan, Actual Asset Allocation",
        "terseLabel": "Defined Benefit Plan, Actual Asset Allocation"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualAssetAllocation",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_DefinedBenefitPlanAmortizationAndDeferral": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount calculated as a basis for determining the effects of amortization expenses and other deferrals.",
        "label": "Defined Benefit Plan Amortization And Deferral",
        "negatedTerseLabel": "Net amortization and deferral",
        "terseLabel": "Net amortization and deferral"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationAndDeferral",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.",
        "label": "Defined Benefit Plan Assumptions Used Expected Long Term Return On Assets",
        "terseLabel": "Expected long term rate of return for the Company Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedExpectedLongTermReturnOnAssets",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested in other assets.",
        "label": "Defined Benefit Plan Expected Rate Of Return On Assets Other Assets",
        "terseLabel": "Weighted average expected long-term rate of return for other assets (in hundredths)"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedRateOfReturnOnAssetsOtherAssets",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule of plan assets at fair value by asset category.",
        "label": "Defined Benefit Plan Fair Value Of Plan Assets By Category [Table Text Block]",
        "terseLabel": "Defined Benefit Plan Fair Value Of Plan Assets By Category [Table Text Block]"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssetsByCategoryTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_DefinedContributionPlanTotalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan Total Expense",
        "label": "Defined Contribution Plan Total Expense",
        "terseLabel": "Defined Contribution Plan Total Expense"
       }
      }
     },
     "localname": "DefinedContributionPlanTotalExpense",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DepreciationAndAmortizationOfLeasedAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.",
        "label": "Depreciation And Amortization Of Leased Assets",
        "terseLabel": "Depreciation And Amortization Of Leased Assets"
       }
      }
     },
     "localname": "DepreciationAndAmortizationOfLeasedAssets",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics [Member]",
        "label": "Diagnostics [Member]",
        "terseLabel": "LabCorp Diagnostics [Member]"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the financial impact of select activity related to the exercise of stock options. This activity includes cash received from option exercises, the corresponding tax benefits realized, and the aggregate intrinsic value of options exercised.",
        "label": "Disclosure Of Share Based Compensation Arrangements Stock Options Exercised [Table Text Block]",
        "terseLabel": "Disclosure of the Impact of Stock Options Exercised"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsStockOptionsExercisedTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_DrugDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Covance Drug Development [Member]",
        "label": "Drug Development [Member]",
        "terseLabel": "Covance Drug Development [Member]"
       }
      }
     },
     "localname": "DrugDevelopmentMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.",
        "label": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment",
        "terseLabel": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment"
       }
      }
     },
     "localname": "EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_EmployeeStockPurchasePlanExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense amount recognized during the period related to the Company's employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Expense",
        "terseLabel": "Expense related to the Company's employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanExpense",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_EmployeeStockPurchasePlanFairValueEmployeePurchaseRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of the employee's purchase right calculated using the Black-Scholes model.",
        "label": "Employee Stock Purchase Plan Fair Value Employee Purchase Right",
        "terseLabel": "Fair value of the employee's purchase right"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanFairValueEmployeePurchaseRight",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "lh_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan in the entity's stock incentive plan.",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_EmployeeStockPurchasePlanNumberOfAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of shares originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for purchase under the employee stock purchase plan.",
        "label": "Employee Stock Purchase Plan Number Of Authorized Shares",
        "terseLabel": "Shares of common stock authorized for issuance under the employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanNumberOfAuthorizedShares",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_EmployeeStockPurchasePlanNumberOfSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under the employee stock purchase plan purchased by eligible employees during the period.",
        "label": "Employee Stock Purchase Plan Number Of Shares Purchased",
        "terseLabel": "Number of shares purchased by eligible employees"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanNumberOfSharesPurchased",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_EmployeeStockPurchasePlanPercentOfMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of the market price of common stock participating employees are able to purchase company stock.",
        "label": "Employee Stock Purchase Plan Percent Of Market Price",
        "terseLabel": "The employee stock purchase plan permits employees to purchase shares of common stock at a certain percentage of the market price (in hundredths)"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanPercentOfMarketPrice",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_ExcessTaxBenefitShareBasedCompensationFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess Tax Benefit - Share-based Compensation, Financing Activities",
        "label": "Excess Tax Benefit - Share-based Compensation, Financing Activities",
        "negatedTerseLabel": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit"
       }
      }
     },
     "localname": "ExcessTaxBenefitShareBasedCompensationFinancingActivities",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ExcludingEnvigoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excluding Envigo",
        "label": "Excluding Envigo [Member]",
        "terseLabel": "Excluding Envigo [Member]"
       }
      }
     },
     "localname": "ExcludingEnvigoMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_FacilityRelatedRestructuringReserveAccrualAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for facility related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.",
        "label": "Facility Related Restructuring Reserve Accrual Adjustment",
        "terseLabel": "Facility Related Restructuring Reserve Accrual Adjustment"
       }
      }
     },
     "localname": "FacilityRelatedRestructuringReserveAccrualAdjustment",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
        "terseLabel": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.",
        "label": "Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts",
        "terseLabel": "Noncontrolling interest puts"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FederalLossCarryoverDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Loss Carryover [Domain]",
        "label": "Federal Loss Carryover [Domain]",
        "terseLabel": "Federal Loss Carryover [Domain]"
       }
      }
     },
     "localname": "FederalLossCarryoverDomain",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_FederalTaxLossCarryovers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The federal loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Federal Tax Loss Carryovers",
        "terseLabel": "Federal tax loss carryovers"
       }
      }
     },
     "localname": "FederalTaxLossCarryovers",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FederalandStateAttributeCarryforwardValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal and State Attribute Carryforward Valuation Allowance",
        "label": "Federal and State Attribute Carryforward Valuation Allowance",
        "terseLabel": "Federal and State Attribute Carryforward Valuation Allowance"
       }
      }
     },
     "localname": "FederalandStateAttributeCarryforwardValuationAllowance",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_FederalandStateAttributeCarryforwards": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal and State Attribute Carryforwards",
        "label": "Federal and State Attribute Carryforwards",
        "terseLabel": "Federal and State Attribute Carryforwards"
       }
      }
     },
     "localname": "FederalandStateAttributeCarryforwards",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ForeignTaxLossCarryoverValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Tax Loss Carryover Valuation Allowance",
        "label": "Foreign Tax Loss Carryover Valuation Allowance",
        "terseLabel": "Foreign Tax Loss Carryover with Valuation Allowance"
       }
      }
     },
     "localname": "ForeignTaxLossCarryoverValuationAllowance",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ForeignTaxLossCarryovers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The foreign loss carryovers, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Foreign Tax Loss Carryovers",
        "terseLabel": "Foreign tax loss carryovers"
       }
      }
     },
     "localname": "ForeignTaxLossCarryovers",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ForeignTaxLossCarryoversExpirein2034": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Tax Loss Carryovers Expire in 2034",
        "label": "Foreign Tax Loss Carryovers Expire in 2034",
        "terseLabel": "Foreign Tax Loss Carryovers Expire in 2034"
       }
      }
     },
     "localname": "ForeignTaxLossCarryoversExpirein2034",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_GainRecognizedonExitofInterestRateSwapArrangement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain Recognized on Exit of Interest Rate Swap Arrangement",
        "label": "Gain Recognized on Exit of Interest Rate Swap Arrangement",
        "terseLabel": "Gain Recognized on Exit of Interest Rate Swap Arrangement"
       }
      }
     },
     "localname": "GainRecognizedonExitofInterestRateSwapArrangement",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Acquired During Period, net of measurement period adjustments",
        "label": "Goodwill, Acquired During Period, net of measurement period adjustments",
        "terseLabel": "Goodwill, Acquired During Period, net of measurement period adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriodNetOfMeasurementPeriodAdjustments",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_GoodwillImpairmentCumulative": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill Impairment, Cumulative",
        "label": "Goodwill Impairment, Cumulative",
        "terseLabel": "Goodwill Impairment, Cumulative"
       }
      }
     },
     "localname": "GoodwillImpairmentCumulative",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income [Abstract]",
        "terseLabel": "Income [Abstract]"
       }
      }
     },
     "localname": "IncomeAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.",
        "label": "Income Loss from Continuing Operations Before Income Taxes and Minority Interest",
        "terseLabel": "Total pre-tax income",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Loss From Continuing Operations Before Income Taxes And Minority Interest [Abstract]",
        "terseLabel": "Pre-tax income [Abstract]"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterestAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_IncomeTaxBenefitMinimumCertaintyPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For tax positions that are more likely than not to be sustained on audit by the taxing authority, the entity recognizes the largest amount of tax benefit that it believes exceeds a minimum likelihood of being recognized. This element represents the minimum percentage of likelihood that a tax benefit will be realized that the entity uses to assess if a benefit should be recognized.",
        "label": "Income Tax Benefit Minimum Certainty Percentage",
        "terseLabel": "Minimum threshold percentage required to recognize income tax benefit (in hundredths)"
       }
      }
     },
     "localname": "IncomeTaxBenefitMinimumCertaintyPercentage",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_IncreaseDecreaseInNoncontrollingInterestPut": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Noncontrolling Interest Put",
        "label": "Increase (Decrease) in Noncontrolling Interest Put",
        "terseLabel": "Increase (Decrease) in Noncontrolling Interest Put"
       }
      }
     },
     "localname": "IncreaseDecreaseInNoncontrollingInterestPut",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_IncrementalCommonSharesAttributableToStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate awards of stock options and nonvested options to be issued to an employee under a stock option arrangement. Such stock options shall be considered to be outstanding as of the grant date for purposes of computing diluted earnings per share even though their exercise may be contingent upon vesting. Those options are included in the diluted Earnings Per Share (EPS) computation even if the employee may not receive (or be able to sell) the stock until some future date.",
        "label": "Incremental Common Shares Attributable To Stock Options",
        "terseLabel": "Dilutive effect of stock options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToStockOptions",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "sharesItemType"
    },
    "lh_IntangibleAssetsFiniteLivedPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for finite-lived intangible assets. This accounting policy also may address: (1) the amortization method used (2) the useful lives of such assets (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets Finite Lived [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_InterestPaidInCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period for interest owed on money borrowed",
        "label": "Interest Paid In Cash",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidInCash",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_InternalUseSoftwarePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software [Policy Text Block]",
        "terseLabel": "Capitalized Software Costs"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_InternationalDevelopedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit plan assets invested in the international capitalization equity securities- developed category.",
        "label": "International Developed [Member]",
        "terseLabel": "International - developed [Member]"
       }
      }
     },
     "localname": "InternationalDevelopedMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_IssuanceOfCommonStockUnderEmployeeStockPlans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan, combined the value of stock issued during the period as a result of the exercise of stock options.",
        "label": "Issuance of common stock under employee stock plans",
        "terseLabel": "Issuance of common stock under employee stock plans"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUnderEmployeeStockPlans",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_LeaseDisclosureTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Disclosure Table Text Block",
        "label": "Lease Disclosure Table Text Block [Table Text Block]",
        "terseLabel": "Lease Disclosure Table Text Block"
       }
      }
     },
     "localname": "LeaseDisclosureTableTextBlockTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_LongTermContractsDurationMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Contracts Duration Maximum",
        "label": "Long Term Contracts Duration Maximum",
        "terseLabel": "Long Term Contracts Duration Maximum"
       }
      }
     },
     "localname": "LongTermContractsDurationMaximum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_LongTermContractsDurationMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Contracts Duration Minimum",
        "label": "Long Term Contracts Duration Minimum",
        "terseLabel": "Long Term Contracts Duration Minimum"
       }
      }
     },
     "localname": "LongTermContractsDurationMinimum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_LongTermDebtExcludingDebtIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt excluding debt issuance costs",
        "label": "Long term debt excluding debt issuance costs",
        "terseLabel": "Long term debt excluding debt issuance costs"
       }
      }
     },
     "localname": "LongTermDebtExcludingDebtIssuanceCosts",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Longtermdebtfutureminimumpaymentsinterestincludedinpayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt, future minimum payments, interest included in payments",
        "label": "Long term debt, future minimum payments, interest included in payments",
        "terseLabel": "Long term debt, future minimum payments, interest included in payments"
       }
      }
     },
     "localname": "Longtermdebtfutureminimumpaymentsinterestincludedinpayments",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Longtermdebtissuancecosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt issuance costs",
        "label": "Long term debt issuance costs",
        "terseLabel": "Long term debt issuance costs"
       }
      }
     },
     "localname": "Longtermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Maximumdeferralpercentageofannualbasesalary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum deferral percentage of annual base salary",
        "label": "Maximum deferral percentage of annual base salary",
        "terseLabel": "Maximum deferral percentage of annual base salary"
       }
      }
     },
     "localname": "Maximumdeferralpercentageofannualbasesalary",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Maximumdeferralpercentageofannualcashincentivepay": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum deferral percentage of annual cash incentive pay",
        "label": "Maximum deferral percentage of annual cash incentive pay",
        "terseLabel": "Maximum deferral percentage of annual cash incentive pay"
       }
      }
     },
     "localname": "Maximumdeferralpercentageofannualcashincentivepay",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_MeasurementPeriodAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Period Adjustments",
        "label": "Measurement Period Adjustments [Member]",
        "terseLabel": "Measurement Period Adjustments"
       }
      }
     },
     "localname": "MeasurementPeriodAdjustmentsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_MedicareandMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicaid [Member]",
        "label": "Medicare and Medicaid [Member]",
        "terseLabel": "Medicare and Medicaid [Member]"
       }
      }
     },
     "localname": "MedicareandMedicaidMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_MutualFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds [Member]",
        "label": "Mutual Funds [Member]",
        "terseLabel": "Mutual Funds [Member]"
       }
      }
     },
     "localname": "MutualFundsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_NetProceedsFromIssuanceOfStockToEmployees": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.",
        "label": "Net proceeds from issuance of stock to employees",
        "terseLabel": "Net proceeds from issuance of stock to employees"
       }
      }
     },
     "localname": "NetProceedsFromIssuanceOfStockToEmployees",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringAndOtherSpecialCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.",
        "label": "Net restructuring and other special charges",
        "terseLabel": "Restructuring and other special charges"
       }
      }
     },
     "localname": "NetRestructuringAndOtherSpecialCharges",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NetRestructuringCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.",
        "label": "Net Restructuring Charges",
        "negatedTerseLabel": "Net restructuring charges",
        "terseLabel": "Net restructuring charges"
       }
      }
     },
     "localname": "NetRestructuringCharges",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoncontrollingInterestMezzanineEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.",
        "label": "Noncontrolling Interest Mezzanine Equity",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMezzanineEquity",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NotePayableCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note payable, current",
        "label": "Note payable, current [Member]",
        "terseLabel": "Note payable, current"
       }
      }
     },
     "localname": "NotePayableCurrentMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_NoteReceivableAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Receivable, Allowance for Credit Loss",
        "label": "Note Receivable, Allowance for Credit Loss",
        "terseLabel": "Note Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "NoteReceivableAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_NoteReceivableCreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Note Receivable, Credit Loss Expense (Reversal)",
        "label": "Note Receivable, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Note Receivable, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "NoteReceivableCreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of years restructuring liabilities expected to be paid out over",
        "label": "Number of years restructuring liabilities expected to be paid out over",
        "terseLabel": "Number of years restructuring liabilities expected to be paid out over"
       }
      }
     },
     "localname": "Numberofyearsrestructuringliabilitiesexpectedtobepaidoutover",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_OtherLiabilitiesNoncurrentOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities Noncurrent, Other",
        "label": "Other Liabilities Noncurrent, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentOther",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_OtheracquireesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other acquirees [Member]",
        "label": "Other acquirees [Member]",
        "terseLabel": "Other acquirees [Member]"
       }
      }
     },
     "localname": "OtheracquireesMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OthercountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other countries [Member]",
        "label": "Other countries [Member]",
        "terseLabel": "Other countries [Member]"
       }
      }
     },
     "localname": "OthercountriesMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_OutstandingStockRepurchaseAuthorizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Stock Repurchase Authorization [Abstract]",
        "terseLabel": "Share repurchase program [Abstract]"
       }
      }
     },
     "localname": "OutstandingStockRepurchaseAuthorizationAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PGDxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PGDx",
        "label": "PGDx [Member]",
        "terseLabel": "PGDx"
       }
      }
     },
     "localname": "PGDxMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_PatentsLicensesAndTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.",
        "label": "Patents, Licenses And Technology [Member]",
        "netLabel": "Patents, licenses and technology [Member]",
        "terseLabel": "Patents, Licenses And Technology [Member]",
        "verboseLabel": "Patents, licenses and technology [Member]"
       }
      }
     },
     "localname": "PatentsLicensesAndTechnologyMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_PerShareAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per Share Amount [Abstract]",
        "terseLabel": "Per Share Amount [Abstract]"
       }
      }
     },
     "localname": "PerShareAmountAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_PercentOfDomesticRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Domestic Revenue",
        "label": "Percent of Domestic Revenue",
        "terseLabel": "Percent of Domestic Revenue"
       }
      }
     },
     "localname": "PercentOfDomesticRevenue",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_PercentofRevenueContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Revenue Contributed",
        "label": "Percent of Revenue Contributed",
        "terseLabel": "Percent of Revenue Contributed"
       }
      }
     },
     "localname": "PercentofRevenueContributed",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Percentofgrossaccountsreceivableduefrompatients": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of gross accounts receivable due from patients",
        "label": "Percent of gross accounts receivable due from patients",
        "terseLabel": "Percent of gross accounts receivable due from patients"
       }
      }
     },
     "localname": "Percentofgrossaccountsreceivableduefrompatients",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of remaining performance obligations recognized as revenue in next year",
        "label": "Percent of remaining performance obligations recognized as revenue in next year",
        "terseLabel": "Percent of remaining performance obligations recognized as revenue in next year"
       }
      }
     },
     "localname": "Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lh_Post2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post 2017",
        "label": "Post 2017 [Member]",
        "terseLabel": "Post 2017"
       }
      }
     },
     "localname": "Post2017Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ProfessionalLiabilityPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for self-insurance of professional liability claims, which may include policies for calculating a liability amount.",
        "label": "Professional Liability [Policy Text Block]",
        "terseLabel": "Professional Liability"
       }
      }
     },
     "localname": "ProfessionalLiabilityPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property Plant And Equipment Estimated Useful Lives [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_PropertyPlantAndEquipmentUsefulLifeSoftwareAverage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software costs are amortized over the estimated useful life of the underlying system.",
        "label": "Property plant and equipment useful life software average",
        "terseLabel": "Estimated useful life of capitalized software costs (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLifeSoftwareAverage",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_Propertyplantandequipmentusefullifesoftwaremaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment useful life software maximum",
        "label": "Property plant and equipment useful life software maximum",
        "terseLabel": "Property plant and equipment useful life software maximum"
       }
      }
     },
     "localname": "Propertyplantandequipmentusefullifesoftwaremaximum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_Propertyplantandequipmentusefullifesoftwareminimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment useful life software minimum",
        "label": "Property plant and equipment useful life software minimum",
        "terseLabel": "Property plant and equipment useful life software minimum"
       }
      }
     },
     "localname": "Propertyplantandequipmentusefullifesoftwareminimum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "decimalItemType"
    },
    "lh_ReimbursableOutofPocketExpensesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursable Out of Pocket Expenses Policy [Policy Text Block]",
        "label": "Reimbursable Out of Pocket Expenses Policy [Policy Text Block]",
        "terseLabel": "Reimbursable Out of Pocket Expenses Policy"
       }
      }
     },
     "localname": "ReimbursableOutofPocketExpensesPolicyPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_RestrictedStockAndPerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock and performance shares in the entity's stock incentive plan.",
        "label": "Restricted Stock And Performance Shares [Member]",
        "terseLabel": "Restricted Stock and Performance Shares [Member]"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceSharesMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_RestrictedStockPerformanceSharesExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The noncash expense that represents the cost of restricted stock and performance shares distributed to employees as compensation.",
        "label": "Restricted Stock Performance Shares Expense",
        "terseLabel": "Restricted stock and performance share compensation expense"
       }
      }
     },
     "localname": "RestrictedStockPerformanceSharesExpense",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ReversalofAccruedIncomeTaxPenaltiesAndInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reversal of Accrued Income Tax Penalties And Interest",
        "label": "Reversal of Accrued Income Tax Penalties And Interest",
        "terseLabel": "Reversal of Accrued Income Tax Penalties And Interest"
       }
      }
     },
     "localname": "ReversalofAccruedIncomeTaxPenaltiesAndInterest",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_SalesCommissionAmortizationPeriodMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Commission Amortization Period Maximum",
        "label": "Sales Commission Amortization Period Maximum",
        "terseLabel": "Sales Commission Amortization Period Maximum"
       }
      }
     },
     "localname": "SalesCommissionAmortizationPeriodMaximum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_SalesCommissionAmortizationPeriodMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Commission Amortization Period Minimum",
        "label": "Sales Commission Amortization Period Minimum",
        "terseLabel": "Sales Commission Amortization Period Minimum"
       }
      }
     },
     "localname": "SalesCommissionAmortizationPeriodMinimum",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Axis]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Axis]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Intangible Assets By Major Class [Domain]",
        "terseLabel": "Schedule Of Other Intangible Assets By Major Class [Domain]"
       }
      }
     },
     "localname": "ScheduleOfOtherIntangibleAssetsByMajorClassDomain",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorLongTermNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
        "label": "Senior Long Term Notes Due2020 Member",
        "terseLabel": "Senior notes due 2020 [Member]"
       }
      }
     },
     "localname": "SeniorLongTermNotesDue2020Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
        "label": "Senior notes due 2020 [Member]",
        "terseLabel": "Senior notes due 2020 [Member]"
       }
      }
     },
     "localname": "SeniorNotesDue2020Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2022 [Member]",
        "label": "Senior notes due 2022 [Member]",
        "terseLabel": "Senior notes due 2022"
       }
      }
     },
     "localname": "SeniorNotesDue2022Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2023",
        "label": "Senior notes due 2023 [Member]",
        "terseLabel": "Senior Notes due 2023"
       }
      }
     },
     "localname": "SeniorNotesDue2023Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2024",
        "label": "Senior notes due 2024 [Member]",
        "terseLabel": "Senior notes due 2024"
       }
      }
     },
     "localname": "SeniorNotesDue2024Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_SeniorNotesFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated fair value of the debt instrument (senior notes) at the balance-sheet date",
        "label": "Senior Notes Fair Value",
        "terseLabel": "Fair market value of senior notes"
       }
      }
     },
     "localname": "SeniorNotesFairValue",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Seniornotesdue2024": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2024",
        "label": "Senior notes due 2024",
        "terseLabel": "Senior notes due 2024"
       }
      }
     },
     "localname": "Seniornotesdue2024",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Seniornotesdue2027": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2027",
        "label": "Senior notes due 2027",
        "terseLabel": "Senior notes due 2027"
       }
      }
     },
     "localname": "Seniornotesdue2027",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_Seniornotesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior notes due 2027 [Member]",
        "label": "Senior notes due 2027 [Member]",
        "terseLabel": "Senior notes due 2027 [Member]"
       }
      }
     },
     "localname": "Seniornotesdue2027Member",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of performance share award terms as to how many shares or portion of an award are no longer contingent on satisfaction of certain performance conditions, thereby giving the employee the legal right to convert the award to shares, to sell the shares, and be entitled to the cash proceeds of such sale.",
        "label": "Share Based Compensation Arrangement Performance Share Awards Vesting Conditions",
        "terseLabel": "Performance share awards, vesting conditions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementPerformanceShareAwardsVestingConditions",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an entity's accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.",
        "label": "Share Based Compensation Option And Incentive Plans [Policy Text Block]",
        "terseLabel": "Stock Compensation Plans"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicyTextBlock",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lh_SharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares [Abstract]",
        "terseLabel": "Shares [Abstract]"
       }
      }
     },
     "localname": "SharesAbstract",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_ShortTermDebtAndLongTermDebtCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-Term Debt And Long-Term Debt, Current Maturities",
        "label": "Short-Term Debt And Long-Term Debt, Current Maturities",
        "verboseLabel": "Short-term borrowings and current portion of long-term debt"
       }
      }
     },
     "localname": "ShortTermDebtAndLongTermDebtCurrentMaturities",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_ShortTermDebtIssueCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term debt issue costs",
        "label": "Short term debt issue costs [Member]",
        "terseLabel": "Short term debt issue costs"
       }
      }
     },
     "localname": "ShortTermDebtIssueCostsMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ShortTermLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term lease",
        "label": "Short term lease [Member]",
        "terseLabel": "Short term lease"
       }
      }
     },
     "localname": "ShortTermLeaseMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_Shorttermdebtissuancecosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term debt issuance costs",
        "label": "Short term debt issuance costs",
        "negatedTerseLabel": "Short term debt issuance costs"
       }
      }
     },
     "localname": "Shorttermdebtissuancecosts",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_SoftwareDepreciation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation recognized in the current period that reflects the allocation of the cost of software related assets over the assets' useful lives.",
        "label": "Software Depreciation",
        "terseLabel": "Software depreciation"
       }
      }
     },
     "localname": "SoftwareDepreciation",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_SwapTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap, Type",
        "label": "Swap, Type [Axis]",
        "terseLabel": "Swap, Type [Axis]"
       }
      }
     },
     "localname": "SwapTypeAxis",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lh_SwapTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap, Type [Domain]",
        "label": "Swap, Type [Domain]",
        "terseLabel": "Swap, Type [Domain]"
       }
      }
     },
     "localname": "SwapTypeDomain",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_ThirdpartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third party [Member]",
        "label": "Third party [Member]",
        "terseLabel": "Third party [Member]"
       }
      }
     },
     "localname": "ThirdpartyMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_TotalShortandLongTermDebtIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Short and Long Term Debt Issuance Costs",
        "label": "Total Short and Long Term Debt Issuance Costs",
        "terseLabel": "Total Short and Long Term Debt Issuance Costs"
       }
      }
     },
     "localname": "TotalShortandLongTermDebtIssuanceCosts",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UKPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UK Plan",
        "label": "UK Plan [Member]",
        "terseLabel": "UK Plan"
       }
      }
     },
     "localname": "UKPlanMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_UnbilledContractsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Contracts Receivable [Member]",
        "label": "Unbilled Contracts Receivable [Member]",
        "terseLabel": "Unbilled Contracts Receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivableMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lh_UnbilledServicesAllowanceforCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Services, Allowance for Credit Loss",
        "label": "Unbilled Services, Allowance for Credit Loss",
        "terseLabel": "Unbilled Services, Allowance for Credit Loss"
       }
      }
     },
     "localname": "UnbilledServicesAllowanceforCreditLoss",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UnbilledServicesCreditLossExpenseReversal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled Services, Credit Loss Expense (Reversal)",
        "label": "Unbilled Services, Credit Loss Expense (Reversal)",
        "terseLabel": "Unbilled Services, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "UnbilledServicesCreditLossExpenseReversal",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits Increase in Reserve From Acquisition",
        "label": "Unrecognized Tax Benefits Increase in Reserve From Acquisition",
        "terseLabel": "Unrecognized Tax Benefits Increase in Reserve From Acquisition"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseinReserveFromAcquisition",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in unrecognized tax benefits resulting from tax positions taken in prior period tax returns, excluding amounts pertaining to examined tax returns.",
        "label": "Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease in reserve as a result of payments"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lh_UsFixedIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Benefit plan assets invested in the U.S. fixed income securities category.",
        "label": "Us Fixed Income [Member]",
        "terseLabel": "U.S. fixed income [Member]"
       }
      }
     },
     "localname": "UsFixedIncomeMember",
     "nsuri": "http://www.labcorp.com/20221231",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r304",
      "r356",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r378",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r461",
      "r463",
      "r465",
      "r466",
      "r995",
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r304",
      "r356",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r378",
      "r455",
      "r456",
      "r457",
      "r458",
      "r460",
      "r461",
      "r463",
      "r465",
      "r466",
      "r995",
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EnergyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Energy [Axis]",
        "terseLabel": "Energy [Axis]"
       }
      }
     },
     "localname": "EnergyAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EnergyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Energy [Domain]",
        "terseLabel": "Energy [Domain]"
       }
      }
     },
     "localname": "EnergyDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r384",
      "r898",
      "r1001",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r451",
      "r452",
      "r453",
      "r454",
      "r608",
      "r804",
      "r829",
      "r857",
      "r858",
      "r895",
      "r913",
      "r923",
      "r997",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r451",
      "r452",
      "r453",
      "r454",
      "r608",
      "r804",
      "r829",
      "r857",
      "r858",
      "r895",
      "r913",
      "r923",
      "r997",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r384",
      "r898",
      "r1001",
      "r1121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NorthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "North America [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r380",
      "r807",
      "r896",
      "r921",
      "r992",
      "r993",
      "r1001",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r380",
      "r807",
      "r896",
      "r921",
      "r992",
      "r993",
      "r1001",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r451",
      "r452",
      "r453",
      "r454",
      "r551",
      "r608",
      "r642",
      "r643",
      "r644",
      "r803",
      "r804",
      "r829",
      "r857",
      "r858",
      "r895",
      "r913",
      "r923",
      "r986",
      "r997",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r451",
      "r452",
      "r453",
      "r454",
      "r551",
      "r608",
      "r642",
      "r643",
      "r644",
      "r803",
      "r804",
      "r829",
      "r857",
      "r858",
      "r895",
      "r913",
      "r923",
      "r986",
      "r997",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r243",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r343",
      "r397",
      "r398",
      "r683",
      "r720",
      "r724",
      "r725",
      "r726",
      "r771",
      "r795",
      "r796",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r243",
      "r311",
      "r312",
      "r313",
      "r315",
      "r316",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r343",
      "r397",
      "r398",
      "r683",
      "r720",
      "r724",
      "r725",
      "r726",
      "r771",
      "r795",
      "r796",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember": {
     "auth_ref": [
      "r243",
      "r315",
      "r316",
      "r322",
      "r329",
      "r397",
      "r398",
      "r683",
      "r720",
      "r726",
      "r771",
      "r795",
      "r796",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Accounting Standards Update, Adjustment [Member]"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodAccountingStandardsUpdateAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r329",
      "r613",
      "r940",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r381",
      "r382",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r897",
      "r922",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r381",
      "r382",
      "r842",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r897",
      "r922",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r329",
      "r613",
      "r940",
      "r941",
      "r965"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Statement, Scenario [Axis]",
        "verboseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED EXPENSES AND OTHER"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHER"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r920"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r970"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableGross": {
     "auth_ref": [
      "r263",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, before Allowance for Credit Loss"
       }
      }
     },
     "localname": "AccountsReceivableGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r386",
      "r387"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other",
        "totalLabel": "Total accrued expenses and other"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued expenses and other [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
     "auth_ref": [
      "r1",
      "r3",
      "r216",
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
        "label": "Accrued Sales Commission",
        "terseLabel": "Accrued Sales Commission"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r101",
      "r252"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r30",
      "r35",
      "r1045"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedPeriodEndLabel": "Net Benefit Plan Adjustments, balance",
        "negatedPeriodStartLabel": "Net Benefit Plan Adjustments, balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r738"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Foreign Currency Translation Adjustments, balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r35",
      "r265",
      "r822",
      "r837",
      "r841"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "negatedLabel": "Accumulated Other Comprehensive Earnings, balance",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Earnings"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r283",
      "r284",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r31",
      "r35",
      "r177",
      "r796",
      "r832",
      "r833",
      "r948",
      "r949",
      "r950",
      "r962",
      "r963",
      "r964"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated Other Comprehensive Earnings (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "verboseLabel": "Weighted average amortization period (in years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "verboseLabel": "Additional Paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r651",
      "r652",
      "r653",
      "r962",
      "r963",
      "r964",
      "r1105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r61",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r147",
      "r148",
      "r617"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r266",
      "r388",
      "r399",
      "r400",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "negatedTerseLabel": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulOtherReceivablesCurrent": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on receivable, classified as other and current.",
        "label": "Allowance for Credit Loss, Receivable, Other, Current",
        "negatedTerseLabel": "Allowance for Credit Loss, Receivable, Other, Current"
       }
      }
     },
     "localname": "AllowanceForDoubtfulOtherReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredSalesCommissions": {
     "auth_ref": [
      "r44",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Deferred Sales Commissions",
        "terseLabel": "Amortization of Deferred Sales Commissions"
       }
      }
     },
     "localname": "AmortizationOfDeferredSalesCommissions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r61",
      "r88",
      "r94"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangibles and other assets",
        "terseLabel": "Amortization of intangibles and other assets",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.",
        "label": "Amount of Deferred Costs Related to Long-Term Contracts",
        "terseLabel": "Amount of Deferred Costs Related to Long-term Contracts"
       }
      }
     },
     "localname": "AmountOfDeferredCostsRelatedToLongTermContracts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r213",
      "r230",
      "r256",
      "r299",
      "r364",
      "r370",
      "r376",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r707",
      "r711",
      "r739",
      "r920",
      "r995",
      "r996",
      "r1112"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r247",
      "r271",
      "r299",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r707",
      "r711",
      "r739",
      "r920",
      "r995",
      "r996",
      "r1112"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldUnderCapitalLeasesMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived property, plant or equipment assets held by a lessee through a capital lease arrangement.",
        "label": "Assets Held under Capital Leases [Member]",
        "terseLabel": "Equipment under capital leases [Member]"
       }
      }
     },
     "localname": "AssetsHeldUnderCapitalLeasesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r186",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Financial Statement Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Buildings and building improvements [Member]",
        "verboseLabel": "Buildings and building improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r700",
      "r907",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r161",
      "r162",
      "r700",
      "r907",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r698",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r698",
      "r699"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r705",
      "r955"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r172",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "terseLabel": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r66",
      "r67",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Change in accrued property, plant and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Capitalized Contract Cost, Amortization"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Capitalized Contract Cost, Amortization Period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Capitalized Contract Cost, Net"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostTableTextBlock": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Table Text Block]",
        "terseLabel": "Capitalized Contract Cost"
       }
      }
     },
     "localname": "CapitalizedContractCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r63",
      "r250",
      "r877"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and Cash Equivalents [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r58",
      "r63",
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "negatedPeriodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r58",
      "r208"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Disclosure of non-cash financing and investing activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW INFORMATION",
        "verboseLabel": "Cash Flow, Supplemental Disclosures [Text Block]"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESTables",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash Surrender Value, Fair Value Disclosure"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Cash, Uninsured Amount"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r299",
      "r332",
      "r333",
      "r340",
      "r342",
      "r346",
      "r347",
      "r392",
      "r455",
      "r458",
      "r459",
      "r460",
      "r466",
      "r467",
      "r495",
      "r496",
      "r498",
      "r502",
      "r508",
      "r739",
      "r859",
      "r939",
      "r956",
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r26",
      "r219",
      "r235"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingent liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r106",
      "r448",
      "r449",
      "r844",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENT LIABILITIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/COMMITMENTSANDCONTINGENTLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r962",
      "r963",
      "r1105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Common shares issued, ending balance (in shares)",
        "periodStartLabel": "Common shares issued, beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r8",
      "r920"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, 88.2 and 93.1 shares outstanding at December 31, 2022 and 2021, respectively",
        "verboseLabel": "Common Stock, Value, Outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of deferred tax assets and liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r38",
      "r279",
      "r281",
      "r291",
      "r817",
      "r826"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings attributable to Laboratory Corporation of America Holdings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r174",
      "r175",
      "r179",
      "r279",
      "r281",
      "r290",
      "r816",
      "r825"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Less: Net earnings attributable to the noncontrolling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r173",
      "r179",
      "r279",
      "r281",
      "r289",
      "r815",
      "r824"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r49",
      "r288",
      "r814",
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Earnings Components [Text Block]"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r915",
      "r984",
      "r985"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent Consideration Classified as Equity, Fair Value Disclosure"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r1000"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Contract Asset, Contract Liability, and Receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r389",
      "r403",
      "r998",
      "r999"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Contract with Customer, Asset, before Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r510",
      "r512",
      "r524"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss, Current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingAxis": {
     "auth_ref": [
      "r899",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
        "label": "Contract with Customer, Basis of Pricing [Axis]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingDomain": {
     "auth_ref": [
      "r899",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
        "label": "Contract with Customer, Basis of Pricing [Domain]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r900",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r900",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract with Customer, Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r510",
      "r511",
      "r524"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r902",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r902",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r968"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate Segment [Member]"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r43",
      "r299",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r739",
      "r995"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenues"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Currency Swap [Member]"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r959",
      "r1098",
      "r1100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r959",
      "r1098"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r677",
      "r687",
      "r959"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current tax expense:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r959",
      "r1098",
      "r1100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r258"
     ],
     "calculation": {
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "negatedTerseLabel": "Debt, Current",
        "terseLabel": "Debt, Current",
        "totalLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r111",
      "r297",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r484",
      "r491",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r214",
      "r217",
      "r228",
      "r304",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r480",
      "r481",
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r767",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r23",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "negatedTerseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
        "verboseLabel": "Interest rate (in hundredths)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r24",
      "r304",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r480",
      "r481",
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r767",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r24",
      "r116",
      "r119",
      "r120",
      "r121",
      "r209",
      "r210",
      "r212",
      "r225",
      "r304",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r480",
      "r481",
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r493",
      "r767",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt Issuance Costs"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt Securities [Member]"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred Compensation Liability, Classified, Noncurrent"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_2",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r959",
      "r1099",
      "r1100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred Federal Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r159",
      "r959",
      "r1099"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r659",
      "r660"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred Income Tax Assets, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r61",
      "r159",
      "r678",
      "r686",
      "r687",
      "r959"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Deferred Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred tax expense/(benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r4",
      "r5",
      "r215",
      "r227",
      "r672"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTerseLabel": "Deferred Tax Liabilities, Gross"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r943"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred Revenue, Current"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueRevenueRecognized1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
        "label": "Deferred Revenue, Revenue Recognized",
        "terseLabel": "Deferred Revenue, Revenue Recognized"
       }
      }
     },
     "localname": "DeferredRevenueRevenueRecognized1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r959",
      "r1099",
      "r1100"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the deferred tax asset for which a valuation reserve exists.",
        "label": "Deferred Tax Asset [Domain]",
        "terseLabel": "Deferred Tax Asset [Domain]"
       }
      }
     },
     "localname": "DeferredTaxAssetDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails",
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "terseLabel": "Deferred Tax Assets, Capital Loss Carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r673"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r1096"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Tax loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Deferred Tax Assets, Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from restructuring reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Restructuring Charges",
        "terseLabel": "Acquisition and restructuring reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r150",
      "r1096"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total gross deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs",
        "terseLabel": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Deferred Tax Liabilities, Leasing Arrangements"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Deferred Tax Liabilities, Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r157",
      "r1097"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r3",
      "r128",
      "r129",
      "r131"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "terseLabel": "Defined-benefit plan obligation"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r560"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Accumulated Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r35",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "terseLabel": "Unamortized net gain included in accumulated other comprehensive earnings"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r542",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "auth_ref": [
      "r556",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "terseLabel": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate for the Company Plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average interest crediting rate used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, cash balance and other defined benefit plans with promised interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate",
        "terseLabel": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r537",
      "r601"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Benefits Paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r534"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Participants contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r579",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r544",
      "r554",
      "r597",
      "r903",
      "r904",
      "r905",
      "r906"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plans Disclosures [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Five Fiscal Years Thereafter"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Next Twelve Months"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": {
     "auth_ref": [
      "r906",
      "r1063"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year",
        "terseLabel": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r528",
      "r566",
      "r592",
      "r905",
      "r906"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "terseLabel": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r541",
      "r552",
      "r554",
      "r555",
      "r903",
      "r904",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r527",
      "r550",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "negatedTerseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "terseLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r528",
      "r533",
      "r565",
      "r591",
      "r905",
      "r906"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Defined Benefit Plan, Interest Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r563",
      "r589",
      "r905",
      "r906"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "negatedLabel": "Defined-benefit plan costs",
        "terseLabel": "Defined benefit plan costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanOtherCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of defined benefit plan cost (credit), classified as other.",
        "label": "Defined Benefit Plan, Other Cost (Credit)",
        "terseLabel": "Defined Benefit Plan, Other Cost (Credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanOtherCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Plan Amendment [Abstract]",
        "terseLabel": "Defined Benefit Plan, Plan Amendment [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r551",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r529",
      "r570",
      "r596"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r531",
      "r564",
      "r590",
      "r905",
      "r906"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r61",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization [Abstract]",
        "terseLabel": "Depreciation and amortization:"
       }
      }
     },
     "localname": "DepreciationAndAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r61",
      "r359"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation, Depletion and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Fair Value, Net [Abstract]",
        "terseLabel": "Derivative Instruments in Statement of Financial Position at Fair Value"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r187",
      "r188",
      "r192",
      "r194",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "netLabel": "Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r200",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r184",
      "r187",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r184",
      "r187",
      "r192",
      "r194",
      "r198",
      "r199",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r191",
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r1102",
      "r1103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r190",
      "r192",
      "r195",
      "r197",
      "r199",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r181",
      "r182",
      "r184",
      "r185",
      "r196",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r523",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r619",
      "r646",
      "r647",
      "r649",
      "r654",
      "r914"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK COMPENSATION PLANS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r138",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Disclosure of Share Based Compensation Arrangements by Share Based Payment Awards"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r907",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date to be Paid",
        "terseLabel": "Dividends Payable, Date to be Paid"
       }
      }
     },
     "localname": "DividendPayableDateToBePaidDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r122",
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r122",
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Dividends, Cash"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Dividends Payable, Amount Per Share"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date Declared",
        "terseLabel": "Dividends Payable, Date Declared"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in YYYY-MM-DD format.",
        "label": "Dividends Payable, Date of Record",
        "terseLabel": "Dividends Payable, Date of Record"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DomesticPlanMember": {
     "auth_ref": [
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Domestic Plan [Member]",
        "terseLabel": "Domestic Plan [Member]"
       }
      }
     },
     "localname": "DomesticPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r292",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r330",
      "r332",
      "r340",
      "r341",
      "r342",
      "r343",
      "r725",
      "r726",
      "r818",
      "r827",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r292",
      "r319",
      "r320",
      "r322",
      "r323",
      "r324",
      "r332",
      "r340",
      "r341",
      "r342",
      "r343",
      "r725",
      "r726",
      "r818",
      "r827",
      "r884"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted earnings per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerSharePotentiallyDilutiveSecurities": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would have been antidilutive for the period presented.",
        "label": "Earnings Per Share, Potentially Dilutive Securities",
        "terseLabel": "Stock Options (in shares)"
       }
      }
     },
     "localname": "EarningsPerSharePotentiallyDilutiveSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r751"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r662"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Federal statutory tax rate reconciliation [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r301",
      "r662",
      "r689"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory U.S. rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of U.S. federal income tax effect"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r1094",
      "r1101"
     ],
     "calculation": {
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "negatedTerseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r648"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested restricted stock and performance share-based compensation arrangements"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost weighted average expected future recognition period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r115",
      "r242",
      "r283",
      "r284",
      "r285",
      "r311",
      "r312",
      "r313",
      "r316",
      "r325",
      "r328",
      "r345",
      "r396",
      "r509",
      "r651",
      "r652",
      "r653",
      "r682",
      "r683",
      "r724",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761",
      "r796",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityFundsMember": {
     "auth_ref": [
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An investment that pools funds from many investors to invest in a combination of underlying investments, primarily equity investments.",
        "label": "Equity Funds [Member]",
        "terseLabel": "Equity Funds"
       }
      }
     },
     "localname": "EquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r257",
      "r737",
      "r879"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r82",
      "r229",
      "r926",
      "r927",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r729",
      "r730",
      "r735"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r203",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r482",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r730",
      "r800",
      "r801",
      "r802",
      "r891",
      "r892",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Defined Benefit Plans, Fair Value of Plan Assets by Category [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r729",
      "r730",
      "r731",
      "r732",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgeAssetsAtFairValue": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative assets designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Assets",
        "negatedTerseLabel": "Fair Value Hedge Assets",
        "terseLabel": "Fair Value Hedge Assets"
       }
      }
     },
     "localname": "FairValueHedgeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
        "label": "Fair Value Hedge Liabilities",
        "negatedTerseLabel": "Fair Value Hedge Liabilities",
        "terseLabel": "Fair Value Hedge Liabilities"
       }
      }
     },
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r1027"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1, 2 and 3"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r482",
      "r554",
      "r559",
      "r730",
      "r800",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r482",
      "r554",
      "r559",
      "r730",
      "r801",
      "r891",
      "r892",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r482",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r730",
      "r802",
      "r891",
      "r892",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Population of Financial Assets and Liabilities Subject to Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r554",
      "r728",
      "r736"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTS",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r482",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r800",
      "r801",
      "r802",
      "r891",
      "r892",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r204",
      "r733"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r775",
      "r782",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r777",
      "r784"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "negatedTerseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r773",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability [Abstract]",
        "terseLabel": "Finance Lease Liability [Abstract]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r773"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedTerseLabel": "Less current portion",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails",
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r773"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Total maturities, due beyond one year"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails",
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r776",
      "r784"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r775",
      "r782",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r787",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r786",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Useful life of finite-lived intangible assets, minimum (years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r254",
      "r429"
     ],
     "calculation": {
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Estimated amortization expense, Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated amortization expense, 2013"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Estimated amortization expense, 2017"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated amortization expense, 2016"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated amortization expense, 2015"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated amortization expense, 2014"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r425",
      "r428",
      "r429",
      "r431",
      "r808",
      "r812"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r89",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-Lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r905",
      "r1026"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Fixed Income Securities [Member]"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "negatedTerseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "auth_ref": [
      "r1104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).",
        "label": "Foreign Currency Gain (Loss) [Member]",
        "terseLabel": "Foreign Currency Gain (Loss)"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions and Translations Policy"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "terseLabel": "Foreign Plan [Member]"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "netLabel": "Furniture and Fixtures [Member]",
        "verboseLabel": "Furniture and fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnOilAndGasHedgingActivity": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) incurred in hedging activities.",
        "label": "Gain (Loss) on Hedging Activity",
        "terseLabel": "Gain (Loss) on Hedging Activity"
       }
      }
     },
     "localname": "GainLossOnOilAndGasHedgingActivity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r819",
      "r820",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [
      "r819",
      "r820",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r888"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "Geographic Distribution, Domestic [Member]"
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r253",
      "r411",
      "r813",
      "r889",
      "r920",
      "r973",
      "r980"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "netLabel": "Goodwill, net",
        "periodEndLabel": "Goodwill, net",
        "periodStartLabel": "Balance as of January 1",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r414",
      "r889"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period",
        "verboseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "negatedTerseLabel": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and Intangible Asset Impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r423",
      "r424",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Goodwill, Policy"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r61",
      "r412",
      "r417",
      "r423",
      "r889"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, Impairment Loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r160",
      "r981"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "verboseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r42",
      "r299",
      "r364",
      "r369",
      "r375",
      "r378",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r739",
      "r886",
      "r995"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r61",
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r300",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r300",
      "r688"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r40",
      "r61",
      "r83",
      "r220",
      "r236",
      "r361"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity method income, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r907",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r433",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r301",
      "r663",
      "r670",
      "r676",
      "r684",
      "r690",
      "r694",
      "r695",
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesExpense": {
     "auth_ref": [
      "r1095"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties recognized in the period arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties Expense",
        "terseLabel": "Income Tax Examination, Penalties Expense"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r302",
      "r327",
      "r328",
      "r362",
      "r661",
      "r685",
      "r692",
      "r828"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.labcorp.com/role/INCOMETAXESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Income tax provision [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r282",
      "r657",
      "r658",
      "r670",
      "r671",
      "r675",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Increase (Decrease) in Accounts Payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "(Increase) decrease in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r955"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "auth_ref": [
      "r955"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "negatedTerseLabel": "Increase (Decrease) in Contract with Customer, Asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedTerseLabel": "Increase (Decrease) in Deferred Liabilities",
        "terseLabel": "Increase (Decrease) in Deferred Liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r882"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Increase (Decrease) in Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in assets and liabilities (net of effects of acquisitions and divestitures):"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Increase in prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r427",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r91",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Components of identifiable intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r253"
     ],
     "calculation": {
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r87",
      "r92"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r211",
      "r222",
      "r286",
      "r358",
      "r766"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateFairValueHedgeAssetAtFairValue": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all derivative assets designated as interest rate fair value hedging instruments.",
        "label": "Interest Rate Fair Value Hedge Asset at Fair Value",
        "terseLabel": "Interest Rate Fair Value Hedge Asset at Fair Value"
       }
      }
     },
     "localname": "InterestRateFairValueHedgeAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateFairValueHedgeDerivativeAtFairValueNet": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivatives designated as interest rate fair value hedging instruments.",
        "label": "Interest Rate Fair Value Hedge Derivative at Fair Value, Net",
        "terseLabel": "Fair Value Hedges, Net"
       }
      }
     },
     "localname": "InterestRateFairValueHedgeDerivativeAtFairValueNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r356",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r374",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r944"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Inventory, Finished Goods, Gross"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r269",
      "r878",
      "r920"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Supplies inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r249",
      "r267",
      "r344",
      "r404",
      "r405",
      "r406",
      "r806",
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r85",
      "r946"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory Valuation Reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r46",
      "r47"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r942"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Joint venture partnerships and equity method investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r1002"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r1109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r788",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r1110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Lessee, Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r1111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": {
     "auth_ref": [
      "r1111"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "auth_ref": [
      "r1111"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r1111"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r1111"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r789"
     ],
     "calculation": {
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lessee, Operating Lease, Renewal Term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r1108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases of Lessee Disclosure [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of Credit Outstanding, Amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r19",
      "r299",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r708",
      "r711",
      "r712",
      "r739",
      "r885",
      "r995",
      "r1112",
      "r1113"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r13",
      "r218",
      "r233",
      "r920",
      "r958",
      "r969",
      "r1106"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r22",
      "r248",
      "r299",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r708",
      "r711",
      "r712",
      "r739",
      "r920",
      "r995",
      "r1112",
      "r1113"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements [Member]",
        "verboseLabel": "Canadian licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LifeAndAnnuityInsuranceProductLineMember": {
     "auth_ref": [
      "r1122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract providing periodic payment upon death of insured.",
        "label": "Life and Annuity Insurance Product Line [Member]",
        "terseLabel": "Life and Annuity Insurance Product Line [Member]"
       }
      }
     },
     "localname": "LifeAndAnnuityInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r16",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Line of Credit Facility [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeDescription": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the fees for amounts available, but unused under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Description",
        "terseLabel": "Line of Credit Facility, Commitment Fee Description"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Line of Credit Facility, Interest Rate at Period End"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r16",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r16",
      "r957"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount of long-term debt and capital lease obligation maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-Term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r109",
      "r304",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r259"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, less current portion",
        "verboseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes Payable, Noncurrent"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r24",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESEffectsofInterestRateSwaponOtherComprehensiveIncomeDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r107",
      "r108",
      "r450",
      "r451",
      "r452",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingencies by Nature of Contingency [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r107",
      "r108",
      "r450",
      "r451",
      "r452",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r107",
      "r108",
      "r450",
      "r451",
      "r452",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MediaContentMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information and entertainment created for consumption by end users or audiences.",
        "label": "Media Content [Member]",
        "terseLabel": "Media Content"
       }
      }
     },
     "localname": "MediaContentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r295"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by (Used in) Investing Activities, Total"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r58",
      "r59",
      "r62"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r41",
      "r62",
      "r221",
      "r237",
      "r246",
      "r277",
      "r280",
      "r285",
      "r299",
      "r315",
      "r319",
      "r320",
      "r322",
      "r323",
      "r327",
      "r328",
      "r338",
      "r364",
      "r369",
      "r375",
      "r378",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r726",
      "r739",
      "r886",
      "r995"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings attributable to Laboratory Corporation of America Holdings",
        "totalLabel": "Net earnings attributable to Laboratory Corporation of America Holdings",
        "verboseLabel": "Net earnings, basic"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r176",
      "r178",
      "r277",
      "r280",
      "r327",
      "r328",
      "r950"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net earnings attributable to the noncontrolling interest",
        "negatedTerseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r331",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net earnings, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r72",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r322",
      "r329",
      "r343",
      "r390",
      "r391",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r651",
      "r652",
      "r653",
      "r680",
      "r681",
      "r682",
      "r683",
      "r702",
      "r703",
      "r704",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r764",
      "r765",
      "r768",
      "r769",
      "r770",
      "r771",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r809",
      "r810",
      "r811",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Non-US"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Notes Payable, Current"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
        "label": "Notes Receivable [Member]",
        "terseLabel": "Notes Receivable"
       }
      }
     },
     "localname": "NotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r364",
      "r369",
      "r375",
      "r378",
      "r886"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r783",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r1107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating Lease, Expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r773"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Operating Lease, Liability [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r773"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedTerseLabel": "Less current portion",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails",
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r773"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Total maturities, due beyond one year"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/LEASESMaturityofLeasesDetails",
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r778",
      "r784"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "negatedTerseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r772"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r787",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r786",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalBalanceSheetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "terseLabel": "Operating Loss Carryforwards, Limitations on Use"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r154"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Operating Loss Carryforwards, Valuation Allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r186",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r255"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets, net"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax [Abstract]",
        "terseLabel": "Net Benefit Plan Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Interest Rate Swap Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r29",
      "r32",
      "r748",
      "r749",
      "r753"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r29",
      "r33",
      "r748",
      "r750",
      "r760"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "negatedTerseLabel": "Tax effect of adjustments, Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r276",
      "r571"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r35",
      "r284",
      "r754",
      "r756",
      "r761",
      "r948"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r84",
      "r288",
      "r754",
      "r759",
      "r761",
      "r814",
      "r823",
      "r948",
      "r949"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other comprehensive earnings (loss) before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
     "auth_ref": [
      "r29",
      "r32"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
        "terseLabel": "Foreign currency translation adjustments",
        "verboseLabel": "Current year adjustments, Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax": {
     "auth_ref": [
      "r32",
      "r36",
      "r37",
      "r276",
      "r752"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r39",
      "r115",
      "r278",
      "r281",
      "r288",
      "r754",
      "r759",
      "r761",
      "r814",
      "r823",
      "r948",
      "r949"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive earnings (loss), net of tax",
        "totalLabel": "Other comprehensive earnings (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r30",
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r30",
      "r32",
      "r905",
      "r1044"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTerseLabel": "Net benefit plan adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r30",
      "r33",
      "r173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Tax effect of adjustments, Net Benefit Plan Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r33",
      "r283",
      "r288",
      "r661",
      "r691",
      "r693",
      "r754",
      "r757",
      "r761",
      "r814",
      "r823"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedLabel": "Tax effect of adjustments, Accumulated Other Comprehensive Earnings",
        "negatedTerseLabel": "(Provision) benefit for income tax related to items of comprehensive earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r945"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Other Inventory, Supplies, Gross",
        "terseLabel": "Other Inventory, Supplies, Gross"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other Investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "OTHER LIABILITIES"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r186",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities [Member]",
        "verboseLabel": "Other Liabilities [Member]"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/OTHERLIABILITIES_2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other Operating Activities, Cash Flow Statement"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchase of common stock",
        "terseLabel": "Payments for Repurchase of Common Stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r437",
      "r954"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments for Restructuring",
        "terseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "terseLabel": "Payments of Ordinary Dividends"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash acquired",
        "terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Payments to Acquire Equity Method Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r551",
      "r553",
      "r559",
      "r578",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r599",
      "r600",
      "r602",
      "r615",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "PENSION AND POSTRETIREMENT PLANS"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r126",
      "r527",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r576",
      "r577",
      "r579",
      "r582",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r602",
      "r603",
      "r614",
      "r905",
      "r906",
      "r910",
      "r911",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r579",
      "r903",
      "r904",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092",
      "r1093"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by position taken for a security.",
        "label": "Position [Axis]",
        "terseLabel": "Position [Axis]"
       }
      }
     },
     "localname": "PositionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PositionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates position taken for a security.",
        "label": "Position [Domain]",
        "terseLabel": "Position [Domain]"
       }
      }
     },
     "localname": "PositionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]",
        "terseLabel": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value per share (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r270",
      "r407",
      "r408",
      "r880"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentInvestingActivities": {
     "auth_ref": [
      "r951"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Investing Activities",
        "terseLabel": "Proceeds from Derivative Instrument, Investing Activities"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from senior note offerings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-Term Lines of Credit",
        "terseLabel": "Payments on revolving credit facilities"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r952",
      "r953"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Proceeds from (Payments for) Other Financing Activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherInvestments": {
     "auth_ref": [
      "r951"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of investments classified as other.",
        "label": "Proceeds from Sale of Other Investments",
        "terseLabel": "Proceeds from Sale of Other Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r54",
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received by the Company"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r246",
      "r277",
      "r280",
      "r294",
      "r299",
      "r315",
      "r327",
      "r328",
      "r364",
      "r369",
      "r375",
      "r378",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r706",
      "r709",
      "r710",
      "r726",
      "r739",
      "r820",
      "r886",
      "r916",
      "r917",
      "r950",
      "r995"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net earnings",
        "totalLabel": "Net earnings"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment by Type [Axis]",
        "verboseLabel": "Property, plant and equipment, net [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r845",
      "r846",
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r100",
      "r251"
     ],
     "calculation": {
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment [Member]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r102",
      "r234",
      "r821",
      "r920"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, by Type [Abstract]",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetByTypeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r845",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "verboseLabel": "Property, plant and equipment, net [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful life, minimum (years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r293",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Accounts Receivable, Credit Loss Expense (Reversal)"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in funds that invest in commercial or residential real estate.",
        "label": "Real Estate Funds [Member]",
        "terseLabel": "Real Estate Funds [Member]"
       }
      }
     },
     "localname": "RealEstateFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of uncertainty related to unrecognized tax benefits.",
        "label": "Nature of Uncertainty [Axis]",
        "terseLabel": "Nature of Uncertainty [Axis]"
       }
      }
     },
     "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r35",
      "r284",
      "r754",
      "r758",
      "r761",
      "r948"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of unrecognized tax benefits [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReductionInTaxesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A potential favorable financial consequence resulting from a ruling or change in tax laws.",
        "label": "Reduction in Taxes [Member]",
        "terseLabel": "Reduction in Taxes"
       }
      }
     },
     "localname": "ReductionInTaxesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r57",
      "r957"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayments of Lines of Credit"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-Term Debt",
        "negatedTerseLabel": "Repayments of Other Long-term Debt",
        "terseLabel": "Repayments of Other Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedTerseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r435",
      "r437",
      "r440",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "RESTRUCTURING AND OTHER SPECIAL CHARGES"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r61",
      "r441",
      "r443",
      "r987"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r436",
      "r437",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Reserve, by Type of Restructuring [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "terseLabel": "Restructuring Costs and Asset Impairment Charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r437",
      "r442"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r437",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Restructuring Reserve, Accrual Adjustment"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r943",
      "r988",
      "r989"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring Reserve, Current"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveNoncurrent": {
     "auth_ref": [
      "r947",
      "r988",
      "r989"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Noncurrent",
        "terseLabel": "Restructuring Reserve, Noncurrent"
       }
      }
     },
     "localname": "RestructuringReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r10",
      "r122",
      "r232",
      "r836",
      "r841",
      "r920"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings",
        "verboseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r242",
      "r311",
      "r312",
      "r313",
      "r316",
      "r325",
      "r328",
      "r396",
      "r651",
      "r652",
      "r653",
      "r682",
      "r683",
      "r724",
      "r832",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanNameAxis": {
     "auth_ref": [
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r913",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Axis]",
        "terseLabel": "Retirement Plan Name [Axis]"
       }
      }
     },
     "localname": "RetirementPlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanNameDomain": {
     "auth_ref": [
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r913",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.",
        "label": "Retirement Plan Name [Domain]",
        "terseLabel": "Retirement Plan Name [Domain]"
       }
      }
     },
     "localname": "RetirementPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r579",
      "r582",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r579",
      "r582",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r1065",
      "r1066",
      "r1067"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r527",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r576",
      "r577",
      "r579",
      "r582",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r614",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r527",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r576",
      "r577",
      "r579",
      "r582",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r602",
      "r603",
      "r604",
      "r614",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFundedStatusDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r521",
      "r522",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUENotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r287",
      "r299",
      "r355",
      "r356",
      "r368",
      "r373",
      "r374",
      "r380",
      "r381",
      "r384",
      "r392",
      "r455",
      "r456",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r466",
      "r467",
      "r739",
      "r820",
      "r995"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]",
        "verboseLabel": "Revolving credit facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
      "http://www.labcorp.com/role/DEBTSENIORNOTESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r785",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r785",
      "r919"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESSupplementalCashFlowDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accrued expenses and other"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Acquired amortizable intangible assets and their respective weighted average amortization periods"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Potential common shares not included in computation of diluted earnings per share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Defined Benefit Plan, Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r161",
      "r162",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "verboseLabel": "Acquisitions [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSDISPOSITIONSDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESTables",
      "http://www.labcorp.com/role/SUPPLEMENTALCASHFLOWINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r24",
      "r116",
      "r119",
      "r120",
      "r121",
      "r209",
      "r210",
      "r212",
      "r225",
      "r891",
      "r893",
      "r960"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures",
        "verboseLabel": "Defined Benefit Plans, Fair Value of Plan Assets by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSFAIRVALUEOFPLANASSETSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r187",
      "r192",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic earnings per Share to Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r89",
      "r93",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r89",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r889",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Carrying Amount of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r959"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetFundedStatusTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of net funded status of pension plans and/or other employee benefit plans.",
        "label": "Schedule of Net Funded Status [Table Text Block]",
        "terseLabel": "Schedule of Net Funded Status [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfNetFundedStatusTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSPensionandPostretirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Share Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, classified as other.",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]",
        "verboseLabel": "Property, plant and equipment, net [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439",
      "r443",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserves"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r616",
      "r618",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANS",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Short-term borrowings and current portion of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r112",
      "r113",
      "r114",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Common shares issued and outstanding [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r352",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r384",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r439",
      "r445",
      "r889",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r364",
      "r367",
      "r372",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r383",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfPayMember": {
     "auth_ref": [
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients who pay out of pocket for a health-related service in absence of insurance to cover the medical or surgical procedure performed.",
        "label": "Self-Pay [Member]",
        "terseLabel": "Self-Pay [Member]"
       }
      }
     },
     "localname": "SelfPayMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Restructuring charges related to severance and other employee costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights",
        "terseLabel": "Restricted stock, vesting increment"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value, granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Number of options vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value, vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "verboseLabel": "Share-based Compensation Arrangements by Share-based Payment Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant under the Company's stock option plans"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r1074"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Number of options cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r1074"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price per option cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r1075"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Number of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, exercisable options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Number of options exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price per exercisable option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price per option exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price per option granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Axis]",
        "verboseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails",
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Options Outstanding and Exercisable at December 31, 2013, by Range of Exercise Prices"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSScheduleofOptionsOutstandingandExercisableatDecember312013byRangeofExercisePricesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term of options outstanding (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, exercisable options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DEBTCREDITFACILITIESDetails",
      "http://www.labcorp.com/role/DEBTSCHEDULEOFSHORTTERMDEBTDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESScheduleofDerivativeInstrumentsinStatementofFinancialPositionatFairValueDetails",
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r71",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]",
        "terseLabel": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/PROPERTYPLANTANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r245",
      "r352",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r378",
      "r384",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r434",
      "r439",
      "r445",
      "r889",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSCHEDULEOFGOODWILLDetails",
      "http://www.labcorp.com/role/REVENUEDetails",
      "http://www.labcorp.com/role/ReceivablesLoansNotesReceivableandOthersDetails",
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r299",
      "r332",
      "r333",
      "r340",
      "r342",
      "r346",
      "r347",
      "r392",
      "r455",
      "r458",
      "r459",
      "r460",
      "r466",
      "r467",
      "r495",
      "r496",
      "r498",
      "r502",
      "r508",
      "r739",
      "r859",
      "r939",
      "r956",
      "r966"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSBusinessAcquisitionsTables",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r27",
      "r115",
      "r242",
      "r283",
      "r284",
      "r285",
      "r311",
      "r312",
      "r313",
      "r316",
      "r325",
      "r328",
      "r345",
      "r396",
      "r509",
      "r651",
      "r652",
      "r653",
      "r682",
      "r683",
      "r724",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r761",
      "r796",
      "r832",
      "r833",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r311",
      "r312",
      "r313",
      "r345",
      "r807"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals",
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r122",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Number of options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "negatedTerseLabel": "Net share settlement tax payments from issuance of stock to employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionPlanExpense": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for option under share-based payment arrangement.",
        "label": "Stock or Unit Option Plan Expense",
        "terseLabel": "Stock option plan expense"
       }
      }
     },
     "localname": "StockOptionPlanExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/STOCKCOMPENSATIONPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Common shares repurchased (in shares)",
        "terseLabel": "Stock Repurchased and Retired During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r7",
      "r8",
      "r115",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Purchase of common stock",
        "negatedTerseLabel": "Purchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r8",
      "r11",
      "r12",
      "r81",
      "r920",
      "r958",
      "r969",
      "r1106"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "BALANCE",
        "periodStartLabel": "BALANCE",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.labcorp.com/role/ConsolidatedBalanceSheetParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r298",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r509",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r762",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r762",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r762",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r762",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails",
      "http://www.labcorp.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r797",
      "r799"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrecognized tax benefits for which a material change is reasonably possible in the next twelve months, typically including the nature of the uncertainty, the event(s) that could cause a material change, and an estimate of the range of the reasonably possible change or a statement that an estimate of the range cannot be made. An unrecognized tax benefit is the difference between a tax position taken in a tax return and the amounts recognized in the financial statements for which it is more likely than not, based on the technical merits of the position, that the tax position will not be sustained upon examination.",
        "label": "Summary of Positions for which Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table Text Block]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits from Uncertain Tax Positions"
       }
      }
     },
     "localname": "SummaryOfPositionsForWhichSignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance [Table Text Block]"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Accrued taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/ACCRUEDEXPENSESANDOTHERDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r901",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r901",
      "r1001"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/REVENUEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "netLabel": "Trade names [Member]",
        "terseLabel": "Trade Names [Member]",
        "verboseLabel": "Trade names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDISPOSITIONSEnvigoDetails",
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGINTANGIBLEASSETS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names [Member]"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury Stock Acquired, Average Cost Per Share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PREFERREDSTOCKANDCOMMONSHAREHOLDERSEQUITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r436",
      "r437",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/RestructuringandRelatedActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledContractsReceivable": {
     "auth_ref": [
      "r805"
     ],
     "calculation": {
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
        "label": "Unbilled Contracts Receivable",
        "terseLabel": "Unbilled Contracts Receivable"
       }
      }
     },
     "localname": "UnbilledContractsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "auth_ref": [
      "r226",
      "r238",
      "r655",
      "r696"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "terseLabel": "Undistributed Earnings of Foreign Subsidiaries"
       }
      }
     },
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r656",
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance as of December 31",
        "periodStartLabel": "Balance as of January 1",
        "terseLabel": "Gross unrecognized income tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r667"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to unrecognized income tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase in reserve for tax positions taken in the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r668"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Decrease in reserve as a result of lapses in the statute of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r669"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized income tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r75",
      "r76",
      "r77",
      "r348",
      "r349",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UseRightsMember": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal right to use or benefit from the use of natural resources or access. Examples include, but are not limited to, drilling rights, water rights, air rights, timber cutting rights and route authorities.",
        "label": "Use Rights [Member]",
        "terseLabel": "Use Rights [Member]"
       }
      }
     },
     "localname": "UseRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/BUSINESSACQUISITIONSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSCOMPONENTSOFIDENTIFIABLEINTANGIBLEASSETSDetails",
      "http://www.labcorp.com/role/GOODWILLANDINTANGIBLEASSETSSUMMARYOFACQUIREDAMORTIZABLEINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences.",
        "label": "Valuation Allowance by Deferred Tax Asset [Axis]",
        "terseLabel": "Valuation Allowance by Deferred Tax Asset [Axis]"
       }
      }
     },
     "localname": "ValuationAllowanceByDeferredTaxAssetAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails",
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation Allowance [Line Items]",
        "terseLabel": "Valuation Allowance [Line Items]"
       }
      }
     },
     "localname": "ValuationAllowanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails",
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceTable": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.",
        "label": "Valuation Allowance [Table]",
        "terseLabel": "Valuation Allowance [Table]"
       }
      }
     },
     "localname": "ValuationAllowanceTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails",
      "http://www.labcorp.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r961"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableAnnuityMember": {
     "auth_ref": [
      "r924",
      "r925",
      "r1123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract providing periodic payment that varies according to investment experience of separate account in which amount paid to provide for annuity is allocated.",
        "label": "Variable Annuity [Member]",
        "terseLabel": "Variable Annuity [Member]"
       }
      }
     },
     "localname": "VariableAnnuityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSDetails",
      "http://www.labcorp.com/role/PENSIONANDPOSTRETIREMENTPLANSOTHERDISCLOSURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeasePayment": {
     "auth_ref": [
      "r779"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability.",
        "label": "Variable Lease, Payment",
        "terseLabel": "Variable Lease, Payment"
       }
      }
     },
     "localname": "VariableLeasePayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/LEASESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/DEBTCOVERTIBLESUBORDINATEDNOTESDetails",
      "http://www.labcorp.com/role/DERIVATIVEINSTRUMENTSANDHEDGINGACTIVITIESTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r331",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Outstanding shares, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r330",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Outstanding shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGEARNINGSPERSHARE"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityNoncurrent": {
     "auth_ref": [
      "r25"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).",
        "label": "Workers' Compensation Liability, Noncurrent",
        "terseLabel": "Workers' Compensation Liability, Noncurrent"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.labcorp.com/role/OTHERLIABILITIES_2"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1072": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1073": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1074": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1075": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1076": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1077": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1078": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1079": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1080": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1081": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1082": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1083": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1084": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1085": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1086": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1087": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1088": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1089": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1090": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1091": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1092": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1093": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1094": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1095": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1096": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1097": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1098": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1099": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5394-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126966630&loc=d3e41228-113958",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(d)(i))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e709-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126928070&loc=d3e28200-109314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=116633155&loc=d3e31531-110899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55302-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r859": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r861": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r862": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r863": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r864": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r865": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r866": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r867": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r868": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r869": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "1402",
   "Subsection": "Instruction 5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r871": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r872": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r873": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r874": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(4)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r875": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1406",
   "Subparagraph": "(5)",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r876": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29G",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819547-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r929": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r931": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r932": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r933": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r934": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r935": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r936": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r937": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r938": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "210-10-S99-1(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131251-203054",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>124
<FILENAME>0000920148-23-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000920148-23-000017-xbrl.zip
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MC$?^GKW@#$ZF8D\69#U0(/3UT6"!MM,Q,$S96(,W^RI4\ R\'NR1P/NLX)U
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MU'MQ'OK "A)X#'0 7:Z^3.$:]K* F9J'&8O7#\!@28"$[ -5ITJ[<X#T ^#
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M,H?*($[S[%D\?#:-O<^P9>@)B=("IE!+['@;$GLI:M$%2@H#B6$3$RI#\35
MU$- (A']20HH0JU#\=,\27/)7KJR)72\S!)JE1F.#"U\+Q/)5T#'OQ>]WX1#
MO<T+*.T4$0<?1;4*9&GGZ\.ZFJ=/)%L03V.9C#3]^D$Z &I1-D2@1?#]VK-R
ME VBVQCDH$\Q*A@(:E?$0>\=[8.0GJ$A'[ S<S7IMAKJPIN&^581C&RK2-_7
MJ=B8W97K':.?5NTLVC=$."57-@JA$N4H^'Y"1[,UGQE$H-,2]@*RM++?@*(-
MB X0\+<6CI)"$;[)=&$O@QD0CQSC9%GA;<3C89C[0/%PK,0E 9V94=H%JC_/
MX_49J.P.Y5F%A>ZS6/<=-BH2S]O-\GKH("1N[KF\V[K3PR3M+ ,CSKO11W;T
M',;-!Y,@I; ;_/A'G@2I'W@<Q267!IF48+%I!UWQ'5P+%BQYY]"%!^QFH#86
M:S] 5Z'.'7AT:;KA-DYR-'=3@?]&($NVN8LM*P7JX."5C(-TN4APD>YU(]W?
MJZA\T6X8DYT6WHLM)UW,>8=U)%_'8Q DPP=5H4)8RR2. @\/^W&")]K(N&7;
M4W]H0CE\3U(D(['S23_8PM2XKDSIJ7CZEQCR!G.&G<XVH%/"7Z&;&N@<;0FV
M=DJ6M@7Z$Z9-^[8UM VC47BYA:X%%*"2#'V8JD3/JBV6K(@=.#JR4\PEF)5]
M4&2\%>A*AB. =@CHX 8Z *P@G##B#?0+:3C%_,L/:XE!GM&A@>1;Y3UV51#A
M8,0C3=N.&2;Q+F9/H 2SGUWNL(V81: A P8:6D8?D-<"7@+"54['-'$>..@H
MU)9P3!%A, DR#6;*&=> <(AI9K!42\\C2$:X;)R7H7T])905;;G%--+J);S>
M(.9+ZT3TM<>F-JR&ATD=^JHEU"BS_1;'MTO/J1_%W&MEQ*%1?DH+_P7-#ORF
M38,JK(PRD0GH@4<N^!GVP:5R(J2B8=+W0Y!Z*@QEI.+MGAB_8XS%ML,P%W&&
M,BLE(Q8#)=$,L?0CX^) @$5"Z+<E^(HXF7/CMLA?V\N3V(^!>!)QA<=>#-.D
ME0S#)0_<1S=/,9S"_7C_F=LZ!+( CQK&JX->3;Z?#O/HL2P\E7W4%G P1TQK
M$/LDMDA@U@_>VM@&:'A/!E?QDDR;XG,#Q(<E:B)A%1 ;S<BTO6AN-T@%A3#*
M"(>1:(=&8,8-CSWOO[V\0N\"O"Q(,6FL[#"=<["OE0:Z#VHN"\+R^M&B;+9:
M0 7DV= F"D6GBG4K62-1+(9Y8M0'PP]Y.;YCKM]V\ J/_14H5%H<(0NT)4/^
MYW*EBNCIP@.*(A-HT1"R02=28 1)?^*M+TA_F&,(@G:>+#WF!,9 %'(H2/3I
M=<'N)%1N92C?,=UL.UPTGSA'H?"BH$AJ$V>43I_#O=9"DMU,^@*#BUD( FKT
MLAPBR:3F?O3NENER&1&:$"(^H<B$KXLSXH-]>UOYU *CB[1%AM1,_B\_)H\M
M@D<U< TD?L["R@<KB=S*:X^RS>OX/I<8(M6P4_)UF6DO?Y*^B4]IY3E6;R%/
M'5^J^,1W67I<D-[#>77 OT66:F:=KF6XGU>=AI6NN3:G>& DY)MW!!K;+CBJ
M5(#3^08W]PVN4<!NAR"C_0OQ>__FHG=]+:CBV.6[^F)1:,)YD@KDS$E9CJ+-
M)5U6A0M#*.4@AH=H*-1FDF:=!9UBI#$:/0O5$";WZE7[\+DIFKNI#^&>1U7)
M)R/3WW(!IJ ]\]!$GJ;JM?GC#6B.:2AGKX.(2XK@36^J]7WQ^>AI04>,?@>]
MCG_6%/W\L'UX?(1$G<'@,]^\6--[F^C]E\RO^:W3/GEYM/3G@W9G^:WW//;D
M9?O5B^6W/O2QS]NOGK]8ZZF_T$+P8L!RIU,9_<]/+WZ:V\?7A],OHE/=0=S:
M^17GQ9Z3+95M(J:J4,=1NU/ZBNB"O]M2O>H-:J>66>")10\-M;YT:XTPUE1@
M-_AH88,/!*_X<J)8O$<3A<!_C]LTYA7TD<73IY?2M%1O9U4L\_R*%"2OA9#1
MR&T0+ )4<> +,\H-F6)[DR;_<4K_A<<-8%CBNBT^)C#X4%668LT=KU#)O<L'
MD][MM;N0$UW Z:E6;F>6Y@8;,/#:7*L(45YSB%D\)-T@Q@C,]J1NM>:,Y<YS
M6IMOMH+FTAJ#9%&_U!FO=JB_D*GAS/RUS?R*:C_LO&B"U7?\HGW4.7Z0U7?4
M/CEY^<W-LY?'[8/#PRW89RPSEFY7^^3Y@BG&7VY+:]=73U^SY<?A\;RM>7BP
M?(J5@\ZSSF/X+M>TZNIKPR\349O9:4C03=8MJ^RTHR5V6J=B:>R.F5$VT;KP
M@D1<RU"IR6H;XYL>TBI<\N+YNERR';?+G'U67K:__MQY<?!F\;\/9YZE9L=2
M/ON:]6^ S"U9=U6S;F,;J>;D__7.)&=3.)O"V10/L"E,KXJ6N*:<^W.XR+:O
M@ -;M>^%LS:^=VOC[W&JIF-QWA:G<2+'7V%PT%:_>%&B^-+<%^R%I>IPNU:$
M6XZJ[C\+L#Q,7..^V5C?K^5)<+Z5E;Z559$49QHYT^BKV/_WWOGYM7C7O7I_
M28WKP#:BX%?W7'2OKR]/^_3I![*5G&&TTC#:2=OG3"9!)#[D85BD(V[L%! '
MXM6+Y4Z1U<8DQLB^SI)LN"O!6E?+W#*U^_ P%PWLQE%G\ZWXUKZSSLGZ$JY]
M\!0HAY66W@<9R1&>"!=,OJ]U]#C#SQE^SO#; </O;??J]+S[[VMN5_SQ_'1W
M;;R5^0'S-IXSZ+X#@PX;)JE(_%,IS+_J][_&J#NY)]+EC+K51MW2O7BP8??B
M86;V][7NA<6V;.&_,ESGK*^UK:^GS]>IQRHO=!=<,?CCZMCO2>]_6LL19M,^
MX#W;U'1\];+]ZF#YSS4VWAR]:RMDG; /;(KN%;J 9UW$3R_ELR6D^-0FT.FG
MZ_Y'/@$^/WA^?/"_W>NCI634V#'?=#8=\[8S\=:;Z<UO_:LSC%%?G/7@WXLS
M<=6[ONG>P(?3J]Y9_T9TWU_U>O#[S<9SV8T5.)-%'E1WF@2A.#IHB<.#P[5V
M_'$F/!P^VH3OJT.)IQ7=/WHPFR]*8&HB\TK]'>OA)#/1.:*U6HNCM[K-N#5[
ME[H"$_:6+TWF3'EJ,E")..S@;#H=RK@Q2\&%(; [VN(-G5=TPS'=8*HFV!MY
MI3#?CI>I\Z+5^'5:F,3B[*_5--/3?T[3.FG^M' :]?OS0<[$"1'QP5HUCYHW
MC<4=JLJQ_>]4<LM)'(V^T[EMDAW8]+GHOO6V@GU#2Q>L-YEZ6%_CA[T$[+\>
M2&_SZ>W&7JZ)0VC\/&!SKV>1CZTKL-)(T0C@:[?QJ2?2? 6\&,%H_)!/^S=]
M3=T[(:K^_O'#Y=7[[H4X_:U[W1.[-/1_]/Y-=+&;8N3#IW?O]7*?WYSMP')_
MO#C=:;E]<U:B[L:/=LU6+5L=XZ?V=5OL, N")C=%R4JZ//U.[:^'4-1NS.SF
MMYZXA/]<B7/TK%Y=BX_=JYM_"RS<='/YC2:]2POR-AYVQ77O]-,56".]ZY;H
M7YPZD?>M#S'E!3X_/VW\V$'<_3T.X+WG2OJBBPWJ1M@0$L\N_,/;./[,R$'X
M?H-2XKLE+;IOSWOH5#B]O+CI7=Q<?RVKK[,(C_&;"_'7A_B_;JV?FAQ!4_5/
M@2#[0ISUWO4O^F@[75-PL'MZ>OGIXJ9_\5[<]*X^7"^#B"R/G55KLCU&7O]Z
MD\36S1O65#N%31\DP=>]=U7E@*=?B_LB@F>Z-/P-E@K>WA!_^K6]TY1VZ"AM
M%:5=4DR+2MI/$T4>ZH^V/'TC*>^>00V'3[N.C(KB?H@__7KX8L5Z;0E><'B\
M"[QZY'AUU49VN?\E!HZ:JQB:RYXG#67/Y[O GL>./5=MY!4P)VZ78\N-V/)E
M0]GRQ2ZPY7/'EJLVDE^#Z$$Y<ZSI6/.I6'/5:<"QYJ_G*LNX![9I'#>A!N^.
M31V;/A6;KCH5.#;]]2QP_J"'\.4KQY</Y\M50LWQY:^V$2EV&W7,^;TRYY:C
MD7TA$%9S>OGA0_\&$Q(Y)*G3%'O_NNE=7&.@TI' MR*!D\;+YT,7Q5UC(T_C
MR23()LJ=:!QG/B%GNJCWRHWDG#C8K[0E3N/H5B7<CAT!</ 9.],7C;^IC;MC
M8,? 3\7 +A2^IN<P+5R'CC\WX<^C53IB6_SY:A?XT\7"5VYD.;W9J<]-V?.X
MH>QY]'(7V-/%Q%=NY,=$3>7,G4PWY\Q5LG]+G'G<?#SVH0N)KX-64<DDB#@)
M-4[$E?)SCS\,17<T2M1(9@J^OHW#6U2QSL?T4$YN*%J[T/U-YF07-5\-!S4J
MUOF0OB\&75YTL4$,ZL+G:X?/'5MNQ)8-3:/8#;9<Y1=W;/GK.^6P+(XEGXPE
M.P>.)=< ,DQS71D)C%F+.\-PJ6/7C=FUH7CMX^;G"0.[.MS1RHWLW6*'&$]Q
MR?2!,W =>SX9>SKPT>K@BXZ\B/<J4@EV1?CKS\]?O:DM%/W7GU\>=D[>I.(T
ME'<#Z7UVO+P1+S<4AW3<_)Q_X&6'0UJ-<QACB^,1:EK+UH.9+NGN[.*-F/7Y
MJI/8MIBU^?E2P*P.E+3Z&"O3L3C%YG89ZEW'G1MQYZJ#U[:X<Q<@O1V'25J=
M9:R&,@^INI53GP]AT(:"!H]W 338<="DU>I3)9D,(O$1(4H9=CVSK0H=JV[&
MJ@U%$186>&.2CS'[N/LO+*S^[W[O_$Q\O+J\Z9U24S;,0NZ?G_?>=\_[-__>
M/2)H*+[E>?.AI$<N_7B-C;R17UQHSO'DT_&D\_VOQIR%H1K!M#-7BG CQGS1
M4-_@\^8[\H]<0O$ZC!G)08!\*;)8G*F,TC"4JZSD6/5I6=6Y\==@52]1,E58
MJB-UKH<-N;.IKH?FN_&/7&KQ.E[">#)54<I@T6&<B/,X357:WB:;[AZ7KB*T
M;7%I\^MS'+DTXS4V\D.0!2/FT<M!J/],&8=VI::A])1-773!N <P<%,=23O!
MP"Z[>#7P+$]N@UL'8OENV7++@;=_"NR*>Z9[D'Z\ZIWVSGH7-^+F\CNH_-M4
M,GBQ&']MFG0^=J&WM0Y!D1]P =$L%KWA4'F(Z8]4ZNPHQZE/QJDN(+<AI\HP
M-*V(>E\R%;FN)YMS;$/3YUXLAM"W:V*!A775 \/J&LRJ;M'J_??NU57WXJ;?
MVT&SJJ'95B^:7U+KN3.KUMC(RV0DH^!/^IY]51_C.^>;<FSZA&SJ;*J5&]G-
MLW&<:#YUO+D);YXT%#SQHOFE?)X[G-,:&]F+AG'B*0UV<LSIF/.IF-,AFU9N
MY/OX5B41!EYE*+K3:1+?RM!9MXY)GXQ)'<!IY4:^"R(9>0%PZ'4F,^72'QV+
M/BF+.G33RHV\B,4'K/&!3-KUL;N?$J=C&8V48]2-&+6A-3]V@U$=BLF.Z57G
MS96"NV^5#Q^.WCA6^&:LT/RJD,]=-X(U-O+<(G(YLH$X^C"06,;U+LC&XES>
M.3/3L>R3L:SK5+#Z)*A\K",GM&J#?T=YR$AZQZF.4Y^(4UT#@W521F]52EWR
M2*_*:":ZGJN+[ICTR9C4H7M6;N2GE#H6?$QB3RG?J5#'G4_&G0[4LTXU,3!P
MLSQQQNV&G-G0NJR[P9D.TK-1M.-#D*8N*OE]\6GSZQ8]=^T'UMC(WF0:QC.E
MQ%L5J6&0B8^A=,K4,>G3,:E#]ZR!C[T-DMA@\$"O9BZ_Q/'H$_*H@_>LKGVB
MHB!.1!^^&63*=UGU&W/HJE.5X]![.-3A>M8YDNIV/HXQ'6,^%6,ZE-'J#.IW
MW5/'DM\Y2^HGG!S"*Z9Q2N5-7B<JI+[";^X"/QOK[2C?-8BS+)Z\/BAND8,T
M#O-L\19>BU__-DA^K0ZB_-]Q4HB(D7HV2)3\_$P.X3SU6H9W<I967S\)HF?E
M@2\;)BT),.X(IH17_[1B,,T450Y=M3J+/,J"9Z=QDN13JE.* $@A(U]<R\AS
M(*OO1Y UO[WN\_:A UFM9E@J<Z=\463(]:,T"[+<<>OWS*U;+J/5%Z+[[EW_
MZD/WIO_/GCB]_&?OHGMQLWOELW9HRYLFH%^X\EGKQ#:^!&FF(D]QALG;/ W0
M=ZK8K/J8Q%.59(%*70**8^CM,[3#Y*T!:T_S!#G4\>5&?-G0'DB[P9<.D;?:
MRUJT5"'5ZCKQ.AY]4AYU:+P'E?%I8>^C.,$_5.8YAOTN&+;YC05?N+I;:VQD
M42"!=.IE-E:)N(BSP'.Z=4-6;6I3C9>[P*H.H+=R(S_((,K@?[!CH%'A"E_[
ME+H>,"MUVBB\3<3-<)*=JNU']1PK?RM6;GZ?P1>N0M<:&]F@I.S=8\Y5].68
M\Q[F=&B^'8?(.'[]H?C50=I6;N3[7"8RRF*74?;=,N:VP3!](2YZ[W<>"M/0
M)H(GS6_[>>*@,&MLY'4^2 ,_D,FL,6F$CDE_*"9U\)8U//[*G6 V8\F&MG8\
M:7YKQQ.';%G'LZ^2D4K2ECB-HS0. [^$<KF6(0PA'HINFJKM5I_:.<9]V=":
M&2?-+Q)WXN N:VRD 7LC?V9C)<YC&8F/LHC P9=!(JQ='&PWJ.X8^%LQ</,S
M]T\<_&6MF/J78))/Q+FZ58D<*7&%ES@>W81'&YJ/L1L\ZG O*S=RL=&5XT_'
MGT_$GP[,LMKKZ\+BCBV?F"T=C.5!,!87(/].673K ?*^$+U_]BYNKL7E.W'6
M>]?]='XCNA=GXJKWH7?6[^U>M/QE0U-O3IJ?*_?21<O7V,C>+6;'H>O05?5T
M_/G$_.D"Y2LW\DI-E(^._$]3,)^(6QVS/I19&YI1<]+\/-:7+H2^SFEG.@T#
MCQ-9@4G?P4_NM/-]L.AB_NIV3SO]?PG1/?O0O^A?WUPQ)KC['HX^N[?C#06
MGS0_,^.5.^&L)Y3C(.(.T8B&Z.;9.$Z";.8DL^/3I^)3=])9?=+!JU(AX?_$
MN<+O'8,Z!GTJ!G6GF]6NPB]>'DYE%B<S+!IP&Z3;CK?N(),V-;%F)YC4@8'7
M\!?JPLZ#F>CZDR *TBRA[C"B.P(3V+'K1NS:T*2;E\W/@WOEH+]K;.29"M7(
M.@S/\FS+X'S'HM^,13N[P*(.^;N&1DV#461YU"E5Q[';Y%B'!5ZYD1=Q],S:
MP<"U=2Q;*C3+SB:G=C=BXE>KNJ9MBXF;GX[^RB&'UV)BS9YL%'.1V9XKW;XA
MFZX*$#HVO8=-7=V[U='5.MWZ0<[$NR!4Z":.AX0N/0UE,'&\ZWCWB7BWX[JZ
MKG&R]>);E<R0/WM)$D<JSE/Q4<ZH8XICUHV8M:%%(HKTH88 U_XEQ/M/W:ON
MQ<V_W28_WB8W32)W#AQ8;8V=U&6$'3;-\>73\:4#IZWCC;A663P<BC@19\K/
MN=@ >R6H!R3_Z8RG!_%O0W.<7S:_1![RK\.NK0LNA8..\_8[!GUJ!G6XM94[
M>:H2;"LG?I?!K6-/QYY/R9X.I[9R)\MMS[&KPA2UJ .^;,BF#2T6\;+YU;:0
M31U6;>5.G@>3(--0M4AH9Y)RD%+'IT_(IPZAMG(GK_-!$K,^=:SI6//)6-/A
MSE;NY(U*)@'#O=FE>Z6"* 6EJB;.X'7<^I3<ZN!GZRC2./$UOSKFW(@Y5[D]
MML6<S2]=",SI\&5K,&<F"5O6]3P5JL3QJ./1I^51!SA:N9,?@A28,Y2$_73,
MZ9CSR9C3H8Y6!T7CR ],XC&V]GL;)TE\YRIC.49]0D9U\*+5EBYA QU7;L25
M#2WU^W*Q&O>6,R;Z0GSH7Y_VSL^[%[W+3[O7Q62'MKIQ KCC\B;6V,GN1$4^
M(:];+DG<L>>3LJ<[R*R1/I$%GDI+15=.X\DDCW2S!)T\\4YZ:3#!O/'3>.H*
MH6W*Q0TM+?JR^:5%D8O=*6>=)"B&9S.[GN:3/.2R#Z9+D:[2$@WCQ*-X>7N;
M/+QS+ R7-).'7S6_-!KRL,NS6+F3O2]3%:6&4Q'*/8F";,8?43V?R8D<*<WH
M3@-OQKX-K=BR(^SK\C!6[J3)+\9L9-%- U\Y%MV,11N:*O5J!U*E.BX'8RU(
MF@='W31.^+C;3;%\<.H,8<>F3\>F+@5C-<X[49*;PF%U0IU]W,>3ZZ0$_CZ-
MHV& F8X!K) KR[,I%S?4)?5JL9NG&9Q^PLDAO&(:IX2^>)TH]G.\N0O\;*SW
MHWS7(,ZR>/+ZH+A%#M(XS+/%6W@M?OW;(/FU.HCR?\=)(55&ZMD :/7S,SG,
M5/):AG=REE9?/PFB9^6!+QLF+0D0\@BFA%?_M&(P#95N+HO% 1(>15PUM#'!
MJ]WPH+MTE94[V8] A*LT$U<R4Z+(UG:G@XT8=67RQ988M>2_;S*GNMR5=:"W
M.?+J5":9]95G:I24S@:]X5!Y:!9&<-QWJM9Q\!-RL(.$K>&'2VZ#6QGB^?Y*
M34'MPC%>ES!"Q]SO,L'J* YGXGCW:7G7X<76.+[>JD0. N=S<]SYQ-SI<& K
MMQ*T:2@9W^4JZCZ83QN*%2F!6!K-IP[KM7(KWV-WGP@V3)S+.SZS_CU/@M0/
MO-(IUF5+;,JY#>TVT3EH?F,NY%P'\UJYE8R^I),K7B^R6-PD 9QE!S-D86<3
M;\BQ#463[ K'.M37:EQUJ+PLB:/ $[TORLM=K:/OB$MWH(T3<*D#?:W<RD_7
M7?&Q>W/5O[P17<]5\]R001M:SG-7&-3AEM9),>SZMT$:8U?:1+P+_-P+)'RX
M(@A>'*7C8.K8]CMAVYT 4W<<KFGE5K(+6/2N^J!@J\%6QZR.69^.60\=M&EU
MK1SO<Q3?A<H?<0@'P1"GH%GQ[RP6;V40/NM3R<$N(9R4#WHXDI&'#JA^E&9!
M1L=;%_'9D+4;6F:G<[ #Y?"!M1WF:752TSA(?&&+81%K7RG;O0)YNO<E  Z.
M1N(T47Z0B>XH4:ZUQ??$S3M0512XV:&@-E;45VHDL=G%2'2CF;C.I],X0>W\
MO^].G2YVW/N4W.M04JM+=6 CJ0SY\[<X]+T8V#=.1C(*_G3GX@<P[*KHQM88
M=EFYX)JLVOI4W#]R,,B&LRUQ\RI2<!G2]PVFB3MZ??I;[^S3>>]Z?4WR9NG@
M[Z?B#1[TU*MPV#[H+*/M9?_%HJ1!Q@66J';+=!H&GAR$2H T]]"E.2K2179I
M-:A.[<;+H:MB='T_46D*HQG&B="U7!^?N!JS>+U__=9_V[_YL?FINRGUO(N3
M"<'#8QEIHMG%>;]]Z+RO[PAY"P_<]24X?>@27*G;.+S%98#)[^34SY9-46RP
M_;LZ^=Y#]QWT*"A.&7F**BL%0ZSSO9-+\.ZA2\!EWZP3%C[FDVGYW+=+J_#^
MP;*?X\)_CP/Z=\'7O$N+\-O#%R'+&,RM7>Y7"AUWN[@&_8>NP6H*N,\\VM!:
M1$-=)5M:HIO?^E=GHONA=W'6@W\OSL15[_JF>P,?3J]Z9_T;T7U_U>O![S>;
M6[Z;&LQ,.;CTT59=AC?C(!4;K(R RVD3E2^"*(N%3$FH3I,@%$<'+7%X<-@1
M>S&<T8-(AN%,^!(];7S9F?+49 #4=MC!*SOP7XDA,;P 9''" ;&%JSNOZ.KC
MEACF"36IL'?1A7_/X3V=([KH1<U%BX^^5M-,/_LYW79"5]4__H.<B1.:V<$^
M_!2C]=!]>WG5O;F\^K<XO;SZB'_W+R_$Y3M<Q:O^:5?\=GE^UK]X?PTSA(F$
M\DXF2GAQ,M6N*K&';0/_^O/+P\.F^DF;T-.0%JCS9K]%71;?YQ(K0V %USU?
M#>%J7\!^J2#:%\,DGH@,WHU0"?H72\3,Z/<LYOMU0NSBS;CY;[L7_RCM8$M<
MM+OM%M) UY\$49!F"?=4Z(Z  UJ58P1K4WS*^5]_/CYY<RKZ8%>HI/T-1,+N
MBI:B+:88PS(FZC\YL"$L>S:6665#IDE\&_C (*R'A]+#"@.!=FS@E=,<6 <]
M':G*\,MLK#>O1<M>?AARVET0AK@]0 M^+-)8 ,?A-2"Y)NQ"\DP+S\5'_LB[
MUH]P9;!^N993NL'I),]R&<)OMRJ2Q@TGC=&0ZI7#>]$SI7QF.&1!W$5F0KX>
M]X0$;%DPT]5+$1!X2Z(DJAP19*2! GC@#)FSV+R!"F/,IGVYW$7^]?I[JR9,
M5S<>[--HX7]GO7?]BS[JGFO2V]W3T\M/%S>@>,1-[^K#<L?8A@NQ)=_H/9[B
M9JK,,ZU7;E#,;#60^..8L-U4Y"F9HR!$P#RU4H-%T# .02R0+B#9GX[!+ 5]
M=,LR9Z(D)N(_N1QIV"(VVA#M>A[8ZV1MD8IO@$%*!DV)?D0Z55XP#)@.F[F,
MUXJJ2XC#=N?%GMS?%?'TO5E8#6>U_^0!XP":P&7(7<QGLA@8UEK K]"9+2-*
M1\-_?A_'Z&^XO$,%?)T/P(:E!#4P8/<"..*!U(<K4_@AD]0V "ZF+]G E2EH
M #KO2XPIIVCZ)@*'AM\-\C3 :J+X=YI[8W/)'5JV?/\(],X(3=FJ_;P7X%7P
M/=:-P"8&^V 5SRAT73^/TM!!FXVP&X+",Y"D <$9"LQPL(<[!W\Q0\<7QF%@
M/"UF'N5GHZF-EK-].%KETR3 TU4L1@'%@A1E%> 7-,42+;3PU7O!&LO8@WO
M,#?UE*L+>C>&@SAA0=9Y)4Z+4AI@J%)\P&7 1(=B?7X@(Z?90J/&/](<Z?%6
M1I_)1SF!IWG2G"$].95>P&=(69V Q F(7/MT9H:T*5A\%GNY;F>M^34U;85J
M'^-HM+DTB@/NG+Q)Q>5P6$( ;)]DD=KN';!DX ^*=?)0RNDTB4&<@XR$SYZ'
M-;*KSI&XL5:I-U9^#MKP(1V[O^D>L%X#+11S$$"O,3)VL:++MD9,Y*S&!QW%
MR*&%^/BH'6)S/LO'MX<=.'1=<*@3IYN+T_]%QSY<$LD@:9 <E=$\KU8&BJ:
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MSK6B.,S [].EI_341M_>\I ^^Y#,G*3-_2^L)BY73SUC="Q!QU'C(D4B-4Z
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M;I5TKILYZM9CRYDZ[XZU\TZ?F+\EU6(51_^W+53LL";C 6GHF0=/RS#5!,G
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MZ$#TP_Q%B7NP'V2;S*.CDQ#?D0M&1KCSVXQ.*AZ(JC!U6 FCZ*+OC$HC5L)
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M[-RA)E? 'W+THUHE<B S [HIGG2J?90V(CQ%3T\P+C \U6LVLC>U 0Q-5HD
M49TG"$2U^H"LDBI%B.X<Q0[_*=&#A,[:!XJP(/(H#CZEL\9MM)%)P-K.##%G
M#%U#]PN+7XJS- #O+1>H C'#Z1RU</,$>9/P/+C%QVA=(6W%0J7]0 WU5\$<
MT+--=ZON:!)$<2]>LR>H_:1' M C82D/"DJZHMZ220IGU'J#?VOK'D\U5ABZ
M48Y>1GU89(PVCS%QA6)'O]* ^/3S&NQY!,;(U9T;IB3Q9A.;==,Z29554)&'
M?#_ WD##)3:QE1*%0&Z/:(0'1\C$D(ZWAD#C+H1N.?IHTS(DM84KF1N..,+\
M#1\91MGV%;;(N<#S6_7H?T,S=#Q0:0<O9)AT8;"ZL&T0L8["YQ?4@QJ.2AP+
MKG S48\8W3;3ELY+]?J7=?J ,Q&#_;:&D(ES/9:)B=2H^]?2'= "+)**_/RB
MRXM.D8V1,,MK2H.^B-ZX[<>]E^/!&QZ@X6LL"?R6M]/7<DXILG4LPR_0(>[1
MW%ZZ[:K;P2PNU]  N7G2W#AVDD9=JY<,YVP]!Q7+#<^Z9\O OL&O_BC,;U+9
MO/6D: )5--S>'XYR(6.%@E!1A@O'%5*2$10L C3O%_ R3.U&LAOFY#H'_;.#
M'O0]1%0$).59YB_0+H-O&GIH5NO@($Q]*_VK*J+ -_F^W4!E/]E%N7A*@'.5
MB$Z'$V$2(=%YX/-$*2@MA=&OX-H1/R-%M2F=?P\[ ]]$/^SR7RV.73,1FN[O
MCP$NG;3+Y]8N&@)4!1&I/.(Z3-(CVPEP/_LT3B=YN++69&A2AW&<'[>8G?UT
MDDYB-HG95C%#=!EDM)T:>B9YF^3M<\G;\U\"*_][*W&9YZI0R\Q8MP_@L-AZ
M(0F.3XWU1[//9%4O0H)2=;?;VZIL1&%>,+KAL[.SG[CE8LWX39SN05A#!&^<
MH %#WFW5.FL:Y92_A+#KCMB(H/[YR36>I&VKM&%L<5&"X>Y6/X8@>1I!9:PB
MAL.T7JJ%ZWGPHG^N2NS&>W./A3!.2XY$124*![*-;44(SY(PW%ZL&4?_E#P4
M-P )(G<=U:K!XB8L=2WBP.7_X#'VTS#GYS%]39,.^A(ZR%<^T6^JN@5I#@LC
M>*LAX(G<5[#MI[/XR\I!'=21BUTX6$V?Y%C(6F.)G-<FM*W=!AM<>FTO"?C[
MBTRN-K_U&EQ&^D!,I\N7:L.8^@*GOL"GE.VPX A!L@6+4(%H<Q1E+D$[PB;T
M*DFC/K3BK&L;$]1SK9DHWF5-KJ*K?Q@(0Q1@@W!X_DS;WU2F@%T[UPJ41(M-
M]*ER?_O]V3-SCUCZ]ET:"VO\=]KO^:D72VQDP]*)C#H38X/\3&_9X8[0^/M<
MV&$!&7_ZFWV/.7;?JS4S4\S5#.M%9.?I"=)S/8SO^/W)CU\2V7&2UX^55R(B
M#D%FCSCT]-/IV0]!>)Y'@9P: /WI47#*OJW4=Q<ISBWU-MR83-(.]/8 YG>7
M./MG1D#O,K86YEA#(+RM0>;#SOY'U#U^>7U__M/9WX?^-^2#LLH6C-]ZI_+@
M3\L^H5+0DWMA\1$"(:;X N7#D_0]1OI*1%I:)]'SI,[":0Z-,3GB\1XNDGQ!
M?&.$]N;SG#),G9=3"=RN/33S->.9O,QJ'6="UHJ[,F^YW];[X@)1]>I,U]X@
MC 3H;(S;O97V6=/[8#U;XDKF]BJ/1&Z9575#M$GRP;J$O['EO<#%:ROX10UK
M'?VK32ILZ-K "Y:I0X5D@#!T9Y6;U\-=TW?I[^'Y+B&D].DZ>\@@8]1'U.2*
MSM&!<>UQ0X0Y22?S0P/^7_5AC4@"RDK=EH2U>)+-QCH^'0G$.1X53H326BN[
M?YDH,JE7T3(O[YW/,_C_.CK1@(Y\ASN*E178S@C_GD5) Z(];QNR&&Q@CMOK
M4WHNXE(LK<2K#\1SF>I?*^RM1('6JEJPK%B*;;_E!OZN]$6CXKRMB=112P/3
MP*\[]#Z"A.D"!QC<4/-:0M^YYVLY,%0:_M(<5QC0]&]R<C$3/$T>8Z6(/\ZB
M YB'ZYN-O-U2@(1=TNXNA?!01]\O%Q=ON7.L]Q6UX(K_B''-^I@.U?/3L_.#
M*D/:KL][JUNWFPW,(./2#IXY)CN5%19(#"$LRP)VU4-4PR?U$H2B1#18WDT7
M*;) PUF<,)_CK99^8J?L,4_#'N*SF)%=VK5EA1P'GO40=K>*SFP(Q:TGS[3U
M1XR%.:+ZF%%NL1@<:=/R)_.N8_/>BZ^HTQJT8:+Q?'&*03:CBEJR>3PTA(0@
M@W+T]2I-&:J!;[2P]9_>M50)R\-Q$C5C-T]XVV1Y]F\]H_08-EBH-=026"/I
M)#>Q=Y5?_Q7Q#1LA^,S5'1HO6J7JA].6FK(%H;IA[RZ#<;T(@*M<97-*S;O2
MN\@3A);\H!A7&W9LW5HM0EB;/A+OZV2.*;.DMF@U]NHU2#2V2T\%UL>V6=LY
M:,")<.D)3!:.$'W]2:Y)TCYJE_S/*X-9<\,VY"1NGUS)_&P2M4G4^J+6PIS1
M)G;B"B%(FRVX2IPX[$[/#:RO$W0#P;5!'$3XH@&W("-J(?I0?"EF5R#H&>O=
M49K6A1/7L9FW4L4)OV$OLXER\%(;Y*=-_I1*RW$<F<3< +V;A,(DM2*.%ZRC
M\L"U$.D]2Y7T?((C"K^"S^\$[7R&V(WDA76F8C@(4D=PWZ31%6E_.8]A]?1_
M@0OE<GD0B1!QO28T6ISI.GK;5@O0_DBO8;R"[CZ-DJI"O#3R 6AA>SAF FZY
M[*^3$V](^%S!TF'VK6D3\^Z>1;7*<Z0KPN)"!/JOX!40%2V:8QK+@&3Z@;<%
M3#W,6$6H\(G.W#9(TE,GN3)E=_8%8AHB!LD0:4V0>76<;RBXJRF['-SWD:OQ
MUV4%KXKCD<$[(A?XGOQV#XH)F.*I++&SJ:ETJN3[Q.JQ:\4-E[::+Z!!#Y?O
M27U#9@/#S"CW$+V^>O[FNE.-&#LQ<!/<3>Z2+&>REISJWRD#X&5JY'BA7E9,
M!!(^]"(I./#N!J3'<PDVTJVCSD,C_*__^/&O?R?D6KQ3O0$[*XT2LQYD+*Y5
MLY)(N5O'@2C?SAS0(P9N0&-'74<I CCZ&1&?@&F94R^UKW*M)\EK!'I>I@\F
MA&_F<6L=:'32).^%WJ_4ISA=;W("G "(G0^D("(5AAC]MY,I,+_5$T$ ^Y88
M5!46T61&UJS 2-IQV@E%$S_#DH5YGM4KG)."T?IM%@FV\AWR[R2UG;EMJ]Z+
MP^)N0BLHS>H%#$H2TF3^"UM"-T'Q#E8TNGGSZIJZ)3"W24F= B$JS5 U;B;6
M9L"2WV5E6V.FJ_06%6?,W(ZAB?=XUZDIZY.;LD(\ED &P:AW<_E#.YCAIW&+
MSD=4$BL4SK2ADGL@SK&5OQ%)UY *Q.2F/&\)KO,\6;SGO!UNS@0T6 56/3W?
M3994:@DR7"QTIN_JYN5%]-)D!>L0U,M3&$"3<^ Y!SSCPHL;@H^PA:A'!V.<
MT Y>=?[SWVO;^%8;:AW=9AL+_'")_RR)L!/_I?L!X9\)RF$M3;Q*;I&D=QF<
MK=U@$O/C+7<,8NK#^4JM]Q%;+:#!;['B22Q>*8Q28@<JFA\8YTHJ7^<._2@I
MWN.NQR'__V7UGJSDA!BB$<E"L5QQN!8LH9( _YF\^DXYAON3//Q)")JG<\ [
M!];E'<RX3[,7PG%PQ"&COV'$Z,!5O>%&C+YU@=OD"5+:354I3Q.</2Q[UD0R
M$<:&N%;_:G7Q:Y<\*009V\*:)?E&ZK,@JZFJ)72%2'U9T1IV9N*R J>%B?9^
M)[KJ>*3M8)1*BJY73<,\3?*MM%_:5H8AIN_HYI[Z7]$\QA'$_8]D4-/I$["8
M4/\(GSXA^?T),T5B(#?6PXM60@/48S0CQB"JD/B1&8%T6+\MEBT%9%^0A[(6
M_W[E,\^)) TRH6'H5N/[2U<,1J&R0H?JLJ6NX] /</H"7(R=)WGJ:12]&WDO
MHNO408_>@Z*58GI<:5^@/QGO\P'C>PE"'5$_.X$ ]1NENNT":PX#)GZI/G[3
MW5:3_ <K__4"IH@BT^%02AZQ ?KL]/P9Z 1,,AV+&3H)W)<5.)@R5I13C.6I
M8RR';2F?A"Y<H<.D-[%D:%S5$,3-5)Y>7EY$0X.,L EM* 'VQW]'KTP[[E4!
M6Z$1)O<$OQNZU[0[P]V=&RP91QOL#2<EP]F<5!J\RM02^Q\7+0,O\"!C+#JH
MB9 WEM_8%G'SFP:;P=M*43=EG5$QO_U01S4JK#ZN!OJD*8B 26FJCX]UX4Z_
M<UEI;!2JSX9'(TOP@M+ QX.+\L.!<0#81:T5EDM1+P87O-N%<[[2[.;[+5!!
M<: :6<Z53V)Q@4XN0N9>Q0YUN>P?'(&!ZQUX9(V0.&Q1<6I1ZO,]N!*3ZN?J
M>1[*5C "7>C_F*$XX^#0@/N2V%UP6RGN+9BKYI[J ?OS-SHD\/HO$.&B7+1<
M2,.;G=SX2FD^YJ3!HCH<A\Q&-*!<N)_%G43MZ8,D@JM?PXVQW@TIWGLP!PD?
M)_^6^\-UA<+20^X%8(1TY0&;NSE=GE"I,RH+4YPQLIOXLZ%7V'/("9=;8NTH
M7+ <>,P4KP]# _:QN<(Y S&42/ RV1V>=JD%/4E12A&FASJ]-$(1=M@D]2I&
M;=F"Z45LY?H2C3\R# W4ZSV30.=HNURL@Y#T\0I!6Z[51KJ=$,J)- )-=-V4
M9<I* F^)C]?A5,9%JJ@"RM1,/6@P! )E$G79@RV_D<K5C&I:$XHA4>4L7("]
M3(IO=Y?DK=*:F1Z-T4?]T$XGW$"+DM-W!>^Q>(]X*TB( $*.>.:U: 0JV2W%
M'E8#B&]3*#)<#7!7YG>X&VU$.Q@=0% @N*.Q]9.#VMQA5YJ8/7Z-FF*=O,>-
MIU^&0^\B/::3\'A,TF<'-TE1NVF-ULV)9,5H]@13EELNZR0JN:^%S#2=4MI4
MH&/@DEQK-<E(E7 )M1>X&9:^QI.+;&]+N:$J?"4F"&TB4S!:)'C#8(-LBY5*
M6["_#KT;!/R-K.0:[5R#''B!R&",S].GR'-FW&'(VY"=R17EC/5C_$[ZDYM@
M>1DUY@^5X@^!_@QATA&>UH6V^Z>3)_B3!S5!"&?.$<?A44,$&X>?NJ@>V44U
MZ9O/JF]^+Z>\WZ<GW,/5-]/!?M@]\E__\?U?__XV! GC2)(,*/HE+^<80Z%F
M<JK@K#T )/]WB'"_..70C,!12K>WM$-.&S#4#9@@TD&!=7#@A5+_K0- %,R^
M[.>8=\0<*2GD@@UQ7V7^P/Z9_BNVL3MIF71AE9S[DZ?E8(!Q, ^ADO!;:DY>
M*AZ&P6]NI;$,_G_9YKK77Z,0$307!5R+\CXJB00=6Z7A\61I&?AG$_'47U22
M $)X,/'5S3-[45S)N334O5RD%.B! 5'ZRX<NH\0:.OD:%,I-D,GQ:^XZ5W0*
MEUROJ=\?1CM)>K"27I!,AU-!S52GB[(HU]F"P,,M?KL>K.RN5$5J/4^JVQ(1
MY];$E0!R(6E()=CK"O$J%H.Q#Y!H76_]1T'HRS<-I=YM>ZR+D(9:H6P;9E&6
MX.D*9<)[)-STS:N+%Y'T@@Z@---#9B8%XCS^=PGTW7 &Y@&430OOGG."^[)%
M04L*_#75S&#FQ?L,IG ]QSQC0^G,8)MZ?]U9*W(@#+Y?#TO)%/V6_*G@F2:^
M^HXK3DQQ@.R3_X;MF,)N-HK=(.Q8&4F.I(+JL&B+.D2<PM0*RA,3H[\DI*4]
M_$R/3Y%+J .?\6_XN+M\$<Y!ASOJQJ;:T9Z[_+!8H77*N<2:^]S$D/4@&VRI
M)7E50M15NOEFFP=:MJ(3IJJ10+:AK/J_V8@X#M_*!;#!?XM=!OLN6#/#A8="
MST81YFVY=,;N_,1#PV7N'^H3LPYC/7.3=&%:,"X:<'OHUGPWCVG1KOO(V>X/
M,&6)+K1T$5OOE:BZM%-):O&V(G!&7;#T8,&X,MRD@@,<ZZ(@^)>%!,8_<*3D
M^R[;IJV4^,[ZUXQW"*-LDYS^J,'NSY/*N4Y7&U%;<;!B,([K3*NA,9\Z"W$:
MYOXFB"NO4C,V%9QT7))W!J89O).8<@L;L6%K&2NPX/,3WITZ1PZFW-M+9V/.
M-&*B">1D=23=JX2.7N9*$OLXFO%HD@2.A&H+T^SX@QKUR,+ J>N'*"61)1TK
MM9_O&B\NH$M3%<OK^O5\F2G2HR 0EMXUI0B&L_G16X[9B4T0"16+5(D)SZGQ
M8[?4DA\2,I_VM#TL[L\O@XQ"N*E*+'9,!<,4"XFWHZD/%^ ET?@1O4LN/J]"
M?0KDJ,FF^QPV7:>(-1A+SBN+?62Q;QPY_ "8PLD*ZIU'+>A*8ZJHQH#Y 019
M4R(6>CY0[E.A(L-_-Z >.0B?N+RB"]2)>:)-MDZ#_L?6&M-;$<P"<72XY[9+
M5X#E^G4CE<5#?!KJ7VU"L?T_VP+I5$$K,): 88&T[U(/WL0M\C)M&4ZK@49Z
ME')A+A)V6SB&?HL'G"IJGB:ZQ%LX=TP(O.J44,\&![EK1CL](L(TAP_VOJ%C
M#;&$*4T!#^+#TG!KRJ)Z%=UV3S7)!VR"LJ0CG$;A4TA()6V;BX7#M&B9C-M,
M 5&"?2B2VZFB+6@=^N;5=3!Z<]@##M;(?ZZI@UXF#Z8?KJ4<",:-\#:.VTMP
MRA;9>ZF3F<CZ.H9TV4/0E*AH8ON^2M,+.0<[=[5.JO>D<1+'H/5^OJL YE!.
MM.WD]$%B4L,0<".S^\;,[BLSN]?^[$K'&&6"G,R2$_MS%P]UW((#>K(DC7$2
M")3]PIW PU8U%SMW2K#R@EOX_^Q*]AQH^^'8= KHL.$;-:?2_Q,Q :P4UR78
M=6J;^!YV>:GK80.&[(=L#0($3OE?B3?C["Q*3M>GT8E68]$+M'TP'3S3^SE;
MKT'^^"HGO.X)*34-^Z1J3\2:$6C<Q?>OHU5Y3]1P7$@B@:.^KL20"?K6R;[:
MCY1KP8J.W1>Z,YU7[-(S0X!>*R9JV5>UNBN[J;*!4K2#B%G8]NB!$[1\Y&DJ
M"=^U/3L]/_O/P,WY(*;/L1CV %3?V])CSIG>X3#XNP[BP3X/MA$)35VP(.]<
MAM-_-]3ZI"^XS$<#"VB'LP37=0M^PNF6Z-K4@C'<@O&4+ X'E!;-3>E'U/N%
M:4X,A.(/J0L<(N$N+I,TD):P!U5Q"\M5PYF5/U#8''LQ,3B!Z)_CD69A G$_
MJ(3OA"(I"P*Q ?EYPGKJ*1[AQB/:.3.&XI2[F95@@A2T*=V1:?_;M&P;)>B^
MBRA!I_=X*@T)9LN)@@EAC[DTU;+?_&2KEX;]L\Q@J'>PO&VE]DK$&KYKR<AB
M-)C)]WKTUHRY@7_]HR0CX(;Q-.I(@$&XHE<5RO"X4/E\K MQ;?S7/@:NMJ4%
M!M KM:G<V,_E1N)?>@J<,J+D5V!Y"5T!Q^&*\KYN/CV*_BAR$E'S2%-(&!,F
MD:8P4W4D4,U46*#/IMZYA&]6]KZ&0>@?<'*3;BO0YU[JWZ."+@T<-*Y1X$;U
MI"!@!7]I$RR .6P0\"OHQ?SI].QO1\2,_-6[K!VVV\?78(<UF]^PKG+ :H*A
M"6([1H<:+M9PMT6B^_ 6R299H-5!W*04Z^0 1@]VIQ\1IY_@<Z.<(5L,Q.%T
MF![!!ITP5)X 0^6'"=-@DK0])$T(ED(0..W7"KXNN;R&RFI(]WLU3M[>GYN2
M80/TZG=32V$5A@ZI\.K#*IMG3?3<-).S6TS?,[ 7G$$[^.-/_!(]OC=APE$&
MLBJ+;(&U60U_4[D?4VQ1&HVB^J%N%#W7C%X&L.WY\,KTJTTE>35T\G,E--C[
M@/JZX:IC#&%.9*Z?3U=,2$,3TM!T*G\)2;O!<K5U%@YVK8/+S&77DK3 $"H?
M'(C=\!>X,C[C_[[,T'_>?@@<8MZH_%R0)"X,$.P0,G$M-'P#"X_!< &UY]0E
MUNT@.FB:9@(4'._UA$G8 Q7VAP*6#XQ<AG4*2= ?P/C4@Z,&L!C+_[%+!!-#
MV":P416ACNFOR^7RNWF24P==O5*JB7)T*YS^@?XO;/FSVR3K8CNYGX,X4$-(
MRJ@N;*"FT;HL%!KR3LJ5<O\P7(.+-&_Y\AP92,A*2$B===Z"2"T1NP8ES2:%
MP)Q6.'XD_?!?@/DR?KFX>#L)6:A"UFXV987>S_^\"@)KXH@MU_/STV?/)KMU
MDK+>#GF'O6$A2)<<8'GN=:9Q)S,UL,6@ZN^H+(  RK#_.6T;^B!5:<ME7;';
M ^?!4"#V8KOQ.O:(D R.'>FF7BJW<W.Q2JI;BX:FV^:&L6.ZW9VZM3LV-A\S
M0,#1AJA_JDAR1JJQW3''@>1YV'SF.VR!Q%I5;]-0-\(T;0/3=N!@Q7_]Q_E/
M9W_O_V^8;1E+R4/JYETL-LK*M-^[&)EM2%%L=N6X#9 @2HMV[?O9]O<WBPH[
M6JBKK;DO]^VVJ'6+!=^/6V 6I@*+XMV#PTZX:QC)V.^27/JTAW[>Z4G1O2CF
MS:3YQ';BF0&=GWO=0&4QVL!"[2AV+FS5_/#\/&U;2K?%:).W7NF[[HJP#9R#
M,P3>_*1IAC3-?-(TC]8T!F-ID>2+5J :^NKF.3JX)!*4[Z.,U(/3/_MXU>/J
M!@03*!0ZX_"9:!:"\T(5D"8/M.\_^YZ?FD+VY>4(7Q?T3A&["?6IP#YSERU)
M94*WVF%OI1O6#+J1S#38+_T,SJ54+;."XZKW98N V2;^,^<8-^.5_%M5< K8
ML9C4;(KL3"E]/T K?$0$3H$8YZ2FNC4!I+IH0\Q50D2\HOL(6XI4V#RIN1MU
MD2<(H4YKK9F=S1J7SGZ:UF.O];A6FSP1<_%CP7@#G^IO.("CESE,6\>U.\()
M,\GY<I]4Z7=Y6;[?@;UZP/DC 3[DQ)&12/HY6(0*;4]OV//5?7H^:,5)4KOF
MQWQ75]BA\'(Z! @O?KL<P SQV\([7=D'!6 8+6X+=_O QLA+[H47T&_#<^W$
M4\H-AW$MG:N4(/JVB9P5O> !:Q_3QPS;TY@[).+FFT^'/?%#'51_[P(H@1V6
M(9''FOW-6NB[L5A1GABH9, ,]9"@G #ZM0*_#RS+F@\<].!(<IQJ4)K$2GH:
MA:, KF0$'HE^&;2H?[5EH]F$:PT5:Y$7#BIEVZI8>^0LP0J>;A5),UPS0H0-
M]!2>G4;1*Q^7H!YP0&/30>KD*-C/1+MC/[0S5$.=0V OA(_MZ'"3_1ZJ_;[*
MJA2;IXK44%G#&B/M$/U]N5RB)P8K_C(H$_IB4V5Y]/U9'#T[>W8^;:]0MU>)
M9L%+-0^G'#6FF$_!4'&QX0W#$K$RSU*!U<!A#\%Q:"A=(>WS.^\]T*(3]4'G
MY!&K>.AFS<.&SO1%E<TY[*%C3ZN1V!/?'KR(.(+;JTT7^5B@E=NB4MEZWE9H
MXZ55<D_E"(WI8R0@J.W14"Q.BRT>LC=\ <!/!\!R:![;]9JKXY+H?UH0&@KJ
M7%CT8HS*GN"M*=M5:OMW%IU<S/@5AR]#XQ3S@&2@F@=)@\K)<[C^PTP3&2+8
M7^VD)YWA([[W2N7F;.O (POMCK>RG7X?G%\XVC(RD DV'\&;\?]MKI.*.4X>
M9@,#8!27/R7% ML[3<AYLL#:^H$*03BV38ED1IW)V.KJ'% 5P$YK#UKJ$YO2
MZL04/DM=^N"2XJ;JKVE?#0QM%A1.EO.__&CKVJ=C*NACRE;!OVD;;/:C*JY@
M#J[.UG7&"/:;WL9H[-OWD!9W_+#7_$ALSO#%:T*A?_&Q&%+3/OV2^]2!D MA
M7QYQ3?*/IV='4Y+\D2)U, D:KH8)6[+ % ]!HK8P%G"U'X&;K)(*M #6W-2]
M"AU0]^"KPPC##7F_RDOV#UY?/7]SO4]R[E#IKPQ;X/?);W[>@.MK:8D*F)L.
M^:O3,L>&K7#7<]]L]>=?S4G]!Z7^__AO'0>GN _3QX5$XTHGP//KZY?1'SCJ
M)J&B <PJFY!0I),!8'YQ@R&:9F^O+Z+K-E?SLGQ/OT\DD==+U,PP;+)N\UL7
MV;O#4_ZV:M% S\A;NM5%HZ8191;97'A-M=@FRG'UZNWU']@)]I/VH5^]N(A^
M!2_D:49FE^]%66 _CML>(R"AU"0#"[3 "<1H6Z52[)>VZ\UN45;<*5V/G57K
MFN-@^BK#LVG#2T,W(KQ1_SX3G%TPTGZMJ%+7V[WA"#LAZ4B&[;*XS1-FZ:/H
M)!/[829ZX2;9,$63&#+Q54+^?Z6!>ABV5X=K*_OR$C >TW]3)"#4+<S:[P83
M=4&$ G"+ACUCIS<')8=Q)=P]P'@)'0C+2>9"W4%N5HU#KB%LJ",.PCW#ZN[%
M["2;4*TF@1L0N)N+Z.W%N^NK-^^BBT40PL;VV3M1WYHR^*:I5'&+'::<C6$H
M8G!4WIJBO@N+K1B]*\N\!A/T7VU6,8D'%6Q2/A]O]V8.)AVZ,.]458%!5Z_Q
M]?&(>'9V=AZ=O,N:7$575U?XT=MV?AJ]/HU^+T^C\[.?O_OQI^A$P!JS FZ=
M)_?1FT53(GONLY]BNL4L](*LP_:N[-GN.^"@>P1X4J'1_0*+1X4<P];[.H^X
M O<5UI^3R]8J_RVIWJNFCB[JNH0/N. /+S4E>$RD,34Y?G*38W#[\O+#8H5X
M5IH"96<UII2%E!M5D-=G^%GF:D$51H8D&#L5HES=PMU65/_TX 2/EO(<T"&F
M]*%CMO(/W1_0-SW:.5LJ';;F^89/6]1Z-V@\\L[2(8)K=8L#".'T/6)3]Z@P
ML"8Q^WP;PF6]"D&FMF2<F>\JCB[!4&TL- T6,-8M1^(=7BR23 2WPC882P!6
MX:F%?'55EG-S$-4QS6O$D)&*49P1!'Y -"UB$,O9++XK&V6BEM0>)#%+YO$J
MX4$GA&B%SZ_Q_[%"DS2#@$<NVX++968F6*_?"FLKX<9$ T9146J'J$OS8-L+
MU<*TN-U/*X1V+ 16GFZ:.*\Q<6Z%*GO_5#DX7J^2ZK8DFRD8^8NZ(XNCWVGT
M"/-F#?YI8X6ZL5[=A+F7K%\91Z]?OXB'^)&8[C%72:IQ<ROR/?ES2L\RY^*C
M6!VF[?89MQL<L_E#] 9Y,:.PF$9M,$2L OR:S0'L$.F9$F@?N,2?Q/79[<PP
MM)TC))X.M7C]40^,1QX1=T8R*>!0)0+,5VQT@O/RM::I#4<<+',N0:K]UB+^
MZGJ3EP^X;W,D2, P#&Q0^(:9BS3[#B&V)A65W-S;EZ0:&;(\^S>C>(LI"^(=
MKPN#0/V_16X "AV#YB!;.[HD7"..*O^#B@ZNKVXNILT>ZF:'$UU]]Q(T%YW3
M+\KB#G0?ND9OD7LIB%"-N)787CGD6EY>7@S6X'!(^YY>,-4ON+ ON*$7-&[7
MV&WZ-61.5/-YDN7?7171:W6;U5+"IIU,!]$![_V;6F/>Y 7F>BM32+9S>"QQ
M3E\GWOKRC\$GWRQ6*FUS)<V6\_Y\]:O=8BZR,W/1PZ(8F)'M[P^/66#S9QYC
M%V*[@.&LRQ0$DCH;.?CL=D FCD[;44.D*Y>(ECM9-'S"8H:+DBL\+IY8@B"Q
M-TZJK$;#%0='<]Q0QY)H1'YQ[P)*>#'!>!S5-J6"L-JVO<E<*%6*?F651 ?@
M1H(DR+\5!)S5V&MD!+&]2NY4I*AG'I5PAA/%<8456-<43% ?$ .D-D6:62/T
MWQ)EX+&8T>+NT7NA_\*V997:7GE#Z)6&7PXN-;U.A65@N70[\WT6&99O/V@1
MI9NB"<6W_7HKEL]/SYY])(3K@0Z -[15R:;=('0);+JW!J5R"C)_D5?])VOI
M);@5&,@D/>VB=9(Z)QPD5BS4P_&R7)"ZB$%("1O4HH7:7 :VZ6<%ZQ<7/\B[
MPV-AY_>:[0WR!12WW^5JR7/[]W#G'RR+,:%]Y^$FL+XG2UAFEC%Q\,!\8+SB
M_$&?LS6\?HN!8\)[REO,?N*99S$;Z$9B3I]&T3]7JE!W<K+BV0"S0W!-%9=W
MR%%=E078$/)D*4272RJNTJ4JD752+UI\5^2#P-K>0C&%%Z%+\4B$^>N^K-(Z
M[))+><^#-OUK>_08)BH(PSWX0E[#=1+";'5AG$&-S-%*SG,B&9/HT69588^F
M3"O:]V6+9MPZ8XRW4WT[(]EA+\$]6(I!S3[BGX ES@M 1C@I\V1M:P7H.#:6
M>7,4\TSO=U![SFS,/PK!,K>GG)QPCA$3$]0116P]V"+"D'0L)8).T892[+I1
MA@ I%3NG2XO]IKJ%]?PWNS+:&)H-[01897IH17P"0CRR[U/AXGX(01K4P+5L
MP7:@VS! IK7BR&E&(^[$Z7W#<6MT&39(Q*Y+-.Y:[=Z3_%6^T2+IPGYZQJ%U
M6SW;<!8S:!,_5\^[7.GE]D<D2!LH3KX<-\+YSW^O+<2?0(C46&Q:TQ.SF9&K
MP"T39F4)0(7%X<]3=M NV.,PX'">RF4 ^RE\\\V T 6QJW"Z6%]A2%F*AI!T
MKR)"V2)J:\''$P0.QX4?UIVD<,UYXUVBD^]8X@3ZY\&P,XM.ICS/@MQ/0SK"
MJ'U(Y7R2W<TH_FE4.D&-)9UGP+TN\#8YQD"E^A#^=?EAE<WQX=2O(#'G>M<[
MZ#OQ54H?7T(L/7)/S2_=>W<.\M*\.._ -+GP?G?=$TNF!3L8?,<9_XT8I2W!
MYN'3*^Y&QS\=OA8+Z@@V0,S'+?VK(DX**N"JF R$XF@:?!F?F$@H=G X9-"8
M_G<:W+:03MS9%?U;V/;WV-H0!!_M6!H]BP0G[7@.7:2[#**))W@=B:U"J@HC
M@_VQ/E;A:Q*4G*DUY9&M*?O$8P\4?M7P@3!).0=+R4U(D$"7-R]O@:2XS3 G
MR;@:]D_4!7QPR.^96]?X>HB\Z>;P8D*H;0NYR&3A:$KY,]"%/:<'=IY(NL8Y
MO,+:Y<K?W=XN]7\8<PR_^V$GX^I_3>DT!UJ1/ZUUW&$@2OSD>9.CBN3/1R/Y
M5X6F'-VT'"I#.XV95C@DCZ<AG8N)DT%APD\LM<$,9]7Y)CZ2Z ^^5@@G -<P
M!3]5HF*"" [_^+>_Z]D[$N,LB&A(^)89'$!9$*%O.I4(2R3H^<)\2-M$!@L_
M&+'4 /[A'P-2Y1S"ICN"DX",N$#. 9T]^2Q6VE=D_RU&[3_=/;M2"8&QZR0&
M+S$)\$#^@PLP)5C$+!-4/UADNN?0.@AED;.GPIX 1N,2]F#QYB8T9&S/3I&/
M5SOH#>+)3/J#%<5]?UQ%<1?L'Z+SB#BO4QW<P>NPPMPGOZ@"02WR@T;73J/H
M4N!A!B+&"RI) [VC2\A9[3&30V+W.1>CH<[R+B1]Q^TC^8-I_?"*W[QX7D9L
M.M0ZW3Q0^7ELZ"&6IJ0;7.?$S<;;;VB..0;#BM!^!0-:2(R[GNEHARZ3J=LY
M/!$CVYNVJMND: ;**,UX83HV234R7*0KXH",T$S2ZR&)';8P)O OZHI!:A;6
M[@.Q='TY)55@A0OB;#1WH;)\*I[6.2$>$2T$TB'"M."[V"+X&TVC5I/I&2A"
MA92Y'Y12,@YT;E;E/19W'G9J:,^Y@D1@D4T#JJ%M*/SHL4MQ^3]:)3</!6S,
M)EM$KQ76GTF/"X+:\SX7EEA4%F7A\(=U+S0RN$Y2U6W.'" /@[]!M:'I961A
M@]%:8GKEZ&U'JG1AK6[LZ8Q@_#S]?"9TP$?N>, T3#%Z00U$I'Y141_XX'WG
M;%ZL9#2-/@EU=C6$^+%>8RL,;$<D5:OH*/-?PO5!G/TL28'&2=WS'J> #1PJ
MK>1+_M4F%=P9#F@<2YZ1]+S 1 B5?6%%:9[=J6J8GB_,==;NVD^G9S^ 5W?@
M=;Y:NE2/W(/&G6R:TGQHL;AVUY0"\!4SL^KW99NGKHO8R4W@;3N6$:?ZR?)A
MB\;E\!ZH*Z$L:D:&%+7KE56%'5A:?1O<R-=8+U#I&HZZI(> /H]'V9FE+D.N
MTR$P>CQV!6>F(*10MV5#6)4PQ-NR!$V>D*(NN4Q!BCB&WHX:YP27COSS*KO-
M,"^(QTW1F'F&&^?4&6= ]'EM]$3[#9G>$KFUE?(;D&!XA/1H=&=H-IE?.RA)
MPIP:-'P.:WI1N!]%RQ3G8('S^.9GZ6$HJ%:)F\,:8IQFU?%*-E56VC(AVW=+
MGMO)N$C,+%.K:YKQ<$P?:SE.VVYT@>@&J\(,%[3KX*4FTF9<.MUUV@N/U5HO
MB0_*/P0E2"XL*T+$/H!96Q"Q!K[77#7WQ/+:,7O'IYY-4P7W8QN3"C>BVXR(
M$&1Z.Q.K5<VVB45@W0:7RI M.KW"ID@/5SQQO&SVU#L]QT[9M>G!A2?SB8+[
M1--ZP1:E\G4D?=JHBKFR<K+$]^+M]3U=K)-7"VYD__X< 8#/_QJ=W(-UO>)#
MA>('U&;8>=A]]SZ"&MJHV?!.E]"$Q%R'W^!$%ST2Y,6+9),A]R;[&9:#<D9W
MZ)'=VYV%+)A5F@O+JG.VZT6UYWC_[6GZ>=YM[$4VDTR%;<#F5X/]V5N>T=%/
M[LJ>\?TPSYT7CM(YL W;53Z,G5C>21'+1JPV[F< ^7M?E/>Y2F]%!Z*XB++)
M\YXR)4 '&ZJ#NQ8)5^J&N2[:O?CY].S'@YI+?CR$PHUOJS)Z559KHF/,!M 2
MCER&TR.3X5<7-\^CBYL7T5^?_<A(ZOJ#'WX^^^[96;ARW3WX]'E/59$V5,"!
M-L)5$;EU8O,['5-]T6S =/&BB?L0G@\WP2Z2JL(P(R@?#<E&_J##6PWF+@QG
M@Q$19K VS0[:'F7;@X:Q:T51#NT+:HP4?WQ9S7:#2@\!;G4X?),?CDMXKV$S
M'+QXX]M)X5[T8U9U-U>W3C*M)R3^;^)2^R3OM.G!E\.L9%;M.<PH-A,A#V%'
MRWP<DU9YT)<*8!X"&!5@#.7) CMP*S)Y.#);M&3Y8]$P?EOC?=TV)/(D8<CJ
M P:M:ILFI:8BV8;NL]H-NDR$_27^=*$2RJ+(HTY8,9N+OX,KLB5K-N9EZ%RQ
MA8MEZHMX)&7'\6CD'X]+(_-C0(Q>)H>MF_AVM/(?6]H).VV@MK6_T>N$1"Y&
M^SH_A=]<)C7(;L%9D1/XH<3A4<Q![8%YU&%L>11;U-%)XD_')8FO5=/PB?:"
M68>9B7 J=SNT5!K_B8P:]F<(*;.W8FY6<MAWHL[*ALPE>R=N*._>S 9H$PGC
MXGVGC-=4</1I!4=#J+V]S8>_)(QTC E(!4_EE_/@==(6:;  #/(HQRUCG:*J
M*?B!MCPAX%1$:0UOA'5 6;&H,,Q>ZZ(+7SY,Y,"7OF&9&1>Z=?(A6[?K?85O
M),E$^?B6*>=YT @=W$^X##\MJT>$^MN*6?Q\7.?RRVS"7_V2K_I*FJQ-J-0"
M7/O-(+$4#!>2/3"!TU16C "E$82?B*7D,[[;2U!4]YBG1<0.736$T8BDHL)+
MY)#2$-8)7+PD.[N)_FRKK$X9[LL@9R%)XHQP6PD6/6/=2)WP,?>QQV[>$9[6
MP]B6]/$<=B!.)>FZO:]WQJ<YL!J$N!E6B(3P0(C5307+A$!J!H+$+>O1&6W!
M3VWG-6;[G6=H6'-YWP*67Z[AER#0;O6!ZN<0=YS4G?.KK6,K&0Z.B[XYGU75
M#3> 8Y$1HNWH6QOV+LM1AM_W&4*^697[U^-2N7K)HFOD(IWT[A=YU7=C)41I
MJ;@7Y9Y8I$ 9%:@PJ10\8HSC.F-UQ%^Q8(^6))&0$^"2T6)#S B)<RVJ&VHJ
MJ;5>M\4Z8$6BK>: WF_9,,OEE]W4] -I],6Z-X61:6OJ=L"LI0'WLJW*M$3,
M?A( W:0+;RT_>)G P*-7><GU-Z^OGK^Y=G^Z0V(.1';L [C@/ B.I^C^@T,2
M4M'6@'=$0PUS3FUJ.+94)W=EQH5C:/>4[5S*@VM#M.D6W"D'$(TEJ-Y42!EG
ML%.3%#45P[$><GG(>\VH]BS),=#)2H7*!2D)1"XH.9J513/M8E0%IQ1@+0XY
MJW8?N'NI#V4=ASV+K ,/.9$W9L>A)@Y37<P\7\=K#=-E8V6E;LL#I^AG.MBD
M*U2'AQB3CEH>P\;T-\=!]^D+:;$%PT':MTX#/=RB49-45RLERR55EJO:'E?Z
M&".^::P20C@V5=PF7$-,3F^B 4_-&0<?W/'/N:I2@QWN8;+$VAYU3J78.8 Z
M!]3>NM;?,X\0W9D>T.X3O;:A6@Q-8BO;(D&\=[=7.DF1!LWT&>CZ$.FX&UP@
MG'.V-^!.N-T$4+5LJP4O%C8290)UFU&_08(P@QA\2;-Z@:BM''U(ZH6JL$)E
MO]4(;C'\F>T4U3CQ=+_")G:P2\AA*DJ?;=)=B5B"^!2N&F ]P\]('![(/$J3
M=7*K3!#_/?B>+D(C<Z2Z?*DQ)\.2/(;AH[]R1SMDD:'/FN2,2U!(?(@A!>@)
M,7Q<8Z N+^N:EUU]V*@"_VT:%2B_76$%4&D)V&P:CH"<Y:=(D<8(NSBE%-Z9
ML=V+[P$;@1?8BC2_>JG]Q@XQ&LFX+@,RUG%L"C-E^?'M;(&UGC7>.:53PV1[
M=G0B# -3AE^N+P>.&)R.8ZA^AGC4 F&'JT,5I5V_NWKQ^C*ZNJ+APG_O?KV,
M7KSY[;>K=[]=_O[N)KKX_67TXOKRY=6[Z/)_WUW^?G/UYO>;SQ^(.=!\/#L]
M.S^N\-R+<@W*D8Z/*3;WA7P+KR]6Z'\9<"'-AJE$-,"MDK:\.P;'X=X1JA=:
M)^\5J&:$?CNAWS*&>4E,PV&CP5VKNS*GY"SFA * T)MUSV0\HEY2$&^(<:9D
M:^9Y6V=4C?\2[*6TM9 S=TF6Z\/^+:'B<D\YK-XM5KHW)A<N- /JPT)Q3;ZI
M0'$+\@>3YSB=)HEE9]2*]U1L,A6;?%JQR5@=!>Y]$A2B:EA&OCS7W(Z-F_9=
MB0:F_?J-W=2U ^TGVY]DQTC(T):N8[^CVLJ3<V<IO;.P ][@M 7( A3J'MCD
M[4%/YXD4X,F*WP\2$NX<#Q<6$Q_.(W0@,)XB C(L.BY2_ANG8WZ2E^'>TZ>;
M]1M2JZ_A&:*Q>HIR7PL B7"S9B7I2@J*D/YS3,NMUTL8PS=?V3\?-&+=8C]C
M26$P:4Y_N& 486XCW<J,7MUASU\",7R0&0M^L@[:]QT+U=2TR1[=[]RUC4A6
M%?;**TYUB,FT=0L>-D/3*;<(,Q>"R,?1S9M7UP<]H\0XQ^ IQCWG$B-UVKO!
MV6TK"Z*3FO:)K[?5"*3PV7$%\(SK!6OY @'4*Z;50RT(?R/RCP43H36?XGR'
MQMR^1(O++)P$]Q9F\<Q*<; )6RW>/6R49W() J%<:%8YVEZ!,BGG8U+.'0B;
M=B/ET]J8-M9Z5E5P=+-O 8Y!MMB*(Q=+<[T<[[?P18'9K9.+&1CRN=JL8,?1
MP7#R?*:I2W^GVW(0T9P&'!;"&*5<EBWT\]<@C )@OLPJ+ F'J]:;)G\@; &&
M37W8-DSIR[,/1SAV$]EV/C?/JM1"P>4&_&#PKN@X,>$8X0^<GU.Q_]E9E)RN
M3R54A8!,;CBWMIA_C#*@H?)T"7LW!A:[TLP9RHZ4;@TU36)Z5&)J*Y=\'3ZM
M\->RPB#"'2_("3V+5MZM%;KW"'9_[,P5?>GAF6T1^0/=(W%TV)D,2LV/S>+N
M%-.A)Y'+Q9=^*/$^JU><_!;1BSIZ381WE=PQ)*QI']-I6 E>HAU )@^?_%C)
MDWV(UC#H%96TI6UE","-[=/K^G":/CK/B5V:28>0MGAR\V59MM7C+!<RIAQ7
MQ#W!?*.%NJ,K9:S0P>&QQ8HFI=A['7M40Q>;I@59.52F!C/7U(CY0^ZN'K8/
M4.,23:9T=',\_:"4K(P<.+Y*\:"%*:C(G[Y*.]8&UV/9 0<[88= [T?V"^;6
MK%>S;F?\]I59)35W?E(E82%E>EA )[UDL@VT1?\XTSDDE3K954_CX%*)<@]I
M$M;Z+\]B& G^QY'*^U69H\K,FVR3DVS\Y5S_XLN\T,_;4^2'F$VLH/V )<TZ
M>.LQE[E'5I@Q3,F!U)@$^?[ G"1T%(4Y3<\.S]@BL4K/J]',G49E=Q-&>TCY
M^4XI_U&^']SK22<B)&PKA/KT0$$=UZ2P97V&]H ,1/>$31X=CY5$RG14?95'
M56S+S/KFF=U4.ZVSA %!J'U$#"VQOHR4))YE.*,GRZ.'9,=$*-!FXYV=ZC'@
M(.T0F!KE3HKQ< >/7!ZQQ\#C(F@.FQ1&H!5-F2*/D%C('<.'&/^&35'C/,D\
M=6U%OTF;&YB8%\H3U662Y31,+=2)>0,)$I-R<94 MI:,W84\E(1J:_,';?AZ
MNF"'B5UTG;FAB'W"^56[%MB;U=&.I]&%[BJQ.%I[ZE,NPJ17,2#@>4+0*@]C
M\\UH,@:Z:A"MP;[5I+^^$OTU(%*RW6OWX.L[8/'D@7W%V\)CMV.]&4?SMAG0
MM[WP68R@5,3-V,=]LH";0V&W)=E0%& [!'93,!4"XQ2AKPPQ$D4%-_ULZ,Y
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MJMN$/8)%GK2HGDZ2&1\F<U!DHNO 1LT?XG #0WI%?CH]^^'P?&V8F]T1):<
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M.%?5MC1W#+E?L(_O,KA>1P$M:0(2?A;$#H @ ;9*7MV6^#W-DH2?ZCT,>>Y
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MCA5BLSVX HD<<XRVI[L0+$"%L<^'Q&4%6E01,B\N'(:;L5GG5DE:RA:CD4_
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M'/ ^0?IWO0'FYCI^DZAW8CR+O@A-JADH, WG9;5;022*?D+B>3C5N!M?4,B
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M5G]$!JU-:55PVX/\K?Q5TXF\5X-B23/ZPL&.8H-2;IHKN%=)(VE.IZ?YY<0
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MX\[-&R RM6<F&0V-B29@*P@E/]W<TD%SQ@:S9E^28?KJJ:43S@]\%:MRLKB
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M2K3:5W\TL+4'@.H7[D 0\;=&/L;%TL!^:>QX+66[E,^"Z''F(M@3*.CL2R,
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MX0,^FUN]+:V#C8ESER_P[2(9;Z%4E-45.+SK_J$C,>BSK LKG6_JQ5H[]!8
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MV@@?5++WT?@!MNEGQ->P:L%X@)2'DY7TZ"2"K^2@7)B5FX!S7VAA,<!2LT8
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MV+-8WR"9T=:E"/2;VF1_;+0@ DEI.=)J_R39B,WU6?'MA463\F!7T0;P@]-
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M1Z/W<X]H!"=M*&930/&('M6ODD?T:$.KN&<J_,0ED -IC=R)UPAO8F5CM=0
M,X!S'="C(FT+2)LJA3JHGN_KKLPMSF!NX0-%DY(#ZN40O-,VH%P-*9U\U0)(
M6G.Z?EO;25VK"4(S'P4/-8 /,'M(R9E[^6SR2N9A:=0;Z\@VS#!JL222&K?*
M)0G=8=74:TH0:;V\%-)T5\SRC:R*;O$NV5.SPY:)@S*J?GI4;K3\%IH^J/N
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MF6WR3A >7SXR%7,9<"3NZA(_0?:LHM'G\ OY<<CHP&=!EA05<6 .4;32$\F
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ML5YV38OV<&K&&4>'(IAX4(A;:3]!)N4[2%V.)4/#I25D%%DZ$9\Y+I4 =#(
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M$SIUPS5YS)]S%+7T^'KF1">E5MT].NI+7H52@WD(Q8- &3RO"><J-%Q,,.T
M(,D./L7:_27:!"O_P'YM[K_%7ES_]RD1PX4"!*&WK7QHK6+CA="=L=M'-K\]
MS!":&,SU9RP:-5]YV#%SG+Z^"M2?/W_V?-)QFE\%,AU-$"@^VS/1P&DFM\VT
MLDN??%5 -0%@'.X(-?JXU6#"W/;D[(/@(BHB530VD/7>E+7V#E=ROP&XR<4C
M\LG11C'-JO%$H!4?KKH2\MU5VQB$$@BUXOG8IGT?/VL!7NA.]Y!K5[<+I]K3
MLJTQWXX.K]P:N<3-SB-8HZ<@<H'<AW\68?(CG96*)UJ=N ND;AQ.+7O0DBJ_
M6OV!COKB4%-Q!AU6WXJ%[=0J=OT<T>.Z#YDX7) ZE>9Q>,*Q$DP;.4YE.L2(
MW)L?;!J%U<" X0LS.LZZKO%)N_8PR@HGX$E4]0Y9%#&J >K#;89E;]8N9NKA
M4E.YLK=+[8M6>YXP=^-./?+:$1+0$+D)><B0UNC]306(&C7>8)H<G_>1UOL^
M14#B*LVV0*1'._KL :08$Z0O?SFM].4?Q59U*+S5S0HMA4#OQ:9,,Z$L(VNV
MB0MXT5BJ*3-?<<K2*P$QH$6D^*K "I5\1A<N'A58GL.1ULU'[YUC$4$8,C4R
M15,KH')_A]2/6!PSU5+EM?;QGTS2HT#EPYP 9Q3PV,/$: 7_!HPEF N2VWW1
M;6_K!GHU^K1EXVB+T\D'3,U\@@>Q<);S1IX%2+SP.+236LL7TZXEUO/'P;08
M>_3<UL[F'\>B?=T075#.EA&RW/F 4<3S :XN]YPNZ_J3ZB.E]AW3LDG(#LJY
M6NA*0E,8-\[Z!JK;6K5Y8F\JWA5R*,!+>$O$0ZG\95D MAK@$AH3^J\NOU%N
MX!X$"?XYMSV!QDX.SXL%-VB)LN LB8)7B%Z,?5)B.RWYT3A?RH0K-+V7$@(U
ML6"ONFW7"-2?1A[A#Y40N;989R7ZD#6W52-B0XIBX?"?):P)*'U Q(X/@123
M)]E5C>H$R?LT0U5NW<PAXL^+-LVA-B[=N+K;S^X6>@@_;PMZ%_(T@*ENM1]<
MEK9Y(&@93CBAAVP=),BH:Q3(YVKT]*#N/2;).Q0#GVPL?6H]YE'F7F3@#/;[
M'#P_BHI$??@HX;.*PQ\4>)V459O<QT+"0WOYN./M'&L]--;R1]6AWO.KET?,
M8XQ@72?'!SQI@/A?3LN2?^B:N^(N+9^X/,3BZ5V4I1Z6J^QJ(5KN'7&R(]&W
MH%X 18L,%:ZOKR>U>XSC1T$6&MY2F+'$%S<W0-0C8^?WXJXNL:/&(J6!$K8-
MP(8MPE34VV"N"F*BQJTE?;/I?=;7,@$E\ZG$^/W'Z\O?KV;7_\#'E?^[?/OF
MU?7'Z[=O/LS>O;^ZO'IU]>;C[./;V>7[*_G[V=7_^WCUY@/\^<GJ_I^D_W=:
MNO]2M<AC$N!*306K1'N>(_5M7O4C:'>IXIO<&M/&"F8K%1;^K%@R838\JB[B
MLS)DU IKY W(ZZ#S"6+>=J7FXBD6U[(D$$YF)& #;>LY3<,[]_2<U#EVQV=.
MG(5YS^P'(T-M00[%9Y%U6\R%=F#(H,/]V$&AC+C;-/5&+L7.7!-!:.]%NP%Z
M-,AF4@U+MP7;HQ1[S"(^A9V\F 7L&U9.7R+B3^CPG%HJ\^U&RB?WNU]*66S%
MM+'0H0=HE=[5!'FLK3<HI9];XIF2[^&S'"60J9.6I34$2,&K>W/-$^Q0RG&2
M-9V?CVBQ+AR+]=ZR6-J5F+W"$;7P]P+[C]<SHG]8 D52Y@S$UI:J;D8[8Q_=
M/3BIXW5JA&C_\>__^?S7]S0D+Y<_O)SP.<=<R[/V/DD"G[-XG91XB1,3K[?-
M35H5?U*BQ_([I<0!.!.L;C*[VF;/)DV '>HR.+$?.\_RU]STI1I6ZJ:X*:JT
M1,25M,=(P2:?=DY?I?XVXIQ8[LRG%\F B3_4KI.7((, QX<9CT8=X4?DZF/X
M  ,7BN84#<\TRZ0O*+2;%I;>7A#$A';D%,)$EZ8C2 I4S4L!L,!6]<9FFI2!
M92W=0/C5 "AOJ,#+]T/WT'0"_:MKBC8O=&*B("JINMGP.<2/6F^0*.8_#[AC
M'A_#OE9DC0#>!04O 3'<VK_V7K_WTDV#,UP?Z.T>0=?P_0CLV,A<EU*Q)7(I
MK5Z-P% .*T$8TGHIJFSG?D]N"\*0]!?\JP82 OW#P.BIH(*B"C#B'V8":.$J
MS=<//VREL"/#!\L]2E.Z23,^!*AO[8<X]Q <V4-PQ.GYUC*N,DQ,@J;$X$^F
M5\N8.2F4E JV/Q^<!(/+DP5WY+B NT%2;4?=<O(29Z7D*:4]6BG72VR9F8SK
M@8?J";D[K"I$@,<19F-UY4[9.2)1!!\*J*71'VIG=W+Y<LQN4OX?_:R;NLYG
M%LUT/OO?3GY.67%1W:1$(KCLV@(*.O!O,+%LA5>.:55WQ1^^[_S*ZL0BE,NR
M1@()BWC^- H J4.D#.7T8Q+W]-T=O+ETA^<7"WVXY)F#23L(I,X8L"Q72!Z_
M5_+!I./0S%X^3V8O?GSQ(P+EQ!W3L%F$X7 IN,AMFM-? )IMI2J1(1.:WN&8
MB@*ULI3=0A[T#CFO+38GA3U(:! *=.%@@[Q<7YR( N@\8<8_4]=B_P-J3E!%
MJ+25C+FD]X%QDIY>2S0VZ-- 1235#I16 H'Z!VJ%#S):*_(B;0IHK=FFGT1%
M]NK^M@8_VV:Q:@&3GDFQ4^3U-C>5&C\$ZRZ7M1$;;#*2B_H:(L.__O!_$:"^
M0NY$S?3QX>K2980]SN4F_/YO"][^O!:T_Z@Q":'*OF/;P33UHKJ3UU*-Y<C
M5V="H"K="-WBY&7/]<M]JNI[^?@W2,@HI6(KF,>?I_DT*$Y+H!>"1YNES;(
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M[>G;#]^AY>N>\6I=E=9\@VA'K:$W"@$,?[5*:9%1_92JEM UHQ1_>>>IRWU
MA^Y5&5 545L(E+HM?*-B#<LCK_*:#,?4+ K?%DT'C#RXN2@YL.N8O""75MD]
M/XE'RUF#0>E2C2Y"L/?+$%4=T)L*$BTZ _+,LS('EE) $XZT<T=.=N[C/HE[
M#/(XQM@AXX/#3>-'.#K]3IGC3?E5&]T>43;[A++YZ> : &.M$R#,"$3ZFS=7
M86>_)Y(BNZ?WE.AK3U&O1^**+9%#+TM7N,-(S10L)A"? '2XKD.X]9(K6@!)
M6MC!P1[]:,QRG% >O#1DR:*VIP:!G5S2 U%3T"=WT$S*EQR28MS/C:6Z(?VP
M%PQ[C]"F7X.9>C^P/UU&?NT>_3I->'EC=TNW/K-JBRS,^\/F'J6,FWTM&2=(
MCHZLBX5993N91Y2"#NL!A(,HX.P_Y@ 5O\GPCXENQ@H7 <,AX2J7*[E'4R76
MU$^JCXQ/AX]1D2PH))X*SF1#1 O*+'U4"_8U,9K5L>*%J+EU$W"2<3:ZPL8#
M&VC)I,DE-F#F4[#+GLKWR!ON4^3KIX/K)GQ1<.G#X<2X'D9HXHVH-8?8 K(E
M"EBGV&&SP8.>R0)%TH>C]G_#1!S&D5U95AKV3;,:[R,6^$!*VTZ$?:&*(6WZ
M?I0H2ZAWJ !-5.R=R;^IX]C0M9@E P%TX-GRGPZN[>([%3>"Y<<B^P=_FO?%
M;GF?K-!>T/"I8128IH;!-8J%:MF=)XI[30UT^L'^B\6_6JX<] RE<:B?I?A9
M$Q@32XNDRMUM/Y=J0>?'C^P)!Z9_?CJX?HI#;<YB8$""O@]V]S>S'4NW"^X8
MG=1=W$LLI<#K"H'O&[]^<*[>>#B+RW.>/_M+E"8K:+O:L!\/GILTC%5MS.(-
M'=6^04,U7/J<*3B#WE_!N,(:/+2U>!/,LVN$#@BCIZ(0!:=U1IU=@YNA\^?[
MLHUW7=.]U-=U7X.QVT>5UP1H*O 04CDY15 &6K]!+LQW?J-NE>J.)Y0W(@7!
MH#+@,Y.2-:L4\@P38ED1TD*(:CBQBHT59+<(#)DNI)M61OP=KM:+681FUK-U
M)6;6(LT^NH=*BJUBW0D?F/,M5#34')2WB[N \%[ YFJ?)%QQ4H1N1U77ZAD^
M6:V!WPEDM:P >P)IL0#MK4OBFSN3WYHG"WN&7"LY9@OVF^\-$'7 ]H1JP8FC
MJL?6HTX%VI6Q[XD>!+_AI=2F<"]"KV.E'X)4N@?':8O^?..1B^;>W?E&<(3C
MW?C@;ET!4!.E^Z!]X3EM\Q4%5* +SE]^?=02>3PBRQ+Y+\_6"61>M'E6U0WV
M^7"M)NWYJQJ./QV"[.;Q.K.W@:)J.X1EC1BP2A_Q4$)S'&],R*-]+SP7[$-O
M*?AGD$&<LQ!6E..7*F;PCK"T^)Y\./%>#^-\?L46F8_^J(_'V4&%.N"T*WH$
M-]1Z2@@&']0%I-]@XU]7R?(&'5)AV9J6$']/=-[[C'8S8*JMTC6S5GK-#NWG
M[G8#U4_'844JD_A;B#;!7BL%'?;Y@[4= #O/Q'8IMOZ=W7_VO+B'&N;*HIR!
M2Q*AKXUV$U1CEE7%1?W<0YRH&8C':%EZHD7Z^Y"/')-BMWYVPS816Y)MPZ?1
M'B+%6Y0:X'2/"'F4 ,A^M<X/L=<OH!R- WM=>"K*2KM^18(LU0*$M8_<3[=1
MI79WVSN6^7EAY1J:6FD6$%B]OOOB$92T)2AI[X(K$K&2$GC*S]%Q9X$0R!_J
MUHDEFEC=0M)-/+M!\:H[2>_]V=MYWV9[]E#".WX1/F5KI3D[0.+4\D_*;EM4
MM2CB&>,MZ$=>K3UZ$R,=-3&@+&*)AIWS(] PYI WQ2G@ZUNKR(BN=U8NF6(.
M3%BRH"&6X4+LE00&[<T_K8)5<M=X5F3'?[R^Z$OWD46<K;.'?*C$VBX5]OF!
MH +N&;PR!36;35L./H-U7 .'.[LI0L*9$S.Q"R02/]VCWSMF=.]@W]I*]ZU]
M]),UWWC08HY3 4LEF((9>LV>4T!3Q )[2Y6*4/0^7^S[5R5S\"B9@'O ;QSN
MTZ?)N(56)1L"B_<H;=T1V8)0$PZ0"H !%8NIFT>_1ZZWV2-EGI=W&&64>:.
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MF6L76M4B9(6Q*2#\J&!6; 9L98<'@9/9-X;#KTG8/MB]1BTDG$2-2 ZCO1E
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MU)1.!X>-L)7/'G9@ FX:Y@Q*[2CIZWD#^-G!^_]W:V^@7G_H]9ZIUSN!(0%
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MF<M)L@JJ:V?D;M/BU0A4A7N<+NP89@F"6F>.-IJ!Y<S@/9@1],4T%(*0+,E
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M\6F7\B#';K99R/)J=WS*8'O>]92*]FLB%Y0S+O5&Y&A(L#5D7%!]W=*>6./
M*"":P!1DI&#:E1A8!'N=5"DU!^<-7F6X8B#_2!94P%Y3$R8NJ.:HR#PAKJ.O
M5%BRKEKD:ZNH8])^SYD2P,([L,Y:UM<OJY2W\-&@VR'33NU6@@AG-#H<7>V.
MYM11PKXZO^-H6Q@?]*X7F(+.^@O+GPFRI8G:1@*8(?(J>/Y HJ+FL(4Q(\H1
MY3.$.AU@; 2DI[F$!DS+6-Q395[VR__$PNR;R4_!.1\8'](.(@L\!XPQ'#MS
M. WJDUZ)D<=6G.OT7D3GM[R<+\T\L>\9>T(,/975^J7M10A4XR<T%(.@"9,
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MS>H]UQL82=NM)8!MT09/OP #=W3"M3#;**J.'O!A>L WY1V01^Z!!XS1&,[
MR'X=C/VY2$YAD&"Z6J$4:CC621Q T.[7Y=<AL?+BV5_%,KNTXA#_]/ROS'R/
MMO 6]2)+! >R$ 4Q:9J&;&CN7O_*$)  ?J@?A](STZ/$8Z_@ +>F -?)GW51
M]/@JAIH^12V5'*+0GB#K,)1#8N:1JV[G'8\YNBM;8$,V'>J#GDY@8NQ1#<!3
MQ;=@J34@HZSLSTL )M2BD) Y4+7;).8%R0?0Z^ BD"4<CE-/-TJ>WA-)])35
MUP[K'Y9Y<#MJ'7 WDN&(_WY*I4 ][[C5EQA1@R*E*YQ$K-Q##Q-=6;[RG<(:
MJK8[[FN[K\>WM?1J"60T9N(A6ZXK$5EP*].X"L2>))+JT-43,PQ,'74W5:X1
M/%I)[K8+%@ZXJLERKD%IQ:04D/P]PW]-K2((=L_PKIDP-;6]:[_RKH;D68@4
M=D1I[#HZ)H3>ZPT8FPB8Z!N;=?Q]MOF7[->'=!+&_3\%<;<2'E1[ E92Q5R;
MCC#+[FC[%Y=#54C\.2'2]UL;O'CZ_(==:X+]GJ%?GC[;^0R-F1O'F5L[<T=1
M^CU%Z;I8FC<K7$F.KEB"+]XGE8H,7X MP96:T=_+'$.^9^5BJ;%^W%$N02X?
M6#O/3,@\O7/]3&QMNOV6T!Q4B6MC=S@)N9^>/OOU)-VYG;^?DX2D?#L-4KH>
M1=_4%QF)Y>^-V)B."@TV^).\+CO(-4=P';:KA!XP6Z :=/&B-]?3-N!S#N^L
MJ25Z.2R^Q(6+=9$'Y6<Z\:P,?I!RZ ?XN^DSDD&'(=]O!EPYJ"TR^XPM<H71
MM=?V9@Z]_54VQ^"]![?'YQSOSUO,(YIR&$UY4)L\G43WW^7#%<5?;:,/%D6L
M$X4# 8T- NU+UN@@"@N..;1#SZ$5_>XP=O?[(D[D88=L#&608DJ<V2]>)3-I
M$_'*&+$#N'$DGE!@TRDK=?Z657:;Y>9:P/UTV/ ($_%.XL#\YI.9M0TV7[6>
M#PN$I:X,:$H.A5J!P'FSS(6J6 H@[V;0%#19PK:DIO!9+9^H]FJ-4%&16JEZ
M77L] ;W1YJFY<;O4)W=#M#!.B:_9.Z"+YKQT7YKF<>@F]85=G<2GHHUPM_1>
M7F^6 $\$?6J7#>V%DT^3(5"G1ZBI"88A$86JPA'"^ 5@.!*1UC!%#&*O",]
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M2-'6MX6S!ET"$?9>"D0!@##ZX")6MXA"]IL$6=,\IT7"D7K:&L+6BGU6[99
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M&*,H+:85^W/-5I2YE)UVGMRO4+3:_L-]U_CN/GE)O]:">(4>=J1-3(>!$;=
M /J\TJ+Z-'4>4T+72WE*)5$%&&"Q2">LS-3)"_]Z;5.700+P+:T^_!Q4PS:<
M?^1Y5""L51$.6U>2;)=-7+$GX[CIDZVQY#RB:E ;H[?ID\L@;GO@MJ<"MR'@
M6-5B/"H/?-8RV!-<,0%%<8V0HX3O6L[AR87B6V L')Z<T 'K5C@5@'_5W >]
M0S:%8.+0X],"I!\W2&QFMX7.*Q]#H"]G%Z<QJ$+Y$HHN$L.C!O4*7!B5W,3/
MSX]JD+*&U-$U(+DVR)B,J/-S<?<*$283UZ$@+\E%U0J2M8=31/7A7*R%M4@+
M)K*H0H5,N1Q'XBI@_BZF;)+>IM-DEJCMEW%AN0D?F0*3LC6[W]:;;&OQZJN%
M!,V+VL4FA!$P*NJ,#OK1.?I"?HV:#\X2ZY(:$DIWR;WZ8"X-SH6IE^DH.W?=
MUJ?I*3]UV(FVRK M96(4EY3][2P/Z NG+,@-#,<U(&G6-Q)&F!OCR]K'.H6L
M^QJ+5UA+L-U\>7MK";Y!F04]\;^2%7CZDTTF:YLK)7L^Q[B6%*\QAU6R"D"%
MQ-;ZP"5%JBHIV67F*%/A-O;2KG7UAV4Z@0-#"%]%!$_L[R7-%<WS]!6H+SI[
M?MG+HGEYA$<5F0Y%X6NKGFV%N5@T&!PB.!^ZNYUSJ+OAW<'A^^V>6;7B!TJJ
M[R2!V.(F9ZS2#]LHI8=$XF]FR70]2; 6IS*_%SJ9.IM!HV0$.H:)\#[F)GOF
M)L],JLX3#7&1GY J*S[#^+Q&]XM/*1BWZBQ4^<%QB5N@]0DR=_;:E"S;>]&;
M.%668,G!7*.@MH72P7A0DD_FM#,E,(H1#!L:+3C,-EWEQ$.IWG]*QLB#!D'<
M>^2I?FIMSNUL#,9B+_X__N8BX&R;[PZ#.>XT^(_M;YIP?Q-&"=#RJ=F E"=S
M-V"WD#.HA'.T 0:9)BRVP4;_&-$#(B[V@Z%&\+[\QKG<CIF'K"/V!UP<+#XZ
M61AUQZ VRKZCA\6/LX/#M^_?')J.ECBX6B2HNT8KRDA<8E9O#6.#M5K/A=6[
M,K]<N;!/S#678VU/32!7CB(2V*?[!4^:$'VZ!\X&W57%W#&N=VW^^%3BM1$R
M5FFT=IJNQZN&=')'4"<FT3*:H/S#P*LN[+J[<)':(#+76>&WZ(''/>Q5L_(=
MEES%.Y:5/4M@WTM@>.$O(L7)MYVGK8B#">J\ZTP*L37MEVLJY\U,"RUKHW;.
MONK(?7!L:\&Q7?*ZT[;*\=8;H@R/HMM8+3D6@E*Q6,!5>J/8,V1@':RWF,ZG
M!BK/U4F)#[>G#/%\??$QH0)0<"!O;DA'_)=5OD?(PDU?>*G(HY+GM*1#R>;C
M.:$.3[ B8B2MTR1J13BQ5NW6Q?#V'11-@VF?/;,+1Y2[<TS6C#',N.&]<B?5
M;EOC"I2C<:&IA"@0)3NE#JG76M1.I>RN'-BE[0W8?7]>PFS'O 2#_D;<SEMW
M"NH96(ODTY6LTT[MGA\\<AJF'BO+X[_C#=RTF5 8B8(T],*XB%_A& DN%A*-
MH(HQN_I!%'XZC:=(5@]N-LPA6"]'T>++/L:X88R1 S-5,ZZ55P3HX1EU@KMB
M /YJ&>BIV=8"]CGO<EX6<Z&\^X(H+V!M/"5R\CP8OA:#[EWOF'8<VE8*7$F_
MIC$HU,[*@A. C^W,VCJ>9BGNB&0EU\6H(_T##@*A?4<$/%1\C@)&783;I'<+
M@YE$AJ=>D&LJ&*@%I*V^#"$:IW>@88M/)@Q=+&*CSA 8+NZ>*5CQXA 5 J<E
M3#G3IY;%?%*45LZI?J9"VZ>]R'UP20"X_<>BC[DH -F3Q:E02U99;P&.<0HG
MH.BRVU3R(*8@%]^-20)X_B8";-3>_N#9S=!:>U"R%ZGI"R]VC#ER:[:'E5.6
M<VD2YT95NW-@1Y5UT6:;27(Y!.#!>)FX7<O/X]?EY>>&ECE*"KDISV3PS4(P
M.N])]RRSY"Z9Q]?23#M=4T$^XX$5QFH-C6*TBL 52P"*+L6M)7$MP]N0T=NH
M<JA2 =]1T2'BCT4Z"0JY5E.\+MP7GN)!,D@$2#W"V1[BF$QQ H%,9DG^I:);
MY6H!Q\_M&$X-4&]"A^X=(NW<=;:"YNW[SF2K/GGW4:&NV!K-<EW/FF*XVF9I
MDR27 #\IY(E JFPK;"K3Q7/4];B^ED2Z8RM]QTY)Y@];EDS%3)%X/JI_8RTZ
M6)N$.U)KM=2TKHD<(R5BY6E"/RLQX%3A6^\8-)A1JRT&X\;:G ^G54)P8\\\
M@[A\ :D4*7E0]]W\&01555%U(@SNY*-J30++?N'XT(A&Z.^Y"JI'&8FT%M'.
MX3J1*,NP38VKQXJ(4T6U@W4INHWG5*"\ON5M68BC%&^LX3(J?,XV_.G=BE42
M^MMN^=U8.+12H&8-40YLU1:[)L?I8L;57A&6KFQ5L7U]Z6E+$*<OF.G-3:&/
MM8/:\FA372OA"'=)#:H,IBBU/I!?X$A#T(F0*6-&T8MQ/$_ONZ&IHD,_Q+U6
M8/+U8:!WHRZW.KO-]*'^*@+3 C1;KGV8B328^I=KO$"T%<X%FA$+.CNXKS7%
M?Z8$XX/_BF^7\_2!<E)4=8S_G=XEN;XJBY?P,,0[QZ?E6+@6+.3X^K)([UD;
MNA]6T21;W4K:_ G)(E]G= J/L_0+C95^%9N!F1\KWBB'$1E2]DF=9"6@2+3'
M\U6:.MR^RG5"O;;I;565H^3'.?;!U9LV+^C*#$,LV"/,G:"(^/'X&4Y!OH5B
M+ F??SZ!I3OCXQ A'#(L+Y]P\%<[-^'!XQ0-2?%V&7>F2+2-E/5S.#_7L/ *
MXKABY,H\@0T;90:66V[IVMH F1<"-Z6HLML#;H+/###A8+L5P>>=9X<4BBN3
MAPN;PH,@N5 !)Q[QT7IUDU+:A<H=,RV>I3J,?Z]AZ:>) &#>42+%PSQ 7S^>
MS]Y4/=# ?-)0SFGF8:I[8 Q-$N/[#XQ84;B1%@0^MTO VUR33[95Y6QI'GCU
M2+M3MI['C$:GA:LB_ 9H4P0 ZU%869"D%>*$HH1*;CW6$ANQ(Q6#+[._BO\$
MS2U>.[*5K"<RN#':2(A3"%YQ)(AY5!J'<TWQ9I@PNJARQ>(_$225YL-]A?W0
MPGH0A<H=3?:*X9-"PJ^OIYIWJG1@(G-_#NE'D2BD&4GC143)%1%[,+!I:Q$C
MVC[\N$G>RRI0NPQN+7T-!N,*C?D*G-Q.@6_=J!"#"DM(!:27#:^&JV3SU#E:
M+9 4/AZ#!)ZN7JF5M]^/&^Y'@QE:N3&GII/ HH!HVC&D3O5*&R'681A0XPS9
M1!0_Q*1 ;?N"('ZX30SZX=%$OX"V<4Q:W^VQ*-@D:>,3:7",BU&@;=D7I.UF
M0=I__-V3J97#\]69=5V[C&NX6+71L2T"-"ZALE?PZ+3SV&@-'KMP1UMD$\G^
M,F:^F4W0[U@R0=WH6%^3)>S;<,U7'N^G>^-T6$H);8MWS'1.L Q>)?#"D$K"
M*AA7\I$[G/*5)V!":^I;E/8ZFHO2-J^E0RW.^!3I2%>;.JGFJ,GOHR4CWV?)
M'8<!"+5:#@+)!I!9;ICQHDS=)<T"9/$,%,&B)JE?J,P)*[[%/-M5*-?=1XGH
MX*H;\RT9GU("XWM_$R\\VY:CK,4#5&ZJ0@T4;W@63;BWRN1*G$'J[R1E:A@K
M<#S6"1;7R!^@T!_@<\B>2YA@0?0DQ0\R85\JQU5*EIM4S.N7&@Z"&KQDK-0K
MA;M=#%"4=U3=OLTWCO+$4",>7XT&G\ 1S>[0DSZ"[XS6^ACU">1;:RP7C(8;
M>J[;=(&Q&OQ^#!O2PQ?KVS'&*JKZ $SRI_/OHDM3"AX@>P2G###E [(XP5BV
MP4=U81YSZA,G%'-*9.#AKR$S)PP@G!+Z4/NL!J:_T$=9K5T#%O(D<P-2+E+D
M@EO?*U:&BTC C%\C%IGS69Y\8S2**[2-Z8Y!*:F]:XH-<A"_-&BOAE(-3;<?
M%1,=!1DN:HK*?(&SA@>;X?)N%K_$,*)QLEAPL#%2LE<5@3?7!XO&# CF\UM@
M*#3[$J\PUXF[9C[7L*'NA5QVBNB,S&RD><Q9G 1<$_@:89^LN[J)0]*'^@Y*
M6:C*J!^E\YR'LG3S^V4W%K&4'>! 'XR@ EO\:87DKZUH\K2* L- C;4:ML'9
M?"U :PANXTCJ%9.J<\^<>"!Z2]H+O"4,J.Y#P9%MNK)!$8_7X/ 3L/[W7 O\
M0FFDB3EW!&*/TCF%_! J:XY!H\4)-BUE"M+%&S[)/7% K($X6ZA)5[O"U8E\
M#*6#\71#":F[>)XN*>AEPN\4%)F"H9,7,-W7[$T]-CHJ%)C0.RB5 2?S="Y1
MOL?NK6"X\<EJW5H:'\A!^Q(,/(WV7F"0".Y\DB3O7O;\E]W*GH_B53J;[=/A
MW^13!U31V==:;P%T=S$VF(XPGDK9D6(@$U&U0VNB/Y0K-*W[4&_2)[DRDTNX
M^'_PA4[Y?B7W@K'>D=R;X%0J O!^2B?D_B7\V!G7;2V7<T[I:#7I-*8H:@X.
M>+P@O8'6(/(71TC22R5&&#"X);I<$V_BZV;) J^B7!Y\&:80F7EJ@DSES@?=
MQ'.>TC+03N?QNQGBW&<-J_5.3(6RF7"<A-3RZ%@@'3*%.1_@4MQPT ;=O.L(
M(82]^9+K"NGFTJV8]9<:2VXR(9?#MJQM'EFWQ50:ARU5.6>.F,%@[F]BGN5,
MR,0:[G9EG^([%,J@U7[R2'F*I,&TA%=>9&*2V@[>8.K5K!>W5!,PI?=@;<"]
M5 &"9PY'X0V%RYA?R>_FJ_BT:3*C0)43'RD]Y":=6W!^V0M.2 X'LM"\W#0>
MPR\6^W3G!C'4=LX-&IW;G9?$;3<R2=DRLXCA\^1<G^U*HI)I%'VR&T**=5'_
MA13?YU;AFXSN,DJF4N!QB\E"D.OY0V. 8495UAD7D/*14F>6EI,Z[5Q[!S5S
MZZS1<)!*$$@ RAZ$!UY7+(^OT>600YTN*LN(Y;JG=<*J>*EX1ET]Y4,7!2X#
M*ZP.36$CBB_E6L;?U<FJHNN;M'>3?$7LF="Q(;#X'!)SZQRFV-S C0U5/'-U
MTQ+EE@D" 3]E#TTK-Y @W-G&B8V,O";CSCDU5>3P($ML.)/L$5HRAP3#I/&=
M BSO(C/D;E D,*BUA9K&B><O'OL%J%:7W4^_V)1_5K&?JJQ4KK,1!C:";/<8
M?8DQ246]M/78:,.1:BN(BNRM-*'2_%HB;<4;[L 7FTHBJ6'VOT7D=E_PT?*"
M#XR@_+I;$92! HIPDYA!4OR.XAK/  X0E%S/@^,PK@%H8;-1]/]4B@#HE[7H
MU%;_8/5>S"?#;?1G<KN^Q80X>6T8\ESGZRQ)UPYL;UT8XRRZWP'0ZX_RC2B#
M+4B?2%?I8PG$ MD5H_#Y0,KB6/#QPXO*H73WBT/)JF(IL+W?5I3B:EJL.@NE
M[O$*(S0PX][I:^BP6B](Y,Q-".B IJY]GIHBC.8 5B-*$B4%-!+BB35O!BH*
MG>$[)S=11C1N5,EIZRH:)T^GKGY&W)(X LEH*)LMAO8Q+X+#PE%B=)"KC 1)
ME5:"$_HN*CV17DOE;QC,XCCD&J'X-N&]9ZH#="8X P)?0+F6.SA003ED6/D2
MV^H?L>YBX5HR!:R:W #QR%8P1(H-9O3EL.K(<"NMDCD\+B)]$_^W%"ZM%_Q/
MK%;BJ5NE*X.L3_51NEA"C>5P<JVP&X<\(UQG%:&+*BR@5YWH.'R[6\?TL:U0
MD_@9'MS7F=,CV-?64XRQ[5,BW^13+_WPKD1EP6F>K%?"5.<L')->C!^<V&J!
MOA)NL']S;^V&)C?"OKDAF;187: <DFO.*8S7*XVW\^54X8>E<^@_7[->+S\B
MP/K\>6R4//GWY<:ZNH(6YU%<SKY"6 )]F /8HU]=+#+0:N?;B'#[E<:<WVG^
MG:^QZ2N6<+NF%D!1WI%-9$I]6?]*'Q[;=MB8*%D:P9@-GSX(]/FYNR+*;:$C
M+%T[58?&47[8.CYW)2&LH!-8_ L2U<3+*S+FL>ZJ)NN".A])UNNN<!YK[!5O
MD\J"HZ$05NT;V%UQQ%818W-0C8,&OS3#9=I2[.X&N3F)YTAQ*56I]I.< 0@D
MA#XY0">[HM .)R&>P]PM'RRK!?YBE:4++(>XC:Y1J+D2R*)IF6FFN@UG-$@T
ML:;6S+I1%7AE7[5Y<+A;YL%HG=TE=^P3#)U^:J4Z_DPX%BB+6\9$^7Y,@QXY
MA>6EN#=+P2ECVR3$M;--36+\ZZG^1O8O[%0#S2-VA/8;\3_].E;\/>6>]")F
MF1;D&)0C+?-%-:"E6$975)Z'(\8J:OQ:J\G3S'2GP^&+OBVA$CZFU[WD M>4
MS85XC*F.$.%&JZBUW6)#)SXEGC..^(]CF(N9@C%XH2$31M[@D9HB4#A]::'W
MJL>=]&41EP;_)"AH?71Z<PKQD_WC\XO#ZF)-2\"<VC11'+T&#3]/&63*!*N\
M @3K]CE26*!IUS#6>L'H-XE4%]!W*KN2C-.[U8'<>=U'Q;L=.RJP5"AB"J3]
M8? M2^<:6>JUHJK2L:*2M[D&D4%U(GH ED-0<DJ"0MP\S%WA6AI,%U(_M4EC
MD8+0:Q-MD5H1N-=MN3&RNL6C=J0>S09GT5AA)+>@2;)8#HTQCX/@.!Q_4.HV
M8+FB.SZWKA$_91;A";6(KT&)6@QQ.&[F$7>%/SXE[B?1><>7.;^E(P^4:GH+
MUK-H4.,^2^,2N+AS(=1<ICDCD9#7&)F*@*>,1-+G<J4VJSE20D2<C-*WQJX8
M#W/$3K4\@!($&(4E/>Z_E"LEO >;8\!]*@SI<[*BB.$<<T%:M U/@NFOD8VV
M*CK3$WOX;LMU2S-%)')BV,:6*.]&3U<(<Z"W!]V81:F&PW'W: W993Z)QRN0
MCB$:7#.J9 _9!^2 /T<PG.W68#N%E0T*HL"J<0!MC)YN7A0$TAFRE-^(JEN8
MK;BP13$R@4Q1I-_XNHV,][ME9 Q9-RN2A<CE=LV-[\K:T!9\\44$Y8KQL6(R
MY4W'>CLER"'^^=KL>8\H;\(.\(JVB$_5(A M(VD*D HUFXN3YG;K8^)/'US
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M,*-ACRUKS%&4S-\,%E)#PCSRIX;196 97;X1!=+W48XXXI*C8BOU0X/O*UT
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M?_?CNX-?WI&!0&"I2=5 $-'BZP[CAY\/WIM!@-''6+.E@9R.!E]W'.]_>7>
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M CU7N>6&Z7L$UACR&A@+C2<VV>T(7^4UH1]L2KZ23-AS&'IWAF^O]('I,SR
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M3Q_O6!=8'/H62*%]6QI[41&?RS5,KJMY]$LE862Y%O*=+9?X_N;9ADF.08+
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M6\-L#J]V^ELO"#)*9/'1QF>G8?*Z=F@7*K7:"KVE";I.:MM[H:5XUQ^6617
MOE"L!&50PS()1H)Q;9))[KZA@9ZL;2!C\/UKI7,_?.EL;BB:U\[M7M\VLZLO
M,R1__JS)W?_L^ZW[!C85_^(VC>G7^TXCYY8.T/N]YBU#:>/^=5^&KO<)B<@;
MM7U?G33E\L>#AX<HP<#>;C!1(\(4B1S8$-BH\W$GDP6[UJJW8S<+,/6+&(CR
M[/5M0_>0K3$.5VIQHCAP76[&U'AL9N)>A:^APLU<K:^]HSW<0UM?A?7_M2"-
MI]?XO5L"^77ULHX59]3R^?#U+)_K[;1\C.&Q(>OGWMSXB(8&G;H/V%<UE8#9
M?4)5VT1I$_L6)0E+WX94YHST#,C!]H&XADZ^U1JFB!;<PC0Z]?U;CQ@\MY^P
M19"H?>:TWW+;<30 LU0IU@H>Y'HJ02*_,>W!!CO3KFAHA[6ZA!? L+_*C:98
M5B4QCL-1V3L%57%51GLG^[&AAAE6?H:GR[(>( \R#/1#) V ?!.A3SL)[^)#
MR1W739@^RGILE')V?5)*;I3YC*"[R);Y8)W!?OI %\@(QH688F77[8)F[7B(
M,LY7KLL<P<LGK(>;$CLWI413819$%%[.G-+X51W=A,@U5#(][0Z;DC#/-"2:
MCJT72*<HCV:]3]P2J?3#3UN:"C#P]DW.4[RE<S,OKU#+;79JN)]$%WP54.]Y
MC=.&3KDS7SWOE03C&NP"0F5/\+#A$R:6E$C_<5'T4;)'1T5KZEW[#[ ST U0
MW)^XW3QQDIF_GYIM%D9"9U<Q_XX<Q1'1=)4QYD,5!1I1_Q%'V*L#6=\:WI#M
MV_AL&GN3:Q90MNM18&IU1:/()9XMO/]S-:P9^U]DJ*&P'#:G-[5/[-8:IEF)
M:72'VN']VTOV#3D=ZQ\U9@9SE_HP;7Y#2&0(6Q.OH6,".OH)I^,'FB2PM2HK
M8S\[#:*%]')P\)%^;5:I)9;J[4*EWG-58_7'ECK?'!6[55[G!N<WP"-L@S]\
M\H3\X14.\>V2A9\$P]@H(S$=L@$B]VSWTB2W1=S>*E&RI0:%=U W8TQ@S)TQ
MYYSN<Y,O+:(U\^BLX,Z)@YPD:P@_E.OI(;JU)S<]W*B:E)?ZGO5DT]BM;9)R
M_318#QX_HH]=2FH>YJ$\TR=@$U F9F@ZRZK]Z-$1)H02;P.S:SWV3H2R<S
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M0_:Q4]O?<0BOX)?GL8CPUF2P#8BQ^[WK^KYW[?QJ^F^$BR<@+^^S9-]8EDP
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M" =% OS(!KW&BZ]C +WD4$9,@6^.'M3<@X"&-_+HN/]LAHE;YL<@/F*2NJK
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M=UR)'T:@.^92XX,\T5,$B[W0,%J,7SPXEAU&=&#^^&AM7),FQ^$Y>,SEU=3
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M<@Z%X3TQ/@DP1]#1H.+RSF]86B^F9/UB0(.=!U?_(98W1[K(/:&2'PV^?6S
M6";93!Y9[4UK)WD/UCH*>:S=X82FPN8,&$KC$ GE7CU79267*>:'6:VHH"^>
MM-2Q09KA5S%HS>=EA5-=7;OKJ&-$&2#=+&9U4I;OZX\+_&[K(DM=\]SD 2::
M^0<%QNWJ1,3KPN4QUD17A7)'>Y\9,<"[=U&\^^BU<5"@<0C>QNGFVX7=$.V;
MZCRC-&H<JF8S=G@&Z6W9GTF[:-F-0IS# ;W6.<"4I(&1Q]R#!_9$]X.#=[CV
M3.-MG!PVF4)V#COOXS2430@A2J%*.4PW+84NTXSOFXDS%]AKMHHN*D73PU#Q
M^^SPVD&[Y'U17E$C'C[.RZ8CGZU\&Y[J@'>1?W*,B]Q%!W8Z<A<PF_P.H#U.
M-YE$EB0F!5.9<&&Q1'@T.4#6SR-QH*J4J>K9:#0=V6194!4:V@Z"JF6:]:-%
MJ\$_TW+I<4XFO.+[,H8ID^>SI*4WLDRB(65!-4?M#2FVKXN[[\MZL6&7GO8
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ME= 3>798I4I<6NB':O@GA:^R!9(:4F6KB1<498$UK1D99RF:?!4=;!]2"L9
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MRHR:"I_ZEC-HFPKD"J41;J1@)M.L=I,ILZ4OR5$T*<0).05K276F?D4^.+6
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M77;2#SC982_L;7*]HV,^2=_KO!^>X;QWVU,VB",+Z >^)53H6XNKNC*_NSX
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M\P:.YW*[DMNTIV:2]O^W00)4TM3(%\<CS 3(VOASM4H^9A$75D3ZFW]O?$"
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MI9PV%%$VSM%3VA/#P7E#2N0JPA].JS!6A2J WDH>H4J]+=R":X62/)&B1#Y
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M5:F>3D302;J3AG *Q.2G0)VV:I/"HT3_OZZ $174X>3:YMODDZP#[7@$B9X
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MPY=0@ #I0*+[V,-8W"[V(>R-[7E"^YXW[OYTF#_%G_64L0W\*%JKM/!;]RK
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M>1+]7!7<];PG["OF*P A6NY4D:T(V1?,J-@*2AUP,2!BI4P3Y;,2XG$@73;
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M2QI8Z\]UNR=CP#=E&\\:4GGB!+_,JI?OXS2N0*'MOI[9?8$5M=BTG/6S8RT
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M3LSTTXF9Z=>D./&04KZ75^?!]QB8+5<S1< Y1%XM[X0'<67"S[:C;24@*A.
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M 6IT;<5"Q5P%31ORSC_)D.!Z[WMC,N+W4=S#8MQZ<:[7SHC/JW)!=;]#9/L
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M68+3TN^'/1- B*6P'7M8?WN^PP=DU1_-#IAK]_A1=G#ZO5C58CI65:,[QZ!
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MZ;?]OUF57IO_NVA7Q7__?U!+ P04    " "\<%Q63Q?JE_X-   R^P  $0
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MK8Q9I<<J(_9 ?!X2R"/;!0_(RN*75UX)X@O4"]1-'0Q9 ./A'ZHW2T\];9F
MMO?C(,2.S.=NL,<VU8S14,W'U4\J@@9T@]9W_Y.+>S2@$K:VE00&7(2H3_PE
MC0,SXF4*Z&_  5^/?1M@AET,.OKM+P3@40:>W]'\0Q$OE85+)RAIQMS^HC+@
M#Y@I.Z?QH6X_Y_K?1-^YL5--<\!>R3E[D;X7\BQ4XT3'74DU:&PE]*V3S](\
MLMKZ$CR/]&IQ]R6[TOEV9@=FKYY8:V=)*G-!\'T%+]3U)]A_Q$FT]W]/2GQ/
MR?N;=Y)1$/H\(<*,.(:<.O=?I?$,Y1!*N,N8'/XK5@R'Z-RZ!*SF= 2\5+?
M9K3H*^IX=(EAAQ+FL-=D+G!TCPV!U1F(<+,U2ISV(Y7/1/B8N<BV/GYH-)JG
M2%B^A?9O"<-Z[V$A>(#*PHF?")OS6"S+UP">X*;F[>;>QYZZFQ'=P Z)0],@
M@!E10S5;HC[U]6YJ/G,Q5 KG@L>A&>P2+Q:IPHW8>\NQ9X0Q$D4$]!Y##GMW
MN>&%A#WHI3XI*HBR8[R2[J(!;\WYII%6M'ZO$Q77&TA0\[ 5^'=EJF&;*AKR
M55 7<$Z]"4C9_68;!LJ:[^M?DUCP9;$A"'<(4L"2/QF33[O"-:8JQ-5H.+OY
M(XL]E71!'=BTG/&EP(&>7$0FA-M>KPI;%+$+"E9U8AE+ I58W:6?UKA4\ZB^
MKH*I5@EH5>\&KIG6=QD'>*D7@H8X[O5=KKA/G-C'8A,:?5/:CH5.@($+_WT&
MV6[=!(Q&Y =HVWSS$.L_@F:<IE&AL,=8'0.I*37C:OT#MD)'$>^Y48ME,]89
M\G@S)2+*YU(Z]G=SQ('<O!5V$J$9<3R6J1XR+'TB/IHG^4X:5$Q!U=)'SY!W
ME*\MA;!#UK?@RE@GNB8B>->5C:EZYE<>D="K3'M7$\C&VB8_8FVFT4:ET_5B
M(1VQTKD7? F [K_V]X\?FL>GPPE@1<XP<TD:VP%ZGC'S2!&_,O"PH%F@[!<>
M,Q>R69X)6AE0F=;K*'8#(1NF;U2D.[OF.-F_T8C&##+AG_B>!KA8"?;$6Q5V
M7^02Z$-U]OY*!C4M@;]SO/G624%*;MDO<XFSFGB>*%-'A/[6&^DJ6JKH)B3Z
M$K9$(R93XY&='P2T>0T\ZNLRW:A4K1OE.>7[@S'8<ID%^I1$NC(JSDO7ZS@@
M#!5ZE8^UW\=BCET>'6Q4'X0;_O0*-F#:+YB*!7Y"MIH!X"5!L&L;7^ 'PA:Z
M(RN5@F5\#@E#,Q%'DI!=7?4]M_ ]M]#0W,)T1K??$TL=;*/SK6VK!]6\%[AF
MY-9GK%.%<:_U&EKH&7&+0R?N1117IMC1H6,F:+BGAC9!,3H/YA? 4?O$7:@A
M!+ GJB"E7-DH/TE_U[I\GP'@ C]3'TT]+ +LD/BE /2,'(-=9>92V*J(DAA1
MPO%G\,VIVO<STBBET4*7@T?54L(X4Y ?"UDJ$#25R0'@9?N;\+US(ZE#VT1L
M V:UKW)?Q&R)17I"^^J$2&==L79"\9SZ5"; ST%Y4T*PG;/OZ#O0X>X^O,D]
M%?0!2^A;$F^*P.[=3HSD?L<V"/ON7F!]]@I\5\]K^(=J18N&(W1KH8EZ0]#
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M/1XY9K;?8,2HE7)K"[9,SQLN5R]<G\V[L1@Y!+P8>3U"^5SP. 3>!+:B#LS
MO;L$#GKCW'LX*%?G3)OS?N[$/4B% #:-;B6 U0X,;&7O]MB^&33UJQR6[X[/
MGW!\#A.&'2P(8IQ5>''^'EDY.A%ULW ?-19'\3Q*3]^52'(D/8*PH\]N2R/
M]=':Q;U2IZGZV]?83U"C=8@:M5H#:"-7K\WV<1?=,(D%Y<"[=*M]U*W7#8$]
M[C:;QZT"%O!*H]/H'M4[AJBUTVJVZ@U38(^[[5K;$-ANK7;</%[#PO5S=ANM
M3O?(%+4V&\V.&6K5I%U32+L_,9%X3UY\3UXT,7DQ[1\-,RS!\5'3$-)NXZAE
M!&FK4VMW35@Y=8^/VYVZ&:2=5JMF1.O5I'432'N!1T0D'ZBZVQ5Q4R=M>E0@
M*4=/ &[6PXMS-/6QHXCCG#UU6/^("53DW$^;G6$-6KMKE_3F%BI@XG.?,#3$
M#S1"HQ]QYL0';,$FUJTUL-"5:LE+LEE\%+*.)_A1Z(+YE4$L_&W3#9C\ED=Z
M?6]2;)\M+?1588?>IPA=$.Q+;Z5HL,#<N7^D;+.2-F03-O-H)'VRFH4,TH%9
MD8/%Y4)]AZ.>6":"%[:K7#@;KK:_<^Y&NH47Y#VA;%@_IFG\RP[CO=,-6O;$
MU=L[?'V_%%1'4KP==-#0I!\_U-NUT^W7LN?R+:_FW\O=6YUS-U'_\V3@?_XO
M4$L#!!0    ( +QP7%;&.3G50 ,  ,T(   2    97AH:6)I=#(S,3(P,C(N
M:'1MU5;?D]HV$'[O7[$QD\L+_NT#:@@S5^ 2IH2[X9RYZ5-'MM>@QI8828;0
MO[YK&RY-TC33=III>=!([.ZG;S]I5YX\F]_-DI_N%[ S50GW;W]8+6=@V:[[
M&,Y<=Y[,X77R9@61X_F0*"8T-UP*5KKN8FV!M3-F'[ON\7ATCJ$CU=9--FX#
M%;FEE!J=W.36=-+\0R.R?/K=Y)EMPUQF=87"0*:0&<RAUEQLX3%'_0YL^^PU
MD_N3XMN=@< +0GB4ZAT_L,YNN"EQ>L&9N-UZXK:;3%*9GZ:3G!^ YR\MCCE&
M13;R\ZPHHO0:T^_#+,4T"*-!&+'(^]DGDBZY=S':G$I\:55<V#ML]H^O!TYP
MO3?C(\_-+O8][[G5NDXGA12&]E,4WTT[F">PSN,"F<E2JKCGM;]Q8[$+5O'R
M%+](>(4:UGB$C:R8>-'7I+:M4?&B<]3\5Z2MB46[/';,AH13<H$7IK[O$[?%
M^QU/.>D6.O['Q/Z,]%=LER0,OC<V*_E6Q!EIC\KZMY.,/DW2"YZ/6QHY9E*Q
MYD[&M<A1-5[6=':W?EBL$[B[A>5ZOKA?T$#+S>+5\B%9;!;SRTV_F<WNWJZ3
MY?H5W"XW;_ZI'+_4VO#B].WU\ ,Z]$>$3 K=E)618'8(7) Z^[- D)Y 88$*
M1=:88(-;KLW9^&"H#MN27$L'PC"T@\$H&@9 MENI*GBP0V B_W*4[L+\:V_H
M1?UN/O)];]C- ]\/ _J_P7A:AQ=X3?@CD 7(6A%+XFPTY&UKN,54U4R=KGK^
MP!L'HW[;#?KD51()ZAKG9)O<9<F[H((+)C+.2CJ$,T7=P*]8VL@AU8FZRP=I
MR')3D>H9@]>RS E5MT0;7"P*S P_H$#]%S&N>J/ 'XY);*H2ZIH-1Z-D"?*
MZG<<NX2;7-A^CTPU,SH@L^,:;H2HR673NCR=AN_9/T(A5<OP1"& =/USF&.&
M54K@H=_J%#A_H_R_]<6]ZD7#L6Y'2J"4W!B$JUXX&D,BZXPR7*WN_P=Y;%C9
M+/M4#,KL8,;HJ.F,X;_?.OZXQK[(^QP[\)QA\RKN9?=9$'<E><#/WLE+8"J-
MD57L?0AA*15M;3X/^<K3>AZ[A[[]Y)C^!E!+ P04    " "\<%Q6^::A!ZH#
M  #2"0  $@   &5X:&EB:70R,S(R,#(R+FAT;<U6;6_:2!#^?K]B2M2TD3!^
MY26$(O6 I.A2$A&JZ#Z=UO: 5[5WK=TEA/OU-VOC1&W2ICKI3N&#Q7C>GGEV
M9KRC-].KR>K/ZQEDILCA^LOOE_,)M!S7O0TGKCM=3>'3ZO,E1!W/AY5B0G/#
MI6"YZ\X6+6AEQI1#U]WM=IU=V)%JXZZ6K@T5N;F4&CNI25OCD7U#3V3I^+?1
M&\>!J4RV!0H#B4)F,(6MYF(#MRGJK^ X!ZN)+/>*;S(#@1>$<"O55W[':KWA
M)L=Q$V?DUO+(K9*,8IGNQZ.4WP%//[2X'Z9QCT7(>J$7L2 ZC0:G<==?QV$<
M8NBE?_D$TB7SVD>;?8X?6@473H8V_[#;ZP3=TISM>&JRH>]Y;UN5Z7BTEL)0
M/D7^]=\ZS$.PVJ()F<A<JN&15_W.K,99LX+G^^&[%2]0PP)WL)0%$^_:FMAV
M-"J^K@TU_QLI-:&HQ%V-K$]Q<BZP0>K[/F&;W6<\YL1;V F^!?8ST"_HFB(,
MWAN'Y7PCA@EQCZKU7Q<9?5^D%[P]JV"DF$C%;$\.MR)%9:U:X\G5XF:V6,'5
M.<P7T]GUC!XD+F<7\YO5;#F;-IW^<3*Y^K)8S1<7<#Y??OX75/V/1?L!G>PM
M0H8*XSTD4F@[0D:"R1"X(";* QE >H5K,A2)55462]QP;0X&-X;FSHZ.!I+.
MI2K@Q@GA_4)V( Q#)^@-HGYP DRDC7;PJ/6[7M^+VO @#WS?ZS_*@>^'050Y
M?_,J/ &YADL66YQ2[6G$'S&3YF-!K"0,/LD\I86@[3NY550+61E(JUUQCK':
M,G(.NFV[&?PVX'V"I8&U5%6EN%YC8BIO*RJ\X]IF2+E.MEI3#*)D(0V"#^^%
M-% JM%R2PI++Q4G#JB59YKQ.O.:"B82SG []@3U6ELB4W5Y5 \*<%#!H4D]D
M43*Q/SX:!'[_3%=PB1:QI2"'HAKZ?<_YHPU,V]2[C"=9%<!F!JZ?%!VT*W9_
M7GB2,;%Y.'^-FVKGEJC(GCJ16J- IK<*GV/F]&4PQT=^SSL+!A6BL$T5Y724
M1,6!O><(:Q_BU;SI&IR-V7#0#-HO3M<%TF>',YJJ[P?*_Z6!ZOQPSQ6, @LG
MEL;(8M@O3>M5K8/ ?H2.CR)JJ^H)US0ZN".>52:W&B=2TDEKN+R\?B5@ERRW
MHET3RF0P88I&2[!7@N[YIH8?ML?!N>=U^O9J4,KZ;C2LA^ .GUP6&L=#0WF/
M+BRF);,U3UU>N%\<GO5MI[IWC?\!4$L#!!0    ( +QP7%9\#97KR 4  $@2
M   3    97AH:6)I=#(T,3 R,#(R+FAT;>586V_;-A1^WZ\X<[!V V1)OJ2.
M+PV0Q@X2U'$"VYO1IX&6*)LK)6HD%4?[]3LDK=A)FB MV@[;\B!8Y+E\YSL7
M,AK\.+PZG7^X'L%:IQRN?WTWOCB%6CT(%JW3(!C.AW ^OQQ#VP\;,)<D4TPS
MD1$>!*-)#6IKK?->$&PV&W_3\H5<!?-I8$RU RZ$HGZLX]KQP*S@DY+X^(?!
MC_4Z#$54I#33$$E*-(VA4"Q;P2*FZB/4ZUNI4Y&7DJW6&IIALP4+(3^R&^+V
M-=.<'E=V!H%['P36R6 IXO)X$+,;8/';&NLF23?LQ-TVZ3;:M-4D2T(:K<Y1
ME+2ZG3"DOS<09(#B3D?IDM.WM91E]34U_GN=9J[[&Q;K=:\1AC_5K-SQ(!&9
M1F<2E=U/9^.1)4UO=9UPMLIZ?Q1*LZ2L.>5*(!)<R-Y!:/_Z9J>>D)3QLO=Z
MSE*J8$(W,!4IR5Y["K-05U2RQ DJ]A=%5 C0OFZVB-$.9QFM(FB$380]NEVS
M)4,^VWXCO _ZN8!>$LH7JGT[!MJ?9.#Z:C&:PM49G,SG5]/)Z,.WC[1OEU@6
M8Z'V&BW_,-??/_BFJ=KWDZO%!$[&8[@<3>#=!YB?CV8CN)[B<S*?>:#71..#
M0H%HI<(@L#?75-)E"9'(,!Q=:,1#LAA(G@N6:04S?),$;D@&J 2_$2(UK)D"
M+0MJ13G9) 4'HK60&2V1"XPOTL[,"FGQ8,/T&E"(0RXV:$4DH(JE<X@3QX-$
M2#2:6AV66?L92:D'.2>1<Z,T-K]G=DE6.N-H+R(YB7!L466W,(R,1L:F\VFB
M'9.ED 3!E3AS9&Y^FWW$<)(BTQ&!<\%CG% *?MX3^ 5.LJP@'*84ES2@RIF0
M*33"^GN+U]@N*9% D<X8AC2BZ9+*5P>--V&_U?#,7&MZCFPK/*-1(2U6&-U&
M:Y*M*)P@48BDT6VU/2#(?6JMF6 B7AA4CCU1:. L16V<I,88$DLE5J(NC;Y9
M04QT):R&%F#2:Y=WH)E;,,1:_C"B)5T3GE06[M$C'^_OUXW!"C&3R+81-3E-
M6.1R^\"6Y[)ELF:B,R-=&8CWT54R# M1VKGOF71JB;7D05R=*<83*DK82$N&
M9QSBXA/)W]E'F7WWINZU<- 02\(XM0K*EIW5-_5%W4Q]H. 05)C4 ^=6U%C8
MRR(N8DW?57_5+-X.Z5YU&!=W%7(JTI0I90S?T9CG'.MVB9#53HM6&ACIWK*B
M/*EC913<]8 Y/3U8X7%O:ZG(3+$0%M]A4H\[&)N+D@@9B:P.X2)#DO8:VDH6
M6*;2%"1:C(5=RZE,3 :<-B[0&XH8*N-("IJ3],^"X=W#526R2)4BTII94K24
M4=?UZ&)I^L"PE4N*K)BNQT(T0*RXR1A.+9L3Z[[ (E2&486##E)[W4!Z(E'P
MV&!$NPA1F1K=#D)3LDEIHT0#F-6$R=0%S=T$O4?62[FR\TWMII[+TMT;*J6D
MW(Y2C 6A&9BD4'2?!L1WPZ3&P6O0BL3_GYQO]G"_F,#B8CX9S6:P.!]-1U=G
MWN/3#!.]_8E;RM:)JEK4MF#S"/LM)G9JGM&E++#2[*AN?0Z93[/R!3<E[3K9
M2>!9A>'4D51.<D5[U8]^S!0>AF6/998:J]1/B5QA!2X%EF/:0Q1]["^-LX%O
MO5B';GMWQ?5#=\W5B%3'E>?MMF^W AT_WFMCH(>=)[=#O_'DWG-F#_UFI_O5
MK;8[_M&;]HO,!I8(1P;RK7*2O:VU:I5"3F(SPGLA-&R:*WO/B#;S6R/<_T3E
M/$R0R/^!?C*TO2M?'1P>]>]J];\1U:N#=J>O[!.F/LQ.)L/1%"?&Q7A\<7*)
MM^!+?^C?B_GK9_\%HMLV1YYZ* M*<#Q4*G;^37P;CHF=P+!@G#.2JJ<YKL!5
M%MJ6IN_)^R=%+;K 3M3O\$_Q\VK[WR3P[F*_R/0DQ<L;NZ&/OE+LRLD> .%.
MA2RQIO!F\;D?-K9/]XW%?NTY_AM02P,$%     @ O'!<5K+6X9*L!0  RA$
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MCI<D<<N??"?89,H.U6"CPB),%Q[@7_II8?UT7SGL]Y:#OP%02P,$%     @
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M2AI5$(L<P]&E1CXD3X 4A6"Y5G");Y+ -<D!G>!70J2&)5.@94FM*2>KM.1
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M3N\\:W\ ?G];)\#>N1)ECZ<[(OP1$>!7B& +!/+L]F(VH.+,FCTRN:E6<TE
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M4QI#(/\#KBJ&JRF:597 _(^#Y(X[G\J=$AI60QX"&- ,G?1?!A\<:,+3&$;
MG9W[V2R%+"=O"8-)!<!:3\8&*\D+%(@J\C8P'[$3=V-A['7-!'W V.@*6A^L
M1LT*8!(6GR"G4+SSS;]U>J-G[$[<;05738Q9B""*@2*>6@NMF9QB#5SC%GC7
M&R'N-L(=3#4K?5+$8L AJ[BK$$R)P9<0D4; G9W[V2R%)( TB8Q1,X0B@31J
MALHHU0"RXQ6%S"6%S! IM!-WFV*L^73&FO4Y/5>SCT2NQ J:W&)SM93HFH=L
M+<IV,'8G[K:!JZ*.%$M@*HW &"#-RT4,]PH4T@?CY^J-$'<;X0X@)8DQ>H "
MWEGTR0>#QOF2([U-#(;-G9W[V2R%R/1MH]XFAPD\4D:DB)QC#M%YOP4+!YL5
M=^^(QL?R'9UO(V\WLSA;;0LV1+%1@#(5SSD9AR94@AK]=O!V$Q)OQ]BK86PN
M+MDFUIM>#@NA6!.H.A_$5"=A#)YV1Z0A$,E:5MW7K"D1P%;-$F+)!DP1D!*R
M&<&4WBYDW\!YQ,12JD-U;<I;DROZF#!Q"L'ZV&+9#M[N0O;V,+89CWTK8.(J
M$'J#VEA3,L7Y7$(:Q2+QCDA#(%*-XFMSDB 6R( EY>RCBH*&V3IL(YBHV87L
M&S@[9!-X<.+[EGI@I:XQ$EHJ))5LAC%,,.Y"]HUB;'92LA*UJ7>%V"0':]A[
M1M;_88$1,'9'I"$0R:N;JPUB]J9"U7S%5(XU4Q-&3'9+=G]LM.IA?[7Y;<XT
M;1</)VT;Z;N9#2'$(00JS2<'@B$KF:M2BZUK*509 7V'P*=K5P\WGKB&, 3,
MGMDB2*K40#P3F]RL,^1VQ%T'<6]$3<9&^ L$+GAE*H4*01(1.ZGB<W M6*@[
M_HX6VIR;D62MYA0!0K8EE5A:M$4(P209P73@3A(.PC-M9!(R8[/5,G "_;=O
M*=$8:QU"H)!B:B.@[Q#X=*,EX4:(:RR75@N'J*DXN9(UKR&P-E6('LV.N#M)
M.&C^HK4>I7@P*@D-9S0FJ$K,/A0;7.8=?T<+K:I]6T B-PK@7"N5JK$MQ":U
MNC:&Z>:=)!R$9]K,^IZ2U(N)HDX'"(6*M<0U 10NFM>,@+Y#X-.-EH0;(:ZC
MF'H/.6\T%:>2J$E"BP#Z*>A-WA%W)PF'S-]H&S=#P*3YMTM84L3&UI?:2H16
M=OP=+;1@G8$43$FY@&7$WF"UG[;LFK=I6W:F;%02/CV:S-NI@KF5Y0Z;F=MN
MQG&(N9\2"^)#5L]48T2B7'R!,32!&VBEUXZO5\%7":3ALL42(T.+D6JN&D3U
MF88<W1B6B3<EOG:TW1QMHV"P#8,()9#BBK<@50EL;'1<P@AHNZ/1YFF$"3*0
M5"F]RK6*Y@^67&%JK09?_0AFE'<:\\:M@SA'C"XW'RA \*OCA[.K 4NVCFA+
M6+O3F-O"UVA2%(<I)%=!@N3>T5ABC2&IRG1I_'S=:<PMI*V!E&IH*7 #:(:(
M!!+5F!UZ&P..@+8[&FV>1K60CTRU^HK@:R7CQ0?,2>.UBVFWM+UC[0!GWTT.
MH9<X6J\YD@L.,<=D>H]W:%+REC2KW6G,;>%K+C;W XJQU @V>DH>0B\T+S6(
MLSA^ONXTYA;2MJ9B38X!R*MG]9&:+34U%9R08LY;63BTH]'::23D0R8#9,4"
MFEQ  ),SWI>LC-IMLAX%=38R!5YM12%FRCD NXHM"MID<\)H(V_! N!VEPUN
MA#1$+E<KDC0;@!"DQ%)=DEY[E:(/8VCHM?,W&^H%EVULXEE4X$!.I=CD,J%G
M]M(,;4G7S>WU-YN90S,N1Q,:Q=I 8NW9G25?<_;03',C(,T.RTL'4#1.J$!M
M(91^ #01I^HH%9]C#"&,(.79Q8X-';+ MA8;)%4P4$@HAVP]$,0&6-,8LN4;
M'3LVDQN#C\@%C+45FM2BG$DMQ-!BMMG1"$BSP_*RDJ#%JG'":^#0P$]&DU7G
M(5)T+F'P6Y*L;BAVS,\.[_(K/IZ=]A>N?7;YF\GL](CF)U3Y;-D'A*;M9+6_
MY;CQJTGE.CLYI>D?3WR/,J/V/H3LJK0651M)08<B$"-1*]#*&)B],:H-=Z'O
M9G/:23)$6%*Q .0YLVEHT%0KR6GRO^/TB!<#;S:U+076+#:"0(-D2@XFAFAC
ML#;JHS%,2.R$R-"9O9'I&>J'_$+*E<A"M:ZP04"?BHO<FAU#<?E0G?9.B&R(
MTYH9UNB9:J8"KCC*6'-![ZSX[%+><7HG1$9*;3*N6.:*OC=P<8V*^FB74;D>
M0TAC*E+?*8-A4PU2*1Q+,BP(-DG)+MKDV=D<2;".8")UIWF'SNS-K"LEY #6
M&*@"L2(V9G)&@I5FN(WA>*:AZH.=YMU403QC=):-JPW NT+.%V=J,D(2HXQA
M \=0.;W3O)NE=A%E-K%$:@YLW_O>.SCXF&-SO9_-CMH[JJU+&10O->7<2NS'
MX.7"0L$D1XDRBXQA66Z]FG>4L_75Q8C2O8:-H&!E2%)C+-B;G6X-BI\DLT:)
M7W;5<<S&]LR36B+HU>;!8_ 5A;=@>\OG2HI1PEB$O,VL2944B(6Q>F,:E):3
M8'-C6%H8EC/=S/$W[*AW"D13^LYPP&(JM<BU5)O<*&8<A^),-X-?P895[:T)
M0<DY$QK.L2]AVR VCA^_ZW:FF^E.(S50Z*>G%0?98;;-YY #H8V)_!C*6H?E
M3#=3G)Q"CWS))B_ 6;)QDMD4H@8FTY9LAK@69[J9TZU9O&F58EE)&BRV]Y_@
MU:8DJRGC^/&[;F>Z$1B;8,T&K0';5-O87,EK?IA:AIPT,&X QE&,FV\FB0Z3
M)V>AUI*+T5C45$M$YXV,X73L3O\[L^EB=CQIM-2G'J@EO)U^NYPL>Z1#HJ]-
M#R]GYZYQ87"[-Y(KBI M.K6V!"T4C8!%DT(;T:HGK6,XDG!'H(W*X%B<(!5J
MH0)Y7VRSJ=76HO>NU#%,[6UTF6O=S!VE%Z(B*;JDV:^I$*K1!#E#(6.J<-*X
M-@(OM"/1ICV10' AQ"2>!'P/:J%YXYOD6)TT\Z\'U^6 /F&X)E,=%!W:7YK1
MY2N?-@)GT\G%S^>3T^/9.?.[WW;"M#B;<V?<O;>O7=[C\J7+O_M-?GW"V 7/
MS=BL/Q>*RYE$O!>V*900Q?4AM6"=Q4$-J84^I!;_W)!^.%FG\BA*DI::4U*1
M^J08@0)WG:W)YHI4U^*0/H]4]J^0ZL.U.XX%()(I;$'04<N)D*.I33,/L"L.
MX.!&P.+:1B"E&)(X22J304S2Z$2Y*B-Z!W5*<<6!57(ZM*#48\-C7ER&I/<3
M0H_YU:1?\DB^TV&8?[<:C-MU-<?0PX0.5:-Y6_QPJC&%;[<79XOE.JL?WD7)
M>_\^TX&Z,SLYG4W?1\GW11(G)[/ID^6LOEQ_Q/J9M7R4N_\%KG B$-LR^F A
MJ:%H(NX@*CU:5B.R.ZY<%5=NMS;I\H>.OZ-)>S"]0Z>3)1V/A#>F2,N"DJQK
MH)Z6/*AO=0%S-F)]WO'FJGCSF)>D0KW=H_E4O]852.,K(4S : V%:%H L%;0
MV K(FGE'UU+<.9JK<S2UGIV<'>NU;34QWZ^;\U&_VRM^,*VSDRM8:;D:#C&[
MF$$T3#F5>+7/_I$^!8@5?'0C6#P9DJ#8_'( 6"A S=LB!"Z:;)D*1B1K.5\V
M?-@J0*\MZF\>7,G6.PB::N5^"@05A\D!IV#(-C.J5N6#"<V;1Y5-Q0*I2G &
MA+BL#H*U%-2"6_)C*$ 80_S</- .*U=P1K59 6\KF2HJ]ZUFC":'<C&3M WX
M7E_2OJX)GF"SFIOC[$(!FXFH!92JLKJUG-!O#32;R9'7!9/"8S3TY9+9@00L
M?6+.I1!"HZJYT-; =,TIZ=KF26U,J%J3$GD@&XIGI";2*D?$V+8&G\UG@&N;
MW!>))<=,R?63F#/6%*/-6>.3![37Z/DV-@(M)/%]5TL/R^Q+< 70H?."(LAC
M7'H>2@Z\F5;U&?OBG&"-!-5(1H^UVI:#)?W?&"J:AAK5-P\N1G52)7)(ZI^B
MRN9<F$*Q3?\;?:#M _>:<^#--+;)+L8 *3H1*.0PQ%K5='L=, J,84?,&!3$
MYH'NN&;BXEM)4!SF9L576S75JCF6='W5%&..L5=2YM$P^-3 Q-8+@:$4,8*9
MO0',R?EK+'39EFAY)3"YU:DMM1C?(OB4<_3-L297X S%MT5NVP#3M>; Z\/'
M"%#P.8CU!4)03+@R62N4:Y+2M@:?3>? ZX,L5IN0<L"$IB^K$&:32R *)&SJ
M&/;0#"DZ;;Z:O/H(ADVTH0FDWDD.2)Q3?0$MU1"W#]#-9( ; 5?52#5]GBHY
M! >LKM8E;BV:4B68L'W@7G,&N!F3#:CCBZ9J&@@BDDT4G\7UQB24O-\^5#>?
M 6[&?,5;SYX4P0KL,8NI'BTXC<&68KZ^31ICCK'KVCWR80:8LA/1\6H:/UN)
M:G<EB8^N&<*8M@>:362 ZX-)=8V"(UQ1$%IE%,ZY($4!J9>5PML T[5F@.O#
MATKL9RI;K#Y!:A&+1JWJ@G@TR=/VX+/I#'!]D &;XFV)ZN@:].Y,3EJSJDA"
MSL:7F[S]=)33S*C!*[908UVM!&H>KSZR>,G>. R-1J0FO^N->^;+\^^.E=NW
MIZV;Y JW;\Z?GI_RAQ;YS=E$[SH]U.LN'SY0FYR]6C'B+_<\6-7HT_20WY?L
M[T^FDY.SDZU4JJ#_-E6KAAM02(BU;U)OC!C4+[01D.C7 */7GP#8$.DY2A(%
MTB!BL&@XJ6"X%@C628[!>.PMM$= HC\%]3[5(PT_\_.?7[CS/Y^E(T,A7RW[
MP 4BU(RI%&>]R@\'N8YI2F28U/DD3SA*ZB!9=-57EH"0;".7!<@*6N\CT1BH
M\Z=M_6I(>?],<]#EV9SUPON3U_W15L:KEIN -'%4(PA%S,ZQ<P5)&EH9*W,V
M*'IN"G-LS7W3!'F,"31JJ0^JK@!7DXJX49TU_5GX]EF/LR7/G\QD^1/-^<%T
MJ>2;E&.^O5CP3O-\Y@EWP52'JG3 0O46@XTMB1%?73,P!O<S%A)ME?IYUP7K
M_!?MK\Z6\Z^>7;[MDQM?^5"3,6P\U 0^!"R474U80O/-I3HB(@YM1G S)U]D
MDZLD9$L(,=7B/%8.B5V4T-*89@3OJ_M?\L/)*VX?N8G%-^?[]&(VOW-,BX]7
M(]^>,/68CU<] A='D]/=?.#GK;OEUE)B(4R@^7?*+IK(E;(W)5/%$5#HZJ7Q
MM9%SE!22'(*7 +ZT C4P16^M=^)=7S*4,E(*K3<O_RP*:?3Z3L'0:/9P4O5.
MO%"I]93KT71V/#L\WT82%1.*Q-2":F,0#^1*=@:Q-FK@_5C.XAJ0'[J!)#*V
MN<*80[-^U=33A)PAY^JH]8[>(R#17PHY![->GW#*2[Y]..?=\NB?6-DJ!=$(
M>@J]=5A%U"2=^CFP-O:]#B-@T,#<T%_@YB@9E(PJ:!=,RR5 ,3;;S) LUZQN
MR=BQ,FB#:NCR34_GU/B 3K9SIKD9"@+)-58!Q+D5AMB,,@<HQC**'0 #]3S;
MS1NH/ED"(,ZJFM&KV&$JF7TVFHRE,:U0O#\E[.YDL9Q/REG/FS\$\]>ON:N)
M=C^+9AL!-A6L<\F)2 0H(=N D(&Q!&)T8S@8=30 ;Z2NDW+$9BVD4JV*3L!
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MB#$/UYJ&C]+Z;,EFGRJETIJ)@%2ST\>I9B(H-E/>3ENZT.N]*G]LXB\D+DY
MLZPB8!OFZAIA0L(2.+415'?_J1AUW8"MS\ *4V[DO.>4(#M0-^AM2:DZHWZP
MANTTL'UN$^J;.:]Z5G>-\:KDR'U?'ZY$>L',WK4LMF\MDS+@>/67+.O:D%KC
M9B1VGH@3 O;MZTUSWKYMUA"$0I7J=IK4JM*J\F+1FUC0O![=GK;K6CM98ZD<
M.-M;>29 '5/):&MLJ6\ M)$C#KBJ>ZS8K3&4]=[-M@0C#8&Y9(S6)2".?2>%
M&5.S@0$L36Y^W;\*@^V=(\0GT-2,F@I+!SDD=%&"&5&9UKKQ_.0/?C!M+']Z
MUN6$YB]7BP97. 6S^4HQ]LD'=1#)J\]/+9!+5@Q;])IFEK?]^\=1*;;CV8"+
MU5R1?GZPB.4*R1A*'$M/E3%$,J,ZXWO(R_V;=R@9 WCGDIB0H'F33?/! ,68
M6Y_$WU:@KWW!>0!01R?5A&9M"!#!9G+,31PX*D'M?%NAOMY5S\WC[ IK-FA+
MDE(!*Y=521U@:=F)<;3M.&^W LQ4O,685?5YD&0)DX^Q*HH-4&0$FZY^IUTD
M3R>S^<%LR8N[9ZR_PX]D*B9AH9R:;Z8FL!$RJ,W5XE,(#C"&X4[%?$8/S_[*
M@\7BC,?4I<+$P,R1(94 U1LT.9G&T3@,DF#<YK(!9-9G,QJ.4$QB1)6@M?E<
M*:%*$2G&5&,&7,GSQ\AT%_8=G9-&JSMG\_EXYI138##"!C03@%I2(;485MWH
MLU7+&4'=SF! 66-OJX:2O1/GC8->!.(*V< Y&!&BZ(=O*0]GT\/E=D7\?H!F
M"^JU$O:9W^)"\\F)Y^018,#%'I>8W-4?^XJ6JJT?K'H0K/*A;VDR?3A;J+K^
M+VZ'D^GASR= /EZ(441YL7RL0O;)3W0Z%N"X-$DYN19(L^"$(08/-D6??4P7
MP%DTT?BK!NZS1L#BGHE[QJ]A!%CS0/WIJDZ%P ;I1RQ;GP%"4EUT<:Z254Y;
M'"IU[\RY39:7APU\2,O'_&IV_*J?4_#!15?)3@N=G1;7@(WZ]XRF<JTU0Q:;
M&_CHK<W!8K(>AN]6!H;-7_,<9]/)!3!S=7+O1OR$:7$VYZ_/EO.ONO>[?//E
M\Y=_]W?_*LK>%0F<0BV]IU<VF7I--&6(%BC*VT,#K+O&59S/7Y6P[OI7)1P9
MR5ETB#2M-K9D8-5"FD!0;='(B&:V;M?*Q]QIU9X<T9P?\^G9O![USB1]='Y^
MDK5SMY\\?L++Y3%?P_+Y1B:UD# $4!>7;8)"M#JGN+?#:!5<!1X1L!^AN6KI
M1"<?XODQXML(J7,A45( HU4Q86OA ,X'J6BC;6\/8="$QJ3!(GE6%OSO,WW3
MO5?ZGU_IY?KA!5<:QOR>41C3&B1&M*Y:31Q]*[+J :6YI*W!@L.<,_J5K7FC
M46?O\L$.H4^R,]_MS+I/L;./+OTKE4<EM" J)%JS@,U0ZN?H6E=8D]%([:V=
M[5#\9#O[.3!_:=:&23"!JCM5];5KO6"D]\K+C6)M;^W,6[]W^6"'T*?:F=^S
M_A/M[.>7_@4[,^"84;K3[%N%:_$V5LG<NRH#5GH+IW-OX=0'.S@_%4X--9\*
MY\\O_0MP!J]Q$#@A&83@3 X@->?HFVJ52FU$A72K NH[LY/3.1_UU_J$7IV=
M\,-974W=?=3'=S;GR>'T8@:\GE].^&UC$1L:4VMHQ3%F32Y4VT05/*F58(OA
M)%N+\7<7;^\=UQ9W>ZTCMV]XJ@^VLK%>LBD[%Z6Y?HH$2?8UFU8TC32Q<801
M)8]C,.7-G*UL3(DF::Q-"2I0SBY":8)("GL=4YGB2$QY,XU0"S4-OEDH]IGP
M0LEDX>I(G_2<R_"GOY_2Z^]6O_=]F>ELL=2/2<.=Y?ZP32D16$N]C9&'/H-C
MH?B2Q;<$R;<X(DM3+"X6&N[0?'XNL_E/-'^/RWUN/*?C[C%7K\]>\?SN[$2=
MZ';95.D'THLATS1Q:='V5GV0DHYXH,)F!-4#CYD6LRF5XW.UI44O 7VB84]O
M6I7C=XYH>J@N](?IG.M,GW[#38%_ZR07WYP_6/+)Q\M0[;+COEXYFIXZF#Q5
M1*%<*D!));)"Z%-*!?MJ[?!K<T8-Y!KK>4PIJVV?7AJ J+,5X%I]T'0EAS2"
M=K2C!G)]W6N##JOS"*&Q@19J!])1]"I=,AH>P6$EMWM(_.4$T+V3T^/9.?.3
MY:R^?'3:D1F);5D,F@\B1B,,:"HZ\4@!P$ -Q8QI\\,FL=F\;&'?*(323/09
M.(5"KN5N82PN0Q[!,;D#L:TU"A#-P*#E8CTY:-YAEJ0Y>5,TI'@W@N+@CR#1
M+. Q+Y;S2>UE&!V/V].FZ9NF"B<TK;Q:IQ^+JFB!@G4IND (U)?>#7KB4GH6
MS::,U_-M"J;-.T'/UDB**7L/P-0*5*ZMGY$6?9,QS(<,!,HK\8?9 $9H3D-4
M!*":36Y9D8G!Y6CCF"8E^_QBWS+Y#J4/HM1WE\5,>M4VFED#Q]%0P(@(KE _
M:8N#.M2<JZ;6840+18,!<B-+01Z-E"+!^V8@9NBME(PM"JOM/;W=B-HJ#0;(
MC?13XE"$,F*MJV[L3#X'S)XQYU*#'5,:]YB7D_FJ<K>#]<M\X.[LA/MA2MOJ
M7'VRD5# 9,W!<V:LO>(BL\>2";B,R+D.",J-N%<#K'8(T1)6%3R0/>;@:G2"
MSFJR,2+W.B H-^)@$YNH8=$[,09J@FP5T-710 9;QFURL >SZ0_;F1V*I'Z.
M9(A<($9'"8RXEL"SLY1YBSSK=6"X$9<:(255IAE]]=!R(%$-:T'3>P^5JFR1
M2[T.##?B2V,11N>P]TT TX]T)>@?4)J5WN%B^+,TFXV&5],=V99J4K:B=@16
MM8H)/K>&KE'$!B-8FQL,*&L\;B8!0B-K5PO?34KD))F;*9K=$<CX+>6*G-R5
MF(@-T((IT8N.DL8?:L';9C/D(LBNC-]$KAZ-]=E&!0SJF7(T:B- ,?M M51+
M-7,$M&.H"AF(PUI?A4<T&:-@(P,62G&Y>%9L:C'!>&/B^$&Y>A-9'QK664F.
MC,U<H:+DHAZLB6DEIR)A3%V)/X3E@XG>.[0X^H:.^W+8AU?] 4HCL=/-Y\TY
M>Q]2961&U86--%N6()2]! 9K1ILWWU@:;:9'NDL^@HG!4#_@,O0&DQH4)%O7
M*K>V'=[HA__96C=@0')F%]$62,91:LQB3 N<(/@Q;0'=-'Z;V?<G*I63\QD3
M Q>;BVN:8%9#7@6S&\&TRUOW_.2(>?GKV[]6F\4N&EYOA]N^DD36]!V]7#TB
M,*3F<D-5B2[&#"GY,(+SYFXV$]9X/'C1?-E!MM$&$(0B'EF]>S!52@AM^#YA
M'?G:1F@W%&?@!%S!6,6DK(\$^V92*811Q;XE&KXSN*$46&/3=XP>G(TAD %/
MDLF54$K)F)%L&O"IEI^.RNU:YV?<'DZH]"::DS^LFAU?6%BC0 CJ_=4;I)*J
M9OP&<T@AU:KY/Y.8-GR?L"/$6CU$1DO-ZG\T P3C4RX0>X?=;&*IR#N=<.7L
M&XIKX)R]B+#S)@))Q*":P=:$,8+F$C!\UW"SF;#&#50I%".^]%)Q0'+D@K%%
MTT>346$;P8[#3]1RVQPBUN<80+.%C&@(B/1AT"RR>I;>;S,2NZW0#%M/A_5Y
MATB25$,2^QRA=WY$E0LQ.<TS+:,?P6SCP.+$9W)O.&Y!F5"<I+[%*+1&R5I)
M-7OK$$L:P5SC3>;!&LMUD$UNQD%4W9@K%Y#0K$F^BNL=14>[^O=+0MRL'G3>
ME*R)(&O$3] H8/4A^9);4CLG":,%]LGI;+J8S7^WE^1UU@?<,%II5N&P3T2"
M Q>P1$;DB(PM.9$19!<?8M1A^^:\_W<U-7Q'A^5P-E?__=%!ZK0XNCUM_7_W
M_GTV>47'_,?'+G_R5[I/D_D_Z?B,OSE_]_"_]$?2O!Z=/^17?/P1RR\O>C ]
M/5LN5E?8K1.]:RRB=]!:)I?8^[[;KS3G7$ZUMI"<22,XH_-/,V3_XC"G=GMY
MP,L5Q5=/?\?S58^*=9'F3QE5MZ3E^?VS:=N^C&V-Y>WH,GK*T9*![!HU!('@
M!6NTGN*.O-=*WN.CBR,CIROU0<=W^_>?G7+;4?BWEREB<APH<O8-#%6LC-'&
MZILF&9I\#I_"?\J_/68ZOJ>#MN2U^KBAF],6$CB!1Q(0VSQ!1%=,##[[''U6
M72&C.";W\WS<#XO[D]?<+GJZ[Y@[6N9*AA+)"%I!B(T+5N>S#2WUW=J%AL_<
M'6FN/UXW\154<S9-\PWF#&A:J9Y#U$2*1T"::YT<OJ$S"D-A:[!L;0P4'$7(
MV(IK%L%)B=D5+G;'UK53PV_4=!Y.A-5T;D^G??[@P52]?%^<^6X^Z^W7'^H-
M1\)<BBE7R;Y$B0!64_O>E*IEUIS(EF:&S]R;C9]Q$0)CP&H25"_H61-<KY!A
ML,F.8#)\N'%2<Y#]L^49'6]#[CP4PA8?HVLF ',#\5P"DU3#J/S-T8S X:Q%
MV#CU/G\4PH8"F<MDJ03?0D_@-&=C%T.-8)UMTG@$O69NN,UI//!)LW!-MB,D
MQ;*XHD@&5WTI+9KA5]K<T/QF?#, :]QZU+*$P! E"5!#*HQD,=H:8FH^#I^T
M0Y\VVJV87AEYT=KF,!<'O9-AH=RWSV*LMA]GKD_MR'O=2OZ&K)BNC\(4O.=:
M63A5<"XB6".U]#W!/DD90=O'W8KIC2:PL0FEEZ=0LF YDHO%.OW'4G1%9,L(
MO%LQW1KF,JKXK:Q)FT$P+A2@0%%S-2XNQ3@"U[LCS?63AH)E+)59*FBJA)A3
M-5 @B<O$8?BD&>Y,\/;,* R%K;79D)D=N(00O*/$E$H+$%("FT>P)W2W8CJF
M%;<UGHLLJ7BRY 0C8';HHDO>^-1[KT/9^=G=BMNP"&L0JV$VN3J$5BQ64#E@
MG"_)M53J\ D[DA6W-3;5\>"M 38D%L2:3$8*)RA<*=2PFSX<.H#(-25;*]CH
M(6% $X6MSVQKMHW<S>AVOY,WUR5OUG<R0$E5O'5<A3W$4K-QP1KT+F7CBW.C
M[>6\H_  *;SYWM=5^1TJ&O78 B:ZPNJD6:#OR^W+'Z-M4K#C^]#YOI'N"="/
M9Z^0R/L(#:5X-MYRDR*%BOCA%W/]A;*%)US/YMO9GVN-%9K2:JNF.D$ I[[1
M%M8XCTE*R973\!DRW F./TG'H5"#'&@BBK;U75D^6DI]LTO!T%O]B"W#I\:?
M0NLNE^7.=7S*O$6*_=2>+&[5^U-*%4,(AKFB;Q"&SX_ANX[/(N-0B$%&^L&8
MQO2>C^@3%B<48[$6);<X@FTJ?PJK?])\0N68WVK,G>?X[::@Z-BF2"G:!#E!
M/X:=2@ZMQ&IK&,&VD.%[CL]CXU"8(<&5I!P EQNPY^*)!-FG "FK+AT^,X94
MA[B%KJ-@*@E\HHH-;)^S= +<; [!8LT[UW'M;!P*,V*VWOO8ST9G<(FR,1!,
M\=EYCH5'<'K-GP)KU0?XP?25&O+).NN3MM!W-",<?77)5X)6@7(V4EDTP-AB
M8 2=[8;O.SZ3CD.AAJ &%AMRY.K[V;194Q5-9 N3S0G'</3539J9JL89]A D
M6.@;DXFIV6:3M)0-RH!5XF*^_.HQ30_?VFW_<Y]>3T[.3L8T0WF3@P@34(N"
M8%H XVWQ#E)R4FLM@GXW8?[;1)],QT;TH9!.DV$#E<1&"N!JR%R+ P2"WLRG
M[93+-GG7H9!.6L9J@8HM%6PN&+)+&/M6?1(7MW7Q^&>[ZD8'641K!1B,9C7
MII& *J688DLJ;.V &RD.U'1WBX&?ON;C-7VJ24(#)YI9MR8-HD8J)TK*X3)O
M/+GU>LGXIQ7:4"CG:[-DJHB0 V)?C"GLJ51#$='#CG);XUF'0KD$'A*'SK@"
MUA?$VB#$(%YS/PX#/LUPH/G87R[+O,DQM^;@0VE8U/F!,I$2H GBC+!@,KMI
ML!T;KW-EECB#DC&TZ" Y*,T5GQ-6,*$WQAXN&S<>CK?!$0^%AAB<#=9&8V.
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M/NM1K4D,%#W%4%"VSO5>(Z ;<;NB+K90,]%(A)H)<T,@UGRO-C');)W;O49
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MU++7:#BM3M"T&PQK*[H=W^YWFQV;>6W>X6W?[SCMK3<?_OT3Q?<YJF=5XR'
MUK/Q>3PPGWQH_N<)^1SVRNGW.V&/->QFSP,?SVV&MA?Z;;OA=OP.:W:[S68/
MS!.0EO,TNQ0*7)?=?#V(>9] U!-R\P85-\\Z3!/^Q+W<_21 >!.WO*GE#SDL
M+OB5EU8DWM+ M4>YQ:QK'L?V99)>PS@YR^'U _@BGV#(CN56P,,H$;#WDPGX
M(JU&>T'1%DQ=_?%+?C[#4/^#(SV5 ]VG<3Y)+?%=<9PV['&7MQI^8/>:#K=;
MS.G WUS7#F&+=]Q6N^_UW*TWYSR?"^'\[__[/Q!RZW_-VK/_JULSD(KUE_PD
M+>"3_TXBU V@$JA\350MYO<M6R2QATF>F<W'WPF?TGB2%"RC*K@L?W8[8-#\
MJPG.28O[#3MTNBV[U?3 76EY;=OW A^[:;L]A%\<IHLVP'J+^_60$WYX1N9?
M."^M(6AT%/3 8G&LI=W<!AZ7/X![?GO!KA7 M\F ?CK.N,\IS..X%GB,Q3"W
M7L#]P.RS\HD_M/)ABJ54JD2V&+)B=NS7+)_?K'2Q?(>7<%@E@?7"%>\(.PE6
M8^)=P!O@[^FG<!&.0MZ'.!5I$#1(EA=6OV$%;)K7S<W\Z%MY9Y)E,!11#H_N
M7<&*R?/;T3[LZ##H=-M]<,[\-K-;[7;3[K4[S&:MENL[O.]SWG_(F?:L=C=*
M/0C\*"H*V"(\!L'/T@0=RGAJ<7 NI]8^)H>93WGX758PZYTX\BJ;O[R'>0::
MIM\)'TQB@9X_M<^L%SC=W=>6VW3KVCB,J$!RC 62CZT*Q(#U#N?YRY]@B1I3
MB3,I]_"SV[2#Z[^8WX'M&3"[V0S;=@N99#V?-VS/:W=#O\59@'7#W[%I%^39
MN@LC*$]BFY++%<.K<(OY/FS3C.%>0\%%?RM9^"G8JHF]\(M\!/L;GI*ITP-D
M?023,*WAB0VW@V,.IVU@#;+TNABJK^MP@',:&_EW1%%!F)U__*T'PO]ZV0CI
M:^>U^ME7?[!T?/)WXM26/UXR5G5+Y8$ZKF>[R@XQC8][R<[3RM&V6O7V/=E1
M'Y1,A;NV?WS9S>,,UH7)N]]@OSWQ^VQR""5W2K8#VW:09M,% 5CZ$6UH7_[H
M:<=B+SY>P[];1[MO860'UX>[,5P?7QZ>G;>HMG7TY^WA[1_#<WV-CL5&AV=O
MXZ/=0>O@_>'%P>UVX^CSI\NCSW\ZAQ?#RW-XUR^[!\V#T;OAT>):GTZOY_&@
MV; ;8=A$O$W'[GFN;_=;[9#W&*R/P[?>?%BL;K\#+_T@&5\M,.&""I^?S88F
MAR!Y"\U#91U0%]OS<O8]<K5J(%K-C/9#JL-6:^D.%QF"Z[]\3WS53I=9P;]\
MY7ZLQGQTNX4F4C5I64?JR)]JKRPJ=P%;I=-O=$([#-I]NQ5Z/9NU6PT[[+K]
ML-OI]<.@^57RR8>HW <4=JU3!?/>8E]WHQ >IA#4-+ZG6=P1D[A1#-^I&*8+
M%$/+[W#/\SLV9QQ!)6W'[GMMW^YQUV\'CM/R.MT'*(:E(!(C5./2;K]'R%YU
MB.K7,1PS3@7EZJN,8YCZBL^UC"H#/Q3#:927,"]/XTFQ_)(5\(\HZN@L:K<D
M_AQFI:H8<-O+.+NT60AC?<7B:S;-MW[?]-CZ86-9I1Y;U1#YKXJ'A\N"SE@"
M>$]\!F:S*(<%/@X"-8K4FN0B8 T31"3UB\B5TXR>%4_QX=<1/!H>:R7P8BE:
MWU=13CY3PA(?CSGPI)#M$'^,[>X"E@6YA<0 4; ,+]9\P5XNC#U;_VM9__?L
M,HX22Z#8OF&&,)[/BH(CR0+.&$P>TJ7"V$ 98<[]M]QB>0[V._Y#326'O4/9
MM$36#N,U$<I_ NN$=D.6QE8*EHVQ?*4[1=M1+U*KT3**MTY9YC&XK7UT$_,I
M@11>.&WK8_T4^P!UW0Y6>KW$5R[?3^(%O1B,%D-(PB@;B9SD&)[-\$<@5P26
M"VC$;!)$A1R7PIA\_Y^611BC1S2F]OTPV\:QI]EVN7;O8C981UOJNS*>T[]\
M\)"8[[7L3C]H@244@HODMYMVF_-VK],*.'<:2[N>+,AX+EOVA^N+]=0SE#+-
MASR.U4%BO5@ 3*VD!6&7OY032_"\=6VK(<,B.#EK[/Q\%Z[(_0M[$0?]1M/N
M-GI8\QST;,]I(OU:P,)&WP_[O+6B#3506_R_.T 1*[.EO_&P6_T7VR9SY(])
MPL6(FPW1#*E&>H8-!J"I4)6A!N.%*'Y36L@7%7(Y%5C 'B50)6$Y0L0BPF6Y
M^ND,P(F-P0R]B6 ?\WAJ_5UJD'<$.8([3I)(Z(])'FQ5%4JCY3'0&U[?:_C@
MD[L>,NYVW68(_DC?:8ENW&ZCTVQL@0KUX1%Q_J\MNS>O58[)_GD7IZS:I>=5
M,AG904K^$%Z^96'[*+BT_[R4R_1H][SY%P.=TNEUNW:CSWIV"W2W[35Z';O?
MZ?1:#;?/./.WWKB-NJLTBUK%-Y87Q7&$+2D]AHX)6LLH-7&:H[4Y!O5#1<,$
M;0N(&GA66! ;XW1?YU51DS=:4N&S-KA(?$?9;P8F)A^"00[[:5*0+X<SJ.KF
MYZ8-?!"JI1?[SYP[JGF1OX]Q@Z*MC^OE$V((5^&5M70[BC',[,AF$+9\WN?=
MON^VO%ZSYSF=7H^';=B2>/[0CFS"INQ6=F1[ 528!DJK>4I/.BI?]GY;M/.\
MMNCMP=EV\R_'X:VNZ[IVT P"NQ6T VRHY=@MI]N'_X9A$/*M-[U>O3V_14=B
MBRKI$L+QCGO9A&53<2*X73H1FM^_KWYIB]S=HYV/!WN'9Z?6_J'J[;*W:[T]
MMT[VWNV=[!WN[#W@!1^_DUQ>]J[@P=LIW!N\]L3G9_"@MS%LD6<FZN";MO\*
MP MJMWIMFX%9:[<:?<_NAZQO][Q6+V1!J]WL-+<L#MI@C**73?C2\/:O5?(?
M0%.#R91Q$=JA-I4I^##7J-<#)0(8.8P,,4#[*E."0*$HO/"893K0] Z4I-BV
MV+@70TRI).4@,*R\,?J<YGWOQ?[37"54\C%&QB2F%]_L9-YD.$P+,C!"U0SU
M@',*<^&\'8/Y.;6(2I4FQ*P,2E(Z&G%5&);0-L2$8NF,L4BJ?:@TFQUE-H,>
MO6/-:$%HP?;W]V<TZJQG]@W+\(VZ^/[MF7_0TQ]TW3-,?[G+TU\X6E+\]TG(
M;%)FSSQEMAK6UUT+)R=@W2H;'*?>:79_>+% MU-OMG\\J5VOWG7NU^%D79"F
M"UHL;-YHY8C$C]F SX-KGJ/X/2)+],K/S(^'6CZT?.2G6SN-%;)V[A[+_:T=
M3!N?3D9P#$_1*SM 'POSD"=1?IG/FT"K406T6>"'+7!KR4+^^CW\ZQ9_T=GV
MJQ;_@6-YP.)W\+C&P,8W;>7*PJ_+*;]?\)'EU!_+RMP<3#](=/O8QTI4W6S.
MH?583Z?Q?0?1$]$MVQOELN+"V&UNO4$+UWK'_"+--@IF3=:TV7X6"N;M1L&L
MNC""X?TQR7B>QE<\P)QF&%H(I<$,\D;;K,<"MY^%.>-NE,VJRR*8UL=9.L8Y
MYAOMLB8KVG:>@W9I;K3+BLLB<KI_X ,6(S[+YT2ENE$R:[*P;?<Y*)G61LFL
MNBRVM]X<P"76*0MY,;5VHQQ+4B;9QIY9E^5=>U6S02\]R3?:B-_*Z\AGD:OO
M]52N_MN2]4]10-=E[Y&5V=Y8F2MNAO0=L#)%S3S2-IV8M;FRL^S>?R=1,:W!
M=S$5"E'AZS"-L2#L #F&LEST#Q!MX*SC2>8/F2SJ%1<;?8HVMNMZ"$V[N>:V
M*RFPSD:!K;HLMK#1J.2H>Z=)R; =T$;5K,?RMK\3K/LT5$UWHVI671:[:"L9
M!(H8DIOD>23Y%K<3%D_S2'!3:$VTDR:!H,?$WYSP?!(7]).C,1>#V=A$:R(<
MST11;<"<JRZ,3J._]>9/9,V-"B(?(-T#'\3JWT8VP=KVTDEA22\0,: ;?;0F
M(M!Y%N#/WD8?K;HP.N[6F](DTGPV.>FET\EX'-._L>1RX[FMT9H_#P74WRB@
ME1?&]M:;'>+=1$HQ4CM@ K%!QJ4BHC8%VX)DGN$'X+!MEYSS>($17=+6TT93
MK8EP=#K/0E-M?+?5E\8>J*J46FWDB@30Y\$&^+5&Z_M,M,VF*F_EI=%UMMX<
M4;^/_4105\.M-GIF35;VF>B9G8V>67EI;&V]*=TF!!JQC+H#O$LS>%9B_3')
MHCR(?,&73.V]CC-^A:S'^TD^%DW%-A;0NLC"VFNF9X$47[\WVHC?RBO)9X%]
M=]RN!K]OT.]/[=4$*4UC8Y:NNBG2;*!9FG'BO*I9>S?<GQ! XB@,(Y]G(@*W
MH]ID6.^Q^2VF 3:1_W59_DYWS2U1H8PV_)ZK+XW-K3>E!L).LCS)-P&Y=5K>
M9Z)L-@Q9JR^-'2R<H;*\J75TG8"M,XS&"$S?@7EG46*]Y0D'(P@!#^)[LH5*
M!+P$M"^M"MPHK341DV>BM#;$6ZLOC?VM-TH]D>;!G "HK;RBB\XR&*9H'2M+
MDY6+9V$;+["J K[QX-9'(IZ)?MIP=JV\-+9<Y!V-$C\:@]54PDFM=YQ+L#O/
MKB)_ ^5:F^5>>^7S+-)^Z_=&&_%;>27Y/!*9K;9*9'[:Y#&?V*L)PW-#X[7Z
MED@/4P?#R(MD4>6":DOKU!_R8!)OC,^U6?).;\V-3Z& -C1<*R^-;6?KS;LT
M0]2+_1]+]L_=Z)DU6=GNG9TW?B^8%W/UN;$D<BRM?KT-PQVG.1$AO<HH<GO%
M7U]'03&4.]V\SDN+(AV]:I27,"]/XTFQ_)('K/YC*2P7Q]2<F23CSV%6BOJ
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M@BGN#[E."=R]D23_[5Q%\T,K7>\#LUISP^L#'Y0U2.NR U?0TMJ6HJ@BL'"
M:#$U[(B1!%E\4VAC?</\JYAM-T[O2IF^8-&IE0:U81N2"TL\HQ-1;@$*" Q>
M%6(C11IBU0@;("=D@;E5^#FE5Y<DBNZ\X]=QBVLC(BMXZAIPGH+=+(YA:@HC
M,VF.YQO(U-!$V%1*U2H)GA);K#+W=T%/2\;[F:3HVDC"JN6@]ZNY9]0;%0X@
M57A:!L.U^87:P_?3+"BCXNK7$XJ>$VN19#LO)0M3/%2@R+) TG95L4$>-\M2
M3=&27,N9SO[=(1=?!;RN-D9YY^C3_J[M]*UCF"F.%6SKL@-6T/XYHWX)@Q1]
M7SWQ8S7Q0Y9+AK8J;_@50LPD%6C92T#62^C"0Y.88#8[_M"2W)EBCU*C#B<P
M,:J4<I:9V4!K1(MAT)*L3"",P6[#D)-H!T&(S7&&318HC):C8O!Y="68FTK@
M!XBM1V1W 6Q[^/6F#,\0^?;R,KP']-QJZIY;F]J]YUJ[MS*'UKNCD\_;)[OV
MAZ.C_^P?OK=.S[;/]@[V#L].YU[\[H9S2U^LVC.M36+[B_;O_J(./E739<0N
ME;X5@%9X/IWE^/]H*>L, /V4<KQ@RTCZ_A".D61 #-.HYD$7"@P#.5U1#FHV
M)QO9FQH/5/S7M;O:S(!JAY,I6=80J=*-2IA\9,U5#QJC+!#.PFMPZ?#_J;N9
MIG@K^=CJUBF<"=* O[L)#BE]FB<)UY4M Q2HS"\JSD%"9XS@H(O*/@H3@9:=
M?<XUF*:Y<%5@M+)WE8=]I6"0LF]537TNGC;W,:S<[$?741S/?B:Z0\U]ROGE
MW!WI1+V)1M2V:/9+4>DS=PV6,\V/&'8)WJ7\(M4=NLIF1+I!E_3E5#,2L3P8
MI1?3I''%1(LE"-T$\PL%-V%-<1[O6,I\#(>0Z#K%M/<F=L&03ZDUU0B, X'"
MSRHF/C9N2R?YLJYM):I:N0DQBT:Y8*[(D*E"9+G"$(EZM51@HATQYD@1%XK_
MW;%)\&&Z<Y-UC"A!$,Q3W6S+^E#&P4XXN48:^=UOU_$?PNFY=\.HLB#,;!T5
M3+CH9I=,1AY<BW)==L6IMBS#NTCMP(T>4!;^$548L.5K2>E8VM%2R0KSTBM%
MYFA>N*CQ6RZG?V'7MYIYDSG=0_)VMP:LS:E \C,7*4']MJ^^YA-^>\ECT_F%
MCI.S,HZ3V\))6-P!0FS6$KH^5RLVP_0B2L'P>LR'Z[(NK8_DP9#1GJO6-!@-
M*T3NQ7HA&@$L#EK)#6>.Y66-")#+@C4L)I%-(Q;D127F!VX@L=*9P!,7W+B%
MG\I#%:E)7_#ZH*[Q/^6/%/])_M*@HZG0W<S.HYXB0DI7J'*JA#@ES$QQ0L^F
M=E6$+BRG\ECJ4?C%MN[TH\I/E*9S&T[+>G&\?;#]\O6:[C%WQ?;8725RM46
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M@FAIAF >K-GR*Y&E!&43C6/CX[5=YE6+XFN2JIE:-=#TF0A>CR)9U"QWN\G
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MWZ@(-I)Z"(I25'SC>0;H*IWM3%RO]+CGC2OK1?1RMCVOSOX("UT3K(BETKV
M,7<FFAR\AKO ;6;R-0M@K" (@M-MML43:%T[S#@7L >=8U3K2P]8^@3I(N!%
M.KMD=N20'.<YWN5*W$0ET<1C0)C22>*7?&H<-[,_7?"JR_)N^D@7F#>8]V$T
M1LG5^ _==:I""R*#;_$4!G>%*Z'W001S53)41+G. ,M\/18ZX#:@2(H,LE37
MY&I^QH9,UKR_0R2YTZ#>IYIH7+=0%D_%SMC(AQ%&L;ES3_=VK(#[,<NX0;Z
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M+U4*8-GJEA*RJ$UF-=IO\P1M\<"(^F,0RUB73L,:(08'\PP2FPM["%<*BV[
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MF&CM)*!\N )_=UJU7K=3[RE=5D,ZY0G!<5B6T!JB=L-&2EQ<T*SWNT+JARS
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M%Z?HMZ%NI;WKQ5/%'T0CH724X#-&W4S$AM@3#C=8EA+X!ZX((]3$J%]KN-W
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MJ)PE/"5YQ@>-]U;P8CVU,^4J3YG*(VE, H(()Q$(EC+2(+9J$"R98'RCQCM
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M34B6;]3/!Y 9&K/><ZOU383':VES+JG5628IXT0(4ZA$%#)E>9YEV1 >?SO
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M^#O.KY/@E@)VG?G/+Q>!8ZI124._/PX3^H^A;+G3JP79CZ)?B;0/N4&SZA2
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M2<&M]ZJ4: 8WJYG 8N;*!7GN?1XO"<D@Z'0"@(XF+AYFQ_^,SKP6DJT#VI$
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M&OQT9KJF@@*F>;KF>8Y6=T+97/P)UF:F1_/C'>P>/'9_<D6)?$?5[J[Z$CZ
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M]UT@7><RW\$A@.62F.=S958 <SBH:X4YE,AU->D5Z>\:IK\"D,.6!.V1G"<
MKF>R7;*V<'[EVL+%QO2W6Q#P"JP"OYA@@WGA2RW?V=+!;L3+%TO>#_VQ':V
MZ+*8F3N[] LO[F]"8C/:KF!Z<$.=5*>^Y'CM"I:[&N*A'P):]Y;[TK9M:Y7?
MJI'//L <0\Q:<%ZPIN-XKQ9YZ.3@(P+]G];'_F?M6R'.X>6C<S.;S>1D7)T9
MLY+>;&F69%E>V%18FC+"DTRG<:HMRU5B=?SWLTT%%>(FJ5F;\H<G+H;KP)5@
M?VZ?A/=<LJ)-?,L9SP=ED_'\YGA_[X^S_</?/^R_??3AS=O?T^=[BCX__.7M
M_M,GY/7;G\>O#W\^?G.HSM8J^TZ>G!X</OMPL/?D;'_OE\D!?._@XU&V_]?^
MZ>O#/\O]IW\>[S_]!=[[;[M_^#I^?O@L.?B(V=3ODOW3OQDQ*5=I%J5%;")*
M.(N$H&D4LR+-<RD9D0G63=@!.E^O]-N<:^V[-"*C#)U!?,^:Y<1$I)LSE]CJ
MFA\WO0OF&RBUUYH3^'CUONGR'#HYM&3O!-U.QX7'84KN;C1=2G9:<W0=POI6
MG,)M8BQ\V97]5V.L1AKZD5H7K^6H#^\'+.()!M,TEO7&[_C>]#)BW5N$OT_8
MT <C]MN-*FL0U[W"&)J.-V.M[D&XDDTC&NQ7;7Q7YGG=ERE#YY4=-QGO3RM]
M)W,U7M3NQT9%B_S--T%%**?_692^/4>##7>WJ=,56<A?U>P=["#0T)Z9-+TA
MSA?MMGWUEVVGVE)7O?#&!]_%L\:^/$A7-<Q=E%/7!F:U.^Y.$SFVT^^3*USO
M31#27 8U&E-#%X_Z73G&WL$AP.*TV7"X0NUM0##PG_N$%B!K%VOIS"1%\5T_
M[,)S>Y $M=@9$>(^P^"+]I<F*@._L.^L;J,GH@YM/AY9T-F$_]D__AN&XXP>
M3;##B-@=/;<;;^'J['=&C+E\<+.T"-=_'72Y$!1"DN_<GS'RQ_UY=Y3NINY[
M@:6?^P)$B#!VTY9#]'%& MW!OCL-LNL*M^>.T?GDIFTZ>=/^J.E4 W<#S0K'
MOEV'F;XO9]74&Y :00.M"N/087QQ@H?O5XNTT4TQ]%MQ/<$0'O$3.+F["QZ?
MO#Z]IM.P&[Z+A37C>4N].[X]3VA6;?12_R2W7]A;V'4<6PKB==G\JFFATMTK
MQQ7<>>'A8BL5$WJ(51*N*#"I>N<2M-2:[N193U C\7=M6]9J(LMIVXC+=U56
M39,;SW-]6^J6WAMOL9NVKP@0A,*)>%O-0L/#,#<0$('>PBVIJ\7,62F;$:8N
M3GKF;%1NL?U!AQ:M/2),XJ&2P7;,9:LK&6QQBU8Q6=(< 2PPXJ 'BN44M,NY
MYSTNC]4W-@RXX/J5N2(-KLU=K_N[D]R-\8WI6MXW-4;7O89=_=;O7;,[NYBY
M0/D@9]0AB!#T[>H466GHB(5S-M.ZLU#][!M9UKNA-]9]Y7P.IZN%W]O'S_]\
MMA<1/L+ $,P\\+)6'_4[+G%Z7(UTY7J1N<!:QP,[K0Q.;^*<3[#SH+7X?N/X
M<W54ALYM3JI ?CBIL,P-4D_9N.;A!=CX/9@RNM=VNDX;CN2R='9&M<#@S_"+
MU^YF)]6LT2Q[<4SN&>Q/CETW70_X;E5 E O7\-R5"8+-G!N_O%!P:+EO(NJ$
MJNU1N$3L7=>XWI:5N*+*=X=SP_H^C7[]._V>JXVG!PBIPK9U36-2?-1/J-?H
M>-EDL])]SV*/XB#KPR+<=\>5ZDB]/U ("JJ#$:H:>S$BM$J=8_I28/)+L4DX
M#/8.]-<W2#5W]LI<4=/<PW"[VJ42PC8\\UKY!>Z>;5_^90R6_\3FEKALT(>"
M4!IP'&ZP<G)HY72*\PP]#L\#6OC;VEQKA^L7$;3OV-GL^9H!1@2+9VL>Z9KR
MNH;+KJNW;]3H+:!G.Z,NW;A1?5'9G8/2Y^]+3Y7Z3!WHEIP*ZQ4JBV7;2+N/
M+V:5!3S\X?QKNS73?XI=T6<[HR?S8U!EVOB'ET*=[R4X=_*;Q+ +#W4;ML%=
MQ:?^WG6'"2K@11Y DR:&W(RKRL_GR<'>DY=7.X%R<C2J9^I_'XR/V^+*?Q^1
MW;<G1P] X9YO_F!92R0I.?GP.46Z<D9//J#J]"U0B[.PW4-:2<ZCE60CK239
M0"O73"OQS14N<[-Y^>CQD]%_B\G)CZ,GA[\>/'O\[/#U=5!.>A[EI%^)<NZT
M(-B7SXX%B%VC<^3@T<,]=WC/L' +JF-'V*,;Y#&#HE5P!8#:8T)O^YDZ=KV_
M05<2,V>-=14:?F@\?Z%#0Y#MQBZROCXN@3J"]Z*QLP97A_NUD58;*?6D/#&X
M)E^!!FVH\]"8OB?J^2P)EUO?CQ;J*X#>R^;D30PW1X>X\X2N&F[#%C0[<(9B
M,NBX<+*H/=5=TW"<Q=L*5= S[[ LI]X+,^UL&>9]-7YO5H3<SB8,(]6@8CN[
MO=];XV,'7 _OLRE0@ZJ;FKOKSIM?T=OC U7A&>\)7HI&W.1%:=;7GFO3^;V3
MW9WR:ZO:!<9Z6W4W^_ZNN[,+)5M,V-L0V!!L Y<,1$WS3]^A",.XAJ@M%]!&
M/9QXO[>CQM9M(##8 PE+E=6B'LD2:!9(V=^NH%]U!-T+,JG-V$8"@_*<T0[K
M7,,]=&88'*2)-FF&.(5Q9Y5S*Z)1JG4=>NL+<6H;D%&UY,O[)[K+*TP3#FC@
M]8'.'9)C= .@U'M?<GML&O]-NX3&[(),H+V]WN.C3?#5!7G[5S$3OEY0[^N5
MCX<H7!Q%IXR>;S8<"/7+";4S DQ"Q&Y]#(3F(CUG #/CQC%GIB4@^1)QF!H#
M"LOZN*F2TB#8R1AF.0IFAJ8WT!@YR_F'^2VZJ\C@KMJ.N6R3NVI M2]'M0E\
M"\-MT$(:<K"7>5V#5$*_+VNL2X,1>*H<[S227_B6&'EYM?%YP9\"!"*_PB X
M$"LEL-F=D.F (Z)CP.<'[P '1H\- )-#L8&9W>BQ"Q_1BA4TIR&!I-O[($TW
MGC$QPLZ.J,[L!;5FO_U2(TFY;\R,,N7[(.P\K<9ZY)(G&F\HGO51Y4L%_(QE
M6!Z%\$OXO!L1B"64IVA?]UN@(^<<PI%^=C'^4Q".0#I[ZG+7@\@V4,U-4DWC
M3-1MS8:Z=\]!*UXJ!M<Z0E"Q/:TFJ%U-&_&HEQ;32,-XLJ'B XCVNI6$=MJ(
M,\"6R@6@@:XP;O+4_-#_1*5Q,BF#&OW!J,7<*ZKXWC##R_K5,6UTH)?KI)>@
M^#M_;Q/)W,1M KP$)Z^[RO7HX9.73^OO=T?X'Q=@,?819XVB,WH/4BL("TUQ
M0GP$-,!J-D=7^"R,YOA.L  XUA2I8$8)E<]])R(#BN9BA@V7,$K#F2UVVI9!
M"H:&KR^U>?+U'($IXC)Z4\(DW65'XK0Z=<8JMTV8OO"?A?&+<HH"B7,<Z,0E
M3\#-(%D7W;[CPDP0#Y<B[=+8.=/'W?<<)B+RP79A.R08WK^SO0'U":RS\M?3
M/;VLH#A;%JSI"I;C.W0U+I*JM_72F+&1L]86HDN$6E>JU9NE:B]YS<LYEECW
M-74P]U-BA KRTS:DL@FT.0/AJ]^J2C1Q2'N@'>$[_L!- 175A?R&$"0,> F5
MZC#L>!H WE&NOYC>&.E.?=*:_QX_>3YZY.X63*L-GXK&KJ1,)V!4;>Y%JU;#
M5?S/HK'GEJT]-P@/:.4#95G=X92"2QNXT2R%.4G.M/7+\Y>'?QP\N1$JS9T%
MX=-DNF9BP!V-W':ME5,0M6FN%RGH+=ZN!S^!D'$D/L*?03AP[=M^ W4%Z?VO
M4 ]POW)2Z*1$,\[C)G5G!Q-W&M-SD#7&^$V7@XT%L"HTC8= _"7KG0M"Q$=^
MJ6;2A+>.5][J9-_ _&9U.^K\N)RY)*&Z06Y_;WLE&U9';M:S843<PJ<SH1>H
M8.V.GFV*)W/F3X#&HZG+LFB75UH?C[\T$>\W<&]Z@?<0:1.==NYKOSW]^?#W
M_S=ZTE:("/6]:A>< S/TW?'\5?9)IB^]T?\Q,%(!A /K FAVJ =;]+@-IFN&
M'#E;@N>O[D?T:;@V?LUW8!YF@@>ZE$1?+V;OS5E3YQ]Y>C7MQ>J=5.-2E2&.
MY\1EHBD7E^=;GL :P]):_$&4<C/Z1H#(T;5'HXLH8*^LF^"KSA<7VB7V/EL^
M3L^XIHY"8/KUJ3'OFKL:,FF:6PHR(LHQ)8;\/>Y:(][_,SANSJ"<A%0:5+^<
M>!K\?R$JV1>!Z3D0I9G#ADY7@M4ZQ<M=IKIU<_7LV$V,774Z'6%J21-R.L,T
M7E#K@^8U/FO%[^K$3!MW22]ZUJ5C-$X]APD@@<+J71G5;EY *N\Q2Z->2>#$
M6RT44DXKYL )>I=.?W9NY%Y2)&J9F.#4A6_C5GD8]-V.UL$P2"=(YJ,_49AO
M3&&MFO+*0<EN0XKH9 3!K+-Z..%ZZL?/?#/0-G*W.P)O)<OI2B9K5Z^G[5LJ
MSU:RPJ1!1,/V 6UV:7!\39H\6:]#>[VXFLI*S'RV31L]ZX@%6Y\NGU)7X=:9
M\D(1]T 'QPZP.[W*:5I!+1?P]W*"*:PP*Q?)(4,L>W@,IPI$<]+/^,%JN7-'
MK2Z,U^<BE;/NJUC(Q*4!W=T+?L6PWGY*P)U=\Z5!K6HJ,[N,3^\E_=#$]H9N
MPSYTP%?,"PG:7?O;8$/N!^J&J(CEQ(J.&!MCU 2^WT7%^\+-[FMSG[GL0A]<
M$/O8]+)5^SFJWI@Y+D/$?0CRP$AB?S-#*(B0"*6@QB]EDFR6Q=K0ABZP A#]
M%#$@I+Y_=U&0\DKLLP^K;_6F)GG/,]:VF75CY&C#G#O4/6\?VY@:T[64[F]<
M-V1_M/7<WZ7=] '\]Y_HFR@'Y)NA<%/==>T.W9B=M[CA.), [8[!A; <4.IK
M7S4WE Q ^]CF.]*/Z.F=E&\-?80_^>CV<--:9NGF +.M\*^KL3*N)D S[7[B
MZ1QY];FZAL_&,OTXB7^D? 1;/@Y:_HF U6L\P9:;H7FD2<D*BA@^U:2APBI<
MH+__S7VTLLR&)?KINE]]<LEI0[N>(=YU&KPBLVE%FK] L<1]NK,+O_3E<R)T
M9X_VY!AJ%"*%],K3G(9-:9(]UG/V0_(9&CX68^'RQ4!,+WW9 R>1N9'ANTXB
M"F.O\B+OJ6BDHLTU=HRUKGF[4YW+VHO/C<2NSX],6\D%N4,6VZVURTY;#,):
MEAWL-&83@!^,)>O2?II^<2T=_.H3@)JRUU@ HVU"^+X,ULYZ,7-V41<9M(/D
MA+RAZ;3YH<2^%<! TLS%?KF6K4:OZG@]AX%[S)?E\+E[O\!\E\<B?#F.;*E,
M!CKN7>5B5UO4X7;F!P49+IBH^D#?A(TVA3\]DZI#;Z@FV,#7_>Y6N[QI(/7\
M(Z'=&WX\7PVX:<I^A#7Z[B4]=_5D?66.?]"=+(\=V_5DWIP24N+2 ?E>P8NF
MA:$34 ,]+M.AU^I 6U[43:7X:H*XJUJ?@J_Y6J'G=A[<_]Y*X>46[ZX(F7-^
M3 !CI:K(8@@W"CYN*P<*N0$*:5RC> B;^"/>\%YB;]<V&N[O&G7]?_:^M;N-
MX]CVKV"=>W),K@4R(O6P?;3N!X:4;"56Q"O*R><A," G C#(#$"*^?6W]ZZJ
M[NJ9 2DI=BS1/.NL6"2!>?2CNAZ[]C[@^@BK2ZS@Z&U9+<XW32L.[M&$"ZIC
M![ 8AJS>;:NL;N+:^M+JFO=WI30ZF6Z^'\ML!X>'!4#+J L/]*Q_!CW.9_;K
M]<4_VB5M0B@7/C#/(T/95,K+EJ+WL,ET"U9MNQ'>(,,\:+L^,L6KI@)Y NLY
M>E4@Z--.U1J,^RK.9?%#L+'W),F8[6#M-3$J8FU93B"++.F;IRD>0,P.Q'SX
M &+^,I[E2P(Q?SV<._V4HZ?8L1R3SQI&3X&YPF8S48Y.[]WY%*+M:>NI*QQ5
M@E+VB/1L:B#[:H^)3Z7]Z$BVO=-FH*_V_6\_)AT%DS OH95+V7X$@9>X8?$A
M-BG:LO%+RDM3,0"!++9'J6IJL).M;"TFD8Q^:MGL,73(;M#$-PKD[!^U<]:=
MP=/.#,9VKBZGR/[H[])(B7P/+A:>;<CA"W'0^PMR+N_IO,SX?\__4[,T5(ZH
MR,E"3\)V<Y**IO1;L(^+C&-+:"5CCVA37FSF(H';S3U#X63.RM&M;"^F@VX<
M,9Y55%E$N\M$/RJ+X>LU*A])IC/9- U2EYL%G49IAPZNXP(2-+)^"R2W_M=/
MAJW7YT*1K H&]CO!S]0A'&^%]LHM=Y3,>Y?!,FF ^&NDU#TOKLVUY&>3ZH5;
M9NA\7.D"".=-V4BW,I[5:B1<9]MKANYK_]@T53NM)L8XV7NK6U_*T\>YQ[.J
M E-P9? N>'A)3^GV1[NG*R[GYY,SOV7;^X>UBDW.J_.FD)X0YI&>?*=Y3:0&
M'.ZDN"JJ.0<\@4]TQEV.?F[92M=>T-ZTZW+ARE*&V$M9A-2FRV<(#G4L3%WB
M040"41;%6#=*)7&;ZX!R>R42B6?KB<]@-:WQ:"KUYT'"\BCEU&*<HO]CW<Q8
M3YC>:E9Q3*(L":Z[];V^/93$[:MWZ*38D&0OKG4=<<@W*>LLQS&1O&K6=UTC
M5.2PC%/'_T5=L$_:>W:X#<=^U!:S4FN;\<;,^\W3@6ZG^SW="AE,5/SF)+^P
MS<2H9R"'D^&?'*,O_G@./%Z:<@SK;*/T!<J%FZ'%W$886BAIPG6^XP;8;MVS
M5?WXR>/!"^-%;1!^_LOH:+4"J!UH2\#*LSXR;U*E03IA&@3%\%@+O\2M_7QV
M[]-&QQG!<R+?SJOQI!QH2AH#*[W >^:QB2X" K]B'"55'368,:%CZ^.@QST)
MEDXANV/J#MTF,%\;*=%#H:!E1@D9H,1O,,YF_D5,1+'Y;XV^&YM[N"(@/K\9
M6<]*N-VW3PY[A:FJ&:W"H@PWQKJ$9P<H6;RRD:_J(:M6ZF!@62K(&\BS\#9A
M03?1 D]+L*&;@:M:J]YZNOERJ>01>L>/>TF:\M'!08AV*\P@]26 BY%Q; 0.
M5RP]8<JJ7JE/%'8MT#O+B40CP7FHJ>G&T)I90(+U)BKA(^7#SA:-MFB*"<6:
MD+1;&/.P%Q5.B?8@WF-2D)P5Q3KTG*0<8%P[L9;#W6OJOX"$CD,<1*RGGBX&
M.8W?L _C?^IT!OVC/A\5 "FIUN!EL%]C8?<([U.Z>Z^+#9JKSF^2FR?2&5^Q
M*?C$U,"/J31SQH/VJWWQ.YW)9<&3K=>D'J%+&E&T.=J4,?LT_'ZR-I:.+)F@
M[,%=2F#B0L+?Y^KVU7#*^&_Q[Z+G)WL.-0U>2+0KPMG(-$ QFA9P%L^!$-D?
M';5=O(EZ1QEW;]4R^24167 S0\RRS TRF_R,5@3;>+,H&^;Z#=S3OT5XA74-
M@5;?#5:BY[$LHV! ,5T$[X) /RJYH"+'KUBOA [%5'K1=%ALJWJ2&EQG$698
MZ7V=RJ=OZ0V>J3"K"D5SK!152P1H1K$JB<1[>\!O[<\I%(8J<(I8%,I'Z49.
MC95J)&5K_V#_Z1_&A&D[A/<SJH<PUF'KZ%"@IF=]=K<Y@!Q*4'W;?<,Q\"C<
M(K]P\@4+W^#SX]GH**Q$-N8</,U8K55_"!%5U@<PGTMO;/@2RD]8%VUDF0YW
MAZ()4;Z+!7IT29OMBE=>07,2%E^8LH)'9*/(?ES5V,GS*5G4T_!PZEL5?&R)
MO,(1'$G(PC$V)\.%C__UIJ7KGG#QDQS%AK)E,!FFBUN2-PG;*EPES@-\D^4E
M"MZC"]@!%7?Z7>V.&1V!\(A-4:/+@98R%T)I+3H73YB=&4_\0HTQU8(+M)"4
M QQ"O@=7&YCGV>A13$E'@:X7SJODK0B4>@^K5_[Q[2;<$40H%4V]6U'YHVNV
M.,-M:0]+V5R(V#)]GCUQM(*+M\>T*::<!Y (,Z.$&XLM86U$GO7HBX\MAR4M
M)6S$4+D=7],=AU5<JXQ73?C6LH15QYA2P\?LL*E1[X]^5ZT9I%J\$;&V >'0
MK^C=[W2Q+#@((6<PC3Q^4FOF6+P29-K'V&SVB:>/#G8FNSN/=W,E#>^?Z%;1
M+3!.@'#LOI1E.GR46C6L8T&2@!BR9#![ F21[/,3M"<M<),$,APY?G"<@DG3
M=K 5X$@Y$9J5<L*E 4J%($/N>H1Z2NOI$T5Q]\@+6DH7/$>UW^7'$C;%$:<N
M)FP''NM^+M!CQ-O%Q::,:J/QE84%9'E5:<E.X-G52FL%4HSK9%D%YQC1\#]4
M+"%:2W+*8TC#C_Q6A!'U(2X+>8(T4RP"3.ME(:S_;&YM9(%#7[5$TX4T)Y93
MW4%A<O^75]&65PCPPN$?G86HOD0W=?Q#"/6:=0@A&._+^HQ_.ZF*\Q+ H>$_
MOT6+.U?)#OIQ28OR%E6[V>YX]/.2P_;WXD8.JK\6*E[R<W,>OOL37Y>+%-D"
MK$0YCT^;^A_HL_SQS>F+E!GIH/A<4U!;IG?F)&GXK[U3<3M4#VI=&7+H\0-R
MZ,MXE@?DT&>I==&E5N:B1%RMW>.Y'9<3]58O1)+9R)"$P&MRF5E?@9-[\Z.<
M''U+?E\/R2S7F^?)?&:@?B\</$Q/H_R:>1ML8U42K#0'DR(B^=E^7BADZZK4
M3'/*T&<$Y6PZ*3\42 !0H^NR7M:-Y?%8$Y>,\D4Q82;LI-D?O<8)'@Z?#0.2
MO^!H_G.SGYV_[I"/67C36"L:P92\,((O^.U&;I1.\\)R[#D]47@F)>5=54TE
M[.27=<NLNJ!K+ZOYM"F7#H)N,6,$\)02<($(@$^#Q?FCO\A?JBGHG.:UY!RT
M]LW/,N2<(@]'"2&!(6V_9UADQ0WS!>NPAL+1/1V]GIS(/WZ,R'CA*F!$#&=3
M@#7KT;)>HKJ'U(7>(?I(]L[MQ^Q+;K5B- O!^)(%"3I"ZHQC.!Y_[V+?Z E\
MS6W^'XM_^"9B%-SR93'8]TSW3>3U9<G8J+QAR"*PRKIYS^R"<GY95N\8DW<9
M GES((\B$_IK=%Z-72HN/D/8-3^$SUP5X]%9B*[^%0XZU\D=INGH[<L7QZ,=
MYU7*T$R!W&I'+S%PT,*;ZIIYL9P53*ROUV6%?]@?-N;8[DK;O>2Z/G93)1->
MWXRH4:Z8/<'F:1($LGS*1HL"Z52EUY.=< 5">>W@R8[>5_-Z4<(C;L P]C7G
M-FY=CR<WRP*4AK!ZMI.-%/&<NK[5,FIB0[<0FM&:,(KAA?R=P8W$^I+?_S_A
MXKCVD_A!L[$1Q:7TG5UF*;$L\=--4?&,\2S^4[NFRV892H9$#61M0,'6JC+L
M,%F/FJI%KCI,8#7=T(J]RMO*C<A4OGT)\?:P3:'D?7 <+\;TPWQDP^?STB[K
MG&+P'Y2,YUV-=MUZ=!1^%F=G'4+!<PA!II3"),P3!2KCY25\G(Z>/J(@)0_C
M[O"S=_BJ;&[<VVG]=>!,3,>==.<4"N,)0_O?A^RI&G*&JNG__:^['=TGW__7
M5R)/MR6]IU* [3W=]+X$$[<./)H8;7-!G#=U,1U1FQ/+8A)'1=?UB;!UG9R8
MA(;6)DU(\4*X6_6BW7S?)VJIR(#=W7[WB>-Z#-*6IMHVG@=WC>>CI_^Q%KR/
MSU&'A\J;\K[;?_08HZ*X@%,@J/9OU]3Z]98@A\PO068O6RFX:!;46MUC2?KU
M\9O6U2*L\2WUQLLR!@*Q! PIK%>A]3!P,,ON2TUB =)XH?^J+0S5:ORK! >.
MEGR</5=XTN!OE A-)*6'Q:?=]*/5Y4T;;&W!DHNY1^UHY]7I48M<N+Y N!J0
M>-*04,*/0UV%V,CPX7+_(D0U1^&==R4;G6#MR_*B)BL9[7W<L)24OBSF,^Y4
M??Y%"0G@S^;$ZS7 _DI[\%<NUGQIN[/?,OL(HW4:8I]%\#4W:V&"^%-5$R\<
M'O'B9CQZK:WW)R4F7(H0)ZZ398 !\8LY6CR U1\QER%,;*R5I_/ZY_GK&_/
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M8H[1>$V//D+V;4>.SN3XN/\)/ZV4Y^D^+:04K);0920O^(3,XL"PX9-ZRO"
MGH65&&D84F:P6CIU&@V>5,,TIP&".)>[%3N_$YT_#N4PTI?$%LGGF,ZODT7"
MDD;W0(*ZQG:EL$^K.7;L/<4^OZ1#/U;T5&>41\$$!=]"-(NE&S(F9EGG,6TT
M S8F?XLQ-EJS-/]4+8E5)U-%U2J];K U]:2I+"Z_*-!O1J"*_H:S<5EN%L$
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M=B0 ORU#'7ONQ0]%F-R@Q4$)2IW6PW>/PI%$2AV%^PQ<-5Y->75:1[5#!X(
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M(FBN!"N1J5N+A,2ZO)"428S>2'ET44DI1PL+8P'T[K7HZQL5FS"*$NQ+I&G
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MFY8MP93^;Q>U$G+;4H<8M_3,T^JVOD@ /.RZ];H4*0*G1:[BXP&N/8'11U_
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M9E9<'!]X\JZ*+JM@*18LTI@BT/5RX#GZ >,9GYW%$)\ YINY[R??BH<05CN
MX/3#9JG@*$P_-_G?DY\FZ]WN 4,93@J"2Q'-Z7<:).^F]]6]N47+;2U:78[0
M3LA3YVGCJB_HI*:R.78FW;G66C;=$D2P!=.AW&.-&01D(C1O-;?N6=='.2J_
MKD>*2B=HF.DB8S3KO&A\'U9&MJQ64WE/D4!+OM40]ER$0V Y5,G*GI&5HU6!
M_ 80XF)W4X(!MC^/:IS;_]4NQT^,O>'/8?K?<.Y=8\N1X)1_*A0GEX+T^QJ,
M:V=(%ZM=Y7T "'4MH8;!<_LH)NIZ3,#CA,X.S[D!R'_3\,>P8$L!O_.47E>M
M?DH9Q,?,.)*BF9Y&&QXL/):X'$VX</E!_MOK-"%./.P ,[B.@5:?/Y*S92TK
M*<V57MJ,]> '32/#0H0(9K&TH\NAB>_2OW%L56@J3<32F=<@SW5@I?KO.YV
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MO8O9<9T6.5+4#4,/;:C>[O^:<+)$N_/R"N#J<IX,&/Y@E,C"P)<EPCM-0GF
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M!4DS$#.X/C0;RBA9[O6!)3G-',].GQ]N2B:M98R@2M*DH\(10N;>_]'QD<N
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M?)L"YZ<.:[(C6QV;KH<Z.%@6I_@9<*R]Z001,9!2W#K5'^110MA,IO,5Y;]
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MZ(-.YCA2!-7<#K\G^W#Q?JM-@UY#]51Q22"8,Y1SNT*QVU;S59E%?"X6',<
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MCTG@J\(IF53)F#98_8QKPU<(W) _),M+[G]:L\ZY=,U4R:@8J^HRYE1?0)2
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M!;2B_0_!)#BFWPTFA/.N T^)U6TBY[:U359JW6=1T&$^#H9Q.@>AY&[,>+*
MB1Q'^<0]B"@@-UNXY:_&J?#WNS601D?0?,TE5V]ZR<?2%$^DLO=X[J;IU.P
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MAF1@JQ,DDWV+)6H'>VZ52%2/F#%;5$;>8IX6H>UQ?O'C3?T4G>EIF8H8*JS
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M@:702P>V.>@K<\D%?_(ZN$SC<J+CY3#V=Y@Q>J>=RU=.I@\/ABFWLY^[3<O
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M3$-[TQP%E:.X&'H;J*FB6<'32H49/BT/AEDZ<8)HI-TDZMFGV& _G$9%&%-
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MP$0#AJZJ G+31-R*;1IG:;T.AKMTEL#WC_?^[GMG^,BE>G'V\NH-H0>;@XZ
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M;I::(,QAOC*BXSHM>W'4CV?!7I* V=2';T^S=)2%=VG*OG)S>!Q^B2;E)#A
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MO\&%=8NFG%N;CQ?@@+\G2G!CSPD3J->X\',X]!(C)3>_'KG)Q_=[W=? #4G
M&)7?\57Y\M9IK)7?L?([5G['S?2>57['RN]8^1T?:^92DZL<C:_6/[/5ZM;;
M*V7!5U[&BHJ7G7BG57D9-]?+V.SV5A$=IW(U/G:NKT.*&/K(,L5D<8S=6LZ_
M)_UT]_96JY7[^#(WI.6'<2Q1!IJ]^D[N%3_L-.M[#!.LK[^RO4 [*DN]BW ]
MM76SC@(+:1 =;#6<*"Q(8#DIW!(X4P3U#6+$#@@#<Q#=>H,K_COU#D,(&/"]
MYFK%A8E;;3,SF2?_G;7_99F5Z^7,Y"Q*Z]*^71XUX"6\F ^%"=BI=WJ+U9TO
M!1/0J>^V'_;8YR^]I\$NAA-0U=[?X7"KO&CK[@NJO&B/XT5[)6XB*2,3D)%5
M;?BK-K3;C5:]L7JF6.4SJDAYV8GO=G97MC;\X1K6>H@/[E'S(QO.].- H/F+
MU\Q53<J#V.OBP^K=0VQK[XQZH*6TUKO::M=[F[VKC^UB[%(E]$OZ&,F[EDC'
MX'#(SB]B3I&="/(&#NWK,((I3V6C*S"&)3RGV4@KAB<X(_*EN>):^.&$W'_X
M)"<2KH?0FNS1)&]@]JXXP1=Y&5?$%TOX4%<,143.1?C>=G$-*1>R;ED2(A6'
MD8R\R+7^D]I1@FY2$R\5O9.^P"';\+#$]GQLZ@5O@LUP%ADU_&3[T]C+NINU
M&LT>.0X;->TYI!O8R9B,[$3V&Q.4.6E3YF4D\,&$A*HG.A"!&'H)3 :W8A(A
MQ,'R&Q$GH?-M>T#9ESA=D"@29S6*<+G',BT5AH4/R0.LZ@6.Q+7MIWRCV4D-
MKOE2_ZW.@^#]6^]LS0DUDP/*.:<]BG$E+L05KM)]KD[4<!8YU7LOC1N,NS8,
MTR@9J5,AG>P%2.IQZ'I#3S N1\R+@%YY(/4QH>6.A8T OT@)XM;Q4U?0I<MT
M!:P58(IGFGS4K*LP=&\\WR_>2V3N143 ?-94]S_8V4FH2)+ @_%T>HD8QU:<
MXH&.<_$"">V[?_K[T<%VLZ?^SMZ';G\/3R<^@E*G8Z'9%6TUITB/PAM>P=.#
M8RN /^2Q@:O*U@]?8/M^Z- 5L!"P*0[B'I_18>< 2&R-[&O4^00.-,";9>B"
M8RLRF7I1;.MF/KVX5^9'>GY7_4Y]I_T@5WVW6^\\L G=G=[O;KVQ]R0HN=V=
MUSW8O7IGP43FU^,YW^@ R --G2HY><.# U58I0(?KO*/EYCYP:U6(D-MIK"]
M^&@^V5?MDU\GAWRKUFAU'SV/<R-"2Q4-KPD-MVNM1K>^L\$T_)H3D;?:._6]
ME2J66)$ P3*:RI#^;R,T%78++1"P7&@5UN00M);/ "G?\O6C]0>2^(-8Z/H2
M2+MQ3U"T(I#732!;>_7>XE)T4VCCM9CT!PN;],NHDFM(YGN-YD,3S-94WU_'
M3=I[<!9@M4G/)C >@C+W^@3&FEI690+C55I6S4YE656*\YV%\/5612 5@<P7
ME*!Q5I;5AEI6%T]@5AF^Z>:2$:?5HXI6;:^U\PC!ESM68HWT_(W:VDZMT6O5
M=ZNMW;RMW4)_\?<$U1YW3]=0G*VGW?=)!"#'?".S'7/'TT!EC[NJ6#!^96;@
M5J>]]_QJ7*5E+[%!K4:]6VW0RFY0Y]6:R:_$%.HO48[URJ).6ZUN[P&(KFNJ
M":_C!K5W>O6=:H-6=X-:O0=D^;T^T;&>9L?YW;6YK\W6V&LO0^N5)OO\MF!E
M"J[P_O0Z2S?JK$R-]:EC_;0 3L.KLR]VF\LX/RKU]9DWZ!__M==JMMY7.6VK
MO4WPWX<B:;X^T7&_J;%RHN,R1.RK!U<URQG/#7,M%.Q;N459O"ATZ?FO-OTW
M:[N[]V$%?O\BO+"N7Q'SZR#F=@U]S,L6ZJ\9,2]CN'X?8:_>!F]UNLMXJ)]A
M9U=$9UD""-4 I&LM@*#XDJV7#FYG]!0"SOQ!(G(LU8(I:\ >#BVLE__1"J\1
MCK'X!FQE).$2%FF6Q-B%N:'R$ANMV/=Z#6M@(W3I!+NN<P/YXN4XB6T<TC9^
MFFT:/S-0?*^\E[HMS?2*LJU(N"GC+L)%&G/Q$C%7@ZN:-8+%%@1^&(=!('R5
MV<+8E&/O5L*;6L,H'%O]V($?J274Q(;C8/O^U  Q#:,K._ <ZP..]T,:PW;&
ML04G\B89S4=,E!O>Z2&=O9^$,36=^IF 3[UK(4$+F?#-^R1%-[);[ &<[#29
M?TL9]N)+D'5W+[\:YG]'D1K-Q+X2VP/8_6_;]A &^[/MW]C3^,V[_/F&HZR6
ML$40QC/3GSO)X?#))GD7[NO_V"LS%FL4B>$_W_R7U[.'0S'L#%H[;;?C[#9Z
MN]W.CF@)L=MN[=@=^]^[B!;OBMO_>6?_:X:6Y[<<6_/>=P<'<Q@PE9 ^G/WV
MZKL_,D\IY;Y4^[A8H[H<DRQMF'<O$YQW@<)>O@FC;\P0/60:43I1V1TQ#MB!
M94/-P$HBA*U%F-MK+]&O)]CF;Y$-:_ON/(UCS[:<R -18&+>>L'0)]JTHRDC
MXBK@6^:_L63P)5RWC-O2DS_;:>",SFS0C^QKF&B\*&KMJA/E;'ZFRL>T[$@0
M4B\L,&Q<1@JP5[8+K-*+D\AFJ',177N.R#"*Q:UP4OH)!F@S5C<(R!3^RM""
M:Y8OKFR_9@V] %&%:V:2Z'!H>Y'<5H^P@SD-*!'.*("UN9K6K?W9,=/._D"I
ME4L=*(EE+D]4I]Z2^DS)LN"9HM3 Q?29F2,THR9(T.9!&*2Q0E4FO6 NC/L,
MS#-3^2Q)>NX_W]S/CIN-]IM["7DGK^WNE-+UDQ-Q&2SZFW]]]OZ3>B[PB9JU
M;T\\=,F=*RJC5?I(%(8<Y4PJ.!MR?"]SW0K@0(9 @HX=C[:OZ&"3,'#LB<3:
MIL48ZL5PD&;Y6$TGR':!2@FS>Q*%UYY+\/FV"W<Y#O)#(%Y'+B^LTC<A&:LQ
M "!V>/($+N#5QV/@J\VQ0&//)!0.TAKZX4T-N,9DXA./8.1_>+LCA!NS4'/%
M($$6+2+BNX4WQB) Q/$4CJ:32L#_T+^F-W"C@Z'M\-RQUP%BQ\-Y<;W8 ?'!
MC0Q.0CC>S08P!WB1%#+9"_;#@&Q<DEX9'5U@=P?9LV'Q5J(K34M'\,9T/$:I
MF5\"O562OV++AM#'OW]^V-1?"JP=S**=YH/ZJO;JO=V'@9'?B7_>JO=Z#T,J
MOZ^OZF)(Y4L/MK?H8TN<<VH;@Y ,ER6O?#VXV>L*JOY1ZEL(KOXP;/77O>^;
MBOI=X:4_)5[ZDW+53:DD.0'SGK08K=BBBU7KHM+-X,TF!B]1H%JU"5WC8&>S
MUNMVEX[<5SUO*V)>06)NUYJ-WJ/#DS\M,3^S&%O/JA8MQM)8=E+S@FOVO-\A
MPS8\.7^K6=OIMNJMJGYB=;=H;Z_S@%23C>$V:ZXT:VXC/<??SVW6-Z$;N$V[
MM12WJ7+NG[UVI=;8Z3Y_<>_J\)OUU&X.J3LTAHS$+;>HY>[,V.<V:[!-'(EZ
MYN('\9_4N[;]!U=HK;%,;74JG6>5]V=W&7R.2N-9A3TCC8<YSS*<9D&36H8J
MV["O;IABX%/-Z-663#S^ JTX4VC6&IA9^E @Q$=8H?7P059GY=6?E6:W^9T.
M^94[+8\@A!>L3:$\HF=-T*,G_HS)89ZS0,K>OA*N].&P1+BN=V+>_CSEP;*3
M.6FH=#E&?:T$JXJ%BXFLC7J#OO^A6>OL@N2@K-")0/>+\#$'=NY[G#"(O9CL
M*4PY]:<R$P]4&\1&HMRUFL[836#REBNH_L-$UQL# 4YENI_T-LL[;T8>W$KI
M@B&<""^@M$!$7$*W$+XV&45"X!.2$?P=6;Z(X[JU:+K<>I#P1TJ+HT3%4QU/
M[L]ZQ]:;F@\81VO!;.I\]J ,LP,U9M'W'V2\%:F$U>R84LUMS.!,0BP9HQ 6
MJN%9:0+<U>RVZ[NY0JY\6-\L@\ W\OVMW/-OO&14DKA-)T]F;Y?6/L!.8ZHU
MG3,["C ;%9]KE#A<BR"%1<]*U6+836\(4B)(X+!N*N$?Z2#4QA%^W@<^F)8&
MW!:O-.!Z'QFP*A)]L-"[N*2G V=CT;>JT[.[LTLG*CL[B[UQB3J*.35#="?5
M4] GL]3BAYT=69[$!]GV.-1@.R"K.%4_G_,-$L?-,L1I-7;K;29$'&4,XH]*
M5 @6EDLG0)F2:?_XRT#6]^!)9;Y&1Q^'0+OAQ9@0#TRH6>\85[3JNKB :D%<
M#V1=5G*R!]HJ2^K.3@-N-%<MOILHE-R?E>TEKU,<C5[;ID*5H68]9KD)S2<(
M!-=B$=.#9?LJL  *9H=)]V&4J"(G6<MB)'V'\/QLJ?)[@+5;@<L5 7"&O(!W
M>I)&,7PR]PZ_=B.L!.(7U?"+L?V-BK'@_< 93;4"QX$*B'IQ#8G%3UVN:9M3
M"<25,/!<>"0( F&!#> YG@@<+G@0 :69X_QD81(30G["8R_&<MRZ=8$J46[-
ML1(*OW 2/JD#80W30*:1Z>SX&>$31C4\XP%0JG!1+(*M<C6RP/B I2#Q0<63
M7.$@RQ0\D9MS?HCS:QOPQ,"^@#:'E1H8JI._Y/>-)Q'K,HX2RFK+"=H36,M;
M(*8$:!$(K?M,A%;+)I5.L.J"WB4?IZH(X;&Z(H]W7U5V&+1'5'K%FP&?X3NJ
M5ENX=&_MY/!''9[=<#D,-%06BEY>#E,H-R>$[W\)BAP985Q.!'O 8X [406?
MDG=X6NZ:C2Q/S"L*+"ORLA;K;N/4)W,/]63$'<.WQ"-D7I$ UNR,[-@0(#E]
M&U22G3TN:21A2 R55.0QC-?A0<.C_Y/:42(B%.X>:MQPV<2>:M9- EA@69FZ
M4A9"MC:E7O8TL([MJ=7:J<EM2$RQ&(/X<X'AWZBZM" $!H;+C[6< 6E6L-8-
MM3O$^:ERC;><#'FVV_%2W,LN76M?747B"J.A68F=/0Y3WI5FO0OL.?=*U+U@
M@#NLDBSRD%9]MU'ZD#90[Q&FQPOT)M F@^[&5R (ASWE*BXQ]K;M($BIC! F
M9X-UA;H/W/)K&@B+J4J7A#0ITFN#K,734U.D1O,.YCL)7B/$1:^"N%B-L:PF
MQ,5+.87T258R#J5TOG@7N:.JW94JM^8=;#CU]GI@+1'% CLDZ BXE);\!KDB
M_('5NLBE3+^D68YOOH3UW< <"+V'1#I(.A!X0HQ)?479'2J7Y73&;94F,5@G
MI(6#F57&&C^*091BN:QIR+7A4)5<VT^O8+.L5KNV4>+0< R6ROV"@"0N2KH5
MK/S0NQ7N=A)N7X,*0R+$4U*&\G[B&WL",BL27&?-^<[P[QV"BJT/6(9,U,$%
M" 5B2CHE#F&TY:^.$5\*ADG"#MZ_33YLZ_/1A]-S:^*G,4C<QFYCYT<-+)*Y
MU,E8= 5Z_LA4 2UM)%Q,7K*O;+S.3&;"M4&@"QB'G[+;PD)CJ=1 ]</@:AM&
MR27Q3.C9//./^6&W5]^='VI@[9'-3!ZC3?I@&$@]CP]9]D;?8P0!I:3P254.
M5QPGZ#@P<.%F8V"BR'9IX4+Y52=ZT '[P#]\J]THTP+M,5L"N$Y(4D0&7G*'
M^0[Z5:+TOIBI8 BZ#$&7&7=E2 9,.65:7#J1^CSIF+7,V1U.LC9*Y'Y3YU8_
M=3"5=^/Y<1D8 I[-IP4C10,TPA5"@CZ81"X!!H' O(D$:;\A,FBIQ/JX&A&Y
M J2;7@:=LE?P\*7Z*Z+$1H V!C:!O0_'#.0CL2J*KBA<5[#YI24#VBBNGIK3
M4 BILAI'!35-3_J;V /#!#QG=VIXCFP,#5BHWHZ9.T78B@HW!0] HX[J$[Z_
M46^UNC_6,)0F6'B$.8<'X7;OOH]9]>=X$<SH0]$G=.>(+$:K=YPH-3A7V2AA
M91!,*:0YE U#^.RWJ5G"HQ7?NGT+CV%61X\@?F<K;+S"M'=1V,&TF_46?H)]
MWYKB_<@_[[]=K=@NKAC\2M8 V,5BV?7;$,9BTK7RJ]+!$<A4<361C9B:":T"
M,MYAZ'LAG4WTK=KNM1TD8!#@X93!V^P P7H"-=R$J>\2WM!-CGVQDI0Z_+*\
M2,[5 $1>_(V.K#K6M@R196)#NSH)H6A3MNF+/J$+N&:+'@*3CP;(C] W[H37
M I85UMOWQJSTPF6QYWK(^G#. Q B!$I6PB/US1+%QZ@,(P9]%=FNV(Y(#O&.
M(#]6+IXYC'1L8[L]]%/)E_GB6D0V)V5[88$+LSI!.@2H"@$0#VMBOF\,;Q'.
M=H?*0JY\Z< F"H;[B!%& @=;]GZD8"V(Z*QDHU&^NP#(RDINA'^M<A4VA4X/
MLMA5G@HS=Z!K(3 K.0E)\? H<60,ZP"##9UO)%1 '9!;#QH'@SK]T&JWZQUV
M@-J<KT)'W'0_2I^GUC(;]9YZ$^>.D&%FCD6Y)@=IDF'T*552^\WZ%^?6610"
M58^S>*%.%.BSG$//I'0]YN>.X4.3@]II,@HCU652J[,?0CMR94R+1@=Z4+M9
M[^)#,Q:=+10?AVPRA>>., X4(OEZ,B"!H8VZ!:JDMB)WB=#;/-P!O1]>YL*!
M=)(0#ZP+.ASJE>Q@+#AV0=#B1LFWD@V=4P5G[0FY%UZF[2G=C@\4K8Y4+(T%
MRT[Q!(ZQ%X)XQU<_; $VY*1]7#Q$;M(B4>\/S5ZWWI+<*SMXRK\>$Y'\:@?L
M:6B91*(MCB" ;7*(-BBLH)WS>!Q!2VN17L@D@RDWYHL4'QQZ$9Q?:;[7***8
M"P'^L-.I[RG30RO3$C14O8_X\4!HIW"([G*$,&RV]<!#?O$H],DNH*BB$S*U
MH\"07G3R]1ATES&I/(/2+B#'#SFG0 43\>WZ=$G/2UNCG/JV)$0["V+0$&!!
MARF&1+,]T/.26C1ZI")1;J;/GMS-"3BRL#YGK7M#SNYEB7%15)YRU@8+B>,P
M=+,;D(8ND%)Q[_]ACR?OK;,PC( <MB[HS[.WI-%''L@VRI6@-$N)RH@V-T,L
M%O$5-X5R3H?#[0^V3YK9Q4B .=*/T!84XPW*^3458C<4*/ 23I!-8*ZQ[:BT
M$,YCP#]&WB1F515)J=5XC_D_B"\)8G0"[(R^;;Y'QZG,#2FJ[?D7X3<AK/5
MKG5,:YW9;&PQ@/8<P#W1.->[R!<4'\87^")))&]F!7US")$68!]CC1$M]'[F
M#-H0,NS3OBVD?ZBTV9G]U@*>E,"\'K#7J7?OR?]1-J,7Q&E$A#AAA5VI_JR[
M@AY+@IYCQHNGAJ_Z#EQ2Y@1P>SCRZ'_+N<2#,*#?0M_GK#;I8)FDR6QRU"G8
MX)$7FMX 71S0[.K:@)UZ^S[+>3;!D+]'Q7P@!.RA;\>Q-_0X'C 6?_]M@PE
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M\YG=9D:*/FXU*7D,]=K0KDT%G'5$V"8/- ;9')X/BQ(XRI3".X-LIB SJ>9
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M<Y"Y62@1, E*Z6:@Z. E)&Q1_*6!M'DXU\R9KXU10KXVCPB:P<OAI:J;I7+
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MQPN8-1:2%F:3,1YB8"8#T6E;L^SGP7/:5W_SF#1BI*]]UC(TRO:A= XS\V
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M@I,S\X%W43<AW5)*SD+?H1=A%JD2U#[RITF(X6[C1[V$DJ;0_@4Z8H32R\(
M(]=H.".U/-LG*LK( X<B?1'KB5R1@T8YRJ!1/E/*-AMFFRA:%!#HU9W0,)DY
M)H40W.U%'!I*"*,ZT8C!Y <; 5FBF2+#0 5_L1<YZ1A["#CT!<9XR&:0)%R0
M!.1KXC@Z\3*,R+-C2+%#3GL@ Y$&88X/D[AIS'J&FF]AI'2B/*@9D@6F%%"Z
MY+60ZZ,"]C M=N#=PXQLZ2[@SAP>&E.&K0:W2FZ'=G029_.5\<'SW,TRWJ9[
ML;.A(YL=F*+4!-M@GAEG.1_*[<VAM8%9!*T9E^;7*DB\!.\M-DS,+\!]<R:V
MF,,R5OO!0@&V!&U(WI-L(_.[G!<Z.F_#&84D8H'732=VK!]8ML=<W3"=&3V/
M.3LCV1T2CQB;FLJ@+?-5.7REFN4FD-V>'[(I#@)S=G!V@/]K[4L>"]A$I4.(
M68(K'B)T-B"V,$XDVZR-\<]S"?Z<?9V!0I88)QJ^6+(I\@+EF!,N.37 RZ^O
MZ0S;\MYJ=&K9&Y)\2C7X!7[*SJ<9O0&F%:>FO\5H6D$<C%17W6XR)J_*%09
M?4*)@$?C:_--2PM4FS]BF'A'T4ML_<G-O;>\Z[?(?F$OHZF,BQ:QG@U%=>8%
M[(I!U^ 6/&AL.U&([6;#,8PS>X2Y5LJOQFGH<OB<3;%UG9^00E>PS( N-10V
M*VW-\7#BVP1SMSG+S5QP"@@X:H\T(H\M8X7H5W3L6"<7L^[+BY4[N]H[BOTA
MS:I@PR=\%R%ZPR(MSFJYE*F[!+<MV9I[^&U<?IMDPT$XCU]1:WE=#;4AK.-R
M/G\NV#CL2C;#7;E]*&$4Z'0UZ2RGWMRQ@7G!D/FP%Q"U;*/* @)4SF4B87:^
MY1=%1W^L,+O,FY1_OU@$/ZO@R!.$7@+V#AC^=)W!9CC6Y6HHP!R>D)%W47R!
M<L!;<QSPG/N1>6X+,\C+ !DJ0+LK2*G\#J,#LD! )6U.T@'P$DP^TEJ4J6-A
M?5^DT\P4Z^3!J'ABOA$5/O1&D (Q&X.H94$KR>3E(U5BL624^07+0BJ*'^D*
M($KR)+K4T1]Y^%ULFP #,#I%JWA.D4@D:>17+Z<@BM)XE%962GCTW'O*>9G2
M7&;/#H\JTP>S@DY/U<T +QNF4<+-"E#[-5MJ;HSV,W-NC47-HGA3JP1N_*=\
MZAZNF4K[BPT2+Q'L^4!)0550I*)T!(7)7;BWT%JKQC4%9&JICC38;@X;V5(K
M"F/4LE^+;BY9H!IJ#5(S%\)@WP]?AT2[VCC\2^F,?NGRR&.H<]>*LM:FZ@M&
MJ\F9F:7L3ZF F5M3*BQ96#-CN,0+L]_1Q+[V7 8H+^B(FD=C?ANU6RV/GA8Q
MZ/625 C@3PD-VV=S(-NG&F=<8>^[[6$D="8YXK7K)MZ2('*@^YR2(^,"-5/5
MO@FC;]3YA@]C39_*6+7[9J>0$7@@0UE[?@Q+1=&E]!3/UQ$KXG@$XE!Y4;X*
M=Y-=-906'L9<IJ$,K1<WABMQRF['=MC4@=Y,G9W!X#+ND+BMDJ477E3+!?W-
M!,9284^9YK/,=!E;HZ*LQZ"LO*F>3V[AO.CX&W(/Q),D0TG&$920-.P!4RX5
M'YPY8]1#F:M%,C\J$L#) J3 K%-6$E%X9 IDZJ21;,&H;D?]>.REXQE$.&X?
M*@L;9?^T[ &RA2TF"Q.\)JDO^L$#D=A6.)#1)*TTE]V@<UF4>4)=2LN:OW-/
MW2C.%4+S^_)KA*Y,M4Z6['&-RM5VIEI0:7D@BW74%ACYS.5NXBJYQ4QN:5?)
M+:LQEI=.;EFH\=;J&']?="9KSG(O-P%K65&780@32Y3^(& >1<>##!Z1^]1,
MHJU;QQF4KM&<27HI37.!- 3B@F@IY@,W&OB</1OLA"/U@ (WA/M.*>0#P<^A
M\%4QOS(V8RZQ!PMM1X:[MES?6$JQ6".:,/8E2W9G6&.R)PKAWGRR;7%_. %'
M+>!,438"T8-\E4WJ\5ML<%KP8/HZBT4%6N\)P]TYPBQ_V 6;A)H.$#I.(6Z*
M)NM<URZ9,/!\!;A^4'H_^3)@,5W$72OHJK+H1KF(YS1449W(Y(KIK%C]5-]S
MJ(9CUH%W1T@!AC9G8O%,M$L&-$JB![%V6VN\D]P2U.2^GSI)B$Y2W;R64L=S
M:26SWKDX\\A2S89R.XX9(3SO#)%KR2A(QI[HIA7E80_M,F4GH<S/'X3A-WD=
ML(I\I^1FX\<'GGG"!EWE0P]JI&HVK'H,Y^$S4@R.\1'%YA'W[0JECP<A:=ZH
M>2I@(:XVS]K':7!T?KY"E9&JMAV8F>3X;K $$%8=W06DSYO .3DO!7\38A,_
MU%P1M0/;Z4EO%Y<]&T$X*O+5RFW-Q'GG/HYX)JFJ4-NH!*TTX7;))9))T;(J
M:,PU\;94+^=")#!W+LU,F8SW&#Q9.@GM,7G> BZ_,P[P3YIGSSGO2QQWVM L
M+E@(1 T7/*Q*&Y!5!:7Y&+!,/[1V&O6&FF!VE#<E;-CWL=;O*N_NGE6"=./J
M@G,Y\ZPJYTD^Q22P_2EU1LBUMJS1(8/-X#](PB%[FT1HZ=94FV<LNAC"?B82
MI\=C]!W.W(+C*_OJS'ACXERBD:.4+A,B,PVR&@O"&Y,MJ#.$$&;E?+,L?26R
M,G)Y\VJA)!'SJ,C9UZW?9562BLWQ8XT.V(-\CFPVO*EZ>=F+?S9+E<"HG9(C
M%%F#+DA"(0)WF6U-&16(KC<J#-D?8-[+.0]4/<L);^J99F$EZM#7W%PC?W46
M&90L+M]I-*$.'L#0<>K G:E>D?90T]Q\K_T8_0ZZG#B-P$S/D@'*#K*F0_I!
MT@[75CM.RABFV##=T4JV9,\&<=6M(\X<"..8=+ABLBI'<ZC]2"ZTD.,H49;M
MIR':](@9F*>@(TH8LV+(@R@HRWW.QNNI&/C#U]>DYVQR2VO;1H'JLGJWQ9YY
M&F;@JFO)-[_P%M+34T8#\X8USH*ZM1%DH4;Y3J;JA?'DD *O.H4R5D7'PI59
M4'?%R6"YU,#E7K#S^AKSX>ELE?'0K2RKR AEY!QGV R'$Z6,<M L/!>9,36R
M!N;%ZA2US!N,F>)$=084J_R*6:\91Y#95N@##"-M>BNE)E(EBIG#4_HH,[=A
M(>(Z\6W&=\+L*_*<3:AG;Z;9&_Y)G<N G1&$:SHX<>:,D1/;:.SGRF3GND7)
M J!6;0[*QEI>Z6,5+W,@%#M 'WXXNCSHKU^KF_+D<>[?N!\:_1LWTZU@FO2>
M#ADKCSBBJV!6C\?U(JJ@V/%M;RQ+4&BA)&WE*HJC@9=$"C0#[L!N3^JR#,L3
MJU<DZ(5Q_ME/Q%W4!LQ_*7W.%:#U8"4(4./;+$(J#Q%)5&0QP#"BF#0@Q284
M# /P^$1$.B<0,W02C:7I>V./E8X:U4<0'&?*D++ "1.J@9ZD"3>7&@,3(/>[
MS(-@I(/L"K1[&&06KLG*MWCM=$\OL:V4$#FT6@Y%1&LH^K%&@(-?'&&=48(5
M)3?9,U@L(3\J%'K'Z6 2BL V\50=T%I\%4VYLE45+5P MQ(A9(U/<+[R0!A=
M"('A9&U8;-VI3'81P"0=RF"38'P2;X=Q)9!K2AE):QI0Q1-(%G&5N?ETYR]@
MU%>I;\L%T$EH \+?3V0&FH?R,N&:<DMA\VLD0*P:HC=GG1*IG_KFGV]*GL>4
M*GL\[X3'*2Z.6LX,4>&)HYE+0L "75N)/7ZY$.N;?['/)#;UJX^POK#8S!O[
M$I?($+54&(G'5',C7NT,LHNH?E:9)GQKUO/I%;K"DD[9.U1*@#L96$:,X!1(
M,&&*E4J6C4J1;OR !/"E?E&WAL(E##=2H'"0W%R+CG;650E)B4>,X4L&/)8D
M$L/UUM9(4(.S-"#X-94.*B?QECNL4L()$AO8E+Z01HKNJ@2J!X'$JK(< ND"
MC@9ZAIAI2U81Y2Q1^N@8\(;#NG6!*:]*4%.K+%A*8,5<R:M\LFY(C%DITU*0
M&ML_](2/$M&UIQL:6+F<Z^SAK'LZ3(@?KZH.T.K1L-NR2EG6<.%/>()85+.L
MFE%Y3  UH[J!B)V""UJS,#I<&J@T^"0W2J]R#CWI1-*%%7Q<C8W,NCG/>8(L
M&Y$5TMBV] 8+_FHFGBPBKP?84=286\W(CTC1/T6P4)2VRQ:,8.TFT+T3C#FK
MQ9(>2+U>TFA'3U1MT7L,[Y;Q8K2%R(E-OB[";T45"O.7,#%.W@]+3&;35] .
M6*G3A<2$<2T=N4;DTG:QX@?C#P;DO*2CNG6F7=Q FM+P0OYW[86^F4<>WS$=
MA1QJ.OQ952/!$GF<Z*6+=VN8$J+R6Y31JE1V%9*J&;)">3MXJG]K2G5UHSVS
MP%SFR&1-D90F*V60[#:KH,6-WA>(PA68;%[+E,WG**K>FCHLJ09";#2ADQ4D
MFQ$I,[!\N6S"0*2.2[MPT39'IN/*S#IF])NL-Q<94EE? <D(Q! I0[DFCP@"
M",9,[(ZXVL?^Q0?R6$KTK(L$[D.\A:J3D9EMU*FRC59C+&N1;?1B@+ &P.IE
M"):'U>DV%.Q_SN%54UC_IBF2-2&*%0-CR:8D9UZD$E/*/$':_Z)*0$BTE_-%
M:H$0R*XL[!!2=ZN"*4: ,<=LN 2P7 X$S4#7RK./7_W%4IR3#.X:A@$"HD)V
M.5!NF\&F)40FOXW&A9$^KMBJJ;HE6;B-3-4S*[KHTH' R9D-'&R.=I#6*.%Q
MO< ;8R9L#C4D>XCC1"F!QN.XU"B,T)J.UZ#;"U6TF;%+('1[*G%$U)VZNJM6
M*/9B12/*:M/4:]%Q#Y\5A#/Y[\QB.]!MTT2N=6X/T<<EK!/0H*QF!PEO["69
MN-K/;[>R,0.0$AY'_3_JQ-@+;2B7:!J>^\\W]W.(9J/WYB$'/I>#O=M2+$#E
MI^,W3\X!YD!KP9)8NWV)#3/[W__]TC^Y/+KL7Q[]?FCU3PXL^.*S^OO@Z&+_
M\^G%EW/XZ</IETOKN'_^V^&E=7YT\1LZ<(%"?1^UE;<;DA-PS%F)JM,7!5FU
M;D^DGBO3D5:!&<"2>8V9DL;]5K).(FCDP-QE&,J9(E/BZ)2LQ==8/=DSE"4I
MT0Z,=_!A)F!X'@.I=/>XQ_,9)Q[IC'AT\7PI"V*<K43.HVQ,=?Y,=",>/8W,
M;,Q497+M(K/A#!U5C(IC23DV16NF)Y9S;KINQ+%++XES]^0';O9F,*I\N?BA
M6&&PT-RR72G.4/F>;57:Z O=IIP":$A51DY3#H2K-NNAY6U*>>] V_&N[9E2
M ##A4]4'9@Y]2;BT#),:C,*(1*FZ(KZQ)R53HN^--K1S0,$('0OC]U@-<?\X
M*7D!N[MC:$ F,*QL'/%.UOI1KO2^6L=#12/G2! ;PA+[^>S+3GWW1R*59K?>
M_K%0'_^3T;Y,):E0Y@(VZ')UXAU+'I5]1T^##\V: 0*(B3(<HH85"!5TN*?)
MFBI^V&FLDE?)M^W"J8/W;7VY.'B;HU=$.)@%+=29ZXP-#<^'&QE4W39S=H9^
MBK%![6\O< /.#<D<0Q33RSP_N<BY1GPO3*QP;AF>#3@!#HC\^$:R3Y;=,).$
MDRE&V71E'C*)!E*4"\M.C!&KG7*^IU+.IUEMK!,(<AG6O/XUZ^+&P[X'F'=3
MLT0:,;[P!XSDQ:"H@SX+BN+A;18!5DEJTO-$FC!8#>A[\+@SILPM&0GWJM!]
M@3#O1],)$@1GM,H1PU(U&S^23T]B3A0V+I523VV8()]NR5;(C;C)D/!U3IVL
MJQV0^W*VRI;6>B:+^8?63KU7MSX1(\8T'NJ_@'D=:ME-&C*;YN3:?IKM,<:3
M,)"N(&K1C7P9M!,)3*2R46C7?MAJMW?JG;>T*3]L-1N=^LY;:G%?>D)K<X[H
M/(& RV.24KXS)3F6(@D_F $.<&;1M+0-B&[W-^0% ;5F4[)0<T46=A1D_<CH
M',RV_2'T<%L!>>)FRY9,LJ]C64>(N??(-DZY_,3\><]Q/C>-^+0RC! ^C&#:
M9ESB/\6%1'#2KR3M9)J=FE2>D-"TQ=BU$8F846IR61.H5^%1NX=+Z]$+8R6X
MX9L!;8O$EXZ5U:I@Y3,W*KM:S1HJ<^R45")!VNX=LU(8YZZX&7:.$R4I:&=E
MO4=&%ZS!9NEJ5*I%VX,<4\R^G?'6[]46"9]C'E_(AZV!1^SB8<^$F9[9S&/Y
M];KYF(0,'F,+4ZI@"ZDKMEZB7^T@16,&7MN6P3=JN4)Q"]5]$V.WF/.1Y[0[
MK5Z].W\6S9)9[#W]+%K+SJ+1J.]N(M.3)4-3)6+A'U8>/J+RP*;*=LY4,4R2
MF47,7&6T8HU:MAF<IMI1LJQ;8PG*I\/&;@AQ8B@BE I=)( Q<%)^<1CHQMA&
M7;BL C G,$PY(HA:B9Y%.@ !YWVW&'LIGY*R$C?)SKF07#4OQ:CXW\MU6<VP
ME).L U[$/5[[Y 4F=7O6:"@Z=LJD9HG2GG-[)(@TKJI"T)-0,-F)LY/+2"9L
M#\(H"F]T,4+FI C,PA-K[-WJQK-T?VYF<AD"4UUG!#9MX]QG]]>,@HU9+P,6
M26P('7U0"VZV*,HVF KF_!"KMS!G/\'"&!,-'[2_T"<$B/SO4VX@FY&AWJ"B
M&TIBL?-6JNTN67)J5$LFM.'BV9!- $/WV)YJ^1X6N'P!=]4HL"NT0\OV+4,O
MP;.0UQDH#LTHVZ'LW9R$V^4;-"/!E)^D5=\%4S46 4*6@CPCA16^;K2;4LJ9
M.04%K0'E71?E7?[L%CB. 0 )K]\F[<3Z?/3A])Q[?C?KC=W&SH]P%DL.XX(!
ME&;KC@#*FH1+]N9&2SX>G?1/]H_ZGZV+R_[EX?'AR>4%14TNOIR=?::_^^=_
M6@?]R_X2 >;R](:7C1Q?2E.HQ)UD>,\*\)@F' 67\^)R$N,25+ /]&:408%]
M@Q+LXW:3'P0W2+@T1E#'*SYB05*SL?W;?-8T=\WN6>O7F+72G9^ULLPA[[ZI
M<EU>1Z[+BK/JWEQ6O?]+_^33X85U=$(,^N#HHO_I_%"R[#^.+G^Q^OO[IU^
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M;W9Z[4[;10NNN70"!#QVQSH=!]X@I5IQX"'(3$H,M'OZI98H44NA#*,>U22
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M38SY$9:[M*@Z ?-;U<VQD:U8D=]+\) ['8^*\6LO@N&.#T%) [4](K\MVA1
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MV5]NJ!HA=Q4,$ZW>2/<^=B;M'GSJ#I"-$8\2(#I=][']-&HM.]\F3:0R,2V
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M:BHX9,!6#-B2 ($H4D)$(3\8Q2)@J08*20XTLH@3:KU#+@&V7ITP5\VV<$6
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M2'=??/=VW*W\A5^5JVF\=P=IZ_[2W:2[YPM^G@M^5GT0PV" @CB ?2KW2G
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M*=S8<*"LA)%;L42$>6F#7-NDBLQ(POXU&X:> XSO+REE&#\1C&?X<+U2(GB
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M#).JGSGRG[13349\31!?=L-8%N]VH8%RE@)J@P22NGC>):6(!:2$$FN;G,U
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M"R4L*UV54][GLM+%95 *>QWU+4VBT&0PD,8$P.-N<N&#5U)$RIM!=[E.T;.
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MQV_E)3+SQ;XXZ;QL":0.(A2%,1"\CU<[YPYH&@+P%DH>=+!FW&*P;E=[1=&
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M[LVAEW6BF<KMG9EFEH1FRD91HJ6GGH!XV42:$0X!&2P$+$J@PE.'*<[U_5>
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MT&M6 IY0NR\9+X40U >K0/ B:@%>2Z!P%!9T5/:B?$B]5;!.6D .@5WQ5ZY
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M="R,8F=B&"%E%Y5+*&"B$(^2 KL2!^+58RNBE,"UB\Y\*ZQ:6+6PZGQ6Q9(
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M%R%B"%HPAPS3">6:RTA;$Y%TQB01:").K:Q32N]>@[D >9E=B_<?H"P 7@"
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M>Z&X:I\-?!=I,Q3XWA]\9VT$HKS!/")..=@()F&D*=C\BD?)O)4D$+ 1%I'
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M]#:@YQ$[1IP,V 8.G&Y <PS$@"ZI-6;.ETF]\Z1^AW=\3(%+87E")KA\[FX
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M>,)H\G9EW9 7QP!%UWGINLXDA^>>C@&\*K/T(K$]U1/K'YK8]BYK-TD105W
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MWR!B-/YF7.5PGJ%T(9["UAXWG)+[:CNGU4FT@U$.E#2'4OCI(?#=P3#G[E9
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MG2/)#="P!]"PH[T=341@X16*SC/$E15(4\-1!G<<E3$\ES89"N9_"TN]TBK
MPB6I@A!$\L2XI0X(Q!@?;.",W<3Q.O#WG\#?FZ*?TBB54 39W-J.1\J1Q<0A
MT = F_-6^I#;6M^H?>TWYT,XVNDW'3IB%5N !.JB >N2,)X,M5AHS;7VU 8L
M'1T 80\ 84?'.R:MEII3%"3(>DXH1388C!C1R1FG DMWUL_V41+]T/&NMJMV
MSAB<#+."<^F],8EYFWQR!"C(#P)_3_A[4^!';+%D3"*)(PA\;@*RW(%^;XCB
M)&GLJ;RNH^6W:NJ_R5%"A8B_3,A_=5J_PE1B*G#03G"7XRQTY(I$KT'N8S*
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MTI;?R$/_-IU]FC:E#)K^C^Y\633)NLZ<XE:VL9^;5U2SG'@'BMQ%VP"Q%CT
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M (IEGOW+FCKUVL>Q"[#=?KZ7<[K^/)BQ/8?.I@^H[[TJ>[F(V1!>QG7'=(E
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M--VY55.O#5C>E&P#O WPM@%OFG,MDTI!!0KP9BW&4G(K(N::.N(*O%W?8V2
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MUBEXU?F@J131<9FS#YDEWI!$+'>,1.K)+'GU\@#-U/@9 SJ+G7;AX2EY>,P
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M5[HF@WT(/#G./3<XZN",C!3L28XCY726O%K< #/AX3$W (]16<<B(MB"U)7
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MP,#Q/@]BM54G&I55 $G!Q)$",9=TB SD*A&@ MQ" UD5]& \1[!,[%XGQLH
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MP&.%C.46.3"7K!7,^Y@6EAA=5'/$J&\A2>Y3NQU.&LUFR8>[":%< 'L>2-
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MYA)+1Y&D."">1$3:*X<\2=Y8[4"X@@U/WA')7Y'3LXJ3_=;+] C_#XT?2W_
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MY'EJUK7[O>K.">[;K=;A&QW?/^K":CT<;;4)\6>CV\M?/]^U'[;9'UPNP$;
MFEJG5Y:2'RNOI1/S6N&GC=9@MX$RVM6KD_V&W\_OG59[W!CB; R+YSSYTHB[
MNN+[W/6HX>] [ELMVX<3@LWYTFG7/N8#JJU=.JA,\%F"U2J)TZW.LOMB-^?6
MK?C+#NC?[NUUXEYFK2&=@4R&Y9S^W^Y@)^REG0#RBBW0"(Z.F_&"./^VK7YF
M?_(N_P+^O7H58-*!6 ;*[/:;F5+;_6:H[=L?<7!!N$QJ PB<=-^/]GKBCAB>
MTB/N2.V.!TVF.-E*:)R+N(&@@N=IVN-N?#_ZX_=1__5&JUI5]:/?K]X4+G==
M2%4W''S\^TDC]/;?&[DHF<HJW3"K8WCCP:=DL=+VKLG=P6<*+Q(A;OP8/KWQ
ML]LN"_M %7V<R[*[7G8V#>]'B@3.:L2DJ\NQKTXPBSQ01^S,E?J_'6VG6UMM
M99&Q$GT\<K%38^3=%3WMH9MS*:OH0ENCO]+6YGSG,C[>6)#X6I^8W.&)9S)/
MXM?)9B/DG:<=&HZ.&6M$]^#:^I?O4'F=+A&A*1>."4M$X,81*PA-V"3.O-.!
MA]V5#!.88(*F\XU<5D%!6ZV4U8G3 E^GGZ--=PYV#K;IZL_US2U2/]O#ZV>'
M9&-E#=</_C[</H#71__9WSG8.]UI7/-S'.P<U8_J!]O9;[&YQ396OIYM;&[Q
M]8.O=/WH6P->P[-]/-I8^?OHOV?G>0J]]<U5MKZR)G:E),E+S1"1><H%-P*9
MJ ,2E#NO,1RAR<4Y_)TQ:JYZ Q2<>;TXXYA.)G(>E W<"V8QY9(9[T0T@DE5
MX0P9X0PI.#-_.-.XAC,B4><XD\C1*! G+A<!!H$T" [IJ21&:\ 9^8X1O"CF
M"V>>;XK8/&I]N<H S*@6++E;L[U>I^'Z ]._UZY]MF !V%Z[<UK[T.X<Y[\S
MK[=3;?D(;N=M[:]V,S]M&3\V'UH6G.9:R[>/XN=VMULP<'88N#ZN:Y$47-*8
M@IHE0==R@@$&.HM4D%(%@CD3(D>4J*8SJX4NPQ!>LFY2N//QN/.ZAN(Q!67$
M>\2"UX@K[) 58 E%A@.A."1/Z<(2?<<D721SRIUW4%!F&=N=DUC78&4AQP(K
M=>,];'3LY&]=\^*]JJ#62K^3P[<Y '4*^E@M7O%J#^B138I3G1>'UG[83J/=
M[];<$(+B($0["#^'42UI#A3:X^-.^R< 32\V3VO_.P5>!JNX5Y@0%BVG4;L\
MBT\(KK1,SA ]-5Y^L:=5$'BS/4R5^?-\]0"7&^F#[>Z/DFA>/"KN_'<?^Z/_
MM.P_IK]QL,[6C];9]MGAS_K9MH"U-#<^K?/ZYKK8V=QI;&_N']7/UOCZV=8)
MV&" @JN[UKM$ ^;().80CR0A;2U'C AXPT=N C )-W)"5Z4<1O>PF;5_M6*5
M-%"]&!'/OP?)#N?Y#7#HW0:PW45PV3:;5R.J%9F"D9!C^C7XT3 B.DB)R D(
M[8I,(S#:4?5&LHU.#5CR$.Z?4P+.X[:M\4KGG +AF_T,I_-$K1\;<+/8;/R(
M8>T\1>-JIA=YRU1Z!N_O1I]BE,HC21@HQJ!+(2.-1]8(23W-B5AY>H?1$SP#
MF4H;E[+HQC-A*DRK(O*-T+= DT<@B2N"ANN@GOT)HB/TX6KY)Z.DF?SQ_<F(
M"JHTB41P8#%X-)V8(J#J>Z*,",Y.34;GV8!#FAF _Y<JW>4MDP^HA<N[0OB0
M8E+(:.P1-\HB ]N,N";!)&R3,AXT 2"?<:MJF+)UU 8-ZVR 78,DHH'<FT!,
M(^&9.NVC#$: ?9?D9R?G@0T^&])+O5]Y/JX2" !Q]!X$N=&2<R>=MBQZS36E
MB2<B)]KX5TEB1 H#A/D\"6'^J?2%&)9S6MM>W.K&U&]^;J2KSDY00/S[T.]D
M>'YS%+1*ZRN'I_4#CT%<\OJ9WTU$2TE!1BHB))CJ0%*.R8B,8\%X*FFR*;<K
M&Y'2\'R7LOBZ[<BEQS'0! =L-$\\6+@2E43"54$,8UP=.1X=.9YTY#<?=3G:
M">! ZIN'NXFRB&FJ\G9EG@QED(DR( **,@T!1ZM9EBUCQWE:Y8ID$/"@^H,-
MWADHQEF5V6\<=]_=>MJYG[:A7&B&,3=66XQ!F!%!C,O%BZXP^',PN-C8W-Z5
M7.26@P%9PC$P. U(@[Z'4H!C\#AA(\/"TM3\G6<36ZV#,Q1S:YC3"D>*G0"\
MT)C>Y<0+?]_W9-=.UE>6=T-((L80$=.,(6 ^#:B- \(&P#NYH&7$$Z'[@M>/
M0=EK#77&7O3[+;#F]TYOYW4NC* \8.,<YRHR;;4+U$MBB#/1QL+KST017W=!
M_5;!1H*< ?.">TF13E(@YI(.D8'&1<0D7K\@B&PCY"S@V,OYPYT8*^?#(*?^
M5@U/2J]RU261B3,.1C=W@"Y4<<X)P[P0Q3,1Q=YNLF"("0L($4 1X,3S3!0)
MY$&>/ >G)7G6\/ M5-'KY"J(?%S=RH( (^"*J^,D=H:5$E>*.( ZXK 6XR)I
M?"^V]SKV>!\HJ!.MWZ\LVJ-CL$ARG<?0_3$H*JF*/EK[N7;BVD6ZOC&P@7TM
M-%**>8Y*HU)6!A9._.G!0!GY3RK'RA6/RE7W#;SZ$4_!R&D#7=WPBPD^F-H)
MK/&\)@/^'EG3B[?FNL_,4:HF.DJONN:?J_+HW+'0B:D9<S7,U0.,/X_AW8%Z
MF4FEWVOD8J!!W<)H?R\,S:J*5_U>.VEW#H$@<VE1IHUN]NXWNONC(J*1LGI>
M N1B*Z9&KZ($%RMGV3!TWXP##*GE.B,[K.R)"2@**,OGP20GC=X^$,*/=J?Z
MS5ZG?0)OM(\SJ69G2/[.H!"G&X=TF^N):MW^T5$NFKB%<.!GV1$RX*WK-G6C
M._3MY1V(S?;)^ZL>_<RF&7L;K4'1T!4?__ @N,FN^M^/VP,.?3_8G1]Q6$TP
M# ->^MTP*( O?F)=M]WL]V[^R5@^\S-%!CZB2[G:@QVZ].]^YR*3?2\B!\!R
MB&R"Y;ZWS1-[VEWX[6J0I-$:75ZJ:A.O/_^-3_F()2RWQ7S^L'.SEMI^)VL#
M_],P%D Y@0H ]G[V,!LEN(P@;A2CTG*[JQ:6UN!G/__XS2[=&+!Z>@J;#*F?
ME__<^+:\N?%MN_9AX]N7_/?:1KVV\;&VO+[Z;>W#<NVOC<\K:_5/WVO+]97:
M]ZT_OZ^MK"U_6UO]/O?/5M_87/U>V]R )ZM_W_B\MK*\N;I2^[A67ZY_6%O^
M7/N^"6^LK]8WY_]1_K62JZXZ _3O[H,.40$TW*F9!<.[2BLX[F6/Y^#C')JQ
M_YXB7CI>PG$E/BH6U46 =.D/U_EM:1(P7</O@89J=:!)6"NL3IPZYL"$T])*
M;IRP2=!?8^\3%Z3I1; S[U.0)N4B(7<N\;KS91E9E%K=Z;*S*WF:DQH?\RO^
MJ(37<A4)ZM9&AE9M&%//96(3JL1J8R5!O]BW24D8SUI%-'<)[[G8O#H"L!IB
MXT?FO7OV3/AUR=DK+0&X^_._GAP\Q;7!*EEM#.>"F^@]T]0( 7\),VC-,D7J
MW2S&#WP8S"X=?//;.36_GED$< ]1A_OEA+SUE36\<_"QN?%I]6R;;OVL'ZSQ
MG<U#L4Y7Q7@KEAUXGD.R<[2=$_).U@^^':W_L\6W-^L'.YNK=/U@O[FQ>7BV
MO7F()Y8H:6^5B40B3'-W0.LCTBD%I#2/A'"+F9#973/K7JIW*F(M<TUO8.>M
M%C!($R0H_/Y'PX]7B9:4XA<#9Z]K"O/3 -F$_'\9@R,T:.2<IGE4$D:6)HV,
MISC@J *78F&)/;S)Z0RSB]^"$KK6^@&DWNXT[@E2;V)D_#R"U.C@3@LV385-
M7\>QR40F4M06"1D2XC119. UTI3%$)11-N3:I+DJ 7\+:M273CRVH'[F\%!K
ME*#?SO*XZ%,O":JNZ%/#0UT=G"E\OU*P!I\5*)L*RK8N09D_JZ]LG>XR+YQP
MA" 78YY(Z3UR-B>7<^^H5S(ZPK.:-:OY\$7-NBN4W=+!LBA>+PG-1D?Y)1\D
M?&-U=(P%O:9"K^UQ18RQ:#"+$>5Q]X@K3Y ERB%%M6$RE\50M; DY$O2Q)XX
M#O("U;Q1?4]1ZFZ"0<:E2R)J$[3G*BI#@A%2A*@TE2K14E+U?#"V-PYC>6JP
M3V!*:J/ GM0VYA1<CAR!P[*>!I+T335910U[7&_7M9*VHGJ])-7KXOB*J3@=
M2AU.4+:HL3$ZBH0R G&G [(:)$BNW6$B\F#-C87'1=MZL=K69KN7Z\!O'Y4^
MC>IUM]GU!2"? B"+&^T>V+CZ<\($G-P(-BH:$*=>(9[ "G4Q2"2Q#2E0&ZL)
M.$+-KA_2W?BH:'=W2*@[MJ>3LNFF4>X>-A6M -OCA! N?S \["^#LRZ8-QWF
MG4[ O$ ]P589%$7,[C?&D=95]P>-O3,F>.+ ;IV9/O@T [U>N3X'?-#IQQ(D
M?7T(5S+/[H%K9Y.F&9(DK<<)199SSP15R%+,43)&2C!S);<J!T7'V\ 5;]SC
MILGF7MI5N6[5AKXXXUXV8*T,IRF>3Q4HT#4-=.%)T!4<D891Y$W.Y[!"(,<8
M1M@(JY3 Q$>^L%0"HJ]*I:L$?ZUYP5A%DWM)P%AOM_P8-A8PG X,Z00PY%Y3
M3H)&PCN.>%0>&68B@*&43G 1A0L AK04$3Q+3.$28#TLL/ K]T#!M"?'M()D
M]T8R-@'):+246V,1$<GFKKT.Z8@%DD+AD(BU,D^$4N+A2#85+Q4_V^VCGWX1
M-;UCA&?86(/!9H=V/^>BC%;_L*##W&W9W<OY9[]!11H\IH8;2[+SE%* 3Y "
MTBJCF&>(!@I2(!J,K'(6.0**+*V:9I&;!E0\*,8\ P9[D*BX.H?GMD:BB1G/
M@R8$:ZY9LI(GC8DFSKD8G;JED6AS?])TJ:'3*C>Y&<V96FL-NH7"IYMY69MP
M]S^;;7]X]=4+)?/[]P[=@K5_W66$1A$\15'E%N)$6V2\9"@D*L$*D]GV6JA%
M (/CW(FJTX\++VK,T%3#EK++VO9#(\]G ?*I5?13NT1 50_'JIGCY8EFKW,&
MTU]VT%73[NUUXEX>:S/L<7G1U[/:B2N]8:NI-[FE<#,.IBSE'_UM6_W<(W/0
M90J_NW:58]CI:H?S&)-^$Q2PDW:_&6K[]D<<CM')C6F;S?9)][P[YL0=,?P1
M.R$N+-7N>- W##J=>+)/W,=-+DJF[M/'3>%%(L3,^[C!/E!%'^>R=^XZ-QO7
M]"\;R<EY:R1W1V5VN^H,/=XR;IIN<5-TV9NF0]&<[]Q83[VW\,3X#D_\1"T!
MYW'$]#!X.A;S*:T 2RO :ZX!Y7,"B\NS^CRW3EB!M<7)XSQSA3,WTW&\YT']
MUS^(]_BH_FEG'[[/-_[Y>+2SN89A+?#]-5J'[V[#VNK__'VT??"QL?/]NE-@
M&^\<90-_+Z^WN7[P]6S]8%UL'VQ36,?^#JQW.SL._OF[.;G?G[38I:!S@#\@
M[JE'.DBPN4+24CE!+3$+2T2^HV1V0?]'[_E7X*O UX2J9L*"P%0X+BF77!B:
M:.#2^>B32$Q.' I7X&N>X.OZ''$&Q!4#Q\A1SA%G5"*->42!)FRYC $GT.<(
M?P?"Z.6T+'W6[*1YU%%S+"RG;L*2NS7;ZW4:KM\;S5+Y;%V>!='NG-8^M#O'
MP[D0V<^S7'EX;>VO=C,_[5W2FEYWI/^A"AR?!@'AT-9:OGT4/[>[W8*#L\/!
M"=U.<5"&$*&1I1(C3I)!!DX9>8LQ<Y$F@CD8P^^8THML.AB<-:"]%5Y[J+91
M>&U.>.VZSJ%P8$JE@!)FP&LZ8F2D4T@$3X1GD<>@0>=X)P2?MG+M&92'JZ'1
M:T/X;I_V=8]HTIS$U6X;:'7%8_BJ FC#@2LYV)6'*];B%0_Z@##9I)C8Q>BX
M'[;3:/>[EP?&Y?*_:L!;%5ZK\I5R4-(>'W?:/P%Q>K%Y6OO?*8 S).,U-B"Q
M2.!!$NTM Z5%!<VUTF+R[.[;S+0O]K2:([K9'B:9_'F^>L#-C?3!=O='Z2<O
M'AYG-+R9KF\N[UHFF'><Y 21@#CF CEM4@[-6TZ)==AA8!BI)GB&\NPK#QM;
M^U<>00C*>/5B1$C_'@S*/.YW_+[M7I^(6=%/LWDUDEN1+*C[(4=^X4?#2&RS
MV?85[<%'F60C,-U1]48U17,XT?-7PS3?#8<>5C,:[TVY5A"M@4)92(E+X75,
MPO/@2(R"&.ZGIMS!,-KFI&&T(X(EA6+/*79[%[L08M02:>4$XL)AH%CI4<[F
MP8E::F0>0$_)!"VX&@5[*2\-7E]KWE5A7945T C]W-2F&FF5R2H/+N[9GR!2
M0A^N5DWL',T@A8_GB*1>=2>^F9'2P>JN="1)'37R(N6&+#PB8RR85-0F*1*H
M>3BWJY)R0L[T -V /$!/.QM@VG&UPP/9.(&P1@(V==I'XT-9._#U./CLMNRU
M0(T7)GA)B>?)"\MBHE$)0;C4/.F)Q%+&8#\N-2V#U;"^&[VUD8B(J,JIE]CG
M9HTD@:D> L,>F)S1#$QC8[!!K-UVY-+C&,"RI,G "?-@);R01+)@(C=XLK)4
MCORQ)Y_#]7:U\7GC*4HDRR()>I1V2B#%=;!)@P9%'1RYN&7RN0<3 HSZSM7Y
MTF4(>AF"7H:@SV0(.K[?$/0R"[?,PGWB6;AXFNS&,@OWSJW[RBS<DD%R=VL<
M+.X4@]?4,FZ,="XEPPP) E3OD%Q5&S=%XDB9A?O+0$^;K!]\A7O ?YNKH%]_
MQ1O_;).-E?W&QC__:6X??#O8/OI*=@[ S#J]%N@YV#JMKVR?P7\_US?70#__
M*G8.MOC&IS6Q\\]_&O5/]<;.RG^.UE?\V97<N(,UN.<VV?4F68Q30BI8C#BW
M'AF9+))4"".%T"I[ /C#B^7**-PR"K>@V>L>A?M4.+8^CF,28R9P8B@:(@''
MG$0VJ(@X<T3:@(W@++=9?4'#01Y5P2W:\Z] IDR7>S6 ^]JGRST5[FZ/XVYD
MD1L1,NX&BSA5 FDK*;(B8.X84]+F8.2T"7FEE^(\0V,9+O<K%-2)$QU,B))P
M#M!G4]+)$69#-#'@$M)^1A3;FZ ]4DND$1&1P!0"W/*#8@M+DP,!%D)@^J8X
M^-SJCZ]""RO#Y5ZTYO7ZALL]%4H=3O#5$>]L(A9T+:E!U^(,:6,9\I(QXY/1
MU-V8^%6TK1>K;97A<J\8(%_5<+FGPL;+P^763NOY^U]WDPA<83 ]20)@Y(1'
MI#E-B 5'M>6$AI03N8TLP^7FAGG+<+E7"VQO9;C<DV'>Z03,,\PGCR7+<^4,
MXB)%9'+;4P46*R8N$!'"PA)^C.AM&2Y7ALL5A'N]P^6>#-?.)N":)"P8[ (2
MR9M<?JR023PA3937.C+EA0!=[D6%<U^%PE:FR[TNQ'J=T^6>#+OP!.P2RN1Q
M A$Q+ &[.);(QFR1,LU%9-H28G-$],%6:/'1S0\PE.ER+QH87_-TN2<#0SH!
M#"EF01''@.J" "O5!&0#YHAQ[B)S"NQ3G].+9^62*WI<&2Y7(.UU#I=[,B!C
MD[0ZX3S#D2/A<(Z]2ID+G2D2Q%)CC*-1$;!(];3=L,IPN4=MJ%F&RY7A<D4:
MO*;A<D\F!?BD&#-S(5I%D!(YWD)$SG;&'A1;K;E50@;G;FH6]HJ&R[V@9H%3
MM4R\\R@R7$:1#4>1X6E'D1'S"D>1#;_&33ZOWX_;@^UX/V@6\B,.FU@,)<FE
MWPTI U_\Q#K@X'[OYI],ZL7Q'.3Q$5%V=3\N_[O?N>A9L1>1ZT1[B&R"Y;ZW
MS1-[VEWX[2JG %,,+P_@F3?Q^O/?^)2/>.2WM5#]P\[-6FK[G:QX_$_#5.--
MN:.2!>X5-DIP&6F,BE%IN=U5.:$ZQ)]__&:7INKV\AP=ACXO_[GQ;7ESX]MV
M[</&MR_Y[[6->FWC8VUY??7;VH?EVE\;GU?6ZI^^UY;K*[7O6W]^7UM96_ZV
MMOI][I^MOK&Y^KVVN0%/5O^^\7EM97ES=:7V<:V^7/^PMORY]GT3WEA?K6_.
M_Z/\:R4W^^D,TABZ^[8SZ%<$=VIFD?"N:I(%NL=Q[ P^SMU-[;^G$)KC;6ZN
M"$FQJ"ZDY-(?KO/;TB1@>HF3(]4B5O)>78_T(J9RYEV/J%E4BL_9B,>YZX\T
MQ8C'.S5"*N/\RCB_TLWHGLX8KKSR6B7I)$]!62F#$5P')Y0)GI1Y6/=TPYQN
MTS7XW;K865FC]:-U7#_[=K1]\/?!SM%76-<RW#,<;I\MG^Y\N.Z&^?M@.[<=
M/6L>PG/1[;.OK/YII[%^5#_:6?%GZROP?/3;P?K*WX=7Q_GYG_6#-;QK75"!
M"(.L5KEI,:5(2YR0=MH E7MO#:OF86%&%]5+Z5M4YF&5>5@O'P'?W(R>I\+!
M]7$<C%3)B#E&-N4FVP;3_)='DA :&;-:<U+-Z)%\6G?TL\_HR<9:116_=&D0
M(Q=&O[JEAWA,S'@>-"%Y3 )+%GA!8Z*)<RY&IRHNH",NH)-ZB'^+W5ZG[WM5
MYX7E5O@V& BS#/OY8Y!,V>CZ9KO;[\1-N.^?S;8_?';:WA[2]C'0]>I)_9\Z
M?+Y\NKZYC=?//C8W/FW![_[3R*$4H/>?.P<[C?KIM1;AN3WXYC+9IEMY-A30
MWM>S]7^V^,XFK/&?M1Q*$=N;'X%JUUC. EK?_+H+@"--Q!HY:1WBUA/DL+8(
M2\TX9508 5I2! 0XSIZ,3C\N3#+0L[15$R75,_DZ^&+MV^KWS6];'S:WOJW5
M/U6.IXW-OU:_U3[\M?SMT^KWFWW$OWRF^7']#SOU9D:X.B/IO MY[C;=N<P/
M-;\/SQ<K?_\TLS_NQ9>3I%-S_ST(GRL\^F&PI#F2-$_.C2?K>[N.8HU!&""5
M<H]^C"UR66(XAZV']Z..>F%)LPFS8P==[D='6[7?S\&=3J.;N]@_TTF/\/A[
MU5J]Y>.'=K?7G:<904\/NN=S&5:^GJZ??=V5D9M$%4:PVP;QR!S2R7A$I98D
M"(&Q= M+S-PP(J@[VMJ+VK3LO^VV6ZW8A&.%_7[WO(=_E='S@D B5XD0:P!5
MC4[N[E;X'UZ?[.( XC:WQ@Q<!<1!]4=.@6S6PCD.YK*2N9B*BPFV<J:%9'W.
M)3E%HP%XU?%?FL!AN]VV;U0?5;,,]F(+B*>9)P#%O:%A9L^5I F0TDX)SJWF
M3BM9DRN+.EU;S90ZAA=Y%A_<Y?(0AE'>ZNES2IO5H^-F^S3&<QCZ<S@$8J@7
M7J%0>!$[/V)5^FF;RR&+_#EK0/C<H+6\&YT-++B(,)P3 IV? HTJAJR726#/
MD]$R5S-/QJQ^J]^M6B)?AJ[G(HZ/0Z8IM' G6OAZ4M_;Y<0S'4Q$RGJ1VQL1
MI ,&\R&J;/ E&ZV=7,Q^Z?@GH]7BZ]+*R6-KY<&J;&P3PJ+-@]0=CEH(P966
MR1FB?S5#O6CEMU'[UDE]>1='R0/5&@D:"-!X  V-1HZ,C"HH^$QAT- XFU :
M,TNM?&8G7;3RL6.F&U]W-1/::4]0"$XC+IU%AF*)2,+),4^=(#%WEKR_(CZU
MG)OYD8\<PJL_&[TW?^K;?&-Y5X3DHK<2B93+WB+&R&2AAE40P2?FK4]5M0A^
M]2KW+$5)4;D?1IM[I_6378^9!@TW(1D-:-F6!:29,RA03X+D+!!>]0P:;ZTQ
M$RU[EO10M.SICO\,](X\.EI;S9 A.!^_U4CG 9Y""B\M]][CF(]_W!GXUK1L
M_.A:=C)>8S@'3@(/DFAOF91.!3 _E1:3Y]H6+?N.U'Y(LTV)>?3N_V?O79O:
M2I*MX;^BX#S/&S,1+J8N63?W!!%T@_TP843;QNW!7QQU-<("<21H&W[]FR7
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M-6'63ML4=(&K7J6-AVL]I9F^NJE.WVZ ^&CWCD(EM#L0VH0V&L[PY'D)JXO
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MD?>G\=,,XYS2TE+BO2G->" 0$Z4D7,=HC=%)!%J&"$DA9MWL;P:P68YNIY5
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MY?>O':V8;2YF!<HJ%IE@465( %;1@/\!2U%V<55CX0M&[:B--50KFF(@PI9
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MI4J!DXF"X9[Y>98V55:])ZN.BE1OG(# !(I4F0DXD8:E381ZFY1@ 7R2)0X
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M[OYK$7WMO1G[^;OS-ZKT<*R'^]L[U&E&E/;(P>Z..,[UK%Q@R$IIP$RT2K$
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M(9%@F@1' E,.RJH2J*USR :<B T)<T9SQI^8E<@Y3/FCRU<3_R;*:0T)[16
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M*S!ZH6 T1QI8@=$#@M%D4H3PP/M\\DA+ZA /PB";"+!!KZ.7F'&>TIQ2EZH
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M\MX2Q$WTR,2<210#_(\1J87+&KI('=Y?@[^@V1W8=M&_?ZS$$\;'5@'$KR6
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MU4&18-/H3]GA\J6Z,[Z>;W47VOJ3C6]P=:.]9$9T\E::=<UWO\>.S5MINP6
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M-?=\/,-ENS2/T]-W]04>GC.I2<ITV:)^#X/Y,X_E/WG.UT%DOY=&S-K@_!/
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MN1 "X29@JXB-EE 7:6+2AA%9*(7F B0VZ^]_)D-#FCGENWG50-%<.ZNO;^P
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M"*9,)QHY4XQ(9 S6B%-FD.6<(:49X=8R(;!:6F4S#*>J;W*E_Y7^/S/]G[*
M@E$J@G&+<AHO DH8D;76H,2%3I8S9[5>(/U_3<=/PZI09<.)D0M@W%'BUNFA
M_[13JW07I\\SA+Y%=2#?]A3J>G_Q>UCYM<:[S:V8D3.&KT?=SA> OT;O8^N_
MQ_ V^>N7O$.5\30/S#R=83P)*ITS+B'XOYR*'BARC'B4<. T>(9E9',SGFX
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M*1AEL:5(&$T1)[G*K9:9N4L)TN\XK*NYD?9:_!=;_)_ ,J\U_$.(^60UW:
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MN]-C?WY-L)M?^G(:JV_UV%\X(V9PD?S$/>%!TF-WH<C11O3QV,5NP<BK(NN
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M(^<=1\PK9Z*-%BN_LJ;K-*;/578?V4:H9??NLCMN%L2@.)5$(6*90CS %#F
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MH2W?"*@O6JJWC0_XP!'.I4@*:9MRB2M)D5:<(&]" +--8Q)!A<%@3TE9#*O
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MX>VC]0/'9++:"P1+2V2J1Y 3WB)!3>36F> 3 ]N.FBG>I]5B_2H2P8KHW;P
M<OWS$4Q=&GY472&(\T"IN9U>ON4*JC'KZI(BVQN?#G(0DW"$H91S1G#F0,UA
MT'!6&:PD 4/"Y/+KTXXA9WW5BB78=..QS?9"MUH</S<=>I.D"7X0FU_;"\*8
M\FJJ&E2[$JZN%_C^P!MN/2P.% 60:VZ%0SHFA8RU+O 0(Q.Y!$CV9TXA0WFM
M'-NC3K?9/[OD0[=9,Z\*$.8%1)WIZZ0&FJL+AVZ?;QXP3H315"*F&.@NRA32
M.1]74DP1DXPAQ&>WTY0C.Y/<J+36C@;=9B\TAY%#IT!Q*C!*@_Z@6Y$C%]NP
MJ/J]43[;"WW7*YU8[4Z_..Z4WJQOL?1QVG;Y); MEU'-9K<",+%BE-.@XNOC
M_&IIX&NS5.G--L6,O^@5V=C[>B P25H FZ+:)\1C-,AA[@#97 J:LLS7P:[C
M?,I!B-LYRGGE+QT2IIN\"A-$OUS$PR75COVB,S+"RL45IQ!\>_%[;T^:N4+E
MQ#)<&+?#FZJ%$P;E2UZ/O+&Q=4 E4Y9+!98C!?/1:89 -<&GP&VPQ'"3$WE1
M.87<5S[,7SIM2_K^LX5X8V[OA=^^G,8+FFT/$-[+ZJ+;.9YI]=<GVAYCW6_!
ML[?NE9H3YKC,WIQA<R'0K9[?Z_-[_N%>I[6'\TN!^<$<= $[1EM(Y89-+Q_(
M:/8.\^Y'5G!34* '-*YEAUN5UO]GT,SUV:X20<#$3ZO_;_5"N792@IDLW%GY
MCA/;S?M)^2D92WY2&2&[<$OO_U4=',':O1E6)\^)7"F9L/#'1CZUN]%WOK8S
M1Q[M(%YCW:>9DC^%6%YM&8CFG\,&O611_ '//4A@?.7S%"AZ&<%Z)QQ9(X !
M$^.PL]20P#/EG>:@SG+R%"JTGLLI<WG^Z4!+(W7R%'G,'.*" UW$P!F]YY)I
M$Q.C>&5-T"G1BWEO?93SOSJ5."H)4>U%Y8EY!8C7R_OLS>]@&H.-TL_[^'ES
MW3=/*CP]++?HP;0Y[@PJ_,U_#7Z)"MFY##-><K,,LT_BO/G%\MH8MJ_W,?8&
MK6Q\O04.N1O[_58L]]H_ ^.&W\.%]4'_,'NTGD/5KSF=-(+G;],#0148U5XC
M)YA&/(%MK9/C*!KF#8\F*6_*5'@W&#2@^_.":L/D%X06Q[ .#GLC_9]WL/+&
M!:RZUL4YH*(L(%3I]*M+U0[ NBYZE[-WY9Q)M1-2G4BY= M59TPJUC"TWW/
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MV>8 )?FS^'+T2?S[_-/Y]OG7 \:2ICY:I'3 H$I GYCD%0+T$$(X;!SQE2:
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MC.(%5$[X:2V E]%__- Q;"/.L4C]_AGK>+!HF^>V#3%S_Y_/'L6\ZQ'_U>W
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MTWHA6Z+K-YV*NE<BG:6&T9>6*VC>=M]]0[ FJLKLY=/ SS+:ZK&@=TI1*:'
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MI::/W6J O\5Q%G;#V\MKTQN0'SJ=:ZU>G=O+QPSO.CO)'!*(46XC7&@/RK]
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M!OBE*)PV#$SRU+?M!'US#:/'@V'?. 9I*O7;"XZZGV]3HX;[M@<^VCS Z?1
MO+A^556?Z[S)6V %\'WU'DS=B0OB&WFXB.M)UPCM^$'5D3%P3>"#>*WQ IM[
MRO:RLQE2A\>_.[T$;W$*?[G/JM[G1@1*^.CN=Z&JMB42E'3K\@;4D='CKJG9
MS0537UL<G/*) )4N.CN.:D&1I347HYP3#LV/2T\/3.-96F\LQ@B56;\B>./\
MP9Y,N,EH0^:[EC48;6/LU0J#U/7,6CL+P^6[^-"'SG7MQ??+.(F\E<3JE7OW
MT?HT),VOOL79'RT8,IZ0BH/[A3KW5E"["K >NV)8Z5OG$;@;E1_\?7(BEQA2
M)8M4;*G6;2[C.K ,P!7L&,.]Z@C4$:,;K^[Y+T^WUT4E%8P@[P;!D%'%$<8%
M\A/_%LRYN-*R7;)3U;CKR$4=WJZ"Q O#W OCW]?@EG"DWAHY=!PB6BN;\#67
MK3K \WP*@W#>33%%#MGT6Y LG9?/600=!R?IZ=03@5GT9F?)*Q 1[AZ,AV&D
MS@7N3TZ\O0\+<CP>Y@7LH!?5W\N,B3K:7P]N0N(5K7FS83+"?Q9^8$_"Q$2G
M1^F F][*(R^T,$%)UVX]'RN=9'<!62GC%=E&T\4)W7G)[5PK#:TWF]6/RZ^(
M!=JPT\OP%&Z#+I,?P@)-J\8;I1"M=%XGQ1W''JBQ=_4T1N;29DIU @=:O;,:
M\;0'J\I-@F>=-VATE!>5V)N94Q"=.Z?73F78FDKNVG3)70MFN0<V<5.G=[)E
M=HH-R7N56?IWWF2*#1'"G3Z0GK]SH-]@7_%'/=E*^PGCIKRL$]:$LX>]Q\/[
MQSIE.DGGO1GE/HT';JK\#0V=IQ1?TT85?(13&,>[*KY=75[K[ W%]QR]C"!I
M3M?\K*J8?BFJ9I81Z;76!;PRMW$RA,T(IE2.J8%."_OZTKE2$<BSEX]P_1J)
M2D.3]R3F%SJ2G-N",CR/[A&@M2,?KZ]ZU..K_"I-/U2WK*F$:.E7E8A1>8+M
MW"N?ZEPZQ[G*Q=#TQOTR7V,RS(6)BN=I&_ 6_#CNK2WSN3"[JI$1,BJ/:I7Q
M4:H%1\Y)UW#$^>^4TX2AP1!=:I>=7;TZZ6<Z3VMFQ^9,%ST87V*Z+,4Z:7@0
MFH)\QG=PL42?4_%QF=YC. <^]6G<ZR%%OBM]B9YPR_R>:DW<87S T_K/ZYW3
MAHY1U!K3CE?YT9DRZ)-/:(\Z%7:R)&_Z([]!;UT<KEX1N&T-76X[L(-8H5;:
M;N<H5?5SEXQBPRL]BY9[2@FZQ5ZN^7/OPS- 0A@CF$H01E?C]_QP,/3>-1>N
M\>II:;*OMVDZEZ3I\#9-9R7&TJ;IM&DZ;9K.C=)T+DV[F4G3236S,E1PB6F6
MRC"5<10EF60@9GB@]#73=%;'5)\H6Y'WSO)Y^\0%OTOS1G1.QB-O@C6KZU8U
M$/,>-,[3SJ:S>ZX29(%3BXZP]8>-L7C-J8I]YT.%FIO7N4J+%CU\(P.GIV'H
M53>B>O1OH,)"#GS]6&7PO87QY[H,4*@YO]^<KCL=$?$/P\5^@46PZ,'KEF4F
M[^L@"OK^Y.DDN@+KZVSK'T<#KP"K\BDL/0";TJ*E/:DU^C(8?@,3YI^=)DR!
M,TK'HRIP,1U9R?O'X[[KZ([V>VY\6DK#:/&I:;CCI=URKHTR8YPLM$VV*@,8
M*"596[ _3?]_N8ZUW=E07VM%NPQKO\=@"0;W9H)<I9^P>F'S4_5KA^/*3]'<
MIT_>=S)C-=5*^)0?)G"NB:!TH5WQ#1@4P0#]14/3WIV*B4=8K5JF[3FKP)6=
M#LK:2$QI<%9(^6GTG<[.9WR"E13^ ]->8Q]H#NG:^0]@$A8((_CRM,O63FG^
MC3C.$=:^#-!\!EY>.H@&Z"=4WA[R/F;J!K(M:N].>-$8W#2]Q7J2]YU3Y,29
M[:6A Q)TW*U)_*K; &S"BN]83&G+HU07 MW*\'F<\FRKL4<8K[R)![7<IQ.P
MZ,>B7YNH+K V%^F83K'8F/"0T@6)U.[R&SJO!9QW,+.K&'KI)'2<OLZO09M>
M#'UF46G^3_F8'$NK_$"ES\?5NS2G"0-N%- B[W7UG_7L]1#H"]_D,H4*S(W\
M[0C^[8C1\3XW*Q01Z R"&=3>*(Q/EYDCFW6=44.NKL&2JO7.+__>_.M7]XE/
M\,YQU_RL+E3__O4R-ZJ9\J)ZKLN:#N.+,DJ:H:;9U?_#B+'%"BH$L"E<C.(I
MIIA\4F+8-:-1YZ_QZ*S2:YY.ILE4!IAWN(!F<I2?%)5_"=V?,[7DI493!S0K
M!0%#NZ.<5)'ANO!L1AJ#8G)N]/32Z"]P\>(D'U8'' ADBCX<TL5,S1B(N$L"
MKZ_AM,!9[N?"_;2%\G3@2AF+\="E'-NA&&N73U:B"@C,9@&&887"M'B?"@"C
M^6<Q-1[TQ:&3VX>>NV7N85^/59GL/,UDJ@$UO<ZU]@>WSDW7-KE*[>-^!,DS
M.V7:ZJ)<BS[6(/9/RS/5N# =2*E4^QF]X[)P=Q6%Q$=KS:I.VR_3]0N@MXE/
M^89G9%+9ZE[M3ZY0I]4R^IWV^9ES9[-::M3#ZP#]),$4GX7_=YL^2R,@ E 2
M8A6I<X-C#L08J]E!2(GF*6EF%4TIKY<%![!( 0N@?8"_?]K\;6$J0%,I+!>]
M5'F;;.$.)KEVE]LZ(=>+-G%J[J:?EQ-?D"Y1AY)FSTJI( ^!((-P40!TYK@[
M=6DV/M.(S.*)\O@#KJ!CDOSQ#G2D\BQ,/C$S\ L,LMEO.E.OH4E6FGV)58*)
M\9A6YH+450%(B33BH'VFR/LI*-:3;:1K3>OW:?B)_LZ5JQ/O_#$86PL*^&-4
MF*;<1A=IQ]NYUMUI)7EG,&PHR5=U$8&@+(5\IYM7T<FBF>C6J.'Q=55]<PA4
MY\BY&DXAP$2NC1IW?.!%W[U:AG:8A$VL@NJ.O97A]"E]J4HG\K)756XJ,'%&
M9G+VIA4,9Q95DY..IIVZT_,P C4T%@ST_\:BR$GU"YH,2*(@:6#*1V5%BDM(
M 9Z[2(NI_5#H&$<$+5&58)T@&JA#9ZH<5'-.K;6RL/)B9]6DY,QY).9H]'S-
MHBG*&@F!J*_!"?GF) /<MC&!MOK]'$DPDSKL60;:;&Y?P1)#>>3*T<RT"ZKF
M*G7:SZ-B()] )3SM=C90/!=H4CX^]H%;=W<L!"E'N%K,*L>W"93F##&//%5=
M+MVYI5ZQ6KM=28D'1?RIU[;4M34:I(W"YS*7>>)0NHPS-A)O:-/1,I_3T5^4
M7.SM=7P]MFBO P?MSLWM'&[7:BU+Q;<>=EE4F<JTBZ5H)Z,R\X@NRA*]FBQ;
MD.1^@4R;HH"[M2I]6NH\#35?,/U@.6@WFHL&/DDS79"*U3!X_$M>-]'C9J(J
M/AD_NG %JK$V%_T*'YD85EDU6E%;>96$7RT*Z>P(S-K+3;?S;AUD75>T0OXF
M=H)0"!$( _# \_C.JO!<3WETL;ZUR$OH69<TFQ<=H)TR4KK04^AJ-D2Y#U6I
M>,-G<I[L\_6FWX7VOI0J]%9/H_Y\69P,ALUD)%6Q"'"L_+LK=:X5>,0M%-X+
MC:\9%W5*.KYQK79D3N$;BG[MNW2:;RG>%RC\4SFS->&&Z:VJ:*[' "[.U)QW
MHUTU&/DTL!8F^?*5-'D]^.Y\<Q]-89QM]'XXT&,'*SCG0?ESB)O\;@Q[\:FJ
M82ECDV7 ;[ILY1U.'][]R^;NNU^=]97#I.J\CQ*.L-JL$__ADDLM+(/ V\ 6
M!I*O$'"J4.AL\*F;.PR'/FF39R])GHW;Y-F5&$N;/-LFS[;)LS=*GKTT&78F
M>5;K,$Q4HD,=12Q- L%,1$VBE 4R"VWX.##NCAQ$"DASAY&$F09E5M@P/T3L
M,I<[@VDSJ#QC'X2\U(O*),PCEWSR6O003U_42#]_YV;4%SW_:%-98/6CI1,U
M]3K$M":5-]#NX6MU[@RH $]%@T)GMJ\W1 7JHT'DXN^B2[9%X0#'7H-"BDE*
M1>>/,8C,<9EII'^3OXG*^JJJ<;O-M-4-! L[[?RRL?UZXU>GMR/J\=#[SNJ[
M7,^(T[5FE68#]TZB2UM4K2VP8A]AS$$?PY=.8<4Y8P+ATQW04=WRI*KW.W'^
M%Y=C,4D&\Z\O)DU$YD*8=8[%+\ZC@!_=*H<PDV'E,S,PKZVTQ*3HHBKJ0K?N
MP4$?5'&'Z*;S(=9F-5;!6$R9*GP2+\)N*0Q7VW%WZB/UL(I3V)M>>;O#EH#K
MKG%JJ;E.C72]\_D$+3'0B%U8MRK;;=XS;<V \MH[&3GTKL')"3J5R_+8/AR[
MQK#K#@_5''W&CW_&_5!FNCE^5:;18A,)U\G#!>O]>Q>]LT[]J^LGW1O]!LX<
ME!JN I,VAW6M+Z+H5]B5#M;!X:%IEZY:U*.>65:P%4<_$"NM62:)#C)7W.>8
M140K>JG+5]W8/' V;L@0$5'P=#E;8%#4IK:[>>%I1))9,!HT7."185Y\Z^CQ
ML$86<5C_>/X'&H-2Y[_'PVKC)OH7SJYKDVH<G*AV?2P<RN>P1N HC_/4B.OB
MV,KY@&$E-[6)@Z$$ABE;(\"[NH,F(RT?G1#<T: /1]KU[5MS$"Z^R\MP=+2V
M*.FL].F5]Y51SAEK&!80;:[AY.@ E;C]<@O9C'S.3;%>&X>>5R]0W7$!\5Z^
MYWHLNM4Z&270$5%>K=ZIT$^!['2,;;;/O*?QT\ Y8SY5W&W'31O3/1RL@H?[
M@V$C@4Z0*ZO%N> -BX;GIN(BLI/Y5$<#/6[>XX"D8URVUDSV6)D^73AT]PD&
M_O1YF#U9CC^5GC#/'Z;/XO1&U2*@.6J<RH\C>&\^\J3; >&4(^9I[KOV^$-:
M _1-/?S#06>>LTB.L,KQ^-6L,7S*748W#";I.822/J;3NR8&3B!V>H,^BL7*
M0^4W:73:]'W507=?H2P:*<5V:-R)]1@S;I8APW>.CIZ&;V;O!PSAE("2!1.]
M,-9<BK'2@[8 _7;&93(EMYH=S!;X6C&A$#V2+G.AC'S6GYW0P?2W+VB'Y+*]
MQT4IW:IN,],3F0K1.9^.Z/2 =')=#:W1'VT69*)$YGN':6.GSF$XJ1'GS9C)
M@O##Z^:'RRB&7^D9:*?%;NGY3]?8&F&S F3:Y>E=D<5Y'L^]HYD%F0SET*.%
MU-UY%N! U' ^&I0">+Q;DY?#$*FTLPJ3 8TXGR8B/,J7;[_4+5D+"E_D![52
MMT@1FK"DTN=>I0;6??*0O;MG_3%N]M7"*ISI?G&8D ,$ZOOWG)\"<V[""XYO
M*@_'1YG=3)N<9BJC>C+Z,NB_V!%>4B/^%7-V*]9<9U3#>$"&#(OIF-*B),!&
M2DHS4)<W?KK4@5UGP$536 A7BH[[$S1)673\M+GRD[^O6&38>2#,PP:M)L<2
MCJ-%*L E Q-*%.6A<_EBJDRHFLX$FQ0 5F#OC7:1)<S'PJS:U^6W$&<"Y2;B
M195&9%.;!0YVU03NRM8KST!%W;.'Y<JQDME$V!JM#YDY6<#-GX;@OC#MU'G+
MC@9='YUV:80HUU<T;>PC6!V8Z_9F#+2?#]: BU5#AJV&T_-'S0UW!KY7PJ;;
M?X'\]^I!9Q^B1N[RAQE*C&'V5['4N1+SKX]PK,.Z)T$-2[4)FM8/U[:S+L2-
MRDI,WZ]Y)A[M9&/1/ @5[4W!2=?672E\%BAYDUL&8J@]@-/0(2.7R9<E;9N?
MV',*O^31D4$Z+1K9K&[1B)GK:H.+AII@7-KKO )26FNZ;/3:4:<2U:/2D"B$
M-8=CX3LF-+4.%.\^_HZ&' XT]XGVSBAVL*M.@L_YM:;8Y[QN<KU-0"$XX>W
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M\JTR-%<*XHL?782>!YK8LF:P=$"T1VOW30/_H7;Y47P_!-7=9<Y5)P>T=A_
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M:L:G,$J3I(&-F,*F92GE4:IU%FH19YIYQG>CXIN6\=T?XYN#>C>AL&'$B0R
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M_N50Y/U?'?SR,PN?7Z=1[!+,]"LWBJWW!F&0$ 6IY4C7XDAJWFAG' $TC27
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M"]MHR<.II?OST9)(*\IXS(C-=$J8XI0(826"I"3*8LYMA"7UM]=*5P]6N>5
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M8M"6* :C8ME+EA5@Q8!:H9SR7&-LM%!"P=0-CS;A4'E8%LFR$QX6;)A/8,\
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M73PH5FE4\P<3:6@D2EHEB>):<<>EM$Z+X*0G7N!*C5H8:$RH44)QKY6(*+I
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MQ#W=.D\EX$8"R20>.?81?N%@$Z<X2B6#BIX16X' 4H' A.<&ZQ2QT!X1GD'
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M=]?;QBJJ+/S9)[6<V;)WR=">(95XY>9/9LD67HNJX"\LV)NY;E2_^(\%"0;
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M2-!<W6@(OYUN[R=XO_8$H(?8'RK%;A3K";?+ = 3C\QJ4996HUC/WN:D45+
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M@44(WV$K,] W([!0X)<GL6\:1G$>3N. ->%WW0/P=E .0L!(]V!!]5%2O7_
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M8QG^7;%+MP:O#<1G$YCV$?E96$$7GD!M1*O.=B_D9T??\1V>X"A[P=)M#\0
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M9S GM<T/M=7Z^N>-]ZNU?V]^6MMH?-RNK3;6:MM?WFUOK&VL?MY8WY[[>VM
MA+!=V]F$.VML;W[:6%O=65^K?=AHK#;>;ZQ^JFWOP"^R)9W_6_GG6A9$ZO39
MLWM@@?=SEAR^Z2B3ZIM:_.$CQ!# M_V7:\'V[+_NX 9,BF!<,?O]>M;!W:_\
MYCJ_K$PCIJDF^N<F]X$>RC.Q,TQV96!;/B[7/O0WS^W1%9\ [&RG<IW!U X,
MK<NMMN G"P:ZE]]0&?-*E[=ECX[.:JYOB/T!^.]3+&BVK?"4__E^<ZW^K\K8
MQK_MT6G_34/3/S*T:LGD#^=@LW;0_IX=!_BBML\*P+"0VJ<=#Y,"OQW:];X_
M,K#[E=RW^K4[&%#\$?UII>;:3JGI82077DDS+Y4+2=?*=8 Q+M=N@ZXY\S77
M^D?S^W[5::=W4/OOJ86GV,E.T:1Z['$[].\[_W+:,SCNMUS+DPQ(S=W3JK?:
MXQQ5G=NA>C*L MO:;X+'V4=ZI3):>4L]P'@^GM Y];W^V"Y?]P#X_5RXO=]N
MA^] ">.?K35AF,U.]6S[7B<\MYZM!)T[)^U*"GIPD6I!-7OQ&+R\4W 4\X/L
MP$0.DEZ^W<V7>+_YY\8:(F;X[\OOZY[$/@CR):IUU*VNW<K7KAYU7SFZ6H>#
M%5)KP3\&B_C2NYQ8P\,UV[U<M,NU/SI9B[@OH="%I0CKLEJ+P$+YP['258!_
MP01T!NWOEFN#H'8X.5?QVFKWAGXU?-I%;P&@ ZCFURJX#C!:C=[VKCSVH_AW
M/!I?]$\E53@>KF]<WMN[L\&+"QVX'VY]%49Q _8(@4F*B%N#D:5"H6!B<EP&
M3.-$('Y-XD=,,YQ/KFU8%:_WK?,UXH;3CL/U7V24#C][G=3>/5]D5>7![*\K
MRH#G:,"#!/18C#X0*GZP=. ]WOIB1-UN(R3XFN__-G* K_G^IXKZW05'+TRE
M9R*PK2;B,WA+K=/[5A;/4-IH9LJ399!W'N1,%O_/ZW_G[AC_VH_'J):^DQ9
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M:\>HS$HGV-"'*YT4!GA=#,"3"RER)9B/'#[M&/'19;]:849UV2V90P;8'64
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MH"ZM(E"7PDC&1)2*E&K+BB#  L!8^8B5LBQRQ7DTTIJDN0TL"&,II[QX&L\
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M4F$SYW;Y3*Q%#3J>& -C,F&F3ZOW#^A2/>OVUCK>FBJ/)Z0FMSW?8FL<G ^
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MLY86^P<27!;<2.](2;4^U]@2<K^"@.<@9C.!MMCWNXOWN$[[4?EC=GDN.J!
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MY5=\SJ]%.>6+B9:F[%GR]*EV-EO5T4WJXM^^ZPZO3E*'JI1-3 $/UZ@)'KM
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MFA-IKK.FK1B/E?0YVT0JB''7!N-H.+Z'?QZA[X?=P617]89)$!R]5J<86D;
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M;#IDIJPEZJ<LL)43I%+./'$)Q,J :*15B":@?9]%RD[;G%:[+G^)"5)---Q
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M1J.;J^O["HP'Q=<>DA(2?7HK92G;403?,TJL9<8:2[G2M7N>U5W!GX;,>T"
M%I+Y[E=S.NA_@=$8TF191W'<_=(=?W^$ULC,M1.:Y!AT:>AEB*4H.!>\5P%H
MV3A;H^LJ"/_$=*RNP!8ZD,Y[>=8V52:AJP">*9<X 6F R* 5<90[8F@N;7]C
M:6FQA8US(_#;"BOO#36WJ>Q]B5?/7_/DIZ.CF_'GP;#[OY ^H0,^?'!DE#&8
M*(R9\?-AV(WPH*-\9FCB (H_E+L (36>$U(1EK/WSD T8J7V^8U]W$;+V'TR
MSU;Y^/BMV#$OVK")-U_2TP7-@H K+*FM64WUE[.C#*5=4ZT>]:ORY(6\ I*!
MS\PXHKT+TWHS&X4A0F;%H@7!7/6952^%^LO2L_X$S%^''ENY)GE[_/'D[T<7
M)W\_/CD]O_CX:=)(\NCT[7\<O_W]Y/3WHS?X5R<7)YOGC:W[@.:7*8V6].A^
M)? HG3 V"$LE$]3KY+A$ERL$C[^5.NL^K.FUY[#[!6GXY4&N"=51<IG*N%'!
M"!*LY )E0Q2S-@1.C3:J\HXS!T;S"]W91\ZF>YCD,SCB@1E\4:@@^.)8XC0P
MR"+0G%<:7;31JK;J\#75Z=,+VLTEN6L_K-1:'/=A>#GMO\28SI(&0TS.92A0
M]L19+0E7+%CG51:I1JG9_1-WY>4TTMF@L>PJEQI-4<Q*GU; 4;& [.&SMU\]
MMJG\GZBP@?#:5*91SG'O!5'>6R*=1X8*5K+0=))::Y?I2F?-SI7X3,58;1VN
M([,6G)R_^V&W["D?_7AJ$K.4(@L,2 BE(P950"REE'#/M6(2_Z=KQZ,>8WC)
MVVP5N;9P*?00SVSW6 %12^&8IVAVE2K91$O/J+R!B%M^R>\*T)P3'EW+R"C'
MO<L9XA)+)!IM(5DN+:^=%;0MI2]-@VQ7Y^M(MI74U]DF=M(?H3%>[.V/W=&T
MD(UYIJ4"08STILSY2,1F"@A5*V\<0#2U-_?G\!S"1E]-WBU<S=YC>X..V-#'
M\07^R]G>M *VUK+E%^/:S4%03XL+Z5%)!:UN&7,P9A^-84 )&.V)5!%WQ\@%
MT9SSY ,3G-5N_KI]>BPY,G;#CG4DWP(K/@P>],D##ME"="1PF:93O;P*EB3.
ME8$ SJ;:]7L/GW\(!\7&\FRA^\,,RZQYU IH6CH*?D2RF\U_<\TL4'$#L;;X
M(L\F"8L0G0Z>>-RVD,,<O[+>DY2C,A0B#=433K:AY"5;>%LZ7D>:E4-O]]>8
MVG!C3.3$AI*[X@PC5D8\."RW)E*#9]!*M\I+XFX[S_:I%0??3')/U:<:J^]V
M9.(J,"I&P1\\>OM!\ V%_UA]#237QGMX"\=%[U.*EH@@T?FW8(AE+I.H8I(L
M4:K52M-&=ZW 9P+@=?6WCL"V4QCZZ8\_CC[^]]F[\Y/?3T_>G;PY.KTX>O/F
M[-/IQ<GI[Q_.WI^\.3D^?PMCW^UM4BFZUL=7*!W=?#F/AY=P8:VR5C!:*DJI
M54):EQ33W%&94V>]1S4< PU?CV(<W/3'W?[EA^&@CU_&:9KGV?#-YT*PD_[#
MW^CV8Q>5\_Y^6$6P5C(\-G ]: ,(DX@77A,\^R7+AG&K:M>6-@9=H7OO$/P(
MWL+TOR?]6;GVM+GLA?\&(SQ5I;2:1R* 3[(+!$&%2Y*\$ F/7*-="ZW!EP/;
M?AW(=EDVI^%O96VUT/!G4Q'=ME:D$3<LC;9;8K%<?J)X6,)OG=8)8@SUD]\;
M =Y6TL]NB;<]G>XZH>@NEW/6^N_X?VZZX^\EH7/0+^N]=1=-EC%GPB97],:B
MP\&3+KUA0U!4.Y%KMS5_%M"NW*\M\F)1&]7&^FDAOO((TUWP9SFHEF)J<P'M
MN*%J<\4-VI+ZUBBA=;DH8(K@_Y<]&2()/ 3"J+6.4>'Q1R^7"JMV5]T2$]81
M=@L,^%C<G#ZD8S_LXUXXNG5WLS(1T"\F45B%J&PLG3@2P<U/!T,SE[RVUS$?
MR?:-Z0IJ&E27\4*+N&9(X>/QWX]//QUO'#-X].^;!P6> _3(Z[>2"FY8Q#<R
MRV#Q=>1,1^6T5]DK#YU'G]6X]Y&_O!S"Y:26YBQ_A"_0OWE@UF9.)5B;B7-1
M$RDS(SYP(#2J( P-R55O,KL,4^,>W/ZZ._:]4BPTNP1^,QB-CZX&PW'W?R</
M_0##[B!UC&5*@+&$NTF\+6L2E%;$"H/O#:/1^=J;Q\K@MK^?5.7*DZ[=K2BE
M;F^E<]^#$>ZG5]U1.8&?8OL#=7!U<]6)7,3@K26"*DZD,J7Q;'#$42D#LY%S
M6+(#K?&T R%"6_*M:&H@1,01\2P=S-8\X6HWW(PA=4(*5+.<B$FEMI%)1JRU
M@J!9E51.F2?JEFK]F0<<CJ)K2;%BVO9*]//?)O3+204E/274&%^F3.+Z61EB
M$VRRT1K-5:CP>D^?=CA:;T6^+21QWJX7?22I(K5)$L-*#U7#<8<IK=)D](II
MA_:9K5T[/GOV@6B]D4@KIF'=[SEG&?T@&(V[\193A\4H-!5H3S"#WHNADGBF
M#($0HDZF9/WE5;?M)Y]^('JL);^*&1U+UCL-@1H)P#RU1&6!MF+6AI2.O$0(
MF8TL69WUT^^?P;.U$N8VW^5J M_U7<2/N159>] E$4(86:[ULB7>\T!TSD%S
MJZ+7U1))=IK254U]<_.[UA%CBVE!J\ XO/RNM82_(#]H$\FUJ$CFO4E1"_3R
M<'^27$<2'$^$:PXFT83NP$JY$;M6X$KY737TMX[ *NOMUGZ_!:($,&7Q9!$@
M)[,]%9XV:-1G:G0V0",:]A4T]\-#MV=N-1+[H(;,*L:V)D"FL95;(($):BEU
M1%-\O$Q"$N<M(SP$;DQ(POJ5JE67*>_A0U^@\C:669M#:&=35L^GYM'TOH]:
MW$.8UR1%BA9?AH".%]-$<0<4UQHYJ][U\CE !V/^U!=_&QVJIUAF)10K@&FK
M+>1#(#O.D&BNJ,<4:"SE-K:%'T I9YE7D1/@MC0_2640GD%XUHC@DS4Y5.\]
MWK[*5\V$:%GCZPBW[K7$V^'-Y5O<R7J#ZX+G]D"BDJN4P!-3HJ>3'(\ FI>.
MBP!:!ZO"H^Y \R9WS/OH'72(WUS2@XIBJCVLQ5_V!R68-DNE4&@_<"4=VOW!
MH24"&BT1Q!)U]@RM$8\8EZOL\<>^5'4U$D]EY^;#<)!NXOAL> [#+]UXV\DD
M).DBKL27A'"I1216\$Q20K.!FF31E*Q@)L][]L$84%6$6_$:Z &>T5$_W2(:
MS3I(K "J8F!I(9#MAYF:Z^BIPBL)N)U7?0XX;I0SQ;MC.:&W&#/:"H8&0CV/
M4=#,<7MZ>5I_)C:U):6O(]?*RKXS#G^'P>707W_N1M^;+C,RX5W S<SE,C0:
M3<2@:9E7$"A(&V/4-;J=+@1P4#M\'3%7O!*>@)I:*0\AS7:A%4!5W.87 MG^
M-E])48.VI%S[]5\(SCK/N321F%R&\FI*20A6$I5,M!0"355ZJVY9]<_L]=O4
M_#K"K=U ]V8XN)Y%?H5-P0MG"75TUI@DHH\2$F/>90<\KA0/6=9 ]\$SMQOF
MKJ2"007Y5;ZP.!T,QY^/KF"(:[I% R'+!(&3I'09NZH%\66Z1 HN:^N4 [52
MW> 2;3Y]\DO7:4-9U@UFG8T_H[%2:AJ'79AY_MYQP1,5)%) HDF.1(.L"#CK
MC A2X\ZT-# R[Y-?LNIJ"*N%VX99 O\_NN//;VY&XP$2Z[4?=4=GN0Q@Z?8O
M)Z>*TDQ[SC1A4I<5E_F=3G"$ZD/PQG" VE=2JR$[&,.[186TD,FW'.4LG+@"
MSI;NKU;%N)NKK3;TO#:5&BBIA>NOE?$RB$9!&82M2EF1QHW3\B (94GGF*6D
M?*50[HLATY)+LWWBTCJZV1*'WMX,_5U[0\\8LTXX8K/F1#I;[C<40Z/8<R-C
M8IJME.K4D#L/,?TISK"-E?"4)+I-DLP:U:^ <(OGUH_H]N?$VERK:U"F@4JV
MO,/,]D 1T,>FALA89MQ30/\@9TN,ME'RI'TTM1M"[XHT&YQ,V^3,.IIH@2L7
MW2L\&<_RQ=#W1QF&9_GWP2#]>$,C.$A&$R,Q,SR574AX($=T!;E,&K=<*53M
M'O(KP#JX,ZFV*IZRQ;3,EEM*KP*RI9-I)8"[.9RJJW<]^C30S?:WG=E%+A.<
M!@^$6X,;)!A/0G"N!!$#AV!!A2UO/#L\J/:#/^NH9$NFS;02_+/O]V%ZP<2S
MID*P3! /(U+B3NQ0#,0H[TUI7_<DNMN*<?,8U\$=6-65\90PMFW"S&B] LHM
M.E-/$>Z/0]5,PVM2J(%Z=K#[S&:",L%"R@YU77+ RU@Z9[0C1E(6O?!&\]I=
MKG9)H@T<K%UP:!VMU+V"?-T=7'_VPRL?X69<+NE\/UU!*E\E*&=K'%Q=^_Z#
M&S?&O;.<$6]I*#,(&7$L6&(=]3&$D$ O3[5?]ZG;3^MN0W&#[4B];N;^Q>?N
M,%W[X?C[+90H8W1"E9$VM+0S"0;M..D0CXV&4ZF$C4L)\/A3#TW!C:16]PW_
M8\*K(2#%IE]VTZP<)$0CI0%DD<"U<9_P*Y6(DE)9YYUC62S5Y,*//S25UI%C
M*R6/O?S!SXCF0%'G$R=,,]PIA,?5Q1@)=UE'X[BCJG[=VP, !Z7VYB*N6*Z!
M''S3Z]Y7<[E,*0-(Q.G(RGP;15P 2JB35/B@( )=^OH^_,2#4ET3:55.OO[#
M_W,PG"UO6HKI6%(JYW*/;"7:E"83[THK*9I"Y@J<Y#7R]YX^^6 <_0J"?:IF
MURA-TU_!6?X!TRU_5P%5,<=^(9#MY]@WU="@+?%63K5>#$ZP%+Q-GAAC.>Y=
MOHR %QX)[G7,3I:Y%2]/Y\\DUV]%Y>M(M85@RWU6*^YKTX:N=U>RPJ"CIC+)
MVAI$1M'0UT(1:YF6D$2(4#M#9C&:@]GM*PM^#B4:CZN:#VV6?;$"N)9BN,_A
MVDWDMI825^)& P5L;>.8)9)*!EE)5;P)W":]8,1SY@FXG%CVS("OG9BY?7(L
MB<CN@AOKR'V;G)@TG[WKEQ:,-R$1(SBZ0$JA(Y,T+ZDX/!I049K:DQ-7P;5]
ME[&>)E>ER*9J:&$DXEWAXON[!K<J6$:32\1Z)4LPHDS*59I0!3HIQIW2M2<_
M/471=%T/.Z2?Y=DLRD=MU$>=Y*P*-"E"-2Y3)AU1T4&7L  :?BA\%VI/*5D-
MV0[:SC1CPF/RMZ" %NA_%./PY@FL-S>(M3\^ZJ?303].O^EXHYP5FA$NRW %
MW I(,(83ARZ(Q]W!IE [B71U="^?+NTHHHUK\?G3=DYAW)%>0P*?B?$ 99B7
M));K\A7C-&IKI:Z>BK,0S8NG1"5!MW _@GO;S:2=_^VN5F"-/D(/EY\N!N\'
M_<L+&%[-0(\ZV2 Z#26+F@NT,Y,E0:M(+#5@;-"&I=J\6!/BBR=+FRII84[*
M"B.[.HZ)1 .R&G@H':V9)-[1,C$[L.2$=7JUKOK-=Y.'L%X\4VJ+ON+5SG.7
M6$>C$8Q_'PY&Z+;*G"R(XHX 1>Z6CD^:.Z*D,"I3J:2L?2'[/**7SXEZ F^A
MN/NHUQM\]?T([P;#MX.;,,XWO4GO@H\0H?NEA$!'MY921SEN<]:2&%<*;"0M
M-:7.$*7 "V1TE'RESCOK'#6KPWOQ1&E+%5LJJIQP&@VH.X@@HO/9EDX9:#TI
MD8CWB9*8J F&ND#--@JW'\%Z\2RI+?H6:IOF07S?]:';ZXZ_=Z3B1@1GB1#)
M$ZF=)D$(3Q@ M0&$X&H;-05W@ Z2$9N)NX6J@9G-?'NG=O>?.+CL%S.)=4+B
MSEBT@IAS:"TS!03YR8CVGGDKI!&N^B3C9:!>/"?JBKUBZLD,X!VB(IUN__(#
M#/-@>%6.O[/0ZTZO8CN).66IH\0DZHBD*A"$%HBPUGJ>#-K,M;FQ$K 7SX_Z
MXJ]Y2?UP%.UP!O'Z'N+@#N)H>$=ICU]/%M7M]^';^#OX82>B-11!>P*V]*]U
MWA,?HR'!JR0S1&-56IIT6 7*BV7,3G0QATQ-DLJ?A&AFG0-F@ZN-\"HK% >?
M>&)EN+%G>%)*H;*7 -F*Y54"RY[RDBE058)SM-MD/O1B;+=SB_$X<Q12(!P-
M8S2'T6T*>+P1;61TFJ9LXO+4XV5/.4SM;B#!.=IM'M*<8^+./;+.\<]1[D(Z
MZ7_ +:@[N!E-9UB7C&KND*0D."BS+DI6=N",!.LDL^"8%F$+;L=ZJ%\LJ7:D
MN#G<:QPPG1>6.8J3UIZC^\A,AY:4'@.<T, SPJ2!.,$LT2DZY96@K'JIZFK(
M7CR'6E# ')YL'$G%_?-3'YWM'MQ-3[A#C#Q_@UY8=_R^A'K!:9%X5L1$"VA.
M2T.\S)Y0RKRGV86T@C6ZVK->K-+;D>8<?6\< T6$IX,QW#-O 3X15#" ! PE
MQ4LF9M!YRIQ$)[5@6G,MEVM[E2>]9%U7E^0<36\<ST1\"Q!Y0.\WE^-(L9(4
M[A ;E#\43\X((9-=;E$>GC8K2&N._AK'(#\,!U^Z)>5GS@'224RD#!Y(YMP3
M:;1&\X)*(H1-.0)E3*Q4\;+&N?T<GA>K_NK"GL.$C:..<TZ5>WX>?[N&_F@2
M(QV.?*_C%3@O1 EXE<BHC&68G9,DVZRX]TEKM;QGQ,J/>[$*;TVF<Y*JFD02
M?SQB%D-,RE#'M2!"!N2F0,LB<!.(8=E2='8%UV[-\_H@E=Z&/.>HO$F\;S&H
M;*-DTCO";'$2 @1BF<KE/$+O,C$55S#!#U*M=60V1Y%-0GOS#8I_#+MC.,NY
MPVF@*FA%8DH<=Q7\PYH8B0,.620*EBUO"?+\,UZR2BM*;XY>&P?U[A8Z+;14
M #:DD!&.+7'CA/M%-IIHF2578*UVM<>._(B@HJI]K[<U@ZN!&.>E+[\JBTKC
MO\;>8 3IMU_&PQNX_^&@/X9OX^/>Y(&__3*:CLUIRH37I:54A/// $C1>-\Q
MVOF$GI[/),52?%N*HX*DE%A+*44/GRE7NXYL$99=%2<W4>^@!3&W4/4P#]>L
M6<(*R%JJ1%Z,:C=UR'6TMP(E&HA^N^20F5MALB['5B)2ERYE0G/B(TA9DEAL
MV,;NL,/ZXVUS8AV)M\"%IU'_V;C#@%Y%=HPH&B:#:"()%->,)H[.@5NE=>W+
MO458MF\PUM+7TZJYYL*NV]UQ%F^XNZ=^BDV:8*P.Q$M@>#Q*7X+&:-@FKG@9
M22227.H1+'W,B]=Q=5FV\+*7.,-34,JY&(M]+%(NW=AM1G\%!/&:*FT !5$]
M7#L7R(NG0#TQMU $^?IFA+[1:'04_^>F.^K>'6O2::Z8%83J$(F<($+?B9C$
M.2XV2UJ].FD!E$-P!RH(>4NZ+U\.838Y816 ;3D%R\#MR#>HH<H5Z-%<#VUX
M"$N!BI"2T"H3$4I*(AA!;'">N(B'&LM,@ZA=N+8CHBSS%W;"DW7$OY ??_OU
MD:#>X[>3OYC\O CB(^17Y;^?/I[<">WKUZ]_0<[$P?#Z+W%P]>M$8 \*ZMX/
M?'_TZ ST_32INQN]A;'O]D8_8AMUKZY[\+P1N>X#?KU?R(\+O'W*#SRHOR3X
M-H9^@O3+JV[Z[9=N,MDY""I+/$6RT"$HY92P7"M=7N?.N@^KX_5-GG+43Y-'
MWC_M/HK*J0'O+2-)>8&'(4W$B>0( Z,Y'H51RNH-=U;$5M_SG58/<R>R ,.(
M%9P2R2+Z8B8H8CQ# UT'H+%]QW='==JM\&*Y%[R^X-OH+;1:3F2FEAHO*;$^
MX[XN'$<7KC2AHT+[4@B*2_^3)*5NARWUU;*EX3L/.A)(9PTH*@D+:!'(S P)
M 0S)AAEN<@PZU;Z(V[<6$%LA2T4UM-&':(UN!,R@3<<Y)W;2ZU*A#6F%HL1P
M%C5P+T+^4S6&V-E>4T-!;70D>K9"/8%P"2BZ!QY2&0N,X,J\>BB-"V2&E-4V
MIK3OL"' SK:;S9300E>B\_@9TDT/SO(/LI@( @7RKMM'IG?[E_="F<6_7,Y4
M*^)<<5REM,2""R1(&97*T2#5:R>-; 9U6]DE6^'2-M0US_#917+*7<1U%N@X
MGW[N=%A M$[(% 0QX"99CI0$+1C)/C$3,X-H:W<S>1;0SN+2VV#$HLRGQIII
MP<B^Q7(; EL%3$LAZQ^ ["8\75%13T9=-95RZZJ73)A@)2<\*R (+Q&;="!"
M&26%<MK3VN;-%E2^)-"\+8VO(]RZ@PK?=OUE?U":K8_N\B)8<&" X!^22*HI
M<26]EO'H(%N;W0JC)I]\[ X2D#>7\*"2>.JFC;P=WER^A2_0&UQ?W8]8DTE1
MK2,0KDM5(2Z$. :,\-(5GQJO%<O+U37OHU^JRAJ+:2N7-Z\_G9^<'I^?'[WY
MST\GYR<7)V>GYQM?U#SW8<TO95:&^N@"AAEKO%>LU,A(D"& 589Z"HD%997M
M//?!U2]3[UT&I[6C3 O"N?)E*B$C@0M-@O44O421ZD^+>@Y/"Q?'HP_#P;O2
MG.*V05:'(\<%*(VKC;PD047B/"[96ZIELB8Z6_N"9058.\@^JL6+%:Z/&RFA
MA<N6&<0W@ZN ?DR!>-])[R3A7MG-W4G]>HG>CFYOOU-QOF_C*UUTQ4>CFZO2
MWN1+::4U_-Z)*:;@HB;1F5(:G3CQG$="8Q36:Q$9;XM951=R@%S<G:);3(^I
ML:C[21D/_J[CHZ8N,$Z8#V@B2([>/!64Q Q1.TF]MFT="ZTMZB>K6R) BQF#
M-1;XP[(@A2Q1Z)*71'<?!7%*<'13M0:C.#!)]YC7/]G<EK);N"*;M>!["V'\
M8!Y1XH8%3A%03+;,(Y+$1X:6CY!*1WRQ.*M]OS$?R0$QJ(*H6[@!>\X./H7Q
M21^]2IBTTW'9JJC*'JO $<D,(RXY06*(UBD6#:]?%+LJN .B23L*:6&$1]7S
M'<8=%;@6R3.26;%7?0)TM"00H[/A&01EL78GP\I+.$ 6[D*Y+0P.J;F<-T\,
MT4==[SN)Y9B9U2AXR4C)-2>6:DV8"-Z U-S /AMP2Q?XD^=;($8+ U*J+G8Z
M<NP]^-'#UOTQH<V*@B<2T(:1(1AB(PN$J>2RRS*(7+M.LOU5_>1[6Q1H8?)+
MZV&'2;)CQQD\PX3EA,K)?)LLB&5,D2S!4E'F9%4O_=_.RGZ2O4TJM##2IMTC
M;)96]<%_GR1.,9&EI+YTNBYC:HW)Q.L,Q%'M12J]V5HKA=[* G_2?PO$J#FT
M9SNKO7W3M0O@N4'?11OTN,M=("T..)?.6,ZYMWMMW?S<\;=,@IH#A=I8X_17
M.LRRY"*>8())--D,]20D&0GWSG#(/*M8NUZO_BI^TKB6BFL.2FJXI-\'@_2U
MV^LM#"QQBV:6BH$XKU7I"I6(#>42Q2:K15 1B; ?U%VVE)_\K:KL-N9!U7PO
M/PP'US <?__0\_TQ_L8Q_NXD ;*3O RVM%6*W#,B,ZXW<,L(4!6= >.XVV<K
M8^'"?A*\12*T,8*JYBIGH= +_^WV1++9@Y7>$EXFO$FF\&4V,A.1*,\&%RI@
MGR,H3Q;TD]XM*+[RQ*R[$^86\=N;X70*;7=0#IBS_ ?XT<UP4D(R_>E1^N?-
M:#RI(>EXQ;6V'C%S[E"D*A+/2_N[,O0I2F>%>)1P-B=UOQ&$ ^#85K50<P!7
MBS[F]#<_#.':=]/M'(2CVVY&MR\-3X9JA:^*S!Z]3H=&O*/9$IM\B*J,H@HO
MX$YQ^4(/@.$OAR@UIY:UONH'_24Z,1K+R^QX/#!B&>B42-!XF 2+.X,'T![V
M.6"Q:%T_R=\>#=J8\-;:(J>11C *3+*4X,**_",:2D)PPJ5*F7KO?(27PO*?
MD>;65%]S8ET[)2ECW[_L3MY8RBTNQ@2B&4675BE)0C",4 J&L=+%3N])N&[9
M4GYRN:JR:T[?:V-=D]?R/@G@UM@"@^X&%YE0&<L!Y!BQ/%GB;-;XBJHH]OHV
M?.ZB?A*[)0+4G#8X6^$,\KNB)'C?_?+P#9QB_ =T+S^/<55?8.@OX=,(\DWO
M?3=#!Z@("8PF8'BYR;2.>.WQS%$1(@\QV>JEH$WP'A QMZ:VFH,19^ 7@WX
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M=$!=8AD74-MP6A7<]B^;6E7S8PNK%1VU,,GGTP@^EFS>&1P'R0 W0 !81C,
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MF4$/B0]H$-3+& N=063"@%"6@O62@=8EK>)=<-5+0P8UA%WI_\'L8!]!UWT
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M,8QH:NIG?-91G(M7UU.^C2@;?R"Z-V&C"ZY&7MTV3,?QZ_KJ[$D3Z"GPYD?
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MXTZO\2 3 @0S'#Q7A5%*.26E(!B>-KW>-Z$ZEX._LOP?6TCO$=I/(USQS7;
M.$A,L!G?*<0'_76[E^GT4,S@Q\RJM)]X1LIT <D)!Q$" ^<2!Q."$@)7(:N3
M[QS/>/:**8YC._OH8S".OX^OWKVY_-"?TV_#Y]3A\-L%<(VS3V>MO&&&X&TO
MF,\^<A*5XT):AW[&#6??AL]LP]&76);:&0?<2[0IDSP8IQ50)V(F6FNEVX;R
M;VMQ]-UG)Y#1..F2 \<5+3Z6 )NH!MPR*N5L-0FUJTY/DNUA'^T^Q?:PCSSK
M$O%]FB[<U;+*S4WB?9ZI-[?,<B^6S'):,.JML2 LPX4JBTYU5!(8]]D)3ZU8
M)_3:\,30[;N>MW;;B+3N0]):8<--D?O'O\:3SV7MOTUGLVGY83X*65#&U'+9
M 83G&7S.!D)F.BJ/\#7?J?6NW_;L]=Y$K U:<Q\N^\UDD69IOB@1],<%_BNB
MRQ+P#]SG-,+S)TB#P;/RA>R$!5-8]#ED030CFEJC:]>6=4?WO VFL38JMN_=
M?Y?=P$)8&"BY\QFHI(7++";POHS;T"K(Z)QFLC8YV*ES/?:QAPI2'I(SD,7$
MHT!(&B\O$#EC-*.R@.@SB]I(RV1]WJ]3YPSL=QY4D'0+SL 5_]P_4OR<EI1T
M\XL?K'2E(T)21Q*P0 FNF5*PE'-PS$:G8J*1UPYT=D Z#WNH*?=&'( _EOR;
MFX_G'[_-DHN7D_NY>3J*S&5;N&B4\.CSXGD%)FE?YL [_"_WBK4(&;M@.P]#
M::*)BF4PZ"%?,$UNZK&65-8O2ST6IR/#B:5"6W2 4RXTE@J,*,8<(N4BRV#X
M;L;WS9_]O%5;1V0-7K/13763SV,TJ9L#Z5U:O/IWN+J.&-_\?3J-?XVOKD9N
M61#O'.00* A<-WB"D%GP++.4"2&UGSB[X'K>)M%, Q4?NHK94BG7S9:ID0F,
M\\)13S&$ 6'+@ *C"SY"\?CQ3N3=).&;/_MYJ[6.R#:DB?KD!B_$WPAY5#_+
M1Y1Z2FA(D%CQ1!VC" D]$$]X2$&3Q!S9K<7-'_[\U5A!:!OT6/G!\.:=77J#
M[J-B8+S4(.22;CAK<-8YP;0QWM?N&3Y!1M]Z3M?^4CT51M\?4>>]1\SQ_+]O
M6BHU#UHS7[R+ (*&LI;L2B"JM>4LD%1[,-Q3>$ZI4F4O76^-]'O*O$EYP0K;
MBH3^7B=&%VS-:E.VXSI634HM+6XUCTHJ&-I,9.">6V%!&<'1^W0,K P1K*+,
M9L*T[<8Q==+FL;/JY!C6L8_D&UC%77+JM^\_LE?C-,,O^?+];?HS72V7S[TV
MBEM>1I\@2D-*-8Q50 0>GB$DBM)IE3%\$MFY7# -]-#@.?(.VN_)E:DF9>WS
MQWA7+*0=P#:Z>_8">IS+J(7&MQE5,W6U/)$Z@7:4>,XUQ8.8.SR790*;2U00
MB<N&46&KETV>@&WMN,E.SK3VT5)+DWHS^7:]F"\EP&Y;BTGVS-M","EY!.&3
M $>I!IU1%(%F&7+M@.D).,.G5!HJ<IO)]-3", W>/!D1J7"05&&-LYKCYO !
M-#%,>**\2_4'[)UR@W>_\+F7?!L4R&SM,^V"ZV=M\-Y+9UT;>P\1^) -WC9Z
MKP5-H )!?*HT.*4R^ 7W@5)>,=.D?OJ4&[R;V,$^<AZ&IM,Z(2-/ 3@K_&%,
M27!9"Q#.TT"C]7@55M;\:=-T]KD">LJW09W<1C:Z+IA^1IK.O735A:KQ$$$/
M1=-)E0\YTPB!4H9VK@-ZN5* ),X*3H-AMNW&/RV:SNJZWT>^#72^;28/GFY&
MIE1(*%DIP8AE(EO2(/&WC39$<ET[E_ ,!I[U.?1K2+I!?>SN 4I= /X:>+:W
M*O<>9'6('@8Z,1X"I9YR:1&9S2+CR<@%N)@39)%DSMP&&VNG"Y[7P+.V=K*/
M^ =@^5RN^*:IV7 \.!U>FX5YV/AL(043K*7>.?NS4?WVN4MZRW@XJM\NJ'Y6
MJM^]--:-YO40<0]']9M]H#Z9!#JBX0N;#7@;/&0M$;2AZ/*V/@9.C>JW@0WL
M(^465+_WZH#)[9M&YH;'&"0P952I&W%@/8\0990Z1NH%66,(W$KU^_C33X;J
M=R_!KU/]]I1:77J%&TBKGLX-T%@4UAFEP1B'MU?(&+8*)D I:8U7,1/J.BIT
M^[><AV(K27$@4FX=K8_H@X)-&7W3&!58GAQHYDWVPE#\JQT5>\*DW+T4VE-J
M%6N1-AT>XA:24IDS7 G06"X6'PH]H;5 0RR=U]*R=:;&+D>N."=%]I1:Q:?8
M39!6]0"6:9\]5Z ,YPA)45PBDY"XCAS_R='X_15YM"*+QHH\1&H5'U0V0>*K
MTY[PI+.5X%FQK1S*:4\%<.Y"M%%D);H>K8\__>P4>8C4&N1'WXXGZ3)O> G(
M47BF" .M2&F,L@2<U!00>0J*66=C[0SY-BQGD]:H(>L&$Q VX7I;N/MF*YOO
M@*]5DF,'MB.E.ZIHLH-Y]%9#B^3'+IR*$QF<QC.1Z@S"9(SKV'+0CU%6(% N
MW5F8R:Z$R%&L9!_I-[".I^?T"6^X2]P 4=Z#8%9C2*$<,(J?Y'.4G.3*IG%B
M@Q'KZF^O(8G["+]ROB5\2?'Z"A=^N?B29NLL";]]_]W]UW3VXLK-Y\L-DI+V
M*44*B08!Z X)\-1BU$)-S,E0*T6'F&"_+WWN7D9C,5>D*]D/Z6JT=P>LFWV0
M?J9Q##>CM2H/LI@>>JB<V]L;<X[$Q81G**>EWI2(0LN3EB,,6"(R1Q]V,QF=
MB,UL\3E.V63V$7\#C^3-Y/UL&M)\_B'-4^EPN9C$EZ4C9?JMG+BWEV.TCEOB
M*)0GB5*T$,$EQL!EO#891O>6UJ=%Z@!L. ^EO6X?D2755DR3?J''K>+SO^/2
MWT[G*)!"_X?^UH=TY8I6YE_&WY:;2RACM"PC3HUQ(#S!&SSG"(P1%RR)-*U3
M*C4AY]B-]+F[/0/JJ<'0F0VP;C=6%V"-<BY;09T.E4=MS4Y;JJ7!G;8=('-2
M:D4D1(*AG8C&8_B8!; H@_$D9?RMYVTO!W![',U<]M%&$]?G'F_Y7^[;[97*
MLZ7>: *.A8SGK*!@9'8@;2!6R,2UK9W;WXQD^/1+)54]IGWL*^?*"1<$<5>#
M96CPC!H!1C/TH((S^"NM@?"$3C_13-H.X<^]3WSN/D,? 54F<USA6$U)[("D
M>Y;CP6</G\(X6,2/U=1#/)63#P\!,4]9B'A>T&0I",,\.*<Y6&.C);H,#^KP
MYCV GIY(&]17TSY2J:N>BR+;@N;B\RS=$%RL:">"ST)D#CQ8/-Y93N"%D6!(
MT$X)C##)[I3RUH\?-DKO(>UI95'5O;80$S4;,5&%87Z.')AV)5F%<'!M##2)
MAC)A3>XPZ6KKQS]/]540U=;=5W.<X?L/KUZ_^O#AU<N/GRY?_)^+=R]?7/[^
M^^6[C_^X^/#J'Y=O7[[Z\/'5?_SQYM._#AYTN/<W]!^!V&]1:\,1)5/42\F=
M2N@DHHOHT35TQ"@3L^4ZCO;^MGYQPT4(UU^OK\J@HV4B\,7TZ[=9^E(NDQ)6
MH1!2B:;>_B#KM6BG%D\+M*Y4JJ(RF&0C9%P0]=Q24IU::5^,?6.ICM_W+BTN
M\R?W[Q$Q.L<R/LY3@_M:>096TPC4$Q64HC15'S&Y)\3AHZ^F=K4>E+546(-$
M\U,8?TMY.L,#-Y3,^SB/PTWP>O/;!3M/&2]GGT$9BE$0*:1:'J,@O#_P_.?<
M)E7[]:(/WC.WO,%4V2!E]!3VU^.)NQK_[Q+Q97Y_$UM<3.*[,E!Y^</[*4;G
M:3&^(9=[?^4FA09N^3_<[3-?*I<-HRA*;T!D2M'AD1:H"4PP(YWW;$!;K;*H
MG]B@AS>*!FRW'Q?3\-\?TK?K6?CBYBDB_@]+Q/'E]6P\^7PS+_SC%S=+\U&4
ME%G'<$N&DG(*)()EEH#G64:N/?6I=GWC/OC.W!:;J:H%]>#XSW%$1W\^XID%
M2F7I@RV]CMX$P%]0""Y&Q[R3*E4?.+[Z\C,WB,.$W(!E;,TRW\^FGV?NZ\7U
MXLMT-OY?M-3EQ$@Z"B1%+9F!D((#X00&Z%9KB%PIM% 6XGH/8NWS8QNT,[>4
M%@IJT)-S9]#OW??RQO$2I?.R.(SEC'/??Y].%J54YE_)S48RD](J;2$R9]'D
MBV!"-) 3Y1'//F*C:'6N[(9WYO;42E$-Z$O6H=Z8.MZ5RXMR9*V7TCHT<6%+
M%YJ*X!41X(-QU$L2#:L^+_A)1#^9Y?101X.&L!6Z>V;]:?I;>N_&C\Q:1)9$
M**<D5Z9T*QBPPB=4=PA99FFYK5UNTAW=3V)$E=54L=+_J8/R,G]( ;]@'6IR
MP9CR^A2E*^QAP8*G*8&7-"@G*#&TMG>T![R?Q*1J*ZIBZ>35EQ&*X.MTLN;-
MK=RXFT3$]6*^<),R=G44O39"$ _!:@(B>;1]B3]*Z2VG+F-HL-9SMN'I<*^O
M/%,C:2KYFG4U>TKEII (??T0#%.04IG.I5@"PPR:LQ)!$$%]E+5=H'WP#36.
M\Q2?:/97T*;$^#$&>'Y<X-K*![WZG^OQXGM9WW12WNIOR-$*A;XG!%+&72$D
M7LC>.0Z!QDR,\HJJVDFA)P$=JZZOG1D\2@#44D>#EY<U3"O&PPZ@&O4!; 1T
MG!Z BHJ;MI+Z8"81.?'9V@#$:-P!)/HR/YY""$E3(7),M'9OT8"FL*.\?VA+
MV$?8#2R@P]%X6_8EDPJE5P&(B@R$H!J,50YXU#H+&D2H'HEW!C>\0UQ!F?O[
M*@=H8M!"DIM:@^5&03><)./0:Y/HL D?)#A%&?#,>&(L.A)JOV%VP77V'DAU
MY31X#-^%<37.N /*1IY)-X3'<57J:WA/$^JAGD'KB1Z@]8H$K4@"10J?80JD
M-/1$H%1*@BNPFM S,J(=3LZIV- ^6FE@.ZOZH2LWF;\LDD_QMS3!7ZRX 3)-
MF49B(7@I$%^9+L24*.RFUNCH0A*URQYW81K>U6FARVE#131P>5Y/9VG\>?+B
M>C9+D_!]U>V[:L.,*FFK\9;FE(#0Y:KFQA0.>D(CS=KQVE;R)*"S-)%Z*F@3
M1:6K-"ONW?*!]4?N>EY>.);'J1::YB!\F4N,H2--"ER($;)065+J7;2UAW]V
M@'7V#G%MU32HXML!\7;S= '9R!WN!/ XWG!U]>YG/CUT,_PQM&H(Y-$((=";
M"Z'0/J)?YSUQH*T/VEM<B&S02W4L ]KA"9^&_>RCD@8-S1<?/WQ,B\7-V]0J
MR52>4VEP99(F T&( I,0H?2<2.L<=[%C/_.&3S_* W9M/4SK"K&!V_KQVL_3
M_UR79/:?A=!BU84?@B_T%0%8( :$+%7KRRQV]#J38&+2M4^ +5#.WOVHH8(6
MI>2/8=UN@2[ &KD96T$=Z4VPANIVFT,/N3=P(;8#Q',K,D$9*.?+I&4;P;C2
M],)%#C23E*MGT 8VB%TO@X/:PS[B;F\'M_=9BL1&IBW$S"F(\NAD'-Z/0AIG
M&$E*NL8V<"S_H9*BGE;_ 5)NX34\](]672Q+^AXKK=8<UVHI(@M<@(]H[S*%
MC"Y38<>JWEFT%<WY^PYU%-&@@V@SLA6)5@=LK3R()W =R8FHI,-.IM%# 2VN
MD*<PQLQDCE8!!HP61$P$K# ,,/S2D?$4%:_>XSRX<>QR*(Y@&_O(O05UVEKL
M?7OC!;S?!*X2%-?+?B2%+A3S8"FC4FJ,GLWN88M/?,$1_(5J2EAG5.LOP:T^
M0TU2KC?O7ES^_NK3Q?]]]?%@VJT-G]&?6&L7L#7J+!4=M]E+0:Q"325KA5,$
MY:L$%2:QT8;/ZW=NWI%77%Q=3?]RDY#>WA7#YQ0<R;R\Q)<N3TO*2&-)T3]$
MW4M"0J@^^NH).'UOB#\F<3Q?S,;^&GVI5VXV&4\^SR_S[5-?<8['<>QFXS0?
M28?B5R(#$;AZX2T'Y_!'[Q0S42C+3>WJP^[HAC]>:MG(^MW12",-HI3'$I@O
MF3KF:?9GFK_ 4_)SBI^F+Z;S!?[^JW]_PTLYC1*G7C#K03$M;_A'O<"H'=>
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M.3IX&%!O>;]VPHF8SH9MTO]QOE2UO9G/KU-\>8TQR.<;S#<U;<L_O%S5ZM_
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M E.U":?*5L@H;6Q?HM<._T^Z'IX&!YG(MX%0%\*> 4W(R7BPQA10]&*"%SY
M2I87%AECV'_ ]P[ C]<_\=%0M[>ZEYWVQVB_N"*)3I M&U(=U:MM%6;$.@+,
M@K!2&2=M3IT#EL=.13X"(S9+4=Y&,X?,1MT$UU%3E!NNU9=LF9<91$BU6#9K
M<*$N70EG>9Z[@C_(&I>D/LKLC93"@4MHY[6_X%.@/Y SQ:S+]GYG\>Z9I=NO
MZ_5X]/MU&6N(T5HC$U@R(<@\MH*6YBVD0B\D0Q&%;-W[X\[CCQV1WY&W][>C
M706Z<@_ZS[_?$P@=Y?\S_\'\^W7![[#\I?[]^[N7-\+YXX\__D;Z3N/)E[^1
M ?GWN6#>OGC]_N6;UV>OG[]]\_[#NQ<?7KY[\=N+UQ_>OCI[_?[-AW^]>/?\
MY?MGK]Z\__W=B_?/<1:&Y]/O 4Z'G[^<K^GBM--3_GZ[I.^7>O6H[S3?:7%D
M-^ HUW-A2&;%,!=IO$M*.1L4>N>]==(PRZ,((ED<[/3$U@;WTE;:W$FFL):A
MHP<E,H.@509MDY-A/M96=S>HEP [U$5(RL8D'>F-S89>X)@\A-IJ)6I,NL0Z
MIZ"_<_QH+T+V9<RN-QS;:*7A#<<6DRQ0)Z=M[>GA,MFA-A2R0WD!Y)9;'Z*4
M.C^\]SV!82$[,*&3B'M4""UR=8?9X!*=U,[7TID:M#:%W&==2% QD-5'3C3]
MT7]_>4+3WMON/ITU>I ;B.MY<K]>S$A4US\(W^8)IZ_)4OGP!YY_Q=_&H]FG
MZ8 '[K3VY$L62UMK;288<@E 7R!F$UQ0AYO6O!'DTZ!B/RT>Y'[B0?C_C6'R
MX8_Q@)FBG?$%2LB\MK-WX'G0($4F)Z<X84W_^_Y-D/ZDW$XZ.\BUP7K41!T<
MQ**+BP$A\]H37=518TI'J#ER)4?:I^-&33PZ<ZUB_<FV'?76(0M]!]R_CB\F
M VE"=)Z<%2^]J./1'02N.>W/"EGT)<CFK0-VA/J3;;MIK4M'W>UA#[_B0$9Z
M&0(68#'0Z<^]AF 2N4<H,!G..6+_J5T;0?U)MMVTUJ&-[Y:P*^1?27+AO"Y@
M^N$33C"46>U)[D-@*4A:!VI04EF(TB:P2:48A3&%]W=I=\/^DXZ-]-JPT? #
MWOE%#;&_GX79Q?0R/#C X)2*7D&8M\)VM<T8YX$PZI!R2I[+YC=I&^ Z#5[M
MJ8\._8T7,2[$:ZZ^,7T;AGF0F(X^^00\IEPSGSR$Q!T4G5)@FDG)^F=E/@CQ
M-)C43DLMFR2OWU'?(>VHHS=W)A /K+0\2AE!<SUOG\C I5) !F9S9,CS 2BU
M&M]I\*F1?I:0:>]KA.W*ND52+*O$(-L20*%A)*"B@'$,,AJ4VK=V(W_D.=![
MD*B?7I;=11TR$?%>6V5R.KSB!JS/=$)K&2!XI2$C.J0-ENNP4:7?T^KUOI4^
ME_=ZWT*N'5N$;P+C"?9ZWT;XJWJ][R"YCHKDVHO C 9KRCPZ("!(-/-.F_7&
MT41L]IX>O]=[ _UM([">#;4>;C 6+0\E:P3+&((*EM5)G1)\,2*7DHMJGE_U
ME/I)[K)/=]10A_O\[=I$;0+V9S_)EAK?J^G?+NHZ>C_).E4Z<V/ !&_)_=9D
M5;ML0&MZ";,R#EWO7FX_;#_)PU%K&RT=JI_DU<FLDBLN1@X<=00E?0 ZU06(
MQ&MO(J:T:MV#Y0$XC[WSWU:*W*2+Y Y:Z-E \@XT<3W5MEA1IX* D;6RB7L'
M(?@,A;NDE9+6F-91C@?@G!I!=M'"@780>0--LVQ\A!1H\U2N=N05.H,P7&G'
MO;*V6Q?V13BG1I!=M'  RWA-6U-NLZ6%1I",U5P.C]45C-55$*SX;#6V#L0_
MK1:T36C47E<=TE>OFN&]_X0X>W55;C WWYB3+DE:N,/H:LDMJ_E ='!R*[C5
MVJ?FB36KL#Q]_[R)%@[$CJM79!-DG=SOU:B.XVNWT=X&E-A#]!VLE@<0)J50
M1"<AE3+/G]$0E:UWU]8%ZX4HS0^@0Y-BC9-\:$YL(_$.7#A+:7*!^=4PQ.$Y
M21>OJ[G)MQ+,9(3(:@+#')>T"-9Z(XW.D>?6Y?&KL!S>Z&BEKW$'87?P<^<-
M3!9194%&C-4%3+'SE@\.?" S1YO(BD+)=6Y=9K4<R9,A0 -!=]@#YJ@N4TVN
M^2A<T=DDLFT5>4TA"_ Y)\@AH/5(EFUIW5IW <334OK.XNW@E*[H(<1M8B[0
M&J4KM:5:#$#(#&2!BA<9<[&M0YZ/J[O3X=R&!AKH4*>VLD/,)KA.>=#L5GK;
M=+CH+D(_9&LO)JRF%P"!99MH$ZNCSK/,H!&S8\&)XH_3[NI CL(AN;"-K#MP
MX&Z7IRR#5\I8D)P3%#JL(+CBP?FL=.1,<=XZ&>1QMLW:2B</M,W:1J ].N$O
MMGHK],22"B?75@JBL"$G-TD+Z!+3QL9L6/-^2H]YB/ ^FMY3O(>;799UBBZP
M )DI#\J9"(Z6"DG7,A@5,\NM,R9^Y-EE[:R_G31PR-EEF^ ZY=EE6^EMTWE5
MNPC]D+/+LN N:NG!9G*#%?.$S_A,<+GG/F.BS>R')L-NL\OZ<&$+6;>=,/+[
M?]WM %N2L)$IX-XQ4"D)".@1,)G B_=9NGL1X27MXNY^XK&/^%U%/-Y?/FT;
M_JT;CN9\\4H4!"ZB <63AL@E0C)%"H>^1"_6:N['&3&WHS);2O$@O?Q^^793
M(_@LS/#C>#+$Z7P;"A@<8YP %G0D 3);0TX>$LN>)1,YNOX=45?">_H67B]=
M=>C?L@36U6NT";!.=M]*4,<Q_+JI<]Q3%QWVH-4 K0N:I9JIFVL3\9H(%5/V
M(&Q(="8ZE4+\L4FRQB \/D>V44$';KSXWXOA[-M[3!>3NW>;(5LZ,YT$&VO:
M1#0&HM*TH=8!+/7N3,O6MTK+D1S>0&FDJG%S.7<9J!EG"Y@04PC9^]K_HL;"
MT4)@9!LGZ9AE-3U;MN_QM8CCJ6A^;QEW>.O_'2;#:BZ=C4:5EM>N$ ]1UYYT
MB@E"Y@O93L$HL,X)IA+&K%HG#RT%\E0TO[^4NZ01A/,7TQFMLS95NKG." 3+
M10G>%4YF<ZG=E&I?)<5-0619I-:J7PKDJ:A^?REW2"^>I[2\''W%Z6R>CW]=
M;(&"#AH>P<L: :D=G9W+M!<%:X5GRF)LG3VZ',E347X#.:_,$SG8I)V[+=?Z
M3-E9]H3.$W;6+NK>=!W%6,K:>:=S5%S9:)-0JG F:N:GM0]/UUGVM".,LEPU
M9%$KQ5+Q9&R&.F11T!^1V]K2B&F3M?<!^_=$WQW_8;H^,M0LJ@(E%5'#20J"
M<19$-C'4(L;VV74_2M?' S%OM^:06ZBMBUO58N DYI +^8% 7J$F'R$@+<*$
M>:9QX%QKE?MWNSV5B;-M*=E;W<=N]/90[O4\5F:4][HFT&G+#*C$9>W3&D&B
MM\Z2J2MUZU3TQU;.> 16;%KFN(UV#EO)M@FR4R]SW$I[FY>T[2+ZPY*#%^VR
M2@@.4^TK8CGXS#74TS[P$A3WK0W6'Z7,L1,GMI%XKQ*GQ<(K\L,=K9"P*%GG
MH#GRS0D0((^*<9.3:AZL^@$JW+;2U685;ML(NH,9O;+PTH=H"4$"$UE-%4$!
M44H&0NF4/+,9>>L;BA^BRG4?"C01]F'*'!5SY-+5]*!$SAT7!;SV&3 KS;44
MMC#3X_5_M&6.>[_Y.XOW<&6.M A&_%,0Z3 #E8LD_TQ7!Y]'<L^4$Z7U*_^X
MRAR/[TXTT,Q!^'*=?+,!KE,N?]Q*;YN6O.TB]$.6/TJ7G,@B@LV16!^9A5@;
M04>'L6C&"^U]/S09=BM_[,*%;63=(_-VL89+NXBY: Y*9UO_8. R63;>AY0B
MZIAY\QN/QUPBMY6&UI?(;2/>#N["W?),%B,6RR1H[\ESD=J #^2Y..[K%:PK
MN;0N='F<]:[[J'A7@:Y\F5M>7O]Z]O+=O\]>_?[BMQ=G[W^_O'5]O_-%]8.?
MMO^E].9@[UU !\64-:9(HZTJPKN25%12L5"2+4X,'OSD1ETP+]T#LC:_<PXO
MNRV^&;VKN6V3X>@C_0(Q9G+]SU_"=#B]O6#Q.!^-0,Y$,+0YU+E(CHD$LDA=
MBK3,8.NIR$T7L$>AS\M1FM#3\#E>_OUR1(^I-S+$#?KUCR]',R0+??;V8C;
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MD>GMC1$@G.28HN$YK9]R_BC[A&\E[4WZA&\CJI6^Y%'ZA%Y6%4\7JTK'*_O
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M*"G^_@D&YOUOL+#QL+'Q*(@(B"C^/S?T3P 9+N ;)C<F!C/@ 1D&)AD&NAL
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MJ^WEB#0_LWVHR5V(GCW5F]:K)/?VN63LSZT\,0\5/CC^WLTED9WJ(+*GIFJ
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MM9'U'("#[W75"?]1)QZY*!JPH'N]!YI$\D2E\G#D/3].BD<]6 "%*'?9D.K
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M3<FDKM'*TP2"E;=8 Q"W9!)C>7/&?HLKGVJ>T#E][>3@K5:_P48QM(7@ Y6
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MS[:DO&K;W>?25*#,H"9\6NK4!(,,,Q?#M2;@&,(J(^W_<2S:0^8DR)P#K*I
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MD#DD$9MD> +B=S,:5J@VA/$+8M(&W_5]_E\')?_[HKR3?C1 ]M/5$_Z?+L,
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M4IP#+BNT-D2T/6Y9<2?EB60AD@S6JY_8HC<QG 6%Z8^A=_%B&$3DO$#X*^Q
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M$B[^BJF(TFB0B?@6 #XBV=-D@,5XIL*![U2MZN;^K,^BJC;\@P#0\B#IM5L
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MD^C=F]^0![XV<CLNVM".@1#L9<]#**;9)N;Z3P_,MNH;L6L^9R<UL.-_'^C
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M(("'"[#ORZ]']..C\D3[ XV1_ 5HR^/47Z+2>T/28%D^F87GP9<<$DQ"G^-
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MH9/3,X(RU ^;55CUB(0$)+A4WMS_7KH#7"A:RX"0(+/!ZW02'[WE6&(+O70
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M'\ +.*=:AW @MTI]'8SAJ<[,4YXB#9/EUB>\Z'H_%YY#=D\3VC?C @'VL94
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M_B2E=6TYLYG9^UXP)]4;W ^'K \5-XY<N>NSMULI0V6JN8IH?XYG;H'$\Q;
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M-7Y7?%0]K59EH<8W9*G6F N?R!XHX%$=O"K404#P2E_ D/ >;@<3=ST^"T.
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MC+]M_@S==1\Q*>#BG_H3@%T5Q#SAY&7N6=8F4CM0[7,OF[\)P'8Q2%\"6KO
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M_MD+0W3E3,]Z.YD+]YF-3NX1+3^-H;>SH<[?"S'^6LK_R[B<^3]02P,$%
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MAL' HWY,_-%I%).$D7?UQ<E?U_[Q[/^;8_[_OSS[?QS[CU]S #8RTB-XR/@
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M"V=@F-1X2"[,MA$!5'*#>?0TE@V-J 9$8L'-G1./F)DD(( :T%TJ>C@"V#L
MGZOK[$K[&CQ,((!3!QH>! "I00"C\B8%<!\$P( )74$ \S$K6[1M49!MS]:X
MTETAG+%%J\0K?=?^\^0Q\^\]=QAR? =BJ/>U#Z\\\-<T3S0;+XI24VQ=46?
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M>7^;+$T%*]QL/6!DY^Y2N'>G^6R%=]ER!>==*X8GD/+/]&^)8CE'7IS>Z1;
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MF(7=3@6'Q('3 8,C?&N*],8EJOH3G.%0NA..\]<I?9P&"HI:.D@J:^NVZ):
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MA*ML$J<8O(N"$HZ'3WH<5^4_VYDQZJ@KL/E/V\>NCAP.SO:\YI\AV>BFO#N
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M E*GX> '/DZ4!=CJ&<D[_DB%H2?1',/.<19T;ZW<%^L]A06P:F0MRF#HG3L
MX\?_FE=><RC-D2F99])0C%94ZYH_VB8G1F(XP;1WZ;L(#$'YI^X.0'5/UP,[
MQ#XV.*[.M[PEB%KJZ)9YYKS9'^%==U."(\(*DT'=K$)HW>$7.JC0(A1$O3I:
MN*KAM(:;8C4H0N9'H$S$4_622D+J]VERG!<3K0[HRK8O\R $9T=QH;4B>7Y$
M=<'GSPNUY';K_?95[Y=^17]*;QSRXM>>V1 M>:WA[GD'Z$PP'&W+WVS8-BO_
MAHQ-%8MJ]"K;)CZY W3%WP%(;ADLUPQ(\ JKF](3AMRIOCK,OQ>FZK-/^"DM
M^;1T/QRX-YZC<YCGGSW?K$BMWK!AR1AV 0N4>(1DV;YPG=!6G?!6L>?MPG.Y
M(;@(+97Q!E5EANP/@<E^=3#R?%$?V9+%:YF6^MIPX[Q*=$\5G_B.T=/][%1R
MEVMY5&USK6_HX+[YNJ+#,N%35)Q;V^!E7X^CD:VN)EL=4*_CYLKM#N '=T:&
M3?IK42YGBG=?[ESSGOK\74P-[%C&J0N]5<-]GUS"K9"TDO8+N\.7%9H'WJ/9
MNL5>F94@S>BU2/[2 %G2_P *1\[/?F- >^Z"S_3A=.>(2VA'M='V&4AIM23]
MAO%AMIKOJ>?@7R/>D55-05J(&-T?[_[15:T=&-7U9$I6Z1Y%ZX?D*>_P:YI"
MJ4>*^,/V+\PE[@!B$2& 25NG 887^@N=8*;3)Z8Z.7A;"LZ_]-%K#N[/D;KD
M5_<L]]$S=*;1&JA;X98QV^#U6#,KO]R$S,L'7D</H;VW9[WQDD\B_0)@A1!+
MHN TL1-01SK!W+YG,^)P>2Y>YW%)C_4ST%#%,:O;0*YVM&/(]>BY:W-Y>5E.
M0RZ,\W!28[N*ZPPOCIE+]F"Q&GXMCYC2#IG#C*>S47K2ZS7)./9N:%]/YZ.S
M;/7P"(/YQ1V$1\@@C(9F_<C^^3D,Y^V("-)0F=G%Z"3ABKY=AYX%:0%=6>11
MEM>=,IXL?08I23SY?,VVUSO[!=YGR(*N:C8HDD-:T_@$!)6()#SVT-[1P[L#
M1,"#W4.[Q=I":QZWSM1PIG[<06[I*^AACQ%^]R+DW'WMS1Q<,-FM*.VJVW9Z
M.\I*U_-9UQ'\E%+4S9/W[+9%Q0AU>*-DZ"VG4ZW\U'S26SQ%8<A1< G4 FU,
M/]A.P_AU[&>>^)0E^K#D/CHOJ>-/IDVT3;28C1)P4&39 IA'J#F\P='?SG5[
MAC+JB+_^0&(HCSMH"S9S<R(ODY@BE8VV%&4;3XBF?TG;T5:4@D93K5;6<TE2
MB?,@EM 0E5V&E)EX3J'DKIF"9)^_-8T^"(SD*$M6"W\/ ]'7U?%[<B4GE/_5
M=&_M]=ECJ0J]1)(7ZT?88JWZQ_.OPLSU)+1_W=X3XWO"YBD4AU7?TN@3U!+K
M9B'YG9KI1MM'0I,C=E%OCOLX%PHL(RGE* HO6YJ9P0068 8A>,N]OL!0C<90
M,6#(H".[R6F_D/-SR.\%GX2EUJ,RC55HYSQ1 )"H<NQ RHQJV1'XVN+WNG/Z
MAB3@/GJXH-)<$B4&R?;D5W3E)]N&T,NO!F:T?WW:1+:8[\]OD*NHUYV9+&5O
MJ6QJL\$ UXSWX#721:<I#X!<%R5;BDH!Y-PMG?/]#2I3GE.?5!]OMFRX8?L%
M8'8+]U.*^6SXY7O<H!<%V#8A5]H7T>B6:MA<VQH!U/^<Z*G!OJUSOGP!;;%>
M-]38PUPYF?JCPFE5RAV LL;>6Q!=)0 +7L*K1I('!L"XS>H]GNDMZ.=IF\6)
MOF!0F6EQ-Q=!Q*YKD:'GOAZU#9TY)L93\N8?\O%OZGU=WDC\:VZ&RN^^%OY9
M73?E,BQ'(#8.B;#8A&;!M(!_2 W92WS':#;7*C\CYJT'/('X92#2WEU#M758
M+>JT8U40KX'G:'X[0#$EM4S,+ 5KRNL!&-[A@-:-42'E^7Q>"[MMXU^M:';T
MRS\R7MOF.9;%V)^<L]^ZHG-Y6YD]&H7"*JU;:0D"%KO@[D>HG;8#C*_?(..)
M_WCU!(]Y8T5MH$:20K9UV2</Z8=?=?5]VH.Q +>]=*+Z:V^JOVK^T-+XF6/L
MI^=IV&)N;Y^KNT<#MJ%P=8LQ4,1=\#!TCWIED(AP_6Y*S5A@*K)O5#3>(8,M
M)U!>46GD-7ZY[P7I9$B!]ZB\+N68[3?\.'-08Q S ;_/38;U( &4E_%K:Y-J
MDT<9T43 I\\&LB HU!69@'' '4 V^=B6@6T[2G\$ECN8M4<RIR]@ZTCX\"=_
M)/2[#M'->T6-(R+#FBGAKN)B'R=EN?9S/$VP/;,MXMR[QIA*_E2>YF6X\!?Y
M.NH1IZ?DOGLW&JAIF%4C3T+>F^7J\,$/7][A5Q3BG4)YR$XO'VW3SL<DJ14&
MY?/8S&S4ENVK&&Z^3Z,I$;42/N3]4G+^]Q#-6(B.PU )1TBX)[4LR%:'D\>[
M<@%U6$?,5+R)Z^\ C3B>-T4-1@$0HA(@M3MP4*8<ZS:SU2O,)#\6O0WJ\P3@
MV.P5(YOWWWC$LT]!_U1#\R&)-ZZR<26PQX5*ZYZ#\+I!XQ)>*KU!E[QWY5VG
MY;])*@K-PDM'R9MDW:NW#S9R&NFG;=[7B&K8P46,"*SAKM?3U=&(81J".<NP
M[T"-9?)%-5D#FY'JAB2^#A,M$D)BMYGM05+K5G&C4/FU'%]"K4GY(+DD<V%*
M!L0=8+8-N=''!1R,H4Q-7O%>[/9 >&J36E)V$P#7>RE<G6^EILW!R>R0:AY2
M]5J^?G0-3N*#=O9HEE?8H.,2%HI#W%LD- XZ7ZV%XS(:>*M9Z*W>BG3KXCRD
M_(@<B4Z@P0DY@*L8'7K,B'=IH-.Y2/KN );++\.:06;!KH\_O>D[#KEL^X[@
M#9(07$NGW4T*[PVRJ]8T>+/58>"[MW:0^*6&P8982=2B]W<V6[X-WXM'(YQS
M5AE$4%_BX74ZO'6+5 C(O^8E886C%T4]7)?Y5M7=QF,K6B>CVDFBJ:#,,F)Q
M>( _BRIUI"M)P$@66?>SV1&&&1>;PM"VEH]5#\(>(695"L$T^(CP9MA%4Z5I
M6&D7+I.F0Q?)[9M-!X]+!!OVNE&0(3T2VKE,BB+M,"2H0T9.-K^D#"Q9G[)M
MJSYZ,56BM292ALW<Q)Q$M2[_QF-0((()BT1 J@.<ARQ"67;]Q$)*-_M.]J.S
M?[BAHS/ JE=R4W6#Z95'>!>@F/XS"60;^04SV:-1_\P3HR[[ATON><L=%TN"
M->4-R=T)I$^.>,VMG^W%&WZ*3/SLYW"1M9EI<M9$8<X<S+I#0#_MPON]5:)J
MW!A9.EU=>QTKYFWX.F(5MDF U=%5AWVH3'$Z\!.R1.]X^A5FG?6] 5D;DXO:
MET?%K 1E&=$8Z+3&F5CS1+YHJZZL"/\V32(:Z1'_IK?^ SUU-&TFFPIWWVQI
MOS6?M^*XM_")F]+D-Q#UCEL28<)J>LV3E].ZM$'XXZ4;*O@?XBNH8A6W\/R3
MM$D Q31YJY<U][,)V1S#\.XVTMIX$HR&,R-Y8&;K;$<OIWB.<@-8(E $_(,A
MIJ9USD]8*%2;.EW,=Y.],E%E3YK-W59RD1?)J\EH^[>420$M>?ND>Z6FM55<
M/8(DG04?*';:VP8C1=ZN.C_!]=VZG]"9<'LZ$6I4'5GW8[FK,3_,[F\H$<'B
M E?"KELN4QVCZKSM18'O.+O'HPH1I6"Z.8<)V&_"Y3RKK!__E/Q3_W-U*B]!
MO-"!?)^Y;O(SK][ ^6V,8H+3YN'O6]CN ;@UKY]&F98IA([*N!C?3XK>0/9;
M8^\OPS<3<]Z[4QTJC+O[^NO9<MT&[\OW2E[+ H3^283;1-I6LNCQX;<F-]+6
MSW9HZ'/+5!@";)<4_LXK\E!C-34"(K]'\O<*7HL;$?DB"%;1_.L1B<4HOZ[R
MW9Y1V?*&R6JET9I0I9OZ,ACN(+]>-_O\D\C;>BU[D:+&GUU>#0(I?-IZ<[]G
M9EA4VO%LM3^C%%?%ZR:.UG6,A2+37R)YHX<I!QS[NSS6<[V(_,PF73CIA)9.
M.V9$UN%<IO6-7X^C1?'G._DD>,C=J79CDL[N '.!ZPFWK(8X,^O(#]>V6SGP
M4T2_C_U#9$E4;M43\T@>W #K][Z'GV+/A/$C/\*#VJIZ&B#HZ,^[K<X^*:W.
M51(NV_2)VU2C@M<UU)^Z9.:&1>8M:B>OT2H;1R\ZU0><=:>-IV#LACQP_:73
MW=IBHP173V!$;;PVC0B2WA]?K&9>K%G)A,1TD3F\3O$I;D6 FMA5AKFF\ZCN
MMH3;JIX!KW+YU%=+@B_[SXFQ<1*VL9]%#I2F]#EU :5F>RU?X*X5CV&>WQ(A
M*;M8(]Q7,<,3P5>PLMCO\CZATZ.[Q[(*G8]NKFL\S.Y]Z=^*C?%"/1$C]4Z3
ME*T+Z[W:>V_IMEBW.;LA(;R:JM2-:*:QB+.YU'9^_DBM(^*@MYP^K[4+Q7^B
M)(^2SU]0>L@W6+;\'0X?:'._ SCZD#$,G?K4W6*=+,NBG'/1,4I^ER,XZ6XL
M^%4,ZCZ2@!5M#:,42]&-*IP#JUUEGV/X8!_FQRH]480,0\F:^;"N4M[XJ<%R
M>K]+@RR9=G]Z'N4_U??II2JJ.G> 8I!NVG?<X=;R?2:9O>RKF3@RK!$UW4M=
MS^%XE:@[@(R.T]N36KAZWG?J_ZE(@LKT2'[2% YX4UWR56A-45XR/K=F<@:?
M__;X&K?AOUZY$)@3YG[^0I]5<<R%F*L4#?L+C*M1&*!68'QQ?O^?<5U*71/]
M:@GHT6710W(1QL??2?Y+B^1?3\G 7CH\1 ,B1[VY &_G&R??GG!DTA!JM%V+
M^ [0X?SUAUVI60?$IB,#*V7%HP  2&_.MF9]&G%YP8X.^PJQ-*"\\3)\MD</
MG'HY+S$8$-'!WQ_ N(_>/@XC%$.#P!;Q@[V\BT6>YTO@D'ABXY26T9[%%E!I
M6$NLQ]5A@9HL^0;-/Z(S!-](V+6H-::T)#>3]83D^=(":@NI9=CQWQ"I6F&G
MPIZB*T%6#U'8)P&G%P-K DBYTL9!^:"H>@7Y4: DHT93GC 9SK'V6-W_GBAL
M"!H"J<8)\GWA;0FOJ8:OCS?SKAHH<_V] SQ=L'%%:,X4,XD'"[]:4YC5:[)T
M-W8J*7@6.9*VI>9W/<.8]!X9 !NMO&KKV!*T'&00\BX\X?TSC&18BP_/&PC0
MDTTX=,LYE8B]^LUP&4&Y=WZM:9F_L$="5<J=VQ"E[=IGQB.UFT*X$+(",D._
M'>U:QCT4-) ;/! &VR'L4B;VB!M.36OK?MJS56)]C6YI7<NIU1N6, ?#_WJE
MBK]OF#D,[R+MVI#%-LC^S:P92S?$2%OE_]!U8ZM-J<LT7UU=/]YQ8OX<TY;C
MR]!U&L%)AVN7M1$"]JUM6\\ZG6SP1R=X;9:DF]6?(E38A&-G>5-L1\1N-"T>
M4?W$+1=Y<4Z^J(,:Z'?A7*ZV!2ORO)?GR [^P,W?7Q_I(!3/^IV6Z9FOOC9S
MJ0_T1AK3\6G^0*6AR>XPM,WN.)FVSDQBG=R?HRHVQ9*6@3RX4RU7^5.NFI*>
M(!Q#=76F7Z-$9X-!@,X=%A1IT-C/0'%J97Z]Y<QMH;PS?/ZF4%2L.D0=G ZK
MR.>QDKVB-;R.EG'DKDH(D \>J*20>Q%GSM$9T47RY.AI<0+PQ32O *J$1Y"S
M_\!T?A/1+UZM^..'/RLV(!)8DVX8==*TPAL"9/\0K:M'!U(<'2TT*/R,Q/S9
MV][M+22/>%6#+R%9ZAIMH ,/R [J&IU=G;3]*\^WBFI66B>0VM'5AU__NDZ9
MWZA6_%TR&JG4Q^_W$XMKD2\%:>1XBX=B,#\)E;5FL3J6D';-/G0+ 6K2>1><
MC8QYG9N^\<*J.JE;N0,$8DAW+9;?^XVT1&(Y%GS 2C+;35\UNI!GT!AV$[SB
M<4F7<-DQ2> &MFSN;VY>IE=^T9>HO#'E4TF"?1S_>W9VTSS EM4J<F.<%<*&
M52E7F7D/^L]U6N$V2P6>@G8:.N]"- .D#ZRPT[)@!M:E#,.4(VV+1QS0CP3_
MJKWP?>^[G"0?XJUY(X]*UPB5O5\J6F++/,1RMSFCWO8 E"\8@- ;B8)3CWP4
M@U?X#HH1%F?<TM=43@O,#PL=S>R9)RV=+F9%2X[HN'$"Y*3[1M4,Q=?MPVAX
M4M=A01A6:-=%TDRQ"X2KT:#YHD[9S>9D;VUM:9%J:_G@=["Y*6[#@AS6!IKO
M1@@UWXGA0C%8VI',8.7#YM8BAGE(7JP1M#,2#FV;-6:^J1@]IG:@PKHA8]6*
MH$AE)6 TKSI$^_H0C=3GQ7*N,*5$3TNZ[KGUK[K&4S%#U:J^)0\Q!DOCT5"Z
MMDO_P7YNR?HCY;GFC(!X.*$:73]TB&>/G);)7V01LRN*W3;@3K9[GN_Q]^H%
MB:Y/Q"/_#V]L[7(J\'$>A?(=PUNL;7P%8C0GMFN2'G._?*DW/."_5/+TX9=Z
MO#H/T7;1C:TJ]*TY'4_C@:_8#.ZG;1A7_/S<3IO>[$EZL"[#K(OLU"M]&;?+
M$Q$2PI:V(.>]CWOKX(7S0QI)+Z6D@;=D]4-.Q)?/OTF"L",<E)WN  00RSL
M^>W[9A.";.ND;W;J!F^1N!DO5G[1&01*$$HJP#+SPW+E_%(]V HN!=O52L.C
M<^5XU \B&#K3:*>:]4KUK'65<Q+J+@EJ1;(9$EG+Z10EL(P\O.]Q:':/0XO8
M7H\UO%P&</-]Z&K5]]C)O@/0,[*6TS+@^1*A(*O >-N_!1+[<P!*FE]_J/.
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M(9"_,GVR^+E!-CI;3T#U$=6W''UJ6H^_.QQKKWJ:--]";5S^3S&*3QIZ\@Y
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M2NPUDL8<G#49%8TH#/.TVKO:ZAX><70#4Y!WYKR."1?=3_83H6ET(XYQD#W
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MM]_/DDPOY$_SL'T]:R5_,3K;@7*IHNG[<&#D9V6?0YK)9PL<^,C)76[S2HT
MMA4[Z)2/ZWK%YLFQ%ZEC:"[RG3J@R9;L0J;@J.&;ZZ%0/SK#JL=J@/+TQ'$"
M61V,+075#$][4:/>UAHTUQWR*W='1MIKOLO0T'Y;NLL2,YT\N&M?[@)B'D?I
M?T#&@>:IAY_-6DFO*$=%]N :5T''D]3>9?ZI63>E*>^]S8R=7@]P!X>/GM%_
MJC!X-O:L%!R"+VDL-[5$ 1YLM,"@V.0R')D[P$Q2PPJ"W]L3C&'TPL6;72)]
M'E1M<BL<VT!][.U#:L;I6B*L3O"O;:U[_2E8+$AFW5,3 J&>2^0NR=H1ZLUO
MLJ5MVJ+C0WPHS[IDV/:U#J>.]L!*S+C>;Q ^QW2O4/79(C] #6KABB,DV'K-
M8;),KB?HFV@$69O=2@:C(P-,W(L25[V#VWS3%G>_:WA_3.:9I<L%A>!3\$K8
M J2Y4]FR&&F:8Z^XC%V52_"3+Y-6S[Y:N/;]>EM1>$[+G?[E^]#Z^E-9F>)X
MX\C?4Q!(7&RD,#&LVP121;'&+#R,.#],\4CZ29!AZA#&?F;[^(+7GMI&S&Y4
M?6W5$QZ:8>Q<DFWJW7_7M\KW8X*Z"K(G4]22;,Y4$S/)3?6^JF1:A!TK?.88
M_J17(^/ MT=W0^W/=+H%F"3<&'@;N9V+_TB'"S"#X=0K"*;9%G._>=\-*H$M
M3Y["D0W@PJ9XS75E9DGS!F,/!] '?[1:7NO#(68*3R"][>/.]Y45F:+GJD^=
MR<H1U\SI3]#Z#_#,W/_CP(_F@@<7MMQHYDPI?8I\I]$.4+Y/;1<-E_/-),S*
M_#'H [5#?S4^<$4=;W\1RC YKN&6(F]9OENP.^MV!HN_- &N@B.-9AHI8'A9
MMZUPC .8*Z#;"HH/_>H$^/!2??@"+@,C736G/9WYM6#O[[P1*V%I"?I$XJM6
ML0._D[$#)^T!F?\<_SG^P;"MCO".R:[TC51ZS31K*;AE->OA(74S1V%*+C3$
M:G>"H!85 B\BLX1Z<?,&5E 9D8F4P)%*2F"U-CS+JQ*+/LS+;=2,OB=O1-Y)
M*=,BONV1>W?8K2QOVM\^6E\QY S\$:3DWMU808JLVHC20FZ+LN_6S(T$5WN^
MK__R+>KCX7R'GK;G#3S7E7[GLH6-+EHY0CS)IN'71\APD9YZ<'3%IIC- \:1
MZ\JBERLQ68G8FUKNM])107>8#0-AZPA 0MR)]9@0-7H3!W3L"".HK9N,Q [<
M0G=M:(#QY,W4MH"I9B,Y7[]#LQ+V@5*W8-%MS@?S[I_<F?XAA"NRBP,$$4!#
M7$*'!7OF(KN;V(1<KZ/ID,S[K'U<;I^B%MR@*?5K\*=%Y2D2UULE&CSRW ]Z
MUIM1=+B&]4[^1*WW,?:"YO3+("\53VH/5ZN[0L5WNMLH3IB^ND>X?DKX@&'Y
M7=MW_;<.E:_<$CS9I<X<9KABY!I833C2<SC7)E,_"/\$.WP]I)D"AX&))K]/
MGYJN>Y3I,NYNRP$,,WIGGP^\&\3DQ[!*C3O5?M!^T.>IG[MS<SJ46;<[E)GP
MJ?9XVND^"^W^E^%DU9W?A8,FKZ*U))VKB>_?=45%9=4^>\SUH<!](6TNQ@\Q
MCZ!W@_$,MT4T_LCX3U>7GN*]8#Q%9PRK#L+\OW<0'R.3I=0#I=NOV)H<>]YS
M2=G813E(HFL<^T>$7HZ\CN\=!0\4TC_1*C,J0E]02U(Q&N370GIBV)&S,QV!
M.T-+VV\).GWQ/AS. 1I+TIK%A7%=T[ F6,^&D$.N"RUT?;$TLHVY[R^#5OKI
MKRT%WP]\\3K[(L_6BIS[&L 6_>WV,W\DS6=EM!>?NKP')X9&TH-ICAE1<CRW
M(A:.46L-WAX\=O"=X_5/3<1%6+_>BI]P5X<9ZUX[@MQ#4>8 SSW](@IGNOQ=
M*]+<1 L.J/("<76RN9#8W(/G (>3-UD_FW#=+C4<8.PQU#'$&P+G3WI"$C!_
ME0/\U/7G $071Z96&X$E)$_8FACCZ_O_<NX5=,?VLA.EI'O6::)E;KK\A.>V
M6 0"=([&;<L8X38K'HEFZ,/84GY(=K(PD?$U#-('A5!#\OCP%GO;&Y@K;>
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MMU".RYP\Q/O/C$"PD'UX&\["EK!X9OK^_M6_8Y%_--#(C0 .H-U(PK%R+W.
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MQ 0':"I$C'X=50=;A"N"Y3@-;F1LF U7JI,6G:8<] P-97TM3_'Q6?*9"EH
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M\%]IX)<J!7?IC04W0T;'%X]_;LLJ?/!,Q%[=;AG$QVAEB/4U./)V(L=T.X7
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M-E[Q5]<71%35DOR/!EF\WE_T8O]YCH&_''W\#R?#G):<A*@VR&Z?WV\R=IG
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M6$;Y(T8HX_U>=_ B]&VW^A78;?W6Z%_(U8;,L[OE^B%V/0R'_@064L)4"@[
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ML>5)VR !>EXA$U"Q+?3JQB>:7I^O24* 7T$(Y[.[B/&N+R:[);UVKNG![0Y
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MB'"KJ\=CC7]+<#EI4AI)XN1+E% "%#467KD1VW^#RA&](ZNR7Y9*U7?J\ZX
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M$OTE'QJ(W7SI<P_I,0R[6C#3Q9^^;OQ66W%Q2*PMS-/1[*ZF4.4YYFD%8VW
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M:>C:Y@QUQ]K<1SI=D^"'SVQ%;ZOO+T$5Y2P,LFUR,EO(CBUNPK,0'@87MZ1
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M8&V!3[)WZR8[9WR%M6CM-P(ILGV#%W>QZ*&TCNF$:N'RL>8/'W(ERP.2153
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M%CNY@J$KN:D.OE_XLB)V5^_[J)L!2+5+#-5]NNC\.\7$T_.Q/YB2=%% F_S
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M*(5;X5<9><W<<&E_%Z*/](0A\I5A[GB*;_!2R+$HG;?=.!%0Z*@P"\2#HN8
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MX,4P.Q8L)DS ?3L_OSQD8\$'SK*Y_)97A]:A=QRP?(,8QE;6S-$%<KH@$Q2
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M\B_$^KB<MX3)FN T]/AP:^%8^MYW8/$ UAN37%"0SDH]8$AFR\;2I-8%6,<
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MQM:17*@X$7F[-6(OKDM,T/FQ$=^Q=QW#5R.$F%9TBRKZ3ZY8$RN&;08D^&L
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MLD U]>/ES3>4B5X]%3RJ9"YQDY;P:V K.;DYF=8V-8\SZC,ZC=,VOWVNXT;
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MU/!BO?GS>1(._HWBG_'!\_ZNP:H#E5-^PKMHO7. RDZ=.^#*,F6C@&R6'=L
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MB#+N!U8;N^-]S8TN6E&!EO4*:&EA(:"4MYD#EMNT$R@;;L3<8#?V5NL<;%<
M"SE^0"YUZ[OU4KO47-\599W_E[:W'6ZQS@/F:A-UHJ=IMTGG5=[;"!F\8D<L
MR]O%)UY^N<4EEP,KS9EK4M6EW%PM<()BAF,.DR"2QD<0>Q 'R(,>\FCF,\$]
M;G1.=+2'N9&(E!)H,4$C)_B]D]3P'NDXEJ=)PPE"(U/%$'",2> L ,W47][J
MV>P'C0_9/QU_;9)Y?%;J;O:>?W"8,: NI<HUK==EOKJ1/_#R@4NF+M=X><W^
MMJYJ=5WE+V(4X4!@!F.!$$09\R!)"8,XQ'$:ISSD=K=)9MW.;7;O2 U:L:]
M*SC82FYG*AB.@9G5X![9T6^:+P75VE"PP\B1S6#8Z:3F@QT03RT)R[>MC8I7
MQ=U=L:J^U 7]XUU5K3E[K;MJ76D5%U9O[NZ7Q2/G^J%/\L.J%G&<Q8Q@*FDJ
M2!17,9@FE$)I<<@_A7(/DX:&1L<P">9&6XT6H%("@ERK =8K.02 M[*W?[M7
MTH,7N7Q6JV9XX#I\J,[:-.,/P-A7[(T"0 L'&A5 HT/G4=-H 3HUVD>U(F/C
MS]I8![T1>]YQV!%EO/'XL+XC\L,O!*#MK&C0;Z<%:T:FON7@OAD=7 $,Y!/K
M9:W>PJN]22-%NU5!#&KVJ+O%7XNR_5-QKUTAU1]^<6+A7C8,1RW@@<U.92%?
MIG7/@KZPH<$7@/)3JA]56_7UBKWY^SJ_UTY@W<XN22."F KX26@D=\F)<M62
MMG;F1;Z(>((CW^J(_FR/<UN@.H&O-.O5^H)^([3U%MH<>.-+0'=PCKW%OA3)
M(==_9NBXNP,\T]_4%X%FZA^X#31\T=IN_G);E/577MZ]YD0U_;Y8W70_MAYE
MOV%EM=<YKQ:I'S(6BP@R7W@0"?D?$C,,XRSRF/!1XL?AXH&7I# PF*VZMIDW
M?0'&FSY:?"@I[PZ0HBR+[W)Q:/R%:.LJ>:\.KANWZ*74K7F62>V,336[T3EK
M(8^&^,A,U4"M) 5*5"!%!TKV[:^N0.>?NE5@))2-[>#1T)[(_'6,NHWM.@BZ
MHR:K76M36:J#=.P9J,/>=^0SLNM;_*I8U?EJ+0GPHURG&L^XC>$4"<JH1S!D
MV&<0L3B !(<)%!E!/)(#E216_K\7R#(W6W;C0E'C'X W:OSZ@K3.]'^ZT.O$
M8HS,C-N)D!]Y,3GDM[(7R""9;:,-V*HSBE7L -:Q'& L)'E>#QE[R,ZZT QH
M<ABY=C&9;WZH;JJZ\A=QDJ1^QE,H(E_N\G&00!P13]K9-$&A-+M)E@V)HMYV
M,3<JW+W9H;>XO.$5*'GC U(70'X9&FQUSU.097[3SDA<507-M\E7ELI7@0&!
M:;[42Y\VR8OZEI?=+Q\W[5*%Q;  [=YHF;'G96,P,BENPK*5=.#525@&AV/O
M:^XX$KO7P;,$8>\K>"S^^L"30RTS4K];J;FS"246%$>"8P&]#,<021,+9C3,
M8"BBE#(B>)1:&EQ/NY@;>>CMR5;$08D7#@!I:A5= L_HQHX5,@-LEV/*.S-)
M]CJ8V-(XIN"^ 7'T2<>7 7\NBZI:4!\)'B(*29P@B'R60D)\#T9!R#,2AX((
MJVE^NKNY37DM%+C?'&'?;XZP>2>WHQN !NT+C_^M,7S.L_\KH,6=X-Q_!Y:Q
M#_V;SN9QXK^CN/%Q_^Y;EWOTO\\QT0;Q@B,B[00>2ILA5D':/H,D4V&&*,XR
MDO@Q#_VAOOR;7N;&(4_<T3=R#G?>WP)JQA<7PS0R35@C=)$?_AX"(WC@;_MX
M-M_[/35/>=WO/SQLVK\1@M,Z?^";\XW/<@?\F2OY9?MZ,_VA4,G?Y"8\)TO>
M'G^\N[O'>:G(1P6'\FK!29HB+PD@25(*4:+<]!&-8<9YG(5"!)%/;)C"E6!S
M(Y>-7OUS1J4:V-7M"NQHUQU%7H&M@J#1\$HY@5%KP\;9R)M1VG.,Y\@L^!Q#
M:4VDKG%WQ+W.Q)J4KEV#^93AG;<_;%%0&9G9>LD_BM=<Y"O.VL-N[<KV.J_H
MLJC6<B9MT\*DH>?SA&'(_41E"L,(IEZ20>9G2< C/PECJYA/:PGF1O.= LK)
MHU4!M#HT;KF@IP7X_:O*MV"4-,;1@)F1]JC#,#([CS8"UA0\&$5'7&O?_Z2D
M.AB>I^PYO*'++NA>%7=$FN:*G!55WZSR_^+L'9-LG(M<?59-U+W.K5IRIGPR
M6NL]YY7\V_J.L]8SH_>'[N)1I5M9K?F",L^+>!Q"$=$$(NPED.!80!:GC(H@
M9BBPHMA)I9\;/6_NM7K:7X&M_J /0)N^ G00Z%.QGJZ@16'K]M3[XQ78.!:T
M6 R[5YSF([.[LIS=IS/5;>B<OIK!UZZ3CI[C&]UI9'^6R^))A^78/?2T0EA[
MI^MB!]K1$>\Z.*J(''5&IN_0%ZF(0AZD#/HD"E10#(:9YX?0CU&,O30-_,RH
MZ(!QCW-;YK340(O=T(\4'&P]=SO9SSAV#$3_]%HR"J8C\_^SPFGL7^X>UHD<
MR]W :^-/;@?544=RPV:F\B"WTZKG.F[YXH!@_%55+'.F?.R^='GLJT(<\#R.
M:>9GOA?!. T)1 PE$&<9@7&6!5'*410&1EE-K7J=&WWW)0=;T=6)AIWO\04#
M<9;%QX%W9":? [(6@?-C(#P1J3M#VB[&W1:Q$W'MQDU-%\MNJ]U._+KURP,=
M2G!>_@4OU_RC:"ZN<[S<^L&U&;(7),,HXUX <8Q462#,(*$J>-WWDR1,HB *
MK*Z-C7J=&\\KH8&66DV+C=P]!TU+9W0S[ U]45PC.K9ORGDPKZ;)UF\#G"N7
M%J,^IW5QL8%AS^7%ZN6!MYV'4WGH;G7X24XU5\JGKK_CDKTM2L'S6MTD+((D
M#K2S;1H)25\A%Y"PA,,DDDPF:*"\7Q9[A3O/W[L-%\EH)IH5+G6:,X?739H<
M4/&Z7C;%T51XXSU^; P"71<Y[_9X<NHV^6_J8I,LQY($+QE7P^O1D8=IHHO2
MHVFEKAH>54?<G3)M9BFMSA7H*>3PNO1R5%U=G%X@R;17J)=#MG>9ZJ!)%Z%+
M+W&55U_N2X[9Q]5?<*E/GY57C+] F0BSP(LD^6+MDLP@%EX*:9B(C,8X0,PJ
MH:AIQW,S'Y\$\UP!+3IH9 ?%"G32:^>T2\*?3@R&&6.. ?'(].@(W0M#J,Y#
M-4I@U8ENGS'<ZCP8IX.P#-YW&$3QJ;5P7J_Y?W!<OI5?Y@))YDI1&D'& BJW
MO8Q XN$4)CQ($Q)RGV6#:R2<ZGANU"4_O]A!6,4AB UWMR, -_8&]TCPQ96R
ME0D'GW N33,E.%"2CQR3<0*K,<,T#G7[_)$;)\ P"N8X]?Y08TK2'&T\AQ<A
M"U& (P9]F@@5 <X@$5D*LPR%8900SXN-LAH?:GQNS-*73=\F8I-Z(><Q-+5S
MAB$SNBVS%<NEI;*OK#-KI-?TQ!;'OE+[5L6!9YP>0C7Y9/4?/^I$P-6;'[RD
M><79PF,DCH(@A21%!**0!9#$1)H47A"2@'(>\\3=V=,)2>9ZY+1)T]SD4*X
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M!RD/8TX$#3FQJC7B5KRY+87O-Y7#];&P(J!6P^:T!/1TO.K585;!O)N8ZT*
MC:;*]5('C4AE[=8ZQ]^!V:KV?*,[\OJU6TI[JH&U7J#&P=_14N18N$D7G7&
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M,6GB^"E$,0YAAN2/09QDGL?B++(\3CK6T]P(8"LHT)(")>K0@Z2C\!J>(KD
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M5D;?YK#E;&8?@<M%="ZJ3;]TST7S4P;#W&2<P<4HKQ><91ZG:01I%$<0,99
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M!L2HFV#B+%+]9&<3QZN;*+X?M6[TUC!":4J$+P^5".\\B?T%B[C@?H @3M)
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MG- H3A&'4BW)$CRFD$@5(<L\+^)>0N1?;3)2]MJV(H4)4DYJT<"]ELV.!/J
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M^0K<XQ(\:/]ON4]L<JCJ\B&L6"YQ66U_:UE*Q&0PS Y6'$,\,IUTJ80;=*7
M*L:]$;GULY="-\:\NZ,4"X@<':&8]#CIT8D%!$^/3&Q>'<I,3>K)O^:2Z]9R
MYDGV>XFKO/HH/I4YE3S87F;$613B- Q@*I(0(AI%4&X80L@"3%).XSB.K#Q3
M3#N>'T>UF5-UTHI.\BN@95>)+UKI!UXH&8^'*4.Y1WETFG(%\ "RLD/+&6,9
M=CLQ;=F!L<]=EN\/-ZWR6F>(N5XQU:ELF:]HSGO>>AL?L= /$0G3"'*2Q!"1
M+(.822,KQ4$6AWZ<T938&EG&O<^/RC;"Z\#M'?%[,=J#'?3LQL;<YAH%\0FL
M+U=@#[+"K$%S:(^9]SVY968-RR$;S;Z1862W"37LA\)O7/+CC,=!P@@4'I?D
MAF@*L6 4!DF@RE]F) H"&W([V=O<R.SM];O/X"_7[[^] ;^]N?[RK0F)L(R&
M.(VO&4$Y0VUD0NK%5^^FXQ@CM,$(%$>$<[JO20G&2.VGA&+VDGW635S=JGBN
MU^M2$M2F/.%F^57,$0J609*A#*(P2B"AJ0=]22I>&+,T38W<>,YW-3?J4.*"
M>RDO8%K@KE:M*,H_F6>#/ /O:?)P"]K8IHS"2XD*&EF[&JY26J?6BSDHQW,B
MGGE_LE2(9GKT,R :OC$PBN&HZ\U^!?"%"'%(B=PT81SZ$(F,PBQ-,101\TA"
M B_UK(IJVW0^-ZXXY8!V!3;R@XT"EF$--N-B9H^,A?;().,.:/LXAP&(N8IV
ML.EZVIB' :#L13X,:</^VOUKB57VWR^/=Z18+B(>,NR%*>1)(NV:&$N[)A,<
MBB1 (0^H%R CK[^]EN=&3:UPH)'._"I]%Z[SE^>#01B9,0SUM[H>/ZCKH OQ
MW98FNP(_J$#_TOOP T-]7=[F2_YAW7@\^IZ?D 3#($O5?383,(O3#'J"\H0G
M641CH].(0XW/;>JUGAI*0-!(:.O)T@/N_ R\!(Z1)Z$%$@/\5/95OL YI=?8
MQ!XI^VKLNZ$<>,9ZR__M?ZCL+IWW.Y=;>))0J-9#B+PXA5CE%^ L2B*?8(P#
M(_^2)^W.;2I^^Q\Z9Y'QOGT'H[.;]*&:CSSK6J7M7=9WM#?V41^*PD1.Z><^
M 9L#B$.J'CUMV'EXJJ.%0Q+VSA$._MF:23X4-?^$'U76W5?KLI1CV+%*C./8
M0Q&D?AA"1'@(4Q8B*&(_(B%G!(>FIX;'^I@;PR@YP7TCZ!6@C:C&,^XHDF>Y
MQP4^(_/006CL6>DH1L8,Y0*KB=C*[G.RX:YS(!SEL:,O3L5IYR3O\=O91R](
M\_(^QR1?YG6^">/B*$UH)AAD))*;FB"E,.6IW-EP:5G%E(4!M8IU/MS-W!BO
M23?2$]-R2I\!55#A!1X2, I\#R*N3F@X5NFO4L;"-$1>A!</O"3%=+#VN_N'
M!=;P@/ABL,8^"K9':5ANFZ,@N,QEL]_)]+EKCBIZ,%?-\:>'<>L[N::N;G+)
MV$T<^*'TDL@7)(AI +T@D43+$@13'$:0!#R(.0U"CUK=.1GT.3?65:$GQ4H[
MC!4"J#3B=2YRM="!?*,-P%H=.[HP&0 S[G ,Z\A$LI6V32BQXW<WBN.+!4".
M2,:DQTD9QP*"I_1C\^HP+OI:<BS;>]0Q%M?T[^N\Y.Q:KO[XAK\JJGH3$11E
M:99D/H=9)#QEFGB0A%D&TPA'B$0B$L0J/,NTX[FQ4B=W$T<$.LFO0"L[4,(;
M1!)=-AIF[#0&QJ-?8KF!UYJH;+%RQ%;&W4Y*6;9@/.4MZ_?M4SM\Y@]YI8NC
M?BKSHFP<A*XWI76_2.)DZF;]VSW#-;]F?UM7VDFYRP41$A(D40!]C'6MB01F
M+)%;L)0P2OW0B_S0-!?$9:+,C> Z;=I0HZ)LW=OD%-P6+M[H!!JEY!\W:@U(
M.W'A8)YFPVF':&1^G&!TK%)BN 'V@AP:%PHP6=(--T#ULW0X:G&8W2C[6=^M
MERH<]W@^UZIZGZ_XNYK?58LPB2D.J0<CHC+PL-"'F8]3&&1)F I"! VL:@':
M"C WFNW)#TZD,WZAE/@9_/Z_R7O7Y<AQ)%WP56"V=G:RS(0Z) &2X.POY:U:
MYV2F\J2RNG>L?H3AFF)/*$(3C%"F^ND7X"6"BAL!!DAQ;&ULNI02"7?_0'QP
M  YW8P<H#7'<&G/N*#O7<DCX!Z;0 9!W]C;[PN?)ZW06/ZKWV1><?2^T=SL]
M+Z?EBWPM/^FVQ?ZZ_?IAN5KG_RI/TDQIO$4A_T/2U4?]3<]"&HJ8"P9Y(##$
M***09BJ"E.$L%-HG33.W6VN]U)@:/7XHUOE#.41I2VD@*ZVO0!2$B>/=MG[=
M8T>'PX,^,"E6!L#2 K"_3]@J.MJVY@H80X"QQ.--N8N0]'6%KI\2X]ZMNPBH
M@TMWE[7FMY;(Q^5*YC\6U7DV?_Z^HHMB7LK_@^8+P]G7*^WZ+GZT+P=]I[]F
MD0@#DD@)4X9,AENF8)8F#(81"YEB"=8]W:/FIV\]K<;]^$5!3:)IJ90>Z&9U
M2;<+AN(*U):"QE30LK6UN'0\A_'>_PX'OF-WYTA'Q>]N3G46Y65GF=P+[<XS
MIM6^[A6H[7MYK_'*9" ?OHK*I>@/7&^EMWJ3J,QR*;BV-5PNEM,["<Z^)E_D
M^E:95.OKJC*$.3?^OORB831Y>99SW=H//=-)/?K6LPCS)"11"&-D(G!(JN<-
M1F/(19P&J9Y24B%[S!L7JC71:>*3+(I_!]H0H+V A=:W +1E#5@O@?XZP.*%
M3>;(OC3*.8/.11UK-R&,T4^C9=DYM9-Q57:9GMBU59KI]WKLI67@IJNW^J3@
M\8&QOZ0\%VDS=IH>'] =2=SCI=G+*NQ\DT]RL6EB5V<985FB2 (590G$(8HA
M9:F G#',B/9.D7#:#3DN9FJ['=M:+[6:5[7OYLB6)S"U(\'+D1J8V]Q!ZEWX
MYC@&GFO<[ EYE7(VQPT]5;GFQ-.7$4#M,E8$I+FGWF*H2P[/",I"%"819"2F
M4/MI,<RDJ;,5*8%#@I(HLSJH=Q,[-8*HM>U'!QT(N]&#/]S&HHMF.5Q[0V:7
MHU8:O*G5/IU!NS>%V.'DF5(ZA+X*Q=@!<8IR+-_N2T&K_$FO3I]D\74YS_5Z
M=1O^2\.,,QI0F&$901Q3"HEF&DA%AFDH:9QDQ(UV3HF:&M7L- 4?\P5=\)S.
M]=@IUJM-CRV^,Q#;\HX/X ;GFJV25Z!2$_Q5_W>0L.IN5+PQRTE!([-)E\&'
M#-+Y1C_6*",7W])""K."TFQ4)>Y9K?07(<T0>?N\>^0K?3:_NC99?C[\UR9?
M/[>&4KF+]OV>+FX?31/%'[J)=7&SJ+;%9DD4)3RD&"8R4GHM)#!D(N.04<$H
MQ4PDS"ISS]B*3XW1JC029NMC6:D+?AA]I7"CLM'ZW8X8I]B; ]-L:0\L#0)M
MHT'+:L">0?NYVG)0FGX%*N/;\UD= [36]H,:@"M000#R17T&XH^YQ^XV3_/
M:&J/.JN,W1G[<]3H\OO->!_*0^'M+J%VP[_1M:Q2?6_RQ8\ZKYT6.^-A&N,@
M$I!GS-Q@CO1R7;$$J@QQ3GC"@Y3-ULLUG=O-6?:BG6:=K0(#1C UF@.MH.,]
M( ? [2:+86 <F.YW"+:6[D9O\$V: 9[/\SH.27_EW.M&H#M>GGC60?"H3.D.
MR#[7]6BA5X[OMW1N\F=^D^M\57)H*\-3FF+!*4UA$,8<8LDSF'$10H4Q8BE3
M,I N.;[/B)J:#USFK*[U!3N%W7*%=<%[GHO\@C;T0>H9O-P3^G0!9YW7QR.
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M@PG6DJX5_&];,/HEP$-6A=Z3U-.O+ANI)ZUMQI\LBE&:$ PSQE*(:9!!EJ$
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M72<\;CM!-HJ7'#I8#UCNK/E%=6 "_K1<_("?\J?R4O+B1V[2MI493+UGV73
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M53.A'&NUY?4+C[7MY4Z#->>Y]UWGC#)HCPR] &@P+94'C?;5#%/I#VX5V%D
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M-Q_4UJE.W YCKXOK;6#A%[F^5=_IKZ]E.IG]K/+;NE%((D+#,(91&"<0QRJ
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M0D_8%)6,-5-Q%A'-5(&"&4$QC--8Z)DC0<RN_K '7:8V:7PHUOF#J03S8K8
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MR@.C/7BAONL)EFU_V!YC#8#RX&=9?@#N<:3E"):W<RU;N2,?;CG"<7C"Y=K
MZU]4VNT=%S,9$<*31$&$6 (Q3QC,F QAHGDOH!2%*G Z AM(SZD1Y$ 75TZ<
M^KSBK:7VMV)'QQ/X @8F[ZET_JM>83K2-1.\PM36\K_M%:8C4 ]YA>F8..>]
MK&O\>QK<R46^7"V6>B4G-C(*<#P+LA1E-,L@PDD,<1@HR"**89!%F8IH$$H:
M6>Y3G1 QM:G": G^!Z@4!:6F0*L*C*[6&QZGX.S<7O( TL!L.B@^UIL]'G :
M:2.G%UXN^QX=4)S<TSCUWEC[%1UZM_8BNIYT+]/SH=RX,B<!J\?EJOP"REI
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M!U\= 68D3$)E+C<2K/^'JP22C&<P%H)BEO(@YF[IAB_19FJ3;_L$L3$'5/;
MTJ##-"?L&91&@=*J2P]Q^_2HZZ'NP/TTXB'O,%UTP<'O!=!Z/PCNH\LK'0Q?
M -OI@^)+&NU'S-_D8WW=YU:9-5;1)%N=!5F4H1 I&,>QR6S(0Y@Q*:#B8<HX
MSL*$I3WBH$\*M!JOXP<_[_0UH[?4V/4F=#?6=G1X&73C4%T_N)SIJQ,*3]1T
M6LZHM--I[CZE=+]PL1_WTGO<R[LD(TY#(DQ)*\HA-CEA""(!Y#3E<8!5ED9.
M%:XLY4[--SNV'+]ZL1YW2,1T48<X.UR^8'Z%#8_>"%_B1=G@Y=]?.BOUM3PC
M&RC.^$!6K_>D+_G#D*)FQ^7*[* <JZ6"@Q0E. R@R'"9T2^"F8@91#A022I9
M)%(WZNJ6.37:>OOGW<V7#W=WX.[#'Y\_?/D.;KY\O/WV^?K[S>T71WJR -R2
MFOS"./A)>JDMV*H[0KD:>X!\\9"%Q'$YR!Z" _YQ>+4?]^B92JY6AM!^-:D6
M<EG,1)0%/ DB2()80BR4N>5E'">&.*()"A"5VV76<DWG=JQS7%J?-=96YG"C
MI90!?JR610%$K3A8TU]@OE/=C7=.@&U'-1=@-YK34V&D-00M%:_ %^EQD74>
M!W\E[H\)&;M8_1E#CY2=/_=TSQSHM+C_<Y$O#..(ZP=SK71&HRP+A5X_4<("
MB(D(828Q@ED8*<I90G!FE=COC(RI>1Y&Q2NP51)46CHF.3\"I=W OQ"@@4>]
M(S;NJ<I/6^\K,?D1">.F(3]MXD'2\3./]JU+MR6+ZX4XK(:W30I+(H$EEWJ@
M2XX@9D$*B<AB&"!)$-&#7V;$K4R=G>"ID<&GF^NW-Y]NOM]\N"L+:[8K:O[?
M_Q>)PO3_Z557T[HC[%AC"'@'II*6RF4.G;JNIL]DOGW1\5;OSE+LR.7OW, X
MK(;G^/Z%M<>KLW\MJB6X+C\L;A??S&4DDZ)'/_!EN5@U_WQ+B[P^YQ4\"-,D
M1#!&4J]N0AE#@CF%2*81$HE0&#FY,-XTFQK7[:Y;7X&M]N78;.O?[ZC>7W?:
M$>*K=-+ C.FI?_K73/>%I>_*ZA?K]3KUUWW!>;)*NS<!/7>Z3;ZTMR:?F@FY
ME8NB#-*[7JWT1UW6@WC[O'NDOE]V_9.NQ&VU]?YQN5(R7YO[Z5K%#[\>\ZKB
M5W&SJ!*R_4/F/^[7VC6NX@\__)(KGA?RZRKG<A8G&0]8C"$3,M,K5QY BE$*
M8Y4P+&44I8G;'OIK6C.UJ:+1%3:AG[+6%CP:=<&C7(%E%5/*J1X5\[D4CKOV
MK_KQ6)X'_'?Y)(8^:3!&PM)*T$8"M* PT63MYVHX0(F'R0I=&GX%6IA4RX(=
M*B;PMTFMV2 #:FA @PWX_\A[T^:X<2Q=^*_@R\14121J2! D@?M-WGH<X[+]
MVNK;,;<^9&"5.)W*5"<S[5+_^A?@DDDI-X )4NQ[9RG+%@F<\X!X< "<I0(G
MX)7&%,8XU&7)J^HR[C7,%(;MX()G$D+US5MJ0Z!6ZZ?/:C./B$IP:DL'9)&&
M6!$*.>,28A:E*65YS+E7!&.W\:DM=57Y*GM(4;1"^F88[0#GMJ[TA6-@FM^)
M%?B.YYBZP;)_=IH>.<OGH5*'V3R//--O>K9I0 UK6,O]K3'E;>:/2"B>)R2!
M*481Q!'.(.-$09E+&G-&=4(CGXEZO)NI3=E=#MO'6DR_"7L"2K>I>SU  T_B
M'3:-A#/0R!AN/I_'(-#,/M')J'/\O*(O9_N%I_VS];Y?;HK-T^>MS57P1;]_
M>%RLGI0JYSP5:4YB 9,L3R 6"$-F=KM0IU1E&1*<Q4XE$,_T,;497XL):CFM
ML_=.4O?TO:?@/#_Q X$T\*SO@8]7/M\+"/1*ZWNJS=&R^UY0JIOD]]*CWHD"
M;O!O450G)JG2NL@J,4DRSZ-,4606])Q;5RV42DA1FD*D&-$)1GFDG1;TTUU,
M;6I;*?\-'$MQDS@'B)]"\_S4#H/1P#-[2'B<X^(#P#12O'L?N'R"QR\@<3(H
M_-1[8P5[7Y"[$\1]Z<F0GJGMO]JX\&6IWK+'8L,6Q3^5_*9*93JYOUG*=^J'
M6JP>[<?S=E5NRCD16<YX)*!,4[/IP:FQ?U@60V[KIC L4DD2GTU/0-FF1JZG
MO3AWOVGT,_N$O8:@5;$ZHNTH"2HM0_C)]AMZMTW:*PWHP"O!R&,9R)7W*M0'
M]?_M)]D$G(:O@M3-T_BZ+OHM$2\.MUMCNZ[*]66[*3?F V[NK\7<[H%5I#.8
M:LK-)CCCD&88P<SF$<:(\CSSRCCNU?O4:+XC7U.:<0:X%;1_L4:_T7#CY<$P
M'IAY#RXC]_OL6G;0$7X&*O'#\6HOU (QIU_?HW)C+UA>LE^_1OQS([.%*FU%
MU:(L[8W@@PT ^V>U%:HO]IK2X7.1(QEE20R5I,)>MQG35C !HT3JA#!":.3D
MR^C1Y]2XK)(;[ 4'7<D;_X"VOKU[NF#7 ;AX8C $K /3U^LBZIZ0>0!DQTK0
M' )AK[S-GEB=SN/LVM!H>9T]->OF>?9]U9O'ZP(9GU9E^<'(_':UW!3+K5D>
MFBKGJV7Y1NG56M7/&9.Z<N3XO5BN;(6XCTO#GZK<[&(_4):(3&@"49)2B%&B
M(,<XATD>4T*S2- T=V3[L))-;4WXNE;0QNH6=;T8AQB2@4?NXC+Q>N,Q\&+2
ME.RQF@&K&MCK!O;*@5J[ML!/I1\P"H)60]"J&#0@:##@3_)GX.[&8MEA4.IP
M\4 =]':>66]5UTN^N9S?S>=4$!%1F[(?(VZ8V) PY3F'"6(JCF.5>=8CNMCC
MU!BV$;C*Z+LL&]_<U>;>[')]V=8==;=3@Z!8#LR.+8S/CF<;<0<)?70&)YQ;
MSH7^QO;0<5/_B+..XXO>1J*Q-85IZ(M^9YBMW!3BF_JAEELU3S%53)$,:A9'
M9G.?"4BE4#!7BF9,*Q+G3O=69_J8&JTT<E:51QM)02.JL^EV$L^+1E@(E 8F
MC$$!<MYZAP!JI*UV'\!\[,=+4)RT!$^^.)9-=TGRCG5V\=&> 8$V6+R.9; Y
M$IO+H[F0<8PEU9 2DM?IIWAJ;*V$X(@+)#3*G+:YY[N9&O554K9!<E5QA<:V
M\HR3.XZIF^ET/5)#'TW6(*UMRIE-$R16%Q1Y?P$L_T"OLUB$BL ZWLFXH5%G
M%3V(63K_=&]OGQ>%()IB$&I3WK+UG=K<+*H1JX_F+!>Q.S5'-!6,IQ2:/9<A
MBC3!D*9(PHS2/"4,$Q1[A1WU$V-J1'(\_6Q;=<>H,@.U,F"OS0SL]?'VUNDS
M=&Y\-/R #,Q7@XU%'V^;*Z ,YUC31XBQ?6BN .J(N\PUK?6ETW7QPS3Y0WU>
MV8;9HDDY)Z)8BA0)B 5)($8H@YPE#.88IPBEJ4B)U['5J8ZF1XFMG#/02MHK
MC]])9%WY['J\!F<L?ZAZD-%Y'(+1S8EN1B:4\\H>4L:%Y_NF^ENJMN+"!R;L
M*=93=?FYL;OP#TJ]4Z58%Y5E-T<R50F7.13&D(*8<PVYC 2,<D%CG.5(*<]T
M?^Z=3XT\K.S[>B&@%7\&]@H HP'HJ.";^\]C9-R(9BB\!R:?D%#WR KHCUFP
MS( >78^<'= ?E,,,@3W:Z$=R7]>K1[7>/%DC:V-S8OQC6U0.QY]V%:$IERB/
MK?DC$^M$(3+((I+"F"4J(3C-J/1*_W>YRZD16BMQO1'9[+)MUE[^_8MP.X#O
MQEYA(1WZ1/YZ-+VIRAV@0 3ET.&HM.0.P$LR\GBS;Y:[U7ICBY6^4WQS:]IX
MMWI@Q7*>J9PH*FW!4%NJFV04$A$+R*3 *&4X%M0I"O]"/U,CFTI,6-7?MH+.
M@!45_%$+ZUM8Z@2TCH?;UP,V].EVA=6M+U8]<IB=12)8=K'CO8R<]^NLJH<9
MN<X_WO,\IK 5K)>RR?3QCFW4[>J-^LH*^8X]_;Y:;FQXU'\KMIX+@C,F4PEY
MAC3$219!AF@*%<H$,:9+'.5^)S3.74^-.%K).YEIK/1-A7"K@.?1C?L@.![F
M# +MT,<[_5'U/^7Q!BC4N8][Q^.>!'D#<G VY-]"WSQ"?U.+Q7\M5S^7WQ4K
M5TLE/Y;E5JWGJ<H2P32!69H3B#/%(3/F"T2<"29)AJ/$J?#YQ9ZF1DA-SAPK
M+?R[%1>T\H):8-_40J<0/D\_07$;F&WZ0]8CV] %.*[(.72JY9$S#UU0\##_
MT*47O%T5WZVW=YTH[M^5#7^<ZS3)F9GU,-'*^BDF&A(E(TAC@EFD4<()<_13
M/-K!U(C@[>J'S6$-K+#/$B3\4<OK'F5R',_S\S\$2D,;&0,!X^R?>#5 (SDG
M]O^2?%P4SZ)QTC_Q^%MC.2>>E;GCF7C^N7[;M2\VC,%F9%ZK>[4LBQ]-U,G^
M8J[\_[9L4>@G6RRA_$\E[U3Y66V^Z%OV9QTY:%Y8&\XUK]1_[D(8L*3$?!7<
M&$[26$]*2TBHL"[> F'&61)Q)^MI!%FG1KN["+!O=L/R_2=[!#?R?[9E=8O@
MF6-HR"%VVSU.9. &7@DJ+<$S-=L8OU]LL->O-O50>0\^+%8_0:7C#/R%%<O=
M;YDV@VZKVRQ861:ZJ#UEJD-VF]9HB!"9$48FT#YW2$E'W1B/ /G+G?087?;U
MWN*;-LFT5H1SI!*8$V-?8ZX%9!F-88X3G=K,13G3\XU/">9=VU[T/D+!Y?K$
M^U+RZ8N(&: R3'0&F;*K;,K-/D2P%(J$13+":803O*M=[>/IY@?<BX+5H_BX
M!<$/9]1\6YS!-(J4L5)B!GF2I5"I7$E&,I4QKVNJOE_<OPYBCJ?%_7 8>J?F
M!$$/_[X#98.Y].U;'MF+[T"E0\>]PT>"%+L\4J.M*LKVU^6*EVK]PQX%?UP^
M;C?FUT:;8E%45M*M^G/SQNCP]SE*A$@2IB")F( 8DP3:6"J(A60Q36DF-+VB
MY.6U\DV-&+J%%6L-0:LB,,;GOM9BI:6M?[W7$U2*@N>:-C48@=485"I?5R[S
MZ@_"C;-><9@'YKU7'>%K"VZ&&H=ARFY>+=UK%M\,!>V%$IS!NNF_P_BX-)N5
MZHRS+J,;8R1(AC%,A;6;<^N>E,H$\C17G&$51:F7Q_>1/J9&\]_%O9+;1>5Q
M_&FUO-M[*8&]Y&6_^L;'('8W%*\ ;F#B/,#LMA=FO2S*$Z@$M"Q?]C"ZA7E"
MQ6.6YJE'>T:'*$-,ZI,]QBB_KA:%>-H;"S%-2(Y5#&.-$<22(4A30Q(Y2M-<
MYDFN,NP5#'*ZKZE11"WJ#-3">H9UG('4C0H" 34P)3S'"/Q12SJ,)>2 2*B0
MC#,]C1N!<5GE@X +AU>NW)A6UDGYR=Z\)<WM+$**:$P(5$K$9FN9I)!A$4&-
MC?6 <J4CY'6U=::OJ=%$=SM12VNG@Y$7))YWWRY >V[>KH-OQ(V8-W+]-U*G
M,0F]*3K2T^ML<$ZK?'*S<N:5OH[0I5BL[-;GB^Z6//ZF%O:8O*H*<5#QN-PO
MFSA)1*ZUACI5-NUBI" SGQA,>9:D.F%((:]SK"OEF1H-?;_]\O:_P-LOOW]]
M__G[S>W'+Y_!UT\WG[_[.DI?-TB.VYSQH!]Z2W2LBGVGT/T?@UA"@? +YG%]
MG30CNV$'@>[0-SM,L_VH]9NRVT&QV=K#I)NE;'J]$9OB1Y6O<N>?$E$I">4"
M)D3:&[Z,0Q+E$D:1QIRI6$;2RTYS[GEJ=/E,\,JEI!$=[&7OG<W6?3S<^'(0
ME =FQE  >Y.C-UB!:-"]WU$)SQN.E]3FWT#/Q-N+Q>JG]8C]L%J_6VWY1F\7
M;9GL;TJHHCH9GV/-(ZQB#G,MK5>,K8/ 40P12@3F<1;EPJN6EUNW4Z.O7>7V
MO8@SL%,%Z-6ZS:-A?>D\<W&[#03"218KK&"2J-P,A(JAD95#R722$8(I1U$/
M9YN XS&^'\X$AL5M10G_U0^\G 1"UC]GNA=0H1*GNW4Z;O9T+R .4JC[O1T^
MDZCI5Q5WR]I%1SS=FBU:N:A,=.MR;+^9.<X5DZE(($[C#&(M""2YD# 7"B.M
M%(Z8YRWH->),;<5QR&;9* 5:K4!'K:YG=[@DHPZCZGKQ.M98#<R38PQ3T/RC
M[NB.D(?409C)Y"-U!\XG+ZE'J_U(^LVV-)V7MO8:+Y9U>9]]D;.$2!%QP[Z*
M8H@E32$U=CT4*D]B)#7*$N1#P><ZFQK!MK*"KK"]CR#.PNS&B:' &YCQ>N/F
M36,N@ 0BJ;-=C4I!+DJ_)!BG=_K1Q\NXFX_+MOQXISK8G*4RC_/()J9(",01
ME89'A(8I1Q+%J<JE0#WVIDZ=3W1KVLH.?FFE_Q68I;Y5H%N%RH]IW$8DRF2>
M8*ILNFF; 8WGD&&)(,^1C%-.\Q1Y,7NXH1@UBO55Q\"-]H,C.S#_7P*U6U8R
MW%K@A5*@1<&MSU%7!R\87BX3?B_[)RSIW,GM[]ZZMW.=F]JR4]ND?/^G6HO"
M/%QY5^YOMQG"N4!"0A9K:FQ4AB'5*H,94I&*%8M([.0,.81P4^.ZO8+677AS
MK\#'!_-H58RKKN33Z -V"KEG" D^LN>I\;7':^@S@_U0?3&#8[4#M4M#5[^N
M7T-Y:@A[!SL-,JKN.6-><W1'RC=S."&UL<V7HF!F%'93LU0+97YB]>W>$U@W
ME[:;5?6*:M2M'NT4+2M_ [?W1;E_KUB*Q5:J$@B;XF%='?&:9NP*TM8Y:]LJ
M9U738F68OWQ<+:6],+85O'E]0%&:U]FB^*>2L^H>V3[,[N[6E>UL.MJLBV59
M"/##NJU9P1J1=AW(W\*DTAGJ(SF=AB=XCZ.E\!D*JV[ZG\'Z\#8UOJ_TYJ>1
MX)UZ-)]Z'; USY7 D8YBF!.-(<:J\HGF4+ XQT+$"J=.OC8GVI_:@M_*"&1'
M2&?R/XK@Q57Y6EP&7EAWD+P+!HGSDG8M-".M2K>6S*L2-Y:YNY^.7316=TO+
M^W8_5RT137'LQRH%B_DGMC%/:;MBE?6RL*NGU:YQ8E76ZUH[%.V"QNK(W]4/
MM:Y?K?[^[V!;*KU=@(5- A-FW3@W$B>I_^A+8['W.8D[!'SVL9X)])L0PR^Z
MW0J:36!],W&S[%;@?F'I93DB628QU#JS!WY:02(XAQQSEL=9Q@3W.E[J*<?D
M.+D3L;D[$+&YLYJX=VM.]3YTZCM6;L=0(XS T.SO!_Z@602N1#-458">4HQ;
M-> ZJ ZJ"ES97#\>_<MJ)7\6B\6WU6+Q8;4V+"WG&94YUED,TU@C6]<M@S1E
MF1DFSBC*:8*)5\7<(WU,C?]:$<$?5DC02.EYE7H,2S<.NQ*A@?G)%QQOTCFC
M?B!".=;#J&1Q1L671'#NT7Z3_+9X*)9W7W3EI&&XY8NV?7Q9?U?K'X5H"^0H
M+#$5A,%$4&Y-HQRRC".H<Q3'(HXDX5Y519QZG1H1U$+;E;@5V_YL!;<%Y1O1
M>U8F<AL&-\8(#N[ '!((5V]J\<(I$-FX]3DJ_7C!\)*0_%[NF5K$&+E-Y'JL
M"='*%CU#N<U#)S D7"*H\BBA/$T(5EX\M&]Z:F1C)>L9^M_!RXTP^J$P,"NX
M >"? .1 UU#Y/O8-CYO>XT"A@VP>AT_TFX@VIK\^$V\]\<LJELMF'#-[#]/H
MS9]%.4\RFBF,,IA19O8(*$\@D8Q!@A13.4:<,Z]S%+=NIS:!O[]_"]I]VPS$
M"$9T!G:J[,-.RB:NL=:FJ=AG%?*<]8Z#X\8(X2$?^IQD.+2]*<8/O$#TX]CI
MJ-3D!\1+VO)\NW="D<=5R19_6:^VC^7'ZL+9&#3V6G"UW!3+K9)?'M6Z=C_]
M;#[ QA(G*,D%P>8[RS,%L>0)9*F-\TF09(DRIDB6>R82Z2/'U$BO50-4>@ K
M:,\-4=^!<>.W$> >F/!Z(=TG2<@U.(5+#M)+BK&3@EP#U9%D(%<UUX\.=TE%
M5C?B']MBK5HO_*9TA:VUTOQ&SHUAE_"(4<A)RB 67$&:R-0LO1DU0R@Y3[/6
M0=Z-!7VZ=YJ+SUWD!R:_2K*R:&^.^4[V&5BJZ@*Y\F-BC0)^?.@W,I1'69RG
M,)9"FVUR9JM98+-$)3GF2:H81UXU&(*/RXA+4BN[]3YK9 1O.D/SN1Z:JHK0
MS?!#X[8^#07XP(M24*R]%ZL^H 5:H;RZ'G59Z@/*R[6H5QOA\H.BYC K(W'*
M<VEH3",,<40P)$F$8"R4TGD>9R3W8K4S?4V-Q$YGN40!\X.BJ_.#]H!O8$JZ
M"KD@^4'1:/E!T53R@R+__* O7^E?F.!EJFPA8JDYRV"<9=A6%Y:0$<2AD#;[
MN"8Q$]*W,,'$LX[7Z?3+<EOEM:D2!_I7'^B7<OQ*=(;>-5?EJIH$XX,F&C^#
M0\!Z Z^:6/R,BL?J#81-)%ZG*&^VP,N[*E=YZPCUU!HL[RS%6%\)\\1_*[;^
M4/Q0<YX0%N49@BFETN;IR2'/HQ2*3'*6\#37R"OY6V])IL8:Y@O+^U0HZ#,(
MCA>38T []#UF4]U@IT5=YV"V<]M\FK59?XUI8I2QCNJ-.L#J ZQ"H2L@7(%I
MT/H(?>1XA>H)5\!UO+;"-0WZ$:94Q;PI*OBA* 5;V/;>+^4[ME%SI(1(<Z0A
M,:80Q!(AR&1J;\\BLYO2]AS/*5W9N4ZF1G.-G* 6M)YB1E1@976CO[.0GF>V
M4$ -3%J],'*F(A<0CK!,J<1O=ZL?_V%>KPG&_+#GE;.-CD(9+FJU;.#T;+#D
M6-]V45 ?I>FQT(7U$V\<R)N#F^>.Y.9WVP<E&Q'K)ZN*U_,(848T99"CR.;.
MY1BRG)B?**(<IP)1E/=(BS.LU#TN"\;(IW,L[=0,[/4&7<7;D(]6]8/8CT;[
M73G>7;*^"H*K4W^%_(@DX0E&40:SG%D;7$>0,,$ARA6-(J%S++PJ@DW@ZWGE
M+&__3WPV;KN&Z7P, Z_2D_@.0F3 &V!XALNA%U+8U\["-P#P#GG\ANBUYW53
ML2PV9OOUPZ:+VIBY5>P$^62D_KA1#^6<YXE,XHA#HAB%6$0*\BS6D/(HR92,
M4Z2\#HQ<.IW:DE/+#"NAP5[JEE3^L(*#2G+?>RB7$7"\D J,Z] W4P$@];^@
M\L HU$V52Y?C7EEY@'!P=^7S;M_TI,_;_:PV[_]L_+_: , Y9A%!MEAF1E0"
M,<L5I'&>0<HXC7A&<AEIOUR8ESN=&BEU)@UK;)6EVOAFO70 FR22"9KDD*%4
M0:QP!GF<$*AE'LDT,?OA*)IO5ANV>"6P=UT/![;UW7G+UNLG>RY]4V5;&0!I
M-Z8/C=_ 3'] [K4GU"\[F4$K=,!\^3X8!<LMZM#ER*E%W4$XS"SJ\6[/<E7R
M?[;EIO6MDK+R'66+KZPPB\M;]EB8:5UE)>,OLY)]4[6OJ6H"+;]6V8P:P]H^
M4/E7S FC/#?D!(5$PJP2G$&:DPSF<9H)P1);E,2KT-7  D]MA:DS5(J.'I[U
MEH8>8#>^G-*P#<RU-U\_OIV!"R55K2M8D_"Y*OID\WMU= I8^6DDX$/5C!I:
MW'&K38T$_D&=JK'Z#57AJOGQ"U\4=Y4<;U<V(2K?5L$E;YZJZBYLO2E$\<B6
MFSF*!94\SV$48VKS\&/(9"2@L87-CB1#*G=+2AE,HJDM&QW12B"ZHE];MLIW
MJ-S6AU$'8. %X'CQJO9O>X5FX)E*@#_5%:XZ6@U9O*HGP(/5K_*5YY5+6/6$
M[W(5J[X-]_1BW!]Q-V?;\S216DK)H:*QC=T2!#);+B E*2%1PKE"B<]9PV$7
M4SM9N+5][/*R+OJFDCR"I1O[78?0P'36$6YW,Q?0&?"DZJ&\_ X[&-=][Z2"
M!WYYIY_L&4N[7@FE9/G!"/6=V>2-U8W5Q^4/U5B'<RX888E-C8*I-:3LI5+$
M$ZAT%J6"DU1(K^WYY2XG9RDU$M=)_:W,-D"PDAITQ/8,R+R,O!LSA,5S8*:X
M%DK_>$MG=$)%65[N<-S82F< #B(JW=_LF]?D1R'54I8V-G.N2:13JB+(*1'6
M9R^!7-F0!Q)'*4=<I2KMX;/WK).)NMCM9)Q58<>^24BZ*#KNI;Q!&2MAB!L0
M/7*$'%$X6.:/;MLCY_,XHM9AEHYC#_7<"ZR6=V9&/'Q>;53YE3U9GYBY3KDB
MC,<0Y=+L!D3.(>=Q!LT6(4UMCHT\]0I>/-;)U&R"2C;0"#<#G\UX7;![W?%T
MW!%<B=+ 4]D?(/^-P1D$0FT-CG4Q[N;@C)('VX-SS_8N0UL7*'S_IST!5LW1
MP]LZOX]-J[I+\+.KNBQ5+G&<84C-]@#B&'%(*&902HU3LV7(=9)YED#UE6%J
M=-'4YK3%OA[7JQ]%:?/O]"UYW6=,7'T6!D5Z<!>&M@ J:.0'OS0:_%J?I-9*
M@+T6@Y3/O@+%< 54O248NYQJ7XB.%%?MW50_3OQF]C_KK=ALUZ9U>R^[3_GX
M:><.*O,(9RI',(TTAQCG.>0RTE"KR/PI<H82+Z/(I=.IL=XSF>L;[$YFTRL<
M<IU&P(WR0N,Z,,>%@-2;T'PP"L1@3EV.2ED^(+SD**]W^Y'27Y?[,G*&#!L6
M+&_OV>9OJ^U"UD6)WVNM;.52RY??;"1P3G"N.-:0)B@SMEJJ(8]B 5-.98H3
MJGGD%>363XRI$5=7"UOAM;7==H5:JXI\/ZU";4E9U:I4/;AVCM.^<OS<2&[X
M41F8]IX-B#7PWCP;B4J)MN[V3HWJP6]!HL'# !F(&WL*,2I;7@?42_Z\LK6^
M9MX/M=RJ;\KFK#6\_56M]6K]8--5[6_>YU(S@00UM"DUA3CA")),,)@2A'2L
M&-/4R\_(J=>I\64CM(WK;,0&';F?.;3T\<IW&PE7>R\POH,;?*&@[6'V>4 5
MS.YSZ7-DP\\#AD/+S^=E[WK<O[,_BX?M@ZPJ+K*%V>D*6\KX3JTT6RZW;&'=
M-TNV8.NG>4XEY2F3,"/2F'HDB2'1,8(LSD429[G.<R=3SZ_;J5%5(SIH90=[
MX>U5="T^L/*#6@'G,M8^8W&>JX9#>&"RF@:XSJ7#!P)YI(KBX<#V*?+= [.3
MM;]]VAJK)'@/_3J5PON\[4WZ-RB*:2>1?]FD1*:YRKBQ.B'F2$*<20J)(!$D
M"M-4D(0+21T)_D074R-S*R7HBNG,)Z<PO$C, 9 9F(0/0/',OGT&'6=F#8#2
M2"SJ_@GYL.0%_4\RXJGWQF*_"W)WF.[2D]ZL]F6[*3=L:2-7JXC&;^K1C/&]
MX<N;[>9^M2[^61?::F\TE1E:FN 4*IIPB(T5"RDG!*8R3GG*<<:%DU^J?]=3
M8\$J3@NL=T+;*^:[-7OPOF#N,0H7^7) ; ?FT8[DH(ZQW<L.G@D?]!:Y/V8G
M6<6WO;'8IJ>>'1;JVT(OFXM\_\D>;^[6JHK/W5E=3!*1F!UUKK$QO1"/(9?$
MF%Z4*B5H'#MF7CK7R=08Q\H)K*!@+ZF7<7$<2B?CZVJ AC>_#K#I9X$=!\G+
M!KL:K/&L,/</RM<0.PO"65/L^)MC&F-G97]ACIU_MM\E2!59:)CS;\7F_NVV
MW*P>U+I*-?*7]:HLYQ*G(J*9@J*J6T)%#DD4:Q@1'5$A(\2IU_7Q^>ZF1H.M
MM."G$1>T\L[J!#HSP)5>&<-L5QJVSN.P5K+8@$]&';]+D LCX7;[$0[?@5ET
M*&B]+T'<$ MT^W&ALU&O/=P4?WG?X?A67S(J-U]T<Z4RC_.42QYAF$E$(>:I
M,;QTJB&3$B6"(H8Q\^.>3NO3HYJR*DO8B.=+'5W<7)FB)QJ#$X,;$#TF^A&%
M@\WK;MLC3^,C:AW.VF,/71]2W)8*^;!:5[&#'XJE86NS6;NQ?AI5'/-<:QPC
ME&#(TQ1!+)(,<B832%6N4JYSH57<-[[8H?^I3?3G$;*_[*J5F@7NUR90=J<%
MV*O1/_C898S<*&- Y <FE="@7Q6F[ '= #'++KV_6@"S!S3GHIE]FNE'@M_%
MO9);&S-='<Z^>9E$J_K7LCVC4O*O2]-V=8+UY='^WF9P*=\\O?]3K451JJ_K
M0JAO-C/<;14AF$BI98X%1%1)B#7-(:5Y"G.FM%0IDS3RXLQAQ9T:Q=8REZ![
MP&N=Z!OQJT($; />*5'MH$$2SX#97B<SFW^I4LL:(*VRH-*V!']4NGH&,@S\
MG;CQ]G1&?V":OYAQL=9G]F)LFS&_-,#>I#\.[H'6B(&%'75)&0?XERO02+WZ
M+5CE>C-_OUVO'E5SO$SR)$TRGL*,5Y6(HQPRG J8"44U$\+\Z51M[V7#4UL$
M:MD\#^8/T#I/L-=@,# 5NJKO3&JG=#U'/^:=#O68O^UIYZ"Y40CBE!+M5#[Y
M^]Z57>SA955>\V^JN+O?*'GS0ZW9W=YAN/JE#>J/YSI%+$<R@E)H G'.*#33
MTYA^(B.89&DDA%>H@5_W4YO C?1MI=I6 =!HT/&7KYX 5@GOLB\^P^-F; T'
M^L",$13O/C5A>L 6KCJ,3^=CUXGI <R1BC%]6ND;JLJ+Q<(:/_5=0?G-[+2*
M'W4NH0SE"-$$YCS1AN-$!(D4!"J">8)ICEBL_.)13_8U-4)K104[6<%>6-]@
MTM,(N]%4(-P&YJ1^D/6(^KP(1K#0SM,]C1R_>5'EPR#-RZ_TM)-8L:ZRRK\K
M2K%8E5N[3VH]$'.B9:Y8!F6LC%644 Y9%E,H$D8%80F.F5>VH7.=38TRK*R@
M$A9TI.V=6.@LSH[F32#TAC9F>@/G;[DX(!+*3CG7U;A6B8/2!S:(RSO>CIO[
M4Y<F>^GS@DEOGGYG_[-:OUVPLGRWLI;./$GS#-$X@BI.,HA9IB'7B$"1IQ0;
M?E&,)8X.G=Z=3XU@6@7 EWV6WI=%(-\\@4H-4.D!_J@U<7=U]!^A\U0T-.Y#
M'U(/ +F/QV1O[$YZ4OJW.):'96]=.YZ7_=OH>;5X]/"X<XWQYFG_2'/+<?.3
MK65S[?6_5;FI2A?;?&G"9CA>V7_J7'[=W-VMJ^3''VU5B659B+J.%Z=QDL0,
M0Q'SQ.S-<@9)*F*H\U@H(5B<$B=B?'5-IL:R.S%!T<H)?EA!9T!U[B17CSW*
M\[S>Y^)X^?BO\!&,>"_91:%[.6GOGH_>7UHLVIO+<@9J/)K[[!H1L%E5_SSK
MWG#/P/ZKVP%3F\0!;SA?>W!#77Z^FA[CWHN^]G =7)F^ND!]R]>MBQ_,IJ+Z
MN+29_RIO(R/&?RIY]\S-:+_5V>VS41HID9CM!\UR"K&B"-(\SZ!".B$HTY0)
MY%>XKK<L4ULG]ZJ CBX5US7:=)SS.AO[W@<BUXRCV_(WTN@,O( -.3 ]ZMA=
M#6FP"G;])1FY=MW5D!U6K;N^R8#D^Q>S\;*!0=^4L#NQ0A=*6E?0&R&V#]N%
MK?3RY>U'LPBLZGS2NUR"7U=KNY1\5IMY&K%,2Y1#&>/(,',D(--*01'EF0$=
M(XD]2XH.(^B_!FW/@%45_&*5_15TU:V]L#L* Z.QW1JM0*WSK)/CLU&[JE8?
M@-Q#?"=7,/_(H_\JR\*8 Q]F\0@X*D.N+"'$?/UE)R#83FM2R/YZAC56<:L?
MF+"E'9]N_BS*N9):Q50E,.72>F$F&A*!,,RR",<)L[D:(Z_8QH,NIK9(-,&[
MK8C&,C1">IKK1X!TX^+KX!F813V1\0]\/*E\J.C'PP[&#8$\J>!!'.3I)_N6
M3_IA.&:U?K*G"M7A19/VOYPCE=/4EJ5'A%1QC\1.<0WC7*8JR;C,B9.C]>6N
MIC;5=Y*"G:AM 0O/P^TS\+I-_#"@#4P O?#J4;7H$A3!BA.=[&CD&D27%#XL
M-73QC9YW>EM>JG]L3>/O;0]U\)9,DC3%<00EP@1BGBC((T)ABD4F4\)HAKT(
MXE@G4Z.&O8R@$K)G5-TQ.!VOHZX$:>B;(E]\_*]LS@ 0ZC;E6!?C7G2<4?+@
M#N+<LR-?X;__Q];8)9W-2^5R<'O/EL\N/#XNOYJ=SDK.4Q)KB@QG,"89Q%+:
M&WMD# V4$(85BD66]ZBI/);\3A-O_'+-G[=56/!*MS?RX$<E]D@7\[X?P<#W
M\$.,Z;_,M7NM_+-+C]IG:V/T/[B4+Y:@!F$"-^P]A^VU+]1]Q?[7N#_O.1C!
MKLO[]N^W_$E5S-\O-Z:G6_;G1VGZ*70A*AEK2IU'<<IC(A6D/.40$QQ!GN8,
M*AQ+%7,4)=KIV.MB3U.S>VMAJX)ES\4%M;QN2\ME@,^O!4%A&YB\>R/F3+'.
M:!SAQ%*)W^Y6/_[#M%'3H?EASX*76QZ%MIP5;'G&_05O-_V/2[&V\87O5/WG
MQZ6M&&\CB58+\\;=QZ69AH:$OFXW<RDCR3.BH-D"&ZLV%2FD4C$H4I(FDD?F
M_YTB?ORZG1IEM**#7UKA?[4&QG/Y0:L ,!HX>^3[#,9Y1AD.XL'/W":!KG.R
MYX%0'BG]<T"T?4(=>H!V,LC!IZVQPAMZZ-<);.CSMC?OOW]X7*R>E*KRW'QM
M<O?;3#?U@M+DRBG;W\AYDL891UED"]@AB+,DA1PA!I%@),,T-[]V2GW6H^^I
MK0#[<XBR$A2TM0^DW;6J15''#*E&3?<,_=Z#<G$1&!+JH0W-1O2F!D@K(K#2
M-[:F#=6J%=C]VO$PJ _8SFO"D*"/M##<WBNP?/F9;VUB+&!VJ+M/&Y35V.P+
MX-BQN3 ;@*RJL5?M/%;;VM^"+"I]43^YLG@W.-;RTE?3SAK3NXEKTW*:I:P^
MM*TZ:+Q1GZK#_5OUY^:-4?'O\RCG,DDS"F.>)! K22 52D#$XBP2B.9<>%4W
M\.M^:LO-+C#5S,2=_#7OM=[=CO4\>PZ'XT'V8" /?1SM@&]SWP>L_*!28)!\
ME#[(!<\OZ=3Y*^6+] 'F=/Y'KU:N3T"\6F]LVJ9WBC=7X;F.I5(ZAQ@+\Y]$
M)I SP: BG/,89YGP2[)TKK,ILU@E+32]/@ K[_4I? ^0]J6LZ_ ;D:!JZ&Z=
MH;LJ.>XI3 9(;7O0U:LEICVE]+FTLB??"5]87K#ROEC:?RQ^J$?V-->YC'"J
M.<PB;DA%D!32-*$PRF+;"M-9'*R\_,O.IT8R;J6YK19@IP8P>H0KAWXP/!>W
MZ(."/C S31#O<$7HK\%]4J7H/? /6I'^%(#]Z](?M#B9ZO2G=/6I47^RC7ZF
MZ,Y9=E>MS<:!MIZS-_)_MN6F<CHP^VVB8H)R2'1JEI TEI#%F$ EL,Y4I%5*
MI(]=ZMSSU-:/#\K RQ9^AJ@[SFY6Z2#H#6VBOG\+6H-H!F($(SKK>,WO-:EB
MTUM=9N#8!=1>PW!6K3>F@4Q<]WY'M7>]X7AI_/HWT#>F7!=+)=^HI?EA8P\H
MN^&!UEG*>ERMU;U:EE5XH8T4_*PV-KBPM-&%JGQ3E:R\97_.M4)::2%AIDD&
M<9PC0W,DARE-4<9S(0CWC",/)]S4F/"OYI<VSO*?2H*EVH [&SIL%J?%5M8.
ME:P3+;RJ7"]%5UF@V-HFK_8,+ HZWFYT^UJC.# C-VJ!1J_JVFSV/,:[&K5G
MRC7AWDV,^+. \5WM5Z-FR+#O\. '"_4.*-K(X=WA03T,Z1Z@CVN/7'<AXG5W
MINEO1IQORN)6+(IJP7IQMT%S13-)!60R9A +\Q.7+#-+A(@B*C.&\KS?D:R_
M,%-; [KGCOO\#PU%6 =0JQ!XKE'?,]P>0^=[QCOL@(QX!NPZ%B-=6O7'-?@Y
M<@]17NF<N3]HI\^AKVBS9P(-5M[;_[=A##_8PMK[9@NP61<VY9_]1;TGZ/Q#
MY\DZI.'0V<V:F,9P?/^GN+?A$U:%6K%YBB-!M<AAPJF-JDM22)$6AJNY(!0K
M0KF>;U8;MG#CZG'%]V+WG1+#,8K59P;L?T%'K1G8:US_LMFP/_NW9R_42!S;
MRE?[^QH/T )2$U4-R0S<6D4]DXV,^]&YK3+3_90&7I<<OZ+9D)]1P)0LKS*,
MH=*]C"O\N*ED7F5@#M+4O(X4WI?(-RB/OJMEL5I_7FU4^6ZK4)3$<Y$RD:>I
MA 2GL5D_!8$L2C!,.5<B59H@MSR*)WN8V@8&_99'_P;*2DZPM(("N57 BNI\
M WD"RXO7NM<C-#!S#PB.\QWL]2"-=-':!RR?N]3S0)R\,#WQVEBWHN>E[EQ]
M7GBPW^[C1HCU5LE/!>,V;5BARJ8XL-0,Q9@JF.4H@YA("BEC# KK8I=JB<S_
M^ISIG.IH:G37R DZ@GK66;X(K9LU' *P@=FO%U;>]N0E( )9?B>[&=5&NZ3L
M2VOJXO-]LQR\5;80XN+C4JH__TL]S9&,--%99OB $<,'J8(TURD4$8V)UCC!
M2OAE-WC1P]2(H(G1;Z0$E9C R.F;S> ED.=G?Q!X!I[VWLCTR%IP0OLKLA6\
M;''D+ 4G%#K,3G#JP=Y5VHN-^E3\L E0GA?W^K#=V+SU]0UU9?K90B/+<E\%
M(HYE+M(<0R1R!''*)*1"YS".TPAKEDB1,\^:[;V%F1H]U+K 2IG#(G<S4"L$
MNAJ!1B7O0N[]1]#-U!AK7 ;FI4M#\EEM9D<'Q(Q640I#9?^MV!K\SHS*=:[B
M 0JJ!H Z7&'X_J*,72;^:M".%(V_OLW@G-PMN%BE $]1)G#&8XB-H04Q)1DD
M#"DH&=(X3CCA.0U$P2_[_M=B7!LG_:RL:(\4[#X#<S6S7@/WJQ*I)](A*?(4
M9L,SXD'/4R' 4Y!X\-W))JZ/WKR0TJ\\E=.O"?7,$6*IT- 8H=HFD8XACZB
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MT+QG?5<D>IKBSXH;=3YW-7YW\G:^[^U3@]^SIZQ@\[*V<BM: "%*L8HCB%6
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MZ2/H>'9W$29#']FUE/LO4*D'KHMBE?%U41[<%4OPU7S)BQZS<8\CTM=IW;Z
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MDN$H3$G*E-?YG(/,J9%#2V70Z RLTE>@K;8?4[A@[T8;/2,Z,(=<"J8WH7C
MTQ.[N$@<E6H\(-CE'9];NY'0IVR1%>IS]FSW<E^7&[@68OVXGMOJ'J^^BT0S
MD<920A**$&)-F5GK" I#G! 4H,"X**1#21)_39R^JS<H4[+5]@*&ZC P;H0U
M$,[C\%>E/"RUWZ];8DC,%WMO0NL.7T_\UD&!4>FN.T"[['?!D_I9E'U8/K)L
M,:.!YG%$4RCMV3U&*85<2 0#1HBBBA*:>#6^.RQF:G[7_G(#_%EIZE^LX!"J
MW59E_EB-OBH[#]/%R[+7* RT+*N%O.FR[+6AYY9E.U=?4$' ;E2OU(-:Y&6$
MD:U3;4M6E_O6/[-\AK5 .K0-3C2W>4K<_$3-"LV6:S.^D0H%\XKD<1$Z-8*H
MCK->*=V4:6_4!G]:Q3WYPFD W-BC;U@'YI(>$.U6P, 1HCYK&IP3.7Z9 T<0
M#E8^<+W7NS+TY^7BWGS,C[8/BU[;DZY'XQ4]KA_K+BMYMC!_5GF1+<1\+97,
M%LU?9JG4:1CR"%+))<0RC"")8YO^@:5YGI91Y$12EZDQ-=JRI@!K2]G;Y@I4
MYH#:'M"H?04:DT!CDXUZ:_[L7%WYD@$\37+C#<O0)V#_.2/B7!![I)$9J6+V
MP"/D4UJ[!V"/UMZ^Y-EC%>?NP?Y6]>X^GN8WITF5S3[4;^W-0B]7C^6[V_RJ
M=.X2I43 @Q0F8<*-=RT9I%HS&(=$"2HB%H1.]0,=9$UM=FIT RU]K\#FMS[^
MM O2IV>8GO$;>B5^$73.'.0!R@%_.5?BM_OE\W^;IU2NLOEAZR&[/'L4HO$P
MLF$3GUOZ/ZMH;0+6_0=L1Y8[,P)JQDB* Q1$,$@5,7ZP0I!):N@DX93C!*&$
M!#Z+]8YZ3(UJ/AI6?RQWREF[('C=".,*A"B(^SNS.#5 EQ]<] 3[6YY>7)6-
M[<3NR<45L): TI1Q3C$<L!SA*..4%I,YSW" RN=0P^5QWCL(K^/7_F _K7OW
M_4>VN/^<+=2[Y6JUM/_(9QHA'&.EH8IMJPF&8LB3)("&+PD3410*YTY3KC*G
M1HD[,9A7H%8=E+H#JSS8:N^\XG0>@K,+_B& '9CTWAI3YR7[$-B.M#[O"6.?
M=;@O6D<7W<X/&FN%[6M9:SGM?6O'#'1595]^9*N%?5Q3(Q<KR9B(8:J%\7/3
ME$#*4@P%1P%.XB#BQ*L+\V$Q4^/L1DO0J.F9"7X82S>7]'*$!B;?/7 &J)Y[
M&H2^\JX/"QDWJ?JDH7L9TZ>O[I@.K>[M=/)-/5E7<7'?6FA_WN3'X%0F41@9
M'HA3#;$($TBCF$%$ I'@B"9"^24K.PB=&BO4.H.-TNU=H0LRDYP&P(T\^H9U
M8"KI 5'_!%4/B/I*'W41.6YRIP<(>ZF7/O=V3(RTY1YL5/(L%21* Y; -*6I
MX1U-()$T-OZ'9$@&B'(9>B5!-D^>&KF4BEV5<?.>>8T;K-PHHA,"0Y_6.ACO
MGY:X:VA?*8B;YXZ;;KAKSEYJX=X%WOLZ36NO:_&O=6;6'1_6*_.!?RTK:GY1
MQ:W^P\BP!WKF^Z]^>RW_L<Z+ZB!;61\AX0*&6$40(Q9"BF,$E8P"&JN4A8%3
M3.NEBDSMTVZ,L:'DE3F@L@=4JE^!A2H+;S]NC0)5&5/ MF8Y;V-<-HIG]XM&
M&YN!2><_:UB<MYQ&&YZ1]J&&'B:?#:I>L#VZ:W79T\?:RNH%@];^5C_/ZY@N
MNWQ\7"[*\KGU'DW D&U KB 7@D(<)@A2&@H8:$5CQA&*$?-*CMV5,+7)J5(0
ME!IZYKON@>?F@%X$R= '"RTT!MC6.FIZ7WFJ>\\?-ROUF'E[.:A'+_1V6:_#
MWVB<JT6V7"V6A<KE6AE8Z"PRV,1IPF"2!('-<I>0:*%A$H6<J13K,')U1H^(
MF-J7;+7\OT&E)R@5!4938%5U]E&.H7G6*>P!HX$_[2'A<7;.>H!I)+>K"UP^
MKM09)(XZ2<?N&\O].:-WR[$Y=V4WE\76':MR0.;SY0];&[5LC3Z+4J8Q22.S
M^(Z,XT+2&/(TCJ"("2,LD B'7AME1^1,C?0V:H*-GG6S>,]-^&.XNODT/: U
M,/UU <K;OSD#0T]>SC$IH_HZ9TS=]7C.77[A/GGYL&T[AT!P*A15$ >I<7XB
MS2%! L,@1D0I)5$<.85=G9$S-3)H;2/7[[93PT<O:#TWV;L#-MZ6NP]6W7?A
M#R/1]Y[\CI2WV:$_;.K1_?HCEX]<W/S+VB[$;G7YU_SZF65SJ]>GY:JL>SJ+
M4QHG,><PI(I!C,((VDX^$)$X(8%,(L*\R@@.I>C42*E2$[!&S[*WP7U9A'F]
MD&7Q9E7F9[/%RW_E("^W'I9E+5KP9)[D&7LTV/B[$=\41G5@YNRAD'=EK-VT
MKM^.ZU=O1VGQ!$IR.X[)6Q?9/J?F?T;9;$>P>RN$[2JO:P_3NJ%PM8J*PR@B
M)&*0ZTB;R2.*(>-)#+7YM0HC'B>)4_;EX<=/CO(WW90[+45WL',DWLZ(#$V7
MSF!T: %YR.;>VC^^>OC(K1\/&;;?]O'@55-KBO,WE1<V,:DZO#O?7R2B.@R5
M#*!.JY#S$'+%%)2:)YB%B.C$JS[M9"R;&DTU"D-6MP:IO%)I6X-HVQKDN>I1
M_ER:.95>-;ZOT\!^ZUN^)--W=!T[UE08V;H>34S'_YZV-1W'_ZV=ZM[M^L_P
MPH<:SO'ZUW15T#\)N#K$+Y</?U%S(_)N58;JO'Q;SN=F'6O5O>9Y66)Z)I&B
M$<<!1*'&$,LT@5P2!H-$L(B%*M0R<LT$]A$\M4FWI:)=_XLJX"2OM@$>C#66
M!8O:'O!G8X;C$L)[6,X>[ \&]L"35Q/)4P%K-3>S$&AT!^UA< #9*XNU"V+'
M4UF]GC9:/FL7&]M)K9WN]Z:H[[NG[VF3UBH"JDEBZ(<BL\:([&DYD00&)$TY
M9RI(B--F]@D94R.>[P=".=+S,6[.D)YEDCZ &MKC'1@CYSBA/K :*5"H(V8^
MC'H.C:/D>?3&L7CRG.8M2CQ[:<<"5^O5HNQF>+V0G[*?95_#^FW$"0T330.[
M%<N-2R93R%48P8A'PO ?45& 9L9OY$OG*E9'A?F\N&V1P[VW&UT!6TB@:VT]
M/W8'E+D@C&.&("4X@AC'"A(9V:Z.(4I2C E+T]E"%:,@O.E<4HR*[J?!T'7;
MW>GGO1QX\ND*F7^AKK-H]%6+Z[B@<<MMG35XKZ+6^3LZ=@)X,NMPFS7]NJ/]
M%V/(>K4RL_5,:\2EXBE,(F3X0J<"DDAB:);("1,H(MROLN!9B5-S5.^6!9N#
M1V9 SXK,]K"V7@57+TOS62P7"KPHYMG$\3SJ;CS2*Y8#T\E&5U"'>FW4O0);
MA7LL^N^*35\5_\_*&[?<OZOY>[7^G6_T7OZ66X/-$\V7M'UFU<24$!%RQ"-(
M!+&K8!)#RK6&C.(X)2S0B5MQI_.BIL8Q'HU@'7 \N_3M$9VA6:,\G6FIVN(*
MK_ZY#K YKX9[A&^D1?$E,/JLC!V1.;I /G?_6.MD1SM:RV77._Q(,U\5LV_V
M"*:L9,X84IC&MOA,$D-,S"J9(Q3"&)G%<D(CBD(G5^S54Z=&A3:*),N+3!BG
MJY5J[546_C5LI^FP,QA#[_UUP\'Y:SUH]RE?R-S0\H/,O[8^T.MGC?*1'E2_
M^1X/_['CAE5S,GFS>%H7^6?UK.9!:-9A4;WD)XG0(<<8DD!SB%.<0!KH$*HD
M$;'B- Y"K]:)YP1.[8/=AC]<@4IEX]M;I4%P!<)R\R#RW%\Y![GC+DN/0 Z]
MUW(*P^J'\*J$LOI'-,0VC"-<?6W&G!,W[I:,H_%[&S.N]_7=J#'/WRF]7*D[
M]G.&N%D9!1&&,4TBB,UR"5*)- R)\0Y")>,T8+/";F,X;M&X2/6BH8WLH5U<
M\:JQH&HJPOXR-ZK_"GBI/"C8S[[:-;:'P7'/IF]P1UF!'6S8^(O5^=>K!M:[
M$[#VV+/Q $R#-VULRYQ(U\8#,+BW;3QT\P4IOP_+N;PQ8I;/I8_:'(8$$4VY
M9A@&BIGU2I!H2!5%4/$H("A!.*;$.^WWL*RI.44;54'6TK7C>=,IC-U(IR?D
M!J::+6@W7J!U2P(^#4>?B<!')(V?#'S:Y(,)P6=NZ48:%0UM\D7>L;FM0/#]
M0:G"N$[74F9V.XS-/V2Y,#.W/>UZ]V+^\;3,V?SWU7+]E-^4S?K,Y&ZO62Z*
M;+%6LMZ[7B[R:K]$L 2;!1E$B1(0AS* 7 <1)"&B2B5FI99ZE1T81^VI45EC
M "@M %_,I9UZ7H\TZ&Z$.+VA')A;.XRB-ZV."VI/##V2TJ.2_;@#L3MOC"S]
M@I7UYJSS6A39<[EO_Y[E#Y_FRQ\;]6<1(9KJ.($$:05Q&E%(8RTA1S1@81PE
MJ?:J9.4L>6H30;42W)[C;U6_ E9Y8+4'&_4[++&=QL-CF=TWRJ,LM2\'N-MB
MVP>L/A?<3G+'7W3[P'%PX>WU@&XD=BW$<FV<\F]*J.S99EU_4<7[.H2(1['2
MDDL8!$S:TL$84FY<X#0,A18I3Z+4JU76*6%3HZI&5[#:*%O6Y?;CI)/PNM%0
M7Z -S#P;O+ZU\&+:#%6K/)\M!5-WX;,[2(:3^H[9<D&K)^HY*6I4MG$Q>I=@
MG.[Q3T_ZP9[NS%WE.DIA+*(@"J&@00RQ#C5D0FL8:QH'6B(52N>4I-9SI\84
M5K<K8+7S6M3NHG6:#2[ 8.@H@W[,=T\DZ@C#6,E#&SCZ210Z8.WQY*#VQ:,E
M!!W0L)T$=.C/%U9@JC+&[;'$<F%W%,L7")&(,9FF,,5$0(QX 'D0<:C2 &-E
M:Z=+KR"*D]*FQD%U58JMDIWVUTX#[.:N] ;;P+3EC5CW6DZGD.B[M--!66]3
MZ>F4V4<+/YV\R=L=N<GSM74\;W6K/\-?;8W*CX]/\^6+4N5OOMJBE#-#$!$)
MD(22(-L0% >0!9&$*=4TY+%&&KG6<_"1.S4J:71OUW(H*WA6M3U5;4#]2X]Z
MGK[C<=8A&@KE@9EG,@ [NUQ# 3V22W9]?[]2][;.DGBP(9VV'DE9"*Q<CU8P
M9\9$)8&L^G#9 K9-PZT<,&"T6<_+EER[HV-T?&"Y*H?IR@XG+QM)VP=4(LP]
M?A+L7]1/M1)9WKJ[*I^;_]:+4]EE/(\ZG5X/&\LI[6)ARVGM='LWI_8N>S3O
MPZV^6YEG:5N^U+8/NUU]5ZOG3%1K(Q+*A.((015R,S.9?T)J#Z6)UG$4!YQ2
MZG4*[2!S:K-2I;+]'AJE[<]6;8,VJ!7OY/2Z#(";Z]LSK -/0[T@ZNT4>V#4
MDVOL(G%4!]D#@ETWV>?6#FE"*F_<\ _+1Y8M9F&0ZHB;-361Q(;?A0P:1SB&
MG.$@%DG$22J<TX5VGSXUBFDI"/ZL5/1)%MH#[S1I7 S)P/3P33UGN2V-:4CA
MZ\K6PZG*[YV'QB]_Z!@$E^01[3USO'RB8^:\RBLZ>E''?3'QH.1Z;KR5IN/H
MIVR1%>IS]FS+)A9F6#,^5]=YKHK\W<L?[!_+U?LYR_-M#Y@XY!Q3&D ID@!B
MQB)(*$]@BC65*9):<R\/XW*5IL8.FU:]['&Y*K)_EZT-LHTEQHNWII0)-L:#
MSU;6HW]2]MQ6@1]-Z=>F+''SC*HE1OE=^3;%N'S,'??S1AW)H<\J:F,LJ6T&
MM+('E@:!K46@,LF6 RZ- J55@W86Z@_KOK85+U=HW+W'W@#<VZ#L[\D=UXGL
M9W5R_IZM5B]-/<GRY"P1C#-F%H8\)A!C)2 3$MG_P8E,B(Z$5Y3&44E3HV2C
M:!--T%:UVRKP*+R.:[\^0!MZQ=<-+_\UWCDL^EK9'94S[GKNG+E[J[BS-UQX
M/OHY6Z@;\V,^"S1C& D&8Q)S:'Y*((D2#'&8BI!A)1/>K4O-1L342*'5G,7J
M"$HENYZ#;H'T//SL!,_0SH\?,MW/._>,[_N0<RO@;4XV]PP\>IRY?V6WDE=E
MK-8JVY;@5#A.*=60(9Q \S.'1&D&99A@&2FAD'3*BSSR_*E]U$UF=JVD?_WB
M@R">/6"\%)J!/^AA4/&K874!.J,6KO) R;M:U1$,3I>HVKUIU+I41S3>+49U
M[#)O#ONBBJ^KI5!*YI^,,MOCM?(8[6[9G*KELSA*%:51 GE $,2!%)"BA$(F
M*4^"@+)0QX[$YBQT:FQG% =/M>; #EYY=MR$#%3GP<5R<Q3M'AW@/@QGJ7$0
M< ?FRPG@ZDRN@^ [$N/>/2@@;+)1MM VW8CE^5)DS&Z _LB*AS+"@3U:;JF3
M*\P?RN&PF>+F^VK"'^HXB6SU.@:BW&/=#))YQ+Q\M!FYNN=,$Y0A6^V(3\5M
M]!-4X3UB1^<']R>--6EXV]::2?SOG5J[QR_+1=4PL&HP.Q,\92+5]HC$%@5
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M249Q4F/_<>&X0],;\HW$L7%758^HP4!W=U8OA'$$K]2@]VH/^ I4:O;K?)[
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MK\7/P.#K-OQ8-]->@I]1=N_N^]SSE]XU?1+UA\V*ZXIAVK!^E1A$1"(721;
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M":-Q:)1;;EJQYT89A\\$!IIK9R>]9FYU!TIYT&N_?4_KO_.4@KVG5(\!V((
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MGE>0IV:M(Z6_")TSB]6B/7;Y+$K5\:/.*--X(56W/[6/DEAD(1(IB9$:/IE
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M-RN_D0\T CI&:>Q!F$44132.8884CBA26R5,<013GE*<9TQB$BDBK$<$<$N
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M,HX3\@'41(%"WQX$D!UHK[ZH*T";LNC-U]96-],1/M])L6PNV.HU* 7?,-7
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M'\?#;UFNGWY9S>%L9QIJP-3],IFD/X:C$3)U6.9R7 S#"!:L'%Y>^>&TB'_
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MZ.U .0U [M-D"L.+\3*]&[_?SB6:W;'VR0^G?_.C:[@7YX!)KBV+0"QU&-(
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M>H6D9J*YW:&LIE+Z]<B?U"K 7<],_,N*, <^"@E1X&X)'@]['SVQLB3/C <
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MFPFX 8@\:MUC1,[>:$%2*HUV%<,#-1I!C&4\*VJ5T;7A\</-!-HF[-E"W,V
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MJ*()/E+1J>3YM582MPOV_%A[)[J<;"O8%M!PVT6040]E?S#FD6RN- F@'0$
M ]DQSE2G2HHN>.B]3\AFRGJL[@TDU[/"?QN.AY?7ES>$2\M,$#(18"D1J:1
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M<@IP,U;1LFB ^4QT !02+S,YF/6$1ZZMY3GRZH'&JT2U8<"V4GT'.&VNAP:
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M )&;=QQ'93W2\-9%R.(D>Z<C(]8P0PM2V23"?#0UW3^RH)/RL76>Q':4=7+
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M-Y88[-IO-%/70EA]V[OKRO2,TF=D!63 3&&1HS49A8"UV8$JF(MNWH9I[Z8
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MYE$8W//PD?/$AD)""U:.#P:V804H ],A>)"^:%#2D4->?('"F0DL1E_<%D,
M-S]\Y#RO(<&P+RM'!L,BX72Q9LCE*E:+R(4K:1*OV42)<%P#M%@2"+0$:60V
MB"WP<._S1T[6&@P2;1@Z+BI^QU![0]58_0/.)[/\*O_K8G%^\^K4!\V4#H9"
M]>H &6YH,0&!FQP5.O*(BG@4'8^_9^2DJZ%0TIC!XZ+EP]_>_KDB.B@M;78"
M3";KIVH[VT#T@/7)(D-=,#T^5.;Z>2.G0@TE_1T9UL$YQ;VIS:]_7'5="J+8
M4%OZ,ZL(N#'5J<A10LA:Z10,FN9EYUN0-6YJR[.>B;464L^XN]&9RZ(W@E4/
M7&$D9=2VCN:RD)2RV1N>>/-\SBW(&O=4I#D4MH7:CG+I &KO9M/3\]N=Y!3W
MAL5@06KRWY04#AP1#TSGC&B=5LV+B3?1L1V8V"]AQ?:60X=86@^E$T*%PNH,
MY3KT1CD&7MI:8,:U%5E$%5J7@FZF9%SCM+^$'X',#NP>UY,^QNED-J_+J)TG
MEQ,DWEY@/618GS))[RW]!TQ&<A<]0PC:* C"<$T&.S/_R"R$+=[2%RIV$>)L
M&(YV8%$V&-YW5Q-%O#&><2-!"%U/'I%#%-) =(')3,%%PN8M+QZ@9SL<_1KM
MWIO)I4^,+<C1^VTV_QH^XG><7N"),,Q*U(96DP29:44Q<* E!<>,RLXF[UJ7
M$F]!5G=7D#MBX'%P[260CC!V8PC)1TRST^GDWY@/,W%[4B;AJ@YQ=>Z2ZSRE
MZRI]^M[%UUJT2"R@U_TX23GEZ&O!F+<UDZBVQQ(B 4M)NF!DXLT+W =92'>W
MJ&UQ/)[0?S'DU]*FR\%R-[YW$I)A/G(!/$1-KI+0X)EDD HFXQ4+Q@WE!@RV
MJ.YND_O3B/W!\(MIQT]LP!R+(B$I$;%.#R'?3DL!)1A3?3ODJG7(/=!2NKM*
M[T\3=A5\!_A?1ZHU^KU6Z),L:I$KJPVL,^UQ*E" FCAY=U)IDTB)!6_=_6DS
M)=W=VK=!7P.V=P">A^*$]WA^F87_KHY#]L7II.M>H+$6/EL./GL)*2;G-4]6
M^-9=[+<FKKLK_^&#N-V%TQ'JFO@P>'ZBHS R!PZ%5W\^9*0@5B%84ZPH*!EO
M/M.H\1*Z2UOH;XM^JJ!_,9R_N>.HOUTM:GV>DWE)A3M#@JJWLH$7<,P8X#(&
MB\H(V[Q=Z+,N<.0^-2]!1]J"Y%?3H/!M<A[.WF%8X%$\FYPN'W>2,OGT)"A0
M2'Z:BM&"2SP"U]D77U24Q?:L-AM7-7);GA>A*_O#X1=3D(W'0<LZEA-O::^5
M3@!3M7#%U-D1M0%\4>B8U%XXT_,Q^?TK&SD_YD5H2B-<_&+:<G>O?972[&)Z
MOO@0?BQOA[DL2K%00'E$4-86"*8@>&:"S!&]5ZW;X#SK D>^K7\1NM,6);^\
M"JVLBO$1@[ 4W!D+BM=+:59/-X3RU@DA@NO:)=MGJ_EKW]&V0,0OIB27/W+"
M'<\^T4XK:_=)95F F%4"$;P56$31::N^C2/IQ.6/;*<"?^U+V1WD_7(1_[?9
M+/\Q.3N[]\1/.'(E=8K@@]'D8&(&%^N-G,O.R*A3QN;#WH99RG;8_\M<PS:5
M_,M5@(W+O[=&YB0'%9TM!I(('%0A]D3A."#3R5NT7OB>/:-[%[:=<KR\6^+^
M4/&+J<KZ?/M3^'.U<;H2T*G@0&".=8HNV0VK"LC,1+'$%XD]'U7=6=!VJO%R
M;[?'1\&X%3Q7&^%J@6\OYI/IZ66-/^V#1^6ARO^3H(4Q+M 2A? D 9T@"+($
MSL=,'J)W4M[*W-Q0WK,7"=OA\^7<73^K2'XQ:[P*WR]_\L,<OX5)/OCS&TX7
M2#^_#.57^BFR94:35JH2**#W%.-X5ARX'&(B!JH<7\!E]>,+W4X[_M^M=7O4
M_,JJ14_!R??ZFXN3E*P37"/0OI9 69,A&MKSHB,C%!!-P)X/ANY;UW:*\Q>_
MPFZ!B:?KB;_4DRF>AG/RN?I7E\LS9+0:;78,B!U5:HE<0BD%"*5S82'XD%HW
M[AYV1=O5?/VU[Z[WQ,&OJ1S7,QL7)TPX8H&-8#BKLZZU@A@M!\;0<FX#3Z:3
M ];'EK*=.ORUKZ-WE?POYDPM#<%U6LO*NT1+L9F0!9A*==?T')S(#KPKAHR"
M3K+K?(V-B]I.*?[:E\[[HZ$#]5BO\+?)='*.[R;?[X[F_2=.3K_0IO3J.\[#
M*7Y>8+DX>S<I>(),QHS6 -HZ%9H[#\$$VB%UPB1BRJYY%?P^]&X'ZI=WC?QL
M,NP K_>O\<::7"'B5?& 'A4H48>V)M)&GNL 5R^Y"JWKTK>A:SO\O;RKW.8R
MZ0!GZ[/<$V&D)DN.(!4C>RZ#!Z]"G=MHO2@^REA:%S"NW[T=7E[>[>9.O-TC
MI#IOTQDT_%@>U'^:K>SMFC^X6![NOPF++VM+?**8M249 S+53F))V3H:CX$W
MV;EL>%2Q]:'!4^C;#EDO[W)P,!EU8)$NK>S9IMU]O21.P5F@)1@'&'P=2>1J
MQ^CHP6 *AA7N16[MD6U#UW9X>SF7?8/)I .</72+><*(6*E3 >LL,4MD#TZI
M %@4*J5R$BP/M!MNHF<[7+V\:[)F,AAU(OAZ-94G9'M_&B'[>_AS\O7BZ^O9
M?#[[@];V)GRC[YS7)EM*>$9L<XX54)A\O09WP(O@A?F(@K=.57L*?=LA[N7=
M+PTFHPXLVJJ(>7%BF=01+=E?Y;'VNT@02JFM"Z7/*=GL<VOKM7[W=FW%7MZE
MRTZ\[0 31]]P3NR?GMYHAV*Y\"() YR;&J(BA2.,K"MJGKTN3L30&AX;R-@.
M*2_O/F)?CC<#S?_ZCSN<I17^U_);R^_4W_J(Y7_4/S]_//SI^02E-)M_^Y^T
MA,NGO_Y\?/C^X/CXU9O__?GP^/#3X='[X[>'QQ^.-GV.YV%RMOAY18O)UV]G
MC_32WN4E_W&]H-M+7;WK#F[:+P[_/,=IIH"S^27.J^EER<O-F3EQ<3X/Z?Q$
M.U5D\0%L*>1Q&YDATK8$)O,L$T5W[0=T/(W"9SV+\-)H%K0$%KP'I2CB]38A
MV*B0L9A2B,W'E;0^BQC<W V K+T.)YXBM ZVTZT"X<)C<E'2FJ0D:Q^4!6>,
M!A=24)J"9"%:]]MJ=SCQ"P"PN9 Z -Z#D;(,/ I,#(I,]>0%:\HGQ<PL:BVD
MU13$M+Z9W_NT8O#KQV< 6C.A= "P;5KBHS:2*[+.,?!PR:N@!85"WKC,K2S*
MM0X<6LTH&/RV\1G@UEI$':#NR2-%;% Q%28!<R&SG6*=?>8*E*R3449(UKSM
M]%-I[*.C[S/@<5#A=0#.3>-*ZT0M;X7-D67PA=$R-'.U SP%]R)9&9W+KNCA
MS>#VX^N&@MJP\G_<^#U9&)UBZM)[6,_E,IK+%#B';)TFQS1&B%9$$*9PP8LF
MO1RJ6^^]1/41N^XE^BW@M+L<1AXY7Z>OW52]U22V(LCKK(-;@A69/%"E(7+Z
MS$<3BLF"N/;X[.A['MX?(O:0WJPI*T<' _<;5I"CYT&28QB,$Z"0-,8%I 6E
M8I5Q*>3;N8*;P;#IX7V<+ P!AKU9.2X8EJG;8<6,-?G1%5J\H+U7ULXQ209P
MEEN@T,!$+PG/RCR*A$U/[B/N;PZ#O9G8I]MQ?=N5A(ZR. 4A5+=,U;+A9,G,
M><VYBF3VGL.?O:)G7&LRME.[FUCZA-B=TPG&K<2H$D3O(EG.F,"A03 V&4UV
M4Z,=JL9TWP.D<2ZBGX2!'8Z+GB*0SC'V\\@7A\ISDR1H$QPM+ =BH65@G91)
M>PPZNV=$VM/G\8Q3<S84WG873D>H:SMETZ-,4A4.25H/BAD+L7[(Q=)&DK0(
MN>=RRJ>-5AVGV*P%FL<3^B^&_.W;V-B2,)G$:R]+8I*-CN)LQXA3M:DE"3"$
MGN=5M6U^-$Z97"^:,PQH?F7-NMGGQC'#?&VU9A3%IRH)!22Z.A0LNXB.4>#2
M\Q:S5^^C<<H%N]2;72'Q*ZO)9:^;X(THV3 (JA;KAJ3!><4@.9=LP,!$&BI*
M&+'GT3CUCEVJQM-A\(LIQ?U=D[5A"KW,P%(M?G%:0Y0<@3&EI9#,F*XWC_UZ
M:8]3HMF+BK0!Q2^F*3=[0\6@!">3 59K26%<;7Z#WH KVHJ@BI-!=*P;3^T*
M-DYA:2_:L*O@?S'\K^.LB"I'TGLKDP,EHH7 >0 3A<E%9BU,SVTBGQ!YCU/<
MV@OJ=Q#W+P;XK6;3F>!=)K]1U-TP<8C5>31.)ZN"\,:^@(.J?2<8CE/,VXN>
MM$7)+Z]"JWEU+NJ()H)FE\+C$%PQ$'E4EAF&P;5N7-;-!,.7>Y'<"R)^>26Y
M/97>%N.RC@$P*=J$E2S@G8I0&/.Q2(%"]!QN/+K GD=_]JLX^Z#D%U.AC2.X
M3X1TS-*F2R%:)M&QFMPB)85M*GKF<@X8>QYUM7%1/8\([455]D=#!^KQ8&TI
M<3(')A"*DXG6$NKP1Z7JJ9S6SA/#6>M6!WL7_(XTNW,?4#:300=X:JE@-]7*
M!FLX"\1?'73M ^XISN$<N,40K$W2F]9]8P=:2L]#-GLQK;M*_A=3@#J -P5I
M$EJ*4Y*B7<2X.E54U,9.2FC.2F;-V\TT7D+/HS-[ ?Q3)=T1T _^G)R_F2W.
M%_RD9%NX\ AH-7'36 VAA )!!I^$RLC*4'D.UU3T/ FS!=QVY/<+[?=V,/T^
M.9T-UNGMY\<_1X^W!Q8T7'>WQ54C!I.*ISB=098L@"HR@T=+1D8H'8J(Q; P
M_':R:-6Y[<EE5"G3OU%Y,'4.L8HA+)=>A\K$*+*TT;4^XQJDL<=S=G#;#3U[
MM_%XBJ@ZV \?&!?S^L?OX5^S^9NS0(NN+05,S,Y*XJ-EC-5]0(/G7H*1B@?M
MA2ZN]4;Y!/)>6+N/)^%DZUDK^PFM;SQ>+^Q]^+HN6T;-2^V&"$HD2W&6M!"]
MM^11,)89%S'XUBV/GDCBN+@<#"K;0W)ON74 RS<7B_/95YQ_Q+/+S>7+Y-M5
MM;O7)9*^DA+7@;DY6'"Y9'!!"!3>\&):W]<^0$ZW<-L?!K-A9-(!O#[-0\;*
MEC7]:(5BD6)I6V^J5#("HI(&=&1:9MHBVM>"WZ9AW$+<YP327MSO #VOPUF8
M)CS^@GC^KO[TN@=4U+2.VGTAV43A.K,%HBL<I(BQ>*VU%:TWQ_MH>6%]*_;Q
MSIJ(HU-8K;3-JA 2,PBD";5&G5-$Q:6&S!5JI15SS8<DW$_-R)%G$VEO :$=
M6-\!B);]S*>Y_E$+);Z',^+IVLXJATSJ3':6.=JE$PH(.H5Z55B0<RX32ZT]
MIP?HZ0](N\C\MI?42@ =@.G>TIOU<E@2ILX/*=[4)!]M(,BD(#LFHU=!2-VZ
M5],C)(W<S6082+440P>H>BB.<,)DF\@33,07<BMM+:%/!DH.09<B@\#6%_C[
MQG;#I3<-9* :L;\#)+U*:7[Q4Q[ :AU"6)63+\!\H'7HX.K4- 4^,-3D'XB"
MK6LA[J-EY+X:PV"H">,[ - RW?ON*IPCL)>8 1ER4#)G<%B+)!CS+) 2>-GZ
M^F<S)2,WEQ@&/ V8W@%T[NL#K=!%%-Y#4EF"\JR>900#*6<6T84DFF-GGW[L
M@^U>SWL$T$ 8G6+JYZZQ21>F# ^D:$+6CBGDZAF9P&7/"_=.)/4,/2M?0C_V
M)XG^R?W8GR*'#KLN.S1,N>+!8Z9M6I@(T6<-RX)R$Y/A^O%F[#MW71ZQ$_N3
MY/9(U^6G,+$#XW+9\O*8I($U=OSI[(R5Y'TH 5(JM)U[66?TE @YT);L8HG1
MMI[__  YX[K,S[IQM1)*O_A:*Y[SDEEO:Z\*5H?8(G@5-(CDLF(V2R];'Q4]
M2-"XAJJ9V+>#TPXR&!%0B_GYR=$?4WK.E\FW)4LL3UH[1:&!9Y8(]PFBC F$
MB$IR9U/(6]WXTY-O (>^N@;-G9>.&WH]BQ':C]&](&0%;L\<#\IQ2%IF(IT%
M\O>$ F&SD$E%+I1JB9$QS<B>@MLD_AVXV,&><V7IEND)1^7X?);^:\F0E'A&
MKS-8K#-R4O7+A!-@BU2&%8]X>]S0_AF\]Q$S;A_$9_5GV@BD V3=I'^E&Q0X
M&"%)QU0IY._[VJTT! ?9>EUL)A7,K2NX[U(Q<M9M&_'>OI'8C]<=H.7!<AX;
M5"U!=, %5T#FV$",,@!C*2C,-C+6W42;P0J?QCX6W$TL'4#LZ!O.24K3TQNC
M*WR,V@JK09HZ<Q!SG5?O!6 QN9 &Y6);;W(;R.CNS&='&=^^IMB3X1U@9N!.
MQ5:R$FO_O> U!\5C+?%QF;A;!)(/BN'V*6)71<<[-JP>I_///DCN" :_F%)<
MSU+!D*.5KD!F=>*#]QQ"'254R#'2P=8$Z9Z[8KV$ 3J]J,!N0G^YR+]J/'-?
M2P*K$D\F($C.!2@F/+C@'+A22"BFJ.R&<G ;+Z7C(3@CH+^IX%\N_I\VTR1*
MJV6PAGQ"K2E>J5-9$]- 6V1.Q4LK12?*\*N,N>EE7V@"B0[4Y$/X48]X%I]F
MJ^6NF80+4OJCLLQP7S'BA#DI@[,%C*$5*9,Y.)T<A451HK#*B=#ZYO@I]'4\
M@F8?V XFH@[@-\[$-B9MBBQ*XDIMPVB*!2=$ 9V93$$+'@9K2M3?F+]QVAYU
M:<>;@>87TZS[I_)(89B*W@)]C,04DJ7WM/DY9IPK*%1(/3>ZW6]4TSC#:7K1
MG#:@^,4T9=T9^U/X<V4V2DA>(Z^MD1*OE:H:?,@*9.'>9K0:?>LRS$$7U/$
MFUXT8S\0_&(:<7.&E8@4 -7;8FMK]Q"!#!SYJ354,J@2,T'VW+'WJ</+1II/
MTXL:["KY7TP!5B8@\Z"XE@)2=K7:TE!,5G($SNHLGI*TZ_JHZ G&?Z0Y,[W
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M:T%0!B<*JZV.L\:D4-KPZ ;8A)1QR[H&WRZ?7USCPO.WD*KW^..)R^-*&EF
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MTR8KX77SD2L;D#4NWH9!Q'Q8Y?2-N,K2ZWF=IC5QO&@O"J,3*B*H7.JP6\'
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M\Y!Q< SM(_@.</-@[G.4D1OA16TH3J#J_HV(F7"?N)(J,XFV];O\3F.XFV<
M#XZ<O43? 73>SV=I_O4;7N"#U826 A-6L@&6>0U.BH=8UZ>34!C=V,ZJU-KZ
M/$[-./W:!X=3(W5T *S'5UZ&Z*1B(@$WB=R\DE>#:!VY?LG6D^-$;EVKN=\*
MTN;MV >'51ME=("JD]F'Q3SA<GE&FB)*OE!$\;"<&8T,KA 7A=?T?#$27!(:
MF#8)I8@4!;=^"-Z(L'%ZM ^.MO9*Z@!Y[S!/0YVR_9,#G7U*,DK@N%JP*10X
MPS4D.C4A&>Y+;-UU])"*<=JZ#XZI/<7? 8"V66T>O A*6DLA:[&U$;Z YYY#
MDB8Y$X7CS0=+;$%>+XT.@SRO#ZVNOI&X=C^1JB6PQDE U'4?J#*USI_$F)4E
M$:)_\!HZ)!K[6S<V&%0VA^3>>NL ED\]Y%E4#)6@6X/S0,YIH8#:UUUM7!=;
MN*1HJ'3VLCH&W/:'P1:/J]OHI/N,3R;W@:G ('M)S'@D9DJI\V<,"BZS%N9>
MR#!<QF>,6?/-D-->W'L4S[<I;WWB48892QR02))CY(/F("#6NG 6K-62HRR\
MM:.VYQO9&*/@FYNE1AKIX-)[\'Z<I6$ZBSH7N4CR$E0"5X.D:#,/(EM$UOKM
MHH^G^S%PM)?T1[=+C[_J>:T"YNPIOC:ZSB<NX(0N0'$/#RJH8E)K$.WWQ#K&
MI-7F:&JCCRZ*Z-<\M_B0;2P> :VV=4DR0K#& D^Z8.":!=\Z"MSQM6N,\:G-
MP;2G!CJXVC8:^:A4XB0(!&,LG0RA [C$$LG)%S3"4KQ\P)>NMUO-\AC,E1K_
MB6LW!?4-NO=X<5O6'103)6@&1>OZ%*W)-,=:(.DT<\'JR'SKW/9FE'7[M+ C
M(C:'W*[JZ0!T]UGY^V*^7#-F7:#V4C&Z^S$Y(#'23[&NW\[.4D!LB;?6DS,W
MHZQ;T.V,B0<9R>8*Z@!V3VTP2>EJ!#+F7X9E>^FY=G18C<,ZYJ(.5V8IT'6!
MC%G&<Y*'W*VTGLIN'\E:P7%@Q?4S;6*- !^>NJ)%CE85*'6(G0J"0:A;S3B:
M+%51:%GKNW@3NKI]31O**.ZMG-U-XOPBG(\R/OWW=^^.SOYY^N;HU;_]?G)V
M_/KHW>G9IY/_]U MO[M\_] CU_<5R2BMOTZJ1#ZH@9+K6MI<AX"EF"@T-L9P
M97RR0TV3.'#K[\WTJL<-Q-V<\U60:&1,*AI9WYOJYH/$P#LC0$3DCK/@9/,!
M/WL1_)(:A+=!WN,-PD-KM6]O]4&5A'5.1%.W3)?$07'Z3\C!@G;.:AZS,:+U
M\J;6]4\':"\>'#1[E$1MH\&^P;GV9=?S[(3F"9*4M6E1!(@^!$C61A(E\E1:
MEW[^94NBMH+*GB51V^BM U@^57Y3ASHSI2Q()K%F S)XS2@BM*@P)R$-;_V:
M])<IB=H*!EN41&VCD^Y+HDC]S&@T$&5=KLOHEJ##6%_#-"M)H&.>/QWY_ 5+
MHG9!3GMQ=Y$C?J((QTB9"L\"0A)DTB42+XYXR8*E[(,*&FUCV_17*8O:QS0U
MTD@'%]^#PAS.9118'/D'=8 O=W1.+(^@O,>$NF0N6E<?O.RRJ'UPM)?TN[!-
M]QOZK2@I<,4@:8%7O4)1(T7IF6,)E@156K^ [#))H9LRJ'W0LX_L.S ]FW4O
M!BY<(6D JNKI:9L@Z%IPZKE*R43%9?M<;JL6TVX*I/:!67L]O9C19ZNP&34&
MK90"SNK<)*0PPS.O0: IH;AL+3?/NN=##-8[0.??H5Z^!E;+BP'<33VC"#QD
M7EM\1-TE52LEHD>PABOOK/?2L9:0>V&S]K92_3ZS]K;1PXNY49704BA3 (VI
MCB;9;.^]@$(>0O0J!&M:M_BUNU'[&-*W%2YVNDZW45('R'O^GKA3UQ@#1Z>+
M 2REECHD53-Y$H16&3DRB[IUTFD;^GHI23YTUFDP'7: SRN>SM<7@EVQS2?:
M%"6YSR2R6OHE1*VWM;4$1V<=-:.PJG7LN@E=X[[X#X>*M1FFABKJ '8;".\_
ML(;PF(^^XR)\1HKIR^7YVVG!"?>I>.8\9&D+*,?K2R+34+AR-C+CZ(8XO)E\
ME-YQ0Y:#P?1@*NWB>6_#>N[DJT^B&8FQ5D<&2\=2.@>)>^<UB52SUH_&#0ON
M![O+#P;* =34S'JVK3$]>O7J[/?CU\?_Y\/Q^X_''X_>OS[]](_CLYUK1I_Y
MO!8UH-N0W*BF\T/X4=W!FOX\2FEQ&<Z7MW5T2@=2=9&@.5+P7 AQJU'-D2>*
MG%5,S+2^5IX@9_\;ECZ/D#D-<7H^O9CB\M7EHI[-GY7;V7G.8@9F%;D,B0Z7
MCZ:NI62B>,>R+:U3I,\2-:Y+UPH=#Z_&EKKHP'T[)OLQ_X&XJD!9Q]A$HBK>
MD .:3#(DKNJ9%I[ 2LT34XJ'V/HP/4O4V/%"4Q#,A]1(!Q#[%/[$Y?6!O&$A
MDH_H8XF 6=168[JFHR(!>94<+UYYW]SQ7T/&V/[\D##:5^KCYA.N9?.AOOI\
M6<PO/W\Y_O/;JMQI$C#') T'462M;0J"Y!$5>)V#-$)D;I]?TO/XYX_M3@^!
MB78"[<"<K!ZP'Y731 ;/BI$,1&!TNRNK@83B0!9R6IWSSH;6U=1/4S1NJ<^P
M1J:A+CI UN.,&"^#"!1&.N9)1EEJ",PAT.E EZ,KW+9N==X/3X,5_PR+IS8:
MZ+1W]/7Q;Y\^OOK'\>O?WQZ?OOGXC].S3Y^.S][5W]XYMM_@,UO$]]N2WBC&
M?XWQ8DV;7)):2H8%4!D)RF8.D7$!)8N467!!66Q\&M=3TJX3\^.7^>+B$RZ^
MUB^ZRG-Q7X)3B@Z.()R34^\@>K*EJ++7#E7@KO4THZ?H&3?D:H"$QQLF]Q1^
M!S?7KQS0/UK5D)C$I&&*C&34F1P[9R'X5%O[6:%?::UL\U;==83TTN.XKY[O
M VAOH?>(G.OR#VX-=]%EX#:N!C(3&\DS<-[D(E1$45K7I#Y"RLCHV5_)S\%F
M!XF/7.QWEX.3Y?(27\V7MR7:R:6<T1,?$6N)=LK@"KG_*<82>33>W%\7OJZP
M[ZFOZ P1N^AO/H PQP7%^_D%_OK<=+.;QP:EBC*090T"N4!P*3 P$FV6%!@R
MYI[%PV.?/G(1<5LH-!'AR*8!9]/YHC*R?'V)I$5Y4^SG2U2N:!"R[@83A:0A
M"_&A"DO)1TDV\WFK\,BGCUS.UM@@M!!A;Y[%V]L: )]T\L@4Z%2?![Q'\ (9
M:&^+J>VJ9-J&="S>;E4#>8#^@R&]TMW$/O+3OV#<5P;>SL-L@DDEK6V!F&K#
MEW>)#A&=)".0)Q0N",S/VHU?/K(C[V%']<P;R*H##Y(^Z6LF*4S)Z0FSA*GZ
M/1.5I)31:_!2%[*:(8++JS?C5%S0TI"AV\Q]7/OY'3D,>VN_D13[&?&XNO3N
MY2R#EYZ).CU5(@58@A$GW&;P$7DA^-O@VF\.?D!&1Q[&?K!I)>H.'(PJC!O2
M"X:H47,P62?".TO@ OTG>/3:BTCN5NOGBCM?/VZ*;P!T["K:9IF7W3P']3?&
MKMSG685WOG*?)U(Y9X(BGSD7 \K5CA%4!4A )G/O<]+/I%D>__!QLW&-O8D&
M\NNTIO;7!-;;T_=_;YQZ6_>1[3-OSQ(^;.+-LF+(?_ @3"8T8%;@C0]0,&9=
M"'->R &L;/O$V^JM;4:?=5G[$:^"+L^M8[7C%BVK3VWD,D41+*1@A'=D[$SS
M,7QKR.@RS;:-WM==)?N(N@-'X^U\]OGB?@I :6N%+Q*8S8PL(_H:;'GBH93B
M%,^6MSX+Z^@8'R][*??^UJM])=TA6JY? UDL-B!=HJE$3F<H&+I$F0%#_A4K
M@L)ST;IH83TEXR)F?PT_ YD=Q-T!:,[P^_S\^W3V^15]]_3B34BU_NEFG%\T
MVC@>$NAHZHI<2\RX$LD<%]1.2TYA?V/L/$E07Q#:1>/SH<0_:DOCNNP!N\DD
MINB,"P%"J8GJD!!<- H*T\HCHHM!/.WP/O'IX[ZJ-01$*PEV8%)^O9M7=C89
MR['X!#);NIIM*! L$V1VT2<GF.5N"/_]5RK&Q4IKCV5/*7>'DSL#U9+061'B
M@7-NZ[1&A"!2!J9B1A/ICSP;%"V]#"#?5\=/0F9'@7<'G)^O3Y;,K:D+V%G0
M539%0$16@)D@K$/R].X_MS7&S=L^QMP,:VIVDW<'L*FW]<V3Y;MP<;E8U?F?
MX;?P8S5D^+1\6$QG:?HMG)_,WN.?%Y_^P//O^&X^N_BRG+A4!UL7!.;KP4NJ
M0-3.@O6B<.^5<*7Y-NI]".[)<NT(F34!UV'T-VZ.^M=0X/1;U=G%_&26%AB6
M.(F69*=)9KD8BEF=]> CL62RC=9KI9EY?F3FT]_1DZ>T'W;:BK,S(U8GI5_G
MRIS6*6NA0<7:2LDY0LRU0ABMT=9:'G3KU6'K*>GIYFMO=G:4^-AU37^3;'D_
MNZ8F=.4KGYV'D"6%J8J\R( "P3KGN"B>7,KXK"%YY,/'34PWMB M!#@Z!+Q^
MP(&?R*2$= 1B'22KE:(%7) 6"GF%)N>2HM\( NL^?-P$=7L(["W '@JD[Q!O
M)YQB 1,9Q7DY4MA7&Z2=4P&X]"PFC8J;YTL<'W[NN-/;&RM^3[&-?.S5W^R#
MN@JE)\EJCIED846@"\P9#JXF0)RRU@2+)O#G:^(?^?"-M&]?B/9;"+"S8Z\F
ML;B CNXI%I($NL$,!(K^*1SBC*N0A+]?;[#)L=_LRG<O1/%[BFWD8R__9AZ6
M4^D)T]EP'<E<\;JHPA)JO909DB%_Q2J#QFUP[-=_^$;:]R]$^RT$.#($N-8/
M\DEF4JPV6-\_HDD)E##^JCH[N*(CB8@"F.=;XM9_]F;O3>RE(&!_^8T+@+M1
MZ^VPTIM.SUJNOVKVG,14'SOJT-Q0YQB8;,$G5.!9H3]1Z//]E>-K +'9=VT&
MD!?Q(CF,?#MZ7;I;I#\QA1O%K82,CF*<(.G.4QB!>^U<-C+$TGIDWCHZ-L//
MBWB5;";NT<.+M67;UC)&/V0P&#*)A#@@V6@H)!W/#'*GG^^DVJ?LG;^(!\9&
M$NS(;%3I',WRJ_!M6KLJZOOZ:3R??KY:,?QLSN:?&!:?_IA/4HX2K:\)&A_K
M F(-41H&])N\>,%CBJWS_VTYV RD+^+YLP,5_\4 3HC%B11!YA0Y! P%E$(!
M/A0)2=I05)88FI>XM.9A,Y"_B ?>+M3\UX+YF_GE8B(M5U[5UBVN%*@D21!,
M>M"Q*,^ULBR$?E%>6=@,Y"_B,;L')?_%,#[]CA.O><)L.+!D.:B8,E!09Z$X
M%%DY[HOHV))7%C;#^(MXLN]!R7\5C!\5(NA6 HQCX%$E2*46.22*3T-V!DIM
MPW.&%,5:+[9LS\5F2'\1.8I.5#W^(^?-&))R22SBU^EL^O7RZPV/TQG],2XO
MB,_SRXQY.KOYDXEB%$D7*8!Y7UM+'5U;BEO0K-YF/J##Y[-@>Q"P&19?2L;D
M4)KHP+C^*KG?PG*Z_$BTA'PZ^_>PF-8WO+-P@7S"&+-2!@?DY]=+PUGPFGZI
MI# B)JY,:#UP;%/:-BOP?!')FD'5T@7<%M/OI)KO^'Y>%436^NO\<G8QP62B
MD\F 986HCTJ"EXQ!-,*HK(,PS?O 'Z-E,SB]B-1.4[%W 9^? W54B"8&6<"0
M607EZ6)WS#/0.>>(VD0QR/CZK78>O:C\S:["[6?PV=_#=/9VOER>SDZGY^0_
M_CTL_X'Y\W3V^2@1^*<7/R:ASMW1NH WM>A!*@V!O"# Q +ZI#@/K4O+GZ=J
M,S"]B#300*KH>![2J[/CUR>?WAR].GE[\NGD^.->DY >^[!6,Y V(G;8Z4>F
M^*PT><2>6PU*$+2BS *XL<SEPI')UL^HPTP_J@?EM/S:D'/=GLA,85+0-<I%
M 54-IS/(ZJ0#H3CSIC0?H_<H,>-WSNV)@0=O!$W$WH$SLW:&B\_!.9\1BN%D
M%)-V$$7BX-$RKE)&XX9XF>IK'E(C%6\R%6D;>7>(F>N6=^EEBHX3%Z&F+G3-
M6A2E@-&=S0736/[G3D7:2L.;347:1MP=@&;]\A4; S?$/Q2F3)V#[\!E)X%'
M$8H.27#7>E#?[FN-AAMZ,XBIV5_B/<+F&OU1FIQR]+7WO#8*:@8^A0R,1VV<
MT2SIYAO57LY.HZV4O.%.HVTDW@%PU@QZB8(,;_:>W#Q%H:2IS:46$1*W5I:8
MN BM1Z_M.#)IL"A[&$NSIZR[0\N=.3[*,I,*"4.H0'SDF"%FC""=L%)JDV5L
M7:G]8@8G;:7C30<G;2/P$8&S7%Q,SL+L\Y6]C=HF5JR'(&T=TETXR:1.6$?G
M+3(ON-PH<4"?>@<A]*N?Z/CE"\>=!=#6B.PNR1[4?SU/D!MF4U )2I825! )
MO'462!A&:VN,VFR:]B8 &'-NYQ[*NJ_N'20WLL+?7>7?;PB7F;@W"9 \(\)Z
M2N D\1%"TA8=CYQO%+H\H_)?OG1DI>^BLGD+^8VM^/#G'<+1>FT0.07>]88B
MQYIN**?)):8_\!*-D!L]K#ZG^+M?.DY\VDSQ.\NO ]?PUWMN9?<*9JXL&D"'
M%E2Q J(*'*S1(5)\1=AM_;3^D(IQA\$,$TCL*>ONT'+S5&>,URX7B'6-EV)!
M0S01P7 A,D=9@AH6+ST$$/OJ]DFH["#H#L#RS*AR+PW+*8!GJ.I<VIJ?DA$"
M\55$C-RSUCG*CB?%[Z_O[>;$;R'\#I"TSAQ?)1Y$R98":,B6NVJ-,P3&)3 M
MI<]6*N^;SUA]A)9QAU@-E,YK(?=.\?.VUE\L;DZ:UJYP$E)QJQ=E.@K.N4!"
M<@FSYB*GYCTYS]#47WIX>\UO *>=U= KK&Y+NY*5=,=+!2217.O[$(+E&830
M)1G& @48A\#45B/&!VO:.IR!VDT#'<!IW:)3A<:;:"/PS"H+@8Y;\8)<2F%0
MH*5/Z66G[$%MT8Y*WF"U[#82[Z>9Z=>=RI7WPC!#1%W7 !D!OD[QS\'$G P:
M5/?<HF=:E3I:3-T>#<U$.?;(WKL;UGUT=!5S#MX(HCM+3;Z^<L!8SBYQ](D/
ML8W^H*G=O=6^N\@ZN"[N-F:>7GS!Q=W.SDE&E8N6#*2L0Z%XK -'K06E>&U(
MP6"P=63T)$']Y?3:7"'MM- !I!Z97)]T%"DK!63OR.</,=,100')9:6#CX(K
MV]J3W7U7P$$?A=N J('<>T#/&OE<YT9^FR\6\S_J:U3X1G]R\6/B2I:.2P_D
M^X<Z$QO!,4R@=22'WZA ?^$ T=%C]/7WFM,(:4/IJ%/\G5QWD==.WJ.+#[B8
MSO/Q+$]0DY\C)8?B@@>57( HM ;-9?9.Y#K$X #P>X2\_D+UX=#70D-=KU]2
M43,Z+ B2JT0^0*TC4]:348^>&:&8M/Q93[S!^J7!II0,XIHW%&I/Z+BVM1^K
MG:TRNC6ZR]JP1>&D\<32JEP@._ Y)<A1A%B85RD^'[1O^FWC3E\_ &(:";I#
M[+S%B_KA\VOY34).T0@G(+M"M[0,$5P=_2J]=S*C+3H_ORYYDV\:>6#[X4"S
MCX0[]8->S;]^G5[4./4-XFM<IL5T95(GDJ2#.G,(W-:YJE%!<++NK% )HQ8I
MB>83%[>@;^09\(=UA9HHJ0< 7IV?&_9.+R^6%V%6Y]U?CT21K%#X2G=V0EM'
M7_!$!XK,L-5U%9(HQ<G6?7'/T33RL/@!@=92&3W/B#C]]^.S3R>_O3W^^/MO
MIV>O3]X??3I^_?[TT[[C(I[_W&:3([9D8=@A$KYHGZT*%( ))#?)<W*3E('(
MK.#6YLR:WPS##)%8N]U:2J98R%!"K&OX1(*H8@1=M#.6,9>L&H"Y>V2,W_.T
MI]Z?[GO:7M0=7%X?+^,2_W5)Y!]_KSS<-)VJC");Z4!&1DY@5AQB(G<P%VDT
M2E1&M<[$/T+*^*C92\7W&W(;R+M/V-RT_,E0DJ?S%+!F?@+24>*&T2]C#C8H
MIYM/=7R4F)&[N5NH^GGX["#W#@#TV^62_+WE\BC]ZW*ZG*YTLFIV5\'ZI#04
M658KY!Q$Q PN8,FR9(RE]4OU(Z3TM.1]?[O30MZ=PJ;^N,#;22H:2TR"4?"@
M;-U7;\!9XD]X%FQD*'CS;5S/$C6N'6JB^@W@M+L>>NC]78E$QY1SU@$D1UG;
M&.LF.G(&"X]HD&5KS49>3]/6[P--:=S=QNPNPQX4?]TCXB63BK@$@T2QXH+B
M *8+!*=34 H1-QN3]K*:OK=2UB--W]M(KJO>7Q\-BRC$-=:+(F-%I@F81Q^5
MD.K.<OJ#]OX.WO2]E<H>[?W=1GX=^ [KIRMYEKPW-M2<>ZF3URP$'0-81\P9
M*U/2K2MS=A]:=J"5> W"W+UEW2-@KET;5!X5+QD$UH4,A=B(WE"\975.,4KN
M4NO9B"]H7-E62MYP7-DV$N\ .&L:R7CA5K,<@*E<-]TQX@!K<ZN7)M+Y4N9^
M6<Q?;LI :QNSIY2[P\DUUI/6-EI!/ A7MVX0(\[6;+Q*10B!6L;6Y<<O8K[
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MQ)SC=!,/C9<>#,[^&MYLQLDVXNZA&G55B?UZ55;)KM^:BG0RYZ1!&&=J6BB
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MG\W/S\M\\4=8Y%N1.2FU5%H#0U^G Y&#&;3GD$LL-E $$C9X MKHJ\;-L0Z
MG$%DW(&)NG.9W^5LHHHMA9< R?)2]XX6\"Y:",X(9U/@6C0?:+Z>E-&JE@?0
M]^.>U,["WQE#WW QG9,!#(N+-M9GN6+DBH77EXOI[/.'JZ]8L79,4=W\!^*5
MQ3T/L^4D$)<B20&9Y;HL3B6(PG@@H\LR#PX=?WXJZ&[?/5H]]'"@.HP>.C!9
M*\K/\-OE(GT)2\Q'LWR&%]/%.FXG6C)TK,X'"84D22>(V.(<!"H9K1*%K/\0
M ?&&](WC81W$N VFIO'K;I^UWSQKETR$;.HRWLP3!%^WZR0E@\:BN&M=G+3/
MY=G<#QOW\MQ"^'M>GL>SW-)Q_P>>YY/9I\5J*]R/=?+2/&<6D/Q5KSTH))_
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MB(*9<7"ROH$8LE/!9 72Q92,+"GJUM#?D=1Q7YX/">M#Z+(#R-Y/SKXAH6_
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M=O7I)^]?G;X[_G3T?XX_OL:+,#U?_DKP<OKUVSD^C:4UG_&_?I)SG]#KCWH
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MG5_DVLSQ9?V\^1TN5F$ZHS_X.+\TK?5??X^KB\5L^7Y^?O[R,G>91"E40B_
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MX#UI8_TY8)T@"]'%NM+26PX*9=W@D#44+U0RRF,,S1^_G(BW<1=Q/UFC.P)
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M/;PNZ\ /WPWF3ZUKXD3*ZN4X.43 V^:1OI\N__9R@;75'0DIJ\NURLQADJH
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M)!Y:AZ,/$C5NO;*)ZG> T^%ZZ !8'R[B$O]^0>)\\8U^^4C_;"VD;#DY69<
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MK-/F(#UTB::KC!%#,C$@1"98[;VAO"X'#]P'K56TSMDT.)[Z.VT.T_.#T#E
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M+^N:L+(;X/])JGA#0>"Q6\)/=4R1O5GW;L;H*=\MM;NDUN]9$C$&'5,TS=]
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M_7I3(AK!R,+J[9"OE3SGJW4Q$(DS39)4W V_1.;XY98CCZH<..DX6&-= O*
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MBSV)W@VZ3ZHN-*1:N\3Q]C-BPERA2-T(B!2UDU2]!\_10-*)TLPLK;B]*GL
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M0QQH:0-/*VEG.[0(I6%#D\>UA-6UN/B_=[/;LOHK8:GQ3!9.YA! A$S!,V'
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MQ=]'J,[3/[]CF#DJJ6QY>"MY13R^N\4,]Q]I[M*OO&$N"9XA<N]*4NO 2*%
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M!/U?;M__1?G#NUGZR__\/U!+ P04    " "\<%Q6=,0PN=,'  !G*@  $P
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MWXNR1X.IG>^M>/V9P *.]65@$D^L0F(9H^34;\AU:R7+0C6.LL5I8Q?IQ3_
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M:70R,S(R,#(R+FAT;5!+ 0(4 Q0    ( +QP7%9\#97KR 4  $@2   3
M          "  90C P!E>&AI8FET,C0Q,#(P,C(N:'1M4$L! A0#%     @
MO'!<5K+6X9*L!0  RA$  !(              ( !C2D# &5X:&EB:70R-#$R
M,#(R+FAT;5!+ 0(4 Q0    ( +QP7%8/OC4,O04  .,1   2
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M=#(T-C(P,C(N:'1M4$L! A0#%     @ O'!<5BI.-K:^!0  -1(  !(
M         ( !$$T# &5X:&EB:70R-#<R,#(R+FAT;5!+ 0(4 Q0    ( +QP
M7%8ZXJ"BPP4  %P2   2              "  ?Y2 P!E>&AI8FET,C0X,C R
M,BYH=&U02P$"% ,4    " "\<%Q6ELP0@K\%   X$@  $@
M@ 'Q6 , 97AH:6)I=#(T.3(P,C(N:'1M4$L! A0#%     @ O'!<5@0UW(^-
MB04 2U8Z  \              ( !X%X# &QH+3(P,C(Q,C,Q+FAT;5!+ 0(4
M Q0    ( +QP7%:__70 0QL  +LX 0 /              "  9KH" !L:"TR
M,#(R,3(S,2YX<V102P$"% ,4    " "\<%Q6=$2^X:PE  "[< $ $P
M        @ $*! D ;&@M,C R,C$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( +QP
M7%;9T+-QY>\  $.A"@ 3              "  ><I"0!L:"TR,#(R,3(S,5]D
M968N>&UL4$L! A0#%     @ O'!<5JLF;1+D:P  <&X  !(
M ( !_1D* &QH+3(P,C(Q,C,Q7V<Q+FIP9U!+ 0(4 Q0    ( +QP7%;J)J:8
M^&H  $=N   2              "  1&&"@!L:"TR,#(R,3(S,5]G,BYJ<&=0
M2P$"% ,4    " "\<%Q6>62XEL5U  #W>   $@              @ $Y\0H
M;&@M,C R,C$R,S%?9S,N:G!G4$L! A0#%     @ O'!<5O5KX@K:?0$ I/ !
M !(              ( !+F<+ &QH+3(P,C(Q,C,Q7V<T+FIP9U!+ 0(4 Q0
M   ( +QP7%9Z>KRS(=(! $O@$@ 3              "  3CE# !L:"TR,#(R
M,3(S,5]L86(N>&UL4$L! A0#%     @ O'!<5MS /ZQ:40$ ;R@/ !,
M         ( !BK<. &QH+3(P,C(Q,C,Q7W!R92YX;6Q02P$"% ,4    " "\
M<%Q6=,0PN=,'  !G*@  $P              @ $5"1  ;&@Q,"UK97@S,3$R
M,#(R+FAT;5!+ 0(4 Q0    ( +QP7%8,TCNQSP<  &HJ   3
M  "  1D1$ !L:#$P+6ME>#,Q,C(P,C(N:'1M4$L! A0#%     @ O'!<5M;B
MR[YY!0  1R4  !(              ( !&1D0 &QH,3 M:V5X,S(R,#(R+FAT
7;5!+!08     '  < !@'  #"'A     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
